,Tech_ID,Title,Serial_Number,Patent_Number,Country,Country_WIPO_ID,File_Date,Issue_Date,Publication_Number,Date_Actually_Filed,Internal_ID,Entity_Size,Priority_Date,Status_Date,Is_Priority,Last_Related_Update,Status,Lawfirm,Attorney,Legal_Reference_Number,Inventors,Application_Type,Created_Date,Docket_No,Expire_Date,IP_Manager,Lead_Inventor,Licensing_Manager,Primary_Key,Publication_Date,Technology_Key,Licensed
0,00-T-001,Light Collectors in Cylinderical Geometry,"05/581,613","3,957,031",*United States,US,5/29/1975,5/18/1976, ,5/29/1975,0002.1-001,None,5/29/1975,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Roland Winston,US Utility,4/12/2018,0002.1-001,5/29/1995,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",612078,,580932,Yes
1,00-T-002,Radiant Energy Collector,"05/492,074","4,002,499",*United States,US,7/26/1974,1/11/1977, ,7/26/1974,0002.2-001,None,7/26/1974,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,Roland Winston,US Utility,4/12/2018,0002.2-001,7/26/1994,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",614263,,580933,Yes
2,00-T-003,Cylindrical Radiant Energy Direction Device With Refractive Medium,"05/714,863","4,114,592",*United States,US,8/16/1976,9/19/1978, ,8/16/1976,0002.3-001,None,8/16/1976,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,Roland Winston,US Utility,4/12/2018,0002.3-001,8/16/1996,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611370,,580934,Yes
3,00-T-004,Ideal Light Concentrators with Reflector Gaps,"05/909,864","4,230,095",*United States,US,5/26/1978,10/28/1980, ,5/26/1978,0009.1-001,None,5/26/1978,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Roland Winston,US Utility,4/12/2018,0009.1-001,5/26/1998,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611878,,580935,Yes
4,00-T-005,Nonimaging Radiant Energy Direction Device,"05/945,923","4,237,332",*United States,US,9/26/1978,12/2/1980, ,9/26/1978,0009.2-001,None,9/26/1978,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Roland Winston,US Utility,4/12/2018,0009.2-001,9/26/1998,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613704,,580936,Yes
5,00-T-006,Energy Transmission with Respect to Convex Sources and Receivers,"06/069,326", ,*United States,US,8/24/1979,, ,8/24/1979,0009.3-001,None,8/24/1979,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Roland Winston,US Utility,4/12/2018,0009.3-001,,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611528,,580937,Yes
6,00-T-006,Energy Transmission with Respect to Convex Sources and Receivers,"06/282,232","4,483,007",*United States,US,7/10/1981,11/13/1984, ,7/10/1981,0009.3-002,None,8/24/1979,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Roland Winston,Continuation,4/12/2018,0009.3-002,11/13/2001,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611529,,580937,Yes
7,00-T-007,Compounds that Enhance Tumor Death,"60/225,526", ,*United States,US,8/15/2000,, ,8/15/2000,0812-001,Small,8/15/2000,,Yes,5/7/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Seongeun Julia Cho, Glyn Dawson",Provisional,4/12/2018,0812-001,8/15/2001,"Sun, Han",Glyn Dawson,"Tennant, Thelma",611239,,581846,Yes
8,00-T-007,Compounds That Enhance Tumor Death,"09/930,559", ,*United States,US,8/15/2001,,US-2003-050236-A1,8/15/2001,0812-002,Small,8/15/2000,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Seongeun Julia Cho, Glyn Dawson",US Utility,4/12/2018,0812-002,8/15/2020,"Sun, Han",Glyn Dawson,"Tennant, Thelma",611240,3/13/2003,581846,Yes
9,00-T-008,Automated Method and System for the Two and Three Dimension,01803856.5, ,China,CN,1/18/2001,,CN 1395713 A,7/18/2002,0813-004,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0813-004,1/18/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610665,2/5/2003,581847,Yes
10,00-T-008,Method System and Computer Readable Medium for the Two-Dimensional and Three-Dimensional Detection of Lesions in Computed Tomography Scans,"60/176,304", ,*United States,US,1/18/2000,, ,1/18/2000,0813-001,Small,1/18/2000,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Provisional,4/12/2018,0813-001,1/18/2001,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612557,,581847,Yes
11,00-T-008,"Method, System and Computer Readable Medium for the Two-Dimensional and Three-Dimensional Detection of Lesions in Computed Tomography Scans","09/759,333","6,898,303",*United States,US,1/16/2001,5/24/2005,US-2002-0006216-A1,1/16/2001,0813-002,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",US Utility,4/12/2018,0813-002,1/18/2020,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612583,1/17/2002,581847,Yes
12,00-T-008,"Method, System and Computer Readable Medium for the Two-Dimensional and Three-Dimensional Detection of Lung Nodules in Computed Tomography Scans",PCT/US01/01478, ,*United States,US,1/18/2001,,WO01054065,1/18/2001,0813-003,Small,1/18/2000,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",PCT,4/12/2018,0813-003,7/18/2002,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612584,7/26/2001,581847,Yes
13,00-T-008,"Method, System and Computer Readable Medium for the Two-Dimensional and Three-Dimensional Detection of Lungs Nodules in Computed Tomography Scans",01942767.3EPO, ,European Patent Office (EPO),EP,1/18/2001,,1249006,7/8/2002,0813-006,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0813-006,1/18/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612585,10/16/2002,581847,Yes
14,00-T-008,"Method, System and Computer Readable Medium for the Two-Dimensional and Three-Dimensional Selection of lesions in Computer Tomography Scans",2001-554287, ,Japan,JP,1/18/2001,,2003-524489,7/18/2002,0813-005,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0813-005,1/18/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612586,8/19/2003,581847,Yes
15,00-T-010,Automated Method and System for the Segmentation of Lung Regions in Computed Tomography Scans,"60/176,297", ,*United States,US,1/18/2000,, ,1/18/2000,0816-001,Small,1/18/2000,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Provisional,4/12/2018,0816-001,1/18/2001,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610650,,581849,Yes
16,00-T-010,Automated Method and System for the Segmentation of lung Regions in Computed Tomography Scans,"09/760,854", ,*United States,US,1/17/2001,,US-2002-009215-A1,1/17/2001,0816-002,Small,1/18/2000,5/15/2006,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",US Utility,4/12/2018,0816-002,,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610651,1/24/2002,581849,Yes
17,00-T-010,Automated Method and System for the Segmentation of Lung Regions in Computed Tomography Scans,PCT/US01/01479, ,*United States,US,1/18/2001,,WO 01/54066 A1,1/18/2001,0816-003,Small,1/18/2000,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",PCT,4/12/2018,0816-003,7/18/2002,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610652,7/26/2001,581849,Yes
18,00-T-010,Automated Method and System for the Segmentation of Lung REgions in Computed Tomography Scans,10194946.4DE, ,Germany,DE,1/18/2001,, ,6/16/2003,0816-005,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Validated EPO,4/12/2018,0816-005,1/18/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610653,,581849,Yes
19,00-T-010,Automated Method and System for the Segmentation of Lung REgions in Computed Tomography Scans,2001-554288, ,Japan,JP,1/18/2001,,2003-523801,7/18/2002,0816-006,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0816-006,1/18/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610654,8/12/2003,581849,Yes
20,00-T-010,Automated Method and System for the Segmentation of Lung Regions in Computed Tomography Scans.,01805098.0, ,China,CN,1/18/2001,,CN 1418353A,9/7/2002,0816-004,Small,1/18/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0816-004,1/18/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610655,5/14/2003,581849,Yes
21,00-T-011,Fast Reconstruction with Uniform Noise Properties in Half-Scan Tomography,"09/503,609","6,324,242",*United States,US,10/5/1999,11/27/2001, ,2/11/2000,0734-003,Small,4/9/1999,,No,4/28/2022,Abandoned,Welsh & Katz,, ,Xiaochuan Pan,Continuation in Part,4/12/2018,0734-003,4/9/2019,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",611571,,581850,Yes
22,00-T-015,"A Firbil Blocking Peptide, A Method for Preventing Fibril  Formation","60/165,424", ,*United States,US,11/14/1999,, ,11/14/1999,0820-001,Small,11/14/1999,,Yes,4/28/2022,Expired - Inactive,Cherskov & Flaynik,, ,"Yair Argon, David Davis, Rosemarie Raffen, Fred Stevens",Provisional,4/12/2018,0820-001,11/14/2000,"Peace, Shane",Yair Argon,"Tennant, Thelma",610203,,581854,Yes
23,00-T-015,"Fibril-Blocking Peptide, A Method for Preventing Fibril Formation","09/712,819","6,878,521",*United States,US,11/13/2000,4/12/2005, ,11/13/2000,0820-002,None,11/14/1999,5/13/2013,No,4/28/2022,Abandoned,Cherskov & Flaynik,, ,"Yair Argon, David Davis, Rosemarie Raffen, Fred Stevens",US Utility,4/12/2018,0820-002,11/13/2020,"Peace, Shane",Yair Argon,"Tennant, Thelma",611577,,581854,Yes
24,00-T-016,Flavopiridol Drug Combinations and methods with Reduced Side Effects,PCT/US01/12526, ,*United States,US,4/12/2001,,WO 01/80896 A2,4/12/2001,0821-002,Small,4/21/2000,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Lalitha Iyer, Mark Ratain",PCT,4/12/2018,0821-002,10/21/2002,"Sun, Han",Mark Ratain,"Tennant, Thelma",611595,11/1/2001,581855,Yes
25,00-T-016,Flavopiridol Drug Combinations and Methods with Reduced Side Effects,"09/835,082", ,*United States,US,4/12/2001,,US-2002-016293-A1,4/12/2001,0821-003,Small,4/21/2000,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Lalitha Iyer, Mark Ratain",Continuation,4/12/2018,0821-003,4/21/2020,"Sun, Han",Mark Ratain,"Tennant, Thelma",611596,2/7/2002,581855,Yes
26,00-T-016,Flavopiridol Drug Combinations and Methods with Reduced Side-Effects,"09/553,829", ,*United States,US,4/21/2000,, ,4/21/2000,0821-001,Small,4/21/2000,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Federico Innocenti, Lalitha Iyer, Mark Ratain",US Utility,4/12/2018,0821-001,4/21/2020,"Sun, Han",Mark Ratain,"Tennant, Thelma",611597,,581855,Yes
27,00-T-018,Method System and Computer Readable Medium for Identifying Chest Radiographs Using Image Mapping and Template Matching Techniques,"60/193,072", ,*United States,US,3/28/2000,, ,3/28/2000,0823-001,Large,3/28/2000,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Hidetaka Arimura, Kunio Doi, Shigehiko Katsuragawa, Junji Morishita",Provisional,4/12/2018,0823-001,3/28/2001,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612556,,581857,Yes
28,00-T-018,"Method, system and computer readable medium for identifying chest radiographs using image mapping and template matching techniques","09/816,217","6,836,558",*United States,US,3/26/2001,12/28/2004,US-2002-0021829-A1,3/26/2001,0823-002,Large,3/28/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Hidetaka Arimura, Kunio Doi, Shigehiko Katsuragawa, Junji Morishita",US Utility,4/12/2018,0823-002,3/28/2020,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612575,2/21/2002,581857,Yes
29,00-T-018,"Method, System and Computer Readable Medium for Identifying Chest Radiographs Using Image Mapping and Template Matching Techniques",PCT/US01/08626, ,*United States,US,3/28/2001,,WO 01/73682 A1,3/28/2001,0823-003,Small,3/28/2000,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Hidetaka Arimura, Kunio Doi, Shigehiko Katsuragawa, Junji Morishita",PCT,4/12/2018,0823-003,9/28/2002,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612576,10/4/2001,581857,Yes
30,00-T-018,"Method, System and Computer Readable Medium for Identifying Chest Radiographs Using Image Mapping and Template Matching Techniques",2001-571325, ,Japan,JP,3/28/2001,,2004-509655,9/20/2002,0823-004,Large,3/28/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Hidetaka Arimura, Kunio Doi, Shigehiko Katsuragawa, Junji Morishita",Nationalized PCT,4/12/2018,0823-004,3/28/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612577,4/2/2004,581857,Yes
31,00-T-019,Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin Gallate,"60/183,668", ,*United States,US,2/18/2000,, ,2/18/2000,0824-001,Small,2/18/2000,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Provisional,4/12/2018,0824-001,2/18/2001,"Dembo, Anna",Richard Hiipakka,"Tennant, Thelma",613479,,581858,Yes
32,00-T-019,Polydyroxylated Benxene-Containing Compounds,"2,371,419", ,Canada,CA,2/15/2001,, ,8/17/2005,0824-005,Large,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Nationalized PCT,4/12/2018,0824-005,2/15/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614071,,581858,Yes
33,00-T-019,Polyhydroxylated Benzene-Containing Compounds,"09/783,901","6,610,749",*United States,US,2/15/2001,8/26/2003,US-2003-139477-A1,2/15/2001,0824-002,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",US Utility,4/12/2018,0824-002,2/18/2020,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614072,7/24/2003,581858,Yes
34,00-T-019,Polyhydroxylated Benzene-Containing Compounds,PCT/US01/04915, ,*United States,US,2/15/2001,,WO 01/60319 A3,2/15/2001,0824-003,Small,2/18/2000,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",PCT,4/12/2018,0824-003,8/18/2002,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614073,8/23/2001,581858,Yes
35,00-T-019,Polyhydroxylated Benzene-Containing Compounds,01910769.7EPO, ,European Patent Office (EPO),EP,2/15/2001,,EP 1 214 070 A2,5/8/2002,0824-004,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Nationalized PCT,4/12/2018,0824-004,2/15/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614074,6/19/2002,581858,Yes
36,00-T-019,Polyhydroxylated Benzene-Containing Compounds,38341/01,783361,Australia,AU,2/15/2001,2/2/2006, ,3/18/2005,0824-006,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Continuation,4/12/2018,0824-006,2/15/2021,"Dembo, Anna",Richard Hiipakka,"Tennant, Thelma",614075,,581858,Yes
37,00-T-019,Polyhydroxylated Benzene-Containing Compounds,90103580,I284038,"Taiwan, Province of China",TW,2/15/2001,7/21/2007, ,10/13/2003,0824-008,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Validated EPO,4/12/2018,0824-008,2/15/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614076,,581858,Yes
38,00-T-019,Polyhydroxylated Benzene-Containing Compounds,"146,010", ,Israel,IL,2/15/2001,,IL-146010-A0,1/4/2002,0824-009,None,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Nationalized PCT,4/12/2018,0824-009,2/15/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614077,7/25/2002,581858,Yes
39,00-T-019,Polyhydroxylated Benzene-Containing Compounds,01800259.5, ,China,CN,2/15/2001,, ,2/14/2003,0824-010,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Divisional,4/12/2018,0824-010,2/14/2023,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614078,,581858,Yes
40,00-T-019,Polyhydroxylated Benzene-Containing Compounds,03105259.2, ,Hong Kong,HK,2/15/2001,,1053055 CN1392796A,7/22/2003,0824-011,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Nationalized PCT,4/12/2018,0824-011,7/22/2023,"Dembo, Anna",Richard Hiipakka,"Tennant, Thelma",614079,10/10/2003,581858,Yes
41,00-T-019,Polyhydroxylated Benzene-Containing Compounds,"10/644,266", ,*United States,US,2/15/2001,, ,8/20/2003,0824-012,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Continuation,4/12/2018,0824-012,2/18/2020,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614080,2/15/2000,581858,Yes
42,00-T-019,Polyhydroxylated Benzene-Containing Compounds Useful in Reducing Endocrine Levels,515442,515442,New Zealand,NZ,2/15/2001,3/26/2004,NZ515442A,9/20/2002,0824-007,Small,2/18/2000,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, Yung-Hsi Kao, Shutsung Liao",Validated EPO,4/12/2018,0824-007,2/15/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614081,3/26/2004,581858,Yes
43,00-T-026,Transgenic Plants Containing Heat Shock Protein,"60/190,769", ,*United States,US,3/20/2000,, ,3/20/2000,0831-001,Large,3/20/2000,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Susan Lindquist, Christine Queitsch, Elizabeth Vierling",Provisional,4/12/2018,0831-001,3/20/2001,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614933,,581865,Yes
44,00-T-026,Transgenic Plants Containing Heat Shock Protein,"60/198,116", ,*United States,US,4/18/2000,, ,4/18/2000,0831-002,Large,4/18/2000,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Sistrunk, Melissa", ,"Susan Lindquist, Christine Queitsch, Elizabeth Vierling",Provisional,4/12/2018,0831-002,4/18/2001,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614934,,581865,Yes
45,00-T-026,Transgenic Plants Containing Heat Shock Protein,PCT/US01/08836, ,*United States,US,3/20/2001,,WO 01/70929 A2,3/20/2001,0831-004,Large,4/18/2000,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Sistrunk, Melissa", ,"Susan Lindquist, Christine Queitsch, Elizabeth Vierling",PCT,4/12/2018,0831-004,9/20/2002,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614935,9/27/2001,581865,Yes
46,00-T-026,Transgenic Plants Containing Heat Shock Proteins,"09/812,350", ,*United States,US,3/20/2001,,US-2002-053097-A1,3/20/2001,0831-003,Large,4/18/2000,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Susan Lindquist, Christine Queitsch, Elizabeth Vierling",US Utility,4/12/2018,0831-003,4/18/2020,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614936,5/2/2002,581865,Yes
47,00-T-027,Liver X Receptor Agonists,"60/288,643", ,*United States,US,5/3/2001,, ,5/3/2001,0832-001,Small,5/3/2001,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Provisional,4/12/2018,0832-001,5/3/2002,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612087,,581866,Yes
48,00-T-027,Liver X Receptor Agonists,2002303553, ,Australia,AU,5/2/2002,, ,2/11/2004,0832-002,None,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0832-002,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612088,,581866,Yes
49,00-T-027,Liver X Receptor Agonists,02731581.1EPO,1392713,European Patent Office (EPO),EP,5/2/2002,10/17/2007,1392713,2/11/2004,0832-003,Small,5/3/2001,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0832-003,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612089,3/3/2004,581866,Yes
50,00-T-027,Liver X Receptor Agonists,"2,446,314","2,446,314",Canada,CA,5/2/2002,2/22/2011, ,2/11/2004,0832-004,Large,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0832-004,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612090,,581866,Yes
51,00-T-027,Liver X Receptor Agonists,02813426.5,ZL 02813426.5,China,CN,5/2/2002,1/9/2008,CN 1525777A,2/11/2004,0832-005,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0832-005,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612091,2/23/2005,581866,Yes
52,00-T-027,Liver X Receptor Agonists,"10/137,695","7,012,069",*United States,US,5/2/2002,3/14/2006,US-2002-193357-A1,5/2/2002,0832-006,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",US Utility,4/12/2018,0832-006,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612092,12/19/2002,581866,Yes
53,00-T-027,Liver X Receptor Agonists,PCT/US02/13594, ,*United States,US,5/2/2002,,WO 02/090375 A3,5/2/2002,0832-007,Small,5/3/2001,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",PCT,4/12/2018,0832-007,11/3/2003,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612093,11/14/2002,581866,Yes
54,00-T-027,Liver X Receptor Agonists,2002-587452,4309661,Japan,JP,5/2/2002,5/15/2009,2005-507588,2/11/2004,0832-008,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0832-008,5/2/2022,"Dembo, Anna",Ching Song,"Tennant, Thelma",612094,3/24/2005,581866,Yes
55,00-T-027,Liver X Receptor Agonists,91109293, ,"Taiwan, Province of China",TW,5/2/2002,, ,5/23/2002,0832-009,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song","Foreign, Non-PCT",4/12/2018,0832-009,5/3/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612095,,581866,Yes
56,00-T-027,Liver X Receptor Agonists,"11/375,699", ,*United States,US,5/2/2002,, ,3/14/2006,0832-010,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Continuation,4/12/2018,0832-010,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612096,,581866,Yes
57,00-T-027,Liver X Receptor Agonists,02731581.1FR,1392713,France,FR,5/2/2002,10/17/2007,1392713,10/17/2007,0832-011,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-011,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612097,3/3/2004,581866,Yes
58,00-T-027,Liver X Receptor Agonists,02731581.1AT,375994,Austria,AT,5/2/2002,6/10/2008,1392713,2/1/2008,0832-012,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-012,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612098,3/3/2004,581866,Yes
59,00-T-027,Liver X Receptor Agonists,02731581.1BE,1392713,Belgium,BE,5/2/2002,10/17/2007,1392713,10/17/2007,0832-013,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-013,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612099,3/3/2004,581866,Yes
60,00-T-027,Liver X Receptor Agonists,02731581.1CH,1392713,Switzerland,CH,5/2/2002,10/17/2007,1392713,10/17/2007,0832-014,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-014,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612100,3/3/2004,581866,Yes
61,00-T-027,Liver X Receptor Agonists,02731581.1DE,602 23 020,Germany,DE,5/2/2002,7/24/2008,1392713,7/24/2008,0832-015,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-015,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612101,3/3/2004,581866,Yes
62,00-T-027,Liver X Receptor Agonists,02731581.1DK,1392713,Denmark,DK,5/2/2002,10/17/2007,1392713,10/17/2007,0832-016,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-016,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612102,3/3/2004,581866,Yes
63,00-T-027,Liver X Receptor Agonists,02731581.1ES,1392713,Spain,ES,5/2/2002,10/17/2007,1392713,10/17/2007,0832-017,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-017,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612103,3/3/2004,581866,Yes
64,00-T-027,Liver X Receptor Agonists,02731581.1FI,1392713,Finland,FI,5/2/2002,10/17/2007,1392713,10/17/2007,0832-018,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-018,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612105,3/3/2004,581866,Yes
65,00-T-027,Liver X Receptor Agonists,02731581.1GB,1392713,United Kingdom,GB,5/2/2002,10/17/2007,1392713,10/17/2007,0832-019,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-019,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612106,3/3/2004,581866,Yes
66,00-T-027,Liver X Receptor Agonists,02731581.1GR,"3,064,371",Greece,GR,5/2/2002,1/17/2008,1392713,1/17/2008,0832-020,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-020,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612107,3/3/2004,581866,Yes
67,00-T-027,Liver X Receptor Agonists,02731581.1IE,1392713,Ireland,IE,5/2/2002,10/17/2007,1392713,2/1/2008,0832-021,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-021,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612108,3/3/2004,581866,Yes
68,00-T-027,Liver X Receptor Agonists,02731581.1IT,1392713,Italy,IT,5/2/2002,10/17/2007,1392713,2/1/2008,0832-022,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-022,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612109,3/3/2004,581866,Yes
69,00-T-027,Liver X Receptor Agonists,02731581.1LU,1392713,Luxembourg,LU,5/2/2002,10/17/2007,1392713,10/17/2007,0832-023,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-023,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612110,3/3/2004,581866,Yes
70,00-T-027,Liver X Receptor Agonists,02731581.1NL,1392713,Netherlands,NL,5/2/2002,10/17/2007,1392713,10/17/2007,0832-024,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-024,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612111,3/3/2004,581866,Yes
71,00-T-027,Liver X Receptor Agonists,02731581.1PT,1392713,Portugal,PT,5/2/2002,10/17/2007,1392713,10/17/2007,0832-025,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-025,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612112,3/3/2004,581866,Yes
72,00-T-027,Liver X Receptor Agonists,02731581.1SE,1392713,Sweden,SE,5/2/2002,10/17/2007,1392713,10/17/2007,0832-026,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-026,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612113,3/3/2004,581866,Yes
73,00-T-027,Liver X Receptor Agonists,02731581.1TR,2008 00330,Turkey,TR,5/2/2002,10/17/2007,1392713,10/17/2007,0832-027,Small,5/3/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Qing Dai, Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0832-027,5/2/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612114,3/3/2004,581866,Yes
74,00-T-031,Methods For Isolating Centromere DNA,01950388.7EPO, ,European Patent Office (EPO),EP,6/22/2001,,EP 1 339 868 A2,1/8/2003,0836-003,Small,6/23/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,3011AA-EP,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",Nationalized PCT,4/12/2018,0836-003,6/22/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613222,3/9/2003,581870,Yes
75,00-T-031,Methods for Isolating Centromere DNA,2001271383, ,Australia,AU,6/22/2001,9/6/2007,7138301,1/8/2003,0836-004,Small,6/23/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,30011-AU,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",Nationalized PCT,4/12/2018,0836-004,6/22/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613223,1/18/2002,581870,Yes
76,00-T-031,Methods For Isolating Plant Centromere DNA,"2,412,609","2,412,609",Canada,CA,6/22/2001,9/7/2010, ,1/8/2003,0836-002,Large,6/23/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,30011-CA,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",Nationalized PCT,4/12/2018,0836-002,6/22/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613224,1/3/2002,581870,Yes
77,00-T-031,Methods for Isolating Plant Centromere DNA,2007202319, ,Australia,AU,6/22/2001,,7138301,5/17/2007,0836-007,Small,6/23/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,30011B-AU,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",Divisional,4/12/2018,0836-007,6/22/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613225,1/18/2002,581870,Yes
78,00-T-031,Methods of Isolating Centromere DNA,PCT/US01/19966, ,*United States,US,6/22/2001,,WO 02/000842 A3,6/22/2001,0836-006,Small,6/23/2000,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30011-PC,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",PCT,4/12/2018,0836-006,12/23/2002,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613333,1/3/2002,581870,Yes
79,00-T-031,Methods of Isolating Plant Centromere DNA,"60/228,793", ,*United States,US,6/23/2000,, ,6/23/2000,0836-001,Small,6/23/2000,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30011,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",Provisional,4/12/2018,0836-001,6/23/2001,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613334,,581870,Yes
80,00-T-031,Use of Methylated Nucleic Acid Segments for Isolating Centromere DNA,"09/888,220","6,649,347",*United States,US,6/22/2001,11/18/2003,US-2002-123053-A1,6/22/2001,0836-005,Small,6/23/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,30011A,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",US Utility,4/12/2018,0836-005,6/23/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",615206,9/5/2002,581870,Yes
81,00-T-031,Use of Methylated Nucleic Acid Segments for Isolating Centromere DNA,"10/620,924","7,132,240",*United States,US,6/22/2001,11/7/2006,US-2004-023282-A1,7/16/2003,0836-008,Small,6/23/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Gregory Copenhaver, Kevin Keith, Song Luo, Daphne Preuss",Continuation,4/12/2018,0836-008,7/16/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",615207,2/5/2004,581870,Yes
82,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,PCT/US02/09885, ,*United States,US,3/29/2002,,WO 02/078640 A3,3/29/2002,0837-002,Small,3/29/2001,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",PCT,4/12/2018,0837-002,9/21/2003,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611301,10/10/2002,581871,Yes
83,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,02728619.4EPO,1415154,European Patent Office (EPO),EP,3/29/2002,10/21/2009,EP 1 415 154 A2,9/29/2003,0837-007,Small,3/29/2001,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-007,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611302,5/6/2004,581871,Yes
84,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,"2,442,684", ,Canada,CA,3/29/2002,11/19/2013, ,9/29/2003,0837-008,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-008,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611303,9/29/2003,581871,Yes
85,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,2002-258663,2002258663,Australia,AU,3/29/2002,6/5/2008, ,9/29/2003,0837-009,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-009,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611304,3/29/2002,581871,Yes
86,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,PA/A/2003/008861,264044,Mexico,MX,3/29/2002,1/23/2009, ,9/29/2003,0837-013,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-013,9/29/2023,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611305,,581871,Yes
87,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,"10/842,989","7,629,317",*United States,US,3/29/2002,12/8/2009,US-2005-031582-A1,5/11/2004,0837-014,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Continuation,4/12/2018,0837-014,7/29/2023,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611306,2/10/2005,581871,Yes
88,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,"10/473,571","8,278,269",*United States,US,3/29/2002,10/2/2012,US-2005-054564-A1,6/22/2004,0837-015,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",US Utility,4/12/2018,0837-015,6/22/2024,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611307,3/10/2005,581871,Yes
89,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,05010217.7EPO, ,European Patent Office (EPO),EP,3/29/2002,, ,5/10/2005,0837-017,Small,3/29/2001,,Yes,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,0837-017,5/10/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611308,,581871,Yes
90,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,"12/604,609","7,910,543",*United States,US,3/29/2002,3/22/2011,US-2010-0113356-A1,5/11/2004,0837-019,Small,3/29/2001,4/2/2019,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0837-019,3/29/2021,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611309,5/6/2010,581871,Yes
91,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,02728619.4DE,1415154,Germany,DE,3/29/2002,10/21/2009, ,10/21/2009,0837-020,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0837-020,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611310,,581871,Yes
92,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,02728619.4FR,1415154,France,FR,3/29/2002,10/21/2009, ,10/27/2009,0837-021,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0837-021,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611311,,581871,Yes
93,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,02728619.4GB,1415154,United Kingdom,GB,3/29/2002,10/21/2009, ,10/27/2009,0837-022,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0837-022,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611312,,581871,Yes
94,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,02728619.4ES,1415154,Spain,ES,3/29/2002,10/21/2009, ,11/30/2009,0837-023,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0837-023,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611313,,581871,Yes
95,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,02728619.4IT,1415154,Italy,IT,3/29/2002,10/21/2009,31127/2009,12/28/2009,0837-024,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0837-024,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611314,,581871,Yes
96,00-T-032,Control of Growth and Repair of Gastro-intestinal Tissues by Gastrokines and Inhibitors,"13/042,958","8,741,838",*United States,US,3/29/2002,6/3/2013, ,3/8/2011,0837-025,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Continuation,4/12/2018,0837-025,3/29/2021,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611315,,581871,Yes
97,00-T-032,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,"13/599,417","8,791,068",*United States,US,3/29/2002,7/29/2014,US-2013-086701,8/30/2012,0837-026,Small,3/29/2001,8/2/2018,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Continuation,4/12/2018,0837-026,3/29/2021,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611316,4/4/2013,581871,Yes
98,00-T-032,Control of Growth and Repair of Grastro-Intestinal Tissues by Gastrokines and Inhibitors,2002-576908,4281947,Japan,JP,3/29/2002,3/27/2009, ,9/29/2003,0837-010,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-010,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611318,,581871,Yes
99,00-T-032,Control of Growth and Repair of Grastro-Intestinal Tissues by Gastrokines and Inhibitors,2007-121196, ,Japan,JP,3/29/2002,, ,5/1/2007,0837-018,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Terence Martin, F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0837-018,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611319,,581871,Yes
100,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,"09/821,726","6,734,289",*United States,US,3/29/2001,5/11/2004,US-2003-017548-A1,3/29/2001,0837-001,Small,3/29/2001,12/21/2021,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Terence Martin, Thomas Powell, F. Gary Toback",US Utility,4/12/2018,0837-001,3/29/2021,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611625,1/23/2003,581871,Yes
101,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,PCT/US02/10148, ,*United States,US,3/29/2002,,WO 02/092758 A3,3/29/2002,0837-003,Small,3/29/2001,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Terence Martin, Thomas Powell, F. Gary Toback",PCT,4/12/2018,0837-003,9/29/2003,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611626,11/21/2002,581871,Yes
102,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,"2,442,635", ,Canada,CA,3/29/2002,, ,9/29/2003,0837-004,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Somnath Bhattacharyya, Terence Martin, Thomas Powell, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-004,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611627,,581871,Yes
103,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,2002303199,2002303199,Australia,AU,3/29/2002,6/26/2008, ,10/6/2003,0837-005,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Somnath Bhattacharyya, Terence Martin, Thomas Powell, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-005,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611628,,581871,Yes
104,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,2002-589626,4295516,Japan,JP,3/29/2002,4/17/2009,2004-532037,9/29/2003,0837-006,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Somnath Bhattacharyya, Terence Martin, Thomas Powell, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-006,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611629,10/21/2004,581871,Yes
105,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,02731209.9EPO, ,European Patent Office (EPO),EP,3/29/2002,,1423409,9/26/2003,0837-011,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Somnath Bhattacharyya, Terence Martin, Thomas Powell, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-011,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611630,6/2/2004,581871,Yes
106,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,PA/a/2003/008855,241668,Mexico,MX,3/29/2002,11/3/2006, ,9/29/2003,0837-012,Small,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Somnath Bhattacharyya, Terence Martin, Thomas Powell, F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0837-012,3/29/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611631,,581871,Yes
107,00-T-032,Gastrokines and Derived Peptides Including Inhibitors,"10/473,524","7,557,083",*United States,US,3/29/2002,7/7/2009,US-2005-065328-A1,10/21/2004,0837-016,None,3/29/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Kan Agarwal, Terence Martin, Thomas Powell, F. Gary Toback",US Utility,4/12/2018,0837-016,9/6/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611632,3/24/2005,581871,Yes
108,00-T-035,Ginseng Berry Extracts and Pharmaceutical Composition from Ginseng Berry for the Treatment of Type 2 Diabetes and Obesity,"60/246,628", ,*United States,US,11/7/2000,, ,11/7/2000,0840-001,Small,11/7/2000,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Chun-Su Yuan,Provisional,4/12/2018,0840-001,11/7/2001,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",611698,,581874,Yes
109,00-T-035,Ginseng Berry Extracts and Pharmaceutical Composition from Ginseng Berry for the Treatment of Type 2 Diabetes and Obesity,PCT/US01/31860, ,*United States,US,10/9/2001,,WO 02/31860,10/9/2001,0840-002,Small,11/7/2000,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Chun-Su Yuan,PCT,4/12/2018,0840-002,5/7/2003,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",611699,5/16/2002,581874,Yes
110,00-T-035,Ginseng Berry Extracts and Pharmaceutical Compositions  from Ginseng Berry for the Treatment of Type 2 Diabetes and Obesity,"09/974,749", ,*United States,US,10/9/2001,,US-2002-0136785-A1,10/9/2001,0840-003,Small,11/7/2000,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Chun-Su Yuan,US Utility,4/12/2018,0840-003,11/7/2020,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",611700,9/26/2002,581874,Yes
111,00-T-041,Compositions and Methods for Optimizing Epirubicin Dosing,"60/264,534", ,*United States,US,1/26/2001,, ,1/26/2001,0846-001,Small,1/26/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"Soma Das, Federico Innocenti, Lalitha Iyer, Mark Ratain",Provisional,4/12/2018,0846-001,1/26/2002,"Sun, Han",Mark Ratain,"Tennant, Thelma",610996,,581880,Yes
112,00-T-041,Compositions and Methods for Optimizing UGT2B7 Substrate Dosings and for Predicting UGT2B7 Substrate Toxicity,"10/057,834", ,*United States,US,1/25/2002,,US-2003-099960-A1,1/25/2002,0846-002,Small,1/26/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Soma Das, Federico Innocenti, Lalitha Iyer, Mark Ratain, Michael Sawyer",US Utility,4/12/2018,0846-002,1/26/2021,"Sun, Han",Mark Ratain,"Tennant, Thelma",610997,5/29/2003,581880,Yes
113,00-T-041,Compounds and Methods for Optimizing UGT2B7 Substrate Dosings and for Predicting UGT2B7 Substrate Toxicity,PCT/US02/02083, ,*United States,US,1/25/2002,,WO 02/059375,1/25/2002,0846-003,Large,1/26/2001,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Soma Das, Federico Innocenti, Lalitha Iyer, Mark Ratain, Michael Sawyer",PCT,4/12/2018,0846-003,7/26/2003,"Sun, Han",Mark Ratain,"Tennant, Thelma",611235,8/1/2002,581880,Yes
114,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease,2002-546435,4004952,Japan,JP,11/28/2001,8/31/2007,2004-528820,5/28/2003,0847-003,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-JP,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0847-003,11/28/2021,"Ramirez, Mario Riojas",Christopher Skelly,"Tennant, Thelma",611681,9/24/2004,581881,Yes
115,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease,"2,430,341", ,Canada,CA,11/28/2001,,CA2430341AA,5/28/2003,0847-005,Large,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-CA,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0847-005,11/28/2021,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611682,6/6/2002,581881,Yes
116,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease,PCT/US01/44279, ,*United States,US,11/28/2001,,WO 02/045431 A3,11/29/2001,0847-006,Small,11/28/2000,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Cawley, Thomas",37922-PC,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",PCT,4/12/2018,0847-006,5/28/2003,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611683,6/6/2002,581881,Yes
117,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease,"09/995,475","6,846,670",*United States,US,11/28/2001,1/25/2005,US-2002-0155432-A1,11/28/2001,0847-007,Small,11/28/2000,12/21/2021,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",37922,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",US Utility,4/12/2018,0847-007,12/25/2021,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611684,10/24/2002,581881,Yes
118,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5EPO,1356071,European Patent Office (EPO),EP,11/28/2001,11/21/2007,1356071,7/9/2003,0847-002,Small,11/28/2000,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,37922-EP,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0847-002,11/28/2021,"Ramirez, Mario Riojas",Christopher Skelly,"Tennant, Thelma",611685,10/29/2003,581881,Yes
119,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5FR,1356071,France,FR,11/28/2001,11/21/2007,1356071,2/12/2008,0847-008,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-FR,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Validated EPO,4/12/2018,0847-008,11/28/2021,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611686,10/29/2003,581881,Yes
120,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5DE,60131569.3-08,Germany,DE,11/28/2001,11/21/2007,1356071,2/19/2008,0847-009,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-DE,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Validated EPO,4/12/2018,0847-009,11/28/2021,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611687,10/29/2003,581881,Yes
121,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5GB,1356071,United Kingdom,GB,11/28/2001,11/21/2007,1356071,2/19/2008,0847-010,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-GB,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Validated EPO,4/12/2018,0847-010,11/28/2021,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611688,10/29/2003,581881,Yes
122,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5IE,1356071,Ireland,IE,11/28/2001,11/21/2007,1356071,1/22/2008,0847-011,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-IE,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Validated EPO,4/12/2018,0847-011,11/28/2021,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611689,10/29/2003,581881,Yes
123,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5AT,E379116,Austria,AT,11/28/2001,11/21/2007,1356071,3/11/2008,0847-012,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-AT,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Validated EPO,4/12/2018,0847-012,11/28/2021,"Ramirez, Mario Riojas",Christopher Skelly,"Tennant, Thelma",611690,10/29/2003,581881,Yes
124,00-T-042,Genetically Engineered Herpes Virus for the Treatment of Cardiovascular Disease.,01999116.5BE,1356071,Belgium,BE,11/28/2001,11/21/2007,1356071,2/19/2008,0847-013,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-BE,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Validated EPO,4/12/2018,0847-013,11/28/2021,"Ramirez, Mario Riojas",Christopher Skelly,"Tennant, Thelma",611691,10/29/2003,581881,Yes
125,00-T-042,Genetically-Engineered Herpes Virus for the Teratment of Cardiovascular Disease,2002217885,2002217885,Australia,AU,11/28/2001,8/16/2007,AU0217885A5,5/28/2003,0847-004,Small,11/28/2000,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,37922-AU,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0847-004,11/28/2021,"Ramirez, Mario Riojas",Christopher Skelly,"Tennant, Thelma",611692,6/11/2002,581881,Yes
126,00-T-042,Genetically-Engineered Herpes Virus for the Treatment of Cardiovascular Disease,"60/253,680", ,*United States,US,11/28/2000,, ,11/29/2000,0847-001,Small,11/28/2000,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rasheed, Nabeela",000,"Bernard Roizman, Lewis Schwartz, Christopher Skelly, Ralph Weichselbaum",Provisional,4/12/2018,0847-001,11/28/2001,"Ramirez, Mario Riojas",Bernard Roizman,"Tennant, Thelma",611693,,581881,Yes
127,00-T-043,Novel Steroidal Derivatives,"60/267,493", ,*United States,US,2/8/2001,, ,2/8/2001,0848-001,Small,2/8/2001,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Provisional,4/12/2018,0848-001,2/8/2002,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613732,,581882,Yes
128,00-T-043,Steroidal Derivatives,PCT/US02/03826, ,*United States,US,2/7/2002,,WO 02/062302 A3,2/7/2002,0848-002,Small,2/8/2001,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",PCT,4/12/2018,0848-002,8/8/2003,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614656,8/15/2002,581882,Yes
129,00-T-043,Steroidal Derivatives,02704407.2EPO, ,European Patent Office (EPO),EP,2/7/2002,,EP 1 385 868 A2,11/3/2003,0848-003,Small,2/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0848-003,2/7/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614657,2/4/2004,581882,Yes
130,00-T-043,Steroidal Derivatives,"2,438,221", ,Canada,CA,2/7/2002,, ,11/3/2003,0848-004,Large,2/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0848-004,2/7/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614658,,581882,Yes
131,00-T-043,Steroidal Derivatives,02807008.9, ,China,CN,2/7/2002,,CN 1498222A,11/3/2003,0848-005,Small,2/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0848-005,2/8/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614659,5/19/2004,581882,Yes
132,00-T-043,Steroidal Derivatives,91102325, ,"Taiwan, Province of China",TW,2/7/2002,, ,5/3/2002,0848-006,Small,2/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0848-006,2/8/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614660,,581882,Yes
133,00-T-043,Steroidal Derivatives,"10/072,128", ,*United States,US,2/8/2002,, ,2/8/2002,0848-007,Small,2/8/2001,12/5/2005,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",US Utility,4/12/2018,0848-007,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614661,,581882,Yes
134,00-T-043,Steroidal Derivatives,2002-562310, ,Japan,JP,2/7/2002,, ,11/3/2003,0848-008,Small,2/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0848-008,2/7/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614662,,581882,Yes
135,00-T-043,Steroidal Derivatives,2002238093, ,Australia,AU,2/7/2002,, ,11/3/2003,0848-009,Small,2/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0848-009,2/7/2022,"Dembo, Anna",Ching Song,"Tennant, Thelma",614663,,581882,Yes
136,00-T-044,Inhibitors and Disassemblers of Fibrilogenesis,"10/103,658", ,*United States,US,3/20/2002,,US-2003-130484-A1,3/20/2002,0849-003,Small,3/20/2001,,No,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"David Gordon, Stephen Meredith",US Utility,4/12/2018,0849-003,3/20/2021,"Butler, Brittany",Stephen Meredith,"Butler, Brittany",612027,7/10/2003,581883,Yes
137,00-T-044,Inhibitors and Disassemblers of Filbrillogenesis,"60/277,477", ,*United States,US,3/20/2001,, ,3/20/2001,0849-001,Small,3/20/2001,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"David Gordon, Stephen Meredith",Provisional,4/12/2018,0849-001,3/20/2002,"Butler, Brittany",Stephen Meredith,"Butler, Brittany",612028,,581883,Yes
138,00-T-044,Methods and Compositions for the Detection of Chromosomal Aberrations,PCT/US02/08803, ,*United States,US,3/20/2002,,WO 02/074931,3/20/2002,0849-002,Small,3/20/2001,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"David Gordon, Stephen Meredith",PCT,4/12/2018,0849-002,9/20/2003,"Butler, Brittany",Stephen Meredith,"Butler, Brittany",612866,9/26/2002,581883,Yes
139,00-T-046,Apparatus for Applying Optical Gradient Forces,"09/680,898", ,*United States,US,10/6/2000,, ,10/6/2000,0851-001,Small,10/6/2000,,Yes,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",US Utility,4/12/2018,0851-001,10/6/2020,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610514,,581885,Yes
140,00-T-046,Apparatus for Applying Optical Gradient Forces,PCT/US01/42465, ,*United States,US,10/5/2001,,WO 02/056431,10/5/2001,0851-002,Small,10/6/2000,,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",PCT,4/12/2018,0851-002,4/6/2003,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610515,7/18/2002,581885,Yes
141,00-T-046,Apparatus for Applying Optical Gradient Forces,2002-556986,4148776,Japan,JP,10/5/2001,7/4/2008,2004-517742,9/29/2004,0851-003,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-003,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610516,6/17/2004,581885,Yes
142,00-T-046,Apparatus for Applying Optical Gradient Forces,10-2003-7004914,641722,"Korea, Republic of",KR,10/5/2001,10/26/2006, ,4/25/2003,0851-004,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-004,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610517,,581885,Yes
143,00-T-046,Apparatus for Applying Optical Gradient Forces,525102, ,New Zealand,NZ,10/5/2001,, ,4/2/2003,0851-005,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-005,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610518,,581885,Yes
144,00-T-046,Apparatus for Applying Optical Gradient Forces,2003112973,2291511,Russian Federation,RU,10/5/2001,1/10/2007, ,5/5/2003,0851-006,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-006,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610519,,581885,Yes
145,00-T-046,Apparatus for Applying Optical Gradient Forces,2002243203,2002243203,Australia,AU,10/5/2001,10/19/2006, ,4/25/2003,0851-007,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-007,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610520,7/24/2002,581885,Yes
146,00-T-046,Apparatus for Applying Optical Gradient Forces,01820222.5,ZL 01 8 20222.5,China,CN,10/5/2001,9/20/2006,1480013,8/11/2003,0851-008,Small,10/6/2000,,Yes,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-008,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610521,3/3/2004,581885,Yes
147,00-T-046,Apparatus for Applying Optical Gradient Forces,200301827-2,95947,Singapore,SG,10/5/2001,, ,4/3/2003,0851-009,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-009,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610522,,581885,Yes
148,00-T-046,Apparatus for Applying Optical Gradient Forces,"155,211","155,211",Israel,IL,10/5/2001,2/1/2007, ,4/25/2003,0851-010,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-010,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610523,,581885,Yes
149,00-T-046,Apparatus for Applying Optical Gradient Forces,01989082.1EPO,1325540,European Patent Office (EPO),EP,10/5/2001,7/16/2008,1325540,5/21/2003,0851-011,Small,10/6/2000,,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-011,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610524,7/9/2003,581885,Yes
150,00-T-046,Apparatus for Applying Optical Gradient Forces,0645/CHENP/2003,229911,India,IN,10/5/2001,, ,4/25/2003,0851-012,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-012,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610525,,581885,Yes
151,00-T-046,Apparatus for Applying Optical Gradient Forces,90124527,NI-177339,"Taiwan, Province of China",TW,10/5/2001,5/11/2003,531661,10/4/2001,0851-013,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-013,10/4/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610526,5/11/2003,581885,Yes
152,00-T-046,Apparatus for Applying Optical Gradient Forces,04105964.7,HK1063242,Hong Kong,HK,10/5/2001,5/4/2007,1063242B,7/8/2004,0851-014,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-014,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610527,5/4/2007,581885,Yes
153,00-T-046,Apparatus for Applying Optical Gradient Forces,"2,425,131", ,Canada,CA,10/5/2001,, ,4/25/2003,0851-015,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0851-015,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610528,,581885,Yes
154,00-T-046,Apparatus for Applying Optical Gradient Forces,"10/310,704","7,133,203",*United States,US,10/5/2001,11/7/2006,US-2002-310704-A1,12/5/2002,0851-016,Small,10/6/2000,2/18/2022,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Continuation,4/12/2018,0851-016,10/6/2020,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610529,5/8/2003,581885,Yes
155,00-T-046,Apparatus for Applying Optical Gradient Forces,01989082.1DE,60134872.9,Germany,DE,10/5/2001,7/16/2008,1325540,7/16/2008,0851-017,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0851-017,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610530,7/9/2003,581885,Yes
156,00-T-046,Apparatus for Applying Optical Gradient Forces,01989082.1GB,1325540,United Kingdom,GB,10/5/2001,7/16/2008,1325540,7/16/2008,0851-018,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0851-018,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610531,7/9/2003,581885,Yes
157,00-T-046,Apparatus for Applying Optical Gradient Forces,01989082.1FR,1325540,France,FR,10/5/2001,7/16/2008,1325540,7/16/2008,0851-019,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0851-019,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610532,7/9/2003,581885,Yes
158,00-T-046,Apparatus for Applying Optical Gradient Forces,01989082.1IT,1325540,Italy,IT,10/5/2001,7/16/2008,1325540,7/16/2008,0851-020,Small,10/6/2000,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0851-020,10/5/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610533,7/9/2003,581885,Yes
159,00-T-048,Compositions and Methods for the Identification of Viral Inhibitors of Host Cell Protein Synthesis Shut-Off,"60/232,582", ,*United States,US,9/13/2000,, ,9/13/2000,0853-001,None,9/13/2000,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Penelope Mavromara, Bernard Roizman",Provisional,4/12/2018,0853-001,9/13/2001,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611008,,581887,Yes
160,00-T-048,Compositions and Methods for the Identification of Viral Inhibitors of Host Cell Protein Synthesis Shut-off,PCT/US01/28653, ,*United States,US,9/13/2001,, ,9/13/2001,0853-002,None,9/13/2000,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Penelope Mavromara, Bernard Roizman",PCT,4/12/2018,0853-002,3/13/2003,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611009,,581887,Yes
161,00-T-049,Making Surfaces Inert by Modifying with Alkanethiolates,"09/689,263","6,972,196",*United States,US,10/11/2000,12/6/2005, ,10/11/2000,0854-001,Small,10/11/2000,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Boivin, Nicolas",07814.00042,"Yan-Yeung Luk, Milan Mrksich",US Utility,4/12/2018,0854-001,10/11/2020,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",612152,,581888,Yes
162,00-T-049,Surface Modifying Composition,PCT/US01/32126, ,*United States,US,10/11/2001,,WO 02/030885 A3,10/11/2001,0854-002,Small,10/11/2000,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Taylor, Jonathan",00052,"Yan-Yeung Luk, Milan Mrksich",PCT,4/12/2018,0854-002,4/11/2003,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614734,4/18/2002,581888,Yes
163,00-T-049,Surface Modifying Composition,"11/124,022", ,*United States,US,10/11/2001,,US-2005-255582-A1,5/6/2005,0854-003,Small,10/11/2000,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Boivin, Nicolas",00133,"Yan-Yeung Luk, Milan Mrksich",Continuation,4/12/2018,0854-003,10/11/2020,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614735,11/17/2005,581888,Yes
164,00-T-051,Use of Anti-VEGF Antibody to Enhance Radiation in Cancer Therapy,"60/128,713", ,*United States,US,4/8/1999,, ,4/8/1999,0856A-001,None,4/8/1999,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9012-002,"Donald Kufe, Ralph Weichselbaum",Provisional,4/12/2018,0856A-001,4/8/2000,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615155,,581890,Yes
165,00-T-051,Use of ANti-VEGF Antibody to Enhance Radiation in Cancer Therapy,PCT/US00/09255, ,*United States,US,4/7/2000,,WO 00/61186,4/7/2000,0856A-002,Small,4/8/1999,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9012-003,"Donald Kufe, Ralph Weichselbaum",PCT,4/12/2018,0856A-002,10/8/2001,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615156,10/19/2000,581890,Yes
166,00-T-051,Use of Anti-VEGF Antibody to Enhance Radiation in Cancer Therapy,"09/545,071", ,*United States,US,4/7/2000,, ,4/7/2000,0856A-003,Small,4/8/1999,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9012-002,"Donald Kufe, Ralph Weichselbaum",US Utility,4/12/2018,0856A-003,4/7/2020,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615157,,581890,Yes
167,00-T-051,Use of Anti-VEGF Antibody to Enhance Radiation in Cancer Therapy,00931923.7EPO, ,European Patent Office (EPO),EP,4/7/2000,,EP 1 187 633 A1,2/12/2002,0856A-004,Small,4/8/1999,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9012-001,"Donald Kufe, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0856A-004,4/7/2020,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615158,3/20/2002,581890,Yes
168,00-T-052,Use of DF3/MUC1 Regulated Expression in Gene Therapy,"60/322,265", ,*United States,US,9/14/2001,, ,9/14/2001,0856B-001,Small,9/14/2001,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9026-001,"Donald Kufe, Ralph Weichselbaum",Provisional,4/12/2018,0856B-001,9/14/2002,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615173,,581891,Yes
169,00-T-052,Use of DF3/MUC1 Regulated Expression in Gene Therapy,"10/244,705","7,247,297",*United States,US,9/16/2002,7/24/2007,US-2003-091539-A1,9/16/2002,0856B-002,Small,9/14/2001,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9026-002,"Donald Kufe, Ralph Weichselbaum",US Utility,4/12/2018,0856B-002,5/22/2023,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615174,5/15/2003,581891,Yes
170,00-T-053,Methods and Compositions Relating to Modulating A20,"60/285,427", ,*United States,US,4/19/2001,, ,4/19/2001,0857-001,None,4/19/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Averil Ma,Provisional,4/12/2018,0857-001,4/19/2002,"Unassigned, Unassigned",Averil Ma,"Unassigned, Unassigned",613073,,581892,Yes
171,00-T-053,Methods and Compostions Relating to Modulation of A20,"10/125,770", ,*United States,US,4/18/2002,,US-2003-171253-A1,4/18/2002,0857-002,Small,4/19/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"David Boone, Eric Lee, Averil Ma",US Utility,4/12/2018,0857-002,4/19/2021,"Unassigned, Unassigned",Averil Ma,"Unassigned, Unassigned",613102,9/11/2003,581892,Yes
172,00-T-054,A Growth Promoting Hexapeptide,"60/031,658", ,*United States,US,11/20/1996,, ,11/20/1996,0528b-001,Large,11/20/1996,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Provisional,4/12/2018,0528b-001,11/20/1997,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",610205,,581893,Yes
173,00-T-054,Growth factor from wounded kidney cells,"60/018,516", ,*United States,US,5/28/1996,, ,5/28/1996,0528b-002,Small,5/28/1996,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Provisional,4/12/2018,0528b-002,5/28/1997,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611718,,581893,Yes
174,00-T-054,Growth Factor from Wounded Kidney Cells,PCT/US97/09223, ,*United States,US,5/27/1997,, ,5/27/1997,0528b-006,Large,11/20/1996,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",PCT,4/12/2018,0528b-006,5/13/1999,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611719,,581893,Yes
175,00-T-054,Growth Promoting Proteins and Peptides for Kidney Epithelial Cells,"11/593,364","7,550,438",*United States,US,5/27/1997,6/23/2009, ,11/6/2006,0528b-005,None,11/20/1996,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Continuation,4/12/2018,0528b-005,11/22/2022,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611720,,581893,Yes
176,00-T-054,Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,"08/974,775","6,096,706",*United States,US,5/27/1997,8/1/2000, ,11/20/1997,0528b-003,Small,11/20/1996,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",US Utility,4/12/2018,0528b-003,11/20/2017,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611722,,581893,Yes
177,00-T-054,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,98924865.3EPO,EP 1 034 187,European Patent Office (EPO),EP,5/27/1997,1/7/2004,WO 1999/026974,5/22/1998,0523-010,Small,11/20/1996,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0523-010,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611975,9/13/2000,581893,Yes
178,00-T-054,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,98924865.3FR,1034187,France,FR,5/27/1997,1/7/2004, ,5/22/1998,0523-011,Small,11/20/1996,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0523-011,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611976,,581893,Yes
179,00-T-054,Methods for Production of Growth-Promoting Proteins and Peptides for Kidney Ephithelial Cells,"09/590,864","6,534,290",*United States,US,5/27/1997,3/18/2003,US6534290,6/9/2000,0528b-004,Small,11/20/1996,,Yes,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0528b-004,11/20/2017,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613257,,581893,Yes
180,00-T-054,Methods for Production of Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,"10/302,651", ,*United States,US,5/27/1997,,US-2003-176340-A1,11/22/2002,0528B-007,Small,11/20/1996,,Yes,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0528B-007,6/9/2020,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613258,9/18/2003,581893,Yes
181,00-T-054,Methods for Production of Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,"10/892,617","7,160,864",*United States,US,5/27/1997,1/9/2007,US-2005-095673-A1,7/16/2004,0528B-008,Small,11/20/1996,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0528B-008,4/15/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613259,5/5/2005,581893,Yes
182,00-T-056,Targeting Tumior Endothelial Cells  and Sensitization to DNA Damaging of Tumor Endothelial Cells with Angiogenin,"60/270,918", ,*United States,US,2/23/2001,, ,2/23/2001,0858-001,Small,2/23/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,0858-001,2/23/2002,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614868,,581895,Yes
183,00-T-058,NOD2 Nucleic Acids and Proteins,"60/244,266", ,*United States,US,10/30/2000,, ,10/30/2000,0860-001,Small,10/30/2000,,Yes,4/28/2022,Expired - Inactive,Medlen & Carrol LLP,"Casimir, David",1981.1-01,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Provisional,4/12/2018,0860-001,10/30/2001,"Peace, Shane",Judy Cho,"Tennant, Thelma",613663,,581897,Yes
184,00-T-058,NOD2 Nucleic Acids and Proteins,"60/286,316", ,*United States,US,4/25/2001,, ,4/25/2001,0860-002,Small,4/25/2001,,No,4/28/2022,Expired - Inactive,Medlen & Carrol LLP,,1981.1-02,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Provisional,4/12/2018,0860-002,4/25/2002,"Peace, Shane",Judy Cho,"Tennant, Thelma",613664,,581897,Yes
185,00-T-058,NOD2 Nucleic Acids and Proteins,"10/002,974","6,858,391",*United States,US,10/26/2001,2/22/2005,US-2002-197616-A1,10/26/2001,0860-003,Small,10/30/2000,2/18/2022,No,4/28/2022,Expired - Inactive,Medlen & Carrol LLP,"Casimir, David",1981.1-03,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",US Utility,4/12/2018,0860-003,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",613665,12/26/2002,581897,Yes
186,00-T-058,NOD2 Nucleic Acids and Proteins,PCT/US01/51068, ,*United States,US,10/26/2001,,WO 02/36773 A2,10/26/2001,0860-004,Small,10/30/2000,,No,4/28/2022,Expired - Inactive,Medlen & Carrol LLP,,1981.1-04,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",PCT,4/12/2018,0860-004,10/30/2020,"Peace, Shane",Judy Cho,"Tennant, Thelma",613666,5/10/2002,581897,Yes
187,00-T-058,Nod2 Nucleic Acids and Proteins,2002243415,2002243415,Australia,AU,10/26/2001,9/6/2007, ,5/6/2003,0860-005,Small,10/30/2000,2/18/2022,No,4/28/2022,Expired - Inactive,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Nationalized PCT,4/12/2018,0860-005,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",613667,,581897,Yes
188,00-T-058,NOD2 Nucleic Acids and Proteins,01989310.6EPO,EP 1 404 712,European Patent Office (EPO),EP,10/26/2001,4/7/2004,WO 2002/044426 A3,5/12/2003,0860-006,Small,10/30/2000,10/28/2021,No,4/28/2022,Granted,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Nationalized PCT,4/12/2018,0860-006,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",613668,6/6/2002,581897,Yes
189,00-T-058,Nod2 Nucleic Acids and Proteins,155616,155616,Israel,IL,10/26/2001,, ,5/6/2003,0860-007,Small,10/30/2000,2/18/2022,No,4/28/2022,Expired - Inactive,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Nationalized PCT,4/12/2018,0860-007,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",613669,,581897,Yes
190,00-T-058,Nod2 Nucleic Acids and Proteins,"2,427,471","2,427,471",Canada,CA,10/26/2001,,,4/26/2003,0860-008,Small,10/30/2000,2/18/2022,No,2/18/2022,Expired - Inactive,Medlen & Carrol LLP,,1981.1-12,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Nationalized PCT,4/12/2018,0860-008,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",613670,,581897,Yes
191,00-T-058,NOD2 Nucleic Acids and Proteins,1989310.6,1404712,Germany,DE,10/26/2001,6/14/2014, ,5/6/2003,0860-010,Small,10/30/2000,10/28/2021,No,4/28/2022,Prosecution by Other Party,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Validated EPO,6/19/2020, ,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",4647785,,581897,Yes
192,00-T-058,NOD2 Nucleic Acids and Proteins,1989310.6,1404712,Spain,ES,10/26/2001,6/14/2014, ,5/6/2003,0860-011,Small,10/30/2000,10/28/2021,No,4/28/2022,Prosecution by Other Party,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Validated EPO,6/19/2020, ,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",4647823,,581897,Yes
193,00-T-058,NOD2 Nucleic Acids and Proteins,1989310.6,1404712,United Kingdom,GB,10/26/2001,6/18/2014, ,5/6/2003,0860-012,Small,10/30/2000,10/28/2021,No,4/28/2022,Prosecution by Other Party,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Validated EPO,6/19/2020, ,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",4647861,,581897,Yes
194,00-T-058,NOD2 Nucleic Acids and Proteins,1989310.6,1404712,France,FR,10/26/2001,6/18/2014, ,5/6/2003,0860-009,Small,10/30/2000,10/28/2021,No,4/28/2022,Prosecution by Other Party,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Validated EPO,6/19/2020, ,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",4647900,,581897,Yes
195,00-T-058,NOD2 Nucleic Acids and Proteins,1989310.6,1404712,Italy,IT,10/26/2001,6/14/2014, ,5/6/2003,0860-013,Small,10/30/2000,10/28/2021,No,4/28/2022,Prosecution by Other Party,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Validated EPO,6/19/2020, ,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",4647938,,581897,Yes
196,00-T-058,NOD2 Nucleic Acids and Proteins,1989310.6,1404712,Switzerland,CH,10/26/2001,6/18/2014, ,5/6/2003,0860-014,Small,10/30/2000,10/28/2021,No,4/28/2022,Prosecution by Other Party,Medlen & Carrol LLP,, ,"Denise Bonen, Judy Cho, Noahiro Inohara, Dan Nicolae, Gabriel Nunez, Yasunori Ogura",Validated EPO,6/19/2020, ,10/26/2021,"Peace, Shane",Judy Cho,"Tennant, Thelma",4647976,,581897,Yes
197,00-T-059,"Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins""","60/893,318", ,*United States,US,3/6/2007,, ,3/6/2007,0862-008,None,3/6/2007,,Yes,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Barry Arnason, Mark Jensen, David White",Provisional,4/12/2018,0862-008,3/6/2008,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",612968,,581898,Yes
198,00-T-059,Polymeric Immunoglobulin Fusion Proteins that,2002-571521, ,Japan,JP,3/11/2002,,2004-536576,3/20/2003,0862-002,Small,3/9/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,, ,"Barry Arnason, Mark Jensen, David White",Nationalized PCT,4/12/2018,0862-002,3/11/2022,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614089,12/9/2004,581898,Yes
199,00-T-059,Polymeric immunoglobulin fusion proteins that target low-affinity FcgammaReceptors,"60/274,392", ,*United States,US,3/9/2001,, ,3/9/2001,0862-001,Small,3/9/2001,,Yes,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Barry Arnason, Mark Jensen, David White",Provisional,4/12/2018,0862-001,3/9/2002,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614090,,581898,Yes
200,00-T-059,Polymeric Immunoglobulin Fusion Proteins that Target Low-Affinity FCy Receptors,02719196.4EPO, ,European Patent Office (EPO),EP,3/11/2002,,EP 1 395 605 A2,3/20/2003,0862-003,Small,3/9/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,, ,"Barry Arnason, Mark Jensen, David White",Nationalized PCT,4/12/2018,0862-003,3/11/2022,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614091,3/10/2004,581898,Yes
201,00-T-059,Polymeric Immunoglobulin Fusion Proteins that target low-affinity FCy Receptors,"2,437,958", ,Canada,CA,3/11/2002,, ,3/20/2003,0862-004,Large,3/9/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,, ,"Barry Arnason, Mark Jensen, David White",Nationalized PCT,4/12/2018,0862-004,3/11/2022,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614092,,581898,Yes
202,00-T-059,Polymeric Immunoglobulin Fusion Proteins that Target Low-Affinity FCy Receptors,PCT/US02/07365, ,*United States,US,3/11/2002,,WO 02/072608 A3,3/11/2002,0862-006,Small,3/9/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Barry Arnason, Mark Jensen, David White",PCT,4/12/2018,0862-006,9/9/2003,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614093,9/19/2002,581898,Yes
203,00-T-059,Polymeric Immunoglobulin Fusion Proteins that Target Low-Affinity FCy Receptors,"10/096,521", ,*United States,US,3/11/2002,,US-2003-161826-A1,3/11/2002,0862-007,Small,3/9/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,, ,"Barry Arnason, Mark Jensen, David White",US Utility,4/12/2018,0862-007,3/9/2021,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614094,8/28/2003,581898,Yes
204,00-T-059,Polymeric Immunoglobulin Fusion Proteins that Target Low-Affinity FCy Receptors.,2002250293, ,Australia,AU,3/11/2002,, ,3/20/2003,0862-005,Small,3/9/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,, ,"Barry Arnason, Mark Jensen, David White",Nationalized PCT,4/12/2018,0862-005,3/11/2022,"Unassigned, Unassigned",Barry Arnason,"Unassigned, Unassigned",614095,,581898,Yes
205,00-T-060,Multiple-templates Matching Techniques for Reduction of False,2002-545549, ,Japan,JP,11/21/2001,,2004-545549,5/20/2003,0861-002,Small,11/21/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",Nationalized PCT,4/12/2018,0861-002,11/21/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613568,6/17/2004,581899,Yes
206,00-T-060,"Process, System and Computer Readable Medium for Pulmonary Nodule Detection Using Multiple-Templates Matching","09/716,335","6,470,092",*United States,US,11/21/2000,10/22/2002, ,11/21/2000,0861-001,Small,11/21/2000,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",US Utility,4/12/2018,0861-001,11/21/2020,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614170,,581899,Yes
207,00-T-060,"Process, System and Computer Readable Medium for Pulmonary Nodule Detection Using Multiple-templates Matching",PCT/US01/43146, ,*United States,US,11/21/2001,,WO 02 43562  A2,11/21/2001,0861-004,Small,11/21/2000,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",PCT,4/12/2018,0861-004,5/21/2003,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614171,6/6/2002,581899,Yes
208,00-T-060,"Process, system and computer readable medium for pulmonary nodule detection using multiple-templates matching","10/231,064","6,683,973",*United States,US,11/21/2001,1/27/2004,US-2003-002723-A1,8/30/2002,0861-005,Small,11/21/2000,2/17/2022,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",Continuation,4/12/2018,0861-005,11/21/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614172,1/2/2003,581899,Yes
209,00-T-060,"Process, System and Computer Readable Medium for tfor Pulmonary Nodule Detection Using Multiple-Templates Matching",01988139.0EPO, ,European Patent Office (EPO),EP,11/21/2001,,EP 1 395 165 A2,4/11/2003,0861-003,Large,11/21/2000,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",Nationalized PCT,4/12/2018,0861-003,11/21/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614173,3/10/2004,581899,Yes
210,00-T-061,Crosslinkable Monomers for Novel Nonlinear Optical Polymers,PCT/US02/22531, ,*United States,US,7/15/2002,,WO 03/032072 A2,7/15/2002,0863-004,Small,7/13/2001,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Blanchard, Jonathan",00069,Luping Yu,PCT,4/12/2018,0863-004,1/13/2004,"Hwang, Luke",Luping Yu,"Tennant, Thelma",611349,4/17/2003,581900,Yes
211,00-T-061,Crosslinkable Monomers for Novel Nonlinear Optical Polymers,"10/196,353", ,*United States,US,7/15/2002,,US-2003-100681-A1,7/15/2002,0863-007,Small,7/13/2001,,No,5/8/2022,Abandoned,Brinks Gilson & Lione,,00068,Luping Yu,US Utility,4/12/2018,0863-007,7/13/2021,"Hwang, Luke",Luping Yu,"Tennant, Thelma",611350,5/29/2003,581900,Yes
212,00-T-061,Novel Nonlinear Optical Compounds and Polymers,PCT/US02/22533, ,*United States,US,7/15/2002,,WO 03/007071 A2,7/15/2002,0863-002,Small,7/13/2001,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Blanchard, Jonathan",00071,Luping Yu,PCT,4/12/2018,0863-002,1/13/2004,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613724,1/23/2003,581900,Yes
213,00-T-061,Novel Nonlinear Optical Compounds and Polymers,"10/196,734", ,*United States,US,7/15/2002,,US-2003-085388-A1,7/15/2002,0863-008,Small,7/13/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00070,Luping Yu,US Utility,4/12/2018,0863-008,7/15/2003,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613725,5/8/2003,581900,Yes
214,00-T-061,Novel Nonlinear Optical Polyesterimides Containing Chromophores With Large Hyperpolarizabilities,"60/305,374", ,*United States,US,7/13/2001,, ,7/13/2001,0863-001,Small,7/13/2001,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00046,Luping Yu,Provisional,4/12/2018,0863-001,7/13/2002,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613726,,581900,Yes
215,00-T-061,Novel Nonlinear Optical Polymers,PCT/US02/22376, ,*United States,US,7/15/2002,,WO 03/007069 A2,7/15/2002,0863-003,Small,7/13/2001,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Blanchard, Jonathan",00067,Luping Yu,PCT,4/12/2018,0863-003,1/13/2004,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613727,1/23/2003,581900,Yes
216,00-T-061,Novel Nonlinear Optical Polymers Incorporating Amines,PCT/US02/22532, ,*United States,US,7/15/2002,,WO 03/007070 A1,7/15/2002,0863-005,Small,7/13/2001,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Blanchard, Jonathan",00073,Luping Yu,PCT,4/12/2018,0863-005,1/13/2004,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613728,1/23/2003,581900,Yes
217,00-T-061,Novel Nonlinear Optical Polymers Incorporating Amines,"10/196,328", ,*United States,US,7/15/2002,,US-2003-086666-A1,7/15/2002,0863-009,Small,7/13/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00072,Luping Yu,US Utility,4/12/2018,0863-009,7/13/2021,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613729,5/8/2003,581900,Yes
218,00-T-061,Novel Nonlinear Opticals Polymers,"10/196,565", ,*United States,US,7/15/2002,,US-2003-092869-A1,7/15/2002,0863-006,Small,7/13/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00066,Luping Yu,US Utility,4/12/2018,0863-006,7/13/2021,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613730,5/15/2003,581900,Yes
219,00-T-062,Doped Semiconductor Nanocrystals,"09/694,090","6,939,604",*United States,US,10/19/2000,9/6/2005, ,10/19/2000,0864-001,Small,10/19/2000,2/18/2022,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00043,"Philippe Guyot-Sionnest, Moonsub Shim, Cengjun Wang",US Utility,4/12/2018,0864-001,10/19/2020,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",611493,,581901,Yes
220,00-T-062,Doped Semiconductor Nanocrystals,PCT/US01/51067, ,*United States,US,10/19/2001,, ,10/19/2001,0864-002,Small,10/19/2000,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Taylor, Jonathan",00053,"Philippe Guyot-Sionnest, Moonsub Shim, Cengjun Wang",PCT,4/12/2018,0864-002,4/19/2003,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",611494,4/17/2003,581901,Yes
221,00-T-062,Doped Semiconductor Nanocrystals,"11/111,153","7,227,177",*United States,US,10/19/2000,6/5/2007,US-2005-189534-A1,4/21/2005,0864-003,Small,10/19/2000,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Penn, Amir",00129,"Philippe Guyot-Sionnest, Moonsub Shim, Cengjun Wang",Continuation,4/12/2018,0864-003,4/21/2025,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",611495,9/1/2005,581901,Yes
222,00-T-063,Methods and Devices for Improving the Speed of Multidimensional Microscopy,"60/254,324", ,*United States,US,12/8/2000,, ,12/8/2000,0865-001,Small,12/8/2000,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Benjamin Glick, Adam Hammond",Provisional,4/12/2018,0865-001,12/8/2001,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613112,,581902,Yes
223,00-T-068,Functional Screening,"60/262,353", ,*United States,US,1/17/2001,, ,1/17/2001,0870-001,Small,1/17/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Gopal Thinakaran,Provisional,4/12/2018,0870-001,1/17/2002,"Dembo, Anna",Gopal Thinakaran,"Butler, Brittany",611619,,581907,Yes
224,00-T-068,Functional Screening,"10/051,767", ,*United States,US,1/17/2002,,US-2003-022151-A1,1/17/2002,0870-002,Small,1/17/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Gopal Thinakaran,US Utility,4/12/2018,0870-002,1/17/2021,"Dembo, Anna",Gopal Thinakaran,"Butler, Brittany",611620,1/30/2003,581907,Yes
225,01-T-002,Controlled Directional Scattering Cavity for Tubular Absorbers,"06/113,155","4,359,265",*United States,US,1/18/1980,11/16/1982, ,1/18/1980,0118.1-001,None,1/18/1980,,Yes,4/28/2022,Expired - Inactive,,, ,Roland Winston,US Utility,4/12/2018,0118.1-001,1/18/2000,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611336,,580939,Yes
226,01-T-003,Radiant Energy Collector,"06/121,541","4,419,984",*United States,US,2/14/1980,12/13/1983, ,2/14/1980,0118.2-001,None,2/14/1980,,Yes,4/28/2022,Expired - Inactive,,, ,William McIntyre,US Utility,4/12/2018,0118.2-001,12/13/2000,"Unassigned, Unassigned",William McIntyre,"Unassigned, Unassigned",614264,,580940,Yes
227,01-T-005,Dopaminergic Stimulatory Factor,"60/333,561", ,*United States,US,11/27/2001,, ,11/27/2001,0875-001,Small,11/27/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Martin Gross, Alfred Heller, Lisa Won",Provisional,4/12/2018,0875-001,11/27/2002,"Sun, Han",Alfred Heller,"Tennant, Thelma",611489,,581912,Yes
228,01-T-005,Dopaminergic Stimulatory factor,"60/411,806", ,*United States,US,9/18/2002,, ,9/18/2002,0875-002,Small,9/18/2002,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Martin Gross, Alfred Heller, Lisa Won",Provisional,4/12/2018,0875-002,9/18/2003,"Sun, Han",Alfred Heller,"Tennant, Thelma",611490,,581912,Yes
229,01-T-005,Dopaminergic Stimulatory Factor,"10/496,913", ,*United States,US,11/26/2002,,US-2005-148500-A1,5/27/2004,0875-003,Small,11/27/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Martin Gross, Alfred Heller, Lisa Won",Nationalized PCT,4/12/2018,0875-003,11/27/2021,"Sun, Han",Alfred Heller,"Tennant, Thelma",611491,7/7/2005,581912,Yes
230,01-T-005,Dopaminergic Stimulatory Factor,PCT/US02/37496, ,*United States,US,11/26/2002,,WO 03/045325 A3,11/26/2002,0875-004,Small,11/27/2001,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Subramony, Priya", ,"Martin Gross, Alfred Heller, Lisa Won",PCT,4/12/2018,0875-004,11/27/2004,"Sun, Han",Alfred Heller,"Tennant, Thelma",611492,6/5/2003,581912,Yes
231,01-T-006,Methods and Kits for Use in Selecting Approaches to Treating Cancer,"60/328,078", ,*United States,US,10/9/2001,, ,10/9/2001,0876-001,Small,10/9/2001,,Yes,4/28/2022,Expired - Inactive,Clark & Elbing LLP,"Michaud, Susan", ,"Nalin Gupta, Nikolai Khodarev, Bernard Roizman, Ralph Weichselbaum",Provisional,4/12/2018,0876-001,10/9/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613114,,581913,Yes
232,01-T-006,Methods and Kits for Use in Selecting Approaches to Treating Cancer,PCT/US02/32146, ,*United States,US,10/9/2002,,WO 03/030719 A2,10/9/2002,0876-002,Small,10/9/2001,,No,4/28/2022,Expired - Inactive,Clark & Elbing LLP,"Michaud, Susan", ,"Nalin Gupta, Nikolai Khodarev, Bernard Roizman, Ralph Weichselbaum",PCT,4/12/2018,0876-002,4/9/2004,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613115,4/17/2003,581913,Yes
233,01-T-006,Methods and Kits for Use in Selecting Approaches to Treating Cancer,02786375.2EPO, ,European Patent Office (EPO),EP,10/9/2002,,1439861,7/13/2004,0876-003,Small,10/9/2001,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",30000-EP,"Nalin Gupta, Nikolai Khodarev, Bernard Roizman, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0876-003,4/9/2022,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613116,7/28/2004,581913,Yes
234,01-T-006,Methods and Kits for Use in Selecting Approaches to Treating Cancer,"10/492,239", ,*United States,US,10/9/2002,,US-2005-048491-A1,4/9/2004,0876-004,Small,10/9/2001,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",45458A,"Nalin Gupta, Nikolai Khodarev, Bernard Roizman, Ralph Weichselbaum",US Utility,4/12/2018,0876-004,10/9/2021,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613117,3/3/2005,581913,Yes
235,01-T-007,Yeast Screens for Agents Affecting Protein Folding,"2,438,661","2,438,661",Canada,CA,2/15/2002,5/31/2011, ,8/14/2003,0877-002,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Nationalized PCT,4/12/2018,0877-002,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615401,,581914,Yes
236,01-T-007,Yeast Screens for Agents Affecting Protein Folding,02718994.3EPO,1392849,European Patent Office (EPO),EP,2/15/2002,1/2/2008,1392849,9/12/2003,0877-003,Small,2/15/2001,,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Nationalized PCT,4/12/2018,0877-003,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615402,3/3/2004,581914,Yes
237,01-T-007,Yeast Screens for Agents Affecting Protein Folding,2002-564603,4344138,Japan,JP,2/15/2002,7/17/2009, ,8/18/2003,0877-004,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Nationalized PCT,4/12/2018,0877-004,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615403,,581914,Yes
238,01-T-007,Yeast Screens for Agents Affecting Protein Folding,2002250102,2002250102,Australia,AU,2/15/2002,7/12/2007, ,9/12/2003,0877-007,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Nationalized PCT,4/12/2018,0877-007,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615404,,581914,Yes
239,01-T-007,Yeast Screens for Agents Affecting Protein Folding,06024213.8EPO,1793001,European Patent Office (EPO),EP,2/15/2002,11/9/2011,1793001,11/22/2006,0877-010,Small,2/15/2001,,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Nationalized PCT,4/12/2018,0877-010,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615405,6/6/2007,581914,Yes
240,01-T-007,Yeast Screens for Agents Affecting Protein Folding,2008-108214,5152977,Japan,JP,2/15/2002,12/14/2012,2008-259509,4/17/2008,0877-011,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Divisional,4/12/2018,0877-011,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615406,10/30/2008,581914,Yes
241,01-T-007,Yeast Screens for Agents Affecting Protein Folding,02718994.3GB,1392849,United Kingdom,GB,2/15/2002,1/2/2008, ,1/2/2008,0877-012,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-012,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615407,,581914,Yes
242,01-T-007,Yeast Screens for Agents Affecting Protein Folding,02718994.3BE,1392849,Belgium,BE,2/15/2002,1/2/2008, ,1/2/2008,0877-013,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-013,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615408,,581914,Yes
243,01-T-007,Yeast Screens for Agents Affecting Protein Folding,02718994.3FR,1392849,France,FR,2/15/2002,1/2/2008, ,1/2/2008,0877-014,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-014,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615409,,581914,Yes
244,01-T-007,Yeast Screens for Agents Affecting Protein Folding,02718994.3CH,1392849,Switzerland,CH,2/15/2002,1/2/2008, ,1/2/2008,0877-015,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-015,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615410,,581914,Yes
245,01-T-007,Yeast Screens for Agents Affecting Protein Folding,02718994.3DE,60224383.1-08,Germany,DE,2/15/2002,1/2/2008,DE 602 24 383 T3,1/2/2008,0877-016,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-016,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615411,6/28/2012,581914,Yes
246,01-T-007,Yeast Screens for Agents Affecting Protein Folding,10180773.3EPO, ,European Patent Office (EPO),EP,2/15/2002,,2319936,10/12/2010,0877-017,Small,2/15/2001,,No,6/8/2022,Abandoned,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Divisional,4/12/2018,0877-017,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615412,5/11/2011,581914,Yes
247,01-T-007,Yeast Screens for Agents Affecting Protein Folding,2007221933,2007221933,Australia,AU,2/15/2002,12/16/2010, ,10/12/2007,0877-018,Small,2/15/2001,,No,6/8/2022,Abandoned,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Divisional,4/12/2018,0877-018,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615413,,581914,Yes
248,01-T-007,Yeast Screens for Agents Affecting Protein Folding,2011200744,2011200744,Australia,AU,2/15/2002,7/15/2013, ,2/22/2011,0877-019,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Divisional,4/12/2018,0877-019,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615414,,581914,Yes
249,01-T-007,Yeast Screens for Agents Affecting Protein Folding,06024213.8FR,1793001,France,FR,2/15/2002,11/9/2011,1793001,11/9/2011,0877-021,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-021,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615415,6/6/2007,581914,Yes
250,01-T-007,Yeast Screens for Agents Affecting Protein Folding,06024213.8GB,1793001,United Kingdom,GB,2/15/2002,11/9/2011,1793001,11/9/2011,0877-022,Small,2/15/2001,2/18/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Validated EPO,4/12/2018,0877-022,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615416,6/6/2007,581914,Yes
251,01-T-007,Yeast Screens For the Treatment of Human Disease,"60/269,157", ,*United States,US,2/15/2001,, ,2/15/2001,0877-001,Small,2/15/2001,,Yes,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,"Brennan, Jack", ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Provisional,4/12/2018,0877-001,2/15/2002,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615417,,581914,Yes
252,01-T-007,Yeast Screens for the Treatment of Human Disease,PCT/US02/04632, ,*United States,US,2/15/2002,,WO 02/065136 A2,2/15/2002,0877-005,Small,2/15/2001,,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,"Brennan, Jack", ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",PCT,4/12/2018,0877-005,8/15/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615418,8/22/2002,581914,Yes
253,01-T-007,Yeast Screens for Treatment of Human Disease,"10/077,584","7,045,290",*United States,US,2/15/2002,5/16/2006,US-2003-073610-A1,2/15/2002,0877-006,Small,2/15/2001,5/16/2006,No,6/8/2022,Issued,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",US Utility,4/12/2018,0877-006,9/13/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615419,4/17/2003,581914,Yes
254,01-T-007,Yeast Screens for Treatment of Human Disease,"11/363,869", ,*United States,US,2/15/2002,,17481-005002,2/27/2006,0877-008,Small,2/15/2001,5/5/2011,No,6/8/2022,Abandoned,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Divisional,4/12/2018,0877-008,,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615420,,581914,Yes
255,01-T-007,Yeast Screens for Treatment of Human Disease,"11/363,870","8,039,209",*United States,US,2/15/2002,10/18/2011,US-2006-0141449,2/27/2006,0877-009,Small,2/15/2001,10/18/2011,No,6/8/2022,Issued,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Divisional,4/12/2018,0877-009,1/4/2025,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615421,6/29/2006,581914,Yes
256,01-T-007,Yeast Screens for Treatment of Human Disease,"13/090,653", ,*United States,US,2/15/2002,,US-2011-0300533-A1,4/20/2011,0877-020,Small,2/15/2001,5/4/2012,No,6/8/2022,Abandoned,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Continuation,4/12/2018,0877-020,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615422,12/8/2011,581914,Yes
257,01-T-007,Yeast Screens for Treatment of Human Disease,"13/462,478", ,*United States,US,2/15/2002,,US-2013-0005608-A1,5/2/2012,0877-023,Small,2/15/2001,12/20/2013,No,6/8/2022,Abandoned,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Continuation,4/12/2018,0877-023,2/15/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615423,1/3/2013,581914,Yes
258,01-T-007,Yeast Screens for Treatment of Human Disease,"14/105,500","9,518,284",*United States,US,2/15/2002,12/13/2016,2014-0273074,12/13/2013,0877-024,Small,2/15/2001,3/24/2022,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Continuation,4/12/2018,0877-024,3/23/2022,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615424,9/18/2014,581914,Yes
259,01-T-007,Yeast Screens for Treatment of Human Disease,"15/345,739", ,*United States,US,2/15/2002,, ,11/8/2016,0877-026,Small,2/15/2001,5/6/2019,No,5/1/2022,Abandoned,Fish & Richardson P.C.,, ,"Sylvia Krobitsch, Susan Lindquist, Tiago Outeiro",Continuation,4/12/2018,0877-026,,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615425,,581914,No
260,01-T-008,Automated Method and System for the Delineation of the Chest Wall in Computed Tomography Scans for the Assessment of Pleural Disease,"09/881,002","6,577,752",*United States,US,6/15/2001,6/10/2003,US-2002-0191827-A1,6/15/2001,0878-001,Large,6/15/2001,8/25/2021,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Heber MacMahon",US Utility,4/12/2018,0878-001,7/5/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610626,12/19/2002,581915,Yes
261,01-T-008,Automated method and system for the delineation of the chest wall in computed tomography scans for the assessment of pleural disease,PCT/US02/16018, ,*United States,US,5/21/2002,,WO 02 103616,5/21/2002,0878-002,Small,6/15/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Heber MacMahon",PCT,4/12/2018,0878-002,12/15/2003,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610627,12/27/2002,581915,Yes
262,01-T-009,PIKT,76289870,"2,620,830",*United States,US,7/24/2001,9/17/2002,,,0880-001,Small,7/24/2001,,Yes,4/12/2018,Registered (TM),"Valauskas Corder, LLC","Valauskas, Charles",,Bob Osterlund,Trademark,4/12/2018,0880-001,7/24/2021,"Ginsburg, Eric",Bob Osterlund,"Smith, Dane",613971,,581916,Yes
263,01-T-010,Controlled Release Composition,"09/797,166","6,764,768",*United States,US,2/28/2001,7/20/2004,US-2002-119305-A1,2/28/2001,0879-001,Small,2/28/2001,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Taylor, Jonathan",07814.00044,"Christian Hodneland, Milan Mrksich",US Utility,4/12/2018,0879-001,2/28/2021,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",611337,8/29/2002,581917,Yes
264,01-T-011,Parallel Scanned Laser Confocal Microscope,"09/917,346", ,*United States,US,7/27/2001,,US-2003-021016-A1,7/27/2001,0881-001,Small,7/27/2001,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,David Grier,US Utility,4/12/2018,0881-001,7/27/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613886,1/30/2003,581918,Yes
265,01-T-011,Parallel Scanned Laser Confocal Microscope,PCT/US02/23594, ,*United States,US,7/25/2002,,WO 03/012517 A2,7/25/2002,0881-002,Small,7/27/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,David Grier,PCT,4/12/2018,0881-002,1/27/2004,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613887,2/13/2003,581918,Yes
266,01-T-014,Regulation of Plant Fertility by Modulation of GABA Levels in Flowers,"60/300,513", ,*United States,US,6/22/2001,, ,6/22/2001,0884-001,Small,6/22/2001,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Provisional,4/12/2018,0884-001,6/22/2002,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614377,,581921,Yes
267,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,2002345817, ,Australia,AU,6/21/2002,, ,3/4/2004,0884-002,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-002,6/21/2022,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614378,,581921,Yes
268,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,"2,451,727", ,Canada,CA,6/21/2002,,"2,451,727",3/19/2004,0884-003,Large,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-003,6/21/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614379,1/3/2003,581921,Yes
269,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,02744564.2EPO, ,European Patent Office (EPO),EP,6/21/2002,,1416794,2/4/2004,0884-004,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-004,6/22/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614380,5/12/2004,581921,Yes
270,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,2003-506493, ,Japan,JP,6/21/2002,, ,3/12/2004,0884-005,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-005,6/21/2022,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614381,,581921,Yes
271,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,530433,530433,New Zealand,NZ,6/21/2002,12/8/2005,NZ-530433-A,3/4/2004,0884-006,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-006,6/21/2022,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614382,8/26/2005,581921,Yes
272,01-T-014,Regulation of Plant Fertility by Modulation of GABA Levels in Flowers,"10/177,717","7,109,149",*United States,US,6/21/2002,9/19/2006,US 2004-0177398 A1,6/21/2002,0884-007,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP","Henry, Thomas", ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",US Utility,4/12/2018,0884-007,6/22/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614383,9/9/2004,581921,Yes
273,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,PA/A/2003/012068, ,Mexico,MX,6/21/2002,, ,12/19/2003,0884-009,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-009,12/19/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614384,,581921,Yes
274,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,Abnd-7509-7, ,Japan,JP,6/21/2002,, ,12/22/2003,0884-010,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP","Henry, Thomas", ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-010,12/22/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614385,,581921,Yes
275,01-T-014,Regulation of Plant Fertility by Modulation of Gaba Levels in Flowers,"159,473", ,Israel,IL,6/21/2002,, ,12/31/2003,0884-011,Small,6/22/2001,,No,6/8/2022,Abandoned,"Woodard, Emhardt, Moriarty, McNett & Henry LLP",, ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",Nationalized PCT,4/12/2018,0884-011,12/31/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614386,,581921,Yes
276,01-T-014,Regulations of Plant Fertility by Modulation of GABA Levels in Flowers,PCT/US02/19923, ,*United States,US,6/21/2002,,WO 03/000039 A3,6/21/2002,0884-008,Small,6/22/2001,,No,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Laura Brass, Ravishankar Palanivelu, Daphne Preuss",PCT,4/12/2018,0884-008,12/22/2003,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614389,1/3/2003,581921,Yes
277,01-T-016,Automated  Computerized Scheme for Classification of Lung Nodules on Chest Images,2002-578236, ,Japan,JP,3/15/2002,,2004-532067,9/18/2003,0885-002,Small,3/28/2001,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Masahito Aoyama, Kunio Doi",Nationalized PCT,4/12/2018,0885-002,3/15/2022,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610582,10/21/2004,581923,Yes
278,01-T-016,Automated Computerized Scheme for Distinction Between Benign and Malignant Solitary Pulmonary Nodules on Chest Images,"09/818,831","6,694,046",*United States,US,3/28/2001,2/17/2004,US-2002-172403-A1,3/28/2001,0885-001,Small,3/28/2001,6/29/2021,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Masahito Aoyama, Kunio Doi",US Utility,4/12/2018,0885-001,1/20/2022,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610584,11/21/2002,581923,Yes
279,01-T-016,Automated Computerized Scheme for Distinction Between Benign and Malignant Solitary Pulmonary Nodules on Chest Images,PCT/US02/06638, ,*United States,US,3/15/2002,,WO 02/080089,3/15/2002,0885-004,Small,3/28/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Masahito Aoyama, Kunio Doi",PCT,4/12/2018,0885-004,9/28/2003,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610585,10/10/2002,581923,Yes
280,01-T-017,PHILOLOGIC,76289871,"2,597,781",*United States,US,7/24/2001,7/23/2002, ,,0886-002,None,7/24/2001,,Yes,11/2/2021,Registered (TM),"Valauskas Corder, LLC","Valauskas, Charles", ,"Leonid Andreev, Scott Deerwester, Catherine Mardikes, Robert Morrissey, Mark Olsen, Stephen Spackman, Keith Waclena, Donald Ziff",Trademark,4/12/2018,0886-002,7/24/2021,"Ginsburg, Eric",Catherine Mardikes,"Smith, Dane",613944,,581924,Yes
281,01-T-017,PHILOLOGIC,76289639,,*United States,US,7/24/2001,,,,0886-003,None,7/24/2001,,No,11/13/2018,Abandoned,"Baniak, Pine & Gannon","Valauskas, Charles",,"Leonid Andreev, Scott Deerwester, Catherine Mardikes, Robert Morrissey, Mark Olsen, Stephen Spackman, Keith Waclena, Donald Ziff",Trademark,4/12/2018,0886-003,,"Ginsburg, Eric",Catherine Mardikes,"Smith, Dane",613945,,581924,Yes
282,01-T-017,UCTech,76289640,"2,743,797",*United States,US,7/24/2001,7/29/2003, ,,0886-001,Small,7/24/2001,,Yes,8/4/2020,Registered (TM),"Baniak, Pine & Gannon","Valauskas, Charles", ,"Leonid Andreev, Scott Deerwester, Catherine Mardikes, Robert Morrissey, Mark Olsen, Stephen Spackman, Keith Waclena, Donald Ziff",Trademark,4/12/2018,0886-001,7/24/2021,"Ginsburg, Eric",Catherine Mardikes,"Smith, Dane",615130,,581924,Yes
283,01-T-018,Multiply Drug Resistant Staphylococcal Aureus and Methods of Use Therefor,"10/299,581", ,*United States,US,11/19/2002,, ,11/19/2002,0887-002,Small,11/19/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Susan Boyle-Vavra, Roberta Carey, Robert Daum",US Utility,4/12/2018,0887-002,11/19/2021,"Bakalyar, Heather",Robert Daum,"Onishi, Kenneth",613570,,581925,Yes
284,01-T-018,Multiply Drug Resistant Staphylococcal Aureus and Methods of Use Thereof,"60/331,692", ,*United States,US,11/19/2001,, ,11/19/2001,0887-001,Small,11/19/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Susan Boyle-Vavra, Roberta Carey, Robert Daum",Provisional,4/12/2018,0887-001,11/19/2002,"Bakalyar, Heather",Robert Daum,"Onishi, Kenneth",613571,,581925,Yes
285,01-T-019,Assessment of Concentration of Inhalational Compounds in the Brain,"09/811,316","6,579,511",*United States,US,3/16/2001,6/17/2003,US 2002-0131936 A1,3/16/2001,0888-001,None,3/16/2001,,Yes,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,Chung-Yuan Lin,US Utility,4/12/2018,0888-001,3/16/2021,"Unassigned, Unassigned",Chung-Yuan Lin,"Unassigned, Unassigned",610569,9/19/2002,581926,Yes
286,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,"10/117,442", ,*United States,US,4/5/2002,,US-2003-082685-A1,4/5/2002,0890-002,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",US Utility,4/12/2018,0890-002,4/6/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610867,5/1/2003,581927,Yes
287,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,2002303247,2002303247,Australia,AU,4/5/2002,7/7/2005,2002303247,9/26/2003,0890-003,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0890-003,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610868,3/24/2005,581927,Yes
288,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,"2,442,971","2,442,971",Canada,CA,4/5/2002,6/7/2011, ,12/15/2003,0890-004,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0890-004,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610869,,581927,Yes
289,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,02731264.4EPO,1390075,European Patent Office (EPO),EP,4/5/2002,1/18/2012,EP 1 390 075 A2,8/22/2003,0890-005,Small,4/6/2001,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0890-005,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610870,2/25/2004,581927,Yes
290,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,2002-578888, ,Japan,JP,4/5/2002,,2004-532213,9/26/2003,0890-006,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0890-006,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610871,10/21/2004,581927,Yes
291,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,PCT/US02/10733, ,*United States,US,4/5/2002,,WO 02/080849 A3,4/5/2002,0890-007,Small,4/6/2001,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",PCT,4/12/2018,0890-007,10/6/2003,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610872,10/17/2002,581927,Yes
292,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,02731264.4FR,1390075,France,FR,4/5/2002,1/18/2012,EP 1 390 075 A2,1/18/2012,0890-010,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Validated EPO,4/12/2018,0890-010,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610873,2/25/2004,581927,Yes
293,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,02731264.4DE,1390075,Germany,DE,4/5/2002,1/18/2012,EP 1 390 075 A2,1/18/2012,0890-011,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Validated EPO,4/12/2018,0890-011,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610874,2/25/2004,581927,Yes
294,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,02731264.4IT,1390075,Italy,IT,4/5/2002,1/18/2012,EP 1 390 075 A2,1/18/2012,0890-012,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Validated EPO,4/12/2018,0890-012,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610875,2/25/2004,581927,Yes
295,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,02731264.4ES,1390075,Spain,ES,4/5/2002,1/18/2012,EP 1 390 075 A2,1/18/2012,0890-013,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Validated EPO,4/12/2018,0890-013,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610876,2/25/2004,581927,Yes
296,01-T-020,Chemotherapeutic Induction of EGR-1 Promoter Activity,02731264.4UK,1390075,United Kingdom,GB,4/5/2002,1/18/2012,EP 1 390 075 A2,1/18/2012,0890-014,Small,4/6/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Validated EPO,4/12/2018,0890-014,4/5/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610877,2/25/2004,581927,Yes
297,01-T-020,Chemotheraputic Induction of EGR-1 Promoter Activity,"60/282,040", ,*United States,US,4/6/2001,, ,4/6/2001,0890-001,Small,4/6/2001,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Provisional,4/12/2018,0890-001,4/6/2002,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610878,,581927,Yes
298,01-T-020,Activation of EGR-1 Promoter by DNA Damaging Chemotherapeutics,"11/467,799","8,034,791",*United States,US,4/5/2002,10/11/2011,US-2007-0036748-A1,8/28/2006,0890-008,Large,4/6/2001,10/11/2011,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Continuation in Part,4/12/2018,0890-008,9/23/2024,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610939,2/15/2007,581927,Yes
299,01-T-021,N4 Virion Single-Stranded DNA Dependent RNA Polymerase,"60/292,845", ,*United States,US,5/22/2001,, ,5/22/2001,0891-001,Small,5/22/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",Provisional,4/12/2018,0891-001,5/22/2002,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613616,,581928,Yes
300,01-T-021,N4 Virion Single-Stranded DNA Dependent Rna Polymerase,"10/153,219","7,452,705",*United States,US,5/22/2002,11/18/2008,US-2003-096349-A1,5/22/2002,0891-002,Small,5/22/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",US Utility,4/12/2018,0891-002,5/22/2022,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613617,5/22/2003,581928,Yes
301,01-T-021,N4 Virion Single-Stranded DNA Dependent RNA Polymerase,PCT/US02/16295, ,*United States,US,5/22/2002,,WO 02/095002 A2,5/22/2002,0891-003,Small,5/22/2001,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",PCT,4/12/2018,0891-003,11/22/2003,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613618,11/28/2002,581928,Yes
302,01-T-021,N4 Virion Single-Stranded DNA Dependent RNA Polymerase,2002310067, ,Australia,AU,5/22/2002,, ,10/27/2003,0891-004,None,5/22/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",Nationalized PCT,4/12/2018,0891-004,10/27/2023,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613619,,581928,Yes
303,01-T-021,N4 Virion Single-Stranded DNA Dependent RNA Polymerase,"2,448,097", ,Canada,CA,5/22/2002,, ,11/22/2003,0891-005,Small,5/22/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",Nationalized PCT,4/12/2018,0891-005,5/22/2022,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613620,,581928,Yes
304,01-T-021,N4 Virion Single-Stranded DNA Dependent RNA Polymerase,2002-592465,4338402,Japan,JP,5/22/2002,7/10/2009,2004-533828,11/22/2003,0891-006,Small,5/22/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",Nationalized PCT,4/12/2018,0891-006,5/22/2022,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613621,11/11/2004,581928,Yes
305,01-T-021,N4 Virion Single-Stranded DNA Dependent RNA Polymerase,02737107.9EPO, ,European Patent Office (EPO),EP,5/22/2002,,1399541,11/22/2003,0891-007,Small,5/22/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",Nationalized PCT,4/12/2018,0891-007,5/22/2022,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613622,3/24/2004,581928,Yes
306,01-T-021,Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences,"10/719,372", ,*United States,US,5/22/2002,, ,11/21/2003,0891-009,Small,5/22/2001,,No,4/28/2022,Abandoned,Medlen & Carrol LLP,"Carroll, Peter", ,"Gary Dahl, Elena Davydova, Svetlana Gerdes, Jerome Jendrisak, Lucia Rothman-Denes",Continuation in Part,4/12/2018,0891-009,5/22/2022,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",614138,,581928,Yes
307,01-T-021,Target-dependent transcription using deletion mutants of N4 RNA polymerase,"10/743,975","7,838,270",*United States,US,5/22/2002,11/23/2010, ,12/23/2003,0891-008,Small,5/22/2001,,No,4/28/2022,Abandoned,Medlen & Carrol LLP,"Carroll, Peter", ,"Elena Davydova, Krystyna Kazmierczak, Lucia Rothman-Denes",Continuation in Part,4/12/2018,0891-008,10/23/2022,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",614850,,581928,Yes
308,01-T-023,Broadband High precision Circular Polarizers and Retarders in Waveguides,"60/357,597", ,*United States,US,2/15/2002,, ,2/15/2002,0893-001,Small,2/15/2002,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Duncan, Malcolm",00058,"John Carlstrom, John Kovac",Provisional,4/12/2018,0893-001,2/15/2003,"Unassigned, Unassigned",John Carlstrom,"Unassigned, Unassigned",610750,,581930,Yes
309,01-T-023,Broadband High Precision Circular Polarizers and Retarders in Waveguides,"10/369,154","6,963,253",*United States,US,2/18/2003,11/8/2005,US-2003-227344-A1,2/18/2003,0893-002,Small,2/15/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00081,"John Carlstrom, John Kovac",US Utility,4/12/2018,0893-002,7/18/2023,"Unassigned, Unassigned",John Carlstrom,"Unassigned, Unassigned",610751,12/11/2003,581930,Yes
310,01-T-026,Cancer treatment by using a combination of an antibody against Her2 and Interleukin-2,01935476.0EPO, ,European Patent Office (EPO),EP,5/15/2001,, ,12/15/2002,0896-009,Large,5/15/2000,,No,4/28/2022,Abandoned,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",Nationalized PCT,4/12/2018,0896-009,12/15/2022,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",610777,,581933,Yes
311,01-T-026,Cancer treatment by using a combination of an antibody against HER2 and Interleukin-2.,"2,408,974", ,Canada,CA,5/15/2001,, ,12/15/2002,0896-004,Large,5/15/2000,,No,4/28/2022,Abandoned,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",Nationalized PCT,4/12/2018,0896-004,12/15/2022,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",610778,5/15/2001,581933,Yes
312,01-T-026,Cancer Treatment by using a Combination of an antibody against Her2 and Interleukin-2.,"152,896", ,Israel,IL,5/15/2001,, ,12/15/2002,0896-005,Large,5/15/2000,,No,4/28/2022,Abandoned,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",Nationalized PCT,4/12/2018,0896-005,12/15/2022,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",610779,,581933,Yes
313,01-T-026,Cancer treatment by using a combination of an antibody against Her2 and Interleukin-2.,2001-583803, ,Japan,JP,5/15/2001,, ,12/15/2002,0896-006,Large,5/15/2000,,No,4/28/2022,Abandoned,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",Nationalized PCT,4/12/2018,0896-006,12/15/2022,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",610780,,581933,Yes
314,01-T-026,Cancer treatments by using a combination of an antibody against Her2 and Interleukin-2,PCT/US01/15525, ,*United States,US,5/15/2001,,WO 01/87336 A1,5/15/2001,0896-003,Large,5/15/2000,,No,4/28/2022,Expired - Inactive,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",PCT,4/12/2018,0896-003,11/15/2002,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",610781,11/22/2001,581933,Yes
315,01-T-026,Methods of Therapy for Cancers Characterized by Overexpression of the HER2 Receptor Protein,"09/855,342","7,306,801",*United States,US,5/14/2001,12/11/2007,US-2002-0031515-A1,5/14/2001,0896-002,Large,5/15/2000,,No,4/28/2022,Abandoned,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",US Utility,4/12/2018,0896-002,5/15/2020,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",613348,3/14/2002,581933,Yes
316,01-T-026,Methods of Therapy for Cancers Characterized by Overexpression of the HER2 Receptor Protein,"11/888,699", ,*United States,US,5/15/2001,, ,8/2/2007,0896-007,Large,5/15/2000,,No,4/28/2022,Abandoned,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",Continuation,4/12/2018,0896-007,5/15/2020,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",613349,,581933,Yes
317,01-T-026,Methods of Therapy for Cancers Characterized by Overexpression of the Her2 Receptor Protein.,"60/204,284", ,*United States,US,5/15/2000,, ,5/15/2000,0896-001,Large,5/15/2000,,Yes,4/28/2022,Expired - Inactive,Alston & Bird (Raleigh),"Henry, Leslie", ,"Michael Caligiuri, Neal Meropol, Richard Schilsky",Provisional,4/12/2018,0896-001,5/15/2001,"Unassigned, Unassigned",Richard Schilsky,"Unassigned, Unassigned",613350,,581933,Yes
318,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,"09/845,045","6,416,190",*United States,US,4/27/2001,7/9/2002, ,4/27/2001,0898-001,Large,4/27/2001,2/18/2022,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Eric Dufresne, David Grier",US Utility,4/12/2018,0898-001,4/27/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610538,,581935,Yes
319,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,PCT/US02/13307, ,*United States,US,4/26/2002,,WO 02/088704 A3,4/26/2002,0898-003,Large,4/27/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",PCT,4/12/2018,0898-003,10/27/2003,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610539,11/7/2002,581935,Yes
320,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,02725832.6EPO,1382231,European Patent Office (EPO),EP,4/26/2002,5/10/2011,1 382 231 A2,9/12/2003,0898-004,Large,4/27/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-004,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610540,1/21/2004,581935,Yes
321,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,2002-585953,5244281,Japan,JP,4/26/2002,4/12/2013,2004-527255,10/27/2003,0898-005,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-005,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610541,9/9/2004,581935,Yes
322,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,2002256374,2002256374,Australia,AU,4/26/2002,5/12/2005, ,8/12/2004,0898-006,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-006,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610542,1/27/2005,581935,Yes
323,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,02808941.3,ZL 02808941.3,China,CN,4/26/2002,5/24/2007,"Vol. 20, No. 24",11/14/2003,0898-007,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-007,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610543,7/2/2004,581935,Yes
324,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,200306189-2,99739,Singapore,SG,4/26/2002,3/30/2006,200604A,10/23/2003,0898-008,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-008,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610544,,581935,Yes
325,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,06111190.9, ,Hong Kong,HK,4/26/2002,,1090704A,10/12/2006,0898-009,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-009,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610545,12/29/2006,581935,Yes
326,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,"10/646,432","6,846,084",*United States,US,4/26/2002,1/25/2005,US-2004-036976-A1,8/22/2003,0898-010,Large,4/27/2001,2/18/2022,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Continuation,4/12/2018,0898-010,4/27/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610546,2/26/2004,581935,Yes
327,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,"10/186,807","6,626,546",*United States,US,4/26/2002,9/30/2003, ,8/22/2003,0898-011,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, Eric Dufresne, David Grier",Divisional,4/12/2018,0898-011,4/27/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610547,7/1/2002,581935,Yes
328,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,04105315.3, ,Hong Kong,HK,4/26/2002,, ,7/20/2004,0898-012,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-012,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610548,1/21/2004,581935,Yes
329,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,"11/010,004","7,104,659",*United States,US,4/26/2002,9/12/2006,US-2005-098717-A1,12/10/2004,0898-013,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Continuation,4/12/2018,0898-013,4/27/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610549,5/12/2005,581935,Yes
330,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,200510104103.3, ,China,CN,4/26/2002,,"Vol. 20, No. 24",9/13/2005,0898-015,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Divisional,4/12/2018,0898-015,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610550,7/2/2004,581935,Yes
331,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,02725832.6GB,1382231,United Kingdom,GB,4/26/2002,8/6/2008, ,8/6/2008,0898-016,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Validated EPO,4/12/2018,0898-016,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610551,1/21/2004,581935,Yes
332,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,02725832.6DE,60228069.9,Germany,DE,4/26/2002,8/6/2008, ,11/21/2008,0898-017,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Validated EPO,4/12/2018,0898-017,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610552,1/21/2004,581935,Yes
333,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,02725832.6IT,1382231,Italy,IT,4/26/2002,8/6/2008, ,8/6/2008,0898-018,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Validated EPO,4/12/2018,0898-018,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610553,1/21/2004,581935,Yes
334,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,02725832.6FR,1382231,France,FR,4/26/2002,8/6/2008, ,8/6/2008,0898-019,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Validated EPO,4/12/2018,0898-019,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610554,1/21/2004,581935,Yes
335,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,08011029.9EPO, ,European Patent Office (EPO),EP,4/26/2002,,1993332,6/19/2008,0898-020,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Divisional,4/12/2018,0898-020,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610555,11/19/2008,581935,Yes
336,01-T-028,Apparatus for Using Optical Tweezers to Manipulate Materials,2012-219456, ,Japan,JP,4/26/2002,, ,11/5/2012,0898-021,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Divisional,4/12/2018,0898-021,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610556,,581935,Yes
337,01-T-028,Apparatus for Using Optical Tweezers to Manipulate to Manipulate Materials,"2,445,336","2,445,336",Canada,CA,4/26/2002,10/21/2008, ,11/7/2005,0898-002,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-002,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610557,,581935,Yes
338,01-T-028,Method and System for Using Optincal Tweezers to Manipulate Materials,04109984.5,1067272,Hong Kong,HK,4/26/2002,1/5/2007, ,10/30/2006,0898-014,Large,4/27/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, Eric Dufresne, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0898-014,4/26/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",612423,,581935,Yes
339,01-T-030,Methods and Compositions to Modulate Apoptosis Pathways,"10/198,755", ,*United States,US,7/18/2002,, ,7/18/2002,0900-002,Small,7/18/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Alicia Algeciras-Schimnich, Marcus Peter",US Utility,4/12/2018,0900-002,7/18/2021,"Unassigned, Unassigned",Marcus Peter,"Unassigned, Unassigned",613081,,581937,Yes
340,01-T-030,Regulation of the Two CD95 Apoptosis Pathways,"60/306,386", ,*United States,US,7/18/2001,, ,7/18/2001,0900-001,Small,7/18/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Alicia Algeciras-Schimnich, Marcus Peter",Provisional,4/12/2018,0900-001,7/18/2002,"Unassigned, Unassigned",Marcus Peter,"Unassigned, Unassigned",614387,,581937,Yes
341,01-T-031,Polypeptide Immobilization,"09/923,760","7,172,905",*United States,US,8/7/2001,2/6/2007,US-2003-119054-A1,8/7/2001,0773-001,Small,8/7/2001,2/6/2007,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00045,"Christian Hodneland, Milan Mrksich",US Utility,4/12/2018,0773-001,1/22/2023,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614110,6/23/2003,581938,Yes
342,01-T-031,Polypeptide Immobilization,PCT/US02/25026, ,*United States,US,8/7/2002,,WO 03/097792 A2,8/7/2002,0773-002,Small,8/7/2001,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Taylor, Jonathan",00074,"Christian Hodneland, Milan Mrksich",PCT,4/12/2018,0773-002,2/7/2004,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614111,11/27/2003,581938,Yes
343,01-T-031,Polypeptide Immobilization,"11/645,095","7,888,055",*United States,US,8/7/2001,2/15/2011,US-2008-0064606-A1,12/21/2006,0773-003,Small,8/7/2001,4/29/2019,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00177,"Christian Hodneland, Milan Mrksich",Continuation,4/12/2018,0773-003,4/18/2024,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614112,3/13/2008,581938,Yes
344,01-T-031,Polypeptide Immobilization,"2,456,698", ,Canada,CA,8/7/2002,, ,2/6/2004,0773-004,Large,8/7/2001,8/9/2010,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00098,"Eugene Chan, Christian Hodneland, Young-Sam Lee, Dal-Hee Min, Milan Mrksich",Nationalized PCT,4/12/2018,0773-004,,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614113,,581938,Yes
345,01-T-031,Polypeptide Immobilization,02807456.5EPO,1552305,European Patent Office (EPO),EP,8/7/2002,7/31/2013,1552305,3/8/2004,0773-005,Small,8/7/2001,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,07814.00096,"Christian Hodneland, Milan Mrksich",Nationalized PCT,4/12/2018,0773-005,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614114,7/13/2005,581938,Yes
346,01-T-031,Polypeptide Immobilization,10183304.4EPO, ,European Patent Office (EPO),EP,8/7/2002,,2311939,9/30/2010,0773-006,Small,8/7/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00296,"Christian Hodneland, Milan Mrksich",Divisional,4/12/2018,0773-006,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614115,4/20/2011,581938,Yes
347,01-T-031,Polypeptide Immobilization,"12/984,948","9,074,300",*United States,US,8/7/2001,7/7/2015,US-2012-0142547-A1,1/5/2011,0773-007,Small,8/7/2001,9/3/2019,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00301,"Christian Hodneland, Milan Mrksich",Continuation,4/12/2018,0773-007,8/7/2021,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614116,6/7/2012,581938,Yes
348,01-T-031,Polypeptide Immobilization,02807456.5DE,1552305,Germany,DE,8/7/2002,7/31/2013, ,7/31/2013,0773-008,Small,8/7/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00096,"Christian Hodneland, Milan Mrksich",Validated EPO,4/12/2018,0773-008,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614117,,581938,Yes
349,01-T-031,Polypeptide Immobilization,02807456.5FR,1552305,France,FR,8/7/2002,7/31/2013, ,7/31/2013,0773-009,Small,8/7/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00096,"Christian Hodneland, Milan Mrksich",Validated EPO,4/12/2018,0773-009,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614118,,581938,Yes
350,01-T-031,Polypeptide Immobilization,02807456.5GB,1552305,United Kingdom,GB,8/7/2002,7/31/2013, ,7/31/2013,0773-010,Small,8/7/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00096,"Christian Hodneland, Milan Mrksich",Validated EPO,4/12/2018,0773-010,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614119,,581938,Yes
351,01-T-031,Polypeptide Immobilization,"14/751,623", ,*United States,US,8/7/2001,,US-2015-0369816,6/26/2015,0773-011,Small,8/7/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00394,"Christian Hodneland, Milan Mrksich",Continuation,4/12/2018,0773-011,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614120,12/25/2015,581938,No
352,01-T-031,Polypeptide Immobilization,Abnd-9814-097, ,Japan,JP,8/7/2002,, ,2/5/2004,0901-005,Small,8/7/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00097,"Eugene Chan, Christian Hodneland, Young-Sam Lee, Dal-Hee Min, Milan Mrksich",Nationalized PCT,4/12/2018,0901-005,8/7/2022,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614121,,581938,Yes
353,01-T-032,Optical Peristalic Pumping with Optical Traps,02814236.5, ,China,CN,6/6/2002,,CN 1529646A,8/30/2004,0902-006,Large,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Sven Behrens, David Grier",Nationalized PCT,4/12/2018,0902-006,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613831,9/15/2004,581939,Yes
354,01-T-032,Optical Peristalic Pumping with Optical Traps,1574/KOLNP/2003, ,India,IN,6/6/2002,, ,12/16/2003,0902-007,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Sven Behrens, David Grier",Nationalized PCT,4/12/2018,0902-007,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613832,,581939,Yes
355,01-T-032,Optical Peristalic Pumping with Optical Traps,200307209-7,101189,Singapore,SG,6/6/2002,, ,12/16/2003,0902-008,Large,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Sven Behrens, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0902-008,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613833,,581939,Yes
356,01-T-032,Optical Peristalic Pumping with Optical Traps,2003-501639,4184257,Japan,JP,6/6/2002,9/12/2008,4184257,12/16/2003,0902-009,Large,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Sven Behrens, David Grier",Nationalized PCT,4/12/2018,0902-009,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613834,11/19/2008,581939,Yes
357,01-T-032,Optical Peristaltic Pumping with Optical Traps,"09/875,812","6,639,208",*United States,US,6/6/2001,10/28/2003,US-2002-185592-A1,6/6/2001,0902-001,Small,6/6/2001,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier, Brian Koss",US Utility,4/12/2018,0902-001,4/3/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613835,12/12/2002,581939,Yes
358,01-T-032,Optical Peristaltic Pumping with Optical Traps,2002314979,2002314979,Australia,AU,6/6/2002,9/14/2006, ,12/16/2003,0902-002,Large,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Sven Behrens, David Grier",Nationalized PCT,4/12/2018,0902-002,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613836,,581939,Yes
359,01-T-032,Optical Peristaltic Pumping with Optical Traps,PCT/US02/18132, ,*United States,US,6/6/2002,,WO 02/098617 A3,6/6/2002,0902-003,Large,6/6/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",PCT,4/12/2018,0902-003,12/6/2003,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613837,3/27/2003,581939,Yes
360,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0EPO,1397233,European Patent Office (EPO),EP,6/6/2002,9/21/2005,1397233,12/16/2003,0902-004,Small,6/6/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Nationalized PCT,4/12/2018,0902-004,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613838,3/17/2004,581939,Yes
361,01-T-032,Optical Peristaltic Pumping with Optical Traps,"2,449,337","2,449,337",Canada,CA,6/6/2002,10/21/2008,"2,449,337",12/16/2003,0902-005,Large,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Nationalized PCT,4/12/2018,0902-005,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613839,12/12/2002,581939,Yes
362,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0FR,1397233,France,FR,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-010,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-010,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613840,3/17/2004,581939,Yes
363,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0CH,1397233,Switzerland,CH,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-011,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-011,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613841,3/17/2004,581939,Yes
364,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0DE,60206267.5,Germany,DE,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-012,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-012,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613842,3/17/2004,581939,Yes
365,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0ES,1397233,Spain,ES,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-013,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-013,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613843,3/17/2004,581939,Yes
366,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0GB,1397233,United Kingdom,GB,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-014,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-014,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613844,3/17/2004,581939,Yes
367,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0IT,1397233,Italy,IT,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-015,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-015,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613845,3/17/2004,581939,Yes
368,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0NL,1397233,Netherlands,NL,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-016,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-016,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613846,3/17/2004,581939,Yes
369,01-T-032,Optical Peristaltic Pumping with Optical Traps,05015523.3EPO, ,European Patent Office (EPO),EP,6/6/2002,,EP  1 397 233 A2,4/19/2006,0902-017,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Sven Behrens, David Grier",Divisional,4/12/2018,0902-017,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613847,3/17/2004,581939,Yes
370,01-T-032,Optical Peristaltic Pumping with Optical Traps,02741910.0AT,E304920,Austria,AT,6/6/2002,9/21/2005,EP  1 397 233 A2,9/21/2005,0902-018,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier",Validated EPO,4/12/2018,0902-018,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613848,3/17/2004,581939,Yes
371,01-T-032,Optical Peristaltic Pumping with Optical Traps,"10/651,370","6,847,032",*United States,US,6/6/2002,1/25/2005,US-2004-051034-A1,8/29/2003,0902-019,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier, Brian Koss",Continuation,4/12/2018,0902-019,6/6/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613849,3/18/2004,581939,Yes
372,01-T-032,Optical Peristaltic Pumping With Optical Traps,"11/041,640","7,075,060",*United States,US,6/6/2002,7/11/2006,US-2005-145785-A1,1/24/2005,0902-020,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, David Grier, Brian Koss",Continuation,4/12/2018,0902-020,6/6/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613850,7/7/2005,581939,Yes
373,01-T-032,Optical Peristaltic Pumping with Optical Traps,05101263.3,HK1068841,Hong Kong,HK,6/6/2002,4/20/2007, ,12/16/2003,0902-021,Small,6/6/2001,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Sven Behrens, Jennifer Curtis, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0902-021,6/6/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613851,,581939,Yes
374,01-T-033,"SNP-Cruncher, Version 1.0",TXu-1-033-477,TXu-1-033-477,*United States,US,1/8/2002,1/8/2002,,,0903-001,None,,,No,4/12/2018,Registered (Copyright),,,,Elliot Gershon,Copyright Application,4/12/2018,0903-001,1/8/2022,"Butler, Brittany",Elliot Gershon,"Butler, Brittany",614573,,581940,Yes
375,01-T-036,Methods and Compositions for Determining Hidden Generic Variation in Plants,"60/298,211", ,*United States,US,6/13/2001,, ,6/13/2001,0906-001,Large,6/13/2001,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Susan Lindquist, Christine Queitsch, Todd Sangster",Provisional,4/12/2018,0906-001,6/13/2002,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612678,,581943,Yes
376,01-T-036,Methods and Compositions for Revealing Hidden Genetic Variation in Plants,"10/170,656", ,*United States,US,6/13/2002,,US-2003-028927-A1,6/13/2002,0906-002,Small,6/13/2001,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Sistrunk, Melissa", ,"Susan Lindquist, Christine Queitsch, Todd Sangster",US Utility,4/12/2018,0906-002,6/13/2021,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612852,2/6/2003,581943,Yes
377,01-T-036,Methods and Compositions for Revealing Hidden Genetic Variation in Plants,PCT/US02/18776, ,*United States,US,6/13/2002,, ,6/13/2002,0906-003,Large,6/13/2001,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Sistrunk, Melissa", ,"Susan Lindquist, Christine Queitsch, Todd Sangster",PCT,4/12/2018,0906-003,12/13/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612853,6/13/2001,581943,Yes
378,01-T-036,Methods and Compositions for Revealing Hidden Genetic Variation in Plants,"60/379,484", ,*United States,US,5/10/2002,, ,5/10/2002,0906-004,Large,5/10/2002,,Yes,6/8/2022,Expired - Inactive,Ropes & Gray LLP,"Granaham, Patricia", ,"Susan Lindquist, Christine Queitsch, Todd Sangster",Provisional,4/12/2018,0906-004,5/10/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612854,6/13/2001,581943,Yes
379,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,"60/341,723", ,*United States,US,12/19/2001,, ,12/19/2001,0910-001,Large,12/19/2001,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Provisional,4/12/2018,0910-001,12/19/2002,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614270,,581947,Yes
380,01-T-040,Rapidly Maturing Fluorescent Proteins and methods for using the Same,PCT/US02/40539, ,*United States,US,12/18/2002,,WO 03/054158 A2,12/18/2002,0910-002,Large,12/19/2001,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",PCT,4/12/2018,0910-002,6/19/2004,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614271,7/3/2003,581947,Yes
381,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,"10/844,064","8,664,471",*United States,US,12/18/2002,3/4/2014,US-2005-149994-A1,5/11/2004,0910-003,Large,12/19/2001,3/4/2014,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"Brooke Bevis, Benjamin Glick",Nationalized PCT,4/12/2018,0910-003,3/9/2026,"Dembo, Anna",Brooke Bevis,"Tennant, Thelma",614272,7/7/2005,581947,Yes
382,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,"2,467,383","2,467,383",Canada,CA,12/18/2002,8/28/2012, ,5/14/2004,0910-004,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"Brooke Bevis, Benjamin Glick",Nationalized PCT,4/12/2018,0910-004,12/18/2022,"Dembo, Anna",Brooke Bevis,"Tennant, Thelma",614273,,581947,Yes
383,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,2002357322, ,Australia,AU,12/18/2002,, ,5/17/2004,0910-005,Large,12/19/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Nationalized PCT,4/12/2018,0910-005,5/17/2024,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614274,,581947,Yes
384,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8EPO,1456223,European Patent Office (EPO),EP,12/18/2002,8/12/2009,1456223,7/30/2004,0910-006,Large,12/19/2001,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Brooke Bevis, Benjamin Glick",Nationalized PCT,4/12/2018,0910-006,8/12/2009,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614275,9/15/2004,581947,Yes
385,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,2003-554863,4700281,Japan,JP,12/18/2002,3/11/2011,JP 4700281 B2,7/16/2004,0910-007,Large,12/19/2001,,No,5/23/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,"Brooke Bevis, Benjamin Glick",Nationalized PCT,4/12/2018,0910-007,12/18/2022,"Dembo, Anna",Brooke Bevis,"Tennant, Thelma",614276,6/5/2011,581947,Yes
386,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,2004118303,2330067,Russian Federation,RU,12/18/2002,7/27/2008, ,5/12/2004,0910-008,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"Brooke Bevis, Benjamin Glick",Nationalized PCT,4/12/2018,0910-008,12/18/2022,"Dembo, Anna",Brooke Bevis,"Tennant, Thelma",614277,,581947,Yes
387,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8BE,1456223,Belgium,BE,12/18/2002,8/12/2009,1456223,8/12/2009,0910-009,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-009,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614278,9/15/2004,581947,Yes
388,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8CH,1456223,Switzerland,CH,12/18/2002,8/12/2009,1456223,8/12/2009,0910-010,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-010,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614279,9/15/2004,581947,Yes
389,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8DE,1456223,Germany,DE,12/18/2002,8/12/2009,1456223,8/12/2009,0910-011,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-011,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614280,9/15/2004,581947,Yes
390,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8ES,1456223,Spain,ES,12/18/2002,8/12/2009,1456223,8/12/2009,0910-012,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-012,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614281,9/15/2004,581947,Yes
391,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8FR,1456223,France,FR,12/18/2002,8/12/2009,1456223,8/12/2009,0910-013,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-013,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614282,9/15/2004,581947,Yes
392,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8GB,1456223,United Kingdom,GB,12/18/2002,8/12/2009,1456223,8/12/2009,0910-014,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-014,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614283,9/15/2004,581947,Yes
393,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8IE,1456223,Ireland,IE,12/18/2002,8/12/2009,1456223,8/12/2009,0910-015,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-015,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614284,9/15/2004,581947,Yes
394,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,02805620.8IT,50200901780353,Italy,IT,12/18/2002,8/12/2009,1456223,8/12/2009,0910-016,Large,12/19/2001,,No,4/28/2022,Issued,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Validated EPO,4/12/2018,0910-016,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614285,9/15/2004,581947,Yes
395,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,2010-277642, ,Japan,JP,12/18/2002,,2011-092198,12/14/2010,0910-017,Large,12/19/2001,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Brooke Bevis, Benjamin Glick",Divisional,4/12/2018,0910-017,12/18/2022,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614286,5/12/2011,581947,Yes
396,01-T-040,Rapidly Maturing Fluorescent Proteins and Methods for Using the Same,"14/159,724", ,*United States,US,12/18/2002,,US-2014-0237632-A1,1/21/2014,0910-018,Large,12/19/2001,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Brooke Bevis, Benjamin Glick",Continuation,4/12/2018,0910-018,12/28/2021,"Dembo, Anna",Brooke Bevis,"Tennant, Thelma",614287,8/21/2014,581947,Yes
397,01-T-046,Induction of Immunity Using Inhibitors of Granzymes,"09/993,363","7,326,692",*United States,US,11/14/2001,2/5/2008,US-2003-0148511-A1,11/14/2001,0917-001,Small,11/14/2001,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Philip Ashton-Rickardt, Joseph Opferman",US Utility,4/12/2018,0917-001,5/28/2024,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612007,8/7/2003,581953,Yes
398,01-T-047,Performance Improvements of Symmetry-Breaking Reflector Structures in Non-imaging Devices,"60/309,439", ,*United States,US,8/1/2001,, ,8/1/2001,0918-001,Small,8/1/2001,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"John Bortz, Narkis Shatz, Roland Winston",Provisional,4/12/2018,0918-001,8/1/2002,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613934,,581954,Yes
399,01-T-047,Performance Improvements of Symmetry-Breaking Reflector Structures in Nonimaging Devices,"10/212,010","6,676,263",*United States,US,8/1/2002,1/13/2004,US-2003-081333-A1,8/1/2002,0918-002,Small,8/1/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,, ,Roland Winston,US Utility,4/12/2018,0918-002,7/25/2017,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613935,5/1/2003,581954,Yes
400,01-T-048,Idebtification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK,2004218009, ,Japan,JP,10/2/2002,,2005-040137,7/26/2004,0919-011,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Concetta Bubici, Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni","Foreign, Non-PCT",4/12/2018,0919-011,7/26/2024,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",611879,2/17/2005,581955,Yes
401,01-T-048,Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK,2004203373, ,Australia,AU,10/2/2002,,AU-4203373-AA,7/23/2004,0919-010,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Concetta Bubici, Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni","Foreign, Non-PCT",4/12/2018,0919-010,7/23/2024,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",611891,2/10/2005,581955,Yes
402,01-T-048,Methods and Compositions for Modulating Apoptosis,"10/263,330", ,*United States,US,10/2/2002,,US-2003-077262-A1,10/2/2002,0919-003,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",US Utility,4/12/2018,0919-003,10/2/2021,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",612795,4/24/2003,581955,Yes
403,01-T-048,Methods and Compositions for Modulating Apoptosis,"2,462,638", ,Canada,CA,10/2/2002,, ,7/25/2003,0919-005,Large,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Nationalized PCT,4/12/2018,0919-005,10/2/2022,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",612796,,581955,Yes
404,01-T-048,Methods and Compositions for Modulating Apoptosis,02776102.2EPO, ,European Patent Office (EPO),EP,10/2/2002,,1 453 467,6/2/2004,0919-006,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Nationalized PCT,4/12/2018,0919-006,10/2/2022,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",612797,9/8/2004,581955,Yes
405,01-T-048,Methods and Compositions for Modulating Apoptosis,2002341941, ,Australia,AU,10/2/2002,, ,7/25/2003,0919-007,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Nationalized PCT,4/12/2018,0919-007,10/2/2022,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",612798,,581955,Yes
406,01-T-048,Methods and compositions for modulating apoptosis,"10/626,905", ,*United States,US,10/2/2002,,US-2004-121463-A1,7/25/2003,0919-008,Small,10/2/2001,,Yes,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Continuation in Part,4/12/2018,0919-008,10/2/2021,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",612799,6/24/2004,581955,Yes
407,01-T-048,Methods and Compositions for Modulating Apoptosis,04017667.9EPO, ,European Patent Office (EPO),EP,10/2/2002,,1 506 784,7/26/2003,0919-009,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Concetta Bubici, Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Nationalized PCT,4/12/2018,0919-009,7/26/2023,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",612800,2/16/2005,581955,Yes
408,01-T-048,Methods and Compostions for Modulating Apoptosis,PCT/US02/31548, ,*United States,US,10/2/2002,,WO 03/028659 A3,10/2/2002,0919-004,Small,10/2/2001,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",PCT,4/12/2018,0919-004,4/2/2004,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",613101,4/10/2003,581955,Yes
409,01-T-048,Modulators of Apoptosis,"60/326,492", ,*United States,US,10/2/2001,, ,10/2/2001,0919-001,Small,10/2/2001,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Provisional,4/12/2018,0919-001,10/2/2002,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",613493,,581955,Yes
410,01-T-048,Modulators of Apoptosis,"60/328,811", ,*United States,US,10/12/2001,, ,10/12/2001,0919-002,Small,10/12/2001,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Enrico DeSmaele, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Provisional,4/12/2018,0919-002,10/12/2002,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",613494,,581955,Yes
411,01-T-049,Methods and Composition Concerning Herpesvirus US3 and BAD-involved Apoptosis,"60/308,929", ,*United States,US,7/31/2001,, ,7/31/2001,0920-001,Small,7/31/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joshua Munger, Bernard Roizman",Provisional,4/12/2018,0920-001,7/31/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612617,,581956,Yes
412,01-T-049,Methods and Composition Concerning Herpesvirus Us3 and Bad-Involved Apoptosis,"10/209,967", ,*United States,US,7/31/2002,,US 2003-0171279 A1,7/31/2002,0920-002,Small,7/31/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Joshua Munger, Bernard Roizman",US Utility,4/12/2018,0920-002,7/31/2021,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612618,9/11/2003,581956,Yes
413,01-T-049,Methods and Composition Concerning Herpesvirus Us3 and Bad-Involved Apoptosis,PCT/US02/24177, ,*United States,US,7/31/2002,,WO 03/012049 A2,7/31/2002,0920-003,Small,7/31/2001,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Joshua Munger, Bernard Roizman",PCT,4/12/2018,0920-003,1/31/2004,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612619,2/13/2003,581956,Yes
414,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array,0294/KOLNP/2004, ,India,IN,9/11/2002,, ,2/26/2004,0921-005,Large,9/13/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Nationalized PCT,4/12/2018,0921-005,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610488,,581957,Yes
415,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical,02817929.3,ZL 02817929.3,China,CN,9/11/2002,6/11/2008,CN 1557115A,2/27/2004,0921-003,Large,9/13/2001,,Yes,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Nationalized PCT,4/12/2018,0921-003,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610489,12/22/2004,581957,Yes
416,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical,200401133-4,103483,Singapore,SG,9/11/2002,5/31/2006, ,2/27/2004,0921-006,Large,9/13/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Nationalized PCT,4/12/2018,0921-006,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610490,,581957,Yes
417,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical,2003-528072,4272519,Japan,JP,9/11/2002,3/6/2009,2005-502482,2/27/2004,0921-007,Large,9/13/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Nationalized PCT,4/12/2018,0921-007,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610491,1/27/2005,581957,Yes
418,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical,2008-334457, ,Japan,JP,9/11/2002,,2009-145355,11/15/2008,0921-010,Large,9/13/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Divisional,4/12/2018,0921-010,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610492,7/2/2009,581957,Yes
419,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical Traps,05104955.0,HK 1072524,Hong Kong,HK,9/11/2002,4/30/2009,1072524A,12/5/2008,0921-008,None,9/13/2001,,No,4/28/2022,Issued,Foley & Lardner,, ,"David Grier, Pamela Korda",Nationalized PCT,4/12/2018,0921-008,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610493,8/26/2005,581957,Yes
420,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of FLowing Particles By a Static Array of Optical Tweezers,"09/951,117","6,797,942",*United States,US,9/13/2001,9/28/2004,US-2003-047676-A1,9/13/2001,0921-001,Small,9/13/2001,,Yes,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",US Utility,4/12/2018,0921-001,9/13/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610494,3/13/2003,581957,Yes
421,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical Tweezers,PCT/US02/28819, ,*United States,US,9/11/2002,,WO 03/024163 A1,9/11/2002,0921-002,Small,9/13/2001,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"David Grier, Pamela Korda",PCT,4/12/2018,0921-002,3/13/2004,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610495,3/20/2003,581957,Yes
422,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles by a Static Array of Optical Tweezers,02798204.0EPO, ,European Patent Office (EPO),EP,9/11/2002,,EP 1 425 944 A1,2/27/2004,0921-004,Small,9/13/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Nationalized PCT,4/12/2018,0921-004,9/11/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610496,9/6/2004,581957,Yes
423,01-T-050,Apparatus and Process for the Lateral Deflection and Separation of Flowing Particles By a Static Array of Optical Tweezers,"10/878,797","7,137,574",*United States,US,9/11/2002,11/21/2006,US-2005-001063-A1,6/28/2004,0921-009,Small,9/13/2001,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Pamela Korda",Continuation,4/12/2018,0921-009,12/16/2021,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610497,1/6/2005,581957,Yes
424,01-T-053,Methods and Compositions involving Sortase B,"10/219,783", ,*United States,US,8/15/2002,,US 2006-0073530 A1,8/15/2002,0924-002,None,8/15/2001,,No,4/28/2022,Abandoned,Goodwin Procter LLP,, ,"Sarkis Mazmanian, Olaf Schneewind, Kenneth Su, Hung Ton-That",US Utility,4/12/2018,0924-002,8/15/2022,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",612987,4/6/2006,581960,Yes
425,01-T-053,Methods and Compositions Relating to Sortase B,"60/312,738", ,*United States,US,8/15/2001,, ,8/15/2001,0924-001,None,8/15/2001,4/1/2020,Yes,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Olaf Schneewind,Provisional,4/12/2018,0924-001,8/15/2002,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",613074,,581960,Yes
426,01-T-054,"Apparatus and Method for Fabricating, Sorting and Integrating Materials with Holographic Optical Traps","10/210,519","6,863,406",*United States,US,8/1/2002,3/8/2005,US-2004-021949-A1,8/1/2002,0925-001,Large,8/1/2002,,Yes,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",US Utility,4/12/2018,0925-001,8/1/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610447,2/5/2004,581961,Yes
427,01-T-054,"Apparatus and Method for Fabricating, Sorting and Integrating Materials with Holographic Optical Traps","11/029,396","7,588,940",*United States,US,7/31/2003,9/15/2009,US-2005-152039-A1,1/6/2005,0925-004,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0925-004,8/1/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610448,7/14/2005,581961,Yes
428,01-T-054,"Apparatus and Method for Fabricating, Sorting and Integrating Materials with Holographic Optical Traps","12/385,202","8,128,242",*United States,US,7/31/2003,3/6/2012,US-2009-0250601-A1,4/1/2009,0925-036,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0925-036,4/1/2029,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610449,10/8/2009,581961,Yes
429,01-T-054,"Apparatus and Method for Fabricating, Sorting and Integrating Materials with Holographic Optical Traps.",092122546,I279787,"Taiwan, Province of China",TW,7/31/2003,4/21/2007,200506869,8/15/2003,0925-003,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-003,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610451,2/16/2005,581961,Yes
430,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",PCT/US03/23991, ,*United States,US,7/31/2003,,WO 04/014112 A3,7/31/2003,0925-002,Large,8/1/2002,,Yes,4/28/2022,Expired - Inactive,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",PCT,4/12/2018,0925-002,2/1/2005,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610452,2/12/2004,581961,Yes
431,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps","2,494,362", ,Canada,CA,7/31/2003,, ,2/1/2005,0925-005,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-005,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610453,,581961,Yes
432,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps","166,578", ,Israel,IL,7/31/2003,, ,2/1/2005,0925-006,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-006,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610455,,581961,Yes
433,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",2004-526276, ,Japan,JP,7/31/2003,, ,2/1/2005,0925-007,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0925-007,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610456,,581961,Yes
434,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",2005-7001893, ,"Korea, Republic of",KR,7/31/2003,, ,2/1/2005,0925-008,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0925-008,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610458,,581961,Yes
435,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",200500588-9,110298,Singapore,SG,7/31/2003,2/28/2007, ,1/27/2004,0925-009,Small,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0925-009,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610460,,581961,Yes
436,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",2005105586, ,Russian Federation,RU,7/31/2003,, ,2/28/2005,0925-010,Small,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0925-010,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610462,,581961,Yes
437,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",03755730.3EPO,1532849,European Patent Office (EPO),EP,7/31/2003,9/12/2007, ,11/11/2004,0925-012,Large,8/1/2002,,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-012,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610463,,581961,Yes
438,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",538379, ,New Zealand,NZ,7/31/2003,, ,2/21/2005,0925-013,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-013,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610465,,581961,Yes
439,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",373/DELNP/2005, ,India,IN,7/31/2003,, ,2/1/2005,0925-014,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-014,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610466,,581961,Yes
440,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",2003273224, ,Australia,AU,7/31/2003,, ,2/1/2005,0925-015,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-015,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610467,,581961,Yes
441,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028231.8EPO,1667500,European Patent Office (EPO),EP,7/31/2003,2/13/2008,1667500,12/22/2005,0925-017,Large,8/1/2002,,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0925-017,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610468,6/7/2006,581961,Yes
442,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028230.0EPO,1684312,European Patent Office (EPO),EP,7/31/2003,6/3/2009,1684312,12/22/2005,0925-018,Large,8/1/2002,,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,, ,David Grier,Divisional,4/12/2018,0925-018,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610469,7/26/2006,581961,Yes
443,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",07100948.6,HK1094276,Hong Kong,HK,7/31/2003,11/6/2009,1094276A,9/23/2009,0925-020,Large,8/1/2002,,No,4/28/2022,Abandoned,Edwards Neils PLLC,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0925-020,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610472,3/23/2007,581961,Yes
444,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",200710109655.2, ,China,CN,7/31/2003,,CN101114054A,5/24/2007,0925-021,None,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0925-021,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610473,1/30/2008,581961,Yes
445,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",07108976.7EPO, ,European Patent Office (EPO),EP,7/31/2003,,1821585,5/25/2007,0925-022,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0925-022,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610474,8/22/2007,581961,Yes
446,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",03755730.3IT,1532849,Italy,IT,7/31/2003,9/12/2007, ,9/12/2007,0925-025,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-025,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610475,,581961,Yes
447,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028231.8DE,60319161.4-08,Germany,DE,7/31/2003,2/13/2008,1667500,2/13/2008,0925-027,Large,8/1/2002,,No,4/28/2022,Abandoned,Edwards Neils PLLC,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-027,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610476,6/7/2006,581961,Yes
448,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028231.8FR,1667500,France,FR,7/31/2003,2/13/2008,1667500,2/13/2008,0925-028,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-028,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610477,6/7/2006,581961,Yes
449,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028231.8IT,1667500,Italy,IT,7/31/2003,2/13/2008,1667500,2/13/2008,0925-029,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-029,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610478,6/7/2006,581961,Yes
450,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028231.8GB,1667500,United Kingdom,GB,7/31/2003,2/13/2008,1667500,2/13/2008,0925-030,Large,8/1/2002,,No,4/28/2022,Abandoned,Edwards Neils PLLC,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-030,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610479,6/7/2006,581961,Yes
451,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",08101662.7, ,Hong Kong,HK,7/31/2003,,1113053A,4/15/2008,0925-031,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-031,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610480,9/19/2008,581961,Yes
452,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028230.0DE,60327903.1-09,Germany,DE,7/31/2003,6/3/2009,1684312,3/25/2009,0925-032,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Validated EPO,4/12/2018,0925-032,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610481,7/26/2006,581961,Yes
453,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028230.0IT,1684312,Italy,IT,7/31/2003,6/3/2009,1684312,4/13/2009,0925-033,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Validated EPO,4/12/2018,0925-033,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610482,7/26/2006,581961,Yes
454,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028230.0FR,1684312,France,FR,7/31/2003,6/3/2009,1684312,5/28/2009,0925-034,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Validated EPO,4/12/2018,0925-034,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610483,7/26/2006,581961,Yes
455,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",05028230.0GB,1684312,United Kingdom,GB,7/31/2003,6/3/2009,1684312,4/1/2009,0925-035,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Validated EPO,4/12/2018,0925-035,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610484,7/26/2006,581961,Yes
456,01-T-054,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographics Optical Traps",03823510.2,ZL 03823510.2,China,CN,7/31/2003,7/25/2007,CN1685773A,3/31/2005,0925-016,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,David Grier,Nationalized PCT,4/12/2018,0925-016,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610485,10/19/2005,581961,Yes
457,01-T-054,"Apparratus and Method for Fabricating, Sorting and Integrating Materials with Holographic Optical Traps",PI0313170-0, ,Brazil,BR,7/31/2003,,Journal # 1906,2/20/2006,0925-011,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0925-011,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610558,7/17/2007,581961,Yes
458,01-T-054,"Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",03755730.3FR,1532849,France,FR,7/31/2003,9/12/2007, ,6/21/2007,0925-023,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-023,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",612449,,581961,Yes
459,01-T-054,"Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",03755730.3DE,60316303.3-08,Germany,DE,7/31/2003,9/12/2007, ,6/21/2007,0925-024,None,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-024,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",612450,6/12/2008,581961,Yes
460,01-T-054,"Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",03755730.3GB,1532849,United Kingdom,GB,7/31/2003,9/12/2007, ,9/12/2007,0925-026,None,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-026,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",612451,,581961,Yes
461,01-T-055,Authomared method and system for the differentiation of bone disease on radiographic images.,PCT/US02/33652, ,*United States,US,11/22/2002,,WO 03/045219 A2,11/22/2002,0926-003,Small,11/23/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Michael Chinander, Murray Favus, Maryellen Giger, Tamara Vokes",PCT,4/12/2018,0926-003,5/22/2004,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610579,6/5/2003,581962,Yes
462,01-T-055,Automated Method and System for the Differentiation of Bone Disease on Radiographic Images,"10/301,836", ,*United States,US,11/22/2002,,US-2003-133601-A1,11/22/2002,0926-002,Small,11/23/2001,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Michael Chinander, Murray Favus, Maryellen Giger, Tamara Vokes",US Utility,4/12/2018,0926-002,11/23/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610647,7/17/2003,581962,Yes
463,01-T-055,"Automated Method, Systemand Computer Program Product for the Diagnosis of Bone Disease on Radiographic Images","60/331,995", ,*United States,US,11/23/2001,, ,11/23/2001,0926-001,Small,11/23/2001,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Michael Chinander, Murray Favus, Maryellen Giger, Tamara Vokes",Provisional,4/12/2018,0926-001,11/23/2002,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610667,,581962,Yes
464,01-T-058,Automated Detection of Polyps in CT Colonography:Evaluation of Volumetric Features for Reduction of False Positives,"60/329,322", ,*United States,US,10/16/2001,, ,10/16/2001,0929-001,Small,10/16/2001,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",Provisional,4/12/2018,0929-001,10/16/2002,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",610587,,581965,Yes
465,01-T-058,Computer-Aided Detection of Three-Dimensional Lesions,PCT/US02/31578, ,*United States,US,10/16/2002,,WO 03/034176 A2,10/16/2002,0929-002,Small,10/16/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",PCT,4/12/2018,0929-002,4/16/2004,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",611242,4/24/2003,581965,Yes
466,01-T-058,Method for Computer-Aided Detection of Three-Dimensional Lesions,"10/270,674","7,379,572",*United States,US,10/16/2002,5/27/2008,US-2003-223627-A1,10/16/2002,0929-003,Small,10/16/2001,5/27/2008,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",US Utility,4/12/2018,0929-003,10/25/2024,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612432,12/4/2003,581965,Yes
467,01-T-058,Method for Computer-Aided Detection of Three-Dimensional Lesions,02801654.1EPO,1436771,European Patent Office (EPO),EP,10/16/2002,6/22/2011,EP 1 436 771 A2,5/24/2004,0929-004,Small,10/16/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",Nationalized PCT,4/12/2018,0929-004,10/16/2022,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612433,7/14/2004,581965,Yes
468,01-T-058,Method for Computer-Aided Detection of Three-Dimensional Lesions,2003-536840, ,Japan,JP,10/16/2002,,2005-506140,6/17/2004,0929-005,Small,10/16/2001,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",Nationalized PCT,4/12/2018,0929-005,10/16/2022,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612434,3/3/2005,581965,Yes
469,01-T-058,Method for Computer-Aided Detection of Three-Dimensional Lesions,02801654.1DE, ,Germany,DE,10/16/2002,, ,8/29/2011,0929-006,Small,10/16/2001,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",Validated EPO,4/12/2018,0929-006,10/16/2022,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612435,,581965,Yes
470,01-T-058,Method for Computer-Aided Detection of Three-Dimensional Lesions,02801654.1FR, ,France,FR,10/16/2002,, ,8/29/2011,0929-007,Small,10/16/2001,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Abraham Dachman, Li Lan, Peter MacEneaney, Yoshitaka Masutani, Janne Nappi, David Rubin, Hiroyuki Yoshida",Validated EPO,4/12/2018,0929-007,10/16/2022,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612436,,581965,Yes
471,01-T-066,Detection of Calcifications within a Medical Image,"10/078,694", ,*United States,US,2/21/2002,,US-2003-165262-A1,2/21/2002,0938-001,Small,2/21/2002,6/8/2006,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Yulei Jiang, Robert ""Bob"" Nishikawa, John Papaioannou, Maria Salfity",US Utility,4/12/2018,0938-001,,"Ginsburg, Eric",Yulei Jiang,"Smith, Dane",611392,9/4/2003,581973,Yes
472,01-T-069,Method of treating disorder related to high cholesterol concentration,"60/348,020", ,*United States,US,11/8/2001,, ,11/8/2001,0937-001,Small,11/8/2001,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Provisional,4/12/2018,0937-001,11/8/2002,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612541,,581976,Yes
473,01-T-069,Method of treating disorder related to high cholesterol concentration,91132850, ,"Taiwan, Province of China",TW,11/8/2002,, ,11/8/2002,0937-002,Small,11/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0937-002,11/8/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612542,5/8/2004,581976,Yes
474,01-T-069,Method of treating disorder related to high cholesterol concentration,PCT/US02/35900, ,*United States,US,11/8/2002,,WO 03/039480 A3,11/8/2002,0937-003,Small,11/8/2001,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",PCT,4/12/2018,0937-003,5/2/2003,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612543,5/15/2003,581976,Yes
475,01-T-069,Method of treating disorder related to high cholesterol concentration,2002356919, ,Australia,AU,11/8/2002,, ,10/20/2005,0937-004,None,11/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0937-004,11/8/2022,"Dembo, Anna",Ching Song,"Tennant, Thelma",612544,,581976,Yes
476,01-T-069,Method of treating disorder related to high cholesterol concentration,"2,466,033", ,Canada,CA,11/8/2002,, ,5/26/2004,0937-005,Large,11/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0937-005,11/8/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612545,,581976,Yes
477,01-T-069,Method of Treating Disorder Related to High Cholesterol Concentration,"10/290,997","7,078,396",*United States,US,11/8/2002,7/18/2006,US-2003-139385-A1,11/8/2002,0937-006,Small,11/8/2001,8/13/2018,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",US Utility,4/12/2018,0937-006,11/8/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612546,7/24/2003,581976,Yes
478,01-T-069,Method of Treating Disorder Related to High Cholesterol Concentration,02802882.7EPO, ,European Patent Office (EPO),EP,11/8/2002,,1450816,5/26/2004,0937-007,None,11/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0937-007,11/8/2022,"Dembo, Anna",Ching Song,"Tennant, Thelma",612547,,581976,Yes
479,01-T-069,Method of Treating Disorder Related to High Cholesterol Concentration,2003-541772, ,Japan,JP,11/8/2002,,2005-508368,5/26/2004,0937-008,Small,11/8/2001,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0937-008,11/8/2022,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612548,3/31/2005,581976,Yes
480,01-T-069,Method of Treating Disorder Related to High Cholesterol Concentration,"11/488,450", ,*United States,US,11/8/2002,,US-2007-0197484-A1,7/18/2006,0937-009,None,11/8/2001,2/9/2010,No,5/8/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Qing Dai, Shutsung Liao, Ching Song",Continuation,4/12/2018,0937-009,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612549,8/23/2007,581976,Yes
481,01-T-069,Method of treating disorder related to high cholesterol concentration,"12/637,165", ,*United States,US,11/8/2002,,US-2010-0093687-A1,12/14/2009,0937-010,Small,11/8/2001,8/1/2011,No,5/8/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Continuation,4/12/2018,0937-010,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612550,4/15/2010,581976,Yes
482,01-T-069,Method of treating disorder related to high cholesterol concentration,"13/046,074", ,*United States,US,11/8/2002,,US-2011-0160174-A1,3/11/2011,0937-011,Small,11/8/2001,3/19/2013,No,5/8/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Continuation,4/12/2018,0937-011,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612551,6/30/2011,581976,Yes
483,01-T-069,Method of treating disorder related to high cholesterol concentration,"13/749,022", ,*United States,US,11/8/2002,,US-2013-0210792-A1,1/24/2013,0937-012,Small,11/8/2001,12/10/2013,No,5/8/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Qing Dai, Shutsung Liao, Ching Song",Continuation,4/12/2018,0937-012,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612552,8/15/2013,581976,Yes
484,01-T-069,Method of treating disorder related to high cholesterol concentration,"14/092,178", ,*United States,US,11/8/2002,,US-2014-0088060-A1,11/27/2013,0937-013,Small,11/8/2001,9/23/2014,No,5/8/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Qing Dai, Shutsung Liao, Ching Song",Continuation,4/12/2018,0937-013,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612553,3/27/2014,581976,Yes
485,01-T-071,Computerized Schemes for Detecting and/or Diagnosing Lesions on Ultrasound Images Using Analysis of Lesion Shadows,"10/079,820", ,*United States,US,2/22/2002,,US-2003-161513-A1,2/22/2002,0944-001,Small,2/22/2002,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Karen Drukker, Maryellen Giger",US Utility,4/12/2018,0944-001,2/22/2022,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611271,8/28/2003,581978,Yes
486,01-T-071,Computerized Schemes for Detecting and/or Diagnosing Lesions on Ultrasound Images Using Analysis of Lesion Shadows,PCT/US03/03119, ,*United States,US,2/20/2003,,WO 03/073364 A1,2/20/2003,0944-002,Small,2/22/2002,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Karen Drukker, Maryellen Giger",PCT,4/12/2018,0944-002,8/22/2004,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611272,9/4/2003,581978,Yes
487,01-T-072,A Novel Subtraction Technique for Computerized Detection of Small Lung Nodules in Computer Tomography Images,PCT/US02/33651, ,*United States,US,11/22/2002,,WO 03/046831 A2,11/22/2002,0945-002,Small,11/23/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",PCT,4/12/2018,0945-002,5/23/2004,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610228,6/5/2003,581979,Yes
488,01-T-072,Subtraction Technique for Computerized Detection of Small Lung Nodules in Computer Tomography Images,"09/990,311","6,678,399",*United States,US,11/23/2001,1/13/2004,US-2003-099388-A1,11/23/2001,0945-001,Small,11/23/2001,3/24/2022,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",US Utility,4/12/2018,0945-001,3/9/2022,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614720,5/29/2003,581979,Yes
489,01-T-073,Computerized Method for Determination of the Likelihood of Malignancy for Pulmonary Nodules on Low-Dose CT,"09/990,310","6,891,964",*United States,US,11/23/2001,5/10/2005,US-2003-099387-A1,11/23/2001,0946-001,Small,11/23/2001,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Masahito Aoyama, Kunio Doi, Qiang Li",US Utility,4/12/2018,0946-001,11/23/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611262,5/29/2003,581980,Yes
490,01-T-073,Computerized Method for Determination of the Likelihood of Malignancy for Pulmonary Nodules on Low-Dose CT,PCT/US02/36121, ,*United States,US,11/22/2002,,WO 03/046809 A1,11/22/2002,0946-002,Small,11/23/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Masahito Aoyama, Kunio Doi, Qiang Li",PCT,4/12/2018,0946-002,5/23/2004,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611263,6/5/2003,581980,Yes
491,01-T-074,Computerized Scheme for Distinguishing Between Benign and Malignant Nodules in Thoracic Computed Tomography Scans By Use of Similar Images,"09/990,377", ,*United States,US,11/23/2001,,US-2003-103663-A1,11/23/2001,0947-001,Small,11/23/2001,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Qiang Li",US Utility,4/12/2018,0947-001,11/23/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611270,6/5/2003,581981,Yes
492,01-T-074,Method for Distinguishing Benign and Malignant Nodules,PCT/US02/33654, ,*United States,US,11/22/2002,,WO 03/046808 A2,11/22/2002,0947-002,Small,11/23/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kunio Doi, Qiang Li",PCT,4/12/2018,0947-002,5/23/2004,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612447,5/6/2003,581981,Yes
493,01-T-075,Automated Method and System for the Detection of Abnormalities in Sonograhic Images,PCT/US02/33653, ,*United States,US,11/22/2002,,WO 03/045231 A1,11/22/2002,0942-003,Small,11/23/2001,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Karen Drukker, Maryellen Giger, Karla Horsch, Carl Vyborny",PCT,4/12/2018,0942-003,5/23/2004,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610631,6/5/2003,581982,Yes
494,01-T-075,Automated Method and System for the Detection of Abnormalities in Sonographic Images,"60/332,005", ,*United States,US,11/23/2001,, ,11/23/2001,0942-001,Small,11/23/2001,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",,092234-9006,"Karen Drukker, Maryellen Giger, Karla Horsch, Carl Vyborny",Provisional,4/12/2018,0942-001,11/23/2002,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610632,,581982,Yes
495,01-T-075,Automated Method and System for the Detection of Abnormalities in Sonographic Images,"10/126,523","6,855,114",*United States,US,4/22/2002,2/15/2005,US-2003-125621-A1,4/22/2002,0942-002,Small,11/23/2001,6/23/2022,No,6/23/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Karen Drukker, Maryellen Giger, Karla Horsch, Carl Vyborny",US Utility,4/12/2018,0942-002,5/16/2022,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610633,7/3/2003,581982,Yes
496,01-T-076,Automated Method and System for Risk-modulated Computer-Aided Diagnosis,"60/354,523", ,*United States,US,2/8/2002,, ,2/8/2002,0943-001,Small,2/8/2002,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo, Carl Vyborny",Provisional,4/12/2018,0943-001,2/8/2003,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610618,,581983,Yes
497,01-T-076,Method and system for risk-modulated diagnosis of disease,"10/360,814","7,123,762",*United States,US,2/10/2003,10/17/2006,US-2003-174873-A1,2/10/2003,0943-002,Large,2/8/2002,10/17/2006,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Maryellen Giger, Zhimin Huo, Carl Vyborny",US Utility,4/12/2018,0943-002,3/20/2025,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612377,9/18/2003,581983,Yes
498,01-T-076,Method and system for risk-modulated diagnosis of disease.,PCT/US03/02674, ,*United States,US,2/10/2003,,WO 03/067371 A2,2/10/2003,0943-003,Small,2/8/2002,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Maryellen Giger, Zhimin Huo, Carl Vyborny",PCT,4/12/2018,0943-003,8/8/2004,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612378,8/14/2003,581983,Yes
499,01-T-078,Methods and Compositions Relating to Anthrax Pathogenesis,"60/336,762", ,*United States,US,11/2/2001,, ,11/2/2001,0949-001,None,11/2/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Andrew Bohm, Wei-Jen Tang",Provisional,4/12/2018,0949-001,11/2/2002,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",613067,,581985,Yes
500,01-T-078,Methods and Compositions Relating to Anthrax Pathogenesis,"10/286,452","7,462,472",*United States,US,11/1/2002,12/9/2008,US-2008-0124746-A1,11/1/2002,0949-002,Small,11/2/2001,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Krawzsenek, Michael", ,"Andrew Bohm, Wei-Jen Tang",US Utility,4/12/2018,0949-002,6/25/2025,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",613068,5/29/2008,581985,Yes
501,01-T-079,Materials and Methods for the Analysis of Gene Expression in CD34+ Stem/Progenitor Cells,"60/338,586", ,*United States,US,10/29/2001,, ,10/29/2001,0950-001,Small,10/29/2001,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",37798,"San Ming Wang, Goulin Zhou",Provisional,4/12/2018,0950-001,10/29/2002,"Unassigned, Unassigned",Goulin Zhou,"Unassigned, Unassigned",612214,,581986,Yes
502,01-T-079,Materials and Methods for the Analysis of Gene Expression in CD34+ Stem/Progenitor Cells,"10/283,374", ,*United States,US,10/29/2002,, ,10/29/2002,0950-002,Small,10/29/2001,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",30002A,"JianJun Chen, Sanggyu Lee, San Ming Wang, Goulin Zhou",US Utility,4/12/2018,0950-002,10/29/2022,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612215,,581986,Yes
503,01-T-079,Materials and Methods for the Analysis of Gene Expression in CD34+ Stem/Progenitor Cells,"11/412,695", ,*United States,US,10/29/2002,, ,4/28/2006,0950-003,Small,10/29/2001,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",41143,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang, Goulin Zhou",Divisional,4/12/2018,0950-003,10/29/2022,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612216,,581986,Yes
504,01-T-080,Genes Abnormally Expressed in myeloid Leukemia Cells with an MLL-AF9 Fusion,"60/343,826", ,*United States,US,12/27/2001,, ,12/27/2001,0951-001,Small,12/27/2001,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rasheed, Nabeela",37928,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang, Goulin Zhou",Provisional,4/12/2018,0951-001,12/27/2002,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",611672,,581987,Yes
505,01-T-080,Genes abnormally expressed in myeloid leukemia cells with an MLL-AF9 fusion,"10/329,465", ,*United States,US,12/23/2002,,US-2003-165949-A1,12/23/2002,0951-002,Small,12/27/2001,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Rasheed, Nabeela",37922,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang",US Utility,4/12/2018,0951-002,12/27/2021,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",611673,9/4/2003,581987,Yes
506,01-T-082,A Method for Reliable and Accurate Idnetification of False Statements,"60/342,619", ,*United States,US,12/21/2001,, ,12/21/2001,0953-001,Small,12/21/2001,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"John Cacioppo, Tyler Lorig",Provisional,4/12/2018,0953-001,12/21/2002,"Cox, Ben",John Cacioppo,"Smith, Dane",610214,,581989,Yes
507,01-T-082,Method and apparatus for identification of false statements.,PCT/US02/40436, ,*United States,US,12/18/2002,,WO 03/059161 A1,12/18/2002,0953-002,Small,12/21/2001,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"John Cacioppo, Tyler Lorig",PCT,4/12/2018,0953-002,6/21/2004,"Cox, Ben",John Cacioppo,"Smith, Dane",612293,7/24/2003,581989,Yes
508,01-T-082,Method and apparatus for identification of false statements.,"10/499,070","7,214,187",*United States,US,12/18/2002,5/8/2007,US-2005-065413-A1,11/10/2004,0953-003,Small,12/21/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"John Cacioppo, Tyler Lorig",Nationalized PCT,4/12/2018,0953-003,11/10/2024,"Cox, Ben",John Cacioppo,"Smith, Dane",612294,3/24/2005,581989,Yes
509,01-T-082,System and Method for identification of false statements.,"11/734,171", ,*United States,US,12/18/2002,,US-2007-0249914-A1,4/10/2007,0953-004,Small,12/21/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"John Cacioppo, Tyler Lorig",Continuation,4/12/2018,0953-004,12/21/2021,"Cox, Ben",John Cacioppo,"Smith, Dane",614782,10/25/2007,581989,Yes
510,01-T-083,Multiple Optical Vortices for Manipulating Particles,"11/059,876","6,995,351",*United States,US,1/16/2003,2/7/2006, ,2/17/2005,0954-006,Small,1/16/2002,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Continuation,4/12/2018,0954-006,1/16/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613566,,581990,Yes
511,01-T-083,"Use of Multiple Optical Vortices for Pumping, Mixing and Sorting","10/050,213","6,737,634",*United States,US,1/16/2002,5/18/2004,US-2003-132373-A1,1/16/2002,0954-001,Small,1/16/2002,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",US Utility,4/12/2018,0954-001,1/16/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615247,7/17/2003,581990,Yes
512,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting",03703856.9EPO,1 466 509,European Patent Office (EPO),EP,1/16/2003,1/5/2013,1 466 509,8/4/2004,0954-003,Small,1/16/2002,,No,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Jennifer Curtis, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0954-003,1/7/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615248,10/13/2004,581990,Yes
513,01-T-083,"Use of Multiple Optical Vortices for Pumping, Mixing and Sorting","10/847,042","6,858,833",*United States,US,1/16/2003,2/22/2005,US-2004-211889-A1,5/17/2004,0954-005,Small,1/16/2002,2/18/2022,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Continuation,4/12/2018,0954-005,1/16/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615249,10/28/2004,581990,Yes
514,01-T-083,"Use of Multiple Optical Vortices for Pumping, Mixing and Sorting","11/266,989","7,176,445",*United States,US,1/16/2003,2/13/2007,US-2006-0054793-A1,11/4/2005,0954-007,Small,1/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Continuation,4/12/2018,0954-007,1/16/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615250,3/16/2006,581990,Yes
515,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting",03703856.9DE, ,Germany,DE,1/16/2003,, ,7/16/2013,0954-008,Small,1/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Validated EPO,4/12/2018,0954-008,1/7/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615251,,581990,Yes
516,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting",03703856.9FR, ,France,FR,1/16/2003,, ,7/16/2013,0954-009,Small,1/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Validated EPO,4/12/2018,0954-009,1/7/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615252,,581990,Yes
517,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting",03703856.9IT, ,Italy,IT,1/16/2003,, ,7/16/2013,0954-010,Small,1/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Validated EPO,4/12/2018,0954-010,1/7/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615253,,581990,Yes
518,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting",03703856.9GB, ,United Kingdom,GB,1/16/2003,, ,7/16/2013,0954-011,Small,1/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",Validated EPO,4/12/2018,0954-011,1/7/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615254,,581990,Yes
519,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting,",PCT/US03/01427, ,*United States,US,1/16/2003,,WO 03/063559 A1,1/16/2003,0954-002,Small,1/16/2002,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier, Brian Koss",PCT,4/12/2018,0954-002,7/16/2004,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615255,7/31/2003,581990,Yes
520,01-T-083,"Use of multiple optical vortices for pumping, mixing and sorting,",2003-563275, ,Japan,JP,1/16/2003,,2005-515878,8/4/2004,0954-004,Small,1/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, David Grier, Brian Koss",Nationalized PCT,4/12/2018,0954-004,1/16/2013,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",615256,6/2/2005,581990,Yes
521,01-T-084,Methods and Compositions for the Inhibition of DNA Repair Protein VRCC-3,"60/407,557", ,*United States,US,8/30/2002,, ,8/30/2002,0955-001,Small,8/30/2002,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rasheed, Nabeela",38743,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,0955-001,8/30/2003,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612878,,581991,Yes
522,01-T-084,Methods and Compositions for the Inhibition of DNA Repair Protein XRCC-3,"60/411,147", ,*United States,US,9/16/2002,, ,9/16/2002,0955-002,Small,9/16/2002,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rasheed, Nabeela",38743A,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,0955-002,9/16/2003,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612879,,581991,Yes
523,01-T-085,Apparatus and Method for Parallel Synthesis of Chemical Libraries,"60/361,827", ,*United States,US,3/4/2002,, ,3/4/2002,0956-001,Small,3/4/2002,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00060,"Sergey Kozmin, Ying Wang",Provisional,4/12/2018,0956-001,3/4/2003,"Ginsburg, Eric",Ying Wang,"Tennant, Thelma",610486,,581992,Yes
524,01-T-085,Device and Method for Multiparallel Synthesis and screening,"10/172,337", ,*United States,US,6/13/2002,,US-2003-165994-A1,6/13/2002,0956-002,Small,3/4/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00064,"Sergey Kozmin, Ying Wang",US Utility,4/12/2018,0956-002,3/4/2022,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",611400,9/4/2003,581992,Yes
525,01-T-087,Methylnaltrexone for the Treatment and Prevention of Equine Colic,PCT/US02/34458, ,*United States,US,10/28/2002,, ,10/28/2002,0958-002,Small,10/26/2001,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Jonathan Moss,PCT,4/12/2018,0958-002,8/4/2004,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613374,,581994,Yes
526,01-T-087,Methylnaltrexone for the Treatment of Equine Colic,"60/354,278", ,*United States,US,10/26/2001,, ,10/26/2001,0958-001,Small,10/26/2001,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Jonathan Moss,Provisional,4/12/2018,0958-001,10/26/2002,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613375,,581994,Yes
527,01-T-088,Method for Determining Biological Expression Levels by Linear Programming,"10/198,141","7,031,845",*United States,US,7/19/2002,4/18/2006,US-2004-014044-A1,7/19/2002,0959-001,Small,7/19/2002,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Terry Clark, Chris Dyanov, Stuart Kurtz, Richard Quigg, L. Ridgway Scott, Stephen Wright",US Utility,4/12/2018,0959-001,7/19/2022,"Bakalyar, Heather",Stuart Kurtz,"Smith, Dane",612444,1/22/2004,581995,Yes
528,02-T-001,Particle Beam Lens,"07/249,857", ,*United States,US,9/27/1988,, ,9/27/1988,0220.1-001,None,9/27/1988,,Yes,4/28/2022,Abandoned,,, ,Zhifeng Shao,US Utility,4/12/2018,0220.1-001,,"Unassigned, Unassigned",Zhifeng Shao,"Unassigned, Unassigned",613893,,580941,Yes
529,02-T-003,Methods for measure gastric emptying and for identifying the prokinetic properties of drugs and drug candidates.,"60/410,113", ,*United States,US,9/12/2002,, ,9/12/2002,0961-001,Small,9/12/2002,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rasheed, Nabeela",38613,Eli Ehrenpreis,Provisional,4/12/2018,0961-001,9/12/2003,"Unassigned, Unassigned",Eli Ehrenpreis,"Unassigned, Unassigned",613229,,581997,Yes
530,02-T-003,"Methods, Formulations, and Kits for Monitoring and Diagnosing Gastric Emptying and Gastroparesis, and Formulations for Determining Gastrointestinal Motility",PCT/US03/28689, ,*United States,US,9/12/2003,,WO 04/024192 A1,9/12/2003,0961-005,Small,9/12/2002,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rasheed, Nabeela",38613A-PC,Eli Ehrenpreis,PCT,4/12/2018,0961-005,3/12/2005,"Unassigned, Unassigned",Eli Ehrenpreis,"Unassigned, Unassigned",613370,3/25/2004,581997,Yes
531,02-T-003,"Methods, Formulations, and Kits for Monitoring and Diagnosing Gastric Emptying and Gastroparesis, and Formulations for Determining Gastrointestinal Motility","10/661,948", ,*United States,US,9/12/2003,,US-2004-126318-A1,9/12/2003,0961-006,Small,9/12/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,38613A,Eli Ehrenpreis,US Utility,4/12/2018,0961-006,9/12/2022,"Unassigned, Unassigned",Eli Ehrenpreis,"Unassigned, Unassigned",613371,7/1/2004,581997,Yes
532,02-T-003,Monitoring and Diagnosing of Gastric Emptying and Gastroparesis,2004-536207, ,Japan,JP,9/12/2003,, ,3/8/2005,0961-003,Small,9/12/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38613A-JP,Eli Ehrenpreis,Nationalized PCT,4/12/2018,0961-003,9/12/2023,"Unassigned, Unassigned",Eli Ehrenpreis,"Unassigned, Unassigned",613515,,581997,Yes
533,02-T-003,Monitoring and Diagnosis of Gastric Emptying and Gastroparesis,"2,498,507", ,Canada,CA,9/12/2003,, ,6/27/2005,0961-002,Small,9/12/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38613A-CA,Eli Ehrenpreis,Nationalized PCT,4/12/2018,0961-002,9/12/2023,"Unassigned, Unassigned",Eli Ehrenpreis,"Unassigned, Unassigned",613516,,581997,Yes
534,02-T-003,MONITORING AND DIAGNOSIS OF GASTRIC EMPTYING AND GASTROPARESIS,03755818.6EPO, ,European Patent Office (EPO),EP,9/12/2003,,1 536 841,3/8/2005,0961-004,Small,9/12/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38613A-EP,Eli Ehrenpreis,Nationalized PCT,4/12/2018,0961-004,9/12/2023,"Unassigned, Unassigned",Eli Ehrenpreis,"Unassigned, Unassigned",613517,6/8/2005,581997,Yes
535,02-T-007,"Apparatus and Method for Fabricating, Sorting, and Integrating Materials with Holographic Optical Traps",06113263.7,1092643,Hong Kong,HK,7/31/2003,7/25/2008,1092643A,7/31/2003,0925-019,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0925-019,7/31/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610471,2/9/2007,582001,Yes
536,02-T-008,Patterned Anisotropic Conductor and Sensitive Magnetometer,"60/356,230", ,*United States,US,2/12/2002,, ,2/12/2002,0966-001,Small,2/12/2002,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"David Grier, Woowon Kang, Pamela Korda",Provisional,4/12/2018,0966-001,2/12/2003,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613909,,582002,Yes
537,02-T-010,Effective Removal of Deleterious Substances in Vivo Using Magnetic Particles,"60/469,765", ,*United States,US,5/12/2003,, ,5/12/2003,0968-001,Small,5/12/2003,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",39093,"Michael Kaminski, Axel Rosengart",Provisional,4/12/2018,0968-001,5/12/2004,"Ginsburg, Eric",Axel Rosengart,"Muite, Kevin",611502,,582004,Yes
538,02-T-013,Heat Transfer Probe,"60/463,490", ,*United States,US,4/17/2003,, ,4/17/2003,0971-001,Small,4/17/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Barrett, Michael", ,"Jeffrey Frank, Axel Rosengart",Provisional,4/12/2018,0971-001,4/17/2004,"Ginsburg, Eric",Axel Rosengart,"Muite, Kevin",611750,,582007,Yes
539,02-T-013,Heat Transfer Probe,"10/827,114","7,118,591",*United States,US,4/19/2004,10/10/2006,US-2005-090881-A1,4/19/2004,0971-002,Small,4/17/2003,10/10/2006,No,4/28/2022,Issued,Joan Pennington,, ,"Tai-Hsin Chien, Jeffrey Frank, Jeff Franklin, Kenneth Kasza, Axel Rosengart, Wenhua Yu",US Utility,4/12/2018,0971-002,4/19/2024,"Ginsburg, Eric",Axel Rosengart,"Muite, Kevin",611751,4/28/2005,582007,Yes
540,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,"60/295,571", ,*United States,US,6/5/2001,, ,6/5/2001,0977-001,Small,6/5/2001,,Yes,4/28/2022,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"Jonathan Moss, Chun-Su Yuan",Provisional,4/12/2018,0977-001,6/5/2002,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615237,,582013,Yes
541,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,"60/374,454", ,*United States,US,4/22/2002,, ,4/22/2002,0977-002,Small,4/22/2002,,No,4/28/2022,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",Provisional,4/12/2018,0977-002,4/22/2003,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615238,,582013,Yes
542,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,PCT/US02/18087, ,*United States,US,6/5/2002,,WO 02/098422 A1,6/5/2002,0977-003,Small,6/5/2001,,No,4/28/2022,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"Jonathan Moss, Chun-Su Yuan",PCT,4/12/2018,0977-003,12/5/2003,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615239,12/12/2002,582013,Yes
543,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,2002314967,2002314967,Australia,AU,6/5/2002,1/17/2008, ,12/16/2003,0977-004,Small,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",Nationalized PCT,4/12/2018,0977-004,6/5/2022,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615240,,582013,Yes
544,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,"10/163,482", ,*United States,US,6/5/2002,,US-2003-022909-A1,6/5/2002,0977-005,Small,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",US Utility,4/12/2018,0977-005,6/5/2021,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615241,1/30/2003,582013,Yes
545,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,02741899.5EPO, ,European Patent Office (EPO),EP,6/5/2002,,EP 1 404 323 A1,3/23/2004,0977-006,Small,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",Nationalized PCT,4/12/2018,0977-006,6/5/2021,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615242,4/7/2004,582013,Yes
546,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,2003-501461, ,Japan,JP,6/5/2002,,2004-535419,12/4/2003,0977-007,Small,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"Jonathan Moss, Chun-Su Yuan",Nationalized PCT,4/12/2018,0977-007,12/4/2023,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615243,11/25/2004,582013,Yes
547,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,04107669.1, ,Hong Kong,HK,6/5/2002,,1064614A,10/6/2004,0977-008,Small,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",Nationalized PCT,4/12/2018,0977-008,6/5/2022,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615244,2/4/2005,582013,Yes
548,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,"2,449,175", ,Canada,CA,6/5/2002,, ,1/6/2007,0977-009,Large,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",Nationalized PCT,4/12/2018,0977-009,6/5/2022,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615245,,582013,Yes
549,02-T-019,Use of Methylnaltrexone to Treat Immune Suppression,2009-5238, ,Japan,JP,6/5/2002,,2009-102382,2/5/2009,0977-010,Small,6/5/2001,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.",, ,"Jonathan Moss, Chun-Su Yuan",Nationalized PCT,4/12/2018,0977-010,6/5/2022,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615246,5/14/2009,582013,Yes
550,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,"10/535,918", ,*United States,US,11/26/2002,,US-2006-0198817-A1,5/23/2005,0978-001,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-001,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612170,9/7/2006,582014,Yes
551,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,2005/04279,2005/04279,South Africa,ZA,11/26/2002,8/30/2006, ,6/23/2005,0978-002,Small,11/26/2002,3/8/2019,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-002,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612171,8/30/2006,582014,Yes
552,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0EPO,1567117,European Patent Office (EPO),EP,11/26/2002,2/8/2012,1567117,6/22/2005,0978-003,Small,11/26/2002,,No,4/28/2022,Expired - Inactive,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-003,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612172,8/31/2005,582014,Yes
553,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,2004-555237,5271475,Japan,JP,11/26/2002,5/17/2013,2006-515837,6/27/2005,0978-004,Small,11/26/2002,3/8/2019,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-004,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612173,6/8/2006,582014,Yes
554,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,05-049705, ,Colombia,CO,11/26/2002,, ,8/3/2005,0978-005,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-005,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612175,,582014,Yes
555,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,00252/2005, ,Egypt,EG,11/26/2002,, ,7/6/2005,0978-006,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-006,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612177,,582014,Yes
556,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,0610710.1,HK1081445,Hong Kong,HK,11/26/2002,4/16/2010,1081445A,1/31/2006,0978-007,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Richard Wu",Nationalized PCT,4/12/2018,0978-007,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612178,5/19/2006,582014,Yes
557,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,200503260-2,113128,Singapore,SG,11/26/2002,7/29/2007, ,5/24/2005,0978-008,Small,11/26/2002,3/8/2019,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-008,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612179,,582014,Yes
558,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,KE/P/2002/00311, ,Kenya,KE,11/26/2002,, ,5/27/2005,0978-009,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-009,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612181,,582014,Yes
559,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,1-2005-501001, ,Philippines,PH,11/26/2002,, ,5/27/2005,0978-010,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-010,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612183,,582014,Yes
560,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,PI0215954-6, ,Brazil,BR,11/26/2002,, ,5/27/2005,0978-011,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-011,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612184,,582014,Yes
561,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,"2,507,018","2,507,018",Canada,CA,11/26/2002,3/25/2014, ,5/27/2005,0978-012,Large,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-012,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612185,,582014,Yes
562,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02829960.4,ZL 02 8 29960.4,China,CN,11/26/2002,9/9/2009,CN 1697644A,5/26/2005,0978-013,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-013,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612186,11/16/2005,582014,Yes
563,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,2005-01714, ,Indonesia,ID,11/26/2002,, ,5/27/2005,0978-014,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-014,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612188,,582014,Yes
564,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,0667/MUMNP/2005,210490,India,IN,11/26/2002,5/10/2007, ,9/12/2005,0978-015,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-015,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612189,,582014,Yes
565,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,168675, ,Israel,IL,11/26/2002,, ,6/1/2005,0978-016,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-016,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612190,,582014,Yes
566,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,10-2005-7009411,10-1087412,"Korea, Republic of",KR,11/26/2002,11/21/2011, ,5/25/2005,0978-017,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-017,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612191,,582014,Yes
567,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,PA/A/2005/005553,321936,Mexico,MX,11/26/2002,7/11/2014, ,9/15/2005,0978-018,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-018,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612192,,582014,Yes
568,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,2005120013,"2,346,694",Russian Federation,RU,11/26/2002,2/20/2009, ,6/1/2005,0978-019,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-019,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612193,,582014,Yes
569,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,PCT/US02/37948, ,*United States,US,11/26/2002,,WO 04/047778 A1,11/26/2002,0978-021,Small,11/26/2002,,Yes,4/28/2022,Expired - Inactive,Armstrong Teasdale,, ,John Alverdy,PCT,4/12/2018,0978-021,5/26/2005,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612194,6/10/2004,582014,Yes
570,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,2002352938,2002352938,Australia,AU,11/26/2002,12/24/2009, ,5/24/2005,0978-022,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Nationalized PCT,4/12/2018,0978-022,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612195,,582014,Yes
571,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,859/MUMNP/2007,237387,India,IN,11/26/2002,12/18/2009, ,8/22/2007,0978-023,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Divisional,4/12/2018,0978-023,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612196,,582014,Yes
572,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,2010-226022, ,Japan,JP,11/26/2002,,2011-012075,10/15/2010,0978-024,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Continuation,4/12/2018,0978-024,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612197,1/20/2011,582014,Yes
573,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0AT,1567117,Austria,AT,11/26/2002,2/8/2012, ,2/8/2012,0978-025,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-025,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612198,,582014,Yes
574,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0BE,1567117,Belgium,BE,11/26/2002,2/8/2012, ,2/8/2012,0978-026,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-026,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612199,,582014,Yes
575,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0CZ,1567117,Czech Republic,CZ,11/26/2002,2/8/2012, ,2/8/2012,0978-027,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-027,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612200,,582014,Yes
576,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0DK,1567117,Denmark,DK,11/26/2002,2/8/2012, ,2/8/2012,0978-028,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-028,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612201,,582014,Yes
577,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0FR,1567117,France,FR,11/26/2002,2/8/2012, ,2/8/2012,0978-029,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-029,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612202,,582014,Yes
578,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0DE,1567117,Germany,DE,11/26/2002,2/8/2012, ,2/8/2012,0978-030,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-030,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612203,,582014,Yes
579,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0IE,1567117,Ireland,IE,11/26/2002,2/8/2012, ,2/8/2012,0978-031,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-031,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612204,,582014,Yes
580,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0IT,1567117,Italy,IT,11/26/2002,2/8/2012, ,2/8/2012,0978-032,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-032,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612205,,582014,Yes
581,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0NL,1567117,Netherlands,NL,11/26/2002,2/8/2012, ,2/8/2012,0978-033,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-033,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612206,,582014,Yes
582,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0PT,1567117,Portugal,PT,11/26/2002,2/8/2012, ,2/8/2012,0978-034,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-034,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612207,,582014,Yes
583,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0ES,1567117,Spain,ES,11/26/2002,2/8/2012, ,2/8/2012,0978-035,Small,11/26/2002,3/11/2022,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-035,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612208,,582014,Yes
584,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0CH,1567117,Switzerland,CH,11/26/2002,2/8/2012, ,2/8/2012,0978-036,Small,11/26/2002,7/16/2021,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-036,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612209,,582014,Yes
585,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,02789898.0GB,1567117,United Kingdom,GB,11/26/2002,2/8/2012, ,2/8/2012,0978-037,Small,11/26/2002,7/26/2021,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Validated EPO,4/12/2018,0978-037,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612210,,582014,Yes
586,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,"2,840,698", ,Canada,CA,11/26/2002,, ,1/27/2014,0978-038,Small,11/26/2002,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,John Alverdy,Divisional,4/12/2018,0978-038,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612211,,582014,Yes
587,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,"14/936,088","9,549,946",*United States,US,11/26/2002,1/24/2017,2016-0129038-A1,11/9/2015,0978-039,Small,11/26/2002,,No,4/28/2022,Issued,Armstrong Teasdale,, ,John Alverdy,Continuation,4/12/2018,0978-039,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612212,5/12/2016,582014,No
588,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,"15/377,568", ,*United States,US,11/26/2002,,US-2017-0281668-A1,12/13/2016,0978-040,Small,11/26/2002,11/1/2018,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Richard Wu",Continuation,4/12/2018,0978-040,,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612213,10/5/2017,582014,No
589,02-T-020,Materials and Methods for Preventing and Treating Microbe-Mediated Epithelial Disorders,"16/159,222", ,*United States,US,11/26/2002,, ,10/12/2018,0978-041,Small,11/26/2002,6/26/2019,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Richard Wu",Continuation,11/28/2018, ,11/26/2022,"Dembo, Anna",John Alverdy,"Tennant, Thelma",1921000,,582014,No
590,02-T-021,High Molecular Weight Polyethylene Glycol Prevents Lethal Sepsis Due to Intestinal Pseudomonas Aeruginosa,"60/529,360", ,*United States,US,12/12/2003,, ,12/12/2003,0979-001,Small,12/12/2003,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",39800,John Alverdy,Provisional,4/12/2018,0979-001,12/12/2004,"Dembo, Anna",John Alverdy,"Tennant, Thelma",611809,,582015,Yes
591,02-T-024,Aberration Correction of Optical Traps,"10/209,730", ,*United States,US,8/1/2002,, ,8/1/2002,0982-001,Small,8/1/2002,,Yes,4/28/2022,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Jennifer Curtis, David Grier, Brian Koss",US Utility,4/12/2018,0982-001,8/1/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610241,,582018,Yes
592,02-T-024,Aberration Correction of Optical Traps,"10/958,591", ,*United States,US,8/1/2002,, ,10/6/2004,0982-002,Small,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Jennifer Curtis, David Grier, Karen Kasza, Brian Koss, Ladavac Kosta",Continuation in Part,4/12/2018,0982-002,8/1/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610242,,582018,Yes
593,02-T-024,Aberration Correction of Optical Traps,"12/155,503", ,*United States,US,8/1/2002,,US-2008-0316575-A1,6/5/2008,0982-003,Large,8/1/2002,,No,4/28/2022,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Jennifer Curtis, David Grier, Karen Kasza, Brian Koss, Ladavac Kosta",Divisional,4/12/2018,0982-003,8/1/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610243,12/25/2008,582018,Yes
594,02-T-032,Massive Training Artificial Neural Network (MTANN) for Detecting Abnormalities in Medical Images,"10/120,420","6,819,790",*United States,US,4/12/2002,11/16/2004,US-2003-194124-A1,4/12/2002,0990-001,Small,4/12/2002,11/16/2004,Yes,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Kenji Suzuki",US Utility,4/12/2018,0990-001,12/27/2022,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612163,10/16/2003,582026,Yes
595,02-T-032,Massive Training Artificial Neural Network (MTANN) for Detecting Abnormalities in Medical Images,PCT/US03/10468, ,*United States,US,4/14/2003,,WO 03/087983  A2,4/14/2003,0990-002,Small,4/12/2002,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Kenji Suzuki",PCT,4/12/2018,0990-002,10/14/2004,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612164,10/23/2003,582026,Yes
596,02-T-034,Tumor associated cellular and mollecular changes induced in endothelial cells,"60/436,029", ,*United States,US,12/23/2002,, ,12/23/2002,0992-001,Small,12/23/2002,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",38744,"Nikolai Khodarev, Ralph Weichselbaum, Jainquing Yu",Provisional,4/12/2018,0992-001,12/23/2003,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615122,,582028,Yes
597,02-T-037,Method of Regulating Angiogenesis by Modulating Intercellular Communication Through Gap Junction Channels,"60/380,947", ,*United States,US,5/15/2002,, ,5/15/2002,0995-001,Small,5/15/2002,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Eric Beyer, Keum Kang, Kyung Seul",Provisional,4/12/2018,0995-001,5/15/2003,"Unassigned, Unassigned",Kyung Seul,"Unassigned, Unassigned",612534,,582031,Yes
598,02-T-038,A Method for Conducting an Autocatalytic Reaction in Plugs in a Microfluidic System,"15/926,988","11,278,898",*United States,US,5/9/2003,3/22/2022,,3/20/2018,0996-049,Large,5/9/2002,4/13/2022,No,6/15/2022,Issued,Brown Rudnick,,31097.0054,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-049,12/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610210,,582032,Yes
599,02-T-038,A Method for Conducting Reactions Involving Biological Molecules in Plugs in a Microfluidic System,"15/926,985",,*United States,US,5/9/2003,,,3/20/2018,0996-047,Large,5/9/2002,,No,6/16/2022,Pending,Brown Rudnick,"Schoen, Adam",UCH-800/US29 31097/53,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-047,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610211,,582032,Yes
600,02-T-038,Device and Method for Pressure-Driven Plug Transport,"60/379,927", ,*United States,US,5/9/2002,, ,5/9/2002,0996-001,Small,5/9/2002,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00062,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Provisional,4/12/2018,0996-001,5/9/2003,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611403,,582032,Yes
601,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/024,627", ,*United States,US,5/9/2003,,US-2011-0142734-A1,2/10/2011,0996-023,Small,5/9/2002,2/18/2021,No,4/28/2022,Abandoned,Brown Rudnick,"Meyers, Thomas",31097.0017,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-023,5/9/2022,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611404,6/16/2011,582032,Yes
602,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/024,206", ,*United States,US,5/9/2003,,US-2011-0176966-A1,2/9/2011,0996-024,Small,5/9/2002,,No,4/28/2022,Abandoned,Brown Rudnick,"Meyers, Thomas",31097.0021,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-024,5/9/2022,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611405,7/21/2011,582032,Yes
603,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/024,171","8,273,573",*United States,US,5/9/2003,9/25/2012,US-2011-0174622-A1,2/9/2011,0996-025,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0020,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-025,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611406,7/21/2011,582032,Yes
604,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/024,165","9,329,107",*United States,US,5/9/2003,5/3/2016,US-2011-0177586-A1,2/9/2011,0996-026,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0019,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-026,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611407,7/21/2011,582032,Yes
605,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/024,155","8,304,193",*United States,US,5/9/2003,11/6/2012,US-2011-0177609-A1,2/9/2011,0996-027,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0049,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-027,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611408,7/21/2011,582032,Yes
606,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/024,145","8,329,407",*United States,US,5/9/2003,12/11/2012,US-2011-0177494-A1,2/9/2011,0996-028,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0048,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-028,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611409,7/21/2011,582032,Yes
607,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/563,347","8,822,148",*United States,US,5/9/2003,9/2/2014, ,7/31/2012,0996-031,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,"Meyers, Thomas",31097.0050,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-031,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611410,,582032,Yes
608,02-T-038,Device and Method for Pressure-Driven Plug Transport,"13/648,922", ,*United States,US,5/9/2003,,US-2013-0101995-A1,10/10/2012,0996-034,Small,5/9/2002,,No,4/28/2022,Abandoned,Brown Rudnick,"Meyers, Thomas",31097.0011,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-034,10/10/2032,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611411,4/25/2013,582032,Yes
609,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"10/434,970","7,129,091",*United States,US,5/9/2003,10/31/2006,US-2005-0272159-A1,5/9/2003,0996-003,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,"Meyers, Thomas",31097.0015,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",US Utility,4/12/2018,0996-003,8/10/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611412,12/8/2005,582032,Yes
610,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,PCT/US03/14794, ,*United States,US,5/9/2003,,WO 04/038363 A2,5/9/2003,0996-005,Small,5/9/2002,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00085,Rustem Ismagilov,PCT,4/12/2018,0996-005,1/8/2005,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611413,5/6/2004,582032,Yes
611,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"10/765,718","7,901,939",*United States,US,5/9/2003,3/8/2011,US-2005-087122-A1,1/26/2004,0996-006,Small,5/9/2002,,No,4/28/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00095,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation in Part,4/12/2018,0996-006,11/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611414,4/28/2005,582032,Yes
612,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,03783044.5EPO,1508044,European Patent Office (EPO),EP,5/9/2003,9/1/2010, ,12/9/2004,0996-007,Small,5/9/2002,,No,4/28/2022,Granted,Brinks Gilson & Lione,,07814.00115,Rustem Ismagilov,Nationalized PCT,4/12/2018,0996-007,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611415,,582032,Yes
613,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"11/589,700","8,889,083",*United States,US,5/9/2003,11/18/2014,US-2007-0172954-A1,10/30/2006,0996-008,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0023,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-008,8/10/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611416,7/26/2007,582032,Yes
614,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"12/777,099", ,*United States,US,5/9/2003,,US-2010-0233026-A1,5/10/2010,0996-010,Small,5/9/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Feng, Yuezhong",00278,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-010,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611417,9/16/2010,582032,Yes
615,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,03783044.5FR,1508044,France,FR,5/9/2003,9/1/2010, ,9/1/2010,0996-011,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0002,Rustem Ismagilov,Validated EPO,4/12/2018,0996-011,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611418,,582032,Yes
616,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,60333995.6,1508044,Germany,DE,5/9/2003,9/1/2010,1508044,9/1/2010,0996-012,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0003,Rustem Ismagilov,Validated EPO,4/12/2018,0996-012,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611419,,582032,Yes
617,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,03783044.5GB,1508044,United Kingdom,GB,5/9/2003,9/1/2010, ,9/1/2010,0996-013,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0005,Rustem Ismagilov,Validated EPO,4/12/2018,0996-013,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611420,,582032,Yes
618,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,03783044.5SE,1508044,Sweden,SE,5/9/2003,9/1/2010, ,9/1/2010,0996-014,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0004,Rustem Ismagilov,Validated EPO,4/12/2018,0996-014,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611421,,582032,Yes
619,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,03783044.5CH,1508044,Switzerland,CH,5/9/2003,9/1/2010, ,9/1/2010,0996-015,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0006,Rustem Ismagilov,Validated EPO,4/12/2018,0996-015,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611422,,582032,Yes
620,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,03783044.5LI,1508044,Lichtenstein,LI,5/9/2003,9/1/2010, ,9/1/2010,0996-016,Small,5/9/2002,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00286,Rustem Ismagilov,Validated EPO,4/12/2018,0996-016,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611423,,582032,Yes
621,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174433.2EPO,2278337,European Patent Office (EPO),EP,5/9/2003,6/26/2019, ,8/27/2010,0996-017,Small,5/9/2002,,No,4/28/2022,Granted,Brown Rudnick,,UCH-800/EP01,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,4/12/2018,0996-017,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611424,,582032,Yes
622,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174436.5EPO,2278338,European Patent Office (EPO),EP,5/9/2003,8/26/2020, ,8/27/2010,0996-018,Small,5/9/2002,12/14/2020,No,4/28/2022,Granted,Brown Rudnick,"Schoen, Adam",31097.0032,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,4/12/2018,0996-018,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611425,,582032,Yes
623,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174435.7EPO,2302389,European Patent Office (EPO),EP,5/9/2003,1/24/2018, ,8/27/2010,0996-019,Small,5/9/2002,5/17/2018,No,4/28/2022,Granted,,,31097.0022,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,4/12/2018,0996-019,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611426,,582032,Yes
624,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10185097.2EPO, ,European Patent Office (EPO),EP,5/9/2003,, ,9/30/2010,0996-020,Small,5/9/2002,,No,6/14/2022,Pending,Brown Rudnick,,31097.0007,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,4/12/2018,0996-020,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611427,,582032,Yes
625,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10183101.4EPO, ,European Patent Office (EPO),EP,5/9/2003,, ,9/30/2010,0996-021,Small,5/9/2002,,No,6/14/2022,Pending,Brown Rudnick,,31097.0030,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,4/12/2018,0996-021,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611428,,582032,Yes
626,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10183131.1EPO,2283917,European Patent Office (EPO),EP,5/9/2003,12/15/2021,,9/30/2010,0996-022,Small,5/9/2002,4/13/2022,No,5/5/2022,Granted,Brown Rudnick,,UCH-800/EP04 31097/29,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,4/12/2018,0996-022,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611429,,582032,Yes
627,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"14/517,602","9,592,506",*United States,US,5/9/2003,3/14/2017,US-2016-0215411-A1,10/17/2014,0996-033,Small,5/9/2002,,No,4/28/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00383,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-033,11/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611430,7/29/2016,582032,Yes
628,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"14/507,938","9,579,622",*United States,US,5/9/2003,2/28/2017, ,10/1/2014,0996-035,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0036,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-035,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611431,,582032,Yes
629,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"14/836,432","9,839,893",*United States,US,5/9/2003,12/12/2017, ,8/26/2015,0996-036,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0037,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-036,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611432,,582032,No
630,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"15/586,896","9,889,446",*United States,US,5/9/2003,2/13/2018, ,5/4/2017,0996-040,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,"Meyers, Thomas",31097.0042,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-040,5/4/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611433,,582032,No
631,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"15/673,929","10,668,471",*United States,US,5/9/2003,6/2/2020,US-2017-0368551-A1,8/10/2017,0996-041,Small,5/9/2002,2/18/2021,No,4/28/2022,Issued,Brown Rudnick,,31097.0044,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-041,5/12/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611434,12/28/2017,582032,No
632,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"15/673,955","9,968,933",*United States,US,5/9/2003,5/15/2018, ,8/10/2017,0996-042,Large,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0045,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-042,5/12/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611435,,582032,No
633,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,17186748.4EPO, ,European Patent Office (EPO),EP,5/9/2003,, ,8/14/2017,0996-043,Small,5/9/2002,,No,5/13/2022,Pending,Brown Rudnick,,31097.0046,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Divisional,4/12/2018,0996-043,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611436,,582032,Yes
634,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"15/825,689",10118174,*United States,US,5/9/2003,11/6/2018, ,11/29/2017,0996-044,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,UCH-800/US26,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Divisional,4/12/2018,0996-044,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611437,,582032,No
635,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"15/861,205","10,562,028",*United States,US,5/9/2003,2/18/2020,US 2018-0193837 A1,1/3/2018,0996-045,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0051,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-045,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611438,7/12/2018,582032,Yes
636,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"15/861,225","10,105,703",*United States,US,5/9/2003,10/23/2018, ,1/3/2018,0996-046,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,"Meyers, Thomas", ,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,4/12/2018,0996-046,5/4/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611439,,582032,Yes
637,02-T-038,Device and method for pressure-driven plug transport.,"60/394,544", ,*United States,US,7/8/2002,, ,7/8/2002,0996-002,Small,7/8/2002,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00065,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Provisional,4/12/2018,0996-002,7/8/2003,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611440,,582032,Yes
638,02-T-038,Method of Performing PCR Reaction in Continuously Flowing Microfluidic Plugs,"15/926,992",,*United States,US,5/9/2003,,,3/20/2018,0996-048,Large,5/9/2002,,No,6/16/2022,Pending,Brown Rudnick,,UCH-800/US31 31097/55,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-048,3/20/2038,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612532,,582032,Yes
639,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2004-546666,4855680,Japan,JP,5/9/2003,11/4/2011, ,11/8/2004,0996-004,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0024,Rustem Ismagilov,Nationalized PCT,4/12/2018,0996-004,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613394,,582032,Yes
640,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2009-194875,5519975,Japan,JP,5/9/2003,4/11/2014,2009-291788,8/25/2009,0996-009,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0025,Rustem Ismagilov,Divisional,4/12/2018,0996-009,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613395,12/17/2009,582032,Yes
641,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2011-151228, ,Japan,JP,5/9/2003,,2011-212679,7/13/2011,0996-029,Small,5/9/2002,2/18/2021,No,4/28/2022,Abandoned,Brown Rudnick,,31097.0026,Rustem Ismagilov,Nationalized PCT,4/12/2018,0996-029,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613396,10/27/2011,582032,Yes
642,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2012-151353,5859393,Japan,JP,5/9/2003,12/25/2015,2012-254452,7/10/2012,0996-030,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0027,Rustem Ismagilov,Divisional,4/12/2018,0996-030,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613397,12/27/2012,582032,Yes
643,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2014-172271,"6,270,278",Japan,JP,5/9/2003,1/12/2018, ,8/27/2014,0996-032,Small,5/9/2002,,No,4/28/2022,Issued,Brown Rudnick,,31097.0035,Rustem Ismagilov,Divisional,4/12/2018,0996-032,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613398,,582032,Yes
644,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2016-245154, ,Japan,JP,5/9/2003,, ,12/19/2016,0996-038,Small,5/9/2002,2/18/2021,No,4/28/2022,Abandoned,Brown Rudnick,,31097.0040,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Divisional,4/12/2018,0996-038,5/11/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613399,,582032,Yes
645,02-T-038,Microfluidic Device and Method for Pressure-Driven Plug Transport And Reaction,2017-63059, ,Japan,JP,5/9/2003,, ,4/19/2017,0996-039,Small,5/9/2002,2/18/2021,No,4/28/2022,Abandoned,Brown Rudnick,,31097.0041,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Divisional,4/12/2018,0996-039,5/11/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613400,,582032,Yes
646,02-T-038,Microfluidic Networks for Rapid Mixing and Non-Dispersing Time-Controlled Transport and Reactions of Multiple Chemical and Biochemical Reagents,"15/087,176",,*United States,US,5/9/2003,,,3/31/2016,0996-037,Small,5/9/2002,,No,6/16/2022,Pending,Brown Rudnick,,UCH-800/US21 31097/39,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,4/12/2018,0996-037,,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613402,7/25/2011,582032,Yes
647,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174435.7FR,2302389,France,FR,5/9/2003,1/24/2018, ,1/24/2018,0996-050,Large,5/9/2002,5/18/2018,No,4/28/2022,Issued,Brinks Gilson & Lione,,00291,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,5/18/2018, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",1380431,,582032,Yes
648,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174435.7DE,60350949.5,Germany,DE,5/9/2003,1/24/2018, ,1/24/2018,0996-051,Large,5/9/2002,5/18/2018,No,4/28/2022,Issued,Brinks Gilson & Lione,,00291,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,5/18/2018, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",1380454,,582032,Yes
649,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174435.7GB,2302389,United Kingdom,GB,5/9/2003,1/24/2018, ,1/24/2018,0996-052,Large,5/9/2002,5/18/2018,No,4/28/2022,Issued,Brinks Gilson & Lione,,00291,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,5/18/2018, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",1380476,,582032,Yes
650,02-T-038,Method of Performing PCR Reaction in Continuously Flowing Microfluidic Plugs,"16/105,257","10,532,358",*United States,US,5/9/2003,1/14/2020, ,8/20/2018,0996-053,Large,5/9/2002,2/6/2020,No,4/28/2022,Issued,Brown Rudnick,, ,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,8/21/2018, ,8/20/2038,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",1679797,,582032,Yes
651,02-T-038,Device and Method for Pressure-Driven Plug Transport,"90/014,045", ,*United States,US,5/9/2003,, ,11/6/2017,0996-054,None,5/9/2002,12/1/2018,No,4/28/2022,Pending,Brown Rudnick,"Meyers, Thomas", ,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Reissue,12/1/2018, ,5/9/2022,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",1930692,,582032,Yes
652,02-T-038,Device and Method for Pressure-Driven Plug Transport,2019-33902, ,Japan,JP,5/9/2003,, ,4/15/2019,0996-055,Large,5/9/2002,11/4/2019,No,4/28/2022,Pending,Brown Rudnick,,31097.0063,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Divisional,11/4/2019, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4099776,,582032,Yes
653,02-T-038,Device and Method for Pressure-Driven Plug Transport,"16/555,545", ,*United States,US,5/9/2003,, ,8/29/2019,0996-056,Large,5/9/2002,11/4/2019,No,5/31/2022,Pending,Brown Rudnick,,31097.0064,"Cory Gerdts, Rustem Ismagilov, Joshua Tice, Bo Zheng",Continuation,11/4/2019, ,8/29/2039,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4099802,,582032,Yes
654,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,"16/888,912", ,*United States,US,5/9/2003,, ,6/1/2020,0996-057,Large,5/9/2002,9/25/2020,No,4/28/2022,Pending,Brown Rudnick,"Schoen, Adam",31097.0066,"Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice",Continuation,9/25/2020, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4916227,,582032,No
655,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174433.2FR,2278337,France,FR,5/9/2003,6/26/2019, ,6/26/2019,0996-058,Large,5/9/2002,10/14/2021,No,4/28/2022,Issued,Brown Rudnick,"Schoen, Adam",UCH-800/FR01,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,12/3/2020, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5155387,,582032,Yes
656,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,60352122.3,2278337,Germany,DE,5/9/2003,6/26/2019, ,6/26/2019,0996-059,Large,5/9/2002,10/14/2021,No,4/28/2022,Issued,Brown Rudnick,"Schoen, Adam",UCH-800/DE01,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Nationalized PCT,12/3/2020, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5155409,,582032,Yes
657,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174433.2GB,2278337,United Kingdom,GB,5/9/2003,6/26/2019, ,6/26/2019,0996-060,Large,5/9/2002,10/14/2021,No,4/28/2022,Issued,Brown Rudnick,"Schoen, Adam",UCH-800/GB01,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,12/3/2020, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5155431,,582032,Yes
658,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174436.5FR,2278338,France,FR,5/9/2003,,,,0996-061,None,5/9/2002,12/14/2020,No,3/30/2022,Issued,Brown Rudnick,"Schoen, Adam",,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,12/14/2020,,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5194593,,582032,Yes
659,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174436.5DE,2278338,Germany,DE,5/9/2003,,,,0996-062,None,5/9/2002,12/14/2020,No,3/30/2022,Issued,Brown Rudnick,"Schoen, Adam",,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,12/14/2020,,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5194615,,582032,Yes
660,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,10174436.5GB,2278338,United Kingdom,GB,5/9/2003,,,,0996-063,None,5/9/2002,12/14/2020,No,3/30/2022,Issued,Brown Rudnick,"Schoen, Adam",,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,12/14/2020,,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5194637,,582032,Yes
661,02-T-038,Device and Method for Pressure-Driven Plug Transport,2021-67056, ,Japan,JP,5/9/2003,, ,4/12/2021,0996-064,Large,5/9/2002,6/29/2021,No,4/28/2022,Pending,Brown Rudnick,"Meyers, Thomas",31097.0074,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Divisional,6/29/2021, ,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5847354,,582032,Yes
662,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,1083131.1,2283917,France,FR,5/9/2003,12/15/2021,,,0996-065,Large,5/9/2002,4/13/2022,No,6/15/2022,Issued,Brown Rudnick,,UCH-800/EP04 31097/29,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,4/13/2022,,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",7072887,,582032,
663,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,1083131.1,2283917,United Kingdom,GB,5/9/2003,12/15/2021,,,0996-066,Large,5/9/2002,4/13/2022,No,6/15/2022,Issued,Brown Rudnick,,UCH-800/EP04 31097/29,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,4/13/2022,,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",7072921,,582032,
664,02-T-038,Device and Method for Pressure-Driven Plug Transport and Reaction,1083131.1,60352705.1,Germany,DE,5/9/2003,12/15/2021,,,0996-067,Large,5/9/2002,4/13/2022,No,6/15/2022,Issued,Brown Rudnick,,UCH-800/EP04 31097/29,"Rustem Ismagilov, Helen Song Baca, Joshua Tice",Validated EPO,4/13/2022,,5/9/2023,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",7072955,,582032,
665,02-T-040,Fanesoid X-Activated Receptor Agonist,92108462, ,"Taiwan, Province of China",TW,4/11/2003,, ,9/22/2003,0998-004,Small,4/12/2002,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Junichi Fukuchi, Shutsung Liao, Ching Song","Foreign, Non-PCT",4/12/2018,0998-004,4/11/2023,"Dembo, Anna",Junichi Fukuchi,"Tennant, Thelma",611562,,582034,Yes
666,02-T-040,Fanesoid X-Activated Receptor Agonists,"60/372,245", ,*United States,US,4/12/2002,, ,4/12/2002,0998-001,Small,4/12/2002,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Junichi Fukuchi, Shutsung Liao, Ching Song",Provisional,4/12/2018,0998-001,4/12/2003,"Dembo, Anna",Junichi Fukuchi,"Tennant, Thelma",611563,,582034,Yes
667,02-T-040,Fanesoid X-Activated Receptor Agonists,"2,482,195", ,Canada,CA,4/10/2003,, ,10/8/2004,0998-003,Large,4/12/2002,4/10/2008,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Junichi Fukuchi, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0998-003,,"Dembo, Anna",Junichi Fukuchi,"Tennant, Thelma",611564,,582034,Yes
668,02-T-040,Fanesoid X-Activated Receptor Agonists,03726239.1EPO, ,European Patent Office (EPO),EP,4/10/2003,, ,10/8/2004,0998-006,Small,4/12/2002,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Junichi Fukuchi, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0998-006,10/8/2024,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611565,,582034,Yes
669,02-T-040,Fanesoid X-Activated Receptor Agonists.,PCT/US03/10968, ,*United States,US,4/10/2003,,WO 03/086303 A2,4/10/2003,0998-002,Small,4/12/2002,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Junichi Fukuchi, Shutsung Liao, Ching Song",PCT,4/12/2018,0998-002,10/12/2004,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611566,10/23/2003,582034,Yes
670,02-T-040,Farnesoid X-Activated Receptor Agonists,"10/411,889", ,*United States,US,4/11/2003,,US-2004-014734-A1,4/11/2003,0998-005,Small,4/12/2002,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Junichi Fukuchi, Shutsung Liao, Ching Song",US Utility,4/12/2018,0998-005,4/12/2022,"Dembo, Anna",Junichi Fukuchi,"Tennant, Thelma",611567,1/22/2004,582034,Yes
671,02-T-048,Hydrogen Bond Promoted Hetero-Olefin Reactions,"60/398,696", ,*United States,US,7/26/2002,, ,7/26/2002,1006-001,Small,7/26/2002,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Blanchard, Jonathan",00077,"Yong Huang, Viresh Rawal",Provisional,4/12/2018,1006-001,7/26/2003,"Ginsburg, Eric",Viresh Rawal,"Tennant, Thelma",611877,,582042,Yes
672,02-T-048,"Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions","10/629,537","7,230,125",*United States,US,7/28/2003,6/12/2007, ,7/28/2003,1006-002,Small,7/26/2002,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00086,"Yong Huang, Viresh Rawal, Avinash Thadani, Aditya Unni",US Utility,4/12/2018,1006-002,7/26/2022,"Ginsburg, Eric",Viresh Rawal,"Tennant, Thelma",613337,,582042,Yes
673,02-T-048,"Methods of Performing Cycloadditions, Reaction Mixtures, and Methods of Performing Asymmetric Catalytic Reactions","11/811,610","8,513,442",*United States,US,7/28/2003,8/20/2013,US-2010-0184999-A1,6/11/2007,1006-003,Small,7/26/2002,2/22/2021,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00189,"Yong Huang, Viresh Rawal, Avinash Thadani, Aditya Unni",Divisional,4/12/2018,1006-003,6/11/2027,"Ginsburg, Eric",Viresh Rawal,"Tennant, Thelma",613338,7/22/2010,582042,Yes
674,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers,"60/393,896", ,*United States,US,7/5/2002,, ,7/5/2002,0933-001,Small,7/5/2002,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00075,"Christopher England, Benjamin Hoiuseman, Milan Mrksich, Jing Su",Provisional,4/12/2018,0933-001,7/5/2003,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610825,,582043,Yes
675,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers,"11/029,224", ,*United States,US,7/7/2003,, ,1/4/2005,0933-004,Small,7/5/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00088,"Christopher England, Benjamin Hoiuseman, Milan Mrksich, Jing Su",Nationalized PCT,4/12/2018,0933-004,7/7/2023,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610826,,582043,Yes
676,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers,"14/160,130", ,*United States,US,7/7/2003,,2014-0134642,1/21/2014,0933-006,Small,7/5/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Fox, Jennifer",00368,"Milan Mrksich, Jing Su",Continuation,4/12/2018,0933-006,7/7/2023,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610827,5/15/2014,582043,Yes
677,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers,"14/224,757", ,*United States,US,7/7/2003,, ,3/25/2014,0933-007,Small,7/5/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Fox, Jennifer",00372,"Milan Mrksich, Jing Su",Continuation,4/12/2018,0933-007,7/7/2023,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610828,,582043,Yes
678,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers with MALDI-TOF-MS,03763298.1EPO, ,European Patent Office (EPO),EP,7/7/2003,,1521961,1/25/2005,0933-002,Small,7/5/2002,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00119,"Milan Mrksich, Jing Su",Nationalized PCT,4/12/2018,0933-002,7/7/2023,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610829,4/13/2005,582043,Yes
679,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers with MALDI-TOF-MS,PCT/US03/21224, ,*United States,US,7/7/2003,, ,7/7/2003,0933-003,Small,7/5/2002,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00089,"Milan Mrksich, Jing Su",PCT,4/12/2018,0933-003,1/5/2005,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610830,,582043,Yes
680,02-T-049,Characterization of Biochips Containing Self-Assembled Monolayers with MALDI-TOF-MS,12171853.0EPO, ,European Patent Office (EPO),EP,7/7/2003,, ,6/13/2012,0933-005,Small,7/5/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Boivin, Nicolas",00346,"Milan Mrksich, Jing Su",Divisional,4/12/2018,0933-005,7/7/2023,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610831,,582043,Yes
681,02-T-051,Intraocular Brachytherapy Device Method,"60/376,346", ,*United States,US,4/29/2002,, ,4/29/2002,1010-001,None,4/29/2002,,Yes,4/28/2022,Abandoned,Welsh & Katz,, ,"Russell Hamilton, Jose Pulido, Srinivasan Vijayakumar",Provisional,4/12/2018,1010-001,4/29/2003,"Unassigned, Unassigned",Russell Hamilton,"Unassigned, Unassigned",612048,,582045,Yes
682,02-T-051,Intraocular Brachytherapy Device Method,"60/467,085", ,*United States,US,4/30/2003,, ,4/30/2003,1010-002,None,4/30/2003,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Russell Hamilton, Jose Pulido, Srinivasan Vijayakumar",Provisional,4/12/2018,1010-002,4/30/2004,"Unassigned, Unassigned",Russell Hamilton,"Unassigned, Unassigned",612049,,582045,Yes
683,02-T-051,Intraocular Brachytherapy Device Method,"10/836,140", ,*United States,US,4/30/2004,,US 2005-0027156,4/30/2004,1010-003,None,4/30/2003,,No,4/28/2022,Released to Inventors,Welsh & Katz,, ,"Russell Hamilton, Jose Pulido, Srinivasan Vijayakumar",US Utility,4/12/2018,1010-003,4/30/2024,"Unassigned, Unassigned",Russell Hamilton,"Unassigned, Unassigned",612050,2/3/2005,582045,Yes
684,02-T-051,Intraocular Brachytherapy Device Method,PCT/US04/13710, ,*United States,US,4/30/2004,,WO 2004/98523,4/30/2004,1010-004,None,4/30/2003,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Russell Hamilton, Jose Pulido, Srinivasan Vijayakumar",PCT,4/12/2018,1010-004,10/30/2005,"Unassigned, Unassigned",Russell Hamilton,"Unassigned, Unassigned",612051,11/18/2004,582045,Yes
685,02-T-052,A New Algorithm for Image Reconstruction and Image Noise Analysis in Computed Tomography,"60/394,961", ,*United States,US,7/10/2002,, ,7/10/2002,1011-001,Small,7/10/2002,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,"Christensen, Jon", ,"Xiaochuan Pan, Lifeng Yu",Provisional,4/12/2018,1011-001,7/10/2003,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",610223,,582046,Yes
686,02-T-052,A New Algorithnm for Image Reconstruction iand Image Noise Analysis in Computed Tomography,"10/616,671","7,245,755",*United States,US,7/10/2003,7/17/2007, ,7/10/2003,1011-002,Small,7/10/2002,,No,5/2/2022,Abandoned,Welsh & Katz,, ,"Xiaochuan Pan, Lifeng Yu",US Utility,4/12/2018,1011-002,5/8/2024,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",610224,,582046,Yes
687,02-T-054,Measuring Gene Expression of Hematopoietic Cells and Methods of Diagnosing and Treating Hematopoietic Conditions,"60/719,879", ,*United States,US,9/23/2005,, ,9/23/2005,1013-001,Small,9/23/2005,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Brusca, Eric",38731,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang, Goulin Zhou",Provisional,4/12/2018,1013-001,9/23/2006,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612232,,582048,Yes
688,02-T-054,Measuring Gene Expression of Hematopoietic Cells and Methods of Diagnosing and Treating Hematopoietic Conditions,"60/727,730", ,*United States,US,10/18/2005,, ,10/18/2005,1013-002,Small,10/18/2005,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Brusca, Eric",41571,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang, Goulin Zhou",Provisional,4/12/2018,1013-002,10/18/2006,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612233,,582048,Yes
689,02-T-055,Optimization of Cancer Treatment with Irinotecan,"60/437,928", ,*United States,US,1/3/2003,, ,1/3/2003,1014-001,Large,1/3/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Provisional,4/12/2018,1014-001,1/3/2004,"Sun, Han",Mark Ratain,"Tennant, Thelma",613853,,582049,Yes
690,02-T-055,Optimization of Cancer Treatment with Irinotecan,"60/446,942", ,*United States,US,2/12/2003,, ,2/12/2003,1014-002,Large,2/12/2003,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Provisional,4/12/2018,1014-002,2/12/2004,"Sun, Han",Mark Ratain,"Tennant, Thelma",613854,,582049,Yes
691,02-T-055,Optimization of Cancer Treatment with Irinotecan,"10/751,606", ,*United States,US,1/5/2004,,US-2004-203034-A1,1/5/2004,1014-003,Large,1/3/2003,3/16/2009,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",US Utility,4/12/2018,1014-003,1/3/2023,"Sun, Han",Mark Ratain,"Tennant, Thelma",613855,10/14/2004,582049,Yes
692,02-T-059,Magnetic Particle-Based Therapy,"10/844,180", ,*United States,US,5/12/2004,,US 2006-0025713 A1,5/12/2004,1018-001,Small,5/12/2003,,No,4/28/2022,Released to Inventors,"Marshall, Gerstein & Borun","Merkel, William",39823,"Michael Kaminski, Axel Rosengart",US Utility,4/12/2018,1018-001,5/12/2023,"Ginsburg, Eric",Axel Rosengart,"Muite, Kevin",612148,2/2/2006,582053,Yes
693,02-T-061,Automated Method and System for Computerized Image Analysis Prognosis,"60/395,305", ,*United States,US,12/7/2002,, ,12/7/2002,1020-001,Small,12/7/2002,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Ioana Bonta, Maryellen Giger, Ruth Heimann, Hui Li, Robert ""Bob"" Nishikawa, Carl Vyborny",Provisional,4/12/2018,1020-001,12/7/2003,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610609,,582055,Yes
694,02-T-061,Automated Method and System for Computerized Image Analysis Prognosis,"10/617,675","7,418,123",*United States,US,7/14/2003,8/26/2008,US-2004-101181-A1,7/14/2003,1020-002,Small,12/7/2002,8/26/2008,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Ioana Bonta, Maryellen Giger, Ruth Heimann, Robert ""Bob"" Nishikawa, Carl Vyborny",US Utility,4/12/2018,1020-002,6/12/2025,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610610,5/27/2004,582055,Yes
695,02-T-066,Generalized Optical Vorticles,"60/411,132", ,*United States,US,9/16/2002,, ,9/16/2002,1025-001,Small,9/16/2002,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,David Grier,Provisional,4/12/2018,1025-001,9/16/2003,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",611670,,582060,Yes
696,02-T-066,Optical Accelerator and Generalized Optical Vortices,PCT/US03/28535, ,*United States,US,9/11/2003,,WO 04/025668 A2,9/11/2003,1025-004,Small,9/16/2002,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,David Grier,PCT,4/12/2018,1025-004,3/16/2005,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613799,3/25/2004,582060,Yes
697,02-T-066,Optical Accelerator and Generalized Optical Vortices,03774468.7EPO, ,European Patent Office (EPO),EP,9/11/2003,, ,9/10/2004,1025-005,None,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-005,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613800,,582060,Yes
698,02-T-066,Optical Accelerator and Generalized Optical Vortices,2003282792, ,Australia,AU,9/11/2003,,AU-3282792-AA,5/11/2005,1025-015,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-015,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613801,4/30/2004,582060,Yes
699,02-T-066,Optical Accelertator and Generalized Optical Vortices,200501578-9,109934,Singapore,SG,9/11/2003,6/29/2007, ,5/11/2005,1025-006,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-006,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613802,,582060,Yes
700,02-T-066,Optical Accelertator and Generalized Optical Vortices,2005108675, ,Russian Federation,RU,9/11/2003,, ,5/11/2005,1025-007,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-007,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613803,,582060,Yes
701,02-T-066,Optical Accelertator and Generalized Optical Vortices,538751, ,New Zealand,NZ,9/11/2003,, ,5/11/2005,1025-008,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-008,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613804,,582060,Yes
702,02-T-066,Optical Accelertator and Generalized Optical Vortices,10-2005-7004523, ,"Korea, Republic of",KR,9/11/2003,, ,5/11/2005,1025-009,Large,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-009,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613805,,582060,Yes
703,02-T-066,Optical Accelertator and Generalized Optical Vortices,2004-571987,4104599,Japan,JP,9/11/2003,4/4/2008, ,9/10/2004,1025-010,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-010,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613806,,582060,Yes
704,02-T-066,Optical Accelertator and Generalized Optical Vortices,0626/KOLNP/2005, ,India,IN,9/11/2003,, ,5/11/2005,1025-011,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-011,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613807,,582060,Yes
705,02-T-066,Optical Accelertator and Generalized Optical Vortices,03821972.7,ZL 03821972.7,China,CN,9/11/2003,11/21/2007, ,5/11/2005,1025-012,Small,9/16/2002,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-012,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613808,,582060,Yes
706,02-T-066,Optical Accelertator and Generalized Optical Vortices,"2,499,294", ,Canada,CA,9/11/2003,,CA-2004-025668-A3,5/11/2005,1025-013,Large,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-013,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613809,3/25/2004,582060,Yes
707,02-T-066,Optical Accelertator and Generalized Optical Vortices,"167,369", ,Israel,IL,9/11/2003,, ,5/16/2005,1025-014,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,David Grier,Nationalized PCT,4/12/2018,1025-014,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613810,,582060,Yes
708,02-T-066,Optical Accelertator and Generalized Optical Vortices,06101906.5,HK 1081721,Hong Kong,HK,9/11/2003,6/13/2008, ,5/11/2005,1025-016,Small,9/11/2003,,No,4/28/2022,Issued,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Nationalized PCT,4/12/2018,1025-016,9/11/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613811,,582060,Yes
709,02-T-066,Transverse Optical Accelerator and Generalized Optical Vortices,"10/659,153","7,109,473",*United States,US,9/10/2003,9/19/2006,US-2005-017161-A1,9/10/2003,1025-003,Small,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,David Grier,US Utility,4/12/2018,1025-003,9/16/2022,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",614940,1/27/2005,582060,Yes
710,02-T-066,Tranverse Optical Accelerator and Generalized Optical Vortices,"11/522,665","7,232,989",*United States,US,9/10/2003,6/19/2007, ,9/18/2006,1025-017,Large,9/16/2002,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Jennifer Curtis, David Grier",Continuation,4/12/2018,1025-017,9/10/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",614941,,582060,Yes
711,02-T-068,System and Method for Computer-Aided Detection and Characterization of Diffuse Lung Disease,"60/422,473", ,*United States,US,10/31/2002,, ,10/31/2002,1027-001,Small,10/31/2002,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Yoishikazu Uchiyama",Provisional,4/12/2018,1027-001,10/31/2003,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614780,,582062,Yes
712,02-T-068,System and Method for Computer-Aided Detection and Characterization of Diffuse Lung Disease,"10/357,442","7,236,619",*United States,US,2/4/2003,6/26/2007,US-2004-086162-A1,2/4/2003,1027-002,Small,10/31/2002,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa, Yoishikazu Uchiyama",US Utility,4/12/2018,1027-002,6/9/2025,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614781,5/6/2004,582062,Yes
713,02-T-069,"A Method, System, and Computer Program Product for Computer-Aided Detection of Nodules with Three Dimensional Shape Enhancement Filters",03777621.8EPO, ,European Patent Office (EPO),EP,11/6/2003,, ,7/7/2005,1028-002,None,1/31/2003,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Qiang Li",Nationalized PCT,4/12/2018,1028-002,11/6/2023,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610217,,582063,Yes
714,02-T-069,"A Method, System, and Computer Program Product for Computer-Aided Detection of Nodules with Three Dimensional Shape Enhancement Filters",PCT/US03/32740, ,*United States,US,11/6/2003,,WO 04/070648 A1,11/6/2003,1028-003,Small,1/31/2003,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kunio Doi, Qiang Li",PCT,4/12/2018,1028-003,7/31/2005,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610218,8/19/2004,582063,Yes
715,02-T-069,"A Method, System, and Computer Program Product for Computer-Aided Detection of Nodules with Three Dimensional Shape Enhancement Filters",2004-567996, ,Japan,JP,11/6/2003,, ,9/25/2005,1028-004,None,1/31/2003,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Qiang Li",Nationalized PCT,4/12/2018,1028-004,11/6/2023,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610219,,582063,Yes
716,02-T-069,"Method, System, and Computer Program Product for Computer-Aided Detection of Nodules with Three Dimensional Shape Enhancement Filters","10/355,147","6,937,776",*United States,US,1/31/2003,8/30/2005,US-2004-151356-A1,1/31/2003,1028-001,Small,1/31/2003,,Yes,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Qiang Li",US Utility,4/12/2018,1028-001,1/31/2023,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612589,8/5/2004,582063,Yes
717,02-T-069,"Selective Enhancement Filters for Nodules, Vessles, and Airway Walls in Three Dimensional CT Scans Version 1.1",TXu1-370-973,TXu1-370-973,*United States,US,8/20/2007,8/20/2007,,,1028-005,None,,,No,4/12/2018,Registered (Copyright),,,,"Kunio Doi, Qiang Li",Copyright Application,4/12/2018,1028-005,8/20/2027,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614442,,582063,Yes
718,02-T-070,Methods and Compositions Related to Transfer RNA Microarrays,"60/445,574", ,*United States,US,2/6/2003,, ,2/6/2003,1029-001,Small,2/6/2003,,Yes,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Tao Pan,Provisional,4/12/2018,1029-001,2/6/2004,"Dembo, Anna",Tao Pan,"Tennant, Thelma",613065,,582064,Yes
719,02-T-071,Device and Method for Multiparallel Synthesis and Screening,"10/358,074", ,*United States,US,6/13/2002,,US-2003-170733-A1,2/3/2003,1030-001,Small,3/4/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00076,"Sergey Kozmin, Ying Wang",Continuation in Part,4/12/2018,1030-001,3/4/2022,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",611401,9/11/2003,582065,Yes
720,02-T-071,Device and Method for Multiparallel Synthesis and Screening,PCT/US03/18975, ,*United States,US,6/13/2003,, ,6/13/2003,1030-002,Small,6/13/2002,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00087,"Sergey Kozmin, Ying Wang",PCT,4/12/2018,1030-002,,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",611402,,582065,Yes
721,02-T-072,Methods for Diagnosing Acute Megakaryoblastic Leukemia,"60/483,954", ,*United States,US,7/1/2003,, ,7/1/2003,1031-001,Small,7/1/2003,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",38893,"John Crispino, Marianne Greene, Michelle Le Beau, Joshua Wechsler",Provisional,4/12/2018,1031-001,7/1/2004,"Unassigned, Unassigned",John Crispino,"Unassigned, Unassigned",613172,,582066,Yes
722,02-T-072,Methods for Diagnosing Acute Megakaryoblastic Leukemia,"10/880,764", ,*United States,US,6/30/2004,,US-2006-0003335-A1,6/30/2004,1031-002,None,7/1/2003,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38893A,"John Crispino, Marianne Greene, Michelle Le Beau, Joshua Wechsler",US Utility,4/12/2018,1031-002,7/1/2023,"Unassigned, Unassigned",John Crispino,"Unassigned, Unassigned",613173,1/5/2006,582066,Yes
723,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,"60/416,716", ,*United States,US,10/7/2002,, ,10/7/2002,1032-001,Small,10/7/2002,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Wrona, Thomas",38819,"Waldemar Debinski, Akiva Mintz, Bernard Roizman, Guo-Jie Ye, Grace Zhou",Provisional,4/12/2018,1032-001,10/7/2003,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614852,,582067,Yes
724,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,"10/530,774","7,501,126",*United States,US,10/6/2003,3/10/2009, ,4/7/2005,1032-002,Small,10/7/2002,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",38819A,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Nationalized PCT,4/12/2018,1032-002,10/6/2024,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614853,,582067,Yes
725,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,03774576.7EPO,1549339,European Patent Office (EPO),EP,10/6/2003,6/5/2019,1549339,4/5/2005,1032-003,Small,10/7/2002,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0702EP,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Nationalized PCT,4/12/2018,1032-003,10/6/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614854,7/6/2005,582067,Yes
726,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,PCT/US03/31598, ,*United States,US,10/6/2003,,WO 04/033639 A2,10/6/2003,1032-004,Small,10/7/2002,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,38819A-PC,"Akiva Mintz, Bernard Roizman, Guo-Jie Ye, Grace Zhou",PCT,4/12/2018,1032-004,4/7/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614855,4/22/2004,582067,Yes
727,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,03774576.7FR,1549339,France,FR,10/6/2003,6/5/2019,,6/5/2019,1032-005,None,10/7/2002,5/28/2019,No,3/21/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",38819A-FR,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Validated EPO,5/28/2019,,10/7/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",3741984,,582067,Yes
728,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,03774576.7DE,60352062.6,Germany,DE,10/6/2003,6/5/2019, ,6/5/2019,1032-009,None,10/7/2002,5/28/2019,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",38819A-DE,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Nationalized PCT,5/28/2019, ,10/6/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",3742022,,582067,Yes
729,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,03774576.7IT,1549339,Italy,IT,10/6/2003,6/5/2019,,8/26/2019,1032-008,None,10/7/2002,5/28/2019,No,3/21/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",38819A-IT,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Validated EPO,5/28/2019,,10/6/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",3742055,,582067,Yes
730,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,03774576.7ES,1549339,Spain,ES,10/6/2003,6/5/2019,,8/7/2019,1032-007,None,10/7/2002,5/28/2019,No,3/21/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",38819A-ES,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Validated EPO,5/28/2019,,10/6/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",3742085,,582067,Yes
731,02-T-073,Targeting of Herpes Simplex Virus to Specific Receptors,03774576.7GB,1549339,United Kingdom,GB,10/6/2003,6/5/2019,,8/20/2019,1032-006,None,10/7/2002,5/28/2019,No,3/21/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",38819A-GB,"Bernard Roizman, Guo-Jie Ye, Grace Zhou",Validated EPO,5/28/2019,,10/6/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",3742115,,582067,Yes
732,02-T-077,"An Anti-Inflammatory, Cytoprotective Factor Derivable from a Probiotic Organism",05722783.7EPO, ,European Patent Office (EPO),EP,2/4/2005,, ,9/6/2006,1036-003,Small,2/6/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40386-EP,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1036-003,2/6/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610309,,582071,Yes
733,02-T-077,"An Anti-Inflammatory, Cytoprotective Factor Derivable from a Probiotic Organism",2005212311, ,Australia,AU,2/4/2005,, ,9/1/2006,1036-004,Small,2/6/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40386-AU,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1036-004,2/4/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610310,,582071,Yes
734,02-T-077,"An Anti-Inflammatory, Cytoprotective Factor Derivable from a Probiotic Organism",200580010236.2, ,China,CN,2/4/2005,, ,9/29/2006,1036-005,Small,2/6/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40386-CN,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1036-005,2/4/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610312,,582071,Yes
735,02-T-077,"An Anti-Inflammatory, Cytoprotective Factor Derivable From a Probiotic Organism","10/589,544", ,*United States,US,2/4/2005,,US-2007-0128303-A1,8/16/2006,1036-006,Large,2/6/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40386,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1036-006,2/6/2024,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610313,6/7/2007,582071,Yes
736,02-T-077,"An Anti-Inflammatory, Cytoprotective Factor Derivable from a Probiotic Organism","2,558,618", ,Canada,CA,2/4/2005,, ,9/1/2006,1036-007,Large,2/6/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40386-CA,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1036-007,2/4/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610314,,582071,Yes
737,02-T-077,"An Anti-Inflammatory, Cytoprotective Factor Derivable from a Probiotic Organism",PCT/US05/03765, ,*United States,US,2/4/2005,,WO 05/077389 A2,2/4/2005,1036-008,Small,2/6/2004,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40386-PC,"Eugene Chang, Elaine Petrof",PCT,4/12/2018,1036-008,8/6/2006,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610315,8/25/2005,582071,Yes
738,02-T-077,Cytoprotective and Anti-Inflammatory Factors Derived form Probiotic and Commensal Flora Microorganisms,"60/542,725", ,*United States,US,2/6/2004,, ,2/6/2004,1036-001,Small,2/6/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William", ,"Eugene Chang, Elaine Petrof",Provisional,4/12/2018,1036-001,2/6/2005,"Dembo, Anna",Eugene Chang,"Butler, Brittany",611371,,582071,Yes
739,02-T-077,Cytoprotective Factors Derived from Probiotic and Commensal Flora Microorganisms,"60/563,996", ,*United States,US,4/20/2004,, ,4/20/2004,1036-002,Small,4/20/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40027,"Eugene Chang, Elaine Petrof",Provisional,4/12/2018,1036-002,4/20/2005,"Dembo, Anna",Eugene Chang,"Butler, Brittany",611372,,582071,Yes
740,02-T-078,Induction of Apoptosis by Cellular Stress,"11/538,186","7,556,935",*United States,US,4/18/2002,7/7/2009, ,10/3/2006,1037-001,Small,4/18/2001,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Rima Kaddurah-Daouk, Donald Kufe, Ralph Weichselbaum",Divisional,4/12/2018,1037-001,4/18/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612003,,582072,Yes
741,02-T-078,Induction of Apoptosis by Cellular Stress,"10/125,003","7,118,862",*United States,US,4/18/2002,10/10/2006,US-2002-182588-A1,4/18/2002,1037-002,Small,4/18/2001,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Rima Kaddurah-Daouk, Donald Kufe, Ralph Weichselbaum",US Utility,4/12/2018,1037-002,4/18/2022,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612004,12/5/2002,582072,Yes
742,02-T-078,Induction of Apoptosis by Cellular Stress,PCT/US02/12224, ,*United States,US,4/18/2002,,WO 02/086065 A2,4/18/2002,1037-003,Small,4/18/2001,,No,4/28/2022,Expired - Inactive,Fish & Richardson P.C.,"Tsao, Y. Rocky", ,"Rima Kaddurah-Daouk, Donald Kufe, Ralph Weichselbaum",PCT,4/12/2018,1037-003,10/18/2003,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612005,10/31/2002,582072,Yes
743,02-T-079,Method and Composition for Treating Mammalian Nerve Tissue Injuries,"2,740,056", ,Canada,CA,4/24/2002,, ,5/11/2011,1038-013,Large,4/24/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00320,"Richard Borgens, Raphael Lee, Riyi Shi",Divisional,4/12/2018,1038-013,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612305,,582073,Yes
744,02-T-079,Method and Compositions for Treating Mammalian Nerve Tissue Injuries,02741682.5EPO, ,European Patent Office (EPO),EP,4/24/2002,,EP 1 389 121 A1,10/15/2003,1038-004,Small,4/24/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00145,"Richard Borgens, Raphael Lee, Riyi Shi",Nationalized PCT,4/12/2018,1038-004,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612313,2/18/2004,582073,Yes
745,02-T-079,Method and Compositions for Treating Mammalian Nerve Tissue Injuries,529526,529526,New Zealand,NZ,4/24/2002,10/30/2006,NZ-529526-A,11/11/2003,1038-007,Small,4/24/2001,6/23/2022,No,6/23/2022,Expired - Inactive,"Mueting, Raasch & Gebhardt, P.A.",,07814.00143,"Richard Borgens, Raphael Lee, Riyi Shi",Nationalized PCT,4/12/2018,1038-007,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612314,12/19/2003,582073,Yes
746,02-T-079,Method and Compositions for Treating Mammalian Nerve Tissue Injuries,543953,543953,New Zealand,NZ,4/24/2002,8/9/2007, ,3/2/2007,1038-010,Small,4/24/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00152,"Richard Borgens, Raphael Lee, Riyi Shi",Divisional,4/12/2018,1038-010,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612315,,582073,Yes
747,02-T-079,Methods and compositions for treating mammalian nerve tissue injures.,"10/132,542","7,837,987",*United States,US,4/24/2002,11/23/2010,US-2003-118545-A1,4/24/2002,1038-002,Small,4/24/2001,11/23/2010,No,5/2/2022,Issued,Purdue University,, ,"Richard Borgens, Raphael Lee, Riyi Shi",US Utility,4/12/2018,1038-002,4/24/2024,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612923,6/26/2003,582073,Yes
748,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,"60/286,200", ,*United States,US,4/24/2001,, ,4/24/2001,1038-001,Small,4/24/2001,,Yes,4/28/2022,Expired - Inactive,"Mueting, Raasch & Gebhardt, P.A.","Sandberg, Victoria", ,"Richard Borgens, Raphael Lee, Riyi Shi",Provisional,4/12/2018,1038-001,4/24/2002,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612924,,582073,Yes
749,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,PCT/US02/13375, ,*United States,US,4/24/2002,,WO 02/092107 A1,4/24/2002,1038-003,Small,4/24/2001,,No,4/28/2022,Expired - Inactive,"Mueting, Raasch & Gebhardt, P.A.","Sandberg, Victoria", ,"Richard Borgens, Raphael Lee, Riyi Shi",PCT,4/12/2018,1038-003,10/24/2003,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612925,11/21/2002,582073,Yes
750,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,2002-589024,,Japan,JP,4/24/2002,,2004-527573,4/20/2005,1038-005,Small,4/24/2001,6/10/2022,No,6/10/2022,Prosecution by Other Party,"Mueting, Raasch & Gebhardt, P.A.",,07814.00144,"Richard Borgens, Raphael Lee, Riyi Shi",Nationalized PCT,4/12/2018,1038-005,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612926,9/9/2004,582073,Yes
751,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,2002-314758,2002314758,Australia,AU,4/24/2002,9/21/2006,,4/20/2005,1038-008,Small,4/24/2001,6/23/2022,No,6/23/2022,Expired - Inactive,"Mueting, Raasch & Gebhardt, P.A.",,07814.000142,"Richard Borgens, Raphael Lee, Riyi Shi",Nationalized PCT,4/12/2018,1038-008,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612927,,582073,Yes
752,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,"10/901,481","9,687,502",*United States,US,4/24/2002,6/27/2017,US-2005-069520-A1,7/28/2004,1038-009,Small,4/24/2001,6/27/2017,No,5/2/2022,Issued,Brinks Gilson & Lione,,07814.00111,"Richard Borgens, Raphael Lee, Riyi Shi",Divisional,4/12/2018,1038-009,12/1/2024,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612928,3/31/2005,582073,Yes
753,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,2006200866,2006200866,Australia,AU,4/24/2002,2/21/2008, ,3/1/2006,1038-011,None,4/24/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00155,"Richard Borgens, Raphael Lee, Riyi Shi",Divisional,4/12/2018,1038-011,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612929,,582073,Yes
754,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries,2009-039488, ,Japan,JP,4/24/2002,, ,2/23/2009,1038-012,Small,4/24/2001,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00197,"Richard Borgens, Raphael Lee, Riyi Shi",Nationalized PCT,4/12/2018,1038-012,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612930,,582073,Yes
755,02-T-079,Methods and Compositions for Treating Mammalian Nerve Tissue Injuries- Owned by Purdue only as of 3/23/11,"2,445,612", ,Canada,CA,4/24/2002,, ,10/23/2003,1038-006,Large,4/24/2001,4/25/2016,No,4/28/2022,Abandoned,"Mueting, Raasch & Gebhardt, P.A.",,00320,"Richard Borgens, Raphael Lee, Riyi Shi",Nationalized PCT,4/12/2018,1038-006,4/24/2022,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612931,,582073,Yes
756,02-T-080,"Computer Interface for the Interactive Display of Manual, Semi-automated & Fully-Automated Measurements on CT Scans (Version 1).",TXu-1-143-125,TXu-1-143-125,*United States,US,7/11/2003,7/11/2003,,,1039-001,Small,,,No,4/12/2018,Registered (Copyright),,,,Samuel Armato,Copyright Application,4/12/2018,1039-001,7/11/2023,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",611241,,582074,Yes
757,02-T-083,Cdna microarray analysis of macrogenerative and dysplastic nodules in end stage hepatitis c virus induced cirrhosis.,"60/433,832", ,*United States,US,12/16/2002,, ,12/16/2002,1042-001,Small,12/16/2002,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Robert Anders, Peter Domer, John Hart, Maria Tretiakova, Lisa Yerian",Provisional,4/12/2018,1042-001,12/16/2003,"Unassigned, Unassigned",Robert Anders,"Unassigned, Unassigned",610812,,582077,Yes
758,02-T-083,cDNA Microarray Expression Profiles to Detect Hepatocellular Carcinoma,"60/448,916", ,*United States,US,2/21/2003,, ,2/21/2003,1042-002,Small,2/21/2003,,Yes,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"Robert Anders, Peter Domer, John Hart, Maria Tretiakova, Lisa Yerian",Provisional,4/12/2018,1042-002,2/21/2004,"Unassigned, Unassigned",Robert Anders,"Unassigned, Unassigned",610813,,582077,Yes
759,02-T-084,Automated Method and System for the Delineation of the Chest Wall in Computed Tomography Scans for the Assessment of Pleural Disease,"10/292,625","6,813,375",*United States,US,5/21/2002,11/2/2004,US-2003-086599-A1,11/13/2002,1043-001,Small,6/15/2001,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Heber MacMahon, Geoffrey Oxnard",Continuation in Part,4/12/2018,1043-001,6/15/2021,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610628,5/8/2003,582078,Yes
760,02-T-085,Increased T-Cell Tumor Infiltration by Mutant Light,"60/477,733", ,*United States,US,6/11/2003,, ,6/11/2003,1044-001,Small,6/11/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Provisional,4/12/2018,1044-001,6/11/2004,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611985,,582079,Yes
761,02-T-085,Increased T-Cell Tumor Infiltration by Mutant Light,"60/478,126", ,*United States,US,6/12/2003,, ,6/12/2003,1044-002,Small,6/12/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Provisional,4/12/2018,1044-002,6/12/2004,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611986,,582079,Yes
762,02-T-085,Increased T-Cell Tumor Infiltration by Mutant Light,"2,529,058", ,Canada,CA,6/10/2004,, ,2/16/2006,1044-003,Large,6/11/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1044-003,6/10/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611987,,582079,Yes
763,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4EPO,EP  1 641 491,European Patent Office (EPO),EP,6/10/2004,1/22/2008, ,12/9/2005,1044-004,Small,6/12/2003,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1044-004,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611988,,582079,Yes
764,02-T-085,Increased T-Cell Tumor Infiltration by Mutant Light,"10/865,623","7,807,784",*United States,US,6/10/2004,10/5/2010,US-2005-025754-A1,6/10/2004,1044-005,Small,6/12/2003,8/6/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,US Utility,4/12/2018,1044-005,12/7/2025,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611989,2/3/2005,582079,Yes
765,02-T-085,Increased T-cell tumor infiltration by mutant light,544219, ,New Zealand,NZ,6/10/2004,, ,12/16/2005,1044-006,Small,6/11/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1044-006,6/10/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611990,,582079,Yes
766,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,PCT/US04/18631, ,*United States,US,6/10/2004,,WO 05/002628 A1,6/10/2004,1044-007,Small,6/12/2003,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,PCT,4/12/2018,1044-007,12/11/2005,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611991,1/13/2005,582079,Yes
767,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,2004253465, ,Australia,AU,6/10/2004,, ,12/9/2005,1044-008,Small,6/12/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1044-008,6/10/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611992,,582079,Yes
768,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,2006-533733,5049011,Japan,JP,6/10/2004,7/27/2012,JP 2007-516694 A,12/9/2005,1044-009,Small,6/12/2003,7/31/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1044-009,6/10/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611993,6/28/2007,582079,Yes
769,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,06110494.4, ,Hong Kong,HK,6/10/2004,, ,1/22/2008,1044-010,Small,6/11/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-010,6/10/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611994,,582079,Yes
770,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4CH,1641491,Switzerland,CH,6/10/2004,1/22/2008, ,1/22/2008,1044-011,Small,6/12/2003,1/14/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-011,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611995,,582079,Yes
771,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4LI,1641491,Lichtenstein,LI,6/10/2004,1/22/2008, ,1/22/2008,1044-012,Small,6/11/2003,,No,4/28/2022,Issued,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-012,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611996,,582079,Yes
772,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4IT,1641491,Italy,IT,6/10/2004,1/22/2008, ,1/22/2008,1044-013,Small,6/12/2003,1/14/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-013,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611997,,582079,Yes
773,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4ES,1641491,Spain,ES,6/10/2004,1/22/2008,2297479 (patent no.),1/22/2008,1044-014,Small,6/12/2003,1/14/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-014,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611998,5/1/2008,582079,Yes
774,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4DE,1641491,Germany,DE,6/10/2004,1/22/2008, ,1/22/2008,1044-015,Small,6/12/2003,1/14/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-015,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611999,,582079,Yes
775,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4FR,1641491,France,FR,6/10/2004,1/22/2008, ,1/22/2008,1044-016,Small,6/12/2003,1/14/2019,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-016,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612000,,582079,Yes
776,02-T-085,Increased T-Cell Tumor Infiltration by Mutant LIGHT,04776477.4GB,1641491,United Kingdom,GB,6/10/2004,1/22/2008, ,1/22/2008,1044-017,Small,6/12/2003,1/14/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1044-017,6/4/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612001,,582079,Yes
777,02-T-087,Human Stem Cell Materials and Methods,"60/424,442", ,*United States,US,11/7/2002,, ,11/7/2002,02-021-001,Small,11/7/2002,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",38531,"Eliezer Huberman, Yong Zhao",Provisional,4/12/2018,02-021-001,11/7/2003,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611848,,582081,Yes
778,02-T-087,Human Stem Cell Materials and Methods,"2,505,394", ,Canada,CA,11/7/2003,, ,5/6/2005,02-021-002,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38531A-CA,"Eliezer Huberman, Yong Zhao",Nationalized PCT,4/12/2018,02-021-002,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611849,5/27/2004,582081,Yes
779,02-T-087,Human Stem Cell Materials and Methods,PCT/US03/35538, ,*United States,US,11/7/2003,,WO 04/043990 A2,11/7/2003,02-021-003,Small,11/7/2002,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",38531A-PC,"Eliezer Huberman, Yong Zhao",PCT,4/12/2018,02-021-003,5/7/2005,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611850,5/27/2004,582081,Yes
780,02-T-087,Human Stem Cell Materials and Methods,"10/704,110", ,*United States,US,11/7/2003,,US-2004-136973-A1,11/7/2003,02-021-004,Small,11/7/2002,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38531A,"Eliezer Huberman, Yong Zhao",US Utility,4/12/2018,02-021-004,11/7/2022,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611851,7/15/2004,582081,Yes
781,02-T-087,Human Stem Cell Materials and Methods,2004-551870, ,Japan,JP,11/7/2003,, ,5/9/2005,02-021-005,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38531A-JP,"Eliezer Huberman, Yong Zhao",Nationalized PCT,4/12/2018,02-021-005,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611852,,582081,Yes
782,02-T-087,Human Stem Cell Materials and Methods,03781813.5EPO, ,European Patent Office (EPO),EP,11/7/2003,, ,5/4/2005,02-021-006,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38531A,"Eliezer Huberman, Yong Zhao",Nationalized PCT,4/12/2018,02-021-006,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611853,,582081,Yes
783,02-T-087,Human Stem Cell Materials and Methods,PCT/US04/16790, ,*United States,US,11/7/2003,,WO 05/046570 A2,5/26/2004,02-021-007,Small,11/7/2002,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",38531B-PC,"Eliezer Huberman, Yong Zhao",PCT,4/12/2018,02-021-007,5/7/2006,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611854,5/26/2005,582081,Yes
784,02-T-087,Human Stem Cell Materials and Methods,"10/854,962", ,*United States,US,11/7/2003,,US-2005-003534-A1,5/26/2004,02-021-008,Small,11/7/2002,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38531B,"Eliezer Huberman, Yong Zhao",Continuation in Part,4/12/2018,02-021-008,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611855,1/6/2005,582081,Yes
785,02-T-087,Human Stem Cell Materials and Methods,"11/834,416", ,*United States,US,11/7/2003,,US-2008-0038238-A1,8/6/2007,02-021-009,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",42703,"Eliezer Huberman, Yong Zhao",Continuation,4/12/2018,02-021-009,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611856,2/14/2008,582081,Yes
786,02-T-087,Human Stem Cell Materials and Methods,"12/954,200", ,*United States,US,11/7/2003,,US-2011-0070644-A1,11/24/2010,02-021-010,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",42703A,"Eliezer Huberman, Yong Zhao",Continuation,4/12/2018,02-021-010,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611857,3/24/2011,582081,Yes
787,02-T-087,Human Stem Cell Materials and Methods,11152200.9EPO, ,European Patent Office (EPO),EP,11/7/2003,,2 357 223,2/8/2011,02-021-011,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",38531C-EP,"Eliezer Huberman, Yong Zhao",Divisional,4/12/2018,02-021-011,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611858,8/17/2011,582081,Yes
788,02-T-087,Human Stem Cell Materials and Methods,"13/662,012", ,*United States,US,11/7/2003,,US-2013-0129696-A1,10/26/2012,02-021-012,Small,11/7/2002,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",42703B,"Eliezer Huberman, Yong Zhao",Continuation,4/12/2018,02-021-012,11/7/2023,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611859,5/23/2013,582081,Yes
789,02-T-089,Automated Method and System for Advanced Non-Parametric Classification of Medical Images and Lesions,"60/429,538", ,*United States,US,11/29/2002,, ,11/29/2002,1047-001,Small,11/29/2002,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Dacian Bonta, Maryellen Giger",Provisional,4/12/2018,1047-001,11/29/2003,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610596,,582083,Yes
790,02-T-089,Automated Method and System for Advanced Non-parametric Classification of Medical Images and Lesions,"10/724,395","7,298,883",*United States,US,12/1/2003,11/20/2007,US-2004-190763-A1,12/1/2003,1047-002,Small,11/29/2002,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Dacian Bonta, Maryellen Giger",US Utility,4/12/2018,1047-002,10/30/2025,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610597,9/30/2004,582083,Yes
791,02-T-090,Automated Method and Patient Recognition Using Chest Radiographs,"60/428,939", ,*United States,US,11/26/2002,, ,11/26/2002,1048-001,Small,11/26/2002,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Junji Morishita, Yasuo Sasaki",Provisional,4/12/2018,1048-001,11/26/2003,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610595,,582084,Yes
792,02-T-090,Automated Method of Patient Recognition Using Chest Radiographs,"10/358,337","7,251,353",*United States,US,2/5/2003,7/31/2007,US-2004-101180-A1,2/5/2003,1048-002,Small,11/26/2002,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa, Junji Morishita",US Utility,4/12/2018,1048-002,2/5/2023,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610666,5/27/2004,582084,Yes
793,02-T-091,A Pharmacologic Method of Lowering Cholesterol Production,"60/561,585", ,*United States,US,4/13/2004,, ,4/13/2004,1049-001,Small,4/13/2004,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Yvonne Lange, Theodore Steck",Provisional,4/12/2018,1049-001,4/13/2005,"Peace, Shane",Theodore Steck,"Tennant, Thelma",610229,,582085,Yes
794,02-T-091,A Pharmacologic Method of Lowering Cholesterol Production,PCT/US05/12628, ,*United States,US,4/13/2005,,WO 2005/00592,4/13/2005,1049-002,Small,4/13/2004,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Cox, Katheryn", ,"Yvonne Lange, Theodore Steck",PCT,4/12/2018,1049-002,10/13/2006,"Peace, Shane",Theodore Steck,"Tennant, Thelma",610230,10/27/2005,582085,Yes
795,02-T-091,A Pharmacologic Method of Lowering Cholesterol Production,"10/599,898", ,*United States,US,4/13/2005,,US 2007-0274917 A1,7/19/2007,1049-003,Small,4/13/2004,10/15/2012,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Yvonne Lange, Theodore Steck",Nationalized PCT,4/12/2018,1049-003,,"Peace, Shane",Theodore Steck,"Tennant, Thelma",610231,11/29/2007,582085,Yes
796,02-T-091,A Pharmacologic Method of Lowering Cholesterol Production,"13/594,564","9,110,051",*United States,US,4/13/2005,8/18/2015, ,8/24/2012,1049-004,Small,4/13/2004,8/18/2015,No,4/28/2022,Issued,Foley & Lardner,, ,"Yvonne Lange, Theodore Steck",Divisional,4/12/2018,1049-004,4/13/2025,"Peace, Shane",Theodore Steck,"Tennant, Thelma",610232,,582085,Yes
797,03-T-001,Method for Ice Slurry Cooling for Organ Ischemia Protection,"60/607,340", ,*United States,US,9/3/2004,, ,9/3/2004,03-118-002,Small,9/3/2004,,Yes,4/28/2022,Expired - Inactive,Fish & Richardson P.C.,"Boivin, Nicolas", ,"Lance Becker, David Beiser, Kenneth Kasza, Brett Laven, John Oras, Arieh Shalhav, HyunJin Son, Terry Vanden Hoek",Provisional,4/12/2018,03-118-002,9/3/2005,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612463,,580942,Yes
798,03-T-001,Use of Ice Slurries for Renal Cooling,"60/575,234", ,*United States,US,5/28/2004,, ,5/28/2004,03-118-001,Small,5/28/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Oguss, Doug",00103,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",Provisional,4/12/2018,03-118-001,5/28/2005,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",615202,,580942,Yes
799,03-T-002,Monomeric Red Flourescent Proteins,"11/100,988","7,250,298",*United States,US,4/7/2005,7/31/2007, ,4/7/2005,1052-004,Large,4/7/2004,7/31/2007,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",US Utility,4/12/2018,1052-004,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613528,,582088,Yes
800,03-T-002,Monomeric Red Flourescent Proteins,PCT/US05/11753, ,*United States,US,4/7/2005,, ,4/10/2005,1052-005,Large,4/7/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",PCT,4/12/2018,1052-005,10/7/2006,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613529,,582088,Yes
801,03-T-002,Monomeric Red Flourescent Proteins,"11/748,641","7,671,185",*United States,US,4/7/2005,3/2/2010, ,5/15/2007,1052-006,Large,4/7/2004,3/2/2010,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Continuation,4/12/2018,1052-006,8/18/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613530,,582088,Yes
802,03-T-002,Monomeric Red Flourescent Proteins,"12/689,276","7,910,714",*United States,US,4/7/2005,3/22/2011,US-2010-0184954-A1,1/19/2010,1052-007,Large,4/7/2004,3/22/2011,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Continuation,4/12/2018,1052-007,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613531,7/22/2010,582088,Yes
803,03-T-002,Monomeric Red Fluorescent Protein,"60/560,340", ,*United States,US,4/7/2004,, ,4/10/2004,1052-001,Large,4/7/2004,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,Benjamin Glick,Provisional,4/12/2018,1052-001,4/7/2005,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613532,,582088,Yes
804,03-T-002,Monomeric Red Fluorescent Proteins,05735217.1EPO,1732944,European Patent Office (EPO),EP,4/7/2005,9/5/2012, ,10/10/2006,1052-002,Large,4/7/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Nationalized PCT,4/12/2018,1052-002,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613533,,582088,Yes
805,03-T-002,Monomeric Red Fluorescent Proteins,2007-507493,4755174,Japan,JP,4/7/2005,6/3/2011,2008-500819,10/6/2006,1052-003,Large,4/7/2004,,No,5/31/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Nationalized PCT,4/12/2018,1052-003,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613534,1/17/2008,582088,Yes
806,03-T-002,Monomeric Red Fluorescent Proteins,05735217.1UK,1732944,United Kingdom,GB,4/7/2005,9/5/2012, ,9/5/2012,1052-008,Large,4/7/2004,,No,5/5/2022,Issued,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Validated EPO,4/12/2018,1052-008,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613535,,582088,Yes
807,03-T-002,Monomeric Red Fluorescent Proteins,05735217.1DE,602005035991.5,Germany,DE,4/7/2005,9/5/2012,1732944,9/5/2012,1052-009,Large,4/7/2004,,No,5/5/2022,Issued,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Validated EPO,4/12/2018,1052-009,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613536,,582088,Yes
808,03-T-002,Monomeric Red Fluorescent Proteins,05735217.1FR,1732944,France,FR,4/7/2005,9/5/2012, ,9/5/2012,1052-010,Large,4/7/2004,,No,5/5/2022,Issued,"Valauskas Corder, LLC",, ,"David Baker, Brooke Bevis, Benjamin Glick, Michelle Scally-Kim, Daniel Strongin",Validated EPO,4/12/2018,1052-010,4/7/2025,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",613537,,582088,Yes
809,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,2004311370, ,Australia,AU,2/19/2004,, ,8/16/2005,1053-002,Small,2/19/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Philip Ashton-Rickardt,Nationalized PCT,4/12/2018,1053-002,2/19/2024,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612870,,582089,Yes
810,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,2006-517074, ,Japan,JP,2/19/2004,,2006-524712,8/19/2005,1053-003,Small,2/19/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Philip Ashton-Rickardt,Nationalized PCT,4/12/2018,1053-003,2/19/2024,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612871,11/2/2006,582089,Yes
811,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,PCT/US04/04954, ,*United States,US,2/19/2004,,WO 05/067958 A2,2/19/2004,1053-004,Small,2/19/2003,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Philip Ashton-Rickardt,PCT,4/12/2018,1053-004,8/19/2005,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612872,7/28/2005,582089,Yes
812,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,"10/782,401", ,*United States,US,2/19/2004,,US-2004-214773-A1,2/19/2004,1053-005,Small,2/19/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Philip Ashton-Rickardt,US Utility,4/12/2018,1053-005,2/19/2023,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612873,10/28/2004,582089,Yes
813,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,"2,514,395", ,Canada,CA,2/19/2004,, ,8/16/2005,1053-006,Small,2/19/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Philip Ashton-Rickardt,Nationalized PCT,4/12/2018,1053-006,8/16/2025,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612874,,582089,Yes
814,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,04821117.1EPO, ,European Patent Office (EPO),EP,2/19/2004,, ,8/22/2005,1053-007,Small,2/19/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Philip Ashton-Rickardt,Nationalized PCT,4/12/2018,1053-007,8/22/2025,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612875,,582089,Yes
815,03-T-003,Methods and Compositions for the Inhibition of Cathepsins,"12/121,592", ,*United States,US,2/19/2004,,US-2009-0324700-A1,5/15/2008,1053-009,Small,2/19/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Philip Ashton-Rickardt,Continuation,4/12/2018,1053-009,2/19/2024,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612876,12/31/2009,582089,Yes
816,03-T-003,Methods and compositions for the inhibition of cathepsins.,"60/448,285", ,*United States,US,2/19/2003,, ,2/19/2003,1053-001,Small,2/19/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,Philip Ashton-Rickardt,Provisional,4/12/2018,1053-001,2/19/2004,"Unassigned, Unassigned",Philip Ashton-Rickardt,"Unassigned, Unassigned",612877,,582089,Yes
817,03-T-004,Generalized Optical Vorticles,"60/451,886", ,*United States,US,3/4/2003,, ,3/4/2003,1025-002,Small,3/4/2003,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Jennifer Curtis, David Grier",Provisional,4/12/2018,1025-002,3/4/2004,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",611671,,582090,Yes
818,03-T-005,Mammalian Prion Proteins,"60/380,953", ,*United States,US,5/15/2002,, ,5/15/2002,1055-002,Large,5/15/2002,,Yes,6/8/2022,Expired - Inactive,Ropes & Gray LLP,, ,"Susan Lindquist, Jiyan Ma",Provisional,4/12/2018,1055-002,5/15/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612155,,582091,Yes
819,03-T-005,Mammalian Prion Proteins,"60/419,574", ,*United States,US,10/17/2002,, ,10/17/2002,1055-004,Large,10/17/2002,,Yes,6/8/2022,Expired - Inactive,Ropes & Gray LLP,, ,"Susan Lindquist, Jiyan Ma",Provisional,4/12/2018,1055-004,10/17/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612156,,582091,Yes
820,03-T-005,Mammalian Prion Proteins and Transgenic Mice Expressing Them,"10/438,628", ,*United States,US,5/15/2003,,US-2004-048237-A1,5/15/2003,1055-001,Large,5/15/2002,11/14/2006,No,6/8/2022,Abandoned,Ropes & Gray LLP,, ,"Susan Lindquist, Jiyan Ma",US Utility,4/12/2018,1055-001,5/15/2023,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612157,3/11/2004,582091,Yes
821,03-T-005,Transgenic Mice Expressing Prion Protein,"60/419,569", ,*United States,US,10/17/2002,, ,10/17/2002,1055-003,Large,10/17/2002,,Yes,6/8/2022,Expired - Inactive,Ropes & Gray LLP,, ,"Susan Lindquist, Jiyan Ma",Provisional,4/12/2018,1055-003,10/17/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614931,,582091,Yes
822,03-T-006,Transgenic mice expressing prion protein.,"60/380,950", ,*United States,US,5/15/2002,, ,5/15/2002,1056-001,Small,5/15/2002,,Yes,6/8/2022,Expired - Inactive,,, ,Susan Lindquist,Provisional,4/12/2018,1056-001,5/15/2003,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614932,,582092,Yes
823,03-T-008,Correction of Optical Trap Configurations,"10/437,689", ,*United States,US,5/13/2003,, ,5/13/2003,1058-001,Small,5/13/2003,,Yes,4/28/2022,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"David Grier, Karen Kasza, Ladavac Kosta",US Utility,4/12/2018,1058-001,5/13/2023,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",611345,,582094,Yes
824,03-T-010,Method of Training Massive Training Artificial Neural Networks (MTANN) for the Detection of Abnormalities in Medical Images,"10/366,482","6,754,380",*United States,US,2/14/2003,6/22/2004, ,2/14/2003,1060-001,Small,2/14/2003,6/22/2004,Yes,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Kenji Suzuki",US Utility,4/12/2018,1060-001,2/14/2023,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612538,,582096,Yes
825,03-T-010,Method of Training Massive Training Artificial Neural Networks (MTANN) for the Detection of Abnormalities in Medical Images,PCT/US04/02018, ,*United States,US,2/12/2004,,WO 2004/074982 A2,2/12/2004,1060-002,Small,2/14/2003,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Kenji Suzuki",PCT,4/12/2018,1060-002,8/14/2005,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612539,9/2/2004,582096,Yes
826,03-T-013,"Method, System and Medium for Prevalence-Based Computerized Ana","60/525,198", ,*United States,US,11/28/2003,, ,11/28/2003,1063-001,Small,11/28/2003,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Karla Horsch, Li Lan, Charles Metz, Carl Vyborny",Provisional,4/12/2018,1063-001,11/28/2004,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612588,,582099,Yes
827,03-T-013,"Method, System, and Medium for Prevalence-Based Computerized Analysis of Medical Images and Information","10/997,935","7,769,215",*United States,US,11/29/2004,8/3/2010,US 2005-0234570 A1,11/29/2004,1063-002,None,11/28/2003,8/3/2010,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Karla Horsch, Li Lan, Charles Metz, Carl Vyborny",US Utility,4/12/2018,1063-002,6/8/2028,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612592,10/20/2005,582099,Yes
828,03-T-014,Method and System for Fractal-Based Analysis of Medical Image Texture,"60/447,295", ,*United States,US,2/14/2003,, ,2/14/2003,1064-001,Small,2/14/2003,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Hui Li",Provisional,4/12/2018,1064-001,2/14/2004,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612366,,582100,Yes
829,03-T-014,Method and System for Fractal-based Analysis of Medical Image Texture,"10/777,041","7,848,558",*United States,US,2/13/2004,12/7/2010,US-2004-258310-A1,2/13/2004,1064-002,Small,2/14/2003,12/7/2010,No,5/31/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Hui Li",US Utility,4/12/2018,1064-002,9/24/2027,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612367,12/23/2004,582100,Yes
830,03-T-018,Anthrax Edema Factor Inhibitors,"60/458,514", ,*United States,US,3/28/2003,, ,3/28/2003,1068-001,Small,3/28/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Krawzsenek, Michael", ,"Milan Mrksich, Wei-Jen Tang",Provisional,4/12/2018,1068-001,3/28/2004,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",610334,,582104,Yes
831,03-T-022,Gemini Vitamin D3 Compounds and Methods of Use Thereof,"2,524,026", ,Canada,CA,4/30/2004,, ,11/18/2005,1072-002,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Nationalized PCT,4/12/2018,1072-002,4/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611636,,582108,Yes
832,03-T-022,Gemini Vitamin D3 Compounds and Methods of Use Thereof,04751195.1EPO, ,European Patent Office (EPO),EP,4/30/2004,, ,11/10/2006,1072-003,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Nationalized PCT,4/12/2018,1072-003,4/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611637,,582108,Yes
833,03-T-022,Gemini VItamin D3 Compounds and Methods of Use Thereof,PCT/US04/13703, ,*United States,US,4/30/2004,, ,4/30/2004,1072-004,None,4/30/2003,,No,4/28/2022,Expired - Inactive,"Edwards, Angell, Palmer & Dodge LLP","Lauro, Peter", ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",PCT,4/12/2018,1072-004,10/30/2005,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611638,,582108,Yes
834,03-T-022,Gemini Vitamin D3 Compounds and Methods of Use Thereof,5128/CHEP/2008, ,India,IN,4/30/2004,, ,11/30/2008,1072-005,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Divisional,4/12/2018,1072-005,4/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611639,,582108,Yes
835,03-T-022,Gemini Vitamin D3 Compounds and Methods of use Thereof,2006-514246, ,Japan,JP,4/30/2004,, ,12/28/2005,1072-006,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Nationalized PCT,4/12/2018,1072-006,4/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611640,,582108,Yes
836,03-T-022,Gemini Vitamin D3 Compounds and Methods of use Thereof,2004235775, ,Australia,AU,4/30/2004,, ,10/28/2005,1072-010,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Nationalized PCT,4/12/2018,1072-010,10/28/2025,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611641,,582108,Yes
837,03-T-022,Gemini Vitamin D3 Compounds and Methods of Use Thereof,3206/CHENP/2005, ,India,IN,4/30/2004,, ,11/30/2005,1072-012,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Nationalized PCT,4/12/2018,1072-012,4/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",611642,,582108,Yes
838,03-T-022,Use of Gemini Vitamin D3 Compounds for Treating Hypertension,"10/553,854", ,*United States,US,4/30/2004,, ,10/19/2005,1072-009,Small,4/30/2003,,No,4/28/2022,Abandoned,"Edwards, Angell, Palmer & Dodge LLP",, ,"Luciano Adorini, Yan Chun Li, Hubert Maehr, Guiseppe Penna, Milan Uskokovic",Divisional,4/12/2018,1072-009,10/19/2025,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615194,,582108,Yes
839,03-T-022,Vitamin D and Vitamin D Analogs or Derivatives as New Anti-Hypertensive Agents,"60/477,900", ,*United States,US,6/12/2003,, ,6/12/2003,1072-001,Small,6/12/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Provisional,4/12/2018,1072-001,6/12/2004,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615383,,582108,Yes
840,03-T-022,Vitamin D and Vitamin D Analogs or Derivatives as New Anti-Hypertensive Agents,"10/865,624", ,*United States,US,6/11/2004,, ,6/11/2004,1072-007,Small,6/12/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Yan Chun Li, Milan Uskokovic",US Utility,4/12/2018,1072-007,6/12/2023,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615384,,582108,Yes
841,03-T-022,Vitamin D and Vitamin D Analogs or Derivatives as New Anti-Hypertensive Agents,"10/962,215", ,*United States,US,6/11/2004,,US-2005-113348-A1,10/8/2004,1072-008,Small,6/12/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Yan Chun Li, Milan Uskokovic",Continuation in Part,4/12/2018,1072-008,6/12/2023,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615385,5/26/2005,582108,Yes
842,03-T-022,Vitamin D and Vitamin D Analogs or Derivatives as New Anti-Hypertensive Agents,"12/715,133", ,*United States,US,6/11/2004,,US-2010-0222307-A1,10/8/2004,1072-011,Small,6/12/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Yan Chun Li, Milan Uskokovic",Divisional,4/12/2018,1072-011,10/8/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615386,9/2/2010,582108,Yes
843,03-T-032,Method for Computerized Detection of Extended Lesions in Volumetric Data,"60/514,599", ,*United States,US,11/28/2003,, ,11/28/2003,1084-001,Small,11/28/2003,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Hans Frimmel, Janne Nappi, Hiroyuki Yoshida",Provisional,4/12/2018,1084-001,11/28/2004,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612437,,582118,Yes
844,03-T-032,"Method for Virtual Endoscopic Visualization of the Colon by Shape-Scale Signatures, Centerlining, and Computerized Detection of Masses","10/974,699", ,*United States,US,10/28/2004,,US-2005-152588-A1,10/28/2004,1084-002,Small,11/28/2003,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Abraham Dachman, Hans Frimmel, Janne Nappi, Hiroyuki Yoshida",US Utility,4/12/2018,1084-002,10/28/2024,"Cox, Ben",Hiroyuki Yoshida,"Juggernauth, Anne",612514,7/14/2005,582118,Yes
845,03-T-036,Automated Method and System for the Detection of Lung Nodules in Low-Dose CT Image for Lung-Cancer Screening,"10/767,342","7,305,111",*United States,US,1/30/2004,12/4/2007,US-2005-171409-A1,1/30/2004,1082-001,Small,1/30/2004,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Hidetaka Arimura, Kunio Doi, Feng Li, Junji Shiraishi",US Utility,4/12/2018,1082-001,12/9/2025,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610646,8/4/2005,582122,Yes
846,03-T-036,"Computerized Scheme for Detection of Lung Nodules in CT scans, Version 2",TXu-1-226-320,TXu-1-226-320,*United States,US,2/27/2005,2/27/2005, ,,1082-002,None,,,No,8/4/2020,Registered (Copyright),University of Chicago,, ,"Hidetaka Arimura, Kunio Doi, Feng Li, Junji Shiraishi",Copyright Application,4/12/2018,1082-002,,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611266,,582122,Yes
847,03-T-037,Panels of Molecular Targets Differentially Expressed during CD8+ T Cell Priming and Methods for Theraphy and Diagnosis Utilizing the Same,PCT/US03/34678, ,*United States,US,10/31/2003,,WO 04/041192 A1,10/31/2003,1083-002,Small,10/31/2002,,No,4/28/2022,Abandoned,Foley Hoag LLP,"Arnold, Beth", ,"Thomas Gajewski, Kuldeep Neote, Panos Zagouras",PCT,4/12/2018,1083-002,10/31/2022,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613877,5/21/2004,582123,Yes
848,03-T-037,Panels of Molecular Targets Differentially Expressed during CD8+ T Cell Priming and Methods for Theraphy and Diagnosis Utilizing the Same,"10/698,350", ,*United States,US,10/31/2003,,US-2005-037369-A1,10/31/2003,1083-003,Small,10/31/2002,,No,4/28/2022,Abandoned,Foley Hoag LLP,, ,"Thomas Gajewski, Kuldeep Neote, Panos Zagouras",US Utility,4/12/2018,1083-003,10/31/2022,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613878,2/17/2005,582123,Yes
849,03-T-037,"Panels of Molecular Targets Differentially Expressed During CD8+ T Cell Priming, and Methods for Therapy and Diagnosis Utilizing the Same","60/422,663", ,*United States,US,10/31/2002,, ,10/31/2002,1083-001,Small,10/31/2002,,Yes,4/28/2022,Expired - Inactive,Foley Hoag LLP,"Arnold, Beth", ,"Thomas Gajewski, Kuldeep Neote, Panos Zagouras",Provisional,4/12/2018,1083-001,10/31/2003,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613879,,582123,Yes
850,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,"60/395,896", ,*United States,US,7/15/2002,, ,7/15/2002,1089-001,Small,7/15/2002,,Yes,4/28/2022,Expired - Inactive,Mayo Foundation for Medical Education and Research,, ,"Lieping Chen, Yang-Xin Fu",Provisional,4/12/2018,1089-001,7/15/2003,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614943,,582125,Yes
851,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,"10/619,824", ,*United States,US,7/14/2003,,US 2004-0109847 A1,7/14/2003,1089-002,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",US Utility,4/12/2018,1089-002,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614944,6/10/2004,582125,Yes
852,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,PCT/US03/22029, ,*United States,US,7/14/2003,, ,7/14/2003,1089-003,Small,7/15/2002,,No,4/28/2022,Expired - Inactive,Fish & Richardson P.C.,"Tsao, Y. Rocky", ,"Lieping Chen, Yang-Xin Fu",PCT,4/12/2018,1089-003,1/15/2005,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614945,,582125,Yes
853,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,"2,492,561", ,Canada,CA,7/14/2003,, ,2/1/2005,1089-004,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Nationalized PCT,4/12/2018,1089-004,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614946,,582125,Yes
854,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,2003249247, ,Australia,AU,7/14/2003,, ,1/11/2005,1089-005,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Nationalized PCT,4/12/2018,1089-005,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614947,,582125,Yes
855,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,538216,538216,New Zealand,NZ,7/14/2003,1/8/2009, ,2/1/2005,1089-006,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Nationalized PCT,4/12/2018,1089-006,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614948,,582125,Yes
856,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,03764649.4EPO, ,European Patent Office (EPO),EP,7/14/2003,, ,2/1/2005,1089-007,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Nationalized PCT,4/12/2018,1089-007,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614949,,582125,Yes
857,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,2004-521818, ,Japan,JP,7/14/2003,, ,2/1/2005,1089-008,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Nationalized PCT,4/12/2018,1089-008,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614950,,582125,Yes
858,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,03821906.9, ,China,CN,7/14/2003,, ,2/1/2005,1089-009,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Nationalized PCT,4/12/2018,1089-009,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614951,,582125,Yes
859,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,"12/269,462", ,*United States,US,7/14/2003,, ,11/12/2008,1089-010,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Continuation,4/12/2018,1089-010,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614952,,582125,Yes
860,03-T-039,Treatment and Prophylaxis with 4-1BB-Binding Agents,2009235998, ,Australia,AU,7/14/2003,, ,11/10/2009,1089-011,Small,7/15/2002,,No,4/28/2022,Abandoned,Fish & Richardson P.C.,, ,"Lieping Chen, Yang-Xin Fu",Divisional,4/12/2018,1089-011,7/14/2023,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614953,,582125,Yes
861,03-T-041,Methods and Compositions for Nerve Regeneration,"60/470,913", ,*United States,US,5/15/2003,, ,5/15/2003,1091-001,Small,5/15/2003,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9005-002,Yimin Zou,Provisional,4/12/2018,1091-001,5/15/2004,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612814,,582127,Yes
862,03-T-041,Methods and Compositions for Nerve Regeneration,PCT/US04/15264, ,*United States,US,5/17/2004,,WO 04/103394 A2,5/17/2004,1091-002,Small,5/15/2003,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9005-005,Yimin Zou,PCT,4/12/2018,1091-002,11/15/2005,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612815,12/2/2004,582127,Yes
863,03-T-041,Methods and Compositions for Nerve Regeneration,04752316.2EPO, ,European Patent Office (EPO),EP,5/17/2004,, ,1/19/2006,1091-003,Small,5/15/2003,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9005-001,Yimin Zou,Nationalized PCT,4/12/2018,1091-003,5/17/2024,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612816,,582127,Yes
864,03-T-041,Methods and Compositions for Nerve Regeneration,"10/847,972","7,374,760",*United States,US,5/17/2004,5/20/2008,US-2005-049495 A1,5/17/2004,1091-004,Small,5/15/2003,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9005-003,Yimin Zou,US Utility,4/12/2018,1091-004,5/28/2025,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612817,3/3/2005,582127,Yes
865,03-T-041,Methods and Compositions for Nerve Regeneration,"12/123,721", ,*United States,US,5/17/2004,,US-2008-0299135-A1,5/20/2008,1091-006,Small,5/15/2003,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9005-004,Yimin Zou,Divisional,4/12/2018,1091-006,5/17/2024,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612818,12/4/2008,582127,Yes
866,03-T-041,Repulsive WNT Signaling Inhibits Axon Regenration Following Central Nervous System Injury,"61/019,393", ,*United States,US,1/7/2008,, ,1/7/2008,1091-005,Small,1/7/2008,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9125-001,Yimin Zou,Provisional,4/12/2018,1091-005,1/7/2009,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",614395,,582127,Yes
867,03-T-044,Optical Fractionation,"60/471,149", ,*United States,US,5/16/2003,, ,5/16/2003,1094-001,Small,5/16/2003,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"David Grier, Kosta Ladavac",Provisional,4/12/2018,1094-001,5/16/2004,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613812,,582130,Yes
868,03-T-044,Optical Fractionation Methods and Apparatus,"10/845,758","7,233,423",*United States,US,5/14/2004,6/19/2007,US 2005-0078343 A1,5/14/2004,1094-003,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,David Grier,US Utility,4/12/2018,1094-003,9/10/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613813,4/14/2005,582130,Yes
869,03-T-044,Optical Fractionation Methods and Apparatus,7021897/2005, ,"Korea, Republic of",KR,5/14/2004,, ,1/10/2006,1094-004,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-004,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613814,,582130,Yes
870,03-T-044,Optical Fractionation Methods and Apparatus,200507196-4,117063,Singapore,SG,5/14/2004,11/30/2007, ,12/2/2005,1094-005,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-005,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613815,,582130,Yes
871,03-T-044,Optical Fractionation Methods and Apparatus,2005139384, ,Russian Federation,RU,5/14/2004,, ,12/15/2005,1094-006,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-006,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613816,,582130,Yes
872,03-T-044,Optical Fractionation Methods and Apparatus,"171,848", ,Israel,IL,5/14/2004,, ,1/10/2006,1094-007,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-007,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613817,,582130,Yes
873,03-T-044,Optical Fractionation Methods and Apparatus,2004241455, ,Australia,AU,5/14/2004,, ,1/10/2006,1094-008,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,David Grier,Nationalized PCT,4/12/2018,1094-008,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613818,,582130,Yes
874,03-T-044,Optical Fractionation Methods and Apparatus,2006-533121, ,Japan,JP,5/14/2004,,2007-516095,1/10/2006,1094-009,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-009,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613819,6/21/2007,582130,Yes
875,03-T-044,Optical Fractionation Methods and Apparatus,200480013395.3,ZL 20048013395.3,China,CN,5/14/2004,8/13/2008, ,1/10/2006,1094-010,Small,5/16/2003,,No,4/28/2022,Issued,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-010,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613820,,582130,Yes
876,03-T-044,Optical Fractionation Methods and Apparatus,543610, ,New Zealand,NZ,5/14/2004,, ,1/10/2006,1094-011,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-011,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613821,,582130,Yes
877,03-T-044,Optical Fractionation Methods and Apparatus,2253/KOLNP/2005, ,India,IN,5/14/2004,, ,1/10/2006,1094-012,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-012,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613822,,582130,Yes
878,03-T-044,Optical Fractionation Methods and Apparatus,"2,525,843", ,Canada,CA,5/14/2004,, ,1/10/2006,1094-014,Large,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-014,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613823,,582130,Yes
879,03-T-044,Optical Fractionation Methods and Apparatus,PCT/US04/15327, ,*United States,US,5/14/2004,,WO 2004/104551 A2,5/14/2004,1094-015,Small,5/16/2003,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,David Grier,PCT,4/12/2018,1094-015,11/16/2005,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613824,12/2/2004,582130,Yes
880,03-T-044,Optical Fractionation Methods and Apparatus,04752357.6EPO, ,European Patent Office (EPO),EP,5/14/2004,, ,1/10/2006,1094-016,Small,5/16/2003,,No,4/28/2022,Abandoned,Foley & Lardner,, ,David Grier,Nationalized PCT,4/12/2018,1094-016,5/14/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613825,,582130,Yes
881,03-T-044,Optical Fractionation Methods and Apparatus,06113563.4, ,Hong Kong,HK,5/16/2004,,1092995A,1/10/2006,1094-017,None,5/16/2003,,No,4/28/2022,Allowed,Foley & Lardner,, ,"David Grier, Kosta Ladavac",Nationalized PCT,4/12/2018,1094-017,5/16/2024,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",613826,2/16/2007,582130,Yes
882,03-T-044,Symmetric Optical Thermal Ratchet for Fractionation and Sorting,"60/498,868", ,*United States,US,8/29/2003,, ,8/29/2003,1094-002,Small,8/29/2003,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"David Grier, Kosta Ladavac",Provisional,4/12/2018,1094-002,8/29/2004,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",614738,,582130,Yes
883,03-T-047,Use of a Combination of Agents that Modulate B7 Activity in Inhibiting Intestinal Allograft Rejection,"09/805,801", ,*United States,US,3/13/2001,,US 2002-0071839 A1,3/13/2001,1097-001,None,3/14/2000,,No,4/28/2022,Abandoned,Lahive & Cockfield LLP,, ,"Mary Collins, Kenneth Newell",US Utility,4/12/2018,1097-001,3/14/2020,"Unassigned, Unassigned",Kenneth Newell,"Unassigned, Unassigned",615152,6/13/2002,582133,Yes
884,03-T-050,Chemo-inducible Cancer Gene Therapy,"10/795,090", ,*United States,US,3/5/2004,,US 2004-0242523 A1,3/5/2004,0890-009,Small,3/6/2003,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Beckett, Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",US Utility,4/12/2018,0890-009,3/6/2023,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610864,12/2/2004,582136,Yes
885,03-T-050,Chemo-Inducible Cancer Gene Therapy,"60/452,489", ,*United States,US,3/6/2003,, ,3/6/2003,0890-015,Small,3/6/2003,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Michael Beckett, Vinay Gupta, Donald Kufe, Helena Mauceri, James Park, Mitchell Posner, Ralph Weichselbaum",Provisional,4/12/2018,0890-015,3/6/2004,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610865,,582136,Yes
886,03-T-051,Method and Apparatus for Assaying Blood Clotting,"60/763,574", ,*United States,US,1/31/2006,, ,1/31/2006,1101-001,Small,1/31/2006,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00158,"Thoung Ha, Rustem Ismagilov, Christian Kastrup, Matthew Runyon, Feng Shen, Helen Song Baca",Provisional,4/12/2018,1101-001,1/31/2007,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612286,,582137,Yes
887,03-T-051,Method and Apparatus for Assaying Blood Clotting,PCT/US07/02532, ,*United States,US,1/31/2007,,WO 2007/089777,1/31/2007,1101-002,Small,1/31/2006,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00183,"Thoung Ha, Rustem Ismagilov, Christian Kastrup, Matthew Runyon, Feng Shen, Helen Song Baca",PCT,4/12/2018,1101-002,7/31/2008,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612287,2/7/2008,582137,Yes
888,03-T-051,Method and Apparatus for Assaying Blood Clotting,2008553307, ,Japan,JP,1/31/2007,, ,7/31/2008,1101-003,Small,1/31/2006,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00237,"Thoung Ha, Rustem Ismagilov, Christian Kastrup, Matthew Runyon, Feng Shen, Helen Song Baca",Nationalized PCT,4/12/2018,1101-003,1/31/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612288,,582137,Yes
889,03-T-051,Method and Apparatus for Assaying Blood Clotting,200780011260.7, ,China,CN,1/31/2007,,CN 101410049A,7/29/2008,1101-004,Small,1/31/2006,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00235,"Thoung Ha, Rustem Ismagilov, Christian Kastrup, Matthew Runyon, Feng Shen, Helen Song Baca",Nationalized PCT,4/12/2018,1101-004,1/31/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612289,4/15/2009,582137,Yes
890,03-T-051,Method and Apparatus for Assaying Blood Clotting,07762741.2EPO, ,European Patent Office (EPO),EP,1/31/2007,,1983889,7/29/2008,1101-005,Small,1/31/2006,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00236,"Thoung Ha, Rustem Ismagilov, Christian Kastrup, Matthew Runyon, Feng Shen, Helen Song Baca",Nationalized PCT,4/12/2018,1101-005,1/31/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612290,10/29/2008,582137,Yes
891,03-T-051,Method and Apparatus for Assaying Blood Clotting,"12/162,763", ,*United States,US,1/31/2007,,US-2009-0104637-A1,7/30/2008,1101-006,Small,1/31/2006,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00233,"Rustem Ismagilov, Christian Kastrup, Matthew Runyon, Feng Shen, Helen Song Baca",Nationalized PCT,4/12/2018,1101-006,1/31/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612291,4/23/2009,582137,Yes
892,03-T-057,Cytoprotective Factors Derived from Probiotic and Commensal Flora Microorganisms,"60/564,049", ,*United States,US,4/20/2004,, ,4/20/2004,1107-001,Small,4/20/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40049,"Eugene Chang, Elaine Petrof",Provisional,4/12/2018,1107-001,4/20/2005,"Dembo, Anna",Eugene Chang,"Butler, Brittany",611373,,582143,Yes
893,03-T-057,Probiotic Compounds from Lactobacillus and Uses Therefor,05779952.0EPO, ,European Patent Office (EPO),EP,4/20/2005,,WO2005/112976,11/20/2006,1107-003,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40049A-EP,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1107-003,4/20/2024,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614141,12/1/2005,582143,Yes
894,03-T-057,Probiotic Compounds from Lactobacillus and Uses Therefor,"2,563,702", ,Canada,CA,4/20/2005,,WO2005/112976,10/18/2006,1107-004,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40049A-CA,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1107-004,4/20/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614142,12/1/2005,582143,Yes
895,03-T-057,Probiotic Compounds from Lactobacillus and Uses Therefor,2007-509640, ,Japan,JP,4/20/2005,,2008-501316,10/18/2006,1107-005,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40049A-JP,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1107-005,4/20/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614143,1/24/2008,582143,Yes
896,03-T-057,Probiotic Compounds from Lactobacillus and Uses Therefor,2006230772, ,Australia,AU,4/20/2005,,WO2005/112976,10/31/2006,1107-006,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40049A-AU,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1107-006,4/20/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614144,12/1/2005,582143,Yes
897,03-T-057,Probiotic Compounds from Lactobacillus and Uses Therefor,200580019583.1, ,China,CN,4/20/2005,,CN1997748A,4/12/2007,1107-009,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40049A-CN,"Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1107-009,4/20/2025,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614145,7/11/2007,582143,Yes
898,03-T-057,Probiotic Compounds from Lactobacillus GG and Uses Therefor,PCT/US05/13646, ,*United States,US,4/20/2005,,WO2005/112976,4/20/2005,1107-002,Small,4/20/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40049A-PC,"Eugene Chang, Elaine Petrof",PCT,4/12/2018,1107-002,10/20/2006,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614146,12/1/2005,582143,Yes
899,03-T-057,Probiotic Compounds from Lactobacillus GG and Uses Therefor,"60/736,461", ,*United States,US,11/14/2005,, ,11/14/2005,1107-007,Small,11/14/2005,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41585,"Martin Boyer, Eugene Chang, Keishi Kojima, Mark Musch, Elaine Petrof, Mark Ropeleski",Provisional,4/12/2018,1107-007,11/14/2006,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614147,,582143,Yes
900,03-T-057,Probiotic Compounds from Lactobacillus GG and Uses Therefor,"11/581,719", ,*United States,US,4/20/2005,,US-2007-0123460-A1,10/16/2006,1107-008,Small,4/20/2004,2/12/2010,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40049A,"Eugene Chang, Elaine Petrof",Continuation in Part,4/12/2018,1107-008,10/16/2026,"Dembo, Anna",Eugene Chang,"Butler, Brittany",614148,5/31/2007,582143,Yes
901,03-T-065,Yease As a Model System for Studying Parkinson's Disease,"60/463,284", ,*United States,US,4/16/2003,, ,4/16/2003,1115-001,Small,4/16/2003,,Yes,4/28/2022,Expired - Inactive,Ropes & Gray LLP,, ,"Susan Lindquist, Tiago Outeiro",Provisional,4/12/2018,1115-001,4/16/2004,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615399,,582151,Yes
902,03-T-065,Yeast ectopically expressing abnorrmally processed proteins and uses therefor,"60/472,317", ,*United States,US,5/20/2003,, ,5/20/2003,1115-002,Small,5/20/2003,,Yes,4/28/2022,Expired - Inactive,Ropes & Gray LLP,, ,"Susan Lindquist, Tiago Outeiro",Provisional,4/12/2018,1115-002,5/20/2004,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",615400,,582151,Yes
903,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,"60/474,826", ,*United States,US,5/30/2003,, ,5/30/2003,1116-001,Large,5/30/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Provisional,4/12/2018,1116-001,5/30/2004,"Sun, Han",Mark Ratain,"Tennant, Thelma",612819,,582153,Yes
904,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,"10/558,510","7,807,350",*United States,US,5/28/2004,10/5/2010,US-2007-0197574-A1,11/28/2005,1116-002,Large,5/30/2003,10/5/2010,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Nationalized PCT,4/12/2018,1116-002,4/2/2026,"Sun, Han",Mark Ratain,"Tennant, Thelma",612820,8/23/2007,582153,Yes
905,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2EPO,1629111,European Patent Office (EPO),EP,5/28/2004,5/28/2008,16291111,12/1/2005,1116-003,Large,5/30/2003,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Nationalized PCT,4/12/2018,1116-003,5/28/2008,"Sun, Han",Mark Ratain,"Tennant, Thelma",612821,3/1/2006,582153,Yes
906,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,PCT/US04/16920, ,*United States,US,5/28/2004,, ,5/28/2004,1116-004,Large,5/30/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",PCT,4/12/2018,1116-004,11/30/2005,"Sun, Han",Mark Ratain,"Tennant, Thelma",612822,,582153,Yes
907,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,"2,527,320", ,Canada,CA,5/28/2004,, ,11/29/2005,1116-005,Large,5/30/2003,5/30/2011,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Nationalized PCT,4/12/2018,1116-005,5/30/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612823,,582153,Yes
908,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,2006-515008, ,Japan,JP,5/28/2004,,2006-526412,11/28/2005,1116-006,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Nationalized PCT,4/12/2018,1116-006,11/28/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",612824,11/24/2006,582153,Yes
909,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2GB,1629111,United Kingdom,GB,5/28/2004,5/28/2008, ,5/28/2008,1116-007,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Validated EPO,4/12/2018,1116-007,5/28/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612825,,582153,Yes
910,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2DE,1629111,Germany,DE,5/28/2004,5/28/2008, ,5/28/2008,1116-008,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Validated EPO,4/12/2018,1116-008,5/28/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612826,,582153,Yes
911,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2FR,1629111,France,FR,5/28/2004,5/28/2008, ,5/28/2008,1116-009,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Validated EPO,4/12/2018,1116-009,5/28/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612827,,582153,Yes
912,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2IT,1629111,Japan,JP,5/28/2004,5/28/2008, ,5/28/2008,1116-010,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Validated EPO,4/12/2018,1116-010,5/28/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612828,,582153,Yes
913,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2BE,1629111,Belgium,BE,5/28/2004,5/28/2008, ,5/28/2008,1116-011,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Validated EPO,4/12/2018,1116-011,5/28/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612829,,582153,Yes
914,03-T-067,Methods and Compositions for Predicting Irinotecan Toxicity,04753702.2ES,1629111,Spain,ES,5/28/2004,5/28/2008, ,5/28/2008,1116-012,Large,5/30/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Federico Innocenti, Carrie Jones, Mark Ratain",Validated EPO,4/12/2018,1116-012,5/28/2024,"Sun, Han",Mark Ratain,"Tennant, Thelma",612830,,582153,Yes
915,03-T-081,Methods and Compositions for Reducing Toxicity Associated with Leflunomide Treatment,"10/903,681", ,*United States,US,7/30/2004,,US-2006-0024376-A1,7/30/2004,1130-001,Small,7/30/2004,,Yes,4/28/2022,Released to Inventors,Michael Best & Friedrich LLP,,092234-9003-001,James Williams,US Utility,4/12/2018,1130-001,7/30/2024,"Unassigned, Unassigned",James Williams,"Unassigned, Unassigned",612845,2/2/2006,582167,Yes
916,03-T-081,Methods and Compositions for Reducing Toxicity Associated with Leflunomide Treatment,PCT/US05/26145, ,*United States,US,7/25/2005,, ,7/25/2005,1130-002,Small,7/30/2004,,No,4/28/2022,Released to Inventors,Michael Best & Friedrich LLP,,092234-9003-WO00,James Williams,PCT,4/12/2018,1130-002,1/30/2007,"Unassigned, Unassigned",James Williams,"Unassigned, Unassigned",612846,,582167,Yes
917,03-T-082,A Catalytic Asymmetric Epoxidation,PCT/US05/00306, ,*United States,US,1/5/2005,, ,1/5/2005,1131-004,Small,1/20/2004,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Garcia, Brian",00112,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",PCT,4/12/2018,1131-004,7/20/2006,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610200,8/11/2005,582168,Yes
918,03-T-082,Catalytic Asymmetric Epoxidation,"10/762,028","7,202,371",*United States,US,1/20/2004,4/10/2007,US-2005-159607-A1,1/20/2004,1131-001,Large,1/20/2004,4/10/2007,Yes,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00093,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",US Utility,4/12/2018,1131-001,2/16/2024,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610796,7/21/2005,582168,Yes
919,03-T-082,Catalytic Asymmetric Epoxidation,05705096.5EPO,1706205,European Patent Office (EPO),EP,1/5/2005,10/29/2008,1706205,6/19/2006,1131-002,Large,1/20/2004,,No,4/28/2022,Granted,Brinks Gilson & Lione,,07814.00165,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Nationalized PCT,4/12/2018,1131-002,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610797,10/4/2006,582168,Yes
920,03-T-082,Catalytic Asymmetric Epoxidation,2006-549384,4909084,Japan,JP,1/5/2005,1/20/2012,2007-522115,7/6/2006,1131-003,Large,1/20/2004,,No,6/1/2022,Issued,Brinks Gilson & Lione,,07814.00166,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Nationalized PCT,4/12/2018,1131-003,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610798,8/9/2007,582168,Yes
921,03-T-082,Catalytic Asymmetric Epoxidation,"11/656,891","7,714,167",*United States,US,1/5/2005,5/11/2010,US-2007-0203347-A1,1/22/2007,1131-005,Large,1/20/2004,5/11/2010,No,6/1/2022,Issued,Brinks Gilson & Lione,,07814.00184,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Continuation,4/12/2018,1131-005,2/20/2026,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610799,8/30/2007,582168,Yes
922,03-T-082,Catalytic Asymmetric Epoxidation,05705096.5FR,1706205,France,FR,1/5/2005,10/29/2008, ,10/29/2008,1131-006,Large,1/20/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,7814-229,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Validated EPO,4/12/2018,1131-006,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610800,,582168,Yes
923,03-T-082,Catalytic Asymmetric Epoxidation,05705096.5DE,1706205,Germany,DE,1/5/2005,10/29/2008, ,10/29/2008,1131-007,Large,1/20/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00230,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Validated EPO,4/12/2018,1131-007,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610801,,582168,Yes
924,03-T-082,Catalytic Asymmetric Epoxidation,05705096.5GB,1706205,United Kingdom,GB,1/5/2005,10/29/2008, ,10/29/2008,1131-008,Large,1/20/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00231,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Validated EPO,4/12/2018,1131-008,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610802,,582168,Yes
925,03-T-082,Catalytic Asymmetric Epoxidation,05705096.5CH,1706205,Switzerland,CH,1/5/2005,10/29/2008, ,10/29/2008,1131-009,Large,1/20/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00232,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Validated EPO,4/12/2018,1131-009,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610803,,582168,Yes
926,03-T-082,Catalytic Asymmetric Epoxidation,05705096.5LI,1706205,Lichtenstein,LI,1/5/2005,10/29/2008, ,10/29/2008,1131-010,Large,1/20/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00232,"Arindrajit Basak, Hisashi Yamamoto, Wei Zhang",Validated EPO,4/12/2018,1131-010,1/5/2025,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610805,,582168,Yes
927,03-T-085,Methods and compositions comprising chimeric Human Acetyl-CoA Carboxylase,"60/685,283", ,*United States,US,5/27/2005,, ,5/27/2005,1134-001,None,5/27/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Piotr Gornicki, Robert Haselkorn",Provisional,4/12/2018,1134-001,5/27/2006,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",612642,,582171,Yes
928,03-T-085,Methods and Compositions Comprising Chimeric Human Acetyl-CoA Carboxylase,"11/913,913", ,*United States,US,5/26/2006,, ,5/26/2006,1134-003,Small,5/27/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Piotr Gornicki, Robert Haselkorn",US Utility,4/12/2018,1134-003,5/26/2026,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",612643,,582171,Yes
929,03-T-086,Membrane Preparation from Pichia Pastoris to Assay gamma-secretase activity,"10/573,307", ,*United States,US,9/23/2004,,ARCD:398USC1,3/24/2006,1135-004,Small,9/24/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Sangram Sisodia, Chunjiang Yu",Continuation,4/12/2018,1135-004,3/24/2026,"Sun, Han",Sangram Sisodia,"Butler, Brittany",612243,,582172,Yes
930,03-T-086,Membrane Preparation From Pichia Pastoris to Assay y-Secretase Activity,PCT/US04/31230, ,*United States,US,9/23/2004,,WO 05/031363 A1,9/23/2004,1135-002,Small,9/24/2003,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Sangram Sisodia, Chunjiang Yu",PCT,4/12/2018,1135-002,3/24/2006,"Sun, Han",Sangram Sisodia,"Butler, Brittany",612244,4/7/2005,582172,Yes
931,03-T-086,Solubilized Membrane Preparation From Pichia Pastoris to Assay y-Secretase Activity,"60/505,601", ,*United States,US,9/24/2003,, ,9/24/2003,1135-001,Small,9/24/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Sangram Sisodia, Chunjiang Yu",Provisional,4/12/2018,1135-001,9/24/2004,"Sun, Han",Sangram Sisodia,"Butler, Brittany",614575,,582172,Yes
932,03-T-086,Solubilized Membrane Preparation From Pichia Pastoris to Assay y-Secretase Activity,"10/948,629", ,*United States,US,9/23/2004,, ,9/23/2004,1135-003,Small,9/24/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Sangram Sisodia, Chunjiang Yu",US Utility,4/12/2018,1135-003,9/24/2024,"Sun, Han",Sangram Sisodia,"Butler, Brittany",614576,,582172,Yes
933,03-T-087,Catalytic Asymmetric Hetero Diels-Alder Reaction of a Heteroaromatic C-Nitroso Dienophile: A Novel Method for Synthesis of Chiral Non-Racemic Amino Alcohols,PCT/US04/43987, ,*United States,US,12/30/2004,, ,12/30/2004,1136-002,Small,1/2/2004,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Garcia, Brian",00120,"Hisashi Yamamoto, Yuhei Yamamoto",PCT,4/12/2018,1136-002,7/2/2006,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610806,,582173,Yes
934,03-T-087,Catalytic Asymmetric Hetero Diels-Alder Reaction of a Heteroaromatic C-Nitroso Dienophile: A Novel Method for Synthesis of Chiral Non-Racemic Amino Alcohols.,"60/534,025", ,*United States,US,1/2/2004,, ,1/2/2004,1136-001,Small,1/2/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00092,"Hisashi Yamamoto, Yuhei Yamamoto",Provisional,4/12/2018,1136-001,1/2/2005,"Ginsburg, Eric",Yuhei Yamamoto,"Juggernauth, Anne",610807,,582173,Yes
935,03-T-087,Catalytic Asymmetric Hetero Diels-Alder Reaction of a Heteroaromatic C-Nitroso Dienophile: A Novel Method for Synthesis of Chiral Non-Racemic Amino Alcohols.,"11/027,551", ,*United States,US,12/30/2004,,US-2005-0261497-A1,12/30/2004,1136-003,Small,1/2/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00121,"Hisashi Yamamoto, Yuhei Yamamoto",US Utility,4/12/2018,1136-003,12/30/2024,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",610808,11/24/2005,582173,Yes
936,03-T-088,Image Modification and Detection Using Massive Training Artificial Neural Networks (MTANN),"10/703,617","7,545,965",*United States,US,11/10/2003,6/9/2009,US-2005-100208-A1,11/10/2003,1137-001,Small,11/10/2003,6/9/2009,Yes,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Kenji Suzuki",US Utility,4/12/2018,1137-001,2/11/2027,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611906,5/12/2005,582174,Yes
937,03-T-094,Measuring Gene Expression of Hematopietic Cells and Methods of Diagnosing and Treating Hematopoietic Conditions,"60/420,325", ,*United States,US,9/23/2005,, ,9/23/2005,1143-001,None,9/23/2005,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Brusca, Eric",40432,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang, Goulin Zhou",Provisional,4/12/2018,1143-001,9/23/2006,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612231,,582180,Yes
938,03-T-095,Measuring Gene Expression of Hematopoietic Cells and Methods of Diagnosing and Treating Hematopoietic Conditions,"60/720,157", ,*United States,US,9/23/2005,, ,9/23/2005,1146-001,Small,9/23/2005,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Brusca, Eric",40431,"JianJun Chen, Sanggyu Lee, Janet Rowley, San Ming Wang, Goulin Zhou",Provisional,4/12/2018,1146-001,9/23/2006,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612234,,582181,Yes
939,03-T-096,Automated Method and System for the Evaluation of Disease and Registration Accuracy in the Subtraction of Temporally Sequential Medical Images,"10/721,827","8,265,728",*United States,US,11/26/2003,9/11/2012,US-2005-111718-A1,11/26/2003,1144-001,Small,11/26/2003,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Heber MacMahon",US Utility,4/12/2018,1144-001,11/26/2023,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610648,5/26/2005,582182,Yes
940,03-T-096,Automated Method and System for the Evaluation of Disease and Registration Accuracy in the Subtraction of Temporally Sequential Medical Images,PCT/US04/32782, ,*United States,US,11/4/2004,,WO 05/057335 A3,11/4/2004,1144-002,Small,11/26/2003,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Heber MacMahon",PCT,4/12/2018,1144-002,5/26/2006,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",610649,6/23/2005,582182,Yes
941,03-T-105,Computerize Scheme for Detection of Intracranial Aneurysm in MRA Version 1.0,TXu-1-371-306,TXu-1-371-306,*United States,US,8/20/2007,8/20/2007,,,1154-002,None,,,No,4/12/2018,Registered (Copyright),,,,"Hidetaka Arimura, Kunio Doi, Qiang Li",Copyright Application,4/12/2018,1154-002,8/20/2027,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611254,,582191,Yes
942,03-T-105,Method for Detection of Abnormalities in Three-Dimensional Imaging Data,"10/849,807", ,*United States,US,5/21/2004,,US-2005-259854-A1,5/21/2004,1154-001,Small,5/21/2004,,Yes,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Hidetaka Arimura, Kunio Doi, Qiang Li",US Utility,4/12/2018,1154-001,5/21/2024,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612441,11/24/2005,582191,Yes
943,03-T-109,"Method, Media, and System for Feature-Based Correlation of Lesions from Multiple Images","60/544,237", ,*United States,US,2/13/2004,, ,2/13/2004,1155-001,Small,2/13/2004,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Li Lan, Gillian Newstead, Hui-Hua Wen",Provisional,4/12/2018,1155-001,2/13/2005,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612563,,582195,Yes
944,03-T-109,"Method, System and Computer Software Product for Feature-Based Correlation of Lesions from Multiple Images","11/056,368","7,298,881",*United States,US,2/14/2005,11/20/2007,US-2006-0004278-A1,2/14/2005,1155-002,Small,2/13/2004,11/20/2007,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Maryellen Giger, Li Lan, Hui-Hua Wen",US Utility,4/12/2018,1155-002,7/26/2025,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612587,1/5/2006,582195,Yes
945,03-T-109,"Method, System, and Computer Software Product for Feature-based Correlation of Lesions from Multiple Images",PCT/US05/04417, ,*United States,US,2/14/2005,,WO 05/079306 A2,2/14/2005,1155-003,Small,2/13/2004,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Maryellen Giger, Hui-Hua Wen",PCT,4/12/2018,1155-003,8/13/2006,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612591,9/1/2005,582195,Yes
946,03-T-111,"Method, system, and computer software product for automated identification of temporal patterns with high initial enhancement in dynamic magnetic resonance breast imaging.","11/056,366","7,983,732",*United States,US,2/14/2005,7/19/2011,US 2006-0018548 A1,2/14/2005,1158-001,Large,2/13/2004,7/19/2011,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Weijie Chen, Maryellen Giger, Gillian Newstead",US Utility,4/12/2018,1158-001,9/9/2029,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612590,1/26/2006,582197,Yes
947,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,"60/549,069", ,*United States,US,3/1/2004,, ,3/1/2004,1163-001,Small,3/1/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wanqing Liu, Mark Ratain",Provisional,4/12/2018,1163-001,3/1/2005,"Sun, Han",Mark Ratain,"Tennant, Thelma",614099,,582200,Yes
948,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,"10/591,228", ,*United States,US,3/1/2005,,US-2007-0275386 A1,8/31/2006,1163-002,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Nationalized PCT,4/12/2018,1163-002,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614100,11/29/2007,582200,Yes
949,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,PCT/US05/06559, ,*United States,US,3/1/2005,, ,3/1/2005,1163-003,Small,3/1/2004,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wanqing Liu, Mark Ratain",PCT,4/12/2018,1163-003,9/1/2006,"Sun, Han",Mark Ratain,"Tennant, Thelma",614101,,582200,Yes
950,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,10-2006-7020515, ,"Korea, Republic of",KR,3/1/2005,, ,8/18/2006,1163-004,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Nationalized PCT,4/12/2018,1163-004,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614102,,582200,Yes
951,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,"2,558,753", ,Canada,CA,3/1/2005,, ,8/23/2006,1163-005,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Nationalized PCT,4/12/2018,1163-005,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614103,,582200,Yes
952,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,200580006465.7, ,China,CN,3/1/2005,, ,8/30/2006,1163-006,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Nationalized PCT,4/12/2018,1163-006,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614104,,582200,Yes
953,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,05724156.4EPO, ,European Patent Office (EPO),EP,3/1/2005,,1 730 306,9/27/2006,1163-007,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Nationalized PCT,4/12/2018,1163-007,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614105,12/13/2006,582200,Yes
954,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,2007-501893, ,Japan,JP,3/1/2005,,2007-527241,10/19/2006,1163-008,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Nationalized PCT,4/12/2018,1163-008,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614106,9/27/2007,582200,Yes
955,03-T-114,Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter,07105514.9, ,Hong Kong,HK,3/1/2005,,1098791,5/25/2007,1163-009,Large,3/1/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Wanqing Liu, Mark Ratain",Validated EPO,4/12/2018,1163-009,3/1/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",614107,7/27/2007,582200,Yes
956,03-T-115,Group 1 CD1 Transgenic Mice and their Uses,"60/588,192", ,*United States,US,7/15/2004,, ,7/15/2004,1164-001,Small,7/15/2004,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Chyung-Ru Wang,Provisional,4/12/2018,1164-001,7/15/2005,"Dembo, Anna",Chyung-Ru Wang,"Tennant, Thelma",611716,,582201,Yes
957,03-T-115,Group 1 CD1 Transgenic Mice and Their Uses,"11/181,234", ,*United States,US,7/14/2005,,US2006/0021075 A1,7/14/2005,1164-002,Small,7/15/2004,,No,4/28/2022,Abandoned,Ballard Spahr LLP,, ,Chyung-Ru Wang,US Utility,4/12/2018,1164-002,7/14/2024,"Dembo, Anna",Chyung-Ru Wang,"Tennant, Thelma",611717,1/26/2006,582201,Yes
958,03-T-117,Total Internal Reflection Fluorescence Apparatus,"11/008,002","7,330,255",*United States,US,12/9/2004,2/12/2008,US 2006-0126063 A1,12/9/2004,1166-001,Small,12/9/2004,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,40373,"Philippe Cluzel, Sabastien Harlepp",US Utility,4/12/2018,1166-001,7/21/2025,"Unassigned, Unassigned",Philippe Cluzel,"Unassigned, Unassigned",614929,6/15/2006,582203,Yes
959,03-T-120,Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK,"11/032,794","7,354,898",*United States,US,10/2/2002,4/8/2008,US-2005-0265970-A1,1/10/2005,0919-013,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Concetta Bubici, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Continuation in Part,4/12/2018,0919-013,10/2/2021,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",611892,12/1/2005,582206,Yes
960,03-T-120,Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting JNK,"12/030,558", ,*United States,US,10/2/2002,,US-2008-0247956-A1,2/13/2008,0919-014,Small,10/2/2001,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Concetta Bubici, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Continuation,4/12/2018,0919-014,10/2/2021,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",611893,10/9/2008,582206,Yes
961,03-T-120,Identification of Novel Factors That Block Programmed Cell death or Apoptosis by Targeting MKK7/JNKK2,"11/000,365","7,326,418",*United States,US,11/29/2004,2/5/2008,US-2005-0267022-A1,11/29/2004,0919-012,Small,12/2/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Concetta Bubici, Guido Franzoso, Salvatore Papa, Francesca Zazzeroni",Continuation in Part,4/12/2018,0919-012,12/2/2022,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",611894,12/1/2005,582206,Yes
962,03-T-120,Identification of Novel Factors that Block Programmed Cell Death or Apoptosis by Targeting MKK7/JNKK2,"60/526,231", ,*United States,US,12/2/2003,, ,12/2/2003,1169-001,Small,12/2/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Guido Franzoso,Provisional,4/12/2018,1169-001,12/2/2004,"Unassigned, Unassigned",Guido Franzoso,"Unassigned, Unassigned",611895,,582206,Yes
963,03-T-121,Methods of Inducing Protective Hypothermia of Organs,"11/140,500", ,*United States,US,5/27/2005,,US-2006-0036302-A1,5/27/2005,1170-001,Small,5/28/2004,2/14/2011,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00135,"Lance Becker, David Beiser, Kenneth Kasza, Brett Laven, John Oras, Arieh Shalhav, HyunJin Son, Terry Vanden Hoek",US Utility,4/12/2018,1170-001,5/28/2024,"Cox, Ben",Lance Becker,"Butler, Brittany",613331,2/16/2006,582207,Yes
964,03-T-121,Methods of Inducing Protective Hypothermia of Organs,PCT/US05/31906, ,*United States,US,9/6/2005,, ,9/6/2005,1170-002,None,9/3/2004,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00147,"Lance Becker, David Beiser, Kenneth Kasza, Brett Laven, John Oras, Arieh Shalhav, HyunJin Son, Terry Vanden Hoek",PCT,4/12/2018,1170-002,3/3/2007,"Cox, Ben",Lance Becker,"Butler, Brittany",613332,,582207,Yes
965,03-T-122,Exact Image Reconstruction on Pi-Lines in Helical Cone-Beam CT,"60/543,331", ,*United States,US,2/10/2004,, ,2/10/2004,1171-001,Small,2/10/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00127,"Xiaochuan Pan, Yu Zou",Provisional,4/12/2018,1171-001,2/10/2005,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611545,,582208,Yes
966,03-T-122,Imaging Method and System,200580012348.1, ,China,CN,2/10/2005,,CN 101023448A,10/10/2006,1171-008,Small,2/10/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00173,"Xiaochuan Pan, Yu Zou",Nationalized PCT,4/12/2018,1171-008,2/10/2025,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611918,8/22/2007,582208,Yes
967,03-T-122,Imaging System,PCT/US05/04314, ,*United States,US,2/10/2005,, ,2/10/2005,1171-003,Small,2/10/2004,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00124,"Xiaochuan Pan, Yu Zou",PCT,4/12/2018,1171-003,8/10/2006,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611919,,582208,Yes
968,03-T-122,Imaging System,"60/674,116", ,*United States,US,4/22/2005,, ,4/22/2005,1171-004,Small,4/22/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00130,"Howard Halpern, Xiaochuan Pan, Yu Zou",Provisional,4/12/2018,1171-004,4/22/2006,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611920,,582208,Yes
969,03-T-122,IMAGING SYSTEM,"11/410,594","7,444,011",*United States,US,2/10/2005,10/28/2008,US-2007-0036418-A1,4/24/2006,1171-006,None,2/10/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00163,"Seungryong Cho, Maryellen Giger, Howard Halpern, Chien-Min Kao, Martin King, Xiaochuan Pan, Charles Pelizzari, Emil Sidky, Dan Xia, Lifeng Yu, Yu Zou",Continuation in Part,4/12/2018,1171-006,2/10/2025,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611921,2/15/2007,582208,Yes
970,03-T-122,IMAGING SYSTEM,PCT/US06/15482, ,*United States,US,4/24/2006,,WO 2006/116316,4/24/2006,1171-007,None,4/22/2005,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00162,"Seungryong Cho, Maryellen Giger, Howard Halpern, Chien-Min Kao, Martin King, Xiaochuan Pan, Charles Pelizzari, Emil Sidky, Dan Xia, Lifeng Yu, Yu Zou",PCT,4/12/2018,1171-007,10/22/2007,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611922,1/17/2008,582208,Yes
971,03-T-122,Imaging System,"12/288,480", ,*United States,US,2/10/2005,,US-2009-0175562-A1,10/21/2008,1171-009,Small,2/10/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Penn, Amir",00246,"Maryellen Giger, Howard Halpern, Chien-Min Kao, Martin King, Xiaochuan Pan, Charles Pelizzari, Emil Sidky, Dan Xia, Lifeng Yu, Yu Zou",Continuation,4/12/2018,1171-009,10/21/2028,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611923,7/9/2009,582208,Yes
972,03-T-122,Imaging System,"12/930,856","8,121,245",*United States,US,2/10/2005,2/21/2012, ,1/19/2011,1171-010,Small,2/10/2004,,No,5/1/2022,Issued,Brinks Gilson & Lione,,00313,"Maryellen Giger, Howard Halpern, Chien-Min Kao, Martin King, Xiaochuan Pan, Charles Pelizzari, Emil Sidky, Dan Xia, Lifeng Yu, Yu Zou",Continuation,4/12/2018,1171-010,2/10/2024,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611924,,582208,Yes
973,03-T-122,Imaging System,"13/400,503","9,025,843",*United States,US,2/10/2005,5/5/2015,US-2012-0215090-A1,2/20/2012,1171-011,Small,2/10/2004,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00339,"Maryellen Giger, Howard Halpern, Chien-Min Kao, Martin King, Xiaochuan Pan, Charles Pelizzari, Emil Sidky, Dan Xia, Lifeng Yu, Yu Zou",Continuation,4/12/2018,1171-011,2/10/2024,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611925,8/23/2012,582208,Yes
974,03-T-122,Imaging System for Generating a Substantially Exact Reconstruction of a Region of Interest,"11/054,788","7,394,923",*United States,US,2/10/2005,7/1/2008,US-2005-249432-A1,2/10/2005,1171-002,Small,2/10/2004,,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00107,"Xiaochuan Pan, Yu Zou",US Utility,4/12/2018,1171-002,2/10/2025,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611926,11/10/2005,582208,Yes
975,03-T-122,Region-of-Interest Reconstruction of Motion-Contaminated Data Using a Pi-Line Based Backprojection-Filtration Algorithm,"60/677,222", ,*United States,US,5/2/2005,, ,5/2/2005,1171-005,Small,5/2/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00131,"Maryellen Giger, Howard Halpern, Chien-Min Kao, Xiaochuan Pan, Charles Pelizzari, Emil Sidky, Dan Xia, Lifeng Yu, Yu Zou",Provisional,4/12/2018,1171-005,5/2/2006,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",614373,,582208,Yes
976,03-T-126,Insulin Regulation of cAMP Regulated Genes,"60/569,118", ,*United States,US,5/7/2004,, ,5/7/2004,1176-001,Small,5/7/2004,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Fred Wondisford,Provisional,4/12/2018,1176-001,5/7/2005,"Unassigned, Unassigned",Fred Wondisford,"Unassigned, Unassigned",612037,,582212,Yes
977,03-T-129,Peptidoglycan-Hydrolyzing Protein Encoded by Bacteriophage N4,"60/563,327", ,*United States,US,4/19/2004,, ,4/19/2004,1172-001,Small,4/19/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"Lucia Rothman-Denes, Emina Stojkovic",Provisional,4/12/2018,1172-001,4/19/2005,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613928,,582215,Yes
978,03-T-129,Peptidoglycan-Hydrolyzing Protein Encoded by Bacteriophage N4,"60/581,860", ,*United States,US,6/22/2004,, ,6/22/2004,1172-002,Small,6/22/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"Lucia Rothman-Denes, Emina Stojkovic",Provisional,4/12/2018,1172-002,6/22/2005,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613929,,582215,Yes
979,03-T-129,Peptidoglycan-Hydrolyzing Protein Encoded by Bacteriophage N4,PCT/US05/13509, ,*United States,US,4/19/2005,, ,4/19/2005,1172-003,Small,4/19/2004,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Hanson, Robert", ,"Lucia Rothman-Denes, Emina Stojkovic",PCT,4/12/2018,1172-003,10/22/2006,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613930,,582215,Yes
980,03-T-129,Peptidoglycan-Hydrolyzing Protein Encoded by Bacteriophage N4,"11/568,067", ,*United States,US,4/19/2005,, ,10/18/2006,1172-004,None,4/19/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Lucia Rothman-Denes, Emina Stojkovic",Nationalized PCT,4/12/2018,1172-004,4/19/2025,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",613931,,582215,Yes
981,03-T-130,Synthesis of Nitroso Diels-Alder Type Products,"60/564,048", ,*United States,US,4/20/2004,, ,4/20/2004,1179-001,Small,4/20/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00099,"Norie Momiyama, Hisashi Yamamoto, Yuhei Yamamoto",Provisional,4/12/2018,1179-001,4/20/2005,"Ginsburg, Eric",Norie Momiyama,"Juggernauth, Anne",614750,,582216,Yes
982,04-T-001,Computerized Scheme for Distinction between Benign and Malignant Nodules in Thoracic Low-Dose CT by Use of Massive Training Artificial Neural Network,"60/587,855", ,*United States,US,7/15/2004,, ,7/15/2004,1180-001,Small,7/15/2004,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Kenji Suzuki",Provisional,4/12/2018,1180-001,7/15/2005,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611267,,582217,Yes
983,04-T-001,Computerized Scheme for Distinction between Benign and Malignant Nodules in Thoracic Low-Dose CT by Use of Massive Training Artificial Neural Network,"11/181,884", ,*United States,US,7/15/2005,, ,7/15/2005,1180-002,Small,7/15/2004,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Kenji Suzuki",US Utility,4/12/2018,1180-002,7/15/2024,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611268,,582217,Yes
984,04-T-001,Computerized Scheme for Distinction between Benign and Malignant Nodules in Thoracic Low-Dose CT by Use of Massive Training Artificial Neural Network,PCT/US05/25305, ,*United States,US,7/15/2005,, ,7/15/2005,1180-003,None,7/15/2004,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kunio Doi, Kenji Suzuki",PCT,4/12/2018,1180-003,1/15/2007,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611269,,582217,Yes
985,04-T-005,T Cell Anergy is Reversed by Active Ras and Regulated by Diacylglycerol Kinase,"60/535,072", ,*United States,US,1/8/2004,, ,1/8/2004,1184-001,Small,1/8/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Thomas Gajewski,Provisional,4/12/2018,1184-001,1/8/2005,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614846,,582221,Yes
986,04-T-005,T Cell Anergy is Reversed by Active Ras and Regulated by Diacylglycerol Kinase,"11/032,516","7,381,401",*United States,US,1/10/2005,6/3/2008,US-2005-0266510-A1,1/10/2005,1184-002,Small,1/8/2004,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Thomas Gajewski,US Utility,4/12/2018,1184-002,1/26/2025,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614847,12/1/2005,582221,Yes
987,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,"60/564,313", ,*United States,US,4/21/2004,, ,4/21/2004,1187-001,Small,4/21/2004,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Randall Mrsny, Jerrold Turner",Provisional,4/12/2018,1187-001,4/21/2005,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613593,,582222,Yes
988,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5EPO,1740601,European Patent Office (EPO),EP,4/21/2005,5/12/2012,1740601,10/13/2006,1187-002,Small,4/21/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Derek McKay, Randall Mrsny, Jerrold Turner",Nationalized PCT,4/12/2018,1187-002,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613594,1/10/2007,582222,Yes
989,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,2007-509587, ,Japan,JP,4/21/2005,,2008-501640,10/10/2006,1187-003,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Derek McKay, Randall Mrsny, Jerrold Turner",Nationalized PCT,4/12/2018,1187-003,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613595,1/24/2008,582222,Yes
990,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,200580019765.9, ,China,CN,4/21/2005,,CN 1997660A,10/25/2006,1187-004,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Derek McKay, Randall Mrsny, Jerrold Turner",Nationalized PCT,4/12/2018,1187-004,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613596,7/11/2007,582222,Yes
991,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,"2,563,508", ,Canada,CA,4/21/2005,, ,10/17/2006,1187-005,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Derek McKay, Randall Mrsny, Jerrold Turner",Nationalized PCT,4/12/2018,1187-005,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613597,,582222,Yes
992,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,2005241009, ,Australia,AU,4/21/2005,,WO 05/108416,10/13/2006,1187-006,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Derek McKay, Randall Mrsny, Jerrold Turner",Nationalized PCT,4/12/2018,1187-006,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613598,5/4/2006,582222,Yes
993,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,"11/111,463","7,585,844",*United States,US,4/21/2005,9/8/2009,US-2005-261196-A1,4/21/2005,1187-007,Small,4/21/2004,10/9/2017,No,5/8/2022,Abandoned,"Valauskas Corder, LLC",, ,"Randall Mrsny, Jerrold Turner",US Utility,4/12/2018,1187-007,7/17/2027,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613599,11/24/2005,582222,Yes
994,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,PCT/US05/13411, ,*United States,US,4/21/2005,,WO 05/108416,4/21/2005,1187-008,Small,4/21/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",PCT,4/12/2018,1187-008,10/21/2006,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613600,5/4/2006,582222,Yes
995,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,07106686.9, ,Hong Kong,HK,4/21/2005,,1100443,6/22/2007,1187-009,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-009,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613601,9/21/2007,582222,Yes
996,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,"12/500,938", ,*United States,US,4/21/2005,,US-2010-0016242-A1,7/10/2009,1187-010,Small,4/21/2004,,No,5/8/2022,Abandoned,"Valauskas Corder, LLC",, ,"Randall Mrsny, Jerrold Turner",Divisional,4/12/2018,1187-010,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613602,1/21/2010,582222,Yes
997,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5BE, ,Belgium,BE,4/21/2005,, ,6/22/2007,1187-011,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-011,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613603,,582222,Yes
998,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5CH, ,Switzerland,CH,4/21/2005,, ,6/22/2007,1187-012,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-012,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613604,,582222,Yes
999,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5DE, ,Germany,DE,4/21/2005,, ,6/22/2007,1187-013,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-013,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613605,,582222,Yes
1000,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5DK, ,Denmark,DK,4/21/2005,, ,6/22/2007,1187-014,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-014,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613606,,582222,Yes
1001,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5ES, ,Spain,ES,4/21/2005,, ,6/22/2007,1187-015,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-015,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613607,,582222,Yes
1002,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5FI, ,Finland,FI,4/21/2005,, ,6/22/2007,1187-016,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-016,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613608,,582222,Yes
1003,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5FR, ,France,FR,4/21/2005,, ,6/22/2007,1187-017,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-017,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613609,,582222,Yes
1004,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5GB, ,United Kingdom,GB,4/21/2005,, ,6/22/2007,1187-018,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-018,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613610,,582222,Yes
1005,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5IE, ,Ireland,IE,4/21/2005,, ,6/22/2007,1187-019,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-019,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613611,,582222,Yes
1006,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5IT, ,Italy,IT,4/21/2005,, ,6/22/2007,1187-020,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-020,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613612,,582222,Yes
1007,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5NL, ,Netherlands,NL,4/21/2005,, ,6/22/2007,1187-021,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-021,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613613,,582222,Yes
1008,04-T-006,Myosin Light Chain Kinase Inhibitors and Methods of Use,05777465.5SE, ,Sweden,SE,4/21/2005,, ,6/22/2007,1187-022,Small,4/21/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Derek McKay, Randall Mrsny, Jerrold Turner",Validated EPO,4/12/2018,1187-022,4/21/2025,"Dembo, Anna",Jerrold Turner,"Tennant, Thelma",613614,,582222,Yes
1009,04-T-009,Phase-Change Particulate Ice Slurry Coolant Medical Delivery Tubing and Insertion Devices,"11/038,570", ,*United States,US,1/18/2005,, ,1/18/2005,04-008-001,Small,1/18/2005,2/6/2010,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00091,"Lance Becker, Kenneth Kasza, John Oras, HyunJin Son, Terry Vanden Hoek",US Utility,4/12/2018,04-008-001,1/18/2025,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",613937,,582225,Yes
1010,04-T-009,Phase-Change Particulate Ice Slurry Coolant Medical Delivery Tubing and Insertion Devices,PCT/US06/00647, ,*United States,US,1/10/2006,,WO 2006/078490,1/10/2006,04-008-002,None,1/18/2005,,No,4/28/2022,Expired - Inactive,Fish & Richardson P.C.,"Boivin, Nicolas", ,"Lance Becker, Kenneth Kasza, John Oras, HyunJin Son, Terry Vanden Hoek",PCT,4/12/2018,04-008-002,7/18/2007,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",613938,7/27/2006,582225,Yes
1011,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,"60/564,031", ,*United States,US,4/20/2004,, ,4/20/2004,1188-001,Small,4/20/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40050,"John Alverdy, Eugene Chang, Elaine Petrof",Provisional,4/12/2018,1188-001,4/20/2005,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614880,,582226,Yes
1012,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,2006140784, ,Russian Federation,RU,4/20/2005,, ,1/4/2007,1188-002,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-RU,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-002,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614881,,582226,Yes
1013,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,"11/578,388", ,*United States,US,4/20/2005,,US-2008-0206188-A1,10/13/2006,1188-003,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-ID,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-003,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614882,8/28/2008,582226,Yes
1014,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,10-2006-7024125, ,"Korea, Republic of",KR,4/20/2005,, ,10/25/2006,1188-004,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-KR,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-004,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614883,,582226,Yes
1015,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,996/2006, ,Egypt,EG,4/20/2005,, ,10/18/2006,1188-005,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William", ,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-005,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614884,,582226,Yes
1016,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,05856625.8EPO, ,European Patent Office (EPO),EP,4/20/2005,, ,12/12/2006,1188-006,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William", ,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-006,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614885,,582226,Yes
1017,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,200580018362.2, ,China,CN,4/20/2005,,CN1964725A,10/18/2006,1188-007,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-CN,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-007,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614886,5/16/2007,582226,Yes
1018,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,PCT/US05/13465, ,*United States,US,4/20/2005,,WO 2006/073430,4/20/2005,1188-008,Small,4/20/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40050A-PC,"John Alverdy, Eugene Chang, Elaine Petrof",PCT,4/12/2018,1188-008,10/20/2006,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614887,7/13/2006,582226,Yes
1019,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,"PI05,100,046", ,Brazil,BR,4/20/2005,, ,10/25/2006,1188-009,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-BR,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-009,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614888,,582226,Yes
1020,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,1-2006-502055, ,Philippines,PH,4/20/2005,, ,10/31/2006,1188-010,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-PH,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-010,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614889,,582226,Yes
1021,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,W-00200603042, ,Indonesia,ID,4/20/2005,, ,11/3/2006,1188-011,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William", ,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-011,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614890,,582226,Yes
1022,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,2005323502, ,Australia,AU,4/20/2005,, ,10/31/2006,1188-012,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-AU,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-012,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614891,,582226,Yes
1023,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,2006/08710, ,South Africa,ZA,4/20/2005,8/27/2008, ,12/6/2006,1188-013,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-ZA,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-013,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614892,,582226,Yes
1024,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,200607285-4, ,Singapore,SG,4/20/2005,, ,11/8/2006,1188-014,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-SG,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-014,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614893,,582226,Yes
1025,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,2007-509597, ,Japan,JP,4/20/2005,,2007-533755,10/30/2006,1188-015,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-JP,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-015,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614894,11/22/2007,582226,Yes
1026,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,6515/DELNP/2006, ,India,IN,4/20/2005,,20479,1/17/2007,1188-017,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-IN,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-017,,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614895,8/31/2007,582226,Yes
1027,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,PA/a/2006/012070, ,Mexico,MX,4/20/2005,, ,12/19/2006,1188-018,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-MX,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-018,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614896,,582226,Yes
1028,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,178659, ,Israel,IL,4/20/2005,, ,11/9/2006,1188-019,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-IL,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-019,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614897,,582226,Yes
1029,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,"2,563,511", ,Canada,CA,4/20/2005,, ,10/17/2006,1188-020,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-CA,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-020,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614898,,582226,Yes
1030,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,06.117.254, ,Colombia,CO,4/20/2005,,No pub. no. assigned,11/6/2006,1188-021,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-CO,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-021,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614899,3/31/2008,582226,Yes
1031,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,07106996.4, ,Hong Kong,HK,4/20/2005,,1102549A,11/2/2006,1188-022,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-HK,"John Alverdy, Eugene Chang, Elaine Petrof",Validated EPO,4/12/2018,1188-022,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614900,11/30/2007,582226,Yes
1032,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,KE/P/2006/00522, ,Kenya,KE,4/20/2005,, ,10/25/2006,1188-023,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050A-KE,"John Alverdy, Eugene Chang, Elaine Petrof",Nationalized PCT,4/12/2018,1188-023,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614901,,582226,Yes
1033,04-T-010,Therapeutic Delivery System Comprising a High Molecular Weight PEG-Like Compound,2012200170, ,Australia,AU,4/20/2005,, ,1/12/2012,1188-024,Small,4/20/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40050B-AU,"John Alverdy, Eugene Chang, Elaine Petrof",Divisional,4/12/2018,1188-024,4/20/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614902,,582226,Yes
1034,04-T-012,Synthesis of Ordered Arrays from Gold Clusters,"60/582,480", ,*United States,US,6/23/2004,, ,6/23/2004,1190-001,Small,6/23/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00100,"Shunji Egusa, Rongchao Jin, Norbert Scherer",Provisional,4/12/2018,1190-001,6/23/2005,"Bakalyar, Heather",Norbert Scherer,"Juggernauth, Anne",614751,,582228,Yes
1035,04-T-012,Synthesis of Ordered Arrays from Gold Clusters,"11/159,778", ,*United States,US,6/23/2005,,2006-0154380 A1,6/23/2005,1190-002,Small,6/23/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00136,"Shunji Egusa, Rongchao Jin, Norbert Scherer",US Utility,4/12/2018,1190-002,6/23/2025,"Bakalyar, Heather",Norbert Scherer,"Juggernauth, Anne",614752,7/13/2006,582228,Yes
1036,04-T-014,Methods and Compositions Relating to the Pharmacogenetics of Abcc2 Gene Variants,"60/550,268", ,*United States,US,3/5/2004,,WO2005/087952 A1,3/5/2004,1192-001,Small,3/5/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Deanna Kroetz, Mark Ratain, Samir Undevia",Provisional,4/12/2018,1192-001,3/5/2005,"Sun, Han",Mark Ratain,"Tennant, Thelma",613075,9/22/2005,582230,Yes
1037,04-T-014,Methods and Compositions Relating to the Pharmacogenetics of Different Gene Variants,PCT/US05/07410, ,*United States,US,3/7/2005,, ,3/7/2005,1192-002,Small,3/5/2004,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Deanna Kroetz, Wanqing Liu, Tan Nguyen, Mark Ratain, Samir Undevia",PCT,4/12/2018,1192-002,9/5/2006,"Sun, Han",Mark Ratain,"Tennant, Thelma",613076,,582230,Yes
1038,04-T-014,Methods and Compositions Relating to the Pharmacogenetics of Different Gene Variants,"10/591,484", ,*United States,US,3/7/2005,,US-2009-0017452-A1,9/1/2006,1192-005,Large,3/5/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Deanna Kroetz, Wanqing Liu, Tan Nguyen, Mark Ratain, Samir Undevia",US Utility,4/12/2018,1192-005,9/1/2026,"Sun, Han",Mark Ratain,"Tennant, Thelma",613077,1/15/2009,582230,Yes
1039,04-T-014,Methods and Compositions Relating to the Pharmacogenetics of Different Gene Variants in the Context of Irinotecan-based Therapies,"60/680,839", ,*United States,US,5/13/2005,, ,5/13/2005,1192-003,Small,5/13/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Soma Das, Anna Di Rienzo, Federico Innocenti, Carrie Jones, Deanna Kroetz, Jacqueline Ramirez, Mark Ratain, Samir Undevia",Provisional,4/12/2018,1192-003,5/13/2006,"Sun, Han",Mark Ratain,"Tennant, Thelma",613078,,582230,Yes
1040,04-T-014,Methods and Compositions Relating to the Pharmacogenetics of Different Gene Variants in the Context of Irinotecan-Based Therapies,PCT/US06/18509, ,*United States,US,5/12/2006,, ,5/12/2006,1192-004,Small,5/13/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Deanna Kroetz, Wanqing Liu, Tan Nguyen, Mark Ratain, Samir Undevia",PCT,4/12/2018,1192-004,11/13/2007,"Sun, Han",Mark Ratain,"Tennant, Thelma",613079,,582230,Yes
1041,04-T-014,Methods and Compositions Relating to the Pharmacogenetics of Different Gene Variants in the Context of Irinotecan-Based Therapies,"11/913,150", ,*United States,US,5/12/2006,,US-2009-0247475-A1,10/9/2008,1192-006,Small,5/13/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Federico Innocenti, Deanna Kroetz, Wanqing Liu, Tan Nguyen, Mark Ratain, Samir Undevia",Nationalized PCT,4/12/2018,1192-006,5/12/2026,"Sun, Han",Mark Ratain,"Tennant, Thelma",613080,10/1/2009,582230,Yes
1042,04-T-019,Combination Therapy of Hedgehog Inhibitors and Radiation,"60/614,617", ,*United States,US,9/30/2004,, ,9/30/2004,1197-001,Small,9/30/2004,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Wei Du, Ralph Weichselbaum",Provisional,4/12/2018,1197-001,9/30/2005,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610944,,582235,Yes
1043,04-T-019,"Combination Therapy of Hedgehog Inhibitors, Radiation and Chemotherapeutic Agents",PCT/US05/35331, ,*United States,US,9/30/2005,,WO 2006/039569,9/30/2005,1197-002,Small,9/30/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Wei Du, Zahra Shafaee, Ralph Weichselbaum",PCT,4/12/2018,1197-002,3/30/2007,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610945,4/3/2006,582235,Yes
1044,04-T-019,"Combination Therapy of Hedgehog Inhibitors, Radiation and Chemotherapeutic Agents","11/576,310", ,*United States,US,9/30/2005,,US-2007-0281040-A1,3/29/2007,1197-003,Small,9/30/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Wei Du, Zahra Shafaee, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1197-003,9/30/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610946,12/6/2007,582235,Yes
1045,04-T-019,"Combination Therapy of Hedgehog Inhibitors, Radiation and Chemotherapeutic Agents",2007-534826, ,Japan,JP,9/30/2005,,2008-514726,3/30/2007,1197-004,Small,9/30/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Wei Du, Zahra Shafaee, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1197-004,9/30/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610947,5/8/2008,582235,Yes
1046,04-T-019,"Combination Therapy of Hedgehog Inhibitors, Radiation and Chemotherapeutic Agents","12/913,459", ,*United States,US,9/30/2005,,US-2011-0046211-A1,10/27/2010,1197-005,Small,9/30/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Wei Du, Zahra Shafaee, Ralph Weichselbaum",Continuation,4/12/2018,1197-005,9/30/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610948,2/24/2011,582235,Yes
1047,04-T-021,Compositions and Methods for Refolding of Denatured Proteins,"11/483,898","8,815,557",*United States,US,7/10/2006,8/26/2014,US-2007-0031955-A1,7/10/2006,1199-002,Small,7/8/2005,8/26/2014,No,5/23/2022,Issued,Brinks Gilson & Lione,,07814.00167,"Florin Despa, Hanne Gissel, Annie Kuo, Raphael Lee, Devkumar Mustafi",US Utility,4/12/2018,1199-002,11/2/2031,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611004,2/8/2007,582237,Yes
1048,04-T-021,COMPOSITIONS AND METHODS FOR REFOLDING OF DENATURED PROTEINS,PCT/US06/26576, ,*United States,US,7/10/2006,, ,7/10/2006,1199-003,None,7/8/2005,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Stankovic, Bratislav",00168,"Florin Despa, Hanne Gissel, Annie Kuo, Raphael Lee, Devkumar Mustafi",PCT,4/12/2018,1199-003,1/8/2008,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611005,,582237,Yes
1049,04-T-021,Compositions and Methods for Refolding of Denatured Proteins,"14/450,760","9,572,340",*United States,US,7/10/2006,2/21/2017,2014-0342345,8/4/2014,1199-004,Small,7/8/2005,2/21/2017,No,4/28/2022,Issued,Brinks Gilson & Lione,,00376,"Florin Despa, Hanne Gissel, Annie Kuo, Raphael Lee, Devkumar Mustafi",Divisional,4/12/2018,1199-004,7/10/2026,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611006,11/20/2014,582237,Yes
1050,04-T-021,Multiblock amphipolar surfactants for assisted refolding of denatured proteins,"60/697,665", ,*United States,US,7/8/2005,, ,7/8/2005,1199-001,Small,7/8/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00113,"Florin Despa, Hanne Gissel, Annie Kuo, Raphael Lee",Provisional,4/12/2018,1199-001,7/8/2006,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",613550,,582237,Yes
1051,04-T-023,HLA-G Effects on Conditions Associated with TH2-Skewed Immune Response,"60/568,597", ,*United States,US,5/6/2004,, ,5/6/2004,1201-001,Small,5/6/2004,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Dan Nicolae, Carole Ober",Provisional,4/12/2018,1201-001,5/6/2005,"Sun, Han",Carole Ober,"Tennant, Thelma",611838,,582239,Yes
1052,04-T-023,Use of HLA-G Genotyping in Immune-Mediated Conditions,"60/669,773", ,*United States,US,4/7/2005,, ,4/7/2005,1201-002,Small,4/7/2005,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Eugene Bleecker, Joan Hunt, Dan Nicolae, Carole Ober, Dirkje Postma, Julian Solway",Provisional,4/12/2018,1201-002,4/7/2006,"Sun, Han",Carole Ober,"Tennant, Thelma",615199,,582239,Yes
1053,04-T-023,Use of HLA-G Genotyping in Immune-Mediated Conditions,PCT/US05/16097, ,*United States,US,5/6/2005,,WO 05/108264 A2,5/6/2005,1201-003,Small,5/6/2004,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Dan Nicolae, Carole Ober",PCT,4/12/2018,1201-003,11/6/2006,"Sun, Han",Carole Ober,"Tennant, Thelma",615200,11/17/2005,582239,Yes
1054,04-T-023,Use of HLA-G Genotyping in Immune-Mediated Conditions,"11/123,788", ,*United States,US,5/6/2005,,US 2005-0287556 A1,5/6/2005,1201-004,Small,5/6/2004,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Dan Nicolae, Carole Ober",US Utility,4/12/2018,1201-004,5/6/2025,"Sun, Han",Carole Ober,"Tennant, Thelma",615201,12/29/2005,582239,Yes
1055,04-T-024,STEP Assessment.  Classroom-based Assessment to Follow Students' Development in Early Reading.,TXu001245542,TXu001245542,*United States,US,6/13/2005,6/13/2005,,,1202-002,Small,6/13/2005,,Yes,4/7/2020,Issued,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9073C,Anthony Bryk,Copyright Application,4/12/2018,1202-002,,"Sun, Han",Anthony Bryk,"Tennant, Thelma",614631,,582240,No
1056,04-T-024,STEP LITERARY ASSESSMENT,75538407,2553040,*United States,US,8/18/1998,3/26/2002,,,1202-001,None,8/18/1998,,Yes,3/30/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9073,"Anthony Bryk, Ann Grussing, David Kerbow, Ben Loh, Nichole Pinkard, Delia Rico, Karen Skalitzky, Virginia Watson",Trademark,4/12/2018,1202-001,8/18/2018,"Sun, Han",Anthony Bryk,"Tennant, Thelma",614632,11/9/1999,582240,Yes
1057,04-T-026,Oleic Acid as a Therapeutic for Treating Neurological Diseases,"60/603,743", ,*United States,US,8/23/2004,, ,8/23/2004,1204-001,Small,8/23/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Martin Gross, Alfred Heller, Lisa Won",Provisional,4/12/2018,1204-001,8/23/2005,"Sun, Han",Alfred Heller,"Tennant, Thelma",613769,,582242,Yes
1058,04-T-029,Mutated Class II Major Histocompatibility Protein and Complexes,PCT/US01/47830, ,*United States,US,12/10/2001,,WO 02/046400 A3,12/10/2001,1220-002,Small,12/8/2000,,No,4/28/2022,Expired - Inactive,,, ,"Jeffrey Bluestone, David Kranz, Scott Starwalt",PCT,4/12/2018,1220-002,6/8/2003,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613574,6/13/2002,582245,Yes
1059,04-T-029,Mutated Class II Major Histocompatibility Proteins and Complexes,"60/254,248", ,*United States,US,12/8/2000,, ,12/8/2000,1220-001,Small,12/8/2000,,Yes,4/28/2022,Expired - Inactive,,, ,"Jeffrey Bluestone, David Kranz, Scott Starwalt",Provisional,4/12/2018,1220-001,12/8/2001,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613575,,582245,Yes
1060,04-T-029,Mutated Class II Major Histocompatibility Proteins and Complexes,"10/015,536", ,*United States,US,12/10/2001,,US-2002-165149-A1,12/10/2001,1220-003,Small,12/8/2000,,No,4/28/2022,Abandoned,,, ,"Jeffrey Bluestone, David Kranz, Scott Starwalt",Continuation in Part,4/12/2018,1220-003,12/8/2020,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613576,11/7/2002,582245,Yes
1061,04-T-030,Microfluidic System with a Plurality of Sequential T-Junctions for Performing Reactions in Microdroplets,"11/174,298","9,477,233",*United States,US,7/1/2005,10/25/2016,,7/1/2005,1207-002,Small,7/2/2004,,No,6/1/2022,Issued,Brown Rudnick,,UCH-800/US16 31097/14,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",US Utility,4/12/2018,1207-002,12/15/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610559,,582246,Yes
1062,04-T-030,Applications of a Microfluidic System,"60/585,801", ,*United States,US,7/2/2004,, ,7/2/2004,1207-001,Small,7/2/2004,,Yes,4/28/2022,Expired Prov - Filed in US,Brinks Gilson & Lione,,00104,"Cory Gerdts, Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice, Bo Zheng",Provisional,4/12/2018,1207-001,7/2/2005,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610560,,582246,Yes
1063,04-T-030,Microfluidic System,PCT/US06/09175, ,*United States,US,3/15/2006,,WO 2006/101851 A2,3/15/2006,1207-003,None,3/16/2005,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00160,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",PCT,4/12/2018,1207-003,9/15/2007,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613404,9/28/2006,582246,Yes
1064,04-T-030,Microfluidic System,06748381.8,1866092,European Patent Office (EPO),EP,3/15/2006,4/29/2020,1866092,8/21/2007,1207-004,Large,3/16/2005,,No,5/31/2022,Granted,Brown Rudnick,,UCH-800/EP07,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Nationalized PCT,4/12/2018,1207-004,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613405,12/19/2007,582246,Yes
1065,04-T-030,Microfluidic System,2008-501972, ,Japan,JP,3/15/2006,,2008-538077,9/14/2007,1207-005,None,3/16/2005,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00195,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Nationalized PCT,4/12/2018,1207-005,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613406,10/9/2008,582246,Yes
1066,04-T-030,Microfluidic System,2011-231160,5671434,Japan,JP,3/15/2006,12/26/2014,2012-71303,10/25/2011,1207-006,Small,3/16/2005,,No,4/28/2022,Issued,Brown Rudnick,,31097.0009,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Divisional,4/12/2018,1207-006,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613407,4/12/2012,582246,Yes
1067,04-T-030,Microfluidic System,2013-203694, ,Japan,JP,3/15/2006,, ,1/23/2014,1207-007,Small,3/16/2005,,No,4/28/2022,Pending,Brown Rudnick,,31097.0033,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Divisional,4/12/2018,1207-007,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613408,,582246,Yes
1068,04-T-030,Methods for Manipulating Spacing between Microdroplets Flowing in a Microfluidic System,"14/184,312","10,054,961",*United States,US,3/16/2005,8/21/2018,,2/19/2014,1207-008,Large,7/2/2004,,No,6/1/2022,Issued,Brown Rudnick,,UCH-800/US17 31097/34,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Continuation,4/12/2018,1207-008,4/5/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613409,,582246,Yes
1069,04-T-030,MICROFLUIDIC SYSTEM,"15/639,151","10,732,649",*United States,US,7/1/2005,8/4/2020,,6/30/2017,1207-010,Small,7/2/2004,2/18/2021,No,6/1/2022,Issued,Brown Rudnick,,UCH-800/US23 31097/43,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Continuation,4/12/2018,1207-010,2/7/2025,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613410,,582246,No
1070,04-T-030,Microfluidic System,"14/978,341","9,696,729",*United States,US,3/16/2005,7/4/2017,,12/22/2015,1207-009,Small,7/2/2004,,No,6/1/2022,Issued,Brown Rudnick,,UCH-800/US20 31097/38,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Continuation,4/12/2018,1207-009,3/16/2025,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",615333,,582246,No
1071,04-T-030,Microfluidic System,20171949.9, ,European Patent Office (EPO),EP,3/15/2006,, ,4/28/2020,1207-011,Small,3/16/2005,7/22/2020,No,4/28/2022,Pending,Brown Rudnick,"Schoen, Adam",031097.0065,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Divisional,7/22/2020, ,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4743359,,582246,Yes
1072,04-T-030,MICROFLUIDIC SYSTEM,"16/983,270",,*United States,US,7/1/2005,,,8/3/2020,1207-012,Large,7/2/2004,9/25/2020,No,6/1/2022,Pending,Brown Rudnick,"Schoen, Adam",UCH-800/U35 31097/70,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Continuation,9/25/2020,,7/1/2025,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4916267,,582246,No
1073,04-T-030,Microfluidic System,06748381.8,1866092,France,FR,3/15/2006,4/29/2020, ,4/29/2020,1207-013,Large,3/16/2005,10/16/2020,No,4/28/2022,Issued,Brown Rudnick,, ,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Validated EPO,10/16/2020, ,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4986732,,582246,Yes
1074,04-T-030,Microfluidic System,06748381.8,602006059365.1,Germany,DE,3/15/2006,4/29/2020,1866092,4/29/2020,1207-014,Large,3/16/2005,10/16/2020,No,4/28/2022,Issued,Brown Rudnick,, ,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Validated EPO,10/16/2020, ,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4986758,12/19/2007,582246,Yes
1075,04-T-030,Microfluidic System,06748381.8,1866092,United Kingdom,GB,3/15/2006,4/29/2020, ,4/29/2020,1207-015,Large,3/16/2005,10/16/2020,No,4/28/2022,Issued,Brown Rudnick,, ,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",Validated EPO,10/16/2020, ,3/15/2026,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",4986784,,582246,Yes
1076,04-T-031,Microfluidic Devices,"60/623,261", ,*United States,US,10/29/2004,, ,10/29/2004,1208-001,Small,10/29/2004,,Yes,4/28/2022,Expired Prov - Filed in US,Brinks Gilson & Lione,"Mrksich, Shannon",00109,"Cory Gerdts, Rustem Ismagilov, Lewis Roach Jr, Helen Song Baca, Joshua Tice, Bo Zheng",Provisional,4/12/2018,1208-001,10/29/2005,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613401,,582247,Yes
1077,04-T-034,Bacterial Detection System,"60/962,426", ,*United States,US,7/26/2007,, ,7/26/2007,1211-001,Small,7/26/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00179,"David Adamson, James Boedicker, Rustem Ismagilov, Christian Kastrup, Hyun Kim, Debarshi Mustafi, Matthew Runyon, Bo Zheng",Provisional,4/12/2018,1211-001,7/26/2008,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610674,,582250,Yes
1078,04-T-034,Co-Incubating Confined Microbial Communities,PCT/US08/71370, ,*United States,US,7/28/2008,,WO 2009/015390,7/28/2008,1211-002,Small,7/26/2007,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00227,"James Boedicker, Rustem Ismagilov, Hyun Kim",PCT,4/12/2018,1211-002,1/26/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610914,1/29/2009,582250,Yes
1079,04-T-034,Co-Incubating Confined Microbial Communities,"12/670,725","9,090,885",*United States,US,7/28/2008,7/28/2015, ,1/26/2010,1211-004,Small,7/26/2007,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00272,"James Boedicker, Rustem Ismagilov, Hyun Kim",Nationalized PCT,4/12/2018,1211-004,7/26/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610915,,582250,Yes
1080,04-T-034,Co-Incubating Confined Microbial Communities,"14/746,494", ,*United States,US,7/28/2008,, ,6/22/2015,1211-006,Small,7/26/2007,,No,4/28/2022,Pending,Brinks Gilson & Lione,,00395,"James Boedicker, Rustem Ismagilov, Hyun Kim",Divisional,4/12/2018,1211-006,7/26/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610916,,582250,No
1081,04-T-034,"Stochastic Confinement to Detect, Manipulate, and Utilize Molecules and Organisms",PCT/US08/71374, ,*United States,US,7/28/2008,,WO 2009/048673,7/28/2008,1211-003,Small,7/26/2007,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00228,"James Boedicker, Cory Gerdts, Toan Huynh, Rustem Ismagilov, Christian Kastrup, Hyun Kim, Matthew Runyon, Feng Shen",PCT,4/12/2018,1211-003,1/26/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614664,4/16/2009,582250,Yes
1082,04-T-034,"Stochastic Confinement to Detect, Manipulate, and Utilize Molecules and Organisms","12/670,739", ,*United States,US,7/28/2008,,US-2010-0227767-A1,1/26/2010,1211-005,Small,7/26/2007,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00273,"James Boedicker, Cory Gerdts, Toan Huynh, Rustem Ismagilov, Christian Kastrup, Hyun Kim, Matthew Runyon, Feng Shen",Nationalized PCT,4/12/2018,1211-005,7/26/2028,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614665,9/9/2010,582250,Yes
1083,04-T-036,Device and Method for Crystallization,"60/881,012", ,*United States,US,1/17/2007,, ,1/17/2007,1213-001,Small,1/17/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00185,Rustem Ismagilov,Provisional,4/12/2018,1213-001,1/17/2008,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611398,,582252,Yes
1084,04-T-036,Device and Method for Crystallization,"61/011,020", ,*United States,US,1/14/2008,, ,1/14/2008,1213-002,Small,1/14/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00202,Rustem Ismagilov,Provisional,4/12/2018,1213-002,1/14/2009,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611399,,582252,Yes
1085,04-T-039,Method for Manipulating a Plurality of Plugs and Performing Reactions Therein in Microfluidic Systems,"11/082,187","7,655,470",*United States,US,3/16/2005,2/2/2010,US-2006-0094117-A1,3/16/2005,1216-001,Small,10/29/2004,,Yes,6/1/2022,Issued,Brown Rudnick,,UCH-800/US15 31097/13,"Cory Gerdts, Rustem Ismagilov, Bo Zheng",US Utility,4/12/2018,1216-001,11/28/2028,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613411,5/4/2006,582255,Yes
1086,04-T-041,Interfaces that Eliminate Non-specific Adsorption and Introduce Specific Interactions,"61/142,304", ,*United States,US,1/2/2009,, ,1/2/2009,1218-001,Small,1/2/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00220,Rustem Ismagilov,Provisional,4/12/2018,1218-001,1/2/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612044,,582257,Yes
1087,04-T-041,Interfaces that Eliminate Non-specific Adsorption and Introduce Specific Interactions,"61/335,570", ,*United States,US,1/7/2010,, ,1/7/2010,1218-002,Small,1/7/2010,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00271,Rustem Ismagilov,Provisional,4/12/2018,1218-002,1/7/2011,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612045,,582257,Yes
1088,04-T-041,Interfaces that Eliminate Non-specific Adsorption and Introduce Specific Interactions,"12/986,777", ,*United States,US,1/7/2011,,US-2011-0165037-A1,1/7/2011,1218-003,Small,1/7/2010,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00300,"Rustem Ismagilov, Jason Kreutz",US Utility,4/12/2018,1218-003,1/7/2031,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",612046,7/7/2011,582257,Yes
1089,04-T-043,Catalyst for Olefin Polymerization and Method for Polymerizing Olefin,2008-057732, ,Japan,JP,2/27/2004,,JP2008-248243A,7/3/2008,1221-002,Small,2/27/2004,,No,4/28/2022,Pending,Brinks Gilson & Lione,, ,"Richard Jordan, K. Michiue",Divisional,4/12/2018,1221-002,2/27/2024,"Ginsburg, Eric",Richard Jordan,"Juggernauth, Anne",610795,6/10/2008,582259,Yes
1090,04-T-043,Olefin Polymerization Catalyst and Method of Polymerizing Olefins,2004-052712, ,Japan,JP,2/27/2004,, ,2/27/2004,1221-001,Small,2/27/2004,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00102,"Richard Jordan, K. Michiue","Foreign, Non-PCT",4/12/2018,1221-001,2/27/2024,"Ginsburg, Eric",Richard Jordan,"Juggernauth, Anne",613768,,582259,Yes
1091,04-T-044,Internal Barium Shielding to Minimize Fetal Radiation,"60/572,581", ,*United States,US,5/17/2004,, ,5/17/2004,1222-001,None,5/17/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00101,David Yousefzadeh,Provisional,4/12/2018,1222-001,5/17/2005,"Ginsburg, Eric",David Yousefzadeh,"Muite, Kevin",612047,,582260,Yes
1092,04-T-044,Methods of Attenuating Internal Radiation Exposure,"11/131,433", ,*United States,US,5/17/2005,,US-2006-0009694-A1,5/17/2005,1222-002,None,5/17/2004,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00132,"Charles Pelizzari, Chester Reft, Matthew Ward, David Yousefzadeh",US Utility,4/12/2018,1222-002,5/17/2025,"Ginsburg, Eric",David Yousefzadeh,"Muite, Kevin",613309,1/12/2006,582260,Yes
1093,04-T-046,Computerized Method for DNA Cloning,"60/592,685", ,*United States,US,7/30/2004,, ,7/30/2004,1223-001,Small,7/30/2004,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Peterson, Jeffrey",092234-9008-001,"Benjamin Glick, Eugene Losev, Michael Scott",Provisional,4/12/2018,1223-001,7/30/2005,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",611264,,582262,Yes
1094,04-T-046,Method and Organization System for Recording Information Regarding Nucleic Acid Constructs,"11/195,318", ,*United States,US,8/1/2005,, ,8/1/2005,1223-002,Small,7/30/2004,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9008-002,"Benjamin Glick, Eugene Losev, Michael Scott, William Stokes",US Utility,4/12/2018,1223-002,7/30/2024,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",612318,,582262,Yes
1095,04-T-047,Compositions and Methods Related to Serpins,"60/656,492", ,*United States,US,2/25/2005,, ,2/25/2005,1225-001,Small,2/25/2005,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Philip Ashton-Rickardt,Provisional,4/12/2018,1225-001,2/25/2006,"Sun, Han",Philip Ashton-Rickardt,"Tennant, Thelma",611209,,582263,Yes
1096,04-T-047,Compositions and Methods Related to Serpins,PCT/US06/06524, ,*United States,US,2/24/2006,, ,2/24/2006,1225-002,Small,2/25/2005,,No,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Philip Ashton-Rickardt, Susan Byrne, Manling Zhang",PCT,4/12/2018,1225-002,8/25/2007,"Sun, Han",Philip Ashton-Rickardt,"Tennant, Thelma",611210,,582263,Yes
1097,04-T-047,Compositions and Methods Related to Serpins,06748251.3EPO, ,European Patent Office (EPO),EP,2/24/2006,,1879448,7/4/2007,1225-003,Small,2/25/2005,,No,4/28/2022,Abandoned,Ballard Spahr LLP,, ,Philip Ashton-Rickardt,Nationalized PCT,4/12/2018,1225-003,2/25/2025,"Sun, Han",Philip Ashton-Rickardt,"Tennant, Thelma",611211,1/23/2008,582263,Yes
1098,04-T-047,Compositions and Methods Related to Serpins,"11/885,002", ,*United States,US,2/24/2006,, ,8/23/2007,1225-005,Small,2/25/2005,,No,4/28/2022,Abandoned,Ballard Spahr LLP,, ,Philip Ashton-Rickardt,Nationalized PCT,4/12/2018,1225-005,2/25/2025,"Sun, Han",Philip Ashton-Rickardt,"Tennant, Thelma",611212,,582263,Yes
1099,04-T-057,Tissue Targeted Complement Modulators,"60/565,907", ,*United States,US,4/28/2004,, ,4/28/2004,1235-001,Small,4/28/2004,,Yes,4/28/2022,Expired - Inactive,Needle & Rosenberg,, ,"Richard Quigg, Stephen Tomlinson",Provisional,4/12/2018,1235-001,4/28/2005,"Unassigned, Unassigned",Richard Quigg,"Unassigned, Unassigned",614920,,582273,Yes
1100,04-T-057,Tissue Targeted Complement Modulators,"11/116,939","8,454,963",*United States,US,4/28/2005,6/4/2013, ,4/28/2005,1235-002,Small,4/28/2004,,No,4/28/2022,Expired - Inactive,Needle & Rosenberg,, ,"Richard Quigg, Stephen Tomlinson",Continuation in Part,4/12/2018,1235-002,7/4/2017,"Unassigned, Unassigned",Richard Quigg,"Unassigned, Unassigned",614921,,582273,Yes
1101,04-T-058,Human Stem Cell Materials and Methods,"10/968,385", ,*United States,US,10/18/2004,,US-2005-0260158-A1,10/18/2004,04-010-001,Small,5/26/2004,,Yes,4/28/2022,Released to Government,"Marshall, Gerstein & Borun","Merkel, William",40358,"Eliezer Huberman, Yong Zhao",Continuation in Part,4/12/2018,04-010-001,11/7/2022,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",611861,11/24/2005,582274,Yes
1102,04-T-058,Pancreatic Islet Beta-Cell-Like Macrophages and Methods to Produce Them,PCT/US05/37341, ,*United States,US,10/13/2005,,WO 2006/04-4842,10/13/2005,04-010-002,None,10/18/2004,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Brusca, Eric",40358-PC,"Eliezer Huberman, Yong Zhao",PCT,4/12/2018,04-010-002,4/18/2007,"Sun, Han",Eliezer Huberman,"Tennant, Thelma",613876,6/8/2006,582274,Yes
1103,04-T-059,Image System for Computed Tomography,"60/630,624", ,*United States,US,11/24/2004,, ,11/24/2004,1236-001,Small,11/24/2004,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00106,"Xiaochuan Pan, Yu Zou",Provisional,4/12/2018,1236-001,11/24/2005,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",611914,,582275,Yes
1104,04-T-060,6 Amino-6 Deoxygalactosylceramides,"2,519,568","2,519,568",Canada,CA,3/20/2003,1/3/2012, ,3/20/2003,1237-003,Small,3/20/2003,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-003,3/20/2023,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610192,11/4/2004,582276,Yes
1105,04-T-060,"6""-Amino-6"" - Deoxygalactosylceramides",03816701.1EPO, ,European Patent Office (EPO),EP,3/20/2003,, ,12/19/2005,1237-002,Small,3/20/2003,10/22/2008,No,6/8/2022,Abandoned,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-002,,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610193,,582276,Yes
1106,04-T-060,"6""-Amino-6""-Deoxyactosylceramides","10/550,165","7,645,873",*United States,US,3/20/2003,1/12/2010,US 2006-0264382 A1,9/20/2005,1237-009,Small,3/20/2003,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-009,3/20/2023,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610194,11/23/2006,582276,Yes
1107,04-T-060,"6""-Amino-6""-Deoxyactosylceramides","12/625,048","7,989,423",*United States,US,3/20/2003,8/2/2011, ,11/24/2009,1237-023,Small,3/20/2003,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Divisional,4/12/2018,1237-023,3/20/2023,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610195,11/23/2006,582276,Yes
1108,04-T-060,"6""-Amino-6""-Deoxyactosylceramides","13/196,631","8,445,272",*United States,US,3/20/2003,5/21/2013,US-2012-0028915-A1,8/2/2011,1237-024,Small,3/20/2003,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Continuation,4/12/2018,1237-024,3/20/2023,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610196,2/2/2012,582276,Yes
1109,04-T-060,"6""-Amino-6""-Deoxyactosylceramides","13/898,070","9,045,512",*United States,US,3/20/2003,6/2/2015,US-2014-00337693-A1,5/20/2013,1237-025,Small,3/20/2003,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Continuation,4/12/2018,1237-025,3/20/2023,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610197,2/6/2014,582276,Yes
1110,04-T-060,"6""-Amino-6""-Deoxygalactosylceramides",PCT/US03/08530, ,*United States,US,3/20/2003,, ,3/20/2003,1237-001,Small,3/20/2003,,Yes,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",PCT,4/12/2018,1237-001,9/20/2005,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610198,,582276,Yes
1111,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,PCT/US06/02781, ,*United States,US,1/26/2006,, ,1/26/2006,1237-010,Small,1/28/2005,,No,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",PCT,4/12/2018,1237-010,7/28/2007,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610675,,582276,Yes
1112,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,"11/814,103","9,295,722",*United States,US,1/26/2006,3/29/2016, ,4/11/2008,1237-028,Small,1/28/2005,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-028,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610676,,582276,Yes
1113,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,2007/06208, ,South Africa,ZA,1/26/2006,, ,10/29/2008,1237-029,Small,1/28/2005,,No,6/8/2022,Allowed,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-029,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610677,,582276,Yes
1114,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,2007-553225, ,Japan,JP,1/26/2006,,2008-528608,7/22/2008,1237-030,Small,1/28/2005,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-030,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610678,7/31/2008,582276,Yes
1115,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,2840/KOLNP/2007,259862,India,IN,1/26/2006,3/28/2014, ,1/28/2009,1237-031,Small,1/28/2005,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-031,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610679,,582276,Yes
1116,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,06733921.8EPO,1848813,European Patent Office (EPO),EP,1/26/2006,4/10/2013, ,10/29/2008,1237-032,Small,1/28/2005,,No,6/8/2022,Expired - Inactive,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-032,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610680,,582276,Yes
1117,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,"2,593,715", ,Canada,CA,1/26/2006,, ,9/18/2008,1237-033,Small,1/28/2005,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-033,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610681,,582276,Yes
1118,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,PI06072992, ,Brazil,BR,1/26/2006,, ,9/18/2008,1237-034,Small,1/28/2005,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-034,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610682,,582276,Yes
1119,04-T-060,Bacterial Glycolipid Activation of CD 1d-Restricted NKT Cells,2006211485,2006211485,Australia,AU,1/26/2006,7/28/2011, ,9/10/2008,1237-035,Small,1/28/2005,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1237-035,1/26/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610683,,582276,Yes
1120,04-T-060,Bacterial Glycolipid Activation of CD1d-Restricted NKT Cells,"60/648,153", ,*United States,US,1/28/2005,, ,1/28/2005,1237-005,Small,1/28/2005,,Yes,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Provisional,4/12/2018,1237-005,1/28/2006,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610684,,582276,Yes
1121,04-T-060,Compositions and Methods for Stimulation of CD1k-Restricted NKT,"60/699,980", ,*United States,US,7/15/2005,, ,7/15/2005,1237-006,Small,7/15/2005,,Yes,6/8/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9003-001,"Albert Bendelac, Paul Savage, Luc Teyton",Provisional,4/12/2018,1237-006,7/15/2006,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",611007,,582276,Yes
1122,04-T-060,Method of Activating NKT Cells,"60/606,941", ,*United States,US,9/3/2004,, ,9/3/2004,1237-004,Small,9/3/2004,,Yes,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Provisional,4/12/2018,1237-004,9/3/2005,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",612515,,582276,Yes
1123,04-T-060,Methods for Activating NKT Cells,"11/218,906","7,998,739",*United States,US,9/2/2005,8/16/2011,US-2006-0073118 A1,9/2/2005,1237-007,None,9/3/2004,8/16/2011,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",US Utility,4/12/2018,1237-007,11/12/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613156,4/6/2006,582276,Yes
1124,04-T-060,Methods of Activating NKT Cells,PCT/US05/31407, ,*United States,US,9/2/2005,,WO3006/029010,9/2/2005,1237-008,None,9/3/2004,,No,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",PCT,4/12/2018,1237-008,3/4/2007,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613291,3/16/2006,582276,Yes
1125,04-T-060,Methods of Activating NKT Cells,"12/901,971", ,*United States,US,9/2/2005,,US-2011-0082106-A1,10/11/2010,1237-027,None,9/3/2004,,No,6/8/2022,Abandoned,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Divisional,4/12/2018,1237-027,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613292,4/7/2011,582276,Yes
1126,04-T-060,Methods of Activating NKT Cells,05810863.0EPO,1786439,European Patent Office (EPO),EP,9/2/2005,4/14/2010,1786439,3/20/2007,1237-011,None,9/3/2004,,No,6/8/2022,Expired - Inactive,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-011,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613293,5/23/2007,582276,Yes
1127,04-T-060,Methods of Activating NKT Cells,"2,578,052", ,Canada,CA,9/2/2005,, ,5/3/2007,1237-012,None,9/3/2004,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-012,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613294,3/16/2006,582276,Yes
1128,04-T-060,Methods of Activating NKT Cells,2007-530414, ,Japan,JP,9/2/2005,, ,7/12/2007,1237-013,None,9/3/2004,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-013,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613295,,582276,Yes
1129,04-T-060,Methods of Activating NKT Cells,2005282684,2005282684,Australia,AU,9/2/2005,6/23/2011, ,7/12/2007,1237-014,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Nationalized PCT,4/12/2018,1237-014,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613296,,582276,Yes
1130,04-T-060,Methods of Activating NKT Cells,05810863.0BE,1786439,Belgium,BE,9/2/2005,4/14/2010, ,4/14/2010,1237-015,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-015,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613297,,582276,Yes
1131,04-T-060,Methods of Activating NKT Cells,05810863.0DK,1786439,Denmark,DK,9/2/2005,4/14/2010, ,4/14/2010,1237-016,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-016,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613298,,582276,Yes
1132,04-T-060,Methods of Activating NKT Cells,05810863.0FI,1786439,Finland,FI,9/2/2005,4/14/2010, ,4/14/2010,1237-017,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-017,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613299,,582276,Yes
1133,04-T-060,Methods of Activating NKT Cells,05810863.0FR,1786439,France,FR,9/2/2005,4/14/2010, ,4/14/2010,1237-018,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-018,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613300,,582276,Yes
1134,04-T-060,Methods of Activating NKT Cells,05810863.0DE,1786439,Germany,DE,9/2/2005,4/14/2010, ,4/14/2010,1237-019,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-019,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613301,,582276,Yes
1135,04-T-060,Methods of Activating NKT Cells,05810863.0IT,1786439,Italy,IT,9/2/2005,4/14/2010, ,4/14/2010,1237-020,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-020,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613302,,582276,Yes
1136,04-T-060,Methods of Activating NKT Cells,05810863.0LU,1786439,Luxembourg,LU,9/2/2005,4/14/2010, ,4/14/2010,1237-021,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-021,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613303,,582276,Yes
1137,04-T-060,Methods of Activating NKT Cells,05810863.0NL,1786439,Netherlands,NL,9/2/2005,4/14/2010, ,4/14/2010,1237-022,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-022,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613304,,582276,Yes
1138,04-T-060,Methods of Activating NKT Cells,05810863.0ES,1786439,Spain,ES,9/2/2005,4/14/2010, ,4/14/2010,1237-036,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-036,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613305,,582276,Yes
1139,04-T-060,Methods of Activating NKT Cells,05810863.0SE,1786439,Sweden,SE,9/2/2005,4/14/2010, ,4/14/2010,1237-037,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-037,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613306,,582276,Yes
1140,04-T-060,Methods of Activating NKT Cells,05810863.0CH,1786439,Switzerland,CH,9/2/2005,4/14/2010, ,4/14/2010,1237-038,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-038,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613307,,582276,Yes
1141,04-T-060,Methods of Activating NKT Cells,05810863.0GB,1786439,United Kingdom,GB,9/2/2005,4/14/2010, ,4/14/2010,1237-026,None,9/3/2004,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton, Dapeng Zhou",Validated EPO,4/12/2018,1237-026,9/2/2025,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613308,,582276,Yes
1142,04-T-061,Methods and Compositions for Modulating Medial Lateral Neuronal Topographic Maps,PCT/US06/11711, ,*United States,US,3/31/2006,,WO 2006/105325,3/31/2006,1238-002,Small,3/31/2005,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9032-004,Yimin Zou,PCT,4/12/2018,1238-002,9/30/2007,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612802,10/5/2006,582277,Yes
1143,04-T-061,Methods and Compositions for Modulating medial-Lateral Neuronal Topographic Maps,"11/904,594", ,*United States,US,3/31/2006,,US-2008-0132441-A1,7/27/2007,1238-003,Small,3/31/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9032-003,Yimin Zou,Nationalized PCT,4/12/2018,1238-003,3/31/2026,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612803,6/5/2008,582277,Yes
1144,04-T-061,Methods and Compositions for Modulating Medial-Lateral Neuronal topographic Maps,06758229.6EPO, ,European Patent Office (EPO),EP,3/31/2006,,1871407,10/31/2007,1238-004,Small,3/31/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9032-001,Yimin Zou,Nationalized PCT,4/12/2018,1238-004,10/31/2027,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612804,1/2/2008,582277,Yes
1145,04-T-061,WNT-RYK Signaling Mediates Medial-Lateral Retinotectal Topographic Mapping,"60/666,989", ,*United States,US,3/31/2005,, ,3/31/2005,1238-001,Small,3/31/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9032-002,Yimin Zou,Provisional,4/12/2018,1238-001,3/31/2006,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",615395,,582277,Yes
1146,04-T-062,Methods and Compositions Involving LCRV Proteins,"60/632,590", ,*United States,US,12/2/2004,, ,12/2/2004,1239-001,Small,12/2/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Krisitin DeBord, R. William DePaolo, Bana Jabri, Elizabeth Morrin, Katie Overheim, Olaf Schneewind",Provisional,4/12/2018,1239-001,12/2/2005,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612960,,582278,Yes
1147,04-T-062,Methods and Compositions Involving LcrV Proteins,PCT/US05/43779, ,*United States,US,12/2/2005,,WO 2006/060728 A2,12/2/2005,1239-002,Small,12/2/2004,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Deborah Anderson, Robert Brubaker, Krisitin DeBord, R. William DePaolo, Bana Jabri, Elizabeth Morrin, Katie Overheim, Olaf Schneewind",PCT,4/12/2018,1239-002,6/2/2007,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612961,6/8/2006,582278,Yes
1148,04-T-062,Methods and Compositions Involving LcrV Proteins,"11/293,024","7,875,280",*United States,US,12/2/2005,1/25/2011,US2006-0177464-A1,12/2/2005,1239-003,Small,12/2/2004,1/25/2011,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Deborah Anderson, Robert Brubaker, Krisitin DeBord, R. William DePaolo, Bana Jabri, Elizabeth Morrin, Katie Overheim, Olaf Schneewind",US Utility,4/12/2018,1239-003,7/23/2027,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612962,8/10/2006,582278,Yes
1149,04-T-063,Treatment of Lupus and Lupus Nephritis,"60/578,807", ,*United States,US,6/10/2004,, ,6/10/2004,1240-001,Small,6/10/2004,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9007-001,Richard Quigg,Provisional,4/12/2018,1240-001,6/10/2005,"Unassigned, Unassigned",Richard Quigg,"Unassigned, Unassigned",615045,,582279,Yes
1150,04-T-066,Methods and Compositions for the Depletion of CD4+ Cells and Treatment of Cancers,"60/625,281", ,*United States,US,11/5/2004,, ,11/5/2004,1243-001,Small,11/5/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Yang-Xin Fu,Provisional,4/12/2018,1243-001,11/5/2005,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612861,,582282,Yes
1151,04-T-067,System and Method of Obtaining Entrained Cylindrical Fluid Flow,"60/648,102", ,*United States,US,1/27/2005,, ,1/27/2005,1244-001,Small,1/27/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00108,"Alfonso Ganan-Calvo, Eric Ginsburg, Jose Lopez-Herrera, Wendy Zhang",Provisional,4/12/2018,1244-001,1/27/2006,"Unassigned, Unassigned",Wendy Zhang,"Unassigned, Unassigned",614793,,582283,Yes
1152,04-T-067,System and Method of Obtaining Entrained Cylindrical Fluid Flow,"11/341,096", ,*United States,US,1/27/2006,,US-2006-0234051-A1,1/27/2006,1244-002,Small,1/27/2005,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Penn, Amir",00156,"Alfonso Ganan-Calvo, Piotr Garstecki, Eric Ginsburg, Miguel-Angel Herrada-Gutierrez, Jose Lopez-Herrera, Pascual Riesco-Chueca, Wendy Zhang",US Utility,4/12/2018,1244-002,1/27/2026,"Unassigned, Unassigned",Wendy Zhang,"Unassigned, Unassigned",614794,10/19/2006,582283,Yes
1153,04-T-070,"An Anti-Inflammatory, Cytoprotective Factor Derivable From a Probiotic Organism","60/945,010", ,*United States,US,6/19/2007,, ,6/19/2007,1247-001,None,6/19/2007,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40367,"Eugene Chang, Elaine Petrof",Provisional,4/12/2018,1247-001,6/19/2008,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610316,,582286,Yes
1154,04-T-070,"An Anti-Inflammatory, Cytoprotective Factor Derivable From a Probiotic Organism",PCT/US08/67552, ,*United States,US,6/19/2008,, ,6/19/2008,1247-002,None,6/19/2007,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40637A-PC,"Eugene Chang, Elaine Petrof",PCT,4/12/2018,1247-002,12/19/2009,"Dembo, Anna",Eugene Chang,"Butler, Brittany",610317,,582286,Yes
1155,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,"60/687,537", ,*United States,US,6/3/2005,, ,6/3/2005,1249-001,Small,6/3/2005,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40357,"John Alverdy, Richard Wu",Provisional,4/12/2018,1249-001,6/3/2006,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613483,,582288,Yes
1156,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,PCT/US06/21442, ,*United States,US,6/2/2006,,WO 2006/132963,6/2/2006,1249-002,Small,6/3/2005,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",40357A-PC,John Alverdy,PCT,4/12/2018,1249-002,12/3/2007,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613484,12/14/2006,582288,Yes
1157,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,"11/445,743", ,*United States,US,6/2/2006,,US 2007-0059272 A1,6/2/2006,1249-003,Small,6/3/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40357A,John Alverdy,US Utility,4/12/2018,1249-003,6/3/2025,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613485,3/15/2007,582288,Yes
1158,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,"2,610,951", ,Canada,CA,6/2/2006,, ,12/5/2007,1249-004,Small,6/3/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40357A-CA,John Alverdy,Nationalized PCT,4/12/2018,1249-004,12/3/2026,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613486,,582288,Yes
1159,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,06771937.7EPO, ,European Patent Office (EPO),EP,6/2/2006,,1 906 838,2/19/2008,1249-005,Small,6/3/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40357A-EP,John Alverdy,Nationalized PCT,4/12/2018,1249-005,12/3/2026,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613487,4/9/2008,582288,Yes
1160,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,MX/a/2007/015262, ,Mexico,MX,6/2/2006,, ,1/29/2008,1249-006,Small,6/3/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40357A-MX,John Alverdy,Nationalized PCT,4/12/2018,1249-006,12/3/2026,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613488,,582288,Yes
1161,04-T-072,Modulation of Microbial Pathogen-Host Cell Interactions,2006255274, ,Australia,AU,6/2/2006,,AU6255274AA,5/9/2008,1249-007,Small,6/3/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",40357A-AU,John Alverdy,Nationalized PCT,4/12/2018,1249-007,12/3/2026,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613489,12/14/2006,582288,Yes
1162,04-T-073,Transcriptional Targeting of Adenoviral Delivered Tumor Necrosis Factor Alpha by Temozolomide in Experimental Glioblastoma,"60/604,251", ,*United States,US,8/25/2004,, ,8/25/2004,1250-001,None,8/25/2004,,Yes,4/28/2022,Expired Prov - Filed PCT,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum",Provisional,4/12/2018,1250-001,8/25/2005,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614930,,582289,Yes
1163,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,PCT/US05/30238, ,*United States,US,8/25/2005,,WO 2006/026348,8/25/2005,1250-002,Small,8/25/2004,,No,4/28/2022,Expired PCT - Nationalized,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum, Bakhtiar Yamini",PCT,4/12/2018,1250-002,2/25/2007,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615298,3/9/2006,582289,Yes
1164,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,"11/574,108", ,*United States,US,8/25/2005,,US-2007-0212298-A1,5/11/2007,1250-003,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum, Bakhtiar Yamini",Nationalized PCT,4/12/2018,1250-003,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615299,9/13/2007,582289,Yes
1165,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,"2,577,550","2,577,550",Canada,CA,8/25/2005,10/16/2012, ,4/19/2007,1250-004,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum, Bakhtiar Yamini",Nationalized PCT,4/12/2018,1250-004,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615300,,582289,Yes
1166,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,05804363.9EPO,1781284,European Patent Office (EPO),EP,8/25/2005,10/13/2010,1781284,4/20/2007,1250-005,Small,8/25/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1250-005,10/13/2010,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615301,5/9/2007,582289,Yes
1167,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,"12/971,953", ,*United States,US,8/25/2005,,US-2011-0091375-A1,12/17/2010,1250-006,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum, Bakhtiar Yamini",Continuation,4/12/2018,1250-006,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615302,4/21/2011,582289,Yes
1168,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,05804363.9DE,1781284,Germany,DE,8/25/2005,10/13/2010,1781284,10/13/2010,1250-007,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum",Validated EPO,4/12/2018,1250-007,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615303,5/9/2007,582289,Yes
1169,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,05804363.9ES,1781284,Spain,ES,8/25/2005,10/13/2010,1781284,10/13/2010,1250-008,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum",Validated EPO,4/12/2018,1250-008,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615304,5/9/2007,582289,Yes
1170,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,05804363.9FR,1781284,France,FR,8/25/2005,10/13/2010,1781284,10/13/2010,1250-009,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Donald Kufe, Ralph Weichselbaum",Validated EPO,4/12/2018,1250-009,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615305,5/9/2007,582289,Yes
1171,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,05804363.9GB,1781284,United Kingdom,GB,8/25/2005,10/13/2010,1781284,10/13/2010,1250-010,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Donald Kufe, Ralph Weichselbaum",Validated EPO,4/12/2018,1250-010,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615306,5/9/2007,582289,Yes
1172,04-T-073,Use of the Combination Comprising Temozolomide and TNF-Alpha for Treating Glioblastoma,05804363.9IT,1781284,Italy,IT,8/25/2005,10/13/2010,1781284,10/13/2010,1250-011,Small,8/25/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Donald Kufe, Ralph Weichselbaum",Validated EPO,4/12/2018,1250-011,8/25/2025,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615307,5/9/2007,582289,Yes
1173,04-T-078,CRP94-Based Methods and Compositions for Preventing and Treating Cancer,"60/566,363", ,*United States,US,4/28/2004,, ,4/28/2004,1255-004,None,4/28/2004,,Yes,4/28/2022,Expired - Inactive,"Caesar, Rivise, Bernstein, Cohen & Pokotilow, LTD.","Volin, Marina", ,Yair Argon,Provisional,4/12/2018,1255-004,4/28/2005,"Peace, Shane",Yair Argon,"Tennant, Thelma",611351,,582294,Yes
1174,04-T-078,GRP 94 Based Composition and Methods of Use Thereof,2004239338, ,Australia,AU,5/12/2004,, ,3/29/2006,1255-011,Small,4/28/2004,,No,4/28/2022,Abandoned,"Dann, Dorfman, Herrell & Skillman",, ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Brigitte Simen, Sherry Wanderling",Nationalized PCT,4/12/2018,1255-011,5/12/2024,"Peace, Shane",Yair Argon,"Tennant, Thelma",611724,,582294,Yes
1175,04-T-078,"GRP94 Knockout Mice, Derived Cell Lines and Methods of USe Thereof","60/477,990", ,*United States,US,6/12/2003,, ,6/12/2003,1255-003,None,6/12/2003,,Yes,4/28/2022,Expired - Inactive,"Dann, Dorfman, Herrell & Skillman","Rigaut, Kathleen", ,"Yair Argon, Brigitte Simen, Sherry Wanderling",Provisional,4/12/2018,1255-003,6/12/2004,"Peace, Shane",Yair Argon,"Tennant, Thelma",611725,,582294,Yes
1176,04-T-078,GRP94-based compositions and methods of use thereof,"10/844,711","7,589,174",*United States,US,5/12/2004,9/15/2009,US 2005-0063982,5/12/2004,1255-006,None,4/28/2004,9/15/2009,No,4/28/2022,Issued,"Dann, Dorfman, Herrell & Skillman",, ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Brigitte Simen, Sherry Wanderling",US Utility,4/12/2018,1255-006,2/11/2027,"Peace, Shane",Yair Argon,"Tennant, Thelma",611726,3/24/2005,582294,Yes
1177,04-T-078,GRP94-based compositions and methods of use thereof,PCT/US04/15120, ,*United States,US,5/12/2004,, ,5/12/2004,1255-007,None,4/28/2004,,No,4/28/2022,Expired - Inactive,"Dann, Dorfman, Herrell & Skillman","Rigaut, Kathleen", ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Brigitte Simen, Sherry Wanderling",PCT,4/12/2018,1255-007,10/28/2006,"Peace, Shane",Yair Argon,"Tennant, Thelma",611727,,582294,Yes
1178,04-T-078,GRP94-based compositions and methods of use thereof,"2,525,385", ,Canada,CA,5/12/2004,, ,5/12/2004,1255-008,None,4/28/2004,,No,4/28/2022,Abandoned,"Dann, Dorfman, Herrell & Skillman",, ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Brigitte Simen, Sherry Wanderling",Nationalized PCT,4/12/2018,1255-008,5/12/2024,"Peace, Shane",Yair Argon,"Tennant, Thelma",611728,,582294,Yes
1179,04-T-078,GRP94-based compositions and methods of use thereof,2006-533063, ,Japan,JP,5/12/2004,, ,11/11/2005,1255-009,None,4/28/2004,,No,4/28/2022,Abandoned,"Dann, Dorfman, Herrell & Skillman",, ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Brigitte Simen, Sherry Wanderling",Nationalized PCT,4/12/2018,1255-009,5/12/2024,"Peace, Shane",Yair Argon,"Tennant, Thelma",611729,,582294,Yes
1180,04-T-078,GRP94-based compositions and methods of use thereof,04752200.8EPO, ,European Patent Office (EPO),EP,5/12/2004,,EP1625141,2/12/2006,1255-010,None,4/28/2004,,No,4/28/2022,Abandoned,"Dann, Dorfman, Herrell & Skillman",, ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Brigitte Simen, Sherry Wanderling",Nationalized PCT,4/12/2018,1255-010,5/12/2024,"Peace, Shane",Yair Argon,"Tennant, Thelma",611730,2/12/2006,582294,Yes
1181,04-T-078,GRP94-based compositions and methods of use thereof,"10/962,951", ,*United States,US,5/12/2004,,US 2006-0029610,10/12/2004,1255-012,None,4/28/2004,10/14/2008,No,4/28/2022,Abandoned,"Dann, Dorfman, Herrell & Skillman","Rigaut, Kathleen", ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Olga Ostrovsky, Brigitte Simen, Sherry Wanderling",Continuation in Part,4/12/2018,1255-012,,"Peace, Shane",Yair Argon,"Tennant, Thelma",611731,2/9/2006,582294,Yes
1182,04-T-078,GRP94-based compositions and methods of use thereof,"11/615,669", ,*United States,US,5/12/2004,, ,12/22/2006,1255-013,None,4/28/2004,12/22/2009,No,4/28/2022,Abandoned,"Dann, Dorfman, Herrell & Skillman","Rigaut, Kathleen", ,"Yair Argon, Chanda Biswas, Tali Gidalevitz, Olga Ostrovsky, Brigitte Simen, Sherry Wanderling",Continuation in Part,4/12/2018,1255-013,,"Peace, Shane",Yair Argon,"Tennant, Thelma",611732,,582294,Yes
1183,04-T-078,GRP94-Based Methods and Compositions for Preventing and Treating Cancer,"60/469,723", ,*United States,US,5/12/2003,, ,5/12/2003,1255-001,None,5/12/2003,,Yes,4/28/2022,Expired - Inactive,"Caesar, Rivise, Bernstein, Cohen & Pokotilow, LTD.","Volin, Marina", ,Yair Argon,Provisional,4/12/2018,1255-001,5/12/2004,"Peace, Shane",Yair Argon,"Tennant, Thelma",611733,,582294,Yes
1184,04-T-078,N-Terminal Peptide Binding Site of GRP94 and Methods of Use Thereof,"60/478,149", ,*United States,US,6/12/2003,, ,6/12/2003,1255-002,None,6/12/2003,,Yes,4/28/2022,Expired - Inactive,"Dann, Dorfman, Herrell & Skillman","Rigaut, Kathleen", ,"Yair Argon, Chanda Biswas, Tali Gidalevitz",Provisional,4/12/2018,1255-002,6/12/2004,"Peace, Shane",Yair Argon,"Tennant, Thelma",613615,,582294,Yes
1185,04-T-078,Tje Endoplasmic Reticulum Chaperone GRP94 is Essential for Mouse Gastrulation and Mesoderm Induction,"60/566,362", ,*United States,US,4/28/2004,, ,4/28/2004,1255-005,None,4/28/2004,,Yes,4/28/2022,Expired - Inactive,"Caesar, Rivise, Bernstein, Cohen & Pokotilow, LTD.","Volin, Marina", ,Yair Argon,Provisional,4/12/2018,1255-005,4/28/2005,"Peace, Shane",Yair Argon,"Tennant, Thelma",614926,,582294,Yes
1186,04-T-084,Methods for Controlling Surface Chemistry and Interfacial Interactions,"60/936,606", ,*United States,US,6/21/2007,, ,6/21/2007,1261-001,Small,6/21/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00193,"Cory Gerdts, Rustem Ismagilov, Jason Kreutz, Liang Li, Lewis Roach Jr, Helen Song Baca, Bo Zheng",Provisional,4/12/2018,1261-001,6/21/2008,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613159,,582300,Yes
1187,04-T-085,Image-Guided Medical Intervention Apparatus and Method,"10/998,509","7,265,356",*United States,US,11/29/2004,9/4/2007,US 2006-0113482 A1,11/29/2004,1262-001,Small,11/29/2004,9/4/2007,Yes,4/28/2022,Issued,Michael Best & Friedrich LLP,,092234-9017-001,"Chin-Tu Chen, Samuel Hellman, Charles Pelizzari, Ralph Weichselbaum",US Utility,4/12/2018,1262-001,11/29/2024,"Ginsburg, Eric",Charles Pelizzari,"Juggernauth, Anne",611917,6/1/2006,582301,Yes
1188,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,"60/628,695", ,*United States,US,11/17/2004,, ,11/17/2004,1266-001,Small,11/17/2004,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,Olatoyosi Odenike,Provisional,4/12/2018,1266-001,11/17/2005,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611823,,582305,Yes
1189,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,"11/281,666", ,*United States,US,11/17/2005,,US-2006-0106049-A1,11/17/2005,1266-002,Small,11/17/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Olatoyosi Odenike,US Utility,4/12/2018,1266-002,11/16/2025,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611824,5/18/2006,582305,Yes
1190,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,PCT/US05/41507, ,*United States,US,11/17/2005,,WO2006/055621,11/17/2005,1266-003,None,11/17/2004,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,Olatoyosi Odenike,PCT,4/12/2018,1266-003,5/17/2007,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611825,5/26/2006,582305,Yes
1191,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,2005307814, ,Australia,AU,11/17/2005,, ,5/1/2007,1266-004,Small,11/17/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Olatoyosi Odenike,Nationalized PCT,4/12/2018,1266-004,11/17/2025,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611826,,582305,Yes
1192,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,"2,586,228", ,Canada,CA,11/17/2005,, ,5/2/2007,1266-005,Small,11/17/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Olatoyosi Odenike,Nationalized PCT,4/12/2018,1266-005,11/17/2025,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611827,,582305,Yes
1193,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,05851707.9EPO, ,European Patent Office (EPO),EP,11/17/2005,,1812036,5/24/2007,1266-006,Small,11/17/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Olatoyosi Odenike,Nationalized PCT,4/12/2018,1266-006,11/17/2025,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611828,8/1/2007,582305,Yes
1194,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,2007-543197, ,Japan,JP,11/17/2005,,2008-520682,5/17/2007,1266-007,Small,11/17/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Olatoyosi Odenike,Nationalized PCT,4/12/2018,1266-007,11/17/2025,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611829,6/19/2008,582305,Yes
1195,04-T-089,Histone Deacetylase Inhibitors and Methods of Use,MX/a/2007/005512, ,Mexico,MX,11/17/2005,, ,5/8/2007,1266-008,Small,11/17/2004,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Olatoyosi Odenike,Nationalized PCT,4/12/2018,1266-008,11/17/2025,"Unassigned, Unassigned",Olatoyosi Odenike,"Unassigned, Unassigned",611830,,582305,Yes
1196,04-T-090,Gram Positive Bacterial Mutants and Methods of Generating and Using such Mutants,"60/591,007", ,*United States,US,7/26/2004,, ,7/26/2004,1267-001,Small,7/26/2004,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fredrik Aslund, Taeok Bae, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1267-001,7/26/2005,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611705,,582306,Yes
1197,04-T-090,Gram Positive Bacterial Mutants and Methods of Generating and Using such Mutants,"11/189,065", ,*United States,US,7/25/2005,, ,7/25/2005,1267-002,Small,7/26/2004,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fredrik Aslund, Taeok Bae, Dominique Missiakas, Olaf Schneewind",US Utility,4/12/2018,1267-002,7/26/2024,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611706,,582306,Yes
1198,04-T-091,Microencapsulation of Particles in a Polymer Solution by Selective Withdrawal Through a High Viscosity Low Density Fluid and Subsequent Crosslinking,"10/992,615",,*United States,US,11/16/2004,,,11/16/2004,1268-001,Small,11/16/2004,,Yes,6/6/2022,Abandoned,Brinks Gilson & Lione,,00118,"William Dilmore, Marc Garfinkel, Milan Mrksich, Sidney Nagel, Jason Wyman",US Utility,4/12/2018,1268-001,11/16/2024,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",613391,,582307,Yes
1199,04-T-092,Methods and COmpositions for the Diagnosis of Dandy-Walker Malformation.,"60/680,083", ,*United States,US,5/12/2005,, ,5/12/2005,1269-001,Small,5/12/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"William Dobyns, Inessa Grinberg, Kathleen Millen",Provisional,4/12/2018,1269-001,5/12/2006,"Unassigned, Unassigned",William Dobyns,"Unassigned, Unassigned",612867,,582308,Yes
1200,04-T-096,"Screening Methods for Anti-Virulence Agents for Gram-Positive, Heme-Utilizing Pathogens","60/697,498", ,*United States,US,7/8/2005,, ,7/8/2005,1273-001,None,7/8/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Olaf Schneewind, Eric Skaar",Provisional,4/12/2018,1273-001,7/8/2006,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",614420,,582312,Yes
1201,04-T-096,"Screening Methods for Anti-Virulence Agents for Gram-Positive, Heme-Utilizing Pathogens","60/706,553", ,*United States,US,8/9/2005,, ,8/9/2005,1273-002,None,8/9/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Olaf Schneewind, Eric Skaar",Provisional,4/12/2018,1273-002,8/9/2006,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",614421,,582312,Yes
1202,04-T-097,Kinetic method for creating highly-ordered monolayers of colloidal particles across macroscopic dimensions.,"60/662,905", ,*United States,US,3/16/2005,, ,3/16/2005,1274-001,Small,3/16/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00126,"Terry Bigioni, Heinrich Jaeger, Xiao-Min Lin",Provisional,4/12/2018,1274-001,3/16/2006,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",612065,,582313,Yes
1203,05-T-003,Hydrogels for Biomolecule Analysis and Corresponding Method to Analyze Biomolecules,"11/305,671","7,588,906",*United States,US,2/24/2005,9/15/2009, ,12/16/2005,1277-003,Small,2/24/2004,11/2/2021,No,4/28/2022,Abandoned,Wisconsin Alumni Research Foundation (WARF),, ,"Shawn Brueggemeier, Stephen Kent, Stephen Kron, Sean Palecek, Laurie Parker",Continuation in Part,4/12/2018,1277-003,3/12/2026,"Sun, Han",Stephen Kron,"Tennant, Thelma",611874,,582316,Yes
1204,05-T-003,Protein-Acrylamide Copolymer Hydrogels and Method of Using Same to Measure Protein Concentration and Activity,"60/547,198", ,*United States,US,2/24/2004,, ,2/24/2004,1277-001,None,2/24/2004,,Yes,4/28/2022,Expired - Inactive,Dewitt Ross & Stevens S.C.,"Leone, Joseph", ,"Shawn Brueggemeier, Stephen Kron, Sean Palecek",Provisional,4/12/2018,1277-001,2/24/2005,"Sun, Han",Stephen Kron,"Tennant, Thelma",614223,,582316,Yes
1205,05-T-003,Protein-Acrylamide Copolymer Hydrogels and Method of Using Same to Measure Protein Concentration and Activity,"11/066,136","7,560,258",*United States,US,2/24/2005,7/14/2009, ,2/24/2005,1277-002,Small,2/24/2004,7/14/2009,No,4/28/2022,Abandoned,Dewitt Ross & Stevens S.C.,, ,"Shawn Brueggemeier, Stephen Kent, Stephen Kron, Sean Palecek, Laurie Parker",US Utility,4/12/2018,1277-002,2/22/2026,"Sun, Han",Stephen Kron,"Tennant, Thelma",614224,,582316,Yes
1206,05-T-007,Methods and compositions for dosing L-Thyroxine,"60/648,927", ,*United States,US,2/1/2005,, ,2/1/2005,1281-001,Small,2/1/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Pei Chen, Soma Das, Andrea Graber, Federico Innocenti, Jacqueline Ramirez, Mark Ratain",Provisional,4/12/2018,1281-001,2/1/2006,"Sun, Han",Mark Ratain,"Tennant, Thelma",612703,,582320,Yes
1207,05-T-007,Methods and compositions for dosing L-Thyroxine,"60/658,429", ,*United States,US,3/4/2005,, ,3/4/2005,1281-002,Small,3/4/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Pei Chen, Soma Das, Andrea Graber, Federico Innocenti, Jacqueline Ramirez, Mark Ratain",Provisional,4/12/2018,1281-002,3/4/2006,"Sun, Han",Mark Ratain,"Tennant, Thelma",612704,,582320,Yes
1208,05-T-007,Methods and compositions for dosing L-Thyroxine,PCT/US06/03846, ,*United States,US,2/1/2006,,WO2006/084133,2/1/2006,1281-003,Small,2/1/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea Graber, Federico Innocenti, Jacqueline Ramirez, Mark Ratain",PCT,4/12/2018,1281-003,8/1/2007,"Sun, Han",Mark Ratain,"Tennant, Thelma",612705,8/10/2006,582320,Yes
1209,05-T-008,Mutations Allowing Rapid Crystallization of Steroid Hormone Receptors,"60/846,024", ,*United States,US,9/19/2006,, ,9/19/2006,1282-001,Small,9/19/2006,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Stankovic, Bratislav",00125,"Geoffrey Greene, Kendall Nettles",Provisional,4/12/2018,1282-001,9/19/2007,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613577,,582321,Yes
1210,05-T-009,Computerized Image Analysis of Gastric Images,"60/647,395", ,*United States,US,1/28/2005,, ,1/28/2005,1283-001,Small,1/28/2005,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Arunas Gasparaitis, Maryellen Giger, Steven Zangan",Provisional,4/12/2018,1283-001,1/28/2006,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611261,,582322,Yes
1211,05-T-010,Methods and compositions comprising chimeric and Full-Length Human Acetyl-CoA Carboxylase,PCT/US06/20461, ,*United States,US,5/26/2006,,WO2006130470,5/26/2006,1134-002,None,5/27/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Piotr Gornicki, Robert Haselkorn",PCT,4/12/2018,1134-002,11/27/2007,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",612641,12/7/2006,582323,Yes
1212,05-T-011,"Method, Apparatus and Kit for Bile or Pancreatic Duct Endoscopy","11/107,056", ,*United States,US,4/15/2005,,US 2006-0235269 A1,4/15/2005,1285-001,Small,4/15/2005,,Yes,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9033-001,Irving Waxman,US Utility,4/12/2018,1285-001,4/15/2025,"Unassigned, Unassigned",Irving Waxman,"Unassigned, Unassigned",612560,10/19/2006,582324,Yes
1213,05-T-014,Analogs of Leucascandrolide A,"11/348,839","7,569,594",*United States,US,2/7/2006,8/4/2009,US-2006-0178355-A1,2/7/2006,1289-002,Small,2/7/2005,,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00159,"Jelena Janjic, Sergey Kozmin",US Utility,4/12/2018,1289-002,11/25/2026,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",610327,8/10/2006,582327,Yes
1214,05-T-014,Analogs of Leucaseandrolide A,"60/650,987", ,*United States,US,2/7/2005,, ,2/7/2005,1289-001,Small,2/7/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Garcia, Brian",00123,"Jelena Janjic, Sergey Kozmin",Provisional,4/12/2018,1289-001,2/7/2006,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",610328,,582327,Yes
1215,05-T-015,Animal Models for Demyelination Disorders,"11/431,372","7,423,194",*United States,US,5/9/2006,9/9/2008, ,5/9/2006,1288-006,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wensheng Lin, Brian Popko",US Utility,4/12/2018,1288-006,6/14/2025,"Peace, Shane",Brian Popko,"Tennant, Thelma",610331,,582328,Yes
1216,05-T-015,Animal Models for Demyelination Disorders,"11/729,242","7,754,941",*United States,US,6/14/2006,7/13/2010,US-2008-0096202-A1,3/27/2007,1288-007,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wensheng Lin, Brian Popko",Continuation,4/12/2018,1288-007,5/9/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",610332,4/24/2008,582328,Yes
1217,05-T-015,Animal Models for Demyelination Disorders,"12/799,670","8,309,790",*United States,US,6/14/2006,11/13/2012,US-2010-0281548-A1,4/28/2010,1288-010,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Divisional,4/12/2018,1288-010,12/20/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",610333,11/4/2010,582328,Yes
1218,05-T-015,Cell-Based Screen for Agents Useful for Reducing Neuronal Demyelination or Promoting Neuronal Remyelination,"11/431,601","7,884,260",*United States,US,5/9/2006,2/8/2011, ,5/9/2006,1288-005,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wensheng Lin, Brian Popko",US Utility,4/12/2018,1288-005,6/14/2025,"Peace, Shane",Brian Popko,"Tennant, Thelma",610814,,582328,Yes
1219,05-T-015,Cell-Based Screen for Agents Useful for Reducing Neuronal Demyelination or Promoting Neuronal Remyelination,"12/965,771","8,415,106",*United States,US,6/14/2006,4/9/2013,US-2011-0207126-A1,12/10/2010,1288-009,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wensheng Lin, Brian Popko",Divisional,4/12/2018,1288-009,6/14/2025,"Peace, Shane",Brian Popko,"Tennant, Thelma",610815,8/25/2011,582328,Yes
1220,05-T-015,Methods for Treating Demyelination Disorders,"60/690,691", ,*United States,US,6/14/2005,, ,6/14/2005,1288-001,Small,6/14/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wong, Karen", ,"Wensheng Lin, Brian Popko",Provisional,4/12/2018,1288-001,6/14/2006,"Peace, Shane",Brian Popko,"Tennant, Thelma",613265,,582328,Yes
1221,05-T-015,Methods for Treating Demyelination Disorders,"60/744,826", ,*United States,US,4/13/2006,, ,4/13/2006,1288-002,Small,4/13/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Provisional,4/12/2018,1288-002,4/13/2007,"Peace, Shane",Brian Popko,"Tennant, Thelma",613266,,582328,Yes
1222,05-T-015,Methods for Treating Demyelination Disorders,"60/792,007", ,*United States,US,4/14/2006,, ,4/14/2006,1288-003,Small,4/14/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Provisional,4/12/2018,1288-003,4/14/2007,"Peace, Shane",Brian Popko,"Tennant, Thelma",613267,,582328,Yes
1223,05-T-015,Methods for Treating Demyelination Disorders,"11/431,782","8,053,627",*United States,US,5/9/2006,11/8/2011, ,5/9/2006,1288-004,Small,6/14/2005,3/21/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wensheng Lin, Brian Popko",US Utility,4/12/2018,1288-004,6/14/2025,"Peace, Shane",Brian Popko,"Tennant, Thelma",613268,,582328,Yes
1224,05-T-015,Methods for Treating Demyelination Disorders,PCT/US06/23215, ,*United States,US,6/14/2006,,WO 2006/138412,6/14/2006,1288-008,Small,6/14/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wong, Karen", ,"Wensheng Lin, Brian Popko",PCT,4/12/2018,1288-008,12/14/2007,"Peace, Shane",Brian Popko,"Tennant, Thelma",613269,12/28/2006,582328,Yes
1225,05-T-015,Methods for Treating Demyelination Disorders,"2,612,374", ,Canada,CA,6/14/2006,, ,5/17/2011,1288-011,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Nationalized PCT,4/12/2018,1288-011,6/14/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",613270,,582328,Yes
1226,05-T-015,Methods for Treating Demyelination Disorders,188127,188127,Israel,IL,6/14/2006,6/30/2012, ,4/9/2012,1288-018,Small,6/14/2005,11/3/2021,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Nationalized PCT,4/12/2018,1288-018,6/14/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",613271,,582328,Yes
1227,05-T-015,Methods for Treating Demyelination Disorders,06773189.3EPO, ,European Patent Office (EPO),EP,6/14/2006,, ,7/24/2014,1288-020,Small,6/14/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Nationalized PCT,4/12/2018,1288-020,6/14/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",613272,,582328,Yes
1228,05-T-015,Methods for Treating Demyelination Disorders,2012-131867, ,Japan,JP,6/14/2006,, ,6/11/2012,1288-021,Small,6/14/2005,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,, ,"Wensheng Lin, Brian Popko",Nationalized PCT,4/12/2018,1288-021,6/14/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",613273,,582328,Yes
1229,05-T-015,Methods for Treating Demyelination Disorders,2008-517080, ,Japan,JP,6/14/2006,, ,12/25/2008,1288-025,Small,6/14/2005,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,,1000355117,"Wensheng Lin, Brian Popko",Nationalized PCT,4/12/2018,1288-025,6/14/2026,"Peace, Shane",Brian Popko,"Tennant, Thelma",613274,,582328,Yes
1230,05-T-016,Methods and Kits for Monitoring Barrett's Metaplasia,"11/367,602","7,537,894",*United States,US,3/2/2006,5/26/2009,US-2006-0199210-A1,3/2/2006,1290-002,Small,3/2/2005,,No,5/8/2022,Abandoned,"Valauskas Corder, LLC",, ,"Nikolai Khodarev, Eric Kimchi, Mitchell Posner, Ralph Weichselbaum",US Utility,4/12/2018,1290-002,6/1/2026,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613113,9/7/2006,582329,Yes
1231,05-T-016,Progression of Barrett's Metaplasia to AdenoCarcinoma is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation,"60/658,424", ,*United States,US,3/2/2005,, ,3/2/2005,1290-001,None,3/2/2005,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Nikolai Khodarev, Eric Kimchi, Mitchell Posner, Ralph Weichselbaum",Provisional,4/12/2018,1290-001,3/2/2006,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614189,,582329,Yes
1232,05-T-017,Use of Opiate Antagonists as Attenuators of Endothelial Cell Migration,"60/725,703", ,*United States,US,10/12/2005,, ,10/12/2005,1291-002,Small,10/12/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-010,Jonathan Moss,Provisional,4/12/2018,1291-002,10/12/2006,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615257,,582330,Yes
1233,05-T-017,Use of Opiate Antagonists to Attenuate Endothelial Cell Migration,"60/731,009", ,*United States,US,10/28/2005,, ,10/28/2005,1291-003,Small,10/28/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-011,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Provisional,4/12/2018,1291-003,10/28/2006,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615258,,582330,Yes
1234,05-T-017,Use of Opiate Antagonists to Attenuate Endothelial Cell Migration,"60/760,851", ,*United States,US,1/20/2006,, ,1/20/2006,1291-004,Small,1/20/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-012,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Provisional,4/12/2018,1291-004,1/20/2007,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615259,,582330,Yes
1235,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,PCT/US06/07892, ,*United States,US,3/7/2006,,WO 2006/096626,3/7/2006,1291-005,Large,3/7/2005,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-014,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",PCT,4/12/2018,1291-005,9/7/2007,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615264,4/5/2007,582330,Yes
1236,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2006220682,2006220682,Australia,AU,3/7/2006,10/18/2012, ,9/4/2007,1291-006,Large,3/7/2005,,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-001,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-006,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615265,,582330,Yes
1237,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,PI06088180, ,Brazil,BR,3/7/2006,, ,9/18/2007,1291-007,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-002,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-007,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615266,,582330,Yes
1238,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"2,600,350","2,600,350",Canada,CA,3/7/2006,2/10/2015, ,9/6/2007,1291-008,Large,3/7/2005,,No,5/23/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-003,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-008,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615267,,582330,Yes
1239,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,200680015606.6,ZL200680015606.6,China,CN,3/7/2006,9/17/2014, ,11/7/2007,1291-009,Large,3/7/2005,,No,5/23/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-004,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-009,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615268,,582330,Yes
1240,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,06748298.4EPO,1861096,European Patent Office (EPO),EP,3/7/2006,12/26/2018,1861096,9/5/2007,1291-010,Large,3/7/2005,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9035-005,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-010,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615269,12/5/2007,582330,Yes
1241,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2008-500798,5241484,Japan,JP,3/7/2006,4/12/2013,2008-531749,9/5/2007,1291-011,Large,3/7/2005,,Yes,5/24/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-007,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-011,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615270,8/14/2008,582330,Yes
1242,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,MX/a/2007/010833,318092,Mexico,MX,3/7/2006,2/18/2014, ,9/5/2007,1291-012,Large,3/7/2005,,Yes,4/28/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-008,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-012,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615271,,582330,Yes
1243,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"11/908,058","9,662,390",*United States,US,3/7/2006,5/30/2017,US-2008-0274119-A1,9/7/2007,1291-013,Large,3/7/2005,,No,5/8/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-013,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-013,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615272,11/6/2008,582330,Yes
1244,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,08102995.3, ,Hong Kong,HK,3/7/2006,,08102995.3,3/14/2008,1291-014,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-006,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Validated EPO,4/12/2018,1291-014,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615273,5/23/2008,582330,Yes
1245,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2007237943,2007237943,Australia,AU,3/7/2006,5/16/2013, ,10/13/2008,1291-015,Small,3/7/2005,,Yes,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-017,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Divisional,4/12/2018,1291-015,3/7/2026,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615274,,582330,Yes
1246,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2013-009283, ,Japan,JP,3/7/2006,,2013-107892,1/22/2013,1291-016,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-016,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Divisional,4/12/2018,1291-016,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615275,6/6/2013,582330,Yes
1247,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2013205180, ,Australia,AU,3/7/2006,, ,4/14/2013,1291-017,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-015,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Divisional,4/12/2018,1291-017,3/7/2026,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615276,,582330,Yes
1248,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,MX/a/2013/009398, ,Mexico,MX,3/7/2006,, ,8/14/2013,1291-018,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-018,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Divisional,4/12/2018,1291-018,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615277,,582330,Yes
1249,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,201410398475.0, ,China,CN,3/7/2006,,CN104248763A,8/14/2014,1291-019,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9035-019,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1291-019,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615278,12/31/2014,582330,Yes
1250,05-T-017,USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION,"15/597,629", ,*United States,US,3/7/2006,,US-2017-0258909-A1,5/17/2017,1291-020,Small,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9035-US05,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1291-020,3/8/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615279,9/14/2017,582330,No
1251,05-T-017,Use of Peripheral Opiate Antagnists to Attenuate Optiod Induced Angiogenesis and Tumor Growth,"60/659,193", ,*United States,US,3/7/2005,, ,3/7/2005,1291-001,Small,3/7/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9035-009,Jonathan Moss,Provisional,4/12/2018,1291-001,3/7/2006,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615290,,582330,Yes
1252,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,06748298.4DE,602006057141.0,Germany,DE,3/7/2006,12/26/2018, ,12/26/2018,1291-021,Large,3/7/2005,12/12/2018,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-DE00,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Validated EPO,12/12/2018, ,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",2146783,,582330,Yes
1253,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,06748298.4FR,1861096,France,FR,3/7/2006,12/26/2018, ,12/26/2018,1291-022,Large,3/7/2005,12/12/2018,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-FR00,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Validated EPO,12/12/2018, ,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",2146809,,582330,Yes
1254,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,06748298.4IT,502019000022157,Italy,IT,3/7/2006,12/26/2018,1861096,12/26/2018,1291-023,Large,3/7/2005,12/12/2018,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-IT00,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Validated EPO,12/12/2018, ,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",2146835,,582330,Yes
1255,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,06748298.4ES,1861096,Spain,ES,3/7/2006,12/26/2018, ,12/26/2018,1291-024,Large,3/7/2005,12/12/2018,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-ES00,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Validated EPO,12/12/2018, ,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",2146861,,582330,Yes
1256,05-T-017,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,06748298.4UK,1861096,United Kingdom,GB,3/7/2006,12/26/2018, ,12/26/2018,1291-025,Large,3/7/2005,12/12/2018,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9035-UK00,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Validated EPO,12/12/2018, ,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",2146887,,582330,Yes
1257,05-T-020,Halogenation of Aromatic Compounds,"60/713,904", ,*United States,US,9/2/2005,, ,9/2/2005,1293-001,None,9/2/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Seaney, Lisa",00128,"Hisashi Yamamoto, Yanhua Zhang",Provisional,4/12/2018,1293-001,9/2/2006,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",611735,,582333,Yes
1258,05-T-020,Lewis Acid Catalyzed Halogenation of Activated Carbon Atoms,PCT/US06/34066, ,*United States,US,8/31/2006,,WO2007/027917,8/31/2006,1293-002,None,9/2/2005,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00170,"Hisashi Yamamoto, Yanhua Zhang",PCT,4/12/2018,1293-002,3/2/2008,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",612073,11/8/2007,582333,Yes
1259,05-T-020,Lewis Acid Catalyzed Halogenation of Activated Carbon Atoms,"12/040,435", ,*United States,US,8/31/2006,,US-2008-0275253-A1,2/29/2008,1293-003,None,9/2/2005,7/1/2012,No,4/28/2022,Released to Government,Brinks Gilson & Lione,,00205,"Kazutaka Shibatomi, Hisashi Yamamoto, Yanhua Zhang",Continuation in Part,4/12/2018,1293-003,,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",612074,11/6/2008,582333,Yes
1260,05-T-020,Lewis Acid Catalyzed Halogenation of Activated Carbon Atoms,10-2008-7008003, ,"Korea, Republic of",KR,8/31/2006,11/28/2013, ,4/15/2008,1293-004,Small,9/2/2005,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00208,"Hisashi Yamamoto, Yanhua Zhang",Nationalized PCT,4/12/2018,1293-004,8/31/2026,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",612075,,582333,Yes
1261,05-T-021,Therapies Involving Lymphotoxin Beta Receptor,"60/689,615", ,*United States,US,6/10/2005,, ,6/10/2005,1295-001,Small,6/10/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Yang-Xin Fu,Provisional,4/12/2018,1295-001,6/10/2006,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614907,,582334,Yes
1262,05-T-021,Therapies Involving Lymphotoxin Beta Receptor,PCT/US06/22241, ,*United States,US,6/8/2006,, ,6/8/2006,1295-002,Small,6/10/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Yang-Xin Fu, James Lo",PCT,4/12/2018,1295-002,12/8/2007,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614908,,582334,Yes
1263,05-T-021,Therapies Involving Lymphotoxin Beta Receptor,"11/917,131", ,*United States,US,6/8/2006,, ,12/10/2007,1295-003,Small,6/10/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Yang-Xin Fu, James Lo",Nationalized PCT,4/12/2018,1295-003,12/8/2026,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614909,,582334,Yes
1264,05-T-023,A magnetic resonance imaging method using vanadyl-based contrast agents,PCT/US07/07690, ,*United States,US,3/27/2007,,WO 2007/126896,3/27/2007,1297-002,Small,3/27/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9059-003,"(Edward) Sean Foxley, Gregory Karczmar, Marvin Makinen, Devkumar Mustafi, Marta Zamora",PCT,4/12/2018,1297-002,9/27/2008,"Cox, Ben",Gregory Karczmar,"Smith, Dane",610207,11/8/2007,582336,Yes
1265,05-T-023,A Magnetic Resonance Imaging Method Using Vanadyl-Based Contrast Agents,"12/294,649", ,*United States,US,3/27/2007,,US-2010-0166662-A1,9/26/2008,1297-003,Small,3/27/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9059-002,"(Edward) Sean Foxley, Gregory Karczmar, Marvin Makinen, Devkumar Mustafi, Marta Zamora",Nationalized PCT,4/12/2018,1297-003,3/27/2027,"Cox, Ben",Gregory Karczmar,"Smith, Dane",610208,7/1/2010,582336,Yes
1266,05-T-023,A Magnetic Resonance Imaging Method Using Vanadyl-Based Molecular Imaging Probes,"60/786,276", ,*United States,US,3/27/2006,, ,3/27/2006,1297-001,None,3/27/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9059-001,"(Edward) Sean Foxley, Gregory Karczmar, Marvin Makinen, Devkumar Mustafi, Marta Zamora",Provisional,4/12/2018,1297-001,3/27/2007,"Cox, Ben",Gregory Karczmar,"Smith, Dane",610209,,582336,Yes
1267,05-T-025,Methods Concerning Lipid Moficiation of Receptors for Advanced Glycation Endproducts (RAGE) by Dawson,"60/673,408", ,*United States,US,4/21/2005,, ,4/21/2005,1299-001,Small,4/21/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Glyn Dawson, Rajendra Goswami, Jingdong Qin",Provisional,4/12/2018,1299-001,4/21/2006,"Sun, Han",Glyn Dawson,"Tennant, Thelma",613155,,582338,Yes
1268,05-T-026,Combination Therapy of Hedgehog Inhibitors and Chemotherapeutic Agents,"60/675,207", ,*United States,US,4/27/2005,, ,4/27/2005,1300-001,Small,4/27/2005,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Wei Du, Zahra Shafaee, Ralph Weichselbaum",Provisional,4/12/2018,1300-001,4/27/2006,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610943,,582339,Yes
1269,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,"60/760,008", ,*United States,US,1/18/2006,, ,1/18/2006,1306-001,Small,1/18/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Provisional,4/12/2018,1306-001,1/18/2007,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611213,,582345,Yes
1270,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,"60/841,521", ,*United States,US,8/31/2006,, ,8/31/2006,1306-002,None,8/31/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Provisional,4/12/2018,1306-002,1/18/2007,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611214,,582345,Yes
1271,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,PCT/US07/60720, ,*United States,US,1/18/2007,,WO2008/019162,1/18/2007,1306-003,Small,1/18/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",PCT,4/12/2018,1306-003,7/18/2008,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611215,2/14/2008,582345,Yes
1272,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,"12/161,315", ,*United States,US,1/18/2007,,US-2009-0317421-A1,7/17/2008,1306-004,Large,1/18/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Nationalized PCT,4/12/2018,1306-004,1/18/2027,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611216,12/24/2009,582345,Yes
1273,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,07840104.9EPO, ,European Patent Office (EPO),EP,1/18/2007,, ,8/14/2008,1306-005,Large,1/18/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Nationalized PCT,4/12/2018,1306-005,1/18/2027,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611217,,582345,Yes
1274,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,"2,637,598", ,Canada,CA,1/18/2007,, ,7/17/2008,1306-006,Large,1/18/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Nationalized PCT,4/12/2018,1306-006,1/18/2027,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611218,,582345,Yes
1275,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,2007281934,2007281934,Australia,AU,1/18/2007,3/4/2013, ,8/7/2008,1306-007,Large,1/18/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Nationalized PCT,4/12/2018,1306-007,1/18/2027,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611219,,582345,Yes
1276,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,11004407.0EPO, ,European Patent Office (EPO),EP,1/18/2007,,2368569,3/28/2011,1306-008,Large,1/18/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Divisional,4/12/2018,1306-008,1/18/2027,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611220,9/28/2011,582345,Yes
1277,05-T-032,Compositions and Methods Related to Staphylococcal Bacterium Proteins,11167985.8EPO, ,European Patent Office (EPO),EP,1/18/2007,,2368570,5/27/2011,1306-009,Large,1/18/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind, Yukiko Stranger-Jones",Divisional,4/12/2018,1306-009,1/18/2027,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611221,9/28/2011,582345,Yes
1278,05-T-033,Vector Beam Generator Using a Passively Phase Stable Optical Interferometer,"60/678,344", ,*United States,US,5/6/2005,, ,5/6/2005,1307-001,Small,5/6/2005,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",41222,"Justin Jureller, Sungnam Park, Norbert Scherer, Kimani Toussaint",Provisional,4/12/2018,1307-001,5/6/2006,"Bakalyar, Heather",Norbert Scherer,"Juggernauth, Anne",615361,,582346,Yes
1279,05-T-033,Vector Beam Generator Using a Passively Phase Stable Optical Interferometer,"11/418,694","7,599,069",*United States,US,5/5/2006,10/6/2009,US-2006-0268408-A1,5/5/2006,1307-002,None,5/6/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Stephens, Paul",41222A,"Justin Jureller, Sungnam Park, Norbert Scherer, Kimani Toussaint",US Utility,4/12/2018,1307-002,5/18/2027,"Bakalyar, Heather",Norbert Scherer,"Juggernauth, Anne",615362,11/30/2006,582346,Yes
1280,05-T-035,Medical Ice Slurry Production Device,"11/229,060","7,389,653",*United States,US,9/15/2005,6/24/2008,US-2007-0056313-A1,9/15/2005,1311-001,Small,9/15/2005,7/23/2012,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00148,"Kenneth Kasza, John Oras, HyunJin Son",US Utility,4/12/2018,1311-001,6/25/2026,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612235,3/15/2007,582348,Yes
1281,05-T-035,MEDICAL ICE SLURRY PRODUCTION DEVICE,PCT/US06/35857, ,*United States,US,9/13/2006,,WO2007/035419,9/13/2006,1311-002,None,9/15/2005,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00171,"Kenneth Kasza, John Oras, HyunJin Son",PCT,4/12/2018,1311-002,3/15/2008,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612236,3/29/2007,582348,Yes
1282,05-T-035,Medical Ice Slurry Production Device,"12/124,824", ,*United States,US,9/13/2006,,US-2008-0236186-A1,5/21/2008,1311-003,Small,9/15/2005,9/1/2009,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00217,"Kenneth Kasza, John Oras, HyunJin Son",Continuation,4/12/2018,1311-003,9/15/2025,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612237,10/2/2008,582348,Yes
1283,05-T-036,Compositions and Method for Brain Specific Targeted Delivery of Therapeutic Agents,"11/997,476", ,*United States,US,8/1/2006,,US-2008-0274202-A1,1/31/2008,1309-004,Small,8/1/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9044-003,"Michael Kaminski, Richard Kraig",Nationalized PCT,4/12/2018,1309-004,8/1/2026,"Sun, Han",Richard Kraig,"Tennant, Thelma",610971,11/6/2008,582349,Yes
1284,05-T-036,Compositions and Method for Tissue-Specific Targeted Delivery of Therapeutic Agents,"60/704,639", ,*United States,US,8/1/2005,, ,8/1/2005,1309-001,Small,8/1/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9044-001,"Michael Kaminski, Richard Kraig",Provisional,4/12/2018,1309-001,8/1/2006,"Sun, Han",Richard Kraig,"Tennant, Thelma",610973,,582349,Yes
1285,05-T-036,Compositions and Method for Tissue-Specific Targeted Delivery of Therapeutic Agents,"60/723,189", ,*United States,US,10/3/2005,, ,10/3/2005,1309-002,Small,10/3/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9044-002,"Michael Kaminski, Richard Kraig",Provisional,4/12/2018,1309-002,10/3/2006,"Sun, Han",Richard Kraig,"Tennant, Thelma",610974,,582349,Yes
1286,05-T-036,Compositions and Method for Tissue-Specific Targeted Delivery of Therapeutic Agents,PCT/US06/29774, ,*United States,US,8/1/2006,, ,8/1/2006,1309-003,Small,8/1/2005,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9044-004,"Michael Kaminski, Richard Kraig",PCT,4/12/2018,1309-003,2/1/2008,"Sun, Han",Richard Kraig,"Tennant, Thelma",610975,,582349,Yes
1287,05-T-037,Methods of Identifying Agents Having Antiangiogenic Activity,"60/718,416", ,*United States,US,9/19/2005,, ,9/19/2005,1310-001,Small,9/19/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9038-001,"Jia Hong, Mark Lingen, Marsha Rosner, Wei-Jen Tang",Provisional,4/12/2018,1310-001,9/19/2006,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613319,,582350,Yes
1288,05-T-037,Methods of Identifying Agents Having Antiangiogenic Activity,PCT/US06/36359, ,*United States,US,9/19/2006,,WO 2007/035678,9/19/2006,1310-002,Small,9/19/2005,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9038-003,"Jia Hong, Marsha Rosner, Wei-Jen Tang",PCT,4/12/2018,1310-002,3/19/2008,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613320,,582350,Yes
1289,05-T-037,Methods of Identifying Agents Having Antiangiogenic Activity,"12/067,356", ,*United States,US,9/19/2006,,WO 2007/035678,3/19/2008,1310-003,Small,9/19/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9038-002,"Jia Hong, Marsha Rosner, Wei-Jen Tang",Nationalized PCT,4/12/2018,1310-003,9/19/2026,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613321,,582350,Yes
1290,05-T-038,Characterizing cell Surface Protein Expression & Nanocytometry,"60/678,254", ,*United States,US,5/6/2005,, ,5/6/2005,1312-001,Small,5/6/2005,,Yes,4/28/2022,Expired Prov - Filed PCT,"University of California, Berkeley (UCBerkeley)",, ,"Andrea Carbonaro, Lucy Godley, Lydia Sohn",Provisional,4/12/2018,1312-001,5/6/2006,"Dembo, Anna",Lucy Godley,"Muite, Kevin",610837,,582351,Yes
1291,05-T-038,Microfluidic System for Identifying or Sizing Individual Articles Passing Through a Channel,PCT/US06/17485, ,*United States,US,5/5/2006,,WO2006/124340A2,5/5/2006,1312-003,None,5/6/2005,5/5/2006,No,4/28/2022,Expired PCT - Nationalized,Gordon & Rees LLP,"Heckadon, David", ,"Andrea Carbonaro, Lucy Godley, Lydia Sohn",PCT,4/12/2018,1312-003,11/6/2007,"Dembo, Anna",Lucy Godley,"Muite, Kevin",613412,11/23/2006,582351,Yes
1292,05-T-038,Microfluidic System for Identifying or Sizing Individual Particles Passing Through a Channel,"11/418,860", ,*United States,US,5/5/2006,, ,5/5/2006,1312-002,None,5/6/2005,,No,5/1/2022,Abandoned,Gordon & Rees LLP,, ,"Andrea Carbonaro, Lucy Godley, Lydia Sohn",Nationalized PCT,4/12/2018,1312-002,5/6/2026,"Dembo, Anna",Lucy Godley,"Muite, Kevin",613413,,582351,Yes
1293,05-T-038,Microfluidic System for Identifying or Sizing Individual Particles Passing Through a Channel,06759184.2EPO, ,European Patent Office (EPO),EP,5/5/2006,, ,4/25/2008,1312-004,Small,5/6/2005,,No,4/28/2022,Abandoned,Gordon & Rees LLP,, ,"Andrea Carbonaro, Lucy Godley, Lydia Sohn",Nationalized PCT,4/12/2018,1312-004,5/6/2026,"Dembo, Anna",Lucy Godley,"Muite, Kevin",613414,,582351,Yes
1294,05-T-038,Microfluidic System for Identifying or Sizing Individual Particles Passing Through a Channel,"2,607,579", ,Canada,CA,5/5/2006,, ,1/28/2008,1312-005,Small,5/6/2005,,No,4/28/2022,Abandoned,Gordon & Rees LLP,, ,"Andrea Carbonaro, Lucy Godley, Lydia Sohn",Nationalized PCT,4/12/2018,1312-005,5/6/2026,"Dembo, Anna",Lucy Godley,"Muite, Kevin",613415,,582351,Yes
1295,05-T-039,NOL7 is a Nucleolar-Associated Tumor Suppressor Gene in Cervical Cancer that Modulates the Angiogenic Phenotype,"60/705,645", ,*United States,US,8/4/2005,, ,8/4/2005,1313-001,Small,8/4/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9039-001,Mark Lingen,Provisional,4/12/2018,1313-001,8/4/2006,"Unassigned, Unassigned",Mark Lingen,"Unassigned, Unassigned",613671,,582352,Yes
1296,05-T-042,Tissue-specific basement membrane gels,"60/728,910", ,*United States,US,10/21/2005,, ,10/21/2005,1316-001,Small,10/21/2005,,Yes,4/28/2022,Expired - Inactive,Pauley Petersen & Erickson,, ,"Eric Brey, Edwardine Labay, Shiri Uriel, Ralph Weichselbaum",Provisional,4/12/2018,1316-001,10/21/2006,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614922,,582355,Yes
1297,05-T-042,Tissue-specific basement membrane gels,"11/585,353", ,*United States,US,10/23/2006,, ,10/23/2006,1316-002,Small,10/21/2005,,No,4/28/2022,Abandoned,Pauley Petersen & Erickson,, ,"Eric Brey, Edwardine Labay, Shiri Uriel, Ralph Weichselbaum",US Utility,4/12/2018,1316-002,10/23/2026,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614923,,582355,Yes
1298,05-T-045,Solid-Phase Protein Kinase Assay,"60/703,178", ,*United States,US,7/28/2005,, ,7/28/2005,1319-001,Small,7/28/2005,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Stephen Kron, Ding Wu",Provisional,4/12/2018,1319-001,7/28/2006,"Sun, Han",Stephen Kron,"Tennant, Thelma",614574,,582358,Yes
1299,05-T-046,Method to predict toxicity or pharmacokinetics of xenobiotics by genotyping aldehyde oxidase,"60/688,504", ,*United States,US,6/8/2005,, ,6/8/2005,1321-001,Small,6/8/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Larry House, Federico Innocenti, Tae Kim, Wanqing Liu, Jacqueline Ramirez, Mark Ratain, Samir Undevia",Provisional,4/12/2018,1321-001,6/8/2006,"Sun, Han",Mark Ratain,"Tennant, Thelma",612559,,582359,Yes
1300,05-T-046,Methods to predict the toxicity or pharmokinetics of xenobiotics by genotyping aldehyde oxidase,"60/811,650", ,*United States,US,6/7/2006,, ,6/7/2006,1321-002,Small,6/7/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Larry House, Federico Innocenti, Tae Kim, Wanqing Liu, Jacqueline Ramirez, Mark Ratain, Samir Undevia",Provisional,4/12/2018,1321-002,6/7/2007,"Sun, Han",Mark Ratain,"Tennant, Thelma",613368,,582359,Yes
1301,05-T-047,Convergent Synthesis of Proteins by Kinetically Controlled Ligation,"60/724,480", ,*United States,US,10/7/2005,, ,10/7/2005,1323-001,Small,10/7/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Duhee Bang, Thomas Durek, Erik Johnson, Stephen Kent, Bradley Pentelute",Provisional,4/12/2018,1323-001,10/7/2006,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",611338,,582360,Yes
1302,05-T-047,Convergent Synthesis of Proteins by Kinetically Controlled Ligation,PCT/US06/39455, ,*United States,US,10/10/2006,,WO2007/100358,10/10/2006,1323-002,Small,10/7/2005,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Voges, Mark", ,"Duhee Bang, Thomas Durek, Erik Johnson, Stephen Kent, Bradley Pentelute",PCT,4/12/2018,1323-002,4/7/2008,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",611339,9/7/2007,582360,Yes
1303,05-T-047,Convergent Synthesis of Proteins by Kinetically Controlled Ligation,"11/545,923","7,674,881",*United States,US,10/10/2006,3/9/2010,US-2007-0082378-A1,10/10/2006,1323-003,Small,10/7/2005,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Duhee Bang, Thomas Durek, Erik Johnson, Stephen Kent, Bradley Pentelute",Nationalized PCT,4/12/2018,1323-003,10/7/2025,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",611340,4/12/2007,582360,Yes
1304,05-T-048,Method of Modulating -Optiod-Mediated Microbial Pathogenesis,"60/687,568", ,*United States,US,6/3/2005,, ,6/3/2005,1322-001,Small,6/3/2005,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41338,"John Alverdy, Jonathan Moss",Provisional,4/12/2018,1322-001,6/3/2006,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",612529,,582361,Yes
1305,05-T-048,Modulation of Cell Barrier Dysfunction,PCT/US06/21604, ,*United States,US,6/5/2006,,WO2007/053194,6/5/2006,1322-002,None,6/3/2005,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-008,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",PCT,4/12/2018,1322-002,12/3/2007,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613471,5/10/2007,582361,Yes
1306,05-T-048,Modulation of Cell Barrier Dysfunction,"11/914,984", ,*United States,US,6/5/2006,, ,11/20/2007,1322-003,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-006,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1322-003,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613472,,582361,Yes
1307,05-T-048,Modulation of Cell Barrier Dysfunction,2006309292, ,Australia,AU,6/5/2006,, ,11/19/2007,1322-004,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-001,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1322-004,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613473,,582361,Yes
1308,05-T-048,Modulation of Cell Barrier Dysfunction,"2,609,985", ,Canada,CA,6/5/2006,, ,11/19/2007,1322-005,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-002,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1322-005,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613474,,582361,Yes
1309,05-T-048,Modulation of Cell Barrier Dysfunction,2008-514938, ,Japan,JP,6/5/2006,,2008-543295,12/3/2007,1322-006,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-004,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1322-006,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613475,11/27/2008,582361,Yes
1310,05-T-048,Modulation of Cell Barrier Dysfunction,06844131.0EPO, ,European Patent Office (EPO),EP,6/5/2006,,1901742,11/19/2007,1322-007,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-003,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1322-007,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613476,3/26/2008,582361,Yes
1311,05-T-048,Modulation of Cell Barrier Dysfunction,"13/483,932", ,*United States,US,6/5/2006,,US-2012-0316190-A1,5/30/2012,1322-008,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9116-009,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1322-008,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613477,12/13/2012,582361,Yes
1312,05-T-048,Modulation of Cell Barrier Dysfunction,"14/061,331", ,*United States,US,6/5/2006,,US-2014-0142133-A1,10/23/2013,1322-010,Large,6/3/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa", ,"John Alverdy, Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1322-010,6/5/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613478,5/22/2014,582361,Yes
1313,05-T-049,Cleavable Polypeptides and Their Applications,"60/836,860", ,*United States,US,8/10/2006,, ,8/10/2006,1320-001,Small,8/10/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Stephen Kent, Stephen Kron, Laurie Parker",Provisional,4/12/2018,1320-001,8/10/2007,"Sun, Han",Stephen Kron,"Tennant, Thelma",610894,,582362,Yes
1314,05-T-050,Gamma 134.5 Deficient HSV and the MAPK Pathway,PCT/US07/61002, ,*United States,US,1/24/2007,,WO2007/087580,1/24/2007,1324-002,Small,1/24/2006,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41491A-PC,"James Mezhir, Bernard Roizman, Kerrington Smith, Ralph Weichselbaum",PCT,4/12/2018,1324-002,7/24/2008,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611623,10/18/2007,582363,Yes
1315,05-T-050,Gamma 134.5 Deficient HSV and the MAPK Pathway,"12/161,763", ,*United States,US,1/24/2007,, ,11/10/2008,1324-003,Small,1/24/2006,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",41491B,"James Mezhir, Bernard Roizman, Kerrington Smith, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1324-003,1/24/2027,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611624,,582363,Yes
1316,05-T-050,Replication of Y1 34.5 Deficient HSV in MEK+ Cells,"60/761,661", ,*United States,US,1/24/2006,, ,1/24/2006,1324-001,Small,1/24/2006,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41491,"James Mezhir, Bernard Roizman, Kerrington Smith, Ralph Weichselbaum",Provisional,4/12/2018,1324-001,1/24/2007,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614394,,582363,Yes
1317,05-T-052,Association Between Polymorphisms At Genetic Loci Affecting Brain Size And cognitive Ability,"60/707,024", ,*United States,US,8/10/2005,, ,8/10/2005,1326-001,Small,8/10/2005,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Patrick Evans, Sandra Gilbert, Bruce Lahn, Nitzan Mekel-Bobrov",Provisional,4/12/2018,1326-001,8/10/2006,"Ginsburg, Eric",Bruce Lahn,"Muite, Kevin",610570,,582365,Yes
1318,05-T-054,Magnetic Drug Targeting Approach with Enhanced Corporal Penetration,"60/648,919", ,*United States,US,2/1/2005,, ,2/1/2005,1328-001,Small,2/1/2005,,Yes,4/28/2022,Expired - Inactive,,, ,"Armin Ebner, Charles Holland, Michael Kaminski, James Ritter, Axel Rosengart",Provisional,4/12/2018,1328-001,2/1/2006,"Ginsburg, Eric",Axel Rosengart,"Muite, Kevin",612143,,582367,Yes
1319,05-T-056,Method for Indexing Nucleic Acid Sequences for Computer Based Searching,"60/747,715", ,*United States,US,5/19/2006,, ,5/19/2006,1329-001,Small,5/19/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Ward, Wendy",092234-9049-001,"Benjamin Glick, Eugene Losev, Michael Scott, William Stokes",Provisional,4/12/2018,1329-001,5/19/2007,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",612465,,582369,Yes
1320,05-T-056,Method for Indexing Nucleic Acid Sequences for Computer Based Searching,PCT/US07/69367, ,*United States,US,5/21/2007,,WO2007/137225,5/21/2007,1329-002,Small,5/19/2006,,No,4/28/2022,Expired PCT - Filed in US only,Michael Best & Friedrich LLP,"Ward, Wendy",092234-9049-003,"Benjamin Glick, William Stokes",PCT,4/12/2018,1329-002,11/19/2008,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",612466,11/29/2007,582369,Yes
1321,05-T-056,Method for Indexing Nucleic Acid Sequences for Computer Based Searching,"12/301,547","8,116,988",*United States,US,5/21/2007,2/14/2012,US-2009-0270277-A1,1/28/2009,1329-003,Small,5/19/2006,2/14/2012,No,4/28/2022,Issued,Michael Best & Friedrich LLP,,092234-9049-002,"Benjamin Glick, William Stokes",Nationalized PCT,4/12/2018,1329-003,9/22/2028,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",612467,10/29/2009,582369,Yes
1322,05-T-057,Methods and Compositions for Inhibiting Cell Division in Bacteria,"60/704,485", ,*United States,US,8/1/2005,, ,8/1/2005,1331-001,None,8/1/2005,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Laby, Ron", ,"Lucia Rothman-Denes, Sho Yano",Provisional,4/12/2018,1331-001,8/1/2006,"Unassigned, Unassigned",Lucia Rothman-Denes,"Unassigned, Unassigned",612774,,582370,Yes
1323,05-T-058,Targeting of Herpes Simplex Virus to Specific Receptors,"60/709,597", ,*United States,US,8/19/2005,, ,8/19/2005,1332-001,None,8/19/2005,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41445,"Hironaga Kamiyama, Bernard Roizman, Grace Zhou",Provisional,4/12/2018,1332-001,8/19/2006,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614856,,582371,Yes
1324,05-T-058,Targeting of Herpes Simplex Virus To Specific Receptors,PCT/US06/32291, ,*United States,US,8/18/2006,,WO2007/24668,8/18/2006,1332-002,None,8/19/2005,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41445-PC,"Hironaga Kamiyama, Bernard Roizman, Grace Zhou",PCT,4/12/2018,1332-002,2/19/2008,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614857,3/1/2007,582371,Yes
1325,05-T-058,Targeting of Herpes Simplex Virus To Specific Receptors,60106650, ,Argentina,AR,8/18/2006,, ,12/1/2006,1332-003,Small,8/19/2005,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",41445-AR,"Hironaga Kamiyama, Bernard Roizman, Grace Zhou",Nationalized PCT,4/12/2018,1332-003,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614859,,582371,Yes
1326,05-T-061,TARGETING OF HERPES SIMPLEX VIRUS TO SPECIFIC RECEPTORS,"11/215,636","7,550,148",*United States,US,10/6/2003,6/23/2009, ,8/30/2005,1334-001,Small,10/7/2002,,Yes,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",41446,"Bernard Roizman, Grace Zhou",Continuation in Part,4/12/2018,1334-001,11/19/2024,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614860,,582374,Yes
1327,05-T-061,Targeting of Herpes Simplex Virus to Specific Receptors,PCT/US06/33865, ,*United States,US,8/30/2006,,WO2007/33865,8/30/2006,1334-002,None,8/30/2005,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41446-PC,"Bernard Roizman, Grace Zhou",PCT,4/12/2018,1334-002,2/29/2008,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614861,3/8/2007,582374,Yes
1328,05-T-061,TARGETING OF HERPES SIMPLEX VIRUS TO SPECIFIC RECEPTORS,"12/065,455","8,927,251",*United States,US,8/30/2006,1/6/2015,US-2010-0221228-A1,2/29/2008,1334-003,Small,8/30/2005,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0703US,"Bernard Roizman, Grace Zhou",Nationalized PCT,4/12/2018,1334-003,10/5/2024,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614862,9/2/2010,582374,Yes
1329,05-T-061,TARGETING OF HERPES SIMPLEX VIRUS TO SPECIFIC RECEPTORS,"14/589,581","9,803,006",*United States,US,8/30/2006,10/31/2017,US-2016-0175370-A1,1/5/2015,1334-004,Small,8/30/2005,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0703US.C1,"Bernard Roizman, Grace Zhou",Continuation in Part,4/12/2018,1334-004,12/21/2023,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614863,9/2/2010,582374,Yes
1330,05-T-065,Compositions and Methods for Inhibiting Adenylyl Cyclase,"60/709,918", ,*United States,US,8/19/2005,, ,8/19/2005,1339-001,Small,8/19/2005,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9047-001,"Young-Sam Lee, Milan Mrksich, Wei-Jen Tang",Provisional,4/12/2018,1339-001,8/19/2006,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",610993,,582378,Yes
1331,05-T-066,A Selective Optoacoustic Imaging Probe,"61/230,935", ,*United States,US,8/3/2009,, ,8/3/2009,1342-001,None,8/3/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00262,"Anthony Green, Patrick La Riviere, James Norris",Provisional,4/12/2018,1342-001,8/3/2010,"Hwang, Luke",James Norris,"Tennant, Thelma",610235,,582379,Yes
1332,05-T-068,Image Construction from Few-Views and Limited Angle Data,"60/773,181", ,*United States,US,2/13/2006,, ,2/13/2006,1343-001,Small,2/13/2006,2/24/2020,Yes,4/28/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,,00157,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",Provisional,4/12/2018,1343-001,2/13/2007,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611903,,582381,Yes
1333,05-T-068,Image Reconstruction from Limited or Imcomplete Data,07750773.9EPO, ,European Patent Office (EPO),EP,2/12/2007,,2024902,8/13/2008,1343-004,Small,2/13/2006,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00242,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",Nationalized PCT,4/12/2018,1343-004,2/12/2027,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611908,2/18/2009,582381,Yes
1334,05-T-068,Image Reconstruction from Limited or Incomplete Data,PCT/US07/03956, ,*United States,US,2/12/2007,,WO2007/095312,2/12/2007,1343-002,Small,2/13/2006,2/24/2020,No,4/28/2022,Expired PCT - Nationalized,Brinks Gilson & Lione,,00187,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",PCT,4/12/2018,1343-002,12/4/2008,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611909,8/23/2007,582381,Yes
1335,05-T-068,Image Reconstruction from Limited or Incomplete Data,"12/223,946","8,605,975",*United States,US,2/12/2007,12/10/2013,US-2011-0044546,8/13/2008,1343-003,Small,2/13/2006,,No,5/1/2022,Issued,Brinks Gilson & Lione,,07814.00241,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",Nationalized PCT,4/12/2018,1343-003,1/10/2031,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611910,2/24/2011,582381,Yes
1336,05-T-068,Image Reconstruction from Limited or Incomplete Data,"14/095,562","8,923,587",*United States,US,2/12/2007,12/30/2014, ,12/3/2013,1343-005,Small,2/13/2006,,No,5/31/2022,Issued,Brinks Gilson & Lione,,00365,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",Continuation,4/12/2018,1343-005,2/13/2026,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611911,,582381,Yes
1337,05-T-068,Image Reconstruction from Limited or Incomplete Data,"14/584,250","9,189,871",*United States,US,2/12/2007,11/10/2015,US-2015-0146949-A1,12/29/2014,1343-006,Small,2/13/2006,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00386,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",Continuation,4/12/2018,1343-006,2/13/2026,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611912,5/28/2015,582381,Yes
1338,05-T-068,Image Reconstruction from Limited or Incomplete Data,"14/933,844","9,613,442",*United States,US,2/12/2007,4/4/2017, ,11/5/2015,1343-007,Small,2/13/2006,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00396,"Chien-Min Kao, Xiaochuan Pan, Emil Sidky",Continuation,4/12/2018,1343-007,2/13/2026,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",611913,,582381,No
1339,05-T-070,"Large Area, Pico-Second Resolution, Time of Flight Detectors","11/583,299","7,485,872",*United States,US,10/19/2006,2/3/2009,US-2007-0187596-A1,10/19/2006,1345-002,Small,10/20/2005,2/3/2009,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00174,"Tim Credo, Henry Frisch, Harold Sanders, Fukun Tang",US Utility,4/12/2018,1345-002,3/30/2027,"Cox, Ben",Henry Frisch,"Tennant, Thelma",612069,8/16/2007,582383,Yes
1340,05-T-070,"Large Area, Pico-Second Resolution, Time of Flight Detectors.","60/728,545", ,*United States,US,10/19/2005,, ,10/19/2005,1345-001,Small,10/19/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00149,"Tim Credo, Henry Frisch, Harold Sanders, Fukun Tang",Provisional,4/12/2018,1345-001,10/19/2006,"Cox, Ben",Henry Frisch,"Tennant, Thelma",612070,,582383,Yes
1341,05-T-073,AgentCell,"78/704,630","3,129,569",*United States,US,8/31/2005,8/15/2006,,,1348-001,Small,8/31/2005,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Peterson, Jeffrey",092234-9050-001,"Philippe Cluzel, Thierry Emonet, Charles Macal, Michael North",Trademark,4/12/2018,1348-001,8/31/2025,"Unassigned, Unassigned",Philippe Cluzel,"Unassigned, Unassigned",610292,,582386,Yes
1342,05-T-074,Methods and Apparatus of Analyzing Magnetic Resonance Image Data Using Fourier Component Imaging,"60/787,446", ,*United States,US,3/30/2006,, ,3/30/2006,1349-001,None,3/30/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9058-001,"(Edward) Sean Foxley, Gregory Karczmar, Milica Medved, Gillian Newstead",Provisional,4/12/2018,1349-001,3/30/2007,"Cox, Ben",Gregory Karczmar,"Smith, Dane",612613,,582387,Yes
1343,05-T-076,Methods and Compositions Involving SLC17A1,"60/776,393", ,*United States,US,2/24/2006,, ,2/24/2006,1351-001,Small,2/24/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Apurva Desai, Wanqing Liu, Mark Ratain, Wei Zhang",Provisional,4/12/2018,1351-001,2/24/2007,"Sun, Han",Mark Ratain,"Tennant, Thelma",612985,,582389,Yes
1344,05-T-076,Methods and Compositions Involving SLC17A1,PCT/US07/62744, ,*United States,US,2/23/2007,,WO 2007/101122,2/23/2007,1351-002,Small,2/24/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Apurva Desai, Wanqing Liu, Mark Ratain, Wei Zhang",PCT,4/12/2018,1351-002,8/23/2008,"Sun, Han",Mark Ratain,"Tennant, Thelma",612986,9/7/2007,582389,Yes
1345,05-T-079,Systems and Methods of Simulating Magnetic Resonance Imaging Protocols,"60/793,346", ,*United States,US,4/20/2006,, ,4/20/2006,1340-001,None,4/20/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9057-001,"Gregory Karczmar, Gillian Newstead",Provisional,4/12/2018,1340-001,4/20/2007,"Cox, Ben",Gregory Karczmar,"Smith, Dane",614845,,582392,Yes
1346,05-T-082,Compositions and Methods Related to a Recombinant Adenoviral Vector that Targets IL 13 Receptors,"60/887,771", ,*United States,US,2/1/2007,, ,2/1/2007,1356-001,Small,2/1/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maciej Lesniak, Ilya Ulasov",Provisional,4/12/2018,1356-001,2/1/2008,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",611037,,582395,Yes
1347,05-T-082,Compositions and Methods Related to a Recombinant Adenoviral Vector that Targets IL 13 Receptors,PCT/US08/52803, ,*United States,US,2/1/2008,,WO2008/095168,2/1/2008,1356-002,Small,2/1/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maciej Lesniak, Ilya Ulasov",PCT,4/12/2018,1356-002,8/1/2009,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",611038,8/7/2008,582395,Yes
1348,05-T-083,ANALYSIS OF CHEMOKINE AND CYTOKINE PRODUCTION BY A HUMAN ALVEOLAR EPITHELIAL CELL LINE IN RESPONSE TO POLLEN SURFACE PROTEINS,"60/890,956", ,*United States,US,2/21/2007,, ,2/21/2007,1357-007,None,2/21/2007,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Jan Lui, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Provisional,4/12/2018,1357-007,2/21/2008,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",610329,,582396,Yes
1349,05-T-083,Diagnostic Pollen Arrays,"60/715,650", ,*United States,US,9/9/2005,, ,9/9/2005,1357-001,Small,9/9/2005,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Provisional,4/12/2018,1357-001,9/9/2006,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",611448,,582396,Yes
1350,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,"60/778,246", ,*United States,US,3/2/2006,, ,3/2/2006,1357-002,Small,3/2/2006,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Provisional,4/12/2018,1357-002,3/2/2007,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612683,,582396,Yes
1351,05-T-083,Methods and Compositions for diagnosis and Immunotherapy of Pollen Allergy,"11/530,627", ,*United States,US,9/11/2006,,US-2007-0183978-A1,9/11/2006,1357-005,Small,9/9/2005,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",US Utility,4/12/2018,1357-005,9/11/2026,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612684,8/9/2007,582396,Yes
1352,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,PCT/US06/35123, ,*United States,US,9/11/2006,,WO 2007/030748,9/11/2006,1357-006,Small,9/9/2005,,No,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",PCT,4/12/2018,1357-006,3/9/2008,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612685,3/15/2007,582396,Yes
1353,05-T-083,Methods And Compositions For Diagnosis And Immunotherapy Of Pollen Allergy,PCT/US07/63188, ,*United States,US,3/2/2007,,WO 2007/103792,3/2/2007,1357-008,None,3/2/2006,,No,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Jan Lui, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",PCT,4/12/2018,1357-008,9/2/2008,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612686,9/13/2007,582396,Yes
1354,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,2006287336, ,Australia,AU,9/11/2006,, ,2/25/2008,1357-009,Small,9/9/2005,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Nationalized PCT,4/12/2018,1357-009,9/11/2026,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612687,,582396,Yes
1355,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,566014, ,New Zealand,NZ,9/11/2006,, ,2/18/2008,1357-010,Small,9/9/2005,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Nationalized PCT,4/12/2018,1357-010,9/11/2026,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612688,,582396,Yes
1356,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,06803244.0EPO, ,European Patent Office (EPO),EP,9/11/2006,,1922332,2/21/2008,1357-011,Small,9/9/2005,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Nationalized PCT,4/12/2018,1357-011,9/11/2026,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612689,5/21/2008,582396,Yes
1357,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,"2,621,439", ,Canada,CA,9/11/2006,, ,3/5/2008,1357-012,Small,9/9/2005,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Nationalized PCT,4/12/2018,1357-012,9/11/2026,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612690,,582396,Yes
1358,05-T-083,Methods and Compositions for Diagnosis and Immunotherapy of Pollen Allergy,"12/281,166", ,*United States,US,9/11/2006,,US-2009-0068233-A1,11/11/2008,1357-013,Small,9/9/2005,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh, Jason Ward",Nationalized PCT,4/12/2018,1357-013,9/11/2026,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612691,3/12/2009,582396,Yes
1359,05-T-083,Methods And Compositions For Diagnosis And Immunotherapy Of Pollen Allergy,07757804.5EPO, ,European Patent Office (EPO),EP,3/2/2007,,EP 1991672,9/10/2008,1357-014,None,3/2/2006,,No,6/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Mohamed Bashir, Matthew Cummings, Jan Lui, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Nationalized PCT,4/12/2018,1357-014,3/2/2027,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",612692,8/8/2007,582396,Yes
1360,05-T-083,Pollen Components and Innate Immunity,"60/778,243", ,*United States,US,3/2/2006,, ,3/2/2006,1357-003,Small,3/2/2006,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Matthew Cummings, Ravishankar Palanivelu, Daphne Preuss, Katinka Vigh",Provisional,4/12/2018,1357-003,3/2/2007,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614069,,582396,Yes
1361,05-T-083,Pollen Components and Innate Immunity,"60/747,127", ,*United States,US,5/12/2006,, ,5/12/2006,1357-004,Small,5/12/2006,,Yes,6/8/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Jan Lui, Daphne Preuss",Provisional,4/12/2018,1357-004,5/12/2007,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614070,,582396,Yes
1362,05-T-084,Photo-Crosslinking Agents and Method for Analyzing DNA Binding Molecules,"60/715,654", ,*United States,US,9/9/2005,, ,9/9/2005,1358-001,Small,9/9/2005,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00140,Chuan He,Provisional,4/12/2018,1358-001,9/9/2006,"Hwang, Luke",Chuan He,"Tennant, Thelma",613966,,582397,Yes
1363,05-T-087,SNP BINDING SITE FOR microRNAs in HLA-G,"12/160,930", ,*United States,US,1/23/2007,, ,7/15/2008,1361-005,None,1/24/2006,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Jihua Fan, Carole Ober, Zheng Tan",Nationalized PCT,4/12/2018,1361-005,1/23/2027,"Sun, Han",Carole Ober,"Tennant, Thelma",614568,,582400,Yes
1364,05-T-087,SNP BINDING SITE FOR microRNAsin HLA-G,PCT/US07/60928, ,*United States,US,1/23/2007,,WO 2007/087539,1/23/2007,1361-004,None,1/24/2006,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,, ,"Jihua Fan, Carole Ober, Zheng Tan",PCT,4/12/2018,1361-004,7/24/2008,"Sun, Han",Carole Ober,"Tennant, Thelma",614569,8/2/2007,582400,Yes
1365,05-T-087,SNP Binding Site for miRNAs in HLA-G,"60/761,488", ,*United States,US,1/24/2006,, ,1/24/2006,1361-001,Small,1/24/2006,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Jihua Fan, Carole Ober, Zheng Tan",Provisional,4/12/2018,1361-001,1/24/2007,"Sun, Han",Carole Ober,"Tennant, Thelma",614570,,582400,Yes
1366,05-T-087,SNP Binding Site for miRNAs in HLA-G,"60/791,579", ,*United States,US,4/11/2006,, ,4/11/2006,1361-002,Small,4/11/2006,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Jihua Fan, Carole Ober, Zheng Tan",Provisional,4/12/2018,1361-002,4/11/2007,"Sun, Han",Carole Ober,"Tennant, Thelma",614571,,582400,Yes
1367,05-T-087,SNP Binding Site for miRNAs in HLA-G,"60/747,630", ,*United States,US,5/18/2006,, ,5/18/2006,1361-003,Small,5/18/2006,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Jihua Fan, Carole Ober, Zheng Tan",Provisional,4/12/2018,1361-003,5/18/2007,"Sun, Han",Carole Ober,"Tennant, Thelma",614572,,582400,Yes
1368,05-T-088,Methods for Altering Expression of Resveratrol Responsive EGR-1 Promoters,"60/883,933", ,*United States,US,1/8/2007,, ,1/8/2007,1362-001,Small,1/8/2007,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Ward, Wendy",092234-9046-001,Ralph Weichselbaum,Provisional,4/12/2018,1362-001,1/8/2008,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613157,,582401,Yes
1369,05-T-090,"Methods and Apparatus for Dynamically Allocating Bandwidth to Spectral, Temporal, and Spatial Dimensions During a Magnetic Resonance Imaging Procedure","60/785,868", ,*United States,US,3/24/2006,, ,3/24/2006,1364-001,None,3/24/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9056-001,"Gregory Karczmar, Milica Medved, Gillian Newstead",Provisional,4/12/2018,1364-001,3/24/2007,"Cox, Ben",Gregory Karczmar,"Smith, Dane",612604,,582403,Yes
1370,05-T-090,"Methods and Apparatus for Dynamically Allocating Bandwith to Spectral, Temporal, and Spatial Dimensions during a Magnetic Resonance Imaging Procedure",PCT/US07/64836, ,*United States,US,3/23/2007,,WO 2007/112319,3/23/2007,1364-002,Small,3/24/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Austin, Christopher",092234-9056-003,"Gregory Karczmar, Milica Medved, Gillian Newstead",PCT,4/12/2018,1364-002,9/24/2008,"Cox, Ben",Gregory Karczmar,"Smith, Dane",612605,10/4/2007,582403,Yes
1371,05-T-090,"Methods and Apparatus for Dynamically Allocating Bandwith to Spectral, Temporal, and Spatial Dimensions during a Magnetic Resonance Imaging Procedure","12/294,201", ,*United States,US,3/23/2007,, ,2/5/2009,1364-003,Small,5/25/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9056-002,"Gregory Karczmar, Milica Medved, Gillian Newstead",Nationalized PCT,4/12/2018,1364-003,3/23/2027,"Cox, Ben",Gregory Karczmar,"Smith, Dane",612606,,582403,Yes
1372,05-T-093,Electrical Conductors and Devices for Prion-Like Proteins,"60/559,286", ,*United States,US,3/31/2004,, ,3/31/2004,1367-001,None,3/31/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Gass, David", ,"Susan Lindquist, Thomas Scheibel",Provisional,4/12/2018,1367-001,3/31/2005,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",611510,,582406,Yes
1373,05-T-093,Electrical Conductors and Devices for Prion-Like Proteins,"11/089,551", ,*United States,US,3/24/2005,,US 2005-0266242 A1,3/24/2005,1367-002,Small,3/31/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Susan Lindquist, Thomas Scheibel",US Utility,4/12/2018,1367-002,3/31/2024,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",611511,12/1/2005,582406,Yes
1374,05-T-093,Electrical Conductors and Devices for Prion-Like Proteins,"12/187,824", ,*United States,US,3/24/2005,,US-2009-0194317-A1,8/7/2008,1367-003,Small,3/31/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Susan Lindquist, Thomas Scheibel",Continuation,4/12/2018,1367-003,3/31/2024,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",611512,8/6/2009,582406,Yes
1375,05-T-093,Electrical Conductors and Devices for Prion-Like Proteins,"13/348,238", ,*United States,US,3/24/2005,, ,1/11/2012,1367-004,Small,3/31/2004,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Susan Lindquist, Thomas Scheibel",Continuation,4/12/2018,1367-004,1/11/2032,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",611513,,582406,Yes
1376,05-T-097,Microencapsulation of Pancreatic Islets within a Thin Coat of Glucagon-Like Peptide-1 Functionalized Poly (Ethylene Glycol),"60/756,026", ,*United States,US,1/4/2006,, ,1/4/2006,1371-001,Small,1/4/2006,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Oguss, Doug",00153,"Marc Garfinkel, Seda Kizilel, Milan Mrksich, Sidney Nagel, Jason Wyman",Provisional,4/12/2018,1371-001,1/4/2007,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",613388,,582410,Yes
1377,05-T-097,Microencapsulation of Pancreatic Islets within a Thin Coat of Glucagon-Like Peptide-1 Functionalized Poly (Ethylene Glycol),"11/649,356", ,*United States,US,1/3/2007,,US-2007-0190036,1/3/2007,1371-002,Small,1/4/2006,,No,6/8/2022,Abandoned,Brinks Gilson & Lione,,00180,"Marc Garfinkel, Seda Kizilel, Milan Mrksich, Sidney Nagel, Jason Wyman",US Utility,4/12/2018,1371-002,1/3/2027,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",613389,8/16/2007,582410,Yes
1378,05-T-097,Microencapsulation of Pancreatic Islets within a Thin Coat of Glucagon-Like Peptide-1 Functionalized Poly (Ethylene Glycol),PCT/US07/00070, ,*United States,US,1/3/2007,,WO 2007/081704A3,1/3/2007,1371-003,Small,1/4/2006,,No,6/8/2022,Expired - Inactive,Brinks Gilson & Lione,"Oguss, Doug",00181,"Marc Garfinkel, Seda Kizilel, Milan Mrksich, Sidney Nagel, Jason Wyman",PCT,4/12/2018,1371-003,7/4/2008,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",613390,11/15/2007,582410,Yes
1379,05-T-100,TERAGRID,78809402,"3,334,655",*United States,US,2/7/2006,11/13/2007,,,1377-001,Small,2/7/2006,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9078,Charlie Catlett,Trademark,4/12/2018,1377-001,2/7/2026,"Ginsburg, Eric",Charlie Catlett,"Smith, Dane",614874,8/28/2007,582413,Yes
1380,05-T-101,Methods for Prognosing Cancer,"60/760,313", ,*United States,US,1/19/2006,, ,1/19/2006,1374-001,None,1/19/2006,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Nikolai Khodarev, Edwardine Labay, Andy Minn, Bernard Roizman, Ralph Weichselbaum",Provisional,4/12/2018,1374-001,1/19/2007,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613260,,582414,Yes
1381,05-T-101,Prognosis and Therapy Predictive Markers and Methods of Use,PCT/US07/60783, ,*United States,US,1/19/2007,,WO 2007/084992,1/19/2007,1374-002,Small,1/19/2006,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Nikolai Khodarev, Edwardine Labay, Andy Minn, Bernard Roizman, Ralph Weichselbaum",PCT,4/12/2018,1374-002,7/19/2008,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614182,7/26/2007,582414,Yes
1382,05-T-101,Prognosis and Therapy Predictive Markers and Methods of Use,"12/087,964","7,892,740",*United States,US,1/19/2007,2/22/2011, ,9/8/2008,1374-003,Small,1/19/2006,,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"Nikolai Khodarev, Edwardine Labay, Andy Minn, Bernard Roizman, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1374-003,4/8/2027,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614183,,582414,Yes
1383,05-T-101,Prognosis and Therapy Predictive Markers and Methods of Use,"13/023,331", ,*United States,US,1/19/2007,, ,2/8/2011,1374-004,Small,1/19/2006,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Nikolai Khodarev, Edwardine Labay, Andy Minn, Bernard Roizman, Ralph Weichselbaum",Continuation,4/12/2018,1374-004,1/19/2027,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614184,,582414,Yes
1384,05-T-101,Prognosis and Therapy Predictive Markers and Methods of Use,"13/734,527", ,*United States,US,1/19/2007,,US-2013-0150258-A1,1/4/2013,1374-005,Small,1/19/2006,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Nikolai Khodarev, Edwardine Labay, Andy Minn, Bernard Roizman, Ralph Weichselbaum",Continuation,4/12/2018,1374-005,1/19/2027,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614185,6/13/2013,582414,Yes
1385,05-T-103,Computer-Aided Method for Detection of Interval Changes in Successive Whole-Body Bone Scans and Related Computer Program Product and System,"60/738,982", ,*United States,US,11/23/2005,, ,11/23/2005,1376-001,Small,11/23/2005,,Yes,4/28/2022,Released to Inventors,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Daniel Appelbaum, Kunio Doi, Qiang Li, Yonglin Pu, Junji Shiraishi",Provisional,4/12/2018,1376-001,11/23/2006,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611247,,582416,Yes
1386,05-T-104,HCV-Reactive T Cell Receptors,PCT/US06/60697, ,*United States,US,11/9/2006,,WO 2007/056760,11/9/2006,1378-002,None,11/10/2005,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Michael Nishimura, Hugo Rosen",PCT,4/12/2018,1378-002,5/10/2008,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611738,5/18/2007,582417,Yes
1387,05-T-104,HCV-Reactive T Cell Receptors,06848416.1EPO, ,European Patent Office (EPO),EP,11/9/2006,, ,3/31/2008,1378-003,None,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-003,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611739,,582417,Yes
1388,05-T-104,HCV-Reactive T Cell Receptors,1589/KOLNP/2008, ,India,IN,11/9/2006,, ,4/22/2008,1378-004,Small,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-004,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611740,,582417,Yes
1389,05-T-104,HCV-Reactive T Cell Receptors,"2,628,248", ,Canada,CA,11/9/2006,, ,2/19/2009,1378-005,Large,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-005,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611741,,582417,Yes
1390,05-T-104,HCV-Reactive T Cell Receptors,2006311255, ,Australia,AU,11/9/2006,, ,4/14/2008,1378-006,Small,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-006,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611742,,582417,Yes
1391,05-T-104,HCV-Reactive T Cell Receptors,"12/092,522", ,*United States,US,11/9/2006,,US-2010-0172888-A1,5/2/2008,1378-007,Small,11/10/2005,2/15/2012,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-007,,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611743,7/8/2010,582417,Yes
1392,05-T-104,HCV-Reactive T Cell Receptors,200680042101.9, ,China,CN,11/9/2006,, ,8/11/2008,1378-008,Small,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-008,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611744,,582417,Yes
1393,05-T-104,HCV-Reactive T Cell Receptors,2008-540336, ,Japan,JP,11/9/2006,, ,5/12/2008,1378-009,Small,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-009,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611745,,582417,Yes
1394,05-T-104,HCV-Reactive T Cell Receptors,10-2008-7011248, ,"Korea, Republic of",KR,11/9/2006,, ,5/9/2008,1378-010,Small,11/10/2005,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Michael Nishimura, Hugo Rosen",Nationalized PCT,4/12/2018,1378-010,11/9/2026,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611746,,582417,Yes
1395,05-T-104,Identification of a Hepatits C Virus-Reactive T Cell Receptor that Does not Require CD8 for Target Cell Recognition,"60/735,699", ,*United States,US,11/10/2005,, ,11/10/2005,1378-001,Small,11/10/2005,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Michael Nishimura, Hugo Rosen",Provisional,4/12/2018,1378-001,11/10/2006,"Unassigned, Unassigned",Michael Nishimura,"Unassigned, Unassigned",611885,,582417,Yes
1396,05-T-106,Compositions and Methods for Treating Pulmonary Hypertension,"60/761,612", ,*United States,US,1/24/2006,, ,1/24/2006,1380-001,Small,1/24/2006,,Yes,4/28/2022,Expired - Inactive,"Sterne, Kessler, Goldstein & Fox PLLC","Goldstein, Jorge", ,"Joe Garcia, Mardi Gomberg-Maitland, Michael Maitland, Liliana Moreno-Vinasco, Mark Ratain",Provisional,4/12/2018,1380-001,1/24/2007,"Unassigned, Unassigned",Mardi Gomberg-Maitland,"Unassigned, Unassigned",611026,,582419,Yes
1397,05-T-106,Compositions and Methods for Treating Pulmonary Hypertension,"60/833,934", ,*United States,US,7/28/2006,, ,7/28/2006,1380-002,Small,7/28/2006,,Yes,4/28/2022,Expired - Inactive,"Sterne, Kessler, Goldstein & Fox PLLC","Goldstein, Jorge", ,"Joe Garcia, Mardi Gomberg-Maitland, Michael Maitland, Liliana Moreno-Vinasco, Mark Ratain",Provisional,4/12/2018,1380-002,7/28/2007,"Unassigned, Unassigned",Mardi Gomberg-Maitland,"Unassigned, Unassigned",611027,,582419,Yes
1398,05-T-106,Compositions and Methods for Treating Pulmonary Hypertension,PCT/US07/60995, ,*United States,US,1/24/2007,,WO2007/087575,1/24/2007,1380-003,Small,1/24/2006,,No,4/28/2022,Expired - Inactive,"Sterne, Kessler, Goldstein & Fox PLLC","Goldstein, Jorge", ,"Joe Garcia, Mardi Gomberg-Maitland, Michael Maitland, Liliana Moreno-Vinasco, Mark Ratain",PCT,4/12/2018,1380-003,7/24/2008,"Unassigned, Unassigned",Mardi Gomberg-Maitland,"Unassigned, Unassigned",611028,8/2/2007,582419,Yes
1399,05-T-106,Compositions and Methods for Treating Pulmonary Hypertension,"12/161,400", ,*United States,US,1/24/2007,,US-2009-0197922-A1,7/18/2008,1380-004,Small,1/24/2006,,No,4/28/2022,Abandoned,"Sterne, Kessler, Goldstein & Fox PLLC",, ,"Joe Garcia, Mardi Gomberg-Maitland, Michael Maitland, Liliana Moreno-Vinasco, Mark Ratain",Nationalized PCT,4/12/2018,1380-004,1/24/2027,"Unassigned, Unassigned",Mardi Gomberg-Maitland,"Unassigned, Unassigned",611029,8/6/2009,582419,Yes
1400,05-T-107,Proteoscape,"78/639,364","3,428,186",*United States,US,5/27/2005,5/13/2008,,,1381-001,None,5/27/2005,,Yes,6/13/2018,Expired - Inactive,Michael Best & Friedrich LLP,"Peterson, Jeffrey",092234-9043-001,"Karl Jablonowski, Piers Nash",Trademark,4/12/2018,1381-001,5/27/2013,"Unassigned, Unassigned",Piers Nash,"Unassigned, Unassigned",614225,,582420,Yes
1401,05-T-110,"The Chemistrode: A Droplet-Based Microfluidic Device for Stimulation and Sampling with High Temporal, Spatial, and Chemical Resolution","61/130,930", ,*United States,US,6/4/2008,, ,6/4/2008,1384-001,None,6/4/2008,4/25/2022,Yes,4/28/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Mrksich, Shannon",00218,"Delai Chen, Rustem Ismagilov",Provisional,4/12/2018,1384-001,6/4/2009,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614875,,582423,Yes
1402,05-T-110,"The Chemistrode: A Plug-Based Microfluidic Device fand Method for Stimulation and Sampling with High Temporal, Spatial, and Chemical Resolution",PCT/US09/46255, ,*United States,US,6/4/2009,,WO 2009/149257,6/4/2009,1384-002,Small,6/4/2008,4/25/2022,No,4/28/2022,Expired PCT - Nationalized,Brinks Gilson & Lione,"Mrksich, Shannon",00256,"Delai Chen, Wenbin Du, Rustem Ismagilov, Weishan Liu",PCT,4/12/2018,1384-002,12/4/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614876,12/10/2009,582423,Yes
1403,05-T-110,"The Chemistrode: A Plug-Based Microfluidic Device and Method for Stimulation and Sampling with High Temporal, Spatial, and Chemical Resolution","12/737,058","8,622,987",*United States,US,6/4/2009,1/7/2014,US-2011-0112503-A1,12/22/2010,1384-003,Small,6/4/2008,,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00297,"Delai Chen, Wenbin Du, Rustem Ismagilov, Weishan Liu",Nationalized PCT,4/12/2018,1384-003,6/4/2029,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614877,5/12/2011,582423,Yes
1404,05-T-112,Smith-Purcell Terahertz Generator and Method of Same,"60/843,655", ,*United States,US,9/11/2006,, ,9/11/2006,1386-001,Small,9/11/2006,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",41940,"Albert Crewe, Oscar Kapp, Kwang-je Kim, Vinit Kumar",Provisional,4/12/2018,1386-001,9/11/2007,"Unassigned, Unassigned",Kwang-je Kim,"Unassigned, Unassigned",614565,,582425,Yes
1405,05-T-113,Method and Compositions for Stabilizing Polypeptide Pharmaceuticals,"60/915,487", ,*United States,US,5/2/2007,, ,5/2/2007,1387-002,None,5/2/2007,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Ward, Wendy",092234-9060-002,"Bryan Krantz, Ali Shandiz, Tobin Sosnick",Provisional,4/12/2018,1387-002,5/2/2008,"Peace, Shane",Tobin Sosnick,"Muite, Kevin",612311,,582426,Yes
1406,05-T-113,Methods and Compositions for Stabilizing Polypeptide Pharmaceuticals,"60/746,239", ,*United States,US,5/2/2006,, ,5/2/2006,1387-001,Small,5/2/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Ward, Wendy",092234-9060-001,"Bryan Krantz, Ali Shandiz, Tobin Sosnick",Provisional,4/12/2018,1387-001,5/2/2007,"Peace, Shane",Tobin Sosnick,"Muite, Kevin",612856,,582426,Yes
1407,05-T-116,Method for Treating Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds,"60/778,165", ,*United States,US,2/28/2006,, ,2/28/2006,1390-001,Small,2/28/2006,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41724,"John Alverdy, Steven Dudek, Joe Garcia",Provisional,4/12/2018,1390-001,2/28/2007,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612508,,582429,Yes
1408,05-T-116,Method for Treating Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds,PCT/US07/63007, ,*United States,US,2/28/2007,,WO 2007/101264,2/28/2007,1390-003,Small,2/28/2006,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41942A-PC,"John Alverdy, Steven Dudek, Joe Garcia",PCT,4/12/2018,1390-003,8/28/2008,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612509,9/7/2007,582429,Yes
1409,05-T-116,Method for Treating Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds,"12/281,102", ,*United States,US,2/28/2007,,US-2009-0186949-A1,8/28/2008,1390-004,Small,2/28/2006,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",41942B,"John Alverdy, Steven Dudek, Joe Garcia",Nationalized PCT,4/12/2018,1390-004,2/28/2027,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612510,7/23/2009,582429,Yes
1410,05-T-116,Method for Treating Epithelial Cell Disorders by Administering High Molecular Weight PEG-like Compunds,"60/787,548", ,*United States,US,3/29/2006,, ,3/29/2006,1390-002,Small,3/29/2006,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41942,"John Alverdy, Steven Dudek, Joe Garcia",Provisional,4/12/2018,1390-002,3/29/2007,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612511,,582429,Yes
1411,05-T-117,Microarray Analysis of Light Chain Variable Gene Expression and Methods of Use,"60/803,099", ,*United States,US,5/24/2006,, ,5/24/2006,1391-001,None,5/24/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9093-001,"Dongyao Ni, Nathan Schoettler, Martin Weigert",Provisional,4/12/2018,1391-001,5/24/2007,"Unassigned, Unassigned",Martin Weigert,"Unassigned, Unassigned",613384,,582430,Yes
1412,05-T-117,Microarray Analysis of Light Chain Variable Gene Expression and Methods of Use,"11/753,263", ,*United States,US,5/24/2007,,US-2008-0003605-A,5/24/2007,1391-002,None,5/24/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9093-002,"Dongyao Ni, Nathan Schoettler, Martin Weigert",US Utility,4/12/2018,1391-002,5/24/2027,"Unassigned, Unassigned",Martin Weigert,"Unassigned, Unassigned",613385,1/3/2008,582430,Yes
1413,05-T-119,INCREASED T-CELL TUMOR INFILTRATION AND ERADICATION OF METASTASES BY MUTANT LIGHT,"11/500,177","7,811,983",*United States,US,6/10/2004,10/12/2010,US-2009-0092640-A1,8/7/2006,1392-001,Small,6/12/2003,,No,5/7/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Continuation in Part,4/12/2018,1392-001,1/11/2024,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611983,4/9/2009,582432,Yes
1414,05-T-119,INCREASED T-CELL TUMOR INFILTRATION AND ERADICATION OF METASTASES BY MUTANT LIGHT,"12/879,881","9,272,025",*United States,US,6/10/2004,3/1/2016,US-2011-0014152-A1,9/10/2010,1392-002,Small,6/12/2003,9/18/2019,No,5/8/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Continuation,4/12/2018,1392-002,8/7/2026,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",611984,1/20/2011,582432,Yes
1415,05-T-119,Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastasis,"15/004,168", ,*United States,US,6/10/2004,,2016-0317631,1/22/2016,1392-003,Small,6/12/2003,,No,5/7/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Divisional,4/12/2018,1392-003,,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",614866,11/4/2016,582432,No
1416,06-T-001,Atypical PKC Mediates WNT Signaling in Growth Cone Guidance,"60/822,581", ,*United States,US,8/16/2006,, ,8/16/2006,1395-001,Small,8/16/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9095-001,Yimin Zou,Provisional,4/12/2018,1395-001,8/16/2007,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",610577,,582435,Yes
1417,06-T-001,Atypical PKC Mediates WNT Signaling in Growth Cone Guidance,PCT/US07/76136, ,*United States,US,8/16/2007,,WO 2008/022278,8/16/2007,1395-002,Small,8/16/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9095-002,Yimin Zou,PCT,4/12/2018,1395-002,2/16/2009,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",610578,2/21/2008,582435,Yes
1418,06-T-003,Melanins Synthesized Chemically or Via Enzyme Catalysis,PCT/US08/88004, ,*United States,US,12/22/2008,,WO 2009/082735,12/22/2008,1397-003,Small,12/21/2007,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00250,"Earle Holmes, Kenneth Thompson",PCT,4/12/2018,1397-003,6/21/2010,"Ginsburg, Eric",Kenneth Thompson,"Muite, Kevin",612238,7/2/2009,582437,Yes
1419,06-T-003,Melanins Synthesized Chemically or Via Enzyme Catalysis,"12/809,369","8,673,983",*United States,US,12/22/2008,3/18/2014, ,6/15/2010,1397-004,Small,12/21/2007,3/18/2014,No,4/28/2022,Issued,Hartman & Hartman,, ,"Earle Holmes, Kenneth Thompson",Nationalized PCT,4/12/2018,1397-004,9/18/2029,"Ginsburg, Eric",Kenneth Thompson,"Muite, Kevin",612239,,582437,Yes
1420,06-T-003,Melanins Synthesized Via Enzyme Catalysis,"60/876,333", ,*United States,US,12/21/2006,, ,12/21/2006,1397-001,Small,12/21/2006,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00172,"Earle Holmes, Kenneth Thompson",Provisional,4/12/2018,1397-001,12/21/2007,"Ginsburg, Eric",Kenneth Thompson,"Muite, Kevin",612240,,582437,Yes
1421,06-T-003,Melanins Synthesized Via Enzyme Catalysis,"61/008,948", ,*United States,US,12/21/2007,, ,12/21/2007,1397-002,Small,12/21/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00201,"Earle Holmes, Kenneth Thompson",Provisional,4/12/2018,1397-002,12/21/2008,"Ginsburg, Eric",Kenneth Thompson,"Muite, Kevin",612241,,582437,Yes
1422,06-T-005,MgrA as a Redox Responsive Regulator of Bacterial Virulence and Antibiotic Sensitivity,PCT/US07/61316, ,*United States,US,1/30/2007,,WO2007/090123,1/30/2007,1399-004,Small,1/30/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Peng Chen, Chuan He",PCT,4/12/2018,1399-004,7/30/2008,"Hwang, Luke",Chuan He,"Tennant, Thelma",613380,8/9/2007,582439,Yes
1423,06-T-005,MGRA is a Redox Regulator of Antibiotic Sensitivity,"60/763,667", ,*United States,US,1/30/2006,, ,1/30/2006,1399-001,None,1/30/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Peng Chen, Chuan He",Provisional,4/12/2018,1399-001,1/30/2007,"Hwang, Luke",Chuan He,"Tennant, Thelma",613381,,582439,Yes
1424,06-T-005,MGRA is a Redox Regulator of Antibiotic Sensitivity and Virulence,"60/865,595", ,*United States,US,11/13/2006,, ,11/13/2006,1399-002,Small,11/13/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Peng Chen, Chuan He",Provisional,4/12/2018,1399-002,11/13/2007,"Hwang, Luke",Chuan He,"Tennant, Thelma",613382,,582439,Yes
1425,06-T-005,MGRA is a Redox Regulator of Antibiotic Sensitivity and Virulence,"11/668,959", ,*United States,US,1/30/2007,,US-2007-0248581-A1,1/30/2007,1399-003,Small,1/30/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Peng Chen, Chuan He",US Utility,4/12/2018,1399-003,1/30/2027,"Hwang, Luke",Chuan He,"Tennant, Thelma",613383,10/25/2007,582439,Yes
1426,06-T-016,Methods of Staging Cancer and Assessing Risk of Metastasis,"60/890,120", ,*United States,US,2/15/2007,, ,2/15/2007,1410-001,Small,2/15/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Ravi Salgia,Provisional,4/12/2018,1410-001,2/15/2008,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",613346,,582450,Yes
1427,06-T-016,"Paxillin Mutations, Methods of Assessing Risk of Metastasis and Methods of Staging Tumors",PCT/US08/54114, ,*United States,US,2/15/2008,, ,2/15/2008,1410-002,Small,2/15/2007,,No,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Ravi Salgia,PCT,4/12/2018,1410-002,8/15/2009,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",613910,,582450,Yes
1428,06-T-016,"Paxillin Mutations, Methods of Assessing Risk of Metastasis and Methods of Staging Tumors","12/526,870", ,*United States,US,2/15/2008,,US-1010-0075320-A1,9/2/2009,1410-003,Small,2/15/2007,,No,4/28/2022,Abandoned,Ballard Spahr LLP,, ,Ravi Salgia,Nationalized PCT,4/12/2018,1410-003,2/15/2018,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",613911,2/25/2010,582450,Yes
1429,06-T-017,Uses of Peripheral Opiate Antagonists in Treatment of Addiction,"60/780,743", ,*United States,US,3/9/2006,, ,3/9/2006,1411-001,Large,3/9/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9086-001,Jonathan Moss,Provisional,4/12/2018,1411-001,3/9/2007,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615332,,582451,Yes
1430,06-T-018,Molecular Affinity Clamp Technology and Uses Thereof,"60/986,475", ,*United States,US,11/8/2007,, ,11/8/2007,1412-001,None,11/8/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jin Huang, Akiko Koide, Shohei Koide",Provisional,4/12/2018,1412-001,11/8/2008,"Peace, Shane",Shohei Koide,"Muite, Kevin",613503,,582452,Yes
1431,06-T-018,Molecular Affinity Clamp Technology and Uses Thereof,"61/016,736", ,*United States,US,12/26/2007,, ,12/26/2007,1412-002,Small,12/26/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jin Huang, Akiko Koide, Shohei Koide",Provisional,4/12/2018,1412-002,12/26/2008,"Peace, Shane",Shohei Koide,"Muite, Kevin",613504,,582452,Yes
1432,06-T-018,Molecular Affinity Clamp Technology and Uses Thereof,PCT/US08/83021, ,*United States,US,11/10/2008,,WO 2009/062170,11/10/2008,1412-003,Small,11/8/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jin Huang, Akiko Koide, Shohei Koide",PCT,4/12/2018,1412-003,5/8/2010,"Peace, Shane",Shohei Koide,"Muite, Kevin",613505,5/14/2009,582452,Yes
1433,06-T-018,Molecular Affinity Clamp Technology and Uses Thereof,"12/742,014","9,885,050",*United States,US,11/10/2008,2/6/2018,US-2011-0143963-A1,12/15/2010,1412-004,Small,11/8/2007,,No,5/2/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jin Huang, Akiko Koide, Shohei Koide",Nationalized PCT,4/12/2018,1412-004,3/8/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",613506,6/16/2011,582452,Yes
1434,06-T-018,Molecular Affinity Clamp Technology and Uses Thereof,08847120.6EPO, ,European Patent Office (EPO),EP,11/10/2008,,2215115,6/7/2010,1412-005,Small,11/8/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jin Huang, Akiko Koide, Shohei Koide",Nationalized PCT,4/12/2018,1412-005,11/10/2028,"Peace, Shane",Shohei Koide,"Muite, Kevin",613507,8/11/2010,582452,Yes
1435,06-T-020,Stochastic Scanning Apparatus Using Multiphoton Multifocal Source,"60/818,195", ,*United States,US,6/30/2006,, ,6/30/2006,1414-001,None,6/30/2006,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",41972,"Justin Jureller, Hee Kim, Norbert Scherer",Provisional,4/12/2018,1414-001,6/30/2007,"Bakalyar, Heather",Norbert Scherer,"Juggernauth, Anne",614666,,582454,Yes
1436,06-T-020,Stochastic Scanning Apparatus Using Multiphoton Multifocal Source,"11/771,064","7,990,524",*United States,US,6/29/2007,8/2/2011, ,6/29/2007,1414-002,None,6/30/2006,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Stephens, Paul",41972A,"Justin Jureller, Hee Kim, Norbert Scherer",US Utility,4/12/2018,1414-002,8/8/2029,"Bakalyar, Heather",Norbert Scherer,"Juggernauth, Anne",614667,,582454,Yes
1437,06-T-021,Apparatus and Methods for Sequential Administration of Growth Factors for Tendon or Soft Tissue Healing,"60/842,547", ,*United States,US,9/6/2006,, ,9/6/2006,1415-001,Small,9/6/2006,,Yes,4/28/2022,Expired - Inactive,"McAndrews, Held & Malloy, Ltd.","Harlin, Michael", ,Daniel Mass,Provisional,4/12/2018,1415-001,9/6/2007,"Cox, Ben",Daniel Mass,"Juggernauth, Anne",610487,,582455,Yes
1438,06-T-024,Receptor-Mediated Delivery Compositions and Methods,"60/833,850", ,*United States,US,7/26/2006,, ,7/26/2006,1418-001,Small,7/26/2006,,Yes,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Anthony Kossiakoff, Ernst Lengyel, Joseph Piccirilli",Provisional,4/12/2018,1418-001,7/26/2007,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614293,,582458,Yes
1439,06-T-024,Receptor-Mediated Delivery: Compositions and Methods,PCT/US07/74493, ,*United States,US,7/26/2007,, ,7/26/2007,1418-002,Small,7/26/2006,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Anthony Kossiakoff, Ernst Lengyel, Joseph Piccirilli",PCT,4/12/2018,1418-002,1/26/2009,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614294,,582458,Yes
1440,06-T-024,Receptor-Mediated Delivery: Compositions and Methods,"12/375,179","9,127,293",*United States,US,7/26/2007,9/8/2015,US2009-0317855-A1,1/26/2009,1418-003,Small,7/26/2006,1/30/2019,No,6/8/2022,Abandoned,"Valauskas Corder, LLC",, ,"Anthony Kossiakoff, Ernst Lengyel, Joseph Piccirilli",Nationalized PCT,4/12/2018,1418-003,10/18/2030,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614295,12/24/2009,582458,Yes
1441,06-T-024,Receptor-Mediated Delivery: Compositions and Methods,"14/806,825", ,*United States,US,7/26/2007,, ,7/23/2015,1418-004,Small,7/26/2006,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC",, ,"Anthony Kossiakoff, Ernst Lengyel, Joseph Piccirilli",Continuation,4/12/2018,1418-004,7/26/2027,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614296,,582458,No
1442,06-T-025,Materials and Methods for Modulating Protective Pathways in Epithelial Cells,"60/942,946", ,*United States,US,6/8/2007,, ,6/8/2007,1419-001,None,6/8/2007,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",42212,"Eugene Chang, Mikihiro Fujiya, Mark Musch",Provisional,4/12/2018,1419-001,6/8/2008,"Dembo, Anna",Eugene Chang,"Butler, Brittany",612165,,582459,Yes
1443,06-T-025,Materials and Methods for Modulating Protective Pathways in Epithelial Cells,PCT/US08/66368, ,*United States,US,6/8/2008,,WO 2008/154518,6/8/2008,1419-002,None,6/8/2007,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",42212A-PC,"Eugene Chang, Mikihiro Fujiya, Mark Musch",PCT,4/12/2018,1419-002,12/8/2009,"Dembo, Anna",Eugene Chang,"Butler, Brittany",612166,12/18/2008,582459,Yes
1444,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"2,915,154","2,915,154",Canada,CA,4/17/2007,10/27/2020, ,12/23/2015,1421-010,Large,4/17/2006,,No,5/24/2022,Issued,Michael Best & Friedrich LLP,,092234-9090-CA01,"Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Divisional,4/12/2018,1421-010,4/18/2027,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615228,,582461,No
1445,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"11/379,010","8,524,731",*United States,US,3/7/2006,9/3/2013,US-2006-0258696-A1,4/17/2006,1421-001,Large,3/7/2005,,Yes,6/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9090-006,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Continuation in Part,4/12/2018,1421-001,3/14/2028,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615280,11/16/2006,582461,Yes
1446,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,PCT/US07/66806, ,*United States,US,4/17/2007,,WO 2007/121447,4/17/2007,1421-002,Large,4/17/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9090-007,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",PCT,4/12/2018,1421-002,10/17/2008,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615281,6/19/2008,582461,Yes
1447,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2013-269363, ,Japan,JP,4/17/2007,, ,12/26/2013,1421-003,Large,4/17/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9090-JP01,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Divisional,4/12/2018,1421-003,4/17/2027,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615282,,582461,Yes
1448,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"2,649,710","2,649,710",Canada,CA,4/17/2007,2/23/2016, ,2/23/2009,1421-004,Large,4/17/2006,,Yes,5/24/2022,Issued,Michael Best & Friedrich LLP,,092234-9090-002,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Nationalized PCT,4/12/2018,1421-004,4/17/2027,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615283,,582461,Yes
1449,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,07760785.1EPO, ,European Patent Office (EPO),EP,4/17/2007,, ,10/13/2008,1421-005,Large,4/17/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9090-003,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Nationalized PCT,4/12/2018,1421-005,4/17/2027,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615284,,582461,Yes
1450,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,2009-506726,5451378,Japan,JP,4/17/2007,1/10/2014,2009-533482,10/17/2008,1421-006,Large,4/17/2006,,Yes,4/28/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9090-009,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Nationalized PCT,4/12/2018,1421-006,4/17/2027,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615285,9/17/2009,582461,Yes
1451,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"14/292,816","9,662,325",*United States,US,3/7/2006,5/31/2017,US-2014-0066467-A1,5/30/2014,1421-007,Large,3/7/2005,,No,6/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9090-010,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Continuation in Part,4/12/2018,1421-007,9/12/2026,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615286,3/6/2014,582461,Yes
1452,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,"13/972,122","9,675,602",*United States,US,3/7/2006,6/13/2017,US-2014-0066467-A1,8/21/2013,1421-008,Large,3/7/2005,,No,6/23/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9090-008,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Continuation,4/12/2018,1421-008,3/7/2026,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615287,3/6/2014,582461,Yes
1453,06-T-027,Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration,09106124.7, ,Hong Kong,HK,4/17/2007,,1126960 A,7/7/2009,1421-009,Large,4/17/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9090-HK00,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Validated EPO,4/12/2018,1421-009,4/17/2027,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615288,9/18/2009,582461,Yes
1454,06-T-027,USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION,"15/597,588", ,*United States,US,3/7/2006,,US-2017-0252336-A1,5/18/2017,1421-011,Small,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9090-US03,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton, Chun-Su Yuan",Continuation,4/12/2018,1421-011,3/8/2025,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",615289,9/7/2017,582461,No
1455,06-T-031,SIRT1 Activation in Managing Heart Failure,"60/824,101", ,*United States,US,8/31/2006,, ,8/31/2006,1425-001,Small,8/31/2006,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Mahesh Gupta,Provisional,4/12/2018,1425-001,8/31/2007,"Unassigned, Unassigned",Mahesh Gupta,"Unassigned, Unassigned",614520,,582465,Yes
1456,06-T-031,SIRT1 Activation in Managing Heart Failure,PCT/US07/77280, ,*United States,US,8/30/2007,, ,8/31/2007,1425-002,Small,8/31/2006,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Mahesh Gupta,PCT,4/12/2018,1425-002,2/28/2009,"Unassigned, Unassigned",Mahesh Gupta,"Unassigned, Unassigned",614521,,582465,Yes
1457,06-T-036,Insulin-Degrading Enzyme Mutants and Methods of Use,"60/826,676", ,*United States,US,9/22/2006,, ,9/22/2006,1429-001,None,9/22/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9111-001,Wei-Jen Tang,Provisional,4/12/2018,1429-001,9/22/2007,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",612038,,582470,Yes
1458,06-T-036,Insulin-Degrading Enzyme Mutants and Methods of Use,"60/888,140", ,*United States,US,2/5/2007,, ,2/5/2007,1429-002,Small,2/5/2007,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9111-002,Wei-Jen Tang,Provisional,4/12/2018,1429-002,2/5/2008,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",612039,,582470,Yes
1459,06-T-036,Insulin-Degrading Enzyme Mutants and Methods of Use,PCT/US07/79297, ,*United States,US,9/24/2007,,WO 2008/036970,9/24/2007,1429-003,Small,9/22/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9111-004,"Yuequan Shen, Wei-Jen Tang",PCT,4/12/2018,1429-003,3/22/2009,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",612040,3/27/2008,582470,Yes
1460,06-T-036,Insulin-Degrading Enzyme Mutants and Methods of Use,"12/442,198", ,*United States,US,9/24/2007,,US-2010-0003232-A1,3/20/2009,1429-004,Small,9/22/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9111-003,"Yuequan Shen, Wei-Jen Tang",Nationalized PCT,4/12/2018,1429-004,9/24/2027,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",612041,1/7/2010,582470,Yes
1461,06-T-037,Binary Amino Acid Libraries for Monobodies,"60/843,357", ,*United States,US,9/9/2006,, ,9/9/2006,1431-001,Small,9/9/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9013-001,"Kaori Esaki, Akiko Koide, Shohei Koide",Provisional,4/12/2018,1431-001,9/9/2007,"Bakalyar, Heather",Shohei Koide,"Butler, Brittany",610711,,582471,Yes
1462,06-T-037,Binary Amino Acid Libraries for Monobodies,PCT/US07/78039, ,*United States,US,9/10/2007,,WO2008/031098,9/10/2007,1431-002,Small,9/9/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9103-002,"Kaori Esaki, Akiko Koide, Shohei Koide",PCT,4/12/2018,1431-002,3/9/2009,"Bakalyar, Heather",Shohei Koide,"Butler, Brittany",610712,3/13/2008,582471,Yes
1463,06-T-040,Bistramide A Analogs,"60/791,580", ,*United States,US,4/11/2006,, ,4/11/2006,1434-001,None,4/11/2006,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00161,Sergey Kozmin,Provisional,4/12/2018,1434-001,4/11/2007,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",610747,,582474,Yes
1464,06-T-041,Control of Growth and Repair of Gastro-Intestinal Tissues by Gastrokines and Inhibitors,"60/790,177", ,*United States,US,4/7/2006,, ,4/7/2006,1435-001,Small,4/7/2006,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Provisional,4/12/2018,1435-001,4/7/2007,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611317,,582475,Yes
1465,06-T-041,Methods and Compositions to Treat Mucositis,PCT/US06/18014, ,*United States,US,5/9/2006,,WO2006/122162,5/9/2006,1435-002,Small,5/10/2005,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,PCT,4/12/2018,1435-002,11/10/2007,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613084,11/16/2006,582475,Yes
1466,06-T-041,Methods and Compositions to Treat Mucositis,"11/913,928","8,017,576",*United States,US,5/9/2006,9/13/2011,US-2008-0194479-A1,12/12/2007,1435-003,Small,5/10/2005,3/19/2019,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,1435-003,10/13/2027,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613085,8/14/2008,582475,Yes
1467,06-T-041,Methods and Compositions to Treat Mucositis,MX/a/2007/013892,290669,Mexico,MX,5/9/2006,10/3/2011, ,11/8/2007,1435-004,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,1435-004,5/10/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613086,,582475,Yes
1468,06-T-041,Methods and Compositions to Treat Mucositis,2008-511298,5058980,Japan,JP,5/9/2006,8/10/2012,2008-544959,11/9/2007,1435-005,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,1435-005,5/9/2026,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613087,12/11/2008,582475,Yes
1469,06-T-041,Methods and Compositions to Treat Mucositis,2006244080, ,Australia,AU,5/9/2006,, ,11/7/2007,1435-006,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,1435-006,5/10/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613088,,582475,Yes
1470,06-T-041,Methods and Compositions to Treat Mucositis,06770157.3EPO,1885390,European Patent Office (EPO),EP,5/9/2006,10/5/2011, ,12/5/2007,1435-007,Small,5/10/2005,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,1435-007,5/9/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613089,,582475,Yes
1471,06-T-041,Methods and Compositions to Treat Mucositis,"2,643,736","2,643,736",Canada,CA,5/9/2006,6/23/2015, ,12/22/2008,1435-008,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Nationalized PCT,4/12/2018,1435-008,5/10/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613090,,582475,Yes
1472,06-T-041,Methods and Compositions to Treat Mucositis,"13/183,166", ,*United States,US,5/9/2006,, ,7/14/2011,1435-009,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Continuation,4/12/2018,1435-009,5/10/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613091,,582475,Yes
1473,06-T-041,Methods and Compositions to Treat Mucositis,06770157.3DE,602006024934.9,Germany,DE,5/9/2006,, ,10/31/2011,1435-010,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Validated EPO,4/12/2018,1435-010,5/9/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613092,,582475,Yes
1474,06-T-041,Methods and Compositions to Treat Mucositis,06770157.3FR,1885390,France,FR,5/9/2006,, ,10/31/2011,1435-011,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Validated EPO,4/12/2018,1435-011,5/9/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613093,,582475,Yes
1475,06-T-041,Methods and Compositions to Treat Mucositis,06770157.3GB,1885390,United Kingdom,GB,5/9/2006,, ,10/31/2011,1435-012,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Validated EPO,4/12/2018,1435-012,5/9/2025,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613094,,582475,Yes
1476,06-T-041,Methods and Compositions to Treat Mucositis,2011-262746, ,Japan,JP,5/9/2006,8/10/2012, ,11/30/2011,1435-014,Small,5/10/2005,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,F. Gary Toback,Divisional,4/12/2018,1435-014,5/9/2026,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",613095,3/8/2012,582475,Yes
1477,06-T-050,Treatment of Inflammatory Diseases,"60/838,222", ,*United States,US,8/17/2006,, ,8/17/2006,1444-001,Small,8/17/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Provisional,4/12/2018,1444-001,8/17/2007,"Peace, Shane",Betty Soliven,"Muite, Kevin",614991,,582484,Yes
1478,06-T-050,Treatment of Inflammatory Diseases,PCT/US07/18331, ,*United States,US,8/17/2007,, ,8/17/2007,1444-002,Small,8/17/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,PCT,4/12/2018,1444-002,2/17/2009,"Peace, Shane",Betty Soliven,"Muite, Kevin",614992,,582484,Yes
1479,06-T-050,Treatment of Inflammatory Diseases,200780034467.6,ZL200780034467.6,China,CN,8/17/2007,3/21/2012,CN 101553216A,3/17/2009,1444-003,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-003,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614993,10/7/2009,582484,Yes
1480,06-T-050,Treatment of Inflammatory Diseases,1762/DELNP/2009, ,India,IN,8/17/2007,,1762/DELNP/2009 A,3/17/2009,1444-004,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-004,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614994,5/15/2009,582484,Yes
1481,06-T-050,Treatment of Inflammatory Diseases,2007284337,2007284337,Australia,AU,8/17/2007,11/1/2012, ,2/16/2009,1444-005,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-005,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614995,,582484,Yes
1482,06-T-050,Treatment of Inflammatory Diseases,"12/377,736","8,258,150",*United States,US,8/17/2007,9/4/2012,US-2010-0310547-A1,2/17/2009,1444-006,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-006,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614996,12/9/2010,582484,Yes
1483,06-T-050,Treatment of Inflammatory Diseases,PI0715950-1, ,Brazil,BR,8/17/2007,, ,2/17/2009,1444-007,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-007,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614997,,582484,Yes
1484,06-T-050,Treatment of Inflammatory Diseases,07837041.8EPO,2056807,European Patent Office (EPO),EP,8/17/2007,9/26/2012,2 056 807,2/17/2009,1444-008,Small,8/17/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-008,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614998,5/13/2009,582484,Yes
1485,06-T-050,Treatment of Inflammatory Diseases,2009-524698,5216769,Japan,JP,8/17/2007,3/8/2013,2010-500995,2/13/2009,1444-009,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-009,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",614999,1/14/2010,582484,Yes
1486,06-T-050,Treatment of Inflammatory Diseases,"2,660,880","2,660,880",Canada,CA,8/17/2007,10/13/2015, ,2/13/2009,1444-010,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-010,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615000,,582484,Yes
1487,06-T-050,Treatment of Inflammatory Diseases,MX/a/2009/001788,307132,Mexico,MX,8/17/2007,1/31/2013,MX/a/2009/001788,2/17/2009,1444-011,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-011,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615001,10/28/2010,582484,Yes
1488,06-T-050,Treatment of Inflammatory Diseases,2009109418,2440110,Russian Federation,RU,8/17/2007,1/20/2012,RU 2009109418 A,3/17/2009,1444-012,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-012,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615002,9/27/2010,582484,Yes
1489,06-T-050,Treatment of Inflammatory Diseases,09109655.8,HK1131047,Hong Kong,HK,8/17/2007,1/25/2013,1131047A,10/19/2009,1444-013,None,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Nationalized PCT,4/12/2018,1444-013,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615003,1/15/2010,582484,Yes
1490,06-T-050,Treatment of Inflammatory Diseases,11170326.0EPO, ,European Patent Office (EPO),EP,8/17/2007,,2392320,8/7/2011,1444-014,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-014,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615004,12/7/2011,582484,Yes
1491,06-T-050,Treatment of Inflammatory Diseases,201210024062.7,ZL 201210024062.7,China,CN,8/17/2007,, ,2/3/2012,1444-015,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-015,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615005,,582484,Yes
1492,06-T-050,Treatment of Inflammatory Diseases,12100297.6, ,Hong Kong,HK,8/17/2007,,HK1159986,10/19/2009,1444-016,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-016,10/19/2029,"Peace, Shane",Betty Soliven,"Muite, Kevin",615006,8/10/2012,582484,Yes
1493,06-T-050,Treatment of Inflammatory Diseases,"13/567,590","9,101,576",*United States,US,8/17/2007,8/11/2015,US-2013-0017190-A1,8/6/2012,1444-017,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Continuation,4/12/2018,1444-017,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615007,1/17/2013,582484,Yes
1494,06-T-050,Treatment of Inflammatory Diseases,2012216651,2012216651,Australia,AU,8/17/2007,11/14/2013, ,9/11/2012,1444-018,Small,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-018,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615008,,582484,Yes
1495,06-T-050,Treatment of Inflammatory Diseases,07837041.8BE,2056807,Belgium,BE,8/17/2007,9/26/2012, ,9/26/2012,1444-019,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-019,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615009,5/13/2009,582484,Yes
1496,06-T-050,Treatment of Inflammatory Diseases,07837041.8DK,2056807,Denmark,DK,8/17/2007,9/26/2012, ,9/26/2012,1444-020,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-020,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615010,5/13/2009,582484,Yes
1497,06-T-050,Treatment of Inflammatory Diseases,07837041.8FI,2056807,Finland,FI,8/17/2007,9/26/2012, ,9/26/2012,1444-021,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-021,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615011,5/13/2009,582484,Yes
1498,06-T-050,Treatment of Inflammatory Diseases,07837041.8FR,2056807,France,FR,8/17/2007,9/26/2012, ,9/26/2012,1444-022,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-022,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615012,5/13/2009,582484,Yes
1499,06-T-050,Treatment of Inflammatory Diseases,07837041.8GB,2056807,United Kingdom,GB,8/17/2007,9/26/2012, ,9/26/2012,1444-023,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-023,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615013,5/13/2009,582484,Yes
1500,06-T-050,Treatment of Inflammatory Diseases,07837041.8LU,2056807,Luxembourg,LU,8/17/2007,9/26/2012, ,9/26/2012,1444-024,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-024,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615014,5/13/2009,582484,Yes
1501,06-T-050,Treatment of Inflammatory Diseases,07837041.8LV,2056807,Latvia,LV,8/17/2007,9/26/2012, ,9/26/2012,1444-025,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-025,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615015,5/13/2009,582484,Yes
1502,06-T-050,Treatment of Inflammatory Diseases,07837041.8SE,2056807,Sweden,SE,8/17/2007,9/26/2012, ,9/26/2012,1444-026,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-026,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615016,5/13/2009,582484,Yes
1503,06-T-050,Treatment of Inflammatory Diseases,07837041.8CH,2056807,Switzerland,CH,8/17/2007,9/26/2012, ,9/26/2012,1444-027,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-027,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615017,5/13/2009,582484,Yes
1504,06-T-050,Treatment of Inflammatory Diseases,07837041.8AT,2056807,Austria,AT,8/17/2007,9/26/2012, ,9/26/2012,1444-028,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-028,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615018,5/13/2009,582484,Yes
1505,06-T-050,Treatment of Inflammatory Diseases,07837041.8BG,2056807,Bulgaria,BG,8/17/2007,9/26/2012, ,9/26/2012,1444-029,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-029,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615019,5/13/2009,582484,Yes
1506,06-T-050,Treatment of Inflammatory Diseases,07837041.8CZ,2056807,Czech Republic,CZ,8/17/2007,9/26/2012, ,9/26/2012,1444-030,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-030,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615020,5/13/2009,582484,Yes
1507,06-T-050,Treatment of Inflammatory Diseases,602007025774.3,2056807,Germany,DE,8/17/2007,9/26/2012, ,9/26/2012,1444-031,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-031,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615021,5/13/2009,582484,Yes
1508,06-T-050,Treatment of Inflammatory Diseases,20120402738,2056807,Greece,GR,8/17/2007,9/26/2012, ,9/26/2012,1444-032,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-032,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615022,5/13/2009,582484,Yes
1509,06-T-050,Treatment of Inflammatory Diseases,07837041.8HU,2056807,Hungary,HU,8/17/2007,9/26/2012, ,9/26/2012,1444-033,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-033,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615023,5/13/2009,582484,Yes
1510,06-T-050,Treatment of Inflammatory Diseases,07837041.8IE,2056807,Ireland,IE,8/17/2007,9/26/2012, ,9/26/2012,1444-034,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-034,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615024,5/13/2009,582484,Yes
1511,06-T-050,Treatment of Inflammatory Diseases,07837041.8IT,2056807,Italy,IT,8/17/2007,9/26/2012, ,9/26/2012,1444-035,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-035,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615025,5/13/2009,582484,Yes
1512,06-T-050,Treatment of Inflammatory Diseases,07837041.8NL,2056807,Netherlands,NL,8/17/2007,9/26/2012, ,9/26/2012,1444-036,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-036,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615026,5/13/2009,582484,Yes
1513,06-T-050,Treatment of Inflammatory Diseases,07837041.8PL,2056807,Poland,PL,8/17/2007,9/26/2012, ,9/26/2012,1444-037,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-037,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615027,5/13/2009,582484,Yes
1514,06-T-050,Treatment of Inflammatory Diseases,07837041.8PT,2056807,Portugal,PT,8/17/2007,9/26/2012, ,9/26/2012,1444-038,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-038,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615028,5/13/2009,582484,Yes
1515,06-T-050,Treatment of Inflammatory Diseases,07837041.8RO,2056807,Romania,RO,8/17/2007,9/26/2012, ,9/26/2012,1444-039,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-039,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615029,5/13/2009,582484,Yes
1516,06-T-050,Treatment of Inflammatory Diseases,07837041.8SK,2056807,Slovakia,SK,8/17/2007,9/26/2012, ,9/26/2012,1444-040,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-040,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615030,5/13/2009,582484,Yes
1517,06-T-050,Treatment of Inflammatory Diseases,07837041.8SI,2056807,Slovenia,SI,8/17/2007,9/26/2012, ,9/26/2012,1444-041,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-041,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615031,5/13/2009,582484,Yes
1518,06-T-050,Treatment of Inflammatory Diseases,07837041.8ES,2056807,Spain,ES,8/17/2007,9/26/2012, ,9/26/2012,1444-042,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-042,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615032,5/13/2009,582484,Yes
1519,06-T-050,Treatment of Inflammatory Diseases,07837041.8TR,2056807,Turkey,TR,8/17/2007,9/26/2012,TR 2012 14039 T4,9/26/2012,1444-043,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-043,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615033,5/13/2009,582484,Yes
1520,06-T-050,Treatment of Inflammatory Diseases,07837041.8HR,2056807,Croatia,HR,8/17/2007,9/26/2012, ,9/26/2012,1444-044,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-044,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615034,5/13/2009,582484,Yes
1521,06-T-050,Treatment of Inflammatory Diseases,07837041.8CY,2056807,Cyprus,CY,8/17/2007,9/26/2012, ,9/26/2012,1444-045,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-045,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615035,5/13/2009,582484,Yes
1522,06-T-050,Treatment of Inflammatory Diseases,07837041.8EE,2056807,Estonia,EE,8/17/2007,9/26/2012, ,9/26/2012,1444-046,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-046,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615036,5/13/2009,582484,Yes
1523,06-T-050,Treatment of Inflammatory Diseases,07837041.8IS,2056807,Iceland,IS,8/17/2007,9/26/2012, ,9/26/2012,1444-047,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-047,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615037,5/13/2009,582484,Yes
1524,06-T-050,Treatment of Inflammatory Diseases,07837041.8LT,2056807,Lithuania,LT,8/17/2007,9/26/2012, ,9/26/2012,1444-048,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-048,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615038,5/13/2009,582484,Yes
1525,06-T-050,Treatment of Inflammatory Diseases,07837041.8MT,2056807,Malta,MT,8/17/2007,9/26/2012, ,9/26/2012,1444-049,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Validated EPO,4/12/2018,1444-049,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615039,5/13/2009,582484,Yes
1526,06-T-050,Treatment of Inflammatory Diseases,MX/a/2013/001203, ,Mexico,MX,8/17/2007,, ,11/11/2015,1444-050,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-050,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615040,,582484,Yes
1527,06-T-050,Treatment of Inflammatory Diseases,2013-041387, ,Japan,JP,8/17/2007,,2013-144694,3/4/2013,1444-051,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-051,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615041,7/25/2013,582484,Yes
1528,06-T-050,Treatment of Inflammatory Diseases,"14/818,534","9,370,497",*United States,US,8/17/2007,6/21/2016,0,8/5/2015,1444-052,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Continuation,4/12/2018,1444-052,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615042,,582484,No
1529,06-T-050,Treatment of Inflammatory Diseases,2015-160277, ,Japan,JP,8/17/2007,,2015-221824,8/17/2015,1444-053,Large,8/17/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Betty Soliven,Divisional,4/12/2018,1444-053,8/17/2027,"Peace, Shane",Betty Soliven,"Muite, Kevin",615043,,582484,No
1530,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,"61/162,544", ,*United States,US,3/23/2009,, ,3/23/2009,1446-001,None,3/23/2009,,Yes,4/28/2022,Expired - Inactive,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",Provisional,4/12/2018,1446-001,3/23/2010,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613249,,582486,Yes
1531,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,PCT/US10/28349, ,*United States,US,3/23/2010,,WO 2010-111294,3/23/2010,1446-002,None,3/23/2009,,No,4/28/2022,Expired - Inactive,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",PCT,4/12/2018,1446-002,9/23/2011,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613250,9/30/2010,582486,Yes
1532,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,"13/259,313", ,*United States,US,3/23/2010,,US-2012-0078017-A1,11/14/2011,1446-003,None,3/23/2009,11/8/2018,No,5/2/2022,Abandoned,Armstrong Teasdale,,37997-00041,"John Alverdy, Olga Zaborina",Nationalized PCT,4/12/2018,1446-003,3/23/2029,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613251,3/29/2012,582486,Yes
1533,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,"2,756,316","2,756,316",Canada,CA,3/23/2010,4/11/2017, ,11/9/2011,1446-004,None,3/23/2009,,No,5/18/2022,Issued,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",Nationalized PCT,4/12/2018,1446-004,3/23/2030,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613252,,582486,Yes
1534,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,PI 1009852-6, ,Brazil,BR,3/23/2010,, ,9/23/2011,1446-005,None,3/23/2009,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",Nationalized PCT,4/12/2018,1446-005,3/23/2029,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613253,,582486,Yes
1535,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,2012-502172,5750096,Japan,JP,3/23/2010,5/22/2015,2012-521987,9/22/2011,1446-006,None,3/23/2009,3/8/2019,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",Nationalized PCT,4/12/2018,1446-006,3/23/2030,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613254,9/20/2012,582486,Yes
1536,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,MX/a/2011/009988, ,Mexico,MX,3/23/2010,, ,9/23/2011,1446-007,None,3/23/2009,,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",Nationalized PCT,4/12/2018,1446-007,3/23/2029,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613255,,582486,Yes
1537,06-T-052,METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED EPITHELIAL DISORDERS,"16/169,636", ,*United States,US,3/23/2010,,us-2020-0016097-a1,10/24/2018,1446-008,Small,3/23/2009,8/20/2021,No,4/28/2022,Abandoned,Armstrong Teasdale,, ,"John Alverdy, Olga Zaborina",Continuation,11/28/2018, ,3/23/2030,"Dembo, Anna",John Alverdy,"Tennant, Thelma",1920908,1/16/2020,582486,Yes
1538,06-T-053,Inhibiting Translation of Aberrant DNMT3B Transcripts in Cancer Cells by Using Inhibitory Nucleic Acids,"60/992,041", ,*United States,US,12/3/2007,, ,12/3/2007,1447-002,Small,12/3/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucy Godley, Kelly Ostler",Provisional,4/12/2018,1447-002,12/3/2008,"Dembo, Anna",Lucy Godley,"Muite, Kevin",612020,,582487,Yes
1539,06-T-053,Inhibiting Translation of Aberrant DNMT3B Transcripts in Cancer Cells Using Inhibitory Nucleic Acids,"60/869,266", ,*United States,US,12/8/2006,, ,12/8/2006,1447-001,Small,12/8/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Lucy Godley, Kelly Ostler",Provisional,4/12/2018,1447-001,12/8/2007,"Dembo, Anna",Lucy Godley,"Muite, Kevin",612021,,582487,Yes
1540,06-T-053,Inhibiting Translation of Aberrant DNMT3B Transcripts in Cancer Cells Using Inhibitory Nucleic Acids,PCT/US07/86854, ,*United States,US,12/7/2007,, ,12/7/2007,1447-003,Small,12/8/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucy Godley, Kelly Ostler",PCT,4/12/2018,1447-003,6/8/2009,"Dembo, Anna",Lucy Godley,"Muite, Kevin",612022,,582487,Yes
1541,06-T-053,Inhibiting Translation of Aberrant DNMT3B Transcripts in Cancer Cells Using Inhibitory Nucleic Acids,"12/518,034", ,*United States,US,12/7/2007,, ,6/5/2009,1447-004,Small,12/8/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucy Godley, Kelly Ostler",Nationalized PCT,4/12/2018,1447-004,12/7/2027,"Dembo, Anna",Lucy Godley,"Muite, Kevin",612023,,582487,Yes
1542,06-T-056,Methods and Compositions for Beta Cell Protection,"60/747,846", ,*United States,US,5/22/2006,, ,5/22/2006,1449-001,Small,5/22/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"David Grdina, Louis Philipson, Michael Roe",Provisional,4/12/2018,1449-001,5/22/2007,"Cox, Ben",David Grdina,"Tennant, Thelma",612660,,582490,Yes
1543,06-T-058,System for the Production of Methane from CO2,"60/813,020", ,*United States,US,6/13/2006,, ,6/13/2006,1452-001,None,6/13/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Peterson, Jeffrey",092234-9094-004,Laurens Mets,Provisional,4/12/2018,1452-001,6/13/2007,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614825,,582492,Yes
1544,06-T-058,System for the Production of Methane from CO2,PCT/US07/71138, ,*United States,US,6/13/2007,,WO 2008/004282,6/13/2007,1452-002,Small,6/13/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9094-006,Laurens Mets,PCT,4/12/2018,1452-002,12/13/2008,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614826,8/7/2008,582492,Yes
1545,06-T-058,System for the Production of Methane from CO2,"12/333,932", ,*United States,US,6/13/2007,,US 2009-0130734 A1,12/12/2008,1452-003,Small,6/13/2006,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,40000,Laurens Mets,Continuation in Part,4/12/2018,1452-003,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614827,5/21/2009,582492,Yes
1546,06-T-058,System for the Production of Methane from CO2,"2,655,474","2,655,474",Canada,CA,6/13/2007,5/24/2016, ,4/8/2009,1452-004,Large,6/13/2006,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun",, ,Laurens Mets,Nationalized PCT,4/12/2018,1452-004,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614828,,582492,Yes
1547,06-T-058,System for the Production of Methane from CO2,07872663.5EPO,2032709,European Patent Office (EPO),EP,6/13/2007,2/17/2021, ,1/13/2009,1452-005,Small,6/13/2006,,No,4/28/2022,Granted,"Marshall, Gerstein & Borun",,31676-40000-EP,Laurens Mets,Nationalized PCT,4/12/2018,1452-005,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614829,,582492,Yes
1548,06-T-058,System for the Production of Methane from CO2,157/KOLNP/2009, ,India,IN,6/13/2007,, ,1/13/2009,1452-006,Small,6/13/2006,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,40000-IN,Laurens Mets,Nationalized PCT,4/12/2018,1452-006,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614830,,582492,Yes
1549,06-T-058,System for the Production of Methane from CO2,"14/480,534", ,*United States,US,6/13/2007,,US2014/0377830 A1,9/8/2014,1452-007,Small,6/13/2006,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,40000B,Laurens Mets,Continuation,4/12/2018,1452-007,9/8/2034,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614831,12/25/2014,582492,Yes
1550,06-T-058,System for the Production of Methane From CO2,"15/647,539", ,*United States,US,6/13/2007,,2018-0094283A1,7/12/2017,1452-008,Small,6/13/2006,2/25/2021,No,4/28/2022,Abandoned,Brinks Gilson & Lione,, ,Laurens Mets,Continuation,4/12/2018,1452-008,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614832,4/5/2018,582492,No
1551,06-T-058,System for the Production of Methane from CO2,E1361512,2032709,Austria,AT,6/13/2007,, ,9/2/2021,1452-009,Small,6/13/2006,9/15/2021,No,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000AT,Laurens Mets,Validated EPO,12/3/2020, ,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5151956,,582492,Yes
1552,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Belgium,BE,6/13/2007,,,,1452-010,None,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000BE,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5151974,,582492,Yes
1553,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Bulgaria,BG,6/13/2007,, ,9/2/2021,1452-011,Small,6/13/2006,9/14/2021,No,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000BG,Laurens Mets,Validated EPO,12/3/2020, ,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5151992,,582492,Yes
1554,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Switzerland,CH,6/13/2007,,,,1452-029,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000CH,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152010,,582492,Yes
1555,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Cyprus,CY,6/13/2007,,,,1452-012,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000CY,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152032,,582492,Yes
1556,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Czech Republic,CZ,6/13/2007,, ,9/2/2021,1452-013,Small,6/13/2006,9/15/2021,No,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000CZ,Laurens Mets,Validated EPO,12/3/2020, ,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152054,,582492,Yes
1557,06-T-058,System for the Production of Methane from CO2,602007060944.5,2032709,Germany,DE,6/13/2007,, ,2/17/2021,1452-014,Small,6/13/2006,9/14/2021,No,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000DE,Laurens Mets,Validated EPO,12/3/2020, ,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152072,,582492,Yes
1558,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Denmark,DK,6/13/2007,,,,1452-015,Small,6/13/2006,9/15/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000DK,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152090,,582492,Yes
1559,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Spain,ES,6/13/2007,,,,1452-027,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000ES,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152108,,582492,Yes
1560,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,France,FR,6/13/2007,,,,1452-017,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000ES,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152126,,582492,Yes
1561,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Finland,FI,6/13/2007,,,,1452-016,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000FI,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152144,,582492,Yes
1562,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,United Kingdom,GB,6/13/2007,,,,1452-032,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000GB,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152166,,582492,Yes
1563,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Hungary,HU,6/13/2007,,,,1452-018,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000HU,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152184,,582492,Yes
1564,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Ireland,IE,6/13/2007,,,,1452-019,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000IE,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152202,,582492,Yes
1565,06-T-058,System for the Production of Methane from CO2,502021000028283,2032709,Italy,IT,6/13/2007,, ,9/2/2021,1452-021,Small,6/13/2006,9/14/2021,No,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000IT,Laurens Mets,Validated EPO,12/3/2020, ,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152220,,582492,Yes
1566,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Iceland,IS,6/13/2007,,,,1452-020,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000IS,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152238,,582492,Yes
1567,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Lithuania,LT,6/13/2007,,,,1452-022,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000LT,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152256,,582492,Yes
1568,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Latvia,LV,6/13/2007,,,,1452-023,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000LV,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152274,,582492,Yes
1569,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Netherlands,NL,6/13/2007,,,,1452-024,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000NL,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152292,,582492,Yes
1570,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Poland,PL,6/13/2007,,,,1452-025,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000PO,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152310,,582492,Yes
1571,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Portugal,PT,6/13/2007,,,,1452-026,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000PT,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152328,,582492,Yes
1572,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Sweden,SE,6/13/2007,,,,1452-028,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000SE,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152346,,582492,Yes
1573,06-T-058,System for the Production of Methane from CO2,07872663.5,2032709,Slovenia,SI,6/13/2007,,,,1452-030,Small,6/13/2006,9/14/2021,No,9/22/2021,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000SI,Laurens Mets,Validated EPO,12/3/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152364,,582492,Yes
1574,06-T-058,System for the Production of Methane from CO2,2021/005345,2032709,Turkey,TR,6/13/2007,, ,9/2/2021,1452-031,Small,6/13/2006,9/14/2021,No,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-40000TR,Laurens Mets,Validated EPO,12/3/2020, ,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5152382,,582492,Yes
1575,06-T-058,System for the Production of Methane From CO2,"17/116,629", ,*United States,US,6/13/2007,,US-2021-0115477-A1,12/9/2020,1452-033,Small,6/13/2006,12/21/2020,No,4/28/2022,Pending,Brinks Gilson & Lione,,31676/4000D,Laurens Mets,Continuation,12/21/2020, ,6/13/2027,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5221566,4/22/2021,582492,No
1576,06-T-058,System for the Production of Methane from CO2,21157493.4, ,European Patent Office (EPO),EP,6/13/2007,, ,2/16/2021,1452-034,Small,6/13/2006,4/26/2021,No,4/28/2022,Pending,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/40000A EP,Laurens Mets,Divisional,2/9/2021, ,6/13/2037,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5365080,,582492,Yes
1577,06-T-061,Methods of Reducing Cell Death Following Hypoxia/Reoxygenation,"60/803,199", ,*United States,US,5/25/2006,, ,5/25/2006,1455-001,None,5/25/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9098-001,Terry Vanden Hoek,Provisional,4/12/2018,1455-001,5/25/2007,"Unassigned, Unassigned",Terry Vanden Hoek,"Unassigned, Unassigned",613343,,582495,Yes
1578,06-T-061,Methods of Reducing Cell Death Following Hypoxia/Reoxygenation,PCT/US07/12535, ,*United States,US,5/25/2007,,WO 2007/139961,5/25/2007,1455-002,Small,5/25/2006,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9098-003,"Lance Becker, David Beiser, Chang-Qing Li, Zuo-Hui Shao, Terry Vanden Hoek",PCT,4/12/2018,1455-002,11/25/2008,"Unassigned, Unassigned",Terry Vanden Hoek,"Unassigned, Unassigned",613344,12/6/2007,582495,Yes
1579,06-T-061,Methods of Reducing Cell Death Following Hypoxia/Reoxygenation,"12/302,140", ,*United States,US,5/25/2007,,US-2009-0110673-A1,11/24/2008,1455-003,Small,5/25/2006,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,,092234-9098-002,"Lance Becker, David Beiser, Chang-Qing Li, Zuo-Hui Shao, Terry Vanden Hoek",Nationalized PCT,4/12/2018,1455-003,5/25/2027,"Unassigned, Unassigned",Terry Vanden Hoek,"Unassigned, Unassigned",613345,4/30/2009,582495,Yes
1580,06-T-062,mDPY-19-1 in Radial Migration,"60/825,015", ,*United States,US,9/8/2006,, ,9/8/2006,1456-001,Small,9/8/2006,,Yes,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9097-001,Yimin Zou,Provisional,4/12/2018,1456-001,9/8/2007,"Unassigned, Unassigned",Yimin Zou,"Unassigned, Unassigned",612229,,582496,Yes
1581,06-T-065,Therapeutics to Inhibit MLL-Menin Interaction for Treating Leukemia,"60/862,067", ,*United States,US,10/19/2006,, ,10/19/2006,1460-001,Small,10/19/2006,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Michael Thirman,Provisional,4/12/2018,1460-001,10/19/2007,"Sun, Han",Michael Thirman,"Tennant, Thelma",614903,,582499,Yes
1582,06-T-065,Therapeutics to Inhibit MLL-Menin Interaction for Treating Leukemia,PCT/US07/81997, ,*United States,US,10/19/2007,,WO2008/070303,10/19/2007,1460-002,Small,10/19/2006,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Michael Thirman,PCT,4/12/2018,1460-002,4/19/2009,"Sun, Han",Michael Thirman,"Tennant, Thelma",614904,6/12/2008,582499,Yes
1583,06-T-065,Therapeutics to Inhibit MLL-Menin Interaction for Treating Leukemia,"12/446,206","8,242,078",*United States,US,10/19/2007,8/14/2012,US-2009-0298772-A1,7/23/2009,1460-003,Small,10/19/2006,,No,4/28/2022,Issued,Barnes & Thornburg,"Martin, Alice", ,Michael Thirman,Nationalized PCT,4/12/2018,1460-003,10/19/2027,"Sun, Han",Michael Thirman,"Tennant, Thelma",614905,12/3/2009,582499,Yes
1584,06-T-065,Therapeutics to Inhibit MLL-Menin Interaction for Treating Leukemia,"13/552,126","8,557,778",*United States,US,10/19/2007,10/15/2013, ,7/18/2012,1460-004,Small,10/19/2006,,No,4/28/2022,Issued,Barnes & Thornburg,"Martin, Alice", ,Michael Thirman,Continuation,4/12/2018,1460-004,10/19/2026,"Sun, Han",Michael Thirman,"Tennant, Thelma",614906,,582499,Yes
1585,06-T-068,Renin Angiotensin Aldosterone System:  Target of Vitamin D Protection and Therapy,"61/036,320", ,*United States,US,3/13/2008,, ,3/13/2008,1709-001,Small,3/13/2008,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Provisional,4/12/2018,1709-001,3/13/2009,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",614393,,582502,Yes
1586,06-T-071,Radiation Phantom with Biological Material in Three-Dimensional Configuration,"60/836,461", ,*United States,US,7/28/2006,, ,7/28/2006,1465-001,Small,7/28/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Michael Altman, Steven Chmura, John Roeske, Vladimir Varchena",Provisional,4/12/2018,1465-001,7/28/2007,"Unassigned, Unassigned",John Roeske,"Unassigned, Unassigned",614265,,582505,Yes
1587,06-T-076,"Bioelectrolytic formation of methane from CO2, water and electric power.",12701286.2AT,2661511,Austria,AT,1/5/2012,6/6/2016,,6/5/2016,1470-017,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-AT,Laurens Mets,Validated EPO,4/12/2018,1470-017,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",610733,11/14/2013,582510,Yes
1588,06-T-076,Electrobiological Methanogensis,"61/222,621", ,*United States,US,7/2/2009,, ,7/2/2009,1470-001,Small,7/2/2009,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,45458-PC,Laurens Mets,Provisional,4/12/2018,1470-001,7/2/2010,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",611515,,582510,Yes
1589,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,"61/430,071", ,*United States,US,1/5/2011,, ,1/5/2011,1470-004,None,1/5/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,45956,Laurens Mets,Provisional,4/12/2018,1470-004,1/5/2012,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612261,,582510,Yes
1590,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,PCT/US12/20386, ,*United States,US,1/5/2012,, ,1/5/2012,1470-008,Small,1/5/2011,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,45956A-PC,Laurens Mets,PCT,4/12/2018,1470-008,7/5/2016,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612262,,582510,Yes
1591,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,1120130173068, ,Brazil,BR,1/5/2012,,2586,7/4/2013,1470-010,Small,1/5/2011,,No,4/28/2022,Pending,"Marshall, Gerstein & Borun",,45956A-BR,Laurens Mets,Nationalized PCT,4/12/2018,1470-010,6/28/2033,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612263,7/28/2020,582510,Yes
1592,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,"2,823,759", ,Canada,CA,1/5/2012,, ,7/3/2013,1470-011,Small,1/5/2011,,No,4/28/2022,Pending,"Marshall, Gerstein & Borun",,45956A-CA,Laurens Mets,Nationalized PCT,4/12/2018,1470-011,6/28/2033,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612264,,582510,Yes
1593,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,"13/978,077","9,428,745",*United States,US,1/5/2012,8/30/2016,US-2014-0011251-A1,7/2/2013,1470-012,Small,1/5/2011,8/30/2016,No,4/28/2022,Issued,"Marshall, Gerstein & Borun",,45956A,Laurens Mets,US Utility,4/12/2018,1470-012,1/5/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612265,1/9/2014,582510,Yes
1594,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,"15/216,616", ,*United States,US,1/5/2012,,US 2016-0319305 A1,7/21/2016,1470-013,Small,1/5/2011,9/18/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,45458D,Laurens Mets,US Utility,4/12/2018,1470-013,6/29/2033,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612266,11/3/2016,582510,Yes
1595,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2EPO,2661511,European Patent Office (EPO),EP,1/5/2012,6/5/2016,2661511,8/5/2013,1470-014,Small,1/5/2011,2/25/2021,No,4/28/2022,Granted,"Marshall, Gerstein & Borun",,45956A-EP,Laurens Mets,Nationalized PCT,4/12/2018,1470-014,1/5/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612267,11/13/2013,582510,Yes
1596,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,16156757.3EPO,3072979,European Patent Office (EPO),EP,1/5/2012,2/24/2021,3072979,2/23/2016,1470-016,Small,1/5/2011,4/19/2021,No,4/28/2022,Granted,"Marshall, Gerstein & Borun",,45956B-EP,Laurens Mets,Divisional,4/12/2018,1470-016,1/5/2031,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612268,9/28/2016,582510,No
1597,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2BE,2661511,Belgium,BE,1/5/2012,6/5/2016,,6/5/2016,1470-018,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-BE,Laurens Mets,Validated EPO,4/12/2018,1470-018,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612269,11/14/2013,582510,Yes
1598,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2CH,2661511,Switzerland,CH,1/5/2012,6/5/2016,,6/5/2016,1470-019,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-CH,Laurens Mets,Validated EPO,4/12/2018,1470-019,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612270,11/14/2013,582510,Yes
1599,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2LI,2661511,Lichtenstein,LI,1/5/2012,6/5/2016,,6/5/2016,1470-020,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-LI,Laurens Mets,Validated EPO,4/12/2018,1470-020,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612271,11/14/2013,582510,Yes
1600,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2DE,60 2012 016 579.0,Germany,DE,1/5/2012,6/5/2016,,6/5/2016,1470-021,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-DE,Laurens Mets,Validated EPO,4/12/2018,1470-021,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612272,11/14/2013,582510,Yes
1601,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2DK,2661511,Denmark,DK,1/5/2012,6/5/2016,,6/5/2016,1470-022,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-DK,Laurens Mets,Validated EPO,4/12/2018,1470-022,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612273,11/14/2013,582510,Yes
1602,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2ES,2661511,Spain,ES,1/5/2012,6/5/2016,,6/5/2016,1470-023,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun",,45956A-ES,Laurens Mets,Validated EPO,4/12/2018,1470-023,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612274,11/14/2013,582510,Yes
1603,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2FI,2661511,Finland,FI,1/5/2012,6/5/2016,,6/5/2016,1470-024,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-FI,Laurens Mets,Validated EPO,4/12/2018,1470-024,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612275,11/14/2013,582510,Yes
1604,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2FR,2661511,France,FR,1/5/2012,6/5/2016,,6/5/2016,1470-025,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-FR,Laurens Mets,Validated EPO,4/12/2018,1470-025,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612276,11/14/2013,582510,Yes
1605,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2HU,2661511,Hungary,HU,1/5/2012,6/5/2016,,6/5/2016,1470-026,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-HU,Laurens Mets,Validated EPO,4/12/2018,1470-026,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612277,11/14/2013,582510,Yes
1606,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2IE,2661511,Ireland,IE,1/5/2012,6/5/2016,,6/5/2016,1470-027,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-IE,Laurens Mets,Validated EPO,4/12/2018,1470-027,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612278,11/14/2013,582510,Yes
1607,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2IS,2661511,Iceland,IS,1/5/2012,6/5/2016,,6/5/2016,1470-028,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-IS,Laurens Mets,Validated EPO,4/12/2018,1470-028,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612280,11/14/2013,582510,Yes
1608,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2IT,502016000069235,Italy,IT,1/5/2012,6/5/2016,,6/5/2016,1470-029,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-IT,Laurens Mets,Validated EPO,4/12/2018,1470-029,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612281,11/14/2013,582510,Yes
1609,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2NL,2661511,Netherlands,NL,1/5/2012,6/5/2016,,6/5/2016,1470-030,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-NL,Laurens Mets,Validated EPO,4/12/2018,1470-030,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612282,11/14/2013,582510,Yes
1610,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2NO,2661511,Norway,NO,1/5/2012,6/5/2016,,6/5/2016,1470-031,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-NO,Laurens Mets,Validated EPO,4/12/2018,1470-031,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612283,11/14/2013,582510,Yes
1611,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2SE,2661511,Sweden,SE,1/5/2012,6/5/2016,,6/5/2016,1470-032,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-SE,Laurens Mets,Validated EPO,4/12/2018,1470-032,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612284,11/14/2013,582510,Yes
1612,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,12701286.2GB,2661511,United Kingdom,GB,1/5/2012,6/5/2016,,6/5/2016,1470-033,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45956A-GB,Laurens Mets,Validated EPO,4/12/2018,1470-033,1/6/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612285,11/14/2013,582510,Yes
1613,06-T-076,METHOD AND SYSTEM FOR CONVERTING ELECTRICITY INTO ALTERNATIVE ENERGY RESOURCES,"15/668,686", ,*United States,US,1/5/2012,,2018-0208884 A1,8/3/2017,1470-034,Small,1/5/2011,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Laurens Mets,Continuation,4/12/2018,1470-034,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612339,7/26/2018,582510,No
1614,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,PCT/US10/40944, ,*United States,US,7/2/2010,,WO 2011/003081 A1,7/2/2010,1470-002,Small,7/2/2009,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45458A-PC,Laurens Mets,PCT,4/12/2018,1470-002,1/2/2012,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612340,1/6/2011,582510,Yes
1615,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,099121889,I500766,"Taiwan, Province of China",TW,7/2/2010,9/21/2015,2011-16628,11/19/2010,1470-003,Small,7/2/2009,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun",,45458A-TW,Laurens Mets,"Foreign, Non-PCT",4/12/2018,1470-003,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612341,5/16/2011,582510,Yes
1616,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,"13/049,775", ,*United States,US,7/2/2010,,US-2011-0165667-A1,3/16/2011,1470-005,Small,7/2/2009,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45458B,Laurens Mets,Continuation in Part,4/12/2018,1470-005,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612342,7/7/2011,582510,Yes
1617,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,"13/204,398", ,*United States,US,7/2/2010,, ,8/5/2011,1470-006,Small,7/2/2009,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",45458C,Laurens Mets,Continuation,4/12/2018,1470-006,7/2/2029,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612343,7/7/2011,582510,Yes
1618,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,1120120000462, ,Brazil,BR,7/2/2010,,2602,2/23/2012,1470-007,Small,7/2/2009,,No,4/28/2022,Pending,"Marshall, Gerstein & Borun",,31676/45458A-BR,Laurens Mets,Nationalized PCT,4/12/2018,1470-007,11/17/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612344,11/17/2020,582510,Yes
1619,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7EPO,2449084,European Patent Office (EPO),EP,7/2/2010,10/28/2020,2449084,1/20/2012,1470-009,Small,7/2/2009,,No,4/28/2022,Granted,"Marshall, Gerstein & Borun","Sintich, Sharon",45458A-EP,Laurens Mets,Nationalized PCT,4/12/2018,1470-009,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612345,5/9/2012,582510,Yes
1620,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10449896,I500766,"Taiwan, Province of China",TW,7/2/2010,9/21/2015, ,6/18/2015,1470-015,Small,7/2/2009,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Laurens Mets,Divisional,4/12/2018,1470-015,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",612346,,582510,No
1621,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,"16/574,984", ,*United States,US,1/5/2012,,US-2020-0248207-A1,9/18/2019,1470-035,Small,1/5/2011,10/22/2019,No,5/4/2022,Pending,"Marshall, Gerstein & Borun",,31676/45956C US,Laurens Mets,Divisional,10/22/2019, ,7/2/2029,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",4045045,8/6/2020,582510,Yes
1622,06-T-076,METHOD AND SYSTEM FOR CONVERTING ELECTRICITY INTO ALTERNATIVE ENERGY RESOURCES,"16/874,373",,*United States,US,1/5/2012,,US-2021-0032582-A1,5/14/2020,1470-036,Small,1/5/2011,6/2/2022,No,6/2/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun",,31676-45458E US,Laurens Mets,Continuation,5/18/2020,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",4560502,2/4/2021,582510,No
1623,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7FR,2449084,France,FR,7/2/2010,10/28/2020,,10/28/2020,1470-037,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun",,31676/458458A FR,Laurens Mets,Validated EPO,9/10/2020,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",4882101,,582510,Yes
1624,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7DE,602010065783.3,Germany,DE,7/2/2010,10/28/2020,2449084,10/28/2020,1470-038,Small,7/2/2009,9/14/2021,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun",, ,Laurens Mets,Validated EPO,9/10/2020, ,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",4882119,,582510,Yes
1625,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,20203855.0, ,European Patent Office (EPO),EP,7/2/2010,, ,10/26/2020,1470-039,Large,7/2/2009,11/25/2020,No,4/28/2022,Pending,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-45458A EPO,Laurens Mets,Divisional,11/25/2020, ,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5124781,,582510,Yes
1626,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,20216725.0,,European Patent Office (EPO),EP,1/5/2012,,3865593,12/22/2020,1470-040,Small,1/5/2011,2/10/2021,No,5/25/2022,Pending,"Marshall, Gerstein & Borun","Sintich, Sharon",31676-45956C EP,Laurens Mets,Divisional,2/10/2021,,1/5/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5368435,8/18/2021,582510,No
1627,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,602012074564.9,3072979,Germany,DE,1/5/2012,2/24/2021,,2/24/2021,1470-041,Small,1/5/2011,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",,Laurens Mets,Validated EPO,2/24/2021,,1/5/2032,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5415038,,582510,No
1628,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7 BE,2449084,Belgium,BE,7/2/2010,10/28/2020, ,10/28/2020,1470-042,Small,7/2/2009,2/25/2021,No,5/25/2022,Issued,"Marshall, Gerstein & Borun","Sintich, Sharon", ,Laurens Mets,Validated EPO,2/25/2021, ,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418474,,582510,Yes
1629,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7 CH,2449084,Switzerland,CH,7/2/2010,10/28/2020,,10/28/2020,1470-043,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A CH,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418494,,582510,Yes
1630,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,Italy,IT,7/2/2010,10/28/2020,,10/28/2020,1470-044,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418512,,582510,Yes
1631,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,Netherlands,NL,7/2/2010,10/28/2020,,10/28/2020,1470-045,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418530,,582510,Yes
1632,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,Norway,NO,7/2/2010,2/15/2021,,10/28/2020,1470-046,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458 A NO,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418548,,582510,Yes
1633,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,Hungary,HU,7/2/2010,10/28/2020,,10/28/2020,1470-047,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A HU,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418566,,582510,Yes
1634,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,Ireland,IE,7/2/2010,10/28/2020,,10/28/2020,1470-048,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A IE,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418584,,582510,Yes
1635,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,Sweden,SE,7/2/2010,10/28/2020,,10/28/2020,1470-049,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A SE,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418602,,582510,Yes
1636,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7 DE,2449084,Denmark,DK,7/2/2010,10/28/2020,,10/28/2020,1470-050,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A DE,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418620,,582510,Yes
1637,06-T-076,Method and System for Converting Electricity Into Alternative Energy Resources,10794826.7,2449084,United Kingdom,GB,7/2/2010,10/28/2020,,10/28/2020,1470-051,Small,7/2/2009,5/25/2022,No,5/25/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458A GB,Laurens Mets,Validated EPO,2/25/2021,,7/2/2030,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",5418638,,582510,Yes
1638,06-T-076,METHOD AND SYSTEM FOR CONVERTING ELECTRICITY INTO ALTERNATIVE ENERGY RESOURCES,"17/690,726",,*United States,US,1/5/2012,,,3/9/2022,1470-052,Small,1/5/2011,3/9/2022,No,6/2/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45458F,Laurens Mets,Continuation,5/4/2022,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",7211067,,582510,
1639,06-T-076,Methanothermobacter Thermautotrophicus Strain and Variants Thereof,"17/673,455",,*United States,US,1/5/2012,,,2/16/2022,1470-053,Small,1/5/2011,5/4/2022,No,6/2/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun","Sintich, Sharon",31676/45956D US,Laurens Mets,Continuation,5/4/2022,,,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",7212464,,582510,
1640,06-T-081,Surface Chemistry and Deposition Techniques,"14/092,728","9,944,982",*United States,US,2/1/2008,4/17/2018, ,11/27/2013,1475-006,Small,2/2/2007,,No,4/28/2022,Issued,Weaver Austin Villeneuve & Sampson LLP,, ,"Milan Mrksich, Stephen Quake, Jerrod Schwartz",Continuation,4/12/2018,1475-006,6/17/2026,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614728,,582515,No
1641,06-T-081,Surface Chemistry and Deposition techniques for Single Molecule Studies,"60/691,535", ,*United States,US,6/17/2005,, ,6/17/2005,1475-001,Small,6/17/2005,,Yes,4/28/2022,Expired - Inactive,,, ,"Milan Mrksich, Stephen Quake, Jerrod Schwartz",Provisional,4/12/2018,1475-001,6/17/2006,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614729,,582515,Yes
1642,06-T-081,Surface Chemistry and Deposition techniques for Single Molecule Studies,"60/899,173", ,*United States,US,2/2/2007,, ,2/2/2007,1475-002,Small,2/2/2007,,Yes,4/28/2022,Expired - Inactive,,, ,"Milan Mrksich, Stephen Quake, Jerrod Schwartz",Provisional,4/12/2018,1475-002,2/2/2008,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614730,,582515,Yes
1643,06-T-081,Surface Chemistry and Deposition techniques for Single Molecule Studies,"12/024,584", ,*United States,US,2/1/2008,,US 2009-0053690 A1,2/1/2008,1475-003,Small,2/2/2007,,No,4/28/2022,Abandoned,Cooley Godward Kronish LLP,, ,"Milan Mrksich, Stephen Quake, Jerrod Schwartz",US Utility,4/12/2018,1475-003,2/1/2028,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614731,,582515,Yes
1644,06-T-081,Surface Chemistry and Deposition techniques for Single Molecule Studies,PCT/US08/52796, ,*United States,US,2/1/2008,,WO 2008/097841,2/1/2008,1475-004,Small,2/2/2007,,No,4/28/2022,Expired - Inactive,Cooley Godward Kronish LLP,, ,"Milan Mrksich, Stephen Quake, Jerrod Schwartz",PCT,4/12/2018,1475-004,8/2/2009,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614732,8/14/2008,582515,Yes
1645,06-T-081,Surface Chemistry and Deposition techniques for Single Molecule Studies,08728823.9EPO, ,European Patent Office (EPO),EP,2/1/2008,, ,10/14/2009,1475-005,Small,2/2/2007,,No,4/28/2022,Abandoned,Cooley Godward Kronish LLP,, ,"Milan Mrksich, Stephen Quake, Jerrod Schwartz",Nationalized PCT,4/12/2018,1475-005,2/1/2028,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614733,,582515,Yes
1646,06-T-084,Composition and Method for Treating Alcoholism,"60/828,830", ,*United States,US,10/10/2006,, ,10/10/2006,1478-001,Small,10/10/2006,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9104-001,Murray Propes,Provisional,4/12/2018,1478-001,10/10/2007,"Unassigned, Unassigned",Murray Propes,"Unassigned, Unassigned",610951,,582518,Yes
1647,06-T-084,Composition and Method for Treating Alcoholism,"11/851,634", ,*United States,US,9/7/2007,,US-2009-005367-A1,9/7/2007,1478-003,Small,10/10/2006,,No,4/28/2022,Abandoned,Global Patent Group LLC,, ,Murray Propes,US Utility,4/12/2018,1478-003,9/7/2027,"Unassigned, Unassigned",Murray Propes,"Unassigned, Unassigned",610952,1/1/2009,582518,Yes
1648,06-T-084,Composition and Method for Treating Alcoholism,PCT/US07/77849, ,*United States,US,9/7/2007,,WO 2008/045641,9/7/2007,1478-004,Small,10/10/2006,,No,4/28/2022,Expired - Inactive,Global Patent Group LLC,"Bennett, Dennis", ,Murray Propes,PCT,4/12/2018,1478-004,4/7/2009,"Unassigned, Unassigned",Murray Propes,"Unassigned, Unassigned",610953,11/20/2008,582518,Yes
1649,06-T-084,Composition and Method for Treating Alcoholism,07814740.2EPO, ,European Patent Office (EPO),EP,7/7/2007,,2073813,2/10/2009,1478-006,Small,10/10/2006,,No,4/28/2022,Abandoned,Global Patent Group LLC,, ,Murray Propes,Nationalized PCT,4/12/2018,1478-006,10/10/2027,"Unassigned, Unassigned",Murray Propes,"Unassigned, Unassigned",610954,7/1/2009,582518,Yes
1650,06-T-084,Composition and Method for Treating Alcoholism and Other Substance Addictions,"61/033,583", ,*United States,US,3/4/2008,, ,3/4/2008,1478-005,None,3/4/2008,,Yes,4/28/2022,Expired - Inactive,Global Patent Group LLC,"Bennett, Dennis", ,Murray Propes,Provisional,4/12/2018,1478-005,3/4/2009,"Unassigned, Unassigned",Murray Propes,"Unassigned, Unassigned",610955,,582518,Yes
1651,06-T-084,Compostion and Method for Treating Alcoholism and Other Substance Addictions,"60/910,017", ,*United States,US,4/4/2007,, ,4/4/2007,1478-002,None,4/4/2007,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9104-002,Murray Propes,Provisional,4/12/2018,1478-002,4/4/2008,"Unassigned, Unassigned",Murray Propes,"Unassigned, Unassigned",611232,,582518,Yes
1652,06-T-089,A Tumor-specific Glycopeptide Epitope,"60/838,070", ,*United States,US,8/16/2006,, ,8/16/2006,1483-001,None,8/16/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Stephen Meredith, Mary Philip, Andrea Schietinger, Hans Schreiber",Provisional,4/12/2018,1483-001,8/16/2007,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610238,,582523,Yes
1653,06-T-103,c-MET MUTATIONS AND USES THEREOF,"60/918,254", ,*United States,US,3/15/2007,, ,3/15/2007,1497-001,Small,3/15/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Ravi Salgia,Provisional,4/12/2018,1497-001,3/15/2008,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610758,,582537,Yes
1654,06-T-103,c-MET MUTATIONS AND USES THEREOF,PCT/US08/57075, ,*United States,US,3/14/2008,,WO2008/113013 A3,3/14/2008,1497-002,Small,3/15/2007,,No,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Ravi Salgia,PCT,4/12/2018,1497-002,9/15/2009,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610759,1/15/2009,582537,Yes
1655,06-T-103,c-MET MUTATIONS AND USES THEREOF,"12/530,172", ,*United States,US,3/14/2008,,US20100062441,9/4/2009,1497-003,Small,3/15/2007,,No,4/28/2022,Abandoned,Ballard Spahr LLP,, ,Ravi Salgia,Nationalized PCT,4/12/2018,1497-003,3/12/2028,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610760,3/11/2010,582537,Yes
1656,06-T-108,Translational Data Mart,"60/888,566", ,*United States,US,2/7/2007,, ,2/7/2007,1502-001,None,2/7/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Olufunmilayo Olopade, Xiaoming Wang",Provisional,4/12/2018,1502-001,2/7/2008,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",614938,,582542,Yes
1657,06-T-108,Translational Data Mart,PCT/US08/53279, ,*United States,US,2/7/2008,,WO 2008/098106,2/7/2008,1502-002,None,2/7/2007,,No,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Olufunmilayo Olopade, Xiaoming Wang",PCT,4/12/2018,1502-002,8/7/2009,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",614939,8/14/2008,582542,Yes
1658,06-T-110,ShearRx,"77/352,262",,*United States,US,12/14/2007,,,,1503-001,Small,12/14/2007,,Yes,4/12/2018,Expired - Inactive,"Mayer, Brown, Rowe & Maw LLP","Weinberger, Seth",,Jonathan Miller,Trademark,4/12/2018,1503-001,12/14/2012,"Sun, Han",Jonathan Miller,"Tennant, Thelma",614490,,582544,Yes
1659,06-T-111,Combination Therapy for Treating Cancer,"60/888,823", ,*United States,US,2/8/2007,, ,2/8/2007,1504-001,Small,2/8/2007,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Yang-Xin Fu, Ralph Weichselbaum",Provisional,4/12/2018,1504-001,2/8/2008,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610940,,582545,Yes
1660,06-T-111,Combination Therapy for Treating Cancer,PCT/US08/53448, ,*United States,US,2/8/2008,, ,2/8/2008,1504-002,Small,2/8/2007,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Yang-Xin Fu, Ralph Weichselbaum",PCT,4/12/2018,1504-002,8/8/2009,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610941,,582545,Yes
1661,06-T-111,Combination Therapy for Treating Cancer,"12/028,399", ,*United States,US,2/8/2008,,US-2009-0093429-A1,2/8/2008,1504-003,Small,2/8/2007,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Yang-Xin Fu, Ralph Weichselbaum",US Utility,4/12/2018,1504-003,2/8/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610942,4/9/2009,582545,Yes
1662,06-T-113,Adjuvants and Methods of Use,PCT/US07/72451, ,*United States,US,6/29/2007,, ,6/29/2007,1506-002,None,6/30/2006,,No,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",PCT,4/12/2018,1506-002,12/30/2008,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610282,,582547,Yes
1663,06-T-113,Adjuvants and Methods of Use,"11/771,128","7,794,722",*United States,US,6/29/2007,9/14/2010, ,4/24/2008,1506-003,None,6/30/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",US Utility,4/12/2018,1506-003,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610283,,582547,Yes
1664,06-T-113,Adjuvants and Methods of Use,07799169.3EPO, ,European Patent Office (EPO),EP,6/29/2007,,2040541,2/17/2009,1506-004,Small,6/30/2006,,No,6/8/2022,Expired - Inactive,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-004,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610284,3/23/2016,582547,Yes
1665,06-T-113,Adjuvants and Methods of Use,"2,655,947", ,Canada,CA,6/29/2007,, ,12/19/2008,1506-005,Small,6/30/2006,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-005,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610285,,582547,Yes
1666,06-T-113,Adjuvants and Methods of Use,2007 269299,200726299,Australia,AU,6/29/2007,5/2/2013, ,12/19/2008,1506-006,Small,6/30/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-006,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610286,,582547,Yes
1667,06-T-113,Adjuvants and Methods of Use,227/KOLNP/2009, ,India,IN,6/29/2007,, ,1/19/2009,1506-007,Small,6/30/2006,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-007,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610287,,582547,Yes
1668,06-T-113,Adjuvants and Methods of Use,2009-5185678,"5,564,672",Japan,JP,6/29/2007,6/27/2014,2009-542712,12/26/2008,1506-008,Small,6/30/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-008,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610288,12/3/2009,582547,Yes
1669,06-T-113,Adjuvants and Methods of Use,PI0713330-8, ,Brazil,BR,6/29/2007,, ,12/30/2008,1506-009,Small,6/30/2006,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-009,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610289,,582547,Yes
1670,06-T-113,Adjuvants and Methods of Use,2009/00203,2009/00203,South Africa,ZA,6/29/2007,6/25/2013, ,1/9/2009,1506-010,Small,6/30/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1506-010,6/29/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610290,,582547,Yes
1671,06-T-113,Adjuvants and Methods of Use,"12/850,428","8,932,594",*United States,US,6/29/2007,1/13/2015,US-2010-0307599-A1,8/4/2010,1506-011,None,6/30/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Divisional,4/12/2018,1506-011,6/30/2026,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",610291,,582547,Yes
1672,06-T-113,Sulfo galactosylceramide compositions and methods,"60/806,330", ,*United States,US,6/30/2006,, ,6/30/2006,1506-001,None,6/30/2006,,Yes,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Provisional,4/12/2018,1506-001,6/30/2007,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",614722,,582547,Yes
1673,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,"60/790,096", ,*United States,US,4/7/2006,, ,4/7/2006,1510-001,Small,4/7/2006,,Yes,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Provisional,4/12/2018,1510-001,4/7/2007,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613425,,582551,Yes
1674,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0AT,2056842,Austria,AT,4/9/2007,10/17/2012, ,10/17/2012,1510-010,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-010,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613426,,582551,Yes
1675,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0BE,2056842,Belgium,BE,4/9/2007,10/17/2012, ,10/17/2012,1510-011,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-011,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613427,,582551,Yes
1676,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0BG,2056842,Bulgaria,BG,4/9/2007,10/17/2012, ,10/17/2012,1510-012,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-012,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613428,,582551,Yes
1677,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0CY,2056842,Cyprus,CY,4/9/2007,10/17/2012, ,10/17/2012,1510-013,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-013,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613429,,582551,Yes
1678,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0CZ,2056842,Czech Republic,CZ,4/9/2007,10/17/2012, ,10/17/2012,1510-014,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-014,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613430,,582551,Yes
1679,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0DK,2056842,Denmark,DK,4/9/2007,10/17/2012, ,10/17/2012,1510-015,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-015,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613431,,582551,Yes
1680,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0EE,2056842,Estonia,EE,4/9/2007,10/17/2012, ,10/17/2012,1510-016,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-016,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613432,,582551,Yes
1681,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0FI,2056842,Finland,FI,4/9/2007,10/17/2012, ,10/17/2012,1510-017,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-017,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613433,,582551,Yes
1682,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0FR,2056842,France,FR,4/9/2007,10/17/2012, ,10/17/2012,1510-018,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-018,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613434,,582551,Yes
1683,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0DE,2056842,Germany,DE,4/9/2007,10/17/2012, ,10/17/2012,1510-019,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-019,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613435,,582551,Yes
1684,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0GR,2056842,Greece,GR,4/9/2007,10/17/2012, ,10/17/2012,1510-020,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-020,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613436,,582551,Yes
1685,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0GB,2056842,United Kingdom,GB,4/9/2007,10/17/2012, ,10/17/2012,1510-021,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-021,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613437,,582551,Yes
1686,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0HU,2056842,Hungary,HU,4/9/2007,10/17/2012, ,10/17/2012,1510-022,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-022,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613438,,582551,Yes
1687,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0IS,2056842,Iceland,IS,4/9/2007,10/17/2012, ,10/17/2012,1510-023,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-023,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613439,,582551,Yes
1688,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0IE,2056842,Ireland,IE,4/9/2007,10/17/2012, ,10/17/2012,1510-024,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-024,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613440,,582551,Yes
1689,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0IT,2056842,Italy,IT,4/9/2007,10/17/2012, ,10/17/2012,1510-025,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-025,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613441,,582551,Yes
1690,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0LV,2056842,Latvia,LV,4/9/2007,10/17/2012, ,10/17/2012,1510-026,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-026,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613442,,582551,Yes
1691,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0LT,2056842,Lithuania,LT,4/9/2007,10/17/2012, ,10/17/2012,1510-027,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-027,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613443,,582551,Yes
1692,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0LU,2056842,Luxembourg,LU,4/9/2007,10/17/2012, ,10/17/2012,1510-028,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-028,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613444,,582551,Yes
1693,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0MT,2056842,Malta,MT,4/9/2007,10/17/2012, ,10/17/2012,1510-029,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-029,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613445,,582551,Yes
1694,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0MC,2056842,Monaco,MC,4/9/2007,10/17/2012, ,10/17/2012,1510-030,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-030,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613446,,582551,Yes
1695,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0NL,2056842,Netherlands,NL,4/9/2007,10/17/2012, ,10/17/2012,1510-031,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-031,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613447,,582551,Yes
1696,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0PL,2056842,Poland,PL,4/9/2007,10/17/2012, ,10/17/2012,1510-032,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-032,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613448,,582551,Yes
1697,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0PT,2056842,Portugal,PT,4/9/2007,10/17/2012, ,10/17/2012,1510-033,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-033,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613449,,582551,Yes
1698,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0SK,2056842,Slovakia,SK,4/9/2007,10/17/2012, ,10/17/2012,1510-034,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-034,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613450,,582551,Yes
1699,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0SI,2056842,Slovenia,SI,4/9/2007,10/17/2012, ,10/17/2012,1510-035,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-035,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613451,,582551,Yes
1700,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0ES,2056842,Spain,ES,4/9/2007,10/17/2012, ,10/17/2012,1510-036,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-036,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613452,,582551,Yes
1701,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0SE,2056842,Sweden,SE,4/9/2007,10/17/2012, ,10/17/2012,1510-037,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-037,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613453,,582551,Yes
1702,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0CH,2056842,Switzerland,CH,4/9/2007,10/17/2012, ,10/17/2012,1510-038,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-038,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613454,,582551,Yes
1703,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0TR,2056842,Turkey,TR,4/9/2007,10/17/2012, ,10/17/2012,1510-039,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-039,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613455,,582551,Yes
1704,06-T-117,Modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells,07760333.0RO,2056842,Romania,RO,4/9/2007,10/17/2012, ,10/17/2012,1510-040,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",Validated EPO,4/12/2018,1510-040,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613456,,582551,Yes
1705,06-T-117,Modified alpha-galactosyl ceramides for staining and stimulating natural killer T cells,PCT/US07/66250, ,*United States,US,4/9/2007,,WO2007/118234,4/9/2007,1510-002,Small,4/7/2006,,No,6/8/2022,Expired - Inactive,Merchant & Gould,"Ward, Wendy", ,"Albert Bendelac, Paul Savage, Luc Teyton",PCT,4/12/2018,1510-002,10/4/2008,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613457,12/6/2007,582551,Yes
1706,06-T-117,Modified alpha-galactosyl ceramides for staining and stimulating natural killer T cells,"12/296,169","8,227,581",*United States,US,4/9/2007,7/24/2012, ,11/5/2008,1510-003,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1510-003,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613458,,582551,Yes
1707,06-T-117,Modified alpha-galactosyl ceramides for staining and stimulating natural killer T cells,PI07106688, ,Brazil,BR,4/9/2007,, ,11/3/2008,1510-004,Small,4/7/2006,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1510-004,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613459,,582551,Yes
1708,06-T-117,Modified alpha-galactosyl ceramides for staining and stimulating natural killer T cells,"13/531,124","8,765,692",*United States,US,4/9/2007,7/1/2014, ,6/22/2012,1510-009,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Continuation,4/12/2018,1510-009,10/24/2033,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613460,,582551,Yes
1709,06-T-117,Modified-galactosyl ceramides for staining and stimulating natural killer T cells,2009/00905,2009/00905,South Africa,ZA,4/9/2007,6/30/2010, ,2/6/2009,1510-005,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1510-005,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613461,,582551,Yes
1710,06-T-117,Modified-galactosyl ceramides for staining and stimulating natural killer T cells,07760333.0EPO,2056842,European Patent Office (EPO),EP,4/9/2007,10/17/2012, ,3/4/2009,1510-006,Small,4/7/2006,,No,6/8/2022,Expired - Inactive,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1510-006,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613462,,582551,Yes
1711,06-T-117,Modified-galactosyl ceramides for staining and stimulating natural killer T cells,"2,661,789","2,661,789",Canada,CA,4/9/2007,6/3/2014, ,6/11/2009,1510-007,Small,4/7/2006,,No,6/8/2022,Issued,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1510-007,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613463,,582551,Yes
1712,06-T-117,Modified-galactosyl ceramides for staining and stimulating natural killer T cells,2007-234753, ,Australia,AU,4/9/2007,, ,7/31/2009,1510-008,Small,4/7/2006,,No,6/8/2022,Pending,Merchant & Gould,, ,"Albert Bendelac, Paul Savage, Luc Teyton",Nationalized PCT,4/12/2018,1510-008,4/9/2027,"Dembo, Anna",Albert Bendelac,"Tennant, Thelma",613464,,582551,Yes
1713,06-T-118,"Method and Compositions Concerning the Vegfr-2 Gene (Kinase Domain Receptor, KDR)","60/911,895", ,*United States,US,4/15/2007,, ,4/15/2007,1511-001,None,4/15/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elisa Cerri, Federico Innocenti, Wanqing Liu, Xin Ye",Provisional,4/12/2018,1511-001,4/15/2008,"Ginsburg, Eric",Federico Innocenti,"Tennant, Thelma",612306,,582552,Yes
1714,06-T-118,"Method and Compositions Concerning the Vegfr-2 Gene (Kinase Domain Receptor, KDR)",PCT/US08/60381, ,*United States,US,4/15/2008,,WO2008/128233,4/15/2008,1511-002,None,4/15/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elisa Cerri, Federico Innocenti, Wanqing Liu, Xin Ye",PCT,4/12/2018,1511-002,10/15/2009,"Ginsburg, Eric",Federico Innocenti,"Tennant, Thelma",612307,10/23/2008,582552,Yes
1715,06-T-122,mexR is a Redox Regulator of Antibiotic Sensitivity and Multidrug Resistance,"60/866,754", ,*United States,US,11/21/2006,, ,11/21/2006,1516-001,Small,11/21/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Hao Chen, Chuan He",Provisional,4/12/2018,1516-001,11/21/2007,"Hwang, Luke",Chuan He,"Tennant, Thelma",613379,,582556,Yes
1716,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,"60/952,565", ,*United States,US,7/28/2007,, ,7/28/2007,1524-001,Small,7/28/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,1524-001,7/28/2008,"Peace, Shane",Philip Connell,"Tennant, Thelma",612805,,582565,Yes
1717,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,"60/972,593", ,*United States,US,9/14/2007,, ,9/14/2007,1524-002,Small,9/14/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,1524-002,9/14/2008,"Peace, Shane",Philip Connell,"Tennant, Thelma",612806,,582565,Yes
1718,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,"61/024,497", ,*United States,US,1/29/2008,, ,1/29/2008,1524-003,Small,1/29/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,1524-003,1/29/2009,"Peace, Shane",Philip Connell,"Tennant, Thelma",612807,,582565,Yes
1719,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,"61/024,513", ,*United States,US,1/29/2008,, ,1/29/2008,1524-004,Small,1/29/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,1524-004,7/28/2008,"Peace, Shane",Philip Connell,"Tennant, Thelma",612808,,582565,Yes
1720,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,PCT/US08/71364, ,*United States,US,7/28/2008,,WO 2009/018219,7/28/2008,1524-005,Small,7/28/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",PCT,4/12/2018,1524-005,1/28/2010,"Peace, Shane",Philip Connell,"Tennant, Thelma",612809,2/5/2009,582565,Yes
1721,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,"12/671,147","8,597,949",*United States,US,7/28/2008,12/3/2013,US-2010-0248371-A1,5/19/2010,1524-006,Small,7/28/2007,12/3/2013,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1524-006,4/17/2030,"Peace, Shane",Philip Connell,"Tennant, Thelma",612810,9/30/2010,582565,Yes
1722,06-T-131,Methods and Compositions for Modulating Rad51 and Homologous Recombination,"14/074,395","9,198,914",*United States,US,7/28/2008,12/1/2015,US-2014-0142103-A1,11/7/2013,1524-007,Small,7/28/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Philip Connell, Ralph Weichselbaum",Divisional,4/12/2018,1524-007,9/4/2028,"Peace, Shane",Philip Connell,"Tennant, Thelma",612811,5/22/2014,582565,Yes
1723,06-T-132,Processing Data Base Information Having Nonwhite Noise,"08/068,712","5,410,492",*United States,US,5/27/1993,4/25/1995, ,4/8/1996,92-099-001,Small,1/29/1992,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Kenneth Gross, Pat Morreale",Continuation in Part,4/12/2018,92-099-001,5/27/2013,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614174,,582566,Yes
1724,06-T-132,SPRT/DBMS,TXu-782-592,TXu-782-592,*United States,US,2/5/1997,2/5/1997, ,,92-099-002,None,,,No,8/4/2020,Registered (Copyright),,, ,"Kenneth Gross, Pat Morreale",Copyright Application,4/12/2018,92-099-002,2/5/2017,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614601,,582566,Yes
1725,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,"60/909,061", ,*United States,US,3/30/2007,, ,3/30/2007,1527-001,Large,3/30/2007,,Yes,4/28/2022,Expired - Inactive,,, ,"Jim Beckett, Gregory Karczmar, Charles Pelizzari, Sham Sokka, Joop Van Waals",Provisional,4/12/2018,1527-001,3/30/2008,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613539,,582568,Yes
1726,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,PCT/US08/50843, ,*United States,US,3/30/2008,,WO/2008/120117,3/30/2008,1527-002,Large,3/30/2007,,No,4/28/2022,Expired - Inactive,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Damen, Daniel", ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",PCT,4/12/2018,1527-002,9/30/2009,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613540,10/9/2008,582568,Yes
1727,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,"12/531,495", ,*United States,US,3/30/2008,, ,9/16/2009,1527-003,Large,3/30/2007,,No,4/28/2022,Allowed,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",Nationalized PCT,4/12/2018,1527-003,3/30/2028,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613541,,582568,Yes
1728,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,08719607.7EPO, ,European Patent Office (EPO),EP,3/30/2008,,EP20080719607,9/16/2009,1527-004,Large,3/30/2007,,No,4/28/2022,Pending,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Damen, Daniel", ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",Nationalized PCT,4/12/2018,1527-004,3/30/2028,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613542,12/16/2009,582568,Yes
1729,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,200880010558.0, ,China,CN,3/30/2008,, ,9/16/2009,1527-005,Large,3/30/2007,,No,4/28/2022,Pending,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Damen, Daniel", ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",Nationalized PCT,4/12/2018,1527-005,3/30/2028,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613543,,582568,Yes
1730,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,6286/CHENP/2009, ,India,IN,3/30/2008,, ,9/16/2009,1527-006,Large,3/30/2007,,No,4/28/2022,Pending,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",Nationalized PCT,4/12/2018,1527-006,3/30/2028,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613544,,582568,Yes
1731,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,10-500394,5305127,Japan,JP,3/30/2008,6/28/2013, ,9/16/2009,1527-007,Large,3/30/2007,,No,4/28/2022,Issued,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Damen, Daniel", ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",Nationalized PCT,4/12/2018,1527-007,3/30/2028,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613545,,582568,Yes
1732,06-T-134,MRI-Guided HIFU Marking to Guide Radiotherapy and Other Procedures,097111042, ,"Taiwan, Province of China",TW,3/30/2008,, ,9/16/2009,1527-008,Large,3/30/2007,,No,4/28/2022,Pending,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Damen, Daniel", ,"Gregory Karczmar, Charles Pelizzari, Sham Sokka",Nationalized PCT,4/12/2018,1527-008,3/30/2028,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613546,,582568,Yes
1733,06-T-135,SYSTEMATIC IDENTIFICATION OF CIS-SILENCED GENES BY TRANSCOMPLEMENTATION,"61/059,514", ,*United States,US,6/7/2008,, ,6/7/2008,1526-001,None,6/7/2008,,Yes,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,Bruce Lahn,Provisional,4/12/2018,1526-001,6/7/2009,"Ginsburg, Eric",Bruce Lahn,"Muite, Kevin",614834,,582569,Yes
1734,06-T-136,Spacers for Microfluidic Channels,"12/520,027", ,*United States,US,12/19/2007,,US-2010-0078077-A1,6/18/2009,1528-003,Small,12/19/2006,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00258,"Delai Chen, Wenbin Du, Rustem Ismagilov, Liang Li",Nationalized PCT,4/12/2018,1528-003,12/19/2027,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614588,4/1/2010,582570,Yes
1735,06-T-136,Using Three-Phase Flow of Immiscible Liquids to Prevent Coalescence of Droplets in Microfluidic Channels: Criteria to Identify the Third Liquid and Validation with Protein Crystallization,"60/875,856", ,*United States,US,12/19/2006,, ,12/19/2006,1528-001,Small,12/19/2006,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00176,"Delai Chen, Rustem Ismagilov, Liang Li",Provisional,4/12/2018,1528-001,12/19/2007,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",615334,,582570,Yes
1736,06-T-136,Using Three-Phase Flow of Immiscible Liquids to Prevent Coalescence of Droplets in Microfluidic Channels: Criteria to Identify the Third Liquid and Validation with Protein Crystallization,PCT/US07/26028, ,*United States,US,12/19/2007,,WO2008/079274,12/19/2007,1528-002,Small,12/19/2006,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00198,"Delai Chen, Wenbin Du, Rustem Ismagilov, Liang Li",PCT,4/12/2018,1528-002,6/19/2009,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",615335,7/3/2008,582570,Yes
1737,06-T-139,Fast Linear-time Connected-Component Labeling Software,TXu1-620-592,,*United States,US,1/29/2008,,,,1531-001,None,1/29/2008,,Yes,4/12/2018,Registered (Copyright),,,,"Yuyan Chao, Lifeng He, Kenji Suzuki",Copyright Application,4/12/2018,1531-001,1/29/2028,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",611568,,582573,Yes
1738,06-T-141,Device for Monitoring pH and Electrolyte Concentration in Saliva or Urine,"60/930,316", ,*United States,US,5/15/2007,, ,5/15/2007,1533-002,Small,5/15/2007,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00191,"Cory Gerdts, Rustem Ismagilov, Matthew Runyon",Provisional,4/12/2018,1533-002,5/15/2008,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611441,,582575,Yes
1739,06-T-141,Silver Sensitive Detection System,"60/899,449", ,*United States,US,2/5/2007,, ,2/5/2007,1533-001,Small,2/5/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00178,"Cory Gerdts, Rustem Ismagilov, Matthew Runyon",Provisional,4/12/2018,1533-001,2/5/2008,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614514,,582575,Yes
1740,06-T-143,Cancer Gene Expression Arrays and Uses Thereof,"60/941,542", ,*United States,US,6/1/2007,, ,6/1/2007,1535-001,Small,6/1/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Thomas Gajewski,Provisional,4/12/2018,1535-001,6/1/2008,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610774,,582577,Yes
1741,06-T-144,Targeting of Herpes Simplex Virus to Specific Receptors,"11/677,026", ,*United States,US,8/18/2006,, ,2/20/2007,1536-001,Small,8/19/2005,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",42553,"Bernard Roizman, Grace Zhou",Continuation in Part,4/12/2018,1536-001,2/19/2026,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614864,,582578,Yes
1742,06-T-144,Targeting of Herpes Simplex Virus to Specific Receptors,PCT/US08/54469, ,*United States,US,2/20/2008,,WO2008/103762,2/20/2008,1536-002,Large,2/20/2007,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",42553A-PC,"Bernard Roizman, Grace Zhou",PCT,4/12/2018,1536-002,8/20/2009,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614865,8/28/2008,582578,Yes
1743,07-T-006,FACECARDS,"77/189,602","3,683,617",*United States,US,5/24/2007,9/15/2009,,,1544-001,None,5/24/2007,,Yes,3/21/2019,Abandoned,Michael Best & Friedrich LLP,"Peterson, Jeffrey",092234-9117-001,"Vineet Arora, Holly Humphrey, Julie Johnson, David Meltzer, Megan Tormey, James Woodruff",Trademark,4/12/2018,1544-001,5/24/2027,"Ramirez, Mario Riojas",Vineet Arora,"Tennant, Thelma",611561,,582586,Yes
1744,07-T-007,Polymers and Uses Thereof,"60/948,301", ,*United States,US,7/6/2007,, ,7/6/2007,1543-001,None,7/6/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Lin Gan, Jennifer Olson, Clifton Ragsdale, Luping Yu",Provisional,4/12/2018,1543-001,7/6/2008,"Bakalyar, Heather",Clifton Ragsdale,"Tennant, Thelma",614096,,582587,Yes
1745,07-T-007,Polymers and Uses Thereof,PCT/US08/69210, ,*United States,US,7/3/2008,,WO 2009/009434 A1,7/3/2008,1543-002,None,7/6/2007,,No,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Lin Gan, Jennifer Olson, Clifton Ragsdale, Luping Yu",PCT,4/12/2018,1543-002,1/6/2010,"Bakalyar, Heather",Clifton Ragsdale,"Tennant, Thelma",614097,1/15/2009,582587,Yes
1746,07-T-007,Polymers and Uses Thereof,"12/667,981", ,*United States,US,7/3/2008,, ,1/6/2010,1543-003,None,7/6/2007,,No,4/28/2022,Abandoned,Ballard Spahr LLP,, ,"Lin Gan, Jennifer Olson, Clifton Ragsdale, Luping Yu",Nationalized PCT,4/12/2018,1543-003,7/3/2018,"Bakalyar, Heather",Clifton Ragsdale,"Tennant, Thelma",614098,,582587,Yes
1747,07-T-009,Photo-Crosslinking Agent and Method for Analyzing DNA Binding Molecules,"60/933,423", ,*United States,US,6/6/2007,, ,6/6/2007,1546-001,Small,6/6/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00186,"Chuan He, Zhihai Qiu",Provisional,4/12/2018,1546-001,6/6/2008,"Hwang, Luke",Chuan He,"Tennant, Thelma",613965,,582589,Yes
1748,07-T-010,Methods and Compositions Involving LtaS,"60/913,469", ,*United States,US,4/23/2007,, ,4/23/2007,1547-001,Small,4/23/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angelika Grundling, Olaf Schneewind",Provisional,4/12/2018,1547-001,4/23/2008,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",612963,,582590,Yes
1749,07-T-010,Methods and Compositions Involving LtaS,PCT/US08/61335, ,*United States,US,4/23/2008,,WO2008/131441,4/23/2008,1547-002,Small,4/23/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angelika Grundling, Olaf Schneewind",PCT,4/12/2018,1547-002,10/23/2009,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",612964,10/30/2008,582590,Yes
1750,07-T-013,Methods of use of Adenine Derivatives for the Treatment of Diabetes and other Disorders,"61/048,813", ,*United States,US,4/29/2008,, ,4/29/2008,1551-001,Small,4/29/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Cristina Alarcon, Christopher Rhodes",Provisional,4/12/2018,1551-001,4/29/2009,"Dembo, Anna",Christopher Rhodes,"Tennant, Thelma",613365,,582593,Yes
1751,07-T-013,Methods of Use of Adenine Derivatives for the Treatment of Diabetes and other Disorders,PCT/US09/42095, ,*United States,US,4/29/2009,,WO2010/002492,4/29/2009,1551-002,Small,4/29/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Cristina Alarcon, Christopher Rhodes",PCT,4/12/2018,1551-002,10/29/2010,"Dembo, Anna",Christopher Rhodes,"Tennant, Thelma",613366,1/7/2010,582593,Yes
1752,07-T-015,Use of Vanadyl Chelates in PET Imaging,"61/082,011", ,*United States,US,7/18/2008,, ,7/18/2008,1553-001,None,7/18/2008,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Yager, Charlene",092234-9155-001,"Daniel Appelbaum, Chin-Tu Chen, Suzanne Conzen, Marvin Makinen",Provisional,4/12/2018,1553-001,7/18/2009,"Bakalyar, Heather",Marvin Makinen,"Muite, Kevin",615308,,582595,Yes
1753,07-T-019,High-Throughput Syntehsis and Purification of Small-Molecules and Libraries Therefrom,"60/902,594", ,*United States,US,2/20/2007,, ,2/20/2007,1557-001,Small,2/20/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00188,"Jiayue Cui, Sergey Kozmin, Ha-Jong Lee, Kenji Matsumoto, Masato Suzuki",Provisional,4/12/2018,1557-001,2/20/2008,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",611821,,582599,Yes
1754,07-T-019,"Method for Assembling High-Purity Chemical Libraries, Compounds Suppressing Acetyl Coenzyme A Carboxylase Activities Discovered by Same",PCT/US08/02240, ,*United States,US,2/20/2008,,WO 2008/103382,2/20/2008,1557-003,Small,2/20/2007,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00204,"Jiayue Cui, Piotr Gornicki, Robert Haselkorn, Sergey Kozmin",PCT,4/12/2018,1557-003,8/20/2009,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",612426,8/28/2008,582599,Yes
1755,07-T-019,"Method for Assembling High-Purity Chemical Libraries, Compounds Suppressing Acetyl Coenzyme A Carboxylase Activities Discovered by Same","12/543,792","8,445,481",*United States,US,2/20/2008,5/21/2013,US-2010-0035892-A1,8/19/2009,1557-004,Small,2/20/2007,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00263,"Jiayue Cui, Piotr Gornicki, Robert Haselkorn, Sergey Kozmin, Stephen Kron, Olesya Ulanovskaya",Continuation in Part,4/12/2018,1557-004,8/19/2029,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",612427,2/11/2010,582599,Yes
1756,07-T-019,"Method for Assembling High-Purity Chemical Libraries, Proapoptotic Compounds Discovered by Same",PCT/US08/02203, ,*United States,US,2/20/2008,,WO 2008/103367,2/20/2008,1557-002,Small,2/20/2007,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00203,"Jiayue Cui, Sergey Kozmin, Ha-Jong Lee, Kenji Matsumoto",PCT,4/12/2018,1557-002,8/20/2009,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",612428,12/31/2008,582599,Yes
1757,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,"60/917,852", ,*United States,US,5/14/2007,, ,5/14/2007,1563-001,None,5/14/2007,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Provisional,4/12/2018,1563-001,5/14/2008,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610408,,582605,Yes
1758,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,PCT/US08/06381, ,*United States,US,5/14/2008,,WO2008/144029,5/14/2008,1563-002,None,5/14/2007,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,PCT,4/12/2018,1563-002,11/14/2009,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610409,,582605,Yes
1759,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,"12/599,946","8,263,081",*United States,US,5/14/2008,9/11/2012,US-2011-0020340-A1,12/30/2009,1563-003,None,5/14/2007,,No,5/8/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1563-003,1/24/2029,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610410,1/27/2011,582605,Yes
1760,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7EPO,EP2160200,European Patent Office (EPO),EP,5/14/2008,7/10/2013,EP2160200,11/7/2013,1563-004,Small,5/14/2007,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,1563-004,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610412,3/10/2010,582605,Yes
1761,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,"13/563,372","9,061,073",*United States,US,5/14/2008,6/23/2015,US-2012-0328558-A1,7/31/2012,1563-005,Small,5/14/2007,,No,5/8/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Divisional,4/12/2018,1563-005,5/14/2027,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610413,12/27/2012,582605,Yes
1762,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,13175640.5EPO, ,European Patent Office (EPO),EP,5/14/2008,,2 650 018,7/11/2013,1563-006,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Divisional,4/12/2018,1563-006,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610414,10/16/2013,582605,Yes
1763,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7CH,2160200,Switzerland,CH,5/14/2008,10/8/2013,2160200,10/8/2013,1563-007,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1563-007,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610415,3/10/2010,582605,Yes
1764,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7DE,602008025926.9,Germany,DE,5/14/2008,9/11/2013,2160200,9/11/2013,1563-008,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1563-008,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610416,3/10/2010,582605,Yes
1765,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7ES,2160200,Spain,ES,5/14/2008,10/9/2013,2160200,10/9/2013,1563-009,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1563-009,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610417,3/10/2010,582605,Yes
1766,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7FR,2160200,France,FR,5/14/2008,9/11/2013,2160200,9/11/2013,1563-010,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1563-010,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610418,3/10/2010,582605,Yes
1767,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7GB,2160200,United Kingdom,GB,5/14/2008,9/11/2013,2160200,9/11/2013,1563-011,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1563-011,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610419,3/10/2010,582605,Yes
1768,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,08754530.7IT,2160200,Italy,IT,5/14/2008,10/8/2013,2160200,10/8/2013,1563-012,Small,5/14/2007,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Validated EPO,4/12/2018,1563-012,5/14/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610420,3/10/2010,582605,Yes
1769,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,"14/717,808","9,623,116",*United States,US,5/14/2008,4/18/2017,US2015/0283260,5/20/2015,1563-013,Small,5/14/2007,,No,5/8/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Divisional,4/12/2018,1563-013,4/18/2028,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610421,10/8/2015,582605,Yes
1770,07-T-025,ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS,"15/488,953", ,*United States,US,5/14/2008,, ,4/17/2017,1563-014,Small,5/14/2007,,No,6/23/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Continuation,4/12/2018,1563-014,,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",610422,,582605,No
1771,07-T-030,Characterization of Biomolecular Interactions Using Self-Assembled Monolayers,"60/920,009", ,*United States,US,3/26/2007,, ,3/26/2007,1568-001,None,3/26/2007,,Yes,6/8/2022,Expired - Inactive,Brinks Gilson & Lione,"Boivin, Nicolas",00190,"Violeta Marin, Milan Mrksich, Steven Patrie",Provisional,4/12/2018,1568-001,3/26/2008,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610832,,582610,Yes
1772,07-T-030,Characterization of Biomolecular Interactions Using Self-Assembled Monolayers,"60/928,496", ,*United States,US,5/9/2007,, ,5/9/2007,1568-002,None,5/9/2007,,Yes,6/8/2022,Expired - Inactive,Brinks Gilson & Lione,"Boivin, Nicolas",00192,"Violeta Marin, Milan Mrksich, Steven Patrie",Provisional,4/12/2018,1568-002,5/9/2008,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610833,,582610,Yes
1773,07-T-030,Characterization of Biomolecular Interactions Using Self-Assembled Monolayers,PCT/US08/58267, ,*United States,US,3/26/2008,, ,3/26/2008,1568-003,None,3/26/2007,,No,6/8/2022,Expired - Inactive,Brinks Gilson & Lione,"Boivin, Nicolas",00210,"Violeta Marin, Milan Mrksich, Steven Patrie",PCT,4/12/2018,1568-003,9/26/2009,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610834,,582610,Yes
1774,07-T-030,Characterization of Biomolecular Interactions Using Self-Assembled Monolayers,"2,682,543", ,Canada,CA,3/26/2008,, ,9/23/2009,1568-005,None,3/26/2007,,No,6/8/2022,Abandoned,Brinks Gilson & Lione,,00266,"Violeta Marin, Milan Mrksich, Steven Patrie",Nationalized PCT,4/12/2018,1568-005,3/26/2028,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610835,,582610,Yes
1775,07-T-030,Characterization of Biomolecular Interactions Using Self-Assembled Monolayers,08744384.2EPO, ,European Patent Office (EPO),EP,3/26/2008,, ,10/20/2009,1568-006,None,3/26/2007,,No,6/8/2022,Abandoned,Brinks Gilson & Lione,,00267,"Violeta Marin, Milan Mrksich, Steven Patrie",Nationalized PCT,4/12/2018,1568-006,3/26/2028,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",610836,,582610,Yes
1776,07-T-030,Immunoassays and Characterization of Biomolecular Interactions Using Self-Assembled Monolayers,"12/565,575", ,*United States,US,3/26/2008,,US-2010-0112722-A1,9/23/2009,1568-004,None,3/26/2007,,No,6/8/2022,Abandoned,Brinks Gilson & Lione,,00265,"Violeta Marin, Milan Mrksich, Steven Patrie",Nationalized PCT,4/12/2018,1568-004,3/26/2028,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",611930,5/6/2010,582610,Yes
1777,07-T-032,Plant Pathogen Resistance,"60/956,301", ,*United States,US,8/16/2007,, ,8/17/2007,1570-001,None,8/16/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0508USP1,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Provisional,4/12/2018,1570-001,8/16/2008,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614022,,582612,Yes
1778,07-T-032,Plant Pathogen Resistance,PCT/US08/73169, ,*United States,US,8/14/2008,,WO 2009/055126 A2,8/15/2008,1570-002,None,8/16/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",PCT,4/12/2018,1570-002,2/16/2010,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614023,4/30/2009,582612,Yes
1779,07-T-032,Plant Pathogen Resistance,"12/191,833","8,318,786",*United States,US,8/14/2008,11/27/2012,US-2009-0048312-A1,8/14/2008,1570-003,None,8/16/2007,11/27/2012,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",US Utility,4/12/2018,1570-003,11/19/2029,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614024,2/19/2009,582612,Yes
1780,07-T-032,Plant Pathogen Resistance,08843231.5EPO,EP 2187736,European Patent Office (EPO),EP,8/14/2008,7/29/2015,2187736,3/4/2010,1570-004,None,8/16/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-004,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614025,5/26/2010,582612,Yes
1781,07-T-032,Plant Pathogen Resistance,PI0815421-0,PI0815421-0,Brazil,BR,8/14/2008,7/29/2015, ,2/12/2010,1570-005,None,8/16/2007,10/28/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0508BR,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-005,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614026,,582612,Yes
1782,07-T-032,Plant Pathogen Resistance,"2,696,438","2,696,438",Canada,CA,8/14/2008,7/29/2015, ,2/12/2010,1570-006,Small,8/16/2007,10/28/2021,No,6/15/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0508CA,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-006,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614027,,582612,Yes
1783,07-T-032,Plant Pathogen Resistance,MX/a/2010/001656,293293,Mexico,MX,8/14/2008,12/7/2011, ,2/9/2010,1570-007,None,8/16/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0508MX,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-007,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614028,,582612,Yes
1784,07-T-032,Plant Pathogen Resistance,2010-521177, ,Japan,JP,8/14/2008,9/20/2013,2010-536785,3/13/2010,1570-008,None,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-008,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614029,12/2/2010,582612,Yes
1785,07-T-032,Plant Pathogen Resistance,2010/01088,2010/01088,South Africa,ZA,8/14/2008,10/27/2010, ,2/16/2010,1570-009,None,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-009,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614030,,582612,Yes
1786,07-T-032,Plant Pathogen Resistance,2008317218,AU 2008317218,Australia,AU,8/14/2008,10/23/2014, ,2/10/2010,1570-010,None,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Nationalized PCT,4/12/2018,1570-010,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614031,7/10/2014,582612,Yes
1787,07-T-032,Plant Pathogen Resistance,2013-151627, ,Japan,JP,8/14/2008,,2013-213070,7/22/2013,1570-011,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Divisional,4/12/2018,1570-011,10/22/2032,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614032,10/17/2013,582612,Yes
1788,07-T-032,Plant Pathogen Resistance,"13/657,557","9,161,533",*United States,US,8/14/2008,10/20/2015, ,10/22/2012,1570-012,Small,8/16/2007,10/20/2015,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Divisional,4/12/2018,1570-012,10/3/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614033,2/19/2009,582612,Yes
1789,07-T-032,Plant Pathogen Resistance,2014246584, ,Australia,AU,8/14/2008,, ,10/9/2014,1570-013,None,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Divisional,4/12/2018,1570-013,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614034,7/10/2014,582612,Yes
1790,07-T-032,Plant Pathogen Resistance,15178546.6EPO, ,European Patent Office (EPO),EP,8/14/2008,,2965625,8/10/2008,1570-014,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Divisional,4/12/2018,1570-014,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614035,7/10/2014,582612,No
1791,07-T-032,Plant Pathogen Resistance,"14/884,874", ,*United States,US,8/14/2008,,US-2016-0029622-A1,10/16/2015,1570-015,Small,8/16/2007,5/2/2017,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Continuation,4/12/2018,1570-015,,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614036,2/19/2009,582612,No
1792,07-T-032,Plant Pathogen Resistance,08843231.5FR,EP 2187736,France,FR,8/14/2008,7/29/2015,2187736,7/29/2015,1570-016,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-016,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614037,5/26/2010,582612,No
1793,07-T-032,Plant Pathogen Resistance,602008039300.3DE,EP 2187736,Germany,DE,8/14/2008,7/29/2015,2187736,7/29/2015,1570-017,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-017,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614038,5/26/2010,582612,No
1794,07-T-032,Plant Pathogen Resistance,08843231.5IE,EP 2187736,Ireland,IE,8/14/2008,7/29/2015,2187736,10/12/2015,1570-018,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-018,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614039,5/26/2010,582612,No
1795,07-T-032,Plant Pathogen Resistance,502015000065733IT,EP 2187736,Italy,IT,8/14/2008,7/29/2015,2187736,10/27/2015,1570-019,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-019,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614040,5/26/2010,582612,No
1796,07-T-032,Plant Pathogen Resistance,08843231.5NL,EP 2187736,Netherlands,NL,8/14/2008,7/29/2015,2187736,10/19/2015,1570-020,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-020,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614041,5/26/2010,582612,No
1797,07-T-032,Plant Pathogen Resistance,08843231.5PL,EP 2187736,Poland,PL,8/14/2008,7/29/2015,2187736,11/18/2015,1570-021,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-021,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614042,5/26/2010,582612,No
1798,07-T-032,Plant Pathogen Resistance,08843231.5PT,EP 2187736,Portugal,PT,8/14/2008,7/29/2015,2187736,10/19/2015,1570-022,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-022,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614043,5/26/2010,582612,No
1799,07-T-032,Plant Pathogen Resistance,08843231.5RO,EP 2187736,Romania,RO,8/14/2008,7/29/2015,2187736,10/15/2015,1570-023,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-023,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614044,5/26/2010,582612,No
1800,07-T-032,Plant Pathogen Resistance,08843231.5ES,EP 2187736,Spain,ES,8/14/2008,7/29/2015,2550481,7/29/2015,1570-024,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-024,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614045,5/26/2010,582612,No
1801,07-T-032,Plant Pathogen Resistance,2015/12887TR,EP 2187736,Turkey,TR,8/14/2008,7/29/2015,2187736,10/15/2015,1570-025,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-025,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614046,5/26/2010,582612,No
1802,07-T-032,Plant Pathogen Resistance,08843231.5GB,EP 2187736,United Kingdom,GB,8/14/2008,7/29/2015,2187736,7/29/2015,1570-026,Small,8/16/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jean Greenberg, Ho Jung, Timothy Tschaplinski",Validated EPO,4/12/2018,1570-026,8/14/2028,"Peace, Shane",Jean Greenberg,"Tennant, Thelma",614047,5/26/2010,582612,No
1803,07-T-035,Treatment of Drug-Induced Nausea with Opioid Antagonists,"60/992,555", ,*United States,US,12/5/2007,, ,12/5/2007,1571-001,Large,12/5/2007,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9123-002,Chun-Su Yuan,Provisional,4/12/2018,1571-001,12/5/2008,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614983,,582615,Yes
1804,07-T-035,Treatment of Drug-Induced Nausea with Opioid Antagonists,PCT/US08/85662, ,*United States,US,12/5/2008,,WO2009/076195,12/5/2008,1571-002,Large,12/5/2007,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9123-003,Chun-Su Yuan,PCT,4/12/2018,1571-002,6/5/2010,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614984,6/18/2009,582615,Yes
1805,07-T-035,Treatment of Drug-Induced Nausea with Opioid Antagonists,2010-537105,5595278,Japan,JP,12/5/2008,8/15/2014,2011-506339,6/4/2010,1571-003,Large,12/5/2007,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9123-004,Chun-Su Yuan,Nationalized PCT,4/12/2018,1571-003,12/5/2028,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614985,3/3/2011,582615,Yes
1806,07-T-035,Treatment of Drug-Induced Nausea with Opioid Antagonists,2014-126063, ,Japan,JP,12/5/2008,,2014-208673,6/19/2014,1571-004,Large,12/5/2007,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9123-004,Chun-Su Yuan,Divisional,4/12/2018,1571-004,2/5/2028,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614986,11/6/2014,582615,Yes
1807,07-T-040,A Voxel Matching Technique for Removal of Artifacts in Medical Subtraction Images,"12/233,031", ,*United States,US,9/18/2008,,US-2009-0074276-A1,9/18/2008,1578-002,Small,9/19/2007,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Stephens, Paul",43225,"Kunio Doi, Yoshinori Itai, Shigehiko Katsuragawa, Hyoungseop Kim",US Utility,4/12/2018,1578-002,9/18/2028,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610240,3/19/2009,582620,Yes
1808,07-T-040,Voxel Matching Technique for Removal of Artifacts in Medical Subtraction Images,"60/973,615", ,*United States,US,9/19/2007,, ,9/19/2007,1578-001,Small,9/19/2007,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",43225P,"Kunio Doi, Yoshinori Itai, Shigehiko Katsuragawa, Hyoungseop Kim",Provisional,4/12/2018,1578-001,9/19/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",615391,,582620,Yes
1809,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,"11/745,782","7,989,116",*United States,US,5/8/2007,8/2/2011,US-2008-0280179 A1,5/8/2007,1580-001,Large,5/8/2007,10/15/2021,No,4/28/2022,Issued,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",US Utility,11/4/2019, ,5/8/2037,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099861,11/13/2008,582622,No
1810,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,PCT/US08/62812, ,*United States,US,5/7/2008,,WO 2008/141018,5/7/2008,1580-002,None,5/8/2007,11/4/2019,No,4/28/2022,Expired PCT - Nationalized,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",PCT,11/4/2019, ,11/7/2009,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099882,11/20/2008,582622,No
1811,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,"2,685,325", ,Canada,CA,5/7/2008,, ,10/26/2009,1580-003,Large,5/8/2007,11/4/2019,No,4/28/2022,Pending,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",Nationalized PCT,11/4/2019, ,10/26/2039,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099917,,582622,No
1812,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,200880014988.X, ,China,CN,5/7/2008,, ,10/26/2009,1580-004,None,5/8/2007,11/4/2019,No,4/28/2022,Pending,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",Nationalized PCT,11/4/2019, ,5/7/2028,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099933,,582622,No
1813,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,2008747735, ,European Patent Office (EPO),EP,5/7/2008,3/25/2015, ,12/4/2009,1580-005,Large,5/8/2007,11/4/2019,No,4/28/2022,Granted,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",Nationalized PCT,11/4/2019, ,12/4/2039,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099947,2/24/2010,582622,No
1814,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,2010507604, ,Japan,JP,5/7/2008,, ,10/30/2009,1580-006,Large,5/8/2007,11/4/2019,No,4/28/2022,Pending,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",Nationalized PCT,11/4/2019, ,5/7/2028,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099962,,582622,No
1815,07-T-042,Novel Electrolyte Utilizing a Lewis Acid/Bronsted Acid Complex,201610102196.4, ,China,CN,5/7/2008,, ,2/25/2016,1580-007,None,5/8/2007,5/27/2021,No,4/28/2022,Abandoned,Dinsmore & Shohl LLP,, ,"Yuichiro Sugiyama, Hisashi Yamamoto",Nationalized PCT,11/4/2019, ,5/25/2036,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",4099989,,582622,No
1816,07-T-043,Novel Electrolyte Utilizing A Lewis Acid/Bronstead Acid Complex,"2,685,325","2,685,325",Canada,CA,5/7/2008,3/31/2015, ,5/7/2008,1581-003,Small,5/8/2007,,No,4/28/2022,Issued,"Gifford, Krass, Sprinkle, Anderson & Citkowski, P.C.",, ,"Yuichiro Sugiyama, Hisashi Yamamoto","Foreign, Non-PCT",4/12/2018,1581-003,7/5/2028,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",613723,,582623,No
1817,07-T-043,Proton Conducting Electrolyte,"11/745,834","7,879,476",*United States,US,5/8/2007,2/1/2011, ,5/8/2007,1581-001,Small,5/8/2007,,Yes,4/28/2022,Abandoned,"Gifford, Krass, Sprinkle, Anderson & Citkowski, P.C.",, ,"Yuichiro Sugiyama, Hisashi Yamamoto",US Utility,4/12/2018,1581-001,5/8/2027,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",614226,,582623,Yes
1818,07-T-043,Proton Conducting Electrolyte,08747751.9EPO,2158230,European Patent Office (EPO),EP,5/7/2008,10/16/2013, ,5/7/2008,1581-002,Small,5/7/2007,,No,4/28/2022,Expired - Inactive,"Gifford, Krass, Sprinkle, Anderson & Citkowski, P.C.",, ,"Yuichiro Sugiyama, Hisashi Yamamoto",Nationalized PCT,4/12/2018,1581-002,5/7/2028,"Ginsburg, Eric",Hisashi Yamamoto,"Juggernauth, Anne",614227,,582623,Yes
1819,07-T-051,Microfluidic Blood Typing and Agglutination Assays,"61/080,541", ,*United States,US,7/14/2008,, ,7/14/2008,1589-001,Small,7/14/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Stankovic, Bratislav",00224,"Rustem Ismagilov, Timothy Kline, Mohammad Pothiawala, Matthew Runyon",Provisional,4/12/2018,1589-001,7/14/2009,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613392,,582631,Yes
1820,07-T-051,Microfluidic Blood Typing and Agglutination Assays,"61/225,307", ,*United States,US,7/14/2009,, ,7/14/2009,1589-002,Small,7/14/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00261,"Rustem Ismagilov, Timothy Kline, Mohammad Pothiawala, Matthew Runyon",Provisional,4/12/2018,1589-002,7/14/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613393,,582631,Yes
1821,07-T-055,Porous Polymeric Materials for Hydrogen Storage,"60/937,511", ,*United States,US,6/28/2007,, ,6/28/2007,06-115-001,None,6/28/2007,,Yes,4/28/2022,Expired - Inactive,,, ,"Di-Jia Liu, Junbing Yang, Luping Yu",Provisional,4/12/2018,06-115-001,6/28/2008,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614124,,582635,Yes
1822,07-T-055,Porous Polymeric Materials for Hydrogen Storage,"12/215,653","8,076,382",*United States,US,6/27/2008,12/13/2011,US 2009-0023828 A1,6/27/2008,06-115-002,None,6/28/2007,,No,4/28/2022,Issued,,, ,"Di-Jia Liu, Junbing Yang, Luping Yu",US Utility,4/12/2018,06-115-002,6/27/2028,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614125,1/22/2009,582635,Yes
1823,07-T-058,Differential Labeling of Cells,"60/822,001", ,*United States,US,8/10/2006,, ,8/10/2006,1595-001,None,8/10/2006,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Akhavan, Ramin", ,"Roumen Balabanov, Brian Popko, Trent Watkins",Provisional,4/12/2018,1595-001,8/10/2007,"Peace, Shane",Brian Popko,"Tennant, Thelma",611449,,582638,Yes
1824,07-T-058,Differential Labeling of Cells,"11/837,437", ,*United States,US,8/10/2007,, ,8/10/2007,1595-002,None,8/10/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Roumen Balabanov, Brian Popko, Trent Watkins",US Utility,4/12/2018,1595-002,8/10/2027,"Peace, Shane",Brian Popko,"Tennant, Thelma",611450,,582638,Yes
1825,07-T-058,Differential Labeling of Cells,07800086.6EPO, ,European Patent Office (EPO),EP,8/10/2007,, ,1/29/2009,1595-003,None,8/10/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Roumen Balabanov, Brian Popko, Trent Watkins",Nationalized PCT,4/12/2018,1595-003,8/10/2027,"Peace, Shane",Brian Popko,"Tennant, Thelma",611451,,582638,Yes
1826,07-T-058,Differential Labeling of Cells,PCT/US07/75742, ,*United States,US,8/10/2007,, ,8/10/2007,1595-004,None,8/10/2006,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Akhavan, Ramin", ,"Roumen Balabanov, Brian Popko, Trent Watkins",PCT,4/12/2018,1595-004,2/10/2010,"Peace, Shane",Brian Popko,"Tennant, Thelma",611452,,582638,Yes
1827,07-T-058,Differential Labeling of Cells,196803, ,Israel,IL,8/10/2007,, ,1/29/2009,1595-005,None,8/10/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Roumen Balabanov, Brian Popko, Trent Watkins",Nationalized PCT,4/12/2018,1595-005,8/10/2027,"Peace, Shane",Brian Popko,"Tennant, Thelma",611453,,582638,Yes
1828,07-T-058,Differential Labeling of Cells,2009-524018, ,Japan,JP,8/10/2007,, ,1/29/2009,1595-006,None,8/10/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Roumen Balabanov, Brian Popko, Trent Watkins",Nationalized PCT,4/12/2018,1595-006,8/10/2027,"Peace, Shane",Brian Popko,"Tennant, Thelma",611454,,582638,Yes
1829,07-T-058,Differential Labeling of Cells,"2,660,321", ,Canada,CA,8/10/2007,, ,1/29/2009,1595-007,None,8/10/2006,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Roumen Balabanov, Brian Popko, Trent Watkins",Nationalized PCT,4/12/2018,1595-007,8/10/2027,"Peace, Shane",Brian Popko,"Tennant, Thelma",611455,,582638,Yes
1830,07-T-062,Methods and Compositions for Treating Diseases and Conditions Involving Higher Molecular Weight Hyaluronan,"60/970,857", ,*United States,US,9/7/2007,, ,9/7/2007,1599-001,Small,9/7/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joe Garcia, Patrick Singleton",Provisional,4/12/2018,1599-001,9/7/2008,"Butler, Brittany",Patrick Singleton,"Butler, Brittany",612920,,582642,Yes
1831,07-T-062,Methods and Compositions for Treating Diseases and Conditions Involving Higher Molecular Weight Hyaluronan,PCT/US08/75437, ,*United States,US,9/5/2008,,WO2009/033047,9/5/2008,1599-002,Small,9/7/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joe Garcia, Patrick Singleton",PCT,4/12/2018,1599-002,9/7/2027,"Butler, Brittany",Patrick Singleton,"Butler, Brittany",612921,3/12/2009,582642,Yes
1832,07-T-062,Methods and Compositions for Treating Diseases and Conditions Involving Higher Molecular Weight Hyaluronan,"12/676,793", ,*United States,US,9/5/2008,,US-2010-0249064,3/5/2010,1599-003,Small,9/7/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joe Garcia, Patrick Singleton",Nationalized PCT,4/12/2018,1599-003,9/5/2018,"Butler, Brittany",Patrick Singleton,"Butler, Brittany",612922,9/30/2010,582642,Yes
1833,07-T-065,"Devices, Systems and Methods to Detect Edema","60/969,810", ,*United States,US,9/4/2007,, ,9/4/2007,1602-001,None,9/4/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"David Grdina, Sungho Jin, Neeraj Jolly, Ratneshwar Lal, Jaishankar Raman",Provisional,4/12/2018,1602-001,9/4/2008,"Unassigned, Unassigned",Jaishankar Raman,"Unassigned, Unassigned",611442,,582645,Yes
1834,07-T-066,Pacemaker,"60/969,834", ,*United States,US,9/4/2007,, ,9/4/2007,1603-001,None,9/4/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"David Grdina, Sungho Jin, Neeraj Jolly, Ratneshwar Lal, Jaishankar Raman",Provisional,4/12/2018,1603-001,9/4/2008,"Unassigned, Unassigned",Jaishankar Raman,"Unassigned, Unassigned",613875,,582646,Yes
1835,07-T-070,Bistable Allosteric Proteins,"61/046,998", ,*United States,US,4/22/2008,, ,4/22/2008,1607-001,Small,4/22/2008,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Ward, Wendy",092234-9121-001,"John Moffat, Phoebe Rice, Tobin Sosnick, Devin Strickland",Provisional,4/12/2018,1607-001,4/22/2009,"Peace, Shane",Tobin Sosnick,"Muite, Kevin",610746,,582650,Yes
1836,07-T-073,Methods and Compositions Involving H2A.Z as a Biomarker for Breast Cancer,"61/054,347", ,*United States,US,5/19/2008,, ,5/19/2008,1610-001,None,5/19/2008,,Yes,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Sujun Hua, Kevin White",Provisional,4/12/2018,1610-001,5/19/2009,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",612956,,582653,Yes
1837,07-T-073,Methods and Compositions Involving H2A.Z as a Biomarker for Breast Cancer,"12/467,772", ,*United States,US,5/18/2009,, ,5/18/2009,1610-002,None,5/19/2008,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Sujun Hua, Kevin White",US Utility,4/12/2018,1610-002,5/19/2029,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",612957,,582653,Yes
1838,07-T-074,Compounds for Treating Vascular Permeability Disorders and Related Methods,"61/097,918", ,*United States,US,9/18/2008,, ,9/18/2008,1611-001,Small,9/18/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Kale, Tamara", ,"Robert Bittman, Steven Dudek, Joe Garcia, Xuequan Lu",Provisional,4/12/2018,1611-001,9/18/2009,"Unassigned, Unassigned",Steven Dudek,"Unassigned, Unassigned",611238,,582654,Yes
1839,07-T-076,"Devices, Systems and Methods to Detect Endothelialization of Implantable Medical Devices","12/203,667","8,478,378",*United States,US,9/3/2008,7/2/2013,US-2009-0062900-A1,9/3/2008,1613-002,Small,9/4/2007,7/2/2013,No,4/28/2022,Issued,Brinks Gilson & Lione,,00243,"Sungho Jin, Neeraj Jolly, Ratneshwar Lal, Jaishankar Raman",US Utility,4/12/2018,1613-002,1/28/2032,"Unassigned, Unassigned",Ratneshwar Lal,"Unassigned, Unassigned",611443,3/5/2009,582656,Yes
1840,07-T-076,"Devices, Systems and Methods to Detect Endothelialization of Intraluminal Implants","60/969,801", ,*United States,US,9/4/2007,, ,9/4/2007,1613-001,None,9/4/2007,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Sungho Jin, Neeraj Jolly, Ratneshwar Lal",Provisional,4/12/2018,1613-001,9/4/2008,"Unassigned, Unassigned",Ratneshwar Lal,"Unassigned, Unassigned",611444,,582656,Yes
1841,07-T-081,Treatment of Drug-induced Nausea with Opioid Antagonists,"60/976,652", ,*United States,US,10/1/2007,, ,10/1/2007,1617-001,Large,10/1/2007,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9119-002,Chun-Su Yuan,Provisional,4/12/2018,1617-001,10/1/2008,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614987,,582661,Yes
1842,07-T-081,Treatment of Drug-induced Nausea with Opioid Antagonists,PCT/US08/78229, ,*United States,US,9/30/2008,,WO2009/045985,9/30/2008,1617-002,Large,10/1/2007,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9119-003,Chun-Su Yuan,PCT,4/12/2018,1617-002,4/1/2010,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614988,4/8/2009,582661,Yes
1843,07-T-081,Treatment of Drug-induced Nausea with Opioid Antagonists,2010-528062,5905198,Japan,JP,9/30/2008,3/25/2016,WO2009/045985,6/1/2010,1617-003,Large,10/1/2007,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9119-001,Chun-Su Yuan,Nationalized PCT,4/12/2018,1617-003,9/30/2028,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614989,4/8/2009,582661,Yes
1844,07-T-081,Treatment of Drug-induced Nausea with Opioid Antagonists,2014-208895, ,Japan,JP,9/30/2008,,2015-28074,10/10/2014,1617-004,Large,10/1/2007,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9119-004,Chun-Su Yuan,Divisional,4/12/2018,1617-004,9/30/2028,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",614990,5/19/2015,582661,Yes
1845,07-T-082,Methods and Compositions Related to Microscale Sample Processing and Evaluation,"60/991,563", ,*United States,US,11/30/2007,, ,11/30/2007,1618-001,Small,11/30/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chih-Pin Chuu, Mark Ciaccio, Richard Jones",Provisional,4/12/2018,1618-001,11/30/2008,"Unassigned, Unassigned",Richard Jones,"Unassigned, Unassigned",613060,,582662,Yes
1846,07-T-082,Methods and Compositions Related to Microscale Sample Processing and Evaluation,PCT/US08/85198, ,*United States,US,12/1/2008,,WO 2009/073632,12/1/2008,1618-002,Small,11/30/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mark Ciaccio, Richard Jones",PCT,4/12/2018,1618-002,5/30/2010,"Unassigned, Unassigned",Richard Jones,"Unassigned, Unassigned",613061,6/11/2009,582662,Yes
1847,07-T-082,Methods and Compositions Related to Microscale Sample Processing and Evaluation,"12/745,407", ,*United States,US,12/1/2008,,US-2011-0028339-A1,5/28/2010,1618-003,Small,11/30/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mark Ciaccio, Richard Jones",Nationalized PCT,4/12/2018,1618-003,12/1/2028,"Unassigned, Unassigned",Richard Jones,"Unassigned, Unassigned",613062,2/3/2011,582662,Yes
1848,07-T-088,"RED FLUORESCENT PROTEINS WITH ENHANCED BACTERIAL EXPRESSION, INCREASED BRIGHTNESS AND REDUCED AGGREGATION","60/984,642", ,*United States,US,11/1/2007,, ,11/1/2007,1626-001,Small,11/1/2007,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Benjamin Glick, Robert Keenan, Rita Strack, Daniel Strongin",Provisional,4/12/2018,1626-001,11/1/2008,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614368,,582668,Yes
1849,07-T-088,"RED FLUORESCENT PROTEINS WITH ENHANCED BACTERIAL EXPRESSION, INCREASED BRIGHTNESS AND REDUCED AGGREGATION",PCT/US08/82264, ,*United States,US,11/3/2008,,WO2009/059305,11/3/2008,1626-002,Small,11/1/2007,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Dibyendu Bhattacharyya, Benjamin Glick, Robert Keenan, Rita Strack, Daniel Strongin",PCT,4/12/2018,1626-002,5/1/2010,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614369,9/11/2009,582668,Yes
1850,07-T-088,"RED FLUORESCENT PROTEINS WITH ENHANCED BACTERIAL EXPRESSION, INCREASED BRIGHTNESS AND REDUCED AGGREGATION","12/740,019","8,679,749",*United States,US,11/3/2008,3/25/2014,US-2011-0020784-A1,9/28/2010,1626-003,Large,11/1/2007,,No,5/8/2022,Issued,"Valauskas Corder, LLC",, ,"Dibyendu Bhattacharyya, Benjamin Glick, Robert Keenan, Rita Strack, Daniel Strongin",Nationalized PCT,4/12/2018,1626-003,5/22/2030,"Dembo, Anna",Benjamin Glick,"Tennant, Thelma",614370,1/27/2011,582668,Yes
1851,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,"60/969,514", ,*United States,US,8/31/2007,, ,9/1/2007,1625-001,Small,8/31/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Olaf Schneewind",Provisional,4/12/2018,1625-001,8/31/2008,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613026,,582670,Yes
1852,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,PCT/US08/74849, ,*United States,US,8/29/2008,,WO2009/029831,8/29/2008,1625-002,Small,8/31/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",PCT,4/12/2018,1625-002,2/28/2010,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613027,3/5/2009,582670,Yes
1853,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,"12/675,597","8,840,906",*United States,US,8/29/2008,9/23/2014,US-2011-0027265-A1,2/26/2010,1625-003,Large,8/31/2007,9/23/2014,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-003,7/7/2031,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613028,2/3/2011,582670,Yes
1854,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,2008292897,2008292897,Australia,AU,8/29/2008,5/7/2015, ,2/24/2010,1625-004,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-004,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613029,,582670,Yes
1855,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,PI0815775.8, ,Brazil,BR,8/29/2008,, ,2/26/2010,1625-005,Large,8/31/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0458BR,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-005,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613030,,582670,Yes
1856,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,"2,697,538","2,697,538",Canada,CA,8/29/2008,2/12/2019, ,2/23/2010,1625-006,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000192499,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-006,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613031,,582670,Yes
1857,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,200880113312.6,200880113312.6,China,CN,8/29/2008,12/9/2015, ,2/26/2010,1625-007,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-007,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613032,,582670,Yes
1858,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,08828277.7EPO,2185190,European Patent Office (EPO),EP,8/29/2008,6/24/2015,2185190,3/1/2010,1625-008,Large,8/31/2007,,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-008,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613033,5/19/2010,582670,Yes
1859,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,2010-523163,5658564,Japan,JP,8/29/2008,12/5/2014,2010-538015,2/26/2010,1625-009,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-009,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613034,12/9/2010,582670,Yes
1860,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,10-2010-7007030, ,"Korea, Republic of",KR,8/29/2008,, ,3/31/2010,1625-010,Large,8/31/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-010,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613035,,582670,Yes
1861,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,10106657.9, ,Hong Kong,HK,8/29/2008,,1139875,2/26/2010,1625-011,Large,8/31/2007,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",1000364499,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-011,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613036,9/30/2010,582670,Yes
1862,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,"13/742,155","9,181,329",*United States,US,8/29/2008,11/10/2015,US-2013-0189249-A1,1/15/2013,1625-012,Large,8/31/2007,11/10/2015,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Olaf Schneewind",Divisional,4/12/2018,1625-012,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613037,7/25/2013,582670,Yes
1863,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,13160878.8EPO,"2,666,784",European Patent Office (EPO),EP,8/29/2008,4/5/2017,2666784,3/25/2013,1625-013,Large,8/31/2007,,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-013,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613038,11/27/2013,582670,Yes
1864,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,2014-157658,6018140,Japan,JP,8/29/2008,10/9/2016,2014-237687,8/12/2014,1625-014,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-014,9/9/2034,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613039,1/1/2015,582670,Yes
1865,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,2015200932,2015200932,Australia,AU,8/29/2008,6/15/2017, ,2/24/2015,1625-015,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Nationalized PCT,4/12/2018,1625-015,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613040,,582670,Yes
1866,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,10-2015-7009851,10-1661946,"Korea, Republic of",KR,8/29/2008,9/27/2016, ,3/31/2010,1625-016,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-016,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613041,,582670,Yes
1867,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,08828277.7DE,602008038715.1,Germany,DE,8/29/2008,6/24/2015,2185190,5/15/2015,1625-017,Small,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Validated EPO,4/12/2018,1625-017,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613042,5/19/2010,582670,Yes
1868,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,08828277.7FR,2185190,France,FR,8/29/2008,6/24/2015, ,5/15/2015,1625-018,Small,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Validated EPO,4/12/2018,1625-018,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613043,,582670,Yes
1869,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,08828277.7BE,2185190,Belgium,BE,8/29/2008,6/24/2015, ,5/15/2015,1625-019,Small,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Validated EPO,4/12/2018,1625-019,8/28/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613044,,582670,Yes
1870,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,08828277.7IT,502015000033658,Italy,IT,8/29/2008,6/24/2015, ,5/15/2015,1625-020,Small,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Validated EPO,4/12/2018,1625-020,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613045,,582670,Yes
1871,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,"14/842,192", ,*United States,US,8/29/2008,,US-2016-0046698-A1,9/1/2015,1625-021,Large,8/31/2007,,No,5/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0458US.D1C1,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Continuation,4/12/2018,1625-021,1/15/2033,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613046,2/18/2016,582670,No
1872,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,08828277.7GB,2185190,United Kingdom,GB,8/29/2008,6/24/2015, ,5/15/2015,1625-022,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Validated EPO,4/12/2018,1625-022,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613047,,582670,No
1873,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,201510736991.4, ,China,CN,8/29/2008,,CN105367656A,11/3/2015,1625-023,Large,8/31/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0458CN.D1,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-023,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613048,,582670,No
1874,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,2016-190589,6437975,Japan,JP,8/29/2008,11/22/2018,2017-2080A,10/1/2016,1625-024,Small,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000199838,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-024,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613049,1/6/2017,582670,Yes
1875,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,13160878.8FR,"2,666,784",France,FR,9/2/2008,4/6/2017, ,6/4/2017,1625-025,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-025,8/30/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613050,12/2/2013,582670,Yes
1876,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,602008049668.6,"2,666,784",Germany,DE,9/2/2008,4/5/2017, ,6/4/2017,1625-026,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-026,8/30/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613051,12/2/2013,582670,Yes
1877,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,13160878.8CH,"2,666,784",Switzerland,CH,9/2/2008,4/6/2017, ,6/4/2017,1625-027,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-027,8/30/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613052,12/2/2013,582670,Yes
1878,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,13160878.8GB,"2,666,784",United Kingdom,GB,9/2/2008,4/6/2017, ,6/4/2017,1625-028,Large,8/31/2007,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Juliane Bubeck Wardenburg, Brook Heaton, Olaf Schneewind",Divisional,4/12/2018,1625-028,8/30/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613053,12/2/2013,582670,Yes
1879,07-T-090,Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions,"15/929,741", ,*United States,US,8/29/2008,,US-2021-0155678-A1,5/19/2020,1625-029,Small,8/31/2007,5/21/2020,No,5/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0458US.D1C2,"Juliane Bubeck Wardenburg, Olaf Schneewind",Continuation,5/21/2020, ,8/29/2028,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",4568541,5/27/2021,582670,No
1880,07-T-093,Methods and Systems For Processing of Neural Signals,"60/964,328", ,*United States,US,8/10/2007,, ,8/10/2007,1630-001,None,8/10/2007,,Yes,4/28/2022,Expired - Inactive,Clark & Elbing LLP,"Belliveau, Michael", ,"Nicholas Hatsopoulos, John Pezaris",Provisional,4/12/2018,1630-001,8/10/2008,"Butler, Brittany",Nicholas Hatsopoulos,"Butler, Brittany",613142,,582673,Yes
1881,07-T-093,Methods and Systems For Processing of Neural Signals,"61/188,689", ,*United States,US,8/12/2008,, ,8/12/2008,1630-002,None,8/12/2008,,Yes,4/28/2022,Expired - Inactive,Clark & Elbing LLP,"Belliveau, Michael", ,"Nicholas Hatsopoulos, John Pezaris",Provisional,4/12/2018,1630-002,8/12/2009,"Butler, Brittany",Nicholas Hatsopoulos,"Butler, Brittany",613143,,582673,Yes
1882,07-T-103,Systems and Methods for Image Colorization,"60/966,276", ,*United States,US,8/27/2007,, ,8/27/2007,1640-001,Small,8/27/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Nigel Parsad, Jonathan Silverstein",Provisional,4/12/2018,1640-001,8/27/2008,"Ramirez, Mario Riojas",Jonathan Silverstein,"Tennant, Thelma",614837,,582683,Yes
1883,07-T-103,Systems and Methods for Image Colorization,"12/229,876", ,*United States,US,8/27/2008,,US-2009-0096807-A1,12/17/2008,1640-002,Small,8/27/2007,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Nigel Parsad, Jonathan Silverstein",Nationalized PCT,4/12/2018,1640-002,8/27/2028,"Ramirez, Mario Riojas",Jonathan Silverstein,"Tennant, Thelma",614838,4/16/2009,582683,Yes
1884,07-T-103,Systems and Methods for Image Colorization,PCT/US08/77494, ,*United States,US,8/27/2008,,WO 2009/029671,8/27/2008,1640-003,Small,8/27/2007,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Nigel Parsad, Jonathan Silverstein",PCT,4/12/2018,1640-003,2/27/2010,"Ramirez, Mario Riojas",Jonathan Silverstein,"Tennant, Thelma",614839,3/5/2009,582683,Yes
1885,07-T-110,Classical and Quanum Routes to Linear Magentoresistance,"61/074,346", ,*United States,US,6/20/2008,, ,6/20/2008,1647-001,Small,6/20/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00200,"Jingshi Hu, Thomas Rosenbaum",Provisional,4/12/2018,1647-001,6/20/2009,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",610893,,582690,Yes
1886,07-T-110,Line Magnetoresistance Sensor,"12/456,797", ,*United States,US,6/22/2009,,US-2009-0315551-A1,6/22/2009,1647-002,Small,6/20/2008,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00257,"Jingshi Hu, Thomas Rosenbaum",US Utility,4/12/2018,1647-002,6/22/2029,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",612082,12/24/2009,582690,Yes
1887,07-T-116,Method for Assaying for an Engineered Insulin with Increased stability to IDE,"60/999,972", ,*United States,US,10/22/2007,, ,10/22/2007,1653-001,Small,10/22/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00196,Wei-Jen Tang,Provisional,4/12/2018,1653-001,10/22/2008,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",612425,,582696,Yes
1888,07-T-121,TLR6 Targeted Immunomodulation,"61/031,211", ,*United States,US,2/25/2008,, ,2/25/2008,1659-001,None,2/25/2008,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Deborah Anderson, R. William DePaolo, Bana Jabri, In Young Kim, Olaf Schneewind",Provisional,4/12/2018,1659-001,2/25/2009,"Dembo, Anna",Bana Jabri,"Tennant, Thelma",614927,,582701,Yes
1889,07-T-128,Methods and Compositions for Diagnosing Autism,"61/015,593", ,*United States,US,12/20/2007,, ,12/20/2007,1665-001,None,12/20/2007,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Christian, William Dobyns, Ravinesh Kumar",Provisional,4/12/2018,1665-001,12/20/2008,"Unassigned, Unassigned",William Dobyns,"Unassigned, Unassigned",612679,,582708,Yes
1890,07-T-128,Methods and Compositions for Diagnosing Autism,"61/078,182", ,*United States,US,7/3/2008,, ,7/3/2008,1665-002,None,7/3/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Christian, William Dobyns, Ravinesh Kumar",Provisional,4/12/2018,1665-002,7/3/2009,"Unassigned, Unassigned",William Dobyns,"Unassigned, Unassigned",612680,,582708,Yes
1891,07-T-128,Methods and Compositions for Diagnosing Autism,"61/083,776", ,*United States,US,7/25/2008,, ,7/25/2008,1665-003,None,7/25/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Christian, William Dobyns, Ravinesh Kumar",Provisional,4/12/2018,1665-003,7/25/2009,"Unassigned, Unassigned",William Dobyns,"Unassigned, Unassigned",612681,,582708,Yes
1892,07-T-132,Identification of Toxin Ligands to Receptors,"61/012,209", ,*United States,US,12/7/2007,, ,12/7/2007,1669-001,Small,12/7/2007,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marx, Jeffrey",00199,"Steve Goldstein, Zoltan Takacs",Provisional,4/12/2018,1669-001,12/7/2008,"Unassigned, Unassigned",Steve Goldstein,"Unassigned, Unassigned",611896,,582712,Yes
1893,07-T-132,Identification of Toxin Ligands to Receptors,"61/074,794", ,*United States,US,6/23/2008,, ,6/23/2008,1669-002,Small,6/23/2008,,Yes,4/28/2022,Released to Inventors,Brinks Gilson & Lione,"Marx, Jeffrey",00219,"Steve Goldstein, Zoltan Takacs",Provisional,4/12/2018,1669-002,6/23/2009,"Unassigned, Unassigned",Steve Goldstein,"Unassigned, Unassigned",611897,,582712,Yes
1894,07-T-139,Human APOA-I Mutants,"61/041,236", ,*United States,US,3/31/2008,, ,3/31/2008,1676-001,None,3/31/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Tapan Biswas, Ronald Carnemolla, Godfrey Getz, Stephen Meredith, Catherine Reardon-Alulis, Xuefeng Ren, Jianjun Wang",Provisional,4/12/2018,1676-001,3/31/2009,"Unassigned, Unassigned",Godfrey Getz,"Unassigned, Unassigned",611841,,582719,Yes
1895,07-T-139,Human APOA-I Mutants,"61/085,755", ,*United States,US,8/1/2008,, ,8/1/2008,1676-002,None,8/1/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Tapan Biswas, Ronald Carnemolla, Godfrey Getz, Stephen Meredith, Catherine Reardon-Alulis, Xuefeng Ren, Jianjun Wang",Provisional,4/12/2018,1676-002,3/31/2009,"Unassigned, Unassigned",Godfrey Getz,"Unassigned, Unassigned",611842,,582719,Yes
1896,07-T-139,Human APOA-I Mutants,PCT/US09/38963, ,*United States,US,3/31/2009,,WO 2009/124055,3/31/2009,1676-003,None,3/31/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Tapan Biswas, Ronald Carnemolla, Godfrey Getz, Stephen Meredith, Catherine Reardon-Alulis, Xuefeng Ren, Jianjun Wang",PCT,4/12/2018,1676-003,9/30/2010,"Unassigned, Unassigned",Godfrey Getz,"Unassigned, Unassigned",611843,10/8/2009,582719,Yes
1897,08-T-001,Ultrasound Based Approach to Diagnosing Heart Failure,"61/034,909", ,*United States,US,3/7/2008,, ,3/7/2008,1679-001,Small,3/7/2008,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Stephens, Paul",43742,Antony Kim,Provisional,4/12/2018,1679-001,3/7/2009,"Unassigned, Unassigned",Antony Kim,"Unassigned, Unassigned",615147,,582721,Yes
1898,08-T-004,Compositions for NK-1 Receptor Mediated Delivery of Agents to Cells and Methods of Using the Compositions,PCT/US08/86274, ,*United States,US,12/10/2008,,WO2009/086274,12/10/2008,1670-003,Small,12/10/2007,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Anthony Kossiakoff, Shahir Rizk",PCT,4/12/2018,1670-003,6/10/2010,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",611229,6/18/2009,582724,Yes
1899,08-T-004,Compositions for NK-1 Receptor Mediated Delivery of Agents to Cells and Methods of Using the Compositions,"12/797,137", ,*United States,US,12/10/2008,,20110165674,6/9/2010,1670-004,Small,12/10/2007,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Anthony Kossiakoff,Nationalized PCT,4/12/2018,1670-004,12/10/2028,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",611230,7/7/2011,582724,Yes
1900,08-T-004,Compositions for NK-1 Receptor Mediated Delivery of Agents to Cells and Methods of Using the Compositions,"13/714,780", ,*United States,US,12/10/2008,,US-2013-0236966-A1,12/14/2012,1670-005,Small,12/10/2007,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Anthony Kossiakoff, Shahir Rizk",Divisional,4/12/2018,1670-005,12/10/2028,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",611231,9/12/2013,582724,Yes
1901,08-T-004,NK-1 Receptor-Mediated Delivery Compositions and Methods,"61/012,514", ,*United States,US,12/10/2007,, ,12/10/2007,1670-001,Small,12/10/2007,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,Anthony Kossiakoff,Provisional,4/12/2018,1670-001,12/10/2008,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",613661,,582724,Yes
1902,08-T-004,NK-1 Receptor-Mediated Delivery Compositions and Methods,"61/114,221", ,*United States,US,11/13/2008,, ,11/13/2008,1670-002,Small,11/13/2008,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,Anthony Kossiakoff,Provisional,4/12/2018,1670-002,12/10/2008,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",613662,,582724,Yes
1903,08-T-007,Methods for Producing Targeted Herpes Viruses,"61/030,210", ,*United States,US,2/20/2008,, ,2/20/2008,1685-001,Small,2/20/2008,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",43656,"Bernard Roizman, Grace Zhou",Provisional,4/12/2018,1685-001,2/20/2009,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613256,,582727,Yes
1904,08-T-008,Molecular Marker for Clear Cell Renal Cell Carcinoma,"60/879,662", ,*United States,US,1/10/2007,, ,1/10/2007,1682-001,Small,1/10/2007,,Yes,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jiang Liu, Kevin White",Provisional,4/12/2018,1682-001,1/10/2008,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",613512,,582728,Yes
1905,08-T-008,Molecular Marker for Clear Renal Cell Carcinoma,PCT/US08/50812, ,*United States,US,1/10/2008,,WO2008/086502 A2,1/10/2008,1682-002,Small,1/10/2007,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jiang Liu, Kevin White",PCT,4/12/2018,1682-002,7/10/2009,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",613513,7/18/2008,582728,Yes
1906,08-T-017,Atomic layer deposition for functionalizing colloidal semiconductor particles,"61/073,286", ,*United States,US,6/17/2008,, ,6/17/2008,08-T-017-001,None,6/17/2008,5/9/2019,,4/28/2022,Expired Prov - Filed in US,Foley & Lardner,, ,"Jeffrey Elam, Philippe Guyot-Sionnest",Provisional,5/9/2019, ,6/17/2009,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",3705436,,582737,No
1907,08-T-017,Atomic layer deposition for functionalizing colloidal semiconductor particles,"12/485,784","8,012,860",*United States,US,6/16/2009,9/6/2011, ,6/16/2009,08-T-017-002,None,6/17/2008,5/9/2019,No,4/28/2022,Issued,Foley & Lardner,, ,"Jeffrey Elam, Philippe Guyot-Sionnest",US Utility,5/9/2019, ,9/6/2031,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",3705501,,582737,No
1908,08-T-024,System for the Production of Methane From CO2,"61/028,413", ,*United States,US,2/13/2008,, ,2/13/2008,1698-001,Small,2/13/2008,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9153-001,Laurens Mets,Provisional,4/12/2018,1698-001,2/13/2009,"Hwang, Luke",Laurens Mets,"Juggernauth, Anne",614833,,582744,Yes
1909,08-T-027,Hybrid solar cells via UV-polymerization of polymer precursor,"61/101,531", ,*United States,US,9/30/2008,, ,9/30/2008,07-053-001,Small,9/30/2008,1/5/2022,Yes,4/28/2022,Expired Prov - Filed in US,Foley & Lardner,"Rechtin, Michael", ,"Seth Darling, Nada Dimitrijevic, Tijana Rajh, Steven Sibener, Sanja Tepavcevic",Provisional,4/12/2018,07-053-001,9/30/2009,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",611871,,582747,Yes
1910,08-T-027,Hybrid solar cells via UV-polymerization of polymer precursor,"12/489,001","8,269,100",*United States,US,6/22/2009,9/18/2012, ,6/22/2009,07-053-002,Small,9/30/2008,,No,4/28/2022,Issued,Foley & Lardner,, ,"Seth Darling, Nada Dimitrijevic, Tijana Rajh, Steven Sibener, Sanja Tepavcevic",US Utility,4/12/2018,07-053-002,6/22/2029,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",611872,,582747,Yes
1911,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,"61/038,577", ,*United States,US,3/21/2008,, ,3/21/2008,1702-001,None,3/21/2008,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-006,"Jonathan Moss, Patrick Singleton",Provisional,4/12/2018,1702-001,3/21/2009,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615096,,582749,Yes
1912,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,PCT/US09/37825, ,*United States,US,3/20/2009,,WO2009/117669,3/20/2009,1702-002,None,3/21/2008,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-008,"Jonathan Moss, Patrick Singleton",PCT,4/12/2018,1702-002,9/21/2010,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615097,9/24/2009,582749,Yes
1913,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,2009225434,2009225434,Australia,AU,3/20/2009,9/4/2014, ,10/20/2010,1702-003,None,3/21/2008,,No,5/23/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-001,"Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1702-003,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615098,,582749,Yes
1914,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,"2,719,134","2,719,134",Canada,CA,3/20/2009,6/30/2015, ,9/21/2010,1702-004,None,3/21/2008,,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-002,"Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1702-004,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615099,,582749,Yes
1915,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,09723085.8EPO,2278966,European Patent Office (EPO),EP,3/20/2009,10/9/2019,2278966,10/20/2010,1702-005,None,3/21/2008,9/19/2019,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9154-003,"Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1702-005,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615100,2/12/2011,582749,Yes
1916,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,"12/933,784","8,685,995",*United States,US,3/20/2009,4/1/2014,US-2011-0021551-A1,10/14/2010,1702-006,None,3/21/2008,,No,4/28/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-007,"Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1702-006,11/11/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615101,1/27/2011,582749,Yes
1917,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,2011-500985,5647098,Japan,JP,3/20/2009,11/14/2014,2011-515415,1/14/2011,1702-007,None,3/21/2008,,No,4/28/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-005,"Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1702-007,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615102,5/19/2011,582749,Yes
1918,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,11107939.6, ,Hong Kong,HK,3/20/2009,,1153665,8/1/2011,1702-008,Large,3/21/2008,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-004,"Jonathan Moss, Patrick Singleton",Validated EPO,4/12/2018,1702-008,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615103,4/5/2012,582749,Yes
1919,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,2013205002,2013205002,Australia,AU,3/20/2009,1/5/2017, ,4/13/2013,1702-009,None,3/21/2008,,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-009,"Jonathan Moss, Patrick Singleton",Divisional,4/12/2018,1702-009,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615104,,582749,Yes
1920,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,"14/179,095","9,526,723",*United States,US,3/20/2009,12/27/2016,US-2014-0163059-A1,2/12/2014,1702-010,None,3/21/2008,,No,4/28/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-010,"Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1702-010,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615105,6/12/2014,582749,Yes
1921,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,2014-226368, ,Japan,JP,3/20/2009,,2015-044847,10/31/2014,1702-011,None,3/21/2008,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9154-011,"Jonathan Moss, Patrick Singleton",Nationalized PCT,4/12/2018,1702-011,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615106,3/12/2015,582749,Yes
1922,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,"15/353,099","10,383,869",*United States,US,3/20/2009,8/20/2019,US-2017-0065581-A1,11/16/2016,1702-012,Large,3/21/2008,,Yes,4/28/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-012,"Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1702-012,3/21/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615107,3/10/2017,582749,No
1923,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,09723085.8FR,2278966,France,FR,3/20/2009,10/9/2019, ,3/20/2009,1702-013,None,3/21/2008,9/19/2019,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-FR00,"Jonathan Moss, Patrick Singleton",Validated EPO,9/19/2019, ,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",3993906,,582749,Yes
1924,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,09723085.8DE,602009060072.9,Germany,DE,3/20/2009,10/9/2019,2278966,3/20/2009,1702-014,None,3/21/2008,9/19/2019,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-DE00,"Jonathan Moss, Patrick Singleton",Validated EPO,9/19/2019, ,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",3993929,,582749,Yes
1925,08-T-029,Treatment with Opioid Antagonists and mTOR Inhibitors,09723085.8GB,2278966,United Kingdom,GB,3/20/2009,10/9/2019, ,3/20/2009,1702-015,None,3/21/2008,9/19/2019,No,5/23/2022,Issued,Michael Best & Friedrich LLP,,092234-9154-UK00,"Jonathan Moss, Patrick Singleton",Validated EPO,9/19/2019, ,3/20/2029,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",3993951,,582749,Yes
1926,08-T-033,EPR Imaging Device for Measuring Oxygen Concentration,"61/033,667", ,*United States,US,3/4/2008,, ,3/4/2008,1705-001,Small,3/4/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00209,"Boris Epel, Howard Halpern, Colin Mailer, Payam Seifi, Subramanian Sundramoorthy",Provisional,4/12/2018,1705-001,3/4/2009,"Cox, Ben",Howard Halpern,"Butler, Brittany",611538,,582753,Yes
1927,08-T-034,Methods and Composition for Modulating Hemtopoietic Stem Cell Migration,"61/050,926", ,*United States,US,5/6/2008,, ,5/6/2008,1706-001,Small,5/6/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angela Colmone, Dorothy Sipkins",Provisional,4/12/2018,1706-001,5/6/2009,"Unassigned, Unassigned",Dorothy Sipkins,"Unassigned, Unassigned",612632,,582754,Yes
1928,08-T-034,Methods and Composition for Modulating Hemtopoietic Stem Cell Migration,"61/061,928", ,*United States,US,6/16/2008,, ,6/16/2008,1706-003,Small,6/16/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angela Colmone, Dorothy Sipkins",Provisional,4/12/2018,1706-003,6/16/2009,"Unassigned, Unassigned",Dorothy Sipkins,"Unassigned, Unassigned",612633,,582754,Yes
1929,08-T-034,Methods and Composition for Modulating Hemtopoietic Stem Cell Migration,PCT/US09/43010, ,*United States,US,5/6/2009,,WO2009/137598,5/6/2009,1706-004,Small,5/6/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angela Colmone, Dorothy Sipkins",PCT,4/12/2018,1706-004,11/6/2010,"Unassigned, Unassigned",Dorothy Sipkins,"Unassigned, Unassigned",612634,11/12/2009,582754,Yes
1930,08-T-034,Methods and Composition for Modulating Hemtopoietic Stem Cell Migration,"12/991,357", ,*United States,US,5/6/2009,, ,11/5/2010,1706-005,Small,5/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angela Colmone, Dorothy Sipkins",Nationalized PCT,4/12/2018,1706-005,5/6/2029,"Unassigned, Unassigned",Dorothy Sipkins,"Unassigned, Unassigned",612635,,582754,Yes
1931,08-T-034,Methods and Compositions for Modulating Hemtopoietic Stem Cell Migration,"61/052,001", ,*United States,US,5/9/2008,, ,5/9/2008,1706-002,Small,5/9/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Angela Colmone, Dorothy Sipkins",Provisional,4/12/2018,1706-002,5/9/2009,"Unassigned, Unassigned",Dorothy Sipkins,"Unassigned, Unassigned",612801,,582754,Yes
1932,08-T-036,Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease,05769488.7EPO, ,European Patent Office (EPO),EP,7/30/2004,, ,7/7/2005,1709-008,Small,7/30/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Nationalized PCT,4/12/2018,1709-008,7/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615309,,582756,Yes
1933,08-T-036,Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease,"12/110,108", ,*United States,US,7/29/2004,, ,4/25/2008,1709-013,Small,7/30/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Continuation,4/12/2018,1709-013,7/29/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615310,,582756,Yes
1934,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,"60/530,842", ,*United States,US,12/18/2003,, ,12/18/2003,1709-015,Small,12/18/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Provisional,4/12/2018,1709-015,12/18/2004,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615311,,582756,Yes
1935,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,"10/903,039", ,*United States,US,7/29/2004,, ,7/29/2004,1709-016,Small,7/30/2003,,Yes,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,US Utility,4/12/2018,1709-016,7/29/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615312,,582756,Yes
1936,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,"11/002,934", ,*United States,US,7/29/2004,, ,12/2/2004,1709-017,Small,7/30/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Continuation in Part,4/12/2018,1709-017,12/2/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615313,,582756,Yes
1937,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,"11/176,103", ,*United States,US,10/27/2004,, ,7/7/2005,1709-018,Small,12/18/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Continuation in Part,4/12/2018,1709-018,7/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615314,,582756,Yes
1938,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,"11/583,224", ,*United States,US,7/29/2004,, ,10/19/2006,1709-019,Small,7/30/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Continuation,4/12/2018,1709-019,7/30/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615315,,582756,Yes
1939,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,PCT/US04/23952, ,*United States,US,7/30/2004,, ,7/30/2004,1709-020,Small,7/30/2003,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,PCT,4/12/2018,1709-020,1/30/2005,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615316,,582756,Yes
1940,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,PCT/US05/24100, ,*United States,US,7/29/2004,, ,7/7/2005,1709-021,Small,7/29/2003,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,PCT,4/12/2018,1709-021,1/29/2007,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615317,,582756,Yes
1941,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,"2,575,153", ,Canada,CA,7/29/2004,, ,1/25/2007,1709-022,Small,7/30/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Nationalized PCT,4/12/2018,1709-022,1/29/2027,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615318,,582756,Yes
1942,08-T-036,Use of Vitamin D Receptor Activators or Vitamin D Analogs to Treat Cardiovascular Disease,2007-523589, ,Japan,JP,7/29/2004,, ,7/7/2005,1709-023,Small,7/30/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Nationalized PCT,4/12/2018,1709-023,7/7/2025,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615319,,582756,Yes
1943,08-T-036,Use of Vitamin Ds or Vitamin D Analogs to Treat Cardiovascular Disease,"60/491,088", ,*United States,US,7/30/2003,, ,7/30/2003,1709-014,Small,7/30/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Provisional,4/12/2018,1709-014,7/30/2004,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615320,,582756,Yes
1944,08-T-036,Use of vitamin Ds to down regulate the renin-angiotensin-aldosterone system,"60/490,478", ,*United States,US,7/28/2003,, ,7/28/2003,1709-011,Small,7/28/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Provisional,4/12/2018,1709-011,7/28/2004,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615321,,582756,Yes
1945,08-T-036,Use of vitamin Ds to down regulate the renin-angiotensin-aldosterone system,"10/900,418", ,*United States,US,7/27/2004,, ,7/27/2004,1709-012,Small,7/28/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,US Utility,4/12/2018,1709-012,7/27/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615322,,582756,Yes
1946,08-T-036,Use of Vitamin Ds to treat kidney disease,2007-523596, ,Japan,JP,7/27/2004,,JP2007/000523596,7/8/2005,1709-002,Small,7/28/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Nationalized PCT,4/12/2018,1709-002,7/28/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615323,,582756,Yes
1947,08-T-036,Use of Vitamin Ds to treat kidney disease,"2,575,155", ,Canada,CA,7/29/2004,, ,7/29/2004,1709-003,Small,7/29/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Nationalized PCT,4/12/2018,1709-003,7/29/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615324,,582756,Yes
1948,08-T-036,Use of Vitamin Ds to treat kidney disease,PCT/US05/24446, ,*United States,US,7/29/2004,,WO2006109659,7/8/2005,1709-004,Small,7/29/2003,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,PCT,4/12/2018,1709-004,1/28/2007,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615325,,582756,Yes
1949,08-T-036,Use of Vitamin Ds to treat kidney disease,PCT/US04/24517, ,*United States,US,7/29/2004,,WO2005011652,7/29/2004,1709-005,Small,7/29/2003,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,PCT,4/12/2018,1709-005,1/29/2006,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615326,,582756,Yes
1950,08-T-036,Use of Vitamin Ds to treat kidney disease,"10/974,243", ,*United States,US,10/27/2004,, ,10/27/2004,1709-006,Small,12/18/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,US Utility,4/12/2018,1709-006,7/29/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615327,,582756,Yes
1951,08-T-036,Use of Vitamin Ds to treat kidney disease,"60/491,025", ,*United States,US,7/29/2003,, ,7/29/2003,1709-007,Small,7/29/2003,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Provisional,4/12/2018,1709-007,7/29/2004,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615328,,582756,Yes
1952,08-T-036,Use of Vitamin Ds to treat kidney disease,05769600.7EPO, ,European Patent Office (EPO),EP,7/28/2004,, ,7/8/2005,1709-009,Small,7/29/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,Nationalized PCT,4/12/2018,1709-009,7/28/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615329,,582756,Yes
1953,08-T-036,Use of Vitamin Ds to treat kidney disease,"10/901,660", ,*United States,US,7/28/2004,, ,7/28/2004,1709-010,Small,7/29/2003,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yan Chun Li,US Utility,4/12/2018,1709-010,7/28/2024,"Unassigned, Unassigned",Yan Chun Li,"Unassigned, Unassigned",615330,,582756,Yes
1954,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,"61/077,242", ,*United States,US,7/1/2008,, ,7/1/2008,1711-001,None,7/1/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Provisional,4/12/2018,1711-001,7/1/2009,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613894,,582758,Yes
1955,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,PCT/US09/47372, ,*United States,US,6/15/2009,,WO2010/002576,6/15/2009,1711-002,None,7/1/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,PCT,4/12/2018,1711-002,1/1/2011,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613895,,582758,Yes
1956,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,"13/001,146", ,*United States,US,6/15/2009,,US-2011-0250278-A1,12/23/2010,1711-003,None,7/1/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000365870,Chun-Su Yuan,Nationalized PCT,4/12/2018,1711-003,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613896,10/13/2011,582758,Yes
1957,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,2011-516438,5985824,Japan,JP,6/15/2009,8/12/2016,2011-526898,12/28/2010,1711-004,Large,7/1/2008,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0467JP,Chun-Su Yuan,Nationalized PCT,4/12/2018,1711-004,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613897,10/20/2011,582758,Yes
1958,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,"2,729,582","2,729,582",Canada,CA,6/15/2009,9/19/2017, ,2/15/2011,1711-005,None,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Nationalized PCT,4/12/2018,1711-005,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613898,,582758,Yes
1959,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,2009265034,2009265034,Australia,AU,6/15/2009,12/17/2015, ,1/11/2011,1711-006,None,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Nationalized PCT,4/12/2018,1711-006,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613899,,582758,Yes
1960,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,09774028.6EPO, ,European Patent Office (EPO),EP,6/15/2009,,2306829,12/23/2010,1711-007,Large,7/1/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Nationalized PCT,4/12/2018,1711-007,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613900,4/13/2011,582758,Yes
1961,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,11109822.2, ,Hong Kong,HK,6/15/2009,,1155907A,9/19/2011,1711-008,Large,7/1/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Validated EPO,4/12/2018,1711-008,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613901,6/1/2012,582758,Yes
1962,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,2014-243740, ,Japan,JP,6/15/2009,,2015-091825,12/5/2014,1711-009,None,7/1/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0467JP.D1,Chun-Su Yuan,Divisional,4/12/2018,1711-009,12/5/2034,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613902,6/8/2015,582758,Yes
1963,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,09774028.6DE,602009043564.7,Germany,DE,6/15/2009,1/5/2017,2306829,1/27/2011,1711-010,Large,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Validated EPO,4/12/2018,1711-010,6/18/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613903,4/16/2011,582758,Yes
1964,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,09774028.6ES,2306829,Spain,ES,6/15/2009,1/5/2017, ,1/27/2011,1711-011,Large,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Validated EPO,4/12/2018,1711-011,6/18/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613904,4/16/2011,582758,Yes
1965,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,09774028.6FR,2306829,France,FR,6/15/2009,1/5/2017, ,1/27/2011,1711-012,Large,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Validated EPO,4/12/2018,1711-012,6/18/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613905,4/16/2011,582758,Yes
1966,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,09774028.6GB,2306829,United Kingdom,GB,6/15/2009,1/5/2017, ,1/27/2011,1711-013,Large,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chun-Su Yuan,Validated EPO,4/12/2018,1711-013,6/18/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613906,4/16/2011,582758,Yes
1967,08-T-038,Particles Containing an Opioid Receptor Antagonist and Methods of Use,09774028.6IT,502017000034145,Italy,IT,6/15/2009,1/5/2017,2306829,3/28/2017,1711-014,Large,7/1/2008,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1001010109,Chun-Su Yuan,Validated EPO,4/12/2018,1711-014,6/18/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613907,4/16/2011,582758,Yes
1968,08-T-038,PARTICLES CONTAINING AN OPIOID RECEPTOR ANTAGONIST AND METHODS OF USE,"15/835,181","10,507,188",*United States,US,6/15/2009,12/17/2019,US-2018-0098947-A1,12/7/2017,1711-015,Small,7/1/2008,12/5/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0467US.C1,Chun-Su Yuan,Continuation,4/12/2018,1711-015,10/8/2039,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",613908,4/12/2018,582758,No
1969,08-T-038,PARTICLES CONTAINING AN OPIOID RECEPTOR ANTAGONIST AND METHODS OF USE,"16/703,081", ,*United States,US,6/15/2009,,US-202-0101026-A1,12/4/2019,1711-016,Large,7/1/2008,12/9/2019,No,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0467US.C2,Chun-Su Yuan,Continuation,12/9/2019, ,6/15/2029,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",4143376,4/2/2020,582758,No
1970,08-T-040,Detecting Bacteria and Their Susceptibility to Antibiotics by Stochastic Confinement in Nanoliter Droplets Using Plug-based Microfluids,"61/052,490", ,*United States,US,5/12/2008,, ,5/12/2008,1713-001,Small,5/12/2008,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,7814-215,Rustem Ismagilov,Provisional,4/12/2018,1713-001,5/12/2009,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611391,,582760,Yes
1971,08-T-047,Identification of LET-7 Regulated Oncofetal Genes,"61/043,159", ,*United States,US,4/8/2008,, ,4/8/2008,1720-001,Small,4/8/2008,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,Marcus Peter,Provisional,4/12/2018,1720-001,4/8/2009,"Unassigned, Unassigned",Marcus Peter,"Unassigned, Unassigned",611890,,582767,Yes
1972,08-T-049,Microfluidic Pumping by Controlled Compression of Microfluidic Tubing,"61/125,076", ,*United States,US,4/22/2008,, ,4/22/2008,1708-001,Small,4/22/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00211,"Wenbin Du, Rustem Ismagilov, Lance Stewart, Peter Von Spect",Provisional,4/12/2018,1708-001,4/22/2009,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613403,,582769,Yes
1973,08-T-056,Compositions and Methods Related to Staphylococcal Bacterium Proteins,"61/084,472", ,*United States,US,7/29/2008,, ,7/29/2008,1727-001,Large,7/29/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1727-001,7/29/2009,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611222,,582776,Yes
1974,08-T-056,Compositions and Methods Related to Staphylococcal Bacterium Proteins,PCT/US09/47990, ,*United States,US,6/19/2009,,WO2010/014304,6/19/2009,1727-002,Large,7/29/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,1727-002,1/29/2011,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611223,2/4/2010,582776,Yes
1975,08-T-056,Compositions and Methods Related to Staphylococcal Bacterium Proteins,"13/056,437","8,758,765",*United States,US,6/19/2009,6/24/2014,US-2011-0206676-A1,1/28/2011,1727-003,Large,7/29/2008,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Monica Burts, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1727-003,1/26/2030,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",611224,8/25/2011,582776,Yes
1976,08-T-058,Hydrogen Bond Donor Catalysts,"61/056,248", ,*United States,US,5/27/2008,, ,5/27/2008,1730-001,Small,5/27/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00216,Viresh Rawal,Provisional,4/12/2018,1730-001,5/27/2009,"Ginsburg, Eric",Viresh Rawal,"Tennant, Thelma",611875,,582778,Yes
1977,08-T-058,Hydrogen Bond Donor Catalysts,"61/181,541", ,*United States,US,5/27/2009,, ,5/27/2009,1730-002,Small,5/27/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00255,Viresh Rawal,Provisional,4/12/2018,1730-002,5/27/2010,"Ginsburg, Eric",Viresh Rawal,"Tennant, Thelma",611876,,582778,Yes
1978,08-T-061,Photovoltaic Polymers,"61/082,071", ,*United States,US,7/18/2008,, ,7/18/2008,1733-001,Small,7/18/2008,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Watkins, Richard",00225,"Yongye Liang, Luping Yu",Provisional,4/12/2018,1733-001,7/18/2009,"Hwang, Luke",Luping Yu,"Tennant, Thelma",613970,,582781,Yes
1979,08-T-061,Semiconducting Polymers,"61/082,418", ,*United States,US,7/21/2008,, ,7/21/2008,1733-002,Small,7/21/2008,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00245,"Yongye Liang, Luping Yu",Provisional,4/12/2018,1733-002,7/21/2009,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614447,,582781,Yes
1980,08-T-061,Semiconducting Polymers,PCT/US09/44364, ,*United States,US,5/18/2009,, ,5/18/2009,1733-003,Small,7/18/2008,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Watkins, Richard",00253,"Yongye Liang, Luping Yu",PCT,4/12/2018,1733-003,1/18/2011,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614448,,582781,Yes
1981,08-T-061,Semiconducting Polymers,"13/054,719","8,436,134",*United States,US,5/18/2009,5/7/2013,US-2011-0124822-A1,1/18/2011,1733-004,Large,7/18/2008,5/7/2013,No,5/8/2022,Issued,Brinks Gilson & Lione,,00312,"Yongye Liang, Luping Yu",US Utility,4/12/2018,1733-004,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614449,5/26/2011,582781,Yes
1982,08-T-061,Semiconducting Polymers,200980135645.3,200980135645.3,China,CN,5/18/2009,4/23/2014, ,1/12/2011,1733-005,Small,7/18/2008,,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00309,"Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,1733-005,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614450,,582781,Yes
1983,08-T-061,Semiconducting Polymers,1034/CHENP/2011,288096,India,IN,5/18/2009,10/5/2017,1034/CHENP/2011,2/14/2011,1733-006,Small,7/18/2008,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00311,"Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,1733-006,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614451,12/2/2011,582781,Yes
1984,08-T-061,Semiconducting Polymers,09798375.3EPO,2307483,European Patent Office (EPO),EP,5/18/2009,4/22/2015,2307483,11/26/2010,1733-007,Small,7/18/2008,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,07814.00310,"Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,1733-007,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614452,4/13/2011,582781,Yes
1985,08-T-061,Semiconducting Polymers,PI0915969-0,PI0915969-0,Brazil,BR,5/18/2009,8/13/2019,PI0915969-0,5/15/2012,1733-008,Small,7/18/2008,,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00308,"Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,1733-008,8/13/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614453,8/13/2019,582781,Yes
1986,08-T-061,Semiconducting Polymers,"13/888,738","8,653,228",*United States,US,5/18/2009,2/18/2014,2014-0005347-A1,5/7/2013,1733-009,Large,7/18/2008,2/18/2014,No,5/8/2022,Issued,Brinks Gilson & Lione,,00353,"Yongye Liang, Luping Yu",Continuation,4/12/2018,1733-009,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614454,1/2/2014,582781,Yes
1987,08-T-061,Semiconducting Polymers,"14/183,151","9,029,499",*United States,US,5/18/2009,5/12/2015,US-2014-0235817-A1,2/18/2014,1733-010,Large,7/18/2008,5/12/2015,No,5/8/2022,Issued,Brinks Gilson & Lione,,00367,"Yongye Liang, Luping Yu",Continuation,4/12/2018,1733-010,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614455,8/21/2014,582781,Yes
1988,08-T-061,Semiconducting Polymers,502015000024802,2307483,Italy,IT,5/18/2009,4/22/2015,EP 2307483,6/17/2015,1733-011,Small,7/18/2008,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00392,"Yongye Liang, Luping Yu",Validated EPO,4/12/2018,1733-011,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614456,,582781,No
1989,08-T-061,Semiconducting Polymers,09798375.3FR, ,France,FR,5/18/2009,,EP 2307483,4/22/2015,1733-012,Small,7/18/2008,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00390,"Yongye Liang, Luping Yu",Validated EPO,4/12/2018,1733-012,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614457,4/13/2011,582781,No
1990,08-T-061,Semiconducting Polymers,60 2009 030 845.9, ,Germany,DE,5/18/2009,, ,5/19/2015,1733-013,Small,7/18/2008,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00391,"Yongye Liang, Luping Yu",Validated EPO,4/12/2018,1733-013,,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614458,6/3/2015,582781,No
1991,08-T-061,Semiconducting Polymers,09798375.3GB,2307483,United Kingdom,GB,5/18/2009,4/22/2015,EP 2307483,4/22/2015,1733-014,Small,7/18/2008,,No,4/28/2022,Issued,Brinks Gilson & Lione,,07814.00393,"Yongye Liang, Luping Yu",Validated EPO,4/12/2018,1733-014,5/18/2029,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614459,,582781,No
1992,08-T-062,Compositions and Methods Related to Bacterial EAP and/or EMP Proteins,"61/103,196", ,*United States,US,10/6/2008,, ,10/6/2008,1734-001,Small,10/6/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1734-001,10/6/2009,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611074,,582782,Yes
1993,08-T-062,Compositions and Methods Related to Bacterial EAP and/or EMP Proteins,"61/170,779", ,*United States,US,4/20/2009,, ,4/20/2009,1734-002,Small,4/20/2009,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1734-002,4/20/2010,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611075,,582782,Yes
1994,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",PCT/US09/59648, ,*United States,US,10/6/2009,,WO2010/042481,10/6/2009,1734-003,Large,10/6/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",PCT,4/12/2018,1734-003,4/6/2011,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611076,4/15/2010,582782,Yes
1995,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins","13/122,793", ,*United States,US,10/6/2009,,US-2011-0262477-A1,4/6/2011,1734-004,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-004,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611077,10/27/2011,582782,Yes
1996,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",2011-530297, ,Japan,JP,10/6/2009,,2012-504660,4/5/2011,1734-005,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-005,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611078,2/23/2012,582782,Yes
1997,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins","2,739,581", ,Canada,CA,10/6/2009,, ,5/24/2011,1734-006,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-006,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611079,,582782,Yes
1998,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",2009302582, ,Australia,AU,10/6/2009,, ,4/14/2011,1734-007,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-007,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611080,,582782,Yes
1999,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",09793315.4EPO,2341929,European Patent Office (EPO),EP,10/6/2009,,2341929,5/13/2011,1734-008,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-008,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611081,7/13/2011,582782,Yes
2000,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",200980146554.X,CN200980146554.X,China,CN,10/6/2009,4/22/2015,CN 102333540A,5/20/2011,1734-009,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-009,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611082,1/25/2012,582782,Yes
2001,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",201102434-6, ,Singapore,SG,10/6/2009,, ,4/6/2011,1734-010,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-010,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611083,,582782,Yes
2002,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",PI0920041-0, ,Brazil,BR,10/6/2009,, ,9/16/2011,1734-011,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-011,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611084,,582782,Yes
2003,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",11110223.5, ,Hong Kong,HK,10/6/2009,,1155948A,9/28/2011,1734-012,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-012,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611085,6/1/2012,582782,Yes
2004,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",3152/DELNP/2011, ,India,IN,10/6/2009,, ,4/29/2011,1734-013,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Nationalized PCT,4/12/2018,1734-013,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611086,,582782,Yes
2005,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",602009043983.9,2341929,Germany,DE,10/6/2009,1/26/2017, ,1/2/2017,1734-014,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Validated EPO,4/12/2018,1734-014,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611087,7/15/2011,582782,Yes
2006,08-T-062,"Compositions and Methods Related to Bacterial EAP, EMP, and/or AdsA Proteins",09793315.4GB,2341929,United Kingdom,GB,10/6/2009,1/26/2017, ,1/2/2017,1734-015,Large,10/6/2008,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Validated EPO,4/12/2018,1734-015,10/6/2029,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611088,7/15/2011,582782,Yes
2007,08-T-080,Compositions and Methods for Detecting Complicated Sarcoidosis,"14/483,803", ,*United States,US,9/12/2014,, ,9/12/2014,1752-005,Small,9/12/2013,,Yes,4/28/2022,Pending,"Valauskas Corder, LLC",, ,"Joe Garcia, Roberto Machado, Wei Zhang, Tong Zhou",US Utility,4/12/2018,1752-005,9/12/2034,"Peace, Shane",Joe Garcia,"Muite, Kevin",610986,,582800,No
2008,08-T-080,Method of Treating Acute Lung Injury Using Sphingosine 1 Phosphate Analogs or Sphingosine 1 Phosphate Receptor Agonists,"13/582,627", ,*United States,US,3/3/2011,, ,3/28/2013,1752-004,Small,3/3/2010,9/9/2021,Yes,4/28/2022,Abandoned,University of Illinois at Chicago,,UA 16-175,"Steven Dudek, Joe Garcia",US Utility,4/12/2018,1752-004,3/4/2031,"Peace, Shane",Joe Garcia,"Muite, Kevin",612540,3/28/2013,582800,No
2009,08-T-080,Methods and Compositions Involving PBEF Inhibitors for Lung Inflammation Conditions and Deseases,"61/076,071", ,*United States,US,6/26/2008,, ,6/26/2008,1752-001,Small,6/26/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Eddie Chiang, Joe Garcia, Shwu-Fan Ma, Jaideep Moitra, Liliana Moreno-Vinasco",Provisional,4/12/2018,1752-001,6/26/2009,"Peace, Shane",Liliana Moreno-Vinasco,"Muite, Kevin",612965,,582800,Yes
2010,08-T-080,Methods and Compositions Involving PBEF Inhibitors for Lung Inflammation Conditions and Deseases,"12/842,773","9,409,983",*United States,US,7/23/2010,8/9/2016,US-2011-0020364-A1,7/23/2010,1752-003,Small,7/23/2009,8/9/2016,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,, ,Joe Garcia,US Utility,4/12/2018,1752-003,8/28/2031,"Peace, Shane",Joe Garcia,"Muite, Kevin",612966,1/27/2011,582800,Yes
2011,08-T-080,Methods and Compositions Involving PBEF Inhibitors for Lung Inflammation Conditions and Diseases,"61/227,878", ,*United States,US,7/23/2009,, ,7/23/2009,1752-002,Small,7/23/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Eddie Chiang, Joe Garcia, Shwu-Fan Ma, Jaideep Moitra, Liliana Moreno-Vinasco",Provisional,4/12/2018,1752-002,7/23/2010,"Peace, Shane",Liliana Moreno-Vinasco,"Muite, Kevin",612967,,582800,Yes
2012,08-T-096,Attentuated Herpesviruses Encoding a MEK Pathway Polypeptide,"61/087,909", ,*United States,US,8/11/2008,, ,8/11/2008,1767-001,Small,8/11/2008,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",44154,"Alice Pui-Wah Poon, Bernard Roizman, Ralph Weichselbaum",Provisional,4/12/2018,1767-001,8/11/2009,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610574,,582816,Yes
2013,08-T-096,Attentuated Herpesviruses Encoding a MEK Pathway Polypeptide,PCT/US09/53186, ,*United States,US,8/7/2009,,WO2010/019480,8/7/2009,1767-002,Small,8/11/2008,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",44154A-PC,"Alice Pui-Wah Poon, Bernard Roizman, Ralph Weichselbaum",PCT,4/12/2018,1767-002,2/11/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610575,2/18/2010,582816,Yes
2014,08-T-096,Attentuated Herpesviruses Encoding a MEK Pathway Polypeptide,"13/058,780", ,*United States,US,8/7/2009,,US-2011-0274661-A1,7/28/2011,1767-003,Small,8/11/2008,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",44154A,"Alice Pui-Wah Poon, Bernard Roizman, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1767-003,8/7/2029,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610576,11/10/2011,582816,Yes
2015,08-T-097,Compositions and Methods Related to Bacterial Adenosine Synthase A (AdsA) Protein,"61/103,190", ,*United States,US,10/6/2008,, ,10/6/2008,1768-001,Small,10/6/2008,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Justin Kern, Dominique Missiakas, Olaf Schneewind, Vilasak Thammavongsa",Provisional,4/12/2018,1768-001,10/6/2009,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611073,,582817,Yes
2016,08-T-099,MICRORNA AND USES THEREOF IN DIABETIC NEPHROPATHY,"61/089,832", ,*United States,US,8/18/2008,, ,8/18/2008,1771-001,Small,8/18/2008,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Xinmin Li, Richard Quigg, Qiang Wang",Provisional,4/12/2018,1771-001,8/18/2009,"Unassigned, Unassigned",Richard Quigg,"Unassigned, Unassigned",613416,,582819,Yes
2017,08-T-101,Materials and Methods for the Preparation of Nanocomposites,"15/133,494","10,121,952",*United States,US,4/23/2010,11/6/2018,US-2016-0308107-A1,4/20/2016,1785-005,Small,4/23/2009,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul",44409B,"Chengyang (Raymond) Jiang, Maksym Kovalenko, Jong-Soo Lee, Dmitri Talapin",Continuation,4/12/2018,1785-005,6/27/2030,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610918,10/20/2016,582821,Yes
2018,08-T-101,Materials and Methods for the Preparation of Nanocomposites,"61/214,434", ,*United States,US,4/23/2009,, ,4/23/2009,1785-001,None,4/23/2009,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",44409,"Maksym Kovalenko, Dmitri Talapin",Provisional,4/12/2018,1785-001,4/23/2010,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612217,,582821,Yes
2019,08-T-101,Materials and Methods for the Preparation of Nanocomposites,PCT/US10/32246, ,*United States,US,4/23/2010,,WO 2010-124212,4/23/2010,1785-002,Small,4/23/2009,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",44409-PC,"Chengyang (Raymond) Jiang, Maksym Kovalenko, Jong-Soo Lee, Dmitri Talapin",PCT,4/12/2018,1785-002,10/23/2011,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612218,3/10/2011,582821,Yes
2020,08-T-101,Materials and Methods for the Preparation of Nanocomposites,"13/266,079","9,346,998",*United States,US,4/23/2010,5/24/2016, ,1/19/2012,1785-003,Small,4/23/2009,,No,5/9/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul",44409A-EP,"Chengyang (Raymond) Jiang, Maksym Kovalenko, Jong-Soo Lee, Dmitri Talapin",Nationalized PCT,4/12/2018,1785-003,6/21/2033,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612219,,582821,Yes
2021,08-T-101,Materials and Methods for the Preparation of Nanocomposites,10767840.1EPO,2430112,European Patent Office (EPO),EP,4/23/2010,9/12/2018,2 430 112,11/23/2011,1785-004,Small,4/23/2009,,No,5/9/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",44409A-EP,"Chengyang (Raymond) Jiang, Maksym Kovalenko, Jong-Soo Lee, Dmitri Talapin",Nationalized PCT,4/12/2018,1785-004,4/23/2030,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612220,3/23/2012,582821,Yes
2022,08-T-101,Materials and Methods for the Preparation of Nanocomposites,602010053546.0,602010053546.0,Germany,DE,4/23/2010,9/12/2018, ,9/10/2018,1785-006,Small,4/23/2009,9/18/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul",44409A-EP,"Chengyang (Raymond) Jiang, Maksym Kovalenko, Jong-Soo Lee, Dmitri Talapin",Nationalized PCT,9/18/2018, ,4/23/2030,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",1699126,,582821,Yes
2023,08-T-101,Materials and Methods for the Preparation of Nanocomposites,10767840.1GB,2430112,United Kingdom,GB,4/23/2010,9/12/2018,EP2430112,8/27/2018,1785-007,Small,4/23/2009,2/7/2019,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul", ,"Chengyang (Raymond) Jiang, Maksym Kovalenko, Jong-Soo Lee, Dmitri Talapin",Nationalized PCT,2/7/2019, ,4/23/2030,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",3497668,3/21/2012,582821,Yes
2024,08-T-124,S2D,"86/404,518", ,*United States,US,9/24/2014,, ,,1773-002,Small,9/24/2014,,Yes,8/4/2020,Abandoned,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9171-001,Scott Stern,Trademark,4/12/2018,1773-002,8/21/2034,"Ramirez, Mario Riojas",Scott Stern,"Tennant, Thelma",614416,,582844,Yes
2025,08-T-124,Symptom to Diagnosis,"86/044,071",,*United States,US,8/21/2013,,,,1773-001,Small,8/21/2013,,Yes,1/26/2021,Allowed,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9127-US00,Scott Stern,Trademark,4/12/2018,1773-001,8/21/2033,"Ramirez, Mario Riojas",Scott Stern,"Tennant, Thelma",614739,,582844,Yes
2026,08-T-124,S2D,"87/899,384", ,*United States,US,4/29/2018,, ,4/29/2018,1773-003,Large,9/24/2014,8/22/2018,No,5/31/2022,Allowed,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9171-US01,Scott Stern,Trademark,8/22/2018, ,,"Ramirez, Mario Riojas",Scott Stern,"Tennant, Thelma",1681558,,582844,Yes
2027,08-T-124,S2D,"97/141,702",,*United States,US,4/29/2018,,,11/24/2021,1773-004,None,9/24/2014,12/3/2021,No,5/31/2022,Pending,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9171-US02,Scott Stern,Trademark,12/3/2021,,,"Ramirez, Mario Riojas",Scott Stern,"Tennant, Thelma",6463165,,582844,Yes
2028,08-T-134,Slip Chip Device and Methods,"15/164,788","10,543,485",*United States,US,3/23/2010,1/28/2020,US-2016-0256870-A1,5/25/2016,1820-023,Small,3/24/2009,1/14/2020,No,4/28/2022,Issued,Fenwick & West LLP,"Shuster, Michael",32591-33315/US,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Continuation,4/12/2018,1820-023,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614526,9/8/2016,582854,Yes
2029,08-T-134,Slip Chip,"15/164,798",,*United States,US,3/23/2010,,US-2016-0288121-A1,5/25/2016,1820-024,Small,3/24/2009,,No,6/17/2022,Pending,Fenwick & West LLP,"Shuster, Michael",TUC-002C2,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Continuation,4/12/2018,1820-024,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614527,10/6/2016,582854,Yes
2030,08-T-134,Slip Chip Device and Methods,"61/162,922", ,*United States,US,3/24/2009,, ,3/24/2009,1820-001,Small,3/24/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00247,"Rustem Ismagilov, Jason Kreutz",Provisional,4/12/2018,1820-001,3/24/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614528,,582854,Yes
2031,08-T-134,Slip Chip Device and Methods,"61/340,872", ,*United States,US,3/22/2010,, ,3/22/2010,1820-002,Small,3/22/2010,,Yes,4/28/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Feng, Yuezhong",00275,Rustem Ismagilov,Provisional,4/12/2018,1820-002,3/22/2011,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614529,,582854,Yes
2032,08-T-134,Slip Chip Device and Methods,PCT/US10/28316, ,*United States,US,3/23/2010,,WO 2010/111265,3/23/2010,1820-003,Small,3/24/2009,11/9/2020,No,4/28/2022,Expired PCT - Nationalized,Brinks Gilson & Lione,"Feng, Yuezhong",00277,"James Boedicker, Delai Chen, Elena Davydova, Wenbin Du, Rustem Ismagilov, Mikhail Karymov, Songzi Kou, Jason Kreutz, Liang Li, Weishan Liu, Elena Lucchetta, Liang Ma, Kevin Paul Nichols, Jammejay Pandey, Rebecca Pompano, Feng Shen, Bing Sun",PCT,4/12/2018,1820-003,9/23/2011,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614530,9/30/2010,582854,Yes
2033,08-T-134,Slip Chip Device and Methods,2011/06816,2011/06816,South Africa,ZA,3/23/2010,11/28/2012, ,9/19/2011,1820-005,Small,3/24/2009,,No,5/23/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00332,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-005,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614531,,582854,Yes
2034,08-T-134,Slip Chip Device and Methods,10-2011-7024884,10-1702154,"Korea, Republic of",KR,3/23/2010,1/25/2017, ,10/6/2011,1820-006,Small,3/24/2009,,No,4/28/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00333,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-006,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614532,,582854,Yes
2035,08-T-134,Slip Chip Device and Methods,2012-502163,5766178,Japan,JP,3/23/2010,6/26/2015,2012-521219,10/31/2011,1820-007,Small,3/24/2009,,No,5/31/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00330,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-007,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614533,9/13/2012,582854,Yes
2036,08-T-134,Slip Chip Device and Methods,201080022620.5,102439717B,China,CN,3/23/2010,1/21/2015, ,11/23/2011,1820-008,Small,3/24/2009,,No,5/23/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00326,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-008,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614534,,582854,Yes
2037,08-T-134,Slip Chip Device and Methods,"13/257,811","9,415,392",*United States,US,3/23/2010,8/16/2016, ,9/20/2011,1820-009,Small,3/24/2009,8/16/2016,No,4/28/2022,Issued,Brinks Gilson & Lione,,00323,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-009,11/9/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614535,,582854,Yes
2038,08-T-134,Slip Chip Device and Methods,6877/CHENP/2011,363734,India,IN,3/23/2010,3/23/2021,6877/CHENP/2011 A,9/26/2011,1820-010,Small,3/24/2009,4/9/2021,No,5/23/2022,Issued,Brinks Gilson & Lione,,00328,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-010,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614536,11/30/2012,582854,Yes
2039,08-T-134,Slip Chip Device and Methods,2010229490,2010229490,Australia,AU,3/23/2010,5/28/2015, ,10/20/2011,1820-011,Small,3/24/2009,,No,5/23/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00324,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-011,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614537,,582854,Yes
2040,08-T-134,Slip Chip Device and Methods,215160,215160,Israel,IL,3/23/2010,7/31/2017, ,9/15/2011,1820-012,Small,3/24/2009,,No,4/28/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",00329,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-012,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614538,,582854,Yes
2041,08-T-134,Slip Chip Device and Methods,10756714.1EPO,2412020,European Patent Office (EPO),EP,3/23/2010,9/30/2020,2412020,9/12/2011,1820-013,Small,3/24/2009,9/25/2020,No,4/28/2022,Granted,Goodwin Procter LLP,,32591-30783/EP,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-013,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614539,2/1/2012,582854,Yes
2042,08-T-134,Slip Chip Device and Methods,NG/C/2011/610,NG/C/2011/610,Nigeria,NG,3/23/2010,3/5/2016, ,9/26/2011,1820-014,Small,3/24/2009,,No,5/23/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong", ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-014,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614541,,582854,Yes
2043,08-T-134,Slip Chip Device and Methods,"2,756,463","2,756,463",Canada,CA,3/23/2010,1/22/2019, ,3/23/2010,1820-015,Small,3/24/2009,,No,5/23/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",32591-30783/CA,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-015,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614542,,582854,Yes
2044,08-T-134,Slip Chip Device and Methods,12106174.1,1165903,Hong Kong,HK,3/23/2010,5/21/2021,1165903,6/25/2012,1820-016,Small,3/24/2009,6/10/2021,No,4/28/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong",32591-30783/HK,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-016,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614543,10/12/2012,582854,Yes
2045,08-T-134,Slip Chip Device and Methods,"13/440,371","9,447,461",*United States,US,3/23/2010,9/20/2016, ,4/5/2012,1820-017,Small,3/24/2009,9/20/2016,No,4/28/2022,Issued,Fenwick & West LLP,,32592-30788/US,"Wenbin Du, Rustem Ismagilov, Jason Kreutz, Feng Shen, Bing Sun",Continuation in Part,4/12/2018,1820-017,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614544,,582854,Yes
2046,08-T-134,Slip Chip Device and Methods,"13/467,482","9,464,319",*United States,US,3/23/2010,10/11/2016, ,5/9/2012,1820-018,Small,3/24/2009,10/11/2016,No,4/28/2022,Issued,Fenwick & West LLP,, ,"Wenbin Du, Rustem Ismagilov, Jason Kreutz, Feng Shen, Bing Sun",Continuation in Part,4/12/2018,1820-018,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614545,,582854,Yes
2047,08-T-134,Slip Chip Device and Methods,2015200465, ,Australia,AU,3/23/2010,, ,1/30/2015,1820-020,Small,3/24/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Divisional,4/12/2018,1820-020,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614546,,582854,Yes
2048,08-T-134,Slip Chip Device and Methods,201510003895.9,104722342B,China,CN,3/23/2010,1/11/2017, ,1/5/2015,1820-021,Small,3/24/2009,,No,5/23/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong", ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Divisional,4/12/2018,1820-021,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614547,,582854,Yes
2049,08-T-134,Slip Chip Device and Methods,2014-266976,"6,141,822",Japan,JP,3/23/2010,5/12/2017,2012-521219,12/29/2014,1820-022,Small,3/24/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,, ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Nationalized PCT,4/12/2018,1820-022,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614548,9/13/2012,582854,Yes
2050,08-T-134,Slip Chip Device and Methods,"15/247,795","10,370,705",*United States,US,3/23/2010,8/6/2019,US-2016-0362734-A1,8/25/2016,1820-025,Large,3/24/2009,,No,4/28/2022,Issued,Fenwick & West LLP,, ,"Wenbin Du, Rustem Ismagilov, Jason Kreutz, Feng Shen, Bing Sun",Divisional,4/12/2018,1820-025,4/5/2032,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614549,12/15/2016,582854,Yes
2051,08-T-134,Slip Chip Device and Methods,10-2017-7002166,10-1796906,"Korea, Republic of",KR,3/23/2010,11/6/2017, ,1/24/2017,1820-026,Large,3/24/2009,,No,4/28/2022,Issued,Brinks Gilson & Lione,"Feng, Yuezhong", ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Divisional,4/12/2018,1820-026,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614550,,582854,Yes
2052,08-T-134,Slip Chip Device and Methods,2016-116332,6263577,Japan,JP,3/23/2010,12/22/2017, ,6/10/2016,1820-027,Small,3/24/2009,,No,4/28/2022,Issued,Fenwick & West LLP,, ,"Wenbin Du, Rustem Ismagilov, Liang Li",Divisional,4/12/2018,1820-027,3/23/3030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614551,,582854,No
2053,08-T-134,Slip Chip Device and Methods,2016-116331,6227059,Japan,JP,3/23/2010,10/20/2017, ,6/10/2016,1820-028,Small,3/24/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,, ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Divisional,4/12/2018,1820-028,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614552,9/13/2012,582854,Yes
2054,08-T-134,Slip Chip Device and Methods,2017202597,2017202597,Australia,AU,3/23/2010,11/14/2019, ,4/19/2017,1820-029,Small,3/24/2009,,No,5/23/2022,Issued,Fenwick & West LLP,,32591-36890/AU,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Divisional,4/12/2018,1820-029,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614553,,582854,Yes
2055,08-T-134,Slip Chip Device and Methods,251198,251198,Israel,IL,3/23/2010,8/31/2019, ,3/15/2017,1820-030,Small,3/24/2009,,No,4/28/2022,Issued,Brinks Gilson & Lione,, ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Divisional,4/12/2018,1820-030,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614554,,582854,Yes
2056,08-T-134,SLIPCHIP,"85/248,752", ,*United States,US,2/23/2012,, ,2/23/2012,1820-004,Small,2/23/2012,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9164-001,"Rustem Ismagilov, Liang Li, Weishan Liu",Trademark,4/12/2018,1820-004,2/23/2032,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614556,,582854,Yes
2057,08-T-134,SLIPCHIP,"86/162,963", ,*United States,US,1/10/2014,, ,1/10/2014,1820-019,Small,2/23/2012,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9164-002,"Rustem Ismagilov, Liang Li, Weishan Liu",Trademark,4/12/2018,1820-019,2/23/2032,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614557,,582854,Yes
2058,08-T-134,SLIPCHIP,"87/490,979", ,*United States,US,6/15/2017,, ,6/15/2017,1820-031,Small,1/10/2014,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9164-US02,"Rustem Ismagilov, Liang Li, Weishan Liu",Trademark,4/12/2018,1820-031,6/15/2037,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614558,,582854,No
2059,08-T-134,SLIPCHIP,"90/290,490",,*United States,US,11/2/2020,,,11/2/2020,1820-032,Small,,11/2/2020,No,5/23/2022,Pending,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9164-US03,"Rustem Ismagilov, Liang Li, Weishan Liu",Trademark,11/2/2020,,11/2/2040,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5049840,,582854,No
2060,08-T-134,Slip Chip Device and Methods,10756714.1FR,2412020,France,FR,3/23/2010,9/30/2020, ,12/31/2020,1820-036,Large,3/24/2009,7/15/2021,No,5/23/2022,Issued,Goodwin Procter LLP,,32591-30783/FR,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Validated EPO,11/24/2020, ,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5123439,,582854,Yes
2061,08-T-134,Slip Chip Device and Methods,602010065562.8,2412020,Germany,DE,3/23/2010,9/23/2020, ,12/31/2020,1820-037,Large,3/24/2009,7/15/2021,No,5/23/2022,Issued,Goodwin Procter LLP,, ,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Validated EPO,11/24/2020, ,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5123514,,582854,Yes
2062,08-T-134,Slip Chip Device and Methods,10756714.1GB,2412020,United Kingdom,GB,3/23/2010,9/23/2020, ,12/31/2020,1820-038,Large,3/24/2009,7/15/2021,No,5/23/2022,Issued,Goodwin Procter LLP,,32591-30783/GB,"Delai Chen, Wenbin Du, Rustem Ismagilov, Jason Kreutz, Liang Li, Kevin Paul Nichols, Feng Shen",Validated EPO,11/24/2020, ,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",5123556,,582854,Yes
2063,08-T-136,Selective Apoptosis Promoters and Methods of Making and Using Same,"61/116,250", ,*United States,US,11/19/2008,, ,11/19/2008,1782-001,Small,11/19/2008,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Qing Dai, Amittha Wickrema, Ying Zhou",Provisional,4/12/2018,1782-001,11/19/2009,"Dembo, Anna",Amittha Wickrema,"Tennant, Thelma",614441,,582856,Yes
2064,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,"60/094,521", ,*United States,US,9/5/2008,, ,9/5/2008,1793-001,Small,9/5/2008,,Yes,4/28/2022,Expired - Inactive,Nath Law Group,"Waller, David", ,"Stephen Kron, David Schwartz",Provisional,4/12/2018,1793-001,9/5/2009,"Sun, Han",Stephen Kron,"Tennant, Thelma",612693,,582875,Yes
2065,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,"12/555,668","8,580,516",*United States,US,9/8/2009,11/12/2013, ,7/16/2013,1793-002,Small,9/5/2008,,No,4/28/2022,Issued,"Valauskas Corder, LLC",, ,"Stephen Kron, David Schwartz",US Utility,4/12/2018,1793-002,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612694,,582875,Yes
2066,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,PCT/US09/56262, ,*United States,US,9/8/2009,, ,9/8/2009,1793-003,Small,9/5/2008,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Stephen Kron, David Schwartz",PCT,4/12/2018,1793-003,3/8/2011,"Sun, Han",Stephen Kron,"Tennant, Thelma",612695,,582875,Yes
2067,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,09812394.6EPO, ,European Patent Office (EPO),EP,9/8/2009,, ,10/19/2012,1793-004,Small,9/5/2008,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Stephen Kron, David Schwartz",Nationalized PCT,4/12/2018,1793-004,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612696,,582875,Yes
2068,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,12189330.9EPO, ,European Patent Office (EPO),EP,9/8/2009,,2604702 A1,10/19/2012,1793-005,Small,9/5/2008,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Stephen Kron, David Schwartz",Divisional,4/12/2018,1793-005,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612697,6/19/2013,582875,Yes
2069,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,"14/076,342", ,*United States,US,9/8/2009,,US 2014/0220696 A1,11/11/2013,1793-006,Small,9/5/2008,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Stephen Kron, David Schwartz",Continuation,4/12/2018,1793-006,9/5/2028,"Sun, Han",Stephen Kron,"Tennant, Thelma",612698,8/7/2014,582875,Yes
2070,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,12189330.9CH,2604702,Switzerland,CH,9/8/2009,7/1/2015, ,10/19/2012,1793-007,Small,9/5/2008,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Valauskas, Charles", ,Stephen Kron,Validated EPO,4/12/2018,1793-007,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612699,,582875,No
2071,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,12189330.9FR,2604702,France,FR,9/8/2009,7/1/2015, ,10/19/2012,1793-008,Small,9/5/2008,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Valauskas, Charles", ,Stephen Kron,Validated EPO,4/12/2018,1793-008,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612700,,582875,No
2072,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,12189330.9DE,602009032018.1,Germany,DE,9/8/2009,7/1/2015, ,10/19/2012,1793-009,Small,9/5/2008,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Valauskas, Charles", ,Stephen Kron,Validated EPO,4/12/2018,1793-009,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612701,,582875,No
2073,08-T-155,Methods and Compositions for Direct Detection of DNA Damage,12189330.9GB,2604702,United Kingdom,GB,9/8/2009,7/1/2015, ,10/19/2012,1793-010,Small,9/5/2008,,No,4/28/2022,Abandoned,"Valauskas Corder, LLC","Valauskas, Charles", ,Stephen Kron,Validated EPO,4/12/2018,1793-010,9/8/2029,"Sun, Han",Stephen Kron,"Tennant, Thelma",612702,,582875,No
2074,08-T-158,Method for Automated Analysis of Sinus Inflammation,"61/463,064", ,*United States,US,2/11/2011,, ,2/11/2011,1797-001,Small,2/11/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",46058,"Samuel Armato, Jayant Pinto, M.D., William Sensakovic, Adam Starkey",Provisional,4/12/2018,1797-001,2/11/2012,"Unassigned, Unassigned",William Sensakovic,"Unassigned, Unassigned",612429,,582878,Yes
2075,08-T-159,Synthesis And Anticancer Activity of New Actin-Targeting Small-Molecule Agents,"61/154,155", ,*United States,US,2/20/2009,, ,2/20/2009,1798-001,Small,2/20/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00251,"Sergey Kozmin, Syed Rizvi",Provisional,4/12/2018,1798-001,2/20/2010,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",614745,,582879,Yes
2076,08-T-159,Synthesis and Anticancer Activity of new Actin-targeting Small-Molecule Agents,"12/707,383","8,350,062",*United States,US,2/17/2010,1/8/2013,US-2010-0217019-A1,2/17/2010,1798-002,Small,2/20/2009,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,07814.00274,"Sergey Kozmin, Syed Rizvi",US Utility,4/12/2018,1798-002,2/17/2030,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",614746,8/26/2010,582879,Yes
2077,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"61/166,432", ,*United States,US,4/3/2009,, ,4/3/2009,1800-001,Large,4/3/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482USP1,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1800-001,4/3/2010,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611111,,582885,Yes
2078,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"61/237,956", ,*United States,US,8/28/2009,, ,8/28/2009,1800-002,Large,8/28/2009,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482USP2,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1800-002,8/28/2010,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611112,,582885,Yes
2079,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"61/287,996", ,*United States,US,12/18/2009,, ,12/18/2009,1800-003,Large,12/18/2009,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482USP3,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1800-003,12/18/2010,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611113,,582885,Yes
2080,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,PCT/US10/29959, ,*United States,US,4/5/2010,,2001/005341,4/5/2010,1800-004,Large,4/3/2009,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482WO,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,1800-004,10/3/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611114,1/13/2011,582885,Yes
2081,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"61/361,218", ,*United States,US,7/2/2010,, ,7/2/2010,1800-005,Large,7/2/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482USP4,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1800-005,7/2/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611115,,582885,Yes
2082,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"61/370,725", ,*United States,US,8/4/2010,, ,8/4/2010,1800-006,Large,8/4/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482USP5,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1800-006,8/4/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611116,,582885,Yes
2083,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2010271116,201027116,Australia,AU,4/5/2010,11/26/2015, ,4/5/2010,1800-007,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482AU,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-007,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611117,,582885,Yes
2084,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2015202158,AU 2015202158 B2,Australia,AU,4/5/2010,8/18/2016, ,4/27/2015,1800-008,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482AU.D1,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2018,1800-008,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611118,,582885,Yes
2085,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5AT,2414387,Austria,AT,4/5/2010,12/18/2015, ,12/16/2015,1800-009,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482AT,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-009,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611119,,582885,No
2086,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5BE,2414387,Belgium,BE,4/5/2010,12/18/2015, ,12/16/2015,1800-010,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482BE,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-010,5/1/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611120,,582885,No
2087,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,PI1010307-4,PI1010307-4,Brazil,BR,4/5/2010,7/27/2021,2638,3/10/2011,1800-011,Large,4/3/2009,8/3/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482BR,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-011,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611121,7/27/2021,582885,Yes
2088,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5BG,2414387,Bulgaria,BG,4/5/2010,12/18/2015, ,12/16/2015,1800-012,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-012,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611123,,582885,No
2089,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"2,757,543","2,757,543",Canada,CA,4/5/2010,7/20/2021, ,11/23/2011,1800-013,Large,4/3/2009,9/13/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482CA,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-013,7/20/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611124,,582885,Yes
2090,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,201080024448.7,ZL 201080024448.7,China,CN,4/5/2010,1/20/2016, ,12/2/2011,1800-014,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-014,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611125,,582885,Yes
2091,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5HR,20160274,Croatia,HR,4/5/2010,12/18/2015, ,12/16/2015,1800-015,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-015,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611127,,582885,No
2092,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5CY,2414387,Cyprus,CY,4/5/2010,12/18/2015, ,12/16/2015,1800-016,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-016,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611129,,582885,No
2093,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5CZ,2414387,Czech Republic,CZ,4/5/2010,12/18/2015, ,12/16/2015,1800-017,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-017,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611131,,582885,No
2094,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5EE,2414387,Estonia,EE,4/5/2010,12/18/2015, ,12/16/2015,1800-019,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-019,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611133,,582885,No
2095,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,10797468.5EPO,EP 2414387,European Patent Office (EPO),EP,4/5/2010,, ,11/11/2011,1800-020,Large,4/3/2009,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482EP,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-020,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611134,2/8/2012,582885,Yes
2096,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,15190262.4EPO, ,European Patent Office (EPO),EP,4/5/2010,,3002293,10/6/2015,1800-021,Large,4/3/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482EP.D1,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-021,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611135,4/6/2016,582885,No
2097,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9EPO,3281947,European Patent Office (EPO),EP,4/5/2010,2/12/2020,3281947,9/26/2017,1800-022,Large,4/3/2009,3/24/2020,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482EP.D2,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-022,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611136,2/14/2018,582885,No
2098,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5FR,2414387,France,FR,4/5/2010,12/18/2015, ,12/16/2015,1800-023,Large,4/3/2009,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-023,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611137,,582885,No
2099,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5DE,60 2010 029 571.0,Germany,DE,4/5/2010,12/18/2015, ,12/16/2015,1800-024,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-024,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611138,,582885,No
2100,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,10-2017-7023725, ,"Korea, Republic of",KR,4/5/2010,, ,8/24/2017,1800-025,Large,4/3/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482KR.D1,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2018,1800-025,4/10/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611139,,582885,Yes
2101,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,12102899.4,HK1162533,Hong Kong,HK,4/5/2010,7/8/2016,1162533A,3/22/2012,1800-026,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-026,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611140,8/3/2012,582885,Yes
2102,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5HU,2414387,Hungary,HU,4/5/2010,12/18/2015, ,12/16/2015,1800-027,Small,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-027,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611142,,582885,No
2103,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,7833/DELNP/2011,323559,India,IN,4/5/2010,10/23/2019,7833/DELNP/2011 A,12/10/2011,1800-029,Large,4/3/2009,1/6/2020,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482IN,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-029,4/4/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611143,12/28/2012,582885,Yes
2104,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5IE,2414387,Ireland,IE,4/5/2010,12/18/2015, ,12/16/2015,1800-030,Small,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-030,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611144,,582885,No
2105,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2012-503769,5789250,Japan,JP,4/5/2010,8/7/2015,2012-522808,9/30/2011,1800-032,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-032,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611145,9/27/2012,582885,Yes
2106,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5LV,2414387,Latvia,LV,4/5/2010,12/18/2015, ,12/16/2015,1800-033,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-033,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611147,,582885,No
2107,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5LI,2414387,Lichtenstein,LI,4/5/2010,12/17/2015, ,12/16/2015,1800-034,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-034,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611148,,582885,No
2108,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5LT,2414387,Lithuania,LT,4/5/2010,12/18/2015, ,12/16/2015,1800-035,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,, ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-035,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611150,,582885,No
2109,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5LU,2414387,Luxembourg,LU,4/5/2010,12/16/2015, ,12/16/2015,1800-036,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-036,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611151,,582885,No
2110,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5MT,2414387,Malta,MT,4/5/2010,12/18/2015, ,12/16/2015,1800-037,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482MT,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-037,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611153,,582885,No
2111,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5MC,2414387,Monaco,MC,4/5/2010,12/18/2015, ,12/16/2015,1800-038,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-038,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611155,,582885,No
2112,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5NO,2414387,Norway,NO,4/5/2010,12/18/2015, ,12/16/2015,1800-040,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-040,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611157,,582885,No
2113,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5PL,2414387,Poland,PL,4/5/2010,12/18/2015, ,12/16/2015,1800-041,Large,4/3/2009,,Yes,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-041,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611159,,582885,No
2114,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5PT,2414387,Portugal,PT,4/5/2010,12/18/2015, ,12/16/2015,1800-042,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-042,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611160,,582885,No
2115,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,10-2011-7026053,1773368,"Korea, Republic of",KR,4/5/2010,8/25/2017, ,9/19/2011,1800-043,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-043,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611161,12/27/2011,582885,Yes
2116,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5RO,2414387,Romania,RO,4/5/2010,12/18/2015, ,12/16/2015,1800-044,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-044,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611163,,582885,No
2117,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,201107080.2,174968,Singapore,SG,4/5/2010,10/25/2016, ,10/13/2011,1800-046,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-046,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611165,,582885,Yes
2118,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5SK,2414387,Slovakia,SK,4/5/2010,12/18/2015, ,12/16/2015,1800-047,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-047,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611167,,582885,No
2119,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5SI,2414387,Slovenia,SI,4/5/2010,12/18/2015, ,12/16/2015,1800-048,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-048,4/7/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611169,,582885,No
2120,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2011/07702,2011/07702,South Africa,ZA,4/5/2010,7/27/2012, ,10/21/2011,1800-049,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-049,4/4/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611170,,582885,Yes
2121,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5ES,2414387,Spain,ES,4/5/2010,12/18/2015, ,12/16/2015,1800-050,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-050,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611171,,582885,No
2122,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5SE,2414387,Sweden,SE,4/5/2010,12/18/2015, ,12/16/2015,1800-051,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-051,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611172,,582885,No
2123,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5CH,2414387,Switzerland,CH,4/5/2010,12/18/2015, ,12/16/2015,1800-052,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-052,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611173,,582885,No
2124,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5TR,2414387,Turkey,TR,4/5/2010,12/18/2015, ,12/16/2015,1800-054,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-054,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611175,,582885,No
2125,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5GB,2414387,United Kingdom,GB,4/5/2010,12/18/2015, ,12/16/2015,1800-055,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-055,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611176,,582885,No
2126,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"13/260,878","9,567,379",*United States,US,4/5/2010,2/14/2017,US-2012-0114686-A1,9/28/2011,1800-056,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-056,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611177,5/10/2012,582885,Yes
2127,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,PCT/US11/42845, ,*United States,US,7/1/2011,,WO 2012/003474,7/1/2011,1800-059,Large,7/2/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,1800-059,1/2/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611178,1/5/2012,582885,Yes
2128,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"13/807,598","8,821,894",*United States,US,7/1/2011,9/2/2014,US-2013-0171183-A1,12/28/2012,1800-060,Large,7/2/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556US,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-060,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611179,7/4/2013,582885,Yes
2129,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"14/466,514","9,315,554",*United States,US,7/1/2011,4/19/2016,US-2015-0056240-A1,8/22/2014,1800-061,Large,7/2/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556US.C1,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,4/12/2018,1800-061,7/3/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611180,2/26/2015,582885,Yes
2130,09-T-003,Compositions and Methods Related to Protein A (SPA) Variants,10797468.5GR,2414387,Greece,GR,4/5/2010,12/18/2015, ,12/16/2015,1800-062,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482GR,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-062,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611181,,582885,No
2131,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2011274367,2011274367,Australia,AU,7/1/2011,8/6/2015, ,12/7/2012,1800-063,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-063,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611182,,582885,Yes
2132,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,BR112013000097-0,BR 112013000097-0,Brazil,BR,7/1/2011,2/1/2022,,7/2/2013,1800-064,Large,7/2/2010,6/2/2022,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556BR,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-064,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611183,,582885,Yes
2133,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"2,803,298","2,803,298",Canada,CA,7/1/2011,7/14/2020, ,2/16/2013,1800-065,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.0556CA,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-065,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611184,,582885,Yes
2134,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,201180032798.2,ZL 201180032798.2,China,CN,7/1/2011,8/26/2015,CN103037885A,12/31/2012,1800-066,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-066,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611185,4/10/2013,582885,Yes
2135,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4EPO,2588120,European Patent Office (EPO),EP,7/1/2011,11/15/2017,2588120,12/7/2012,1800-067,Large,7/2/2010,2/22/2022,No,6/21/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556EP,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-067,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611186,5/8/2013,582885,Yes
2136,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,559/DELNP/2013, ,India,IN,7/1/2011,, ,12/7/2012,1800-068,Large,7/2/2010,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556IN,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-068,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611187,10/17/2014,582885,Yes
2137,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2013-518766,"6,002,128",Japan,JP,7/1/2011,9/9/2016,2013-534532,12/28/2012,1800-069,Large,7/2/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000316828,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-069,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611188,9/5/2013,582885,Yes
2138,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,10-2013-7002673, ,"Korea, Republic of",KR,7/1/2011,, ,1/31/2013,1800-070,Large,7/2/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-070,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611189,,582885,Yes
2139,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,201209110.4,186290,Singapore,SG,7/1/2011,4/28/2015, ,12/7/2012,1800-071,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368603,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-071,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611190,,582885,Yes
2140,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,2012/09561,2012/09561,South Africa,ZA,7/1/2011,10/26/2016, ,12/14/2012,1800-072,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1800-072,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611191,,582885,Yes
2141,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4BE,2588120,Belgium,BE,7/1/2011,11/15/2017, ,7/1/2011,1800-073,Small,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-073,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611192,,582885,No
2142,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4FR,2588120,France,FR,7/1/2011,11/15/2017, ,7/1/2011,1800-074,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-074,4/9/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611194,5/12/2013,582885,Yes
2143,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4NL,2588120,Netherlands,NL,7/1/2011,11/15/2017, ,7/1/2011,1800-075,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-075,4/9/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611196,5/12/2013,582885,Yes
2144,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4ES,11801511.4,Spain,ES,7/1/2011,11/15/2017, ,7/1/2011,1800-076,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-076,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611198,5/12/2013,582885,Yes
2145,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4GB,2588120,United Kingdom,GB,7/1/2011,11/15/2017, ,7/1/2011,1800-077,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-077,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611200,5/12/2013,582885,Yes
2146,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4TR,2588120,Turkey,TR,7/1/2011,11/15/2017, ,7/1/2011,1800-079,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-079,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611201,5/12/2013,582885,Yes
2147,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,602011043426.8,602011043426.8,Germany,DE,7/1/2011,12/16/2015, ,7/1/2011,1800-080,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-080,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611202,5/12/2013,582885,Yes
2148,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4IE,2588120,Ireland,IE,7/1/2011,11/15/2017, ,7/1/2011,1800-081,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-081,4/9/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611203,5/12/2013,582885,Yes
2149,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,11801511.4IT,2588120,Italy,IT,7/1/2011,11/15/2017, ,7/1/2011,1800-082,Large,7/2/2010,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000368134,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-082,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611204,5/12/2013,582885,Yes
2150,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5DK,2414387,Denmark,DK,4/5/2010,12/18/2015, ,12/16/2015,1800-018,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-018,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614207,,582885,No
2151,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5IS,2414387,Iceland,IS,4/5/2010,12/18/2015, ,12/16/2015,1800-028,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-028,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614208,,582885,No
2152,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5IT,2414387,Italy,IT,4/5/2010,12/18/2015, ,12/16/2015,1800-031,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-031,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614209,,582885,No
2153,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5NL,2414387,Netherlands,NL,4/5/2010,12/18/2015, ,12/16/2015,1800-039,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-039,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614210,,582885,No
2154,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5SM,2414387,San Marino,SM,4/5/2010,12/19/2015, ,12/16/2015,1800-045,Small,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-045,4/7/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614212,,582885,No
2155,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5MK,2414387,"Macedonia, former Yugoslav Republic of",MK,4/5/2010,12/19/2015, ,12/16/2015,1800-053,Small,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-053,4/7/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614214,,582885,No
2156,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,"15/060,861", ,*United States,US,7/1/2011,, ,3/4/2016,1800-057,Large,7/2/2010,,No,5/1/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000200708,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,4/12/2018,1800-057,9/12/2037,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614215,,582885,No
2157,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,10797468.5FI,2414387,Finland,FI,4/5/2010,12/18/2015, ,12/16/2015,1800-058,Large,4/3/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/12/2018,1800-058,4/6/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614216,,582885,No
2158,09-T-003,Protein A as a Subunit Vaccine Against Staphylococcal Disease,"15/702,037","10,464,971",*United States,US,7/1/2011,11/5/2019,US-2017-0369536-A1,9/12/2017,1800-078,Large,7/2/2010,10/18/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556US.C3,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,4/12/2018,1800-078,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614217,12/28/2017,582885,No
2159,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,BR122019005971-3, ,Brazil,BR,4/5/2010,, ,3/26/2019,1800-083,Large,4/3/2009,11/3/2021,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482BR.D1,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2019, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",3612269,,582885,Yes
2160,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"16/661,155","11,059,866",*United States,US,7/1/2011,7/13/2021,US-2020-0140494-A1,10/23/2019,1800-084,Large,7/2/2010,6/28/2021,No,6/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556US.C4,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,11/4/2019,,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4099164,5/7/2020,582885,No
2161,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Albania,AL,4/5/2010,2/12/2020, ,2/12/2020,1800-085,Large,4/3/2009,3/24/2020,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482AL,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420499,,582885,No
2162,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Austria,AT,4/5/2010,2/12/2020, ,2/12/2020,1800-086,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482AT,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420529,,582885,No
2163,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Belgium,BE,4/5/2010,2/12/2020, ,2/12/2020,1800-087,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482BE,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420570,,582885,No
2164,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Bulgaria,BG,4/5/2010,2/12/2020, ,2/12/2020,1800-088,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482BG,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420600,,582885,No
2165,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Switzerland,CH,4/5/2010,2/12/2020, ,2/12/2020,1800-089,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482CH,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420630,,582885,No
2166,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Cyprus,CY,4/5/2010,2/12/2020, ,2/12/2020,1800-090,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482CY,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420660,,582885,No
2167,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Czech Republic,CZ,4/5/2010,2/12/2020, ,2/12/2020,1800-091,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482CZ,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420690,,582885,No
2168,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Denmark,DK,4/5/2010,2/12/2020, ,2/12/2020,1800-093,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482DK,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420720,,582885,No
2169,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,602010063121.4,Germany,DE,4/5/2010,2/12/2020, ,2/12/2020,1800-092,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482DE,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/2/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420750,,582885,No
2170,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Estonia,EE,4/5/2010,2/12/2020, ,2/12/2020,1800-094,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482EE,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420780,,582885,No
2171,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Spain,ES,4/5/2010,2/12/2020, ,2/12/2020,1800-095,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482ES,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420810,,582885,No
2172,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Finland,FI,4/5/2010,2/12/2020, ,2/12/2020,1800-096,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482FI,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420840,,582885,No
2173,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,France,FR,4/5/2010,2/12/2020, ,2/12/2020,1800-097,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482FR,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420870,,582885,No
2174,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,United Kingdom,GB,4/5/2010,2/12/2020, ,2/12/2020,1800-098,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482GB,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420900,,582885,No
2175,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,20200401288,Greece,GR,4/5/2010,2/12/2020, ,2/12/2020,1800-099,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482GR.D2,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420930,,582885,No
2176,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,381-03/20-012/0727,3281947,Croatia,HR,4/5/2010,2/12/2020, ,2/12/2020,1800-100,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482HR.D2,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420960,,582885,No
2177,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Hungary,HU,4/5/2010,2/12/2020, ,2/12/2020,1800-101,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482HU,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4420990,,582885,No
2178,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Ireland,IE,4/5/2010,2/12/2020, ,2/12/2020,1800-102,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482IE,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421020,,582885,No
2179,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Iceland,IS,4/5/2010,2/12/2020, ,2/12/2020,1800-103,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482IS,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421050,,582885,No
2180,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,502020000042367,3281947,Italy,IT,4/5/2010,2/12/2020, ,2/12/2020,1800-104,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482IT,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421080,,582885,No
2181,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Lichtenstein,LI,4/5/2010,2/12/2020, ,2/12/2020,1800-105,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482LI,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421110,,582885,No
2182,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Lithuania,LT,4/5/2010,2/12/2020, ,2/12/2020,1800-106,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482LT,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421140,,582885,No
2183,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Luxembourg,LU,4/5/2010,2/12/2020, ,2/12/2020,1800-107,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482LU,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421170,,582885,No
2184,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Latvia,LV,4/5/2010,2/12/2020, ,2/12/2020,1800-108,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482LV,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421200,,582885,No
2185,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,MKP/2020/266,3281947,"Macedonia, former Yugoslav Republic of",MK,4/5/2010,2/12/2020, ,2/12/2020,1800-110,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482MK,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421230,,582885,No
2186,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Malta,MT,4/5/2010,2/12/2020, ,2/12/2020,1800-111,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482MT,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421260,,582885,No
2187,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Monaco,MC,4/5/2010,2/12/2020, ,2/12/2020,1800-109,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482MC,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421290,,582885,No
2188,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Netherlands,NL,4/5/2010,2/12/2020, ,2/12/2020,1800-112,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482NL,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421320,,582885,No
2189,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Norway,NO,4/5/2010,2/12/2020, ,2/12/2020,1800-113,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482NO,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421350,,582885,No
2190,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Poland,PL,4/5/2010,2/12/2020, ,2/12/2020,1800-114,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482PL,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421380,,582885,No
2191,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Portugal,PT,4/5/2010,2/12/2020, ,2/12/2020,1800-115,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482PT,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421410,,582885,No
2192,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Romania,RO,4/5/2010,2/12/2020, ,2/12/2020,1800-116,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482RO,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421440,,582885,No
2193,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Serbia,RS,4/5/2010,2/12/2020, ,2/12/2020,1800-117,Large,4/3/2009,3/24/2020,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482RS,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421470,,582885,No
2194,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Sweden,SE,4/5/2010,2/12/2020, ,2/12/2020,1800-118,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482SE,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421500,,582885,No
2195,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Slovenia,SI,4/5/2010,2/12/2020, ,2/12/2020,1800-119,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482SI,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421530,,582885,No
2196,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Slovakia,SK,4/5/2010,2/12/2020, ,2/12/2020,1800-120,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482SK,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421560,,582885,No
2197,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,202000246,3281947,San Marino,SM,4/5/2010,2/12/2020, ,2/12/2020,1800-121,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482SM,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421590,,582885,No
2198,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,17193256.9,3281947,Turkey,TR,4/5/2010,2/12/2020, ,2/12/2020,1800-122,Large,4/3/2009,3/24/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0482TR,"Alice Cheng, Hwan Kim, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/24/2020, ,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4421620,,582885,No
2199,09-T-003,Compositions and Methods Related to Protein A (SpA) Variants,"17/340,532", ,*United States,US,7/1/2011,,US-2021-0290748-A1,6/7/2021,1800-123,None,7/2/2010,6/9/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0556US.C5,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,6/9/2021, ,7/1/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",5810516,9/23/2021,582885,No
2200,09-T-004,"Variation in the CHI3L1 Gene Influences Serum YKL-40 Levels, Asthma Risk, and Lung Function",PCT/US08/85036, ,*United States,US,11/26/2008,, ,11/26/2008,1801-001,None,11/28/2007,,No,4/28/2022,Expired - Inactive,"Drinker Biddle Reath, LLP","Doyle, Kathryn", ,"Jack Elias, Chupp Geoffrey, Carole Ober",PCT,4/12/2018,1801-001,5/28/2010,"Sun, Han",Carole Ober,"Tennant, Thelma",615360,,582886,Yes
2201,09-T-012,Platelet Aggregation Inhibitors,"61/239,499", ,*United States,US,9/3/2009,, ,9/3/2009,1805-001,None,9/3/2009,,Yes,6/8/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00252,"Milan Mrksich, Juan Sanchez-Cortes",Provisional,4/12/2018,1805-001,9/3/2010,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614064,,582894,Yes
2202,09-T-012,Platelet Aggregation Inhibitors,PCT/US10/47695, ,*United States,US,9/2/2010,,WO 2011/028915,9/2/2010,1805-002,None,9/3/2009,,Yes,6/8/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00289,"Milan Mrksich, Juan Sanchez-Cortes",PCT,4/12/2018,1805-002,3/3/2012,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614065,3/10/2011,582894,Yes
2203,09-T-012,Platelet Aggregation Inhibitors,"13/393,608", ,*United States,US,9/2/2010,,US 2012/0252730 A1,6/19/2012,1805-003,None,9/2/2010,,No,6/8/2022,Abandoned,Brinks Gilson & Lione,,00341,"Milan Mrksich, Juan Sanchez-Cortes",Nationalized PCT,4/12/2018,1805-003,9/3/2029,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",614066,10/4/2012,582894,Yes
2204,09-T-031,System and Method for Providing an Edge Device Between two Healthcare Entities,"61/161,045", ,*United States,US,3/17/2009,, ,3/17/2009,1815-001,Small,3/17/2009,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rueth, Randall",44701,"Paul Chang, Ben Patel, Michael Sorensen, Eric Yablonka",Provisional,4/12/2018,1815-001,3/17/2010,"Ginsburg, Eric",Paul Chang,"Smith, Dane",614792,,582913,Yes
2205,09-T-032,System and Method for Manipulating Domain Pinning and Reversal in Ferromagnetic Materials,"61/270,561", ,*United States,US,7/10/2009,, ,7/10/2009,1816-001,Small,7/10/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00260,"Gabriel Aeppli, Thomas Rosenbaum, Daniel Silevitch",Provisional,4/12/2018,1816-001,7/10/2010,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",614784,,582914,Yes
2206,09-T-032,System and Method for Manipulating Domain Pinning and Reversal in Ferromagnetic Materials,PCT/US10/41485, ,*United States,US,7/9/2010,,WO 2011/006042 A1,7/9/2010,1816-002,Small,7/10/2009,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00287,"Gabriel Aeppli, Thomas Rosenbaum, Daniel Silevitch",PCT,4/12/2018,1816-002,1/10/2012,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",614785,1/13/2011,582914,Yes
2207,09-T-032,System and Method for Manipulating Domain Pinning and Reversal in Ferromagnetic Materials,"13/383,059","8,558,333",*United States,US,7/9/2010,10/15/2013,US-2012-0162815-A1,1/9/2012,1816-003,Small,7/10/2009,10/15/2013,No,5/8/2022,Issued,Brinks Gilson & Lione,,00337,"Gabriel Aeppli, Thomas Rosenbaum, Daniel Silevitch",Nationalized PCT,4/12/2018,1816-003,7/9/2030,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",614786,6/28/2012,582914,Yes
2208,09-T-032,System and Method for Manipulating Domain Pinning and Reversal in Ferromagnetic Materials,10797895.9EPO, ,European Patent Office (EPO),EP,7/9/2010,, ,3/21/2012,1816-004,Small,7/10/2009,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00336,"Gabriel Aeppli, Thomas Rosenbaum, Daniel Silevitch",Nationalized PCT,4/12/2018,1816-004,7/9/2030,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",614787,,582914,Yes
2209,09-T-032,System and Method for Manipulating Domain Pinning and Reversal in Ferromagnetic Materials,"14/053,100", ,*United States,US,7/9/2010,,US 2014/0036388 A1,10/14/2013,1816-005,Small,7/10/2009,10/27/2015,No,5/1/2022,Abandoned,Brinks Gilson & Lione,,00356,"Gabriel Aeppli, Thomas Rosenbaum, Daniel Silevitch",Divisional,4/12/2018,1816-005,,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",614788,2/6/2014,582914,Yes
2210,09-T-036,Signaling Pathway Signature for Metastasis Suppressor RKIP Reveals Prognostic Potential of Let-7-Regulated Genes,"61/161,639", ,*United States,US,3/19/2009,, ,3/19/2009,1821-001,Small,3/19/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andy Minn, Marsha Rosner",Provisional,4/12/2018,1821-001,3/19/2010,"Sun, Han",Marsha Rosner,"Tennant, Thelma",614513,,582918,Yes
2211,09-T-058,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,"61/228,479", ,*United States,US,7/24/2009,, ,7/24/2009,1834-001,Large,7/24/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Hwan Kim, Molly McAdow, Olaf Schneewind",Provisional,4/12/2018,1834-001,7/24/2010,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611063,,582940,Yes
2212,09-T-058,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,"12/842,811", ,*United States,US,7/23/2010,, ,7/23/2010,1834-002,Large,7/24/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",US Utility,4/12/2018,1834-002,7/23/2030,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611064,,582940,Yes
2213,09-T-058,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,"61/367,260", ,*United States,US,7/23/2010,, ,7/23/2010,1834-003,Large,7/23/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1834-003,7/23/2011,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611065,,582940,Yes
2214,09-T-064,LIGANDS OF INSULIN DEGRADING ENZYME AND THEIR USES,PCT/IB11/50886, ,European Patent Office (EPO),EP,3/2/2011,,WO 2011/107948,3/2/2011,1837-001,None,3/4/2010,,No,4/28/2022,Abandoned,Cabinet Ores,"Noel, Chantal", ,"Benoit Deprez, Wei-Jen Tang",Nationalized PCT,4/12/2018,1837-001,9/4/2012,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",612077,9/9/2011,582946,Yes
2215,09-T-065,Molecular Affinity Clamp Technology and Uses Thereof,"61/221,358", ,*United States,US,6/29/2009,, ,6/29/2009,1838-001,None,6/29/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Matthew Biancalana, Jin Huang, Akiko Koide, Shohei Koide",Provisional,4/12/2018,1838-001,6/29/2010,"Peace, Shane",Shohei Koide,"Muite, Kevin",613508,,582947,Yes
2216,09-T-065,Molecular Affinity Clamp Technology and Uses Thereof,"12/826,322","8,263,350",*United States,US,6/29/2010,9/11/2012,US-2011-0045604-A1,6/29/2010,1838-002,Small,6/29/2009,,No,5/6/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0485US,"Matthew Biancalana, Jin Huang, Akiko Koide, Shohei Koide",US Utility,4/12/2018,1838-002,6/29/2030,"Peace, Shane",Shohei Koide,"Muite, Kevin",613509,2/24/2011,582947,Yes
2217,09-T-067,6TO16,77731266,"3,776,487",*United States,US,5/7/2009,4/13/2010, ,5/7/2009,1840-001,None,5/7/2009,,Yes,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9157-US00,"Anthony Bryk, Ann Grussing, David Kerbow, Ben Loh, Nichole Pinkard, Delia Rico, Rob Schnieders, Karen Skalitzky, Virginia Watson",Trademark,4/12/2018,1840-001,5/7/2029,"Sun, Han",Rob Schnieders,"Tennant, Thelma",610199,,582949,Yes
2218,09-T-070,Antibodies Directed Against H1N1 Swine-Origin Influenza,"61/250,479", ,*United States,US,10/9/2009,, ,10/9/2009,1835-001,None,10/9/2009,,Yes,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,Patrick Wilson,Provisional,4/12/2018,1835-001,10/9/2010,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610390,,582952,Yes
2219,09-T-070,Antibodies Directed Against Influenza,"61/431,406", ,*United States,US,1/10/2011,, ,1/10/2011,1835-004,Large,1/10/2011,,Yes,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Provisional,4/12/2018,1835-004,1/10/2012,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610391,,582952,Yes
2220,09-T-070,Antibodies Directed Against Influenza,"61/548,704", ,*United States,US,10/18/2011,, ,10/18/2011,1835-005,Large,10/18/2011,,Yes,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Provisional,4/12/2018,1835-005,10/18/2012,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610392,,582952,Yes
2221,09-T-070,Antibodies Directed Against Influenza,PCT/US12/20824, ,*United States,US,1/10/2012,,WO 2012/096994 A2,1/10/2012,1835-006,Large,1/10/2011,,No,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",PCT,4/12/2018,1835-006,7/10/2013,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610393,7/19/2012,582952,Yes
2222,09-T-070,Antibodies Directed Against Influenza,"61/603,895", ,*United States,US,2/27/2012,, ,2/27/2012,1835-007,Large,2/27/2012,,Yes,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Provisional,4/12/2018,1835-007,2/27/2013,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610394,,582952,Yes
2223,09-T-070,Antibodies Directed Against Influenza,PCT/US12/60912, ,*United States,US,10/18/2012,,WO 2013/05924 A3,10/18/2012,1835-010,Large,10/18/2011,,No,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",PCT,4/12/2018,1835-010,1/10/2031,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610395,4/25/2013,582952,Yes
2224,09-T-070,Antibodies Directed Against Influenza,2012205663,2012205663,Australia,AU,10/18/2011,7/6/2017, ,10/18/2011,1835-012,Large,1/10/2011,,No,4/28/2022,Issued,Klarquist Sparkman LLP,,11049 AU,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-012,10/18/2031,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610396,6/13/2013,582952,Yes
2225,09-T-070,Antibodies Directed Against Influenza,"2,824,389", ,Canada,CA,1/10/2012,, ,1/10/2012,1835-013,Large,10/18/2011,,No,4/28/2022,Abandoned,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-013,1/10/2032,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610397,6/13/2013,582952,Yes
2226,09-T-070,Antibodies Directed Against Influenza,"13/978,607","9,469,685",*United States,US,1/10/2012,10/18/2016,US 2014-0046039 A1,7/8/2013,1835-014,Large,1/10/2011,10/18/2016,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-014,1/10/2032,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610399,2/13/2014,582952,Yes
2227,09-T-070,Antibodies Directed Against Influenza,"14/350,632","9,321,829",*United States,US,10/18/2012,4/26/2016,US 2014-0348851-A1,4/9/2014,1835-017,Small,10/18/2011,4/26/2016,No,4/28/2022,Issued,Klarquist Sparkman LLP,,11177 US,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Continuation,4/12/2018,1835-017,10/18/2032,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610400,10/27/2014,582952,Yes
2228,09-T-070,Antibodies Directed Against Influenza,"2,852,474", ,Canada,CA,10/18/2012,, ,4/15/2014,1835-018,Small,10/18/2011,,No,4/28/2022,Pending,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-018,10/18/2032,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610401,,582952,No
2229,09-T-070,Antibodies Directed Against Influenza,2012326025,2012326025,Australia,AU,10/18/2012,12/18/2018, ,4/16/2014,1835-019,Small,10/18/2011,,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-019,10/18/2032,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610402,,582952,No
2230,09-T-070,Antibodies Directed Against Influenza,"15/083,515","10,208,107",*United States,US,10/18/2012,2/19/2019, ,3/29/2016,1835-020,Large,10/18/2011,2/19/2019,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Continuation,4/12/2018,1835-020,10/18/2032,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610403,,582952,No
2231,09-T-070,Recombinant Antibodies against H1H1 Influenza,"61/260,650", ,*United States,US,11/12/2009,,0,11/12/2009,1835-002,None,11/12/2009,,Yes,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Provisional,4/12/2018,1835-002,11/12/2010,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614297,,582952,Yes
2232,09-T-070,Recombinant Antibodies against H1H1 Influenza,PCT/US10/52274, ,*United States,US,10/12/2010,,0,10/12/2010,1835-003,None,10/9/2009,,No,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,"Alpert Siegel, Susan", ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",PCT,4/12/2018,1835-003,4/9/2012,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614298,,582952,Yes
2233,09-T-070,Recombinant Antibodies against H1H1 Influenza,10822829.7EPO, ,European Patent Office (EPO),EP,10/12/2010,,2486054,10/12/2012,1835-008,Large,10/9/2009,,Yes,4/28/2022,Abandoned,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-008,10/12/2020,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614299,8/15/2012,582952,Yes
2234,09-T-070,Recombinant Antibodies against H1H1 Influenza,"13/500,879","9,458,226",*United States,US,10/12/2010,10/4/2016,US-2012-0282273-A1,4/6/2012,1835-009,Large,10/9/2009,10/4/2016,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-009,4/26/2031,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614300,11/8/2012,582952,Yes
2235,09-T-070,Recombinant Antibodies against H1H1 Influenza,13101816.5, ,Hong Kong,HK,10/12/2010,,1174646A,2/8/2013,1835-011,Large,10/9/2009,,No,4/28/2022,Abandoned,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Validated EPO,4/12/2018,1835-011,10/12/2020,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614301,6/14/2013,582952,Yes
2236,09-T-070,Recombinant Antibodies against H1H1 Influenza,12734165.9EPO, ,European Patent Office (EPO),EP,10/12/2010,, ,6/14/2013,1835-015,Large,10/9/2009,,No,4/28/2022,Abandoned,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Validated EPO,4/12/2018,1835-015,10/12/2020,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614302,11/20/2013,582952,Yes
2237,09-T-070,Recombinant Antibodies against H1H1 Influenza,12841118.8EPO,2768858,European Patent Office (EPO),EP,10/12/2010,8/1/2018,2768858,4/17/2014,1835-016,Large,10/9/2009,,No,4/28/2022,Expired - Inactive,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Nationalized PCT,4/12/2018,1835-016,10/12/2030,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",614303,8/14/2014,582952,Yes
2238,09-T-070,Recombinant Antibodies against H1H1 Influenza,12841118.8DE,2768858,Germany,DE,10/12/2010,8/1/2018, ,4/17/2014,1835-021,None,10/9/2009,2/9/2019,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Validated EPO,2/9/2019, ,10/12/2030,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",3499570,,582952,Yes
2239,09-T-070,Recombinant Antibodies against H1H1 Influenza,12841118.8,2768858,France,FR,10/12/2010,8/1/2018, ,4/17/2014,1835-022,None,10/9/2009,2/9/2019,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Validated EPO,2/9/2019, ,10/12/2030,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",3499596,,582952,Yes
2240,09-T-070,Recombinant Antibodies against H1H1 Influenza,12841118.8,2768858,United Kingdom,GB,10/12/2010,8/1/2018, ,4/17/2014,1835-023,None,10/9/2009,2/9/2019,No,4/28/2022,Issued,Klarquist Sparkman LLP,, ,"Rafi Ahmed, Patrick Wilson, Jens Wrammert",Validated EPO,2/9/2019, ,10/12/2030,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",3499622,,582952,Yes
2241,09-T-075,Liver X Receptor Agonists,"61/229,386", ,*United States,US,7/29/2009,, ,7/29/2009,1846-001,Small,7/29/2009,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",Provisional,4/12/2018,1846-001,7/29/2010,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612115,,582957,Yes
2242,09-T-075,Liver X Receptor Agonists,"12/846,326","8,829,213",*United States,US,7/29/2010,9/9/2014,US-2011-0059932-A1,6/28/2013,1846-002,Small,7/29/2009,10/15/2018,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",US Utility,4/12/2018,1846-002,2/16/2031,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612116,3/10/2011,582957,Yes
2243,09-T-075,Liver X Receptor Agonists,PCT/US10/43719, ,*United States,US,7/29/2010,,WO2011/014661,7/29/2010,1846-003,Small,7/29/2009,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",PCT,4/12/2018,1846-003,1/29/2012,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612117,,582957,Yes
2244,09-T-075,Liver X Receptor Agonists,10805047.7EPO, ,European Patent Office (EPO),EP,7/29/2010,,2459581,1/26/2012,1846-004,Small,7/29/2009,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",Nationalized PCT,4/12/2018,1846-004,7/29/2030,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612118,,582957,Yes
2245,09-T-075,Liver X Receptor Agonists,239/MUMNP/2012, ,India,IN,7/29/2010,, ,1/30/2012,1846-005,Small,7/29/2009,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",Nationalized PCT,4/12/2018,1846-005,7/29/2030,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612119,,582957,Yes
2246,09-T-075,Liver X Receptor Agonists,"2,769,203", ,Canada,CA,7/29/2010,, ,3/8/2012,1846-006,Small,7/29/2009,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",Nationalized PCT,4/12/2018,1846-006,7/29/2030,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612120,,582957,Yes
2247,09-T-075,Liver X Receptor Agonists,201080033617.3, ,China,CN,7/29/2010,,CN102482315A,1/29/2012,1846-007,Small,7/29/2009,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",Nationalized PCT,4/12/2018,1846-007,7/29/2030,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612121,5/30/2012,582957,Yes
2248,09-T-075,Liver X Receptor Agonists,2012-523043, ,Japan,JP,7/29/2010,, ,1/27/2012,1846-008,Small,7/29/2009,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP",, ,"Richard Hiipakka, John Kokontis, Shutsung Liao, DaCheng Peng",Nationalized PCT,4/12/2018,1846-008,7/29/2030,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612122,,582957,Yes
2249,09-T-076,Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC),"61/321,198", ,*United States,US,4/6/2010,, ,4/7/2010,1847-001,None,4/6/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, Chunxiao Song",Provisional,4/12/2018,1847-001,4/6/2011,"Hwang, Luke",Chuan He,"Tennant, Thelma",610962,,582958,Yes
2250,09-T-076,Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC),"13/095,505","8,741,567",*United States,US,4/6/2011,6/3/2014,US-2011-0301045-A1,4/27/2011,1847-002,Small,4/6/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0491US,"Chuan He, Chunxiao Song",Nationalized PCT,4/12/2018,1847-002,4/27/2031,"Hwang, Luke",Chuan He,"Tennant, Thelma",610963,12/8/2011,582958,Yes
2251,09-T-076,Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC),PCT/US11/31370, ,*United States,US,4/6/2011,,WO 2-11/127136,4/6/2011,1847-003,Small,4/6/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, Chunxiao Song",PCT,4/12/2018,1847-003,10/6/2012,"Hwang, Luke",Chuan He,"Tennant, Thelma",610964,10/13/2011,582958,Yes
2252,09-T-076,Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC),"14/267,727", ,*United States,US,4/6/2011,,US-2015-0056616-A1,5/1/2014,1847-004,Small,4/6/2010,12/13/2019,No,6/15/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0491US.D1,"Chuan He, Chunxiao Song",Divisional,4/12/2018,1847-004,5/1/2034,"Hwang, Luke",Chuan He,"Tennant, Thelma",610965,2/26/2015,582958,Yes
2253,09-T-076,Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC),"16/713,657", ,*United States,US,4/6/2011,,US-2020-0102616-A1,12/13/2019,1847-005,Small,4/6/2010,12/13/2019,No,6/15/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0491US.D1C1,"Chuan He, Chunxiao Song",Continuation,12/13/2019, ,4/6/2031,"Hwang, Luke",Chuan He,"Tennant, Thelma",4190880,4/2/2020,582958,Yes
2254,09-T-080,Methods and Compositions Related to Anti-Angiogenic Peptides,"61/306,742", ,*United States,US,2/22/2010,, ,2/22/2010,1848-001,None,2/22/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Alexandre Chlenski, Susan Cohn",Provisional,4/12/2018,1848-001,2/22/2011,"Butler, Brittany",Susan Cohn,"Butler, Brittany",613011,,582962,Yes
2255,09-T-080,Methods and Compositions Related to Anti-Angiogenic Peptides,PCT/US11/25745, ,*United States,US,2/22/2011,,WO 2011/103583,2/22/2011,1848-002,None,2/22/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Alexandre Chlenski, Susan Cohn",PCT,4/12/2018,1848-002,8/22/2012,"Butler, Brittany",Susan Cohn,"Butler, Brittany",613012,8/25/2011,582962,Yes
2256,09-T-081,Methods and Compositions for Imaging cancer Cells,"61/228,481", ,*United States,US,7/24/2009,, ,7/24/2009,1849-001,Small,7/24/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0486USP1,Bulent Aydogan,Provisional,4/12/2018,1849-001,7/24/2010,"Cox, Ben",Bulent Aydogan,"Juggernauth, Anne",612758,,582963,Yes
2257,09-T-081,Methods and Compositions for Imaging Cancer Cells,"12/843,664","9,107,895",*United States,US,7/26/2010,8/18/2015,US-2011-0020243-A1,7/26/2010,1849-002,Small,7/24/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0486US,"Bulent Aydogan, Tijana Rajh",US Utility,4/12/2018,1849-002,5/26/2031,"Cox, Ben",Bulent Aydogan,"Juggernauth, Anne",612759,1/27/2011,582963,Yes
2258,09-T-096,A Universal Robotic Gripping Mechanism Based on Jamming of Granular Materials,"61/248,708", ,*United States,US,10/5/2009,, ,10/5/2009,1858-001,Small,10/5/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mehta, Manish",00268,Heinrich Jaeger,Provisional,4/12/2018,1858-001,10/5/2010,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",610239,,582978,Yes
2259,09-T-098,Compositions and Methods Related to Obstructive Sleep Apnea,PCT/US09/62968, ,*United States,US,11/2/2009,,WO 2010/051532,11/2/2009,1860-002,None,10/31/2008,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Sina Gharib, David Gozal, Abdelnaby Khalyfa",PCT,4/12/2018,1860-002,4/30/2011,"Dembo, Anna",David Gozal,"Butler, Brittany",611097,5/6/2010,582980,Yes
2260,09-T-098,Methods for Diagnosis and Treatment of Obstructive Sleep Apnea,"61/110,113", ,*United States,US,10/31/2008,, ,10/31/2008,1860-001,None,10/31/2008,,Yes,4/28/2022,Expired - Inactive,Stites & Harbison PLLC,"Wright, Terry", ,"Sina Gharib, David Gozal, Abdelnaby Khalyfa",Provisional,4/12/2018,1860-001,10/31/2009,"Dembo, Anna",David Gozal,"Butler, Brittany",613178,,582980,Yes
2261,09-T-108,Slip Chip Device and Methods,"61/262,375", ,*United States,US,11/18/2009,, ,11/18/2009,1863-001,Small,11/18/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00266,Rustem Ismagilov,Provisional,4/12/2018,1863-001,11/18/2010,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614555,,582990,Yes
2262,09-T-118,Methods and Compositions Related to Immunogenic Fibrils,"61/263,213", ,*United States,US,11/20/2009,, ,11/20/2009,1877-001,Small,11/20/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Joel Collier,Provisional,4/12/2018,1877-001,11/20/2010,"Dembo, Anna",Joel Collier,"Tennant, Thelma",613054,,583000,Yes
2263,09-T-118,Methods and Compositions Related to Immunogenic Fibrils,PCT/US10/57480, ,*United States,US,11/19/2010,,2011/063264,11/19/2010,1877-002,Small,11/20/2009,6/22/2020,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Joel Collier,PCT,4/12/2018,1877-002,5/20/2012,"Dembo, Anna",Joel Collier,"Tennant, Thelma",613055,5/26/2011,583000,Yes
2264,09-T-118,Methods and Compositions Related to Immunogenic Fibrils,"13/510,863","9,241,987",*United States,US,11/19/2010,1/26/2016,US-2012-0282292-A1,7/18/2012,1877-003,Small,11/20/2009,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joel Collier, Jai Simha Rudra",Nationalized PCT,4/12/2018,1877-003,11/19/2030,"Dembo, Anna",Joel Collier,"Tennant, Thelma",613056,11/8/2012,583000,Yes
2265,09-T-118,Methods and Compositions Related to Immunogenic Fibrils,"14/866,344","9,849,174",*United States,US,11/19/2010,12/26/2017,US-2016-0074509-A1,9/25/2015,1877-004,Small,11/20/2009,12/26/2017,No,5/2/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000220430,"Joel Collier, Jai Simha Rudra",Continuation in Part,4/12/2018,1877-004,11/19/2030,"Dembo, Anna",Joel Collier,"Tennant, Thelma",613057,3/17/2016,583000,No
2266,09-T-118,METHODS AND COMPOSITIONS RELATED TO IMMUNOGENIC FIBRILS,"14/974,859","10,596,238",*United States,US,11/19/2010,3/24/2020,US-2016-0151507-A1,12/18/2015,1877-005,Small,11/20/2009,3/5/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0490US.C1,"Joel Collier, Jai Simha Rudra",Continuation,4/12/2018,1877-005,12/18/2035,"Dembo, Anna",Joel Collier,"Tennant, Thelma",613058,6/3/2016,583000,No
2267,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,PCT/US11/46160, ,*United States,US,8/1/2011,, ,8/1/2011,1888-005,None,7/30/2010,,No,4/28/2022,Expired - Inactive,Lando & Anastasi,"Billings, Nathan", ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",PCT,4/12/2018,1888-005,1/30/2013,"Peace, Shane",Shohei Koide,"Muite, Kevin",611578,,583016,Yes
2268,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,"13/813,409","9,512,199",*United States,US,8/1/2011,12/6/2016, ,11/7/2013,1888-006,Large,7/30/2010,12/6/2016,No,5/8/2022,Issued,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-006,8/21/2033,"Peace, Shane",Shohei Koide,"Muite, Kevin",611579,,583016,Yes
2269,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,2011283646,2011283646,Australia,AU,8/1/2011,10/22/2015, ,2/22/2013,1888-007,Large,7/30/2010,,No,4/28/2022,Issued,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-007,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611580,,583016,Yes
2270,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,BR112013002345-7, ,Brazil,BR,8/1/2011,, ,7/7/2014,1888-008,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-008,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611581,,583016,Yes
2271,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,"2,805,862", ,Canada,CA,8/1/2011,, ,1/16/2013,1888-009,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-009,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611582,,583016,Yes
2272,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,201180047431.8, ,China,CN,8/1/2011,,CN103403027,9/9/2013,1888-010,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-010,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611583,11/20/2013,583016,Yes
2273,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,11746713.4, ,European Patent Office (EPO),EP,8/1/2011,, ,3/28/2012,1888-011,Large,7/30/2010,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,,ARCD.P0725EP,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-011,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611584,,583016,Yes
2274,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,596/DELNP/2013, ,India,IN,8/1/2011,, ,7/12/2013,1888-012,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-012,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611585,,583016,Yes
2275,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,224220, ,Israel,IL,8/1/2011,, ,12/28/2014,1888-013,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-013,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611586,,583016,Yes
2276,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,2013-523251, ,Japan,JP,8/1/2011,,2013-539362A,4/24/2013,1888-014,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-014,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611587,10/24/2013,583016,Yes
2277,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,1020137005001, ,"Korea, Republic of",KR,8/1/2011,, ,12/12/2013,1888-015,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-015,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611588,,583016,Yes
2278,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,MX/a/2013/001144, ,Mexico,MX,8/1/2011,, ,6/5/2013,1888-016,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-016,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611589,,583016,Yes
2279,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,2013108962, ,Russian Federation,RU,8/1/2011,, ,7/1/2014,1888-017,Large,7/30/2010,,No,4/28/2022,Pending,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-017,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611590,,583016,Yes
2280,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,2013006580,187225,Singapore,SG,8/1/2011,10/16/2015, ,2/28/2013,1888-018,Large,7/30/2010,,No,4/28/2022,Issued,Lando & Anastasi,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, Andreas Loew, Brian Vash, John Wojcik",Nationalized PCT,4/12/2018,1888-018,8/1/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611591,,583016,Yes
2281,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,16187306.2EPO, ,European Patent Office (EPO),EP,8/1/2011,, ,9/5/2016,1888-019,Small,7/30/2010,,No,4/28/2022,Pending,Novartis International AG,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",Divisional,4/12/2018,1888-019,7/30/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611592,,583016,No
2282,09-T-134,FIBRONECTIN CRADLE MOLECULES AND LIBRARIES THEREOF,2016-124152, ,Japan,JP,8/1/2011,, ,8/1/2016,1888-020,Small,7/30/2010,,No,4/28/2022,Pending,Novartis International AG,, ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",Divisional,4/12/2018,1888-020,7/30/2031,"Peace, Shane",Shohei Koide,"Muite, Kevin",611593,,583016,No
2283,09-T-134,Methods and Compositions Involving Fibronectin Type III (FN3) Monobodies,"61/369,160", ,*United States,US,7/30/2010,, ,7/30/2010,1888-001,None,7/30/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",Provisional,4/12/2018,1888-001,7/30/2011,"Peace, Shane",Shohei Koide,"Muite, Kevin",612952,,583016,Yes
2284,09-T-134,Methods and Compositions Involving Fibronectin Type III (FN3) Monobodies,"61/369,222", ,*United States,US,7/30/2010,, ,7/30/2010,1888-002,None,7/30/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",Provisional,4/12/2018,1888-002,7/30/2011,"Peace, Shane",Shohei Koide,"Muite, Kevin",612953,,583016,Yes
2285,09-T-134,Methods and Compositions Involving Fibronectin Type III (FN3) Monobodies,"61/474,632", ,*United States,US,4/12/2011,, ,4/12/2011,1888-003,None,4/12/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",Provisional,4/12/2018,1888-003,4/12/2012,"Peace, Shane",Shohei Koide,"Muite, Kevin",612954,,583016,Yes
2286,09-T-134,Methods and Compositions Involving Fibronectin Type III (FN3) Monobodies,"61/474,648", ,*United States,US,4/12/2011,, ,4/12/2011,1888-004,None,4/12/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Landrum, Charles", ,"Ryan Gilbreth, Akiko Koide, Shohei Koide, John Wojcik",Provisional,4/12/2018,1888-004,4/12/2012,"Peace, Shane",Shohei Koide,"Muite, Kevin",612955,,583016,Yes
2287,09-T-137,Methods of Making Self-Healing Polymer and Gel Compositions,PCT/US10/61154, ,*United States,US,12/17/2010,, ,12/17/2010,1890-002,Small,12/17/2009,,No,5/1/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00299,"Niels Holten-Andersen, Ka Yee Lee, J.Herbert Waite",PCT,4/12/2018,1890-002,6/17/2012,"Ginsburg, Eric",Ka Yee Lee,"Juggernauth, Anne",613335,,583019,Yes
2288,09-T-137,Methods of Making Self-Healing Polymer and Gel Compositions,"13/516,079", ,*United States,US,12/17/2010,,US-2013-0053594-A1,8/27/2012,1890-003,Small,12/17/2009,,No,4/28/2022,Abandoned,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Niels Holten-Andersen, Ka Yee Lee, J.Herbert Waite",Nationalized PCT,4/12/2018,1890-003,12/17/2029,"Ginsburg, Eric",Ka Yee Lee,"Juggernauth, Anne",613336,2/28/2013,583019,Yes
2289,09-T-137,Mussel-Inspired Self-Healing Hydrogels,"61/284,472", ,*United States,US,12/17/2009,, ,12/17/2009,1890-001,Small,12/17/2009,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00270,"Niels Holten-Andersen, Ka Yee Lee, J.Herbert Waite",Provisional,4/12/2018,1890-001,12/17/2010,"Ginsburg, Eric",Ka Yee Lee,"Juggernauth, Anne",613572,,583019,Yes
2290,09-T-141,Materials and Methods for the Preparation of Nanocomposites,"61/264,790", ,*United States,US,11/28/2009,, ,11/28/2009,1893-001,Small,11/28/2009,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",45155,"Maksym Kovalenko, Dmitri Talapin",Provisional,4/12/2018,1893-001,11/28/2010,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612221,,583023,Yes
2291,10-T-008,Use of Flat Panel Microchannel Photomultipliers in Sampling Calorimeters with Timing,"14/982,387","9,625,588",*United States,US,3/9/2011,4/18/2017,2016/0116605,12/29/2015,1902-005,Small,3/9/2010,4/18/2017,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0003-05,"Henry Frisch, Chien-Min Kao",Continuation,4/12/2018,1902-005,3/9/2031,"Cox, Ben",Chien-Min Kao,"Smith, Dane",610182,4/29/2016,583031,No
2292,10-T-008,Use of Flat Panel Microchannel Photomultipliers in Sampling Calorimeters with Timing,"61/339,865", ,*United States,US,3/9/2010,, ,3/9/2010,1902-001,Small,3/9/2010,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00276,"Chin-Tu Chen, Woon-Seng Choong, Henry Frisch, Jean-Francois Genat, Herve Grabas, Chien-Min Kao, Hee-Jong Kim, Fukun Tang",Provisional,4/12/2018,1902-001,3/9/2011,"Cox, Ben",Chien-Min Kao,"Smith, Dane",615175,,583031,Yes
2293,10-T-008,Use of Flat Panel Microchannel Photomultipliers in Sampling Calorimeters with Timing,"13/044,442","8,604,440",*United States,US,3/9/2011,12/10/2013,US-2011-0220802-A1,3/9/2011,1902-002,Small,3/9/2010,12/10/2013,No,4/28/2022,Issued,Brinks Gilson & Lione,,00316,"Chin-Tu Chen, Woon-Seng Choong, Henry Frisch, Jean-Francois Genat, Herve Grabas, Chien-Min Kao, Hee-Jong Kim, Fukun Tang",US Utility,4/12/2018,1902-002,1/14/2032,"Cox, Ben",Henry Frisch,"Smith, Dane",615176,9/15/2011,583031,Yes
2294,10-T-008,Use of Flat Panel Microchannel Photomultipliers in Sampling Calorimeters with Timing,"61/464,749", ,*United States,US,3/8/2011,, ,3/8/2011,1902-003,Small,3/8/2011,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Penn, Amir",00317,"Chin-Tu Chen, Woon-Seng Choong, Henry Frisch, Jean-Francois Genat, Herve Grabas, Chien-Min Kao, Hee-Jong Kim, Fukun Tang",Provisional,4/12/2018,1902-003,3/8/2012,"Cox, Ben",Chien-Min Kao,"Smith, Dane",615177,,583031,Yes
2295,10-T-008,Use of Flat Panel Microchannel Photomultipliers in Sampling Calorimeters with Timing,"14/090,647","9,244,180",*United States,US,3/9/2011,1/26/2016, ,11/26/2013,1902-004,Small,3/9/2010,1/26/2016,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0003-04,"Chin-Tu Chen, Woon-Seng Choong, Henry Frisch, Jean-Francois Genat, Herve Grabas, Chien-Min Kao, Hee-Jong Kim, Michael Minot, Eric Oberla, Fukun Tang",Continuation,4/12/2018,1902-004,6/1/2031,"Cox, Ben",Chin-Tu Chen,"Smith, Dane",615178,,583031,Yes
2296,10-T-011,Use of Opioid Antagonists,"12/723,339","8,518,962",*United States,US,3/7/2006,8/27/2013,US-2010-0286059-A1,3/12/2010,1899-001,Large,3/7/2005,,No,5/8/2022,Issued,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9159-001,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Continuation in Part,4/12/2018,1899-001,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615260,11/11/2010,583034,Yes
2297,10-T-011,Use of Opioid Antagonists,PCT/US11/28314, ,*United States,US,3/7/2006,, ,3/14/2011,1899-002,Large,3/7/2005,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9159-002,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",PCT,4/12/2018,1899-002,9/14/2012,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615261,,583034,Yes
2298,10-T-011,Use of Opioid Antagonists,"13/972,129","9,717,725",*United States,US,3/7/2006,8/1/2017,US-2014-0011831-A1,8/21/2013,1899-003,Large,3/7/2005,,No,5/8/2022,Issued,Michael Best & Friedrich LLP,,092234-9159-003,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1899-003,4/23/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615262,1/9/2014,583034,Yes
2299,10-T-011,Use of Opioid Antagonists,"15/643,674", ,*United States,US,3/7/2006,,US-2018-0008594-A1,7/7/2017,1899-004,Small,3/7/2005,4/27/2021,No,5/8/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9159-US02,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Continuation,4/12/2018,1899-004,3/8/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615263,1/11/2018,583034,No
2300,10-T-011,Use of Opioid Antagonists,"17/074,002", ,*United States,US,3/7/2006,, ,10/19/2020,1899-005,Small,3/7/2005,10/21/2020,No,6/22/2022,Pending,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9159-US03,"Joe Garcia, Mark Lingen, Jonathan Moss, Patrick Singleton",Divisional,10/21/2020, ,3/7/2026,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4997663,,583034,No
2301,10-T-014,Methods and Compostitions Involving MDIVI-I and Related Compounds,"61/402,272", ,*United States,US,8/26/2010,, ,8/26/2010,1901-001,None,8/26/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Stephen Archer, Jalees Rehman",Provisional,4/12/2018,1901-001,8/26/2011,"Unassigned, Unassigned",Stephen Archer,"Unassigned, Unassigned",613103,,583037,Yes
2302,10-T-014,Methods and Compostitions Involving MDIVI-I and Related Compounds,"61/611,226", ,*United States,US,3/15/2012,, ,3/15/2012,1901-002,None,3/15/2012,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Stephen Archer, Jalees Rehman",Provisional,4/12/2018,1901-002,3/15/2013,"Unassigned, Unassigned",Stephen Archer,"Unassigned, Unassigned",613104,,583037,Yes
2303,10-T-029,METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER,"14/172,051","9,149,485",*United States,US,3/24/2011,10/6/2015,US-2014-0186367-A1,2/4/2014,1914-003,Small,3/24/2010,9/29/2021,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Maria Kocherginsky, Deng Pan",Continuation,4/12/2018,1914-003,3/24/2031,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613019,7/3/2014,583052,Yes
2304,10-T-029,Methods and Compositions Related to Glucocorticoid Receptor Antagonists and Breast Cancer,"14/296,127","9,623,032",*United States,US,3/24/2011,4/18/2017,US-2014-0315866-A1,6/4/2014,1914-004,Small,3/24/2010,9/29/2021,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Maria Kocherginsky, Deng Pan",Continuation,4/12/2018,1914-004,3/24/2031,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613020,10/23/2014,583052,Yes
2305,10-T-029,Methods and Compositions Related to Glucocorticoid Receptor Antagonists and Breast Cancer,"14/451,207", ,*United States,US,3/24/2011,,US-2014-0341849-A1,8/4/2014,1914-005,Small,3/24/2010,9/27/2016,No,4/28/2022,Abandoned,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Maria Kocherginsky, Deng Pan",Continuation,4/12/2018,1914-005,,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613021,11/20/2014,583052,Yes
2306,10-T-029,METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER,"15/448,827","10,441,596",*United States,US,3/24/2011,10/15/2019,US-2017-0182066-A1,3/3/2017,1914-006,Small,3/24/2010,9/29/2021,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1040478-000150US,"Suzanne Conzen, Maria Kocherginsky, Deng Pan",Continuation,4/12/2018,1914-006,3/24/2031,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613022,6/29/2017,583052,No
2307,10-T-029,Methods of Breast Cancer Prognosis,"61/317,182", ,*United States,US,3/24/2010,, ,3/24/2010,1914-001,None,3/24/2010,11/1/2021,Yes,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Larissa Belova, Suzanne Conzen, Gini Fleming, Maria Kocherginsky, Rita Nanda, Deng Pan",Provisional,4/12/2018,1914-001,3/24/2011,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613310,,583052,Yes
2308,10-T-029,Methods of Breast Cancer Prognosis,"13/071,363","8,710,035",*United States,US,3/24/2011,4/29/2014,US-2011-0269728-A1,3/24/2011,1914-002,Small,3/24/2010,4/29/2014,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Larissa Belova, Suzanne Conzen, Gini Fleming, Maria Kocherginsky, Rita Nanda, Deng Pan",US Utility,4/12/2018,1914-002,5/28/2031,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613311,11/3/2011,583052,Yes
2309,10-T-029,METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER,"16/596,342", ,*United States,US,3/24/2011,, ,10/8/2019,1914-007,Small,3/24/2010,2/22/2022,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP",,096487-1158267-000160US,"Suzanne Conzen, Maria Kocherginsky, Deng Pan",Continuation,10/23/2019, ,3/24/2031,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",4053821,,583052,No
2310,10-T-029,METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER,"17/577,882", ,*United States,US,3/24/2011,, ,1/18/2022,1914-008,Small,3/24/2010,2/22/2022,No,5/26/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP",,096487-1293223-000170US,"Suzanne Conzen, Maria Kocherginsky, Deng Pan",Continuation,2/22/2022, ,3/24/2031,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",6839897,,583052,No
2311,10-T-033,Genetically Altered Ciliates And Uses Thereof,"61/601,921", ,*United States,US,2/22/2012,, ,2/22/2012,1915-001,Small,2/22/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Aaron Turkewitz,Provisional,4/12/2018,1915-001,2/22/2013,"Dembo, Anna",Aaron Turkewitz,"Tennant, Thelma",611677,,583056,Yes
2312,10-T-033,Genetically Altered Ciliates And Uses Thereof,"13/773,327","9,127,285",*United States,US,2/21/2013,9/8/2015,.,2/21/2013,1915-002,Small,2/22/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joseph Briguglio, Aaron Turkewitz",US Utility,4/12/2018,1915-002,2/21/2033,"Dembo, Anna",Aaron Turkewitz,"Tennant, Thelma",611678,8/29/2013,583056,Yes
2313,10-T-034,Regulated Secretion of Soluble Heterologous Proteins in Ciliates,"13/257,903","8,722,361",*United States,US,3/22/2010,5/13/2014, ,1/9/2012,1916,None,3/20/2009,,,5/8/2022,Issued,,, ,"Theodore Clark, Ashot Papoyan, Aaron Turkewitz",Nationalized PCT,2/14/2019, ,5/28/2030,"Dembo, Anna",Aaron Turkewitz,"Tennant, Thelma",3507378,5/3/2012,583057,No
2314,10-T-035,Wireless Recording and Stimulation of Brain Activity,"12/687,675","8,849,369",*United States,US,1/14/2010,9/30/2014,US 2010-0198297 A1,1/14/2010,1917-001,Small,1/15/2009,4/26/2022,No,5/6/2022,Abandoned,Goodwin Procter LLP,, ,"Stuart Cogen, John Ebersole, (Vernon) Leo Towle, Phillip Troyk",US Utility,4/12/2018,1917-001,5/4/2033,"Cox, Ben",(Vernon) Leo Towle,"Tennant, Thelma",615394,8/5/2010,583058,Yes
2315,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,"61/321,050", ,*United States,US,4/5/2010,, ,4/5/2010,1931-001,Large,4/5/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1931-001,4/5/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611103,,583071,Yes
2316,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,PCT/US11/31213, ,*United States,US,4/5/2011,,WO 2011/127032,4/5/2011,1931-002,Large,4/5/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,1931-002,10/5/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611104,10/13/2011,583071,Yes
2317,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,2013-503834, ,Japan,JP,4/5/2011,,2013-523818,10/5/2012,1931-003,Large,4/5/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1931-003,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611105,6/17/2013,583071,Yes
2318,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,"13/639,465","8,808,699",*United States,US,4/5/2011,8/19/2014,US-2013-0136746-A1,10/4/2012,1931-004,Large,4/5/2010,,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1931-004,4/5/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611106,5/30/2013,583071,Yes
2319,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,11766582.8EPO, ,European Patent Office (EPO),EP,4/5/2011,,2555794,11/15/2012,1931-005,Large,4/5/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000213531,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1931-005,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611107,2/13/2013,583071,Yes
2320,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,"14/335,411","9,212,219",*United States,US,4/5/2011,12/15/2015,US-2014-0335095-A1,7/18/2014,1931-006,Large,4/5/2010,,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,4/12/2018,1931-006,4/5/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611108,11/13/2014,583071,Yes
2321,10-T-048,COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SPA) ANTIBODIES AS AN ENHANCER OF IMMUNE RESPONSE,"14/968,023","9,907,850",*United States,US,4/5/2011,3/6/2018,US-2016-0175441-A1,12/14/2015,1931-007,Small,4/5/2010,,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,,1000208852,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Continuation,4/12/2018,1931-007,4/5/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611109,6/25/2016,583071,No
2322,10-T-048,Compositions and Methods Related to Protein A (SpA) Antibodies as an Enhancer of Immune Response,2016-74958,6042574,Japan,JP,4/5/2011,11/20/2016, ,4/8/2016,1931-008,Large,4/5/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2018,1931-008,4/9/2030,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611110,6/21/2013,583071,Yes
2323,10-T-053,H2S and O2 Sensing,"61/323,621", ,*United States,US,4/13/2010,, ,4/13/2010,1935-001,Small,4/13/2010,,Yes,4/28/2022,Expired - Inactive,Johns Hopkins University,"Bakalyar, Heather", ,"Nanduri Prabhakar, Solomon Snyder",Provisional,4/12/2018,1935-001,4/13/2011,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",611734,,583076,Yes
2324,10-T-053,Methods for Treatment of Sleep-Related Breathing Disorders,"61/347,069", ,*United States,US,5/21/2010,, ,5/21/2010,1935-002,Small,5/21/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Rollins, Sarah", ,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",Provisional,4/12/2018,1935-002,5/21/2011,"Hwang, Luke",Gregory Stein,"Tennant, Thelma",613279,,583076,Yes
2325,10-T-053,METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS,PCT/US11/31977, ,*United States,US,4/11/2011,, ,4/11/2011,1935-003,Small,4/13/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Hostetler, Michael", ,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",PCT,4/12/2018,1935-003,10/13/2012,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",613280,,583076,Yes
2326,10-T-053,METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS,"2,796,268", ,Canada,CA,4/11/2011,, ,10/11/2012,1935-004,Small,4/13/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",Nationalized PCT,4/12/2018,1935-004,4/11/2031,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",613281,,583076,Yes
2327,10-T-053,METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS,"13/640,711","10,688,096",*United States,US,4/11/2011,6/23/2020, ,2/1/2013,1935-005,Small,4/13/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0595US,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",Nationalized PCT,4/12/2018,1935-005,6/6/2032,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",613282,,583076,Yes
2328,10-T-053,METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS,11769384.6EPO, ,European Patent Office (EPO),EP,4/11/2011,, ,1/23/2013,1935-006,Small,4/13/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",Nationalized PCT,4/12/2018,1935-006,4/11/2031,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",613283,,583076,Yes
2329,10-T-053,METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS,2011240843, ,Australia,AU,4/11/2011,, ,2/1/2013,1935-007,Small,4/13/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",Nationalized PCT,4/12/2018,1935-007,4/11/2031,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",613284,,583076,Yes
2330,10-T-053,METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS,603553, ,New Zealand,NZ,4/11/2011,, ,2/1/2013,1935-008,Small,4/13/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Moataz Gadalla, Gary Pace, Nanduri Prabhakar, Solomon Snyder, Gregory Stein",Nationalized PCT,4/12/2018,1935-008,,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",613285,,583076,Yes
2331,10-T-069,Identification of Antibodies in Mucosal Cells,"61/352,467", ,*United States,US,6/8/2010,, ,6/8/2010,1945-001,Small,6/8/2010,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Jones, Mitchell", ,"Roberto DiNiro, Ludvig Sollid, Patrick Wilson",Provisional,4/12/2018,1945-001,6/8/2011,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",611888,,583092,Yes
2332,10-T-070,C-CBL Mutations and Uses Thereof,"61/351,501", ,*United States,US,6/4/2010,, ,6/4/2010,1944-001,Small,6/4/2010,,Yes,4/28/2022,Expired - Inactive,Ballard Spahr LLP,, ,"Soundararajan Krishnaswamy, Suvobroto Nandi, Ravi Salgia, Yi-Hung Tan",Provisional,4/12/2018,1944-001,6/4/2011,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610754,,583093,Yes
2333,10-T-070,C-CBL Mutations and Uses Thereof,PCT/US11/39125, ,*United States,US,6/3/2011,,WO 2011/153472A2,6/3/2011,1944-002,Small,6/4/2010,,No,4/28/2022,Expired - Inactive,Ballard Spahr LLP,"Marty, Scott", ,"Soundararajan Krishnaswamy, Suvobroto Nandi, Ravi Salgia, Yi-Hung Tan",PCT,4/12/2018,1944-002,12/4/2012,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610755,12/8/2011,583093,Yes
2334,10-T-070,C-CBL Mutations and Uses Thereof,"13/701,569", ,*United States,US,6/3/2011,, ,12/3/2012,1944-003,Small,6/4/2010,,No,4/28/2022,Abandoned,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Soundararajan Krishnaswamy, Suvobroto Nandi, Ravi Salgia, Yi-Hung Tan",Nationalized PCT,4/12/2018,1944-003,6/3/2021,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610756,,583093,Yes
2335,10-T-070,c-CBL Mutations and Uses Thereof,"15/077,409", ,*United States,US,6/3/2011,, ,3/22/2016,1944-004,Small,6/4/2010,5/25/2018,No,4/28/2022,Abandoned,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1088504-000420US,"Soundararajan Krishnaswamy, Suvobroto Nandi, Ravi Salgia, Yi-Hung Tan",Continuation,4/12/2018,1944-004,,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",610757,,583093,No
2336,10-T-070,c-CBL Mutations and Uses Thereof,"15/990,301", ,*United States,US,6/3/2011,,US-2018-0327864-A1,5/25/2018,1944-005,Small,6/4/2010,7/9/2018,No,6/16/2022,Pending,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1089928-000430US,"Soundararajan Krishnaswamy, Suvobroto Nandi, Ravi Salgia, Yi-Hung Tan",Continuation,7/9/2018, ,6/3/2031,"Dembo, Anna",Ravi Salgia,"Tennant, Thelma",1582785,11/15/2018,583093,No
2337,10-T-080,Methods and Compositions to Reduce Liver Damage Associated with Conditions or Therapies that Affect the Immune System,"61/365,243", ,*United States,US,7/16/2010,, ,7/16/2010,1953-001,Small,7/16/2010,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,Provisional,4/12/2018,1953-001,7/16/2011,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",613082,,583103,Yes
2338,10-T-080,Methods and Compositions to Reduce Liver Damage Associated with Conditions or Therapies that Affect the Immune System,"13/183,617", ,*United States,US,7/15/2011,,US-2012-0014947-A1,7/15/2011,1953-002,Small,7/16/2010,,No,5/8/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Yang-Xin Fu,US Utility,4/12/2018,1953-002,7/16/2030,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",613083,1/19/2012,583103,Yes
2339,10-T-080,Utilization of TNFalpha inhibitors to prevent or reduce liver damage induced by CD137 or LTbetaR agonist treatment,"15/082,898", ,*United States,US,7/15/2011,,US-2016-0250327,3/28/2016,1953-003,Small,7/16/2010,,No,5/8/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Continuation,4/12/2018,1953-003,,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",615336,9/2/2016,583103,No
2340,10-T-085,Real-time Mapping of Electronic Structure with Single-shot Two-Dimensional Electronic Spectrocopy,"61/401,610", ,*United States,US,8/16/2010,, ,8/16/2010,1955-001,Small,8/16/2010,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",45577,"Gregory Engel, Elad Harel",Provisional,4/12/2018,1955-001,8/16/2011,"Hwang, Luke",Elad Harel,"Smith, Dane",614290,,583108,Yes
2341,10-T-085,Real-time Mapping of Electronic Structure with Single-shot Two-Dimensional Electronic Spectrocopy,PCT/US11/48001, ,*United States,US,8/16/2011,,WO 2012/024347,8/16/2011,1955-002,Small,8/16/2010,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",45577A-PC,"Gregory Engel, Elad Harel",PCT,4/12/2018,1955-002,2/16/2013,"Hwang, Luke",Elad Harel,"Smith, Dane",614291,2/23/2012,583108,Yes
2342,10-T-085,Real-time Mapping of Electronic Structure with Single-shot Two-Dimensional Electronic Spectrocopy,"13/814,427","9,001,320",*United States,US,8/16/2011,4/7/2015,US-2013-0222801-A1,5/15/2013,1955-003,Small,8/16/2010,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul",45577A,"Gregory Engel, Elad Harel",Nationalized PCT,4/12/2018,1955-003,8/16/2031,"Hwang, Luke",Elad Harel,"Smith, Dane",614292,8/29/2013,583108,Yes
2343,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,"61/381,372", ,*United States,US,9/9/2010,, ,9/9/2010,1960-001,Large,9/9/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1960-001,9/9/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612971,,583112,Yes
2344,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,"61/435,617", ,*United States,US,1/24/2011,, ,1/24/2011,1960-002,Large,1/24/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1960-002,9/9/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612972,,583112,Yes
2345,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,PCT/US11/51079, ,*United States,US,9/9/2011,,WO 2012/034067,9/9/2011,1960-003,Large,9/9/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,1960-003,3/9/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612973,3/15/2012,583112,Yes
2346,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,2013-528349,"5,793,194",Japan,JP,9/9/2011,8/14/2015,2013-542919,3/8/2013,1960-004,Large,9/9/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1960-004,9/9/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612974,11/28/2013,583112,Yes
2347,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,11758342.7EPO, ,European Patent Office (EPO),EP,9/9/2011,,2614074,4/4/2013,1960-005,Large,9/9/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000233476,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1960-005,9/9/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612975,7/17/2013,583112,Yes
2348,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,201180051168.X,ZL201180051168.X,China,CN,9/9/2011,12/14/2016,CN 103314008A,4/23/2013,1960-006,Large,9/9/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1960-006,9/9/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612976,9/18/2013,583112,Yes
2349,10-T-089,Methods and Compositions Involving Protective Staphylococcal Antigens,"13/821,943","9,095,540",*United States,US,9/9/2011,8/4/2015,US-2013-0230550-A1,5/22/2013,1960-007,Large,9/9/2010,,No,6/16/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0499US,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1960-007,9/9/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612977,9/5/2013,583112,Yes
2350,10-T-090,Mutant HSP70 to Prevent Autoimmune Disease,"61/379,107", ,*United States,US,9/1/2010,, ,9/1/2010,1961-001,Small,9/1/2010,9/1/2011,Yes,4/28/2022,Expired - Inactive,Hartman & Hartman,"Hartman, Gray", ,"Jose Guevara, Caroline Le Poole, Andrew Zloza",Provisional,4/12/2018,1961-001,9/1/2011,"Unassigned, Unassigned",Jose Guevara,"Unassigned, Unassigned",613573,,583113,Yes
2351,10-T-091,Methods and Composition For Protection of Cells and Tissues from Computed Tomography Radiation,"61/383,592", ,*United States,US,9/17/2010,, ,9/17/2010,1962-001,None,9/17/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",ARCD.P0497US.P1,David Grdina,Provisional,4/12/2018,1962-001,9/17/2011,"Cox, Ben",David Grdina,"Tennant, Thelma",612640,,583114,Yes
2352,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,PCT/US11/51946, ,*United States,US,9/16/2011,,WO 2012/037466,9/16/2011,1962-002,None,9/17/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",ARCD.P0497WO,David Grdina,PCT,4/12/2018,1962-002,3/16/2013,"Cox, Ben",David Grdina,"Tennant, Thelma",612841,3/22/2012,583114,Yes
2353,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,"13/822,223","9,877,976",*United States,US,9/16/2011,1/30/2018,US-2013-0251634-A1,3/11/2013,1962-003,Small,9/17/2010,1/30/2018,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0497US,David Grdina,Nationalized PCT,4/12/2018,1962-003,3/10/2034,"Cox, Ben",David Grdina,"Tennant, Thelma",612842,9/26/2013,583114,Yes
2354,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1EPO,2663297,European Patent Office (EPO),EP,9/16/2011,10/23/2019, ,6/27/2013,1962-004,Small,9/17/2010,10/23/2019,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497EP,David Grdina,Nationalized PCT,4/12/2018,1962-004,9/16/2021,"Cox, Ben",David Grdina,"Tennant, Thelma",612843,11/20/2013,583114,Yes
2355,10-T-091,METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION,"15/862,171","10,987,366",*United States,US,9/16/2011,4/27/2021,2018-0193363,1/4/2018,1962-005,Large,9/17/2010,4/14/2021,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497US.C1,David Grdina,Continuation,4/12/2018,1962-005,9/23/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",612844,7/12/2018,583114,No
2356,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1FR,2663297,France,FR,9/16/2011,10/23/2019, ,8/23/2019,1962-006,Small,9/17/2010,8/26/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0497FR,David Grdina,Validated EPO,8/26/2019, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",3919419,,583114,Yes
2357,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1,602011062919.0,Germany,DE,9/16/2011,10/23/2019, ,8/23/2019,1962-007,Small,9/17/2010,8/26/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0497DE,David Grdina,Validated EPO,8/26/2019, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",3919441,,583114,Yes
2358,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,19194979.1, ,European Patent Office (EPO),EP,9/16/2011,,3632419,9/2/2019,1962-008,Small,9/17/2010,10/14/2019,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497EP.D1,David Grdina,Divisional,10/14/2019, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4033286,4/8/2020,583114,Yes
2359,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1BE,2663297,Belgium,BE,9/16/2011,10/23/2019,,1/22/2020,1962-009,Small,9/17/2010,1/22/2020,No,3/18/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497BE,David Grdina,Nationalized PCT,1/22/2020,,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4238858,,583114,Yes
2360,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1GR,2663297,Greece,GR,9/16/2011,10/23/2019, ,1/22/2020,1962-010,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497GR,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4238908,,583114,Yes
2361,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1HU,2663297,Hungary,HU,9/16/2011,10/23/2019, ,1/22/2020,1962-011,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497HU,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4238930,,583114,Yes
2362,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1IT,502020000004900,Italy,IT,9/16/2011,10/23/2019,2663297,1/22/2020,1962-012,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497IT,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4238952,,583114,Yes
2363,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1NL,2663297,Netherlands,NL,9/16/2011,10/23/2019, ,1/22/2020,1962-013,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497NL,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4238974,,583114,Yes
2364,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1PO,2663297,Poland,PL,9/16/2011,10/23/2019, ,1/22/2020,1962-014,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497PO,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4238996,,583114,Yes
2365,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1TK,2663297,Turkey,TR,9/16/2011,10/23/2019, ,1/22/2020,1962-015,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497TK,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4239018,,583114,Yes
2366,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1ES,2663297,Spain,ES,9/16/2011,10/23/2019, ,1/22/2020,1962-016,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497SE,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4239040,,583114,Yes
2367,10-T-091,Methods and Compositions for Protection of Cells and Tissues from Computed Tomography Radiation,11771290.1GB,2663297,United Kingdom,GB,9/16/2011,10/23/2019, ,1/22/2020,1962-017,Small,9/17/2010,1/22/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497GB,David Grdina,Validated EPO,1/22/2020, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",4239062,,583114,Yes
2368,10-T-091,METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION,"17/302,143", ,*United States,US,9/16/2011,,US-2021-0244751-A1,4/26/2021,1962-018,Small,9/17/2010,4/28/2021,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0497US.C2,David Grdina,Continuation,4/28/2021, ,9/16/2031,"Cox, Ben",David Grdina,"Tennant, Thelma",5641343,8/12/2021,583114,No
2369,10-T-095,TROPIC CELL-BASED VIROTHERAPY FOR THE TREATMENT OF CANCER,"61/780,752",,*United States,US,3/13/2013,,,3/13/2013,1965-001,Small,3/13/2013,,Yes,6/2/2022,Expired - Inactive,Perkins Coie LLP,"Dueppen, Lara",,"Karen Aboody, David Curiel, Maciej Lesniak",Provisional,4/12/2018,1965-001,3/13/2014,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",615119,,583118,Yes
2370,10-T-095,TROPIC CELL-BASED VIROTHERAPY FOR THE TREATMENT OF CANCER,PCT/US14/26770,,*United States,US,3/14/2014,,WO 2014/160475 A1,3/14/2014,1965-002,Small,3/13/2013,,No,6/2/2022,Expired - Inactive,Perkins Coie LLP,"Dueppen, Lara",,"Karen Aboody, David Curiel, Maciej Lesniak",PCT,4/12/2018,1965-002,9/14/2015,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",615120,10/3/2014,583118,No
2371,10-T-095,TROPIC CELL-BASED VIROTHERAPY FOR THE TREATMENT OF CANCER,"14/852,378","10,238,699",*United States,US,3/14/2014,3/26/2019,US 2016/0317591,9/12/2015,1965-003,Small,3/13/2013,,No,6/2/2022,Issued,Perkins Coie LLP,,054435-8112.US01,"Karen Aboody, Alexandra (Sandy) Annala, David Curiel, Maciej Lesniak",Continuation,4/12/2018,1965-003,3/13/2034,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",615121,11/3/2016,583118,No
2372,10-T-095,TROPIC CELL-BASED VIROTHERAPY FOR THE TREATMENT OF CANCER,"16/361,100","10,709,745",*United States,US,3/14/2014,7/14/2020,US 2019/0275093 A1,3/21/2019,1965-004,Small,3/13/2013,4/22/2019,No,6/2/2022,Issued,Perkins Coie LLP,,054435-8112.US03,"Karen Aboody, Alexandra (Sandy) Annala, David Curiel, Maciej Lesniak",Continuation,4/22/2019,1965-004,3/14/2034,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",3639449,9/12/2019,583118,No
2373,10-T-095,TROPIC CELL-BASED VIROTHERAPY FOR THE TREATMENT OF CANCER,"16/927,304",,*United States,US,3/14/2014,,US-2021-0060101-A1,7/13/2020,1965-005,Small,3/13/2013,8/22/2020,No,6/2/2022,Pending,Perkins Coie LLP,,54435-8112.US04,"Karen Aboody, Alexandra (Sandy) Annala, David Curiel, Maciej Lesniak",Continuation,8/22/2020,1965-005,3/14/2034,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",4847972,3/4/2021,583118,No
2374,10-T-098,Compositions and Methods Related to Attenuated Staphylococcal Strains,"61/435,584", ,*United States,US,1/24/2011,, ,1/24/2011,1967-002,Small,1/24/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1967-002,9/9/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611070,,583121,Yes
2375,10-T-098,Compositions and Methods Related to Attenuated Staphylococcal Strains,PCT/US11/51090, ,*United States,US,9/9/2011,,WO 2012/034077,9/9/2011,1967-003,Small,9/9/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,1967-003,3/9/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611071,3/15/2012,583121,Yes
2376,10-T-098,Compositions and Methods Related to Attenuated Staphylococcal Strains,"13/821,937", ,*United States,US,9/9/2011,,US-2013-0236419-A1,6/3/2013,1967-004,Small,9/9/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,1967-004,9/9/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611072,9/12/2013,583121,Yes
2377,10-T-098,Compositions and Methods Related to Staphylococcal Strains,"61/381,363", ,*United States,US,9/9/2010,, ,9/9/2010,1967-001,Large,9/9/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Hye-Young Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,1967-001,9/9/2011,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611228,,583121,Yes
2378,10-T-103,Delivery of Nanoparticles to Neurons,"13/679,335","8,859,284",*United States,US,10/20/2010,10/14/2014, ,11/16/2012,1970-005,None,10/22/2009,10/14/2014,No,5/8/2022,Issued,,, ,"Glyn Dawson, Ryan Walters",Continuation in Part,4/12/2018,1970-005,10/20/2030,"Sun, Han",Glyn Dawson,"Tennant, Thelma",611375,,583126,Yes
2379,10-T-103,Modular Functional Peptides for Delivery of Nanoparticles,"13/621,880","8,835,172",*United States,US,10/20/2010,9/16/2014, ,9/18/2012,1970-004,None,10/22/2009,9/16/2014,No,5/8/2022,Issued,,, ,Glyn Dawson,Continuation in Part,4/12/2018,1970-004,1/13/2031,"Sun, Han",Glyn Dawson,"Tennant, Thelma",613465,,583126,Yes
2380,10-T-103,Modular Functional Peptides for the Intracellular Delivery of Nanoparticles,PCT/US10/53341, ,*United States,US,10/20/2010,, ,10/20/2010,1970-001,None,10/22/2009,,No,4/28/2022,Expired - Inactive,,, ,Glyn Dawson,PCT,4/12/2018,1970-001,6/20/2012,"Sun, Han",Glyn Dawson,"Tennant, Thelma",613466,,583126,Yes
2381,10-T-103,Modular Functional Peptides for the Intracellular Delivery of Nanoparticles,"12/908,601","8,409,858",*United States,US,10/20/2010,4/2/2013, ,10/20/2010,1970-002,None,10/22/2009,4/2/2013,No,5/8/2022,Issued,,, ,Glyn Dawson,US Utility,4/12/2018,1970-002,7/16/2031,"Sun, Han",Glyn Dawson,"Tennant, Thelma",613467,,583126,Yes
2382,10-T-103,Modular Functional Peptides for the Intracellular Delivery of Nanoparticles,10825574.6EPO, ,European Patent Office (EPO),EP,10/20/2010,, ,2/28/2012,1970-003,None,10/22/2009,10/7/2015,No,4/28/2022,Abandoned,,, ,Glyn Dawson,Nationalized PCT,4/12/2018,1970-003,,"Sun, Han",Glyn Dawson,"Tennant, Thelma",613468,,583126,Yes
2383,10-T-106,Antibodies To Rickettsia and Immunogens For Generating Rickettsia Antibodies,"61/426,352", ,*United States,US,12/22/2010,, ,12/22/2010,1975-001,Small,12/22/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Yvonne Chan, Juan Martinez",Provisional,4/12/2018,1975-001,12/22/2011,"Onishi, Kenneth",Juan Martinez,"Onishi, Kenneth",610404,,583129,Yes
2384,10-T-107,Vaccines Against Toxoplasma Gondii,"61/455,900", ,*United States,US,10/28/2010,, ,10/28/2010,1976-001,Small,10/28/2010,,Yes,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Rima McLeod,Provisional,4/12/2018,1976-001,10/28/2011,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615355,,583130,Yes
2385,10-T-107,Vaccines Against Toxoplasma Gondii,"61/456,000", ,*United States,US,10/29/2010,, ,10/29/2010,1976-002,Small,10/29/2010,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,Rima McLeod,Provisional,4/12/2018,1976-002,10/29/2011,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615356,,583130,Yes
2386,10-T-107,Vaccines Against Toxoplasma Gondii,"61/456,309", ,*United States,US,11/4/2010,, ,11/4/2010,1976-003,Small,11/4/2010,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Rima McLeod,Provisional,4/12/2018,1976-003,11/4/2011,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615357,,583130,Yes
2387,10-T-107,Vaccines Against Toxoplasma Gondii,PCT/US11/59147, ,*United States,US,11/3/2011,,WO 2012/061599,11/3/2011,1976-004,Small,10/28/2010,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Rima McLeod,PCT,4/12/2018,1976-004,4/28/2013,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615358,5/10/2012,583130,Yes
2388,10-T-107,Vaccines Against Toxoplasma Gondii,"13/823,668", ,*United States,US,11/3/2011,,US-2013-0273094-A1,3/14/2013,1976-005,Small,10/28/2010,,No,4/28/2022,Released to Inventors,Mcdonnell Boehnen Hulbert & Berghoff LLP,,002505.00004,Rima McLeod,Nationalized PCT,4/12/2018,1976-005,11/3/2031,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615359,10/17/2013,583130,Yes
2389,10-T-108,ROLE OF ADAM10 and ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"61/525,088", ,*United States,US,8/18/2011,, ,8/18/2011,1971-005,None,8/18/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Provisional,4/12/2018,1971-005,8/18/2012,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614405,,583131,Yes
2390,10-T-108,ROLE OF ADAM10 and ITS RELEVANCE TO DISEASE AND THERAPEUTICS,PCT/US11/60010, ,*United States,US,11/9/2011,, ,11/9/2011,1971-006,None,11/9/2010,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,PCT,4/12/2018,1971-006,5/9/2013,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614406,,583131,Yes
2391,10-T-108,ROLE OF ADAM10 and ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"13/884,502","9,150,865",*United States,US,11/9/2011,10/6/2015,US-2014-0178399-A1,7/24/2013,1971-007,Small,11/9/2010,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Nationalized PCT,4/12/2018,1971-007,11/9/2031,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614407,6/26/2014,583131,Yes
2392,10-T-108,ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS,11839643.1EPO, ,European Patent Office (EPO),EP,11/9/2011,,2637679,6/6/2013,1971-008,Small,11/9/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Nationalized PCT,4/12/2018,1971-008,11/9/2031,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614408,9/18/2013,583131,Yes
2393,10-T-108,ROLE OF ADAM10 and ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"14/875,214", ,*United States,US,11/9/2011,,US-2014-0178399-A1,10/5/2015,1971-009,Small,11/9/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000317973,Juliane Bubeck Wardenburg,Continuation,4/12/2018,1971-009,10/5/2035,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614409,,583131,No
2394,10-T-108,ROLE OF THE S. AUREUS ALPHA-HEMOLYSIN (HLA) INTERACTION WITH ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"61/411,765", ,*United States,US,11/9/2010,, ,11/9/2010,1971-001,None,11/9/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Provisional,4/12/2018,1971-001,11/9/2011,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614410,,583131,Yes
2395,10-T-108,ROLE OF THE S. AUREUS ALPHA-HEMOLYSIN (HLA) INTERACTION WITH ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"61/453,648", ,*United States,US,3/17/2011,, ,3/17/2011,1971-002,None,3/17/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Provisional,4/12/2018,1971-002,3/17/2012,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614411,,583131,Yes
2396,10-T-108,ROLE OF THE S. AUREUS ALPHA-HEMOLYSIN (HLA) INTERACTION WITH ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"61/511,030", ,*United States,US,7/23/2011,, ,7/23/2011,1971-003,Small,7/23/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Provisional,4/12/2018,1971-003,11/9/2011,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614412,,583131,Yes
2397,10-T-108,ROLE OF THE S. AUREUS ALPHA-HEMOLYSIN (HLA) INTERACTION WITH ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS,"61/511,032", ,*United States,US,7/23/2011,, ,7/23/2011,1971-004,Small,7/23/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Juliane Bubeck Wardenburg,Provisional,4/12/2018,1971-004,11/9/2011,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",614413,,583131,Yes
2398,10-T-112,"Method, System, Software and Medium for Advanced Intelligent Image Analysis and Display of Medical Images and information","61/344,951", ,*United States,US,11/26/2010,, ,11/26/2010,1979-001,Small,11/26/2010,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Jeremy Bancroft-Brown, Neha Bhooshan, Michael Chinander, Karen Drukker, Maryellen Giger, Andrew Jamieson, Li Lan, Hui Li, Gillian Newstead, Robert Tomek",Provisional,4/12/2018,1979-001,11/26/2011,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612593,,583135,Yes
2399,10-T-112,"Method, System, Software and Medium for Advanced Intelligent Image Analysis and Display of Medical Images and information","13/305,495","9,208,556",*United States,US,11/28/2011,12/8/2015,US2012/0189176 A1,11/28/2011,1979-002,Small,11/26/2010,,No,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Jeremy Bancroft-Brown, Neha Bhooshan, Michael Chinander, Karen Drukker, Maryellen Giger, Andrew Jamieson, Li Lan, Hui Li, Gillian Newstead, Robert Tomek",US Utility,4/12/2018,1979-002,11/28/2031,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612594,7/26/2012,583135,Yes
2400,10-T-118,Semiconducting Polymers,"61/463,604", ,*United States,US,2/18/2011,, ,2/18/2011,1983-001,None,2/18/2011,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00315,Luping Yu,Provisional,4/12/2018,1983-001,2/18/2012,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614460,,583141,Yes
2401,10-T-120,Digital Isothermal Quantification of Nucleic Acids Via Simultaneous Chemical Initiation of Recombinase Polymerase Amplication (RPA) Reactions on SlipChip,"61/516,628", ,*United States,US,4/5/2011,, ,4/5/2011,1987-001,Small,4/5/2011,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00314,Rustem Ismagilov,Provisional,4/12/2018,1987-001,4/5/2012,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611457,,583143,Yes
2402,11-T-001,Tunable light-controlled interacting protein tags and methods of use,"61/569,006", ,*United States,US,12/9/2011,, ,12/9/2011,1985-001,Small,12/9/2011,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Michael Glotzer, Tobin Sosnick, Devin Strickland",Provisional,4/12/2018,1985-001,12/9/2012,"Peace, Shane",Devin Strickland,"Muite, Kevin",615123,,583144,Yes
2403,11-T-002,Methods and Compositions for Measuring Cell Permeability,"61/696,989", ,*United States,US,9/5/2012,, ,9/5/2012,1986-001,Small,9/5/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Konstantin Birukov, Oleksii Dubrovskyi",Provisional,4/12/2018,1986-001,9/5/2013,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",612793,,583145,Yes
2404,11-T-002,Methods and Compositions for Measuring Cell Permeability,"14/019,055","9,588,106",*United States,US,9/5/2013,3/7/2017,US-2014-0065638-A1,9/5/2013,1986-002,Large,9/5/2012,3/7/2017,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Konstantin Birukov, Oleksii Dubrovskyi",US Utility,4/12/2018,1986-002,1/27/2034,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",612794,3/6/2014,583145,Yes
2405,11-T-003,"FXR Inhibitor, Bile Acid Sequestrant as Combination Therapy for Cholesterol Reduction","61/439,145", ,*United States,US,2/3/2011,, ,2/3/2011,1994-001,Small,2/3/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Michael Davidson, Godfrey Getz, Catherine Reardon-Alulis",Provisional,4/12/2018,1994-001,2/3/2012,"Bakalyar, Heather",Michael Davidson,"Tennant, Thelma",611621,,583146,Yes
2406,11-T-003,"FXR Inhibitor, Bile Acid Sequestrant as Combination Therapy for Cholesterol Reduction",PCT/US12/23742, ,*United States,US,2/3/2012,,WO2012/106581,2/3/2012,1994-002,Small,2/3/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Michael Davidson, Godfrey Getz, Catherine Reardon-Alulis",PCT,4/12/2018,1994-002,8/3/2013,"Bakalyar, Heather",Michael Davidson,"Tennant, Thelma",611622,8/9/2012,583146,Yes
2407,11-T-004,Methods and/or Use of Oligonucleotide Bead-Conjugates for Assays and Detections,"13/302,801", ,*United States,US,11/22/2011,, ,11/22/2011,1988-002,Small,11/22/2010,,No,5/1/2022,Abandoned,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",US Utility,4/12/2018,1988-002,11/22/2031,"Sun, Han",Stephen Kron,"Tennant, Thelma",613147,,583147,Yes
2408,11-T-004,Methods and/or Use of Oligonucleotide Conjugates for Assays and Detections,"61/344,931", ,*United States,US,11/22/2010,, ,11/22/2010,1988-001,Small,11/22/2010,,Yes,4/28/2022,Expired - Inactive,Jones Day,, ,"Stephen Kron, David Schwartz, Jimmy Williams",Provisional,4/12/2018,1988-001,11/22/2011,"Sun, Han",Stephen Kron,"Tennant, Thelma",613148,,583147,Yes
2409,11-T-004,Methods and/or Use of Oligonucleotide Conjugates for Assays and Detections,PCT/US11/61874, ,*United States,US,11/22/2011,,WO2012/071428,11/22/2011,1988-008,Small,11/22/2010,,No,4/28/2022,Expired - Inactive,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",PCT,4/12/2018,1988-008,5/22/2013,"Sun, Han",Stephen Kron,"Tennant, Thelma",613149,5/31/2012,583147,Yes
2410,11-T-004,Methods and/or Use of Oligonucleotide Conjugates for Assays and Flow Cytometry Detections,"13/302,877", ,*United States,US,11/22/2011,, ,11/22/2011,1988-004,Small,11/22/2010,,No,5/1/2022,Pending,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",US Utility,4/12/2018,1988-004,11/22/2031,"Sun, Han",Stephen Kron,"Tennant, Thelma",613150,,583147,Yes
2411,11-T-004,Methods and/or Use of Oligonucleotide Conjugates for Assays and Microscopy/Imaging Detections,"13/302,890", ,*United States,US,11/22/2011,, ,11/22/2011,1988-005,Small,11/22/2010,,No,5/1/2022,Abandoned,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",US Utility,4/12/2018,1988-005,11/22/2031,"Sun, Han",Stephen Kron,"Tennant, Thelma",613151,,583147,Yes
2412,11-T-004,Methods and/or Use of Oligonucleotide Conjugates for Suppressing Background Due to Cross-Hybridization,"13/898,015","9,222,936",*United States,US,11/22/2011,12/30/2015, ,5/20/2013,1988-009,Small,11/22/2010,,Yes,5/1/2022,Issued,Jones Day,, ,"Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Xinfang Zhao",US Utility,4/12/2018,1988-009,5/20/2033,"Sun, Han",Stephen Kron,"Tennant, Thelma",613152,,583147,No
2413,11-T-004,Methods and/or Use of Oligonucleotide Conjugates Having Varied Degrees of Labeling for Assays and Detections,"13/302,819", ,*United States,US,11/22/2011,, ,11/22/2011,1988-007,Small,11/22/2010,,No,5/1/2022,Abandoned,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",US Utility,4/12/2018,1988-007,11/22/2031,"Sun, Han",Stephen Kron,"Tennant, Thelma",613153,,583147,Yes
2414,11-T-004,Methods and/or Use of Producing and Providing Sets of Oligonucleotide Conjugates for Assays and Detections,"13/302,851", ,*United States,US,11/22/2011,, ,11/22/2011,1988-006,Small,11/22/2010,,No,5/1/2022,Abandoned,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",US Utility,4/12/2018,1988-006,11/22/2031,"Sun, Han",Stephen Kron,"Tennant, Thelma",613154,,583147,Yes
2415,11-T-004,"Methods, Systems and/or Use of Oligonucleotide Conjugates to Develop Panels for Use in Assays and Detections","13/302,910", ,*United States,US,11/22/2011,, ,11/22/2011,1988-003,Small,11/22/2010,,No,5/1/2022,Abandoned,Jones Day,, ,"William Busa, Amy Flor, Stephen Kron, David Schwartz, Jimmy Williams, Chungang Zhao, Xinfang Zhao",US Utility,4/12/2018,1988-003,11/22/2031,"Sun, Han",Stephen Kron,"Tennant, Thelma",613372,,583147,Yes
2416,11-T-005,Composition and Methods Related to Modification of 5-Methylcytosine (5-mC),"14/110,007","9,611,510",*United States,US,4/6/2012,4/4/2017,US-2014-0322707-A1,2/16/2014,1989-003,Small,4/6/2011,4/4/2017,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0504US,"Chuan He, Chunxiao Song, Miao Yu, Liang Zhang",Nationalized PCT,4/12/2018,1989-003,2/16/2033,"Hwang, Luke",Chuan He,"Tennant, Thelma",610966,10/30/2014,583148,Yes
2417,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),"61/472,435", ,*United States,US,4/6/2011,, ,4/6/2011,1989-001,Small,4/6/2011,10/18/2018,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Landrum, Charles",ARCD.P0504US.P1,"Chuan He, Chunxiao Song, Liang Zhang",Provisional,4/12/2018,1989-001,4/6/2012,"Hwang, Luke",Chuan He,"Tennant, Thelma",611090,,583148,Yes
2418,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),PCT/US12/32489, ,*United States,US,4/6/2012,,WO2012/138973,4/6/2012,1989-002,Small,4/6/2011,10/18/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,,ARCD.P0504WO,"Chuan He, Chunxiao Song, Liang Zhang",PCT,4/12/2018,1989-002,10/6/2013,"Hwang, Luke",Chuan He,"Tennant, Thelma",611091,10/11/2012,583148,Yes
2419,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),12768638.4EPO,2694686,European Patent Office (EPO),EP,4/6/2012,11/22/2017,2694686,11/6/2013,1989-004,Small,4/6/2011,,No,4/28/2022,Opposition,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0504EP,"Chuan He, Chunxiao Song, Liang Zhang",Nationalized PCT,4/12/2018,1989-004,4/6/2032,"Hwang, Luke",Chuan He,"Tennant, Thelma",611092,2/12/2014,583148,Yes
2420,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),12768638.4CH,2694686,Switzerland,CH,4/6/2012,11/22/2017, ,10/6/2013,1989-005,Small,4/6/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0504CH,"Chuan He, Chunxiao Song, Liang Zhang",Validated EPO,4/12/2018,1989-005,4/6/2032,"Hwang, Luke",Chuan He,"Tennant, Thelma",611093,2/12/2014,583148,Yes
2421,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),12768638.4DE,602012040112.5,Germany,DE,4/6/2012,11/22/2017, ,10/6/2013,1989-006,Small,4/6/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0504DE,"Chuan He, Chunxiao Song, Liang Zhang",Validated EPO,4/12/2018,1989-006,4/6/2032,"Hwang, Luke",Chuan He,"Tennant, Thelma",611094,2/12/2014,583148,Yes
2422,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),12768638.4FR,2694686,France,FR,4/6/2012,11/22/2017, ,10/6/2013,1989-007,Small,4/6/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0504FR,"Chuan He, Chunxiao Song, Liang Zhang",Validated EPO,4/12/2018,1989-007,4/6/2032,"Hwang, Luke",Chuan He,"Tennant, Thelma",611095,2/12/2014,583148,Yes
2423,11-T-005,Compositions and Methods Related to Modification of 5-Methylcytosine (5-mC),12768638.4GB,2694686,United Kingdom,GB,4/6/2012,11/22/2017, ,10/6/2013,1989-008,Small,4/6/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0504GB,"Chuan He, Chunxiao Song, Liang Zhang",Validated EPO,4/12/2018,1989-008,4/6/2032,"Hwang, Luke",Chuan He,"Tennant, Thelma",611096,2/12/2014,583148,Yes
2424,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,"61/060,510", ,*United States,US,6/11/2008,, ,6/11/2008,1990-001,Large,6/11/2008,,Yes,4/28/2022,Expired - Inactive,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Heim, Patricia", ,"Lina Arbash-Meinel, Gillian Newstead",Provisional,4/12/2018,1990-001,6/11/2009,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613554,,583149,Yes
2425,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,PCT/IB09/52296, ,International Bureau,IB,6/1/2009,,WO 2009/150566 A1,6/1/2009,1990-002,Large,6/11/2008,,No,4/28/2022,Expired - Inactive,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,"Heim, Patricia", ,"Lina Arbash-Meinel, Gillian Newstead",Nationalized PCT,4/12/2018,1990-002,12/11/2010,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613556,12/17/2009,583149,Yes
2426,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,200980120768.X,200980120768.X,China,CN,6/1/2009,3/5/2014,102083370 A,6/1/2009,1990-003,Large,6/11/2008,,No,4/28/2022,Issued,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Lina Arbash-Meinel, Gillian Newstead",Nationalized PCT,4/12/2018,1990-003,6/1/2029,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613557,12/17/2009,583149,Yes
2427,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,09762093.4EPO, ,European Patent Office (EPO),EP,6/1/2009,, ,6/1/2009,1990-004,Large,6/11/2008,,No,4/28/2022,Expired - Inactive,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Lina Arbash-Meinel, Gillian Newstead",Nationalized PCT,4/12/2018,1990-004,8/24/2011,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613558,12/17/2009,583149,Yes
2428,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,"12/996,031","8,452,613",*United States,US,6/1/2009,5/28/2013,US 20110087089 A1,12/3/2010,1990-005,Large,6/11/2008,,No,4/28/2022,Issued,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Lina Arbash-Meinel, Gillian Newstead",Nationalized PCT,4/12/2018,1990-005,12/3/2030,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613559,,583149,Yes
2429,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,148/CHENP/2011, ,India,IN,6/1/2009,, ,6/1/2009,1990-006,Large,6/11/2008,,No,4/28/2022,Expired - Inactive,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Lina Arbash-Meinel, Gillian Newstead",Validated EPO,4/12/2018,1990-006,6/2/2018,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613561,12/17/2009,583149,Yes
2430,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,2011-513081, ,Japan,JP,6/1/2009,, ,6/1/2009,1990-007,Large,6/11/2008,,No,4/28/2022,Expired - Inactive,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Lina Arbash-Meinel, Gillian Newstead",Nationalized PCT,4/12/2018,1990-007,6/2/2018,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613563,12/17/2009,583149,Yes
2431,11-T-006,Multiple Modality Computer Aided Diagnostic System and Method,2010154662,2566462,Russian Federation,RU,6/1/2009,10/27/2015, ,6/1/2009,1990-008,Large,6/11/2008,,No,4/28/2022,Issued,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Lina Arbash-Meinel, Gillian Newstead",Nationalized PCT,4/12/2018,1990-008,6/1/2029,"Ramirez, Mario Riojas",Gillian Newstead,"Juggernauth, Anne",613565,12/17/2009,583149,Yes
2432,11-T-012,Methods and Compositions for Inhibiting Glyoxalase 1 (Glo1),"61/780,509", ,*United States,US,3/13/2013,, ,3/13/2013,1997-001,Small,3/13/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Ivy Aneas-Swanson, Margaret Distler, Andrew Hawk, Stephen Meredith, Marcelo Nobrega, Abraham Palmer, Leigh Plant, Greta Sokoloff",Provisional,4/12/2018,1997-001,3/13/2014,"Unassigned, Unassigned",Abraham Palmer,"Unassigned, Unassigned",612775,,583155,Yes
2433,11-T-012,Methods and Compositions for Inhibiting Glyoxalase 1 (Glo1),PCT/US14/24901, ,*United States,US,3/12/2014,,WO 2014/159720,3/12/2014,1997-002,Small,3/13/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Ivy Aneas-Swanson, Margaret Distler, Andrew Hawk, Stephen Meredith, Marcelo Nobrega, Abraham Palmer, Leigh Plant, Greta Sokoloff",PCT,4/12/2018,1997-002,9/13/2015,"Unassigned, Unassigned",Abraham Palmer,"Unassigned, Unassigned",612776,10/2/2014,583155,Yes
2434,11-T-015,Methods and Compositions Involving Induced Senescent Cells for Cancer Treatment,PCT/US12/66369, ,*United States,US,11/21/2012,,WO 2013/078392,11/21/2012,1999-002,Small,11/21/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elena Efimova, Amy Flor, Stephen Kron, Yuru (Ruth) Meng, Ralph Weichselbaum",PCT,4/12/2018,1999-002,5/21/2014,"Sun, Han",Ralph Weichselbaum,"Tennant, Thelma",612958,5/30/2013,583158,Yes
2435,11-T-015,Methods and Compositions Involving Induced Senescent Cells for Cancer Treatment,"14/359,745", ,*United States,US,11/21/2012,,US 2015/0024008,5/21/2014,1999-003,Small,11/21/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elena Efimova, Amy Flor, Stephen Kron, Yuru (Ruth) Meng, Ralph Weichselbaum",Nationalized PCT,4/12/2018,1999-003,11/21/2031,"Sun, Han",Ralph Weichselbaum,"Tennant, Thelma",612959,1/22/2015,583158,Yes
2436,11-T-015,Vaccine and Method of Use,"61/562,117", ,*United States,US,11/21/2011,, ,11/21/2011,1999-001,Small,11/21/2011,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Elena Efimova, Stephen Kron, Yuru (Ruth) Meng, Ralph Weichselbaum",Provisional,4/12/2018,1999-001,11/21/2012,"Sun, Han",Ralph Weichselbaum,"Tennant, Thelma",615354,,583158,Yes
2437,11-T-025,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,"61/526,166", ,*United States,US,8/22/2011,, ,8/22/2011,2115-001,Large,8/22/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2115-001,8/22/2012,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611066,,583168,Yes
2438,11-T-025,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,"61/451,471", ,*United States,US,3/10/2011,, ,3/10/2011,2115-002,Large,3/10/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2115-002,3/10/2012,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611067,,583168,Yes
2439,11-T-025,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,PCT/US12/28618, ,*United States,US,3/9/2012,,WO 2012/122533,3/9/2012,2115-003,Large,3/10/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2115-003,9/9/2013,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611068,9/13/2012,583168,Yes
2440,11-T-025,Compositions and Methods Related to Antibodies to Staphylococcal Proteins ISDA or ISDB,"13/959,147", ,*United States,US,3/9/2012,,US-2014-0037650-A1,8/5/2013,2115-004,Large,3/10/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",US Utility,4/12/2018,2115-004,3/9/2032,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611069,2/6/2014,583168,Yes
2441,11-T-027,Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins,"61/453,685", ,*United States,US,3/17/2011,, ,3/17/2011,2006-001,Small,3/17/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Ernst Lengyel,Provisional,4/12/2018,2006-001,3/17/2012,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",611011,,583170,Yes
2442,11-T-027,Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins,"13/422,712","8,748,470",*United States,US,3/16/2012,6/10/2014,US-2012-0289570-A1,3/16/2012,2006-002,Small,3/17/2011,,No,5/17/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0503US,"Hilary Ann Kenny, Ernst Lengyel, Kristin Nieman",US Utility,4/12/2018,2006-002,3/16/2032,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",611012,11/15/2012,583170,Yes
2443,11-T-027,Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins,"14/276,598", ,*United States,US,3/16/2012,,US-2014-0363522-A1,5/13/2014,2006-003,Small,3/17/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hilary Ann Kenny, Ernst Lengyel, Kristin Nieman",US Utility,4/12/2018,2006-003,5/13/2034,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",611013,12/11/2014,583170,Yes
2444,11-T-031,Marker Panels for Idiopathic Pulmonary Fibrosis Diagnosis and Evaluation,"13/039,989","8,846,341",*United States,US,9/4/2009,9/30/2014,,3/3/2011,2007-001,Small,9/5/2008,9/30/2014,No,6/2/2022,Issued,Baker Botts L.L.P.,,,"Kevin Gibson, Jose Herazo-Maya, Naftali Kaminski, Imre Noth",Nationalized PCT,4/12/2018,2007-001,9/4/2029,"Sun, Han",Imre Noth,"Muite, Kevin",612159,,583174,Yes
2445,11-T-031,Marker Panels for Idiopathic Pulmonary Fibrosis Diagnosis and Evaluation,PCT/US09/56085,,*United States,US,9/4/2009,,,9/4/2009,2007-002,Small,9/5/2008,,No,6/2/2022,Expired - Inactive,Baker Botts L.L.P.,"Lendaris, Steven",,"Kevin Gibson, Jose Herazo-Maya, Naftali Kaminski, Imre Noth",PCT,4/12/2018,2007-002,3/4/2011,"Sun, Han",Imre Noth,"Muite, Kevin",612160,,583174,Yes
2446,11-T-031,Marker Panels for Idiopathic Pulmonary Fibrosis Diagnosis and Evaluation,"61/094,725",,*United States,US,9/5/2008,,,9/5/2008,2007-003,Small,9/5/2008,,Yes,6/2/2022,Expired - Inactive,Baker Botts L.L.P.,"Lendaris, Steven",,"Kevin Gibson, Jose Herazo-Maya, Naftali Kaminski, Imre Noth",Provisional,4/12/2018,2007-003,9/5/2009,"Sun, Han",Imre Noth,"Muite, Kevin",612161,,583174,Yes
2447,11-T-031,Marker Panels for Idiopathic Pulmonary Fibrosis Diagnosis and Evaluation,"14/277,194",,*United States,US,9/4/2009,,,5/14/2014,2007-004,Small,9/5/2008,9/16/2016,No,6/2/2022,Abandoned,Baker Botts L.L.P.,,,"Kevin Gibson, Jose Herazo-Maya, Naftali Kaminski, Imre Noth",Continuation,4/12/2018,2007-004,,"Sun, Han",Imre Noth,"Muite, Kevin",612162,,583174,Yes
2448,11-T-038,Assembly of Square-Pyramidal Metalloporphyrins on HOPG,"61/516,235", ,*United States,US,3/31/2011,, ,3/31/2011,2010-001,Small,3/31/2011,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00318,"Michael Hopkins, Cameron Iverson",Provisional,4/12/2018,2010-001,3/31/2012,"Ginsburg, Eric",Michael Hopkins,"Juggernauth, Anne",610567,,583181,Yes
2449,11-T-038,Assembly of Square-Pyramidal Metalloporphyrins on HOPG,"61/685,948", ,*United States,US,3/27/2012,, ,3/27/2012,2010-002,Small,3/27/2012,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00342,"Michael Hopkins, Cameron Iverson",Provisional,4/12/2018,2010-002,3/27/2013,"Ginsburg, Eric",Michael Hopkins,"Juggernauth, Anne",610568,,583181,Yes
2450,11-T-038,Molecular Cartesian-Coordinate Platforms,PCT/US12/31346, ,*United States,US,3/30/2012,,WO2012/135565,3/30/2012,2010-003,Small,3/31/2011,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00340,"Michael Hopkins, Cameron Iverson, Wing-Yeung (Wayne) Lau",PCT,4/12/2018,2010-003,9/30/2013,"Ginsburg, Eric",Michael Hopkins,"Juggernauth, Anne",613510,10/4/2012,583181,Yes
2451,11-T-038,Molecular Cartesian-Coordinate Platforms,"14/008,013", ,*United States,US,3/30/2012,,US-2014-0330000--A1,10/16/2013,2010-004,Small,3/31/2011,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Feng, Yuezhong",00355,"Michael Hopkins, Cameron Iverson, Wing-Yeung (Wayne) Lau",US Utility,4/12/2018,2010-004,3/30/2032,"Ginsburg, Eric",Michael Hopkins,"Juggernauth, Anne",613511,11/6/2014,583181,Yes
2452,11-T-039,Method and Apparatus for Resonator Signal Production and Measurement,"61/496,842", ,*United States,US,6/14/2011,, ,6/14/2011,2012-001,Small,6/14/2011,,Yes,4/28/2022,Expired Prov - Filed PCT,"Marshall, Gerstein & Borun","Stephens, Paul",46219,"Boris Epel, Howard Halpern, Subramanian Sundramoorthy",Provisional,4/12/2018,2012-001,6/14/2012,"Cox, Ben",Howard Halpern,"Juggernauth, Anne",612297,,583182,Yes
2453,11-T-039,Method and Apparatus for Resonator Signal Production and Measurement,PCT/US12/42474, ,*United States,US,6/14/2012,,WO2012/174249,6/14/2012,2012-002,Small,6/14/2011,6/22/2020,No,4/28/2022,Expired PCT - Nationalized,"Marshall, Gerstein & Borun","Stephens, Paul",46219A-PC,"Boris Epel, Howard Halpern, Subramanian Sundramoorthy",PCT,4/12/2018,2012-002,12/14/2013,"Cox, Ben",Howard Halpern,"Juggernauth, Anne",612298,12/20/2012,583182,Yes
2454,11-T-039,Method and Apparatus for Resonator Signal Production and Measurement,"14/128,423","10,551,450",*United States,US,6/14/2012,2/4/2020, ,8/4/2014,2012-003,Small,6/14/2011,3/11/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul",46219A,"Boris Epel, Howard Halpern, Subramanian Sundramoorthy",Nationalized PCT,4/12/2018,2012-003,6/17/2036,"Cox, Ben",Howard Halpern,"Juggernauth, Anne",612299,,583182,Yes
2455,11-T-041,Methods and Compositions for Regulating Gene Expression Using Light,"61/641,049", ,*United States,US,5/1/2012,, ,5/1/2012,2014-001,Small,5/1/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andreas Moeglich, John Moffat, Robert Ohlendorf",Provisional,4/12/2018,2014-001,5/1/2013,"Unassigned, Unassigned",John Moffat,"Unassigned, Unassigned",612849,,583184,Yes
2456,11-T-043,Methods and Compositions for Inhibiting Staphylococcus Agglutination in Blood,"61/508,430", ,*United States,US,7/15/2011,, ,7/15/2011,2017-001,Small,7/15/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2017-001,7/15/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612787,,583186,Yes
2457,11-T-043,Methods and Compositions for Inhibiting Staphylococcus Agglutination in Blood,"61/530,869", ,*United States,US,9/2/2011,, ,9/2/2011,2017-002,Small,9/2/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2017-002,7/15/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612788,,583186,Yes
2458,11-T-043,Methods and Compositions for Inhibiting Staphylococcus Agglutination in Blood,PCT/US12/46739, ,*United States,US,7/13/2012,,WO 2013/012743,7/13/2012,2017-003,Small,7/15/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2017-003,1/15/2014,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612789,1/24/2013,583186,Yes
2459,11-T-043,Methods and Compositions for Inhibiting Staphylococcus Agglutination in Blood,"14/233,109", ,*United States,US,7/13/2012,,US-2014-0271649-A1,1/15/2014,2017-004,Small,7/15/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2017-004,7/13/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612790,9/18/2014,583186,Yes
2460,11-T-052,Methods and Compositions for Live-Cell Monitoring of Sulphide,"61/712,134", ,*United States,US,10/10/2012,, ,10/10/2012,2022-001,Small,10/10/2012,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Chuan He,Provisional,4/12/2018,2022-001,10/10/2013,"Hwang, Luke",Chuan He,"Tennant, Thelma",612792,,583195,Yes
2461,11-T-055,"Multiolume Devices, Kits and Related Methods for Quantification and Detection of Nucleic Acids and other Analytes","14/177,194","10,196,700",*United States,US,2/10/2014,2/5/2019,US-2017-0051365-A9,2/10/2014,2024-002,Small,3/23/2010,2/5/2019,No,4/28/2022,Issued,Fenwick & West LLP,, ,"Wenbin Du, Rustem Ismagilov, Jason Kreutz, Feng Shen, Bing Sun",Continuation in Part,4/12/2018,2024-002,3/23/2030,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613552,2/23/2017,583198,Yes
2462,11-T-055,"Multiolume Devices, Kits and Related Methods for Quantification and Detection of Nucleic Acids and other Analytes","14/177,190","9,493,826",*United States,US,2/10/2014,11/15/2016, ,2/10/2014,2024-003,Small,3/23/2010,11/15/2016,No,4/28/2022,Issued,Fenwick & West LLP,,32592-30790/US (T),"Wenbin Du, Rustem Ismagilov, Jason Kreutz, Feng Shen, Bing Sun",Continuation in Part,4/12/2018,2024-003,4/10/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613553,,583198,Yes
2463,11-T-055,Quantification of Nucleic Acids with Large Dynamic Range Using Multivolume Digital Reverse Transcription PCR (RT-PCR) on a Rotational SlipCHip Tested with Viral Load,"61/518,601", ,*United States,US,5/9/2011,, ,5/9/2011,2024-001,Small,5/9/2011,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Baum, Allen",00321,Rustem Ismagilov,Provisional,4/12/2018,2024-001,5/9/2012,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614232,,583198,Yes
2464,11-T-058,"Gb1 peptidic libraries and compounds, and methods of screening the same",PCT/US11/60276, ,*United States,US,10/11/2011,, ,10/11/2011,2027-004,Small,10/12/2010,,No,4/28/2022,Expired - Inactive,"Bozicevic, Field & Francis",, ,"Dana Ault-Riche, Stephen Kent, Sachdev Sidhu, Maruti Uppalapati",PCT,4/12/2018,2027-004,5/10/2013,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",611635,,583201,No
2465,11-T-058,"Methods and Compositions for Identifying D-peptidic Compounds that Specifically Bind Target
Proteins","61/413,316", ,*United States,US,10/12/2010,, ,10/12/2010,2027-001,None,10/12/2010,,Yes,4/28/2022,Expired - Inactive,"Bozicevic, Field & Francis","Field, Bret", ,"Dana Ault-Riche, Stephen Kent, Sidhu Sachdev, Sachdev Sidhu, Maruti Uppalapati",Provisional,4/12/2018,2027-001,10/12/2011,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",612755,,583201,Yes
2466,11-T-058,METHODS AND COMPOSITIONS FOR IDENTIFYING D-PEPTIDIC COMPOUNDS THAT SPECIFICALLY BIND TARGET PROTEINS,"13/294,078","9,285,372",*United States,US,10/11/2011,3/15/2016,US 2012-0178643 A1,11/10/2011,2027-002,Small,10/12/2010,,No,4/28/2022,Issued,"Bozicevic, Field & Francis",, ,"Dana Ault-Riche, Stephen Kent, Sachdev Sidhu, Maruti Uppalapati",US Utility,4/12/2018,2027-002,10/11/2031,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",612756,7/12/2012,583201,No
2467,11-T-058,Methods and Compositions for Identifying D-Peptidic Compounds that Specifically Bind Target Proteins,"15/012,603", ,*United States,US,10/11/2011,,US 2016-0223560 A1,8/4/2016,2027-003,Small,10/12/2010,,No,4/28/2022,Pending,"Bozicevic, Field & Francis",, ,"Dana Ault-Riche, Stephen Kent, Sachdev Sidhu, Maruti Uppalapati",US Utility,4/12/2018,2027-003,10/12/2030,"Peace, Shane",Stephen Kent,"Juggernauth, Anne",612757,8/14/2016,583201,No
2468,11-T-060,"Methods and Compositions Involving Protective Staphylococcal Antigens, Such as EBH Polypeptides","61/483,396", ,*United States,US,5/6/2011,, ,5/6/2011,2025-001,Large,5/6/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2025-001,5/6/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612978,,583203,Yes
2469,11-T-060,"Methods and Compositions Involving Protective Staphylococcal Antigens, Such as EBH Polypeptides","13/465,541","8,945,588",*United States,US,5/7/2012,2/3/2015,US-2012-0282247-A1,5/7/2012,2025-002,Large,5/6/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Hwan Kim, Dominique Missiakas, Olaf Schneewind",US Utility,4/12/2018,2025-002,10/30/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612979,11/8/2012,583203,Yes
2470,11-T-061,Materials and Methods for the Preparation of Nanocomposites,"61/486,595", ,*United States,US,5/16/2011,, ,5/16/2011,2032-001,Small,5/16/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Goodman, Jonathan",45861,"Angshuman Nag, Dmitri Talapin",Provisional,4/12/2018,2032-001,5/16/2012,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612222,,583204,Yes
2471,11-T-061,Materials and Methods for the Preparation of Nanocomposites,PCT/US12/38218, ,*United States,US,5/16/2012,,WO2012/158847,5/16/2012,2032-002,Small,5/16/2011,,No,5/9/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Goodman, Jonathan",45861A-PC,"Angshuman Nag, Dmitri Talapin",PCT,4/12/2018,2032-002,11/16/2013,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612223,11/22/2012,583204,Yes
2472,11-T-061,Materials and Methods for the Preparation of Nanocomposites,"14/117,070","9,882,001",*United States,US,5/16/2012,1/30/2018,US-2014-0346442-A1,7/25/2014,2032-003,Small,5/16/2011,,No,5/9/2022,Issued,"Marshall, Gerstein & Borun",,45861A,"Angshuman Nag, Dmitri Talapin",Nationalized PCT,4/12/2018,2032-003,8/18/2032,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612224,11/27/2014,583204,Yes
2473,11-T-061,Materials and Methods for the Preparation of Nanocomposites,"15/882,823","10,600,865",*United States,US,5/16/2012,3/24/2020,US-2018-0301530-A1,1/29/2018,2032-004,Small,5/16/2011,10/4/2019,No,4/28/2022,Issued,"Marshall, Gerstein & Borun",,27373-45861B,"Angshuman Nag, Dmitri Talapin",Continuation,4/12/2018,2032-004,5/16/2032,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",612225,10/18/2018,583204,Yes
2474,11-T-064,Treatments for Migraine and Related Disorders,"61/510,673", ,*United States,US,7/22/2011,, ,7/22/2011,2029-001,Small,7/22/2011,6/16/2021,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512USP1,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Provisional,4/12/2018,2029-001,7/22/2012,"Sun, Han",Richard Kraig,"Tennant, Thelma",615108,,583207,Yes
2475,11-T-064,Treatments for Migraine and Related Disorders,PCT/US12/47683, ,*United States,US,7/20/2012,,WO2013/016223,7/20/2012,2029-002,Small,7/22/2011,,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512WO,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",PCT,4/12/2018,2029-002,1/22/2014,"Sun, Han",Richard Kraig,"Tennant, Thelma",615109,1/31/2013,583207,Yes
2476,11-T-064,Treatments for Migraine and Related Disorders,"14/234,276","9,399,053",*United States,US,7/20/2012,7/26/2016,US-2014-0294761-A1,5/27/2014,2029-003,Small,7/22/2011,7/20/2012,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512US,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Nationalized PCT,4/12/2018,2029-003,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",615110,10/2/2014,583207,Yes
2477,11-T-064,Treatments for Migraine and Related Disorders,2012287120,AU 2012287120,Australia,AU,7/20/2012,6/8/2017, ,2/11/2014,2029-004,Small,7/22/2011,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512AU,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Nationalized PCT,4/12/2018,2029-004,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",615111,,583207,Yes
2478,11-T-064,Treatments for Migraine and Related Disorders,12817792.0EPO,2734634,European Patent Office (EPO),EP,7/20/2012,8/21/2019,2734634,2/21/2014,2029-005,Small,7/22/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512EP,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Nationalized PCT,4/12/2018,2029-005,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",615112,5/28/2014,583207,Yes
2479,11-T-064,TREATMENTS FOR MIGRAINE AND RELATED DISORDERS,"15/171,327","9,827,294",*United States,US,7/20/2012,11/28/2017,US-2016-0263194-A1,6/4/2016,2029-006,Small,7/22/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000193717,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Continuation,4/12/2018,2029-006,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",615113,9/17/2016,583207,No
2480,11-T-064,Treatments for Migraine and Related Disorders,2017203461,AU 2017203461,Australia,AU,7/20/2012,12/20/2018, ,5/24/2017,2029-007,Small,7/22/2011,1/10/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512AU.D1,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Divisional,4/12/2018,2029-007,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",615114,,583207,No
2481,11-T-064,Treatments for Migraine and Related Disorders,"15/791,802","10,391,150",*United States,US,7/20/2012,8/27/2019,US-2018-0036380-A1,10/24/2017,2029-008,Small,7/22/2011,2/6/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512US.C2,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Continuation,4/12/2018,2029-008,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",615115,2/8/2018,583207,No
2482,11-T-064,Treatments for Migraine and Related Disorders,2018271278,AU 2018271278,Australia,AU,7/20/2012,9/10/2020, ,11/27/2018,2029-009,Small,7/22/2011,11/28/2018,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512AU.D2,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Divisional,11/28/2018, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",1921721,,583207,No
2483,11-T-064,Treatments for Migraine and Related Disorders,"16/551,032", ,*United States,US,7/20/2012,,US-2019-0374612-A1,8/26/2019,2029-010,Small,7/22/2011,7/13/2021,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512US.C3,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Continuation,8/28/2019, ,7/22/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",3957321,12/12/2019,583207,No
2484,11-T-064,Treatments for Migraine and Related Disorders,19192519.7EPO, ,European Patent Office (EPO),EP,7/20/2012,,3628325,8/20/2019,2029-011,Small,7/22/2011,9/10/2019,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512EP.D1,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Divisional,9/10/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",3987847,4/1/2020,583207,Yes
2485,11-T-064,Treatments for Migraine and Related Disorders,12817792.0AT,2734634,Austria,AT,7/20/2012,8/21/2019, ,11/19/2019,2029-012,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512AT,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4077820,,583207,Yes
2486,11-T-064,Treatments for Migraine and Related Disorders,12817792.0BE,2734634,Belgium,BE,7/20/2012,8/21/2019, ,9/27/2019,2029-013,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512BE,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4077854,,583207,Yes
2487,11-T-064,Treatments for Migraine and Related Disorders,12817792.0DK,2734634,Denmark,DK,7/20/2012,8/21/2019, ,10/10/2019,2029-014,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512DK,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4077888,,583207,Yes
2488,11-T-064,Treatments for Migraine and Related Disorders,12817792.0FI,2734634,Finland,FI,7/20/2012,8/21/2019, ,10/15/2019,2029-015,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512FI,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4077923,,583207,Yes
2489,11-T-064,Treatments for Migraine and Related Disorders,12817792.0FR,2734634,France,FR,7/20/2012,8/21/2019, ,10/22/2019,2029-016,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512FR,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4077957,,583207,Yes
2490,11-T-064,Treatments for Migraine and Related Disorders,12817792.0DE,602012063213.5,Germany,DE,7/20/2012,8/21/2019, ,9/25/2019,2029-017,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512DE,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4077991,,583207,Yes
2491,11-T-064,Treatments for Migraine and Related Disorders,12817792.0IE,2734634,Ireland,IE,7/20/2012,8/21/2019, ,11/28/2019,2029-018,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512IE,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078025,,583207,Yes
2492,11-T-064,Treatments for Migraine and Related Disorders,12817792.0IT,502019000087662,Italy,IT,7/20/2012,8/21/2019,2734634,10/18/2019,2029-019,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512IT,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078059,,583207,Yes
2493,11-T-064,Treatments for Migraine and Related Disorders,12817792.0NL,2734634,Netherlands,NL,7/20/2012,8/21/2019, ,10/16/2019,2029-025,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512NL,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078093,,583207,Yes
2494,11-T-064,Treatments for Migraine and Related Disorders,12817792.0NO,2734634,Norway,NO,7/20/2012,8/21/2019, ,9/26/2019,2029-020,None,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512NO,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078127,,583207,Yes
2495,11-T-064,Treatments for Migraine and Related Disorders,12817792.0PO,2734634,Poland,PL,7/20/2012,8/21/2019, ,10/17/2019,2029-021,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512PO,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078161,,583207,Yes
2496,11-T-064,Treatments for Migraine and Related Disorders,12817792.0ES,2734634,Spain,ES,7/20/2012,8/21/2019, ,10/16/2019,2029-022,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512ES,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078195,,583207,Yes
2497,11-T-064,Treatments for Migraine and Related Disorders,12817792.0SE,2734634,Sweden,SE,7/20/2012,8/21/2019, ,10/18/2019,2029-023,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512SE,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078229,,583207,Yes
2498,11-T-064,Treatments for Migraine and Related Disorders,12817792.0CH,2734634,Switzerland,CH,7/20/2012,8/21/2019, ,9/25/2019,2029-024,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512CH,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078263,,583207,Yes
2499,11-T-064,Treatments for Migraine and Related Disorders,12817792.0TR,2734634,Turkey,TR,7/20/2012,8/21/2019, ,10/16/2019,2029-026,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512TR,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078297,,583207,Yes
2500,11-T-064,Treatments for Migraine and Related Disorders,12817792.0GB,2734634,United Kingdom,GB,7/20/2012,8/21/2019, ,11/4/2019,2029-027,Small,7/22/2011,10/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512GB,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,10/29/2019, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4078331,,583207,Yes
2501,11-T-064,Treatments for Migraine and Related Disorders,2020223768, ,Australia,AU,7/20/2012,, ,8/28/2020,2029-028,Small,7/22/2011,9/4/2020,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512AU.D3,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Divisional,9/4/2020, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4870682,,583207,No
2502,11-T-064,Treatments for Migraine and Related Disorders,42020016277.4, ,Hong Kong,HK,7/20/2012,,40026411A,9/15/2020,2029-029,Small,7/22/2011,9/22/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512EHK.D1,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Validated EPO,9/22/2020, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",4910726,1/8/2021,583207,Yes
2503,11-T-064,Treatments for Migraine and Related Disorders,"17/249,123", ,*United States,US,7/20/2012,,US-2021-0205414-A1,2/22/2021,2029-030,Small,7/22/2011,2/22/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0512US.C4,"Yelena Grinberg, Marcia Kraig, Richard Kraig, Heidi Mitchell, Aya Pusic",Continuation,2/22/2021, ,7/20/2032,"Sun, Han",Richard Kraig,"Tennant, Thelma",5405196,7/8/2021,583207,No
2504,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,"61/275,839", ,*United States,US,9/2/2009,, ,9/2/2009,2035-001,None,9/2/2009,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Harburger, David", ,"Brian Popko, Maria Traka",Provisional,4/12/2018,2035-001,9/2/2010,"Peace, Shane",Brian Popko,"Tennant, Thelma",613133,,583209,Yes
2505,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,PCT/US10/47761, ,*United States,US,9/2/2010,,WO 2011/028969,9/2/2010,2035-002,None,9/2/2009,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Brian Popko, Maria Traka",PCT,4/12/2018,2035-002,3/2/2012,"Peace, Shane",Brian Popko,"Tennant, Thelma",613134,3/10/2011,583209,Yes
2506,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,10814538.4EPO, ,European Patent Office (EPO),EP,9/2/2010,,2473031,9/2/2010,2035-003,None,9/2/2009,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,,1000203118,"Brian Popko, Maria Traka",Nationalized PCT,4/12/2018,2035-003,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613135,7/11/2012,583209,Yes
2507,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,2010289419, ,Australia,AU,9/2/2010,, ,9/2/2010,2035-004,None,9/2/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Brian Popko, Maria Traka",Nationalized PCT,4/12/2018,2035-004,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613136,,583209,Yes
2508,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,"2,773,109", ,Canada,CA,9/2/2010,, ,9/2/2010,2035-005,None,9/2/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Brian Popko, Maria Traka",Nationalized PCT,4/12/2018,2035-005,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613137,,583209,Yes
2509,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,218424, ,Israel,IL,9/2/2010,, ,3/1/2012,2035-006,None,9/2/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Brian Popko, Maria Traka",Nationalized PCT,4/12/2018,2035-006,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613138,,583209,Yes
2510,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,2012-528073, ,Japan,JP,9/2/2010,, ,9/2/2010,2035-007,None,9/2/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Brian Popko, Maria Traka",Nationalized PCT,4/12/2018,2035-007,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613139,,583209,Yes
2511,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,"13/393,782", ,*United States,US,9/2/2010,, ,5/18/2012,2035-008,None,9/2/2009,,No,5/8/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Brian Popko, Maria Traka",Nationalized PCT,4/12/2018,2035-008,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613140,,583209,Yes
2512,11-T-066,Methods and Systems for Inducible Ablation of Neural Cells,12113479.9, ,Hong Kong,HK,9/2/2010,, ,9/2/2010,2035-009,None,9/2/2009,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Brian Popko, Maria Traka",Validated EPO,4/12/2018,2035-009,9/2/2030,"Peace, Shane",Brian Popko,"Tennant, Thelma",613141,,583209,Yes
2513,11-T-068,"OLIGONUCLEOTIDE-MEDIATED QUANTITATIVE MULTIPLEXED
IMMUNOASSAYS","15/606,045","10,550,421",*United States,US,6/14/2013,2/4/2020,US-2017-0268036-A1,5/27/2017,2037-004,Small,6/15/2012,1/21/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0532US.C1,"Ryan Duggan, Amy Flor, Stephen Kron",Continuation,4/12/2018,2037-004,9/5/2033,"Sun, Han",Amy Flor,"Tennant, Thelma",613782,9/21/2017,583211,No
2514,11-T-068,Oligonucleotide-Mediated Quantitative Multiplexed Immunoassays,"61/660,261", ,*United States,US,6/15/2012,, ,6/15/2012,2037-001,Small,6/15/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Ryan Duggan, Amy Flor, Stephen Kron",Provisional,4/12/2018,2037-001,6/15/2013,"Sun, Han",Amy Flor,"Tennant, Thelma",613783,,583211,Yes
2515,11-T-068,Oligonucleotide-Mediated Quantitative Multiplexed Immunoassays,PCT/US13/45872, ,*United States,US,6/14/2013,,WO 2013/188756,6/14/2013,2037-002,Small,6/15/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Ryan Duggan, Amy Flor, Stephen Kron",PCT,4/12/2018,2037-002,12/15/2014,"Sun, Han",Amy Flor,"Tennant, Thelma",613784,12/19/2013,583211,Yes
2516,11-T-068,Oligonucleotide-Mediated Quantitative Multiplexed Immunoassays,"14/408,065","9,663,818",*United States,US,6/14/2013,5/30/2017,US-20150344937-A1,12/15/2014,2037-003,Small,6/15/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Ryan Duggan, Amy Flor, Stephen Kron",Nationalized PCT,4/12/2018,2037-003,6/15/2032,"Sun, Han",Amy Flor,"Tennant, Thelma",613785,12/3/2015,583211,Yes
2517,11-T-069,Gripping and Holding Apparatus and Method,"61/324,567", ,*United States,US,4/15/2010,, ,4/15/2010,2041-001,Small,4/15/2010,,Yes,4/28/2022,Expired - Inactive,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Provisional,4/12/2018,2041-001,4/15/2011,"Hwang, Luke",John Amend,"Juggernauth, Anne",611707,,583212,Yes
2518,11-T-069,Gripping and Holding Apparatus and Method,"61/436,688", ,*United States,US,1/27/2011,, ,1/27/2011,2041-002,Small,1/27/2011,,Yes,4/28/2022,Expired - Inactive,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Provisional,4/12/2018,2041-002,1/27/2012,"Hwang, Luke",John Amend,"Juggernauth, Anne",611708,,583212,Yes
2519,11-T-069,Gripping and Releasing Apparatus and Method,PCT/US11/32429, ,*United States,US,4/14/2011,,WO 2011/130475 A2,4/14/2011,2041-003,Small,4/15/2010,,Yes,4/28/2022,Expired - Inactive,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",PCT,4/12/2018,2041-003,10/15/2012,"Hwang, Luke",John Amend,"Juggernauth, Anne",611709,10/20/2011,583212,Yes
2520,11-T-069,Gripping and Releasing Apparatus and Method,10-2012-70283362012, ,"Korea, Republic of",KR,4/14/2011,,WO 2011/130475 A2,10/29/2012,2041-004,Small,4/15/2010,,No,4/28/2022,Pending,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Nationalized PCT,4/12/2018,2041-004,4/14/2031,"Hwang, Luke",John Amend,"Juggernauth, Anne",611710,10/20/2011,583212,Yes
2521,11-T-069,Gripping and Releasing Apparatus and Method,201180029673.4,ZL201180029673.4,China,CN,4/14/2011,8/26/2015,CN102939189A,12/17/2012,2041-005,Small,4/15/2010,,No,4/28/2022,Issued,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Nationalized PCT,4/12/2018,2041-005,4/14/2031,"Hwang, Luke",John Amend,"Juggernauth, Anne",611711,2/20/2013,583212,Yes
2522,11-T-069,Gripping and Releasing Apparatus and Method,112011101331.0, ,Germany,DE,4/14/2011,, ,10/15/2012,2041-006,Small,4/15/2010,,No,4/28/2022,Pending,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Validated EPO,4/12/2018,2041-006,4/14/2031,"Hwang, Luke",John Amend,"Juggernauth, Anne",611712,,583212,Yes
2523,11-T-069,Gripping and Releasing Apparatus and Method,"13/641,230","8,882,165",*United States,US,4/14/2011,11/11/2014, ,10/15/2012,2041-007,Small,4/15/2010,11/11/2014,No,4/28/2022,Issued,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Nationalized PCT,4/12/2018,2041-007,4/14/2031,"Hwang, Luke",John Amend,"Juggernauth, Anne",611713,,583212,Yes
2524,11-T-069,Gripping and Releasing Apparatus and Method,2013-505127, ,Japan,JP,4/14/2011,, ,10/15/2012,2041-008,Small,4/15/2010,,No,4/28/2022,Pending,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Nationalized PCT,4/12/2018,2041-008,4/14/2031,"Hwang, Luke",John Amend,"Juggernauth, Anne",611714,,583212,Yes
2525,11-T-069,Gripping and Releasing Apparatus and Method,"14/518,184","9,120,230",*United States,US,4/14/2011,9/1/2015, ,10/20/2014,2041-009,Small,4/15/2010,9/1/2015,No,4/28/2022,Issued,"Bond, Schoeneck & King, PLLC",, ,"John Amend, Eric Brown, Heinrich Jaeger, Hod Lipson",Divisional,4/12/2018,2041-009,4/14/2031,"Hwang, Luke",John Amend,"Juggernauth, Anne",611715,,583212,Yes
2526,11-T-070,"System for Storing, Retrieving and Displaying Medical Data from Disparate Sources","61/490,437", ,*United States,US,5/26/2011,, ,5/26/2011,2038-001,Small,5/26/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Rueth, Randall",44852,Paul Chang,Provisional,4/12/2018,2038-001,5/26/2012,"Ginsburg, Eric",Paul Chang,"Smith, Dane",614813,,583213,Yes
2527,11-T-070,"System for Storing, Retrieving and Displaying Medical Data from Disparate Sources","13/482,592", ,*United States,US,5/29/2012,, ,5/29/2012,2038-002,Small,5/26/2011,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,44852A,"Paul Chang, David Paushter",US Utility,4/12/2018,2038-002,5/29/2032,"Ginsburg, Eric",Paul Chang,"Smith, Dane",614814,,583213,Yes
2528,11-T-071,5ESSENTIALS,86650839,4926217,*United States,US,6/4/2015,3/30/2016,,,2003-001,Small,6/4/2015,,Yes,3/30/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9162-001,Nicholas Montgomery,Trademark,4/12/2018,2003-001,3/30/2026,"Sun, Han",Nicholas Montgomery,"Tennant, Thelma",610191,1/14/2016,583214,No
2529,11-T-072,Selenophene Polymers,"61/517,205", ,*United States,US,4/15/2011,, ,4/15/2011,2039-001,None,4/15/2011,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00319,Luping Yu,Provisional,4/12/2018,2039-001,4/15/2012,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614444,,583215,Yes
2530,11-T-072,SEMICONDUCTING POLYMERS,PCT/US12/33601, ,*United States,US,4/13/2012,,WO 2012/142469,4/13/2012,2039-002,None,4/15/2011,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00343,"Hae Son, Luping Yu",PCT,4/12/2018,2039-002,10/15/2013,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614461,,583215,Yes
2531,11-T-072,SEMICONDUCTING POLYMERS,"14/111,473","9,153,785",*United States,US,4/13/2012,10/6/2015,US-2014-0145119-A1,10/11/2013,2039-003,Small,4/15/2011,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00362,"Hae Son, Luping Yu",Nationalized PCT,4/12/2018,2039-003,4/15/2031,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614462,5/29/2014,583215,Yes
2532,11-T-072,SEMICONDUCTING POLYMERS,201280028860.5, ,China,CN,4/13/2012,,CN 103619902 A.,12/12/2013,2039-004,Small,4/15/2011,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00357,"Hae Son, Luping Yu",Nationalized PCT,4/12/2018,2039-004,4/13/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614463,3/5/2014,583215,Yes
2533,11-T-072,SEMICONDUCTING POLYMERS,8423/CHENP/2013, ,India,IN,4/13/2012,, ,10/18/2013,2039-005,Small,4/15/2011,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00359,"Hae Son, Luping Yu",Nationalized PCT,4/12/2018,2039-005,4/13/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614464,,583215,Yes
2534,11-T-072,SEMICONDUCTING POLYMERS,10-2013-7030162,10-1545429,"Korea, Republic of",KR,4/13/2012,8/11/2015, ,11/13/2013,2039-006,Small,4/15/2011,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00361,"Hae Son, Luping Yu",Nationalized PCT,4/12/2018,2039-006,4/13/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614465,,583215,Yes
2535,11-T-072,SEMICONDUCTING POLYMERS,2014-505356, ,Japan,JP,4/13/2012,,P2014-518562A,12/10/2013,2039-007,Small,4/15/2011,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00360,"Hae Son, Luping Yu",Nationalized PCT,4/12/2018,2039-007,4/13/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614466,7/31/2014,583215,Yes
2536,11-T-072,SEMICONDUCTING POLYMERS,12771160.4EPO, ,European Patent Office (EPO),EP,4/13/2012,, ,12/10/2013,2039-008,Small,4/15/2011,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00358,"Hae Son, Luping Yu",Nationalized PCT,4/12/2018,2039-008,4/13/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614467,,583215,Yes
2537,11-T-076,Nanoparticle-Based Deslination and Filtration System,"61/559,555", ,*United States,US,11/14/2011,, ,11/14/2011,2045-001,Small,11/14/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Liddell, (William) Andrew", ,"Jinbo He, Heinrich Jaeger, Xiao-Min Lin",Provisional,4/12/2018,2045-001,11/14/2012,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",613626,,583219,Yes
2538,11-T-076,Nanoparticle-Based Deslination and Filtration System,PCT/US12/65074, ,*United States,US,11/14/2012,,WO 2013/074669,11/14/2012,2045-002,Small,11/14/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Liddell, (William) Andrew", ,"Jinbo He, Heinrich Jaeger, Xiao-Min Lin",PCT,4/12/2018,2045-002,5/14/2014,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",613627,5/23/2013,583219,Yes
2539,11-T-076,Nanoparticle-Based Deslination and Filtration System,"14/351,709", ,*United States,US,11/14/2012,,US-2014-0246384-A1,4/14/2014,2045-003,Small,11/14/2011,,No,5/1/2022,Abandoned,Norton Rose Fulbright US LLP,"Liddell, (William) Andrew",1000354482,"Jinbo He, Heinrich Jaeger, Xiao-Min Lin",Nationalized PCT,4/12/2018,2045-003,11/14/2032,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",613628,9/4/2014,583219,Yes
2540,11-T-077,METHODS OF DESIGNING AGGREGATES OPTIMIZED FOR SPECIFIED PROPERTIES,"61/524,246", ,*United States,US,8/16/2011,, ,8/16/2011,2046-001,None,8/16/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Heinrich Jaeger, Marc Miskin",Provisional,4/12/2018,2046-001,8/16/2012,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",613313,,583220,Yes
2541,11-T-077,Methods of Designing Aggregates Optimized for Specified Properties,PCT/US12/51194, ,*United States,US,8/16/2012,,WO 2013/025929,8/16/2012,2046-002,Small,8/16/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Heinrich Jaeger, Marc Miskin",PCT,4/12/2018,2046-002,2/16/2014,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",613314,2/21/2013,583220,Yes
2542,11-T-077,Methods of Designing Aggregates Optimized for Specified Properties,"14/239,090", ,*United States,US,8/16/2012,,US-2014-0290531-A1,2/14/2014,2046-003,Small,8/16/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Heinrich Jaeger, Marc Miskin",Nationalized PCT,4/12/2018,2046-003,8/16/2031,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",613315,10/2/2014,583220,Yes
2543,11-T-080,Biomarkers for Assessing Idiopathic Pulmonary Fibrosis,PCT/US12/65540, ,*United States,US,11/16/2012,,WO 2013/074938,11/16/2012,2049-002,Small,11/18/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0594WO,"Joe Garcia, Kevin Gibson, Jose Herazo-Maya, Yong Huang, Naftali Kaminski, Imre Noth",PCT,4/12/2018,2049-002,5/18/2014,"Sun, Han",Imre Noth,"Muite, Kevin",610734,5/23/2013,583223,Yes
2544,11-T-080,Biomarkers for Assessing Idiopathic Pulmonary Fibrosis,"14/358,945","10,036,069",*United States,US,11/16/2012,7/31/2018, ,5/16/2014,2049-003,Small,11/18/2011,7/31/2018,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0594US,"Joe Garcia, Kevin Gibson, Jose Herazo-Maya, Yong Huang, Naftali Kaminski, Imre Noth",Nationalized PCT,4/12/2018,2049-003,8/31/2033,"Sun, Han",Imre Noth,"Muite, Kevin",610735,,583223,Yes
2545,11-T-080,Biomarkers for Assessing Risk of Progression of Disease in Persons with Idopathic Pulmonary Fibrosis,"61/561,543", ,*United States,US,11/18/2011,, ,11/18/2011,2049-001,Small,11/18/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0594US.P1,"Joe Garcia, Kevin Gibson, Jose Herazo-Maya, Yong Huang, Naftali Kaminski, Imre Noth",Provisional,4/12/2018,2049-001,11/18/2012,"Sun, Han",Imre Noth,"Muite, Kevin",610736,,583223,Yes
2546,11-T-080,Biomarkers for Assessing Idiopathic Pulmonary Fibrosis,"16/031,384","10,961,582",*United States,US,11/16/2012,3/30/2021,US-2018-0320234-A1,7/10/2018,2049-004,Small,11/18/2011,3/16/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.PO594US.D1,"Joe Garcia, Kevin Gibson, Jose Herazo-Maya, Yong Huang, Naftali Kaminski, Imre Noth",Divisional,7/11/2018, ,11/16/2032,"Sun, Han",Imre Noth,"Muite, Kevin",1588607,11/8/2018,583223,Yes
2547,11-T-080,Biomarkers for Assessing Idiopathic Pulmonary Fibrosis,"17/301,187", ,*United States,US,11/16/2012,, ,3/29/2021,2049-005,None,11/18/2011,3/29/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0594US.D1C1,"Joe Garcia, Kevin Gibson, Jose Herazo-Maya, Yong Huang, Naftali Kaminski, Imre Noth",Continuation,3/29/2021, ,11/16/2032,"Sun, Han",Imre Noth,"Muite, Kevin",5521252,,583223,Yes
2548,11-T-082,DEVELOPMENT OF A NEW PARADIGM FOR ANTIMICROBIAL DELIVERY IN APICOMPLEXAN TOXOPLASMA GONDII,"61/501,464", ,*United States,US,6/27/2011,, ,6/27/2011,2048-001,Small,6/27/2011,,Yes,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,Rima McLeod,Provisional,4/12/2018,2048-001,6/27/2012,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",611498,,583225,Yes
2549,11-T-086,Mid-Infrared Photodetectors,"61/488,563", ,*United States,US,5/20/2011,, ,5/20/2011,2033-001,Small,5/20/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Goodman, Jonathan",46249,"Philippe Guyot-Sionnest, Sean Keuleyan, Emmanuel Lhuillier",Provisional,4/12/2018,2033-001,5/20/2012,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",613418,,583229,Yes
2550,11-T-086,Mid-Infrared Photodetectors,PCT/US12/38852, ,*United States,US,5/21/2012,,WO 2012/162246,5/21/2012,2033-002,Small,5/20/2011,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Goodman, Jonathan",46249A-PC,"Philippe Guyot-Sionnest, Sean Keuleyan, Emmanuel Lhuillier",PCT,4/12/2018,2033-002,11/21/2013,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",613419,11/29/2012,583229,Yes
2551,11-T-086,Mid-Infrared Photodetectors,"14/117,064","9,318,628",*United States,US,5/21/2012,4/19/2016,US-2014-0299772-A,11/25/2013,2033-003,Small,5/20/2011,,No,5/8/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0009-03-US,"Philippe Guyot-Sionnest, Sean Keuleyan, Emmanuel Lhuillier",Nationalized PCT,4/12/2018,2033-003,5/21/2032,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",613420,10/9/2014,583229,Yes
2552,11-T-086,Mid-Infrared Photodetectors,"15/062,418","10,290,753",*United States,US,5/21/2012,5/14/2019,US-2016-0258809 A1,3/7/2016,2033-004,Small,5/20/2011,2/6/2019,No,5/8/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0009-04,"Philippe Guyot-Sionnest, Sean Keuleyan, Emmanuel Lhuillier",Continuation,4/12/2018,2033-004,5/20/2032,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",613421,9/9/2016,583229,No
2553,11-T-087,COMPOSITION AND METHODS RELATED TO IDENTIFICATION OF 5-HYDROXYLMETHYLCYTOSINE (5-hmC),"61/512,334", ,*United States,US,7/27/2011,, ,7/27/2011,2051-001,None,7/27/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, Chunxiao Song, Liang Zhang",Provisional,4/12/2018,2051-001,7/27/2012,"Hwang, Luke",Chuan He,"Tennant, Thelma",610961,,583230,Yes
2554,11-T-091,Immunogenic Protein Conjugates And Method For Making And Using The Same,"61/515,733", ,*United States,US,8/5/2011,, ,8/5/2011,2055-001,Small,8/5/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Gabriella Garufi, Hannah Maier, Dominique Missiakas, So-Young Oh, Olaf Schneewind, Yating Wang",Provisional,4/12/2018,2055-001,8/5/2012,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611931,,583234,Yes
2555,11-T-091,Immunogenic Protein Conjugates And Method For Making And Using The Same,PCT/US12/49673, ,*United States,US,8/5/2012,,WO 2013/022808,8/5/2012,2055-002,Small,8/5/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Gabriella Garufi, Hannah Maier, Dominique Missiakas, So-Young Oh, Olaf Schneewind, Yating Wang",PCT,4/12/2018,2055-002,8/5/2032,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611932,2/14/2013,583234,Yes
2556,11-T-091,Immunogenic Protein Conjugates And Method For Making And Using The Same,"14/237,320", ,*United States,US,8/5/2012,,US-2014-0302084-A1,2/5/2014,2055-003,Small,8/5/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Gabriella Garufi, Hannah Maier, Dominique Missiakas, So-Young Oh, Olaf Schneewind, Yating Wang",Nationalized PCT,4/12/2018,2055-003,8/5/2032,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611933,10/9/2014,583234,Yes
2557,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,"61/523,751", ,*United States,US,8/15/2011,, ,8/15/2011,2056-001,Small,8/15/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2056-001,8/15/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611050,,583235,Yes
2558,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,"61/615,083", ,*United States,US,3/23/2012,, ,3/23/2012,2056-002,Small,3/23/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2056-002,3/23/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611051,,583235,Yes
2559,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,"61/618,417", ,*United States,US,3/30/2012,, ,3/30/2012,2056-003,Small,3/30/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2056-003,8/15/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611052,,583235,Yes
2560,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,"61/674,135", ,*United States,US,7/20/2012,, ,7/20/2012,2056-004,Small,7/20/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2056-004,8/15/2012,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611053,,583235,Yes
2561,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,PCT/US12/50991, ,*United States,US,8/15/2012,,WO 2013/025834,8/15/2012,2056-005,Small,8/15/2011,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2056-005,2/15/2014,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611054,2/21/2013,583235,Yes
2562,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,2014-526184,6317670,Japan,JP,8/15/2012,4/6/2018, ,2/14/2014,2056-006,Small,8/15/2011,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000354136,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-006,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611055,,583235,Yes
2563,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,201280040136.4,CN 10390635B,China,CN,8/15/2012,7/14/2017,103906535,2/17/2014,2056-007,Small,8/15/2011,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-007,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611056,7/2/2014,583235,Yes
2564,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,"14/238,811","9,556,281",*United States,US,8/15/2012,1/31/2017, ,3/12/2014,2056-008,Small,8/15/2011,,No,5/1/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0514US,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-008,10/4/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611057,,583235,Yes
2565,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,"2,845,259", ,Canada,CA,8/15/2012,,WO 2013/025834,2/13/2014,2056-009,Small,8/15/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000230066,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-009,8/15/2031,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611058,2/21/2013,583235,Yes
2566,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,12823843.3EPO,2744517,European Patent Office (EPO),EP,8/15/2012,3/13/2019,2744517,3/5/2014,2056-010,Small,8/15/2011,,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",1000358535,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-010,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611059,6/25/2014,583235,Yes
2567,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,2012296576,AU 2012296576,Australia,AU,8/15/2012,12/21/2017, ,3/12/2014,2056-011,Small,8/15/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0514AU,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-011,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611060,,583235,Yes
2568,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,BR112014003315-3, ,Brazil,BR,8/15/2012,, ,2/12/2014,2056-012,Small,8/15/2011,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000195774,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-012,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611061,,583235,Yes
2569,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,14111361.2,1197654,Hong Kong,HK,8/15/2012,3/29/2018, ,10/11/2014,2056-013,Small,8/15/2011,5/12/2021,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000207476,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2056-013,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611062,,583235,Yes
2570,11-T-092,Methods and Compositions for Inhibiting Staphylococcus Agglutination in Blood,"15/377,050","10,047,149",*United States,US,8/15/2012,8/14/2018,US-2017-0218055-A1,12/13/2016,2056-014,Small,8/15/2011,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2018,2056-014,9/9/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612791,8/3/2017,583235,No
2571,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,12823843.3,2744517,France,FR,8/15/2012,, ,8/15/2012,2056-015,Small,8/15/2011,10/28/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,1/25/2019, ,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",3473855,,583235,Yes
2572,11-T-092,Compositions and Methods Related to Antibodies to Staphylococcal Protein A,12823843.3,602012057849.1,Germany,DE,8/15/2012,, ,8/15/2012,2056-016,Small,8/15/2011,10/28/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Andrea DeDent, Carla Emolo, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Validated EPO,1/25/2019, ,8/15/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",3473885,,583235,Yes
2573,11-T-097,Methods and Compositions for Prevention and Control of Virus Infection,"61/532,428", ,*United States,US,9/8/2011,, ,9/8/2011,2060-001,None,9/8/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alexander Chervonsky, Tatyana Golovkina",Provisional,4/12/2018,2060-001,9/8/2012,"Dembo, Anna",Tatyana Golovkina,"Tennant, Thelma",612839,,583240,Yes
2574,11-T-097,Methods and Compositions for Prevention and Control of Virus Infection,"61/532,435", ,*United States,US,9/8/2011,, ,9/8/2011,2060-002,None,9/8/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alexander Chervonsky, Tatyana Golovkina",Provisional,4/12/2018,2060-002,9/8/2012,"Dembo, Anna",Tatyana Golovkina,"Tennant, Thelma",612840,,583240,Yes
2575,11-T-099,Fluidic Devices for Biospecimen Preservation,"61/636,426",,*United States,US,4/20/2012,,,4/20/2012,2063-001,Small,4/20/2012,,Yes,6/2/2022,Expired - Inactive,Clark & Elbing LLP,"McDonald, J. Cooper",,"Stefano Begolo, Rustem Ismagilov, Qichao Pan",Provisional,4/12/2018,2063-001,4/20/2013,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611603,,583242,Yes
2576,11-T-099,Fluidic Devices for Biospecimen Preservation,"13/868,009","9,808,798",*United States,US,4/22/2013,11/7/2017,,4/22/2013,2063-002,Small,4/20/2012,11/7/2017,No,6/2/2022,Issued,Goodwin Procter LLP,,32592-30794/US(T),"Stefano Begolo, Rustem Ismagilov, Qichao Pan",Nationalized PCT,4/12/2018,2063-002,5/14/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611604,,583242,Yes
2577,11-T-099,Fluidic Devices for Biospecimen Preservation,PCT/US13/37658,,*United States,US,4/22/2013,,,4/22/2013,2063-003,Small,4/20/2012,,No,6/2/2022,Abandoned,Clark & Elbing LLP,"McDonald, J. Cooper",,"Stefano Begolo, Rustem Ismagilov, Qichao Pan",PCT,4/12/2018,2063-003,10/20/2014,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611605,,583242,Yes
2578,11-T-100,Parallelized Sample Handling,"61/814,090", ,*United States,US,4/19/2013,, ,4/19/2013,2064-001,Small,4/19/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Provisional,4/12/2018,2064-001,4/19/2014,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613888,,583243,Yes
2579,11-T-100,Parallelized Sample Handling,"61/903,156", ,*United States,US,11/12/2013,, ,11/12/2013,2064-002,Small,11/12/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Provisional,4/12/2018,2064-002,11/12/2014,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613889,,583243,Yes
2580,11-T-100,Parallelized Sample Handling,PCT/US14/34728, ,*United States,US,4/18/2014,, ,4/18/2014,2064-003,Small,4/19/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",PCT,4/12/2018,2064-003,10/19/2015,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613890,,583243,Yes
2581,11-T-100,Parallelized Sample Handling,"14/785,480", ,*United States,US,4/18/2014,,US-2016-0114322-A1,10/19/2015,2064-004,Small,4/19/2013,1/9/2020,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,,SLIP-21.US1,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-004,,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613891,4/28/2016,583243,No
2582,11-T-100,Parallelized Sample Handling,11201508618R, ,Singapore,SG,4/18/2014,, ,4/18/2015,2064-013,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/SG,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-013,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613892,,583243,No
2583,11-T-100,Parallelized Sample Handling,2014253749, ,Australia,AU,4/18/2014,, ,11/9/2015,2064-005,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/AU,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-005,,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614591,,583243,No
2584,11-T-100,Parallelized Sample Handling,112015026407-7, ,Brazil,BR,4/18/2014,,BR112015026407-7,10/16/2015,2064-006,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,TCC-021BR,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-006,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614592,9/5/2017,583243,No
2585,11-T-100,Parallelized Sample Handling,"2,918,388", ,Canada,CA,4/18/2014,, ,10/15/2015,2064-007,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/CA,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-007,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614593,,583243,No
2586,11-T-100,Parallelized Sample Handling,201480034616.9,105745172,China,CN,4/18/2014,8/10/2018,CN 105745172 A,8/10/2018,2064-008,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/CN,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-008,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614594,7/6/2016,583243,No
2587,11-T-100,Parallelized Sample Handling,14785518.3EPO, ,European Patent Office (EPO),EP,4/18/2014,,2986554,11/19/2015,2064-009,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,3259230649/EP,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Li, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-009,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614595,,583243,No
2588,11-T-100,Parallelized Sample Handling,7107/CHENP/2015, ,India,IN,4/18/2014,, ,11/18/2015,2064-010,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/IN,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-010,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614596,,583243,No
2589,11-T-100,Parallelized Sample Handling,2016-509140,6533516,Japan,JP,4/18/2014,5/31/2019, ,10/15/2015,2064-011,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/JP,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-011,4/18/2024,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614597,,583243,No
2590,11-T-100,Parallelized Sample Handling,10-2015-7032933, ,"Korea, Republic of",KR,4/18/2014,, ,4/18/2014,2064-012,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/KR,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-012,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614598,,583243,No
2591,11-T-100,Parallelized Sample Handling,2015/08323, ,South Africa,ZA,4/18/2014,, ,11/11/2015,2064-014,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-30649/ZA,"Rustem Ismagilov, Liang Ma",Nationalized PCT,4/12/2018,2064-014,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614599,,583243,No
2592,11-T-100,Parallelized Sample Handling,16114540.8,1226049,Hong Kong,HK,4/18/2014,10/11/2019,1226049B,2/1/2019,2064-015,Small,4/19/2013,,No,4/28/2022,Abandoned,Goodwin Procter LLP,,3259230649/HK,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Nationalized PCT,4/12/2018,2064-015,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",614600,10/11/2019,583243,No
2593,11-T-100,Parallelized Sample Handling,"16/367,036", ,*United States,US,4/18/2014,,US-2019-0336969-A1,3/27/2019,2064-016,Large,4/19/2013,4/29/2019,No,4/28/2022,Abandoned,Goodwin Procter LLP,,32592-43256/US,"Stefano Begolo, Wenbin Du, Toan Huynh, Rustem Ismagilov, Mikhail Karymov, Liang Ma, Qichao Pan, George Sawicki",Continuation,4/29/2019, ,4/18/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",3657632,11/7/2019,583243,No
2594,11-T-102,"Control of Initiation, Rae, and Routing of Spontaneous Capillary-Driven Flow of Liquid Droplets through Microfluidic Channels on SlipChip","61/629,418", ,*United States,US,11/18/2011,, ,11/18/2011,2066-001,Small,11/18/2011,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00335,"Rustem Ismagilov, Mikhail Karymov, Carol Platt, Rebecca Pompano",Provisional,4/12/2018,2066-001,11/18/2012,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611320,,583245,Yes
2595,11-T-105,Analog-to-digital chemical signal conversion using threshold kinetics and microfluidics,"15/000,864","10,585,091",*United States,US,7/17/2014,3/10/2020,US-2016-0266105-A1,1/19/2016,2069-003,Small,9/20/2013,3/10/2020,No,6/8/2022,Issued,Goodwin Procter LLP,,32592-30805/US,"Shencheng Ge, Toan Huynh, Rustem Ismagilov, Jason Kreutz, Weishan Liu, Stephanie McCalla, Justin Rolando, Travis Schlappi",Nationalized PCT,4/12/2018,2069-003,7/17/2034,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610326,9/15/2016,583248,No
2596,11-T-105,Chemical Analog-to-Digital Signal Conversion Based on Robust Theshold Chemistry and its Evaluation in the Context of Microfluidics-Based Quantitative Assays,"61/880,399", ,*United States,US,9/20/2013,, ,9/20/2013,2069-001,Small,9/20/2013,7/1/2020,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,, ,"Toan Huynh, Rustem Ismagilov",Provisional,4/12/2018,2069-001,9/20/2014,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",610856,,583248,Yes
2597,11-T-105,Digital Assay for Quantifying and Concentrating Analytes,PCT/US14/47092, ,*United States,US,7/17/2014,, ,7/17/2014,2069-002,Small,9/20/2013,7/1/2020,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,, ,"Shencheng Ge, Toan Huynh, Rustem Ismagilov, Jason Kreutz, Weishan Liu, Stephanie McCalla, Justin Rolando, Travis Schlappi",PCT,4/12/2018,2069-002,3/20/2016,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",611456,,583248,Yes
2598,11-T-106,NASBA and visual readout on SlipChip,"61/710,454",,*United States,US,10/6/2012,,,10/6/2012,2061-001,Small,10/6/2012,,Yes,6/2/2022,Expired - Inactive,Fenwick & West LLP,,,"Stefano Begolo, Andrew Chiang, Elena Davydova, Rustem Ismagilov, Mikhail Karymov, Jason Kreutz, Bing Sun",Provisional,4/12/2018,2061-001,10/6/2012,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613646,,583249,No
2599,11-T-106,NASBA and visual readout on SlipChip,PCT/US13/63594,,*United States,US,10/14/2013,,,10/14/2013,2061-002,Large,10/6/2012,,No,6/2/2022,Expired - Inactive,Fenwick & West LLP,"Hurt, Nicholas",,"Stefano Begolo, Andrew Chiang, Elena Davydova, Rustem Ismagilov, Mikhail Karymov, Jason Kreutz, Bing Sun",PCT,4/12/2018,2061-002,6/14/2015,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613647,,583249,No
2600,11-T-106,NASBA and visual readout on SlipChip,"14/433,602",,*United States,US,10/14/2013,,,10/14/2013,2061-003,Large,10/6/2012,,Yes,6/2/2022,Abandoned,Fenwick & West LLP,,,"Stefano Begolo, Andrew Chiang, Elena Davydova, Rustem Ismagilov, Mikhail Karymov, Jason Kreutz, Bing Sun",Nationalized PCT,4/12/2018,2061-003,,"Hwang, Luke",Rustem Ismagilov,"Ginsburg, Eric",613648,,583249,No
2601,11-T-108,DNA Hypomethylating Agents to Treat Autonomic Dysfunction in Children and Adults,"61/577,475", ,*United States,US,12/19/2011,, ,12/19/2011,2071-001,None,12/19/2011,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucy Godley, Jayasri Nanduri, Nanduri Prabhakar",Provisional,4/12/2018,2071-001,12/19/2012,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",611485,,583251,Yes
2602,11-T-113,Closed Loop Ice Slurry Refrigeration System,"61/851,921", ,*United States,US,3/14/2013,, ,3/14/2013,2074-001,Small,3/14/2013,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Feng, Yuezhong",00352,"Peter Clark, Sanford Wolgel",Provisional,4/12/2018,2074-001,3/14/2014,"Unassigned, Unassigned",Sanford Wolgel,"Unassigned, Unassigned",610897,,583256,Yes
2603,11-T-116,Protein Scaffolds for Selective Enrichment of Metal Ions,"61/623,154", ,*United States,US,4/12/2012,, ,4/12/2012,2077-001,Small,4/12/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mike Bosscher, Chuan He, Lu Zhou",Provisional,4/12/2018,2077-001,4/12/2013,"Hwang, Luke",Chuan He,"Tennant, Thelma",614219,,583259,Yes
2604,11-T-116,Protein Scaffolds for Selective Enrichment of Metal Ions,PCT/US13/31039, ,*United States,US,3/13/2013,,WO 2013/154731,3/13/2013,2077-002,Small,4/12/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mike Bosscher, Chuan He, Lu Zhou",PCT,4/12/2018,2077-002,10/12/2014,"Hwang, Luke",Chuan He,"Tennant, Thelma",614220,10/17/2013,583259,Yes
2605,11-T-116,Protein Scaffolds for Selective Enrichment of Metal Ions,"14/394,024","9,255,019",*United States,US,3/13/2013,2/9/2016,US-2015-0266755-A1,10/10/2014,2077-003,Small,4/12/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mike Bosscher, Chuan He, Lu Zhou",Nationalized PCT,4/12/2018,2077-003,3/13/2033,"Hwang, Luke",Chuan He,"Tennant, Thelma",614221,9/24/2015,583259,Yes
2606,11-T-117,Compositions and Mehtods Related to Recombinant Antibodies to Histone Posttanslational Modifications,"61/839,972", ,*United States,US,6/27/2013,, ,6/27/2013,2089-001,Small,6/27/2013,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Takamitsu Hattori, Akiko Koide, Shohei Koide, Joseph Taft",Provisional,4/12/2018,2089-001,6/27/2014,"Peace, Shane",Shohei Koide,"Muite, Kevin",610970,,583260,Yes
2607,11-T-117,Compositions and Methods Related to Recombinant Antibodies to Histone Posttranslational Modifications,"61/866,934", ,*United States,US,8/16/2013,, ,8/16/2013,2089-002,Small,8/16/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Takamitsu Hattori, Akiko Koide, Shohei Koide, Joseph Taft",Provisional,4/12/2018,2089-002,8/16/2014,"Peace, Shane",Shohei Koide,"Muite, Kevin",611205,,583260,Yes
2608,11-T-117,Compositions and Methods Related to Recombinant Antibodies to Histone Posttranslational Modifications,PCT/US14/44716, ,*United States,US,6/27/2014,, ,6/27/2014,2089-003,Small,8/16/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Takamitsu Hattori, Akiko Koide, Shohei Koide, Joseph Taft",PCT,4/12/2018,2089-003,12/27/2015,"Peace, Shane",Shohei Koide,"Muite, Kevin",611206,,583260,Yes
2609,11-T-117,Compositions and Methods Related to Recombinant Antibodies to Histone Posttranslational Modifications,"14/900,692","10,208,110",*United States,US,6/27/2014,2/19/2019,US-2016-0130329-A1,12/22/2015,2089-004,Small,8/16/2013,2/19/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000203247,"Takamitsu Hattori, Akiko Koide, Shohei Koide, Joseph Taft",Nationalized PCT,4/12/2018,2089-004,2/18/2035,"Peace, Shane",Shohei Koide,"Muite, Kevin",611207,5/13/2016,583260,No
2610,11-T-118,Methods and Compositions Involving Fibrillizing Polypeptides for Nanofibers,"61/782,193", ,*United States,US,3/14/2013,, ,3/14/2013,2079-001,Small,3/14/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joel Collier, Gregory Hudalla",Provisional,4/12/2018,2079-001,3/14/2014,"Dembo, Anna",Joel Collier,"Tennant, Thelma",612949,,583261,Yes
2611,11-T-118,Methods and Compositions Involving Fibrillizing Polypeptides for Nanofibers,"14/209,757","9,200,082",*United States,US,3/13/2014,12/1/2015,US-2014-0273148-A1,3/13/2014,2079-002,Small,3/14/2013,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joel Collier, Gregory Hudalla",US Utility,4/12/2018,2079-002,3/14/2033,"Dembo, Anna",Joel Collier,"Tennant, Thelma",612950,9/18/2014,583261,Yes
2612,11-T-118,Methods and Compositions Involving Fibrillizing Polypeptides for Nanofibers,"14/951,646", ,*United States,US,3/13/2014,,US-2016-0074488-A1,11/25/2015,2079-003,Small,3/14/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joel Collier, Gregory Hudalla",Continuation,4/12/2018,2079-003,3/14/2033,"Dembo, Anna",Joel Collier,"Tennant, Thelma",612951,,583261,No
2613,11-T-120,DRUGS THAT TARGET LIGAND-SPECIFIC BINDING SITES ON CXCR4,"61/547,846", ,*United States,US,10/17/2011,, ,10/17/2011,2081-001,None,10/17/2011,,Yes,4/28/2022,Expired - Inactive,,, ,"Matthias Majetschak, Wei-Jen Tang",Provisional,4/12/2018,2081-001,10/17/2012,"Sun, Han",Wei-Jen Tang,"Tennant, Thelma",611496,,583263,Yes
2614,11-T-130,Stable Formulations of Growth Factor Peptides (NX001),"61/554,575", ,*United States,US,11/2/2011,, ,11/2/2011,2084-001,None,11/2/2011,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Ann Berger, F. Gary Toback",Provisional,4/12/2018,2084-001,11/2/2012,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614610,,583273,Yes
2615,11-T-130,Stable Formulations of Growth Factor Peptides (NX001),PCT/US12/62375, ,*United States,US,10/29/2012,, ,10/29/2012,2084-002,None,11/2/2011,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Ann Berger, F. Gary Toback",PCT,4/12/2018,2084-002,4/29/2014,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614611,,583273,Yes
2616,11-T-130,Stable Formulations of Growth Factor Peptides (NX001),"14/354,835", ,*United States,US,10/29/2012,,US2014/0287995,4/28/2014,2084-003,None,11/2/2011,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Ann Berger, F. Gary Toback",Nationalized PCT,4/12/2018,2084-003,11/2/2031,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614612,9/25/2014,583273,Yes
2617,11-T-130,Stable Formulations of Growth Factor Peptides (NX001),12845883.3EPO, ,European Patent Office (EPO),EP,10/29/2012,,2 773 364,6/20/2014,2084-004,None,11/2/2011,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Ann Berger, F. Gary Toback",Nationalized PCT,4/12/2018,2084-004,4/29/2014,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614613,9/10/2014,583273,Yes
2618,11-T-132,Color X-Ray Histology for Multi-Stained Biologic Sample,"61/553,066", ,*United States,US,10/28/2011,, ,10/28/2011,2088-001,Small,10/28/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul", ,"Keith Cheng, Darin Clark, Patrick La Riviere, Yuxin Steve Wang",Provisional,4/12/2018,2088-001,10/28/2012,"Cox, Ben",Patrick La Riviere,"Smith, Dane",610921,,583275,Yes
2619,11-T-132,Color X-Ray Histology for Multi-Stained Biologic Sample,PCT/US12/62431, ,*United States,US,10/29/2012,,WO 2013/063577,10/29/2012,2088-002,Small,10/28/2011,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",46619A-PC,Patrick La Riviere,PCT,4/12/2018,2088-002,4/29/2014,"Cox, Ben",Patrick La Riviere,"Smith, Dane",610922,5/2/2013,583275,Yes
2620,11-T-132,Color X-Ray Histology for Multi-Stained Biologic Sample,"14/354,855","9,513,233",*United States,US,10/29/2012,12/6/2016,US-2014-0301528-A1,4/28/2014,2088-003,Small,10/28/2011,12/6/2016,No,5/7/2022,Issued,"Marshall, Gerstein & Borun","Stephens, Paul",46619A,"Keith Cheng, Darin Clark, Patrick La Riviere, Yuxin Steve Wang",Nationalized PCT,4/12/2018,2088-003,2/9/2033,"Cox, Ben",Patrick La Riviere,"Smith, Dane",610923,10/9/2014,583275,Yes
2621,11-T-134,New Uses of a Gastrokine Protein,"61/739,501", ,*United States,US,12/19/2012,, ,12/19/2012,2090-001,Small,12/19/2012,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"David Boone, Shirley Paski",Provisional,4/12/2018,2090-001,12/19/2013,"Peace, Shane",David Boone,"Tennant, Thelma",613659,,583277,Yes
2622,11-T-134,New Uses of a Gastrokine Protein,PCT/US13/73399, ,*United States,US,12/5/2013,,WO2014/099400,12/5/2013,2090-002,Small,12/19/2012,,No,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"David Boone, Shirley Paski",PCT,4/12/2018,2090-002,6/19/2015,"Peace, Shane",David Boone,"Tennant, Thelma",613660,6/26/2014,583277,Yes
2623,11-T-135,"Method, System, Software and Medium for Advanced Intelligent Image-Based Arrays for Analysis and Display of Biomedical Information","61/564,150", ,*United States,US,11/28/2011,, ,11/28/2011,2091-001,None,11/28/2011,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Li Lan, Hui Li",Provisional,4/12/2018,2091-001,11/28/2012,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612595,,583278,Yes
2624,11-T-135,"Method, System, Software and Medium for Advanced Intelligent Image-Based Arrays for Analysis and Display of Biomedical Information",PCT/US12/66806, ,*United States,US,11/28/2012,,WO 2013/082123,11/28/2012,2091-002,Small,11/28/2011,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Li Lan, Hui Li",PCT,4/12/2018,2091-002,11/28/2032,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612596,5/19/2016,583278,Yes
2625,11-T-135,"Method, System, Software and Medium for Advanced Intelligent Image-Based Arrays for Analysis and Display of Biomedical Information","14/361,122", ,*United States,US,11/28/2012,,US-2014-0375671-A1,5/28/2014,2091-003,Small,11/28/2011,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Maryellen Giger, Li Lan, Hui Li",Nationalized PCT,4/12/2018,2091-003,11/28/2032,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612597,12/25/2014,583278,Yes
2626,11-T-138,METHODS AND COMPOSITIONS FOR PREDICTING RESPONSE TO GLP-1 ANALOGS,"61/713,870", ,*United States,US,10/15/2012,, ,10/15/2012,2093-001,None,10/15/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Louis Philipson, Sindhu Rajan",Provisional,4/12/2018,2093-001,10/15/2013,"Butler, Brittany",Louis Philipson,"Butler, Brittany",612831,,583281,Yes
2627,11-T-138,METHODS AND COMPOSITIONS FOR PREDICTING RESPONSE TO GLP-1 ANALOGS,"13/795,320", ,*United States,US,3/12/2013,,US-2014-0107028-A1,3/12/2013,2093-002,None,10/15/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Louis Philipson, Sindhu Rajan",US Utility,4/12/2018,2093-002,3/12/2033,"Butler, Brittany",Louis Philipson,"Butler, Brittany",612832,4/17/2014,583281,Yes
2628,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,"61/576,222", ,*United States,US,12/15/2011,, ,12/15/2011,2092-001,None,12/15/2011,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Provisional,4/12/2018,2092-001,12/15/2012,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612661,,583282,Yes
2629,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,PCT/US12/69013, ,*United States,US,12/11/2012,,WO 2013/090293,12/11/2012,2092-002,Small,12/15/2011,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,PCT,4/12/2018,2092-002,6/11/2014,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612662,6/20/2013,583282,Yes
2630,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,"14/363,243","9,493,532",*United States,US,12/11/2012,11/15/2016,US2015/0056219,6/5/2014,2092-003,Small,12/15/2011,,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,2092-003,12/15/2031,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612663,2/26/2015,583282,Yes
2631,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,201280069840.2, ,China,CN,12/11/2012,,CN 104284680,8/15/2014,2092-004,Small,12/15/2011,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,2092-004,6/5/2034,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612664,1/14/2015,583282,Yes
2632,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,2014-547350, ,Japan,JP,12/11/2012,, ,6/5/2014,2092-005,Small,12/15/2011,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,2092-005,6/5/2034,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612665,,583282,Yes
2633,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,2012352454, ,Australia,AU,12/11/2012,, ,6/25/2014,2092-006,Small,12/15/2011,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,2092-006,12/11/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612666,,583282,Yes
2634,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,"2,858,876", ,Canada,CA,12/11/2012,,CN 104284680,12/11/2012,2092-007,Small,12/15/2011,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,2092-007,6/5/2034,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612667,1/14/2015,583282,Yes
2635,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,12806814.5EPO,2790730,European Patent Office (EPO),EP,12/11/2012,1/23/2019,2 790 730,7/11/2014,2092-008,Small,12/15/2011,1/24/2019,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David",34884/EP-1/PCT,Yang-Xin Fu,Nationalized PCT,4/12/2018,2092-008,6/5/2034,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612668,10/22/2014,583282,Yes
2636,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,"15/341,678","10,167,328",*United States,US,12/11/2012,1/1/2019,2017-0137484,11/2/2016,2092-010,Small,12/15/2011,,No,6/9/2022,Issued,"Casimir Jones, S.C.","Staple, David",34884.403,Yang-Xin Fu,Divisional,4/12/2018,2092-010,12/15/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",612669,5/18/2017,583282,No
2637,11-T-139,"New human LIGHT mutants with greater stability and affinity for mouse receptors, and HER2/neu fusion constructs of the new LIGHT mutants",2016-55140,6113883,Japan,JP,12/11/2012,3/24/2017,2016-117766,3/18/2016,2092-009,Small,12/15/2011,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Yang-Xin Fu,Divisional,4/12/2018,2092-009,12/11/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",613658,7/3/2016,583282,No
2638,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,12806814.5FR,2790730,France,FR,12/11/2012,1/23/2019, ,12/11/2012,2092-011,None,12/15/2011,1/17/2019,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David",34884/EP,Yang-Xin Fu,Validated EPO,1/17/2019, ,12/11/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",3397591,,583282,Yes
2639,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,12806814.5DE,602012056278.1,Germany,DE,12/11/2012,1/23/2019,2790730,12/11/2012,2092-012,None,12/15/2011,1/17/2019,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David",34884/EP-DE,Yang-Xin Fu,Validated EPO,1/17/2019, ,12/11/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",3397619,,583282,Yes
2640,11-T-139,METHODS AND COMPOSITIONS FOR CANCER THERAPY USING MUTANT LIGHT MOLECULES WITH INCREASED AFFINITY TO RECEPTORS,12806814.5GB,2790730,United Kingdom,GB,12/11/2012,1/23/2019, ,12/11/2012,2092-013,None,12/15/2011,1/17/2019,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David",34884/EP-UK,Yang-Xin Fu,Validated EPO,1/17/2019, ,12/11/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",3397633,,583282,Yes
2641,11-T-140,Methods and Compositions for Assessing Oligometastases for Risk of Progression or response to Treatment Using a MicroRNA Gene Signature,"61/560,131", ,*United States,US,11/15/2011,, ,11/15/2011,2094-001,Small,11/15/2011,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Yves Lussier, Ralph Weichselbaum, Hongmei Xing",Provisional,4/12/2018,2094-001,11/15/2012,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612652,,583283,Yes
2642,12-T-008,Methods and Compositions for Inhibiting Gram Positive Bacteria,"61/691,159", ,*United States,US,8/20/2012,, ,8/20/2012,2102-001,Small,8/20/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Dominique Missiakas, Stefan Richter, Olaf Schneewind",Provisional,4/12/2018,2102-001,8/20/2013,"Bakalyar, Heather",Dominique Missiakas,"Butler, Brittany",612777,,583293,Yes
2643,12-T-008,Methods and Compositions for Inhibiting Gram Positive Bacteria,"61/752,171", ,*United States,US,1/14/2013,, ,1/14/2013,2102-002,Small,1/14/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Dominique Missiakas, Stefan Richter, Olaf Schneewind",Provisional,4/12/2018,2102-002,8/20/2013,"Bakalyar, Heather",Dominique Missiakas,"Butler, Brittany",612778,,583293,Yes
2644,12-T-008,Methods and Compositions for Inhibiting Gram Positive Bacteria,PCT/US13/55854, ,*United States,US,8/20/2013,, ,8/20/2013,2102-003,Small,8/20/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Dominique Missiakas, Stefan Richter, Olaf Schneewind",PCT,4/12/2018,2102-003,8/20/2033,"Bakalyar, Heather",Dominique Missiakas,"Butler, Brittany",612779,,583293,Yes
2645,12-T-008,Methods and Compositions for Inhibiting Gram Positive Bacteria,"14/422,756", ,*United States,US,8/20/2013,,US-2015-0246024-A1,2/20/2015,2102-004,Small,8/20/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Dominique Missiakas, Stefan Richter, Olaf Schneewind",Nationalized PCT,4/12/2018,2102-004,8/20/2033,"Bakalyar, Heather",Dominique Missiakas,"Butler, Brittany",612780,9/3/2015,583293,Yes
2646,12-T-009,INHIBITORS OF CACNA1A/ALPHA1A SUBUNIT INTERNAL RIBOSOMAL ENTRY SITE (IRES) AND METHODS OF TREATING SPINOCEREBELLAR ATAXIA TYPE 6,"61/882,451", ,*United States,US,9/25/2013,, ,9/25/2013,2104-001,None,9/25/2013,,Yes,5/2/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47917,"Xiaofei Du, Christopher Gomez",Provisional,4/12/2018,2104-001,9/25/2014,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",612032,,583294,Yes
2647,12-T-009,INHIBITORS OF CACNA1A/ALPHA1A SUBUNIT INTERNAL RIBOSOMAL ENTRY SITE (IRES) AND METHODS OF TREATING SPINOCEREBELLAR ATAXIA TYPE 6,PCT/US14/45316, ,*United States,US,7/2/2014,,WO2015/047512,7/2/2014,2104-002,None,9/25/2013,,No,5/2/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47917A-PC,"Xiaofei Du, Christopher Gomez",PCT,4/12/2018,2104-002,3/25/2016,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",612033,4/2/2015,583294,Yes
2648,12-T-009,Reducing expression of the alpha-1ACTtranscription factor as a treatment for SCA6 ataxia,"15/024,492","10,017,765",*United States,US,7/2/2014,7/10/2018,US 20160237431 A1,3/24/2016,2104-003,Small,9/25/2013,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",47917A,"Xiaofei Du, Christopher Gomez",Nationalized PCT,4/12/2018,2104-003,7/2/2034,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",614371,8/19/2016,583294,No
2649,12-T-010,Glucocorticoid receptor-mediated cell survival following androgen receptor blockade in castrate-resistant prostate cancer,"15/013,660","9,801,893",*United States,US,2/21/2013,10/31/2017,US-20 16-0 151388-A 1,2/2/2016,2105-005,Small,2/24/2012,4/8/2022,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Russell Szmulewitz",Continuation,4/12/2018,2105-005,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",611701,6/2/2016,583295,No
2650,12-T-010,METHOD OF TREATMENT FOR PROSTATE CANCER WITH ANDROGEN RECEPTOR ANTAGONISTS AND GLUCOCORTICOID RECEPTOR ANTAGONISTS,"15/704,726","10,300,076",*United States,US,2/21/2013,5/28/2019,WO 2013/126581 A1,9/14/2017,2105-008,Small,2/24/2012,4/8/2022,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Russell Szmulewitz",Continuation,4/12/2018,2105-008,2/24/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",612555,8/29/2013,583295,No
2651,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,"61/603,137", ,*United States,US,2/24/2012,, ,2/24/2012,2105-001,None,2/24/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Suzanne Conzen, Russell Szmulewitz",Provisional,4/12/2018,2105-001,2/24/2013,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",613013,,583295,Yes
2652,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,PCT/US13/27150, ,*United States,US,2/21/2013,,WO 2013/126581,2/21/2013,2105-002,Small,2/24/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Suzanne Conzen, Russell Szmulewitz",PCT,4/12/2018,2105-002,8/21/2014,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",613014,8/29/2013,583295,Yes
2653,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,"14/380,606","9,289,436",*United States,US,2/21/2013,3/22/2016,US2015/0010503 A1,8/22/2014,2105-003,Small,2/24/2012,4/8/2022,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Russell Szmulewitz",Nationalized PCT,4/12/2018,2105-003,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",613015,1/8/2015,583295,Yes
2654,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,13751132.5EPO, ,European Patent Office (EPO),EP,2/21/2013,, ,9/22/2014,2105-004,Small,2/24/2012,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Suzanne Conzen, Russell Szmulewitz",Nationalized PCT,4/12/2018,2105-004,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",613016,,583295,Yes
2655,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,European Patent Office (EPO),EP,2/21/2013,8/25/2021, ,8/10/2016,2105-006,Small,2/24/2012,9/15/2021,No,4/28/2022,Granted,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1018715,"Suzanne Conzen, Russell Szmulewitz",Divisional,4/12/2018,2105-006,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",613017,,583295,No
2656,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,17104439.2,HK1230921,Hong Kong,HK,2/21/2013,1/7/2022,EP3111950A1,5/3/2017,2105-007,Small,2/24/2012,4/8/2022,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1046107-000210HK,"Suzanne Conzen, Russell Szmulewitz",Nationalized PCT,4/12/2018,2105-007,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",613018,12/15/2017,583295,No
2657,12-T-010,METHOD OF TREATMENT FOR PROSTATE CANCER WITH ANDROGEN RECEPTOR ANTAGONISTS AND GLUCOCORTICOID RECEPTOR ANTAGONISTS,"16/374,157","10,729,699",*United States,US,2/21/2013,8/4/2020, ,4/3/2019,2105-009,Small,2/24/2012,9/30/2021,No,4/28/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1128825-000240US,"Suzanne Conzen, Russell Szmulewitz",Continuation,4/24/2019, ,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",3649211,,583295,No
2658,12-T-010,METHOD OF TREATMENT FOR PROSTATE CANCER WITH ANDROGEN RECEPTOR ANTAGONISTS AND GLUCOCORTICOID RECEPTOR ANTAGONISTS,"16/913,916", ,*United States,US,2/21/2013,, ,6/26/2020,2105-010,Small,2/24/2012,4/8/2022,No,5/24/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",096487-1200081-000250US,"Suzanne Conzen, Russell Szmulewitz",Continuation,7/1/2020, ,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",4684255,,583295,No
2659,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,France,FR,2/21/2013,8/25/2021,,,2105-015,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809442,,583295,No
2660,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Ireland,IE,2/21/2013,8/25/2021,,,2105-017,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809466,,583295,No
2661,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Netherlands,NL,2/21/2013,8/25/2021,,,2105-021,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809490,,583295,No
2662,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,United Kingdom,GB,2/21/2013,8/25/2021,,,2105-028,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809517,,583295,No
2663,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,602013079015.9,3111950,Germany,DE,2/21/2013,8/25/2021,,,2105-016,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809541,,583295,No
2664,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Denmark,DK,2/21/2013,8/25/2021,,,2105-013,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809565,,583295,No
2665,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Austria,AT,2/21/2013,8/25/2021,,,2105-011,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809589,,583295,No
2666,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Belgium,BE,2/21/2013,8/25/2021,,,2105-012,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809613,,583295,No
2667,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,502021000092495,3111950,Italy,IT,2/21/2013,8/25/2021,,,2105-018,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809637,,583295,No
2668,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Luxembourg,LU,2/21/2013,8/25/2021,,,2105-019,None,2/24/2012,9/29/2021,No,2/11/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809661,,583295,No
2669,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Spain,ES,2/21/2013,8/25/2021,,,2105-025,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809685,,583295,No
2670,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Switzerland,CH,2/21/2013,8/25/2021,,,2105-027,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809709,,583295,No
2671,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Sweden,SE,2/21/2013,,,,2105-026,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809733,,583295,No
2672,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Portugal,PT,2/21/2013,8/25/2021,,,2105-024,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Divisional,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809757,,583295,No
2673,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Monaco,MC,2/21/2013,8/25/2021,,,2105-020,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809781,,583295,No
2674,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Norway,NO,2/21/2013,8/25/2021,,,2105-022,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809805,,583295,No
2675,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Poland,PL,2/21/2013,8/25/2021,,,2105-023,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809829,,583295,No
2676,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,16183642.4,3111950,Finland,FI,2/21/2013,8/25/2021,,,2105-014,None,2/24/2012,9/29/2021,No,5/25/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth",,"Suzanne Conzen, Russell Szmulewitz",Validated EPO,6/9/2021,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809853,,583295,No
2677,12-T-010,Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer,21183080.7, ,European Patent Office (EPO),EP,2/21/2013,, ,6/4/2021,2105-029,None,2/24/2012,4/8/2022,No,5/24/2022,Prosecution by Other Party,"Kilpatrick, Townsend & Stockton LLP","Weber, Kenneth", ,"Suzanne Conzen, Russell Szmulewitz",Divisional,6/9/2021, ,2/21/2033,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",5809925,,583295,No
2678,12-T-018,NOVEL AGENTS FOR IN VIVO IMAGING OF CENTRAL NERVOUS SYSTEM USING POSITRON EMISSION TOMOGRAPHY,"61/424,827", ,*United States,US,12/20/2010,, ,12/20/2010,2112-001,Small,12/20/2010,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Pedro Brugarolas, Brian Popko",Provisional,4/12/2018,2112-001,12/20/2011,"Peace, Shane",Brian Popko,"Tennant, Thelma",613714,,583303,Yes
2679,12-T-018,NOVEL AGENTS FOR IN VIVO IMAGING OF CENTRAL NERVOUS SYSTEM USING POSITRON EMISSION TOMOGRAPHY,"13/330,713", ,*United States,US,12/20/2011,, ,12/20/2011,2112-002,Small,12/20/2010,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Pedro Brugarolas,US Utility,4/12/2018,2112-002,12/20/2030,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",613715,,583303,Yes
2680,12-T-018,NOVEL AGENTS FOR IN VIVO IMAGING OF CENTRAL NERVOUS SYSTEM USING POSITRON EMISSION TOMOGRAPHY,"13/467,856", ,*United States,US,5/17/2013,, ,5/9/2012,2112-003,Small,5/17/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Pedro Brugarolas, Brian Popko",Continuation,4/12/2018,2112-003,5/9/2032,"Peace, Shane",Brian Popko,"Tennant, Thelma",613716,,583303,Yes
2681,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"61/648,214", ,*United States,US,5/17/2012,, ,5/17/2012,2112-004,None,5/17/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Provisional,4/12/2018,2112-004,5/17/2013,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615179,,583303,Yes
2682,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,PCT/US13/41638, ,*United States,US,5/17/2013,,WO 2013/173746,5/17/2013,2112-005,Small,5/17/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",PCT,4/12/2018,2112-005,11/17/2014,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615180,11/21/2013,583303,Yes
2683,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"13/897,035", ,*United States,US,5/17/2013,,US-2014-0004044-A1,5/17/2013,2112-006,Small,5/17/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Nationalized PCT,4/12/2018,2112-006,5/17/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615181,1/2/2014,583303,Yes
2684,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"14/329,597","9,617,215",*United States,US,5/17/2013,4/11/2017,US-2014-0369932-A1,7/11/2014,2112-007,Small,5/17/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0568US,"Daniel Appelbaum, Pedro Brugarolas, Chin-Tu Chen, Brian Popko",Continuation in Part,4/12/2018,2112-007,7/11/2034,"Peace, Shane",Brian Popko,"Tennant, Thelma",615182,12/18/2014,583303,Yes
2685,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,2013262578,2013262578,Australia,AU,5/17/2013,10/26/2017, ,12/12/2014,2112-008,Small,5/17/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000206357,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Nationalized PCT,4/12/2018,2112-008,5/17/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615183,,583303,Yes
2686,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,13791136.8EPO,2850044,European Patent Office (EPO),EP,5/17/2013,5/17/2017,2850044,12/17/2014,2112-009,Small,5/17/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000319838,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Nationalized PCT,4/12/2018,2112-009,5/17/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615184,3/25/2015,583303,Yes
2687,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"2,911,307","2,911,307",Canada,CA,5/17/2013,5/25/2021, ,5/17/2013,2112-010,Small,5/17/2012,6/25/2021,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0529CA,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Nationalized PCT,4/12/2018,2112-010,5/17/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615185,,583303,No
2688,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"15/452,179","10,442,767",*United States,US,5/17/2013,10/15/2019,US-2017-0174629-A1,3/7/2017,2112-011,Small,5/17/2012,10/4/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000193467,"Daniel Appelbaum, Pedro Brugarolas, Chin-Tu Chen, Brian Popko",Continuation,4/12/2018,2112-011,7/14/2034,"Peace, Shane",Brian Popko,"Tennant, Thelma",615186,6/22/2017,583303,Yes
2689,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,13791136.8FR,2850044,France,FR,5/17/2013,5/17/2017, ,5/17/2013,2112-012,Small,5/17/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Validated EPO,4/12/2018,2112-012,5/20/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615187,3/28/2015,583303,Yes
2690,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,13791136.8GB,2850044,United Kingdom,GB,5/17/2013,5/17/2017, ,5/17/2013,2112-013,Small,5/17/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Validated EPO,4/12/2018,2112-013,5/20/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615188,3/28/2015,583303,Yes
2691,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,602013021345.3,2850044,Germany,DE,5/17/2013,5/17/2017, ,5/17/2013,2112-014,Small,5/17/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Daniel Appelbaum, Pedro Brugarolas, Brian Popko",Validated EPO,4/12/2018,2112-014,5/17/2033,"Peace, Shane",Pedro Brugarolas,"Tennant, Thelma",615189,3/28/2015,583303,Yes
2692,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"16/584,071", ,*United States,US,5/17/2013,,US-2020-0017445-A1,9/26/2019,2112-015,Small,5/17/2012,10/9/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0568US.C2,"Daniel Appelbaum, Pedro Brugarolas, Chin-Tu Chen, Brian Popko",Continuation,10/9/2019, ,5/17/2033,"Peace, Shane",Brian Popko,"Tennant, Thelma",4030242,1/16/2020,583303,Yes
2693,12-T-018,Use of Fluorinated Derivatives of 4-aminopyridine in Therapeutics and Medical Imaging,"16/947,395", ,*United States,US,5/17/2013,,US-2021-0017133-A1,7/30/2020,2112-016,Small,5/17/2012,8/4/2020,No,6/13/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0568US.C3,"Daniel Appelbaum, Pedro Brugarolas, Chin-Tu Chen, Brian Popko",Continuation,8/4/2020, ,5/17/2033,"Peace, Shane",Brian Popko,"Tennant, Thelma",4779780,1/21/2021,583303,Yes
2694,12-T-020,Compositions and Methods for Treating Artherosclerosis,093116906, ,"Taiwan, Province of China",TW,6/10/2004,, ,6/11/2004,2113-007,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam","Foreign, Non-PCT",4/12/2018,2113-007,6/11/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611016,,583305,Yes
2695,12-T-020,Compositions and Methods for Treating Atherosclerosis,"60/478,131", ,*United States,US,6/13/2003,, ,6/13/2003,2113-001,Small,6/13/2003,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Provisional,4/12/2018,2113-001,6/13/2004,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611017,,583305,Yes
2696,12-T-020,Compositions and Methods for Treating Atherosclerosis,"60/544,565", ,*United States,US,2/13/2004,, ,2/13/2004,2113-002,Small,2/13/2004,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Provisional,4/12/2018,2113-002,6/13/2004,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611018,,583305,Yes
2697,12-T-020,Compositions and Methods for Treating Atherosclerosis,PCT/CA04/00846, ,Canada,CA,6/10/2004,, ,6/11/2004,2113-003,Small,6/13/2003,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-003,12/11/2005,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611019,,583305,Yes
2698,12-T-020,Compositions and Methods for Treating Atherosclerosis,"10/866,330","7,291,590",*United States,US,6/10/2004,11/6/2007, ,6/10/2004,2113-008,Small,6/13/2003,10/24/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",US Utility,4/12/2018,2113-008,6/10/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611020,,583305,Yes
2699,12-T-020,Compositions and Methods for Treating Atherosclerosis,"11/268,690","7,700,544",*United States,US,6/10/2004,4/20/2010, ,11/7/2005,2113-009,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Continuation in Part,4/12/2018,2113-009,6/10/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611021,,583305,Yes
2700,12-T-020,Compositions and Methods for Treating Atherosclerosis,"11/872,309", ,*United States,US,6/10/2004,, ,10/15/2007,2113-010,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Divisional,4/12/2018,2113-010,6/10/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611022,,583305,Yes
2701,12-T-020,Compositions and Methods for Treating Atherosclerosis,"12/701,709","8,703,698",*United States,US,6/10/2004,4/22/2014, ,2/8/2010,2113-011,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Continuation,4/12/2018,2113-011,7/3/2026,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611023,,583305,Yes
2702,12-T-020,Compositions and Methods for Treating Atherosclerosis,"12/950,389", ,*United States,US,6/10/2004,, ,11/19/2010,2113-012,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Continuation,4/12/2018,2113-012,6/10/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611024,,583305,Yes
2703,12-T-020,Compositions and Methods for Treating Atherosclerosis,PCT/CA06/01825, ,Canada,CA,6/10/2004,, ,11/7/2006,2113-019,Small,6/13/2003,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-019,5/7/2008,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",611025,,583305,Yes
2704,12-T-020,"Peptides Enhancing CEH activity or ACAT inhibitory activity, pharmaceutical Compositions comprising these peptides and their use in the treatment of Artherosclerosis","2,531,890", ,Canada,CA,6/10/2004,, ,6/11/2004,2113-004,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-004,6/11/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613913,,583305,Yes
2705,12-T-020,"Peptides Enhancing CEH activity or ACAT inhibitory activity, pharmaceutical Compositions comprising these peptides and their use in the treatment of Artherosclerosis",2006-515582, ,Japan,JP,6/10/2004,, ,6/10/2004,2113-005,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-005,6/10/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613914,,583305,Yes
2706,12-T-020,"Peptides Enhancing CEH activity or ACAT inhibitory activity, pharmaceutical Compositions comprising these peptides and their use in the treatment of Artherosclerosis",2004247286,200424786,Australia,AU,6/10/2004,5/19/2011, ,6/11/2004,2113-006,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-006,6/11/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613915,,583305,Yes
2707,12-T-020,"Peptides Enhancing CEH activity or ACAT inhibitory activity, pharmaceutical Compositions comprising these peptides and their use in the treatment of Artherosclerosis",200480023040.2, ,China,CN,6/10/2004,, ,6/10/2004,2113-013,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-013,6/11/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613916,,583305,Yes
2708,12-T-020,"Peptides Enhancing CEH activity or ACAT inhibitory activity, pharmaceutical Compositions comprising these peptides and their use in the treatment of Artherosclerosis",04737788.2EPO, ,European Patent Office (EPO),EP,6/10/2004,, ,6/10/2004,2113-016,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Nationalized PCT,4/12/2018,2113-016,6/11/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613917,,583305,Yes
2709,12-T-020,"Peptides Enhancing CEH activity or ACAT inhibitory activity, pharmaceutical Compositions comprising these peptides and their use in the treatment of Artherosclerosis",10184991.7EPO, ,European Patent Office (EPO),EP,6/10/2004,, ,6/11/2004,2113-017,Small,6/13/2003,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"John Ancsin, Zongchao Jia, Robert Kisilevsky, Shui Pang Tam",Divisional,4/12/2018,2113-017,6/11/2024,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613918,,583305,Yes
2710,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,"61/642,837", ,*United States,US,5/4/2012,, ,5/4/2012,2116-001,Large,5/4/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Provisional,4/12/2018,2116-001,5/4/2013,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610716,,583309,Yes
2711,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,PCT/US13/31078, ,*United States,US,3/13/2013,,WO2013/16577,3/13/2013,2116-002,Large,5/4/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",PCT,4/12/2018,2116-002,11/4/2014,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610717,11/7/2013,583309,Yes
2712,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,MX/a/2014/013425, ,Mexico,MX,3/13/2013,, ,11/4/2014,2116-003,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-003,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610719,,583309,Yes
2713,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,701690, ,New Zealand,NZ,3/13/2013,, ,11/5/2014,2116-004,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-004,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610720,,583309,Yes
2714,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,13785315.6EPO, ,European Patent Office (EPO),EP,3/13/2013,,2854537,11/27/2014,2116-005,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-005,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610721,4/8/2015,583309,Yes
2715,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,235390, ,Israel,IL,3/13/2013,, ,10/29/2014,2116-006,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Validated EPO,4/12/2018,2116-006,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610722,,583309,Yes
2716,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,10-2014-7034096, ,"Korea, Republic of",KR,3/13/2013,, ,12/3/2014,2116-007,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-007,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610723,,583309,Yes
2717,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,1120140274967, ,Brazil,BR,3/13/2013,, ,11/4/2014,2116-008,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-008,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610724,,583309,Yes
2718,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,2013257211, ,Australia,AU,3/13/2013,, ,11/5/2014,2116-009,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-009,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610725,,583309,Yes
2719,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,"14/398,914", ,*United States,US,3/13/2013,,US-2015-0190523-A1,11/4/2014,2116-010,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-010,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610726,7/9/2015,583309,Yes
2720,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,"2,872,400", ,Canada,CA,3/13/2013,, ,12/3/2014,2116-011,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-011,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610727,,583309,Yes
2721,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,201380028597.4, ,China,CN,3/13/2013,,CN104470361A,11/28/2014,2116-012,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-012,3/4/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610728,3/25/2015,583309,Yes
2722,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,2015-510266, ,Japan,JP,3/13/2013,,2015-515982,10/31/2014,2116-013,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-013,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610729,6/4/2015,583309,Yes
2723,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,9359/DELNP/2014, ,India,IN,3/13/2013,, ,11/7/2014,2116-014,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-014,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610730,,583309,Yes
2724,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,2014/08030, ,South Africa,ZA,3/13/2013,, ,11/3/2014,2116-015,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Nationalized PCT,4/12/2018,2116-015,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610731,,583309,Yes
2725,12-T-024,Bioavailability of Oral Methylnaltrexone Increases with a Phosphatidylcholine-Based Formulation,15108676.7, ,Hong Kong,HK,3/13/2013,,1207940A,9/7/2015,2116-016,Large,5/4/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Maojian Gu, Dong-Hai Lin, Chong-Zhi Wang, Chun-Su Yuan",Validated EPO,4/12/2018,2116-016,3/13/2033,"Dembo, Anna",Chun-Su Yuan,"Tennant, Thelma",610732,2/19/2016,583309,No
2726,12-T-029,"Methods, Devices, and Systems for Text Filters for Language Transformation","61/616,349", ,*United States,US,3/27/2012,, ,3/27/2012,2117-001,Small,3/27/2012,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Andrey Rzhetsky,Provisional,4/12/2018,2117-001,3/27/2013,"Ramirez, Mario Riojas",Andrey Rzhetsky,"Smith, Dane",613369,,583314,Yes
2727,12-T-032,Compositions and Methods Related to Staphylococcal SBI,"61/618,465", ,*United States,US,3/30/2012,, ,3/30/2012,2120-001,Small,3/30/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2120-001,3/30/2013,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611226,,583317,Yes
2728,12-T-032,Compositions and Methods Related to Staphylococcal SBI,PCT/US13/32230, ,*United States,US,3/15/2013,,WO 2013/142349,3/15/2013,2120-002,Small,3/30/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Hwan Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2120-002,3/15/2033,"Bakalyar, Heather",Olaf Schneewind,"Butler, Brittany",611227,9/26/2013,583317,Yes
2729,12-T-034,Semiconducting Polymers,"61/594,933", ,*United States,US,2/3/2012,, ,2/3/2012,2122-001,Small,2/3/2012,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00338,"Feng He, Yongye Liang, Luping Yu",Provisional,4/12/2018,2122-001,2/3/2013,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614468,,583319,Yes
2730,12-T-034,Semiconducting Polymers,PCT/US13/24337, ,*United States,US,2/1/2013,,WO 2013/116643,2/1/2013,2122-002,Small,2/3/2012,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00351,"Feng He, Yongye Liang, Luping Yu",PCT,4/12/2018,2122-002,8/1/2014,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614469,8/13/2013,583319,Yes
2731,12-T-034,Semiconducting Polymers,"14/376,354","9,379,331",*United States,US,2/1/2013,6/28/2016,US-2015-0041726-A1,8/1/2014,2122-003,Small,2/3/2012,,No,4/28/2022,Issued,Brinks Gilson & Lione,"Marshall, Ryan",00377,"Feng He, Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,2122-003,2/3/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614470,2/2/2015,583319,Yes
2732,12-T-034,Semiconducting Polymers,10-2014-7024556, ,"Korea, Republic of",KR,2/1/2013,, ,9/1/2014,2122-004,Small,2/3/2012,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Marshall, Ryan",00382,"Feng He, Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,2122-004,2/3/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614471,,583319,Yes
2733,12-T-034,Semiconducting Polymers,2014-555749, ,Japan,JP,2/1/2013,,JP-2014-555749,9/25/2014,2122-005,Small,2/3/2012,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Marshall, Ryan",00381,"Feng He, Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,2122-005,2/3/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614472,2/23/2015,583319,Yes
2734,12-T-034,Semiconducting Polymers,"2,863,606", ,Canada,CA,2/1/2013,, ,2/1/2013,2122-006,Small,2/3/2012,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Marshall, Ryan",00378,"Feng He, Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,2122-006,2/1/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614473,,583319,Yes
2735,12-T-034,Semiconducting Polymers,201380008007.1, ,China,CN,2/1/2013,,CN 104169332 A,2/1/2013,2122-007,Small,2/3/2012,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Marshall, Ryan",00379,"Feng He, Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,2122-007,2/3/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614474,11/26/2014,583319,Yes
2736,12-T-034,Semiconducting Polymers,13743133.4EPO, ,European Patent Office (EPO),EP,2/1/2013,,2809706,2/1/2013,2122-008,Small,2/3/2012,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Marshall, Ryan",00380,"Feng He, Yongye Liang, Luping Yu",Nationalized PCT,4/12/2018,2122-008,2/3/2032,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614475,12/10/2014,583319,Yes
2737,12-T-036,Cardiac Risk Evaluation,"61/721,973", ,*United States,US,11/2/2012,, ,11/2/2012,2124-001,Small,11/2/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0535US.P1,"Matthew Churpek, Dana Edelson",Provisional,4/12/2018,2124-001,11/2/2013,"Cox, Ben",Dana Edelson,"Tennant, Thelma",610791,,583321,Yes
2738,12-T-036,Cardiac Risk Evaluation,"61/731,619", ,*United States,US,11/30/2012,, ,11/30/2012,2124-002,Small,11/30/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0535US.P2,"Matthew Churpek, Dana Edelson, Robert Gibbons",Provisional,4/12/2018,2124-002,11/30/2013,"Cox, Ben",Dana Edelson,"Tennant, Thelma",610792,,583321,Yes
2739,12-T-036,Cardiac Risk Evaluation,PCT/US13/67992, ,*United States,US,11/1/2013,,WO 2014/071145,11/1/2013,2124-003,Small,11/30/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0535WO,"Matthew Churpek, Dana Edelson, Robert Gibbons",PCT,4/12/2018,2124-003,11/30/2032,"Cox, Ben",Dana Edelson,"Tennant, Thelma",610793,5/8/2014,583321,Yes
2740,12-T-036,Cardiac Risk Evaluation,"14/440,251", ,*United States,US,11/1/2013,,US-2015-0332012-A1,5/1/2015,2124-004,Small,11/30/2012,5/1/2015,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0535US,"Matthew Churpek, Dana Edelson, Robert Gibbons",Nationalized PCT,4/12/2018,2124-004,11/30/2032,"Cox, Ben",Dana Edelson,"Tennant, Thelma",610794,11/19/2015,583321,Yes
2741,12-T-040,Live Attenuated Pseudomonas Aeruginosa Vaccines,"61/692,568", ,*United States,US,8/23/2012,, ,8/23/2012,2129-001,Small,8/23/2012,,Yes,4/28/2022,Expired - Inactive,"Schwegman, Lundberg & Woessner","Embretson, Janet", ,"Xin Deng, Chuan He, Min Wu",Provisional,4/12/2018,2129-001,8/23/2013,"Hwang, Luke",Chuan He,"Tennant, Thelma",612086,,583325,Yes
2742,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,"61/638,797", ,*United States,US,4/26/2012,, ,4/26/2012,2132-001,Small,4/26/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2132-001,4/26/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611040,,583330,Yes
2743,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,PCT/US13/31927, ,*United States,US,3/15/2013,,WO 2013/162751,3/15/2013,2132-002,Small,4/26/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2132-002,10/26/2014,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611041,10/31/2013,583330,Yes
2744,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,"14/397,049","9,701,738",*United States,US,3/15/2013,7/11/2017,US-2015-0368322-A1,10/24/2014,2132-003,Small,4/26/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-003,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611042,,583330,Yes
2745,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,2015-508964,6251730,Japan,JP,3/15/2013,12/1/2017,2015-515492,3/15/2013,2132-004,Small,4/26/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000364463,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-004,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611043,,583330,Yes
2746,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,BR112014026808-8, ,Brazil,BR,3/15/2013,,BR112014026808-8,10/27/2014,2132-005,Small,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003BR,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-005,4/26/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611044,5/15/2018,583330,Yes
2747,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,13781905.8EPO,2841101,European Patent Office (EPO),EP,3/15/2013,8/7/2019, ,11/25/2014,2132-006,Small,4/26/2012,12/19/2019,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003EP,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-006,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611045,,583330,Yes
2748,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,201380033151.0,ZL201380033151.0,China,CN,3/15/2013,5/24/2017, ,3/15/2013,2132-007,Small,4/26/2012,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003CN,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-007,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611046,,583330,Yes
2749,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,"15/627,670", ,*United States,US,3/15/2013,,US-2014-0306004-A1,6/20/2017,2132-012,Small,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000346821,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Continuation,4/12/2018,2132-012,3/19/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611047,10/26/2017,583330,Yes
2750,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,2017-226624,6251730,Japan,JP,3/15/2013,12/1/2017,JP 2018-58871 A,11/27/2017,2132-013,Large,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1001007998,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2018,2132-013,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611048,4/12/2018,583330,Yes
2751,12-T-045,Monoclonal antibodies that neutralize coagulase activity during staph aureus disease,2013252888,2013252888,Australia,AU,3/15/2013,9/27/2018, ,11/19/2014,2132-008,Large,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,,1000364462,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-008,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",613522,,583330,No
2752,12-T-045,Monoclonal antibodies that neutralize coagulase activity during staph aureus disease,"2,910,320", ,Canada,CA,3/15/2013,, ,3/15/2013,2132-009,Small,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,,DMOS.P0003CA,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-009,1/23/2020,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",613523,,583330,No
2753,12-T-045,Monoclonal antibodies that neutralize coagulase activity during staph aureus disease,15108152.0, ,Hong Kong,HK,3/15/2013,,HK 1207321A,8/24/2015,2132-010,Small,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003EHK,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-010,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",613524,1/31/2016,583330,No
2754,12-T-045,Monoclonal antibodies that neutralize coagulase activity during staph aureus disease,702282,702282,New Zealand,NZ,3/15/2013,11/1/2016, ,3/15/2013,2132-011,Small,4/26/2012,12/23/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2132-011,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",613525,,583330,No
2755,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,13781905.8,2841101,France,FR,3/15/2013,8/7/2019,,11/12/2019,2132-016,Small,4/26/2012,10/14/2021,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003FR,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,12/9/2019,,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4144171,,583330,Yes
2756,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,602013058850.3,2841101,Germany,DE,3/15/2013,, ,9/24/2019,2132-015,Small,4/26/2012,10/14/2021,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003DE,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,12/9/2019, ,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4144197,,583330,Yes
2757,12-T-045,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,13781905.8,2841101,United Kingdom,GB,3/15/2013,8/7/2019, ,3/15/2013,2132-014,None,4/26/2012,10/14/2021,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0003GB,"Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,12/9/2019, ,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4144223,,583330,Yes
2758,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,2013252883,2013252883,Australia,AU,3/14/2013,8/30/2018, ,11/18/2014,2133-010,Small,4/26/2012,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,,1000353619,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-010,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611866,,583331,No
2759,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3EPO,2844275,European Patent Office (EPO),EP,3/14/2013,5/13/2020, ,3/14/2013,2133-011,Small,4/26/2012,,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002EP,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-011,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611867,,583331,No
2760,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,15108219.1,1207571,Hong Kong,HK,3/14/2013,3/12/2021,1207571A,8/25/2015,2133-012,Small,4/26/2012,4/9/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,DMOS.P0002EHK,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-012,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611868,2/6/2016,583331,No
2761,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,"61/638,831", ,*United States,US,4/26/2012,, ,4/26/2012,2133-001,Small,4/26/2012,11/4/2021,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2133-001,4/26/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614616,,583331,Yes
2762,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,"61/674,619", ,*United States,US,7/23/2012,, ,7/23/2012,2133-002,Small,7/23/2012,11/4/2021,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2133-002,7/23/2013,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614617,,583331,Yes
2763,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,PCT/US13/31695, ,*United States,US,3/14/2013,, ,3/14/2013,2133-003,Small,4/26/2012,11/4/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2133-003,4/26/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614618,,583331,Yes
2764,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,"14/397,031","9,968,668",*United States,US,3/14/2013,5/15/2018, ,10/24/2014,2133-004,Small,4/26/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000343134,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-004,8/3/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614619,,583331,Yes
2765,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,2015-508962,6670106,Japan,JP,3/14/2013,3/3/2020,6670106,10/27/2014,2133-005,Small,4/26/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002JP,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-005,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614620,3/18/2020,583331,Yes
2766,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,BR112014026861-4, ,Brazil,BR,3/14/2013,,BR112014026861-4,10/27/2014,2133-006,Small,4/26/2012,,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002BR,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-006,4/26/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614621,5/15/2018,583331,Yes
2767,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,201380033361.X,201380033361.X,China,CN,3/14/2013,8/24/2021, ,11/23/2014,2133-007,Small,4/26/2012,9/7/2021,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002CN,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-007,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614622,,583331,Yes
2768,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,702285,702285,New Zealand,NZ,3/14/2013,11/1/2016, ,11/24/2014,2133-008,Small,4/26/2012,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-008,4/26/2032,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614623,,583331,Yes
2769,12-T-046,Staphylococcal Coagulase Antigens and Methods of Their Use,"2,910,319","2,910,319",Canada,CA,3/14/2013,6/14/2022,,10/23/2015,2133-009,Small,4/26/2012,6/21/2022,No,6/21/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002CA,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2133-009,3/15/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614624,,583331,No
2770,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,2018-046291, ,Japan,JP,3/14/2013,,2018-121640,3/14/2018,2133-013,Small,4/26/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002JP.D1,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Divisional,4/12/2018,2133-013,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614625,8/9/2018,583331,Yes
2771,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,"15/962,115","10,857,220",*United States,US,3/14/2013,12/8/2020,2018-024339,4/25/2018,2133-014,Small,4/26/2012,4/25/2018,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002US.C1,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Continuation,4/25/2018, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",1357907,8/30/2018,583331,Yes
2772,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3AT,2844275,Austria,AT,3/14/2013,5/13/2020, ,8/10/2020,2133-015,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002AT,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472231,,583331,No
2773,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3BE,2844275,Belgium,BE,3/14/2013,5/13/2020, ,7/16/2020,2133-016,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002BE,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472269,,583331,No
2774,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3HR,2844275,Croatia,HR,3/14/2013,5/13/2020, ,7/17/2020,2133-017,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002HR,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472314,,583331,No
2775,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3DK,2844275,Denmark,DK,3/14/2013,5/13/2020, ,7/6/2020,2133-018,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002DK,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472352,,583331,No
2776,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3FI,2844275,Finland,FI,3/14/2013,5/13/2020, ,7/21/2020,2133-019,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002FI,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472390,,583331,No
2777,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3FR,2844275,France,FR,3/14/2013,5/13/2020, ,7/21/2020,2133-020,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002FR,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472428,,583331,No
2778,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,602013069082.0,2844275,Germany,DE,3/14/2013,5/13/2020, ,6/17/2020,2133-021,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002DE,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Validated EPO,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472466,,583331,No
2779,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3GB,2844275,United Kingdom,GB,3/14/2013,5/13/2020, ,7/24/2020,2133-022,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002GB,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472504,,583331,No
2780,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3IE,2844275,Ireland,IE,3/14/2013,5/13/2020, ,8/5/2020,2133-023,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002IE,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472542,,583331,No
2781,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,50202000068818,2844275,Italy,IT,3/14/2013,5/13/2020, ,7/21/2020,2133-024,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002IT,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472580,,583331,No
2782,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3NL,2844275,Netherlands,NL,3/14/2013,5/13/2020, ,7/16/2020,2133-025,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002NL,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472618,,583331,No
2783,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3PO,2844275,Poland,PL,3/14/2013,5/13/2020, ,7/22/2020,2133-026,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002PO,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472656,,583331,No
2784,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3ES,2844275,Spain,ES,3/14/2013,5/13/2020, ,7/20/2020,2133-027,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002ES,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472694,,583331,No
2785,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3CH,2844275,Switzerland,CH,3/14/2013,5/13/2020, ,8/12/2020,2133-028,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002CH,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472732,,583331,No
2786,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,13781494.3SE,2844275,Sweden,SE,3/14/2013,5/13/2020, ,7/16/2020,2133-029,Large,4/26/2012,4/16/2020,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002SE,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/16/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4472770,,583331,No
2787,12-T-046,Hybrid Coa and vWbp subunit vaccine derived from combinations of variable portions of coagulases,20173462.1, ,European Patent Office (EPO),EP,3/14/2013,,3805395,5/7/2020,2133-030,Large,4/26/2012,5/7/2020,No,5/23/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002EP.D1,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Divisional,5/7/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4531295,4/14/2021,583331,No
2788,12-T-046,Staphylococcal Coagulase Antigens And Methods Of Their Use,"17/247,294", ,*United States,US,3/14/2013,,US-2021-0093706-A1,12/7/2020,2133-031,Large,4/26/2012,12/8/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0002US.C1C1,"Alice Cheng, Andrea DeDent, Carla Emolo, Molly McAdow, Dominique Missiakas, Olaf Schneewind",Continuation,12/8/2020, ,3/14/2033,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",5169888,4/1/2021,583331,Yes
2789,12-T-049,Composition and Methods Related to Identification of 5-Formylcytosine (5-fC),"61/656,924", ,*United States,US,6/7/2012,, ,6/7/2012,2136-001,Small,6/7/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Qing Dai, Chuan He, Chunxiao Song",Provisional,4/12/2018,2136-001,6/7/2013,"Hwang, Luke",Chuan He,"Tennant, Thelma",610960,,583334,Yes
2790,12-T-051,Staphylococcus Live Cell Vaccines,"61/819,406", ,*United States,US,5/3/2013,, ,5/3/2013,2137-001,Small,5/3/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fabiana Falugi, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2137-001,5/3/2014,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614626,,583336,Yes
2791,12-T-051,Staphylococcus Live Cell Vaccines,PCT/US14/36658, ,*United States,US,5/2/2014,,WO 2014/179744,5/2/2014,2137-002,Small,5/3/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fabiana Falugi, Hwan Kim, Dominique Missiakas, Olaf Schneewind",PCT,4/12/2018,2137-002,11/3/2015,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614627,11/6/2014,583336,Yes
2792,12-T-051,Staphylococcus Live Cell Vaccines,"14/888,873", ,*United States,US,5/2/2014,,US-2016-0074497-A1,11/3/2015,2137-003,Small,5/3/2013,,No,5/17/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fabiana Falugi, Hwan Kim, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,4/12/2018,2137-003,5/2/2034,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",614628,,583336,No
2793,12-T-052,Viral Footprints in Atherosclerotic Plaques,"61/643,055", ,*United States,US,5/4/2012,, ,5/4/2012,2138-001,Small,5/4/2012,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",46977P1,Christopher Skelly,Provisional,4/12/2018,2138-001,5/4/2013,"Bakalyar, Heather",Christopher Skelly,"Tennant, Thelma",615381,,583337,Yes
2794,12-T-052,Viral Footprints in Atherosclerotic Plaques,"61/643,164", ,*United States,US,5/4/2012,, ,5/4/2012,2138-002,Small,5/4/2012,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",46977P2,Christopher Skelly,Provisional,4/12/2018,2138-002,5/4/2013,"Bakalyar, Heather",Christopher Skelly,"Tennant, Thelma",615382,,583337,Yes
2795,12-T-055,CONVERSION OF CARDIOMYOCYTES INTO FAST CONDUCTING CARDIOMYOCYTES OR SLOW CONDUCTING NODAL CELLS,"61/648,668", ,*United States,US,5/18/2012,, ,5/18/2012,2140-001,None,5/18/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Ivan Moskowitz,Provisional,4/12/2018,2140-001,5/18/2013,"Bakalyar, Heather",Ivan Moskowitz,"Tennant, Thelma",611341,,583340,Yes
2796,12-T-055,CONVERSION OF CARDIOMYOCYTES INTO FAST CONDUCTING CARDIOMYOCYTES OR SLOW CONDUCTING NODAL CELLS,PCT/US13/41593, ,*United States,US,5/17/2013,,WO/2013/173714,5/17/2013,2140-002,None,5/18/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Arnolds, Ivan Moskowitz",PCT,4/12/2018,2140-002,11/17/2013,"Bakalyar, Heather",Ivan Moskowitz,"Tennant, Thelma",611342,11/21/2013,583340,Yes
2797,12-T-055,CONVERSION OF CARDIOMYOCYTES INTO FAST CONDUCTING CARDIOMYOCYTES OR SLOW CONDUCTING NODAL CELLS,"14/401,915", ,*United States,US,5/17/2013,, ,11/18/2014,2140-003,Small,5/18/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Arnolds, Ivan Moskowitz",Nationalized PCT,4/12/2018,2140-003,11/18/2034,"Bakalyar, Heather",David Arnolds,"Tennant, Thelma",611343,,583340,Yes
2798,12-T-058,Methods of Treating Obesity,"61/650,867", ,*United States,US,5/23/2012,, ,5/23/2012,2144-001,None,5/23/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Yang-Xin Fu,Provisional,4/12/2018,2144-001,5/23/2013,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",613358,,583343,Yes
2799,12-T-058,Methods of Treating Obesity,PCT/US13/42478, ,*United States,US,5/23/2013,, ,5/23/2013,2144-002,Small,5/23/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Yang-Xin Fu,PCT,4/12/2018,2144-002,11/23/2014,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",613359,,583343,Yes
2800,12-T-058,Methods of Treating Obesity,"14/403,017", ,*United States,US,5/23/2013,,US-2015-0157692-A1,11/21/2014,2144-003,Small,5/23/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Yang-Xin Fu,Nationalized PCT,4/12/2018,2144-003,5/23/2032,"Sun, Han",Yang-Xin Fu,"Tennant, Thelma",613360,6/11/2015,583343,Yes
2801,12-T-059,Antibiotic Methods and Compositions for Bacteria Infections,"61/721,310", ,*United States,US,11/1/2012,, ,11/1/2012,2145-001,Small,11/1/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum",Provisional,4/12/2018,2145-001,11/1/2013,"Peace, Shane",Robert Daum,"Onishi, Kenneth",610385,,583344,Yes
2802,12-T-059,Antibiotic Methods and Compositions for Bacteria Infections,PCT/US13/68085, ,*United States,US,11/1/2013,,WO2014/071198,11/1/2013,2145-002,Small,11/1/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum",PCT,4/12/2018,2145-002,5/1/2015,"Peace, Shane",Robert Daum,"Onishi, Kenneth",610386,5/8/2014,583344,Yes
2803,12-T-059,Antibiotic Methods and Compositions for Bacteria Infections,"14/439,850","9,861,619",*United States,US,11/1/2013,1/9/2018,US-2015-0283120-A1,4/30/2015,2145-003,Small,11/1/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000207526,"Susan Boyle-Vavra, Robert Daum",Nationalized PCT,4/12/2018,2145-003,1/14/2034,"Peace, Shane",Robert Daum,"Onishi, Kenneth",610387,10/8/2015,583344,Yes
2804,12-T-059,Antibiotic Methods and Compositions for Bacteria Infections,2015-540824, ,Japan,JP,11/1/2013,,2015-536949,6/16/2015,2145-004,Small,11/1/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum",Nationalized PCT,4/12/2018,2145-004,11/1/2032,"Peace, Shane",Robert Daum,"Onishi, Kenneth",610388,5/8/2014,583344,Yes
2805,12-T-059,Antibiotic Methods and Compositions for Bacteria Infections,13850898.1EPO, ,European Patent Office (EPO),EP,11/1/2013,,2916653,11/1/2013,2145-005,Small,11/1/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum",Nationalized PCT,4/12/2018,2145-005,11/1/2033,"Peace, Shane",Robert Daum,"Onishi, Kenneth",610389,9/16/2015,583344,Yes
2806,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,"61/683,596", ,*United States,US,8/15/2012,, ,8/15/2012,2146-001,Small,8/15/2012,11/17/2021,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543US.P1,"Yelena Grinberg, Richard Kraig, Aya Pusic",Provisional,4/12/2018,2146-001,8/15/2013,"Sun, Han",Richard Kraig,"Tennant, Thelma",611546,,583345,Yes
2807,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,PCT/US13/55187, ,*United States,US,8/15/2013,,WO 2014/028763,8/15/2013,2146-002,Small,8/15/2012,11/17/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543WO,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",PCT,4/12/2018,2146-002,2/15/2015,"Sun, Han",Richard Kraig,"Tennant, Thelma",611547,2/20/2014,583345,Yes
2808,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,"14/420,680","10,231,997",*United States,US,8/15/2013,3/19/2019,US-2015-0216899-A1,2/10/2015,2146-003,Small,8/15/2012,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543US,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,4/12/2018,2146-003,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",611548,8/6/2015,583345,Yes
2809,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,"2,882,248", ,Canada,CA,8/15/2013,, ,8/15/2013,2146-004,Small,8/15/2012,1/6/2020,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543CA,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,4/12/2018,2146-004,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",611549,,583345,Yes
2810,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,13829748.6EPO,2885414,European Patent Office (EPO),EP,8/15/2013,9/23/2020,2885414,3/16/2015,2146-005,Large,8/15/2012,,No,5/2/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543EP,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,4/12/2018,2146-005,,"Sun, Han",Richard Kraig,"Tennant, Thelma",611550,6/24/2015,583345,Yes
2811,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,2013302526,AU2013302526,Australia,AU,8/15/2013,7/5/2018, ,8/15/2013,2146-006,Large,8/15/2012,7/12/2018,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543AU,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,4/12/2018,2146-006,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",611551,,583345,Yes
2812,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,2015-527641, ,Japan,JP,8/15/2013,, ,2/16/2015,2146-007,Small,8/15/2012,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543JP,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,4/12/2018,2146-007,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",611552,,583345,Yes
2813,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,"16/259,563","11/369,634",*United States,US,8/15/2013,6/28/2022,US-2019-0160097-A1,1/28/2019,2146-008,Small,8/15/2012,6/15/2022,No,6/17/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543US.C1,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Continuation,2/6/2019,,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",3496587,5/30/2019,583345,Yes
2814,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,13829748.6,602013072810.0,Germany,DE,8/15/2013,9/23/2020,2885414,3/16/2015,2146-010,Small,8/15/2012,9/8/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543DE,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,9/8/2020, ,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",4877887,,583345,Yes
2815,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,13827948.6,2885414,France,FR,8/15/2013,9/23/2020, ,3/16/2015,2146-009,Small,8/15/2012,9/8/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543FR,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,9/8/2020, ,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",4877917,,583345,Yes
2816,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,13829748.6,2885414,United Kingdom,GB,8/15/2013,9/23/2020, ,3/16/2015,2146-011,Small,8/15/2012,9/8/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543GB,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Nationalized PCT,9/8/2020, ,8/15/2033,"Sun, Han",Richard Kraig,"Tennant, Thelma",4877947,,583345,Yes
2817,12-T-060,Exosome-Based Therapeutics Against Neurodegenerative Disorders,"17/804,348",,*United States,US,8/15/2013,,,5/27/2022,2146-012,Small,8/15/2012,5/27/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0543US.C2,"Yelena Grinberg, Richard Kraig, Aya Pusic, Kae Pusic",Continuation,5/12/2022,,,"Sun, Han",Richard Kraig,"Tennant, Thelma",7245544,,583345,
2818,12-T-062,Single-base Resolution Sequencing of 5-Formylcytosine (5FC) and 5-Carboxylcytosine (5CAC),"61/809,103", ,*United States,US,4/5/2013,, ,4/5/2013,2148-001,None,4/5/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, Frederick Jiang, Chunxiao Song",Provisional,4/12/2018,2148-001,4/5/2014,"Hwang, Luke",Chuan He,"Tennant, Thelma",614515,,583347,Yes
2819,12-T-062,Single-base Resolution Sequencing of 5-Formylcytosine (5FC) and 5-Carboxylcytosine (5CAC),PCT/US14/32997, ,*United States,US,4/4/2014,,WO 2014/165770,4/4/2014,2148-002,Small,4/5/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, Frederick Jiang, Chunxiao Song",PCT,4/12/2018,2148-002,10/5/2015,"Hwang, Luke",Chuan He,"Tennant, Thelma",614516,10/9/2014,583347,Yes
2820,12-T-070,METHODS AND COMPOSITIONS USING ADAM10 INHIBITORS TO TREAT BACTERIAL INFECTIONS,"14/781,962","10,472,391",*United States,US,4/4/2014,11/12/2019,US 2016/0052964 A1,10/2/2015,2153-003,Small,4/5/2013,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0547US,"Wallace Bradford, Juliane Bubeck Wardenburg, Leyi Gong, Katherine Weh",Nationalized PCT,4/12/2018,2153-003,4/4/2034,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613096,2/25/2016,583355,No
2821,12-T-070,Methods and Compositions Using Adamio Inhibitors to Treat Bacterial Infections,"61/809,064", ,*United States,US,4/5/2013,, ,4/5/2013,2153-001,Small,4/5/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wallace Bradford, Juliane Bubeck Wardenburg, Leyi Gong",Provisional,4/12/2018,2153-001,4/5/2014,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613097,,583355,Yes
2822,12-T-070,Methods and Compositions Using Adamio Inhibitors to Treat Bacterial Infections,PCT/US14/32959, ,*United States,US,4/4/2014,,WO 2014/165746,4/4/2014,2153-002,Small,4/5/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Wallace Bradford, Juliane Bubeck Wardenburg, Leyi Gong",PCT,4/12/2018,2153-002,10/5/2015,"Peace, Shane",Juliane Bubeck Wardenburg,"Ginsburg, Eric",613098,10/9/2014,583355,Yes
2823,12-T-083,Materials and Methods for Preventing and Treating Anastomotic Leaks,"61/684,641", ,*United States,US,8/17/2012,, ,8/17/2012,2152-001,Small,8/17/2012,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",46776,John Alverdy,Provisional,4/12/2018,2152-001,8/17/2013,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612167,,583368,Yes
2824,12-T-083,Materials and Methods for Preventing and Treating Anastomotic Leaks,PCT/US13/31684, ,*United States,US,4/17/2013,,WO 2014/028052.,4/17/2013,2152-002,Small,8/17/2012,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",46776A-PC,John Alverdy,PCT,4/12/2018,2152-002,12/17/2014,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612168,2/20/2014,583368,Yes
2825,12-T-083,Materials and Methods for Preventing and Treating Anastomotic Leaks,"14/421,762","9,937,199",*United States,US,4/17/2013,4/10/2018,2015-0297634-A1,2/13/2015,2152-003,Small,8/17/2012,,No,4/28/2022,Issued,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",747327,John Alverdy,US Utility,4/12/2018,2152-003,3/14/2033,"Dembo, Anna",John Alverdy,"Tennant, Thelma",612169,10/22/2015,583368,Yes
2826,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,"61/695,698", ,*United States,US,8/31/2012,, ,8/31/2012,2156-001,Small,8/31/2012,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",47154,Kenji Suzuki,Provisional,4/12/2018,2156-001,8/31/2013,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",614724,,583369,Yes
2827,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,PCT/US13/57641, ,*United States,US,8/30/2013,,WO 2014/036473,8/30/2013,2156-002,Small,8/31/2012,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Stephens, Paul",47154A-PC,Kenji Suzuki,PCT,4/12/2018,2156-002,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",614725,3/6/2014,583369,Yes
2828,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,"14/423,997","9,332,953",*United States,US,8/30/2013,5/10/2016, ,2/25/2015,2156-003,Small,8/31/2012,5/10/2016,No,4/28/2022,Issued,Munck Wilson Mandala,, ,Kenji Suzuki,Nationalized PCT,4/12/2018,2156-003,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",614726,,583369,Yes
2829,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5EPO,2890300,European Patent Office (EPO),EP,8/30/2013,1/2/2019,2 890 300,3/31/2015,2156-004,Small,8/31/2012,,No,4/28/2022,Granted,Munck Wilson Mandala,, ,Kenji Suzuki,Nationalized PCT,4/12/2018,2156-004,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",614727,7/8/2015,583369,Yes
2830,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5FR,2890300,France,FR,8/30/2013,1/2/2019,,2/28/2015,2156-006,Small,8/31/2012,2/10/2020,No,8/31/2021,Issued,Munck Wilson Mandala,,ALGO03-00003FR,Kenji Suzuki,Validated EPO,2/10/2020,,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262698,,583369,Yes
2831,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5DE,602013049329.4,Germany,DE,8/30/2013,1/2/2019,2890300,2/28/2015,2156-007,Small,8/31/2012,2/10/2020,No,8/31/2021,Issued,Munck Wilson Mandala,,ALGO03-00003DE,Kenji Suzuki,Validated EPO,2/10/2020,,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262718,7/8/2015,583369,Yes
2832,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5IT,502019000008475,Italy,IT,8/30/2013,1/2/2019,2890300,2/28/2015,2156-008,Small,8/31/2012,2/10/2020,No,8/31/2021,Issued,Munck Wilson Mandala,,ALGO03-00003IT,Kenji Suzuki,Validated EPO,2/10/2020,,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262736,7/8/2015,583369,Yes
2833,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5CH,2890300,Switzerland,CH,8/30/2013,1/2/2019,,2/28/2015,2156-011,Small,8/31/2012,2/10/2020,No,8/31/2021,Issued,Munck Wilson Mandala,,ALGO03-00003CH,Kenji Suzuki,Validated EPO,2/10/2020,,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262754,,583369,Yes
2834,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5SE,2890300,Sweden,SE,8/30/2013,1/2/2019,,2/28/2015,2156-010,Small,8/31/2012,2/10/2020,No,8/31/2021,Issued,Munck Wilson Mandala,,ALGO03-00003SE,Kenji Suzuki,Validated EPO,2/10/2020,,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262772,,583369,Yes
2835,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5GB,2890300,United Kingdom,GB,8/30/2013,1/2/2019,,2/28/2015,2156-012,Small,8/31/2012,2/10/2020,No,8/31/2021,Issued,Munck Wilson Mandala,,ALGO03-00003GB,Kenji Suzuki,Validated EPO,2/10/2020,,8/30/2033,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262790,,583369,Yes
2836,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5BE, ,Belgium,BE,8/30/2013,, ,8/30/2013,2156-005,Small,8/31/2012,2/10/2020,No,4/28/2022,Abandoned,Munck Wilson Mandala,,ALGO03-00003BE,Kenji Suzuki,Validated EPO,2/10/2020, ,,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262808,,583369,Yes
2837,12-T-084,Supervised Machine Learning Technique for Reduction of Radiation Dose in Computed Tomography Imaging,13833595.5IE, ,Ireland,IE,8/30/2013,, ,8/30/2013,2156-009,Small,8/31/2012,2/10/2020,No,4/28/2022,Abandoned,Munck Wilson Mandala,,ALGO03-00003IE,Kenji Suzuki,Validated EPO,2/10/2020, ,,"Ramirez, Mario Riojas",Kenji Suzuki,"Juggernauth, Anne",4262826,,583369,Yes
2838,12-T-093,USE OF STREPTOLYDIGIN AND ITS SYNTHETIC ANALOGS TO TREAT CLOSTRIDUM DIFFICILE INFECTION,"61/741,491", ,*United States,US,7/20/2012,, ,7/20/2012,2159-001,Small,7/20/2012,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Feng, Yuezhong",00348,"Julian Hurdle, Sergey Kozmin, Anthony Martinez, Sergey Pronin",Provisional,4/12/2018,2159-001,7/20/2013,"Ginsburg, Eric",Sergey Kozmin,"Tennant, Thelma",615297,,583378,Yes
2839,12-T-095,Modulation of Reactivation of a Latent Virus,"61/823,355", ,*United States,US,5/14/2013,, ,5/14/2013,2161-001,Small,5/14/2013,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47741,"Te Du, Bernard Roizman, Grace Zhou",Provisional,4/12/2018,2161-001,5/14/2014,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613490,,583380,Yes
2840,12-T-095,Modulation of Reactivation of a Latent Virus,PCT/US14/00110, ,*United States,US,5/14/2014,,WO 2014/185973,5/14/2014,2161-002,Small,5/14/2013,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47741A-PC,"Te Du, Bernard Roizman, Grace Zhou",PCT,4/12/2018,2161-002,5/14/2034,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613491,1/22/2015,583380,Yes
2841,12-T-095,Modulation of Reactivation of a Latent Virus,"14/891,200","9,669,036",*United States,US,5/14/2014,6/6/2017,2016-0089376-A1,11/13/2015,2161-003,Small,5/14/2013,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0705US,"Te Du, Bernard Roizman, Grace Zhou",Nationalized PCT,4/12/2018,2161-003,5/14/2034,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613492,,583380,No
2842,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"61/697,766", ,*United States,US,9/6/2012,, ,9/6/2012,2163-001,Small,9/6/2012,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47153,Elizabeth McNally,Provisional,4/12/2018,2163-001,9/6/2013,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610428,,583383,Yes
2843,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,PCT/US13/58636, ,*United States,US,9/6/2013,,WO 2014/039916,9/9/2013,2163-002,Small,9/6/2012,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47153A-PC,Elizabeth McNally,PCT,4/12/2018,2163-002,3/6/2015,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610429,3/13/2014,583383,Yes
2844,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"14/426,348","9,499,817",*United States,US,9/6/2013,11/22/2016,2015-0225718-A1,3/5/2015,2163-003,Small,9/6/2012,11/22/2016,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",47153A,Elizabeth McNally,Nationalized PCT,4/12/2018,2163-003,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610430,8/13/2015,583383,Yes
2845,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,2460/DELNP/2015,347710,India,IN,9/6/2013,9/25/2020,WO 2014/039916,3/26/2015,2163-004,Small,9/6/2012,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",47153A-IN,Elizabeth McNally,Nationalized PCT,4/12/2018,2163-004,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610431,4/22/2016,583383,Yes
2846,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,112015005091-3,BR112015005091-3,Brazil,BR,9/6/2013,7/6/2021, ,3/6/2015,2163-005,Small,9/6/2012,10/14/2021,No,5/2/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153A BR,Elizabeth McNally,Nationalized PCT,4/12/2018,2163-005,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610432,5/21/2019,583383,Yes
2847,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"2,884,245", ,Canada,CA,9/6/2013,, ,3/5/2015,2163-006,Small,9/6/2012,,No,5/2/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A CA,Elizabeth McNally,Nationalized PCT,4/12/2018,2163-006,9/6/2032,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610433,,583383,Yes
2848,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1EPO,2892617,European Patent Office (EPO),EP,9/6/2013,6/13/2018, ,9/6/2013,2163-007,Small,9/6/2012,7/27/2018,No,5/2/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A-,Elizabeth McNally,Nationalized PCT,4/12/2018,2163-007,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610434,,583383,Yes
2849,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,TN2015/0079, ,Tunisia,TN,9/6/2013,, ,3/5/2015,2163-008,Small,9/6/2012,,No,4/28/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",47153A-TN,Elizabeth McNally,Nationalized PCT,4/12/2018,2163-008,9/6/2032,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610436,,583383,Yes
2850,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"15/254,817","9,777,271",*United States,US,9/6/2013,10/3/2017,US-2016-0369277-A1,9/2/2016,2163-010,Small,9/6/2012,10/3/2017,No,4/28/2022,Issued,"Marshall, Gerstein & Borun",,47153B,Elizabeth McNally,Divisional,4/12/2018,2163-010,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610437,12/22/2016,583383,No
2851,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"15/698,406", ,*United States,US,9/6/2013,,US-2018-0037889-A1,9/7/2017,2163-011,Small,9/6/2012,8/1/2018,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,47153C,Elizabeth McNally,Continuation,4/12/2018,2163-011,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610438,2/8/2018,583383,No
2852,12-T-098,Mini-Sgcg demonstrates feasibility for exon skipping to correct limb girdle muscular dystrophy,16100188.4HK,HK1212272,Hong Kong,HK,9/6/2013,9/13/2019,1212272,1/8/2016,2163-009,Small,9/6/2012,11/6/2019,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",47153A-HK,Elizabeth McNally,Validated EPO,4/12/2018,2163-009,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",613422,6/10/2015,583383,No
2853,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6EPO,3421602,European Patent Office (EPO),EP,9/6/2013,3/3/2021,EP 3421602 A1,6/12/2018,2163-012,Small,9/6/2012,3/2/2021,No,5/4/2022,Granted,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B EP,Elizabeth McNally,Divisional,7/23/2018, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1655425,1/2/2019,583383,Yes
2854,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"16/041,278", ,*United States,US,9/6/2013,,US-2018-0327743-A1,7/20/2018,2163-013,Small,9/6/2012,3/7/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,47153D,Elizabeth McNally,Continuation,8/22/2018, ,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1681599,11/15/2018,583383,No
2855,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1AL,2892617,Albania,AL,9/6/2013,6/13/2018, ,8/20/2018,2163-014,Small,9/6/2012,10/23/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A AL,Elizabeth McNally,Validated EPO,10/23/2018, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823693,,583383,Yes
2856,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1AT,2892617,Austria,AT,9/6/2013,6/13/2018, ,9/6/2013,2163-015,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A AT,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823707,,583383,Yes
2857,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1BE,2892617,Belgium,BE,9/6/2013,6/13/2018, ,9/6/2013,2163-016,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A BE,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823721,,583383,Yes
2858,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1CY,2892617,Cyprus,CY,9/6/2013,6/13/2018, ,9/3/2018,2163-017,Small,9/6/2012,10/23/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A CY,Elizabeth McNally,Validated EPO,10/23/2018, ,9/3/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823737,,583383,Yes
2859,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1CZ,2892617,Czech Republic,CZ,9/6/2013,6/13/2018, ,9/6/2013,2163-018,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A CZ,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823751,,583383,Yes
2860,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1DK,2892617,Denmark,DK,9/6/2013,6/13/2018, ,9/6/2013,2163-019,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A DK,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823765,,583383,Yes
2861,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1FR,2892617,France,FR,9/6/2013,6/13/2018, ,9/6/2013,2163-020,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A FR,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823779,,583383,Yes
2862,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1HR,2892617,Croatia,HR,9/6/2013,6/13/2018, ,9/12/2018,2163-021,Small,9/6/2012,10/23/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A HR,Elizabeth McNally,Validated EPO,10/23/2018, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823793,,583383,Yes
2863,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1DE,602013039014.2,Germany,DE,9/6/2013,6/13/2018,2892617,9/6/2013,2163-022,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A DE,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823807,,583383,Yes
2864,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1GR,2892617,Greece,GR,9/6/2013,6/13/2018, ,9/12/2018,2163-023,Small,9/6/2012,10/23/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A GR,Elizabeth McNally,Validated EPO,10/23/2018, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823821,,583383,Yes
2865,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1HU,2892617,Hungary,HU,9/6/2013,6/13/2018, ,9/6/2013,2163-024,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A HU,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823835,,583383,Yes
2866,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1IE,2892617,Ireland,IE,9/6/2013,6/13/2018, ,9/6/2013,2163-025,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A IE,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823849,,583383,Yes
2867,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1IT,502018000026406,Italy,IT,9/6/2013,6/13/2018,2892617,9/6/2013,2163-026,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A IT,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823863,,583383,Yes
2868,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1MK,2892617,"Macedonia, former Yugoslav Republic of",MK,9/6/2013,6/13/2018, ,7/22/2019,2163-027,Small,9/6/2012,10/23/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A MK,Elizabeth McNally,Validated EPO,10/23/2018, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823877,,583383,Yes
2869,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1MT,2892617,Malta,MT,9/6/2013,6/13/2018, ,9/12/2018,2163-028,Small,9/6/2012,10/23/2018,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A MT,Elizabeth McNally,Validated EPO,10/23/2018, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823891,,583383,Yes
2870,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1NL,2892617,Netherlands,NL,9/6/2013,6/13/2018, ,9/6/2013,2163-029,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A NL,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823907,,583383,Yes
2871,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1PT,2892617,Portugal,PT,9/6/2013,6/13/2018, ,9/6/2013,2163-030,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A PT,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823921,,583383,Yes
2872,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1RO,2892617,Romania,RO,9/6/2013,6/13/2018, ,9/6/2013,2163-031,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A RO,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823935,,583383,Yes
2873,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1RS,2892617,Serbia,RS,9/6/2013,6/13/2018, ,9/6/2013,2163-032,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A RS,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823949,,583383,Yes
2874,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1ES,2892617,Spain,ES,9/6/2013,6/13/2018, ,9/6/2013,2163-033,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A ES,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823965,,583383,Yes
2875,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1SE,2892617,Sweden,SE,9/6/2013,6/13/2018, ,9/6/2013,2163-034,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A SE,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823979,,583383,Yes
2876,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1CH,2892617,Switzerland,CH,9/6/2013,6/13/2018, ,9/6/2013,2163-035,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A CH,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1823993,,583383,Yes
2877,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1SI,2892617,Slovenia,SI,9/6/2013,6/13/2018, ,9/6/2013,2163-036,Small,9/6/2012,10/23/2018,No,5/23/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A SI,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1824007,,583383,Yes
2878,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1TR,2892617,Turkey,TR,9/6/2013,6/13/2018, ,9/6/2013,2163-037,Small,9/6/2012,10/23/2018,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A TR,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1824021,,583383,Yes
2879,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1GB,2892617,United Kingdom,GB,9/6/2013,6/13/2018, ,9/6/2013,2163-038,Small,9/6/2012,10/23/2018,No,6/15/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A GB,Elizabeth McNally,Validated EPO,10/23/2018,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1824035,,583383,Yes
2880,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"16/295,341", ,*United States,US,9/6/2013,,US-2019-0194659-A1,3/7/2019,2163-039,Small,9/6/2012,10/15/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373-47153E,Elizabeth McNally,Continuation,4/22/2019, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",3639344,6/27/2019,583383,No
2881,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,19126076.9,4002849,Hong Kong,HK,9/6/2013,12/3/2021,40002849,6/28/2019,2163-040,Small,9/6/2012,1/9/2022,No,5/2/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153B HK,Elizabeth McNally,Validated EPO,10/8/2019, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4028768,4/3/2020,583383,Yes
2882,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"16/656,177", ,*United States,US,9/6/2013,,US-2020-0040340-A1,10/17/2019,2163-041,Small,9/6/2012,11/20/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/47153F,Elizabeth McNally,Continuation,11/20/2019, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4123430,2/6/2020,583383,No
2883,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"16/886,171", ,*United States,US,9/6/2013,,US-2020-0291403-A1,5/28/2020,2163-042,Small,9/6/2012,6/8/2020,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/47153G,Elizabeth McNally,Continuation,6/8/2020, ,3/6/2015,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4618391,9/17/2020,583383,No
2884,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,"17/143,847", ,*United States,US,9/6/2013,,US-2021-0147845-A1,1/7/2021,2163-043,Small,9/6/2012,9/28/2021,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/47153H,Elizabeth McNally,Continuation,1/14/2021,2163-043,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5273867,5/20/2021,583383,No
2885,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,AL/P/2021/320,3421602,Albania,AL,9/6/2013,3/3/2021,,,2163-044,Small,9/6/2012,3/4/2021,No,1/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B AL,Elizabeth McNally,Validated EPO,2/16/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386671,,583383,Yes
2886,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,E-1367237,3421602,Austria,AT,9/6/2013,3/3/2021,,,2163-045,Small,9/6/2012,3/4/2021,No,1/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B AT,Elizabeth McNally,Validated EPO,2/16/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386693,,583383,Yes
2887,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6BE,3421602,Belgium,BE,9/6/2013,3/3/2021,,,2163-046,Small,9/6/2012,3/4/2021,No,1/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B BE,Elizabeth McNally,Validated EPO,2/16/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386715,,583383,Yes
2888,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,26130,3421602,Bulgaria,BG,9/6/2013,3/3/2021,,,2163-047,Small,9/6/2012,3/4/2021,No,1/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B BG,Elizabeth McNally,Validated EPO,2/16/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386849,,583383,Yes
2889,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6CY,3421602,Cyprus,CY,9/6/2013,3/3/2021,,,2163-048,Small,9/6/2012,3/4/2021,No,1/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B CY,Elizabeth McNally,Validated EPO,2/16/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386871,,583383,Yes
2890,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6CH,3421602,Switzerland,CH,9/6/2013,3/3/2021,,,2163-049,Small,9/6/2012,3/4/2021,No,1/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B CH,Elizabeth McNally,Validated EPO,2/16/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386893,,583383,Yes
2891,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6CZ,3421602,Czech Republic,CZ,9/6/2013,3/3/2021,,,2163-050,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B CZ,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386915,,583383,Yes
2892,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6DK,3421602,Denmark,DK,9/6/2013,3/3/2021,,,2163-051,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B DK,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386953,,583383,Yes
2893,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,602013076109.4,3421602,Germany,DE,9/6/2013,3/3/2021,,,2163-052,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B DE,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386975,,583383,Yes
2894,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6FI,3421602,Finland,FI,9/6/2013,3/3/2021,,,2163-053,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B FI,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5386997,,583383,Yes
2895,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6FR,3421602,France,FR,9/6/2013,3/3/2021,,,2163-054,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B FR,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387019,,583383,Yes
2896,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,300410607,3421602,Spain,ES,9/6/2013,3/3/2021,,,2163-055,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B ES,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387041,,583383,Yes
2897,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6GB,3421602,United Kingdom,GB,9/6/2013,3/3/2021,,,2163-056,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B GB,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387063,,583383,Yes
2898,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,P20210877T,3421602,Croatia,HR,9/6/2013,3/3/2021,,,2163-057,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B HR,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387085,,583383,Yes
2899,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,20210401359,3421602,Greece,GR,9/6/2013,3/3/2021,,,2163-058,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B GR,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387107,,583383,Yes
2900,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,E18177365,3421602,Hungary,HU,9/6/2013,3/3/2021,,,2163-059,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B HU,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387129,,583383,Yes
2901,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6IE,3421602,Ireland,IE,9/6/2013,3/3/2021,,,2163-060,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B IE,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387151,,583383,Yes
2902,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,502021000044435,3421602,Italy,IT,9/6/2013,3/3/2021,,,2163-061,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B IT,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387173,,583383,Yes
2903,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6LV,3421602,Latvia,LV,9/6/2013,3/3/2021,,,2163-062,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B LV,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387195,,583383,Yes
2904,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6LT,3421602,Lithuania,LT,9/6/2013,3/3/2021,,,2163-063,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B LT,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387217,,583383,Yes
2905,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6LU,3421602,Luxembourg,LU,9/6/2013,3/3/2021,,,2163-064,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B LU,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387239,,583383,Yes
2906,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,P 2021/447,3421602,"Macedonia, former Yugoslav Republic of",MK,9/6/2013,3/3/2021,,,2163-065,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B MK,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387261,,583383,Yes
2907,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6MT,3421602,Malta,MT,9/6/2013,3/3/2021,,,2163-066,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B MT,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387283,,583383,Yes
2908,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6MC,3421602,Monaco,MC,9/6/2013,3/3/2021,,,2163-067,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B MC,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387305,,583383,Yes
2909,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6NL,3421602,Netherlands,NL,9/6/2013,3/3/2021,,,2163-072,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B NL,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387327,,583383,Yes
2910,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6NO,3421602,Norway,NO,9/6/2013,3/3/2021,,,2163-068,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B NO,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387349,,583383,Yes
2911,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6PL,3421602,Poland,PL,9/6/2013,3/3/2021,,,2163-073,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B PL,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387371,,583383,Yes
2912,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,20211000020245,3421602,Portugal,PT,9/6/2013,3/3/2021,,,2163-069,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B PT,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387393,,583383,Yes
2913,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6RO,3421602,Romania,RO,9/6/2013,3/3/2021,,,2163-070,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B RO,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387415,,583383,Yes
2914,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,P-656/2021,3421602,Serbia,RS,9/6/2013,3/3/2021,,,2163-071,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B RS,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387437,,583383,Yes
2915,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,P-201331887,3421602,Slovenia,SI,9/6/2013,3/3/2021,,,2163-074,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B SI,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387459,,583383,Yes
2916,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6SE,3421602,Sweden,SE,9/6/2013,3/3/2021,,,2163-075,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B SE,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387537,,583383,Yes
2917,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,2021/007613,3421602,Turkey,TR,9/6/2013,3/3/2021,,,2163-076,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B TR,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387559,,583383,Yes
2918,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6SK,3421602,Slovakia,SK,9/6/2013,3/3/2021,,,2163-077,Small,9/6/2012,3/4/2021,No,1/25/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B SK,Elizabeth McNally,Validated EPO,2/16/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5387581,,583383,Yes
2919,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,18177365.6LI,3421602,Lichtenstein,LI,9/6/2013,3/3/2021,,,2163-080,Small,9/6/2012,3/4/2021,No,7/26/2021,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153B LI,Elizabeth McNally,Validated EPO,3/4/2021,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5442474,,583383,Yes
2920,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,1800,1800,Guyana,GY,9/6/2013,2/14/2022, ,6/14/2021,2163-079,None,9/6/2012,3/2/2022,No,6/24/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153A/GY,Elizabeth McNally,Validated EPO,7/22/2021, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5940728,,583383,Yes
2921,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,2892617,926,Gibraltar,GI,9/6/2013,7/12/2021, ,6/14/2021,2163-078,None,9/6/2012,10/28/2021,No,5/2/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/47153A GI,Elizabeth McNally,Validated EPO,7/23/2021, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5942368,,583383,Yes
2922,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1,2892617,Haiti,HT,9/6/2013,6/13/2018, ,6/14/2021,2163-081,None,9/6/2012,11/3/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A-,Elizabeth McNally,Validated EPO,8/25/2021, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6083036,,583383,Yes
2923,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1,2892617,Grenada,GD,9/6/2013,6/14/2021, ,6/14/2021,2163-082,None,9/6/2012,11/3/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A-GD,Elizabeth McNally,Validated EPO,8/25/2021, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6083499,,583383,Yes
2924,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1,520/5/2021,"Virgin Islands, British",VG,9/6/2013,6/15/2021,,6/15/2021,2163-083,Large,9/6/2012,8/25/2021,No,3/18/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A- VG,Elizabeth McNally,Nationalized PCT,8/25/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6085317,,583383,Yes
2925,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,13835266.1,2892617,Sierra Leone,SL,9/6/2013,6/13/2018, ,6/15/2021,2163-084,None,9/6/2012,11/3/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A-SL,Elizabeth McNally,Validated EPO,8/25/2021, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6085348,,583383,Yes
2926,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,P1125,2892617,Jersey,JE,9/6/2013,6/13/2018, ,8/16/2021,2163-085,Large,9/6/2012,10/28/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A-JE,Elizabeth McNally,Validated EPO,8/25/2021, ,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6085436,,583383,Yes
2927,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies,"17/470,892",,*United States,US,9/6/2013,,US-2021-0403910-A1,9/9/2021,2163-086,Small,9/6/2012,4/11/2022,No,6/16/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/47153I,Elizabeth McNally,Continuation,9/28/2021,2163-086,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6215490,12/30/2021,583383,No
2928,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies,520/5/2021,2892617,"Virgin Islands, British",VG,9/6/2013,,,8/5/2021,2163-087,Small,9/6/2012,11/4/2021,No,3/30/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-47153A-,Elizabeth McNally,Nationalized PCT,10/26/2021,,9/6/2033,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6306777,,583383,Yes
2929,12-T-098,Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies,"17/727,376",,*United States,US,9/6/2013,,,4/22/2022,2163-088,Small,9/6/2012,4/27/2022,No,6/15/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373/47153J,Elizabeth McNally,Continuation,4/11/2022,,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",7056569,,583383,
2930,12-T-099,Anti-Tumor Therapy,"61/827,402", ,*United States,US,5/24/2013,, ,5/24/2013,2165-001,Small,5/24/2013,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00002,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Provisional,4/12/2018,2165-001,5/24/2014,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610372,,583384,Yes
2931,12-T-099,Anti-Tumor Therapy,"61/842,045", ,*United States,US,7/2/2013,, ,7/2/2013,2165-002,Small,7/2/2013,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00004,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Provisional,4/12/2018,2165-002,7/2/2014,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610373,,583384,Yes
2932,12-T-099,Anti-Tumor Therapy,PCT/US14/38885, ,*United States,US,5/21/2014,,WO2014/189996A1,5/22/2014,2165-003,Small,5/24/2013,,No,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00009,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",PCT,4/12/2018,2165-003,11/21/2015,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610374,11/24/2014,583384,Yes
2933,12-T-099,Anti-Tumor Therapy,PCT/US14/43775, ,*United States,US,6/24/2014,,WO2015/002766A1,6/24/2014,2165-004,Small,7/2/2013,,No,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00011,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",PCT,4/12/2018,2165-004,1/2/2016,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610375,1/8/2015,583384,Yes
2934,12-T-099,Anti-Tumor Therapy,"14/893,690","9,790,504",*United States,US,5/21/2014,10/17/2017,US-2016-0222387-A1,11/24/2015,2165-005,Small,5/24/2013,,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-628-WO-US,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2165-005,5/21/2034,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610376,8/4/2016,583384,No
2935,12-T-099,Anti-Tumor Therapy,"14/901,929", ,*United States,US,6/24/2014,,US-2016-0367627-A1,12/29/2015,2165-006,Small,7/2/2013,,No,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-584-WO-US,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2165-006,6/24/2034,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610377,12/23/2016,583384,No
2936,12-T-099,ANTI-TUMOR THERAPY,"15/636,952", ,*United States,US,5/21/2014,,US-2017-0298362-A1,6/29/2017,2165-007,Small,5/24/2013,,No,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-628-US-CON,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Continuation,4/12/2018,2165-007,,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610378,10/19/2017,583384,No
2937,12-T-099,ANTI-TUMOR THERAPY,"15/975,396","10,561,708",*United States,US,6/24/2014,2/18/2020,US-2018-0256678-A1,5/9/2018,2165-008,None,7/2/2013,5/9/2018,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-584-US-CON,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Continuation,6/25/2018, ,6/26/2034,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",1509891,9/13/2018,583384,No
2938,12-T-099,ANTI-TUMOR THERAPY,"16/179,577", ,*United States,US,5/21/2014,,US-2019-0071679-A1,11/2/2018,2165-009,Small,5/24/2013,3/19/2019,No,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-628-US-CON-DIV,"Nikolai Khodarev, Bernard Roizman, Ravi Sood, Ralph Weichselbaum",Divisional,11/28/2018, ,5/21/2034,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",1920857,3/7/2019,583384,No
2939,12-T-117,Purine Derivative Compounds for Medical Use,14305215.7EPO,2907514,European Patent Office (EPO),EP,2/17/2014,, ,2/17/2014,2173-001,Small,2/17/2014,11/12/2018,Yes,4/28/2022,Granted,Nony Paris,,S3_EP_MANROS_BR60792,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",Nationalized PCT,4/12/2018,2173-001,2/17/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",614229,,583402,Yes
2940,12-T-117,Purine Derivative Compounds for Medical Use,"14/623,799","10,561,661",*United States,US,2/17/2015,2/18/2020, ,2/17/2015,2173-002,Small,2/17/2014,,No,5/8/2022,Issued,Nony Paris,, ,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",US Utility,4/12/2018,2173-002,3/2/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",614230,,583402,Yes
2941,12-T-117,Purine Derivative Compounds for Medical Use,14305215.7FR,2907514,France,FR,2/17/2014,, ,2/17/2014,2173-003,None,2/17/2014,12/31/2019,No,4/28/2022,Issued,Nony Paris,,S3_EP_MANROS_BR60792,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",Validated EPO,12/31/2019, ,2/17/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",4198965,,583402,Yes
2942,12-T-117,Purine Derivative Compounds for Medical Use,14305215.7DE,2907514,Germany,DE,2/17/2014,, ,2/17/2014,2173-004,None,2/17/2014,12/31/2019,No,4/28/2022,Issued,Nony Paris,,S3_EP_MANROS_BR60792,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",Validated EPO,12/31/2019, ,2/17/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",4198987,,583402,Yes
2943,12-T-117,Purine Derivative Compounds for Medical Use,14305215.7IT,2907514,Italy,IT,2/17/2014,, ,2/17/2014,2173-005,None,2/17/2014,12/31/2019,No,4/28/2022,Issued,Nony Paris,,S3_EP_MANROS_BR60792,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",Validated EPO,12/31/2019, ,2/17/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",4199009,,583402,Yes
2944,12-T-117,Purine Derivative Compounds for Medical Use,14305215.7ES,2907514,Spain,ES,2/17/2014,, ,2/17/2014,2173-006,None,2/17/2014,12/31/2019,No,4/28/2022,Issued,Nony Paris,,S3_EP_MANROS_BR60792,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",Validated EPO,12/31/2019, ,2/17/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",4199031,,583402,Yes
2945,12-T-117,Purine Derivative Compounds for Medical Use,14305215.7GB,2907514,United Kingdom,GB,2/17/2014,, ,2/17/2014,2173-007,None,2/17/2014,12/31/2019,No,4/28/2022,Issued,Nony Paris,,S3_EP_MANROS_BR60792,"Laurent Meijer, Deborah Nelson, Vladimir Riazanski",Validated EPO,12/31/2019, ,2/17/2034,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",4199053,,583402,Yes
2946,12-T-119,Methods for Detecting Cytosine Modifications,"62/442,230", ,*United States,US,1/4/2017,, ,1/4/2017,2174-001,Small,1/4/2017,,Yes,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,, ,"Chuan He, Frederick Jiang",Provisional,4/12/2018,2174-001,1/4/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",613160,,583404,No
2947,12-T-119,Methods for Detecting Cytosine Modifications,PCT/US18/12288, ,*United States,US,1/4/2018,,WO2018/129120,1/4/2018,2174-002,Small,1/4/2017,,No,6/8/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",1001011267,"Chuan He, Lulu Hu, Frederick Jiang",PCT,4/12/2018,2174-002,7/4/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",613161,7/12/2018,583404,No
2948,12-T-119,Methods for Detecting Cytosine Modifications,"16/475,402", ,*United States,US,1/4/2018,,US-2020-0190581-A1,7/2/2019,2174-003,Small,1/4/2017,7/2/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0622US,"Chuan He, Lulu Hu, Frederick Jiang",Nationalized PCT,7/2/2019, ,1/4/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",3788628,6/18/2020,583404,No
2949,12-T-121,GB1 Peptidic Compounds and Methods for Making and Using the Same,"61/722,010", ,*United States,US,11/2/2012,, ,11/2/2012,2176-001,Small,11/2/2012,,Yes,4/28/2022,Expired - Inactive,"Bozicevic, Field & Francis","Field, Bret", ,"Dana Ault-Riche, Stephen Kent, Dong Jun Lee, Kalyaneswar Mandal, Sachdev Sidhu, Maruti Uppalapati",Provisional,4/12/2018,2176-001,11/2/2013,"Bakalyar, Heather",Stephen Kent,"Juggernauth, Anne",611633,,583406,Yes
2950,12-T-121,GB1 Peptidic Compounds and Methods for Making and Using the Same,PCT/US13/68137, ,*United States,US,11/1/2013,,WO 2014/071234,11/1/2013,2176-002,Small,11/2/2012,,No,4/28/2022,Abandoned,"Bozicevic, Field & Francis","Field, Bret", ,"Dana Ault-Riche, Stephen Kent, Dong Jun Lee, Kalyaneswar Mandal, Sachdev Sidhu, Maruti Uppalapati",PCT,4/12/2018,2176-002,11/2/2032,"Bakalyar, Heather",Stephen Kent,"Juggernauth, Anne",611634,5/8/2014,583406,Yes
2951,12-T-128,Methods and Compositions for Inhibiting Human Copper Trafficking Proteins Atoxi and CCS,"61/755,845", ,*United States,US,1/23/2013,, ,1/23/2013,2183-001,Small,1/23/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, HuaLiang Jiang, Hong Liu, Cheng Luo, Sisheng Ouyang, Jing Wang, Xizowei Wu, Yu Zhou",Provisional,4/12/2018,2183-001,1/23/2014,"Hwang, Luke",Chuan He,"Tennant, Thelma",612781,,583413,Yes
2952,12-T-128,Methods and Compositions for Inhibiting Human Copper Trafficking Proteins Atoxi and CCS,PCT/US14/12793, ,*United States,US,1/23/2014,,WO 2014/116859,1/23/2014,2183-002,Small,1/23/2013,7/23/2015,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, HuaLiang Jiang, Hong Liu, Cheng Luo, Sisheng Ouyang, Jing Wang, Xizowei Wu, Yu Zhou",PCT,4/12/2018,2183-002,7/23/2015,"Hwang, Luke",Chuan He,"Tennant, Thelma",612782,7/31/2014,583413,Yes
2953,12-T-128,Methods and Compositions for Inhibiting Human Copper Trafficking Proteins Atoxi and CCS,"14/762,980", ,*United States,US,1/23/2014,,US-2016-0074373-A1,7/23/2015,2183-003,Small,1/23/2013,5/2/2017,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, HuaLiang Jiang, Hong Liu, Cheng Luo, Sisheng Ouyang, Jing Wang, Xizowei Wu, Yu Zhou",Nationalized PCT,4/12/2018,2183-003,,"Hwang, Luke",Chuan He,"Tennant, Thelma",612783,,583413,No
2954,12-T-128,Methods and Compositions for Inhibiting Human Copper Trafficking Proteins Atoxi and CCS,14742923.7EPO, ,European Patent Office (EPO),EP,1/23/2014,,1451/2948438,1/23/2014,2183-004,Small,1/23/2013,9/27/2017,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, HuaLiang Jiang, Hong Liu, Cheng Luo, Sisheng Ouyang, Jing Wang, Xizowei Wu, Yu Zhou",Nationalized PCT,4/12/2018,2183-004,,"Hwang, Luke",Chuan He,"Tennant, Thelma",612784,12/2/2015,583413,No
2955,12-T-128,Methods and Compositions for Inhibiting Human Copper Trafficking Proteins Atoxi and CCS,201480014052.2, ,China,CN,1/23/2014,,05189474 A,9/10/2015,2183-005,Small,1/23/2013,8/29/2017,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, HuaLiang Jiang, Hong Liu, Cheng Luo, Sisheng Ouyang, Jing Wang, Xizowei Wu, Yu Zhou",Nationalized PCT,4/12/2018,2183-005,,"Hwang, Luke",Chuan He,"Tennant, Thelma",612785,,583413,No
2956,12-T-128,Methods and Compositions for Inhibiting Human Copper Trafficking Proteins Atoxi and CCS,2015-555279, ,Japan,JP,1/23/2014,, ,7/22/2014,2183-006,Small,1/23/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, HuaLiang Jiang, Hong Liu, Cheng Luo, Sisheng Ouyang, Jing Wang, Xizowei Wu, Yu Zhou",Nationalized PCT,4/12/2018,2183-006,1/23/2034,"Hwang, Luke",Chuan He,"Tennant, Thelma",612786,,583413,No
2957,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,"61/719,202", ,*United States,US,10/26/2012,, ,10/26/2012,2184-001,Small,10/26/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Thomas Gajewski, Michael Leung, Stefani Spranger",Provisional,4/12/2018,2184-001,10/26/2013,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614740,,583417,Yes
2958,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,PCT/US13/66936, ,*United States,US,10/25/2013,,WO 2014/066834,10/25/2013,2184-002,Small,10/26/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Thomas Gajewski, Michael Leung, Stefani Spranger",PCT,4/12/2018,2184-002,4/25/2015,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614741,5/1/2014,583417,Yes
2959,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,"14/438,310","10,034,939",*United States,US,10/25/2013,7/31/2018,US-2015-0352206-A1,4/24/2015,2184-003,Small,10/26/2012,7/16/2018,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000211526,"Thomas Gajewski, Michael Leung, Stefani Spranger",Nationalized PCT,4/12/2018,2184-003,10/26/2033,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614742,12/10/2015,583417,Yes
2960,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,13849295.4EPO, ,European Patent Office (EPO),EP,10/25/2013,,2911669,5/22/2015,2184-004,Small,10/26/2012,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0551EP,"Thomas Gajewski, Michael Leung, Stefani Spranger",Nationalized PCT,4/12/2018,2184-004,10/25/2033,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614743,9/2/2015,583417,Yes
2961,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,"2,889,182", ,Canada,CA,10/25/2013,, ,10/25/2013,2184-005,Small,10/26/2012,1/16/2020,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0551CA,"Thomas Gajewski, Michael Leung, Stefani Spranger",Validated EPO,4/12/2018,2184-005,10/25/2033,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614744,,583417,Yes
2962,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,"16/031,650","10,967,060",*United States,US,10/25/2013,4/6/2021,US-2018-0333492-A1,7/10/2018,2184-006,Small,10/26/2012,3/22/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0551US.C1,"Thomas Gajewski, Michael Leung, Stefani Spranger",Continuation,7/11/2018, ,10/25/2033,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",1588571,11/22/2018,583417,Yes
2963,12-T-132,Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer,"17/248,745", ,*United States,US,10/25/2013,,US-2021-0228715-A1,2/5/2021,2184-007,Small,10/26/2012,2/5/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0551US.C2,"Thomas Gajewski, Michael Leung, Stefani Spranger",Continuation,2/5/2021, ,10/25/2033,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",5354743,7/29/2021,583417,Yes
2964,12-T-138,Compositions and Methods Related to Obstructive Sleep Apnea,"61/773,936", ,*United States,US,3/7/2013,, ,3/8/2013,2188-001,Small,3/7/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lev Becker, David Gozal",Provisional,4/12/2018,2188-001,3/7/2014,"Dembo, Anna",David Gozal,"Muite, Kevin",611098,,583423,Yes
2965,12-T-138,Compositions and Methods Related to Obstructive Sleep Apnea,PCT/US14/21750, ,*United States,US,3/7/2014,,WO 2014/038583,3/7/2014,2188-002,Small,3/7/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lev Becker, David Gozal",PCT,4/12/2018,2188-002,9/7/2015,"Dembo, Anna",David Gozal,"Muite, Kevin",611099,9/12/2014,583423,Yes
2966,12-T-138,Compositions and Methods Related to Obstructive Sleep Apnea,"14/771,875", ,*United States,US,3/7/2014,,US-2016-0042121-A1,9/1/2015,2188-003,Small,3/7/2013,11/11/2018,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000348768,"Lev Becker, David Gozal",Nationalized PCT,4/12/2018,2188-003,3/7/2034,"Dembo, Anna",David Gozal,"Muite, Kevin",611100,,583423,No
2967,12-T-138,Compositions and Methods Related to Obstructive Sleep Apnea,201480026312.8,ZL201480026312.8,China,CN,3/7/2014,10/18/2019,CN 105229165 A,12/8/2015,2188-004,Small,3/7/2013,11/6/2019,Yes,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0552CN,"Lev Becker, David Gozal",Nationalized PCT,4/12/2018,2188-004,3/7/2034,"Dembo, Anna",David Gozal,"Muite, Kevin",611101,1/9/2016,583423,No
2968,12-T-138,Compositions and Methods Related to Obstructive Sleep Apnea,16107779.4, ,Hong Kong,HK,3/7/2014,,1219762,5/7/2016,2188-005,Small,3/7/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0552CHK,"Lev Becker, David Gozal",Nationalized PCT,4/12/2018,2188-005,3/7/2034,"Dembo, Anna",David Gozal,"Muite, Kevin",611102,,583423,No
2969,12-T-138,Compositions and Methods Related to Obstructive Sleep Apnea,"16/185,641", ,*United States,US,3/7/2014,,US-2019-0147982-A1,11/9/2018,2188-006,Small,3/7/2013,11/28/2018,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0552US.C1,"Lev Becker, David Gozal",Continuation,11/28/2018, ,3/7/2034,"Dembo, Anna",David Gozal,"Muite, Kevin",1921507,5/16/2019,583423,No
2970,12-T-139,Identification of 5-Methyl-C In Nucleic Acid Templates,"61/637,687", ,*United States,US,4/24/2012,, ,4/24/2012,2189-001,Large,4/24/2012,,Yes,4/28/2022,Expired - Inactive,"Pacific Biosciences of California, Inc.",, ,"Tyson Clark, Chuan He, Frederick Jiang, Jonas Korlach, Liang Zhang",Provisional,4/12/2018,2189-001,4/24/2013,"Hwang, Luke",Chuan He,"Tennant, Thelma",611882,,583424,Yes
2971,12-T-139,Identification of 5-Methyl-C In Nucleic Acid Templates,PCT/US13/37829, ,*United States,US,4/23/2013,, ,4/23/2013,2189-002,Large,4/24/2012,,No,4/28/2022,Expired - Inactive,"Pacific Biosciences of California, Inc.",, ,"Tyson Clark, Chuan He, Frederick Jiang, Jonas Korlach, Liang Zhang",PCT,4/12/2018,2189-002,10/24/2014,"Hwang, Luke",Chuan He,"Tennant, Thelma",611883,,583424,Yes
2972,12-T-139,Identification of 5-Methyl-C In Nucleic Acid Templates,"13/868,661","9,175,348",*United States,US,4/23/2013,11/3/2015, ,4/23/2013,2189-003,Large,4/24/2012,11/3/2015,No,4/28/2022,Issued,"Pacific Biosciences of California, Inc.",, ,"Tyson Clark, Chuan He, Frederick Jiang, Jonas Korlach, Liang Zhang",US Utility,4/12/2018,2189-003,7/31/2033,"Hwang, Luke",Chuan He,"Tennant, Thelma",611884,,583424,Yes
2973,12-T-141,Composition and Methods for Delivering Antibiotics,"61/721,128", ,*United States,US,11/1/2012,, ,11/1/2012,2191-001,Small,11/1/2012,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Benoit Roux, Brigitte Ziervogel",Provisional,4/12/2018,2191-001,11/1/2013,"Unassigned, Unassigned",Benoit Roux,"Unassigned, Unassigned",610956,,583426,Yes
2974,12-T-142,Methods and Compositions for Countermeasures Against Radiation,"61/940,773", ,*United States,US,2/17/2014,, ,2/17/2014,2192-001,Small,2/17/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Grdina, Richard Miller, Jeffrey Murley",Provisional,4/12/2018,2192-001,2/17/2015,"Cox, Ben",David Grdina,"Tennant, Thelma",612670,,583427,Yes
2975,12-T-142,Methods and Compositions for Countermeasures Against Radiation,"61/975,438", ,*United States,US,4/4/2014,, ,4/4/2014,2192-002,Small,4/4/2014,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Grdina, Richard Miller, Jeffrey Murley",Provisional,4/12/2018,2192-002,2/17/2015,"Cox, Ben",David Grdina,"Tennant, Thelma",612671,,583427,Yes
2976,12-T-142,Methods and Compositions for Countermeasures Against Radiation,"14/624,157", ,*United States,US,2/17/2015,,US-2015-0231093-A1,2/17/2015,2192-003,Small,2/17/2014,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Grdina, Richard Miller, Jeffrey Murley",US Utility,4/12/2018,2192-003,2/17/2035,"Cox, Ben",David Grdina,"Tennant, Thelma",612672,8/20/2015,583427,Yes
2977,13-T-007,Compositions and Methods for Diagnosing or Prognosing Interstitial Lung Disease,"61/759,820", ,*United States,US,2/1/2013,, ,2/1/2013,2198-001,Small,2/1/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joe Garcia, Naftali Kaminski, Imre Noth",Provisional,4/12/2018,2198-001,2/1/2014,"Butler, Brittany",Imre Noth,"Butler, Brittany",610987,,583438,Yes
2978,13-T-007,Compositions and Methods for Diagnosing or Prognosing Interstitial Lung Disease,PCT/US14/14395, ,*United States,US,2/3/2014,, ,2/3/2014,2198-002,Small,2/1/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joe Garcia, Naftali Kaminski, Imre Noth",PCT,4/12/2018,2198-002,8/3/2015,"Butler, Brittany",Imre Noth,"Butler, Brittany",610988,,583438,Yes
2979,13-T-008,Methods and Apparatuses Involving Mass Spectrometry to Identify Foreign Proteins in a Sample,"61/755,101", ,*United States,US,1/22/2013,, ,1/22/2013,2199-001,Small,1/22/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Stephen Kron, Samuel Volchenboum",Provisional,4/12/2018,2199-001,1/22/2014,"Ginsburg, Eric",Samuel Volchenboum,"Smith, Dane",612614,,583439,Yes
2980,13-T-008,Methods and Apparatuses Involving Mass Spectrometry to Identify Proteins in a Sample,"61/908,600", ,*United States,US,11/25/2013,, ,11/25/2013,2199-002,Small,11/25/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Stephen Kron, Samuel Volchenboum",Provisional,4/12/2018,2199-002,1/22/2014,"Ginsburg, Eric",Samuel Volchenboum,"Smith, Dane",612615,,583439,Yes
2981,13-T-008,Methods and Apparatuses Involving Mass Spectrometry to Identify Proteins in a Sample,PCT/US14/12564, ,*United States,US,1/22/2014,,WO 2014/116711,1/23/2014,2199-003,Small,1/22/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Stephen Kron, Samuel Volchenboum",PCT,4/12/2018,2199-003,7/22/2015,"Ginsburg, Eric",Samuel Volchenboum,"Smith, Dane",612616,7/31/2014,583439,Yes
2982,13-T-036,METHODS AND COMPOSITIONS INVOLVING RAD51 INHIBITORS,"61/731,982", ,*United States,US,11/30/2012,, ,11/30/2012,2201-001,Small,11/30/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Brian Budke, Philip Connell, Jay Kalin, Alan Kozikowski, Michal Pawlowski",Provisional,4/12/2018,2201-001,11/30/2013,"Peace, Shane",Philip Connell,"Tennant, Thelma",612982,,583467,Yes
2983,13-T-036,METHODS AND COMPOSITIONS INVOLVING RAD51 INHIBITORS,PCT/US13/72172, ,*United States,US,11/27/2013,,WO 2014/085545,11/27/2013,2201-002,Small,11/30/2012,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Brian Budke, Philip Connell, Jay Kalin, Alan Kozikowski, Michal Pawlowski",PCT,4/12/2018,2201-002,5/27/2015,"Peace, Shane",Philip Connell,"Tennant, Thelma",612983,6/5/2014,583467,Yes
2984,13-T-036,METHODS AND COMPOSITIONS INVOLVING RAD51 INHIBITORS,"14/648,115","10,912,761",*United States,US,11/27/2013,2/9/2021, ,5/28/2015,2201-003,Small,11/30/2012,1/21/2021,No,5/2/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0555US,"Brian Budke, Philip Connell, Jay Kalin, Alan Kozikowski, Michal Pawlowski",US Utility,4/12/2018,2201-003,12/15/2033,"Peace, Shane",Philip Connell,"Tennant, Thelma",612984,,583467,Yes
2985,13-T-054,Methods and Compositions for Bacteria Infections,"61/789,716", ,*United States,US,3/15/2013,, ,3/15/2013,2215-001,Small,3/15/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum, Micheal Johnson Ph.D.",Provisional,4/12/2018,2215-001,3/15/2014,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612653,,583485,Yes
2986,13-T-054,Methods and Compositions for Bacteria Infections,PCT/US14/29237, ,*United States,US,3/14/2014,, ,3/14/2014,2215-002,Small,3/15/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum, Micheal Johnson Ph.D.",PCT,4/12/2018,2215-002,9/15/2015,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612654,9/18/2014,583485,Yes
2987,13-T-054,Methods and Compositions for Bacteria Infections,"14/776,965","9,675,592",*United States,US,3/14/2014,6/13/2017,US-2016-0120852-A1,9/15/2015,2215-003,Small,3/15/2013,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum, Micheal Johnson Ph.D.",Nationalized PCT,4/12/2018,2215-003,3/14/2034,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612655,,583485,No
2988,13-T-054,Methods and Compositions for Bacteria Infections,14764384.5EPO, ,European Patent Office (EPO),EP,3/14/2014,,2969003,3/14/2014,2215-004,Small,3/15/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000220371,"Susan Boyle-Vavra, Robert Daum, Micheal Johnson Ph.D.",Nationalized PCT,4/12/2018,2215-004,,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612656,,583485,No
2989,13-T-054,Methods and Compositions for Bacteria Infections,2016-503023, ,Japan,JP,3/14/2014,,JP2016-516055,9/8/2015,2215-005,Small,3/15/2013,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",1000203994,"Susan Boyle-Vavra, Robert Daum, Micheal Johnson Ph.D.",Nationalized PCT,4/12/2018,2215-005,3/14/2024,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612657,,583485,No
2990,13-T-054,Methods and Compositions for Bacteria Infections,"15/618,258", ,*United States,US,3/14/2014,,US-2017-0273954-A1,6/9/2017,2215-006,Small,3/15/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Susan Boyle-Vavra, Robert Daum, Micheal Johnson Ph.D.",Nationalized PCT,4/12/2018,2215-006,3/17/2034,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612658,9/28/2017,583485,No
2991,13-T-055,MODULATING INTERCELLULAR COMMUNICATION PROTEIN ACTIVITY TO PREVENT AND TREAT CATARACTS,"61/776,575", ,*United States,US,3/11/2013,, ,3/11/2013,2216-001,Small,3/11/2013,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47557,"Viviana Berthoud-Barrandeguy, Eric Beyer, Peter Minogue",Provisional,4/12/2018,2216-001,3/11/2014,"Dembo, Anna",Eric Beyer,"Tennant, Thelma",613469,,583486,Yes
2992,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,"61/935,129", ,*United States,US,2/3/2014,, ,2/3/2014,2218-001,Small,2/3/2014,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Murray, John",00371,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Provisional,4/12/2018,2218-001,2/3/2015,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",610999,,583487,Yes
2993,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,PCT/US15/14296, ,*United States,US,2/3/2015,, ,2/3/2015,2218-002,Small,2/3/2014,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00388,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",PCT,4/12/2018,2218-002,8/3/2016,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",611000,8/6/2015,583487,Yes
2994,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5EPO,3102721,European Patent Office (EPO),EP,2/3/2015,4/15/2020,3102721,2/3/2015,2218-005,Small,2/3/2014,,No,4/28/2022,Granted,Barnes & Thornburg,,21459-313113,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Nationalized PCT,4/12/2018,2218-005,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",611001,4/15/2020,583487,Yes
2995,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,201580018619.8,201580018619.8,China,CN,2/3/2015,8/13/2019,107002289,2/3/2015,2218-006,Small,2/3/2014,3/26/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-309763,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Nationalized PCT,4/12/2018,2218-006,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",611002,8/8/2015,583487,Yes
2996,13-T-056,Methods of quantitative assessment of DNA-binding proteins density,2016-549801,6985010,Japan,JP,2/3/2015,12/21/2021,2017-506073,8/3/2016,2218-003,Small,2/3/2014,1/20/2022,No,6/16/2022,Issued,Barnes & Thornburg,"Martin, Alice",21459-309766,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Nationalized PCT,4/12/2018,2218-003,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",613341,3/2/2017,583487,Yes
2997,13-T-056,Compositions and Methods for quantitative assessment of DNA-protein complex density,"15/115,081", ,*United States,US,2/3/2015,,US-2016-0341743-A1,7/28/2016,2218-004,Small,2/3/2014,,No,4/28/2022,Pending,Barnes & Thornburg,"Martin, Alice",21459-309764,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Nationalized PCT,4/12/2018,2218-004,8/5/2033,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",613342,11/25/2016,583487,Yes
2998,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5GB,3102721,United Kingdom,GB,2/3/2015,4/15/2020, ,2/3/2020,2218-013,Small,2/3/2014,10/14/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324035,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477307,,583487,Yes
2999,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5DE,602015050733.9,Germany,DE,2/3/2015,4/15/2020,3102721,2/3/2020,2218-009,Small,2/3/2014,10/14/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324032,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477333,,583487,Yes
3000,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5FR,3102721,France,FR,2/3/2015,4/15/2020, ,2/3/2020,2218-008,Small,2/3/2014,10/14/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324034,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477359,,583487,Yes
3001,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5IT,502020000065791,Italy,IT,2/3/2015,4/15/2020,3102721,2/3/2020,2218-010,Small,2/3/2014,10/14/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324036,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477385,,583487,Yes
3002,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5BE,3102721,Belgium,BE,2/3/2015,4/15/2020, ,2/29/2020,2218-007,Small,2/3/2014,4/20/2020,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324030,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477411,,583487,Yes
3003,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5ES,3102721,Spain,ES,2/3/2015,4/15/2020, ,3/2/2020,2218-011,Small,2/3/2014,10/14/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324033,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477437,,583487,Yes
3004,13-T-056,Compositions and Methods for Quantitative Assessment of DNA-Protein Complex Density,15744035.5CH,3102721,Switzerland,CH,2/3/2015,4/15/2020, ,2/3/2020,2218-012,Small,2/3/2014,10/14/2021,No,5/23/2022,Issued,Barnes & Thornburg,,21459-324031,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Validated EPO,4/20/2020, ,2/3/2035,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4477463,,583487,Yes
3005,13-T-056,Compositions and Methods for quantitative assessment of DNA-protein complex density,"16/906,513", ,*United States,US,2/3/2015,,2020-0319204-A1,6/19/2020,2218-014,Small,2/3/2014,7/1/2020,No,6/21/2022,Pending,Barnes & Thornburg,"Martin, Alice",21459-321777,"Zhonglei Chen, Adrian Grzybowski, Alexander Ruthenburg",Divisional,7/1/2020, ,,"Ramirez, Mario Riojas",Alexander Ruthenburg,"Tennant, Thelma",4683789,10/8/2020,583487,Yes
3006,13-T-057,ANTIBODIES TO TARGET DOMAINS OF NICASTRIN AND USES THEREOF,"61/777,153", ,*United States,US,3/12/2013,, ,3/12/2013,2219-001,Small,3/12/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Robert Hoey, Shohei Koide, Sangram Sisodia, Xulun Zhang",Provisional,4/12/2018,2219-001,3/12/2014,"Sun, Han",Sangram Sisodia,"Butler, Brittany",610405,,583488,Yes
3007,13-T-059,Polymer Compositions and Methods of Use Thereof,"61/910,783", ,*United States,US,12/2/2013,, ,12/2/2013,2221-001,Small,12/2/2013,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00363,"Todd Emrick, Ka Yee Lee, Jeremy Marks, Jia-Yu Wang",Provisional,4/12/2018,2221-001,12/2/2014,"Ginsburg, Eric",Ka Yee Lee,"Juggernauth, Anne",614082,,583490,Yes
3008,13-T-059,Polymer Compositions and Methods of Use Thereof,PCT/US14/68039, ,*United States,US,12/2/2014,, ,12/2/2014,2221-002,Small,12/2/2013,6/2/2015,No,4/28/2022,Abandoned,Brinks Gilson & Lione,,00384,"Todd Emrick, Ka Yee Lee, Jeremy Marks, Jia-Yu Wang",PCT,4/12/2018,2221-002,6/2/2015,"Ginsburg, Eric",Ka Yee Lee,"Juggernauth, Anne",614083,,583490,Yes
3009,13-T-066,DIRECT EVOLUTION OF A REGIOSELECTIVE HALOGENASE FOR INCREASED THERMOSTABILITY,"15/100,065","10,344,267",*United States,US,11/26/2014,7/9/2019,US-2017-0002334-A1,5/27/2016,2226-003,Small,11/27/2013,12/19/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0569US,"Mary Andorfer, Jared Lewis, James Payne, Catherine Poor",Nationalized PCT,4/12/2018,2226-003,5/8/2035,"Ginsburg, Eric",Jared Lewis,"Juggernauth, Anne",611458,1/6/2017,583497,Yes
3010,13-T-066,Directed Evolution Of A Regioselective Halogenase For Increased Thermostability,"61/909,951", ,*United States,US,11/27/2013,, ,11/27/2013,2226-001,Small,11/27/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mary Andorfer, Jared Lewis, James Payne",Provisional,4/12/2018,2226-001,11/27/2014,"Ginsburg, Eric",Jared Lewis,"Juggernauth, Anne",611461,,583497,Yes
3011,13-T-066,Directed Evolution Of A Regioselective Halogenase For Increased Thermostability,PCT/US14/67661, ,*United States,US,11/26/2014,,WO2015/081228,11/26/2014,2226-002,Small,11/27/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mary Andorfer, Jared Lewis, James Payne, Catherine Poor",PCT,4/12/2018,2226-002,5/27/2016,"Ginsburg, Eric",Jared Lewis,"Juggernauth, Anne",611462,6/4/2015,583497,Yes
3012,13-T-067,Increase of fractional uptake by vanadyl chelate,"61/984,720", ,*United States,US,4/25/2014,, ,4/25/2014,2227-001,Small,4/25/2014,,Yes,4/28/2022,Expired - Inactive,,, ,"Chin-Tu Chen, Suzanne Conzen, Marvin Makinen",Provisional,4/12/2018,2227-001,4/25/2015,"Bakalyar, Heather",Marvin Makinen,"Muite, Kevin",611982,,583498,Yes
3013,13-T-071,Treatment of Spinal Cord Injury or Traumatic Brain Injury by Inhibition of Amyloidogenic Protein and Synuclein Protein Accumulation or Aggregation,"61/901,733", ,*United States,US,11/8/2013,, ,11/8/2013,MBL-0015-001,Small,11/8/2013,,Yes,4/28/2022,Expired - Inactive,Clark & Elbing LLP,, ,"Gal Bitan, David Busch, Jennifer Morgan",Provisional,4/12/2018,MBL-0015-001,11/8/2014,"Peace, Shane",Jennifer Morgan,"Muite, Kevin",615046,,583502,Yes
3014,13-T-071,Treatment of Spinal Cord Injury or Traumatic Brain Injury by Inhibition of Amyloidogenic Protein and Synuclein Protein Accumulation or Aggregation,"14/536,176","10,918,657",*United States,US,11/7/2014,2/16/2021,US-2015-0202222-A1,11/7/2014,MBL-0015-002,Small,11/8/2013,10/14/2021,No,4/28/2022,Issued,Weaver Austin Villeneuve & Sampson LLP,,UCLAP118US,"Gal Bitan, David Busch, Jennifer Morgan",US Utility,4/12/2018,MBL-0015-002,11/21/2034,"Peace, Shane",Jennifer Morgan,"Muite, Kevin",615047,7/23/2015,583502,Yes
3015,13-T-071,Treatment of Spinal Cord Injury or Traumatic Brain Injury by Inhibition of Amyloidogenic Protein and Synuclein Protein Accumulation or Aggregation,"17/173,106", ,*United States,US,11/7/2014,, ,2/10/2021,MBL-0015-003,Small,11/8/2013,8/30/2021,No,4/28/2022,Abandoned,Weaver Austin Villeneuve & Sampson LLP,"Hunter, Tom", ,"Gal Bitan, David Busch, Jennifer Morgan",Divisional,2/10/2021, ,11/7/2034,"Peace, Shane",Jennifer Morgan,"Muite, Kevin",5370473,,583502,Yes
3016,13-T-076,Expression Profiling Reveals Cathepsins Involved in Secretory Vesicle Maturation in Tetrhymena Thermophila,"61/843,206", ,*United States,US,7/5/2013,, ,7/5/2013,2230-001,Small,7/5/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joseph Briguglio, Santosh Kumar, Aaron Turkewitz",Provisional,4/12/2018,2230-001,7/5/2014,"Dembo, Anna",Aaron Turkewitz,"Tennant, Thelma",611558,,583507,Yes
3017,13-T-076,Expression Profiling Reveals Cathepsins Involved in Secretory Vesicle Maturation in Tetrhymena Thermophila,PCT/US14/45414, ,*United States,US,7/3/2014,,WO 2015/003136,7/3/2014,2230-002,Small,7/5/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joseph Briguglio, Santosh Kumar, Aaron Turkewitz",PCT,4/12/2018,2230-002,1/3/2016,"Dembo, Anna",Aaron Turkewitz,"Tennant, Thelma",611559,1/8/2015,583507,Yes
3018,13-T-080,Methods and Compositions Related to T-Cell Activity,"15/937,044","10,815,531",*United States,US,3/14/2014,10/27/2020,US-2018-0312929-A1,3/27/2018,2232-005,Small,3/15/2013,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560US.C1,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",Continuation,4/12/2018,2232-005,4/1/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613064,11/1/2018,583511,No
3019,13-T-080,Methods for Diagnosis and Treatment of Cancer Through Identification and Suppression of T-cell Anergy by way of the EGR2 Transcriptome,"61/794,535", ,*United States,US,3/15/2013,, ,3/15/2013,2232-001,Small,3/15/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560US.P1,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",Provisional,4/12/2018,2232-001,3/15/2014,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613174,,583511,Yes
3020,13-T-080,Methods for Diagnosis and Treatment of Cancer Through Identification and Suppression of T-cell Anergy by way of the EGR2 Transcriptome,PCT/US14/29173, ,*United States,US,3/14/2014,,WO 2014/144666,3/14/2014,2232-002,Small,3/15/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560WO,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",PCT,4/12/2018,2232-002,9/14/2015,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613175,9/18/2014,583511,Yes
3021,13-T-080,Methods for Diagnosis and Treatment of Cancer Through Identification and Suppression of T-cell Anergy by way of the EGR2 Transcriptome,"14/777,123","9,944,992",*United States,US,3/14/2014,4/17/2018,US-2016-0024593-A1,9/15/2015,2232-003,Small,3/15/2013,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560US,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",Nationalized PCT,4/12/2018,2232-003,3/14/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613176,,583511,No
3022,13-T-080,Methods for Diagnosis and Treatment of Cancer Through Identification and Suppression of T-cell Anergy by way of the EGR2 Transcriptome,14763660.9EPO, ,European Patent Office (EPO),EP,3/14/2014,,2970909,3/14/2014,2232-004,Small,3/15/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560EP,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",Nationalized PCT,4/12/2018,2232-004,3/14/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613177,,583511,No
3023,13-T-080,Methods for Diagnosis and Treatment of Cancer Through Identification and Suppression of T-cell Anergy by way of the EGR2 Transcriptome,18181943.4EPO,,European Patent Office (EPO),EP,3/14/2014,,3404116,7/5/2018,2232-006,Small,3/15/2013,8/1/2018,No,6/6/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560EP.D1,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",Divisional,8/1/2018,,3/14/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",1672001,11/21/2018,583511,No
3024,13-T-080,Methods and Compositions Related to T-Cell Activity,"16/948,455", ,*United States,US,3/14/2014,,US-2021-0139994-A1,9/18/2020,2232-008,Small,3/15/2013,9/22/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0560US.C2,"Thomas Gajewski, Robbert Spaapen, Yuanyuan Zha, Yan Zheng",Continuation,9/22/2020,2232-008,3/14/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4910409,5/13/2021,583511,No
3025,13-T-081,Prognostic and Predictive Breast Cancer Signature,"14/952,265","10,679,730",*United States,US,5/28/2014,6/9/2020,US-2016-0078167-A1,11/25/2015,2241-003,Small,5/28/2013,,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0608US.CP1,"UnJin Lee, Marsha Rosner, Miao Sun",Continuation in Part,4/12/2018,2241-003,4/8/2037,"Sun, Han",Marsha Rosner,"Tennant, Thelma",610183,3/18/2016,583512,No
3026,13-T-081,Prognostic and Predictive Breast Cancer Signature,"61/828,103", ,*United States,US,5/28/2013,, ,5/28/2013,2241-001,Small,5/28/2013,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00005,"Kiran Chada, JianJun Chen, Ping Chen, Casey Frankenberger, Suzana Gomes, Chuan He, Hao Huang, Marsha Rosner, Devipriya Sankarasharma, Chunxiao Song, Miao Sun",Provisional,4/12/2018,2241-001,5/28/2014,"Sun, Han",Marsha Rosner,"Tennant, Thelma",614186,,583512,Yes
3027,13-T-081,Prognostic and Predictive Breast Cancer Signature,PCT/US14/39807, ,*United States,US,5/28/2014,,WO 2014/193964,5/28/2014,2241-002,Small,5/28/2013,,No,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00010,"Kiran Chada, JianJun Chen, Ping Chen, Casey Frankenberger, Suzana Gomes, Chuan He, Hao Huang, Marsha Rosner, Devipriya Sankarasharma, Chunxiao Song, Miao Sun",PCT,4/12/2018,2241-002,11/28/2015,"Sun, Han",Marsha Rosner,"Tennant, Thelma",614187,8/13/2015,583512,Yes
3028,13-T-083,Semiconducting Polymers and Ternary Blends Thereof,"61/934,558", ,*United States,US,1/31/2014,, ,1/31/2014,2234-001,Small,1/31/2014,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00369,"Luyao Lu, Tao Xu, Luping Yu",Provisional,4/12/2018,2234-001,1/31/2015,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614476,,583514,Yes
3029,13-T-083,SEMICONDUCTING POLYMERS AND TERNARY BLENDS THEREOF,"62/033,802", ,*United States,US,8/6/2014,, ,8/6/2014,2234-002,Small,8/6/2014,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00375,"Luyao Lu, Tao Xu, Luping Yu",Provisional,4/12/2018,2234-002,1/31/2015,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614477,,583514,Yes
3030,13-T-083,SEMICONDUCTING POLYMERS AND TERNARY BLENDS THEREOF,"14/610,937", ,*United States,US,1/30/2015,,US-2016-0204348-A1,1/30/2015,2234-003,Small,1/31/2014,,No,5/8/2022,Abandoned,Brinks Gilson & Lione,"Marshall, Ryan",00387,"Luyao Lu, Tao Xu, Luping Yu",US Utility,4/12/2018,2234-003,1/31/2034,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614478,,583514,Yes
3031,13-T-087,Development of Novel Drugs and Biologics that Target the Androgen Receptor,"15/158,432","9,650,359",*United States,US,10/25/2013,5/16/2017,US-2016-0257666-A1,5/18/2016,2236-007,Small,10/26/2012,4/5/2022,Yes,4/28/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,, ,"Minna Balbas, Michael Evans, Geoffrey Greene, David Hosfield, Charles Sawyers, Yang Shen",Divisional,4/12/2018,2236-007,5/18/2036,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",611397,9/8/2016,583518,No
3032,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,"61/719,117", ,*United States,US,10/26/2012,, ,10/26/2012,2236-001,Small,10/26/2012,,Yes,4/28/2022,Expired - Inactive,Choate Hall & Stewart LLP,, ,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Provisional,4/12/2018,2236-001,10/26/2013,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613495,,583518,Yes
3033,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,PCT/US13/66875, ,*United States,US,10/25/2013,,WO 2014/066799,10/25/2013,2236-002,Small,10/26/2012,,No,5/2/2022,Expired - Inactive,Choate Hall & Stewart LLP,"McLean, Thomas", ,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",PCT,4/12/2018,2236-002,4/25/2015,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613496,8/21/2014,583518,Yes
3034,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,"14/438,584","9,365,542",*United States,US,10/25/2013,6/14/2016,US-2015-0274693-A1,4/24/2015,2236-003,Small,10/26/2012,4/5/2022,No,4/28/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,, ,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Yang Shen, Kevin Vavra",Nationalized PCT,4/12/2018,2236-003,10/26/2032,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613497,10/1/2015,583518,Yes
3035,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,2013334102,2013334102,Australia,AU,10/25/2013,11/29/2018,,4/25/2015,2236-004,Small,10/26/2012,4/5/2022,No,4/5/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,,,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Nationalized PCT,4/12/2018,2236-004,10/25/2033,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613498,,583518,Yes
3036,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,13849577.5EPO, ,European Patent Office (EPO),EP,10/25/2013,,EP 2 911 666,10/25/2013,2236-005,Small,10/26/2012,4/5/2022,No,6/16/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,,2003080-0843,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Nationalized PCT,4/12/2018,2236-005,10/25/2033,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613499,9/2/2015,583518,Yes
3037,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,"2,889,756", ,Canada,CA,10/25/2013,, ,10/25/2013,2236-006,Small,10/26/2012,4/5/2022,No,4/28/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,,2003080-0842,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Nationalized PCT,4/12/2018,2236-006,10/25/2033,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613500,,583518,Yes
3038,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,"15/594,275","10,450,294",*United States,US,10/25/2013,10/22/2019,US-2017-0320849-A1,5/12/2017,2236-008,Small,10/26/2012,4/5/2022,No,4/28/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,,2003080-1392,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Divisional,4/12/2018,2236-008,10/26/2032,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613501,11/9/2017,583518,No
3039,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,2018267619,2018267619,Australia,AU,10/25/2013,9/24/2020, ,11/16/2018,2236-009,Small,10/26/2012,4/5/2022,No,4/28/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,,2003080-1637,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Divisional,11/29/2018, ,10/25/2033,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",1923222,,583518,Yes
3040,13-T-087,MODULATORS OF RESISTANT ANDROGEN RECEPTOR,"16/658,245",,*United States,US,10/25/2013,,US-2020-0172504-A1,10/21/2019,2236-010,Small,10/26/2012,4/5/2022,No,6/23/2022,Prosecution by Other Party,Choate Hall & Stewart LLP,,2003080-1755,"Victor Cruz, Bradley Green, Geoffrey Greene, David Hosfield, Muriel Laine', Shyamala Rajan, Kevin Vavra",Divisional,12/17/2019,,10/26/2033,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",4192374,6/4/2020,583518,No
3041,13-T-090,Image Domain Pansharpening Method and System for Spectral CT With Large Pixel Energy Discriminating Detectors,"13/960,819","9,437,016",*United States,US,8/7/2013,9/6/2016,,8/7/2013,2239-001,Large,8/7/2013,6/17/2022,Yes,6/17/2022,Prosecution by Other Party,"Yoshida & Associates, LLC",,,"Patrick La Riviere, Adam Petschke, David Rigie",US Utility,4/12/2018,2239-001,1/19/2034,"Cox, Ben",Patrick La Riviere,"Smith, Dane",611904,,583521,Yes
3042,13-T-090,Image Domain Pansharpening Method and System for Spectral CT With Large Pixel Energy Discriminating Detectors,2014-161436,,Japan,JP,8/7/2014,,,8/7/2014,2239-003,Large,8/7/2013,6/17/2022,No,6/17/2022,Prosecution by Other Party,"Yoshida & Associates, LLC",,,"Patrick La Riviere, Adam Petschke, David Rigie","Foreign, Non-PCT",4/12/2018,2239-003,8/7/2033,"Cox, Ben",Patrick La Riviere,"Smith, Dane",611905,,583521,Yes
3043,13-T-090,Sinogram (Data) Domain Pansharpening Method and System for Spectral CT,"13/960,821","10,176,603",*United States,US,8/7/2013,1/8/2019,,8/7/2013,2239-002,Large,8/7/2013,6/17/2022,Yes,6/17/2022,Prosecution by Other Party,"Yoshida & Associates, LLC",,,"Patrick La Riviere, Adam Petschke, David Rigie, Yuexing Zhang",US Utility,4/12/2018,2239-002,2/25/2034,"Cox, Ben",Patrick La Riviere,"Smith, Dane",614518,,583521,Yes
3044,13-T-090,Sinogram (Data) Domain Pansharpening Method and System for Spectral CT,2014-161437,,Japan,JP,8/7/2014,,,8/7/2014,2239-004,Large,8/7/2013,6/17/2022,No,6/17/2022,Prosecution by Other Party,"Yoshida & Associates, LLC",,A001301384,"Patrick La Riviere, Adam Petschke, David Rigie, Yuexing Zhang","Foreign, Non-PCT",4/12/2018,2239-004,8/7/2033,"Cox, Ben",Patrick La Riviere,"Smith, Dane",614519,,583521,Yes
3045,13-T-090,Sinogram (Data) Domain Pansharpening Method and System for Spectral CT,2018-171956,,Japan,JP,8/7/2014,,,9/13/2018,2239-005,Large,8/7/2013,6/17/2022,No,6/21/2022,Prosecution by Other Party,"Yoshida & Associates, LLC",,,"Patrick La Riviere, Adam Petschke, David Rigie, Yuexing Zhang","Foreign, Non-PCT",12/1/2018,,9/13/2038,"Cox, Ben",Patrick La Riviere,"Smith, Dane",1929991,,583521,Yes
3046,13-T-090,Sinogram (Data) Domain Pansharpening Method and System for Spectral CT,"15/703,760",,*United States,US,8/7/2014,,,9/13/2017,2239-006,Large,8/7/2013,6/17/2022,No,6/17/2022,Prosecution by Other Party,"Yoshida & Associates, LLC",,,"Patrick La Riviere, Adam Petschke, David Rigie, Yuexing Zhang",US Utility,12/1/2018,,9/13/2037,"Cox, Ben",Patrick La Riviere,"Smith, Dane",1930056,,583521,Yes
3047,13-T-097,Use of Fluorinated Derivatives of 4-Aminopyridine in Therapeutics and Medical Imaging,"61/845,878", ,*United States,US,7/12/2013,, ,7/12/2013,2250-001,Small,7/12/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Isaac Appelbaum, Pedro Brugarolas, Chin-Tu Chen, Brian Popko",Provisional,4/12/2018,2250-001,7/12/2014,"Peace, Shane",Brian Popko,"Tennant, Thelma",615190,,583528,Yes
3048,13-T-097,Use of Fluorinated Derivatives of 4-Aminopyridine in Therapeutics and Medical Imaging,PCT/US14/46379, ,*United States,US,7/11/2014,, ,7/11/2014,2250-002,Small,7/12/2013,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Isaac Appelbaum, Pedro Brugarolas, Chin-Tu Chen, Brian Popko",PCT,4/12/2018,2250-002,1/12/2016,"Peace, Shane",Brian Popko,"Tennant, Thelma",615191,,583528,Yes
3049,13-T-101,Compositions and Methods Related to Staphylococcal ESXD,"61/845,409", ,*United States,US,7/12/2013,, ,7/12/2013,2244-001,Small,7/12/2013,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Mark Anderson, Dominique Missiakas, Olaf Schneewind",Provisional,4/12/2018,2244-001,7/12/2014,"Bakalyar, Heather",Dominique Missiakas,"Butler, Brittany",611225,,583532,Yes
3050,13-T-105,Voltage Sensitive Composition and Method of Use Thereof,"61/917,091", ,*United States,US,12/17/2013,, ,12/17/2013,2249-001,Small,12/17/2013,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Murray, John",00366,"Francisco Bezanilla, Raymond Lezzi Jr., Michael Priest, Jeremy Treger",Provisional,4/12/2018,2249-001,12/17/2014,"Butler, Brittany",Francisco Bezanilla,"Butler, Brittany",615387,,583536,Yes
3051,13-T-105,Voltage Sensitive Composition and Method of Use Thereof,"62/021,832", ,*United States,US,7/8/2014,, ,7/8/2014,2249-002,Small,7/8/2014,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Murray, John",00374,"Francisco Bezanilla, Raymond Lezzi Jr., Michael Priest, Jeremy Treger",Provisional,4/12/2018,2249-002,7/8/2015,"Butler, Brittany",Francisco Bezanilla,"Butler, Brittany",615388,,583536,Yes
3052,13-T-105,Voltage Sensitive Composition and Method of Use Thereof,PCT/US14/70887, ,*United States,US,12/17/2014,,WO/095344,12/17/2014,2249-003,Small,12/17/2013,,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Murray, John",00385,"Francisco Bezanilla, Raymond Lezzi Jr., Michael Priest, Jeremy Treger",PCT,4/12/2018,2249-003,12/17/2033,"Butler, Brittany",Francisco Bezanilla,"Butler, Brittany",615389,6/25/2015,583536,Yes
3053,13-T-106,Genomic Prescribing System and Methods,"15/027,099", ,*United States,US,10/7/2014,,US-2016-0239636-A1,4/4/2016,2240-004,Small,10/7/2013,5/14/2019,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,"Keith Danahey, Peter O'Donnell, Mark Ratain",Nationalized PCT,4/12/2018,2240-004,,"Sun, Han",Mark Ratain,"Tennant, Thelma",611696,8/18/2016,583537,No
3054,13-T-106,Genomic Prescribing System and Methods,14851797.2EPO, ,European Patent Office (EPO),EP,10/7/2014,,3055692,5/8/2016,2240-005,Small,10/7/2013,7/23/2019,No,4/28/2022,Abandoned,"Valauskas Corder, LLC",, ,Mark Ratain,Nationalized PCT,4/12/2018,2240-005,,"Sun, Han",Mark Ratain,"Tennant, Thelma",611697,8/18/2016,583537,No
3055,13-T-106,SYSTEM AND METHODS FOR PROVIDING CUSTOMIZED MEDICAL SERVICES,"61/887,767", ,*United States,US,10/7/2013,, ,10/7/2013,2240-001,None,10/7/2013,,Yes,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Valauskas, Charles", ,"Keith Danahey, Peter O'Donnell, Mark Ratain, Don Saner",Provisional,4/12/2018,2240-001,10/7/2014,"Sun, Han",Mark Ratain,"Tennant, Thelma",614796,,583537,Yes
3056,13-T-106,SYSTEM AND METHODS FOR PROVIDING CUSTOMIZED MEDICAL SERVICES,PCT/US14/59472, ,*United States,US,10/7/2014,,WO 2015/054234,10/7/2014,2240-002,Small,10/7/2013,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC",, ,"Keith Danahey, Peter O'Donnell, Mark Ratain",PCT,4/12/2018,2240-002,4/7/2016,"Sun, Han",Mark Ratain,"Tennant, Thelma",614797,4/16/2015,583537,Yes
3057,13-T-112,Compositions and Methods Related to Recombinant Antibodies to Histone Posttranslational Modifications,"61/866,937", ,*United States,US,8/16/2013,, ,8/16/2013,2254-002,Small,8/16/2013,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Takamitsu Hattori, Akiko Koide, Shohei Koide, Joseph Taft, Kyoko Yokomuri",Provisional,4/12/2018,2254-002,8/16/2014,"Bakalyar, Heather",Shohei Koide,"Butler, Brittany",611208,,583543,Yes
3058,13-T-114,System and Method for Cancer Detection Using Hybrid Multidimensional Magnetic Resonance Imaging,"61/775,469", ,*United States,US,3/8/2013,, ,3/8/2013,2217-001,None,3/8/2013,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,"Stone, Jonathan",148385.00003,"Gregory Karczmar, Aytekin Oto",Provisional,4/12/2018,2217-001,3/8/2014,"Cox, Ben",Gregory Karczmar,"Smith, Dane",614779,,583545,Yes
3059,13-T-117,COMPOSITIONS AND METHODS FOR IDENTIFYING ENDOGENOUS DNA-DNA INTERACTIONS,"62/395,130", ,*United States,US,9/15/2016,, ,9/15/2016,2258-001,Small,9/15/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Ryan Bourgo, Geoffrey Greene",Provisional,4/12/2018,2258-001,9/15/2017,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",610989,,583548,No
3060,13-T-117,COMPOSITIONS AND METHODS FOR IDENTIFYING ENDOGENOUS DNA-DNA INTERACTIONS,"15/706,277", ,*United States,US,9/15/2017,,2018-0073062 A1,9/15/2017,2258-002,Small,9/15/2016,6/25/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Ryan Bourgo, Geoffrey Greene",US Utility,4/12/2018,2258-002,,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",610990,3/15/2018,583548,No
3061,13-T-118,Anti-Tumor Therapy,"61/927,383", ,*United States,US,1/15/2014,, ,1/15/2014,2259-001,Small,1/15/2014,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00007,"Nikolai Khodarev, Ralph Weichselbaum",Provisional,4/12/2018,2259-001,1/15/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610379,,583549,Yes
3062,13-T-118,Anti-Tumor Therapy,PCT/US14/62228, ,*United States,US,10/24/2014,,WO2015/108595,10/24/2014,2259-002,Small,1/15/2014,,No,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00012,"Liufu Deng, Yang-Xin Fu, Nikolai Khodarev, Ralph Weichselbaum",PCT,4/12/2018,2259-002,4/24/2016,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610380,7/23/2015,583549,Yes
3063,13-T-118,ANTI-TUMOR THERAPY,"15/109,945", ,*United States,US,10/24/2014,,US-2016-0333355-A1,7/6/2016,2259-003,Small,1/15/2014,,No,4/28/2022,Released to Inventors,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-629-WO-US,"Liufu Deng, Yang-Xin Fu, Nikolai Khodarev, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2259-003,4/25/2026,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610381,11/18/2016,583549,Yes
3064,13-T-118,ANTI-TUMOR THERAPY,14878697.3EPO, ,European Patent Office (EPO),EP,10/24/2014,,3094342,7/28/2016,2259-004,Small,1/15/2014,,No,4/28/2022,Released to Inventors,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John", ,"Liufu Deng, Yang-Xin Fu, Nikolai Khodarev, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2259-004,4/26/2016,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",610383,10/27/2016,583549,Yes
3065,13-T-119,Methods and Compositions for Treating S. Aureus Infections,"62/041,342", ,*United States,US,8/25/2014,, ,8/25/2014,2260-001,Small,8/25/2014,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anita Chong, Robert Daum, Christopher Montgomery",Provisional,4/12/2018,2260-001,8/25/2015,"Unassigned, Unassigned",Christopher Montgomery,"Unassigned, Unassigned",612932,,583550,Yes
3066,13-T-120,Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants,"61/936,307", ,*United States,US,2/5/2014,, ,2/5/2014,2261-001,Small,2/5/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47860,"Boris Engels, Christian Idel, Hans Schreiber",Provisional,4/12/2018,2261-001,2/5/2015,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610881,,583551,Yes
3067,13-T-120,Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants,PCT/US15/14665, ,*United States,US,2/5/2015,,WO 2015/120180,2/5/2015,2261-002,Small,2/5/2014,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",47860A-PC,"Boris Engels, Christian Idel, Hans Schreiber",PCT,4/12/2018,2261-002,8/5/2016,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610882,8/13/2015,583551,Yes
3068,13-T-120,Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants,"15/117,063", ,*United States,US,2/6/2015,,US-2017-0145108-A1,8/5/2016,2261-003,Small,2/5/2014,8/13/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",47860A,"Boris Engels, Christian Idel, Hans Schreiber",Nationalized PCT,4/12/2018,2261-003,2/6/2034,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610883,5/25/2017,583551,Yes
3069,13-T-120,Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants,15746143.5EPO, ,European Patent Office (EPO),EP,2/5/2015,,3102236,3/11/2016,2261-004,Small,2/5/2014,12/18/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",47860A-EP,"Boris Engels, Christian Idel, Hans Schreiber",Nationalized PCT,4/12/2018,2261-004,2/5/2035,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610884,12/15/2016,583551,Yes
3070,13-T-130,Thirty Million Words,"85/907,418","4,440,111",*United States,US,11/26/2013,, ,,2269-001,Small,11/26/2013,,Yes,8/4/2020,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9167-001,"Shannon Sapolich, Dana Suskind",Trademark,4/12/2018,2269-001,11/26/2022,"Ramirez, Mario Riojas",Dana Suskind,"Smith, Dane",614911,,583561,Yes
3071,13-T-131,Tune In Talk More Take Turns,"86/108,463","4,587,659",*United States,US,11/4/2013,10/7/2020,,,2294-001,Small,11/4/2013,,Yes,10/22/2020,Issued,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9166-001,Dana Suskind,Trademark,4/12/2018,2294-001,11/4/2033,"Ramirez, Mario Riojas",Dana Suskind,"Smith, Dane",615124,,583562,Yes
3072,13-T-133,METHODS OF DIAGNOSING AND PROGNOSING LUPUS DISORDERS USING ANTI-VIMENTIN ANTIBODIES,"61/897,804", ,*United States,US,10/30/2013,, ,10/30/2013,2270-001,None,10/30/2013,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48119,"Marcus Clark, Andrew Kinloch",Provisional,4/12/2018,2270-001,10/30/2014,"Dembo, Anna",Andrew Kinloch,"Tennant, Thelma",613317,,583564,Yes
3073,13-T-134,Recombinant Antibody Network (RAN) Platform,"16/759,271",,*United States,US,,,,,13-T-134-001,Small,,6/2/2022,,6/2/2022,Prosecution by Other Party,,,2014-18-0234,Anthony Kossiakoff,US Utility,4/12/2021,,,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",5556332,,1950743,
3074,13-T-134,Recombinant Antibody Network (RAN) Platform,18800441.0,,European Patent Office (EPO),EP,,,,,13-T-134-002,Small,,6/2/2022,,6/2/2022,Prosecution by Other Party,,,2014-18-0234,Anthony Kossiakoff,"Foreign, Non-PCT",4/12/2021,,,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",5556345,,1950743,
3075,13-T-135,Nanoscale Carriers for the Co-Delivery of Chemotherapeutics and Nucleic Acids,"61/900,698",,*United States,US,11/6/2013,, ,11/6/2013,2271-001,Small,11/6/2013,,Yes,6/8/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00001,"Chunbai He, Wenbin Lin, Demin Liu",Provisional,4/12/2018,2271-001,11/6/2014,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613638,,583566,Yes
3076,13-T-135,Nanoscale Carriers for the Co-Delivery of Chemotherapeutics and Nucleic Acids,PCT/US14/64388,,*United States,US,11/6/2014,,WO 2015/069926,11/6/2014,2271-002,Small,11/6/2013,,No,6/8/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00010,"Chunbai He, Wenbin Lin, Demin Liu",PCT,4/12/2018,2271-002,5/6/2016,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613639,5/14/2015,583566,Yes
3077,13-T-135,"Nanoscale Carriers for the Delivery of Co-Delivery of Chemotherapeutics, Nucleic Acids and Photosensitizers","15/034,799","10,517,822",*United States,US,11/6/2014,12/31/2019,US-2016/0346204-A1,5/5/2016,2271-004,Small,11/6/2013,,No,6/8/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/2 PCT/US,"Chunbai He, Wenbin Lin, Demin Liu",Nationalized PCT,4/12/2018,2271-004,11/6/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613640,12/3/2016,583566,Yes
3078,13-T-135,"Nanoscale Carriers for the Delivery or Co-Delivery of Chemotherapeutics, Nucleic Acids and Photosensitizers",2014800722580,105873569,China,CN,11/6/2014,7/28/2020,105873569,7/6/2016,2271-005,Small,11/6/2013,,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/2 PCT/CN,"Chunbai He, Wenbin Lin, Demin Liu",Nationalized PCT,4/12/2018,2271-005,11/6/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613641,8/18/2016,583566,Yes
3079,13-T-135,Nanoscale Coordination Polymers for the Co-delivery of Chemotherapeutics and Nucleic Acids,2016528894,6590802,Japan,JP,11/6/2014,9/27/2019,,5/6/2016,2271-003,Small,11/6/2013,11/5/2019,No,6/8/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/2 PCT/JP,"Chunbai He, Wenbin Lin, Demin Liu",Nationalized PCT,4/12/2018,2271-003,11/6/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613642,5/20/2015,583566,Yes
3080,13-T-135,Nanoscale Coordination Polymers for the Co-delivery of Chemotherapeutics and Nucleic Acids,14860910.0EPO, ,European Patent Office (EPO),EP,11/6/2014,,3065713,11/6/2014,2271-006,Small,11/6/2013,,No,4/28/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/2 PCT/EP,"Chunbai He, Wenbin Lin, Demin Liu",Nationalized PCT,4/12/2018,2271-006,11/6/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613643,9/16/2016,583566,Yes
3081,13-T-135,Nanoscale Coordination Polymers for the Co-delivery of Chemotherapeutics and Nucleic Acids,2019-167976, ,Japan,JP,11/6/2014,, ,9/17/2019,2271-007,Small,11/6/2013,10/22/2019,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/2/2 PCT/JP DIV,"Chunbai He, Wenbin Lin, Demin Liu",Divisional,10/22/2019, ,11/6/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4045909,,583566,Yes
3082,13-T-135,"Nanoscale Carriers for the Delivery of Co-Delivery of Chemotherapeutics, Nucleic Acids and Photosensitizers","16/577,818",,*United States,US,11/6/2014,,US-2020-0085742-A1,9/20/2019,2271-008,Small,11/6/2013,10/31/2019,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/2/2 PCT/US CON,"Chunbai He, Wenbin Lin, Demin Liu",Continuation,10/31/2019,2271-008,11/6/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4094700,3/19/2020,583566,Yes
3083,13-T-136,Tamper-proof cover for surgical instrument table,"61/887,680", ,*United States,US,10/7/2013,, ,10/7/2013,2272-001,Small,10/7/2013,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mehta, Manish",00454,"Seon-Kyu Lee, Stewart Thomas",Provisional,4/12/2018,2272-001,10/7/2014,"Bakalyar, Heather",Seon-Kyu Lee,"Tennant, Thelma",614849,,583567,Yes
3084,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,2014321200, ,Australia,AU,9/23/2014,, ,9/23/2014,2273-004,Small,9/23/2013,,No,4/28/2022,Abandoned,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2273-004,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",611612,,583570,No
3085,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,14845394.7EPO,3049536,European Patent Office (EPO),EP,9/23/2014,5/22/2019,3 049 536,4/11/2016,2273-005,Small,9/23/2013,,No,4/28/2022,Granted,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2273-005,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",611613,8/4/2016,583570,No
3086,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,201480063952.6,4152626,China,CN,9/23/2014,12/15/2020,CN105793437A,5/23/2016,2273-006,Small,9/23/2013,1/4/2021,No,6/9/2022,Issued,Armstrong Teasdale,,42979-00006,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2273-006,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",611614,7/20/2016,583570,Yes
3087,13-T-139,Methods and Compositions Relating to Cancer Therapy with DNA Damaging Agents,"61/881,331", ,*United States,US,9/23/2013,, ,9/23/2013,2273-001,Small,9/23/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Provisional,4/12/2018,2273-001,9/23/2014,"Peace, Shane",Philip Connell,"Tennant, Thelma",613069,,583570,Yes
3088,13-T-139,Methods and Compositions Relating to Cancer Therapy with DNA Damaging Agents,PCT/US14/56942, ,*United States,US,9/23/2014,,WO 2015/042570 A1,9/23/2014,2273-002,Small,9/23/2013,,No,4/28/2022,Expired - Inactive,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",PCT,4/12/2018,2273-002,3/23/2016,"Peace, Shane",Philip Connell,"Tennant, Thelma",613070,3/26/2015,583570,Yes
3089,13-T-139,Methods and Compositions Relating to Cancer Therapy with DNA Damaging Agents,"15/078,810", ,*United States,US,9/23/2014,,US-2016-0369353-A1,3/23/2016,2273-003,Small,9/23/2013,,No,4/28/2022,Pending,Armstrong Teasdale,,42979-4,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2273-003,9/25/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",613071,12/22/2016,583570,No
3090,13-T-139,Methods and Compositions Relating to Cancer Therapy with DNA Damaging Agents,"2,958,290", ,Canada,CA,9/23/2014,, ,9/23/2014,2273-007,Small,9/23/2013,,No,4/28/2022,Abandoned,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2273-007,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",613072,,583570,No
3091,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,19172280.0EPO, ,European Patent Office (EPO),EP,9/23/2014,,3543353,5/2/2019,2273-008,Large,9/23/2013,5/2/2019,No,4/28/2022,Abandoned,Stoel Reaves LLP,,30411EP1,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Divisional,5/2/2019, ,9/24/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",3681278,9/25/2019,583570,No
3092,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,14845394.7FR,3049536,France,FR,9/23/2014,, ,7/25/2019,2273-009,Small,9/23/2013,10/15/2021,No,4/28/2022,Issued,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Validated EPO,8/6/2019, ,9/24/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",3881847,,583570,No
3093,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,14845394.7DE,602014047394.6,Germany,DE,9/23/2014,, ,8/6/2019,2273-010,Small,9/23/2013,10/15/2021,No,4/28/2022,Issued,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Validated EPO,8/6/2019, ,9/24/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",3881869,,583570,No
3094,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,14845394.7GB,3049536,United Kingdom,GB,9/23/2014,, ,7/8/2019,2273-011,Small,9/23/2013,10/15/2021,No,4/28/2022,Issued,Stoel Reaves LLP,, ,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Validated EPO,8/6/2019, ,9/24/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",3881891,,583570,No
3095,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,202011481549.9, ,China,CN,9/23/2014,,112592975,12/14/2020,2273-012,Small,9/23/2013,12/14/2020,No,4/28/2022,Pending,Stoel Reaves LLP,,1002-SWL-2015-001-2.CN,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Divisional,12/14/2020, ,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",5195853,4/2/2021,583570,Yes
3096,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,202011481550.1, ,China,CN,9/23/2014,,112522408A,12/14/2020,2273-013,Small,9/23/2013,12/17/2020,No,4/28/2022,Pending,Stoel Reaves LLP,,1002-SWL-2015-001-1.CN,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Divisional,12/17/2020, ,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",5203229,3/19/2021,583570,Yes
3097,13-T-139,Four gene signature for prediction of DNA repair mechanism and selection of cancer treatment,42021029384.1,,Hong Kong,HK,9/23/2014,,40039126A,4/15/2021,2273-014,Large,9/23/2013,4/27/2021,No,3/18/2022,Pending,Stoel Reaves LLP,,21P0038C-HK1-SW,"Philip Connell, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,4/27/2021,,9/23/2034,"Peace, Shane",Philip Connell,"Tennant, Thelma",5632096,7/9/2021,583570,Yes
3098,13-T-142,Compositions and Methods for Preventing Food Allergy Sensitization,"61/937,952", ,*United States,US,2/10/2014,, ,2/10/2014,2276-001,Small,2/10/2014,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Cathryn Nagler,Provisional,4/12/2018,2276-001,2/10/2015,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",610998,,583573,Yes
3099,13-T-143,A CENTRIFUGE MICROSCOPE CAPABLE OF REALIZING POLARIZED LIGHT OBSERVATION,"08/908,220","5,982,535",*United States,US,8/7/1997,11/9/1999, ,8/7/1997,MBL-0005-001,Small,8/7/1997,8/7/2017,Yes,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,"Koji Ichie, Shinya Inoue, Chikara Nagano, Naobumi Okada, Keisuke Suzuki, Hajime Takahashi",US Utility,4/12/2018,MBL-0005-001,8/7/2017,"Butler, Brittany",Shinya Inoue,"Butler, Brittany",610201,,583574,Yes
3100,13-T-144,SLIT SCAN CENTRIFUGE MICROSCOPE,"08/910,109","5,930,033",*United States,US,8/13/1997,7/27/1999, ,8/13/1997,MBL-0006-001,Small,8/13/1997,8/13/2017,Yes,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,"Shinya Inoue, Keisuke Suzuki",US Utility,4/12/2018,MBL-0006-001,8/13/2017,"Butler, Brittany",Shinya Inoue,"Butler, Brittany",614559,,583575,Yes
3101,13-T-145,RETARDANCE MEASUREMENT SYSTEM AND METHOD,"10/616,080","7,202,950",*United States,US,7/8/2003,4/10/2007, ,7/8/2003,MBL-0009-001,None,7/8/2003,4/10/2007,Yes,4/28/2022,Issued,Marine Biological Laboratory (MBL),, ,"Rudolf Oldenbourg, Michael Shribak",US Utility,4/12/2018,MBL-0009-001,8/11/2024,"Cox, Ben",Michael Shribak,"Tennant, Thelma",614399,,583576,Yes
3102,13-T-145,RETARDANCE MEASUREMENT SYSTEM AND METHOD,"11/333,621","7,239,388",*United States,US,7/8/2003,7/3/2007, ,1/17/2006,MBL-0009-002,None,7/8/2003,7/3/2007,No,4/28/2022,Issued,Marine Biological Laboratory (MBL),, ,"Rudolf Oldenbourg, Michael Shribak",Divisional,4/12/2018,MBL-0009-002,7/8/2023,"Cox, Ben",Michael Shribak,"Tennant, Thelma",614400,,583576,Yes
3103,13-T-145,RETARDANCE MEASUREMENT SYSTEM AND METHOD,"11/715,750","7,372,567",*United States,US,7/8/2003,5/13/2008, ,3/8/2007,MBL-0009-003,None,7/8/2003,5/13/2008,No,4/28/2022,Issued,Marine Biological Laboratory (MBL),, ,"Rudolf Oldenbourg, Michael Shribak",Continuation,4/12/2018,MBL-0009-003,7/8/2023,"Cox, Ben",Michael Shribak,"Tennant, Thelma",614401,,583576,Yes
3104,13-T-146,INSTANTANEOUS POLARIZATION MEASUREMENT SYSTEM AND METHOD,"10/616,328","7,079,247",*United States,US,7/8/2003,7/18/2006, ,7/8/2003,MBL-0010-001,Small,7/8/2003,7/18/2006,Yes,4/28/2022,Issued,Marine Biological Laboratory (MBL),, ,"Paul Cronin, Clifford Hoyt, Peter Miller, Rudolf Oldenbourg, Michael Shribak",US Utility,4/12/2018,MBL-0010-001,6/23/2024,"Cox, Ben",Michael Shribak,"Tennant, Thelma",612036,,583577,Yes
3105,13-T-147,USE OF MARINE ALGAE FOR PRODUCING HYDROCARBONS,"12/967,478", ,*United States,US,12/14/2010,, ,12/14/2010,MBL-0011-001,Small,12/17/2009,5/16/2014,No,4/28/2022,Abandoned,Ropes & Gray LLP,, ,"Scott Lindell, Christopher Reddy",US Utility,4/12/2018,MBL-0011-001,,"Peace, Shane",Scott Lindell,"Tennant, Thelma",615203,,583578,Yes
3106,13-T-147,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"14/187,929", ,*United States,US,12/14/2010,,US-2014-0171608-A1,2/24/2014,MBL-0011-002,Small,12/17/2009,8/24/2016,No,4/28/2022,Abandoned,Ropes & Gray LLP,, ,"Scott Lindell, Christopher Reddy",Continuation in Part,4/12/2018,MBL-0011-002,,"Peace, Shane",Scott Lindell,"Tennant, Thelma",615204,6/19/2014,583578,Yes
3107,13-T-147,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"14/599,460","9,970,034",*United States,US,1/17/2015,5/15/2018,US 2015-0140619 A1,1/17/2015,MBL-0011-003,Small,12/17/2009,5/4/2020,No,4/28/2022,Issued,Ropes & Gray LLP,,168111.010206/US,"Scott Lindell, Gregory O'Neil, Christopher Reddy",Continuation in Part,5/4/2020, ,1/17/2035,"Peace, Shane",Scott Lindell,"Tennant, Thelma",4525473,5/21/2015,583578,Yes
3108,13-T-147,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"15/949,983","10,208,321",*United States,US,4/10/2018,2/19/2019,US 2018-0230501 A1,2/19/2019,MBL-0011-004,Small,12/17/2009,5/4/2020,No,4/28/2022,Issued,Ropes & Gray LLP,,WWUN166263,"Scott Lindell, Gregory O'Neil, Christopher Reddy",Divisional,5/4/2020, ,4/10/2038,"Peace, Shane",Scott Lindell,"Tennant, Thelma",4525596,8/16/2018,583578,Yes
3109,13-T-147,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"61/414,491", ,*United States,US,11/17/2010,, ,11/17/2010,MBL-0011-005,Small,11/17/2010,5/4/2020,No,4/28/2022,Expired Prov - Filed in US,Ropes & Gray LLP,,168111.010204,"Scott Lindell, Gregory O'Neil, Christopher Reddy",Provisional,5/4/2020, ,11/17/2011,"Peace, Shane",Scott Lindell,"Tennant, Thelma",4525650,,583578,Yes
3110,13-T-147,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"61/287,585", ,*United States,US,12/17/2009,, ,12/17/2009,MBL-0011-007,Small,12/17/2009,5/4/2020,No,4/28/2022,Expired Prov - Filed in US,Ropes & Gray LLP,, ,"Scott Lindell, Gregory O'Neil, Christopher Reddy",Provisional,5/4/2020, ,12/17/2010,"Peace, Shane",Scott Lindell,"Tennant, Thelma",4525795,,583578,Yes
3111,13-T-147,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"16/259,339", ,*United States,US,1/28/2019,,US 2019-0161777 A1,1/28/2019,MBL-0011-008,Small,12/17/2009,5/4/2020,No,4/28/2022,Pending,Ropes & Gray LLP,,168111.010207/US/CON,"Scott Lindell, Gregory O'Neil, Christopher Reddy",Continuation,5/4/2020, ,1/28/2039,"Peace, Shane",Scott Lindell,"Tennant, Thelma",4525838,5/30/2019,583578,Yes
3112,13-T-148,USE OF MARINE ALGAE FOR PRODUCING POLYMERS,"13/298,576","9,879,288",*United States,US,11/17/2011,1/30/2018, ,11/17/2011,MBL-0012-001,Small,11/17/2010,1/30/2018,No,4/28/2022,Issued,Ropes & Gray LLP,, ,"Scott Lindell, Christopher Reddy",US Utility,4/12/2018,MBL-0012-001,9/1/2033,"Peace, Shane",Scott Lindell,"Tennant, Thelma",615205,,583579,Yes
3113,13-T-149,COMPOUNDS AND METHODS FOR TREATING CYSTIC FIBROSIS,"61/557,021", ,*United States,US,11/8/2011,, ,11/8/2011,MBL-0013-001,Small,11/8/2011,,Yes,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,"Miles Hacker, Joshua Hamilton, Bruce Stanton",Provisional,4/12/2018,MBL-0013-001,11/8/2012,"Unassigned, Unassigned",Joshua Hamilton,"Unassigned, Unassigned",611236,,583580,Yes
3114,13-T-149,COMPOUNDS AND METHODS FOR TREATING CYSTIC FIBROSIS,PCT/US12/64145, ,*United States,US,11/8/2012,, ,11/8/2012,MBL-0013-002,Small,11/8/2011,,No,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,"Miles Hacker, Joshua Hamilton, Bruce Stanton",PCT,4/12/2018,MBL-0013-002,5/8/2014,"Unassigned, Unassigned",Joshua Hamilton,"Unassigned, Unassigned",611237,,583580,Yes
3115,13-T-150,Methods and Systems of Detecting Exocytosis of a Target Molecule from a Population of Cells,"61/822,639", ,*United States,US,5/13/2013,, ,5/13/2013,MBL-0014-001,Small,5/13/2013,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48624,"Emma Heart, Mark Messerli, Munan Xu",Provisional,4/12/2018,MBL-0014-001,5/13/2014,"Dembo, Anna",Mark Messerli,"Juggernauth, Anne",613144,,583581,Yes
3116,13-T-150,Methods and Systems of Detecting Exocytosis of a Target Molecule from a Population of Cells,PCT/US14/37682, ,*United States,US,5/12/2014,,WO 2014/186282,5/12/2014,MBL-0014-002,Small,5/13/2013,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48624-PC,"Emma Heart, Mark Messerli, Munan Xu",PCT,4/12/2018,MBL-0014-002,11/13/2015,"Dembo, Anna",Mark Messerli,"Juggernauth, Anne",613145,11/20/2014,583581,Yes
3117,13-T-150,Methods and Systems of Detecting Exocytosis of a Target Molecule from a Population of Cells,"14/889,568","9,739,734",*United States,US,5/12/2014,8/22/2017,US-2016-0084782-A1,11/6/2015,MBL-0014-003,Small,5/13/2013,8/22/2017,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",48624,"Emma Heart, Mark Messerli, Munan Xu",Nationalized PCT,4/12/2018,MBL-0014-003,5/12/2034,"Dembo, Anna",Mark Messerli,"Juggernauth, Anne",613146,3/24/2016,583581,No
3118,13-T-151,MANAGING TAXONOMIC INFORMATION,"10/087,621","7,650,327",*United States,US,3/1/2002,1/19/2010, ,3/1/2002,MBL-0007-001,Small,3/1/2002,,Yes,4/28/2022,Abandoned,Marine Biological Laboratory (MBL),, ,"Catherine Norton, David Pratt Remsen",US Utility,4/12/2018,MBL-0007-001,3/1/2022,"Unassigned, Unassigned",David Pratt Remsen,"Unassigned, Unassigned",612158,,583582,Yes
3119,13-T-152,POLARIZED LIGHT MICROSCOPY,"08/241,842","5,521,705",*United States,US,5/12/1994,5/28/1996, ,5/12/1994,MBL-0004-001,Small,5/12/1994,5/12/2014,Yes,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,"Guang Mei, Rudolf Oldenbourg",US Utility,4/12/2018,MBL-0004-001,5/12/2014,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",614067,,583583,Yes
3120,13-T-153,ORIENTATION INDEPENDENT DIFFERENTIAL INTERFERENCE CONTRAST MICROSCOPY TECHNIQUE AND DEVICE,"11/002,834","7,233,434",*United States,US,12/2/2004,6/19/2007,,12/2/2004,MBL-0008-001,Small,12/17/2003,6/19/2007,No,5/31/2022,Issued,Marine Biological Laboratory (MBL),,B0877.70031US00,Michael Shribak,US Utility,4/12/2018,MBL-0008-001,7/25/2025,"Cox, Ben",Michael Shribak,"Tennant, Thelma",613861,,583584,Yes
3121,13-T-153,ORIENTATION INDEPENDENT DIFFERENTIAL INTERFERENCE CONTRAST MICROSCOPY TECHNIQUE AND DEVICE,"11/820,219","7,564,618",*United States,US,12/2/2004,7/21/2009,,6/19/2007,MBL-0008-002,Small,12/17/2003,7/21/2009,No,5/31/2022,Issued,Marine Biological Laboratory (MBL),,B0877.70031US01,Michael Shribak,Divisional,4/12/2018,MBL-0008-002,12/2/2024,"Cox, Ben",Michael Shribak,"Tennant, Thelma",613862,,583584,Yes
3122,13-T-155,MICROSCOPE SYSTEM FOR USING TRANSMITTED LIGHT TO OBSERVE LIVING ORGANISMS,"08/658,285","6,005,709",*United States,US,6/5/1996,12/21/1999, ,6/5/1996,MBL-0002-001,Small,6/5/1996,6/5/2016,Yes,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,Robert Silver,US Utility,4/12/2018,MBL-0002-001,6/5/2016,"Unassigned, Unassigned",Robert Silver,"Unassigned, Unassigned",613417,,583586,Yes
3123,13-T-157,POLAROGRAPHIC SELF-REFERENCING PROBE AND METHOD FOR USING,"08/834,902","5,968,340",*United States,US,4/7/1997,10/19/1999, ,4/7/1997,MBL-0003-001,Small,4/7/1997,4/7/2017,Yes,4/28/2022,Expired - Inactive,Marine Biological Laboratory (MBL),, ,"Stephen Land, Richard Sanger, Peter Smith",US Utility,4/12/2018,MBL-0003-001,4/7/2017,"Unassigned, Unassigned",Stephen Land,"Unassigned, Unassigned",614068,,583588,Yes
3124,13-T-158,USE OF STING AGONIST AS CANCER TREATMENT,"61/906,330", ,*United States,US,11/19/2013,, ,11/20/2013,2277-001,Small,11/19/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Thomas Gajewski, Leticia Pecino, Seng-Ryong Woo",Provisional,4/12/2018,2277-001,11/19/2014,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615291,,583589,Yes
3125,13-T-158,USE OF STING AGONIST AS CANCER TREATMENT,PCT/US14/66436, ,*United States,US,11/19/2014,,WO 2015/077354,11/19/2014,2277-002,Small,11/19/2013,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Leticia Pecino, Seng-Ryong Woo",PCT,4/12/2018,2277-002,5/19/2016,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615292,5/28/2015,583589,Yes
3126,13-T-158,USE OF STING AGONIST AS CANCER TREATMENT,"15/035,432", ,*United States,US,11/19/2014,,2016-0287623,5/9/2016,2277-003,Large,11/19/2013,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Thomas Dubensky, Thomas Gajewski, Laura Glickman, David Kanne, Edward Lemmens, Meredith Leong, Leticia Pecino, Seng-Ryong Woo",Nationalized PCT,4/12/2018,2277-003,,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615293,10/9/2016,583589,No
3127,13-T-158,USE OF STING AGONIST AS CANCER TREATMENT,14864073.3EPO, ,European Patent Office (EPO),EP,11/19/2014,,3071209,6/3/2016,2277-004,Small,11/19/2013,5/6/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,Thomas Gajewski,Nationalized PCT,4/12/2018,2277-004,11/22/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615294,9/30/2016,583589,No
3128,13-T-158,USE OF STING AGONIST AS CANCER TREATMENT,2016-554555, ,Japan,JP,11/19/2014,,2016-538344,5/17/2016,2277-005,Small,11/19/2013,5/6/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Leticia Pecino, Seng-Ryong Woo",Nationalized PCT,4/12/2018,2277-005,11/19/2034,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615295,12/8/2016,583589,No
3129,13-T-158,USE OF STING AGONIST AS CANCER TREATMENT,"15/783,570", ,*United States,US,11/19/2014,,2018-0028553,10/13/2017,2277-006,Large,11/19/2013,5/6/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Thomas Dubensky, Thomas Gajewski, Laura Glickman, David Kanne, Edward Lemmens, Meredith Leong, Leticia Pecino, Seng-Ryong Woo",Continuation,4/12/2018,2277-006,,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615296,2/1/2018,583589,No
3130,13-T-160,Nanoprosthesis for Retinal Ganglion Cell Photo-Activation,"61/931,415", ,*United States,US,1/24/2014,, ,1/24/2014,2279-001,Small,1/24/2014,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,,00370,"Francisco Bezanilla, Stephen Kent, David Pepperberg",Provisional,4/12/2018,2279-001,1/24/2015,"Butler, Brittany",Francisco Bezanilla,"Butler, Brittany",613637,,583591,Yes
3131,13-T-162,Methods and Compositions Related to HSP90 Inhibitors and Breast Cancer,"61/915,411", ,*United States,US,12/12/2013,, ,12/12/2013,2280-001,Small,12/12/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Suzanne Conzen,Provisional,4/12/2018,2280-001,12/12/2014,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613023,,583593,Yes
3132,13-T-162,Methods and Compositions Related to HSP90 Inhibitors and Breast Cancer,PCT/US14/70032, ,*United States,US,12/12/2014,, ,12/12/2014,2280-002,Small,12/12/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Suzanne Conzen,PCT,4/12/2018,2280-002,6/12/2016,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613024,,583593,Yes
3133,13-T-162,METHODS AND COMPOSITIONS RELATED TO HSP90 INHIBITORS AND BREAST CANCER,"15/103,187","10,071,130",*United States,US,12/12/2014,9/11/2018,US_2016-0317601-A1,6/9/2016,2280-003,Small,12/12/2013,,No,5/23/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000208154,Suzanne Conzen,Nationalized PCT,4/12/2018,2280-003,12/14/2034,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613025,11/4/2016,583593,No
3134,13-T-163,CACNA1C ALLELE AND TREATMENT OF MOOD DISORDERS,"62/035,970", ,*United States,US,8/11/2014,, ,8/11/2014,2281-001,Small,8/11/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48562,"Judith Badner, Elliot Gershon, Chun-Yu Liu",Provisional,4/12/2018,2281-001,8/11/2015,"Butler, Brittany",Elliot Gershon,"Butler, Brittany",610761,,583594,Yes
3135,13-T-163,CACNA1C ALLELE AND TREATMENT OF MOOD DISORDERS,"14/823,973", ,*United States,US,8/11/2015,,2016/0040240 A1.,8/11/2015,2281-002,Small,8/12/2014,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",48562A,"Judith Badner, Elliot Gershon, Chun-Yu Liu",US Utility,4/12/2018,2281-002,8/11/2035,"Butler, Brittany",Elliot Gershon,"Butler, Brittany",610762,,583594,No
3136,14-T-003,CLOSED LOOP WORKFLOW,"13/378,054", ,*United States,US,6/16/2010,, ,12/14/2011,2813-001,Large,7/1/2009,,Yes,4/28/2022,Pending,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-001,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610898,,583597,No
3137,14-T-003,CLOSED LOOP WORKFLOW,2014-206099,"6,129,804",Japan,JP,6/16/2010,4/21/2017, ,6/16/2010,2813-002,Large,7/1/2009,,No,4/28/2022,Issued,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-002,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610899,,583597,No
3138,14-T-003,CLOSED LOOP WORKFLOW,PI 1010203-5, ,Brazil,BR,6/16/2010,, ,6/16/2010,2813-003,Large,7/1/2009,,No,4/28/2022,Pending,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-003,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610901,,583597,No
3139,14-T-003,CLOSED LOOP WORKFLOW,201080029356.8,201080029356.8,China,CN,6/16/2010,4/27/2016, ,6/16/2010,2813-004,Large,7/1/2009,,No,4/28/2022,Issued,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-004,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610902,,583597,No
3140,14-T-003,CLOSED LOOP WORKFLOW,617/CHENP/2012, ,India,IN,6/16/2010,, ,6/16/2010,2813-005,Large,7/1/2009,,No,4/28/2022,Pending,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-005,6/16/2030,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610903,,583597,No
3141,14-T-003,CLOSED LOOP WORKFLOW,2012-516906,"5,631,390",Japan,JP,6/16/2010,6/16/2010, ,6/16/2010,2813-006,Large,7/1/2009,,No,4/28/2022,Issued,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-006,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610904,,583597,No
3142,14-T-003,CLOSED LOOP WORKFLOW,2012103345,"2,554,522",Russian Federation,RU,6/16/2010,6/27/2015, ,6/16/2010,2813-007,Large,7/1/2009,,No,4/28/2022,Issued,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-007,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610906,,583597,No
3143,14-T-003,CLOSED LOOP WORKFLOW,PCT/IB10/52715, ,International Bureau,IB,6/16/2010,, ,6/16/2010,2813-008,Large,7/1/2009,,No,4/28/2022,Expired - Inactive,,, ,"Paul Chang, Paul Seltzer",PCT,4/12/2018,2813-008,12/16/2011,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610908,,583597,No
3144,14-T-003,CLOSED LOOP WORKFLOW,10-2012-7002528, ,"Korea, Republic of",KR,6/16/2010,, ,6/16/2010,2813-009,Large,7/1/2009,,No,4/28/2022,Pending,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-009,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610910,,583597,No
3145,14-T-003,CLOSED LOOP WORKFLOW,"61/222,132", ,*United States,US,7/1/2009,, ,7/1/2009,2813-010,Large,7/1/2009,,Yes,4/28/2022,Expired - Inactive,,, ,"Paul Chang, Paul Seltzer",Provisional,4/12/2018,2813-010,7/1/2010,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610911,,583597,No
3146,14-T-003,CLOSED LOOP WORKFLOW,"61/263,054", ,*United States,US,11/20/2009,, ,11/20/2009,2813-011,Large,11/20/2009,,No,4/28/2022,Expired - Inactive,,, ,"Paul Chang, Paul Seltzer",Provisional,4/12/2018,2813-011,11/20/2010,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610912,,583597,No
3147,14-T-003,CLOSED LOOP WORKFLOW,10739697.0, ,European Patent Office (EPO),EP,6/16/2010,, ,6/16/2010,2813-012,Large,7/1/2009,,No,4/28/2022,Abandoned,,, ,"Paul Chang, Paul Seltzer",Nationalized PCT,4/12/2018,2813-012,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",610913,,583597,No
3148,14-T-003,CLOSED LOOP WORKFLOW,"16/188,579", ,*United States,US,6/16/2010,, ,11/13/2018,2813-013,Large,7/1/2009,11/13/2018,No,4/28/2022,Pending,,, ,"Paul Chang, Paul Seltzer",Divisional,11/18/2018, ,12/14/2031,"Ginsburg, Eric",Paul Chang,"Smith, Dane",1900519,,583597,No
3149,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,PCT/US12/45954, ,*United States,US,7/9/2012,, ,7/9/2012,2285-001,Small,7/8/2011,,No,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00002,Wenbin Lin,PCT,4/12/2018,2285-001,1/8/2014,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612245,,583598,Yes
3150,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,"14/131,575","9,693,957",*United States,US,7/9/2012,7/4/2017,2014-0234210-A1,3/7/2014,2285-002,Small,7/8/2011,7/4/2017,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00006,Wenbin Lin,Nationalized PCT,4/12/2018,2285-002,4/17/2033,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612246,8/21/2014,583598,Yes
3151,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,12810577.2EPO,2728180,European Patent Office (EPO),EP,7/9/2012,1/23/2019,EP 2729180,2/10/2014,2285-003,Small,7/8/2011,,No,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00003,Wenbin Lin,Nationalized PCT,4/12/2018,2285-003,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612247,5/14/2014,583598,Yes
3152,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,2014520238,6049712,Japan,JP,7/9/2012,12/2/2018, ,7/9/2012,2285-004,Small,7/8/2011,,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00005,Wenbin Lin,Nationalized PCT,4/12/2018,2285-004,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612248,,583598,Yes
3153,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,"15/613,847","10,596,116",*United States,US,7/9/2012,3/24/2020,US-2017-0333347-A1,6/5/2017,2285-005,Small,7/8/2011,,Yes,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",421/287/2 PCT/US CON,"Joseph Della Rocca, Stephanie Kramer, Wenbin Lin, Demin Liu, Christopher Poon",Continuation,4/12/2018,2285-005,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612249,11/23/2017,583598,Yes
3154,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,12810577.2GB,2729180,United Kingdom,GB,7/9/2012,1/23/2019, ,7/9/2012,2285-006,Small,7/8/2011,12/6/2018,No,6/9/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,Wenbin Lin,Validated EPO,12/6/2018, ,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1942513,,583598,Yes
3155,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,12810577.2FR,2729180,France,FR,7/9/2012,1/23/2019, ,7/9/2012,2285-007,None,7/8/2011,12/6/2018,No,6/9/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,Wenbin Lin,Validated EPO,12/6/2018, ,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1942538,,583598,Yes
3156,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,12810577.2DE,2729180,Germany,DE,7/9/2012,1/23/2019, ,7/9/2012,2285-008,Small,7/8/2011,12/6/2018,No,6/9/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,Wenbin Lin,Validated EPO,12/6/2018, ,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1942561,,583598,Yes
3157,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,19151591.5EPO, ,European Patent Office (EPO),EP,7/9/2012,,3494974,1/14/2019,2285-009,Small,7/8/2011,2/4/2019,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",421/287/2 PCT/EP DIV,"Joseph Della Rocca, Stephanie Kramer, Wenbin Lin, Demin Liu, Christopher Poon",Divisional,2/4/2019, ,7/8/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",3492702,6/12/2019,583598,Yes
3158,14-T-004,Metal Bisphosphonate Nanoparticles for Anti-Cancer Therapy and Imaging and for Treating Bone Disorders,"16/800,855", ,*United States,US,7/9/2012,,US-2020-0222321-A1,2/25/2020,2285-010,Small,7/8/2011,2/26/2020,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",421/287/3 PCT/US CON,"Joseph Della Rocca, Stephanie Kramer, Wenbin Lin, Demin Liu, Christopher Poon",Continuation,2/26/2020, ,7/9/2032,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4383514,7/16/2020,583598,Yes
3159,14-T-011,"MODULATION OF LAMININ ALPHA-4 IN THE PREVENTION, TREATMENT, AND MANAGEMENT OF METABOLIC SYNDROMES","62/033,526", ,*United States,US,8/5/2014,, ,8/5/2014,2290-001,Small,8/5/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48700,"Eric Brey, Ronald Cohen, Jill Kortesmaa, Karl Tryggvason, Marcella Vaicik",Provisional,4/12/2018,2290-001,8/5/2015,"Sun, Han",Ronald Cohen,"Tennant, Thelma",613480,,583605,Yes
3160,14-T-011,"MODULATION OF LAMININ ALPHA-4 IN THE PREVENTION, TREATMENT, AND MANAGEMENT OF METABOLIC SYNDROMES",PCT/US15/43821, ,*United States,US,8/5/2015,,WO 2016/022694,8/5/2015,2290-002,Small,8/5/2014,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48700A-PC,"Eric Brey, Ronald Cohen, Jill Kortesmaa, Karl Tryggvason, Marcella Vaicik",PCT,4/12/2018,2290-002,8/5/2034,"Sun, Han",Ronald Cohen,"Tennant, Thelma",613481,,583605,No
3161,14-T-011,"MODULATION OF LAMININ ALPHA-4 IN THE PREVENTION, TREATMENT, AND MANAGEMENT OF METABOLIC SYNDROMES","15/500,845", ,*United States,US,8/5/2015,, ,1/31/2017,2290-003,Small,8/5/2014,2/16/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",48700A,"Eric Brey, Ronald Cohen, Jill Kortesmaa, Karl Tryggvason, Marcella Vaicik",Nationalized PCT,4/12/2018,2290-003,,"Sun, Han",Ronald Cohen,"Tennant, Thelma",613482,,583605,No
3162,14-T-013,Solvent Annealing of Block Copolymer Films Under Super-Saturated Atmospheres,"14/187,071", ,*United States,US,2/21/2014,, ,2/21/2014,2291-001,Small,2/21/2014,,Yes,4/28/2022,Pending,,, ,"Yves-Andre Chapuis, Paul Nealey, Ricardo Ruiz, Lei Wan, Shisheng Xiong",US Utility,4/12/2018,2291-001,2/21/2034,"Hwang, Luke",Ricardo Ruiz,"Juggernauth, Anne",614577,,583607,Yes
3163,14-T-015,Chiral Ligand-Based Metal-Organic Frameworks for Broad-Scope Asymmetric Catalysis,"61/971,890", ,*United States,US,3/28/2014,, ,3/28/2014,2293-001,Small,3/28/2014,,Yes,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00007,"Joonhyung Frederick Cho, Joseph Falkowski, Wenbin Lin, Takahiro Sawano",Provisional,4/12/2018,2293-001,3/28/2015,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",610887,,583609,Yes
3164,14-T-015,Chiral Ligand-Based Metal-Organic Frameworks for Broad-Scope Asymmetric Catalysis,PCT/US15/23331, ,*United States,US,3/30/2015,,WO2015/149068,3/30/2015,2293-002,Small,3/28/2014,,No,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00011,"Joseph Falkowski, Wenbin Lin, Takahiro Sawano",PCT,4/12/2018,2293-002,3/28/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",610888,10/1/2015,583609,Yes
3165,14-T-015,Chiral Ligand-Based Metal-Organic Frameworks for Broad-Scope Asymmetric Catalysis,"15/129,851","10,118,169",*United States,US,3/30/2015,11/6/2018,US-2017-0173572-A1,9/28/2016,2293-003,Small,3/28/2014,11/6/2018,No,5/23/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00024,"Joonhyung Frederick Cho, Joseph Falkowski, Wenbin Lin, Takahiro Sawano",Nationalized PCT,4/12/2018,2293-004,3/30/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",610889,6/22/2017,583609,Yes
3166,14-T-016,Combined MV+kV inverse treatment planning for optimal kV dose incorporation in IGRT,"62/033,533", ,*United States,US,8/5/2014,, ,8/5/2014,2295-001,Small,8/5/2014,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,"Stone, Jonathan",148385.00008,"Zachary Grelewicz, Rodney Wiersma",Provisional,4/12/2018,2295-001,8/5/2015,"Ramirez, Mario Riojas",Rodney Wiersma,"Tennant, Thelma",610949,,583610,Yes
3167,14-T-016,"SYSTEMS AND METHODS FOR RADIATION TREATMENT PLANNING USING COMBINED
IMAGING AND TREATMENT DOSE","14/818,808","9,782,607",*United States,US,8/5/2015,10/10/2017,US-2016-0038767-A1,8/5/2015,2295-002,Small,8/5/2014,,No,4/28/2022,Issued,"Bell & Manning, LLC","Kalafut, Christopher",148385.00013,"Zachary Grelewicz, Rodney Wiersma",US Utility,4/12/2018,2295-002,8/5/2035,"Ramirez, Mario Riojas",Rodney Wiersma,"Tennant, Thelma",614843,2/11/2016,583610,No
3168,14-T-019,OUTLIER,"86/252,578",,*United States,US,4/15/2014,2/3/2016,,,2298-001,Small,4/15/2014,,Yes,6/7/2021,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9169-US00,"Jeanne Century, Melanie LaForce",Trademark,4/12/2018,2298-001,4/15/2034,"Sun, Han",Jeanne Century,"Tennant, Thelma",613863,,583613,Yes
3169,14-T-019,OUTLIER,"86/252,605",4894135,*United States,US,4/15/2014,2/3/2016,,,2298-002,Small,4/15/2014,,Yes,7/27/2021,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9170-US00,"Jeanne Century, Melanie LaForce",Trademark,4/12/2018,2298-002,4/15/2034,"Sun, Han",Jeanne Century,"Tennant, Thelma",613864,,583613,Yes
3170,14-T-024,LAPPD,"86/246,181", ,*United States,US,4/8/2014,, ,,2304-001,Small,4/8/2014,,Yes,2/16/2022,Allowed,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9168-001,Henry Frisch,Trademark,4/12/2018,2304-001,4/8/2019,"Cox, Ben",Henry Frisch,"Tennant, Thelma",612068,,583618,Yes
3171,14-T-026,Treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis,"61/977,062", ,*United States,US,4/8/2014,, ,4/8/2014,2306-001,Small,4/8/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48565,"Brian Popko, Raymond Roos",Provisional,4/12/2018,2306-001,4/8/2015,"Butler, Brittany",Raymond Roos,"Butler, Brittany",614954,,583620,Yes
3172,14-T-027,Methods of Treating CAncer Using RAD51 Small Molecule Stimulators,"61/950,689", ,*United States,US,3/10/2014,,ARCD-P0576US-P1,3/10/2014,2307-001,Small,3/10/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Brian Budke, Philip Connell, Ralph Weichselbaum",Provisional,4/12/2018,2307-001,3/10/2015,"Bakalyar, Heather",Philip Connell,"Tennant, Thelma",613351,,583621,Yes
3173,14-T-027,Methods of Treating CAncer Using RAD51 Small Molecule Stimulators,PCT/US15/19578, ,*United States,US,3/10/2015,,WO 2015/138377,3/10/2015,2307-002,Small,3/10/2014,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Douglas Bishop, Brian Budke, Philip Connell, Ralph Weichselbaum",PCT,4/12/2018,2307-002,3/10/2034,"Bakalyar, Heather",Philip Connell,"Tennant, Thelma",613352,9/17/2015,583621,Yes
3174,14-T-027,Methods of Treating Cancer Using RAD51 Small Molecule Stimulators,"15/124,283", ,*United States,US,3/10/2015,,US-2017-0014360-A,9/7/2016,2307-003,Small,3/10/2014,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000342849,"Douglas Bishop, Brian Budke, Philip Connell, Ralph Weichselbaum",Nationalized PCT,4/12/2018,2307-003,3/12/2034,"Bakalyar, Heather",Philip Connell,"Tennant, Thelma",613353,1/21/2017,583621,Yes
3175,14-T-029,ALKALI  SEMI-METAL FILMS AD METHOD AND APPARATUS FOR RABRICATING THEM,"62/003,888", ,*United States,US,5/28/2014,, ,5/28/2014,2308-002,Small,5/28/2014,,Yes,4/28/2022,Expired - Inactive,Burns & Levinson LLP,, ,"Klaus Attenkofer, Harish Bhandari, Henry Frisch, Vivek Nagarkar, Olena Ovechkina, John Smedley",Provisional,4/12/2018,2308-002,5/28/2015,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610297,,583623,Yes
3176,14-T-029,ALKALI ANTIMONIDE FILMS AND METHOD AND APPARATUS FOR FABRICATING THEM,"61/933,526", ,*United States,US,1/30/2014,, ,1/30/2014,2308-001,Small,1/30/2014,,Yes,4/28/2022,Expired - Inactive,Burns & Levinson LLP,, ,"Klaus Attenkofer, Harish Bhandari, Henry Frisch, Vivek Nagarkar, Olena Ovechkina, John Smedley",Provisional,4/12/2018,2308-001,1/30/2015,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610298,,583623,Yes
3177,14-T-029,ALKALI ANTIMONIDE FILMS AND METHOD AND APPARATUS FOR FABRICATING THEM,"14/608,777","9,916,958",*United States,US,1/29/2015,3/13/2018, ,1/29/2015,2308-003,Small,1/30/2014,,No,4/28/2022,Issued,Burns & Levinson LLP,, ,"Klaus Attenkofer, Harish Bhandari, Henry Frisch, Vivek Nagarkar, Olena Ovechkina, John Smedley",US Utility,4/12/2018,2308-003,1/30/2034,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610299,,583623,Yes
3178,14-T-029,Alkali Semi-Metal Films and Method and Apparatus for Fabricating them,"15/884,947", ,*United States,US,1/29/2015,, ,1/31/2018,2308-004,Small,1/30/2014,,No,4/28/2022,Pending,Burns & Levinson LLP,,31102-107DIV,"Klaus Attenkofer, Harish Bhandari, Henry Frisch, Vivek Nagarkar, Olena Ovechkina, John Smedley",Divisional,4/12/2018,2308-004,1/29/2035,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610300,,583623,No
3179,14-T-029,Alkali Semi-Metal Films and Method and Apparatus for Fabricating them,"17/402,171", ,*United States,US,1/29/2015,, ,8/13/2021,2308-005,Small,1/30/2014,10/1/2021,No,4/28/2022,Prosecution by Other Party,Burns & Levinson LLP,,31102-107DIV,"Klaus Attenkofer, Harish Bhandari, Henry Frisch, Vivek Nagarkar, Olena Ovechkina, John Smedley",Continuation in Part,8/18/2021, ,1/29/2035,"Cox, Ben",Henry Frisch,"Tennant, Thelma",6050900,,583623,No
3180,14-T-030,Spectral x-ray computed tomography reconstruction using a vectorial total variation,"14/305,936","9,672,638",*United States,US,6/16/2014,6/6/2017, ,6/16/2014,2309-001,Small,6/16/2014,,Yes,4/28/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt", ,"Patrick La Riviere, Adam Petschke, David Rigie",US Utility,4/12/2018,2309-001,6/16/2034,"Cox, Ben",Patrick La Riviere,"Smith, Dane",614589,,583624,Yes
3181,14-T-030,Spectral x-ray computed tomography reconstruction using a vectorial total variation,2015-121570,6564254,Japan,JP,6/16/2015,8/2/2019, ,6/16/2015,2309-002,Small,6/16/2014,,No,5/16/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt", ,"Patrick La Riviere, Adam Petschke, David Rigie","Foreign, Non-PCT",4/12/2018,2309-002,6/16/2035,"Cox, Ben",Patrick La Riviere,"Smith, Dane",614590,,583624,No
3182,14-T-033,Metal-Organic Frameworks Containing Nitrogen-Donor Ligands for Highly Efficient Catalytic Organic Transformations,PCT/US15/23387, ,*United States,US,3/30/2015,,WO 2015/149072,3/30/2015,2311-002,Small,4/22/2014,,No,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00012,"Wenbin Lin, Kuntal Manna, Teng Zhang",PCT,4/12/2018,2311-002,10/22/2016,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612257,10/1/2015,583627,Yes
3183,14-T-033,Metal-Organic Frameworks Containing Nitrogen-Donor Ligands for Highly Efficient Catalytic Organic Transformations,"15/129,853","10,647,733",*United States,US,3/30/2015,5/12/2020,US-2017-0182486-A,9/28/2016,2311-003,Small,4/22/2014,4/27/2020,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/4 PCT/US,"Wenbin Lin, Kuntal Manna, Teng Zhang",Nationalized PCT,4/12/2018,2311-003,4/24/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612258,6/29/2017,583627,Yes
3184,14-T-033,Metal-Organic Frameworks Containing Nitrogen-Donor Ligands for Highly Efficient Catalytic Organic Transformationss,"61/982,722", ,*United States,US,4/22/2014,, ,4/22/2014,2311-001,Small,4/22/2014,,Yes,4/28/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00008,"Wenbin Lin, Kuntal Manna, Teng Zhang",Provisional,4/12/2018,2311-001,4/22/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612259,,583627,Yes
3185,14-T-034,The Undefeated Mind,"86/738,429","6,019,105",*United States,US,8/27/2015,3/24/2020,,,2312-001,Small,8/27/2015,1/16/2020,Yes,12/8/2021,Granted,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9176-001,"Ingrid Busching, Ginger Carr, Alex Lickerman, Michael Quinn, Kelly Hogan Stewart",Trademark,4/12/2018,2312-001,3/24/2029,"Ramirez, Mario Riojas",Alex Lickerman,"Tennant, Thelma",614878,,583628,No
3186,14-T-035,3H4 antibody and codon-optimized 3H4 antibody sequence,"15/115,536","10,189,908",*United States,US,2/5/2015,1/29/2019,US-2017-0166652-A1,7/29/2016,2313-003,Small,2/5/2014,1/29/2019,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0704US,"Boris Engels, Christian Idel, Hans Schreiber",Nationalized PCT,4/12/2018,2313-003,4/8/2035,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610188,6/15/2017,583629,Yes
3187,14-T-035,Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants,"61/936,304", ,*United States,US,2/5/2014,, ,2/5/2014,2313-001,Small,2/5/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48054,"Boris Engels, Christian Idel, Hans Schreiber",Provisional,4/12/2018,2313-001,2/5/2015,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610885,,583629,Yes
3188,14-T-035,Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants,PCT/US15/14673, ,*United States,US,2/5/2015,,WO 2015/120187,2/5/2015,2313-002,Small,2/5/2014,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48054A-PC,"Boris Engels, Christian Idel, Hans Schreiber",PCT,4/12/2018,2313-002,2/5/2034,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",610886,8/13/2015,583629,Yes
3189,14-T-036,RECURRENT FUSION GENES IN HUMAN CANCERS,"15/310,753", ,*United States,US,5/13/2015,, ,11/12/2016,2314-003,Small,5/13/2014,4/9/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373-48684A,"Chaitanya Bandlamudi, Kevin White",Nationalized PCT,4/12/2018,2314-003,5/15/2035,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",614365,,583630,No
3190,14-T-036,RECURRENT FUSION POLYPEPTIDES IN HUMAN CANCERS,"61/992,791", ,*United States,US,5/13/2014,, ,5/13/2014,2314-001,Small,5/13/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48684,"Chaitanya Bandlamudi, Kevin White",Provisional,4/12/2018,2314-001,5/13/2015,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",614366,,583630,Yes
3191,14-T-036,RECURRENT FUSION POLYPEPTIDES IN HUMAN CANCERS,PCT/US15/30677, ,*United States,US,5/13/2015,,WO2015/175732,5/13/2015,2314-002,Small,5/13/2014,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48684A-PC,"Chaitanya Bandlamudi, Kevin White",PCT,4/12/2018,2314-002,11/13/2016,"Unassigned, Unassigned",Kevin White,"Unassigned, Unassigned",614367,11/19/2015,583630,Yes
3192,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,"62/082,902", ,*United States,US,11/21/2014,, ,11/21/2014,2315-001,Small,11/21/2014,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Provisional,4/12/2018,2315-001,11/21/2015,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613919,,583631,Yes
3193,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,PCT/US15/61845, ,*United States,US,11/20/2015,,WO 2016/081828,11/20/2015,2315-002,Small,11/21/2014,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,PCT,4/12/2018,2315-002,5/20/2017,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613920,5/28/2016,583631,No
3194,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,104138613, ,"Taiwan, Province of China",TW,11/20/2015,,201625678,11/20/2015,2315-003,Small,11/21/2014,9/19/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,"Foreign, Non-PCT",4/12/2018,2315-003,,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613921,,583631,No
3195,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,"15/528,042", ,*United States,US,11/20/2015,, ,5/18/2017,2315-005,Small,11/21/2014,11/13/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Nationalized PCT,4/12/2018,2315-005,11/21/2035,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613922,5/28/2016,583631,No
3196,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,2017-527339, ,Japan,JP,11/20/2015,, ,5/18/2017,2315-006,Small,11/21/2014,9/19/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Nationalized PCT,4/12/2018,2315-006,11/21/2035,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613923,6/8/2017,583631,No
3197,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,201580063016.X, ,China,CN,11/20/2015,,107106639,5/19/2017,2315-007,Small,11/21/2014,9/19/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Nationalized PCT,4/12/2018,2315-007,5/21/2017,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613924,8/29/2017,583631,No
3198,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,"2,967,649", ,Canada,CA,11/20/2015,, ,11/20/2015,2315-008,Small,11/21/2014,9/19/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Nationalized PCT,4/12/2018,2315-008,11/21/2035,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613925,5/28/2016,583631,No
3199,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,15861786.0EPO, ,European Patent Office (EPO),EP,11/20/2015,,3220941,6/15/2017,2315-009,Small,11/21/2014,9/19/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Nationalized PCT,4/12/2018,2315-009,5/20/2017,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613926,9/27/2017,583631,No
3200,14-T-037,Peptides to Stimulate Lipase Activity for the Treatment of Hypertriglyceridemia,201717019096, ,India,IN,11/20/2015,, ,5/31/2017,2315-010,Small,11/21/2014,9/19/2018,No,4/28/2022,Abandoned,"Casimir Jones, S.C.",, ,John Ancsin,Nationalized PCT,4/12/2018,2315-010,11/21/2035,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613927,,583631,No
3201,14-T-037,SYNTHETIC PEPTIDES,"62/339,144", ,*United States,US,5/20/2016,, ,5/20/2016,2315-004,Small,5/20/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Provisional,4/12/2018,2315-004,5/20/2017,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",614777,,583631,No
3202,14-T-039,AN ULTRA-RAPID PARATHYROID HORMONE ASSAY TO DISTINGUISH PARATHYROID FROM NON-PARATHYROID TISSUE,"62/004,841", ,*United States,US,5/29/2014,, ,5/29/2014,2317-001,Small,5/29/2014,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",48716,"Raymon Grogan, Neal Scherberg",Provisional,4/12/2018,2317-001,5/29/2015,"Butler, Brittany",Raymon Grogan,"Butler, Brittany",610325,,583633,Yes
3203,14-T-040,Electrically conductive nanomaterials reinforced cardiac microtissues,PCT/US16/13647, ,*United States,US,1/17/2016,, ,1/17/2016,2318-002,Small,1/16/2015,,No,4/28/2022,Expired PCT - Filed in US only,"Myers Bigel Sibley & Sajovec, P.A.","Bobay, Erin", ,"Ying Mei, Donald Merick, Dylan Richards, Bozhi Tian, Tan Yu",PCT,4/12/2018,2318-002,,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",611514,,583634,No
3204,14-T-040,TISSUES CONTAINING SEMICONDUCTOR NANOMATERIALS AND METHOD OF PREPARING AND USING THE SAME,"15/543,701","10,988,735",*United States,US,1/17/2016,4/27/2021,US-2017-0369847-A1,7/14/2017,2318-003,Small,1/17/2015,4/9/2021,No,5/2/2022,Issued,"Myers Bigel Sibley & Sajovec, P.A.",,9662.65,"Ying Mei, Donald Menick, Dylan Richards, Bozhi Tian, Tan Yu",Nationalized PCT,4/12/2018,2318-003,2/13/2036,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",614924,12/28/2017,583634,No
3205,14-T-040,Tissues Containing Semiconductor Nanomaterials and Methods of Preparing and Using the Same,"62/104,258", ,*United States,US,1/16/2015,, ,1/16/2015,2318-001,Small,1/16/2015,,Yes,4/28/2022,Expired - Inactive,"Myers Bigel Sibley & Sajovec, P.A.","Bobay, Erin", ,"Ying Mei, Donald Menick, Dylan Richards, Bozhi Tian, Tan Yu",Provisional,4/12/2018,2318-001,1/16/2016,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",614925,,583634,Yes
3206,14-T-044,METAL-ORGANIC FRAMEWORK TEMPLATED SYNTHESIS OF POROUS INORGANIC MATERIALS AS NOVEL SORBENTS,"14/242,087","9,597,658",*United States,US,4/1/2014,3/21/2017,US-2014-0319058-A1,4/1/2014,2319-001,Large,4/1/2013,3/21/2017,No,4/28/2022,Issued,"J. Bennett Mullinax, LLC",, ,"Carter Abney, Wenbin Lin, Kathryn Taylor-Pashow",US Utility,4/12/2018,2319-001,11/20/2034,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612256,10/30/2014,583638,Yes
3207,14-T-047,Methods for Determining Prognosis for Breast Cancer Patients,"62/090,809", ,*United States,US,12/11/2014,, ,12/11/2014,2323-001,Small,12/11/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"UnJin Lee, Marsha Rosner",Provisional,4/12/2018,2323-001,12/11/2015,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613168,,583641,Yes
3208,14-T-058,A High-Resolution Time-of-Flight-PET Camera based on Large-Area Fast Photodetectors and High-Z-Metal-Loaded Low-Density Scintillator,PCT/US16/26640, ,*United States,US,4/8/2016,,WO2016168076,4/8/2016,2331-003,Small,4/13/2015,,No,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0005-02,"Henry Frisch, Hee-Jong Kim, Eric Oberla, Minfang Yeh",PCT,4/12/2018,2331-003,10/15/2017,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610206,10/20/2016,583652,No
3209,14-T-058,POSITRON-EMISSION TOMOGRAPHY DETECTOR SYSTEMS BASED ON LOW-DENSITY LIQUID SCINTILLATORS AND PRECISE TIME-RESOLVING PHOTODETECTORS,"62/146,780", ,*United States,US,4/13/2015,, ,4/13/2015,2331-001,Small,4/13/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0005,"Bernhard Adams, Andrey Elagin, Henry Frisch, Eugene Hwang, Hee-Jong Kim, Eric Oberla, Matthew Wetstein, Minfang Yeh",Provisional,4/12/2018,2331-001,4/13/2016,"Cox, Ben",Henry Frisch,"Tennant, Thelma",614130,,583652,Yes
3210,14-T-058,POSITRON-EMISSION TOMOGRAPHY DETECTOR SYSTEMS BASED ON LOW-DENSITY LIQUID SCINTILLATORS AND PRECISE TIME-RESOLVING PHOTODETECTORS,"62/163,538", ,*United States,US,5/19/2015,, ,5/19/2015,2331-002,Small,5/19/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0005-01,"Henry Frisch, Hee-Jong Kim, Eric Oberla, Minfang Yeh",Provisional,4/12/2018,2331-002,5/19/2016,"Cox, Ben",Henry Frisch,"Tennant, Thelma",614131,,583652,Yes
3211,14-T-058,Positron-Emission Tomography Detector Systems Based on Low-Density Liquid Scintillators and Precise Time-Resolving Photodetectors,"15/553,275","10,132,942",*United States,US,4/8/2016,11/20/2018,20180038968,8/24/2017,2331-004,Small,4/13/2015,11/20/2018,No,4/28/2022,Issued,"Bell & Manning, LLC",,05400-0005-03,"Henry Frisch, Hee-Jong Kim, Eric Oberla, Minfang Yeh",Nationalized PCT,4/12/2018,2331-004,4/8/2036,"Cox, Ben",Henry Frisch,"Tennant, Thelma",614132,2/8/2018,583652,No
3212,14-T-059,Artificial metalloenzyme,"62/021,495", ,*United States,US,7/7/2014,, ,7/7/2014,2325-001,Small,7/7/2014,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Chinn, Richard", ,Jared Lewis,Provisional,4/12/2018,2325-001,7/7/2015,"Ginsburg, Eric",Jared Lewis,"Juggernauth, Anne",610565,,583653,Yes
3213,14-T-059,Artificial Metalloenzyme,"14/791,863", ,*United States,US,7/6/2015,, ,7/6/2015,2325-002,Small,7/7/2014,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Chinn, Richard", ,Jared Lewis,US Utility,4/12/2018,2325-002,7/7/2034,"Ginsburg, Eric",Jared Lewis,"Juggernauth, Anne",610566,,583653,No
3214,14-T-060,"Methods, Systems, and Devices Related to the Analysis and/or Use of Proteomic and/or Health Related Information","62/033,019", ,*United States,US,8/4/2014,, ,8/4/2014,2330-001,Small,8/4/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Samuel Volchenboum,Provisional,4/12/2018,2330-001,8/4/2015,"Ginsburg, Eric",Samuel Volchenboum,"Smith, Dane",613373,,583654,Yes
3215,14-T-061,SYSTEMS AND METHODS FOR PROVIDING CONTINUOUS COOLING AT CRYOGENIC TEMPERATURES,"62/341,530", ,*United States,US,5/25/2016,, ,5/25/2016,2332-001,Small,5/25/2016,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Schermerhorn, Ryan",50533,"Andrew Oriani, David Schuster",Provisional,4/12/2018,2332-001,5/25/2017,"Cox, Ben",David Schuster,"Juggernauth, Anne",614841,,583655,No
3216,14-T-061,SYSTEMS AND METHODS FOR PROVIDING CONTINUOUS COOLING AT CRYOGENIC TEMPERATURES,"15/605,701","10,724,768",*United States,US,5/26/2017,7/28/2020,US-2017-034252-A1,5/26/2017,2332-002,Small,5/25/2016,,No,6/8/2022,Issued,"Marshall, Gerstein & Borun","Schermerhorn, Ryan",27373-50533A,"Andrew Oriani, David Schuster",US Utility,4/12/2018,2332-002,1/29/2038,"Cox, Ben",David Schuster,"Juggernauth, Anne",614842,11/30/2017,583655,No
3217,14-T-061,SYSTEMS AND METHODS FOR PROVIDING CONTINUOUS COOLING AT CRYOGENIC TEMPERATURES,"16/934,992", ,*United States,US,5/26/2017,,US-2020-0348054-A1,7/21/2020,2332-003,Small,5/25/2016,7/28/2020,No,6/22/2022,Pending,"Marshall, Gerstein & Borun","Schermerhorn, Ryan",27373-50533B,"Andrew Oriani, David Schuster",Continuation,7/28/2020, ,5/26/2037,"Cox, Ben",David Schuster,"Juggernauth, Anne",4754817,11/5/2020,583655,No
3218,14-T-062,Heat-Inducible Self-Assembling Protein Domains,"62/068,390", ,*United States,US,10/24/2014,, ,10/24/2014,2333-001,Small,10/24/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Drummond, Pavel Laskowski, Joshua Riback, Alexandra Rojek, Jamie Scott",Provisional,4/12/2018,2333-001,10/24/2015,"Dembo, Anna",David Drummond,"Tennant, Thelma",611753,,583656,Yes
3219,14-T-062,Heat-Inducible Self-Assembling Protein Domains,PCT/US15/57139, ,*United States,US,10/23/2015,,WO 2016/065273,10/23/2015,2333-002,Small,10/24/2014,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Drummond, Jakub Kucharczyk, Pavel Laskowski, Joshua Riback, Ronald Rock, Alexandra Rojek, Jagoda Rokicka, Jamie Scott",PCT,4/12/2018,2333-002,4/24/2017,"Dembo, Anna",David Drummond,"Tennant, Thelma",611754,,583656,No
3220,14-T-062,Heat-Inducible Self-Assembling Protein Domains,"15/521,330","11,053,504",*United States,US,10/25/2015,7/6/2021,US-2018-0305699-A1,4/24/2017,2333-003,Small,10/24/2014,6/22/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0583US,"David Drummond, Jakub Kucharczyk, Pavel Laskowski, Joshua Riback, Ronald Rock, Alexandra Rojek, Jagoda Rokicka, Jamie Scott",Nationalized PCT,4/12/2018,2333-003,7/8/2036,"Dembo, Anna",David Drummond,"Tennant, Thelma",611755,4/24/2017,583656,No
3221,14-T-063,Heat-Inducible Droplet-Forming Protein Domains,"62/028,716", ,*United States,US,7/24/2014,, ,7/24/2014,2334-001,Small,7/24/2014,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,David Drummond,Provisional,4/12/2018,2334-001,7/24/2015,"Dembo, Anna",David Drummond,"Tennant, Thelma",611752,,583657,Yes
3222,14-T-064,Methods and Compositions for the Treatment of Demyelinating Disorders,"61/772,875", ,*United States,US,3/5/2013,, ,3/5/2013,2335-002,Small,3/5/2013,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Benjamin Clayton, Brian Popko, Sharon Way",Provisional,4/12/2018,2335-002,3/5/2014,"Peace, Shane",Brian Popko,"Tennant, Thelma",612905,,583658,Yes
3223,14-T-064,Methods and Compositions for the Treatment of Demyelinating Disorders,PCT/US14/20896, ,*United States,US,3/5/2014,,WO 2014/138298 A1,3/5/2014,2335-003,Small,3/5/2013,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Benjamin Clayton, Brian Popko, Sharon Way",PCT,4/12/2018,2335-003,9/5/2015,"Peace, Shane",Brian Popko,"Tennant, Thelma",612906,9/12/2014,583658,Yes
3224,14-T-064,Methods and Compositions for the Treatment of Demyelinating Disorders,"14/773,088","10,905,663",*United States,US,3/5/2014,2/2/2021,US-2016-0015659-A1,9/4/2015,2335-004,Small,3/5/2013,,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0602US,"Benjamin Clayton, Brian Popko, Sharon Way",Nationalized PCT,4/12/2018,2335-004,1/23/2035,"Peace, Shane",Brian Popko,"Tennant, Thelma",612907,,583658,No
3225,14-T-064,Methods of Compositions for the Treatment of Demyelinating Disorders,"61/606,310", ,*United States,US,3/2/2012,, ,3/2/2012,2335-001,Small,3/2/2012,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wong, Karen", ,"Benjamin Clayton, Brian Popko, Sharon Way",Provisional,4/12/2018,2335-001,3/2/2013,"Peace, Shane",Brian Popko,"Tennant, Thelma",613312,,583658,Yes
3226,14-T-064,Treatment of Demyelinating Disorders,"17/248,432", ,*United States,US,3/5/2014,,US-2021-0161836-A1,1/25/2021,2335-005,Small,3/5/2013,1/25/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0602US.C1,"Benjamin Clayton, Brian Popko, Sharon Way",Continuation,1/25/2021, ,3/5/2034,"Peace, Shane",Brian Popko,"Tennant, Thelma",5299535,6/3/2021,583658,No
3227,14-T-066,Three Dimensional Block-Copolymer Films Formed  by Electrohydrodynamic Jet Printing and Self-Assembly,"15/043,048", ,*United States,US,8/15/2014,,US-2016-0297986-A1,2/12/2016,2336-003,Small,8/14/2013,,No,4/28/2022,Abandoned,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Andrew Alleyne, Placid Ferreira, Paul Nealey, M. Serdar Onses, John Rogers",Nationalized PCT,4/12/2018,2336-003,,"Hwang, Luke",John Rogers,"Butler, Brittany",614912,10/13/2016,583660,No
3228,14-T-066,Three Dimensional Block-Copolymer Films Formed By Electrohydrodynamic Jet printing and Self- Assembly,"61/865,919", ,*United States,US,8/14/2013,, ,8/14/2013,2336-001,Small,8/14/2013,,Yes,4/28/2022,Expired - Inactive,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Andrew Alleyne, Placid Ferreira, Paul Nealey, M. Serdar Onses, John Rogers",Provisional,4/12/2018,2336-001,8/14/2014,"Hwang, Luke",Paul Nealey,"Butler, Brittany",614913,,583660,Yes
3229,14-T-066,Three Dimensional Block-Copolymer Films Formed By Electrohydrodynamic Jet printing and Self- Assembly,PCT/US14/51120, ,*United States,US,8/14/2014,,WO2015/023875 A1,8/14/2014,2336-002,Small,8/14/2013,,No,4/28/2022,Expired - Inactive,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Andrew Alleyne, Placid Ferreira, Paul Nealey, M. Serdar Onses, John Rogers",PCT,4/12/2018,2336-002,2/14/2016,"Hwang, Luke",Paul Nealey,"Butler, Brittany",614914,2/19/2015,583660,Yes
3230,14-T-069,ANTI-GLUTEN ANTIBODIES AND USES THEREOF,PCT/US15/27315, ,*United States,US,4/23/2015,, ,4/23/2015,2337-002,Small,4/24/2014,,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Jones, Mitchell", ,"Carole Dunand, Ludvig Sollid, Oyvind Steinsbo, Patrick Wilson",PCT,4/12/2018,2337-002,4/24/2034,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",610367,,583663,Yes
3231,14-T-069,Monoclonal antibodies from human gluten-specific B cells,"61/983,718", ,*United States,US,4/24/2014,, ,4/24/2014,2337-001,Small,4/24/2014,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Jones, Mitchell", ,"Carole Dunand, Ludvig Sollid, Oyvind Steinsbo, Patrick Wilson",Provisional,4/12/2018,2337-001,4/24/2015,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",613521,,583663,Yes
3232,14-T-076,Methods and Compositions Involving a Protein G Variant,"62/065,156", ,*United States,US,10/17/2014,, ,10/17/2014,2340-001,Small,10/17/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Lucas Bailey, Anthony Kossiakoff, Kimberly Sheehy",Provisional,4/12/2018,2340-001,10/17/2015,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612945,,583670,No
3233,14-T-076,METHODS AND COMPOSITIONS INVOLVING A PROTEIN G VARIANT,"62/065,516", ,*United States,US,10/17/2014,, ,10/17/2014,2340-002,None,10/17/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucas Bailey, Anthony Kossiakoff, Kimberly Sheehy",Provisional,4/12/2018,2340-002,10/17/2015,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612946,,583670,Yes
3234,14-T-076,METHODS AND COMPOSITIONS INVOLVING A PROTEIN G VARIANT,PCT/US15/55870, ,*United States,US,10/16/2015,,WO 2016/061427,10/16/2015,2340-003,None,10/17/2014,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucas Bailey, Anthony Kossiakoff",PCT,4/12/2018,2340-003,4/17/2017,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612947,,583670,No
3235,14-T-076,Methods and Compositions Involving Protein G Variants,"15/519,576","10,759,834",*United States,US,10/16/2015,9/1/2020,US-2018-0044385-A1,4/17/2017,2340-004,Small,10/17/2014,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0581US,"Lucas Bailey, Anthony Kossiakoff, Kimberly Sheehy",Nationalized PCT,4/12/2018,2340-004,8/15/2036,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612980,2/15/2018,583670,No
3236,14-T-076,Methods and Compositions Involving Protein G Variants,15849930.1EPO, ,European Patent Office (EPO),EP,10/16/2015,, ,5/16/2017,2340-005,Small,10/17/2014,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Lucas Bailey, Anthony Kossiakoff, Kimberly Sheehy",Nationalized PCT,4/12/2018,2340-005,10/17/2035,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612981,,583670,No
3237,14-T-081,High-Affinity Immunopolymers,"62/076,430", ,*United States,US,11/6/2014,, ,11/6/2014,2343-001,Small,11/6/2014,,Yes,4/28/2022,Expired - Inactive,"VLP Law Group, LLP","Roise, David", ,"Amy Flor, Stephen Kron, David Schwartz",Provisional,4/12/2018,2343-001,11/6/2015,"Sun, Han",David Schwartz,"Tennant, Thelma",611818,,583675,Yes
3238,14-T-081,High-Affinity Immunopolymers,PCT/US15/59424, ,*United States,US,11/6/2015,,WO 2016/073833,11/6/2015,2343-002,Small,11/6/2014,,No,4/28/2022,Expired - Inactive,"VLP Law Group, LLP","Roise, David", ,"Amy Flor, Stephen Kron, David Schwartz",PCT,4/12/2018,2343-002,5/6/2017,"Sun, Han",David Schwartz,"Tennant, Thelma",611819,5/12/2016,583675,No
3239,14-T-081,High-Affinity Immunopolymers,"15/525,061", ,*United States,US,11/6/2015,,2019/0112356-A1,5/6/2017,2343-003,Small,11/6/2014,8/20/2019,No,5/1/2022,Abandoned,"VLP Law Group, LLP",, ,"Amy Flor, Stephen Kron, David Schwartz",Nationalized PCT,4/12/2018,2343-003,11/7/2035,"Sun, Han",Stephen Kron,"Tennant, Thelma",611820,4/18/2019,583675,No
3240,14-T-083,METHODS AND COMPOSITIONS FOR DIAGNOSING INFECTION BY EBOLA VIRUS,"62/065,539", ,*United States,US,10/17/2014,, ,10/17/2014,2345-001,None,10/17/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Zygmunt Derewenda, Daniel Engel, Anthony Kossiakoff",Provisional,4/12/2018,2345-001,10/17/2015,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612682,,583677,Yes
3241,14-T-092,"Monobody Selective for a State, Isoform or Mutant of RAS","62/064,170", ,*United States,US,10/15/2014,, ,10/15/2014,2349-001,Small,10/15/2014,,Yes,4/28/2022,Expired - Inactive,Licata & Tyrrell PC,, ,"Akiko Koide, Shohei Koide, John O'Bryan",Provisional,4/12/2018,2349-001,10/15/2015,"Bakalyar, Heather",Shohei Koide,"Butler, Brittany",613518,,583686,Yes
3242,14-T-092,"Monobody Selective for a State, Isoform or Mutant of RAS","62/242,448", ,*United States,US,10/16/2015,, ,10/16/2015,2349-002,Small,10/16/2015,,Yes,4/28/2022,Expired - Inactive,Licata & Tyrrell PC,, ,"Akiko Koide, Shohei Koide, John O'Bryan",Provisional,4/12/2018,2349-002,10/16/2016,"Bakalyar, Heather",Shohei Koide,"Butler, Brittany",613519,,583686,No
3243,14-T-094,Methods and Compositions Pertaining to Human Cerebral Cavernous Malformations,"62/075,491", ,*United States,US,11/5/2014,, ,11/5/2014,2350-001,Small,11/5/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Issam Awad,Provisional,4/12/2018,2350-001,11/5/2015,"Dembo, Anna",Issam Awad,"Butler, Brittany",613007,,583688,Yes
3244,14-T-094,Methods and Compositions Pertaining to Human Cerebral Cavernous Malformations,PCT/US15/59135, ,*United States,US,11/5/2015,,WO 2016/073664,11/5/2015,2350-002,Small,11/5/2014,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Issam Awad,PCT,4/12/2018,2350-002,5/5/2017,"Dembo, Anna",Issam Awad,"Butler, Brittany",613008,,583688,No
3245,14-T-094,Methods and Compositions Pertaining to Human Cerebral Cavernous Malformations,"15/523,521", ,*United States,US,11/5/2015,,US-2017-0313779-A1,5/1/2017,2350-003,Small,11/5/2014,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0584US,Issam Awad,Nationalized PCT,4/12/2018,2350-003,11/7/2034,"Dembo, Anna",Issam Awad,"Butler, Brittany",613009,11/2/2017,583688,No
3246,14-T-095,Methods and Compositions Related to Immunogenic Fibrils,"62/055,281", ,*United States,US,9/25/2014,, ,9/25/2014,2352-001,Small,9/25/2014,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Joel Collier, Jai Simha Rudra",Provisional,4/12/2018,2352-001,9/25/2015,"Dembo, Anna",Joel Collier,"Tennant, Thelma",613059,,583689,Yes
3247,14-T-096,Compositionally Matched Molecular Solders for Semiconductors,"62/085,966", ,*United States,US,12/1/2014,, ,12/1/2014,2353-001,Small,12/1/2014,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0006,"Dmitriy Dolzhnikov, Jaeyoung Jang, Matthew Panthani, Jae Sung Son, Dmitri Talapin, Hao Zhang",Provisional,4/12/2018,2353-001,12/1/2015,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610967,,583690,Yes
3248,14-T-096,Compositionally Matched Molecular Solders for Semiconductors,PCT/US15/63145, ,*United States,US,12/1/2015,,WO2016089840,12/1/2015,2353-002,Small,12/1/2014,,No,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0006-02,"Dmitriy Dolzhnikov, Jaeyoung Jang, Matthew Panthani, Jae Sung Son, Dmitri Talapin, Hao Zhang",PCT,4/12/2018,2353-002,6/1/2017,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610968,,583690,No
3249,14-T-096,Compositionally Matched Molecular Solders for Semiconductors,"15/528,871","10,283,357",*United States,US,12/1/2015,5/7/2019,20180144934,5/23/2017,2353-003,Small,12/1/2014,,No,4/28/2022,Issued,"Bell & Manning, LLC","Porembski, Philip",05400-0006-03,"Dmitriy Dolzhnikov, Jaeyoung Jang, Matthew Panthani, Jae Sung Son, Dmitri Talapin, Hao Zhang",Nationalized PCT,4/12/2018,2353-003,12/1/2034,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610969,5/24/2018,583690,No
3250,14-T-097,A Nanoscale Metal-Organic Framework for Photodynamic Cancer Therapy,"62/063,770", ,*United States,US,10/14/2014,, ,10/14/2014,2346-001,Small,10/14/2014,2/27/2020,Yes,4/28/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00009,"Chunbai He, Wenbin Lin, Kuangda Lu",Provisional,4/12/2018,2346-001,10/14/2015,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",610221,,583691,Yes
3251,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",PCT/US15/55574, ,*United States,US,10/14/2015,,WO 2016/061256,10/16/2015,2346-002,Small,10/14/2014,2/27/2020,No,4/28/2022,Expired PCT - Nationalized,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00014,"Chunbai He, Wenbin Lin, Kuangda Lu",PCT,4/12/2018,2346-002,10/14/2017,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613631,,583691,No
3252,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof","15/518,665","10,206,871",*United States,US,10/14/2015,2/19/2019, ,10/14/2015,2346-003,Small,10/14/2014,2/19/2019,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00032,"Chunbai He, Guangxu Lan, Wenbin Lin, Kuangda Lu, Kaiyuan Ni",Nationalized PCT,4/12/2018,2346-003,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613632,4/23/2016,583691,No
3253,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",2017-520324,6731404,Japan,JP,10/14/2015,7/8/2020, ,10/14/2015,2346-004,Small,10/14/2014,,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5 PCT/JP,"Chunbai He, Wenbin Lin, Kuangda Lu",Nationalized PCT,4/12/2018,2346-004,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613633,4/23/2016,583691,No
3254,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",15851357.2,3206987,European Patent Office (EPO),EP,10/14/2015,7/1/2020,3206987,4/21/2017,2346-005,Small,10/14/2014,10/26/2021,No,6/16/2022,Opposition,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5 PCT/EP,"Chunbai He, Wenbin Lin, Kuangda Lu",Nationalized PCT,4/12/2018,2346-005,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613634,8/23/2017,583691,No
3255,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",201580068173.X, ,China,CN,10/14/2015,, ,10/14/2015,2346-006,Small,10/14/2014,4/1/2021,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5 PCT/CN,"Chunbai He, Wenbin Lin, Kuangda Lu",Nationalized PCT,4/12/2018,2346-006,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613635,4/23/2016,583691,No
3256,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof","15/884,036","10,806,694",*United States,US,10/14/2015,10/20/2020,2018-0153796,10/14/2015,2346-007,Small,10/14/2014,10/2/2020,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5/3 CIP,"Chunbai He, Guangxu Lan, Wenbin Lin, Kuangda Lu, Kaiyuan Ni",Continuation in Part,4/12/2018,2346-007,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613636,6/7/2018,583691,No
3257,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof","16/235,752","10,780,045",*United States,US,10/14/2015,9/22/2020,US-2019-0209460-A1,12/28/2018,2346-008,Small,10/14/2014,1/17/2019,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5/4 CON,"Chunbai He, Wenbin Lin, Kuangda Lu",Continuation,1/17/2019,2346-008,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",3417193,7/11/2019,583691,No
3258,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof","16/519,252", ,*United States,US,10/14/2015,, ,7/23/2019,2346-009,Small,10/14/2014,10/1/2019,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5/5 CON,"Chunbai He, Wenbin Lin, Kuangda Lu",Continuation,9/10/2019,2346-009,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",3987907,,583691,No
3259,14-T-097,"Metal-organic framework, pharmaceutical formulation and use thereof in medicament preparation",201911001924.2, ,China,CN,10/14/2015,,110731961,10/21/2019,2346-010,Small,10/14/2014,11/26/2019,No,4/28/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5/2 PCT/CN DIV,"Chunbai He, Wenbin Lin, Kuangda Lu",Divisional,11/26/2019, ,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4132237,1/31/2020,583691,No
3260,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",15851357.2,602015055218.0,Germany,DE,10/14/2015,7/1/2020,3206987,5/25/2020,2346-012,Small,10/14/2014,4/23/2020,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5 EP/DE,"Chunbai He, Wenbin Lin, Kuangda Lu",Validated EPO,4/23/2020, ,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4481943,,583691,No
3261,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",15851357.2,3206987,France,FR,10/14/2015,7/1/2020, ,5/25/2020,2346-011,Small,10/14/2014,4/23/2020,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5 EP/FR,"Chunbai He, Wenbin Lin, Kuangda Lu",Validated EPO,4/23/2020, ,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4481973,,583691,No
3262,14-T-097,"Nanoparticles for Photodynamic Therapy, X-Ray induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, and any Combination Thereof",15851357.2,3206987,United Kingdom,GB,10/14/2015,7/1/2020, ,5/25/2020,2346-013,Small,10/14/2014,4/23/2020,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/5 EP/GB,"Chunbai He, Wenbin Lin, Kuangda Lu",Validated EPO,4/23/2020, ,10/14/2035,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4482005,,583691,No
3263,14-T-098,CAR T-Cells utilizing single-chain antibody fragment against human IL13Ra2 and uses thereof,PCT/US16/14984, ,*United States,US,1/26/2016,,WO 2016/123142,1/26/2016,2354-002,Small,1/26/2015,,No,4/28/2022,Expired PCT - Nationalized,"Marshall, Gerstein & Borun","Merkel, William",49102A,"Irina Balyasnikova, Maciej Lesniak",PCT,4/12/2018,2354-002,7/27/2017,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610790,8/5/2016,583692,No
3264,14-T-098,IL13RA2 BINDING AGENTS AND USE THEREOF IN CANCER TREATMENT,"62/107,984", ,*United States,US,1/26/2015,, ,1/27/2015,2354-001,Small,1/26/2015,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",49102,"Irina Balyasnikova, Maciej Lesniak",Provisional,4/12/2018,2354-001,1/26/2016,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",611898,,583692,Yes
3265,14-T-098,IL13Ra2 Binding Agents and Use Thereof in Cancer Treatment,16743989.2EPO, ,European Patent Office (EPO),EP,1/26/2016,,3250609,1/26/2016,2354-003,Small,1/26/2015,,No,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0695EP,"Irina Balyasnikova, Maciej Lesniak",Nationalized PCT,4/12/2018,2354-003,1/26/2036,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",611899,12/6/2017,583692,No
3266,14-T-098,IL13Ra2 Binding Agents and Use Thereof in Cancer Treatment,"15/545,945","10,308,719",*United States,US,1/26/2016,6/4/2019,US-2018-0134796-A1,1/26/2016,2354-004,Small,1/26/2015,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",49102A,"Irina Balyasnikova, Maciej Lesniak",Nationalized PCT,4/12/2018,2354-004,1/26/2036,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",611900,5/17/2018,583692,No
3267,14-T-098,IL13Ra2 Binding Agents and Use Thereof in Cancer Treatment,2017-558362, ,Japan,JP,1/26/2016,, ,1/26/2016,2354-005,Small,1/26/2015,2/22/2022,No,5/24/2022,In Appeal,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0695JP,"Irina Balyasnikova, Maciej Lesniak",Nationalized PCT,4/12/2018,2354-005,7/24/2037,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",611901,,583692,No
3268,14-T-098,IL13Ra2 Binding Agents and Use Thereof in Cancer Treatment,201680018571.5,CN 107683289,China,CN,1/26/2016,8/6/2021,107683289,1/26/2016,2354-006,Small,1/26/2015,5/31/2022,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0695CN,"Irina Balyasnikova, Maciej Lesniak",Nationalized PCT,4/12/2018,2354-006,7/24/2037,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",611902,2/9/2018,583692,No
3269,14-T-098,IL13Ra2 Binding Agents and Use Thereof in Cancer Treatment,18104508.7, ,Hong Kong,HK,1/26/2016,,1245287A,4/4/2018,2354-007,None,1/26/2015,5/29/2018,No,4/28/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",49102A-HK,"Irina Balyasnikova, Maciej Lesniak",Validated EPO,5/29/2018, ,1/26/2036,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",1425457,8/24/2018,583692,No
3270,14-T-098,IL13Ra2 Binding Agents and Use Thereof in Cancer Treatment,"16/385,853","10,851,169",*United States,US,1/26/2016,12/1/2020,US-2019-0300616-A1,4/16/2019,2354-008,Small,1/26/2015,5/3/2019,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0695US.C1,"Irina Balyasnikova, Maciej Lesniak",Continuation,5/3/2019, ,1/26/2036,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",3681649,10/3/2019,583692,No
3271,14-T-098,IL13Ralpha2 Binding Agents and Use Thereof in Cancer Treatment,"16/949,900", ,*United States,US,1/26/2016,,US-2021-0221895-A1,11/19/2020,2354-009,Small,1/26/2015,9/1/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0695US.C2,"Irina Balyasnikova, Maciej Lesniak",Continuation,9/1/2020, ,1/26/2036,"Sun, Han",Irina Balyasnikova,"Tennant, Thelma",4866501,7/22/2021,583692,No
3272,14-T-103,COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING,"62/144,712", ,*United States,US,4/8/2015,, ,4/8/2015,2356-001,Small,4/8/2015,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",49246,"Quan Gao, Elizabeth McNally, Eugene Wyatt",Provisional,4/12/2018,2356-001,4/8/2016,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610978,,583697,Yes
3273,14-T-103,COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING,PCT/US16/26477, ,*United States,US,4/7/2016,,WO 2016/164602,4/7/2016,2356-002,Small,4/8/2015,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Allikian, Michael",49246A-PC,"Elizabeth McNally, Eugene Wyatt",PCT,4/12/2018,2356-002,10/7/2016,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610979,10/14/2016,583697,No
3274,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,"15/564,681","10,273,483",*United States,US,4/7/2016,4/30/2019,US-2018-0080030-A1,4/7/2016,2356-003,Small,4/8/2015,,No,4/28/2022,Issued,"Marshall, Gerstein & Borun",,49246A,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,4/12/2018,2356-003,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610980,3/22/2018,583697,No
3275,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,TN2017/0427, ,Tunisia,TN,4/7/2016,, ,4/7/2016,2356-004,Small,4/8/2015,,No,5/23/2022,Pending,"Marshall, Gerstein & Borun",,49246A-TN,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,4/12/2018,2356-004,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610981,,583697,No
3276,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,"2,981,960", ,Canada,CA,4/7/2016,, ,4/7/2016,2356-005,Small,4/8/2015,,No,6/24/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A CA,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,4/12/2018,2356-005,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610982,,583697,No
3277,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2EPO,3283500,European Patent Office (EPO),EP,4/7/2016,11/11/2020,3283500,4/7/2016,2356-006,Small,4/8/2015,,No,4/28/2022,Granted,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A-EP,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,4/12/2018,2356-006,,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610983,2/21/2018,583697,No
3278,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,BR112017021485-7, ,Brazil,BR,4/7/2016,,2588,10/16/2017,2356-007,Small,4/8/2015,,No,5/23/2022,Pending,"Marshall, Gerstein & Borun",,49246A-BR,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,4/12/2018,2356-007,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610984,8/18/2020,583697,No
3279,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,201717037933, ,India,IN,4/7/2016,, ,4/7/2016,2356-008,Small,4/8/2015,,No,6/8/2022,Pending,"Marshall, Gerstein & Borun",,49246A-IN,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,4/12/2018,2356-008,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",610985,12/29/2017,583697,No
3280,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,18110160.3,1250720,Hong Kong,HK,4/7/2016,8/13/2021, ,8/7/2018,2356-009,Small,4/8/2015,8/31/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",49246A-HK,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/4/2018, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",1690554,,583697,No
3281,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,"16/395,741","10,801,029",*United States,US,4/7/2016,10/13/2020,US-2019-0249180-A1,4/26/2019,2356-010,Small,4/8/2015,2/15/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-49246B,"Elizabeth McNally, Eugene Wyatt",Continuation,5/22/2019, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",3733429,8/15/2019,583697,No
3282,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,2020000759,3283500,Albania,AL,4/7/2016,11/11/2020, ,11/11/2020,2356-011,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-49246A  AL,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883581,,583697,No
3283,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,E-1333508,3283500,Austria,AT,4/7/2016,11/11/2020, ,11/11/2020,2356-012,Large,4/8/2015,9/10/2020,No,5/23/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-49246A AT,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883603,,583697,No
3284,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 BE,3283500,Belgium,BE,4/7/2016,11/11/2020, ,11/11/2020,2356-013,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373-49246A BE,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883625,,583697,No
3285,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,25098,3283500,Bulgaria,BG,4/7/2016,11/11/2020, ,11/11/2020,2356-014,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A BG,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883757,,583697,No
3286,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 CH,3283500,Switzerland,CH,4/7/2016,11/11/2020, ,11/11/2020,2356-040,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A CH,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883779,,583697,No
3287,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,CY20201101145,3283500,Cyprus,CY,4/7/2016,11/11/2020, ,11/11/2020,2356-016,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A CY,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883801,,583697,No
3288,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 CZ,3283500,Czech Republic,CZ,4/7/2016,11/11/2020, ,11/11/2020,2356-017,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A CZ,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883823,,583697,No
3289,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 DK,3283500,Denmark,DK,4/7/2016,11/11/2020, ,11/11/2020,2356-018,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A DK,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883845,,583697,No
3290,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,6020016047724.6,3283500,Germany,DE,4/7/2016,11/11/2020, ,11/11/2020,2356-021,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A DE,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883867,,583697,No
3291,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 FI,3283500,Finland,FI,4/7/2016,11/11/2020, ,11/11/2020,2356-019,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A FI,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883889,,583697,No
3292,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2FR,3283500,France,FR,4/7/2016,11/11/2020, ,11/11/2020,2356-020,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A FR,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883911,,583697,No
3293,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,300395787,3283500,Spain,ES,4/7/2016,11/11/2020, ,11/11/2020,2356-038,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A ES,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883933,,583697,No
3294,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 GB,3283500,United Kingdom,GB,4/7/2016,11/11/2020, ,11/11/2020,2356-044,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A GB,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883955,,583697,No
3295,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,P20210139T,3283500,Croatia,HR,4/7/2016,11/11/2020, ,11/11/2020,2356-015,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A HR,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883977,,583697,No
3296,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,20200403414,3283500,Greece,GR,4/7/2016,11/11/2020, ,11/11/2020,2356-022,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A GR,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4883999,,583697,No
3297,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,E052604,3283500,Hungary,HU,4/7/2016,11/11/2020, ,11/11/2020,2356-023,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A HU,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884021,,583697,No
3298,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 IE,3283500,Ireland,IE,4/7/2016,11/11/2020, ,11/11/2020,2356-024,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A IE,"Elizabeth McNally, Eugene Wyatt",Nationalized PCT,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884043,,583697,No
3299,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 LT,3283500,Lithuania,LT,4/7/2016,11/11/2020, ,11/11/2020,2356-027,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A LT,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884089,,583697,No
3300,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 LU,3283500,Luxembourg,LU,4/7/2016,11/11/2020, ,11/11/2020,2356-028,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A LU,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884111,,583697,No
3301,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 LV,3283500,Latvia,LV,4/7/2016,11/11/2020, ,11/11/2020,2356-026,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A LV,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884133,,583697,No
3302,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,P 2020/892,3283500,"Macedonia, former Yugoslav Republic of",MK,4/7/2016,11/11/2020, ,11/11/2020,2356-029,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A MK,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884155,,583697,No
3303,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 MT,3283500,Malta,MT,4/7/2016,11/11/2020, ,11/11/2020,2356-030,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",16777291.2 MT,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884177,,583697,No
3304,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 NL,3283500,Netherlands,NL,4/7/2016,11/11/2020, ,11/11/2020,2356-032,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A NL,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884199,,583697,No
3305,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 NO,3283500,Norway,NO,4/7/2016,11/11/2020, ,11/11/2020,2356-033,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A NO,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884221,,583697,No
3306,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2PL,3283500,Poland,PL,4/7/2016,11/11/2020, ,11/11/2020,2356-034,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A PL,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884243,,583697,No
3307,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,20211000002611,3283500,Portugal,PT,4/7/2016,11/11/2020, ,11/11/2020,2356-035,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A PT,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884265,,583697,No
3308,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 RO,3283500,Romania,RO,4/7/2016,11/11/2020, ,11/11/2020,2356-043,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A RO,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884287,,583697,No
3309,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,61349,3283500,Serbia,RS,4/7/2016,11/11/2020, ,11/11/2020,2356-036,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A RS,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884309,,583697,No
3310,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2SE,3283500,Sweden,SE,4/7/2016,11/11/2020, ,11/11/2020,2356-041,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A SE,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884331,,583697,No
3311,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,P-201630981,3283500,Slovenia,SI,4/7/2016,11/11/2020, ,11/11/2020,2356-037,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A SI,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884353,,583697,No
3312,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 SK,3283500,Slovakia,SK,4/7/2016,11/11/2020, ,11/11/2020,2356-039,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A SK,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884375,,583697,No
3313,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2TR,3283500,Turkey,TR,4/7/2016,11/11/2020, ,11/11/2020,2356-042,Small,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A TR,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884397,,583697,No
3314,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,16777291.2 MC,3283500,Monaco,MC,4/7/2016,11/11/2020, ,11/11/2020,2356-031,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A MC,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884419,,583697,No
3315,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,50202100000003776,3283500,Italy,IT,4/7/2016,11/11/2020, ,11/11/2020,2356-025,Large,4/8/2015,9/10/2020,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/49246A IT,"Elizabeth McNally, Eugene Wyatt",Validated EPO,9/10/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4884441,,583697,No
3316,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping,20197997.8, ,European Patent Office (EPO),EP,4/7/2016,, ,9/24/2020,2356-045,Large,4/8/2015,10/2/2020,No,5/2/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/49246B/EP,"Elizabeth McNally, Eugene Wyatt",Divisional,10/2/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4936435,,583697,No
3317,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,"17/020,328", ,*United States,US,4/7/2016,,US-2021-0032631-A1,9/14/2020,2356-047,Large,4/8/2015,6/9/2021,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/49246C,"Elizabeth McNally, Eugene Wyatt",Continuation,10/2/2020, ,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",4947243,2/4/2021,583697,No
3318,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,"17/331,420", ,*United States,US,4/7/2016,, ,5/26/2021,2356-048,Small,4/8/2015,6/9/2021,No,4/28/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373/49246D,"Elizabeth McNally, Eugene Wyatt",Continuation,6/9/2021,2356-048,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",5811171,,583697,No
3319,14-T-103,Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping,"17/571,302", ,*United States,US,4/7/2016,,US-2022- 0119820-A1,1/7/2022,2356-049,Small,4/8/2015,1/14/2022,No,5/31/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373/49246D,"Elizabeth McNally, Eugene Wyatt",Continuation,1/14/2022,2356-049,4/7/2036,"Sun, Han",Elizabeth McNally,"Tennant, Thelma",6598388,4/21/2022,583697,No
3320,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,10-2017-7037299, ,"Korea, Republic of",KR,6/1/2016,, ,6/1/2016,2398-019,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.751,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2390-019,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614955,,583699,No
3321,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"62/169,112", ,*United States,US,6/1/2015,, ,6/5/2015,2398-001,Small,6/1/2015,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David",UCHI-34458/US-1/PRO,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Provisional,4/12/2018,2398-001,6/1/2016,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614956,,583699,No
3322,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"62/248,741", ,*United States,US,10/30/2015,, ,10/31/2015,2398-002,Small,10/30/2015,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David",UCHI-34458/US-2-PRO,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Provisional,4/12/2018,2398-002,10/30/2016,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614957,,583699,No
3323,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,P160101610, ,Argentina,AR,6/1/2016,,AR 104859 A1,6/1/2016,2398-003,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.904,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-003,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614958,8/23/2017,583699,No
3324,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,PCT/US16/35228, ,*United States,US,6/1/2016,,WO 2016/196605,6/4/2016,2398-004,Small,6/1/2015,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David",UCHI34458WO,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",PCT,4/12/2018,2398-004,12/1/2017,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614959,12/9/2016,583699,No
3325,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"16/901,823","9,855,302",*United States,US,6/1/2016,1/2/2018,2016-0354416,6/15/2020,2398-005,Small,6/1/2015,6/23/2020,No,6/9/2022,Issued,"Casimir Jones, S.C.","Staple, David",UCHI-34458/US-3/ORD,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",US Utility,4/12/2018,2398-005,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614960,12/8/2016,583699,No
3326,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,105117266, ,"Taiwan, Province of China",TW,6/1/2016,,201717975,6/1/2016,2398-006,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458.905,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-006,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614961,6/1/2017,583699,No
3327,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2016000241, ,"Venezuela, Bolivarian Republic of",VE,6/1/2016,, ,6/1/2016,2398-007,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-007,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614963,8/24/2017,583699,No
3328,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,36701, ,Uruguay,UY,6/1/2016,, ,6/1/2016,2398-008,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-008,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614965,,583699,No
3329,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"15/718,735", ,*United States,US,6/1/2016,,2018-0015131,9/28/2017,2398-009,Small,6/1/2015,2/28/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34458/US-4/CON,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,4/12/2018,2398-009,,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614966,1/18/2018,583699,No
3330,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,11201709693W,11201709693W,Singapore,SG,6/1/2016,7/24/2020, ,6/1/2016,2398-010,Small,6/1/2015,,No,5/31/2022,Issued,"Casimir Jones, S.C.","Staple, David",34458.811,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-010,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614967,,583699,No
3331,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2017-3024, ,Chile,CL,6/1/2016,, ,6/1/2016,2398-011,Small,6/1/2015,,No,8/4/2020,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458/CL-1/PCT,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-011,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614968,,583699,No
3332,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2016270750, ,Australia,AU,6/1/2016,, ,6/1/2016,2398-012,Small,6/1/2015,,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.721,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-012,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614969,,583699,No
3333,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,BR 112017025813-7, ,Brazil,BR,6/1/2016,, ,6/1/2016,2398-013,Small,6/1/2015,,No,5/31/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.781,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-013,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614970,,583699,No
3334,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"2,987,129", ,Canada,CA,6/1/2016,, ,6/1/2016,2398-014,Small,6/1/2015,,No,5/31/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.711,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-014,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614971,,583699,No
3335,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,201680031836.5, ,China,CN,6/1/2016,,CN 107847530A,6/1/2016,2398-015,Small,6/1/2015,,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.731,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-015,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614972,3/27/2018,583699,No
3336,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,201717044218, ,India,IN,6/1/2016,, ,6/1/2016,2398-016,Small,6/1/2015,,No,6/15/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.741,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-016,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614973,,583699,No
3337,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,255940, ,Israel,IL,6/1/2016,, ,6/1/2016,2398-017,Small,6/1/2015,,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.801,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-017,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614974,,583699,No
3338,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2017-561803, ,Japan,JP,6/1/2016,, ,6/1/2016,2398-018,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.701,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-018,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614975,,583699,No
3339,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,MX/a/2017/015473, ,Mexico,MX,6/1/2016,, ,6/1/2016,2398-020,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-020,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614976,,583699,No
3340,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,737782, ,New Zealand,NZ,6/1/2016,, ,6/1/2016,2398-021,Small,6/1/2015,,No,5/31/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.791,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-021,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614977,,583699,No
3341,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,002514-2017/DIN, ,Peru,PE,6/1/2016,,2018-0673,6/1/2016,2398-022,Small,6/1/2015,,No,6/15/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458.877,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-022,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614978,4/19/2018,583699,No
3342,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2017141448, ,Russian Federation,RU,6/1/2016,, ,6/1/2016,2398-023,Small,6/1/2015,4/28/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",34458.851,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-023,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614979,,583699,No
3343,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,a2017 11648, ,Ukraine,UA,6/1/2016,, ,6/1/2016,2398-024,Small,6/1/2015,,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.876,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-024,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614980,,583699,No
3344,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2017/07986, ,South Africa,ZA,6/1/2016,, ,6/1/2016,2398-025,Small,6/1/2015,,No,5/31/2022,Granted,"Casimir Jones, S.C.","Staple, David",34458.841,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-025,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614981,,583699,No
3345,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,16804316.4EPO, ,European Patent Office (EPO),EP,6/1/2016,,3303401,6/1/2016,2398-026,Small,6/1/2015,,No,5/31/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458.611,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,4/12/2018,2398-026,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",614982,4/11/2018,583699,No
3346,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,18112446.5, ,Hong Kong,HK,6/1/2016,,1253064,10/5/2018,2398-027,Small,6/1/2015,11/5/2018,No,8/4/2020,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458/HK-1/REP,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Validated EPO,11/5/2018, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",1871405,6/6/2019,583699,No
3347,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"16/282,517", ,*United States,US,6/1/2016,,US-2019-0183942,2/22/2019,2398-028,Small,6/1/2015,1/28/2020,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34458/US-5/CON,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,3/4/2019, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3551233,6/20/2019,583699,No
3348,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"16/437,972", ,*United States,US,6/1/2016,, ,6/11/2019,2398-029,None,6/1/2015,7/16/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34458.306,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,7/16/2019, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3797972,,583699,No
3349,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2019/07641,2019/07641,South Africa,ZA,6/1/2016,5/26/2021, ,11/19/2019,2398-030,None,6/1/2015,4/27/2021,No,5/31/2022,Issued,"Casimir Jones, S.C.","Staple, David",UCHI-34458.842,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Divisional,12/31/2019, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4199320,,583699,No
3350,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"16/795,226", ,*United States,US,6/1/2016,, ,2/19/2020,2398-031,Small,6/1/2015,3/18/2020,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34458.307,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,3/18/2020, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4412808,,583699,No
3351,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"16/942,496", ,*United States,US,6/1/2016,, ,7/29/2020,2398-032,Small,6/1/2015,3/10/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34458.309,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,8/5/2020, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4809179,,583699,No
3352,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"17/192,519", ,*United States,US,6/1/2016,, ,3/4/2021,2398-033,Small,6/1/2015,11/29/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34458.310,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,3/10/2021, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",5470331,,583699,No
3353,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2021110871, ,Russian Federation,RU,6/1/2016,, ,4/21/2021,2398-034,None,6/1/2015,4/28/2021,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",34458.852,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Divisional,4/28/2021, ,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",5641478,,583699,No
3354,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,2021-153369,,Japan,JP,6/1/2016,,,9/13/2021,2398-035,Large,6/1/2015,9/27/2021,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458.702,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Nationalized PCT,9/27/2021,,6/1/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",6209034,,583699,No
3355,14-T-105,TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA,"17/517,084", ,*United States,US,6/1/2016,, ,11/2/2021,2398-036,Small,6/1/2015,11/18/2021,No,6/24/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34458.311,"Thomas Gajewski, Leticia Pecino, Ayelet Sivan",Continuation,11/18/2021, ,6/21/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",6408249,,583699,No
3356,14-T-117,METHODS AND COMPOSITION FOR NEUTRALIZATION OF INFLUENZA,"62/093,870", ,*United States,US,12/18/2014,, ,12/19/2014,2365-001,Small,12/18/2014,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Carole Dunand, Patrick Wilson",Provisional,4/12/2018,2365-001,12/18/2015,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",612636,,583711,Yes
3357,14-T-117,METHODS AND COMPOSITION FOR NEUTRALIZATION OF INFLUENZA,PCT/US15/66281, ,*United States,US,12/20/2015,,WO 2016/100615,12/19/2015,2365-002,Small,12/18/2014,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Carole Dunand, Patrick Wilson",PCT,4/12/2018,2365-002,,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",612637,8/20/2016,583711,No
3358,14-T-117,METHODS AND COMPOSITION FOR NEUTRALIZATION OF INFLUENZA,"15/536,857","10,357,563",*United States,US,12/20/2015,7/23/2019,2017-0360931,6/16/2017,2365-003,Small,12/18/2014,,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David",34263.252,"Carole Dunand, Patrick Wilson",Nationalized PCT,4/12/2018,2365-003,12/20/2035,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",612638,12/21/2017,583711,No
3359,14-T-118,METHODS AND COMPOSITION FOR MODIFYING ENZYMES,"62/193,955", ,*United States,US,7/17/2015,, ,7/18/2015,2367-001,Small,7/17/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Provisional,4/12/2018,2367-001,7/17/2016,"Peace, Shane",Shohei Koide,"Muite, Kevin",612626,,583712,No
3360,14-T-118,METHODS AND COMPOSITION FOR MODIFYING ENZYMES,PCT/US16/42516, ,*United States,US,7/15/2016,,WO 2017/015119,7/16/2016,2367-002,Small,7/17/2015,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000224455,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",PCT,4/12/2018,2367-002,1/17/2018,"Peace, Shane",Shohei Koide,"Muite, Kevin",612627,1/27/2017,583712,No
3361,14-T-118,METHODS AND COMPOSITION FOR MODIFYING ENZYMES,"15/745,496", ,*United States,US,7/15/2016,,US-2018-0208678-A1,1/17/2018,2367-003,Small,7/17/2015,,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0590US,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Nationalized PCT,4/12/2018,2367-003,7/15/2036,"Peace, Shane",Shohei Koide,"Muite, Kevin",612628,7/26/2018,583712,No
3362,14-T-118,METHODS AND COMPOSITION FOR MODIFYING ENZYMES,2018-502147, ,Japan,JP,7/15/2016,,2018-524012 A,7/15/2016,2367-004,Small,7/17/2015,,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0590JP,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Nationalized PCT,4/12/2018,2367-004,7/15/2036,"Peace, Shane",Shohei Koide,"Muite, Kevin",612629,8/30/2018,583712,No
3363,14-T-118,METHODS AND COMPOSITION FOR MODIFYING ENZYMES,16828310.9EPO, ,European Patent Office (EPO),EP,7/15/2016,,3325641,7/15/2016,2367-005,Small,7/17/2015,,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,,ARCD.P0590EP,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Nationalized PCT,4/12/2018,2367-005,7/15/2036,"Peace, Shane",Shohei Koide,"Muite, Kevin",612631,5/30/2018,583712,No
3364,14-T-118,METHODS AND COMPOSITION FOR MODIFYING ENZYMES,,,*United States,US,7/15/2016,,,,2367-006,Small,7/17/2015,5/31/2022,No,6/23/2022,,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Continuation,5/31/2022,,,"Peace, Shane",Shohei Koide,"Muite, Kevin",7343624,,583712,
3365,14-T-119,SYSTEM AND METHOD FOR PRESENTING LARGE DNA MOLECULES FOR ANALYSIS,"61/877,570", ,*United States,US,9/13/2013,, ,9/13/2013,2369-001,Large,9/13/2013,,Yes,4/28/2022,Expired - Inactive,Wisconsin Alumni Research Foundation (WARF),, ,Juan de Pablo,Provisional,4/12/2018,2369-001,9/13/2014,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",614789,,583713,Yes
3366,14-T-119,SYSTEM AND METHOD FOR PRESENTING LARGE DNA MOLECULES FOR ANALYSIS,"14/485,119", ,*United States,US,9/12/2014,, ,9/12/2014,2369-002,Large,9/13/2013,,No,4/28/2022,Pending,Wisconsin Alumni Research Foundation (WARF),, ,Juan de Pablo,US Utility,4/12/2018,2369-002,9/12/2034,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",614790,,583713,Yes
3367,14-T-119,System and Method for Presenting Large DNA Molecules for Analysis,PCT/US14/55484, ,*United States,US,9/13/2014,,WO 2015/038953 A1,9/12/2014,2369-003,Small,9/13/2014,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,P140056WO01,Juan de Pablo,PCT,4/12/2018,2369-003,3/13/2016,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",614791,3/20/2015,583713,No
3368,14-T-120,SYSTEM AND METHOD TO DETECT AND VISUALIZE FINDING-SPECIFIC SUGGESTIONS AND PERTINENT PATIENT INFORMATION IN RADIOLOGY WORKFLOW,"14/551,167", ,*United States,US,11/24/2014,, ,11/24/2014,2366-001,Large,11/24/2014,,Yes,4/28/2022,Pending,,, ,Paul Chang,US Utility,4/12/2018,2366-001,11/24/2034,"Ginsburg, Eric",Paul Chang,"Smith, Dane",614795,,583714,Yes
3369,15-T-001,CONTRAST MEDIUM UPTAKE TIME COMPUTATION USING MAGNETIC RESONANCE IMAGING,"15/248,445","9,972,089",*United States,US,8/27/2016,5/15/2018,20170061613,8/27/2016,2368-002,Small,8/26/2015,,No,4/28/2022,Issued,"Bell & Manning, LLC","Bell, Callie",05400-0012-02,"Hiroyuki Abe, Xiaobing Fan, Gregory Karczmar, Gillian Newstead, Aytekin Oto, Federico Pineda, Shiyang Wang",US Utility,4/12/2018,2368-002,8/27/2036,"Cox, Ben",Gregory Karczmar,"Smith, Dane",611280,3/2/2017,583715,No
3370,15-T-001,ULTRAFAST BILATERAL DCE-MRI OF THE BREAST WITH FOURIER SAMPLING,"62/210,016", ,*United States,US,8/26/2015,, ,8/26/2015,2368-001,Small,8/26/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Bell, Callie",05400-0012,"Hiroyuki Abe, Xiaobing Fan, Gregory Karczmar, Milica Medved, Gillian Newstead, Aytekin Oto, Federico Pineda, David Schacht, Shiyang Wang",Provisional,4/12/2018,2368-001,8/26/2016,"Cox, Ben",Gregory Karczmar,"Smith, Dane",615131,,583715,No
3371,15-T-002,Atomic Layer Chemical Pattern For Block Copolymer Assembly,"15/215,016","9,927,706",*United States,US,7/20/2016,3/27/2018,US-2017-0062229-A1,7/20/2016,2370-002,Small,7/20/2015,3/27/2018,No,6/6/2022,Issued,Weaver Austin Villeneuve & Sampson LLP,,,"Mike Arnold, Tzu-Hsuan Chang, Robert Jacobberger, Zhenqiang (Jack) Ma, Paul Nealey, Shisheng Xiong",US Utility,4/12/2018,2370-002,7/20/2036,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",610572,3/2/2017,583716,No
3372,15-T-002,Atomic Layer Chemical Patterns for Block Copolymer Assembly,"62/194,661",,*United States,US,7/20/2015,,,7/21/2015,2370-001,Small,7/20/2015,,Yes,6/6/2022,Expired - Inactive,Weaver Austin Villeneuve & Sampson LLP,,,"Mike Arnold, Tzu-Hsuan Chang, Robert Jacobberger, Zhenqiang (Jack) Ma, Paul Nealey, Shisheng Xiong",Provisional,4/12/2018,2370-001,7/20/2016,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",610573,,583716,No
3373,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Nobel Metal Nanocrystals,PCT/US16/31522, ,*United States,US,5/9/2016,,WO2016200525,5/10/2016,2373-002,Small,6/8/2015,,No,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0011-02,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",PCT,4/12/2018,2373-002,12/9/2017,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610737,12/16/2016,583719,No
3374,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble Metal Nanocrystals,2017-564023, ,Japan,JP,5/9/2016,,2018-525305,5/9/2016,2373-009,Small,6/8/2015,,No,4/28/2022,Abandoned,"Bell & Manning, LLC",,05400-0011-06,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-0009,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610738,9/6/2018,583719,No
3375,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble Metal Nanocrystals,"62/172,481", ,*United States,US,6/8/2015,, ,6/8/2015,2373-001,Small,6/8/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0011,"Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Provisional,4/12/2018,2373-001,6/8/2016,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610739,,583719,No
3376,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,2016274238,2016274238,Australia,AU,5/9/2016,8/13/2020, ,5/9/2016,2373-003,Small,6/8/2015,,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0011-08,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-003,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610740,,583719,No
3377,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,"15/580,061","11,045,874",*United States,US,5/9/2016,6/29/2021,20180297120,5/9/2016,2373-004,Small,6/8/2015,6/17/2021,No,4/28/2022,Issued,"Bell & Manning, LLC",,05400-0011-03,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-004,12/1/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610741,10/18/2018,583719,No
3378,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,16807983.8EPO,3303662,European Patent Office (EPO),EP,5/9/2016,3/9/2022,3303662,1/5/2018,2373-005,Small,6/8/2015,2/25/2022,No,6/13/2022,Granted,"Bell & Manning, LLC","Manning, Michelle",05400-0011-07,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-005,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610742,4/11/2018,583719,No
3379,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,201847000501,374808,India,IN,5/9/2016,8/18/2021,201847000501,5/9/2016,2373-006,Small,6/8/2015,8/26/2021,No,4/28/2022,Issued,"Bell & Manning, LLC",,05400-0011-09,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-006,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610743,1/12/2018,583719,No
3380,15-T-005,BIPYRAMID-TEMPLATED SYNTHESIS OF MONODISPERSE NOBLE METAL NANOCRYSTALS,"2,988,553","2,988,553",Canada,CA,5/9/2016,2/15/2022, ,5/9/2016,2373-007,Small,6/8/2015,2/23/2022,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0011-04,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-007,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610744,,583719,No
3381,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble Metal Nanocrystals,201680042044.8,ZL201680042044.8,China,CN,5/9/2016,7/13/2021,CN107849726A,5/9/2016,2373-008,Small,6/8/2015,10/14/2021,No,4/28/2022,Issued,"Bell & Manning, LLC",,05400-0011-05,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,4/12/2018,2373-008,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",610745,3/27/2018,583719,No
3382,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,18112712.2,,Hong Kong,HK,10/4/2018,,1253414,10/4/2018,2373-010,Small,6/8/2015,11/14/2018,No,2/21/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0011-07,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,11/14/2018,,6/8/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",1890976,6/14/2019,583719,No
3383,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble Metal Nanocrystals,2020-208316, ,Japan,JP,5/9/2016,,2021-052786,12/16/2020,2373-011,Small,6/8/2015,1/26/2021,No,6/13/2022,Pending,"Bell & Manning, LLC",,05400-0011-JP-DIV,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Nationalized PCT,1/26/2021, ,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",5324124,4/8/2021,583719,No
3384,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,202148002844,389898,India,IN,5/9/2016,2/21/2022,202148002844 A,1/21/2021,2373-013,Small,6/8/2015,3/3/2022,No,5/31/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0011-IN-DIV2,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Divisional,2/10/2021, ,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",5368863,1/29/2021,583719,No
3385,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble Metal Nanocrystals,"17/205,140", ,*United States,US,5/9/2016,,US-2021-0276095-A1,3/18/2021,2373-012,None,6/8/2015,3/18/2021,No,6/13/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0011-CON,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Continuation,3/18/2021, ,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",5495230,9/9/2021,583719,No
3386,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,202148048563, ,India,IN,5/9/2016,, ,10/25/2021,2373-014,Small,6/8/2015,10/26/2021,No,5/31/2022,Pending,"Bell & Manning, LLC",,05400-0011-IN-DIV-3,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Divisional,10/26/2021, ,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",6306577,,583719,No
3387,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,16807983.8,3303662,France,FR,5/9/2016,3/9/2022,3303662,1/5/2018,2373-015,Small,6/8/2015,3/24/2022,No,3/30/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0011-07,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Validated EPO,2/21/2022,,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",6829936,4/11/2018,583719,
3388,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,16807983.8,3303662,United Kingdom,GB,5/9/2016,3/9/2022,3303662,1/5/2018,2373-016,Small,6/8/2015,3/24/2022,No,3/30/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0011-07,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Validated EPO,2/21/2022,,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",6829971,4/11/2018,583719,
3389,15-T-005,Bipyramid-Templated Synthesis of Monodisperse Noble metal Nanocrystals,16807983.8,602016069886.2,Germany,DE,5/9/2016,3/9/2022,3303662,1/5/2018,2373-017,Small,6/8/2015,3/24/2022,No,3/30/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0011-07,"Zoya Cheglakov, Kyle Gibson, Jung-Hoon Lee, Yossi Weizmann",Validated EPO,2/21/2022,,5/9/2036,"Cox, Ben",Yossi Weizmann,"Tennant, Thelma",6830006,4/11/2018,583719,
3390,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2,"15/545,950", ,*United States,US,1/26/2016,,US-2018-0170922-A1,1/26/2016,2374-004,Small,1/26/2015,11/7/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696US,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Nationalized PCT,4/12/2018,2374-004,1/24/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610783,6/21/2018,583720,No
3391,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2,201680019057.3,107835820,China,CN,1/26/2016,10/15/2021,107835820,1/26/2016,2374-005,Small,1/26/2015,1/28/2022,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696CN,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Nationalized PCT,4/12/2018,2374-005,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610784,3/23/2018,583720,No
3392,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2,2017-558363,6912386,Japan,JP,1/26/2016,7/12/2021, ,1/26/2016,2374-006,Small,1/26/2015,8/11/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696JP,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Nationalized PCT,4/12/2018,2374-006,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610785,,583720,No
3393,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2,16743990.0EPO,3250611,European Patent Office (EPO),EP,1/26/2016,4/21/2021,3250611,1/26/2016,2374-007,Small,1/26/2015,4/7/2021,No,5/2/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696EP,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Nationalized PCT,4/12/2018,2374-007,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610786,12/6/2017,583720,No
3394,15-T-006,CAR T CELLS RECOGNIZING CANCER-SPECIFIC IL13RA2,"62/107,980", ,*United States,US,1/26/2015,,blah,1/27/2015,2374-001,Small,1/26/2015,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",49101,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Provisional,4/12/2018,2374-001,1/26/2016,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610787,,583720,Yes
3395,15-T-006,CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL13RA2,"62/245,771", ,*United States,US,10/23/2015,, ,10/24/2015,2374-002,Small,10/23/2015,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",49923,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Provisional,4/12/2018,2374-002,10/23/2016,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610788,,583720,No
3396,15-T-006,CAR T-Cells Recognizing Cancer-Specific IL13Ra2,PCT/US16/14985, ,*United States,US,1/26/2016,,WO 2016/123143,1/28/2016,2374-003,Small,1/26/2015,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",49923A,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",PCT,4/12/2018,2374-003,7/28/2017,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",610789,8/5/2016,583720,No
3397,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2,18104510.3,HK 1245288,Hong Kong,HK,1/26/2016,12/3/2021,1245288A,4/4/2018,2374-008,Small,1/26/2015,2/17/2022,No,6/16/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696EHK,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Nationalized PCT,5/18/2018, ,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",1380709,8/24/2018,583720,No
3398,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2,"16/675,861", ,*United States,US,1/26/2016,,US-2020-0181227-A1,11/6/2019,2374-009,Small,1/26/2015,11/20/2019,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696US.C1,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Continuation,11/20/2019, ,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",4123640,6/11/2020,583720,No
3399,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2, , ,Germany,DE,1/26/2016,, ,7/26/2017,2374-011,Small,1/26/2015,6/24/2021,No,8/17/2021,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696DE,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Validated EPO,12/17/2020, ,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",5206032,,583720,No
3400,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2, , ,France,FR,1/26/2016,, ,7/26/2017,2374-010,Small,1/26/2015,6/24/2021,No,1/4/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696FR,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Validated EPO,12/17/2020, ,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",5206337,,583720,No
3401,15-T-006,CAR T Cells Recognizing Cancer-Specific IL 13Ra2, , ,United Kingdom,GB,1/26/2016,, ,7/26/2017,2374-012,Small,1/26/2015,6/24/2021,No,1/4/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0696GB,"Irina Balyasnikova, Stephen Gottschalk, Maciej Lesniak",Validated EPO,12/17/2020, ,1/26/2036,"Sun, Han",Maciej Lesniak,"Tennant, Thelma",5206371,,583720,No
3402,15-T-013,Methods for Predicting Patient Response to Anti-Epilepsy Drugs and for Treating Epilepsy,"62/116,788", ,*United States,US,2/16/2015,, ,2/16/2015,2376-001,Small,2/16/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Charles Marcuccilli, Andrew Tryba",Provisional,4/12/2018,2376-001,2/16/2016,"Unassigned, Unassigned",Charles Marcuccilli,"Unassigned, Unassigned",613248,,583727,Yes
3403,15-T-014,"""ExplORer"" Surgical Information System Copyright",1-2609156761,TX 8-199-998,*United States,US,8/4/2015,8/4/2015, ,,2377-001,Small,8/4/2015,,Yes,8/4/2020,Registered (Copyright),,, ,"Alexander Langerman, Marko Rojnica",Copyright Application,4/12/2018,2377-001,,"Sun, Han",Alexander Langerman,"Tennant, Thelma",610185,5/28/2015,583728,No
3404,15-T-024,DYNAMIC SPATIOTEMPORAL BRAIN ANALYSES USING HIGH-PERFORMANCE ELECTRICAL NEUROIMAGING,"62/213,818", ,*United States,US,9/3/2015,, ,9/3/2015,2382-002,Small,9/3/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Bell, Callie",05400-0007-03,"John Cacioppo, Stephanie Cacioppo",Provisional,4/12/2018,2382-002,9/3/2016,"Cox, Ben",Stephanie Cacioppo,"Smith, Dane",611499,,583738,No
3405,15-T-024,HIGH PERFORMANCE IDENTIFICATION OF THE CHRONOARCHITECTURE OF DATA WITH A TEMPORAL DIMENSION,"62/131,094", ,*United States,US,3/10/2015,, ,3/10/2015,2382-001,Small,3/10/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0007-02,"John Cacioppo, Stephanie Cacioppo, Hakizumwami Runesha, Robin Weiss",Provisional,4/12/2018,2382-001,3/10/2016,"Cox, Ben",John Cacioppo,"Smith, Dane",611810,,583738,Yes
3406,15-T-024,STATE IDENTIFICATION IN DATA WITH A TEMPORAL DIMENSION,"15/066,022","10,085,684",*United States,US,3/12/2016,10/2/2018,US-2016-0262684-A1,3/12/2016,2382-003,Small,3/10/2015,,No,4/28/2022,Issued,"Bell & Manning, LLC","Bell, Callie",05400-0007-04,"John Cacioppo, Stephanie Cacioppo, Robin Weiss",US Utility,4/12/2018,2382-003,11/13/2036,"Cox, Ben",John Cacioppo,"Smith, Dane",614629,9/16/2016,583738,No
3407,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,"62/128,285", ,*United States,US,3/4/2015,, ,3/6/2015,2381-001,Small,3/4/2015,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Stefani Spranger",Provisional,4/12/2018,2381-001,3/4/2016,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610692,,583740,Yes
3408,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,PCT/US16/20944, ,*United States,US,3/7/2016,,WO 2016/141312,3/7/2016,2381-002,Small,3/4/2015,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Stefani Spranger",PCT,4/12/2018,2381-002,9/5/2017,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610693,9/10/2016,583740,No
3409,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,"15/555,099","10,753,938",*United States,US,3/4/2016,8/25/2020,2018-0038868,3/4/2016,2381-003,Small,3/4/2015,8/13/2020,No,6/8/2022,Issued,"Casimir Jones, S.C.","Staple, David",UCHI-34341/US-2/PCT,"Thomas Gajewski, Stefani Spranger",Nationalized PCT,4/12/2018,2381-003,3/7/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610694,2/8/2018,583740,No
3410,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,16759593.3EPO, ,European Patent Office (EPO),EP,3/4/2016,,3265179,3/4/2016,2381-004,Small,3/4/2015,2/18/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34341.611,"Thomas Gajewski, Stefani Spranger",Nationalized PCT,4/12/2018,2381-004,3/4/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610695,1/10/2018,583740,No
3411,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,"2,978,450", ,Canada,CA,3/4/2016,, ,3/4/2016,2381-005,Small,3/4/2015,2/18/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",34341.711,"Thomas Gajewski, Stefani Spranger",Nationalized PCT,4/12/2018,2381-005,3/4/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610696,,583740,No
3412,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,2016226069, ,Australia,AU,3/4/2016,, ,3/4/2016,2381-006,Small,3/4/2015,2/18/2021,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",34341.721,"Thomas Gajewski, Stefani Spranger",Nationalized PCT,4/12/2018,2381-006,3/4/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610697,,583740,No
3413,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,"16/933,614", ,*United States,US,3/4/2016,,US-2021-0148917-A1,7/20/2020,2381-007,Small,3/4/2015,7/22/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34341.303,"Thomas Gajewski, Stefani Spranger",Continuation,7/22/2020, ,3/4/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4745567,5/20/2021,583740,No
3414,15-T-026,BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY,20200896.7, ,European Patent Office (EPO),EP,3/4/2016,, ,10/8/2020,2381-008,Large,3/4/2015,10/14/2020,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34341.612,"Thomas Gajewski, Stefani Spranger",Divisional,10/14/2020, ,3/4/2036,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4981532,,583740,No
3415,15-T-028,Methods for Determining Prognosis for Breast Cancer Patients,"62/132,222", ,*United States,US,3/12/2015,, ,3/13/2015,2383-001,Small,3/12/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Stellman, Laurie", ,"Russell Bainer, Casey Frankenberger, Daniel Rabe, Marsha Rosner",Provisional,4/12/2018,2383-001,3/12/2016,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613169,,583742,Yes
3416,15-T-028,Methods for Determining Prognosis for Breast Cancer Patients,PCT/US16/21972, ,*United States,US,3/11/2016,,WO 2016/145294,3/13/2016,2383-002,Small,3/12/2015,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Russell Bainer, Casey Frankenberger, Daniel Rabe, Marsha Rosner",PCT,4/12/2018,2383-002,9/13/2017,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613170,9/16/2016,583742,No
3417,15-T-028,Methods for Determining Prognosis for Breast Cancer Patients,"15/556,474", ,*United States,US,3/11/2016,,US-2018-0104232-A1,9/7/2017,2383-003,Small,3/12/2015,4/24/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0589US,"Russell Bainer, Casey Frankenberger, Daniel Rabe, Marsha Rosner",Nationalized PCT,4/12/2018,2383-003,9/7/2037,"Sun, Han",Marsha Rosner,"Tennant, Thelma",613171,4/19/2018,583742,No
3418,15-T-029,PROFILE/VIEW ORDERING FOR HIGH-RESOLUTION 3D VOLUMETRIC AND 2D/3D CINE-CMR ACQUISITIONS,"62/161,319", ,*United States,US,5/14/2015,, ,5/14/2015,2396-001,Small,5/14/2015,,Yes,4/28/2022,Abandoned,"Bell & Manning, LLC","Bell, Callie",05400-0010,"Keigo Kawaji, Amit Patel, Sui-Cheng Wang",Provisional,4/12/2018,2396-001,5/14/2016,"Cox, Ben",Keigo Kawaji,"Smith, Dane",614181,,583743,Yes
3419,15-T-030,"Targeting CD36 Utilizing Synthetic Amphipathic Peptide Atagnists to Prevent Pulmonary Infection, Inflamation and Lung Injury","62/035,161", ,*United States,US,8/8/2014,, ,8/8/2014,2384-001,Large,8/8/2014,,Yes,4/28/2022,Expired - Inactive,Sheridan Ross PC,"Gary, Connell", ,"Konstantin Birukov, Anna Birukova, A V Bocharov, T L Eggerman, T L Remaley",Provisional,4/12/2018,2384-001,8/8/2015,"Dembo, Anna",Konstantin Birukov,"Butler, Brittany",614851,,583744,Yes
3420,15-T-034,METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS,"62/150,926", ,*United States,US,4/22/2015,, ,4/22/2015,2387-001,Small,4/22/2015,,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fernando Martinez, Imre Noth, Justin Oldham",Provisional,4/12/2018,2387-001,4/22/2016,"Sun, Han",Imre Noth,"Muite, Kevin",613275,,583748,Yes
3421,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,PCT/US16/28361, ,*United States,US,4/20/2016,,WO 2016/172150A1,4/20/2016,2387-002,Small,4/22/2015,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Fernando Martinez, Imre Noth, Justin Oldham",PCT,4/12/2018,2387-002,10/20/2017,"Sun, Han",Imre Noth,"Muite, Kevin",613276,10/28/2016,583748,No
3422,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,"15/567,988","10,543,185",*United States,US,4/20/2016,1/28/2020,US-2018-0133184-A1,10/20/2017,2387-003,Small,4/22/2015,1/13/2020,No,4/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0591US,"Fernando Martinez, Imre Noth, Justin Oldham",Nationalized PCT,4/12/2018,2387-003,5/16/2036,"Sun, Han",Imre Noth,"Muite, Kevin",613277,5/17/2018,583748,No
3423,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,16783721.0EPO,3285794,European Patent Office (EPO),EP,4/20/2016,3/18/2020,3285794,4/20/2016,2387-004,Small,4/22/2015,4/27/2020,No,4/28/2022,Granted,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0591EP,"Fernando Martinez, Imre Noth, Justin Oldham",Nationalized PCT,4/12/2018,2387-004,4/20/2036,"Sun, Han",Imre Noth,"Muite, Kevin",613278,2/28/2018,583748,No
3424,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,"16/744,822", ,*United States,US,4/20/2016,,US-2020-0155494-A1,1/16/2020,2387-005,Small,4/22/2015,4/22/2021,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0591US.D1,"Fernando Martinez, Imre Noth, Justin Oldham",Divisional,1/23/2020, ,4/20/2036,"Sun, Han",Imre Noth,"Muite, Kevin",4240084,5/21/2020,583748,No
3425,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,16783721.0FR,3285794,France,FR,4/20/2016,3/18/2020, ,4/20/2016,2387-006,Small,4/22/2015,1/30/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0591FR,"Fernando Martinez, Imre Noth, Justin Oldham",Nationalized PCT,1/30/2020, ,4/20/2036,"Sun, Han",Imre Noth,"Muite, Kevin",4250705,,583748,No
3426,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,602016032141.6,3285794,Germany,DE,4/20/2016,3/18/2020, ,4/20/2016,2387-007,Small,4/22/2015,1/30/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0591DE,"Fernando Martinez, Imre Noth, Justin Oldham",Nationalized PCT,1/30/2020, ,4/20/2036,"Sun, Han",Imre Noth,"Muite, Kevin",4250736,,583748,No
3427,15-T-034,Methods for Treating Idiopathic Pulmonary Fibrosis,16783721.0GB,3285794,United Kingdom,GB,4/20/2016,3/18/2020, ,4/20/2016,2387-008,Small,4/22/2015,1/30/2020,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0591GB,"Fernando Martinez, Imre Noth, Justin Oldham",Nationalized PCT,1/30/2020, ,4/20/2036,"Sun, Han",Imre Noth,"Muite, Kevin",4250766,,583748,No
3428,15-T-035,SEMICONDUCTOR SYSTEM WITH TRANSITIONAL METAL IMPURITY FOR QUANTUM INFORMATION PROCESSING,"62/307,990", ,*United States,US,3/14/2016,, ,3/14/2016,2389-001,Small,3/14/2016,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Chen, Gang",00398,"David Awschalom, William Franklin Koehl",Provisional,4/12/2018,2389-001,3/16/2017,"Cox, Ben",David Awschalom,"Tennant, Thelma",614479,,583749,No
3429,15-T-035,SEMICONDUCTOR SYSTEM WITH TRANSITIONAL METAL IMPURITY FOR QUANTUM INFORMATION PROCESSING,"15/457,619","10,372,015",*United States,US,3/13/2017,8/6/2019, ,3/17/2017,2389-002,Small,3/14/2016,,No,4/28/2022,Issued,Brinks Gilson & Lione,,00406,"David Awschalom, Berk Diler Kovos, William Franklin Koehl, Samuel Whiteley",US Utility,4/12/2018,2389-002,3/13/2037,"Cox, Ben",David Awschalom,"Tennant, Thelma",614480,,583749,No
3430,15-T-035,SEMICONDUCTOR SYSTEM WITH TRANSITIONAL METAL IMPURITY FOR QUANTUM INFORMATION PROCESSING,"16/524,903","10,747,087",*United States,US,7/29/2019,8/18/2020, ,7/29/2019,2389-003,Small,3/14/2016,8/8/2019,No,4/28/2022,Issued,Brinks Gilson & Lione,"Chen, Gang",7814-00414,"David Awschalom, Berk Diler Kovos, William Franklin Koehl, Samuel Whiteley",Continuation,8/8/2019, ,3/13/2037,"Cox, Ben",David Awschalom,"Tennant, Thelma",3902127,,583749,No
3431,15-T-035,SEMICONDUCTOR SYSTEM WITH TRANSITIONAL METAL IMPURITY FOR QUANTUM INFORMATION PROCESSING,"16/936,122", ,*United States,US,7/29/2019,, ,7/22/2020,2389-004,Small,3/14/2016,7/23/2020,No,4/28/2022,Abandoned,Brinks Gilson & Lione,"Chen, Gang",7814-00419,"David Awschalom, Berk Diler Kovos, William Franklin Koehl, Samuel Whiteley",Continuation,7/23/2020, ,7/29/2039,"Cox, Ben",David Awschalom,"Tennant, Thelma",4747959,,583749,No
3432,15-T-039,"Treatment strategies for certain forms of essential hypertension by restoring the oxygen sensing in the carotid body involving CO, NO, and cGMP-dependent H2S signaling pathway","62/178,665", ,*United States,US,4/17/2015,, ,4/17/2015,2390-001,Small,4/17/2015,,Yes,4/28/2022,Expired - Inactive,,, ,"Aaron Fox, Ganesh Kumar, Jayasri Nanduri, Nanduri Prabhakar",Provisional,4/12/2018,2390-001,4/17/2016,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",615095,,583753,Yes
3433,15-T-040,Treatment of TNF-alpha Cytotoxicity,"62/382,829", ,*United States,US,9/2/2016,, ,9/2/2016,2391-001,Small,9/2/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,Anning Lin,Provisional,4/12/2018,2391-001,9/2/2017,"Sun, Han",Anning Lin,"Tennant, Thelma",615048,,583754,No
3434,15-T-040,Treatment of TNF-alpha Cytotoxicity,PCT/US17/49802, ,*United States,US,9/1/2017,,WO 2018/045258,9/1/2017,2391-002,Small,9/2/2016,,No,4/28/2022,Expired PCT - Filed in US only,"Casimir Jones, S.C.",, ,Anning Lin,PCT,4/12/2018,2391-002,3/1/2019,"Sun, Han",Anning Lin,"Tennant, Thelma",615049,3/8/2018,583754,No
3435,15-T-040,Treatment of TNF-alpha Cytotoxicity,"16/329,499","10,751,324",*United States,US,9/1/2017,8/25/2020,US-2019-0192484,2/28/2019,2391-003,Small,9/2/2016,3/22/2019,No,4/28/2022,Issued,"Casimir Jones, S.C.",,UCHI-34949/US,Anning Lin,Nationalized PCT,3/22/2019, ,9/1/2037,"Sun, Han",Anning Lin,"Tennant, Thelma",3578374,6/27/2019,583754,No
3436,15-T-049,METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER,"62/150,468", ,*United States,US,4/21/2015,, ,4/21/2015,2395-001,Small,4/21/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Suzanne Conzen,Provisional,4/12/2018,2395-001,4/21/2016,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",612914,,583763,Yes
3437,15-T-051,TARGETING THE SERINE/GLYCINE SYNTHESIS PATHWAY,"62/364,065", ,*United States,US,7/19/2016,, ,7/19/2016,2399-001,Small,7/19/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Robert Hamanaka, Gokhan Mutlu, Recep Nigdelioglu",Provisional,4/12/2018,2399-001,7/19/2017,"Butler, Brittany",Gokhan Mutlu,"Butler, Brittany",614867,,583765,No
3438,15-T-054,"Nanomaterials for Photodynamic Therapy, Photodynamic/Immuno Therapy Radiotherapy Radio-Immuotherapy, Radio-Chemotherapy, and Radio-Chemo-Immunotherapy","62/173,103",,*United States,US,6/9/2015,,,6/9/2015,2402-001,Small,6/9/2015,,Yes,6/6/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00013,Wenbin Lin,Provisional,4/12/2018,2402-001,6/9/2016,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613625,,583768,No
3439,15-T-055,Design of ultrasensitive DNA-based fluorescent pH sensitive nanodevices,PCT/US16/33050, ,*United States,US,5/18/2016,,WO 2016/187284,5/23/2016,2403-002,Small,5/19/2015,,No,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,,19-297/WO,"Saheli Halder, Yamuna Krishnan",PCT,4/12/2018,2403-002,11/24/2017,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",611388,11/26/2016,583769,Yes
3440,15-T-055,Design of ultrasensitive DNA-based fluorescent pH sensitive nanodevices,"15/575,014","11,136,618",*United States,US,5/18/2016,10/5/2021,US 2018-0245137 A1,11/17/2017,2403-003,Small,5/19/2015,9/21/2021,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-US,"Saheli Halder, Yamuna Krishnan",US Utility,4/12/2018,2403-003,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",611389,8/30/2018,583769,Yes
3441,15-T-055,Design of ultrasensitive DNA-based fluorescent pH sensitive nanodevices,2016264193, ,Australia,AU,5/18/2016,, ,5/18/2016,2403-006,Small,5/19/2015,,No,5/31/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-AU,"Saheli Halder, Yamuna Krishnan",Nationalized PCT,4/12/2018,2403-006,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",611390,11/26/2016,583769,Yes
3442,15-T-055,Methods and Composition for Determining pH,"62/163,718", ,*United States,US,5/19/2015,, ,5/20/2015,2403-001,Small,5/19/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Saheli Halder, Yamuna Krishnan",Provisional,4/12/2018,2403-001,5/19/2016,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",612620,,583769,Yes
3443,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1,3298151,European Patent Office (EPO),EP,5/18/2016,3/10/2021,EP3298151,5/18/2016,2403-004,Small,5/19/2015,4/26/2021,No,4/28/2022,Granted,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Nationalized PCT,4/12/2018,2403-004,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",612621,3/28/2018,583769,Yes
3444,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,201717045652,395844,India,IN,5/18/2016,4/29/2022,201717045652 A,5/18/2016,2403-005,Small,5/19/2015,5/26/2022,No,6/13/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-IN,"Saheli Halder, Yamuna Krishnan",Nationalized PCT,4/12/2018,2403-005,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",612622,1/26/2018,583769,Yes
3445,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,738500, ,New Zealand,NZ,5/18/2016,, ,5/18/2016,2403-007,Small,5/19/2015,,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,,19-297-WO-NZ,"Saheli Halder, Yamuna Krishnan",Nationalized PCT,4/12/2018,2403-007,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",612623,11/26/2016,583769,Yes
3446,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,201680042679.8, ,China,CN,5/18/2016,,CN108292205,5/18/2016,2403-008,Small,5/19/2015,,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-CN,"Saheli Halder, Yamuna Krishnan",Nationalized PCT,4/12/2018,2403-008,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",612624,7/17/2018,583769,Yes
3447,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,19101402.9, ,Hong Kong,HK,1/28/2019,,HK1258924,1/28/2019,2403-009,Small,5/19/2015,3/4/2019,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-297/WO-HK,"Saheli Halder, Yamuna Krishnan",Validated EPO,3/4/2019, ,5/19/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",3551127,11/22/2019,583769,Yes
3448,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1FR,,France,FR,5/18/2016,,,6/8/2021,2403-011,None,5/19/2015,6/24/2021,No,6/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021,,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746583,,583769,Yes
3449,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1IE,,Ireland,IE,5/18/2016,,,6/8/2021,2403-013,None,5/19/2015,6/24/2021,No,6/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021,,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746627,,583769,Yes
3450,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1NL,,Netherlands,NL,5/18/2016,,,5/28/2021,2403-014,None,5/19/2015,6/24/2021,No,6/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021,,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746680,,583769,Yes
3451,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1GB,,United Kingdom,GB,5/18/2016,,,,2403-016,None,5/19/2015,6/24/2021,No,8/18/2021,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021,,,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746728,,583769,Yes
3452,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1DE,,Germany,DE,5/18/2016,,,6/8/2021,2403-012,None,5/19/2015,6/24/2021,No,6/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021,,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746772,,583769,Yes
3453,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1BE, ,Belgium,BE,5/18/2016,, ,6/8/2021,2403-010,None,5/19/2015,6/24/2021,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021, ,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746817,,583769,Yes
3454,15-T-055,METHODS AND COMPOSITION FOR DETERMINING pH,16797204.1CH, ,Switzerland,CH,5/18/2016,, ,6/8/2021,2403-015,None,5/19/2015,6/24/2021,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-WO-EP,"Saheli Halder, Yamuna Krishnan",Validated EPO,5/18/2021, ,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5746861,,583769,Yes
3455,15-T-055,Methods and Compositions for Determining pH,"17/466,474", ,*United States,US,5/18/2016,, ,9/3/2021,2403-017,None,5/19/2015,9/9/2021,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-297-US-DIV,"Saheli Halder, Yamuna Krishnan",Divisional,9/9/2021, ,5/18/2036,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",6144778,,583769,Yes
3456,15-T-060,COMPOSITION AND METHODS FOR DETECTING ADENOSINE MODIFICATIONS,"62/211,948", ,*United States,US,8/31/2015,, ,8/31/2015,2406-001,Small,8/31/2015,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Kai Chen, Qing Dai, Chuan He",Provisional,4/12/2018,2406-001,8/31/2016,"Hwang, Luke",Chuan He,"Tennant, Thelma",610957,,583774,No
3457,15-T-060,COMPOSITION AND METHODS FOR DETECTING ADENOSINE MODIFICATIONS,PCT/US16/49407, ,*United States,US,8/30/2016,,WO 2017/040477,8/30/2016,2406-002,Small,8/31/2015,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000193368,"Kai Chen, Qing Dai, Chuan He",PCT,4/12/2018,2406-002,3/3/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",610958,3/10/2017,583774,No
3458,15-T-060,Composition and Methods for Detecting Adenosine Modifications,"15/756,195", ,*United States,US,8/30/2016,,2018-0245128,2/28/2018,2406-003,Small,8/31/2015,,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0597US,"Kai Chen, Qing Dai, Chuan He",US Utility,4/12/2018,2406-003,8/31/2035,"Hwang, Luke",Chuan He,"Tennant, Thelma",610959,8/30/2018,583774,No
3459,15-T-070,Methods for Making and Using Therapeutic Exomes,PCT/IB17/54927, ,International Bureau,IB,8/11/2017,,WO 2018/029656 A2,8/11/2017,2410-003,Small,8/13/2016,1/3/2019,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000217483,"Richard Kraig, Aya Pusic, Kae Pusic, Lisa Won",PCT,4/12/2018,2410-003,2/11/2019,"Sun, Han",Richard Kraig,"Tennant, Thelma",613226,2/15/2018,583784,No
3460,15-T-070,METHODS FOR MAKING AND USING THERAPEUTIC EXOSOMES,"62/171,292", ,*United States,US,6/5/2015,, ,6/6/2015,2410-001,Small,6/5/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Richard Kraig, Aya Pusic, Kae Pusic",Provisional,4/12/2018,2410-001,6/5/2016,"Sun, Han",Richard Kraig,"Tennant, Thelma",613227,,583784,No
3461,15-T-070,Methods for Making and Using Therapeutic Exosomes,"62/374,560", ,*United States,US,8/13/2016,, ,8/12/2016,2410-002,Small,8/13/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Richard Kraig, Aya Pusic, Kae Pusic, Lisa Won",Provisional,4/12/2018,2410-002,8/13/2017,"Sun, Han",Richard Kraig,"Tennant, Thelma",613228,,583784,No
3462,15-T-073,Methods for the Assessment of the Triglyceride Lowering Potential of Blood Samples for the Diagnosis of Hypertriglyceridemia,"62/214,001", ,*United States,US,9/3/2015,, ,9/4/2015,2412-001,Small,9/3/2015,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,Provisional,4/12/2018,2412-001,9/3/2016,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",613261,,583787,No
3463,15-T-073,"SYSTEMS AND METHODS FOR CHARACTERIZATION OF
HYPERTRIGLYCERIDEMIA",PCT/US16/50178, ,*United States,US,9/4/2016,,WO 2017/040983,9/4/2016,2412-002,Small,9/3/2015,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,John Ancsin,PCT,4/12/2018,2412-002,3/5/2018,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",614835,3/10/2017,583787,No
3464,15-T-073,SYSTEMS AND METHODS FOR CHARACTERIZATION OF HYPERTRIGLYCERIDEMIA,"15/757,074", ,*United States,US,9/2/2016,,US 2018/0179574,9/2/2016,2412-003,Small,9/3/2015,10/31/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.",,34593.252,John Ancsin,Nationalized PCT,4/12/2018,2412-003,3/2/2038,"Unassigned, Unassigned",John Ancsin,"Unassigned, Unassigned",614836,6/28/2018,583787,No
3465,15-T-075,UCHICAGO SOLUTIONS,86665442,,*United States,US,6/17/2015,,,,2419-001,Small,6/17/2015,,Yes,4/12/2018,Allowed,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9173-001,Timothy Honaker,Trademark,4/12/2018,2419-001,,"Sun, Han",Timothy Honaker,"Tennant, Thelma",615128,,583789,No
3466,15-T-075,UCHICAGO SOLUTIONS,86665477,,*United States,US,6/17/2015,,,,2419-002,Small,6/17/2015,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9173-002,Timothy Honaker,Trademark,4/12/2018,2419-002,,"Sun, Han",Timothy Honaker,"Tennant, Thelma",615129,,583789,No
3467,15-T-079,High Aspect Ratio Nanofibril Materials,"61/858,314",,*United States,US,7/26/2013,,,7/26/2013,2414-001,Small,7/26/2013,,Yes,5/20/2022,Expired - Inactive,Clark & Elbing LLP,"McDonald, J. Cooper",,"Carrie Brubaker, Jeffrey Hubbell, Diana Velluto",Provisional,4/12/2018,2414-001,7/26/2014,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",611801,,583793,No
3468,15-T-079,High Aspect Ratio Nanofibril Materials,PCT/US14/48009, ,*United States,US,7/24/2014,,WO2015/013510 A1,7/25/2014,2414-002,Small,7/26/2013,,No,4/28/2022,Expired - Inactive,Clark & Elbing LLP,, ,"Carrie Brubaker, Jeffrey Hubbell, Diana Velluto",PCT,4/12/2018,2414-002,,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",611802,1/29/2015,583793,No
3469,15-T-079,High Aspect Ratio Nanofibril Materials,"14/907,370","10,711,106",*United States,US,7/24/2014,7/14/2020,US 2016-0177036 A1,7/24/2014,2414-003,Small,7/25/2013,,Yes,4/28/2022,Issued,Clark & Elbing LLP,"McDonald, J. Cooper",51137-002002,"Carrie Brubaker, Jeffrey Hubbell, Diana Velluto",Nationalized PCT,4/12/2018,2414-003,11/13/2034,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",611803,6/24/2016,583793,No
3470,15-T-081,Methods of Treating Cancers with CT45 Targeted Therapies,"62/334,782", ,*United States,US,5/12/2016,, ,5/11/2016,2415-001,Small,5/12/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0606US.P1,"Fabian Coscia, Ernst Lengyel, Matthias Mann, Marion Zillhardt Curtis",Provisional,4/12/2018,2415-001,5/12/2017,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",613356,,583795,No
3471,15-T-081,Methods of Treating Cancers with CT45 Targeted Therapies,PCT/IB17/52781, ,International Bureau,IB,5/12/2017,,WO 2017/195153,5/11/2017,2415-002,Small,5/12/2016,,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0606WO,"Fabian Coscia, Ernst Lengyel, Matthias Mann, Marion Zillhardt Curtis",PCT,4/12/2018,2415-002,11/13/2018,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",613357,11/16/2017,583795,No
3472,15-T-081,Methods of Treating Cancers with CT45 Targeted Therapies,"16/300,267","11,261,223",*United States,US,5/12/2017,3/1/2022,US-2019-0144516-A1,11/9/2018,2415-003,Small,5/11/2016,2/17/2022,No,3/30/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0606US,"Fabian Coscia, Ernst Lengyel, Matthias Mann, Marion Zillhardt Curtis",Nationalized PCT,11/28/2018,,5/11/2037,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",1921090,5/16/2019,583795,No
3473,15-T-081,Methods of Treating Cancers with CT45 Targeted Therapies,"17/649,200",,*United States,US,5/12/2017,,US-2022-0153797-A1,1/28/2022,2415-004,Small,5/11/2016,1/28/2022,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0606US.D1,"Fabian Coscia, Ernst Lengyel, Matthias Mann, Marion Zillhardt Curtis",Divisional,1/28/2022,,5/11/2037,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",6724960,5/19/2022,583795,No
3474,15-T-088,Inhibitors of Cacna 1A/Alpha 1A Subunit Interval Ribosomal Entry Site (IRES) and Mehtods of Treating Spinocerebellar Ataxia Type 6,"62/200,933", ,*United States,US,8/4/2015,, ,8/5/2015,2420-001,Small,8/4/2015,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",49587,"Xiaofei Du, Christopher Gomez, Yu Miyazaki",Provisional,4/12/2018,2420-001,8/4/2016,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",612029,,583802,No
3475,15-T-088,Inhibitors of Cacna 1A/Alpha 1A Subunit Interval Ribosomal Entry Site (IRES) and Mehtods of Treating Spinocerebellar Ataxia Type 6,PCT/US16/45492, ,*United States,US,8/6/2016,,WO2017/024111,8/6/2016,2420-002,Small,8/4/2015,6/22/2021,No,4/28/2022,Expired PCT - Nationalized,"Marshall, Gerstein & Borun","Merkel, William",49857A-PC,"Xiaofei Du, Christopher Gomez, Yu Miyazaki",PCT,4/12/2018,2420-002,2/7/2018,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",612030,2/10/2017,583802,No
3476,15-T-088,Inhibitors of Cacna 1A/Alpha 1A Subunit Interval Ribosomal Entry Site (IRES) and Mehtods of Treating Spinocerebellar Ataxia Type 6,"15/743,560", ,*United States,US,1/10/2018,,2018-0201937,1/10/2018,2420-003,Small,8/4/2015,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",49857A,"Xiaofei Du, Christopher Gomez, Yu Miyazaki",Nationalized PCT,4/12/2018,2420-003,8/6/2036,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",612031,7/19/2018,583802,No
3477,15-T-088,Inhibitors of Cacna 1A/Alpha 1A Subunit Interval Ribosomal Entry Site (IRES) and Mehtods of Treating Spinocerebellar Ataxia Type 6,"16/450,760","11,034,962",*United States,US,8/4/2016,6/15/2021,2020-0063142-A1,6/24/2019,2420-004,Small,8/4/2015,6/9/2021,No,4/28/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",49857B,"Xiaofei Du, Christopher Gomez, Yu Miyazaki",Divisional,7/18/2019, ,8/4/2036,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",3799763,2/27/2020,583802,No
3478,15-T-088,Inhibitors of Cacna1A/Alpha1A Subunit Internal Ribosomal Entry Site (IRES) and Methods of Treating Spinocerebellar Ataxia Type 6,"17/348,090", ,*United States,US,6/24/2019,,US-2022-0025378-A1,6/15/2021,2420-005,Small,8/4/2015,6/17/2021,No,6/8/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373/49857C,"Xiaofei Du, Christopher Gomez, Yu Miyazaki",Continuation,6/17/2021, ,6/24/2039,"Peace, Shane",Christopher Gomez,"Tennant, Thelma",5823736,1/27/2022,583802,No
3479,15-T-090,Chicago Innovation Mentors Trademark,86725305,,*United States,US,8/14/2015,,,,2421-001,Small,8/14/2015,,Yes,4/12/2018,Pending,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9174-001,Alan Thomas,Trademark,4/12/2018,2421-001,,"Ginsburg, Eric",Alan Thomas,"Tennant, Thelma",610880,,583804,No
3480,15-T-090,CIM Trademark,86725355,,*United States,US,8/14/2015,,,,2421-002,Small,8/14/2015,,Yes,4/12/2018,Opposition,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9175-001,Alan Thomas,Trademark,4/12/2018,2421-002,,"Ginsburg, Eric",Alan Thomas,"Tennant, Thelma",610892,,583804,No
3481,15-T-102,TO&THROUGH,86650854,,*United States,US,6/3/2015,,,,2423-001,Small,6/3/2015,,Yes,3/30/2022,Granted,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9172-001,John Gasko,Trademark,4/12/2018,2423-001,,"Sun, Han",John Gasko,"Tennant, Thelma",614928,,583816,No
3482,15-T-103,MRI METHODS AND APPARATUS FOR RECOLLECTION OF BAD RAW DATA THROUGH OPERATOR-INTERACTIVE CONTROL DURING AND AFTER THE SCAN,"62/287,017", ,*United States,US,1/27/2016,, ,1/27/2016,2429-001,Small,1/27/2016,,Yes,4/28/2022,Abandoned,"Bell & Manning, LLC","Bell, Callie",05400-0015,"Keigo Kawaji, Amit Patel",Provisional,4/12/2018,2429-001,,"Cox, Ben",Keigo Kawaji,"Smith, Dane",613538,,583817,No
3483,15-T-104,Polymer Conjugate Vaccines,"62/234,352", ,*United States,US,9/29/2015,, ,9/29/2015,2431-001,Small,9/29/2015,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0607US.P1,"Sachiko Hirosue, Jeffrey Hubbell, David Wilson",Provisional,4/12/2018,2431-001,9/29/2016,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",614084,,583818,No
3484,15-T-104,Polymer Conjugate Vaccines,PCT/US16/54315, ,*United States,US,9/29/2016,,WO 2017/058996,9/29/2016,2431-002,Small,9/29/2015,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000201632,"Sachiko Hirosue, Jeffrey Hubbell, David Wilson",PCT,4/12/2018,2431-002,9/29/2036,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",614085,4/6/2017,583818,No
3485,15-T-104,Polymer Conjugate Vaccines,"15/764,366", ,*United States,US,9/29/2016,,US-2018-0280524-A1,3/29/2018,2431-003,Small,9/29/2015,,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0607US,"Sachiko Hirosue, Jeffrey Hubbell, David Wilson",Nationalized PCT,4/12/2018,2431-003,9/29/2036,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",614086,10/4/2018,583818,No
3486,15-T-104,Polymer Conjugate Vaccines,16852545.9EPO, ,European Patent Office (EPO),EP,3/29/2018,,3356371,3/29/2018,2431-004,Small,9/29/2015,,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0607EP,"Sachiko Hirosue, Jeffrey Hubbell, David Wilson",Nationalized PCT,4/12/2018,2431-004,9/29/2036,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",614087,8/8/2018,583818,No
3487,15-T-104,Polymer Conjugate Vaccines,201680069873.5, ,China,CN,5/29/2018,,CN 108770357,5/29/2018,2431-005,Small,9/29/2015,6/20/2018,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0607CN,"Sachiko Hirosue, Jeffrey Hubbell, David Wilson",Nationalized PCT,6/20/2018, ,9/29/2036,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1504187,11/6/2018,583818,No
3488,15-T-104,Polymer Conjugate Vaccines,2018-536089, ,Japan,JP,3/28/2018,,2018-531318,3/28/2018,2431-006,Small,9/29/2015,6/20/2018,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000201632,"Sachiko Hirosue, Jeffrey Hubbell, David Wilson",Nationalized PCT,6/20/2018, ,9/29/2036,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1504209,10/25/2018,583818,No
3489,15-T-107,Method of Making Trabecular Bone In Vitro,PCT/US16/52277, ,*United States,US,9/16/2016,, ,9/16/2016,2433-001,Small,9/16/2016,3/17/2018,Yes,4/28/2022,Expired - Inactive,,, ,"Harry Blair, Quitterie Larrouture, Deborah Nelson, Paul Schlesinger, Irina Tourkova",PCT,4/12/2018,2433-001,3/16/2018,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",612528,,583821,No
3490,15-T-107,Method of Making Trabecular Bone In Vitro,"15/760,452","11,060,060",*United States,US,9/16/2016,7/13/2021,US-2018-0258399-A1,3/15/2018,2433-002,None,9/16/2016,6/25/2021,No,4/28/2022,Issued,The Webb Law Firm,, ,"Harry Blair, Quitterie Larrouture, Deborah Nelson, Paul Schlesinger, Irina Tourkova",Nationalized PCT,5/8/2018, ,9/12/2038,"Dembo, Anna",Deborah Nelson,"Tennant, Thelma",1367492,9/13/2018,583821,No
3491,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,"62/562,138",,*United States,US,9/22/2017,, ,9/22/2017,2436-001,Small,9/22/2017,11/9/2020,Yes,6/13/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,,00407,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Provisional,4/12/2018,2436-001,9/22/2018,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",614783,,583826,No
3492,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,PCT/US18/52175,,*United States,US,9/21/2018,,WO 2019/060688,9/21/2018,2436-002,Small,9/22/2017,,No,6/13/2022,Expired PCT - Nationalized,"Bell & Manning, LLC","Manning, Michelle",05400-0032-02,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",PCT,9/22/2018,2436-002,3/21/2020,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",1700553,3/28/2019,583826,No
3493,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,201880070637.4, ,China,CN,9/21/2018,,CN 111278362A,4/29/2020,2436-003,Small,9/22/2017,3/11/2020,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-CN,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,3/11/2020, ,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",4407619,6/12/2020,583826,No
3494,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,2020-516528, ,Japan,JP,9/21/2018,,2020-534082,3/19/2020,2436-005,Small,9/22/2017,3/11/2020,No,5/31/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-JP,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,3/11/2020, ,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",4407653,11/26/2020,583826,No
3495,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,10-2020-7011415, ,"Korea, Republic of",KR,9/21/2018,, ,4/20/2020,2436-006,Small,9/22/2017,3/11/2020,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-KR,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,3/11/2020, ,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",4407725,,583826,No
3496,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,18858231.6,,European Patent Office (EPO),EP,9/21/2018,,3684257,3/19/2020,2436-004,Small,9/22/2017,3/11/2020,No,3/18/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-EP,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,3/11/2020,,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",4407759,7/29/2020,583826,No
3497,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,"16/648,375","11,278,254",*United States,US,9/21/2018,3/22/2022,US-2020-0222016-A1,3/18/2020,2436-007,Small,9/22/2017,3/7/2022,No,6/13/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0032-US,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,3/11/2020,2436-007,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",4407910,7/16/2020,583826,No
3498,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,18858231.6GB, ,United Kingdom,GB,9/21/2018,, ,3/19/2020,2436-008,Small,9/22/2017,3/11/2020,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-08,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,3/11/2020, ,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",4408005,,583826,No
3499,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,62020021593.2, ,Hong Kong,HK,9/21/2018,,40031632A,12/4/2020,2436-009,Large,9/22/2017,12/8/2020,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-HK,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Nationalized PCT,12/8/2020, ,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",5169819,3/12/2021,583826,No
3500,15-T-112,System and Method for Low-Dose Multi-Spectral X-Ray Tomography,"17/550,711",,*United States,US,9/21/2018,,US-2022-0104783-A1,12/14/2021,2436-010,Small,9/22/2017,1/9/2022,No,6/13/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0032-DIV,"Buxin Chen, Xiaochuan Pan, Emil Sidky, Dan Xia, Zheng Zhang",Divisional,1/9/2022,15-T-112,9/21/2038,"Cox, Ben",Xiaochuan Pan,"Juggernauth, Anne",6559351,4/7/2022,583826,No
3501,15-T-113,Recombinant Antibodies that Recognize the C-Terminal Domains of Ebola Virus Nucleoprotein,PCT/US15/56017, ,*United States,US,10/16/2015,,WO 2016/061504,10/17/2015,2438-002,Small,10/18/2014,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,, ,"Elena Davydova, Zygmunt Derewenda, Daniel Engel, Mateusz Jaskolowski, Anthony Kossiakoff",PCT,4/12/2018,2438-002,4/17/2017,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614304,,583827,No
3502,15-T-113,Recombinant Antibodies that Recognize the C-Terminal Domains of Ebola Virus Nucleoprotein,"15/518,417","10,640,549",*United States,US,10/16/2015,5/5/2020,US-2018-0334494,4/11/2017,2438-003,Small,10/18/2014,,No,4/28/2022,Issued,Barnes & Thornburg,,38347-263647,"Elena Davydova, Zygmunt Derewenda, Daniel Engel, Mateusz Jaskolowski, Anthony Kossiakoff",Nationalized PCT,4/12/2018,2438-003,11/4/2035,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614305,11/22/2018,583827,No
3503,15-T-113,Structure of C-Terminal Domains of EbolaVirus Nucleoprotein and Uses Thereof,"62/065,392", ,*United States,US,10/18/2014,, ,10/18/2014,2438-001,Small,10/18/2014,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Elena Davydova, Zygmunt Derewenda, Daniel Engel, Mateusz Jaskolowski, Anthony Kossiakoff",Provisional,4/12/2018,2438-001,10/18/2015,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",614670,,583827,No
3504,15-T-114,TVAX for cancer therapy,"62/314,595", ,*United States,US,3/30/2016,, ,3/29/2016,2437-001,Small,3/30/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Donald Kufe, Ralph Weichselbaum",Provisional,4/12/2018,2437-001,3/30/2017,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615125,,583828,No
3505,15-T-117,"STABILIZATION OF ACTIVE METAL CATALYSTS AT METAL-ORGANIC FRAMEWORK
NODES FOR HIGHLY EFFICIENT ORGANIC TRANSFORMATIONS",PCT/US16/56649, ,*United States,US,10/12/2016,,WO 2017/066328,10/12/2016,2441-002,Small,10/12/2015,12/29/2020,No,4/28/2022,Expired PCT - Filed in US only,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00026,"Pengfei Ji, Wenbin Lin, Kuntal Manna",PCT,4/12/2018,2441-002,4/14/2018,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",614604,4/20/2017,583831,No
3506,15-T-117,Stabilization of Active Metal Catalysts at Metal-Organic Framework Nodes for Highly Efficient Organic Transformations,"62/240,178", ,*United States,US,10/12/2015,, ,10/12/2015,2441-001,Small,10/12/2015,12/29/2020,Yes,4/28/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00015,"Pengfei Ji, Wenbin Lin, Kuntal Manna",Provisional,4/12/2018,2441-001,10/12/2016,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",614605,,583831,No
3507,15-T-117,Stabilization of Active Metal Catalysts at Metal-Organic Framework Nodes for Highly Efficient Organic Transformations,"15/767,862","10,953,393",*United States,US,10/12/2016,3/23/2021,US-2018-0361370-A1,4/12/2018,2441-003,Small,10/12/2015,3/10/2021,,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/6 PCT/US,"Pengfei Ji, Wenbin Lin, Kuntal Manna",Nationalized PCT,4/23/2018, ,11/21/2036,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1348219,12/20/2018,583831,No
3508,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"62/065,550", ,*United States,US,10/17/2014,, ,10/17/2014,2443-001,Small,10/17/2014,,Yes,4/28/2022,Expired - Inactive,"McCarter & English, LLP","Gulati, Maneesh", ,"Lorin Johnson, Jonathan Moss",Provisional,4/12/2018,2443-001,10/17/2015,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615229,,583833,No
3509,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"62/140,876", ,*United States,US,3/31/2015,, ,3/31/2015,2443-002,Small,3/31/2015,,No,4/28/2022,Expired - Inactive,"McCarter & English, LLP",, ,"Lorin Johnson, Jonathan Moss",Provisional,4/12/2018,2443-002,10/17/2015,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615230,,583833,No
3510,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"62/222,746", ,*United States,US,9/23/2015,, ,9/23/2015,2443-003,Small,9/23/2015,,No,4/28/2022,Expired - Inactive,"McCarter & English, LLP",, ,"Lorin Johnson, Jonathan Moss",Provisional,4/12/2018,2443-003,10/17/2015,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615231,,583833,No
3511,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,PCT/US15/56060, ,*United States,US,10/16/2015,, ,10/16/2015,2443-004,Small,10/17/2014,,No,4/28/2022,Expired - Inactive,"McCarter & English, LLP",, ,"Lorin Johnson, Jonathan Moss",PCT,4/12/2018,2443-004,4/17/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615232,,583833,No
3512,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,2017-520536,6686013,Japan,JP,10/16/2015,4/3/2020,2017-531023,4/13/2017,2443-005,Small,10/17/2014,,No,4/28/2022,Issued,"McCarter & English, LLP",,119557-11943,"Lorin Johnson, Jonathan Moss",Nationalized PCT,4/12/2018,2443-005,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615233,10/19/2017,583833,No
3513,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"15/477,724", ,*United States,US,10/16/2015,,US-2017-0202832-A1,4/3/2017,2443-006,Small,10/17/2014,10/28/2019,No,4/28/2022,Abandoned,"McCarter & English, LLP",,119557-11904,"Lorin Johnson, Jonathan Moss",Nationalized PCT,4/12/2018,2443-006,4/3/2037,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615234,7/20/2017,583833,No
3514,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,15851308.5EPO,3206491,European Patent Office (EPO),EP,10/16/2015,, ,10/16/2015,2443-007,Small,10/17/2014,10/31/2019,No,4/28/2022,Granted,"McCarter & English, LLP",,119557-11935,"Lorin Johnson, Jonathan Moss",Nationalized PCT,4/12/2018,2443-007,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615235,,583833,No
3515,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,201580069102.1, ,China,CN,10/16/2015,,107249327,10/16/2015,2443-008,Small,10/17/2014,8/18/2021,No,4/28/2022,Abandoned,"McCarter & English, LLP",, ,"Lorin Johnson, Jonathan Moss",Nationalized PCT,4/12/2018,2443-008,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615236,10/13/2017,583833,No
3516,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"3,002,137", ,Canada,CA,10/16/2015,, ,4/17/2018,2443-009,Large,10/17/2014,5/18/2018,No,4/28/2022,Pending,"McCarter & English, LLP",,119557-11926,"Lorin Johnson, Jonathan Moss",Nationalized PCT,5/18/2018, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",1380621,,583833,No
3517,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,18104461.2, ,Hong Kong,HK,10/16/2015,,1245013A,4/4/2018,2443-010,None,10/17/2014,1/7/2022,No,4/28/2022,Abandoned,"McCarter & English, LLP",,119557-11939,"Lorin Johnson, Jonathan Moss",Nationalized PCT,5/18/2018, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",1380653,8/24/2018,583833,No
3518,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,19211300.9EPO, ,European Patent Office (EPO),EP,10/16/2015,,3718404,11/25/2019,2443-011,Large,10/17/2014,12/31/2019,No,4/28/2022,Pending,"McCarter & English, LLP",,119557-11979,"Lorin Johnson, Jonathan Moss",Divisional,12/31/2019, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4199591,10/7/2020,583833,No
3519,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"16/667,300", ,*United States,US,10/16/2015,, ,10/29/2019,2443-012,Small,10/17/2014,2/19/2020,No,4/28/2022,Abandoned,"McCarter & English, LLP",,119557-11905,"Lorin Johnson, Jonathan Moss",Continuation,2/19/2020, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4283785,,583833,No
3520,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,602015042693.2, ,Germany,DE,10/16/2015,, ,4/28/2017,2443-013,Small,10/17/2014,3/23/2020,No,4/28/2022,Pending,"McCarter & English, LLP",,119557-11995,"Lorin Johnson, Jonathan Moss",Nationalized PCT,3/23/2020, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4416799,,583833,No
3521,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,15851308.5GB,3206491,United Kingdom,GB,10/16/2015,,,4/21/2020,2443-015,Small,10/17/2014,3/23/2020,No,3/18/2022,Issued,"McCarter & English, LLP",,119557-11986,"Lorin Johnson, Jonathan Moss",Nationalized PCT,3/23/2020,,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4416944,,583833,No
3522,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,15851308.5FR,3206491,France,FR,10/16/2015,, ,4/21/2020,2443-014,Small,10/17/2014,3/18/2022,No,4/28/2022,Issued,"McCarter & English, LLP",,119557-11985,"Lorin Johnson, Jonathan Moss",Validated EPO,3/23/2020, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4416976,,583833,No
3523,15-T-119,Use of Methylnaltrexone to Attenuate Tumor Progression,"17/063,470", ,*United States,US,10/16/2015,,US-2021-0121456-A1,10/5/2020,2443-016,Small,10/17/2014,10/14/2020,No,5/27/2022,Pending,"McCarter & English, LLP",,119557-11906,"Lorin Johnson, Jonathan Moss",Continuation,10/14/2020, ,10/16/2035,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",4981389,4/29/2021,583833,No
3524,15-T-122,COLLOIDS OF INORGANIC NANOCRYSTALS IN MOLTEN INORGANIC MEDIA,"62/251,867", ,*United States,US,11/6/2015,, ,11/7/2015,2445-001,Small,11/6/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0014,"Dmitri Talapin, Hao Zhang",Provisional,4/12/2018,2445-001,11/6/2016,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610919,,583836,No
3525,15-T-122,COLLOIDS OF INORGANIC NANOCRYSTALS IN MOLTEN INORGANIC MEDIA AND RELATED METHODS,PCT/US16/60484, ,*United States,US,11/4/2016,,WO 2017105662,11/4/2016,2445-002,Small,11/6/2015,5/4/2018,No,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0014-02,"Vishwas Srivastava, Dmitri Talapin, Hao Zhang",PCT,4/12/2018,2445-002,5/4/2018,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610920,6/22/2017,583836,No
3526,15-T-122,COLLOIDS OF INORGANIC NANOCRYSTALS IN MOLTEN INORGANIC MEDIA AND RELATED METHODS,"15/772,950","11,040,323",*United States,US,11/4/2016,6/22/2021,20180318784,5/2/2018,2445-003,Small,11/6/2015,6/9/2021,No,4/28/2022,Issued,"Bell & Manning, LLC","Porembski, Philip",05400-0014-03,"Vishwas Srivastava, Dmitri Talapin, Hao Zhang",Nationalized PCT,5/4/2018,2445-003,10/10/2041,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",1366159,11/8/2018,583836,No
3527,15-T-123,Halometalate Ligand-Capped Group II-VI Nanocrystals,"62/249,540", ,*United States,US,11/2/2015,, ,11/2/2015,2446-001,Small,11/2/2015,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0013,"James Kurley, Jake Russell, Dmitri Talapin, Hao Zhang",Provisional,4/12/2018,2446-001,11/2/2016,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",611736,,583837,No
3528,15-T-123,HALOMETALLATE LIGAND-CAPPED SEMICONDUCTOR NANOCRYSTALS,PCT/US16/60026, ,*United States,US,11/2/2016,,WO2017079225,11/2/2016,2446-002,Small,11/2/2015,4/30/2018,No,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0013-02,"Margaret Hervey Hudson, James Kurley, Jake Russell, Dmitri Talapin, Hao Zhang",PCT,4/12/2018,2446-002,5/3/2018,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",611737,5/11/2017,583837,No
3529,15-T-123,HALOMETALLATE LIGAND-CAPPED SEMICONDUCTOR NANOCRYSTALS,"15/772,258","10,541,134",*United States,US,11/2/2016,1/21/2020,20180315600,4/30/2018,2446-003,Small,11/2/2015,1/6/2020,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0013-03,"Margaret Hervey Hudson, James Kurley, Jake Russell, Dmitri Talapin, Hao Zhang",Nationalized PCT,4/30/2018, ,11/2/2036,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",1359810,11/1/2018,583837,No
3530,15-T-124,Quantifying Met Protein for Cancer Treatment,"62/232,234", ,*United States,US,9/24/2015,, ,9/24/2015,2447-001,Small,9/24/2015,,Yes,4/28/2022,Expired - Inactive,Perkins Coie LLP,"Booth, Paul", ,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Provisional,4/12/2018,2447-001,9/24/2016,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",614235,,583838,No
3531,15-T-124,Quantifying Met Protein for Cancer Treatment,PCT/US16/53804, ,*United States,US,9/26/2016,, ,9/26/2016,2447-002,Small,9/24/2015,,No,4/28/2022,Expired - Inactive,Perkins Coie LLP,, ,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",PCT,4/12/2018,2447-002,3/26/2018,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",614236,,583838,No
3532,15-T-124,QUANTIFYING MET PROTEIN FOR CANCER TREATMENT,"15/276,686","10,288,616",*United States,US,9/26/2016,5/14/2019, ,9/26/2016,2447-003,Small,9/24/2015,,No,4/28/2022,Issued,Perkins Coie LLP,, ,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Nationalized PCT,4/12/2018,2447-003,9/26/2036,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",614237,,583838,No
3533,15-T-124,Quantifying Met Protein for Cancer Treatment,258340, ,Israel,IL,9/26/2016,, ,3/25/2018,2447-004,Small,9/24/2015,1/18/2021,No,4/28/2022,Abandoned,Perkins Coie LLP,,PAT.000418.IL001,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Nationalized PCT,1/18/2021, ,,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",5280041,,583838,No
3534,15-T-124,Quantifying Met Protein for Cancer Treatment,2018-515596, ,Japan,JP,9/26/2016,,2018531234,9/28/2016,2447-005,None,9/24/2015,1/18/2021,No,4/28/2022,Abandoned,Perkins Coie LLP,,PAT.000418.JP001,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Nationalized PCT,1/18/2021, ,,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",5280076,10/25/2018,583838,No
3535,15-T-124,Quantifying Met Protein for Cancer Treatment,10-2018-7011642,,"Korea, Republic of",KR,9/26/2016,,10-2018-067557,3/26/2018,2447-006,None,9/24/2015,1/18/2021,No,2/17/2022,Abandoned,Perkins Coie LLP,,PAT.000418.KR001,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Nationalized PCT,1/18/2021,,,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",5280106,6/20/2018,583838,No
3536,15-T-125,"Compositions and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases","62/270,264",,*United States,US,12/22/2015,,,12/21/2015,2449-001,Small,12/22/2015,,Yes,5/20/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,,,"Colin Fishwick, Leroy Hood, Taek-Kyun Kim, Hernan Lorenzi, Rima McLeod, Martin McPhillie, Kai Wang, Ying Zhou, Yong Zhou",Provisional,4/12/2018,2449-001,12/21/2016,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",611030,,583839,No
3537,15-T-125,"Compositions and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases",PCT/US16/67795, ,*United States,US,12/20/2016,,WO 2017/112678 A1,12/20/2016,2449-002,Small,12/22/2015,6/20/2018,No,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,, ,"Kamal El Bissati, Colin Fishwick, James Gordon, Mark Hickman, Leroy Hood, Taek-Kyun Kim, QiGui Li, Hernan Lorenzi, Rima McLeod, Martin McPhillie, Craig Roberts, Kai Wang, Ying Zhou, Yong Zhou",PCT,4/12/2018,2449-002,6/20/2018,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",611031,6/29/2017,583839,No
3538,15-T-125,"Compositions and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases","62/306,385", ,*United States,US,3/10/2016,, ,3/10/2016,2449-003,Small,3/10/2016,,No,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,, ,"Colin Fishwick, Leroy Hood, Taek-Kyun Kim, Hernan Lorenzi, Rima McLeod, Martin McPhillie, Kai Wang, Ying Zhou, Yong Zhou",Provisional,4/12/2018,2449-003,3/10/2017,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",611032,,583839,No
3539,15-T-125,"Compositions and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases","16/063,877", ,*United States,US,12/20/2016,, ,6/19/2018,2449-004,Small,12/22/2015,6/26/2018,No,6/16/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",15-2033-PCT-US,"Kamal El Bissati, Colin Fishwick, Mark Hickman, Leroy Hood, Taek-Kyun Kim, QiGui Li, Hernan Lorenzi, Rima McLeod, Martin McPhillie, Craig Roberts, Kai Wang, Ying Zhou, Yong Zhou",Nationalized PCT,6/26/2018, ,12/20/2036,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",1511419,,583839,No
3540,15-T-125,"Compositions and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases",16879977.3EPO, ,European Patent Office (EPO),EP,12/20/2016,,EP3394032,7/20/2018,2449-005,Small,12/21/2015,9/30/2018,No,6/16/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,,15-2033-PCT-EP,"Kamal El Bissati, Colin Fishwick, James Gordon, Mark Hickman, Leroy Hood, Taek-Kyun Kim, QiGui Li, Hernan Lorenzi, Rima McLeod, Martin McPhillie, Craig Roberts, Kai Wang, Ying Zhou, Yong Zhou",Nationalized PCT,10/1/2018, ,12/20/2036,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",1736542,10/31/2018,583839,No
3541,15-T-125,"Compositions and Methods for Treating, Detecting, and Identifying Compounds to Treat Apicomplexan Parasitic Diseases",,,*United States,US,12/20/2016,,,,2449-006,None,12/22/2015,5/26/2022,No,6/23/2022,,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",,"Kamal El Bissati, Colin Fishwick, Mark Hickman, Leroy Hood, Taek-Kyun Kim, QiGui Li, Hernan Lorenzi, Rima McLeod, Martin McPhillie, Craig Roberts, Kai Wang, Ying Zhou, Yong Zhou",Divisional,5/26/2022,,,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",7326647,,583839,
3542,15-T-127,Injectable pastes based on oppositely charged polymer/calcium phosphate hybrid nanoparticles,"62/307,755", ,*United States,US,3/15/2016,, ,3/14/2016,2448-001,Small,3/15/2016,,Yes,4/28/2022,Expired - Inactive,Weaver Austin Villeneuve & Sampson LLP,, ,"Juan de Pablo, Nader Taheri Qazvini, Monirosadat Sadati, Matthew Tirrell",Provisional,4/12/2018,2448-001,,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",612034,,583841,No
3543,15-T-127,Injectable pastes based on oppositely charged polymer/calcium phosphate hybrid nanoparticles,PCT/US17/22198, ,*United States,US,3/13/2017,,WO 2017/209823,3/13/2017,2448-002,Small,3/14/2016,,No,4/28/2022,Expired - Inactive,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Juan de Pablo, Nader Taheri Qazvini, Monirosadat Sadati, Matthew Tirrell",PCT,4/12/2018,2448-002,9/13/2018,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",612035,12/7/2017,583841,No
3544,15-T-127,Injectable pastes based on oppositely charged polymer/calcium phosphate hybrid nanoparticles,"16/084,864", ,*United States,US,3/13/2017,,US-2019-0054012-A1,9/13/2018,2448-003,Small,3/14/2016,9/13/2018,No,4/28/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Juan de Pablo, Nader Taheri Qazvini, Monirosadat Sadati, Matthew Tirrell",Nationalized PCT,9/13/2018, ,3/13/2037,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",1697044,2/21/2019,583841,No
3545,15-T-128,Protein G Expression tag,"62/290,208", ,*United States,US,2/3/2016,, ,2/3/2016,2500-001,Small,2/3/2016,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Michael Baxa, Joshua Riback, Tobin Sosnick",Provisional,4/12/2018,2500-001,2/3/2017,"Peace, Shane",Tobin Sosnick,"Muite, Kevin",614218,,583842,No
3546,15-T-132,ELECTRON ACCEPTORS BASED ON ALPHA-POSITION SUBSTITUTED PDI FOR OPV SOLAR CELLS,"62/272,278", ,*United States,US,12/30/2015,, ,12/30/2015,2504-001,Small,12/30/2015,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00397,"Qinghe Wu, Luping Yu, Donglin Zhao",Provisional,4/12/2018,2504-001,12/30/2016,"Hwang, Luke",Luping Yu,"Tennant, Thelma",611520,,583846,No
3547,15-T-132,ELECTRON ACCEPTORS BASED ON ALPHA-POSITION SUBSTITUTED PDI FOR OPV SOLAR CELLS,"62/319,990", ,*United States,US,4/8/2016,, ,4/8/2016,2504-002,Small,4/8/2016,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00399,"Qinghe Wu, Luping Yu, Donglin Zhao",Provisional,4/12/2018,2504-002,4/8/2017,"Hwang, Luke",Luping Yu,"Tennant, Thelma",611521,,583846,No
3548,15-T-132,ELECTRON ACCEPTORS BASED ON ALPHA-POSITION SUBSTITUTED PDI FOR OPV SOLAR CELLS,PCT/US16/69356, ,*United States,US,12/30/2016,,WO 2017/117477,12/30/2016,2504-003,Small,12/30/2015,6/29/2018,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Marshall, Ryan",00404,"Zhengxu Cai, Qinghe Wu, Luping Yu, Donglin Zhao",PCT,4/12/2018,2504-003,6/30/2018,"Hwang, Luke",Luping Yu,"Tennant, Thelma",611522,7/6/2017,583846,No
3549,15-T-132,Electron Acceptors Based on Alpha-position Substituted PDI for OPV Solar Cells,"16/067,501","10,818,849",*United States,US,12/30/2016,10/27/2020,US-2019-0044074-A1,6/29/2018,2504-004,Small,12/30/2015,6/29/2018,No,4/28/2022,Issued,Brinks Gilson & Lione,"Marshall, Ryan",7814-00409,"Zhengxu Cai, Qinghe Wu, Luping Yu, Donglin Zhao",Nationalized PCT,6/29/2018, ,12/30/2036,"Hwang, Luke",Luping Yu,"Tennant, Thelma",1514614,2/7/2019,583846,No
3550,15-T-141,Performance and Energy Management in Power-constrained Computing Environments,"62/307,210", ,*United States,US,3/12/2016,, ,3/12/2016,2512-001,Small,3/12/2016,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt", ,"Henry (Hank) Hoffmann, John Lafferty, Nikita Mishra",Provisional,4/12/2018,2512-001,3/13/2017,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",613932,,583855,No
3551,15-T-141,Performance and Energy Management in Power-constrained Computing Environments,"15/457,743","11,009,836",*United States,US,3/13/2017,5/18/2021,US-2017-0261949-A1,3/13/2017,2512-002,Small,3/12/2016,,No,5/25/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",,500278US,"Henry (Hank) Hoffmann, John Lafferty, Nikita Mishra",US Utility,4/12/2018,2512-002,8/2/2039,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",613933,9/14/2017,583855,No
3552,15-T-142,Method of Forming Topcoat for Patterning,"62/416,299",,*United States,US,11/2/2016,,,11/2/2016,2513-001,Small,11/2/2016,,Yes,6/6/2022,Expired - Inactive,,"Lewis, Jana",,"Karen Gleason, Do Kim, Priya Moni, Paul Nealey, Hyo Suh",Provisional,4/12/2018,2513-001,11/3/2017,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",612523,,583856,No
3553,15-T-142,Method of Forming Topcoat for Patterning,"15/685,609","10,755,942",*United States,US,8/24/2017,8/25/2020,,8/24/2017,2513-002,Small,11/2/2016,10/23/2020,No,6/6/2022,Issued,,,MTV-16201,"Karen Gleason, Do Kim, Priya Moni, Paul Nealey, Hyo Suh",US Utility,4/12/2018,2513-002,8/24/2037,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",612524,,583856,No
3554,16-T-003,Small Molecules Inhibitors of RAD51,"62/302,569", ,*United States,US,3/5/2016,, ,3/2/2016,2516-001,Small,3/5/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Brian Budke, Philip Connell, Alan Kozikowski, Wei Lv",Provisional,4/12/2018,2516-001,,"Peace, Shane",Philip Connell,"Tennant, Thelma",614561,,583859,No
3555,16-T-003,Small Molecules Inhibitors of RAD51,PCT/IB17/51227, ,International Bureau,IB,3/3/2017,,WO 2017/149493 A1,3/3/2017,2516-002,Small,3/5/2016,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000198050,"Brian Budke, Philip Connell, Alan Kozikowski, Wei Lv",PCT,4/12/2018,2516-002,9/3/2018,"Peace, Shane",Philip Connell,"Tennant, Thelma",614562,9/8/2017,583859,No
3556,16-T-003,Small Molecules Inhibitors of RAD51,"16/081,662","10,973,819",*United States,US,3/3/2017,4/13/2021,US-20190083491-A1,8/31/2018,2516-003,Small,3/5/2016,3/25/2021,No,5/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0610US,"Brian Budke, Philip Connell, Alan Kozikowski, Wei Lv",Nationalized PCT,9/5/2018, ,3/3/2037,"Peace, Shane",Philip Connell,"Tennant, Thelma",1692368,3/21/2019,583859,No
3557,16-T-007,RNAS WITH TUMOR RADIO/CHEMO-SENSITIZING AND IMMUNOMODULATORY PROPERTIES AND METHODS OF THEIR PREPARATION AND APPLICATION,"62/309,178", ,*United States,US,3/16/2016,, ,3/16/2016,2519-001,Small,3/16/2016,,Yes,4/28/2022,Expired - Inactive,Quarles & Brady LLP,,148385.00016,"Nikolai Khodarev, Sean Pitroda, Diana Rose Ranoa, Ralph Weichselbaum",Provisional,4/12/2018,2519-001,3/16/2017,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",614402,,583863,No
3558,16-T-007,RNAS WITH TUMOR RADIO/CHEMO-SENSITIZING AND IMMUNOMODULATORY PROPERTIES AND METHODS OF THEIR PREPARATION AND APPLICATION,"15/459,602", ,*United States,US,3/17/2017,,US-2017-0268001-A1,3/17/2017,2519-002,Small,3/16/2016,1/18/2019,No,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-630-US,"Nikolai Khodarev, Sean Pitroda, Diana Rose Ranoa, Ralph Weichselbaum",US Utility,4/12/2018,2519-002,,"Dembo, Anna",Nikolai Khodarev,"Tennant, Thelma",614403,9/21/2017,583863,No
3559,16-T-022,COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHLOCOCCUS AUREUS DISEASE,PCT/IB17/50763, ,*United States,US,2/10/2017,, ,2/10/2017,2532-002,Small,2/14/2016,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000341602,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",PCT,4/12/2018,2532-002,8/12/2018,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611039,,583878,No
3560,16-T-022,Compositions and Methods Related to Antibodies that Neutralize Coagulase Activity During Staphylococcus Aureus Disease,"62/294,413", ,*United States,US,2/12/2016,, ,2/12/2016,2532-001,Small,2/12/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0004US.P1,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",Provisional,4/12/2018,2532-001,2/12/2017,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",611049,,583878,No
3561,16-T-022,COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHLOCOCCUS AUREUS DISEASE,2017218768, ,Australia,AU,2/10/2017,, ,7/20/2018,2532-006,Large,2/12/2016,7/13/2018,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0004AU,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",Nationalized PCT,7/13/2018, ,2/10/2037,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",1590841,,583878,No
3562,16-T-022,COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHLOCOCCUS AUREUS DISEASE,17749960.5EPO, ,European Patent Office (EPO),EP,2/10/2017,,3416979,9/11/2018,2532-004,Large,2/12/2016,7/13/2018,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0004EP,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",Nationalized PCT,7/13/2018, ,2/10/2037,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",1590879,12/26/2018,583878,No
3563,16-T-022,COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHLOCOCCUS AUREUS DISEASE,2018-542268, ,Japan,JP,2/10/2017,,JP 2019-514343A,8/10/2018,2532-005,Large,2/12/2016,7/13/2018,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0004JP,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",Nationalized PCT,7/13/2018, ,2/10/2037,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",1590917,6/6/2019,583878,No
3564,16-T-022,COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHLOCOCCUS AUREUS DISEASE,"16/077,213","11,214,600",*United States,US,2/10/2017,1/4/2022,US-2019-0012342-A1,8/10/2018,2532-003,Large,2/12/2016,12/22/2021,No,6/13/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0004US,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",Nationalized PCT,7/13/2018,2532-003,2/10/2037,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",1590955,4/18/2019,583878,No
3565,16-T-022,COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHLOCOCCUS AUREUS DISEASE,"17/645,344",,*United States,US,2/10/2017,, ,12/21/2021,2532-007,None,2/12/2016,1/9/2022,No,6/13/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",DMOS.P0004US.C1,"Mark de Been, Carla Emolo, Jeroen Geurtsen, Molly McAdow, Dominique Missiakas, Olaf Schneewind, Lena Thomer",Continuation,1/9/2022,2532-007,2/10/2037,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6559918,,583878,No
3566,16-T-024,Metal-organic Layers as Heterogeneous Catalysts,"62/293,130", ,*United States,US,2/9/2016,, ,2/9/2016,2534-001,Small,2/9/2016,,Yes,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00016,"Lingyun Cao, Wenbin Lin, Zekai Lin, Cheng Wang",Provisional,4/12/2018,2534-001,,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612260,,583880,No
3567,16-T-034,COMPOSITIONS AND METHODS INVOLVING THERMOPHILIC FIBRONECTIN TYPE III (FN3) MONOBODIES,"62/634,616", ,*United States,US,2/23/2018,, ,2/23/2018,2541-001,Small,2/23/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0616US.P1,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Provisional,4/12/2018,2541-001,2/23/2019,"Peace, Shane",Shohei Koide,"Muite, Kevin",611034,,583890,No
3568,16-T-034,COMPOSITIONS AND METHODS INVOLVING THERMOPHILIC FIBRONECTIN TYPE III (FN3) MONOBODIES,PCT/US19/18866, ,*United States,US,2/21/2019,,WO 2019/165017A1,2/21/2019,2541-002,Small,2/23/2018,3/4/2019,No,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0616WO,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",PCT,3/4/2019, ,8/23/2020,"Peace, Shane",Shohei Koide,"Muite, Kevin",3551084,8/29/2019,583890,No
3569,16-T-034,Methods and Composition Involving Thermophilic Fibronectin Type III (FN3) Monobodies,"15/733,530", ,*United States,US,2/21/2019,,US-2021-0079063-A1,8/21/2020,2541-003,Small,2/23/2018,8/22/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0616US,"Akiko Koide, Shohei Koide, Shun-ichi Tanaka",Nationalized PCT,8/22/2020, ,2/21/2039,"Peace, Shane",Shohei Koide,"Muite, Kevin",4848157,3/18/2021,583890,No
3570,16-T-038,AMORPHOUS AND POROUS SILICON MATERIALS AND RELATED METHODS,"62/350,328", ,*United States,US,6/15/2016,, ,6/16/2016,2545-001,Small,6/15/2016,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC",,05400-0018,"Francisco Bezanilla, Joao Carvalho-de-Souza, Yuanwen Jiang, Bozhi Tian",Provisional,4/12/2018,2545-001,6/16/2017,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",610306,,583894,No
3571,16-T-038,AMORPHOUS AND POROUS SILICON MATERIALS AND RELATED METHODS,"15/623,133","10,663,450",*United States,US,6/15/2017,5/26/2020,US-2017-0363607-A1,6/15/2017,2545-002,Small,6/16/2016,,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-099-US,"Francisco Bezanilla, Joao Carvalho-de-Souza, Yuanwen Jiang, Bozhi Tian",US Utility,4/12/2018,2545-002,9/10/2037,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",610307,12/21/2017,583894,No
3572,16-T-040,Batch Production of Microchannel Plate Photo-Multipliers,"15/468,371","9,911,584",*United States,US,3/24/2017,3/6/2018,US-2017-0278687-A1,3/24/2017,2547-002,Small,3/24/2016,3/6/2018,No,4/28/2022,Issued,"Bell & Manning, LLC",,05400-0017-02,"Andrey Elagin, Henry Frisch, Matthew Wetstein",US Utility,4/12/2018,2547-002,3/24/2037,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610690,9/28/2017,583896,No
3573,16-T-040,Batch Production of MicroChannel Plate Photo-Multipliers with Reflection-Mode Photocathodes,"62/312,852", ,*United States,US,3/24/2016,, ,3/24/2016,2547-001,Small,3/24/2016,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0017,"Evan Angelico, Andrey Elagin, Henry Frisch, Matthew Wetstein",Provisional,4/12/2018,2547-001,3/26/2017,"Cox, Ben",Henry Frisch,"Tennant, Thelma",610691,,583896,No
3574,16-T-041,BTK MUTATION AN IBRUTINIB RESISTANCE,"62/338,311", ,*United States,US,5/18/2016,, ,5/18/2016,2550-001,Small,5/18/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,Y. Lynn Wang,Provisional,4/12/2018,2550-001,5/18/2017,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",610752,,583897,No
3575,16-T-041,BTK MUTATION AN IBRUTINIB RESISTANCE,PCT/US17/33354, ,*United States,US,5/18/2017,,WO 2017/201302,5/18/2017,2550-002,Small,5/18/2016,11/29/2018,No,4/28/2022,Expired PCT - Filed in US only,"Casimir Jones, S.C.","Staple, David", ,Y. Lynn Wang,PCT,4/12/2018,2550-002,11/19/2018,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",610753,11/23/2017,583897,No
3576,16-T-041,BTK Mutation and Ibrutinib Resistance,"16/302,015","11,118,233",*United States,US,5/18/2017,9/14/2021,US-2019-0153543,11/15/2018,2550-003,Small,5/18/2016,8/31/2021,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David",UCHI-34859.252,Y. Lynn Wang,Nationalized PCT,11/29/2018, ,7/31/2037,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",1923174,5/23/2019,583897,No
3577,16-T-041,BTK Mutation and Ibrutinib Resistance,"17/399,831", ,*United States,US,5/18/2017,, ,8/11/2021,2550-004,Small,5/18/2016,8/26/2021,No,5/2/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34859.303,Y. Lynn Wang,Continuation,8/26/2021, ,5/18/2037,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",6087164,,583897,No
3578,16-T-043,VENTRICULAR FILLING PHASE SLOPE AS AN INDICATOR OF HIGH PULMONARY CAPILLARY WEDGE PRESSURE AND/OR CARDIAC INDEX,"62/306,418", ,*United States,US,3/10/2016,, ,3/10/2016,2552-001,Small,3/10/2016,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Bell, Callie",05400-0016,"Jonathan Grinstein, Nir Uriel",Provisional,4/12/2018,2552-001,3/10/2017,"Ramirez, Mario Riojas",Nir Uriel,"Smith, Dane",615363,,583899,No
3579,16-T-043,VENTRICULAR FILLING PHASE SLOPE AS AN INDICATOR OF HIGH PULMONARY CAPILLARY WEDGE PRESSURE AND/OR CARDIAC INDEX,PCT/US17/21767, ,*United States,US,3/12/2017,,WO2017156386,3/11/2017,2552-002,Small,3/11/2016,,No,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, Philip",05400-0016-02,"Jonathan Grinstein, Nir Uriel",PCT,4/12/2018,2552-002,9/11/2018,"Ramirez, Mario Riojas",Nir Uriel,"Smith, Dane",615364,9/14/2017,583899,No
3580,16-T-043,VENTRICULAR FILLING PHASE SLOPE AS AN INDICATOR OF HIGH PULMONARY CAPILLARY WEDGE PRESSURE AND/OR CARDIAC INDEX,"16/082,019","11,247,037",*United States,US,3/12/2017,2/15/2022,US-2020-0246524-A1,9/4/2018,2552-003,Small,3/10/2016,2/17/2022,No,4/28/2022,Issued,"Bell & Manning, LLC","Porembski, Philip",05400-0016-03,"Jonathan Grinstein, Nir Uriel",Nationalized PCT,9/4/2018, ,3/12/2037,"Ramirez, Mario Riojas",Nir Uriel,"Smith, Dane",1691279,8/6/2020,583899,No
3581,16-T-043,VENTRICULAR FILLING PHASE SLOPE AS AN INDICATOR OF HIGH PULMONARY CAPILLARY WEDGE PRESSURE AND/OR CARDIAC INDEX,17764176.8EPO, ,European Patent Office (EPO),EP,3/10/2017,, ,9/5/2018,2552-004,Small,3/10/2016,9/17/2018,No,4/28/2022,Abandoned,"Bell & Manning, LLC","Porembski, Philip", ,"Jonathan Grinstein, Nir Uriel",Nationalized PCT,9/17/2018, ,3/10/2037,"Ramirez, Mario Riojas",Nir Uriel,"Smith, Dane",1698858,,583899,No
3582,16-T-043,VENTRICULAR FILLING PHASE SLOPE AS AN INDICATOR OF HIGH PULMONARY CAPILLARY WEDGE PRESSURE AND/OR CARDIAC INDEX,201780016167.9, ,China,CN,3/10/2017,,CN108778359A,9/10/2018,2552-005,Small,3/11/2016,11/13/2018,No,4/28/2022,Abandoned,"Bell & Manning, LLC","Porembski, Philip", ,"Jonathan Grinstein, Nir Uriel",Nationalized PCT,11/13/2018, ,3/10/2037,"Ramirez, Mario Riojas",Nir Uriel,"Smith, Dane",1883976,11/9/2018,583899,No
3583,16-T-045,Optimization based reconstruction with an image-total-variation constraint in PET,"62/301,187", ,*United States,US,2/28/2016,, ,2/28/2016,2554-001,Large,2/28/2016,,Yes,4/28/2022,Expired - Inactive,Law Offices of Douglas B. McKnight,"McKnight, Douglas", ,Xiaochuan Pan,Provisional,4/12/2018,2554-001,3/1/2017,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",613852,,583901,No
3584,16-T-045,Optimization-based Reconstruction with an Image-Total-Variation Constraint in PET,PCT/IB17/50776, ,International Bureau,IB,2/14/2017,, ,2/14/2017,2554-002,Small,2/14/2017,,Yes,4/28/2022,Expired - Inactive,Philips Medical Systems Nederland B.V.,, ,"Xiaochuan Pan, Zheng Zhang",PCT,4/12/2018,2554-002,8/14/2018,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",613856,,583901,No
3585,16-T-045,Optimization-based Reconstruction with an Image-Total-Variation Constraint in PET,"16/070,791", ,*United States,US,2/14/2017,, ,7/18/2018,2554-003,Large,2/14/2017,5/19/2021,No,4/28/2022,Pending,Philips Medical Systems Nederland B.V.,,2016P00246WOUS,"Xiaochuan Pan, Zheng Zhang",Nationalized PCT,5/19/2021, ,2/14/2037,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",5749301,,583901,No
3586,16-T-045,Optimization-based Reconstruction with an Image-Total-Variation Constraint in PET,17707119.8, ,European Patent Office (EPO),EP,2/14/2017,, ,1/10/2018,2554-004,Large,2/14/2017,5/19/2021,No,4/28/2022,Pending,Philips Medical Systems Nederland B.V.,, ,"Xiaochuan Pan, Zheng Zhang",Nationalized PCT,5/19/2021, ,2/14/2037,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",5749325,,583901,No
3587,16-T-045,Optimization-based Reconstruction with an Image-Total-Variation Constraint in PET,201780014044.1, ,China,CN,2/14/2017,, ,8/29/2018,2554-005,Large,2/14/2017,5/19/2021,No,4/28/2022,Pending,Philips Medical Systems Nederland B.V.,, ,"Xiaochuan Pan, Zheng Zhang",Nationalized PCT,5/19/2021, ,2/14/2037,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",5749349,,583901,No
3588,16-T-046,Alpha-Helical Peptide Nanofibers as a Self-Adjuvanting Vaccine Platform,"62/316,973", ,*United States,US,4/1/2016,, ,4/1/2016,2555-001,Small,4/1/2016,,Yes,6/2/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Joel Collier, Yaoying Wu",Provisional,4/12/2018,2555-001,,"Dembo, Anna",Joel Collier,"Tennant, Thelma",610303,,583902,No
3589,16-T-046,Alpha-Helical Peptide Nanofibers as a Self-Adjuvanting Vaccine Platform,PCT/US17/25596, ,*United States,US,3/31/2017,, ,3/31/2017,2555-002,Small,4/1/2016,,No,6/2/2022,Expired - Inactive,Michael Best & Friedrich LLP,, ,"Joel Collier, Vincent Conticello, Yaoying Wu",PCT,4/12/2018,2555-002,9/30/2018,"Dembo, Anna",Joel Collier,"Tennant, Thelma",610304,,583902,No
3590,16-T-046,Alpha-Helical Peptide Nanofibers as a Self-Adjuvanting Vaccine Platform,"16/090,561", ,*United States,US,3/31/2017,, ,10/1/2018,2555-003,Small,4/1/2016,12/5/2019,No,6/2/2022,Pending,Michael Best & Friedrich LLP,,028193-9266-US02,"Joel Collier, Vincent Conticello, Yaoying Wu",Nationalized PCT,12/5/2019, ,3/31/2037,"Dembo, Anna",Joel Collier,"Tennant, Thelma",4141055,,583902,No
3591,16-T-048,Successful Aging and Frailty Evaluation (S.A.F.E.) Clinic,87090422,"5,145,688",*United States,US,4/13/2016,2/21/2017,,,2556-001,Small,4/13/2016,,Yes,1/22/2019,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9178-001,Megan Huisingh-Scheetz,Trademark,4/12/2018,2556-001,,"Ramirez, Mario Riojas",Megan Huisingh-Scheetz,"Smith, Dane",614721,,583904,No
3592,16-T-049,"Resin Composition for Forming a Phase-Separated Structure, and Method of Producing Structure Containing Phase-Separated Structure","15/047,468", ,*United States,US,2/19/2016,, ,2/19/2016,2558-001,Small,2/19/2016,,Yes,4/28/2022,Pending,Tokyo Ohka Kogyo Co. LTD.,, ,"Kawaue Akiya, Xuanxuan Chen, Takaya Maehashi, Tasuku Matsumiya, Ken Miyagi, Paul Nealey, Takehiro Seshimo, Hitoshi Yamano",US Utility,4/12/2018,2558-001,2/19/2036,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",614396,,583905,No
3593,16-T-049,"Resin Composition for Forming a Phase-Separated Structure, and Method of Producing Structure Containing Phase-Separated Structure","15/047,520", ,*United States,US,2/19/2016,, ,2/19/2016,2558-002,Small,2/19/2016,,Yes,4/28/2022,Pending,Tokyo Ohka Kogyo Co. LTD.,, ,"Kawaue Akiya, Xuanxuan Chen, Takaya Maehashi, Tasuku Matsumiya, Ken Miyagi, Paul Nealey, Takehiro Seshimo, Hitoshi Yamano",US Utility,4/12/2018,2558-002,2/19/2036,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",614397,,583905,No
3594,16-T-049,"Resin Composition for Forming a Phase-Separated Structure, and Method of Producing Structure Containing Phase-Separated Structure","15/185,899", ,*United States,US,6/17/2016,, ,6/17/2016,2558-003,Small,2/18/2016,,No,4/28/2022,Pending,Tokyo Ohka Kogyo Co. LTD.,, ,"Kawaue Akiya, Xuanxuan Chen, Takaya Maehashi, Tasuku Matsumiya, Ken Miyagi, Paul Nealey, Takehiro Seshimo, Hitoshi Yamano",US Utility,4/12/2018,2558-003,6/17/2036,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",614398,,583905,No
3595,16-T-055,Synthesis of Meta-Substituted [18F]-3-Fluoro-4-Aminopyridines by Direct Radiofluorination of Pyridine N-Oxides,"62/327,664", ,*United States,US,4/26/2016,, ,4/26/2016,2565-001,Small,4/26/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,Pedro Brugarolas,Provisional,4/12/2018,2565-001,4/26/2017,"Dembo, Anna",Pedro Brugarolas,"Tennant, Thelma",614748,,583911,No
3596,16-T-055,Synthesis of Meta-Substituted [18F]-3-Fluoro-4-Aminopyridines by Direct Radiofluorination of Pyridine N-Oxides,"15/497,747","10,160,695",*United States,US,4/26/2017,12/25/2018,US-2017-0355648-A1,4/26/2017,2565-002,Small,4/26/2016,,No,5/31/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",1000341449,Pedro Brugarolas,US Utility,4/12/2018,2565-002,4/26/2036,"Dembo, Anna",Pedro Brugarolas,"Tennant, Thelma",614749,,583911,No
3597,16-T-056,Mallet with Radiolucent Head,"62/366,844", ,*United States,US,7/26/2016,, ,7/26/2016,2568-001,Small,7/26/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Victor Guarino, Seon-Kyu Lee",Provisional,4/12/2018,2568-001,7/27/2017,"Ramirez, Mario Riojas",Seon-Kyu Lee,"Tennant, Thelma",612153,,583912,No
3598,16-T-056,MALLET WITH RADIOLUCENT HEAD,"15/659,747","10,610,278",*United States,US,7/26/2017,4/7/2020,US-2018-0028224-A1,7/26/2017,2568-002,Small,7/26/2016,,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,,ARCD.P0620US,"Victor Guarino, Seon-Kyu Lee",US Utility,4/12/2018,2568-002,2/10/2038,"Ramirez, Mario Riojas",Seon-Kyu Lee,"Tennant, Thelma",612154,2/1/2018,583912,No
3599,16-T-057,Compositions and Methods for the Prevention of Cisplatin-Induced Acute Kidney Injury,"62/328,061", ,*United States,US,4/28/2016,, ,4/27/2016,2569-001,Small,4/28/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Peili Chen, Patrick Cunningham, F. Gary Toback",Provisional,4/12/2018,2569-001,4/28/2017,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611010,,583913,No
3600,16-T-058,Gene Therapy for Hepatospecific Peripheral Tissue Antigen Expression,"62/350,111", ,*United States,US,6/14/2016,, ,6/14/2016,2570-001,Small,6/14/2016,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Martina Damo, Jeffrey Hubbell",Provisional,4/12/2018,2570-001,6/16/2017,"Butler, Brittany",Jeffrey Hubbell,"Tennant, Thelma",611643,,583914,No
3601,16-T-059,LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION,"62/329,133", ,*United States,US,4/28/2016,, ,4/28/2016,2571-001,Small,4/28/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Priscilla Briquez, Manuel Fankhauser, Sachiko Hirosue, Jeffrey Hubbell, Melody Swartz, Efthymia Vokali, Shann C.S. Yu",Provisional,4/12/2018,2571-001,4/28/2017,"Peace, Shane",Melody Swartz,"Tennant, Thelma",612141,,583915,No
3602,16-T-059,LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION,PCT/US17/30242, ,*United States,US,4/29/2017,,WO 2017/190074 A1,4/28/2017,2571-002,Small,4/28/2016,10/31/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",1000335289,"Priscilla Briquez, Maria Broggi, Manuel Fankhauser, Sachiko Hirosue, Jeffrey Hubbell, Lambert Potin, Maria Sasso, Melody Swartz, Efthymia Vokali, Shann C.S. Yu",PCT,4/12/2018,2571-002,10/29/2018,"Peace, Shane",Melody Swartz,"Tennant, Thelma",612142,11/2/2017,583915,No
3603,16-T-059,LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION,"16/096,990","10,980,877",*United States,US,4/27/2018,4/20/2021,US-2019-00999485-A1,10/26/2018,2571-003,Small,4/27/2017,4/1/2021,No,4/28/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0614US,"Priscilla Briquez, Maria Broggi, Manuel Fankhauser, Sachiko Hirosue, Jeffrey Hubbell, Lambert Potin, Maria Sasso, Melody Swartz, Efthymia Vokali, Shann C.S. Yu",Nationalized PCT,10/31/2018, ,4/28/2037,"Peace, Shane",Melody Swartz,"Tennant, Thelma",1854915,4/4/2019,583915,No
3604,16-T-059,LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION,"17/301,099", ,*United States,US,4/27/2018,, ,3/24/2021,2571-004,Small,4/27/2017,1/11/2022,No,5/2/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0614US.C1,"Priscilla Briquez, Maria Broggi, Manuel Fankhauser, Sachiko Hirosue, Jeffrey Hubbell, Lambert Potin, Maria Sasso, Melody Swartz, Efthymia Vokali, Shann C.S. Yu",Nationalized PCT,3/26/2021, ,4/27/2038,"Peace, Shane",Melody Swartz,"Tennant, Thelma",5515488,,583915,No
3605,16-T-059,LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION,"17/453,736", ,*United States,US,4/27/2018,,US-2022-0047700-A1,11/5/2021,2571-005,None,4/27/2017,11/9/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0614US.C2,"Priscilla Briquez, Maria Broggi, Manuel Fankhauser, Sachiko Hirosue, Jeffrey Hubbell, Lambert Potin, Maria Sasso, Melody Swartz, Efthymia Vokali, Shann C.S. Yu",Continuation,11/9/2021, ,4/27/2038,"Peace, Shane",Melody Swartz,"Tennant, Thelma",6370395,2/17/2022,583915,No
3606,16-T-060,Synthetic DNA Binding Domain Peptides and Uses Thereof,"62/329,497", ,*United States,US,4/29/2016,, ,4/29/2016,2573-001,Small,4/29/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Raymond Moellering, Xianghang (Sean) Shangguan",Provisional,4/12/2018,2573-001,4/29/2017,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",614754,,583916,No
3607,16-T-060,Synthetic DNA Binding Domain Peptides and Uses Thereof,PCT/US17/30217, ,*United States,US,4/29/2017,,WO 2017/190061,4/29/2017,2573-002,Small,4/29/2016,,No,4/28/2022,Expired PCT - Filed in US only,"Casimir Jones, S.C.","Staple, David", ,"Raymond Moellering, Xianghang (Sean) Shangguan",PCT,4/12/2018,2573-002,10/30/2018,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",614755,11/2/2017,583916,No
3608,16-T-060,Synthetic DNA Binding Domain Peptides and Uses Thereof,"16/096,609", ,*United States,US,4/29/2017,,US-2019-0135868,10/25/2018,2573-003,Small,4/29/2016,11/14/2018,No,6/15/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",746790,"Raymond Moellering, Xianghang (Sean) Shangguan",Nationalized PCT,11/14/2018, ,4/29/2037,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",1891291,5/9/2019,583916,No
3609,16-T-062,Engineered T Cell and T Cell Receptors and Methods of Treating Cancer,"62/486,314", ,*United States,US,4/18/2017,, ,4/17/2017,2574-002,Small,4/18/2017,4/16/2018,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,50757A,"Victoria Lee, Daniel Leventhal, Sven Malchow, Peter Savage",Provisional,4/12/2018,2574-002,4/18/2018,"Dembo, Anna",Peter Savage,"Tennant, Thelma",611530,,583918,No
3610,16-T-062,ENGINEERED T CELLS AND T CELL RECEPTORS AND METHODS OF TREATING CANCER,"62/327,348", ,*United States,US,4/25/2016,, ,4/25/2016,2574-001,Small,4/25/2016,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",50757,"Victoria Lee, Daniel Leventhal, Sven Malchow, Peter Savage",Provisional,4/12/2018,2574-001,4/25/2017,"Dembo, Anna",Peter Savage,"Tennant, Thelma",611531,,583918,No
3611,16-T-062,Engineered T Cell and T Cell Receptors and Methods of Treating Cancer,"62/658,970", ,*United States,US,4/17/2018,, ,4/17/2018,2574-003,None,4/17/2018,4/17/2018,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,50757B,"Victoria Lee, Daniel Leventhal, Sven Malchow, Peter Savage",Provisional,5/7/2018,2574-003,4/17/2019,"Dembo, Anna",Peter Savage,"Tennant, Thelma",1366525,,583918,No
3612,16-T-062,Engineered T Cell and T Cell Receptors and Methods of Treating Cancer,"62/700,732", ,*United States,US,7/19/2018,, ,7/19/2018,2574-004,None,7/19/2018,8/3/2018,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",27373/50757C US,"Victoria Lee, Daniel Leventhal, Sven Malchow, Peter Savage",Provisional,8/3/2018,2574-004,7/19/2019,"Dembo, Anna",Peter Savage,"Tennant, Thelma",1674663,,583918,No
3613,16-T-062,Engineered T Cell and T Cell Receptors and Methods of Treating Cancer,"62/876,625", ,*United States,US,7/20/2019,, ,7/20/2019,2574-005,Small,7/20/2019,7/31/2019,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/50757D,"Victoria Lee, Daniel Leventhal, Sven Malchow, Peter Savage",Provisional,7/31/2019,2574-005,7/20/2020,"Dembo, Anna",Peter Savage,"Tennant, Thelma",3868099,,583918,No
3614,16-T-064,POLYPHOSPHORUS COMPOUNDS AND HIGH MOLECULAR WEIGHT PEG FOR PREVENTING AND TREATING ANASTOMOTIC LEAKS,"62/328,397", ,*United States,US,4/28/2016,, ,4/28/2016,2577-001,Small,4/28/2016,,Yes,4/28/2022,Released to Government,"Marshall, Gerstein & Borun","Merkel, William",50753,John Alverdy,Provisional,4/12/2018,2577-001,4/28/2017,"Dembo, Anna",John Alverdy,"Tennant, Thelma",614122,,583920,No
3615,16-T-066,Methods and Compositions for Treating Breast and Prostate Cancer,PCT/IB17/53601, ,International Bureau,IB,6/17/2017,,2017/216772,6/16/2017,2581-003,Small,6/16/2016,,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",1000202387,"Suzanne Conzen, Russell Szmulewitz",PCT,4/12/2018,2581-003,12/17/2018,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",612912,12/21/2017,583922,No
3616,16-T-066,Methods and Compositions for Treating Breast and Prostrate Cancer,"62/383,799", ,*United States,US,9/6/2016,, ,9/6/2016,2581-002,Small,9/6/2016,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Suzanne Conzen, Russell Szmulewitz",Provisional,4/12/2018,2581-002,6/16/2017,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",612913,,583922,No
3617,16-T-066,METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER,"62/351,023", ,*United States,US,6/16/2016,, ,6/16/2016,2581-001,Small,6/16/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Suzanne Conzen,Provisional,4/12/2018,2581-001,6/16/2017,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",612915,,583922,No
3618,16-T-066,Methods and Compositions for Treating Breast and Prostate Cancer,"16/306,626", ,*United States,US,6/17/2017,,US-2019-0134004-A1,12/3/2018,2581-004,Small,6/16/2016,4/1/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0619US,"Suzanne Conzen, Russell Szmulewitz",Nationalized PCT,10/30/2018, ,6/17/2037,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",1838180,5/9/2019,583922,No
3619,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF","62/339,594", ,*United States,US,5/20/2016,, ,5/20/2016,2583-001,Small,5/21/2016,,Yes,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00021,"Christina Chan, Xiaopin Duan, Wenbo Han, Chunbai He, Wenbin Lin",Provisional,4/12/2018,2583-001,5/21/2017,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613629,,583924,No
3620,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF",PCT/US17/33822, ,*United States,US,5/22/2017,,WO 2017/201528,5/22/2017,2583-002,Small,5/21/2016,,No,4/28/2022,Expired PCT - Nationalized,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00035,"Christina Chan, Xiaopin Duan, Wenbo Han, Wenbin Lin",PCT,4/12/2018,2583-002,11/24/2018,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613630,11/23/2017,583924,No
3621,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF","16/302,185","11,246,877",*United States,US,5/23/2017,2/15/2022,US-2019-0269706-A1,11/16/2018,2583-003,Small,5/21/2016,2/17/2022,No,5/24/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/8 PCT/US,"Christina Chan, Xiaopin Duan, Wenbo Han, Wenbin Lin",Nationalized PCT,11/18/2018,2583-003,5/23/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1900891,9/5/2019,583924,No
3622,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF",17800330.7EPO, ,European Patent Office (EPO),EP,5/23/2017,,3439666,11/5/2018,2583-004,Small,5/21/2016,11/24/2018,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/8 PCT/EP,"Christina Chan, Xiaopin Duan, Wenbo Han, Wenbin Lin",Nationalized PCT,11/24/2018, ,5/23/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1912249,2/13/2019,583924,No
3623,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF",2018561060, ,Japan,JP,5/23/2017,, ,11/20/2018,2583-005,Small,5/21/2016,11/26/2018,No,6/24/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/8 PCT/JP,"Christina Chan, Xiaopin Duan, Wenbo Han, Wenbin Lin",Nationalized PCT,11/26/2018, ,5/23/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1913369,,583924,No
3624,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF",201780031000.X, ,China,CN,5/23/2017,,109310702A,11/19/2018,2583-006,Small,5/21/2016,1/14/2019,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/8 PCT/CN,"Christina Chan, Xiaopin Duan, Wenbo Han, Wenbin Lin",Nationalized PCT,11/26/2018, ,5/23/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1913415,2/5/2019,583924,No
3625,16-T-068,"NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY,
PHOTODYNAMIC THERAPY, IMMUNOTHERAPY, AND ANY COMBINATION
THEREOF",2022032275, ,Japan,JP,5/23/2017,, ,3/3/2022,2583-007,Small,5/21/2016,3/22/2022,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/8/2 PCT/JP DIV,"Christina Chan, Xiaopin Duan, Wenbo Han, Wenbin Lin",Divisional,2/21/2022, ,5/23/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",6830473,,583924,No
3626,16-T-069,EVOLUTION OF A PROXIMITY-DEPENDENT SPLIT RNA POLYMERASE AS A VERSATILE BIOSENSOR PLATFORM,"62/346,174", ,*United States,US,6/6/2016,, ,6/6/2016,2584-001,Small,6/6/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0618US.P1,"Bryan Dickinson, Jinyue Pu, Julia Zinkus",Provisional,4/12/2018,2584-001,6/6/2017,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",611541,,583925,No
3627,16-T-069,EVOLUTION OF A PROXIMITY-DEPENDENT SPLIT RNA POLYMERASE AS A VERSATILE BIOSENSOR PLATFORM,PCT/IB17/53324, ,*United States,US,6/7/2017,,WO 2017/212400,6/6/2017,2584-003,Small,6/6/2016,12/1/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0618WO,"Bryan Dickinson, Jinyue Pu, Julia Zinkus",PCT,4/12/2018,2584-003,12/7/2018,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",611542,12/14/2017,583925,No
3628,16-T-069,PROXIMITY-DEPENDENT SPLIT RNA POLYMERASES AS A VERSATILE BIOSENSOR PLATFORM,"62/424,875", ,*United States,US,11/21/2016,, ,11/21/2016,2584-002,Small,11/21/2016,12/29/2020,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0618US.P2,"Bryan Dickinson, Jinyue Pu, Julia Zinkus",Provisional,4/12/2018,2584-002,6/7/2017,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",614228,,583925,No
3629,16-T-069,PROXIMITY-DEPENDENT SPLIT RNA POLYMERASE AS A VERSATILE BIOSENSOR PLATFORM,"16/305,298", ,*United States,US,6/7/2017,,US-2020-0332371-A1,11/28/2018,2584-004,Small,6/6/2016,12/1/2018,No,6/6/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0618US,"Bryan Dickinson, Jinyue Pu, Julia Zinkus",Nationalized PCT,12/1/2018,2584-004,6/7/2037,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",1929884,10/22/2020,583925,No
3630,16-T-073,"BACKLIGHT UNIT INCLUDING ANISOTROPIC SEMICONDUCTOR NANOCRYSTAL PARTICLES, PRODUCTION METHOD THEREOF, AND ELECTRONIC DEVICE INCLUDING THE SAME","15/147,473", ,*United States,US,5/5/2016,, ,5/5/2016,2588-001,Large,5/5/2016,,Yes,4/28/2022,Pending,PanKorea Patent & Law Firm,, ,Dmitri Talapin,US Utility,4/12/2018,2588-001,5/5/2036,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610672,,583929,No
3631,16-T-073,"BACKLIGHT UNIT INCLUDING ANISOTROPIC SEMICONDUCTOR NANOCRYSTAL PARTICLES, PRODUCTION METHOD THEREOF, AND ELECTRONIC DEVICE INCLUDING THE SAME",10-2017-0026672, ,"Korea, Republic of",KR,2/28/2017,, ,2/28/2017,2588-002,Large,5/5/2016,,No,4/28/2022,Pending,PanKorea Patent & Law Firm,, ,"Patrick Cunningham, Eun Joo Jang, Hyun Kang, Dmitri Talapin","Foreign, Non-PCT",4/12/2018,2588-002,5/5/2037,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",610673,,583929,No
3632,16-T-079,METHODS AND COMPOSITIONS INVOLVING A PROTEIN G VARIANT,"62/362,866", ,*United States,US,7/15/2016,, ,7/15/2016,2593-001,Small,7/15/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Lucas Bailey, Elena Davydova, Anthony Kossiakoff, Tomasz (Tomek) Slezak",Provisional,4/12/2018,2593-001,7/15/2017,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",612948,,583935,No
3633,16-T-081,CANCER IMMUNOTHERAPY,"62/345,552", ,*United States,US,6/3/2016,, ,6/3/2016,2596-001,Small,6/3/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Riyue Bao, Thomas Gajewski, Jason Luke",Provisional,4/12/2018,2596-001,6/3/2017,"Sun, Han",Jason Luke,"Tennant, Thelma",610775,,583937,No
3634,16-T-085,ENZYMATICALLY CLEAVABLE PEPTIDE AMPHIPHILES,"62/383,157", ,*United States,US,9/2/2016,, ,9/2/2016,2601-001,Small,9/2/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Handan Acar, James LaBelle, Matthew Tirrell",Provisional,4/12/2018,2601-001,9/2/2017,"Dembo, Anna",Matthew Tirrell,"Muite, Kevin",611535,,583941,No
3635,16-T-085,ENZYMATICALLY CLEAVABLE PEPTIDE AMPHIPHILES,"15/693,739", ,*United States,US,9/1/2017,,2018-0066031,9/1/2017,2601-002,Small,9/2/2016,12/17/2019,No,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-35018.202,"Handan Acar, James LaBelle, Matthew Tirrell",US Utility,4/12/2018,2601-002,9/1/2037,"Dembo, Anna",Matthew Tirrell,"Muite, Kevin",611536,3/8/2018,583941,No
3636,16-T-096,INHIBITION OF ENTERIC INFECTION,"62/360,085", ,*United States,US,7/8/2016,, ,7/8/2016,2608-001,Small,7/8/2016,,Yes,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Yun-Gi Kim, Cathryn Nagler, Gabriel Nunez",Provisional,4/12/2018,2608-001,7/9/2017,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",612024,,583952,No
3637,16-T-096,INHIBITION OF ENTERIC INFECTION THROUGH THE MODULATION OF MICROBIOTA,"62/442,527", ,*United States,US,1/5/2017,, ,1/5/2017,2608-002,Small,1/5/2017,,No,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David", ,"Yun-Gi Kim, Cathryn Nagler, Gabriel Nunez",Provisional,4/12/2018,2608-002,1/5/2018,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",612025,,583952,No
3638,16-T-096,INHIBITION OF ENTERIC INFECTION THROUGH THE MODULATION OF MICROBIOTA,PCT/US18/12481, ,*United States,US,1/5/2018,, ,1/5/2018,2608-003,Small,1/5/2017,,No,4/28/2022,Expired PCT - Filed in US only,"Casimir Jones, S.C.","Staple, David", ,"Yun-Gi Kim, Cathryn Nagler, Gabriel Nunez",PCT,4/12/2018,2608-003,7/5/2019,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",612026,,583952,No
3639,16-T-096,Inhibition of Enteric Infection Through the Modulation of Microbiota,"16/476,216", ,*United States,US,1/5/2018,,US-2019-0388483-A1,7/5/2019,2608-004,Small,1/5/2017,7/18/2019,No,6/16/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-34936.253,"Yun-Gi Kim, Cathryn Nagler, Gabriel Nunez",Nationalized PCT,7/18/2019, ,1/5/2028,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",3799631,12/26/2019,583952,No
3640,16-T-096,INHIBITION OF ENTERIC INFECTION THROUGH THE MODULATION OF MICROBIOTA,18736263.7, ,European Patent Office (EPO),EP,1/5/2018,,3565533,8/5/2019,2608-005,Small,1/5/2017,8/6/2019,No,5/24/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34936.611,"Yun-Gi Kim, Cathryn Nagler, Gabriel Nunez",Nationalized PCT,8/6/2019, ,1/5/2038,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",3900284,11/13/2019,583952,No
3641,16-T-098,Coagulation Testing in Underfilled Patient Samples,"62/490,961", ,*United States,US,4/27/2017,, ,4/27/2017,2610-001,Small,4/27/2017,4/27/2018,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.",, ,"Adam Cloe, Krzysztof Mikrut, Jonathan Miller",Provisional,4/12/2018,2610-001,4/27/2018,"Sun, Han",Jonathan Miller,"Tennant, Thelma",610917,,583954,No
3642,16-T-098,Coagulation Testing in Underfilled Patient Samples,"15/965,343","10,976,305",*United States,US,4/27/2018,4/13/2021,US-2018-0313817,4/27/2018,2610-002,Small,4/27/2017,3/29/2021,No,4/28/2022,Issued,"Casimir Jones, S.C.","Staple, David",35248.202,"Adam Cloe, Krzysztof Mikrut, Jonathan Miller",US Utility,5/1/2018, ,4/27/2038,"Sun, Han",Jonathan Miller,"Tennant, Thelma",1364221,11/1/2018,583954,No
3643,16-T-101,Quantifying KRAS for Optimal Cancer Therapy,"62/281,266", ,*United States,US,1/21/2016,, ,1/21/2016,2613-001,Small,1/21/2016,,Yes,4/28/2022,Expired - Inactive,Perkins Coie LLP,, ,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Provisional,4/12/2018,2613-001,1/21/2017,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",614233,,583957,No
3644,16-T-101,Quantifying KRAS for Optimal Cancer Therapy,PCT/US17/14371, ,*United States,US,1/20/2017,, ,2/20/2017,2613-002,Small,1/21/2016,,No,4/28/2022,Expired PCT - Filed in US only,Perkins Coie LLP,, ,"Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",PCT,4/12/2018,2613-002,7/20/2018,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",614234,,583957,No
3645,16-T-101,Quantifying KRAS for Optimal Cancer Therapy,"16/071,815", ,*United States,US,1/20/2017,, ,7/20/2018,2613-003,None,1/21/2016,2/13/2019,No,4/28/2022,Pending,Perkins Coie LLP,,3900.0032C,"Adele Blackler, Daniel Catenacci, Fabiola Cecchi, Todd Hembrough, Wei-Li Laio",Nationalized PCT,2/13/2019, ,1/20/2037,"Dembo, Anna",Daniel Catenacci,"Tennant, Thelma",3505334,,583957,No
3646,16-T-102,Method of Screening Compounds Targeting Proteasome and WNT Signaling Pathway In Vivo,"62/533,732", ,*United States,US,7/18/2017,, ,7/18/2017,2614-001,Small,7/18/2017,,Yes,4/28/2022,Expired - Inactive,Texas A&M University,, ,"Wei Du, Tianyi Zhang",Provisional,4/12/2018,2614-001,7/18/2018,"Dembo, Anna",Wei Du,"Tennant, Thelma",612537,,583958,No
3647,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,"62/376,671", ,*United States,US,8/18/2016,, ,8/18/2016,2616-001,Small,8/18/2016,,Yes,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00033,"Pengfei Ji, Wenbin Lin, Kuntal Manna",Provisional,4/12/2018,2616-001,8/18/2017,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612253,,583960,No
3648,16-T-104,METAL OXIDE-SUPPORTED EARTH-ABUNDANT METAL CATALYSTS FOR HIGHLY EFFICIENT ORGANIC TRANSFORMATIONS,"62/470,920", ,*United States,US,3/15/2017,, ,3/14/2017,2616-002,Small,3/15/2017,,Yes,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",Provisional,4/12/2018,2616-002,3/15/2018,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612254,,583960,No
3649,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,PCT/US17/47531, ,*United States,US,8/18/2017,,WO 2018/035421,8/18/2017,2616-003,Small,8/18/2016,,No,4/28/2022,Expired PCT - Nationalized,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00036,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",PCT,4/12/2018,2616-003,2/18/2019,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",612255,2/22/2018,583960,No
3650,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,"16/314,326", ,*United States,US,8/18/2017,,US-2020-0324276-A1,12/28/2018,2616-004,Small,8/18/2016,1/23/2019,No,6/2/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/9 PCT/US,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",Nationalized PCT,12/1/2018, ,8/18/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1930441,10/15/2020,583960,No
3651,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,201780049676.1, ,China,CN,8/18/2017,,109562355,2/13/2019,2616-005,Small,8/18/2016,2/2/2022,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/9 PCT-CN,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",Nationalized PCT,12/1/2018, ,8/18/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1930471,4/2/2019,583960,No
3652,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,17842185.5EPO, ,European Patent Office (EPO),EP,8/18/2017,,3474987,1/21/2019,2616-006,Small,8/18/2016,2/1/2019,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/9 PCT/EP,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",Nationalized PCT,12/1/2018, ,8/18/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1930501,5/1/2019,583960,No
3653,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,2019506613, ,Japan,JP,8/18/2017,, ,2/7/2019,2616-007,Small,8/18/2016,12/1/2018,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/9 PCT-JP,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",Nationalized PCT,12/1/2018, ,8/18/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1930531,,583960,No
3654,16-T-104,Metal Oxide-Supported Earth-Abundant Metal Catalysts for Highly Efficient Organic Transformations,10-2019-7007553, ,"Korea, Republic of",KR,8/18/2017,, ,3/14/2019,2616-008,Small,8/18/2016,12/1/2018,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/9 PCT-KR,"Pengfei Ji, Wenbin Lin, Zekai Lin, Kuntal Manna, Takahiro Sawano",Nationalized PCT,12/1/2018, ,8/18/2037,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1930561,,583960,No
3655,16-T-107,COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3,"62/431,147", ,*United States,US,12/7/2016,, ,12/7/2016,2619-001,Small,12/7/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Gregory Bird, Rachel Eclov, James LaBelle, Loren Walensky",Provisional,4/12/2018,2619-001,12/7/2017,"Dembo, Anna",James LaBelle,"Muite, Kevin",610994,,583963,No
3656,16-T-107,COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3,PCT/US17/65147, ,*United States,US,12/7/2017,, ,12/7/2017,2619-002,Small,12/7/2016,,No,4/28/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.","Staple, David", ,"Gregory Bird, Rachel Eclov, James LaBelle, Loren Walensky",PCT,4/12/2018,2619-002,6/7/2019,"Dembo, Anna",James LaBelle,"Muite, Kevin",610995,,583963,No
3657,16-T-107,COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3,"16/464,590", ,*United States,US,12/7/2017,,US-2021-0094990-A1,5/28/2019,2619-003,Small,12/7/2016,6/18/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",35105.252,"Gregory Bird, Rachel Eclov, James LaBelle, Loren Walensky",Nationalized PCT,6/18/2019, ,12/7/2037,"Dembo, Anna",James LaBelle,"Muite, Kevin",3770909,4/1/2021,583963,No
3658,16-T-107,COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3,17879332.9EPO, ,European Patent Office (EPO),EP,12/7/2017,,3551213,6/12/2019,2619-004,None,12/7/2016,7/18/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",35105.611,"Gregory Bird, Rachel Eclov, James LaBelle, Loren Walensky",Nationalized PCT,7/18/2019, ,12/7/2037,"Dembo, Anna",James LaBelle,"Muite, Kevin",3799239,10/16/2019,583963,No
3659,16-T-109,Universal Microfluidic Culture System to Analyze and Control Stem Cell Dynamics,"62/506,362", ,*United States,US,5/15/2017,, ,5/15/2017,2620-001,Small,5/15/2017,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000346536,"Savas Tay, Ce Zhang",Provisional,4/12/2018,2620-001,5/15/2018,"Cox, Ben",Savas Tay,"Tennant, Thelma",615150,,583965,No
3660,16-T-109,Universal Microfluidic Culture System to Analyze and Control Stem Cell Dynamics,PCT/US18/32727, ,*United States,US,5/15/2018,,WO2018213282A2,5/15/2018,2620-002,Small,5/15/2017,7/12/2018,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0636WO,"Savas Tay, Ce Zhang",PCT,7/12/2018, ,11/15/2019,"Cox, Ben",Savas Tay,"Tennant, Thelma",1588900,11/22/2018,583965,No
3661,16-T-109,Universal Microfluidic Culture System to Analyze and Control Cell Dynamics,"16/614,174",,*United States,US,5/15/2018,,US-2022-0041966-A1,11/15/2019,2620-003,Small,5/15/2017,11/21/2019,No,5/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0636US,"Savas Tay, Ce Zhang",Nationalized PCT,11/21/2019,,5/15/2038,"Cox, Ben",Savas Tay,"Tennant, Thelma",4124224,2/10/2022,583965,No
3662,16-T-111,"SINGLE-SITE COBALT CATALYSTS AT NEW Zr8(mu2-O)8(mu2-OH)4 METALORGANIC
FRAMEWORK NODES FOR HIGHLY ACTIVE HYDROGENATION
OF ALKENES, IMINES, CARBONYLS, AND HETEROCYCLES","62/380,784", ,*United States,US,8/29/2016,, ,8/29/2016,2621-001,Small,8/29/2016,,Yes,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00023,"Pengfei Ji, Wenbin Lin, Kuntal Manna",Provisional,4/12/2018,2621-001,8/30/2017,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",614517,,583967,No
3663,16-T-115,COMPOSITIONS AND METHODS FOR INDUCING IMMUNE SYSTEM MAINTAINANCE TO PREVENT AND/OR TREAT INFECTIONS,"62/410,897", ,*United States,US,10/21/2016,, ,10/21/2016,2625-001,Small,10/21/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"John Alverdy, Jack Gilbert, Safiyh Taghavi, Daniel ""Niels"" van der Lelie",Provisional,4/12/2018,2625-001,10/21/2017,"Cox, Ben",John Alverdy,"Tennant, Thelma",610991,,583971,No
3664,16-T-115,Compositions and Methods for Inducing Immune System Maintenance to Prevent and/or Treat Infections,PCT/US17/57581, ,*United States,US,10/20/2017,,WO 2018/075886,10/20/2017,2625-002,Small,10/21/2016,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"John Alverdy, Jack Gilbert, Safiyh Taghavi, Daniel ""Niels"" van der Lelie",PCT,4/12/2018,2625-002,4/21/2019,"Cox, Ben",Jack Gilbert,"Tennant, Thelma",610992,4/26/2018,583971,No
3665,16-T-116,Allergy Desensitization,"62/398,041", ,*United States,US,9/22/2016,, ,9/22/2016,2624-001,Small,9/22/2016,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David",UCHI-35003/US-1/PRO,"Jack Gilbert, Safiyh Taghavi, Daniel ""Niels"" van der Lelie",Provisional,4/12/2018,2624-001,9/22/2017,"Cox, Ben",Jack Gilbert,"Tennant, Thelma",610302,,583972,No
3666,16-T-116,"Immune Response Modulation Using Live Biotherapeutics, for Conditions Such as Allergy Desensitization",PCT/US17/52988, ,*United States,US,9/22/2017,,WO 2018/057914,9/22/2017,2624-002,Small,9/22/2016,,No,4/28/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.","Staple, David",UCHI-35003/WO-1/ORD,"Jack Gilbert, Safiyh Taghavi, Daniel ""Niels"" van der Lelie",PCT,4/12/2018,2624-002,3/22/2019,"Cox, Ben",Jack Gilbert,"Tennant, Thelma",611928,3/29/2018,583972,No
3667,16-T-116,"Immune Response Modulation Using Live Biotherapeutics, for Conditions Such as Allergy Desensitization","16/335,636",,*United States,US,9/22/2017,,US-2020-0016256,3/21/2019,2624-003,Small,9/22/2016,4/22/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35003.252,"Jack Gilbert, Safiyh Taghavi, Daniel ""Niels"" van der Lelie",Nationalized PCT,4/22/2019,,9/22/2037,"Cox, Ben",Jack Gilbert,"Tennant, Thelma",3638765,1/16/2020,583972,No
3668,16-T-116,"Immune Response Modulation Using Live Biotherapeutics, for Conditions Such as Allergy Desensitization","3,038,061", ,Canada,CA,9/22/2017,, ,3/22/2019,2624-004,Small,9/22/2016,4/22/2019,No,6/16/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35003/CA-1/PCT,"Jack Gilbert, Safiyh Taghavi, Daniel ""Niels"" van der Lelie",Nationalized PCT,4/22/2019, ,9/22/2037,"Cox, Ben",Jack Gilbert,"Tennant, Thelma",3638795,,583972,No
3669,16-T-118,"INACTIVATORS OF TOXOPLASMA GONDII ORNITHINE AMINOTRANSFERASE
FOR TREATING TOXOPLASMOSIS AND MALARIA","62/406,104", ,*United States,US,10/10/2016,, ,10/10/2016,2627-001,Small,10/10/2016,,Yes,4/28/2022,Expired - Inactive,"Andrus Intellectual Property Law, LLP",, ,"Dustin Hawker, Hoang Le, Rima McLeod, Richard Silverman",Provisional,4/12/2018,2627-001,10/10/2017,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",611980,,583974,No
3670,16-T-118,Inactivators of Toxoplasma Gondii Ornithine Aminotransferase for Treating Toxoplasmosis and Malaria,"15/728,714","10,632,088",*United States,US,10/10/2017,4/28/2020, ,10/10/2017,2627-002,Small,10/10/2016,4/21/2020,No,4/28/2022,Issued,"Andrus Intellectual Property Law, LLP",, ,"Dustin Hawker, Hoang Le, Rima McLeod, Richard Silverman",US Utility,4/12/2018,2627-002,10/10/2037,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",611981,,583974,No
3671,16-T-118,Inactivators of Toxoplasma Gondii Ornithine Aminotransferase for Treating Toxoplasmosis and Malaria,"16/836,870",,*United States,US,10/10/2017,,,3/31/2020,2627-003,Small,10/10/2016,6/2/2022,No,6/2/2022,Prosecution by Other Party,"Andrus Intellectual Property Law, LLP",,2016-166-03,"Dustin Hawker, Hoang Le, Rima McLeod, Richard Silverman",Divisional,5/26/2020,,,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",4574701,,583974,No
3672,16-T-119,DE NOVO SYNTHESIS OF PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH PATHOGEN VIRULENCE SUPPRESSING PROPERTIES THAT PREVENT INFECTION-RELATED MORTALITY,"62/483,132", ,*United States,US,4/7/2017,, ,4/7/2017,2630-002,Small,4/7/2017,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",51915,"John Alverdy, Wei Chen, Jun Mao, Matthew Tirrell, Olga Zaborina",Provisional,4/12/2018,2630-002,10/1/2017,"Dembo, Anna",John Alverdy,"Tennant, Thelma",611374,,583975,No
3673,16-T-119,PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH ANTI-MICROBIAL PROPERTIES,"62/402,655", ,*United States,US,9/30/2016,, ,9/30/2016,2630-001,Small,9/30/2016,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",51283,"John Alverdy, Wei Chen, Jun Mao, Matthew Tirrell, Olga Zaborina",Provisional,4/12/2018,2630-001,9/30/2017,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613963,,583975,No
3674,16-T-119,PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH ANTI-MICROBIAL PROPERTIES,PCT/US17/54424, ,*United States,US,9/29/2017,,WO 2018/064536,9/29/2017,2630-003,Small,10/1/2016,,No,4/28/2022,Expired PCT - Nationalized,"Marshall, Gerstein & Borun","Merkel, William",51283A,"John Alverdy, Wei Chen, Jun Mao, Matthew Tirrell, Olga Zaborina",PCT,4/12/2018,2630-003,3/29/2019,"Dembo, Anna",John Alverdy,"Tennant, Thelma",613964,4/5/2018,583975,No
3675,16-T-119,PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH ANTI-MICROBIAL PROPERTIES,"16/338,330", ,*United States,US,9/29/2017,,US-2019-0247423-A1,3/29/2019,2630-004,Small,10/1/2016,5/3/2019,No,6/24/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",747332/US,"John Alverdy, Wei Chen, Jun Mao, Matthew Tirrell, Olga Zaborina",Nationalized PCT,5/3/2019, ,10/1/2036,"Dembo, Anna",John Alverdy,"Tennant, Thelma",3681504,8/15/2019,583975,No
3676,16-T-119,PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH ANTI-MICROBIAL PROPERTIES,17857533.8EPO, ,European Patent Office (EPO),EP,9/29/2017,,3518895,4/30/2019,2630-005,Small,10/1/2016,5/7/2019,No,4/28/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Merkel, William",747331,"John Alverdy, Wei Chen, Jun Mao, Matthew Tirrell, Olga Zaborina",Nationalized PCT,5/7/2019, ,9/29/2037,"Dembo, Anna",John Alverdy,"Tennant, Thelma",3684807,8/7/2019,583975,No
3677,16-T-119,PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH ANTI-MICROBIAL PROPERTIES,201780074195.6, ,China,CN,9/29/2017,,110325175,5/30/2019,2630-006,Small,9/30/2016,7/16/2019,No,8/4/2020,Pending,"Leydig, Voit & Mayer, Ltd.","Merkel, William",27373-51283ACN,"John Alverdy, Wei Chen, Jun Mao, Matthew Tirrell, Olga Zaborina",Nationalized PCT,5/21/2019, ,9/29/2037,"Dembo, Anna",John Alverdy,"Tennant, Thelma",3731816,10/11/2019,583975,No
3678,16-T-120,Tissue Organoids,"62/432,346", ,*United States,US,12/9/2016,, ,12/9/2016,2628-001,Small,12/9/2016,,Yes,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,,002606.00003,Xiaoyang Wu,Provisional,4/12/2018,2628-001,12/9/2017,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",614915,,583976,No
3679,16-T-120,Tissue Organoids,"62/554,560", ,*United States,US,9/5/2017,, ,9/5/2017,2628-003,Small,9/5/2017,,No,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",002606.00005,"Xiaoyang Wu, Ming Xu",Provisional,4/12/2018,2628-003,9/5/2018,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",614916,,583976,No
3680,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),"62/436,942", ,*United States,US,12/21/2016,, ,12/20/2016,2632-001,Small,12/21/2016,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Provisional,4/12/2018,2632-001,12/21/2017,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",612066,,583979,No
3681,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),PCT/US17/67689, ,*United States,US,12/20/2017,,WO 2018/119126,12/20/2017,2632-002,Small,12/21/2016,,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0624WO,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",PCT,4/12/2018,2632-002,6/20/2019,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",612067,6/28/2018,583979,No
3682,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),17884341.3EPO, ,European Patent Office (EPO),EP,12/20/2017,,3558288,6/14/2019,2632-003,Small,12/21/2016,6/17/2019,No,4/28/2022,Pending,Dechert LLP,"Reid, Andrea",403257-001EP,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Nationalized PCT,6/17/2019, ,12/20/2037,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",3769625,10/30/2019,583979,No
3683,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),"16/470,445", ,*United States,US,12/20/2017,, ,6/17/2019,2632-004,Small,12/21/2016,6/17/2019,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0624US,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Nationalized PCT,6/17/2019, ,12/20/2037,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",3769655,,583979,No
3684,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),2017382228,,Australia,AU,12/20/2017,,,6/14/2019,2632-005,Small,12/21/2016,6/17/2019,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0624AU,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Nationalized PCT,6/17/2019,,12/20/2037,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",3769688,,583979,No
3685,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),201780086951.7,,China,CN,12/20/2017,,CN 110381934 A,8/20/2019,2632-006,Small,12/21/2016,6/17/2019,No,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0624CN,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Nationalized PCT,6/17/2019,,12/20/2037,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",3769718,10/25/2019,583979,No
3686,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),"15/929,512",,*United States,US,12/20/2017,,US-2021-0085648,5/6/2020,2632-007,Small,12/21/2016,6/9/2022,No,6/24/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0624US.C1,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Continuation,5/7/2020,,12/20/2037,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",4531943,3/25/2021,583979,No
3687,16-T-123,L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB),"17/808,645",,*United States,US,12/20/2017,,,6/24/2022,2632-008,Small,12/21/2016,6/24/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0624US.C2,"Michael Kates, David McCormick, Miguel Muzzio, Nanduri Prabhakar",Continuation,6/3/2022,,,"Hwang, Luke",Nanduri Prabhakar,"Tennant, Thelma",7389331,,583979,
3688,16-T-125,Small Molecules that Bind MR1,"62/411,208", ,*United States,US,10/21/2016,, ,10/21/2016,2634-001,Small,10/21/2016,,Yes,4/28/2022,Expired - Inactive,Oregon Health Sciences University,, ,"Erin Adams, Cara Froyd, Melanie Harriff, William Hildebrand, Haihong Jin, David Lewinsohn, Curtis McMurtrey, Aaron Nilsen",Provisional,4/12/2018,2634-001,10/21/2017,"Sun, Han",Erin Adams,"Tennant, Thelma",614563,,583981,No
3689,16-T-125,Small Molecules that Bind MR1,"15/789,955", ,*United States,US,10/20/2017,, ,10/20/2017,2634-002,Small,10/21/2016,,No,4/28/2022,Allowed,Oregon Health Sciences University,, ,"Erin Adams, Cara Froyd, Melanie Harriff, William Hildebrand, Haihong Jin, David Lewinsohn, Curtis McMurtrey, Aaron Nilsen",US Utility,4/12/2018,2634-002,10/20/2037,"Sun, Han",Erin Adams,"Tennant, Thelma",614564,,583981,No
3690,16-T-126,Tissue Organoids,"62/432,350", ,*United States,US,12/9/2016,, ,12/9/2016,2638-001,Small,12/9/2016,,Yes,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,,16-1381-PRO,"Xiaoyang Wu, Ming Xu",Provisional,4/12/2018,2638-001,12/9/2017,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",614917,,583982,No
3691,16-T-126,Tissue Organoids,PCT/US17/65374, ,*United States,US,12/8/2017,,2018/107064,12/8/2017,2638-002,Small,12/10/2016,,No,4/28/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",002606.00008,"Xiaoyang Wu, Ming Xu, Jiping Yue",PCT,4/12/2018,2638-002,6/8/2019,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",614918,6/14/2018,583982,No
3692,16-T-126,Tissue Organoids,"16/467,754", ,*United States,US,12/8/2017,,US-2020-0131482-A1,6/7/2019,2638-003,Small,12/10/2016,6/11/2019,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",16-1381-WO-US,"Xiaoyang Wu, Ming Xu, Jiping Yue",Nationalized PCT,6/11/2019, ,12/8/2037,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3766432,4/30/2020,583982,No
3693,16-T-126,Tissue Organoids,201780084946.2, ,China,CN,12/8/2017,,CN 110291188 A,7/29/2019,2638-004,Small,12/10/2016,7/30/2019,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",16-1381-WO-CN,"Xiaoyang Wu, Ming Xu, Jiping Yue",Nationalized PCT,7/30/2019, ,12/8/2037,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3866321,9/27/2019,583982,No
3694,16-T-126,Tissue Organoids,17835745.5,,European Patent Office (EPO),EP,12/8/2017,,3551746,2/1/2021,2638-005,Small,12/10/2016,3/8/2022,No,5/4/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",16-1381-WO-EP,"Xiaoyang Wu, Ming Xu, Jiping Yue",Nationalized PCT,8/7/2019,,12/8/2037,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3901037,10/16/2019,583982,No
3695,16-T-126,Tissue Organoids,22161080.1, ,European Patent Office (EPO),EP,12/8/2017,, ,3/9/2022,2638-006,Small,12/10/2016,3/24/2022,No,6/16/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",16-1381-WO-EP-DIV,"Xiaoyang Wu, Ming Xu, Jiping Yue",Divisional,3/8/2022, ,12/8/2037,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",6905635,,583982,No
3696,16-T-127,MODULATION OF AUTOPHAGY FOR THE TREATMENT/PREVENTION OF EPIDERMAL DAMAGE/INJURY,"62/419,280", ,*United States,US,11/8/2016,, ,11/8/2016,2635-001,Small,11/8/2016,,Yes,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Yu-Ying He, Lei Qiang",Provisional,4/12/2018,2635-001,11/8/2017,"Sun, Han",Yu-Ying He,"Tennant, Thelma",613470,,583983,No
3697,16-T-128,LINKERS CLEAVABLE BY ENZYMES THAT RECOGNIZE CYSTEINE POST-TRANSLATIONAL MODIFICATIONS,"62/428,034", ,*United States,US,11/30/2016,, ,11/30/2016,2636-001,Small,11/30/2016,9/21/2020,Yes,4/28/2022,Expired Prov - Filed in US,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00028,"Bryan Dickinson, Rahul Kathayat",Provisional,4/12/2018,2636-001,12/2/2017,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",612083,,583984,No
3698,16-T-128,LINKERS CLEAVABLE BY ENZYMES THAT RECOGNIZE CYSTEINE POST-TRANSLATIONAL MODIFICATIONS,"62/556,873", ,*United States,US,9/11/2017,, ,9/11/2017,2636-002,Small,9/11/2017,,No,4/28/2022,Expired - Inactive,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00038,"Michael Beck, Bryan Dickinson, Rahul Kathayat",Provisional,4/12/2018,2636-002,9/11/2018,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",612084,,583984,No
3699,16-T-128,SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS,"15/827,497","10,413,583",*United States,US,11/30/2017,9/17/2019,2018-0147250,11/30/2017,2636-003,Small,11/30/2016,,No,4/28/2022,Issued,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/11/3,"Michael Beck, Bryan Dickinson, Rahul Kathayat",US Utility,4/12/2018,2636-003,11/30/2037,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",614778,5/31/2018,583984,No
3700,16-T-129,NANOSCALE METAL-ORGANIC  LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY OF COLON CANCER,"62/540,275", ,*United States,US,8/2/2017,, ,8/2/2017,2637-001,Small,8/2/2017,12/28/2020,Yes,4/28/2022,Expired Prov - Filed in US,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",00027,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",Provisional,4/12/2018,2637-001,8/2/2018,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613644,,583985,No
3701,16-T-129,"NANOSCALE METAL-ORGANIC LAYERS AND METAL-ORGANIC NANOPLATES FOR X-RAY INDUCED PHOTDYNAMIC THERAPY, RADIOTHERAPY, RADIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF","62/623,826", ,*United States,US,1/30/2018,, ,1/30/2018,2637-002,Small,1/30/2018,12/28/2020,Yes,4/28/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",Provisional,4/12/2018,2637-002,8/2/2018,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",613645,,583985,No
3702,16-T-129,"Nanoscale Metal-Organic Layers and Metal-Organic Nanoplates for X-Ray Induced Photodynamic Therapy, Radiotherapy, Radiodynamic Therapy, Chemotherapy, Immunotherapy, and Any Combination Thereof",PCT/US18/45005, ,*United States,US,8/2/2018,,WO2019/028250,8/2/2018,2637-003,Small,8/2/2017,8/7/2018,No,4/28/2022,Expired PCT - Nationalized,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/10 PCT,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",PCT,8/7/2018,2637-003,2/2/2020,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1675478,2/7/2019,583985,No
3703,16-T-129,"Nanoscale Metal-Organic Layers and Metal-Organic Nanoplates for X-Ray Induced Photodynamic Therapy, Radiotherapy, Radiodynamic Therapy, Chemotherapy, Immunotherapy, and Any Combination Thereof","16/634,486",,*United States,US,8/2/2018,,US-2020-0254095-A1,1/27/2020,2637-004,Small,8/2/2017,2/7/2020,No,6/16/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/10 PCT/US,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",Nationalized PCT,2/7/2020,2637-004,8/2/2038,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4261031,8/13/2020,583985,No
3704,16-T-129,"Nanoscale Metal-Organic Layers and Metal-Organic Nanoplates for X-Ray Induced Photodynamic Therapy, Radiotherapy, Radiodynamic Therapy, Chemotherapy, Immunotherapy, and Any Combination Thereof",18840272.1,,European Patent Office (EPO),EP,8/2/2018,,3638367,1/16/2020,2637-005,Small,8/2/2017,2/21/2020,No,6/2/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/10 PCT/EP,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",Nationalized PCT,2/21/2020,,8/2/2038,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4299443,4/22/2020,583985,No
3705,16-T-129,"Nanoscale Metal-Organic Layers and Metal-Organic Nanoplates for X-Ray Induced Photodynamic Therapy, Radiotherapy, Radiodynamic Therapy, Chemotherapy, Immunotherapy, and Any Combination Thereof",2020505792, ,Japan,JP,8/2/2018,, ,2/3/2020,2637-006,Small,8/2/2017,3/2/2020,No,4/28/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/10 PCT/JP,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",Nationalized PCT,3/2/2020, ,8/2/2038,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4391255,,583985,No
3706,16-T-129,"Nanoscale Metal-Organic Layers and Metal-Organic Nanoplates for X-Ray Induced Photodynamic Therapy, Radiotherapy, Radiodynamic Therapy, Chemotherapy, Immunotherapy, and Any Combination Thereof",201880064003.8, ,China,CN,8/2/2018,,111194232,3/31/2020,2637-007,Small,8/2/2017,4/14/2020,No,6/17/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/10 PCT/CN,"Guangxu Lan, Wenbin Lin, Kaiyuan Ni",Nationalized PCT,4/14/2020, ,8/2/2038,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4467938,5/22/2020,583985,No
3707,16-T-131,Compound,"15/667,893", ,*United States,US,8/3/2017,, ,8/3/2017,2639-001,Small,8/3/2017,10/15/2018,Yes,4/28/2022,Abandoned,Schwarz & Partner Patentanwalte,, ,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",US Utility,4/12/2018,2639-001,8/3/2037,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",611233,,583987,No
3708,16-T-131,Phospholipid Analogues,PCT/EP18/70481, ,European Patent Office (EPO),EP,7/27/2018,,WO2019/025324A1,7/27/2018,2639-002,Small,8/3/2017,8/9/2018,No,4/28/2022,Expired PCT - Nationalized,Schwarz & Partner Patentanwalte,, ,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",PCT,8/9/2018, ,2/3/2020,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",1676230,2/7/2019,583987,No
3709,16-T-131,Phospholipid Analogues,"3,071,476",,Canada,CA,7/27/2018,,,2/17/2020,2639-003,Small,8/3/2017,6/22/2022,No,6/22/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26457-WOCA,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Nationalized PCT,2/28/2020,,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",4387284,,583987,No
3710,16-T-131,Phospholipid Analogues,18746703.0,3661602,European Patent Office (EPO),EP,7/27/2018,5/26/2021, ,2/21/2020,2639-004,Small,8/3/2017,6/25/2021,No,4/28/2022,Granted,Schwarz & Partner Patentanwalte,,26458-WOEP,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Nationalized PCT,3/18/2020, ,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",4411798,,583987,No
3711,16-T-131,Phospholipid analogues,"16/635,883","10,954,255",*United States,US,7/27/2018,3/23/2021,US 2020-0157127-A1,1/31/2020,2639-005,Small,8/3/2017,6/22/2022,No,6/22/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26459-WOUS/AP/CM,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Continuation,4/1/2020,,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",4438990,5/21/2020,583987,No
3712,16-T-131,Phospholipid Analogues,602018017752.3,3661602,Germany,DE,7/27/2018,5/26/2021, ,9/8/2021,2639-006,None,8/3/2017,9/16/2021,No,4/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEPDE,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021, ,,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903279,,583987,No
3713,16-T-131,Phospholipid Analogues,18746703.0,3661602,France,FR,7/27/2018,5/26/2021, ,9/8/2021,2639-007,None,8/3/2017,9/16/2021,No,4/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEPFR,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021, ,,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903313,,583987,No
3714,16-T-131,Phospholipid Analogues,18746703.0,3661602,Switzerland,CH,7/27/2018,5/26/2021, ,8/6/2021,2639-008,None,8/3/2017,9/16/2021,No,4/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEPCH,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021, ,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903347,,583987,No
3715,16-T-131,Phospholipid Analogues,18746703.0,3661602,United Kingdom,GB,7/27/2018,5/26/2021, ,9/8/2021,2639-009,None,8/3/2017,9/16/2021,No,4/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEP,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021, ,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903389,,583987,No
3716,16-T-131,Phospholipid Analogues,,,Lichtenstein,LI,7/27/2018,,,,2639-010,None,8/3/2017,9/16/2021,No,1/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEP,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021,,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903423,,583987,No
3717,16-T-131,Phospholipid Analogues,18746703.0,3661602,Belgium,BE,7/27/2018,5/26/2021, ,9/8/2021,2639-011,None,8/3/2017,9/16/2021,No,4/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEPBE,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021, ,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903457,,583987,No
3718,16-T-131,Phospholipid Analogues,18746703.0,3661602,Ireland,IE,7/27/2018,5/26/2021, ,9/8/2021,2639-012,None,8/3/2017,9/16/2021,No,4/28/2022,Prosecution by Other Party,Schwarz & Partner Patentanwalte,,26458-WOEPIE,"Konstantin Birukov, Anna Birukova, Valery Bochkov, Olga Oskolkova",Validated EPO,7/14/2021, ,7/27/2038,"Dembo, Anna",Konstantin Birukov,"Muite, Kevin",5903491,,583987,No
3719,16-T-132,pending - we did not end up filing this application,,,*United States,US,,,,,2640-001,None,,12/3/2018,,8/5/2021,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373-53013,"Yu-Ying He, Seungwon Yang",Provisional,12/3/2018,,,"Sun, Han",Yu-Ying He,"Tennant, Thelma",1931439,,583988,No
3720,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,"62/487,823", ,*United States,US,4/20/2017,, ,4/20/2017,2644-001,Small,4/20/2017,4/20/2018,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1000337407,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Provisional,4/12/2018,2644-001,4/20/2018,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",612919,,583991,No
3721,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,PCT/US18/28505, ,*United States,US,4/20/2018,,WO 2018/195386 A1,4/20/2018,2644-002,Small,4/20/2017,11/7/2019,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627WO,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",PCT,4/24/2018, ,10/20/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1356508,10/25/2018,583991,No
3722,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,"16/606,539", ,*United States,US,4/20/2018,,US-2020-0123228-A1,10/18/2019,2644-003,Small,4/20/2017,10/27/2019,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627US,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,10/27/2019, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4074732,4/23/2020,583991,No
3723,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,2019-557434, ,Japan,JP,4/20/2018,,JP 2020-517658 A,10/21/2019,2644-004,Small,4/20/2017,10/27/2019,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627JP,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,10/27/2019, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4075042,3/18/2020,583991,No
3724,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,MX/E/2019/071593, ,Mexico,MX,4/20/2018,, ,10/21/2019,2644-005,Small,4/20/2017,11/4/2019,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627MX,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,11/4/2019, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4099580,,583991,No
3725,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,18787963.0, ,European Patent Office (EPO),EP,4/20/2018,,3612209,11/6/2019,2644-006,Small,4/20/2017,11/11/2019,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627EP,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,11/11/2019, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4107628,2/26/2020,583991,No
3726,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,2018256453, ,Australia,AU,4/20/2018,, ,11/13/2019,2644-007,Small,4/20/2017,11/18/2019,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627AU,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,11/18/2019, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4119058,,583991,No
3727,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,201880041832.4, ,China,CN,4/20/2018,,CN 111132693 A,12/20/2019,2644-008,Small,4/20/2017,12/22/2019,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627CN,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,12/22/2019, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4197404,5/8/2020,583991,No
3728,16-T-135,Methods and Compositions for Treating Cancer with ECM-Affinity Peptides Linked to Immunotherapeutic Antibodies,62020015011.3, ,Hong Kong,HK,4/20/2018,,4025976 A,8/26/2020,2644-009,Small,4/20/2017,10/14/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0627EHK,"Kazuto Fukunaga, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Melody Swartz",Nationalized PCT,10/14/2020, ,4/20/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4979916,12/31/2020,583991,No
3729,16-T-136,BLUE PHASES ON PATTERNED SURFACES,"62/538,760", ,*United States,US,7/30/2017,, ,7/30/2017,2642-001,Small,7/30/2017,12/28/2020,Yes,4/28/2022,Expired Prov - Filed in US,Weaver Austin Villeneuve & Sampson LLP,, ,"Juan de Pablo, Xiao Li, Jose Martinez-Gonzalez, Paul Nealey, Monirosadat Sadati, Rui Zhang, Ye Zhou",Provisional,4/12/2018,2642-001,7/30/2018,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",610748,,583992,No
3730,16-T-136,BLUE PHASES ON PATTERNED SURFACES,"16/048,891","10,969,642",*United States,US,7/30/2018,4/6/2021,US-2019-0049767,7/30/2018,2642-002,Small,7/30/2017,3/26/2021,No,4/28/2022,Issued,Weaver Austin Villeneuve & Sampson LLP,,P005/2642-002,"Juan de Pablo, Xiao Li, Jose Martinez-Gonzalez, Paul Nealey, Monirosadat Sadati, Rui Zhang, Ye Zhou",US Utility,8/28/2018,2642-002,7/30/2038,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",1684814,2/14/2019,583992,No
3731,16-T-136,Blue Phases on Patterned Surfaces,"17/249,646", ,*United States,US,7/30/2018,,US-2021-0263357-A1,3/8/2021,2642-003,Small,7/30/2017,3/10/2021,No,6/6/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP005D1US,"Juan de Pablo, Xiao Li, Jose Martinez-Gonzalez, Paul Nealey, Monirosadat Sadati, Rui Zhang, Ye Zhou",Divisional,3/10/2021,2642-003,7/30/2038,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",5473285,8/26/2021,583992,No
3732,16-T-141,METHODS AND COMPOSITIONS FOR TREATING CANCER,"62/517,626",,*United States,US,6/9/2017,,,6/9/2017,2647-001,Small,6/9/2017,,Yes,6/9/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0634US.P1,"Jiyoung Lee, Marsha Rosner",Provisional,4/12/2018,2647-001,6/9/2018,"Sun, Han",Marsha Rosner,"Tennant, Thelma",612916,,583997,No
3733,16-T-141,METHODS AND COMPOSITIONS FOR TREATING CANCER,"16/005,052","10,888,569",*United States,US,6/11/2018,1/12/2021,,6/11/2018,2647-002,Small,6/9/2017,7/11/2018,No,6/9/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0634US,"Jiyoung Lee, Marsha Rosner",US Utility,7/11/2018,2647-002,6/11/2038,"Sun, Han",Marsha Rosner,"Tennant, Thelma",1588448,,583997,No
3734,16-T-142,OXALOBACTER FORMIGENES (Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS,"62/448,178", ,*United States,US,1/19/2017,, ,1/19/2017,2649-001,Small,1/19/2017,12/28/2020,Yes,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David", ,"Donna Arvans, Hatim Hassan",Provisional,4/12/2018,2649-001,1/19/2018,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",613865,,583998,No
3735,16-T-142,OXALOBACTER FORMIGENES (Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS,PCT/US18/14494, ,*United States,US,1/19/2018,,WO 2018/136779,1/19/2018,2649-002,Small,1/19/2017,,No,4/28/2022,Expired PCT - Filed in US only,"Casimir Jones, S.C.","Staple, David", ,"Donna Arvans, Hatim Hassan",PCT,4/12/2018,2649-002,7/19/2019,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",613866,7/26/2018,583998,No
3736,16-T-142,OXALOBACTER FORMIGENES (Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS,"16/479,516", ,*United States,US,1/19/2018,,US-2020-0188451-A1,7/19/2019,2649-003,Small,1/19/2017,7/23/2019,No,5/31/2022,Pending,"Casimir Jones, S.C.","Staple, David",35113.252,"Donna Arvans, Hatim Hassan",Nationalized PCT,7/23/2019,2649-003,1/19/2038,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",3848366,6/18/2020,583998,No
3737,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,"62/447,199", ,*United States,US,1/17/2017,, ,1/17/2017,2650-001,Small,1/17/2017,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Brendan Horton, Jason Williams",Provisional,4/12/2018,2650-001,1/17/2018,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",611500,,584000,No
3738,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,PCT/US18/14008, ,*United States,US,1/17/2018,,WO 2018/186924,1/17/2018,2650-002,Small,1/17/2017,,No,4/28/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.","Staple, David", ,"Thomas Gajewski, Brendan Horton, Jason Williams",PCT,4/12/2018,2650-002,7/17/2019,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",611501,10/11/2018,584000,No
3739,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,"16/476,219", ,*United States,US,1/17/2018,,US-2020-0010557,7/5/2019,2650-005,Small,1/17/2017,7/18/2019,No,5/2/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35120.252,"Thomas Gajewski, Brendan Horton, Jason Williams",Nationalized PCT,7/18/2019, ,1/17/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3798932,1/9/2020,584000,No
3740,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,"3,049,445", ,Canada,CA,1/17/2018,, ,7/4/2019,2650-003,Small,1/17/2017,7/18/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35120.711,"Thomas Gajewski, Brendan Horton, Jason Williams",Nationalized PCT,7/18/2019, ,1/17/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3798958,,584000,No
3741,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,201880016246.4,,China,CN,1/17/2018,,CN110740748A,9/5/2019,2650-007,Small,1/17/2017,7/18/2019,No,3/21/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35120.731,"Thomas Gajewski, Brendan Horton, Jason Williams",Nationalized PCT,7/18/2019,,1/17/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3798984,1/31/2020,584000,No
3742,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,18780614.6EPO, ,European Patent Office (EPO),EP,1/17/2018,,3570887,7/3/2019,2650-006,Small,1/17/2017,7/18/2019,No,6/15/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35120.611,"Thomas Gajewski, Brendan Horton, Jason Williams",Nationalized PCT,7/18/2019, ,1/17/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3799010,11/27/2019,584000,No
3743,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,2019-537357, ,Japan,JP,1/17/2018,, ,7/10/2019,2650-004,Small,1/17/2017,7/18/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35120.701,"Thomas Gajewski, Brendan Horton, Jason Williams",Nationalized PCT,7/18/2019, ,1/17/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",3799037,,584000,No
3744,16-T-144,DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT,62020008097.1,,Hong Kong,HK,1/17/2018,,40017948,5/26/2020,2650-008,None,1/17/2017,7/1/2020,No,3/18/2022,Pending,"Casimir Jones, S.C.","Staple, David",35120.821,"Thomas Gajewski, Brendan Horton, Jason Williams",Nationalized PCT,7/1/2020,,1/17/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4684095,9/25/2020,584000,No
3745,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,"62/513,519", ,*United States,US,6/2/2017,, ,6/1/2017,2662-001,Small,6/2/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,Polsinelli Shughart PC,,NIH20306P,"Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",Provisional,4/12/2018,2662-001,6/2/2018,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",614844,,584001,No
3746,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,PCT/US18/35303, ,*United States,US,5/31/2018,, ,5/31/2018,2662-002,Small,6/2/2017,12/19/2018,No,5/8/2022,Expired PCT - Nationalized,Polsinelli Shughart PC,,060734-596491,"Talon Chandler, Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",PCT,12/19/2018, ,11/30/2019,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",3348495,,584001,No
3747,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,201880035990.9,ZL 201880035990.9,China,CN,5/31/2018,3/4/2022,,11/29/2019,2662-004,Small,6/2/2017,3/17/2022,No,3/18/2022,Prosecution by Other Party,Polsinelli Shughart PC,,NIH20306PCTCN,"Talon Chandler, Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",Nationalized PCT,11/3/2020,,5/30/2038,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",5052907,,584001,No
3748,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,18810466.5,,European Patent Office (EPO),EP,5/31/2018,,3631556,11/19/2019,2662-005,Small,6/2/2017,3/17/2022,No,3/21/2022,Prosecution by Other Party,Polsinelli Shughart PC,,NIH20306PCTEP,"Talon Chandler, Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",Nationalized PCT,11/3/2020,,5/31/2038,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",5052957,4/8/2020,584001,No
3749,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,271042,,Israel,IL,5/31/2018,,01/2020,12/1/2019,2662-006,Small,6/2/2017,3/17/2022,No,3/21/2022,Prosecution by Other Party,Polsinelli Shughart PC,,NIH20306PCTIL,"Talon Chandler, Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",Nationalized PCT,11/3/2020,,5/31/2038,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",5053008,1/30/2020,584001,No
3750,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,2019-566626,,Japan,JP,5/31/2018,,,12/2/2019,2662-007,Small,6/2/2017,3/17/2022,No,3/21/2022,Prosecution by Other Party,Polsinelli Shughart PC,,NIH20306PCTJP,"Talon Chandler, Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",Nationalized PCT,11/3/2020,,5/31/2038,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",5053058,,584001,No
3751,16-T-145,SYSTEMS AND METHODS FOR THREE-DIMENSIONAL FLUORESCENCE POLARIZATION VIA MULTIVIEW IMAGING,"16/616,891",,*United States,US,5/31/2018,,US-2020-0386683-A1,11/25/2019,2662-003,Small,6/2/2017,3/17/2022,No,5/20/2022,Prosecution by Other Party,Polsinelli Shughart PC,,NIH20306PCTUS,"Talon Chandler, Abhishek Kumar, Patrick La Riviere, Shalin Mehta, Rudolf Oldenbourg, Hari Shroff, Yicong Wu",Nationalized PCT,11/3/2020,,5/31/2038,"Cox, Ben",Rudolf Oldenbourg,"Juggernauth, Anne",5053108,12/10/2020,584001,No
3752,16-T-146,GPR56 Monobody Compositions and Methods,"62/553,645", ,*United States,US,9/1/2017,, ,9/1/2017,2653-001,Small,9/1/2017,8/3/2018,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000202500,"Demet Arac-Ozkan, Akiko Koide, Shohei Koide, Gabriel Salzman",Provisional,4/12/2018,2653-001,9/1/2018,"Bakalyar, Heather",Shohei Koide,"Butler, Brittany",611702,,584002,No
3753,17-T-002,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS","62/486,566", ,*United States,US,4/18/2017,, ,4/19/2017,2656-001,Small,4/18/2017,,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0019,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Provisional,4/12/2018,2656-001,4/18/2018,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",613967,,584005,No
3754,17-T-002,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS",PCT/US18/28068, ,*United States,US,4/18/2018,,WO2018195143,4/18/2018,2656-002,Small,4/18/2017,,No,4/28/2022,Expired PCT - Nationalized,"Bell & Manning, LLC","Manning, Michelle",05400-0019-03,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",PCT,4/19/2018, ,10/18/2019,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",1332272,10/25/2018,584005,No
3755,17-T-002,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS","16/604,045",,*United States,US,4/18/2018,,US-2020-0249570-A1,10/9/2019,2656-003,Small,4/18/2017,10/22/2019,No,6/23/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0019-US,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Nationalized PCT,10/22/2019,,4/18/2038,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4046773,8/6/2020,584005,No
3756,17-T-002,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS",201880033898.9,,China,CN,4/18/2018,,CN110832618A,11/22/2019,2656-004,None,4/18/2017,10/22/2019,No,3/21/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0019-CN,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Nationalized PCT,10/22/2019,,4/18/2038,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4046852,2/21/2020,584005,No
3757,17-T-002,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS",2019-556337, ,Japan,JP,4/18/2018,,2020-520469,10/16/2019,2656-006,Small,4/18/2017,10/22/2019,No,6/23/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0019-JP,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Nationalized PCT,10/22/2019, ,4/18/2038,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4046874,7/9/2020,584005,No
3758,17-T-002,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS",2019-7033764,,"Korea, Republic of",KR,4/18/2018,,,11/15/2019,2656-007,Small,4/18/2017,10/22/2019,No,3/21/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0019-KR,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Nationalized PCT,10/22/2019,,4/18/2038,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4046898,,584005,No
3759,17-T-002,"Photoactive, Inorganic ligand-capped inorganic nanocrystals",18788500.9EPO, ,European Patent Office (EPO),EP,4/18/2018,,3613070,11/5/2019,2656-005,Small,4/18/2017,10/22/2019,No,6/15/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0019-EP,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Nationalized PCT,10/22/2019, ,4/18/2038,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4046920,2/26/2020,584005,No
3760,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,"13/575,311", ,*United States,US,1/7/2011,,US 2012-0303384 A1,1/7/2011,2658-001,Small,2/5/2010,,No,4/28/2022,Pending,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",US Utility,4/12/2018,2658-001,1/7/2031,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615088,11/30/2012,584007,No
3761,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,"61/301,671", ,*United States,US,2/5/2010,, ,2/5/2010,2658-002,Small,2/5/2010,,Yes,4/28/2022,Expired - Inactive,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",Provisional,4/12/2018,2658-002,2/5/2011,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615089,,584007,No
3762,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,PCT/IB11/50070, ,*United States,US,1/7/2011,, ,1/7/2011,2658-003,Small,2/6/2010,,No,4/28/2022,Expired - Inactive,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",PCT,4/12/2018,2658-003,7/7/2012,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615090,,584007,No
3763,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,11704310.9EPO, ,European Patent Office (EPO),EP,1/7/2011,, ,1/7/2011,2658-004,Small,2/5/2010,,No,4/28/2022,Pending,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",Nationalized PCT,4/12/2018,2658-004,1/11/2031,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615091,,584007,No
3764,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,201180008079.7, ,China,CN,1/7/2011,, ,1/7/2011,2658-005,Small,2/5/2010,,No,4/28/2022,Pending,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",Nationalized PCT,4/12/2018,2658-005,1/7/2031,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615092,,584007,No
3765,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,6595/CHENP/2012, ,India,IN,1/7/2011,, ,1/7/2011,2658-006,Small,2/5/2010,,No,4/28/2022,Pending,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",Nationalized PCT,4/12/2018,2658-006,1/7/2031,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615093,,584007,No
3766,17-T-004,TREATMENT PLAN CREATION WORKFLOW TRACKING,2012-551707, ,Japan,JP,1/7/2011,, ,1/7/2011,2658-007,Small,2/5/2010,,No,4/28/2022,Pending,,, ,"Hania Al-Hallaq, Lina Arbash-Meinel, Christopher Stepaniak",Nationalized PCT,4/12/2018,2658-007,1/7/2031,"Dembo, Anna",Hania Al-Hallaq,"Tennant, Thelma",615094,,584007,No
3767,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,"62/486,124", ,*United States,US,4/17/2017,, ,4/17/2017,2660-001,Small,4/17/2017,4/17/2018,Yes,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David", ,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Provisional,4/12/2018,2660-001,4/17/2018,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",614088,,584008,No
3768,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,PCT/US18/27955, ,*United States,US,4/17/2018,,WO 2018-195067,4/17/2018,2660-002,Small,4/17/2017,4/18/2018,No,6/8/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.",,UCHI-35145.601,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",PCT,4/24/2018, ,10/17/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1357003,10/25/2018,584008,No
3769,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,1120190217428, ,Brazil,BR,4/17/2018,, ,10/22/2019,2660-003,Small,4/17/2017,10/22/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.781,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,10/22/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4045972,,584008,No
3770,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,2019-556663, ,Japan,JP,4/17/2018,, ,10/23/2019,2660-004,Small,4/17/2017,11/4/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.701,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,11/4/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4099221,,584008,No
3771,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,201880025751.5, ,China,CN,4/17/2018,,110891982,10/17/2019,2660-005,Small,4/17/2017,11/12/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.731,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,11/4/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4099312,3/17/2020,584008,No
3772,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,"3,060,243", ,Canada,CA,4/17/2018,, ,10/16/2019,2660-006,Small,4/17/2017,11/12/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.711,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,11/12/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4111304,,584008,No
3773,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,18788367.3, ,European Patent Office (EPO),EP,4/17/2018,,3612570,11/12/2019,2660-007,Small,4/17/2017,11/18/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.611,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,11/18/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4118936,2/26/2020,584008,No
3774,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,2018255269, ,Australia,AU,4/17/2018,, ,10/16/2019,2660-008,Small,4/17/2017,11/18/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.721,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,11/18/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4119114,,584008,No
3775,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,"16/605,449", ,*United States,US,4/17/2018,,US-2020-0048390-A1,10/15/2019,2660-009,Small,4/17/2017,11/18/2019,No,6/24/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.252,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,11/18/2019, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4119160,2/13/2020,584008,No
3776,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,10-2019-7033820,,"Korea, Democratic People's Republic of",KP,4/17/2018,,,12/1/2019,2660-010,Small,4/17/2017,12/6/2019,No,3/21/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.751,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,12/6/2019,,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4141901,,584008,No
3777,17-T-005,POLYMER MATERIALS FOR DELIVERY OF SHORT CHAIN FATTY ACIDS TO THE INTESTINE FOR APPLICATIONS IN HUMAN HEALTH AND TREATMENT OF DISEASE,62020013532.0, ,Hong Kong,HK,4/17/2018,,40024984,8/12/2020,2660-011,Large,4/17/2017,10/2/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35145.821,"Jeffrey Hubbell, Cathryn Nagler, Catherine Plunkett, Ruyi Wang, D. Scott Wilson",Nationalized PCT,10/2/2020, ,4/17/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4942349,12/18/2020,584008,No
3778,17-T-011,METHODS AND COMPOSITIONS RELATED TO TRIPLE-NEGATIVE BREAST CANCER,"62/597,534", ,*United States,US,12/12/2017,, ,12/12/2017,2667-001,Small,12/12/2017,,Yes,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0638USP1,"Suzanne Conzen, Maria Kocherginsky, Diana Szymanski",Provisional,4/12/2018,2667-001,12/12/2018,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",613066,,584014,No
3779,17-T-011,METHODS AND COMPOSITIONS RELATED TO TRIPLE-NEGATIVE BREAST CANCER,"16/217,350", ,*United States,US,12/12/2018,,US-2019-0279769-A1,12/12/2018,2667-002,Small,12/12/2017,12/19/2018,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0638US,"Suzanne Conzen, Lei Huang, Maria Kocherginsky, Diana Szymanski",US Utility,12/19/2018, ,12/12/2038,"Dembo, Anna",Suzanne Conzen,"Tennant, Thelma",3348434,9/12/2019,584014,No
3780,17-T-012,Methods and Compositions for Spacial and Temporal Measurement of Catalytic Activity,"62/484,666", ,*United States,US,4/12/2017,, ,4/12/2017,2668-001,Small,4/12/2017,9/14/2021,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1000173134,"Krishna Dan, Yamuna Krishnan, Aneesh Veetil",Provisional,4/12/2018,2668-001,4/12/2018,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",612855,,584015,No
3781,17-T-012,Methods and Compositions for Spacial and Temporal Measurement of Catalytic Activity,PCT/US18/27391, ,*United States,US,4/12/2018,, ,4/12/2018,2668-002,Small,4/12/2017,4/20/2018,No,4/28/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,, ,"Kasturi Chakraborty, Krishna Dan, Yamuna Krishnan, Aneesh Veetil",PCT,5/7/2018,2668-002,10/12/2019,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",1366446,,584015,No
3782,17-T-012,Methods and Compositions for Spacial and Temporal Measurement of Catalytic Activity,"16/603,722",,*United States,US,4/12/2018,,US-2021-0096129-A1,10/8/2019,2668-003,Small,4/12/2017,10/31/2019,No,6/23/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-347-WO-US,"Kasturi Chakraborty, Krishna Dan, Yamuna Krishnan, Aneesh Veetil",Nationalized PCT,10/31/2019,2668-003,4/12/2038,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",4093456,4/1/2021,584015,No
3783,17-T-014,A DNA-based Voltmeter for Organelles,"62/961,615", ,*United States,US,1/15/2020,, ,1/15/2020,2669-001,Small,1/15/2020,3/2/2021,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-037-PRO,"Yamuna Krishnan, Anand Saminathan, Aneesh Veetil",Provisional,1/23/2020, ,1/15/2021,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",4240266,,584017,No
3784,17-T-014,A DNA-based Voltmeter for Organelles,PCT/US21/13745, ,*United States,US,1/15/2021,,WO 2021/194613,1/15/2021,2669-002,Small,1/15/2020,1/25/2021,No,6/23/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-037-WO,"Yamuna Krishnan, Anand Saminathan, Aneesh Veetil",PCT,1/25/2021, ,7/15/2022,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5300045,9/30/2021,584017,No
3785,17-T-014,A DNA-based Voltmeter for Organelles,,,*United States,US,1/15/2021,,,,2669-003,Small,1/15/2020,6/2/2022,No,6/23/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",20-037-WO-US,"Yamuna Krishnan, Anand Saminathan, Aneesh Veetil",Nationalized PCT,5/26/2022,,,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",7333089,,584017,
3786,17-T-014,A DNA-based Voltmeter for Organelles,,,European Patent Office (EPO),EP,1/15/2021,,,,2669-004,Small,1/15/2020,6/2/2022,No,6/2/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-037-WO-EP,"Yamuna Krishnan, Anand Saminathan, Aneesh Veetil",Nationalized PCT,5/26/2022,,,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",7333150,,584017,
3787,17-T-017,Method and Composition for Measurement of Nitric Oxide,"62/946,720", ,*United States,US,12/11/2019,, ,12/11/2019,2674-001,Small,12/11/2019,12/11/2019,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-2367-PRO,"Maulik Jani, Yamuna Krishnan, Aneesh Veetil",Provisional,12/17/2019, ,12/11/2020,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",4192302,,584020,No
3788,17-T-017,Method and Composition for Measurement of Nitric Oxide,PCT/US20/64544,,*United States,US,12/11/2020,,WO 2021/119448,12/11/2020,2674-002,None,12/11/2019,5/16/2022,No,6/23/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-2367-WO,"Maulik Jani, Yamuna Krishnan, Aneesh Veetil",PCT,12/14/2020,,6/11/2022,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5195899,6/17/2021,584020,No
3789,17-T-017,Method and Composition for Measurement of Nitric Oxide,"17/784,481",,*United States,US,12/11/2019,,,6/10/2022,2674-003,Small,12/11/2019,6/15/2022,No,6/23/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-2367-WO-US,"Maulik Jani, Yamuna Krishnan, Aneesh Veetil",Nationalized PCT,5/16/2022,,,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",7257581,,584020,
3790,17-T-017,Method and Composition for Measurement of Nitric Oxide,20829491.8,,European Patent Office (EPO),EP,12/11/2019,,,,2674-004,Small,12/11/2019,5/16/2022,No,6/13/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-2367-WO-EP,"Maulik Jani, Yamuna Krishnan, Aneesh Veetil",Nationalized PCT,5/16/2022,,,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",7257610,,584020,
3791,17-T-025,"REAGENT COMPOUNDS, COMPOSITIONS, KITS, AND METHODS FOR AMPLIFIED ASSAYS","62/363,821", ,*United States,US,7/19/2016,, ,7/18/2016,2681-001,Small,7/19/2016,,Yes,4/28/2022,Expired - Inactive,"VLP Law Group, LLP","Roise, David", ,"Stephen Kron, David Schwartz",Provisional,4/12/2018,2681-001,7/19/2017,"Sun, Han",Stephen Kron,"Tennant, Thelma",614288,,584028,No
3792,17-T-025,"Reagent Compounds, Compositions, Kits, and Methods for Amplified Assays",PCT/US17/42656, ,*United States,US,7/18/2017,, ,7/18/2017,2681-002,Small,7/19/2016,,No,4/28/2022,Expired PCT - Filed in US only,"VLP Law Group, LLP",, ,"Stephen Kron, David Schwartz",PCT,4/12/2018,2681-002,1/18/2019,"Sun, Han",Stephen Kron,"Tennant, Thelma",614289,,584028,No
3793,17-T-025,"Reagent Compounds, Compositions, Kits, and Methods for Amplified Assays","16/318,793", ,*United States,US,7/18/2017,,2019/0265235-A1,1/18/2019,2681-003,Small,7/19/2016,2/6/2019,No,6/3/2022,Pending,"VLP Law Group, LLP",,2068-00-003US1,"Stephen Kron, David Schwartz",Nationalized PCT,2/6/2019, ,7/18/2037,"Sun, Han",Stephen Kron,"Tennant, Thelma",3496224,8/29/2019,584028,No
3794,17-T-026,Methods and Compositions for Detecting 2O-Methyl Modifications in RNA,"62/502,181", ,*United States,US,5/5/2017,, ,5/5/2017,2682-001,Small,5/5/2017,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000344455,"Qing Dai, Dan Dominissini, Chuan He",Provisional,4/12/2018,2682-001,5/5/2017,"Hwang, Luke",Chuan He,"Tennant, Thelma",612673,,584029,No
3795,17-T-029,"STRONG, REBONDABLE, DYNAMIC CROSS-LINKED CELLULOSE NANOCRYSTAL POLYMER NANOCOMPOSITE ADHESIVES","62/502,959", ,*United States,US,5/8/2017,, ,5/8/2017,2684-001,Small,5/8/2017,5/8/2018,Yes,4/28/2022,Expired - Inactive,"Hudak, Shunk & Farine Co. LPA","Hudak, Daniel", ,"Elvis Cudjoe, Stuart Rowan",Provisional,4/12/2018,2684-001,5/8/2018,"Hwang, Luke",Stuart Rowan,"Juggernauth, Anne",614669,,584032,No
3796,17-T-029,"STRONG, REBONDABLE, DYNAMIC CROSS-LINKED CELLULOSE NANOCRYSTAL POLYMER NANOCOMPOSITE ADHESIVES",PCT/US18/31374, ,*United States,US,5/7/2018,,WO 2018/208663,5/7/2018,2684-002,Small,5/8/2017,5/8/2018,No,4/28/2022,Expired PCT - Filed in US only,"Hudak, Shunk & Farine Co. LPA","Hudak, Daniel", ,"Elvis Cudjoe, Stuart Rowan",PCT,5/8/2018, ,11/8/2019,"Hwang, Luke",Stuart Rowan,"Juggernauth, Anne",1368165,11/15/2018,584032,No
3797,17-T-029,"STRONG, REBONDABLE, DYNAMIC CROSS-LINKED CELLULOSE NANOCRYSTAL POLYMER NANOCOMPOSITE ADHESIVES","16/610,985", ,*United States,US,5/7/2018,,US-2020-0270488-A1,11/5/2019,2684-003,None,5/8/2017,11/21/2019,No,4/28/2022,Pending,"Hudak, Shunk & Farine Co. LPA","Hudak, Daniel",CWRU-SS-PROV-PCT-US,"Elvis Cudjoe, Stuart Rowan",Nationalized PCT,11/21/2019, ,5/7/2038,"Hwang, Luke",Stuart Rowan,"Juggernauth, Anne",4123812,8/27/2020,584032,No
3798,17-T-032,Method for Highly Sensitive DNA Methylation Analysis,"62/468,907", ,*United States,US,3/8/2017,, ,3/8/2017,2687-001,Small,3/8/2017,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0628US.P1,"Chuan He, Pradnya Narkhede, Boxuan Zhao",Provisional,4/12/2018,2687-001,3/8/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",612461,,584035,No
3799,17-T-032,Method for Highly Sensitive DNA Methylation Analysis,PCT/US18/21591, ,*United States,US,3/8/2018,,2018/165459,3/8/2018,2687-002,Small,3/8/2017,,No,6/8/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0628WO,"Xiao-Long Cui, Chuan He, Chang Liu, Pradnya Narkhede, Boxuan Zhao",PCT,4/12/2018,2687-002,9/8/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",612462,9/13/2018,584035,No
3800,17-T-032,Method for Highly Sensitive DNA Methylation Analysis,"16/491,278","11,130,991",*United States,US,3/8/2018,9/28/2021,US-2020-0032330-A1,9/5/2019,2687-003,Small,3/8/2017,9/9/2021,No,6/8/2022,Issued,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0628US,"Xiao-Long Cui, Chuan He, Chang Liu, Pradnya Narkhede, Boxuan Zhao",Nationalized PCT,9/5/2019, ,3/8/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",3985679,1/30/2020,584035,No
3801,17-T-032,Method for Highly Sensitive DNA Methylation Analysis,201880026692.3, ,China,CN,3/8/2018,,CN 111183145 A,10/22/2019,2687-004,Small,3/8/2017,10/24/2019,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0628CN,"Xiao-Long Cui, Chuan He, Chang Liu, Pradnya Narkhede, Boxuan Zhao",Nationalized PCT,10/24/2019, ,3/8/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",4066853,5/19/2020,584035,No
3802,17-T-032,Method for Highly Sensitive DNA Methylation Analysis,62020020273.2, ,Hong Kong,HK,3/8/2018,,40030372,11/19/2020,2687-005,Small,3/8/2017,11/20/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0628CHK,"Xiao-Long Cui, Chuan He, Chang Liu, Pradnya Narkhede, Boxuan Zhao",Nationalized PCT,11/20/2020, ,3/8/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",5106033,2/26/2021,584035,No
3803,17-T-032,Method for Highly Sensitive DNA Methylation Analysis,"17/448,958", ,*United States,US,3/8/2018,,US-2022-0033890-A1,9/27/2021,2687-006,Small,3/8/2017,9/27/2021,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0628US.D1,"Xiao-Long Cui, Chuan He, Chang Liu, Pradnya Narkhede, Boxuan Zhao",Divisional,9/27/2021, ,3/8/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",6208120,2/3/2022,584035,No
3804,17-T-033,Methods Related to RNA Methylation and Cancer,"62/477,262", ,*United States,US,3/28/2017,, ,3/27/2017,2686-001,Small,3/28/2017,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000319155,"Mark Eckert, Bryan Harada, Chuan He, Ernst Lengyel, Jianzhao Liu, Jun Liu",Provisional,4/12/2018,2686-001,3/28/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",613367,,584036,No
3805,17-T-035,CELLULAR ANALYSIS,"62/489,605", ,*United States,US,4/26/2017,, ,4/25/2017,2689-001,Small,4/26/2017,10/28/2019,Yes,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0020,"Marcus Clark, Maryellen Giger, Vladimir Liarski, Adam Sibley",Provisional,4/12/2018,17-T-035 PROV,4/26/2018,"Cox, Ben",Marcus Clark,"Smith, Dane",610816,,584038,No
3806,17-T-035,Cellular Analysis,PCT/US18/29426, ,*United States,US,4/25/2018,,WO2018200715,4/25/2018,2689-002,Small,4/26/2017,4/25/2018,No,4/28/2022,Expired PCT - Filed in US only,"Bell & Manning, LLC","Manning, Michelle",05400-0020,"Marcus Clark, Maryellen Giger, Vladimir Liarski, Adam Sibley",PCT,4/25/2018,17-T-035 PCT,10/25/2019,"Cox, Ben",Marcus Clark,"Smith, Dane",1357959,11/1/2018,584038,No
3807,17-T-035,Cellular Analysis,"16/607,218",,*United States,US,4/25/2018,,US-2020-0380672-A1,10/22/2019,2689-003,Small,4/26/2017,10/22/2019,No,6/16/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0020-US,"Marcus Clark, Maryellen Giger, Vladimir Liarski, Adam Sibley",Nationalized PCT,10/22/2019,17-T-035US,4/25/2038,"Cox, Ben",Marcus Clark,"Smith, Dane",4046038,12/3/2020,584038,No
3808,17-T-035,Cellular Analysis,18791433.8, ,European Patent Office (EPO),EP,4/25/2018,,3616160,11/25/2019,2689-004,Small,4/26/2017,11/26/2019,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0020-EP,"Marcus Clark, Maryellen Giger, Vladimir Liarski, Adam Sibley",Nationalized PCT,11/26/2019, ,4/25/2038,"Cox, Ben",Marcus Clark,"Smith, Dane",4132042,3/4/2020,584038,No
3809,17-T-040,Methods and Compositions for Treating Alzheimer's Disease,"62/532,797", ,*United States,US,7/14/2017,, ,7/14/2017,2692-002,Small,7/14/2017,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000202368,"Robert Andrew, Celia Fernandez, Gopal Thinakaran",Provisional,4/12/2018,2692-002,7/14/2018,"Dembo, Anna",Gopal Thinakaran,"Butler, Brittany",612908,,584043,No
3810,17-T-040,Methods and Compositions for Treating Alzheimer's Disease,"62/643,511", ,*United States,US,3/15/2018,, ,3/15/2018,2692-003,Small,3/15/2018,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Robert Andrew, Celia Fernandez, Gopal Thinakaran",Provisional,4/12/2018,2692-003,3/15/2019,"Dembo, Anna",Gopal Thinakaran,"Butler, Brittany",612909,,584043,No
3811,17-T-040,METHODS AND COMPOSITIONS FOR TREATING ALZHEIMERS DISEASE,"62/528,642", ,*United States,US,7/5/2017,, ,7/5/2017,2692-001,Small,7/5/2017,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000335212,"Robert Andrew, Celia Fernandez, Gopal Thinakaran",Provisional,4/12/2018, ,7/5/2018,"Dembo, Anna",Gopal Thinakaran,"Butler, Brittany",612910,,584043,No
3812,17-T-040,METHODS AND COMPOSITIONS FOR TREATING ALZHEIMERS DISEASE,"16/028,121", ,*United States,US,7/5/2018,, ,7/5/2018,2692-004,Small,7/5/2017,7/23/2018,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000335212,"Robert Andrew, Celia Fernandez, Gopal Thinakaran",US Utility,7/23/2018, ,7/5/2038,"Dembo, Anna",Gopal Thinakaran,"Butler, Brittany",1655539,,584043,No
3813,17-T-041,Methods and Compositions for Treating Cancer,"62/520,325", ,*United States,US,6/15/2017,, ,6/15/2017,2695-001,Small,6/15/2017,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000191503,"Lev Becker, Chang Cui",Provisional,4/12/2018,2695-001,6/15/2018,"Sun, Han",Lev Becker,"Tennant, Thelma",612917,,584044,No
3814,17-T-041,Methods and Compositions for Treating Cancer,PCT/US18/37800, ,*United States,US,6/15/2018,,WO 2018/232273 A1,6/15/2018,2695-002,Small,6/15/2017,7/11/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633WO,"Lev Becker, Chang Cui",PCT,7/11/2018, ,12/15/2019,"Sun, Han",Lev Becker,"Tennant, Thelma",1588497,12/20/2018,584044,No
3815,17-T-041,Methods and Compositions for Treating Cancer,"16/621,549", ,*United States,US,6/15/2018,,US-2021-0299234-A1,9/24/2021,2695-008,Small,6/15/2017,12/13/2019,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633US,"Lev Becker, Chang Cui",Nationalized PCT,12/13/2019, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",4190054,9/30/2021,584044,No
3816,17-T-041,Methods and Compositions for Treating Cancer,2018285710, ,Australia,AU,6/15/2018,, ,12/17/2019,2695-003,Small,6/15/2017,12/13/2019,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633AU,"Lev Becker, Chang Cui",Nationalized PCT,12/13/2019, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",4190077,,584044,No
3817,17-T-041,Methods and Compositions for Treating Cancer,"3,066,738", ,Canada,CA,6/15/2018,, ,12/9/2019,2695-004,Small,6/15/2017,12/13/2019,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633CA,"Lev Becker, Chang Cui",Nationalized PCT,12/13/2019, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",4190099,,584044,No
3818,17-T-041,Methods and Compositions for Treating Cancer,201880053084.1, ,China,CN,6/15/2018,,11032075,2/14/2020,2695-005,Small,6/15/2017,12/13/2019,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633CN,"Lev Becker, Chang Cui",Nationalized PCT,12/13/2019, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",4190127,4/17/2020,584044,No
3819,17-T-041,Methods and Compositions for Treating Cancer,18817894.1, ,European Patent Office (EPO),EP,6/15/2018,,3638293,12/9/2019,2695-006,Small,6/15/2017,12/13/2019,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633EP,"Lev Becker, Chang Cui",Nationalized PCT,12/13/2019, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",4190149,4/22/2020,584044,No
3820,17-T-041,Methods and Compositions for Treating Cancer,2019-569454, ,Japan,JP,6/15/2018,,2020-524141 A,12/13/2019,2695-007,Small,6/15/2017,12/13/2019,No,6/23/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633JP,"Lev Becker, Chang Cui",Nationalized PCT,12/13/2019, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",4190171,8/13/2020,584044,No
3821,17-T-041,Methods and Compositions for Treating Cancer,62020018247.0, ,Hong Kong,HK,6/15/2018,,40029045 A,10/16/2020,2695-009,Small,6/15/2017,10/26/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0633EHK,"Lev Becker, Chang Cui",Nationalized PCT,10/26/2020, ,6/15/2038,"Sun, Han",Lev Becker,"Tennant, Thelma",5007291,2/11/2021,584044,No
3822,17-T-043,Compositions and Method for Reducing Virulence of Microorganisms,"62/640,352", ,*United States,US,3/8/2018,, ,3/8/2018,2691-002,Small,3/8/2018,2/25/2019,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.",, ,"Eugene Chang, Jeannette Messer",Provisional,4/12/2018,2691-002,3/8/2019,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",610972,,584046,No
3823,17-T-043,COMPOSITIONS AND METHODS FOR REDUCING VIRULENCE OF MICROORGANISMS,"62/520,827", ,*United States,US,6/17/2017,, ,6/16/2017,2691-001,Small,6/17/2017,,Yes,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David", ,"Eugene Chang, Jeannette Messer",Provisional,4/12/2018,2691-001,6/17/2018,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",611003,,584046,No
3824,17-T-043,Compositions and Method for Reducing Virulence of Microorganisms,"62/814,599", ,*United States,US,3/6/2019,, ,3/6/2019,2691-003,Small,3/6/2019,3/22/2019,No,4/28/2022,Expired Prov - Filed in US,"Casimir Jones, S.C.",,CCF IDF 2018-267,"Eugene Chang, Jeannette Messer",Provisional,3/22/2019, ,3/6/2020,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",3578274,,584046,No
3825,17-T-043,Compositions and Method for Reducing Virulence of Microorganisms,"62/821,854", ,*United States,US,3/21/2019,, ,3/21/2019,2691-004,Small,3/21/2019,5/28/2019,No,4/28/2022,Expired Prov - Filed in US,"Casimir Jones, S.C.",,CCF-37593/US-2/PRO,"Eugene Chang, Jeannette Messer",Provisional,5/28/2019, ,3/21/2020,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",3742657,,584046,No
3826,17-T-043,Compositions and Method for Reducing Virulence of Microorganisms,"16/807,792", ,*United States,US,3/3/2020,, ,3/3/2020,2691-005,Small,3/6/2019,4/15/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.",,CCF-37593.203,"Eugene Chang, Jeannette Messer",US Utility,4/15/2020, ,3/3/2040,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",4470320,,584046,No
3827,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,"62/569,215", ,*United States,US,10/6/2017,, ,10/6/2017,2696-001,Small,10/6/2017,10/22/2018,Yes,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.",, ,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Provisional,4/12/2018,2696-001,10/6/2018,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",614438,,584047,No
3828,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,PCT/US18/54664, ,*United States,US,10/5/2018,,WO 2019/071164,10/5/2018,2696-002,Small,10/6/2017,10/22/2018,No,4/28/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.",,UCHI-35360/WO-1/ORD,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",PCT,10/22/2018, ,4/6/2020,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",1820133,4/11/2019,584047,No
3829,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,"16/753,684",,*United States,US,10/5/2018,,US-2020-0341001-A1,4/3/2020,2696-003,Small,10/6/2017,3/4/2020,No,6/9/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35360.252,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Nationalized PCT,3/4/2020,,10/5/2038,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",4396570,10/29/2020,584047,No
3830,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,3077085, ,Canada,CA,10/5/2018,, ,9/2/2020,2696-005,Small,10/6/2017,3/4/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35360.711,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Nationalized PCT,3/4/2020, ,10/5/2038,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",4396596,,584047,No
3831,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,201880076364.4, ,China,CN,10/5/2018,,CN 111787930 A,5/26/2020,2696-006,Small,10/6/2017,3/4/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35360.731,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Nationalized PCT,3/4/2020, ,10/5/2038,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",4396622,10/16/2020,584047,No
3832,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,2018346765, ,Australia,AU,10/5/2018,, ,3/24/2020,2696-004,Small,10/6/2017,3/4/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35360.721,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Nationalized PCT,3/4/2020, ,10/5/2038,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",4396648,,584047,No
3833,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,18864648.3, ,European Patent Office (EPO),EP,10/5/2018,,3691662,3/27/2020,2696-007,Small,10/6/2017,3/4/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35360.611,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Nationalized PCT,3/4/2020, ,10/5/2038,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",4396674,8/12/2020,584047,No
3834,17-T-044,Screening of T Lympocytes for Cancer-Specific Antigens,2020-540688, ,Japan,JP,10/5/2018,, ,10/5/2018,2696-008,Small,10/6/2017,3/4/2020,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35360.701,"Tetsuro Hikichi, Yusuke Nakamura, Jae-Hyun Park, Sachiko Yoshimura",Nationalized PCT,3/4/2020, ,10/5/2038,"Sun, Han",Yusuke Nakamura,"Tennant, Thelma",4396700,,584047,No
3835,17-T-048,COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING PATHOGENIC FUNGAL INFECTION AND FOR MAINTENANCE OF MICROBIOME COMMENSALISM,"62/506,902", ,*United States,US,5/16/2017,, ,5/16/2017,2698-001,Small,5/16/2017,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Eugene Chang, Katharine Harris, Joseph Pierre",Provisional,4/12/2018,2698-001,5/16/2018,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",611014,,584051,No
3836,17-T-048,COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING PATHOGENIC FUNGAL INFECTION AND FOR MAINTENANCE OF MICROBIOME COMMENSALISM,"62/581,358", ,*United States,US,11/3/2017,, ,11/3/2017,2698-002,Small,11/3/2017,,No,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-35185/US-2/PRO,"Eugene Chang, Katharine Harris, Joseph Pierre",Provisional,4/12/2018,2698-002,5/16/2018,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",611015,,584051,No
3837,17-T-048,Compositions and Methods for Treating And/Or Preventing Pathogenic Fungal Infection and for Maintenance of Microbiome Commensalism,PCT/US18/32997, ,*United States,US,5/16/2018,, ,5/16/2018,2698-003,Small,5/16/2017,11/18/2019,No,4/28/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.","Staple, David",UCHI-35185.601,"Eugene Chang, Katharine Harris, Joseph Pierre",PCT,6/8/2018, ,11/16/2019,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",1432023,,584051,No
3838,17-T-048,Compositions and Methods for Treating And/Or Preventing Pathogenic Fungal Infection and for Maintenance of Microbiome Commensalism,18801716.4, ,European Patent Office (EPO),EP,5/16/2018,,3625247,11/12/2019,2698-004,Small,5/16/2017,11/18/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35185.611,"Eugene Chang, Katharine Harris, Joseph Pierre",Nationalized PCT,11/18/2019, ,5/16/2038,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",4118991,3/25/2020,584051,No
3839,17-T-048,Compositions and Methods for Treating And/Or Preventing Pathogenic Fungal Infection and for Maintenance of Microbiome Commensalism,"16/611,128", ,*United States,US,5/16/2018,,2020-0062823,11/5/2019,2698-005,Small,5/16/2017,11/25/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35185.253,"Eugene Chang, Katharine Harris, Joseph Pierre",Nationalized PCT,11/25/2019, ,5/16/2038,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",4125944,2/27/2020,584051,No
3840,17-T-048,Compositions and Methods for Treating And/Or Preventing Pathogenic Fungal Infection and for Maintenance of Microbiome Commensalism,201880039735.1, ,China,CN,5/16/2018,,110741015,12/16/2019,2698-006,Small,5/16/2017,12/27/2019,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35185.731,"Eugene Chang, Katharine Harris, Joseph Pierre",Nationalized PCT,12/27/2019, ,5/16/2038,"Dembo, Anna",Eugene Chang,"Onishi, Kenneth",4198200,1/31/2020,584051,No
3841,17-T-049,"Highly Diastereoselective Construction of the 4,5-Spirocycle via Palladium-Catalyzed Intramolecular Alkenylation","62/506,882", ,*United States,US,5/17/2017,, ,5/16/2017,2699-001,Small,5/17/2017,5/18/2018,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Chinn, Richard", ,"Guangbin Dong, Jiaxin Xie",Provisional,4/12/2018,2699-001,5/17/2018,"Hwang, Luke",Guangbin Dong,"Muite, Kevin",611822,,584052,No
3842,17-T-049,"Highly Diastereoselective Construction of the 4,5-Spirocycle via Palladium-Catalyzed Intramolecular Alkenylation",PCT/US18/032964, ,*United States,US,5/16/2018,,WO 2018/213442,5/16/2018,2699-002,None,5/17/2017,5/18/2018,No,4/28/2022,Expired PCT - Nationalized,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,"Guangbin Dong, Jiaxin Xie",PCT,5/21/2018, ,11/16/2019,"Hwang, Luke",Guangbin Dong,"Muite, Kevin",1382918,11/22/2018,584052,No
3843,17-T-049,"Highly Diastereoselective Construction of the 4,5-Spirocycle via Palladium-Catalyzed Intramolecular Alkenylation","16/614,155", ,*United States,US,5/16/2018,,US-2020-0079749-A1,11/15/2019,2699-003,Small,5/17/2017,11/26/2019,No,6/22/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/13 PCT/US,"Guangbin Dong, Jiaxin Xie",Nationalized PCT,11/26/2019, ,5/16/2038,"Hwang, Luke",Guangbin Dong,"Muite, Kevin",4132636,3/12/2020,584052,No
3844,17-T-049,"Highly Diastereoselective Construction of the 4,5-Spirocycle via Palladium-Catalyzed Intramolecular Alkenylation",201880032142.2, ,China,CN,5/16/2018,,110650735,11/14/2019,2699-004,Small,5/17/2017,12/17/2019,No,4/28/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/13 PCT/CN,"Guangbin Dong, Jiaxin Xie",Nationalized PCT,12/17/2019, ,5/16/2038,"Hwang, Luke",Guangbin Dong,"Muite, Kevin",4192963,1/3/2020,584052,No
3845,17-T-051,"MICROBIOME BIOMARKERS FOR ANTI-PD-1/PD-L1 RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF","62/515,366", ,*United States,US,6/5/2017,, ,6/5/2017,2717-001,Small,6/5/2017,,Yes,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Riyue Bao, Jessica Fessler, Thomas Gajewski, Jason Luke, Vyara Matson",Provisional,4/12/2018,2717-001,6/6/2018,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613386,,584054,No
3846,17-T-051,"MICROBIOME BIOMARKERS IMMUNOTHERAPY RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF","62/577,454", ,*United States,US,10/26/2017,, ,10/26/2017,2717-002,Small,10/26/2017,,No,4/28/2022,Expired - Inactive,"Casimir Jones, S.C.","Staple, David", ,"Riyue Bao, Jessica Fessler, Thomas Gajewski, Jason Luke, Vyara Matson",Provisional,4/12/2018,2717-002,10/26/2018,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",613387,,584054,No
3847,17-T-051,"MICROBIOME BIOMARKERS FOR ANTI-PD-1/PD-L1 RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF",PCT/US18/36052, ,*United States,US,6/5/2018,,WO 2018/226690,6/5/2018,2717-003,Small,6/5/2017,9/16/2019,No,4/28/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.","Staple, David",UCHI-35305/WO-1/ORD,"Riyue Bao, Jessica Fessler, Thomas Gajewski, Jason Luke, Vyara Matson",PCT,7/11/2018, ,12/15/2019,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",1588317,12/13/2018,584054,No
3848,17-T-051,"Microbiome Biomarkers Immunotherapy Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof","16/618,700", ,*United States,US,6/5/2018,,2021/0177918,12/2/2019,2717-005,Small,6/5/2017,12/31/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35305.253,"Riyue Bao, Jessica Fessler, Thomas Gajewski, Jason Luke, Vyara Matson",Nationalized PCT,12/31/2019, ,6/5/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4199374,6/17/2021,584054,No
3849,17-T-051,"MICROBIOME BIOMARKERS FOR ANTI-PD-1/PD-L1 RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF",18812758.3EPO, ,European Patent Office (EPO),EP,6/5/2018,,3634443,12/12/2019,2717-004,Small,6/5/2017,12/31/2019,No,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35305.611,"Riyue Bao, Jessica Fessler, Thomas Gajewski, Jason Luke, Vyara Matson",Nationalized PCT,12/31/2019, ,6/5/2038,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",4199410,4/15/2020,584054,No
3850,17-T-052,CANCER IMMUNOTHERAPY,"15/612,657", ,*United States,US,6/2/2017,, ,6/2/2017,2703-002,Small,6/2/2017,12/31/2019,Yes,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-34906/US-2/ORD,"Riyue Bao, Thomas Gajewski, Jason Luke",US Utility,4/12/2018,2596-002,6/3/2018,"Sun, Han",Jason Luke,"Tennant, Thelma",610776,,584055,No
3851,17-T-053,Automatically Detecting Distributed Concurrency Bugs in Cloud Systems,"62/374,449", ,*United States,US,8/12/2016,, ,8/12/2016,2704-001,Small,8/12/2016,,Yes,4/28/2022,Expired - Inactive,"Schwegman, Lundberg & Woessner",, ,"Haryadi Gunawi, Guangpu Li, Haopeng Liu, Shan Lu, Chen Tian, Xiaofeng Yang, Feng Ye",Provisional,4/12/2018,2704-001,8/12/2017,"Ramirez, Mario Riojas",Shan Lu,"Smith, Dane",610669,,584056,No
3852,17-T-053,Automatically Detecting Distributed Concurrency Errors in Cloud Systems,"15/668,469", ,*United States,US,8/3/2017,, ,8/3/2017,2704-002,Small,8/12/2016,,No,4/28/2022,Pending,"Schwegman, Lundberg & Woessner",, ,"Haryadi Gunawi, Guangpu Li, Haopeng Liu, Shan Lu, Chen Tian, Xiaofeng Yang, Feng Ye",US Utility,4/12/2018,2704-002,8/3/2037,"Ramirez, Mario Riojas",Shan Lu,"Smith, Dane",610670,,584056,No
3853,17-T-055,Nucleic Acids Comprising a 2O-Methyl Modification Motif and Uses Thereof,"62/502,199", ,*United States,US,5/5/2017,, ,5/5/2017,2705-001,Small,5/5/2017,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Qing Dai, Dan Dominissini, Chuan He",Provisional,4/12/2018,2705-001,5/6/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",613742,,584058,No
3854,17-T-057,SEPARATION OF ISOTOPES IN SPACE AND TIME BY GAS-SURFACE ATOMIC DIFFRACTION,"62/508,836", ,*United States,US,5/20/2017,, ,5/19/2017,2707-001,Small,5/20/2017,5/17/2018,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Porembski, N. Meredith",05400-0021,"Jacob Graham, Kevin Nihill, Steven Sibener",Provisional,4/12/2018,2707-001,5/20/2018,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",614483,,584060,No
3855,17-T-057,Separation of Isotopes in Space and Time by Gas-Surface Atomic Diffraction,PCT/US18/33145, ,*United States,US,5/17/2018,,WO2018213549,5/17/2018,2707-002,Small,5/20/2017,5/17/2018,No,4/28/2022,Expired PCT - Filed in US only,"Bell & Manning, LLC","Porembski, N. Meredith",05400-0021-02,"Jacob Graham, Kevin Nihill, Steven Sibener",PCT,5/18/2018, ,11/17/2019,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",1380552,11/22/2018,584060,No
3856,17-T-057,Separation of Isotopes in Space and Time by Gas-Surface Atomic Diffraction,"16/612,872", ,*United States,US,5/17/2018,,US-2020-0139302-A1,11/12/2019,2707-003,Small,5/20/2017,11/12/2019,No,6/23/2022,Pending,"Bell & Manning, LLC","Porembski, N. Meredith",05400-0021-US,"Jacob Graham, Kevin Nihill, Steven Sibener",Nationalized PCT,11/12/2019, ,5/17/2038,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",4111212,5/7/2020,584060,No
3857,17-T-058,ISOTOPE ENRICHMENT VIA DIFFERENTIAL CONDENSATION AND REFLECTION OF ISOTOPES DURING SUPERSONIC BEAM GAS-SURFACE SCATTERING,"62/529,660", ,*United States,US,7/7/2017,, ,7/7/2017,2708-001,Small,7/7/2017,7/2/2018,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0022,"Jacob Graham, Kevin Nihill, Steven Sibener",Provisional,4/12/2018,2708-001,7/7/2017,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",612064,,584061,No
3858,17-T-058,Isotope Enrichment via Differential Condensation and Reflection of Isotopes During Supersonic Beam Gas-surface Scattering,PCT/US18/40609, ,*United States,US,7/2/2018,,WO 2019/032223,7/2/2018,2708-002,Small,7/7/2017,,No,5/1/2022,Abandoned,"Bell & Manning, LLC","Manning, Michelle",05400-0022-02,"Jacob Graham, Kevin Nihill, Steven Sibener",PCT,7/3/2018, ,1/2/2020,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",1562934,2/19/2019,584061,No
3859,17-T-064,USE OF ACTIVIN FOR DETECTING POSTPARTUM CARDIAC DYSFUNCTION,"62/525,472", ,*United States,US,6/27/2017,, ,6/27/2017,2713-001,Small,6/27/2017,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,,1000202494,Sajid Shahul,Provisional,4/12/2018,2713-001,6/28/2018,"Bakalyar, Heather",Sajid Shahul,"Butler, Brittany",615153,,584067,No
3860,17-T-064,Use of Activin for Detecting Postpartum Cardiac Dysfunction,"62/634,270", ,*United States,US,2/23/2018,, ,2/23/2018,2713-002,Small,2/23/2018,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,Sajid Shahul,Provisional,4/12/2018,2713-002,6/27/2018,"Bakalyar, Heather",Sajid Shahul,"Butler, Brittany",615154,,584067,No
3861,17-T-064,USE OF ACTIVIN FOR DETECTING POSTPARTUM CARDIAC DYSFUNCTION,PCT/US18/39747, ,*United States,US,6/27/2018,,WO 2019/005963 A1,6/27/2018,2713-003,None,6/27/2017,7/11/2018,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0639WO,Sajid Shahul,PCT,7/11/2018, ,12/27/2019,"Bakalyar, Heather",Sajid Shahul,"Butler, Brittany",1588526,1/3/2019,584067,No
3862,17-T-073,"Method of Performing an End-to-End Surgical Anastomosis using a Biodegradable Guide, Mucoadhesive Polymer, and Biologic Adhesive","62/525,685", ,*United States,US,6/27/2017,, ,6/27/2017,2720-001,Small,6/27/2017,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Schermerhorn, Ryan",52202,"John Alverdy, Herbert Mason Hedberg",Provisional,4/12/2018,2720-001,6/27/2018,"Cox, Ben",Herbert Mason Hedberg,"Tennant, Thelma",612531,,584076,No
3863,17-T-074,"COMBINED OXYGEN UTILIZATION, STRAIN, AND ANATOMIC IMAGING WITH MAGNETIC RESONANCE IMAGING","62/576,446", ,*United States,US,10/24/2017,, ,10/24/2017,2721-001,Small,10/24/2017,10/23/2018,Yes,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Kalafut, Christopher",148385.00021,"Charles Cantrell, Timothy Carroll, Keigo Kawaji, Amit Patel",Provisional,4/12/2018,2721-001,10/24/2018,"Cox, Ben",Keigo Kawaji,"Smith, Dane",610950,,584077,No
3864,17-T-074,"COMBINED OXYGEN UTILIZATION, STRAIN, AND ANATOMIC IMAGING WITH MAGNETIC RESONANCE IMAGING",PCT/US18/57004, ,*United States,US,10/23/2018,,WO 21019/083934,10/23/2018,2721-002,Small,10/24/2017,10/23/2018,No,4/28/2022,Expired PCT - Filed in US only,"Bell & Manning, LLC","Kalafut, Christopher", ,"Charles Cantrell, Timothy Carroll, Keigo Kawaji, Amit Patel",PCT,11/2/2018, ,4/24/2020,"Cox, Ben",Keigo Kawaji,"Smith, Dane",1867920,5/2/2019,584077,No
3865,17-T-074,"COMBINED OXYGEN UTILIZATION, STRAIN, AND ANATOMIC IMAGING WITH MAGNETIC RESONANCE IMAGING","16/649,919",,*United States,US,10/23/2018,,US-2020-0305757-A1,3/23/2020,2721-003,Small,10/24/2017,3/30/2020,No,5/18/2022,Pending,"Bell & Manning, LLC","Kalafut, Christopher",05400-0030-US,"Charles Cantrell, Timothy Carroll, Keigo Kawaji, Amit Patel",Nationalized PCT,3/30/2020,,10/23/2038,"Cox, Ben",Keigo Kawaji,"Smith, Dane",4432655,10/1/2020,584077,No
3866,17-T-080,FREEZE-DRIED FORMULATIONS INCLUDING NANOPARTICLES AND METHODS OF FREEZE-DRYING,"62/532,502", ,*United States,US,7/14/2017,, ,7/14/2017,2726-001,Small,7/14/2017,7/17/2018,Yes,6/21/2022,Expired Prov - Filed PCT,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise", ,"Johnny Alfaro-Perez, Juan de Pablo, Nader Taheri Qazvini",Provisional,4/12/2018,2726-001,7/14/2018,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",611618,,584083,No
3867,17-T-080,Freeze-dried Formulations Including Nanoparticles and Methods of Freeze-drying,PCT/US18/42063, ,*United States,US,7/13/2018,,WO 2019/014576,7/13/2018,2726-002,Small,7/15/2017,,No,6/21/2022,Expired PCT - Nationalized,Weaver Austin Villeneuve & Sampson LLP,,UCHIP006WO,"Johnny Alfaro-Perez, Juan de Pablo, Nader Taheri Qazvini",PCT,7/17/2018, ,1/13/2020,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",1596802,1/17/2019,584083,No
3868,17-T-080,Freeze-Dried Formulations Including Nanoparticles and Methods of Freeze-Drying,"16/630,816",,*United States,US,7/13/2018,, ,1/13/2020,2726-003,Small,7/15/2017,1/15/2020,No,6/21/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP006US/2726-002,"Johnny Alfaro-Perez, Juan de Pablo, Nader Taheri Qazvini",Nationalized PCT,1/15/2020,,7/13/2038,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",4233851,,584083,No
3869,17-T-080,Freeze-dried Formulations Including Nanoparticles and Methods of Freeze-drying,18831200.3, ,European Patent Office (EPO),EP,7/13/2018,,3651743,1/30/2020,2726-004,Small,7/15/2017,2/4/2020,No,6/21/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP006EP,"Johnny Alfaro-Perez, Juan de Pablo, Nader Taheri Qazvini",Nationalized PCT,2/4/2020,2726-004,7/13/2038,"Hwang, Luke",Juan de Pablo,"Tennant, Thelma",4256059,5/20/2020,584083,No
3870,17-T-083,METHODS AND COMPOSITIONS COMPRISING LAMININ PEPTIDES,"62/585,101", ,*United States,US,11/13/2017,, ,11/13/2017,2729-001,Small,11/13/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1001001933,"Priscilla Briquez, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara",Provisional,4/12/2018,2729-001,11/13/2018,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",612644,,584086,No
3871,17-T-083,Methods and Compositions for the Treatment of Wounds,"62/758,845", ,*United States,US,11/12/2018,, ,11/12/2018,2729-003,Small,11/12/2018,11/12/2018,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0663US.P1,"Priscilla Briquez, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Anna Randi, Richard Starke",Provisional,11/18/2018, ,11/12/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1900473,,584086,No
3872,17-T-083,METHODS AND COMPOSITIONS COMPRISING LAMININ PEPTIDES,PCT/US18/60760, ,*United States,US,11/13/2018,,WO 2019/094938 A2,11/13/2018,2729-002,Small,11/13/2017,11/13/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0644WO,"Priscilla Briquez, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Anna Randi, Richard Starke",PCT,11/18/2018, ,5/13/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1900574,5/16/2019,584086,No
3873,17-T-083,Methods and Compositions for the Treatment of Wounds,"15/733,085",,*United States,US,11/13/2018,, US-2021-0040179-A1,5/13/2020,2729-004,Small,11/13/2017,5/13/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0644US,"Priscilla Briquez, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Anna Randi, Richard Starke",Nationalized PCT,5/13/2020,,11/13/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4548286,2/11/2021,584086,No
3874,17-T-083,METHODS AND COMPOSITIONS COMPRISING LAMININ PEPTIDES,18815081.7,,European Patent Office (EPO),EP,11/13/2018,,3710466,5/14/2020,2729-005,Small,11/13/2017,5/14/2020,No,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0644EP,"Priscilla Briquez, Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Anna Randi, Richard Starke",Nationalized PCT,5/14/2020,,11/13/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4556457,9/23/2020,584086,No
3875,17-T-084,A Theseometer for Measuring Proprioception Performance,"62/597,230", ,*United States,US,12/11/2017,, ,12/11/2017,2730-001,Small,12/11/2017,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,52299,"Austin Hilvert, Peggy Mason, Yuri Sugano",Provisional,4/12/2018,2730-001,12/11/2018,"Cox, Ben",Peggy Mason,"Smith, Dane",610237,,584087,No
3876,17-T-084,A Theseometer for Measuring Proprioception Performance,"62/777,535", ,*United States,US,12/10/2018,, ,12/10/2018,2730-002,Small,12/10/2018,1/3/2019,No,4/28/2022,Expired Prov - Filed in US,"Marshall, Gerstein & Borun","Merkel, William",27373-52299P2,"Austin Hilvert, Peggy Mason, Yuri Sugano",Provisional,1/3/2019, ,12/10/2019,"Cox, Ben",Peggy Mason,"Smith, Dane",3385365,,584087,No
3877,17-T-084,A Theseometer for Measuring Proprioception Performance,"16/707,861", ,*United States,US,12/9/2019,,US-2020-0178874-A1,12/9/2019,2730-003,Small,12/10/2018,12/11/2019,No,6/9/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",27373-52299B,"Austin Hilvert, Peggy Mason, Ashley Riley, Yuri Sugano",US Utility,12/11/2019, ,12/9/2039,"Cox, Ben",Peggy Mason,"Smith, Dane",4183394,6/12/2020,584087,No
3878,17-T-089,TECHNOLOGIES FOR LONG-LIVED 3D MULTIMODE MICROWAVE CAVITIES,"62/642,514", ,*United States,US,3/13/2018,, ,3/13/2018,2734-001,Small,3/13/2018,,Yes,5/6/2022,Expired Prov - Filed in US,Barnes & Thornburg,"Kelsey, Jeffrey", ,"Srivatsan Chakram, Ravi Naik, David Schuster",Provisional,4/12/2018,2734-001,3/13/2019,"Cox, Ben",David Schuster,"Juggernauth, Anne",614869,,584092,No
3879,17-T-089,TECHNOLOGIES FOR LONG-LIVED 3D MULTIMODE MICROWAVE CAVITIES,"16/352,191","10,964,997",*United States,US,3/13/2019,3/30/2021,US-2019-0288367-A1,3/13/2019,2734-002,Small,3/13/2018,3/14/2019,No,5/6/2022,Issued,Barnes & Thornburg,"Kelsey, Jeffrey",21459-292597,"Srivatsan Chakram, Ravi Naik, David Schuster",US Utility,3/14/2019, ,6/28/2039,"Cox, Ben",David Schuster,"Juggernauth, Anne",3567188,9/19/2019,584092,No
3880,17-T-089,TECHNOLOGIES FOR LONG-LIVED 3D MULTIMODE MICROWAVE CAVITIES,"17/184,842", ,*United States,US,3/13/2019,,US-2021-0184329-A1,2/25/2021,2734-003,Small,3/13/2018,6/16/2022,No,6/16/2022,Abandoned,Barnes & Thornburg,"Kelsey, Jeffrey",21459-335052,"Srivatsan Chakram, Ravi Naik, David Schuster",Continuation,2/28/2021, ,3/13/2039,"Cox, Ben",David Schuster,"Juggernauth, Anne",5424813,6/17/2021,584092,No
3881,17-T-089,TECHNOLOGIES FOR LONG-LIVED 3D MULTIMODE MICROWAVE CAVITIES,,,*United States,US,3/13/2019,,,,2734-004,None,3/13/2018,6/16/2022,No,6/16/2022,,Barnes & Thornburg,"Kelsey, Jeffrey",,"Srivatsan Chakram, Ravi Naik, David Schuster",Continuation,6/16/2022,,,"Cox, Ben",David Schuster,"Juggernauth, Anne",7460258,,584092,
3882,17-T-094,METHODS OF DIAGNOSING AND TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE,"62/544,533", ,*United States,US,8/11/2017,, ,8/11/2017,2739-001,Small,8/11/2017,,Yes,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",002606.00004,Arlene Chapman,Provisional,4/12/2018,2739-001,8/11/2018,"Unassigned, Unassigned",Arlene Chapman,"Unassigned, Unassigned",613318,,584097,No
3883,17-T-099,TREATMENT OF LIVER FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES,"62/598,894", ,*United States,US,12/14/2017,, ,12/14/2017,2744-001,Small,12/14/2017,12/16/2018,Yes,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",002606.00006,"Lev Becker, Xiaoyang Wu, Jiping Yue",Provisional,4/12/2018,2744-001,12/14/2018,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",615044,,584102,No
3884,17-T-099,Treatment of Fibrosis with Genetically-Engineered Macrophages,PCT/US18/65773, ,*United States,US,12/14/2018,,WO 2019/118888 A1,12/14/2018,2744-002,Small,12/14/2017,12/16/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0669WO,"Lev Becker, Jianfeng Du, Xuewen Gou, Xiaoyang Wu, Jiping Yue, Yingming Zhao",PCT,12/16/2018, ,6/14/2020,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3324395,6/20/2019,584102,No
3885,17-T-099,Treatment of Fibrosis with Genetically-Engineered Macrophages,"15/733,201", ,*United States,US,12/14/2018,,US-2021-0100837-A1,6/9/2020,2744-003,Small,12/14/2017,6/9/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0669US,"Lev Becker, Jianfeng Du, Xuewen Gou, Xiaoyang Wu, Jiping Yue, Yingming Zhao",Nationalized PCT,6/10/2020, ,,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",4620419,4/8/2021,584102,No
3886,17-T-099,Treatment of Fibrosis with Genetically-Engineered Macrophages,18888657.6,,European Patent Office (EPO),EP,12/14/2018,,3724219,6/29/2020,2744-004,Small,12/14/2017,7/1/2020,No,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0669EP,"Lev Becker, Jianfeng Du, Xuewen Gou, Xiaoyang Wu, Jiping Yue, Yingming Zhao",Nationalized PCT,7/1/2020,,12/14/2038,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",4683471,10/21/2020,584102,No
3887,17-T-099,Treatment of Fibrosis with Genetically-Engineered Macrophages,201880089541.2, ,China,CN,12/14/2018,,112236445,8/14/2020,2744-005,Small,12/14/2017,8/10/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0669CN,"Lev Becker, Jianfeng Du, Xuewen Gou, Xiaoyang Wu, Jiping Yue, Yingming Zhao",Nationalized PCT,8/10/2020, ,12/14/2038,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",4816391,1/15/2021,584102,No
3888,17-T-099,Treatment of Fibrosis with Genetically-Engineered Macrophages,62021035094.3,,Hong Kong,HK,12/14/2018,,40045585,7/15/2021,2744-006,None,12/14/2017,7/19/2021,No,4/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0669CHK,"Lev Becker, Jianfeng Du, Xuewen Gou, Xiaoyang Wu, Jiping Yue, Yingming Zhao",Nationalized PCT,7/19/2021,,12/14/2038,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",5913698,10/22/2021,584102,No
3889,17-T-102,Robust Security Volatility Estimation Using Intraday Transaction Data,"62/562,709", ,*United States,US,9/25/2017,, ,9/25/2017,2745-001,Small,9/25/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,,1000200578,"Rui Da, Dacheng Xiu",Provisional,4/12/2018,2745-001,9/25/2018,"Ramirez, Mario Riojas",Dacheng Xiu,"Smith, Dane",614404,,584105,No
3890,17-T-102,Robust Security Volatility Estimation Using Intraday Transaction Data,PCT/US18/52617, ,*United States,US,9/25/2018,,WO 2019/060884 A1,9/25/2018,2745-002,Small,9/25/2017,10/22/2018,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0643WO,"Rui Da, Dacheng Xiu",PCT,10/22/2018, ,3/25/2020,"Ramirez, Mario Riojas",Dacheng Xiu,"Smith, Dane",1820089,3/28/2019,584105,No
3891,17-T-102,Robust Security Volatility Estimation Using Intraday Transaction Data,"16/650,730",,*United States,US,9/25/2018,, US-2020-0273103-A1,3/25/2020,2745-003,Small,9/25/2017,3/1/2020,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0643US,"Rui Da, Dacheng Xiu",Nationalized PCT,3/1/2020,,9/25/2038,"Ramirez, Mario Riojas",Dacheng Xiu,"Smith, Dane",4388603,8/27/2020,584105,No
3892,17-T-105,SYSTEMS AND METHODS FOR OPTICAL RESONANCE IMAGING,"62/582,598", ,*United States,US,11/7/2017,, ,11/7/2017,2748-001,Small,11/7/2017,,Yes,4/28/2022,Expired Prov - Filed in US,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt", ,"Marco Allodi, Gregory Engel",Provisional,4/12/2018,2748-001,11/7/2018,"Hwang, Luke",Gregory Engel,"Smith, Dane",614840,,584108,No
3893,17-T-105,SYSTEMS AND METHODS FOR OPTICAL RESONANCE IMAGING,"16/181,738","11,156,553",*United States,US,11/6/2018,10/26/2021,US-2019-0137393-A1,11/6/2018,2748-002,Small,11/7/2017,10/7/2021,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0036,"Marco Allodi, Gregory Engel",US Utility,11/18/2018,2748-002,11/6/2038,"Hwang, Luke",Gregory Engel,"Smith, Dane",1901017,5/9/2019,584108,No
3894,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION,"62/563,362", ,*United States,US,9/26/2017,, ,9/26/2017,2750-001,Small,9/26/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Provisional,4/12/2018,2750-001,9/26/2018,"Cox, Ben",Gregory Karczmar,"Smith, Dane",613672,,584110,No
3895,17-T-107,Non-invasive Estimation of Prostate Tissue Composition,"62/691,268", ,*United States,US,6/28/2018,, ,6/28/2018,2750-002,Small,6/28/2018,7/5/2018,No,4/28/2022,Expired Prov - Filed PCT,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Provisional,7/5/2018, ,6/28/2019,"Cox, Ben",Gregory Karczmar,"Smith, Dane",1578169,,584110,No
3896,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION,PCT/EP18/75117, ,European Patent Office (EPO),EP,9/18/2018,, ,9/18/2018,2750-003,Large,9/26/2017,3/3/2021,No,4/28/2022,Expired PCT - Nationalized,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,, ,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",PCT,9/22/2018, ,3/18/2020,"Cox, Ben",Gregory Karczmar,"Smith, Dane",1700499,,584110,No
3897,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA,"16/650,470",,*United States,US,9/18/2018,,,3/25/2020,2750-004,Large,9/26/2017,6/2/2022,No,6/2/2022,Prosecution by Other Party,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,,2017P02463WOUS,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Nationalized PCT,7/7/2020,,,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4692849,,584110,No
3898,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA,201880069320.9,,China,CN,9/18/2018,,,4/24/2020,2750-005,Large,9/26/2017,6/2/2022,No,6/2/2022,Prosecution by Other Party,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,,2017P02463WOCN,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Nationalized PCT,7/7/2020,,9/18/2038,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4692891,,584110,No
3899,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA,2020-517128,,Japan,JP,9/18/2018,,,4/14/2020,2750-007,Large,9/26/2017,6/2/2022,No,6/2/2022,Prosecution by Other Party,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,,2017P02463WOJP,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Nationalized PCT,7/7/2020,,9/18/2038,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4692934,,584110,No
3900,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA,202047017089,,India,IN,9/18/2018,,,4/24/2020,2750-006,Large,9/26/2017,6/2/2022,No,6/2/2022,Prosecution by Other Party,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,,,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Nationalized PCT,7/7/2020,,9/18/2038,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4692968,,584110,No
3901,17-T-107,NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA,18779575.2,,European Patent Office (EPO),EP,9/18/2018,,,4/24/2020,2750-010,Large,9/26/2017,6/2/2022,No,6/2/2022,Prosecution by Other Party,PHILIPS INTELLECTUAL PROPERTY & STANDARDS,,2017P02463WOEP,"Aritrick Chatterjee, Ajit Devaraj, Gregory Karczmar, Aytekin Oto",Nationalized PCT,7/7/2020,,9/18/2038,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4693033,,584110,No
3902,17-T-108,Methods and Compositions for Bacteria Infections,"62/563,835", ,*United States,US,9/27/2017,, ,9/27/2017,2751-001,Small,9/27/2017,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",1000338891,"Robert Daum, Richard Lee",Provisional,4/12/2018,2751-001,9/27/2018,"Peace, Shane",Robert Daum,"Onishi, Kenneth",612659,,584111,No
3903,17-T-115,METHODS AND COMPOSITIONS FOR STEM CELL EXPANSION,"62/570,076", ,*United States,US,10/9/2017,, ,10/9/2017,2756-001,Small,10/9/2017,,Yes,6/8/2022,Expired Prov - Filed PCT,Bryan Cave,, ,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Provisional,4/12/2018,2756-001,10/9/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",612857,,584118,No
3904,17-T-115,METHODS AND COMPOSITIONS FOR STEM CELL EXPANSION,"62/695,820", ,*United States,US,7/9/2018,, ,7/9/2018,2756-002,Small,7/9/2018,9/4/2018,No,6/8/2022,Expired Prov - Filed PCT,Bryan Cave,, ,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Provisional,9/4/2018, ,10/9/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",1690503,,584118,No
3905,17-T-115,Methods and Compositions for Stem Cell Expansion,PCT/US18/55092, ,*United States,US,10/9/2018,,WO 2019/074980,10/9/2018,2756-003,Small,10/9/2017,11/12/2018,No,6/8/2022,Expired PCT - Nationalized,Bryan Cave,, ,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",PCT,11/12/2018, ,4/9/2020,"Hwang, Luke",Chuan He,"Tennant, Thelma",1883774,4/18/2019,584118,No
3906,17-T-115,METHODS AND COMPOSITIONS FOR STEM CELL EXPANSION,2020-520317,,Japan,JP,10/9/2018,,,4/9/2020,2756-004,Small,10/9/2017,4/11/2022,No,6/8/2022,Prosecution by Other Party,Bryan Cave,"Fitzpatrick, Ethan",1065334.000158,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Nationalized PCT,4/16/2020,,10/9/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",4473020,,584118,No
3907,17-T-115,Methods and Compositions for Expansion of Cell Population,18866285.2,,European Patent Office (EPO),EP,10/9/2018,,,5/11/2020,2756-005,Small,10/9/2017,4/11/2022,No,6/10/2022,Prosecution by Other Party,Bryan Cave,"Fitzpatrick, Ethan",1065334.000159,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Nationalized PCT,5/18/2020,,10/9/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",4560580,,584118,No
3908,17-T-115,Methods and Compositions for Expansion of Cell Population,10-2020-7013360, ,"Korea, Republic of",KR,10/9/2018,, ,5/8/2020,2756-006,Small,10/9/2017,4/11/2022,No,6/8/2022,Prosecution by Other Party,Bryan Cave,"Fitzpatrick, Ethan",1065334.000160,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Nationalized PCT,5/28/2020, ,10/9/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",4597608,,584118,No
3909,17-T-115,Methods and Compositions for Expansion of Cell Population,"16/754,714", ,*United States,US,10/9/2018,, ,4/8/2020,2756-007,Small,10/9/2017,4/11/2022,No,6/8/2022,Prosecution by Other Party,Bryan Cave,"Fitzpatrick, Ethan",1065334.000151,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Nationalized PCT,6/8/2020, ,10/9/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",4618012,,584118,No
3910,17-T-115,Methods and Compositions for Stem Cell Expansion,201880079157.4,,China,CN,10/9/2018,,CN111511376A,6/8/2020,2756-008,Small,10/9/2017,4/11/2022,No,6/10/2022,Prosecution by Other Party,Bryan Cave,"Fitzpatrick, Ethan",1065334.000157,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Nationalized PCT,6/17/2020,,10/9/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",4640885,8/13/2020,584118,No
3911,17-T-115,Methods and Compositions for Expansion of Cell Population,62020021778.9, ,Hong Kong,HK,10/9/2018,,40031696,12/9/2020,2756-009,Small,10/9/2017,4/11/2022,No,6/8/2022,Prosecution by Other Party,Bryan Cave,"Fitzpatrick, Ethan",1065334.000157,"Chuan He, Linheng Li, Zhenrui Li, Pengxu Qian",Nationalized PCT,3/26/2021, ,10/9/2038,"Hwang, Luke",Chuan He,"Tennant, Thelma",5515427,3/12/2021,584118,No
3912,17-T-116,Chemical Platform Assisted Proximity Capture (CAP-C),"62/668,543", ,*United States,US,5/8/2018,, ,5/8/2018,2757-001,Small,5/8/2018,,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0654US.P1,Chuan He,Provisional,5/29/2018, ,5/8/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",1425389,,584119,No
3913,17-T-116,Chemical Platform Assisted Proximity Capture (CAP-C),"62/668,994", ,*United States,US,5/9/2018,, ,5/9/2018,2757-002,Small,5/9/2018,,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,, ,Chuan He,Provisional,5/29/2018, ,5/8/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",1425417,,584119,No
3914,17-T-116,Chemical Platform Assisted Proximity Capture (CAP-C),PCT/US19/31309, ,*United States,US,5/8/2019,,WO 2019/217549 A1,5/8/2019,2757-003,Small,5/8/2018,,No,6/8/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0654WO,"Chuan He, Qiancheng You",PCT,5/24/2019, ,11/8/2020,"Hwang, Luke",Chuan He,"Tennant, Thelma",3739765,11/14/2019,584119,No
3915,17-T-116,Chemical Platform Assisted Proximity Capture (CAP-C),"17/250,024", ,*United States,US,5/8/2019,,US-2021-0317506-A1,11/6/2020,2757-004,Small,5/8/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0654US,"Chuan He, Qiancheng You",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984172,10/14/2021,584119,No
3916,17-T-116,Chemical Platform Assisted Proximity Capture (CAP-C),201980040272.5, ,China,CN,5/8/2019,,112384524,12/15/2020,2757-005,Small,5/8/2018,10/15/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0654CN,"Chuan He, Qiancheng You",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984190,2/19/2021,584119,No
3917,17-T-116,Chemical Platform Assisted Proximity Capture (CAP-C),19799707.5, ,European Patent Office (EPO),EP,5/8/2019,,3790887,12/8/2020,2757-006,Small,5/8/2018,12/14/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0654EP,"Chuan He, Qiancheng You",Nationalized PCT,12/14/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5194011,3/17/2021,584119,No
3918,17-T-118,COMPOSITIONS AND METHODS RELATED TO DEGRADATION OF CD95 AND THE TREATMENT OF CANCER,"62/610,711", ,*United States,US,12/27/2017,, ,12/27/2017,2759-001,Small,12/27/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1001005124,"Lev Becker, Chang Cui",Provisional,4/12/2018,2759-001,12/27/2018,"Sun, Han",Lev Becker,"Tennant, Thelma",611089,,584121,No
3919,17-T-119,METHODS AND COMPOSITIONS COMPRISING STAPHYLOCOCCUS PROTEIN A (SpA) Variants,"62/593,100", ,*United States,US,11/30/2017,, ,11/30/2017,2760-001,Small,11/30/2017,12/4/2018,Yes,5/2/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0645US.P1,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Provisional,4/12/2018,2760-001,11/30/2018,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",612645,,584122,No
3920,17-T-119,METHODS AND COMPOSITIONS COMPRISING STAPHYLOCOCCUS PROTEIN A (SpA) Variants,"62/774,440", ,*United States,US,12/3/2018,, ,12/3/2018,2760-002,Small,12/3/2018,12/4/2018,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676US.P1,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Provisional,12/4/2018, ,12/3/2019,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",1934192,,584122,No
3921,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,"62/847,832", ,*United States,US,5/14/2019,, ,5/14/2019,2760-003,Small,5/14/2019,5/20/2019,,5/2/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676US.P2,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Provisional,5/20/2019, ,5/14/2020,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",3725699,,584122,No
3922,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,PCT/US20/70048, ,*United States,US,5/13/2020,,WO 2020/232471 A2,5/13/2020,2760-004,Small,5/14/2019,5/13/2020,No,5/23/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676US,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",PCT,5/13/2020, ,11/14/2021,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",4548200,11/19/2020,584122,No
3923,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,"17/595,252",,*United States,US,5/13/2020,,,11/12/2021,2760-005,Small,5/14/2019,11/12/2021,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676US,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/12/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6390406,,584122,No
3924,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,521430821,,Saudi Arabia,SA,5/13/2020,,,11/11/2021,2760-029,Large,5/14/2019,11/20/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676SA,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393421,1/1/2020,584122,No
3925,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,QA/202111/00650,,Qatar,QA,5/13/2020,,,11/14/2021,2760-028,Large,5/14/2019,11/20/2021,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676QA,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393490,,584122,No
3926,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,"3,139,981",,Canada,CA,5/13/2020,,,12/1/2021,2760-009,Large,5/14/2019,11/18/2021,No,3/30/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676CA,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393537,,584122,No
3927,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,20805312.4,,European Patent Office (EPO),EP,5/13/2020,,3969031,11/15/2021,2760-015,None,5/14/2019,11/18/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676EP,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393596,3/23/2023,584122,No
3928,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,2021-567950,,Japan,JP,5/13/2020,,,11/12/2021,2760-019,Large,5/14/2019,11/18/2021,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676JP,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393655,,584122,No
3929,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,2020273471,,Australia,AU,5/13/2020,,,11/23/2021,2760-006,None,5/14/2019,12/1/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676AU,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393719,,584122,No
3930,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,202117057091,,India,IN,5/13/2020,,,12/8/2021,2760-016,None,5/14/2019,1/8/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676IN,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393778,,584122,No
3931,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,BR1120210229027,,Brazil,BR,5/13/2020,,,11/12/2021,2760-008,Large,5/14/2019,11/20/2021,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676BR,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393837,,584122,No
3932,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,2021/09009,,South Africa,ZA,5/13/2020,,,11/12/2021,2760-031,Large,5/14/2019,11/20/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676ZA,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393896,,584122,No
3933,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,202080051512.4,,China,CN,5/13/2020,,CN 114340652,1/14/2022,2760-011,None,5/14/2019,1/26/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676CN,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6393955,4/12/2022,584122,No
3934,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,288060,,Israel,IL,5/13/2020,,,11/11/2021,2760-018,Large,5/14/2019,11/18/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676IL,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394014,,584122,No
3935,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,10-2021-7040912,,"Korea, Republic of",KR,5/13/2020,,,12/14/2021,2760-020,None,5/14/2019,1/9/2022,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676KR,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394073,,584122,No
3936,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,782605,,New Zealand,NZ,5/13/2020,,,11/23/2021,2760-024,Large,5/14/2019,12/1/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676NZ,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394132,,584122,No
3937,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,202102992,,Chile,CL,5/13/2020,,,11/12/2021,2760-010,Large,5/14/2019,11/18/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676CL,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394191,,584122,No
3938,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,MX/a/2021/013833,,Mexico,MX,5/13/2020,,,11/11/2021,2760-023,Large,5/14/2019,11/18/2021,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676MX,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394250,,584122,No
3939,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,11202112479U,,Singapore,SG,5/13/2020,,,11/10/2021,2760-030,Large,5/14/2019,11/18/2021,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676SG,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394304,,584122,No
3940,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,1-2021-07616,,Vietnam,VN,5/13/2020,,,11/26/2021,2760-035,None,5/14/2019,1/8/2022,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676VN,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394363,,584122,No
3941,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,NC2021/0015337,,Colombia,CO,5/13/2020,,953,11/12/2021,2760-012,Large,5/14/2019,12/1/2021,No,3/30/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676CO,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394422,2/17/2022,584122,No
3942,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,1811/2021,,Egypt,EG,5/13/2020,,,11/14/2021,2760-013,Large,5/14/2019,11/18/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676EG,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394481,,584122,No
3943,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,1-2021-552875,,Philippines,PH,5/13/2020,,,11/12/2021,2760-027,None,5/14/2019,1/12/2022,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676PH,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394540,,584122,No
3944,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,P00202109977,,Indonesia,ID,5/13/2020,,,11/12/2021,2760-017,Large,5/14/2019,11/18/2021,No,5/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676ID,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394599,,584122,No
3945,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,a202107159,,Ukraine,UA,5/13/2020,,,12/14/2021,2760-033,None,5/14/2019,1/9/2022,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676UA,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394658,,584122,No
3946,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,NG/PT/PCT/2021/5783,,Nigeria,NG,5/13/2020,,,11/12/2021,2760-025,Large,5/14/2019,12/1/2021,No,3/30/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676NG,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394717,,584122,No
3947,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,20210283,,Bahrain,BH,5/13/2020,,,11/14/2021,2760-007,Small,5/14/2019,11/18/2021,No,3/30/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676BH,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394776,,584122,No
3948,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,202193110,,Eurasian Patent Organization(EAPO),EA,5/13/2020,,EA 202193110 A1,12/13/2021,2760-014,None,5/14/2019,1/20/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676EA,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394835,4/25/2022,584122,No
3949,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,KW/P/2021/000461,,Kuwait,KW,5/13/2020,,,11/14/2021,2760-021,Large,5/14/2019,11/18/2021,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676KW,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394894,,584122,No
3950,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,PI2021006708,,Malaysia,MY,5/13/2020,,,11/10/2021,2760-022,None,5/14/2019,11/18/2021,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676MY,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6394953,,584122,No
3951,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,OM/P/2021/00460,,Oman,OM,5/13/2020,,,11/11/2021,2760-026,Large,5/14/2019,11/18/2021,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676OM,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6395012,,584122,No
3952,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,2101007036,,Thailand,TH,5/13/2020,,,11/11/2021,2760-032,Large,5/14/2019,11/18/2021,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676TH,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6395071,,584122,No
3953,17-T-119,Methods and Compositions Comprising Staphylococcus Protein A (SpA) Variants,P6002052/2021,,United Arab Emirates,AE,5/13/2020,,,11/11/2021,2760-034,Large,5/14/2019,11/18/2021,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0676AE,"Xinhai Chen, Hwan Kim, Dominique Missiakas, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,11/15/2021,,5/13/2040,"Peace, Shane",Olaf Schneewind,"Ginsburg, Eric",6395130,,584122,No
3954,17-T-120,Remodilins for Airway Remodeling and Organ Fibrosis,"62/827,980", ,*United States,US,4/2/2019,, ,4/2/2019,2761-001,Small,4/2/2019,7/20/2020,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0660US.P1,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Chan Young Park, Julian Solway",Provisional,4/12/2019,2761-001,4/2/2020,"Hwang, Luke",Julian Solway,"Muite, Kevin",3611991,,584123,No
3955,17-T-120,Remodilins for Airway Remodeling and Organ Fibrosis,PCT/US20/26371, ,*United States,US,4/2/2020,,WO 2020/206109 A1,4/2/2020,2761-002,Small,4/2/2019,10/4/2021,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0660WO,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Chan Young Park, Julian Solway",PCT,3/25/2020,2761-002,10/2/2021,"Hwang, Luke",Julian Solway,"Muite, Kevin",4424181,10/8/2020,584123,No
3956,17-T-120,Remodilins for Airway Remodeling and Organ Fibrosis,"17/594,086",,*United States,US,4/2/2020,,,10/1/2021,2761-003,Small,4/2/2019,10/4/2021,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0660US,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Chan Young Park, Julian Solway",Nationalized PCT,10/4/2021,,4/2/2040,"Hwang, Luke",Julian Solway,"Muite, Kevin",6245877,,584123,No
3957,17-T-120,Remodilins for Airway Remodeling and Organ Fibrosis,20783111.6,,European Patent Office (EPO),EP,4/2/2020,,3946301,11/22/2021,2761-004,Small,4/2/2019,11/4/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0660EP,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Chan Young Park, Julian Solway",Nationalized PCT,11/4/2021,,4/20/2040,"Hwang, Luke",Julian Solway,"Muite, Kevin",6351859,2/9/2022,584123,No
3958,17-T-121,Air Quality-Life Index,"87/685,690", ,*United States,US,11/15/2017,, ,11/15/2017,2762-001,Small,11/15/2017,,Yes,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,,092234-9180-002,Michael Greenstone,Trademark,4/12/2018,2762-001,,"Ginsburg, Eric",Michael Greenstone,"Smith, Dane",610294,,584124,No
3959,17-T-122,METHODS AND COMPOSITIONS RELATED TO NEUROBLASTOMA,"62/573,663", ,*United States,US,10/17/2017,, ,10/17/2017,2763-001,Small,10/17/2017,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",1000345842,"Susan Cohn, Lucy Godley",Provisional,4/12/2018,2763-001,10/17/2018,"Dembo, Anna",Lucy Godley,"Muite, Kevin",613063,,584125,No
3960,17-T-126,Multiplex 5mc Marker Barcode Counting for Methylation Detection in Cell-free DNA,"62/609,922", ,*United States,US,12/22/2017,, ,12/22/2017,2766-001,Small,12/22/2017,,Yes,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1001012138,"Chuan He, Ji Nie",Provisional,4/12/2018,2766-001,12/22/2018,"Hwang, Luke",Chuan He,"Tennant, Thelma",613569,,584129,No
3961,17-T-126,Multiplex 5mc Marker Barcode Counting for Methylation Detection in Cell-free DNA,PCT/US18/66485, ,*United States,US,12/19/2018,,WO 2019-126313 A1,12/19/2018,2766-002,Small,12/22/2017,12/28/2018,No,6/8/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0651WO,"Chuan He, Ji Nie",PCT,12/28/2018,2766-002,6/22/2020,"Hwang, Luke",Chuan He,"Tennant, Thelma",3376149,6/27/2019,584129,No
3962,17-T-126,Multiplex 5mc Marker Barcode Counting for Methylation Detection in Cell-Free DNA,"15/733,262", ,*United States,US,12/19/2018,, ,6/18/2020,2766-003,Small,12/22/2017,6/22/2020,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0651US,"Chuan He, Ji Nie",US Utility,6/22/2020, ,,"Hwang, Luke",Chuan He,"Tennant, Thelma",4650673,,584129,No
3963,17-T-128,AQLI,"87/685,678","5,528,663",*United States,US,11/15/2017,7/31/2018, ,11/15/2017,2768-001,Small,11/15/2017,8/23/2018,Yes,4/28/2022,Issued,Michael Best & Friedrich LLP,,092234-9179-002,Michael Greenstone,Trademark,4/12/2018,2768-001,11/15/2037,"Ginsburg, Eric",Michael Greenstone,"Smith, Dane",610561,,584131,No
3964,17-T-132,Chemical Probe-Dependent Evaluation of Protein Activity and Uses Thereof,"62/589,946", ,*United States,US,11/22/2017,, ,11/22/2017,2776-001,Small,11/22/2017,,Yes,5/26/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1001004454,"Gang Li, Raymond Moellering",Provisional,4/12/2018,2776-001,11/22/2018,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",610861,,584135,No
3965,17-T-132,Chemical Probe-Dependent Evaluation of Protein Activity and Uses Thereof,PCT/US18/62231, ,*United States,US,11/21/2018,,WO 2019/104155 A2,11/21/2018,2776-002,Small,11/22/2017,11/28/2018,No,5/26/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0646WO,"Gang Li, Raymond Moellering",PCT,11/28/2018, ,5/22/2020,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",1921560,5/30/2019,584135,No
3966,17-T-132,Chemical Probe-Dependent Evaluation of Protein Activity and Uses Thereof,"15/733,113",,*United States,US,11/21/2018,,US-2020-0355673-A1,5/19/2020,2776-003,Small,11/22/2017,3/26/2020,No,5/26/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0646US,"Gang Li, Raymond Moellering",Nationalized PCT,3/26/2020,,11/21/2038,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4425553,11/12/2020,584135,No
3967,17-T-132,Chemical Probe-Dependent Evaluation of Protein Activity and Uses Thereof,18880198.9,,European Patent Office (EPO),EP,11/21/2018,, 3714053,5/21/2020,2776-004,Small,11/22/2017,5/21/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0646EP,"Gang Li, Raymond Moellering",Nationalized PCT,3/26/2020,,11/21/2038,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4425571,9/30/2020,584135,No
3968,17-T-133,METHOD AND APPARATUS TO REDUCE ARTIFACTS IN A COMPUTED-TOMOGRAPHY (CT) IMAGE BY ITERATIVE RECONSTRUCTION (IR) USING A COST FUNCTION WITH A DE-EMPHASIS OPERATOR,"62/581,465", ,*United States,US,11/3/2017,, ,11/3/2017,2773-001,Small,11/3/2017,5/22/2020,,4/28/2022,Expired Prov - Filed in US,,, ,"Yu-Bing Chang, Joseph Manak, Xiaochuan Pan, Dan Xia, Jingwu Yao, Zheng Zhang",Provisional,11/13/2018,2773-001,11/3/2018,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",1884071,,584136,No
3969,17-T-133,METHOD AND APPARATUS TO REDUCE ARTIFACTS IN A COMPUTED-TOMOGRAPHY (CT) IMAGE BY ITERATIVE RECONSTRUCTION (IR) USING A COST FUNCTION WITH A DE-EMPHASIS OPERATOR,"16/179,751","10,789,738",*United States,US,11/2/2018,9/29/2020, ,11/2/2018,2773-002,Small,11/3/2017,11/15/2018,No,5/8/2022,Issued,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Yu-Bing Chang, Joseph Manak, Xiaochuan Pan, Dan Xia, Jingwu Yao, Zheng Zhang",US Utility,11/15/2018,2773-002,3/29/2039,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",1894616,,584136,No
3970,17-T-134,STREAM CIPHERS FOR DIGITAL STORAGE ENCRYPTION,"62/625,148", ,*United States,US,2/1/2018,, ,2/1/2018,2774-001,Small,2/1/2018,,Yes,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,, ,"Bernard III Dickens, Ariel Feldman, Haryadi Gunawi, Henry (Hank) Hoffmann",Provisional,4/12/2018,2774-001,2/1/2019,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",614668,,584137,No
3971,17-T-134,STREAM CIPHERS FOR DIGITAL STORAGE ENCRYPTION,"16/264,991","11,139,959",*United States,US,2/1/2019,10/5/2021,US-2019-0238312-A1,2/1/2019,2774-002,Small,2/1/2018,9/16/2021,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Borella, Mike",17-1807-US,"Bernard III Dickens, Ariel Feldman, Haryadi Gunawi, Henry (Hank) Hoffmann",US Utility,2/7/2019, ,4/3/2040,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",3497874,8/1/2019,584137,No
3972,17-T-137,IMAGE TRANSFORMATION WITH A HYBRID AUTOENCODER AND GENERATIVE ADVERSARIAL NETWORK MACHINE LEARNING ARCHITECTURE,"62/593,354", ,*United States,US,12/1/2017,, ,12/1/2017,2777-001,Small,12/1/2017,,Yes,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",002606.00007,Jason Salavon,Provisional,4/12/2018,2777-001,12/1/2018,"Ramirez, Mario Riojas",Jason Salavon,"Smith, Dane",611915,,584140,No
3973,17-T-137,IMAGE TRANSFORMATION WITH A HYBRID AUTOENCODER AND GENERATIVE ADVERSARIAL NETWORK MACHINE LEARNING ARCHITECTURE,"62/633,851", ,*United States,US,2/22/2018,, ,2/22/2018,2777-002,Small,2/22/2018,,No,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John", ,Jason Salavon,Provisional,4/12/2018,2777-002,12/1/2018,"Ramirez, Mario Riojas",Jason Salavon,"Smith, Dane",611916,,584140,No
3974,17-T-137,IMAGE TRANSFORMATION WITH A HYBRID AUTOENCODER AND GENERATIVE ADVERSARIAL NETWORK MACHINE LEARNING ARCHITECTURE,"16/206,538","10,803,347",*United States,US,11/30/2018,10/13/2020,US-2019-0171908-A1,11/30/2018,2777-003,Small,12/1/2017,11/30/2018,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",17-1706-US,Jason Salavon,US Utility,11/30/2018, ,3/13/2039,"Ramirez, Mario Riojas",Jason Salavon,"Smith, Dane",1929211,6/6/2019,584140,No
3975,17-T-138,Electrometry by Optical Charge Conversion of Defects in the Solid-State,"62/630,503", ,*United States,US,2/14/2018,, ,2/14/2018,2778-001,Small,2/14/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Marshall, Ryan",7814-408,"David Awschalom, Samuel Whiteley, Gary Wolfowicz",Provisional,4/12/2018,2778-001,2/14/2019,"Cox, Ben",David Awschalom,"Juggernauth, Anne",611519,,584141,No
3976,17-T-138,Electrometry by Optical Charge Conversion of Defects in the Solid-State,PCT/US19/17817, ,*United States,US,2/13/2019,, ,2/13/2019,2778-002,Small,2/14/2018,3/4/2019,No,4/28/2022,Expired PCT - Filed in US only,Brinks Gilson & Lione,"Marshall, Ryan",7814-410,"David Awschalom, Samuel Whiteley, Gary Wolfowicz",PCT,3/4/2019, ,8/14/2020,"Cox, Ben",David Awschalom,"Juggernauth, Anne",3551192,,584141,No
3977,17-T-138,Electrometry by Optical Charge Conversion of Defects in the Solid-State,"16/968,471", ,*United States,US,2/13/2019,, ,8/7/2020,2778-003,Small,2/14/2018,8/19/2020,No,5/31/2022,Pending,Brinks Gilson & Lione,"Marshall, Ryan",507814.5000421,"David Awschalom, Samuel Whiteley, Gary Wolfowicz",Nationalized PCT,8/19/2020, ,2/13/2039,"Cox, Ben",David Awschalom,"Juggernauth, Anne",4840063,,584141,No
3978,17-T-140,"A System, Method, and Apparatus for Creating, Monitoring, Analyzing, and Classifying Behavior and Dynamically Adjusting a Hierarchical, Combined Learned Control System for Optimization and/or Supervision Under At Least One Operational Constraint and/","62/609,244", ,*United States,US,12/21/2017,, ,12/21/2017,2780-001,Small,12/21/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,,002606.00011,"Henry (Hank) Hoffmann, Lester Teichner, Benjamin Vear",Provisional,4/12/2018,2780-001,12/21/2018,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",610236,,584143,No
3979,17-T-140,Combined Learned and Dynamic Control System,PCT/US18/66854, ,*United States,US,12/20/2018,, ,12/20/2018,2780-002,Small,12/21/2017,1/18/2019,No,4/28/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John", ,"Henry (Hank) Hoffmann, Lester Teichner, Benjamin Vear",PCT,1/18/2019, ,6/21/2020,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",3422617,,584143,No
3980,17-T-140,Combined Learned and Dynamic Control System,18892269.4,,European Patent Office (EPO),EP,12/20/2018,,,7/21/2020,2780-003,Small,12/21/2017,6/3/2020,No,6/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",17-1814-WO-EP,"Henry (Hank) Hoffmann, Lester Teichner, Benjamin Vear",Nationalized PCT,6/3/2020,,12/20/2038,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",4610326,,584143,No
3981,17-T-140,Combined Learned and Dynamic Control System,2020-534567,,Japan,JP,12/20/2018,,,6/19/2020,2780-004,Small,12/21/2017,6/3/2020,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",17-1814-WO-JP,"Henry (Hank) Hoffmann, Lester Teichner, Benjamin Vear",Nationalized PCT,6/3/2020,,12/20/2038,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",4610348,,584143,No
3982,17-T-140,Combined Learned and Dynamic Control System,"16/771,410", ,*United States,US,12/20/2018,,US-2020-0348628-A1,6/10/2020,2780-005,Small,12/21/2017,6/19/2020,No,6/17/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",17-1814-WO-US,"Henry (Hank) Hoffmann, Lester Teichner, Benjamin Vear",Nationalized PCT,6/19/2020, ,12/20/2038,"Ramirez, Mario Riojas",Henry (Hank) Hoffmann,"Smith, Dane",4647416,11/5/2020,584143,No
3983,17-T-141,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS","62/608,839", ,*United States,US,12/21/2017,, ,12/21/2017,2781-001,Small,12/21/2017,4/18/2018,Yes,4/28/2022,Expired - Inactive,"Bell & Manning, LLC","Manning, Michelle",05400-0019-02,"Dmitri Talapin, Yuanyuan Wang, Hao Zhang",Provisional,4/12/2018,2781-001,12/21/2018,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",613968,,584144,No
3984,18-T-002,Janus Membranes by Atomic Layer Deposition,"15/977,831", ,*United States,US,5/11/2018,, ,5/11/2018,2793-001,Small,5/11/2018,,Yes,4/28/2022,Pending,Foley & Lardner,, ,"Seth Darling, Ruben Waldman, Hao-Cheng Yang",US Utility,5/23/2018, ,5/11/2038,"Ramirez, Mario Riojas",Ruben Waldman,"Tennant, Thelma",1416636,,584147,No
3985,18-T-003,Filtration Membranes,"15/680,064",,*United States,US,8/17/2017,,,8/17/2017,2794-001,Small,8/17/2017,6/2/2022,Yes,6/2/2022,Prosecution by Other Party,,,051583-0776,"Seth Darling, Jeffrey Elam, Ruben Waldman",US Utility,5/28/2020,,,"Ramirez, Mario Riojas",Seth Darling,"Tennant, Thelma",4597688,,584148,No
3986,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,"62/638,520", ,*United States,US,3/5/2018,, ,3/5/2018,2786-001,Small,3/5/2018,,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Provisional,4/12/2018,2786-001,3/5/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",612918,,584149,No
3987,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,"62/727,156", ,*United States,US,9/5/2018,, ,9/5/2018,2786-002,Small,9/5/2018,3/6/2019,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Provisional,9/5/2018, ,3/5/2018,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1692321,,584149,No
3988,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,PCT/US19/20685, ,*United States,US,3/5/2019,,WO 2019/173289,3/5/2019,2786-003,Small,3/5/2018,3/6/2019,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652WO,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",PCT,3/6/2019, ,9/5/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3554093,9/12/2019,584149,No
3989,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,"15/733,582", ,*United States,US,3/5/2019,, ,9/3/2020,2786-004,Small,3/5/2018,9/6/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652US,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Nationalized PCT,9/6/2020, ,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4874877,,584149,No
3990,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,201980030391.2, ,China,CN,3/5/2019,,CN 112292391 A,12/21/2020,2786-007,Small,3/5/2018,9/6/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652CN,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Nationalized PCT,9/6/2020, ,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4874952,1/29/2021,584149,No
3991,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,19764476.8,,European Patent Office (EPO),EP,3/5/2019,,3930687,9/21/2020,2786-008,Small,3/5/2018,9/6/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652EP,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Nationalized PCT,9/6/2020,,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4874994,1/5/2022,584149,No
3992,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,2019232729, ,Australia,AU,3/5/2019,, ,9/11/2020,2786-005,Small,3/5/2018,9/6/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652AU,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Nationalized PCT,9/6/2020, ,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4875040,,584149,No
3993,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,1120200181960, ,Brazil,BR,3/5/2019,, ,10/30/2020,2786-006,Small,3/5/2018,9/6/2020,No,5/23/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652BR,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Nationalized PCT,9/6/2020, ,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4875082,,584149,No
3994,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,2020-546407, ,Japan,JP,3/5/2019,,2021-514991 A,10/13/2020,2786-009,Small,3/5/2018,9/6/2020,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652JP,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Nationalized PCT,9/6/2020, ,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4875124,6/17/2021,584149,No
3995,18-T-004,METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES,62021034909.3, ,Hong Kong,HK,3/5/2019,,40045229 A,7/13/2021,2786-014,None,3/5/2018,7/15/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0652EHK,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Aslan Mansurov, Koichi Sasaki, Melody Swartz",Validated EPO,7/15/2021, ,3/5/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5905404,10/15/2021,584149,No
3996,18-T-005,Methods and Compositions for Targeting Liver Sinusoidal Endothelian Cells C-Type Lectin (LSECtin),"62/647,911", ,*United States,US,3/26/2018,, ,3/26/2018,2787-001,Small,3/26/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0653US.P1,"Jeffrey Hubbell, Tomasz (Tomek) Slezak, Elyse Watkins",Provisional,4/12/2018,2787-001,3/26/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",610184,,584150,No
3997,18-T-005,Methods and Compositions for Targeting Liver Sinusoidal Endothelian Cells C-Type Lectin (LSECtin),PCT/US19/24052, ,*United States,US,3/26/2019,, ,3/26/2019,2787-002,Small,3/26/2018,3/26/2019,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0653WO,"Jeffrey Hubbell, Tomasz (Tomek) Slezak, Elyse Watkins",PCT,3/26/2019, ,9/26/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3589395,,584150,No
3998,18-T-005,Methods and Compositions for Targeting Liver Sinusoidal Endothelian Cells C-Type Lectin (LSECtin),"15/733,657", ,*United States,US,3/26/2019,,US-2021-0171642-A1,9/25/2020,2787-003,Small,3/26/2018,9/25/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0653US,"Jeffrey Hubbell, Tomasz (Tomek) Slezak, Elyse Watkins",Nationalized PCT,9/25/2020, ,3/26/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4915870,6/10/2021,584150,No
3999,18-T-005,Methods and Compositions for Targeting Liver Sinusoidal Endothelian Cells C-Type Lectin (LSECtin),2020-551882, ,Japan,JP,3/26/2019,,2021-519305 A,9/25/2020,2787-004,Small,3/26/2018,9/25/2020,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0653JP,"Jeffrey Hubbell, Tomasz (Tomek) Slezak, Elyse Watkins",Nationalized PCT,9/25/2020, ,3/26/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4915896,8/10/2021,584150,No
4000,18-T-005,Methods and Compositions for Targeting Liver Sinusoidal Endothelian Cells C-Type Lectin (LSECtin),19774313.1,,European Patent Office (EPO),EP,3/26/2019,,3774890,10/8/2020,2787-005,Small,3/26/2018,10/14/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0653EP,"Jeffrey Hubbell, Tomasz (Tomek) Slezak, Elyse Watkins",Nationalized PCT,10/14/2020,,3/26/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4981675,2/17/2021,584150,No
4001,18-T-005,Methods and Compositions for Targeting Liver Sinusoidal Endothelian Cells C-Type Lectin (LSECtin),62021036954.7,,Hong Kong,HK,3/26/2019,,40047160 A,8/13/2021,2787-006,Small,3/26/2018,8/19/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0653EHK,"Jeffrey Hubbell, Tomasz (Tomek) Slezak, Elyse Watkins",Nationalized PCT,8/19/2021,,3/26/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6060287,11/12/2021,584150,No
4002,18-T-006,Methods and Composition for Neutralization of Influenza,"62/637,508", ,*United States,US,3/2/2018,, ,3/2/2018,2788-001,Small,3/2/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.",,UCHI-35579/US-1/PRO,"Yaoqing Chen, Patrick Wilson",Provisional,4/12/2018,2788-001,3/2/2019,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",612639,,584151,No
4003,18-T-006,Methods and Composition for Neutralization of Influenza,PCT/US19/20223, ,*United States,US,3/1/2019,,WO 2019/169231,3/1/2019,2788-002,Small,3/2/2018,3/22/2019,No,4/28/2022,Expired Prov - Filed in US,"Casimir Jones, S.C.",,35579.601,"Yaoqing Chen, Haley Dugan, Patrick Wilson",PCT,3/22/2019, ,9/2/2020,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",3578462,9/6/2019,584151,No
4004,18-T-006,Methods and Composition for Neutralization of Influenza,"16/977,327",,*United States,US,3/1/2019,,US-2021-0002354-A1,9/1/2020,2788-004,Small,3/2/2018,9/9/2020,No,6/22/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-35579.252,"Yaoqing Chen, Haley Dugan, Patrick Wilson",Nationalized PCT,9/9/2020,,3/1/2039,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",4879705,1/7/2021,584151,No
4005,18-T-006,Methods and Composition for Neutralization of Influenza,19760165.1, ,European Patent Office (EPO),EP,3/1/2019,,3758749,9/22/2020,2788-005,Small,3/2/2018,10/14/2020,No,6/8/2022,Pending,"Casimir Jones, S.C.",,UCHI-35579.611,"Yaoqing Chen, Haley Dugan, Patrick Wilson",Nationalized PCT,10/14/2020, ,3/1/2039,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",4980549,1/6/2021,584151,No
4006,18-T-008,PHOTOELECTROCHEMICAL MODULATION OF NEURONAL ACTIVITY WITH FREE-STANDING COAXIAL SILICON NANOWIRES,"62/635,852", ,*United States,US,2/27/2018,, ,2/27/2018,2790-001,Small,2/27/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Porembski, N. Meredith",19-100-PRO,"Francisco Bezanilla, Joao Carvalho-de-Souza, Ramya Parameswaran, Bozhi Tian",Provisional,4/12/2018,2790-001,2/27/2019,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",613969,,584153,No
4007,18-T-008,Methods and Systems for Modulating Cellular Activation,PCT/US19/18620, ,*United States,US,2/19/2019,,WO 2019/168714,2/19/2019,2790-002,Small,2/19/2018,3/11/2019,No,4/28/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-102-WO,"Erin Adams, Francisco Bezanilla, Michael Burke, Joao Carvalho-de-Souza, Yuanwen Jiang, Kelliann Koehler, Ramya Parameswaran, Bozhi Tian",PCT,3/11/2019, ,8/19/2020,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",3561529,9/6/2019,584153,No
4008,18-T-008,Methods and Systems for Modulating Cellular Activation,"16/975,034", ,*United States,US,2/19/2019,,US-2020-0390803,8/21/2020,2790-003,Small,2/19/2018,8/25/2020,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-102-WO-US,"Erin Adams, Francisco Bezanilla, Michael Burke, Joao Carvalho-de-Souza, Yuanwen Jiang, Kelliann Koehler, Ramya Parameswaran, Bozhi Tian",Nationalized PCT,8/25/2020, ,2/19/2039,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",4851568,12/17/2020,584153,No
4009,18-T-008,Methods and Systems for Modulating Cellular Activation,19759936.8, ,European Patent Office (EPO),EP,2/19/2019,,3758766,8/27/2020,2790-004,Small,2/19/2018,8/27/2020,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-102-WO-EP,"Erin Adams, Francisco Bezanilla, Michael Burke, Joao Carvalho-de-Souza, Yuanwen Jiang, Kelliann Koehler, Ramya Parameswaran, Bozhi Tian",Nationalized PCT,8/27/2020, ,2/19/2039,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",4856635,1/6/2021,584153,No
4010,18-T-014,Autologous and Allogenic Macrophages and Monocytes for Use in Therapeutic Methods,"62/625,245", ,*United States,US,2/1/2018,, ,2/1/2018,2799-001,Small,2/1/2018,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Lev Becker, Howard Shuman, Court Turner",Provisional,4/12/2018,2799-001,2/1/2019,"Sun, Han",Lev Becker,"Tennant, Thelma",610580,,584159,No
4011,18-T-014,Autologous and Allogenic Macrophages and Monocytes for Use in Therapeutic Methods,"62/625,253", ,*United States,US,2/1/2018,, ,2/1/2018,2799-002,Small,2/1/2018,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Lev Becker, Howard Shuman, Court Turner",Provisional,4/12/2018,2799-002,2/1/2019,"Sun, Han",Lev Becker,"Tennant, Thelma",610581,,584159,No
4012,18-T-016,Methods and kits for diagnosis and triage of patients with colorectal liver metastases,"62/659,936", ,*United States,US,4/19/2018,, ,4/19/2018,2801-001,Small,4/19/2018,4/19/2018,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0657US.P1,"Nikolai Khodarev, Sean Pitroda, Ralph Weichselbaum",Provisional,4/25/2018, ,4/19/2019,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",1357598,,584161,No
4013,18-T-016,Methods and kits for diagnosis and triage of patients with colorectal liver metastases,PCT/US19/28071, ,*United States,US,4/18/2019,,WO 2019/204576 A1,4/18/2019,2801-002,Small,4/19/2018,4/19/2019,No,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0657WO,"Nikolai Khodarev, Sean Pitroda, Ralph Weichselbaum",PCT,4/19/2019, ,10/19/2020,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",3637085,10/24/2019,584161,No
4014,18-T-016,Methods and Kits for Diagnosis and Triage of Patients with Colorectal Liver Metastases,"17/048,791", ,*United States,US,4/18/2019,,US-2021-0115519-A1,10/19/2020,2801-003,Small,4/19/2018,10/19/2020,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0657US,"Nikolai Khodarev, Sean Pitroda, Ralph Weichselbaum",Nationalized PCT,10/16/2020, ,4/18/2039,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",4988677,4/22/2021,584161,No
4015,18-T-018,No_Patent_Title Suspense,Bell Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-001,Small,2/14/2018,,Yes,4/28/2022,Pending,"Bell & Manning, LLC",, ,Cole Johnson,Not Provided,4/12/2018,0000-001,,"Neu, Nick",Cole Johnson,"Neu, Nick",610171,,584163,No
4016,18-T-018,No_Patent_Title Suspense,Brinks Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-002,Small,2/14/2018,,Yes,4/28/2022,Pending,Brinks Gilson & Lione,, ,Cole Johnson,Not Provided,4/12/2018,0000-002,,"Neu, Nick",Cole Johnson,"Neu, Nick",610172,,584163,No
4017,18-T-018,No_Patent_Title Suspense,Brown Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-003,Small,2/14/2018,,Yes,4/28/2022,Pending,Brown Rudnick,,031097.0001,Cole Johnson,Not Provided,4/12/2018,0000-003,,"Neu, Nick",Cole Johnson,"Neu, Nick",610173,,584163,No
4018,18-T-018,No_Patent_Title Suspense,Casimir Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-004,Small,2/14/2018,,Yes,4/28/2022,Pending,"Casimir Jones, S.C.",, ,Cole Johnson,Not Provided,4/12/2018,0000-004,,"Neu, Nick",Cole Johnson,"Neu, Nick",610174,,584163,No
4019,18-T-018,No_Patent_Title Suspense,Fulbright Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-005,Small,2/14/2018,,Yes,4/28/2022,Pending,Norton Rose Fulbright US LLP,, ,Cole Johnson,Not Provided,4/12/2018,0000-005,,"Neu, Nick",Cole Johnson,"Neu, Nick",610175,,584163,No
4020,18-T-018,No_Patent_Title Suspense,Jenkins Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-006,Small,2/14/2018,,Yes,4/28/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,, ,Cole Johnson,Not Provided,4/12/2018,0000-006,,"Neu, Nick",Cole Johnson,"Neu, Nick",610176,,584163,No
4021,18-T-018,No_Patent_Title Suspense,Marshall Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-007,Small,2/14/2018,,Yes,4/28/2022,Pending,"Marshall, Gerstein & Borun",, ,Cole Johnson,Not Provided,4/12/2018,0000-007,,"Neu, Nick",Cole Johnson,"Neu, Nick",610177,,584163,No
4022,18-T-018,No_Patent_Title Suspense,McDonnell Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-008,Small,2/14/2018,,Yes,5/31/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,, ,Cole Johnson,Not Provided,4/12/2018,0000-008,,"Neu, Nick",Cole Johnson,"Neu, Nick",610178,,584163,No
4023,18-T-018,No_Patent_Title Suspense,Michael Best Suspens, ,*United States,US,2/14/2018,, ,2/14/2018,0000-009,Small,2/14/2018,,No,4/28/2022,Pending,Michael Best & Friedrich LLP,, ,Cole Johnson,Not Provided,4/12/2018,0000-009,,"Neu, Nick",Cole Johnson,"Neu, Nick",610179,,584163,No
4024,18-T-018,No_Patent_Title Suspense,Quarles Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-010,Small,2/14/2018,,Yes,4/28/2022,Pending,Quarles & Brady LLP,, ,Cole Johnson,Not Provided,4/12/2018,0000-010,,"Neu, Nick",Cole Johnson,"Neu, Nick",610180,,584163,No
4025,18-T-018,Weaver Suspense,Weaver Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-011,Small,2/14/2018,,Yes,4/28/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,, ,Cole Johnson,Not Provided,4/12/2018,0000-011,,"Neu, Nick",Cole Johnson,"Neu, Nick",610181,,584163,No
4026,18-T-018,Oblon Suspense,Oblon Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-012,Small,2/14/2018,,Yes,4/28/2022,Pending,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,Cole Johnson,Not Provided,4/12/2018,0000-012,,"Neu, Nick",Cole Johnson,"Neu, Nick",613767,,584163,No
4027,18-T-018,Foley Suspense,Foley Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-013,None,2/14/2018,6/8/2018,No,4/28/2022,Pending,Foley Hoag LLP,, ,Cole Johnson,Not Provided,6/8/2018, ,2/14/2038,"Neu, Nick",Cole Johnson,"Neu, Nick",1431655,,584163,No
4028,18-T-018,Leydig Suspense,Leydig Suspense,,*United States,US,2/14/2018,,,,0000-015,None,2/14/2018,7/8/2020,No,11/2/2021,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",,Cole Johnson,Not Provided,7/8/2020,,,"Neu, Nick",Cole Johnson,"Neu, Nick",4693968,,584163,No
4029,18-T-018,Norton Rose Suspense,Norton Suspense,,*United States,US,2/14/2018,,,,0000-16,None,2/14/2018,,No,1/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD:001,Cole Johnson,Not Provided,9/23/2020,,,"Neu, Nick",Cole Johnson,"Neu, Nick",4913146,,584163,No
4030,18-T-022,DESIGN OF SILICON STRUCTURES FOR MULTISCALE AND OPTICALLY-CONTROLLED BIOINTERFACES,"62/635,969", ,*United States,US,2/27/2018,, ,2/27/2018,2808-001,Small,2/27/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Porembski, N. Meredith",19-100-PRO2,"Yuanwen Jiang, Bozhi Tian",Provisional,4/12/2018,2808-001,2/27/2019,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",611387,,584167,No
4031,18-T-023,COVARIANT NEURAL NETWORK ARCHITECTURE FOR DETERMINING ATOMIC POTENTIALS,"62/637,934", ,*United States,US,3/2/2018,, ,3/2/2018,2806-001,Small,3/2/2018,3/4/2019,Yes,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-332-PRO,Imre (Risi) Mikls Kondor,Provisional,4/12/2018,2806-001,3/2/2019,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",611348,,584168,No
4032,18-T-023,COVARIANT NEURAL NETWORK ARCHITECTURE FOR DETERMINING ATOMIC POTENTIALS,PCT/US19/20536, ,*United States,US,3/4/2019,,WO 2019/169384,3/4/2019,2806-002,Small,3/2/2018,3/6/2019,No,4/28/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-332-WO,Imre (Risi) Mikls Kondor,PCT,3/6/2019,2806-002,9/3/2020,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",3555214,9/6/2019,584168,No
4033,18-T-023,COVARIANT NEURAL NETWORK ARCHITECTURE FOR DETERMINING ATOMIC POTENTIALS,"16/975,962", ,*United States,US,3/4/2019,,US-2020-0402607-A1,8/26/2020,2806-003,Small,3/2/2018,8/27/2020,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-332-WO-US,Imre (Risi) Mikls Kondor,Nationalized PCT,7/23/2020, ,3/4/2039,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",4747812,12/24/2020,584168,No
4034,18-T-023,COVARIANT NEURAL NETWORK ARCHITECTURE FOR DETERMINING ATOMIC POTENTIALS,"3,092,647", ,Canada,CA,3/4/2019,, ,8/28/2020,2806-004,Large,3/2/2018,2/23/2021,No,6/23/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-332-WO-CA,Imre (Risi) Mikls Kondor,Nationalized PCT,8/27/2020, ,3/4/2039,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",4859271,,584168,No
4035,18-T-023,COVARIANT NEURAL NETWORK ARCHITECTURE FOR DETERMINING ATOMIC POTENTIALS,19760055.4, ,European Patent Office (EPO),EP,3/4/2019,,3759624,9/30/2020,2806-006,Small,3/2/2018,9/18/2020,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-332-WO-EP,Imre (Risi) Mikls Kondor,Nationalized PCT,9/18/2020, ,3/4/2039,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",4904814,1/6/2021,584168,No
4036,18-T-025,GENETICALLY-ENGINEERED MICROBES AND COMPOSITIONS THEREOF,"62/652,688", ,*United States,US,4/4/2018,, ,4/4/2018,2812-001,Small,4/4/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John", ,Xiaoyang Wu,Provisional,4/12/2018,2812-001,4/4/2019,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",611694,,584170,No
4037,18-T-025,GENETICALLY-ENGINEERED MICROBES AND COMPOSITIONS THEREOF,PCT/US19/25855, ,*United States,US,4/4/2019,,WO 2019/195592,4/4/2019,2812-002,Small,4/4/2018,4/4/2019,No,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-395-WO,Xiaoyang Wu,PCT,4/5/2019, ,10/4/2020,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3606890,10/10/2019,584170,No
4038,18-T-028,Systems and Methods for Oleophobic Composite Membranes,"15/994,825",,*United States,US,5/31/2018,,,5/31/2018,18-T-028-001,Small,5/31/2018,6/2/2022,Yes,6/2/2022,Prosecution by Other Party,,,051583-0837,"Lin Chen, Seth Darling, Jeffrey Elam, Ruben Waldman, Hao-Cheng Yang",US Utility,5/28/2020,,,"Ramirez, Mario Riojas",Seth Darling,"Tennant, Thelma",4598000,,584173,No
4039,18-T-034,ForeignBodyRetrievalDevice,"62/961,417", ,*United States,US,1/15/2020,, ,1/15/2020,2817-001,Small,1/15/2020,2/5/2020,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0689US.P1,"Seon-Kyu Lee, Thuong Van Ha",Provisional,2/5/2020, ,1/15/2021,"Ramirez, Mario Riojas",Seon-Kyu Lee,"Tennant, Thelma",4257452,,1950921,No
4040,18-T-034,ForeignBodyRetrievalDevice,PCT/US21/70022, ,*United States,US,1/12/2021,,WO 2021/146747 A1,1/12/2021,2817-002,Small,1/15/2020,1/14/2021,No,6/6/2022,Pending,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0689WO,"Seon-Kyu Lee, Thuong Van Ha",PCT,1/14/2021, ,7/15/2022,"Ramirez, Mario Riojas",Seon-Kyu Lee,"Tennant, Thelma",5272934,7/22/2021,1950921,No
4041,18-T-036,Combination of Micheliolide Derivatives or Nanoparticles with Ionizing Radiation and Checkpoint Inhibitors for Cancer Therapy,"62/657,112", ,*United States,US,4/13/2018,, ,4/13/2018,2821-001,Small,4/13/2018,,Yes,4/28/2022,Expired Prov - Filed in US,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles", ,"Christina Chan, Wenbo Han, Wenbin Lin",Provisional,4/25/2018, ,4/13/2019,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",1357379,,1357345,No
4042,18-T-036,Combination of Micheliolide Derivatives or Nanoparticles with Ionizing Radiation and Checkpoint Inhibitors for Cancer Therapy,"16/381,774", ,*United States,US,4/11/2019,,US-2019-0314324-A1,4/11/2019,2821-002,Small,4/13/2018,5/3/2019,No,4/28/2022,Abandoned,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/12/2,"Christina Chan, Wenbo Han, Wenbin Lin",US Utility,5/3/2019,2821-002,4/11/2039,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",3681606,10/17/2019,1357345,No
4043,18-T-036,Combination of Micheliolide Derivatives or Nanoparticles with Ionizing Radiation and Checkpoint Inhibitors for Cancer Therapy,"16/859,594", ,*United States,US,4/11/2019,,US-2020-0261403-A1,4/27/2020,2821-003,Small,4/13/2018,5/5/2020,No,6/24/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/12/3 DIV,"Christina Chan, Wenbo Han, Wenbin Lin",Divisional,5/5/2020,2821-003,4/11/2039,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4526740,8/20/2020,1357345,No
4044,18-T-036,Combination of Micheliolide Derivatives or Nanoparticles with Ionizing Radiation and Checkpoint Inhibitors for Cancer Therapy,,,*United States,US,4/11/2019,,,,2821-004,Small,4/13/2018,5/12/2022,No,5/20/2022,,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",,"Christina Chan, Wenbo Han, Wenbin Lin",Continuation,5/12/2022,,,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",7243645,,1357345,
4045,18-T-037,PROCESS FOR PRODUCTION OF CELLULOSE NANOFIBERS FROM MISCANTHUS X. GIGANTEUS AND COMPOSITES THEREFROM,"62/758,048", ,*United States,US,11/9/2018,, ,11/9/2018,18-T-037-001,Small,11/9/2018,11/9/2018,,4/28/2022,Expired Prov - Filed PCT,"Hudak, Shunk & Farine Co. LPA","Hudak, Daniel",UOFC-A-PROV,"Stuart Rowan, Han Yang",Provisional,10/31/2018, ,11/9/2019,"Hwang, Luke",Stuart Rowan,"Juggernauth, Anne",1854771,,1357551,No
4046,18-T-037,PROCESS FOR PRODUCTION OF CELLULOSE NANOFIBERS FROM MISCANTHUS X. GIGANTEUS AND COMPOSITES THEREFROM,PCT/US19/59092, ,*United States,US,10/31/2019,,WO 2020/096854,10/31/2019,18-T-037-002,Small,11/9/2018,4/28/2021,No,4/28/2022,Expired PCT - Filed in US only,"Hudak, Shunk & Farine Co. LPA","Hudak, Daniel",UOFC-A-PROV-PCT,"Stuart Rowan, Han Yang",PCT,11/5/2019, ,5/9/2021,"Hwang, Luke",Stuart Rowan,"Juggernauth, Anne",4100582,5/14/2020,1357551,No
4047,18-T-037,PROCESS FOR PRODUCTION OF CELLULOSE NANOFIBERS FROM MISCANTHUS X. GIGANTEUS AND COMPOSITES THEREFROM,"17/291,803",,*United States,US,10/31/2019,,,5/6/2021,18-T-037-003,Small,11/9/2018,5/11/2021,No,3/18/2022,Pending,"Hudak, Shunk & Farine Co. LPA","Hudak, Daniel",UOFC-A-PROV-PCT-US,"Stuart Rowan, Han Yang",Nationalized PCT,5/11/2021,,10/31/2039,"Hwang, Luke",Stuart Rowan,"Juggernauth, Anne",5723670,,1357551,No
4048,18-T-038,Optics to Reduce Skew in Integrated Cavity Output Spectroscopic Devices,"62/686,828", ,*United States,US,6/19/2018,, ,6/19/2018,18-T-038-001,Small,6/19/2018,,,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Kalafut, Christopher", ,"Benjamin Clouser, Elisabeth Moyer, Laszlo Sarkozy",Provisional,6/20/2018, ,6/19/2019,"Cox, Ben",Elisabeth Moyer,"Smith, Dane",1504339,,1359231,No
4049,18-T-038,Optics to Reduce Skew in Integrated Cavity Output Spectroscopic Devices,"16/445,612","11,047,736",*United States,US,6/19/2019,6/29/2021,US-2019-0383663-A1,6/19/2019,18-T-038-002,Small,6/19/2018,6/16/2021,No,4/28/2022,Issued,"Bell & Manning, LLC","Kalafut, Christopher",05400-0025-NP,"Benjamin Clouser, Elisabeth Moyer, Laszlo Sarkozy",Nationalized PCT,6/19/2019, ,6/19/2039,"Cox, Ben",Elisabeth Moyer,"Smith, Dane",3771877,12/19/2019,1359231,No
4050,18-T-039,Materials and Methods of Using an Inhibitor of Plasminogen Activation to Treat Anastomotic Leak,"62/661,415", ,*United States,US,4/23/2018,, ,4/23/2018,2814-001,Small,4/23/2018,,,4/28/2022,Expired Prov - Filed PCT,"Marshall, Gerstein & Borun","Merkel, William",27373-53025A,"John Alverdy, Olga Zaborina",Provisional,5/29/2018,2814-001,4/23/2019,"Dembo, Anna",John Alverdy,"Tennant, Thelma",1425325,,1361099,No
4051,18-T-039,Materials and Methods of Using an Inhibitor of Plasminogen Activation to Treat Anastomotic Leak,PCT/US19/28748, ,*United States,US,4/23/2019,,WO 2019/209844,4/23/2019,2814-002,Small,4/23/2018,5/3/2019,No,5/31/2022,Expired PCT - Filed in US only,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",747334,"John Alverdy, Richard Jacobson, Olga Zaborina",PCT,5/3/2019,2814-002,10/23/2020,"Dembo, Anna",John Alverdy,"Tennant, Thelma",3681812,10/31/2019,1361099,No
4052,18-T-039,Materials and Methods of Using an Inhibitor of Plasminogen Activation to Treat Anastomotic Leak,"17/049,793", ,*United States,US,4/23/2019,,US-2021-0252040-A1,10/22/2020,2814-003,Small,4/23/2018,10/20/2020,No,4/28/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",747335,"John Alverdy, Richard Jacobson, Olga Zaborina",Nationalized PCT,10/20/2020,2814-003,4/23/2039,"Dembo, Anna",John Alverdy,"Tennant, Thelma",4996259,8/19/2021,1361099,No
4053,18-T-040,Personalized leukemia/lymphoma therapeutic model,"62/665,344", ,*United States,US,5/1/2018,, ,5/1/2018,2816-001,Small,5/1/2018,5/9/2019,,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.",, ,"Pin Lu, Y. Lynn Wang",Provisional,5/29/2018, ,5/1/2019,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",1425354,,1366386,No
4054,18-T-040,Personalized leukemia/lymphoma therapeutic model,PCT/US19/30013, ,*United States,US,4/30/2019,,WO2019/213144,4/30/2019,2816-002,Small,5/1/2018,3/18/2022,No,4/28/2022,Expired PCT - Filed in US only,"Casimir Jones, S.C.",,36404.601,"Pin Lu, Y. Lynn Wang",PCT,5/9/2019, ,11/1/2020,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",3705741,11/17/2019,1366386,No
4055,18-T-040,Personalized Leukemia/Lymphoma Therapeutic Model,"17/051,068",,*United States,US,4/30/2019,,US-2021-0228646-A1,10/27/2020,2816-003,Small,5/1/2018,9/5/2020,No,5/2/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-36404.252,"Pin Lu, Y. Lynn Wang",Nationalized PCT,9/5/2020,,10/27/2040,"Sun, Han",Y. Lynn Wang,"Tennant, Thelma",4874725,7/29/2021,1366386,No
4056,18-T-041,Prediction and Demonstration of a C-MOS Compatible SN-Based Resistive Non-Volatile Memory,"62/656,697", ,*United States,US,4/12/2018,, ,4/12/2018,18-T-041-001,Small,4/12/2018,,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-542-PRO,"Supratik Guha, Sushant Sonde",Provisional,6/8/2018, ,4/12/2019,"Cox, Ben",Supratik Guha,"Tennant, Thelma",1431704,,1370017,No
4057,18-T-041,Silicon Compatible Tin-based Cationic Filamentary Device,PCT/US19/27145, ,*United States,US,4/12/2019,,WO 2019/200206,4/12/2019,18-T-041-002,Small,4/12/2018,4/19/2019,No,6/13/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-542-WO,"Supratik Guha, Sushant Sonde",PCT,4/19/2019, ,10/12/2020,"Cox, Ben",Supratik Guha,"Tennant, Thelma",3637123,10/17/2019,1370017,No
4058,18-T-041,Silicon Compatible Tin-based Cationic Filamentary Device,"17/042,691", ,*United States,US,4/12/2019,,US-2021-0126192-A1,9/28/2020,18-T-041-003,Small,4/12/2018,10/1/2020,No,5/31/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-542-WO-US,"Supratik Guha, Sushant Sonde",US Utility,10/1/2020, ,4/12/2039,"Cox, Ben",Supratik Guha,"Tennant, Thelma",4935284,4/29/2021,1370017,No
4059,18-T-042,Microresonator-based Ion Selective Optode,"62/702,019",,*United States,US,7/23/2018,,,7/23/2018,18-T-042-001,Small,7/23/2018,8/8/2018,,6/6/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-682-PRO,"Supratik Guha, Tijana Rajh, Xufeng Zhang",Provisional,8/8/2018,18-T-042-001,7/23/2019,"Cox, Ben",Supratik Guha,"Tennant, Thelma",1675904,,1370044,No
4060,18-T-042,Resonator-based Ion-Selective Sensor,PCT/US19/43010,,*United States,US,7/23/2019,,WO 2020/023496,7/23/2019,18-T-042-002,Small,7/23/2018,3/3/2021,No,6/6/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-682-WO,"Supratik Guha, Tijana Rajh, Xufeng Zhang",PCT,8/8/2019,18-T-042-002,1/23/2021,"Cox, Ben",Supratik Guha,"Tennant, Thelma",3902016,1/30/2020,1370044,No
4061,18-T-042,Resonator-based Ion-Selective Sensor,"17/262,195",,*United States,US,7/23/2019,,US-2021-0310944-A1,1/21/2021,18-T-042-003,Small,7/23/2018,1/25/2021,No,6/21/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-682-WO-US,"Supratik Guha, Tijana Rajh, Xufeng Zhang",Nationalized PCT,1/25/2021,18-T-042-003,7/23/2039,"Cox, Ben",Supratik Guha,"Tennant, Thelma",5300087,10/7/2021,1370044,No
4062,18-T-043,Methods and Compositions for Treating Cancer,"62/658,804", ,*United States,US,4/17/2018,, ,4/17/2018,18-T-043-001,Small,4/17/2018,4/17/2018,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-560-PRO,"Marsha Rosner, Ali Yesilkanal",Provisional,5/18/2018,18-T-043-001,4/17/2019,"Sun, Han",Marsha Rosner,"Tennant, Thelma",1380134,,1379884,No
4063,18-T-043,Methods and Compositions for Treating Cancer,PCT/US19/27817, ,*United States,US,4/17/2019,,WO 2019/204399 A1,4/17/2019,18-T-043-002,Small,4/17/2018,4/22/2019,No,6/13/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-560-WO-PCT,"Marsha Rosner, Ali Yesilkanal",PCT,4/22/2019,18-T-043-002,10/17/2020,"Sun, Han",Marsha Rosner,"Tennant, Thelma",3638077,10/24/2019,1379884,No
4064,18-T-043,Methods and Compositions for Treating Cancer,"17/048,282", ,*United States,US,4/17/2019,,US-2021-0100803-A1,10/16/2020,18-T-043-003,Small,4/17/2018,10/16/2020,No,6/16/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-560-WO-US,"Marsha Rosner, Ali Yesilkanal",US Utility,10/16/2020,18-T-043-003,4/17/2039,"Sun, Han",Marsha Rosner,"Tennant, Thelma",4988715,4/8/2021,1379884,No
4065,18-t-044,Methods Concerning N7-Methyl Guanosine (m7G) Modifications of Nucleic Acids,"62/676,835", ,*United States,US,5/25/2018,, ,5/25/2018,2819-001,Small,5/25/2018,3/26/2019,,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Chuan He, Chang Liu, Li-Sheng Zhang",Provisional,6/5/2018, ,5/25/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",1430490,,1425222,No
4066,18-T-045,Cancer Treatment with 237 Car-T Cell-based Therapeutics Recognizing the TN Epitope,"62/729,951",,*United States,US,9/11/2018,, ,9/11/2018,18-T-045-001,Small,9/11/2018,9/26/2018,,6/6/2022,Expired Prov - Filed PCT,"Marshall, Gerstein & Borun","Merkel, William",27373-52963,"Boris Engels, Yanran He, David Kranz, Hans Schreiber, Karin Schreiber, Preeti Sharma",Provisional,9/26/2018,18-T-045-001,9/11/2019,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",1705057,,1425877,No
4067,18-T-045,Cancer Treatment with 237 Car-T Cell-based Therapeutics Recognizing the TN Epitope,PCT/US19/50652,,*United States,US,9/11/2019,,WO 2020/056023 A1,9/11/2019,18-T-045-002,None,9/11/2018,3/31/2021,No,6/6/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0706WO,"Yanran He, David Kranz, Hans Schreiber, Karin Schreiber, Preeti Sharma",PCT,10/9/2019,18-T-045-002,3/11/2021,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",4030293,3/19/2020,1425877,No
4068,18-T-045,Cancer Treatment with 237 Car-T Cell-Based Therapeutics Recognizing the TN Epitope,"17/250,832",,*United States,US,9/11/2019,,,3/9/2021,18-T-045-003,Small,9/11/2018,3/10/2021,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0706US,"Yanran He, David Kranz, Hans Schreiber, Karin Schreiber, Preeti Sharma",Nationalized PCT,3/10/2021,18-T-045-003,,"Dembo, Anna",Hans Schreiber,"Tennant, Thelma",5468902,,1425877,No
4069,18-T-046,Biomimetic and Uninformed Search-Based Optical Training of Cardiobyocytes and Isolated Hearts with a Polymer-Silicon Mesh,"62/675,059",,*United States,US,5/22/2018,,,5/22/2018,18-T-046-001,None,5/22/2018,,,6/2/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-102-PRO,"Kelliann Koehler, Ramya Parameswaran, Bozhi Tian",Provisional,6/5/2018,,5/22/2019,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",1430602,,1429388,No
4070,18-T-047,Methods of Modulating Cellular Activation,"62/674,713", ,*United States,US,5/22/2018,, ,5/22/2018,18-T-047-001,Small,5/22/2018,,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-101-PRO,"Erin Adams, Michael Burke, Ramya Parameswaran, Bozhi Tian",Provisional,6/7/2018, ,5/22/2019,"Cox, Ben",Erin Adams,"Juggernauth, Anne",1431277,,1429415,No
4071,18-T-048,Compositions and Methods Concerning Immune Tolerance,"62/669,044", ,*United States,US,5/9/2018,, ,5/9/2018,2804-001,Small,5/9/2018,,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659US.P1,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Provisional,7/4/2018, ,5/9/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1577509,,1430815,No
4072,18-T-048,Compositions and Methods Concerning Immune Tolerance,PCT/US19/31440, ,*United States,US,5/9/2019,,WO 2019/217628,5/9/2019,2804-002,Small,5/9/2018,,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659WO,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",PCT,5/24/2019, ,11/9/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3740825,11/14/2019,1430815,No
4073,18-T-048,Compositions and Methods Concerning Immune Tolerance,2019265734, ,Australia,AU,5/9/2019,, ,12/1/2020,2804-003,Small,5/9/2018,10/15/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659AU,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4982906,,1430815,No
4074,18-T-048,Compositions and Methods Concerning Immune Tolerance,"3,099,404", ,Canada,CA,5/9/2019,, ,11/4/2020,2804-004,Small,5/9/2018,10/15/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659CA,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4982932,,1430815,No
4075,18-T-048,Compositions and Methods Concerning Immune Tolerance,201980045533.2, ,China,CN,5/9/2019,,112384239,1/6/2021,2804-005,Small,5/9/2018,10/15/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659CN,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4982958,2/19/2021,1430815,No
4076,18-T-048,Compositions and Methods Concerning Immune Tolerance,19800870.8, ,European Patent Office (EPO),EP,5/9/2019,,3790577,11/26/2020,2804-006,Small,5/9/2018,10/15/2020,No,6/15/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659EP,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4982985,3/17/2021,1430815,No
4077,18-T-048,Compositions and Methods Concerning Immune Tolerance,2020-563514, ,Japan,JP,5/9/2019,,2020-563514,11/6/2020,2804-007,Small,5/9/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659JP,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983011,10/21/2021,1430815,No
4078,18-T-048,Compositions and Methods Concerning Immune Tolerance,"17/250,015", ,*United States,US,5/9/2019,,US-2021-0244812-A1,11/3/2020,2804-008,Small,5/9/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659US,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983037,8/12/2021,1430815,No
4079,18-T-048,Compositions and Methods Concerning Immune Tolerance,202092723, ,Eurasian Patent Organization(EAPO),EA,5/9/2019,, ,12/10/2020,2804-009,Small,5/9/2018,10/15/2020,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659EA,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983063,,1430815,No
4080,18-T-048,Compositions and Methods Concerning Immune Tolerance,278538, ,Israel,IL,5/9/2019,, ,11/8/2020,2804-010,Small,5/9/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659IL,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983089,,1430815,No
4081,18-T-048,Compositions and Methods Concerning Immune Tolerance,770527, ,New Zealand,NZ,5/9/2019,, ,12/1/2020,2804-011,Small,5/9/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659NZ,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983115,,1430815,No
4082,18-T-048,Compositions and Methods Concerning Immune Tolerance,11202011078V,,Singapore,SG,5/9/2019,,,11/9/2020,2804-012,Small,5/9/2018,10/15/2020,No,11/16/2021,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659SG,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020,,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983141,,1430815,No
4083,18-T-048,Compositions and Methods Concerning Immune Tolerance,10-2020-7035421, ,"Korea, Republic of",KR,5/9/2019,, ,12/9/2020,2804-013,Small,5/9/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659KR,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,10/15/2020, ,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4983167,,1430815,No
4084,18-T-048,Compositions and Methods Concerning Immune Tolerance,62021037329.1,,Hong Kong,HK,5/9/2019,,40047644 A,8/20/2021,2804-014,Small,5/9/2018,8/26/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0659HK,"Kym Brunggel, Jeffrey Hubbell, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,8/26/2021,,5/9/2039,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6087297,11/19/2021,1430815,No
4085,18-T-049,Colloidal INXGA1-XP and INXGA1-XAS Nanocrystals Synthesized in Molten Salts,"62/690,035", ,*United States,US,6/26/2018,, ,6/26/2018,18-T-049-001,Small,6/26/2018,,,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Manning, Michelle", ,"Vishwas Srivastava, Dmitri Talapin",Provisional,6/26/2018, ,6/26/2019,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",1511989,,1430839,No
4086,18-T-049,Colloidal Ternary Group III-V Nanocrystals Synthesized in Molten Salts,"16/452,949","11,247,914",*United States,US,6/26/2019,2/15/2022,US-2019-0389738-A1,6/26/2019,18-T-049-002,Small,6/26/2018,2/17/2022,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0024-NP,"Vishwas Srivastava, Dmitri Talapin",US Utility,6/27/2019, ,6/26/2039,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",3779644,12/26/2019,1430839,No
4087,18-T-049,Colloidal Ternary Group III-V Nanocrystals Synthesized in Molten Salts,"17/567,499",,*United States,US,1/3/2022,,US-2022-0127155-A1,1/3/2022,18-T-049-003,Small,6/26/2018,1/10/2022,No,6/15/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0024-DIV,"Vishwas Srivastava, Dmitri Talapin",Divisional,1/10/2022,18-T-049-003,6/26/2039,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",6562067,4/28/2022,1430839,No
4088,18-T-050,Low Refractive Index Surface Layers and Related Methods,"15/649,448", ,*United States,US,7/13/2017,, ,7/13/2017,2809-001,Small,7/13/2017,6/8/2018,Yes,4/28/2022,Pending,"Marshall, Gerstein & Borun","Merkel, William",32802/16-158,"Diana Berman, Supratik Guha, Elena Shevchenko",US Utility,6/8/2018, ,7/13/2037,"Cox, Ben",Diana Berman,"Tennant, Thelma",1432156,,1431997,No
4089,18-T-052,Device and Method for Stool Sample Collection,"62/711,063", ,*United States,US,7/27/2018,, ,7/27/2018,18-T-052-001,Small,7/27/2018,8/8/2018,,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Kalafut, Christopher",05400-0028,"Jack Gilbert, Kevin Honaker, David Kim, Catherine Yunis",Provisional,8/8/2018, ,7/27/2019,"Cox, Ben",Jack Gilbert,"Tennant, Thelma",1675684,,1505280,No
4090,18-T-052,Device and Method for Stool Sample Collection,"16/524,336","11,375,986",*United States,US,7/29/2019,7/5/2022,,7/29/2019,18-T-052-002,Small,7/27/2018,6/21/2022,No,6/21/2022,Issued,"Bell & Manning, LLC","Kalafut, Christopher",05400-0028,"David Kim, Catherine Yunis",US Utility,8/8/2019,,7/29/2039,"Cox, Ben",,"Tennant, Thelma",3902063,,1505280,No
4091,18-T-053,"Microfluidic Devices, Systems, and Methods for Investigating Three-Dimensional Cellular Structures","62/683,161", ,*United States,US,6/11/2018,, ,6/11/2018,2714-001,Small,6/11/2018,6/11/2018,,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0658.US.P1,"Michael Junkin, Brooke Schuster, Savas Tay",Provisional,6/26/2018, ,6/11/2019,"Cox, Ben",Savas Tay,"Tennant, Thelma",1510787,,1506115,No
4092,18-T-053,"Microfluidic Devices, Systems, and Methods for Investigating Three-Dimensional Cellular Structures","16/438,356", ,*United States,US,6/11/2019,,US-2019-0376013-A1,6/11/2019,2714-002,Small,6/11/2018,6/26/2019,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0658US,"Michael Junkin, Brooke Schuster, Savas Tay",US Utility,6/26/2019, ,6/11/2039,"Cox, Ben",Savas Tay,"Tennant, Thelma",3779134,12/12/2019,1506115,No
4093,18-T-054,Routing In Navigation Applications Based on Restorative Score,"62/676,630", ,*United States,US,5/25/2018,, ,5/25/2018,18-T-054-001,Small,5/25/2018,,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John", ,"Marc Berman, Omid Kardan, Thomas Kompare, Kathryn Schertz",Provisional,7/12/2018,18-T-054-001,5/25/2019,"Ramirez, Mario Riojas",Marc Berman,"Smith, Dane",1589379,,1514943,No
4094,18-T-054,Routing In Navigation Applications Based on Restorative Score,"16/418,522","11,204,251",*United States,US,5/21/2019,12/21/2021,US-2019-0360821,5/21/2019,18-T-054-002,Small,5/25/2018,12/2/2021,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-695-US,"Marc Berman, Omid Kardan, Thomas Kompare, Kathryn Schertz",US Utility,6/3/2019,18-T-054-002,1/24/2040,"Ramirez, Mario Riojas",Marc Berman,"Smith, Dane",3760780,11/28/2019,1514943,No
4095,18-T-055,Use of Metastases-Specific Signatures for Treatment of Cancer,"62/703,237", ,*United States,US,7/25/2018,, ,7/25/2018,2807-001,Small,7/25/2018,8/8/2018,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1007-PRO,Mike Spiotto,Provisional,8/8/2018, ,7/25/2019,"Dembo, Anna",Mike Spiotto,"Tennant, Thelma",1675606,,1581107,No
4096,18-T-055,Use of Metastases-Specific Signatures for Treatment of Cancer,PCT/US19/43312, ,*United States,US,7/24/2019,, ,7/24/2019,2807-002,Small,7/25/2018,7/31/2019,No,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1007-WO,Mike Spiotto,PCT,7/31/2019, ,1/25/2021,"Dembo, Anna",Mike Spiotto,"Tennant, Thelma",3868150,,1581107,No
4097,18-T-055,Use of Metastases-Specific Signatures for Treatment of Cancer,"17/262,471", ,*United States,US,7/24/2019,, ,1/22/2021,2807-003,Small,7/25/2018,1/25/2021,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1007-WO-US,Mike Spiotto,Nationalized PCT,1/25/2021, ,7/24/2039,"Dembo, Anna",Mike Spiotto,"Tennant, Thelma",5300520,,1581107,No
4098,18-T-057,Methods for the Amplification of Bisulfite-Treated DNA,"62/711,184", ,*United States,US,7/27/2018,, ,7/27/2018,18-T-057-001,Small,7/27/2018,8/8/2018,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0664USP1,"Xiao-Long Cui, Chuan He, Ji Nie",Provisional,8/8/2018, ,7/27/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",1675835,,1585561,No
4099,18-T-057,Methods for the Amplification of Bisulfite-Treated DNA,PCT/US19/43603, ,*United States,US,7/26/2019,,WO 2020/023842 A1,7/26/2019,18-T-057-002,Small,7/27/2018,7/29/2019,No,6/8/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0664WO,"Xiao-Long Cui, Chuan He, Ji Nie",PCT,7/29/2019, ,1/27/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",3856280,1/30/2020,1585561,No
4100,18-T-057,Methods for the Amplification of Bisulfite-Treated DNA,"17/250,365",,*United States,US,7/26/2019,,US-2021-0310062-A1,1/11/2021,18-T-057-003,Small,7/27/2018,1/5/2021,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0664US,"Xiao-Long Cui, Chuan He, Ji Nie",Nationalized PCT,1/5/2021,,7/26/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5242183,10/7/2021,1585561,No
4101,18-T-057,Methods for the Amplification of Bisulfite-Treated DNA,201980060856.9,,China,CN,7/26/2019,,112714796,3/17/2021,18-T-057-004,Small,7/27/2018,7/14/2021,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0664CN,"Xiao-Long Cui, Chuan He, Ji Nie",Nationalized PCT,1/5/2021,,7/26/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5242207,4/27/2021,1585561,No
4102,18-T-057,Methods for the Amplification of Bisulfite-Treated DNA,62021041281.8,,Hong Kong,HK,7/26/2019,,40051505,10/27/2021,18-T-057-005,Small,7/27/2018,11/4/2021,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0664CHK,"Xiao-Long Cui, Chuan He, Ji Nie",Nationalized PCT,11/4/2021,,7/26/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",6349117,1/7/2022,1585561,No
4103,18-T-058,Sensor,"62/677,844", ,*United States,US,5/30/2018,, ,5/30/2018,18-T-058-001,Small,5/30/2018,,,4/28/2022,Expired Prov - Filed PCT,Barnes & Thornburg,"Kelsey, Jeffrey", ,"Aashish Clerk, Hoi-Kwan Lau",Provisional,7/12/2018, ,5/30/2019,"Cox, Ben",Aashish Clerk,"Smith, Dane",1589415,,1585705,No
4104,18-T-058,Technologies for Quantum Sensing,PCT/US19/34527, ,*United States,US,5/30/2019,,WO 2019/232133 A1,5/30/2019,18-T-058-002,Small,5/30/2018,6/18/2019,No,4/28/2022,Expired PCT - Filed in US only,Barnes & Thornburg,"Kelsey, Jeffrey",21459-295742,"Aashish Clerk, Hoi-Kwan Lau",PCT,6/18/2019, ,11/30/2020,"Cox, Ben",Aashish Clerk,"Smith, Dane",3771375,12/5/2019,1585705,No
4105,18-T-058,Technologies for Quantum Sensing,"17/056,599","11,174,162",*United States,US,5/30/2019,11/16/2021, ,11/18/2020,18-T-058-003,Small,5/30/2018,11/4/2021,No,4/28/2022,Issued,Barnes & Thornburg,"Kelsey, Jeffrey",21459-328564,"Aashish Clerk, Hoi-Kwan Lau",Nationalized PCT,2/4/2021, ,5/30/2039,"Cox, Ben",Aashish Clerk,"Smith, Dane",5350557,,1585705,No
4106,18-T-059,A Fully Fourier Space Spherical Convolutional Neural Network based on Clebsch-Gordan Transforms,"62/688,200", ,*United States,US,6/21/2018,, ,6/21/2018,18-T-059-001,Small,6/21/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John", ,"Imre (Risi) Mikls Kondor, Zhen Lin, Shubhendu Trivedi",Provisional,7/12/2018, ,6/21/2019,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",1589317,,1585728,No
4107,18-T-059,A Fully Fourier Space Spherical Convolutional Neural Network based on Clebsch-Gordan Transforms,PCT/US19/38236, ,*United States,US,6/20/2019,,WO 2019/246397,6/20/2019,18-T-059-002,Small,6/21/2018,6/20/2019,No,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-389-WO,"Imre (Risi) Mikls Kondor, Zhen Lin, Shubhendu Trivedi",PCT,6/20/2019, ,12/20/2020,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",3773495,12/26/2019,1585728,No
4108,18-T-059,A Fully Fourier Space Spherical Convolutional Neural Network based on Clebsch-Gordan Transforms,"17/253,840", ,*United States,US,6/20/2019,,US-2021-0272233-A1,12/18/2020,18-T-059-003,Small,6/21/2018,1/4/2021,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-389-WO-US,"Imre (Risi) Mikls Kondor, Zhen Lin, Shubhendu Trivedi",Nationalized PCT,1/4/2021, ,6/20/2039,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",5237155,9/2/2021,1585728,No
4109,18-T-061,"Remodilins to Prevent or Treat Cancer Metastasis, Glaucoma, and Hypoxia","62/828,122", ,*United States,US,4/2/2019,, ,4/2/2019,18-T-061-001,Small,4/2/2019,4/12/2019,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0661US.P1,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Gokhan Mutlu, Chan Young Park, Marsha Rosner, Julian Solway",Provisional,4/12/2019,18-T-061-001,4/2/2020,"Hwang, Luke",Julian Solway,"Muite, Kevin",3612066,,1585800,No
4110,18-T-061,"Remodilins to Prevent or Treat Cancer Metastasis, Glaucoma, and Hypoxia",PCT/US20/26383, ,*United States,US,4/2/2020,,WO 2020/206118 A1,4/2/2020,18-T-061-002,Small,4/2/2019,3/9/2022,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0661WO,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Gokhan Mutlu, Chan Young Park, Marsha Rosner, Julian Solway",PCT,3/25/2020,18-T-061-002,10/2/2021,"Hwang, Luke",Julian Solway,"Muite, Kevin",4424304,10/8/2020,1585800,No
4111,18-T-061,"Remodilins to Prevent or Treat Cancer Metastasis, Glaucoma, and Hypoxia","17/594,090",,*United States,US,4/2/2020,,US-2022-0040207-A1,10/1/2021,18-T-061-003,None,4/2/2019,10/4/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0661US,"Nickolai Dulin, Jeffrey Fredberg, Ramaswamy Krishnan, Diane Luci, David Maloney, David McCormick, Gokhan Mutlu, Chan Young Park, Marsha Rosner, Julian Solway",Nationalized PCT,10/4/2021,,4/2/2040,"Hwang, Luke",Julian Solway,"Muite, Kevin",6244736,2/10/2022,1585800,No
4112,18-T-062,Bidirectional Evaluation for General-Purpose Programming,"62/711,252",,*United States,US,7/27/2018,,,7/27/2018,18-T-062-001,Small,7/27/2018,,Yes,6/6/2022,Expired Prov - Filed PCT,"Marshall, Gerstein & Borun","Merkel, William",27373/53194P/US,"Ravi Chugh, Mikael Mayer",Provisional,7/30/2018,18-T-062-001,7/27/2019,"Ramirez, Mario Riojas",Ravi Chugh,"Smith, Dane",1670146,,1585893,No
4113,18-T-062,Bidirectional Evaluation for General-Purpose Programming,PCT/US19/43846,,*United States,US,7/29/2019,,WO 2020/023951,7/29/2019,18-T-062-002,Small,7/27/2018,7/29/2019,No,6/6/2022,Expired Prov - Filed in US,"Marshall, Gerstein & Borun","Merkel, William",27373/53194/PCT,"Ravi Chugh, Mikael Mayer",PCT,7/29/2019,18-T-062-002,1/27/2021,"Ramirez, Mario Riojas",Ravi Chugh,"Smith, Dane",3856212,1/30/2020,1585893,No
4114,18-T-062,Bidirectional Evaluation for General-Purpose Programming,"17/160,098",,*United States,US,7/29/2019,,,1/27/2021,18-T-062-003,Small,7/27/2018,7/7/2021,No,6/6/2022,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",27373/53194-CON1,"Ravi Chugh, Mikael Mayer",Nationalized PCT,2/3/2021,18-T-062-003,7/29/2039,"Ramirez, Mario Riojas",Ravi Chugh,"Smith, Dane",5349349,,1585893,No
4115,18-T-062,Bidirectional Evaluation for General-Purpose Programming,"17/227,227","11,301,243",*United States,US,7/29/2019,4/12/2022,2021-0263729-A1,4/9/2021,18-T-062-004,Small,7/27/2018,4/4/2022,No,6/6/2022,Issued,"Marshall, Gerstein & Borun","Merkel, William",27373/53194-CON2,"Ravi Chugh, Mikael Mayer",Continuation,7/7/2021,18-T-062-004,7/29/2039,"Ramirez, Mario Riojas",Ravi Chugh,"Smith, Dane",5876540,8/26/2021,1585893,No
4116,18-T-063,"Coherent, atomically-thin transition-metal dichalcogenide superlattices with engineered strain","62/679,085",,*United States,US,6/1/2018,, ,6/1/2018,18-T-063-001,Large,6/1/2018,,,6/22/2022,Expired Prov - Filed in US,"Harness, Dickey & Pierce PLC",,2557S1-002838-US-PS1,"Jinseong Heo, Minhyun Lee, Jiwoong Park, Hyeonjin Shin, Saien Xie",Provisional,7/23/2018,18-T-063-001,6/1/2019,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",1655652,,1585958,No
4117,18-T-063,Superlattice structure including two-dimensional material and device including the superlattice structure,"16/428,006",,*United States,US,5/31/2019,,,5/31/2019,18-T-063-002,Large,6/1/2018,4/26/2022,No,6/22/2022,Prosecution by Other Party,"Harness, Dickey & Pierce PLC",,2557S1-002838-US-01,"Jinseong Heo, Minhyun Lee, Jiwoong Park, Hyeonjin Shin, Saien Xie",US Utility,6/20/2019,18-T-063-002,5/31/2039,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",3772340,,1585958,No
4118,18-T-063,Superlattice structure including two-dimensional material and device including the superlattice structure,10-2019-0064875,,"Korea, Republic of",KR,5/31/2019,,,5/31/2019,18-T-063-003,None,6/1/2018,6/20/2019,No,6/22/2022,Pending,"Harness, Dickey & Pierce PLC",,2557S1-002838-KR,"Jinseong Heo, Minhyun Lee, Jiwoong Park, Hyeonjin Shin, Saien Xie","Foreign, Non-PCT",6/20/2019,18-T-063-003,5/31/2039,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",3772374,,1585958,No
4119,18-T-063,Superlattice structure including two-dimensional material and device including the superlattice structure,"17/515,713",,*United States,US,5/31/2019,,,11/1/2021,18-T-063-004,Large,6/1/2018,4/26/2022,No,6/23/2022,Prosecution by Other Party,"Harness, Dickey & Pierce PLC",,SI-56365-USC1,"Jinseong Heo, Minhyun Lee, Jiwoong Park, Hyeonjin Shin, Saien Xie",Continuation,4/26/2022,18-T-063-004,5/31/2039,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",7139264,,1585958,No
4120,18-T-064,Automatically Detecting Time-of-fault Bugs in Cloud Systems,"15/938,841", ,*United States,US,3/28/2018,, ,3/28/2018,18-T-064-001,Large,3/28/2018,7/16/2018,Yes,5/8/2022,Pending,"Conley Rose, PC",,4502-37700,"Shen Chen, Guangpu Li, Haopeng Liu, Shan Lu, Chen Tian, Xu Wang, Feng Ye",US Utility,7/16/2018,18-T-064-001,3/28/2038,"Ramirez, Mario Riojas",Shan Lu,"Smith, Dane",1595491,,1588814,No
4121,18-T-065,Resistive Switching Memory Device,"15/994,589", ,*United States,US,5/31/2018,, ,5/31/2018,18-T-065-001,None,5/31/2018,5/8/2019,Yes,4/28/2022,Pending,,,32802/17-127,"Bhaswar Chakrabarti, Supratik Guha, Leonidas Ocola, Sushant Sonde",US Utility,5/8/2019, ,5/31/2038,"Cox, Ben",Supratik Guha,"Tennant, Thelma",3694282,,1596945,No
4122,18-T-068,Real-Time Adaptive Radiation Therapy,"62/713,684", ,*United States,US,8/2/2018,, ,8/2/2018,18-T-068-001,Small,8/2/2018,,Yes,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Kalafut, Christopher", ,"Xinmin Liu, Rodney Wiersma",Provisional,8/3/2018, ,8/2/2019,"Bakalyar, Heather",Rodney Wiersma,"Tennant, Thelma",1674651,,1671750,No
4123,18-T-068,Real-Time Adaptive Radiation Therapy,"62/756,770", ,*United States,US,11/7/2018,, ,11/7/2018,18-T-068-002,Small,11/7/2018,11/7/2018,No,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Kalafut, Christopher", ,"Xinmin Liu, Rodney Wiersma",Provisional,11/18/2018, ,11/7/2019,"Bakalyar, Heather",Rodney Wiersma,"Tennant, Thelma",1900952,,1671750,No
4124,18-T-068,Real-Time Adaptive Radiation Therapy,"16/529,124", ,*United States,US,8/1/2019,, ,8/1/2019,18-T-068-003,Small,8/2/2018,8/1/2019,No,4/28/2022,Released to Inventors,"Bell & Manning, LLC","Kalafut, Christopher", ,"Xinmin Liu, Rodney Wiersma",US Utility,8/1/2019, ,8/1/2039,"Bakalyar, Heather",Rodney Wiersma,"Tennant, Thelma",3868694,,1671750,No
4125,18-T-069,Systems and Methods for Interferometric Multifocus Microscopy,"62/688,646", ,*United States,US,6/22/2018,, ,6/22/2018,18-T-069-001,Small,6/22/2018,8/6/2018,,4/28/2022,Expired Prov - Filed PCT,Fox Rothschild LLP,,174423.02200,"Oliver Cossairt, Kuan He, Mark Hereld, Aggelos Katsaggelos, Norbert Scherer",Provisional,8/6/2018,18-T-069-001,6/22/2019,"Ramirez, Mario Riojas",Norbert Scherer,"Juggernauth, Anne",1674912,,1674724,No
4126,18-T-069,Systems and Methods for Interferometric Multifocus Microscopy,PCT/US19/38394, ,*United States,US,6/21/2019,, ,6/21/2019,18-T-069-002,Small,6/22/2018,3/3/2021,No,4/28/2022,Expired PCT - Nationalized,Fox Rothschild LLP,,174423.02200,"Oliver Cossairt, Kuan He, Mark Hereld, Aggelos Katsaggelos, Norbert Scherer",PCT,6/25/2019,18-T-069-002,12/22/2020,"Ramirez, Mario Riojas",Norbert Scherer,"Juggernauth, Anne",3777799,,1674724,No
4127,18-T-069,Systems and Methods for Interferometric Multifocus Microscopy,"15/734,172", ,*United States,US,6/21/2019,, ,12/1/2020,18-T-069-003,Small,6/22/2018,1/8/2021,No,4/28/2022,Pending,Fox Rothschild LLP,, ,"Oliver Cossairt, Kuan He, Mark Hereld, Aggelos Katsaggelos, Norbert Scherer",Nationalized PCT,1/8/2021,18-T-069-003,6/21/2039,"Ramirez, Mario Riojas",Norbert Scherer,"Juggernauth, Anne",5254651,,1674724,No
4128,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,"62/693,750", ,*United States,US,7/3/2018,, ,7/3/2018,18-T-070-001,Large,7/3/2018,7/3/2018,,4/28/2022,Expired Prov - Filed PCT,Polsinelli Shughart PC,,E-128-2018-0-US-01,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Hari Shroff, Harshad Vishwasrao, Yicong Wu",Provisional,8/22/2018,18-T-070-001,7/3/2019,"Cox, Ben",Patrick La Riviere,"Smith, Dane",1682130,,1675222,No
4129,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,"62/789,210", ,*United States,US,1/7/2019,, ,1/7/2019,18-T-070-002,Small,1/7/2019,7/17/2019,No,4/28/2022,Expired Prov - Filed PCT,Polsinelli Shughart PC,,E-128-2018-1-US-01,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Hari Shroff, Harshad Vishwasrao, Yicong Wu",Provisional,7/17/2019,18-T-070-002,1/7/2020,"Cox, Ben",Patrick La Riviere,"Smith, Dane",3798472,,1675222,No
4130,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,PCT/US19/39551, ,*United States,US,6/27/2019,, ,6/27/2019,18-T-070-003,Small,7/3/2018,1/6/2020,No,4/28/2022,Expired Prov - Filed in US,Polsinelli Shughart PC,,E-128-2018-2-PCT-01,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Hari Shroff, Harshad Vishwasrao, Yicong Wu",PCT,1/6/2020,18-T-070-003,1/3/2021,"Cox, Ben",Patrick La Riviere,"Smith, Dane",4205868,,1675222,No
4131,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,"17/253,090", ,*United States,US,6/27/2019,,US-2021-0271060-A1,12/16/2020,18-T-070-004,Small,7/3/2018,12/17/2020,No,5/16/2022,Pending,Polsinelli Shughart PC,,NIH20307PCTUS,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Xuesong LI, Hari Shroff, Harshad Vishwasrao, Yicong Wu",Nationalized PCT,12/17/2020,18-T-070-004,6/27/2039,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5205653,9/9/2021,1675222,No
4132,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,2020-573194,,Japan,JP,6/27/2019,,,12/28/2020,18-T-070-005,Small,7/3/2018,4/29/2022,No,6/23/2022,Prosecution by Other Party,,,E-128-2018-2-JP-04,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Hari Shroff, Harshad Vishwasrao, Yicong Wu",Nationalized PCT,1/3/2021,,6/27/2039,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5234180,,1675222,No
4133,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,2019800560945, ,China,CN,6/27/2019,,112639448,2/25/2021,18-T-070-006,Small,7/3/2018,1/3/2021,No,4/28/2022,Pending,Polsinelli Shughart PC,,E-128-2018-2-CN-02,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Xuesong LI, Hari Shroff, Harshad Vishwasrao, Yicong Wu",Nationalized PCT,1/3/2021, ,6/27/2039,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5234405,4/9/2021,1675222,No
4134,18-T-070,Systems and Methods for Improved Axial Resolution in Microscopy Using Photoswitching and Standing Wave Illumination Techniques,19830480.0, ,European Patent Office (EPO),EP,6/27/2019,,3799622,12/30/2020,18-T-070-007,Small,7/3/2018,3/18/2022,No,4/28/2022,Prosecution by Other Party,Polsinelli Shughart PC,,E-128-2018-2-EP03,"Jiji Chen, John Giannini, Min Guo, Patrick La Riviere, Hari Shroff, Harshad Vishwasrao, Yicong Wu",Nationalized PCT,1/3/2021, ,6/27/2039,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5234451,4/7/2021,1675222,No
4135,18-T-071,Methods and Reagents for Toxoplasma Gondi Infection Diagnosis,"62/718,984", ,*United States,US,8/16/2018,, ,8/16/2018,18-T-071-001,Small,8/16/2018,,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,,18-1290-PRO,"Kamal El Bissati, Denis Limone, Joseph Lykins, Rima McLeod, Francois Peyron",Provisional,9/4/2018, ,8/16/2019,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",1690339,,1677296,No
4136,18-T-071,"Rapid, Inexpensive, Fingerstick, Whole-Blood, Sensitive, Specific, Point-of-Care Test for Anti-Toxoplasma Antibodies","62/764,969", ,*United States,US,8/16/2018,, ,8/16/2018,18-T-071-002,Small,8/16/2018,,,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0665US.P1,Rima McLeod,Provisional,9/4/2018, ,8/16/2019,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",1690676,,1677296,No
4137,18-T-071,Methods and Reagents for Toxoplasma Gondi Infection Diagnosis,"16/542,865", ,*United States,US,8/16/2019,, ,8/16/2019,18-T-071-003,Small,8/16/2018,8/29/2019,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1290-US,"Kamal El Bissati, Denis Limone, Joseph Lykins, Rima McLeod, Francois Peyron",US Utility,8/29/2019, ,8/16/2039,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",3969352,,1677296,No
4138,18-T-073,Compositions and Methods for Inducing Immune Tolerance,"62/521,270", ,*United States,US,6/16/2017,, ,6/16/2017,18-T-073-001,Small,6/16/2017,,Yes,4/28/2022,Expired Prov - Filed PCT,,, ,"Jeffrey Hubbell, Stephan Kontos, Kristen Lorentz, D. Scott Wilson",Provisional,9/12/2018, ,,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1696568,,1678718,No
4139,18-T-073,Compositions and Methods for Inducing Immune Tolerance,PCT/US18/37631, ,*United States,US,6/14/2018,,wo 2018/232176 A1,6/14/2018,18-T-073-002,Small,6/16/2017,9/12/2018,No,4/28/2022,Expired PCT - Nationalized,,, ,"Jeffrey Hubbell, Stephan Kontos, Kristen Lorentz, D. Scott Wilson",PCT,9/12/2018, ,12/16/2019,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",1696599,12/20/2018,1678718,No
4140,18-T-073,Compositions and Methods for Inducing Immune Tolerance,"16/622,732","11,253,551",*United States,US,6/14/2018,2/22/2022,2020/0101146 A1,12/13/2019,18-T-073-003,Small,6/16/2017,2/17/2022,No,4/28/2022,Issued,,,ANOK.019NP,"Jeffrey Hubbell, Stephan Kontos, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,2/4/2020, ,6/14/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4255934,4/2/2020,1678718,No
4141,18-T-073,Compositions and Methods for Inducing Immune Tolerance,18739986.0,,European Patent Office (EPO),EP,6/14/2018,,3638296,1/3/2020,18-T-073-004,Small,6/16/2017,3/18/2020,No,5/31/2022,Pending,,,ANOK.019EP,"Jeffrey Hubbell, Stephan Kontos, Kristen Lorentz, D. Scott Wilson",Nationalized PCT,3/18/2020,,6/14/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4411868,4/22/2020,1678718,No
4142,18-T-073,Compositions and Methods for Inducing Immune Tolerance,"17/567,779", ,*United States,US,6/14/2018,, ,1/3/2022,18-T-073-005,None,6/16/2017,1/11/2022,No,4/28/2022,Pending,,,ANOK.019C1,"Jeffrey Hubbell, Stephan Kontos, Kristen Lorentz, D. Scott Wilson",Continuation,1/11/2022, ,6/14/2038,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6579410,,1678718,No
4143,18-T-074,Neurophysiological biomarkers for neurodegenerative disorders,"62/727,362", ,*United States,US,9/5/2018,, ,9/5/2018,18-T-074-001,Small,9/5/2018,10/22/2018,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1164-PRO,"Naoum Issa, Kourosh Rezania",Provisional,10/22/2018, ,9/5/2019,"Ramirez, Mario Riojas",Naoum Issa,"Smith, Dane",1820414,,1678892,No
4144,18-T-074,Neurophysiological biomarkers for neurodegenerative disorders,"16/561,981", ,*United States,US,9/5/2019,,US-2020-0069204-A1,9/5/2019,18-T-074-002,Small,9/5/2018,9/11/2019,No,6/16/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1164-US,"Naoum Issa, Kourosh Rezania",US Utility,9/11/2019, ,9/5/2035,"Ramirez, Mario Riojas",Naoum Issa,"Smith, Dane",3989477,3/5/2020,1678892,No
4145,18-T-076,Machine Learning Classifier for Salivary Gland Cancer,"62/727,488", ,*United States,US,9/5/2018,, ,9/5/2018,18-T-076-001,Small,9/5/2018,,,4/28/2022,Expired - Inactive,Armstrong Teasdale,"Brennan, Patrick",37997-4,"Jakob Kather, Alexander Pearson",Provisional,11/13/2018, ,9/5/2019,"Cox, Ben",Alexander Pearson,"Smith, Dane",1886457,,1692296,No
4146,18-T-077,Plasmids for Manipulation of Wolbachia,"62/768,165", ,*United States,US,11/16/2018,, ,11/16/2018,18-T-077-001,Small,11/16/2018,11/25/2019,,4/28/2022,Expired Prov - Filed PCT,,, ,"Sarah Bordenstein, Seth Bordenstein, A. Eren, Julie Reveillaud",Provisional,11/18/2018, ,11/16/2019,"Dembo, Anna",A. Eren,"Tennant, Thelma",1900679,,1694897,No
4147,18-T-077,Plasmids for Manipulation of Wolbachia,"62/811,131", ,*United States,US,2/27/2019,, ,2/27/2019,18-T-077-002,Small,2/27/2019,3/11/2019,No,4/28/2022,Expired Prov - Filed PCT,,, ,"Sarah Bordenstein, Seth Bordenstein, A. Eren, Julie Reveillaud",Provisional,3/11/2019, ,2/27/2020,"Dembo, Anna",A. Eren,"Tennant, Thelma",3561825,,1694897,No
4148,18-T-077,Plasmids for Manipulation of Wolbachia,PCT/US19/61611, ,*United States,US,11/15/2019,,WO 2020/102626 A1,11/15/2019,18-T-077-003,Small,11/16/2018,6/24/2021,No,4/28/2022,Expired PCT - Filed in US only,,,10644-077WO1,"Sarah Bordenstein, Seth Bordenstein, A. Eren, Julie Reveillaud",PCT,11/25/2019, ,5/16/2021,"Dembo, Anna",A. Eren,"Tennant, Thelma",4125786,5/22/2020,1694897,No
4149,18-T-077,Plasmids for Manipulation of Wolbachia,"17/293,634",,*United States,US,11/15/2019,,,5/13/2021,18-T-077-004,Small,11/16/2018,6/25/2021,No,3/18/2022,Pending,,,10644-077US1,"Sarah Bordenstein, Seth Bordenstein, A. Eren, Julie Reveillaud",Nationalized PCT,6/25/2021,,11/15/2039,"Dembo, Anna",A. Eren,"Tennant, Thelma",5843130,,1694897,No
4150,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease","62/755,945", ,*United States,US,11/5/2018,, ,11/5/2018,18-T-078-001,Small,11/5/2018,11/12/2019,,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666US.P1,"Dionysios Antonopoulos, Riyue Bao, John Colson, Cathryn Nagler",Provisional,11/5/2018, ,11/5/2019,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",1872049,,1696023,No
4151,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",PCT/US19/59865, ,*United States,US,11/5/2019,,WO 2020/097077,11/5/2019,18-T-078-002,Small,11/5/2018,6/24/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666WO,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",PCT,11/12/2019, ,5/5/2021,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",4110374,5/14/2020,1696023,No
4152,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease","17/309,185", ,*United States,US,11/5/2019,,US-2021-0386796-A1,5/4/2021,18-T-078-003,Small,11/5/2018,5/7/2021,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666US,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021, ,11/5/2039,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503708,12/16/2021,1696023,No
4153,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease","3,118,679",,Canada,CA,11/5/2019,,,5/3/2021,18-T-078-006,Small,11/5/2018,6/24/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666CA,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,11/5/2029,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503785,,1696023,No
4154,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",19882127.4,,European Patent Office (EPO),EP,11/5/2019,,3876755,5/11/2021,18-T-078-008,Small,11/5/2018,6/24/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666EP,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,11/5/2039,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503824,9/15/2021,1696023,No
4155,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",2021-524290,,Japan,JP,11/5/2019,,2022-510780,4/30/2021,18-T-078-010,Small,11/5/2018,6/24/2021,No,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666JP,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503863,1/28/2022,1696023,No
4156,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",2019374773,,Australia,AU,11/5/2019,,,5/18/2021,18-T-078-004,Small,11/5/2018,9/15/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666AU,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,11/5/2039,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503902,,1696023,No
4157,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",120210087672,,Brazil,BR,11/5/2019,,,5/5/2021,18-T-078-005,Small,11/5/2018,7/1/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666BR,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,11/5/2039,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503941,,1696023,No
4158,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",201980087923.6,,China,CN,11/5/2019,,CN 113271796 A,7/5/2021,18-T-078-007,Small,11/5/2018,9/15/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666CN,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5503980,8/17/2021,1696023,No
4159,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",62021039346.3,,Hong Kong,HK,11/5/2019,,,9/24/2021,18-T-078-009,Small,11/5/2018,9/28/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666EHK,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,11/5/2039,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5504019,,1696023,No
4160,18-T-078,"Methods and Compositions for Treating Infectious, Autoimmune, and Allergic Disease",10-2021-7017306,,"Korea, Republic of",KR,11/5/2019,,,6/4/2021,18-T-078-011,Small,11/5/2018,6/28/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0666KR,"Dionysios Antonopoulos, Riyue Bao, John Colson, Lauren Hesser, Cathryn Nagler",Nationalized PCT,3/23/2021,,,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5504058,,1696023,No
4161,18-T-079,System and Method for Multi-Site Radiotherapy,"62/733,263", ,*United States,US,9/19/2018,, ,9/19/2018,18-T-079-001,Small,9/19/2018,10/22/2018,,4/28/2022,Expired Prov - Filed PCT,Armstrong Teasdale,,37997-8,"Steven Chmura, Shan Lu, Ralph Weichselbaum",Provisional,10/22/2018, ,9/19/2019,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",1820041,,1696157,No
4162,18-T-079,System and Method for Multi-Site Radiotherapy,PCT/US19/51710, ,*United States,US,9/18/2019,,WO 2020/061179,9/18/2019,18-T-079-002,Small,9/19/2018,6/24/2021,No,4/28/2022,Expired Prov - Filed in US,Armstrong Teasdale,,37997-73,"Steven Chmura, Shan Lu, Ralph Weichselbaum",PCT,10/9/2019, ,3/19/2021,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",4030498,3/26/2020,1696157,No
4163,18-T-079,System and Method for Multi-Site Radiotherapy,"17/274,908", ,*United States,US,9/18/2019,,US-2022-0047892-A1,3/10/2021,18-T-079-003,Small,9/19/2018,3/10/2021,No,4/28/2022,Pending,Armstrong Teasdale,,37997-00092,"Steven Chmura, Shan Lu, Ralph Weichselbaum",Nationalized PCT,3/10/2021, ,9/18/2039,"Dembo, Anna",Steven Chmura,"Tennant, Thelma",5470914,2/17/2022,1696157,No
4164,18-T-080,Tuning the Molecular Interaction of Solvents Via Protein Polymer Modification,"62/744,075", ,*United States,US,10/10/2018,, ,10/10/2018,18-T-080-001,Small,10/10/2018,10/22/2018,,4/28/2022,Expired Prov - Filed PCT,Sheridan Ross PC,"Gary, Connell", ,"Garrett Chado, Joel Kaar, Mark Stoykovich",Provisional,10/22/2018, ,10/10/2019,"Hwang, Luke",Mark Stoykovich,"Juggernauth, Anne",1820585,,1696639,No
4165,18-T-080,Thermoresponsive Solubility of Proteins in Aqueous and Non-native solvents by Tuning Molecular Interactions via Polymer Modification,PCT/US19/55416, ,*United States,US,10/9/2019,, ,10/19/2019,18-T-080-002,Small,10/10/2018,6/24/2021,No,4/28/2022,Expired PCT - Filed in US only,Sheridan Ross PC,"Gary, Connell",2848B-315-PCT,"Garrett Chado, Joel Kaar, Mark Stoykovich",PCT,11/20/2019, ,4/10/2021,"Hwang, Luke",Mark Stoykovich,"Juggernauth, Anne",4123505,,1696639,No
4166,18-T-080,Thermoresponsive Solubility of Proteins in Aqueous and Non-native solvents by Tuning Molecular Interactions via Polymer Modification,"17/284,186",,*United States,US,10/9/2019,,,4/9/2021,18-T-080-003,None,10/10/2018,6/25/2021,No,3/18/2022,Pending,Sheridan Ross PC,"Gary, Connell",2848B-315-PUS,"Garrett Chado, Joel Kaar, Mark Stoykovich",Nationalized PCT,6/25/2021,,10/9/2039,"Hwang, Luke",Mark Stoykovich,"Juggernauth, Anne",5843287,,1696639,No
4167,18-T-082,System and Method for Compilation of Aggregated Instructions for Quantum Computers,"62/730,813", ,*United States,US,9/13/2018,, ,9/13/2018,18-T-082-001,Small,9/13/2018,,Yes,4/28/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick", ,"Frederic Chong, Pranav Gokhale, Henry (Hank) Hoffmann, Nelson Leung, David Schuster, Yunong Shi",Provisional,9/17/2018, ,9/13/2019,"Cox, Ben",Frederic Chong,"Smith, Dane",1698802,,1697204,No
4168,18-T-082,System and Method for Compilation of Aggregated Instructions for Quantum Computers,"62/773,581", ,*United States,US,11/30/2018,, ,11/30/2018,18-T-082-002,Small,11/30/2018,11/30/2018,No,4/28/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick", ,"Frederic Chong, Pranav Gokhale, Henry (Hank) Hoffmann, Nelson Leung, David Schuster, Yunong Shi",Provisional,11/30/2018, ,11/30/2019,"Cox, Ben",Frederic Chong,"Smith, Dane",1929745,,1697204,No
4169,18-T-082,System and Method of Optimizing Instructions for Quantum Computers,PCT/US19/50870, ,*United States,US,9/12/2019,,WO2020/056176,9/12/2019,18-T-082-003,Small,9/13/2018,3/8/2021,No,4/28/2022,Expired PCT - Nationalized,Armstrong Teasdale,"Brennan, Patrick",37997,"Frederic Chong, Pranav Gokhale, Henry (Hank) Hoffmann, Nelson Leung, David Schuster, Yunong Shi",PCT,9/15/2019,18-T-082-003,3/13/2021,"Cox, Ben",Frederic Chong,"Smith, Dane",3991362,3/19/2020,1697204,No
4170,18-T-082,System and Method of Optimizing Instructions for Quantum Computers,"17/273,938", ,*United States,US,9/12/2019,,US-2021-0334081-A1,3/5/2021,18-T-082-004,None,9/13/2018,3/8/2021,No,6/22/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-89,"Frederic Chong, Pranav Gokhale, Henry (Hank) Hoffmann, Nelson Leung, David Schuster, Yunong Shi",Nationalized PCT,1/27/2021,18-T-082-004,9/12/2039,"Cox, Ben",Frederic Chong,"Smith, Dane",5330962,10/28/2021,1697204,No
4171,18-T-082,System and Method of Optimizing Instructions for Quantum Computers,19858809.7, ,European Patent Office (EPO),EP,9/12/2019,,3850478,3/11/2021,18-T-082-005,Small,9/13/2018,9/15/2021,No,6/14/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-00091,"Frederic Chong, Pranav Gokhale, Henry (Hank) Hoffmann, Nelson Leung, David Schuster, Yunong Shi",Nationalized PCT,1/27/2021, ,9/12/2039,"Cox, Ben",Frederic Chong,"Smith, Dane",5330996,7/21/2021,1697204,No
4172,18-T-082,System and Method of Optimizing Instructions for Quantum Computers,2021-514626,,Japan,JP,9/12/2019,,2022-500776,3/11/2021,18-T-082-006,Small,9/13/2018,9/15/2021,No,6/22/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-90,"Frederic Chong, Pranav Gokhale, Henry (Hank) Hoffmann, Nelson Leung, David Schuster, Yunong Shi",Nationalized PCT,1/27/2021,,9/12/2039,"Cox, Ben",Frederic Chong,"Smith, Dane",5331638,1/4/2022,1697204,No
4173,18-T-083,Methods and Compositions for Treating Respiratory Syncytial Virus (RSV),"62/748,175", ,*United States,US,10/19/2018,, ,10/19/2018,18-T-083-001,Small,10/19/2018,10/19/2018,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0667US.P1,"Chuan He, Jianrong Li, Mijia Lu, Stefan Niewiesk, Mark Peeples, Miaoge Xue, Zijie Zhang, Boxuan Zhao",Provisional,10/29/2018, ,10/19/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",1835551,,1699631,No
4174,18-T-083,Methods and Compositions for Treating Negative-Sense Single-Stranded RNA Virus,PCT/US19/56942, ,*United States,US,10/18/2019,,WO 2020/081937,10/18/2019,18-T-083-002,Small,10/19/2018,4/20/2021,No,6/8/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0667WO,"Chuan He, Jianrong Li, Mijia Lu, Stefan Niewiesk, Mark Peeples, Miaoge Xue, Zijie Zhang, Boxuan Zhao",PCT,11/11/2019, ,4/19/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",4108653,4/23/2020,1699631,No
4175,18-T-083,Methods and Compositions for Treating Negative-Sense Single-Stranded RNA Virus,"17/309,038", ,*United States,US,10/18/2019,,US-2022-0033783-A1,4/16/2021,18-T-083-003,Small,10/19/2018,4/19/2021,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0667US,"Chuan He, Jianrong Li, Mijia Lu, Stefan Niewiesk, Mark Peeples, Miaoge Xue, Zijie Zhang, Boxuan Zhao",Nationalized PCT,3/8/2021, ,10/18/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5461200,2/3/2022,1699631,No
4176,18-T-084,Bionic Breast,"62/799,568",,*United States,US,1/31/2019,,,1/31/2019,18-T-084-001,Small,1/31/2019,2/6/2019,,6/3/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1100-PRO,"Sliman Bensmaia, Gillian Feldmeth, Stacy Lindau",Provisional,1/28/2019,18-T-084-001,1/31/2020,"Sun, Han",Sliman Bensmaia,"Tennant, Thelma",3484178,,1699681,No
4177,18-T-084,Bionic Breast,PCT/US20/16255,,*United States,US,1/31/2020,, ,1/31/2020,18-T-084-002,Small,1/31/2019,12/8/2021,No,6/15/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1100-WO,"Sliman Bensmaia, Gillian Feldmeth, Stacy Lindau, Katie Long, Sihong Wang",PCT,2/4/2020,18-T-084-002,7/31/2021,"Sun, Han",Sliman Bensmaia,"Tennant, Thelma",4255388,,1699681,No
4178,18-T-084,Bionic Breast,20749282.8,,European Patent Office (EPO),EP,1/31/2020,,,8/31/2021,18-T-084-003,Small,1/31/2019,9/7/2021,No,6/3/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1100-WO-EP,"Sliman Bensmaia, Gillian Feldmeth, Stacy Lindau, Katie Long, Sihong Wang",Nationalized PCT,9/7/2021,18-T-084-003,1/31/2040,"Sun, Han",Sliman Bensmaia,"Tennant, Thelma",6139556,,1699681,No
4179,18-T-084,Bionic Breast,"17/426,583",,*United States,US,1/31/2020,,US-2022-0143408-A1,7/28/2021,18-T-084-004,Small,1/31/2019,12/8/2021,No,6/15/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1100-WO-US,"Sliman Bensmaia, Gillian Feldmeth, Stacy Lindau, Katie Long, Sihong Wang",Nationalized PCT,12/8/2021,18-T-084-004,1/31/2040,"Sun, Han",Sliman Bensmaia,"Tennant, Thelma",6482243,5/12/2022,1699681,No
4180,18-T-086,Training Artificial Neural Networks Using Context-Dependent Gating with Weight Stabilization,"62/800,167", ,*United States,US,2/1/2019,, ,2/1/2019,18-T-086-001,Small,2/1/2019,2/6/2019,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1681-PRO,"David Freedman, Gregory Grant, Nicolas Masse",Provisional,2/6/2019,18-T-086-001,2/1/2020,"Ramirez, Mario Riojas",David Freedman,"Smith, Dane",3496414,,1699734,No
4181,18-T-086,Training Artificial Neural Networks Using Context-Dependent Gating with Weight Stabilization,"16/774,343","11,205,097 B2",*United States,US,1/28/2020,12/21/2021, ,1/28/2020,18-T-086-002,Small,2/1/2019,12/8/2021,No,4/28/2022,Issued,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1681-US,"David Freedman, Gregory Grant, Nicolas Masse",US Utility,1/30/2020,18-T-086-002,1/28/2040,"Ramirez, Mario Riojas",David Freedman,"Smith, Dane",4250638,,1699734,No
4182,18-T-086,Training Artificial Neural Networks Using Context-Dependent Gating with Weight Stabilization,"17/524,338", ,*United States,US,1/28/2020,,US-2022-0067442-A1,11/11/2021,18-T-086-003,Small,2/1/2019,11/12/2021,No,5/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1681-US-CON,"David Freedman, Gregory Grant, Nicolas Masse",Continuation,11/12/2021, ,1/28/2040,"Ramirez, Mario Riojas",David Freedman,"Smith, Dane",6389722,3/3/2022,1699734,No
4183,18-T-087,LIMA Crossover Catheter System,"62/740,957", ,*United States,US,10/4/2018,, ,10/4/2018,18-T-087-001,Small,10/4/2018,10/16/2018,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0670US.P1,Sandeep Nathan,Provisional,10/16/2018, ,10/4/2019,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",1799463,,1702012,No
4184,18-T-087,LIMA Crossover Catheter System,"62/876,928", ,*United States,US,7/22/2019,, ,7/22/2019,18-T-087-002,Small,7/22/2019,10/16/2018,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0670US.P2,Sandeep Nathan,Provisional,10/16/2018, ,7/22/2020,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",1800074,,1702012,No
4185,18-T-087,Lima Crossover Integrated Catheter System,PCT/US19/54683, ,*United States,US,10/4/2019,,WO 2020/072895,10/4/2019,18-T-087-003,Small,10/4/2018,4/15/2021,No,4/28/2022,Expired PCT - Filed in US only,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0670WO,Sandeep Nathan,PCT,10/15/2019, ,4/16/2022,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",4036213,4/9/2020,1702012,No
4186,18-T-087,Lima Crossover Integrated Catheter System,"17/250,957",,*United States,US,10/4/2019,,US-2021-0346654-A1,4/1/2021,18-T-087-004,None,10/4/2018,4/1/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0670US,Sandeep Nathan,Nationalized PCT,2/18/2021,,10/4/2039,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",5398117,11/11/2021,1702012,No
4187,18-T-089,Compositions and Methods for Activating NRF2-Dependent Gene Expression,"62/745,454", ,*United States,US,10/14/2018,, ,10/14/2018,18-T-089-001,Small,10/14/2018,10/22/2018,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Jae Won Chang, John Coukos, Gihoon Lee, Raymond Moellering, Gokhan Mutlu",Provisional,10/22/2018, ,10/14/2019,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",1820270,,1772371,No
4188,18-T-089,Compositions and Methods for Activating NRF2-Dependent Gene Expression,PCT/US19/56105, ,*United States,US,10/14/2019,,WO 2020/081446,10/14/2019,18-T-089-002,Small,10/14/2018,6/24/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0671WO,"Jae Won Chang, John Coukos, Gihoon Lee, Raymond Moellering, Gokhan Mutlu",PCT,10/23/2019,18-T-089-002,4/14/2021,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4053899,4/23/2020,1772371,No
4189,18-T-089,Compositions and Methods for Activating NRF2-Dependent Gene Expression,"17/309,017",,*United States,US,10/14/2019,,US-2022-0031656-A1,4/14/2021,18-T-089-003,Small,10/14/2018,4/14/2021,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0671US,"Jae Won Chang, John Coukos, Gihoon Lee, Raymond Moellering, Gokhan Mutlu",Nationalized PCT,3/25/2021,18-T-089-003,10/14/2039,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",5513854,2/3/2022,1772371,No
4190,18-T-089,Compositions and Methods for Activating NRF2-Dependent Gene Expression,19873293.5,,European Patent Office (EPO),EP,10/14/2019,,3863723,4/22/2021,18-T-089-004,None,10/14/2018,9/15/2021,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0671EP,"Jae Won Chang, John Coukos, Gihoon Lee, Raymond Moellering, Gokhan Mutlu",Nationalized PCT,3/26/2021,,10/14/2039,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",5515718,8/18/2021,1772371,No
4191,18-T-091,Mucosal Exclusion Anastomosis Device,"62/748,806", ,*United States,US,10/22/2018,, ,10/22/2018,18-T-091-001,Small,10/22/2018,10/26/2018,,4/28/2022,Abandoned,Armstrong Teasdale,,37997-9,Herbert Mason Hedberg,Provisional,10/26/2018, ,10/22/2019,"Cox, Ben",Herbert Mason Hedberg,"Tennant, Thelma",1834593,,1780285,No
4192,18-T-091,Mucosal Exclusion Anastomosis Device,"62/924,305", ,*United States,US,10/22/2019,, ,10/22/2019,18-T-091,Small,10/22/2019,10/22/2019,No,4/28/2022,Expired Prov - Filed in US,Armstrong Teasdale,"Brennan, Patrick",37997-78,Herbert Mason Hedberg,Provisional,10/22/2019, ,10/22/2020,"Cox, Ben",Herbert Mason Hedberg,"Tennant, Thelma",4046998,,1780285,No
4193,18-T-091,Mucosal Exclusion Anastomosis Device and Methods,"17/077,509", ,*United States,US,10/22/2020,,US-2021-0113323-A1,10/22/2020,18-T-091-002,Small,10/22/2019,8/12/2020,No,4/28/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-83,Herbert Mason Hedberg,US Utility,8/12/2020, ,10/20/2040,"Cox, Ben",Herbert Mason Hedberg,"Tennant, Thelma",4824979,4/22/2021,1780285,No
4194,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,"62/774,314", ,*United States,US,12/2/2018,, ,12/2/2018,2727-001,Small,12/2/2018,1/14/2019,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-PRO,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",Provisional,11/13/2018, ,12/2/2019,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",1884690,,1822711,No
4195,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,PCT/US19/64053, ,*United States,US,12/2/2019,,WO 2020/117701,12/2/2019,2727-002,Small,12/2/2018,6/24/2021,No,4/28/2022,Expired PCT - Nationalized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-WO,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",PCT,12/16/2019, ,6/2/2021,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",4191748,6/11/2020,1822711,No
4196,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,"17/295,704",,*United States,US,12/2/2019,,US-2022-0011325-A1,5/20/2021,2727-003,Small,12/2/2018,5/21/2021,No,4/27/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-WO-US,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung, Anand Saminathan",Nationalized PCT,5/3/2021,2727-003,12/2/2039,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5647837,1/13/2022,1822711,No
4197,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,19893431.7,,European Patent Office (EPO),EP,12/2/2019,,3887519,6/2/2021,2727-004,Small,12/2/2018,5/26/2021,No,3/18/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-WO-EP,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",Nationalized PCT,5/3/2021,,12/2/2039,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5647882,10/6/2021,1822711,No
4198,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,2021-531481,,Japan,JP,12/2/2019,,,6/1/2021,2727-007,Small,12/2/2018,5/26/2021,No,3/18/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-WO-JP,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",Nationalized PCT,5/18/2021,,12/2/2039,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5744871,,1822711,No
4199,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,202117029348,,India,IN,12/2/2019,,,6/30/2021,2727-006,Small,12/2/2018,7/8/2021,No,3/30/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-WO-IN,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",Nationalized PCT,5/18/2021,,12/2/2039,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5744916,,1822711,No
4200,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,201980090973.X,,China,CN,12/2/2019,,CN 113383075 A,7/30/2021,2727-005,Small,12/2/2018,8/4/2021,No,3/18/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",18-1897-WO-CN,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",Nationalized PCT,5/18/2021,,12/2/2039,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",5744961,9/10/2021,1822711,No
4201,18-T-094,Methods of Determining pH and Calcium or Chloride Concentration in Samples,62022047604.3,,Hong Kong,HK,12/2/2019,,,2/4/2022,2727-008,Small,12/2/2018,3/2/2022,No,5/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",18-1897-WO-EP-HK,"Kasturi Chakraborty, Yamuna Krishnan, Ka Ho Leung",Nationalized PCT,1/25/2022,,,"Sun, Han",Yamuna Krishnan,"Tennant, Thelma",6699498,,1822711,No
4202,18-T-289,Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles,"62/349,707", ,*United States,US,6/14/2016,, ,6/14/2016,18-T-289-001,Small,6/14/2016,2/8/2019,,4/28/2022,Expired Prov - Filed PCT,Dinsmore & Shohl LLP,,116-038-UC,"JianJun Chen, Seungpyo Hong, Xi Jiang, Zejuan Li",Provisional,2/8/2019, ,6/14/2017,"Sun, Han",JianJun Chen,"Tennant, Thelma",3498791,,1850428,No
4203,18-T-289,Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles,PCT/US17/37424, ,*United States,US,6/14/2017,,WO2017/218638,6/14/2017,18-T-289-002,None,6/14/2016,2/8/2019,No,4/28/2022,Expired PCT - Filed in US only,Dinsmore & Shohl LLP,,116-038-UC,"JianJun Chen, Seungpyo Hong, Xi Jiang, Zejuan Li",PCT,2/8/2019, ,12/14/2018,"Sun, Han",JianJun Chen,"Tennant, Thelma",3498869,12/21/2017,1850428,No
4204,18-T-289,Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles,"16/310,104", ,*United States,US,6/14/2017,, ,12/14/2018,18-T-289-003,Small,6/14/2016,2/8/2019,No,4/28/2022,Pending,Dinsmore & Shohl LLP,,116-038-UC,"JianJun Chen, Seungpyo Hong, Xi Jiang, Zejuan Li",Nationalized PCT,2/8/2019, ,6/14/2037,"Sun, Han",JianJun Chen,"Tennant, Thelma",3498941,,1850428,No
4205,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,"62/782,690", ,*United States,US,12/20/2018,, ,12/20/2018,18-T-649-001,Small,12/20/2018,1/3/2019,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672US.P1,"Lev Becker, Chang Cui",Provisional,11/14/2018, ,12/20/2019,"Sun, Han",Lev Becker,"Tennant, Thelma",1891494,,1870987,No
4206,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,PCT/US19/67890, ,*United States,US,12/20/2019,,WO 2020/132465 A1,12/20/2019,18-T-649-002,Small,12/20/2018,6/16/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672WO,"Lev Becker, Chang Cui",PCT,12/31/2019, ,6/20/2021,"Sun, Han",Lev Becker,"Tennant, Thelma",4199669,6/25/2020,1870987,No
4207,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,"17/346,480",,*United States,US,12/20/2019,,US-2022-0000977-A1,6/14/2021,18-T-649-003,Small,12/20/2018,9/15/2021,No,5/13/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672US,"Lev Becker, Chang Cui",Nationalized PCT,5/11/2021,,12/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",5723194,1/6/2022,1870987,No
4208,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,3123853,,Canada,CA,12/20/2019,,,6/16/2021,18-T-649-005,Small,12/20/2018,7/1/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672CA,"Lev Becker, Chang Cui",Nationalized PCT,5/11/2021,,12/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",5723226,,1870987,No
4209,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,19899959.1,,European Patent Office (EPO),EP,12/20/2019,,3897669,6/29/2021,18-T-649-007,Small,12/20/2018,5/11/2021,No,4/12/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672EP,"Lev Becker, Chang Cui",Nationalized PCT,5/11/2021,,12/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",5723258,10/27/2021,1870987,No
4210,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,2021-535554,,Japan,JP,12/20/2019,,2022-514354A,6/18/2021,18-T-649-008,Small,12/20/2018,9/15/2021,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672JP,"Lev Becker, Chang Cui",Nationalized PCT,5/11/2021,,12/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",5723290,2/10/2022,1870987,No
4211,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,2019403393,,Australia,AU,12/20/2019,,,7/9/2021,18-T-649-004,Small,12/20/2018,7/19/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672AU,"Lev Becker, Chang Cui",Nationalized PCT,5/11/2021,,12/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",5723336,,1870987,No
4212,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,201980092976.7,,China,CN,12/20/2019,,CN 113677351 A,8/20/2021,18-T-649-006,Small,12/20/2018,8/23/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672CN,"Lev Becker, Chang Cui",Nationalized PCT,5/11/2021,,10/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",5723368,11/19/2021,1870987,No
4213,18-T-649,Methods and Compositions Related to Therapeutic Peptides for Cancer Therapy,62021043288.1,,Hong Kong,HK,12/20/2019,,40055503,11/29/2021,18-T-649-009,Small,12/20/2018,1/6/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0672EHK,"Lev Becker, Chang Cui",Nationalized PCT,1/6/2022,,12/20/2039,"Sun, Han",Lev Becker,"Tennant, Thelma",6554356,3/11/2022,1870987,No
4214,18-T-652,WOMANLAB,"88/092,554", ,*United States,US,8/24/2018,, ,8/24/2018,18-T-652-001,Small,,8/24/2018,,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9182-US01,Stacy Lindau,Trademark,11/6/2018, ,,"Sun, Han",Stacy Lindau,"Tennant, Thelma",1872767,,1872756,No
4215,18-T-658,Methods and Compositions Comprising an NFKB Inhibitor and an Adjuvant,"62/776,860", ,*United States,US,12/7/2018,, ,12/7/2018,18-T-658-001,Small,12/7/2018,12/19/2018,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0677US.P1,"Aaron Esser-Kahn, Brittany Moser",Provisional,12/19/2018, ,12/7/2019,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",3345050,,1883058,No
4216,18-T-658,Methods and Compositions Comprising an NFKB Inhibitor and an Adjuvant,"62/924,315", ,*United States,US,10/22/2019,, ,10/22/2019,18-T-658-002,Small,10/22/2019,10/24/2019,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0677US.P2,"Aaron Esser-Kahn, Brittany Moser",Provisional,10/24/2019, ,10/22/2020,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",4063915,,1883058,No
4217,18-T-658,Methods and Compositions Comprising an NFKB Inhibitor and an Adjuvant,PCT/US19/64888, ,*United States,US,12/6/2019,,WO 2020/118159 A1,12/6/2019,18-T-658-003,Small,12/7/2018,5/25/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0677WO,"Aaron Esser-Kahn, Brittany Moser",PCT,12/9/2019, ,6/7/2021,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",4143195,6/11/2020,1883058,No
4218,18-T-658,Methods and Compositions Comprising an NFKB Inhibitor and an Adjuvant,"17/337,610",,*United States,US,12/6/2019,,US-2021-0346495-A1,6/3/2021,18-T-658-004,Small,12/7/2018,6/9/2021,No,6/13/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0677US,"Aaron Esser-Kahn, Brittany Moser",Nationalized PCT,5/25/2021,18-T-658-004,12/6/2039,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5760899,11/11/2021,1883058,No
4219,18-T-658,Methods and Compositions Comprising an NFKB Inhibitor and an Adjuvant,19892608.1,,European Patent Office (EPO),EP,12/6/2019,,3890766,6/6/2021,18-T-658-005,Small,12/7/2018,8/4/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0677EP,"Aaron Esser-Kahn, Brittany Moser",Nationalized PCT,5/25/2021,,12/6/2039,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5760918,10/13/2021,1883058,No
4220,18-T-658,Methods and Compositions Comprising an NFKB Inhibitor and an Adjuvant,201980091497.3,,China,CN,12/6/2019,,CN 113412111 A,8/6/2021,18-T-658-006,None,12/7/2018,8/6/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0677CN,"Aaron Esser-Kahn, Brittany Moser",Nationalized PCT,5/27/2021,,12/6/2039,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5769359,9/17/2021,1883058,No
4221,18-T-659,"Apparatus, System, and Method for Mechanical Ablation with Therapeutic Ultrasound","62/814,570", ,*United States,US,3/6/2019,, ,3/6/2019,18-T-659-001,Small,3/6/2019,3/6/2019,,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0680US.P1,"Kenneth Bader, Viktor Bollen",Provisional,3/6/2019, ,3/6/2020,"Cox, Ben",Kenneth Bader,"Smith, Dane",3555576,,1883341,No
4222,18-T-659,"Apparatus, System, and Method for Mechanical Ablation with Therapeutic Ultrasound","16/809,732", ,*United States,US,3/6/2019,,US-2020-0282239-A1,3/5/2020,18-T-659-002,Small,3/6/2019,3/10/2020,No,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0680US,"Kenneth Bader, Viktor Bollen",US Utility,3/10/2020, ,3/6/2039,"Cox, Ben",Kenneth Bader,"Smith, Dane",4405558,9/10/2020,1883341,No
4223,18-T-660,"PHOTOACTIVE, INORGANIC LIGAND-CAPPED INORGANIC NANOCRYSTALS","62/746,710", ,*United States,US,10/17/2018,, ,10/17/2018,18-T-660-001,Small,10/17/2018,11/13/2018,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle", ,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang",Provisional,11/13/2018, ,10/17/2019,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",1884022,,1883667,No
4224,18-T-660,"Photosensitive, Inorganic Ligand-Capped Inorganic Nanocrystals",PCT/US19/55784, ,*United States,US,10/11/2019,,WO 2020/123021,10/11/2019,18-T-660-002,Small,10/17/2018,6/24/2021,No,4/28/2022,Expired PCT - Nationalized,"Bell & Manning, LLC","Manning, Michelle",05400-0035-PCT,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang, Haoqi Wu",PCT,10/24/2019, ,4/17/2021,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4067083,6/18/2020,1883667,No
4225,18-T-660,"Photosensitive, Inorganic Ligand-Capped Inorganic Nanocrystals",108137241, ,"Taiwan, Province of China",TW,10/16/2019,,202024296,10/16/2019,18-T-660-003,Small,10/17/2018,10/24/2019,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0035-TW,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang, Haoqi Wu","Foreign, Non-PCT",10/24/2019, ,10/16/2039,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4067295,7/1/2020,1883667,No
4226,18-T-660,"Photosensitive, Inorganic Ligand-Capped Inorganic Nanocrystals","17/283,457",,*United States,US,10/11/2019,,US-2022-0011664-A1,4/7/2021,18-T-660-004,Small,10/17/2018,4/9/2021,No,4/27/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0035-US,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang, Haoqi Wu",Nationalized PCT,3/29/2021,,10/11/2039,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",5519642,1/13/2022,1883667,No
4227,18-T-660,"Photosensitive, Inorganic Ligand-Capped Inorganic Nanocrystals",2021-521027,,Japan,JP,10/11/2019,,2022-512720,4/15/2021,18-T-660-007,None,10/17/2018,6/24/2021,No,3/22/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0035-JP,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang, Haoqi Wu",Nationalized PCT,3/29/2021,,10/11/2039,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",5519711,2/7/2022,1883667,No
4228,18-T-661,Systems and Methods for Advance Healthcare Assistance,"62/802,467", ,*United States,US,2/7/2019,, ,2/7/2019,18-T-661-001,Small,2/7/2019,1/10/2020,,4/28/2022,Abandoned,Armstrong Teasdale,"Brennan, Patrick",37997-71,"Michael Cui, David Liebovitz",Provisional,2/12/2019, ,2/7/2020,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",3501907,,1883948,No
4229,18-T-665,Quantum Error Correction Method,"62/813,107", ,*United States,US,3/3/2019,, ,3/3/2019,18-T-665-001,Small,3/3/2019,3/4/2019,,4/28/2022,Expired Prov - Filed PCT,Barnes & Thornburg,"Kelsey, Jeffrey",21459-286367,"Srivatsan Chakram, David Schuster",Provisional,3/4/2019, ,3/3/2020,"Cox, Ben",David Schuster,"Juggernauth, Anne",3550313,,1893862,No
4230,18-T-665,Quantum Error Correction Method,PCT/US20/20851, ,*United States,US,3/3/2020,,WO 2020/180902 A1,3/3/2020,18-T-665-002,Small,3/3/2019,3/9/2022,No,5/23/2022,Expired PCT - Filed in US only,Barnes & Thornburg,"Kelsey, Jeffrey",21459-317529,"Srivatsan Chakram, David Schuster",PCT,3/19/2020, ,9/3/2021,"Cox, Ben",David Schuster,"Juggernauth, Anne",4413204,9/10/2020,1893862,No
4231,18-T-665,Quantum Error Correction Method,"17/435,307",,*United States,US,3/31/2020,,2022-0156630-A1,8/31/2021,18-T-665-003,Small,3/3/2019,8/31/2021,No,6/17/2022,Pending,Barnes & Thornburg,"Kelsey, Jeffrey",21459-345901,"Srivatsan Chakram, David Schuster",Nationalized PCT,8/4/2021,,3/31/2040,"Cox, Ben",David Schuster,"Juggernauth, Anne",5983605,5/19/2022,1893862,No
4232,18-T-666,Hello Greenlight (Trademark),"88/262,399", ,*United States,US,1/15/2019,, ,1/15/2019,18-T-666-001,Small,,1/23/2019,,4/28/2022,Pending,Michael Best & Friedrich LLP,"Brown, Jeffrey",092234-9184-US01,"Amanda Geppert, Melissa Gilliam, Laura Paradis",Trademark,1/23/2019, ,,"Ginsburg, Eric",Melissa Gilliam,"Smith, Dane",3468270,,1894421,No
4233,18-T-668,Compositions and Methods for Detecting and Treating Acute Respiratory Distress Syndrome (ARDS),"62/758,172", ,*United States,US,11/9/2018,, ,11/9/2018,18-T-668-001,Small,11/9/2018,11/9/2018,,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Sajid Shahul,Provisional,11/18/2018, ,11/9/2019,"Bakalyar, Heather",Sajid Shahul,"Tennant, Thelma",1900983,,1899018,No
4234,18-T-669,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,"62/782,911", ,*United States,US,12/20/2018,, ,12/20/2018,18-T-669-001,Small,12/20/2018,12/28/2018,,6/8/2022,Expired - Inactive,"Casimir Jones, S.C.",,UCHI-37430.101,"Bryan Dickinson, Chuan He, Huiqing Zhou",Provisional,12/28/2018, ,12/20/2019,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",3376247,,1900403,No
4235,18-T-677,Systems and Methods for Modulating RNA,"62/788,571", ,*United States,US,1/4/2019,, ,1/4/2019,18-T-677-001,Small,1/4/2019,1/14/2019,Yes,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678US.P1,"Bryan Dickinson, Simone Rauch",Provisional,1/14/2019,18-T-677-001,1/4/2020,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",3393974,,1924847,No
4236,18-T-677,Systems and Methods for Modulating RNA,"62/831,342", ,*United States,US,4/9/2019,, ,4/9/2019,18-T-677-002,None,4/9/2019,4/19/2019,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678US.P2,"Bryan Dickinson, Simone Rauch",Provisional,4/19/2019,18-T-677-002,4/9/2020,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",3637156,,1924847,No
4237,18-T-677,Systems and Methods for Modulating RNA,"62/903,080", ,*United States,US,9/20/2019,, ,9/20/2019,18-T-677-003,None,9/20/2019,10/8/2019,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678US.P3,"Bryan Dickinson, Simone Rauch",Provisional,10/8/2019,18-T-677-003,9/20/2020,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",4029356,,1924847,No
4238,18-T-677,Systems and Methods for Modulating RNA,"62/929,339", ,*United States,US,11/1/2019,, ,11/1/2019,18-T-677-004,Small,11/1/2019,11/20/2019,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678US.P4,"Bryan Dickinson, Simone Rauch",Provisional,11/20/2019,18-T-677-004,11/1/2020,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",4123545,,1924847,No
4239,18-T-677,Systems and Methods for Modulating RNA,PCT/US20/12169, ,*United States,US,1/3/2020,,WO 2020/142676,1/3/2020,18-T-677-005,Small,1/4/2019,7/8/2021,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678WO,"Bryan Dickinson, Simone Rauch",PCT,1/3/2020,18-T-677-005,7/4/2021,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",4204180,7/9/2020,1924847,No
4240,18-T-677,Systems and Methods for Modulating RNA,10-2021-7024731,,"Korea, Republic of",KR,1/3/2020,,,8/4/2021,18-T-677-006,None,1/4/2019,6/25/2021,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678KR,"Bryan Dickinson, Simone Rauch",Nationalized PCT,6/25/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5843022,,1924847,No
4241,18-T-677,Systems and Methods for Modulating RNA,3125299,,Canada,CA,1/3/2020,,,6/28/2021,18-T-677-007,None,1/4/2019,7/1/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678CA,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/1/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5858191,,1924847,No
4242,18-T-677,Systems and Methods for Modulating RNA,2021-538952,,Japan,JP,1/3/2020,,2022-516919 A,7/2/2021,18-T-677-008,Small,1/4/2019,7/7/2021,No,4/26/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678JP,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/7/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5876466,3/3/2022,1924847,No
4243,18-T-677,Systems and Methods for Modulating RNA,284516,,Israel,IL,1/3/2020,,,6/30/2021,18-T-677-009,None,1/4/2019,7/7/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678IL,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/7/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5877967,,1924847,No
4244,18-T-677,Systems and Methods for Modulating RNA,2021/04568,,South Africa,ZA,1/3/2020,,,6/30/2021,18-T-677-010,None,1/4/2019,7/7/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678ZA,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/7/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5878021,,1924847,No
4245,18-T-677,Systems and Methods for Modulating RNA,11202107209W,,Singapore,SG,1/3/2020,,,6/30/2021,18-T-677-011,None,1/4/2019,7/7/2021,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678SG,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/7/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5878154,,1924847,No
4246,18-T-677,Systems and Methods for Modulating RNA,"17/309,936",,*United States,US,1/3/2020,,US-2022-0038962-A1,7/1/2021,18-T-677-012,None,1/4/2019,7/8/2021,No,6/15/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678US,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/8/2021,18-T-677-012,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5878678,2/17/2022,1924847,No
4247,18-T-677,Systems and Methods for Modulating RNA,BR 1120210131736,,Brazil,BR,1/3/2020,,,7/2/2021,18-T-677-013,None,1/4/2019,7/8/2021,No,4/1/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678BR,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/8/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5880242,,1924847,No
4248,18-T-677,Systems and Methods for Modulating RNA,MX/a/2021/008153,,Mexico,MX,1/3/2020,,,7/2/2021,18-T-677-014,None,1/4/2019,7/8/2021,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678MX,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/8/2021,,1/20/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5880569,,1924847,No
4249,18-T-677,Systems and Methods for Modulating RNA,202080018393.2,,China,CN,1/3/2020,,CN 113543797 A,9/2/2021,18-T-677-015,Small,1/4/2019,7/9/2021,No,4/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678CN,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/9/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5887834,10/22/2021,1924847,No
4250,18-T-677,Systems and Methods for Modulating RNA,20736077.7,,European Patent Office (EPO),EP,1/3/2020,,3906042,7/12/2021,18-T-677-016,None,1/4/2019,7/9/2021,No,6/15/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678EP,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/9/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5887902,11/10/2021,1924847,No
4251,18-T-677,Systems and Methods for Modulating RNA,2020204917,,Australia,AU,1/3/2020,,,7/30/2021,18-T-677-018,None,1/4/2019,7/9/2021,No,3/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678AU,"Bryan Dickinson, Simone Rauch",Nationalized PCT,7/9/2021,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5887996,,1924847,No
4252,18-T-677,Systems and Methods for Modulating RNA,62022048288.4,,Hong Kong,HK,1/3/2020,,40060450,2/15/2022,18-T-677-017,Small,1/4/2019,2/22/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0678CHK,"Bryan Dickinson, Simone Rauch",Nationalized PCT,2/7/2022,,1/3/2040,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",6770727,5/20/2022,1924847,No
4253,18-T-678,Small Molecular Regulation of Tobacco Etch Virus Protease Activity,"62/855,583", ,*United States,US,5/31/2019,, ,5/31/2019,18-T-678-001,Small,5/31/2019,,,4/28/2022,Abandoned,Armstrong Teasdale,"Brennan, Patrick", ,"Julie Allombert, Heather Pinkett, Howard Shuman",Provisional,6/3/2019, ,5/31/2020,"Dembo, Anna",Howard Shuman,"Butler, Brittany",3760695,,1925846,No
4254,18-T-679,COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH,"62/699,975", ,*United States,US,7/18/2018,, ,7/18/2018,18-T-679-001,Small,7/18/2018,11/30/2018,,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.",, ,"Donna Arvans, Hatim Hassan",Provisional,11/30/2018, ,7/18/2019,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",1929840,,1929835,No
4255,18-T-679,COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH,PCT/US19/42416, ,*United States,US,7/18/2019,,WO 2020/018799,7/18/2019,18-T-679-002,Small,7/18/2018,7/22/2019,No,5/8/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.",,36476.601,"Donna Arvans, Hatim Hassan",PCT,7/22/2019, ,1/22/2022,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",3845626,1/23/2020,1929835,No
4256,18-T-679,COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH,"17/260,690", ,*United States,US,7/18/2019,,2021-0275629,1/15/2021,18-T-679-003,Small,7/18/2018,1/21/2021,No,6/15/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-36476.252,"Donna Arvans, Hatim Hassan",Nationalized PCT,1/21/2021, ,7/18/2039,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",5289145,9/9/2021,1929835,No
4257,18-T-679,COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH,19838795.3, ,European Patent Office (EPO),EP,7/18/2019,,3836949,1/22/2021,18-T-679-004,Small,7/18/2018,2/2/2021,No,6/15/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-36476.611,"Donna Arvans, Hatim Hassan",Nationalized PCT,2/2/2021, ,7/18/2039,"Dembo, Anna",Hatim Hassan,"Tennant, Thelma",5345805,6/23/2021,1929835,No
4258,18-T-683,A scalable large-area optical sensing platform with compact light delivery & imaging system,"16/146,360", ,*United States,US,9/28/2018,, ,9/28/2018,18-T-683-001,None,9/28/2018,3/23/2022,Yes,4/28/2022,Prosecution by Other Party,,,ANL-IN-18-010,"Zoe Cardon, Supratik Guha, Xufeng Zhang",US Utility,5/8/2019, ,9/28/2038,"Cox, Ben",Supratik Guha,"Juggernauth, Anne",3694249,,1950923,No
4259,18-T-684,Transradial Approach/Angiography Board,"62/802,424", ,*United States,US,2/7/2019,, ,2/7/2019,18-T-684-001,Small,2/7/2019,3/2/2021,,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0668US.P1,"Anokha Nathan, Sandeep Nathan",Provisional,2/12/2019, ,2/7/2020,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",3501566,,1950925,No
4260,18-T-684,Transradial Approach/Angiography Board,"62/972,355", ,*United States,US,2/10/2020,, ,2/10/2020,18-T-684-002,Small,2/10/2020,3/2/2021,,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0709US.P1,"Anokha Nathan, Sandeep Nathan",Provisional,2/10/2020, ,2/10/2021,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",4263575,,1950925,No
4261,18-T-684,Transradial Approach/Angiography Board,"63/159,808",,*United States,US,3/11/2021,,,3/11/2021,18-T-684-003,Small,3/11/2021,5/20/2022,No,5/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0709US.P2,"Anokha Nathan, Sandeep Nathan",Provisional,3/12/2021,,3/11/2022,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",5479302,,1950925,No
4262,18-T-684,Transradial Approach/Angiography Board,"63/320,929", ,*United States,US,3/17/2022,, ,3/17/2022,18-T-684-004,Small,,3/18/2022,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0765US.P1,"Anokha Nathan, Sandeep Nathan",Provisional,3/1/2022, ,3/17/2023,"Cox, Ben",Sandeep Nathan,"Tennant, Thelma",6869985,,1950925,No
4263,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,"62/782,906", ,*United States,US,12/20/2018,, ,12/20/2018,18-T-689-001,Small,12/20/2018,12/28/2018,,6/8/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Schlueter, Peter", ,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Provisional,12/28/2018, ,12/20/2019,"Hwang, Luke",Chuan He,"Tennant, Thelma",3376211,,1964377,No
4264,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,PCT/US19/68001, ,*United States,US,12/20/2019,,WO 2020/132536,12/20/2019,18-T-689-002,Small,12/20/2018,6/22/2021,Yes,6/8/2022,Expired PCT - Nationalized,"Casimir Jones, S.C.","Schlueter, Peter",UCHI-37446.601,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",PCT,1/3/2020, ,6/20/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",4204137,6/25/2020,1964377,No
4265,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,"17/311,448",,*United States,US,12/20/2019,,2022-0025004,6/7/2021,18-T-689-003,None,12/20/2018,6/24/2021,No,6/15/2022,Pending,"Casimir Jones, S.C.","Schlueter, Peter",UCHI-37446.252,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Nationalized PCT,5/11/2021,,12/20/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5723446,1/27/2022,1964377,No
4266,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,"3,123,221",,Canada,CA,12/20/2019,,,6/11/2021,18-T-689-004,None,12/20/2018,7/8/2021,No,6/8/2022,Pending,"Casimir Jones, S.C.","Schlueter, Peter",37446.711,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Nationalized PCT,5/11/2021,,12/20/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5723510,,1964377,No
4267,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,19901156.0,,European Patent Office (EPO),EP,12/20/2019,,3897671,6/22/2021,18-T-689-006,None,12/20/2018,7/8/2021,No,6/15/2022,Pending,"Casimir Jones, S.C.","Schlueter, Peter",UCHI-37446.611,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Nationalized PCT,5/11/2021,,12/20/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5723550,10/27/2021,1964377,No
4268,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,2021-535185,,Japan,JP,12/20/2019,,,6/17/2021,18-T-689-007,Small,12/20/2018,9/15/2021,No,6/15/2022,Pending,"Casimir Jones, S.C.","Schlueter, Peter",UCHI-37446.701,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Nationalized PCT,5/11/2021,,12/20/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",5723584,,1964377,No
4269,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,201980092133.7,,China,CN,12/20/2019,,,8/13/2021,18-T-689-005,Small,12/20/2018,9/1/2021,No,6/15/2022,Pending,"Casimir Jones, S.C.","Schlueter, Peter",UCHI-37446.731,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Nationalized PCT,5/11/2021,,,"Hwang, Luke",Chuan He,"Tennant, Thelma",5723620,,1964377,No
4270,18-T-689,Compositions and Methods Related to Site-Specific Identification of RNA Modifications,62022052033.7,,Hong Kong,HK,12/20/2019,,40062426,4/20/2022,18-T-689-008,Small,12/20/2018,5/11/2022,No,6/24/2022,Pending,"Casimir Jones, S.C.","Schlueter, Peter",UCHI-37446.821,"Dali Han, Chuan He, Ralph Weichselbaum, Meng Xu",Nationalized PCT,5/11/2022,,12/20/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",7240420,6/10/2022,1964377,
4271,18-T-690,Cabozantinib unlocks efficient in vivo targeted delivery of neutrophil-loaded nanoparticles into prostate tumors,"62/803,281", ,*United States,US,2/8/2019,, ,2/8/2019,18-T-690-001,None,2/8/2019,1/21/2020,,4/28/2022,Expired - Inactive,Clark & Elbing LLP,,BWH25486,"Jeffrey Karp, Akash Patnaik",Provisional,2/26/2019, ,2/8/2020,"Sun, Han",Akash Patnaik,"Tennant, Thelma",3522157,,3327930,No
4272,19-T-003,System And Method For Secondary Amplification Of Refractive Detection Signals,"16/265,638", ,*United States,US,2/1/2019,, ,2/1/2019,19-T-003-001,Small,,12/1/2021,,4/28/2022,Abandoned,,, ,"Benjamin Diroll, Supratik Guha, Xufeng Zhang",US Utility,4/28/2021, ,,"Cox, Ben",Supratik Guha,"Tennant, Thelma",5637060,,3386249,No
4273,19-T-004,Multi-Band Infrared Imaging Using Stacked Colloidal Quantum-Dot Photodiodes,"62/799,827",,*United States,US,2/1/2019,, ,2/1/2019,19-T-004-001,Small,2/1/2019,2/6/2019,,6/22/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0037,"Matthew Ackerman, Philippe Guyot-Sionnest, Xin Tang",Provisional,2/6/2019,19-T-004-001,2/1/2020,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",3496362,,3386604,No
4274,19-T-004,Multi-Band Infrared Imaging Using Stacked Colloidal Quantum-Dot Photodiodes,"62/870,218",,*United States,US,7/3/2019,,,7/3/2019,19-T-004-002,Small,7/3/2019,7/18/2019,No,6/22/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0037,"Matthew Ackerman, Philippe Guyot-Sionnest, Xin Tang",Provisional,7/18/2019,19-T-004-002,7/3/2020,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",3799140,,3386604,No
4275,19-T-004,Multi-Band Infrared Imaging Using Stacked Colloidal Quantum-Dot Photodiodes,PCT/US20/16049,,*United States,US,1/31/2020,,WO 2020/160370,1/31/2020,19-T-004-003,Small,2/1/2019,8/3/2021,No,6/22/2022,Expired PCT - Nationalized,"Bell & Manning, LLC","Manning, Michelle",05400-0037-PCT,"Matthew Ackerman, Philippe Guyot-Sionnest, Xin Tang",PCT,2/3/2020,19-T-004-003,8/1/2021,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",4253588,8/6/2020,3386604,No
4276,19-T-004,Multi-Band Infrared Imaging Using Stacked Colloidal Quantum-Dot Photodiodes,"17/422,973",,*United States,US,1/31/2020,,US-2022-0085225-A1,7/14/2021,19-T-004-004,Large,2/1/2019,7/19/2021,No,6/22/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0037-US,"Matthew Ackerman, Philippe Guyot-Sionnest, Xin Tang",Nationalized PCT,7/19/2021,19-T-004-004,1/31/2040,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",5914115,3/17/2022,3386604,No
4277,19-T-004,Multi-Band Infrared Imaging Using Stacked Colloidal Quantum-Dot Photodiodes,20748763.8,,European Patent Office (EPO),EP,1/31/2020,,3917873,7/21/2021,19-T-004-005,Large,2/1/2019,8/3/2021,No,6/6/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0037-EP,"Matthew Ackerman, Philippe Guyot-Sionnest, Xin Tang",Nationalized PCT,8/3/2021,,1/31/2040,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",5977051,12/8/2021,3386604,No
4278,19-T-004,Multi-Band Infrared Imaging Using Stacked Colloidal Quantum-Dot Photodiodes,2021-544497,,Japan,JP,1/31/2020,,2022-524919,7/30/2021,19-T-004-006,Large,2/1/2019,8/3/2021,No,6/22/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0037-JP,"Matthew Ackerman, Philippe Guyot-Sionnest, Xin Tang",Nationalized PCT,8/3/2021,,1/31/2040,"Hwang, Luke",Philippe Guyot-Sionnest,"Juggernauth, Anne",5979298,5/11/2022,3386604,No
4279,19-T-011,Compositions and Methods for Inhibition of Cancer Metastasis,"62/893,144", ,*United States,US,8/28/2019,, ,8/28/2019,19-T-011-001,Small,8/28/2019,9/10/2019,,4/28/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-124-PRO,"Marc Ferrer, Hilary Ann Kenny, Ernst Lengyel, Min Shen",Provisional,9/10/2019, ,8/28/2020,"Dembo, Anna",Ernst Lengyel,"Tennant, Thelma",3987982,,3471213,No
4280,19-T-012,Methods of Treating Demyelinating Diseases,"62/796,429", ,*United States,US,1/24/2019,, ,1/24/2019,19-T-012-001,Small,1/24/2019,1/15/2020,,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-106-PRO,Raymond Roos,Provisional,2/6/2019, ,1/24/2020,"Butler, Brittany",Raymond Roos,"Butler, Brittany",3496535,,3474652,No
4281,19-T-012,Methods of Treating Demyelinating Diseases,"62/796,432", ,*United States,US,1/24/2019,, ,1/24/2019,19-T-012-002,Small,1/24/2019,1/15/2020,No,4/28/2022,Expired - Inactive,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-106-PRO2,Raymond Roos,Provisional,2/6/2019, ,1/24/2020,"Butler, Brittany",Raymond Roos,"Butler, Brittany",3496564,,3474652,No
4282,19-T-015,Science Companion,"76/975,962",1071557,*United States,US,2/21/2001,12/23/2003,,,19-T-015-001,Small,,10/28/2021,No,10/28/2021,Registered (TM),,,092318-9082-WO01,Debbie Leslie,Trademark,2/5/2021,,,"Ramirez, Mario Riojas",Debbie Leslie,"Tennant, Thelma",5356858,,3482681,No
4283,19-T-015,Science Companion,"78/682,641",3191925,*United States,US,2/21/2001,1/2/2007,,,19-T-015-002,Small,,10/28/2021,No,10/28/2021,Registered (TM),,,,Debbie Leslie,Trademark,2/17/2021,,,"Ramirez, Mario Riojas",Debbie Leslie,"Tennant, Thelma",5395274,,3482681,No
4284,19-T-017,Microwave-to-optical photonic transduction using solid-state defects,"62/814,070", ,*United States,US,3/5/2019,, ,3/5/2019,19-T-017-001,Small,3/5/2019,3/11/2019,,4/28/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,,7814-412,"David Awschalom, Kevin Miao, Samuel Whiteley",Provisional,2/26/2019,19-T-017-001,3/5/2020,"Cox, Ben",David Awschalom,"Juggernauth, Anne",3524335,,3490030,No
4285,19-T-017,Methods and Systems for Frequency Conversion and Modulation Using Solid-State Defects,PCT/US20/20939, ,*United States,US,3/4/2020,, ,3/4/2020,19-T-017-002,Small,3/5/2019,2/21/2022,No,4/28/2022,Expired PCT - Filed in US only,Brinks Gilson & Lione,"Chen, Gang",7814-417,"David Awschalom, Kevin Miao, Samuel Whiteley",PCT,4/2/2020,19-T-017-002,9/5/2021,"Cox, Ben",David Awschalom,"Juggernauth, Anne",4456605,,3490030,No
4286,19-T-017,Methods and Systems for Frequency Conversion and Modulation Using Solid State Defects,"17/435,987",,*United States,US,3/4/2020,,,9/2/2021,19-T-017-003,Small,3/5/2019,9/9/2021,No,5/19/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000431,"David Awschalom, Kevin Miao, Samuel Whiteley",Nationalized PCT,8/13/2021,19-T-017-003,3/4/2040,"Cox, Ben",David Awschalom,"Juggernauth, Anne",6024077,,3490030,No
4287,19-T-020,Electrically tunable quantum information processing device based on a doped semiconductor structure embedded with a defect,"62/819,221",,*United States,US,3/15/2019,, ,3/15/2019,19-T-020-001,Small,3/15/2019,4/22/2019,,6/23/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Marshall, Ryan",7814-411,"Christopher Anderson, David Awschalom, Alexandre Bourassa",Provisional,4/22/2019,19-T-020-001,3/15/2020,"Cox, Ben",David Awschalom,"Juggernauth, Anne",3639290,,3495930,No
4288,19-T-020,Electrically tunable quantum information processing device based on a doped semiconductor structure embedded with a defect,"62/863,674",,*United States,US,6/19/2019,, ,6/19/2019,19-T-020-002,Small,6/19/2019,7/18/2019,No,6/23/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Marshall, Ryan",7814-413,"Christopher Anderson, David Awschalom, Alexandre Bourassa",Provisional,7/18/2019,19-T-020-002,6/19/2020,"Cox, Ben",David Awschalom,"Juggernauth, Anne",3799285,,3495930,No
4289,19-T-020,Electrically tunable quantum information processing device based on a doped semiconductor structure embedded with a defect,PCT/US20/22702,,*United States,US,3/13/2020,, ,3/13/2020,19-T-020-003,Small,3/15/2019,8/12/2021,No,6/23/2022,Expired PCT - Nationalized,Brinks Gilson & Lione,"Marshall, Ryan",7814-416,"Christopher Anderson, David Awschalom, Alexandre Bourassa",PCT,3/25/2020,19-T-020-003,9/15/2021,"Cox, Ben",David Awschalom,"Juggernauth, Anne",4425005,,3495930,No
4290,19-T-020,Electrically tunable quantum information processing device based on a doped semiconductor structure embedded with a defect,"17/438,600",,*United States,US,3/13/2020,,,9/13/2021,19-T-020-004,Small,3/15/2019,9/21/2021,No,6/23/2022,Pending,Brinks Gilson & Lione,"Chen, Gang",507814.5000432,"Christopher Anderson, David Awschalom, Alexandre Bourassa",Nationalized PCT,8/12/2021,19-T-020-004,3/13/2040,"Cox, Ben",David Awschalom,"Juggernauth, Anne",6022865,,3495930,No
4291,19-T-023,Methods of Fabricating Vacuum Housings with Hermetic Solder Seals Using Capillary Solder Wicks,"62/831,474", ,*United States,US,4/9/2019,, ,4/9/2019,19-T-023-001,Small,4/9/2019,3/2/2021,No,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Manning, Michelle",05400-0038-PV,"Evan Angelico, Andrey Elagin, Henry Frisch, Eric Spieglan",Provisional,4/9/2019, ,4/9/2020,"Cox, Ben",Henry Frisch,"Tennant, Thelma",3609843,,3509238,No
4292,19-T-023,Methods of Fabricating Vacuum Housings with Hermetic Solder Seals Using Capillary Solder Wicks,"16/842,261","11,194,059",*United States,US,4/7/2020,12/7/2021,US-2000-0326433-A1,4/7/2020,19-T-023-002,Small,4/9/2019,11/23/2021,No,4/28/2022,Issued,"Bell & Manning, LLC","Manning, Michelle",05400-0038-NP,"Evan Angelico, Andrey Elagin, Henry Frisch, Eric Spieglan",US Utility,4/8/2020,19-T-023-002,4/7/2040,"Cox, Ben",Henry Frisch,"Tennant, Thelma",4465326,10/15/2020,3509238,No
4293,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflamatory Agents,"62/809,988", ,*United States,US,2/25/2019,, ,2/25/2019,19-T-024-001,Small,2/25/2019,2/26/2019,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679US.P1,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",Provisional,2/26/2019, ,2/25/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3518411,,3509479,No
4294,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents,PCT/US20/19668, ,*United States,US,2/25/2020,,WO 2020/176478 A1,2/25/2020,19-T-024-002,Small,2/25/2019,3/9/2022,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679WO,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",PCT,3/11/2020, ,8/25/2021,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4407552,9/3/2020,3509479,No
4295,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents,"17/310,802",,*United States,US,2/25/2020,,,8/25/2021,19-T-024-003,Large,2/25/2019,8/27/2021,No,6/3/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679US,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",Nationalized PCT,8/3/2021,,,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5981306,,3509479,No
4296,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents,20762257.2,,European Patent Office (EPO),EP,2/25/2020,,3930687,9/7/2021,19-T-024-005,Small,2/25/2019,9/9/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679EP,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",Nationalized PCT,8/3/2021,,2/25/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5981349,1/5/2022,3509479,No
4297,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents,2021-549595,,Japan,JP,2/25/2020,,2022-521428,8/24/2021,19-T-024-006,Small,2/25/2019,8/25/2021,No,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679JP,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",Nationalized PCT,8/3/2021,,2/25/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5981389,4/4/2022,3509479,No
4298,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents,202080030419.5,,China,CN,2/25/2020,,CN 113710229 A,10/20/2021,19-T-024-004,Small,2/25/2019,10/28/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679CN,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",Nationalized PCT,8/3/2021,,2/25/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5981429,11/26/2021,3509479,No
4299,19-T-024,Methods and Compositions for Treating Inflammatory and Autoimmune Conditions with ECM-Affinity Peptides Linked to Anti-Inflammatory Agents,,,Hong Kong,HK,2/25/2020,,,,19-T-024-007,Small,2/25/2019,6/24/2022,No,6/24/2022,,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0679EPHK,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Kiyomitsu Katsumata, Aslan Mansurov",Nationalized PCT,6/24/2022,,,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7493257,,3509479,
4300,19-T-028,EFFICIENT PROCESSING CONVOLUTIONAL NEURAL NETWORK LAYERS USING ANALOG-MEMORY-BASED HARDWARE,"62/745,132", ,*United States,US,10/12/2018,, ,10/12/2018,19-T-028-001,Small,10/12/2018,2/28/2019,,4/28/2022,Expired Prov - Filed in US,,,P201804196US01,"Geoffrey Burr, Benjamin Killeen",Provisional,2/28/2019, ,10/12/2019,"Ginsburg, Eric",Benjamin Killeen,"Smith, Dane",3546516,,3546434,No
4301,19-T-028,EFFICIENT PROCESSING OF CONVOLUTIONAL NEURAL NETWORK LAYERS USING ANALOG-MEMORY-BASED HARDWARE,"16/363,463", ,*United States,US,3/25/2019,, ,3/25/2019,19-T-028-002,Large,10/12/2018,3/28/2019,No,4/28/2022,Pending,,, ,"Geoffrey Burr, Benjamin Killeen",US Utility,3/28/2019, ,3/25/2039,"Ginsburg, Eric",Benjamin Killeen,"Smith, Dane",3592472,,3546434,No
4302,19-T-029,Tunable high-Q superconducting mm-wave cavities for circuit and cavity QED experiments,"62/813,064", ,*United States,US,3/3/2019,, ,3/3/2019,19-T-029-001,Small,3/3/2019,3/4/2019,,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Kelsey, Jeffrey",21459-292063,"Alexander Anferov, David Schuster, Jonathan Simon, Aziza Suleymanzade",Provisional,3/4/2019, ,3/3/2020,"Cox, Ben",David Schuster,"Juggernauth, Anne",3550143,,3548711,No
4303,19-T-029,Tunable High-Q Superconducting MM-Wave Cavities for Circuit and Cavity QED Experiments,"63/107,987", ,*United States,US,10/30/2020,, ,10/30/2020,19-T-029-002,Small,,11/1/2021,No,4/28/2022,Expired Prov - Filed in US,Barnes & Thornburg,"Kelsey, Jeffrey",21459-328754,"Alexander Anferov, Ravi Naik, Andrew Oriani, David Schuster, Jonathan Simon, Aziza Suleymanzade",Provisional,10/30/2020, ,10/30/2021,"Cox, Ben",David Schuster,"Juggernauth, Anne",5023384,,3548711,No
4304,19-T-029,Millimeter-Wave Resonator and Associated Methods,"17/452,654",,*United States,US,10/28/2021,,US-2022-0140463-A1,10/28/2021,19-T-029-003,Small,3/3/2019,11/4/2021,No,5/31/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",722073,"Alexander Anferov, David Schuster, Jonathan Simon, Aziza Suleymanzade",US Utility,9/8/2021,,10/28/2041,"Cox, Ben",David Schuster,"Juggernauth, Anne",6143837,5/5/2022,3548711,No
4305,19-T-030,Trapping single electrons on helium using a superconducting reservoir,"62/813,065", ,*United States,US,3/3/2019,, ,3/3/2019,19-T-030-001,Small,3/3/2019,3/2/2021,,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Kelsey, Jeffrey",21459-292064,"Gerwin Koolstra, David Schuster",Provisional,3/4/2019, ,3/3/2020,"Cox, Ben",David Schuster,"Juggernauth, Anne",3550177,,3548757,No
4306,19-T-031,Accessing nonlinearity in superconducting mm wave coplaner resonators,"62/813,066", ,*United States,US,3/3/2019,, ,3/3/2019,19-T-031-001,Small,3/3/2019,3/4/2019,,4/28/2022,Expired Prov - Filed PCT,Barnes & Thornburg,"Kelsey, Jeffrey",21459-292065,"Alexander Anferov, David Schuster, Jonathan Simon, Aziza Suleymanzade",Provisional,3/4/2019, ,3/3/2020,"Cox, Ben",David Schuster,"Juggernauth, Anne",3550205,,3548804,No
4307,19-T-031,Accessing nonlinearity in superconducting mm wave coplaner resonators,PCT/US20/20831, ,*United States,US,3/3/2020,, ,3/3/2020,19-T-031-002,Small,3/3/2019,3/9/2022,No,4/28/2022,Expired PCT - Filed in US only,Lathrop GPM LLP,"Kelsey, Jeffrey",702978,"Alexander Anferov, David Schuster, Jonathan Simon, Aziza Suleymanzade",PCT,4/22/2020, ,9/3/2021,"Cox, Ben",David Schuster,"Juggernauth, Anne",4480705,,3548804,No
4308,19-T-031,Coplanar Superconductive Millimeter-Wave Resonator with High Kinetic Inductance and Associated Methods,"17/435,565",,*United States,US,3/3/2020,,US-2022-0131254-A1,9/1/2021,19-T-031-003,Small,3/3/2019,9/2/2021,No,5/31/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",721420,"Alexander Anferov, David Schuster, Jonathan Simon, Aziza Suleymanzade",Nationalized PCT,8/18/2021,,3/3/2040,"Cox, Ben",David Schuster,"Juggernauth, Anne",6052508,4/28/2022,3548804,No
4309,19-T-032,Random access quantum information processing in 3D multimode cavities,"62/813,067", ,*United States,US,3/3/2019,, ,3/3/2019,19-T-032-001,Small,3/3/2019,3/2/2021,,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Kelsey, Jeffrey",21459-292066,"Srivatsan Chakram, Andrew Oriani, David Schuster",Provisional,3/4/2019, ,3/3/2020,"Cox, Ben",David Schuster,"Juggernauth, Anne",3550236,,3548835,No
4310,19-T-033,Tuning Josephson Junctions,"62/813,068", ,*United States,US,3/3/2019,, ,3/3/2019,19-T-033-001,Small,3/3/2019,3/4/2019,,4/28/2022,Expired Prov - Filed PCT,Barnes & Thornburg,"Kelsey, Jeffrey",21459-292067,"Larry Chen, Andrew Oriani, David Schuster",Provisional,3/4/2019, ,3/3/2020,"Cox, Ben",David Schuster,"Juggernauth, Anne",3550266,,3548885,No
4311,19-T-033,Technologies for Tuning Superconducting Josephson Junctions,PCT/US20/20594, ,*United States,US,3/2/2020,,WO 2020/180762 A1,3/2/2020,19-T-033-002,Small,3/3/2019,3/9/2022,No,4/28/2022,Expired PCT - Filed in US only,Barnes & Thornburg,"Kelsey, Jeffrey",21459-310109,"Larry Chen, Andrew Oriani, David Schuster",PCT,3/2/2020, ,9/3/2021,"Cox, Ben",David Schuster,"Juggernauth, Anne",4389003,9/10/2020,3548885,No
4312,19-T-033,Technologies for Tuning Superconducting Josephson Junctions,"17/434,184",,*United States,US,3/2/2020,,2022-0140221-A1,8/26/2021,19-T-033-003,Small,3/3/2019,8/27/2021,No,6/17/2022,Pending,Barnes & Thornburg,"McCusker, Kevin",21459-345902,"Larry Chen, Andrew Oriani, David Schuster",Nationalized PCT,8/3/2021,,3/2/2040,"Cox, Ben",David Schuster,"Juggernauth, Anne",5981242,5/5/2022,3548885,No
4313,19-T-034,Method for Manufacturing Rare Earth Ion Doped Oxide Thin Film Devices,"62/814,187", ,*United States,US,3/5/2019,, ,3/5/2019,19-T-034-001,Small,3/5/2019,3/14/2019,,6/7/2022,Expired Prov - Filed PCT,Barnes & Thornburg,,21459-292133,"Supratik Guha, Manish Kumar Singh, Tian Zhong",Provisional,3/14/2019,19-T-034-001,3/5/2020,"Cox, Ben",Tian Zhong,"Tennant, Thelma",3568047,,3550368,No
4314,19-T-034,Rare Earth Ion Doped Oxide Thin Films,"62/814,181", ,*United States,US,3/5/2019,, ,3/5/2019,19-T-034-002,None,3/5/2019,3/14/2019,,6/7/2022,Expired Prov - Filed PCT,Barnes & Thornburg,,21459-292132,"Supratik Guha, Manish Kumar Singh, Tian Zhong",Provisional,3/14/2019,19-T-034-002,3/5/2020,"Cox, Ben",Tian Zhong,"Tennant, Thelma",3568132,,3550368,No
4315,19-T-034,Method for Manufacturing Rare Earth Ion Doped Oxide Thin Film Devices,"62/838,126", ,*United States,US,3/5/2019,, ,4/24/2019,19-T-034-003,None,3/5/2019,5/9/2019,No,6/7/2022,Expired Prov - Filed PCT,Barnes & Thornburg,,21459-294919,"Supratik Guha, Manish Kumar Singh, Tian Zhong",Provisional,5/9/2019,19-T-034-003,3/5/2020,"Cox, Ben",Tian Zhong,"Tennant, Thelma",3705970,,3550368,No
4316,19-T-034,Rare-Earth Ion Doped Thin Film Technologies,PCT/US20/21257, ,*United States,US,3/5/2020,,WO 2020/181131 A1,3/5/2020,19-T-034-004,Small,3/5/2019,3/9/2022,No,6/7/2022,Expired PCT - Nationalized,Barnes & Thornburg,"McCusker, Kevin",21459-315394,"Supratik Guha, Manish Kumar Singh, Tian Zhong",PCT,3/11/2020, ,9/5/2021,"Cox, Ben",Tian Zhong,"Tennant, Thelma",4407340,9/10/2020,3550368,No
4317,19-T-034,Rare-Earth Ion Doped Thin Film Technologies,"17/434,221",,*United States,US,3/5/2020,,US-2022-0136133-A1.,8/26/2021,19-T-034-005,Small,3/5/2019,8/27/2021,No,6/17/2022,Pending,Barnes & Thornburg,"McCusker, Kevin",21459-345904,"Supratik Guha, Manish Kumar Singh, Tian Zhong",Nationalized PCT,8/3/2021,19-T-034-005,3/5/2040,"Cox, Ben",Tian Zhong,"Tennant, Thelma",5979596,5/5/2022,3550368,No
4318,19-T-034,Rare-Earth Ion Doped Thin Film Technologies,20765570.5,,European Patent Office (EPO),EP,3/5/2020,,3935674,9/29/2021,19-T-034-006,None,3/5/2019,10/14/2021,No,6/16/2022,Pending,Barnes & Thornburg,"McCusker, Kevin",21459-345903,"Supratik Guha, Tian Zhong",Nationalized PCT,8/3/2021,,3/5/2040,"Cox, Ben",Tian Zhong,"Tennant, Thelma",5979615,1/12/2022,3550368,No
4319,19-T-037,Compositions and Methods Related to Kethoxal Derivatives,PCT/US19/31287, ,*United States,US,5/8/2019,, ,5/8/2019,19-T-037-001,Small,5/8/2018,3/3/2021,No,6/8/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681WO,"Chuan He, Xiaocheng Weng, Tong Wu",PCT,5/24/2019, ,11/8/2020,"Hwang, Luke",Chuan He,"Tennant, Thelma",3739542,,3564642,No
4320,19-T-037,Compositions and Methods Related to Kethoxal Deriatives,"17/250,023", ,*United States,US,5/8/2019,,US-2021-0214773-A1,11/6/2020,19-T-037-002,Small,5/8/2018,10/15/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681US,"Chuan He, Xiaocheng Weng, Tong Wu",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984270,7/15/2021,3564642,No
4321,19-T-037,Compositions and Methods Related to Kethoxal Deriatives,201980045569.0, ,China,CN,5/8/2019,,112367988,1/6/2021,19-T-037-004,Small,5/8/2018,10/15/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681CN,"Chuan He, Xiaocheng Weng, Tong Wu",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984300,2/12/2021,3564642,No
4322,19-T-037,Compositions and Methods Related to Kethoxal Deriatives,19799458.5AU, ,Australia,AU,5/8/2019,, ,11/27/2020,19-T-037-003,Small,5/8/2018,10/15/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681AU,"Chuan He, Xiaocheng Weng, Tong Wu",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984350,,3564642,No
4323,19-T-037,Compositions and Methods Related to Kethoxal Deriatives,19799458.5, ,European Patent Office (EPO),EP,5/8/2019,,3790544,11/26/2020,19-T-037-005,Small,5/8/2018,10/15/2020,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681EP,"Chuan He, Xiaocheng Weng, Tong Wu",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984381,3/17/2021,3564642,No
4324,19-T-037,Compositions and Methods Related to Kethoxal Deriatives,2020-562567, ,Japan,JP,5/8/2019,,2021-523133,11/6/2020,19-T-037-006,Small,5/8/2018,10/15/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681JP,"Chuan He, Xiaocheng Weng, Tong Wu",Nationalized PCT,10/15/2020, ,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",4984447,9/2/2021,3564642,No
4325,19-T-037,Compositions and Methods Related to Kethoxal Deriatives,62021038886.9,,Hong Kong,HK,5/8/2019,,40048610 A,9/15/2021,19-T-037-007,Small,5/8/2018,9/29/2021,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0681EHK,"Chuan He, Xiaocheng Weng, Tong Wu",Nationalized PCT,9/29/2021,,5/8/2039,"Hwang, Luke",Chuan He,"Tennant, Thelma",6222249,12/3/2021,3564642,No
4326,19-T-041,Novel Material for Skin Wound Closure and Scar Prevention,"62/845,648", ,*United States,US,5/9/2019,, ,5/9/2019,19-T-041-001,Small,5/9/2019,5/14/2019,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0683US.P1,"Xiaoyang Wu, Jian Zhang",Provisional,5/14/2019, ,5/9/2020,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3718735,,3585353,No
4327,19-T-041,Novel Material for Skin Wound Closure and Scar Prevention,PCT/US20/70036, ,*United States,US,5/8/2020,,WO 2020/227738 A1,5/8/2020,19-T-041-002,Small,5/9/2019,3/9/2022,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0683WO,"Xiaoyang Wu, Jian Zhang",PCT,4/8/2020, ,11/9/2021,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",4465111,11/12/2020,3585353,No
4328,19-T-041,Novel Material for Skin Wound Closure and Scar Prevention,"17/595,098",,*United States,US,5/8/2020,,,11/9/2021,19-T-041-003,Small,5/9/2019,11/10/2021,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0683US,"Xiaoyang Wu, Jian Zhang",Nationalized PCT,11/10/2021,,5/8/2040,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",6374771,,3585353,No
4329,19-T-041,Novel Material for Skin Wound Closure and Scar Prevention,202080049438.2,,China,CN,5/8/2020,,CN 114072163 A,1/6/2022,19-T-041-004,Small,5/9/2019,1/12/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0683CN,"Xiaoyang Wu, Jian Zhang",Nationalized PCT,1/12/2022,,5/8/2040,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",6588366,2/18/2022,3585353,No
4330,19-T-042,Lactate Responses System and Methods,"62/848,432", ,*United States,US,5/15/2019,, ,5/15/2019,19-T-042-001,Small,5/15/2019,5/17/2019,,6/16/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0684US.P1,"Xiaoyang Wu, Jian Zhang",Provisional,5/17/2019, ,5/15/2020,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",3723708,,3589282,No
4331,19-T-042,Lactate Responses System and Methods,PCT/US20/70052, ,*United States,US,5/15/2020,,WO 2020/232474 A1,5/15/2020,19-T-042-002,Small,5/15/2019,3/9/2022,No,6/16/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0684WO,"Xiaoyang Wu, Jian Zhang",PCT,5/1/2020, ,11/15/2021,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",4520825,11/19/2020,3589282,No
4332,19-T-042,Lactate Responses System and Methods,"17/595,326",,*United States,US,5/15/2020,,,11/15/2021,19-T-042-003,Small,5/15/2019,11/15/2021,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0684US,"Xiaoyang Wu, Jian Zhang",Nationalized PCT,11/3/2021,,5/15/2040,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",6342664,,3589282,No
4333,19-T-042,Lactate Responses System and Methods,20805313.2,,European Patent Office (EPO),EP,5/15/2020,,,12/1/2021,19-T-042-004,None,5/15/2019,1/6/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0684EP,"Xiaoyang Wu, Jian Zhang",Nationalized PCT,11/3/2021,,5/15/2040,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",6342694,,3589282,No
4334,19-T-042,Lactate Responses System and Methods,202080051043.6,,China,CN,5/15/2020,,CN 114599401 A,1/13/2022,19-T-042-005,Small,5/15/2019,1/26/2022,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0684CN,"Xiaoyang Wu, Jian Zhang",Nationalized PCT,11/3/2021,,5/15/2040,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",6342724,6/7/2022,3589282,No
4335,19-T-043,Four Quadrant Tensor Analysis of Hybrid Data,"62/935,808", ,*United States,US,11/15/2019,, ,11/15/2019,19-T-043-001,Small,11/15/2019,11/18/2019,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Kalafut, Christopher",05400-0039-PV,"Aritrick Chatterjee, Xiaobing Fan, Gregory Karczmar, Aytekin Oto",Provisional,11/18/2019, ,11/15/2020,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4118889,,3610117,No
4336,19-T-043,Cancer Detection Based on Four Quadrant Mapping and Matrix Analysis of Image Data,PCT/US20/59997, ,*United States,US,11/11/2020,,WO 2021/0964946,11/11/2020,19-T-043-002,Small,11/15/2019,4/26/2022,No,5/31/2022,Expired PCT - Filed in US only,"Bell & Manning, LLC","Kalafut, Christopher",05400-0039-PCT,"Aritrick Chatterjee, Xiaobing Fan, Gregory Karczmar, Aytekin Oto",PCT,10/19/2020, ,5/15/2022,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4992799,5/20/2021,3610117,No
4337,19-T-043,Cancer Detection Based on Four Quadrant Mapping and Matrix Analysis of Image Data,"17/771,957",,*United States,US,11/11/2020,,,4/26/2022,19-T-043-003,Small,11/15/2019,4/28/2022,No,6/15/2022,Pending,"Bell & Manning, LLC","Kalafut, Christopher",05400-0039-US,"Aritrick Chatterjee, Xiaobing Fan, Gregory Karczmar, Aytekin Oto",Nationalized PCT,4/26/2022,,11/11/2040,"Cox, Ben",Gregory Karczmar,"Smith, Dane",7133953,,3610117,
4338,19-T-045,Characterization of Lesions Via Determination Of Vascular Metrics Using MRI Data,"62/910,286", ,*United States,US,10/3/2019,, ,10/3/2019,19-T-045-001,Small,10/3/2019,3/3/2021,,4/28/2022,Expired Prov - Filed PCT,Foley & Lardner,,619927-0006,"Hiroyuki Abe, Rina Barber, Aritrick Chatterjee, Ty Easley, Xiaobing Fan, David Hormuth, Gregory Karczmar, Byol Kim, Milica Medved, Robert Moser, Todd Oliver, Aytekin Oto, Federico Pineda, Deepa Sheth, Shiyang Wang, Chengyue Wu, Thomas Yankeelov",Provisional,10/7/2019,19-T-045-001,10/3/2020,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4028084,,3610402,No
4339,19-T-045,Characterization of Lesions Via Determination Of Vascular Metrics Using MRI Data,PCT/US20/54127,,*United States,US,10/2/2020,,,10/2/2020,19-T-045-002,Small,10/3/2019,6/10/2022,No,6/10/2022,Prosecution by Other Party,Foley & Lardner,,619927-0010,"Hiroyuki Abe, Rina Barber, Aritrick Chatterjee, Ty Easley, Xiaobing Fan, David Hormuth, Gregory Karczmar, Byol Kim, Milica Medved, Robert Moser, Todd Oliver, Aytekin Oto, Federico Pineda, Deepa Sheth, Shiyang Wang, Chengyue Wu, Thomas Yankeelov",PCT,10/2/2020,19-T-045-002,4/3/2022,"Cox, Ben",Gregory Karczmar,"Smith, Dane",4939189,,3610402,No
4340,19-T-046,"Photoactive, Inorganic Ligand-Capped Inorganic Nanocrystals","62/853,448", ,*United States,US,5/28/2019,, ,5/28/2019,19-T-046-001,Small,5/28/2019,10/24/2019,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle", ,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang",Provisional,5/29/2019, ,5/28/2020,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",3744134,,3610597,No
4341,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,"62/856,375", ,*United States,US,6/3/2019,, ,6/3/2019,19-T-048-001,Small,6/3/2019,,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1001070609,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Provisional,6/21/2019, ,6/3/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3773870,,3612735,No
4342,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,PCT/US20/70112, ,*United States,US,6/3/2020,, ,6/3/2020,19-T-048-002,Small,6/3/2019,1/24/2022,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687WO,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",PCT,6/4/2020, ,12/3/2021,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4611990,,3612735,No
4343,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,"17/596,106",,*United States,US,6/3/2020,,,12/3/2021,19-T-048-003,Small,6/3/2019,12/3/2021,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687US,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,11/23/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6429672,,3612735,No
4344,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,2021-571669,,Japan,JP,6/3/2020,,,12/2/2021,19-T-048-005,Small,6/3/2019,1/6/2022,No,3/18/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687JP,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,12/1/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6454381,,3612735,No
4345,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,BR1120210244026,,Brazil,BR,6/3/2020,,,12/2/2021,19-T-048-004,Small,6/3/2019,1/6/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687BR,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,12/1/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6454415,,3612735,No
4346,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,MX/a/2021/014867,,Mexico,MX,6/3/2020,,,12/2/2021,19-T-048-006,Small,6/3/2019,1/9/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687MX,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,12/1/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6454648,,3612735,No
4347,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,"3,144,533",,Canada,CA,6/3/2020,,,12/20/2021,19-T-048-007,Small,6/3/2019,1/9/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687CA,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,1/9/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6560137,,3612735,No
4348,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,20818190.9,,European Patent Office (EPO),EP,6/3/2020,,3976061,12/21/2021,19-T-048-008,None,6/3/2019,1/9/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687EP,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,1/9/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6560505,4/6/2022,3612735,No
4349,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,2020286523,,Australia,AU,6/3/2020,,,12/24/2021,19-T-048-009,None,6/3/2019,1/9/2022,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687AU,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,1/9/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6560704,,3612735,No
4350,19-T-048,METHODS AND COMPOSITIONS FOR TREATING CANCER,202080056122.6,,China,CN,6/3/2020,,CN 114206355 A,2/7/2022,19-T-048-010,Small,6/3/2019,2/7/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0687CN,"Laura Gray, Jeffrey Hubbell, Tiffany Marchell, David Wilson",Nationalized PCT,2/7/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6771085,3/18/2022,3612735,No
4351,19-T-050,Diels-Alder cycloadditions for the stabilization of peptide macrocycles and biologics,"62/831,484",,*United States,US,4/9/2019,,,4/9/2019,19-T-050-001,Small,4/9/2019,4/22/2019,,6/13/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",746711,"Raymond Moellering, Jeffrey Montgomery",Provisional,4/22/2019,19-T-050-001,4/9/2020,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",3639261,,3638270,No
4352,19-T-050,Versatile Peptide Macrocyclization with Diels-Alder Cycloadditions,"62/894,478",,*United States,US,8/30/2019,,,8/30/2019,19-T-050-002,Small,8/30/2019,9/10/2019,No,6/13/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",746712,"Raymond Moellering, Jeffrey Montgomery",Provisional,9/10/2019,19-T-050-002,8/30/2020,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",3988096,,3638270,No
4353,19-T-050,Diels-Alder cycloadditions for the stabilization of peptide macrocycles and biologics,PCT/US20/27531,,*United States,US,4/9/2020,,WO 2022/210535 A9,4/9/2020,19-T-050-003,Small,4/9/2019,10/11/2021,No,6/13/2022,Expired PCT - Nationalized,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",749097,"Raymond Moellering, Jeffrey Montgomery",PCT,4/7/2020,19-T-050-003,10/9/2021,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4463910,4/21/2022,3638270,No
4354,19-T-050,Versatile Peptide and Protein Macrocyclization and Multimerization with Diels-Alder Cycloadditions,"17/602,044",,*United States,US,4/9/2020,,,10/7/2021,19-T-050-004,Small,4/9/2019,10/11/2021,No,6/13/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757883,"Raymond Moellering, Jeffrey Montgomery",Nationalized PCT,10/11/2021,19-T-050-004,4/9/2040,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",6263442,,3638270,No
4355,19-T-050,Diels-Alder cycloadditions for the stabilization of peptide macrocycles and biologics,20788557.5,,European Patent Office (EPO),EP,4/9/2020,,3953367,10/27/2021,19-T-050-005,None,4/9/2019,10/21/2021,No,6/22/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757990,"Raymond Moellering, Jeffrey Montgomery",Nationalized PCT,10/18/2021,19-T-050-005,,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",6282447,2/16/2022,3638270,No
4356,19-T-050,Diels-Alder cycloadditions for the stabilization of peptide macrocycles and biologics,202080042036.X,,China,CN,4/9/2020,,CN 114174313 A,12/7/2021,19-T-050-006,Small,4/9/2019,11/18/2021,No,6/14/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757991,"Raymond Moellering, Jeffrey Montgomery",Nationalized PCT,11/18/2021,,4/9/2040,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",6412283,3/11/2022,3638270,No
4357,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,"62/856,468", ,*United States,US,6/3/2019,, ,6/3/2019,19-T-052-001,Small,6/3/2019,,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",1001070610,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Provisional,6/21/2019, ,6/3/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3773840,,3638586,No
4358,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,PCT/US20/70113, ,*United States,US,6/3/2020,,WO 2020/247974 A1,6/3/2020,19-T-052-002,Small,6/3/2019,1/24/2022,No,4/28/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688WO,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",PCT,6/4/2020, ,12/3/2021,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4611933,12/10/2020,3638586,No
4359,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,"17/596,118",,*United States,US,6/3/2020,,,12/3/2021,19-T-052-003,Small,6/3/2019,12/3/2021,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688US,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,11/23/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6429708,,3638586,No
4360,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,2021-571671,,Japan,JP,6/3/2020,,,12/2/2021,19-T-052-005,Small,6/3/2019,1/5/2022,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688JP,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,12/1/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6454698,,3638586,No
4361,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,BR 11 2021 024438 7,,Brazil,BR,6/3/2020,,,12/2/2021,19-T-052-004,Small,6/3/2019,1/6/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688BR,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,12/1/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6454732,,3638586,No
4362,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,MX/2021/014932,,Mexico,MX,6/3/2020,,,12/3/2021,19-T-052-006,Small,6/3/2019,1/20/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688MX,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,12/1/2021,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6454767,,3638586,No
4363,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,"3,144,535",,Canada,CA,6/3/2020,,,12/20/2021,19-T-052-007,Small,6/3/2019,1/9/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688CA,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,1/9/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6560059,,3638586,No
4364,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,20818032.3,,European Patent Office (EPO),EP,6/3/2020,,3976111,12/21/2021,19-T-052-008,Small,6/3/2019,1/9/2022,No,6/15/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688EP,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,1/9/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6560581,4/6/2022,3638586,No
4365,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,2020289485,,Australia,AU,6/3/2020,,,12/24/2021,19-T-052-009,None,6/3/2019,1/9/2022,No,3/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688AU,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,1/9/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6560771,,3638586,No
4366,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,202117060713,,India,IN,6/3/2020,,,12/24/2021,19-T-052-011,Small,6/3/2019,1/19/2022,No,5/18/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688IN,,Nationalized PCT,1/16/2022,,6/3/2040,"Peace, Shane",,"Tennant, Thelma",6603073,,3638586,No
4367,19-T-052,Methods and Compositions for Treating Cancer with Collagen Binding Drug Carriers,202080055104.6,,China,CN,6/3/2020,,CN 114173822,1/28/2022,19-T-052-010,Small,6/3/2019,2/2/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0688CN,"Jeffrey Hubbell, Jun Ishihara, Koichi Sasaki",Nationalized PCT,1/16/2022,,6/3/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6603125,3/11/2022,3638586,No
4368,19-T-053,Methods and Compositions for Treating Sickle Cell Disease and Thalassemia,"62/907,087", ,*United States,US,9/27/2019,, ,9/27/2019,19-T-053-001,Small,9/27/2019,10/21/2019,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1432-PRO US,"John Cao, Lucy Godley, Amittha Wickrema",Provisional,10/21/2019, ,9/27/2020,"Dembo, Anna",Lucy Godley,"Muite, Kevin",4041378,,3638639,No
4369,19-T-053,Methods and Compositions for Treating Sickle Cell Disease and Thalassemia,PCT/US20/52842,,*United States,US,9/25/2020,,WO 2021/062238 A1,9/25/2020,19-T-053-002,Small,9/27/2019,6/10/2022,No,6/13/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1432-WO,"John Cao, Lucy Godley, Amittha Wickrema",PCT,10/3/2020,,3/27/2022,"Dembo, Anna",Lucy Godley,"Muite, Kevin",4947577,4/1/2021,3638639,No
4370,19-T-053,Methods and Compositions for Treating Sickle Cell Disease and Thalassemia,"17/763,445",,*United States,US,9/25/2020,,,3/24/2022,19-T-053-003,Small,9/27/2019,3/24/2022,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1432-WO-US,"John Cao, Lucy Godley, Amittha Wickrema",Nationalized PCT,3/18/2022,19-T-053-003,9/25/2040,"Dembo, Anna",Lucy Godley,"Muite, Kevin",6946437,,3638639,
4371,19-T-055,System and Method of Partial Compilation with Variational Algorithms for Quantum Computers,"62/900,120", ,*United States,US,9/13/2019,, ,9/13/2019,19-T-055-001,Small,9/13/2019,9/17/2019,,4/28/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",37997-72,"Frederic Chong, Yongshan Ding, Pranav Gokhale, Thomas Propson",Provisional,9/17/2019, ,9/13/2020,"Cox, Ben",Frederic Chong,"Smith, Dane",3992731,,3642757,No
4372,19-T-055,System and Method of Partial Compilation with Variational Algorithms for Quantum Computers,PCT/US20/49932, ,*United States,US,9/9/2020,,WO 2021/050541,9/9/2020,19-T-055-002,Small,9/13/2019,4/19/2022,Yes,6/23/2022,Expired PCT - Nationalized,Armstrong Teasdale,"Brennan, Patrick",37997-00081,"Frederic Chong, Yongshan Ding, Pranav Gokhale, Thomas Propson",PCT,8/5/2020, ,3/13/2022,"Cox, Ben",Frederic Chong,"Smith, Dane",4807670,3/18/2021,3642757,No
4373,19-T-055,System and Method of Partial Compilation with Variational Algorithms for Quantum Computers,"17/641,036",,*United States,US,9/9/2020,,,3/7/2022,19-T-055-003,Small,9/13/2019,6/23/2022,No,6/23/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-96,"Frederic Chong, Yongshan Ding, Pranav Gokhale, Thomas Propson",Nationalized PCT,2/9/2022,,,"Cox, Ben",Frederic Chong,"Smith, Dane",6785223,,3642757,No
4374,19-T-055,System and Method of Partial Compilation with Variational Algorithms for Quantum Computers,20862224.1,,European Patent Office (EPO),EP,9/9/2020,,,3/2/2022,19-T-055-004,Small,9/13/2019,3/4/2022,No,6/14/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-00098,"Frederic Chong, Yongshan Ding, Pranav Gokhale, Thomas Propson",Nationalized PCT,2/9/2022,,9/9/2040,"Cox, Ben",Frederic Chong,"Smith, Dane",6785258,,3642757,No
4375,19-T-055,System and Method of Partial Compilation with Variational Algorithms for Quantum Computers,2022-515880,,Japan,JP,9/9/2020,,,3/10/2022,19-T-055-005,Small,9/13/2019,3/14/2022,No,5/31/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-00097,"Frederic Chong, Yongshan Ding, Pranav Gokhale, Thomas Propson",Nationalized PCT,2/9/2022,,9/9/2040,"Cox, Ben",Frederic Chong,"Smith, Dane",6785293,,3642757,No
4376,19-T-056,"Design, Synthesis and Directed Self-Assembly (DSA) of High  Block Copolymers","62/966,523",,*United States,US,1/27/2020,,,,19-T-056-001,Small,1/27/2020,1/28/2020,,3/4/2022,Abandoned,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP007PUS,"Moshe Dolejsi, Hongbo Feng, Paul Nealey, Stuart Rowan, Ning Zhu",Provisional,1/28/2020,,1/27/2021,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",4247324,,3649872,No
4377,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,"62/851,386", ,*United States,US,5/22/2019,, ,5/22/2019,19-T-065-001,Small,5/22/2019,,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690US.P1,"Chuan He, Pingluan Wang, Tong Wu",Provisional,6/18/2019, ,5/22/2020,"Hwang, Luke",Chuan He,"Tennant, Thelma",3771669,,3682920,No
4378,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,"62/987,932", ,*United States,US,3/11/2020,, ,3/11/2020,19-T-065-002,Small,5/22/2019,3/11/2020,No,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690US.P2,"Chuan He, Pingluan Wang, Tong Wu",Provisional,3/11/2020, ,3/11/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",4407866,,3682920,No
4379,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,PCT/US20/70073,,*United States,US,5/22/2020,,WO 2020/237262 A1,5/22/2020,19-T-065-003,Small,5/22/2019,3/9/2022,No,6/8/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690WO,"Chuan He, Pingluan Wang, Tong Wu",PCT,5/26/2020,19-T-065-003,11/22/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",4571577,11/26/2020,3682920,No
4380,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,"17/595,477",,*United States,US,5/22/2020,,US-2022-0143198-A1,11/17/2021,19-T-065-004,Small,5/22/2019,11/18/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690US,"Chuan He, Pingluan Wang, Tong Wu",Nationalized PCT,11/12/2021,,5/22/2040,"Hwang, Luke",Chuan He,"Tennant, Thelma",6391853,5/12/2022,3682920,No
4381,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,20809173.6,,European Patent Office (EPO),EP,5/22/2020,,3972576,11/18/2021,19-T-065-006,None,5/22/2019,11/23/2021,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690EPO,"Chuan He, Pingluan Wang, Tong Wu",Nationalized PCT,11/12/2021,,5/22/2040,"Hwang, Luke",Chuan He,"Tennant, Thelma",6391892,3/30/2022,3682920,No
4382,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,2021-569010,,Japan,JP,5/22/2020,,,11/19/2021,19-T-065-007,Small,5/22/2019,11/23/2021,No,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690JP,"Chuan He, Pingluan Wang, Tong Wu",Nationalized PCT,11/12/2021,,5/22/2040,"Hwang, Luke",Chuan He,"Tennant, Thelma",6391933,,3682920,No
4383,19-T-065,Compositions and Methods Related to Tethered Kethoxal Derivatives,202080052815.8,,China,CN,5/22/2020,,CN 114269332 A,1/21/2022,19-T-065-005,Small,5/22/2019,3/7/2022,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0690CN,"Chuan He, Pingluan Wang, Tong Wu",Nationalized PCT,11/12/2021,,5/22/2040,"Hwang, Luke",Chuan He,"Tennant, Thelma",6391972,4/1/2022,3682920,No
4384,19-T-066,BLOCK COPOLYMER SELF-ALIGNMENT ON ISOLATED CHEMICAL STRIPES,"62/953,387", ,*United States,US,12/24/2019,, ,12/24/2019,19-T-066-001,Small,12/24/2019,1/9/2020,,4/28/2022,Expired Prov - Filed PCT,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",P190247US01,"Michael Arnold, Robert Jacobberger, Paul Nealey, Shisheng Xiong",Provisional,1/9/2020, ,12/24/2020,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",4209214,,3684355,No
4385,19-T-066,BLOCK COPOLYMER SELF-ALIGNMENT ON ISOLATED CHEMICAL STRIPES,PCT/US20/66693, ,*United States,US,12/22/2020,,WO 2021/133840 A1,12/22/2020,19-T-066-002,Small,12/24/2019,1/4/2021,No,4/28/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",P190247WO01,"Michael Arnold, Robert Jacobberger, Paul Nealey, Shisheng Xiong",PCT,1/4/2021, ,6/24/2022,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",5238414,7/1/2021,3684355,No
4386,19-T-066,BLOCK COPOLYMER SELF-ALIGNMENT ON ISOLATED CHEMICAL STRIPES,109145699, ,"Taiwan, Province of China",TW,12/23/2020,, ,12/23/2020,19-T-066-003,Small,12/24/2019,1/4/2021,No,4/28/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",P190247TW01,"Michael Arnold, Robert Jacobberger, Paul Nealey, Shisheng Xiong","Foreign, Non-PCT",1/4/2021, ,12/23/2040,"Hwang, Luke",Paul Nealey,"Juggernauth, Anne",5238521,,3684355,No
4387,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,"62/407,202", ,*United States,US,10/12/2016,, ,10/12/2016,19-T-068-001,None,10/12/2016,,,4/28/2022,Expired Prov - Filed PCT,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 PRO,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Provisional,5/7/2019, ,10/12/2017,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3685145,,3684991,No
4388,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,"62/537,992", ,*United States,US,7/28/2017,, ,7/28/2017,19-T-068-002,None,7/28/2017,5/7/2019,No,4/28/2022,Expired Prov - Filed PCT,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 PRO2,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Provisional,5/7/2019, ,7/28/2018,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3685195,,3684991,No
4389,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,PCT/US17/56070, ,*United States,US,10/11/2017,, ,10/11/2018,19-T-068-003,None,10/12/2016,5/7/2019,No,4/28/2022,Expired PCT - Nationalized,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 WO,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",PCT,5/7/2019, ,4/20/2019,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3685234,,3684991,No
4390,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,"16/341,084","11,116,977",*United States,US,10/11/2017,9/14/2021,US-2020-0230416-A1,4/11/2019,19-T-068-004,Small,10/12/2016,8/30/2021,No,4/28/2022,Issued,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 US PCT,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Nationalized PCT,5/8/2019, ,4/28/2038,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3686517,7/23/2020,3684991,No
4391,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,2017342076, ,Australia,AU,10/11/2017,, ,10/11/2017,19-T-068-005,None,10/12/2016,5/8/2019,No,4/28/2022,Pending,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 WO,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Nationalized PCT,5/8/2019, ,10/11/2037,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3686543,,3684991,No
4392,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,"3,039,917", ,Canada,CA,10/11/2017,, ,10/11/2017,19-T-068-006,None,10/12/2016,5/8/2019,No,4/28/2022,Pending,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 WO,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Nationalized PCT,5/8/2019, ,10/11/2037,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3686569,,3684991,No
4393,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,17787851.9EPO,3525876,European Patent Office (EPO),EP,10/11/2017,12/2/2020,35255876,10/11/2017,19-T-068-007,Small,10/12/2016,1/28/2022,No,4/28/2022,Granted,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 WO,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Nationalized PCT,5/8/2019, ,,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",3686595,8/21/2019,3684991,No
4394,19-T-068,Systems and Methods for Controlling Levels of Perceived Intensity of a Sensory Stimulus,"17/397,192", ,*United States,US,10/11/2017,,US-2022-0001183-A1,8/9/2021,19-T-068-008,None,10/12/2016,8/11/2021,No,4/28/2022,Pending,"Tarolli, Sundheim, Covell & Tummino LLP",,CWR-026106 US PCT,"Sliman Bensmaia, Benoit Delhaye, Emily Graczyk, Hannes Saal, Dustin Tyler",Continuation,8/11/2021, ,10/11/2037,"Cox, Ben",Sliman Bensmaia,"Juggernauth, Anne",6014777,1/6/2022,3684991,No
4395,19-T-069,Synthetic chemical reagents to modulate and enhance antigen-specific T-cell response to vaccination and immunotherapy via Inflammasome activation,,,*United States,US,,,,,19-T-069-001,Small,,8/13/2021,,6/15/2022,Authorized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0692US.P1,"Aaron Esser-Kahn, Sampa Maiti, Saikat Manna, Adam Weiss",Provisional,8/13/2021,,,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",6024875,,3686432,
4396,19-T-070,Toll-like Receptor Agonist Formulations and Methods of Use,"62/960,520", ,*United States,US,1/13/2020,, ,1/13/2020,19-T-070-001,Small,1/13/2020,1/16/2020,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0693US.P1,"WenJun Du, Aaron Esser-Kahn, Sampa Maiti, Saikat Manna",Provisional,1/16/2020,19-T-070-001,1/13/2021,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",4235823,,3686685,No
4397,19-T-070,Toll-like Receptor Agonist Formulations and Methods of Use,PCT/US21/70024,,*United States,US,1/13/2021,,WO 2021/146749 A1,1/13/2021,19-T-070-002,Small,1/13/2020,1/4/2021,No,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0693WO,"WenJun Du, Aaron Esser-Kahn, Sampa Maiti, Saikat Manna",PCT,1/4/2021,19-T-070-002,7/13/2022,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5236387,7/22/2021,3686685,No
4398,19-T-070,Toll-like Receptor Agonist Formulations and Methods of Use,,,*United States,US,1/13/2021,,,,19-T-070-003,Small,1/13/2020,5/24/2022,No,6/2/2022,Authorized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0693US,"WenJun Du, Aaron Esser-Kahn, Sampa Maiti, Saikat Manna",Nationalized PCT,5/24/2022,,,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",7310348,,3686685,
4399,19-T-070,Toll-like Receptor Agonist Formulations and Methods of Use,,,European Patent Office (EPO),EP,1/13/2021,,,,19-T-070-004,Small,1/13/2020,5/24/2022,No,6/2/2022,Authorized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0693EP,"WenJun Du, Aaron Esser-Kahn, Sampa Maiti, Saikat Manna",Nationalized PCT,5/24/2022,,,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",7310386,,3686685,
4400,19-T-072,Millifluidic System for Thrombosis Analysis Under Patient-Specific Physiological Conditions,"62/890,642", ,*United States,US,8/23/2019,, ,8/23/2019,19-T-072-001,Small,8/23/2019,9/24/2019,,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0694US.P1,"Anindita Basu, Mary Hammes, Andres Moya-Rodriguez",Provisional,9/24/2019, ,8/23/2020,"Cox, Ben",Anindita Basu,"Juggernauth, Anne",4002841,,3705339,No
4401,19-T-072,Millifluidic System for Thrombosis Analysis Under Patient-Specific Physiological Conditions,"16/947,882", ,*United States,US,8/21/2020,,US-2021-0056867-A1,8/21/2020,19-T-072-002,Small,8/23/2019,8/22/2020,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0694US,"Anindita Basu, Mary Hammes, Andres Moya-Rodriguez",US Utility,8/22/2020, ,8/21/2040,"Cox, Ben",Anindita Basu,"Juggernauth, Anne",4847914,2/25/2021,3705339,No
4402,19-T-073,Method and Apparatus for Spectral Computed Tomography (CT) with Multi-Material Decomposition into Three or More Material Components,"16/839,733","11,238,585",*United States,US,4/3/2020,2/1/2022,US-2021-0312612-A1,4/3/2020,19-T-073-001,Small,,5/25/2022,,6/10/2022,Prosecution by Other Party,,,PTMA-19057-US,"Patrick La Riviere, Yan Liu, Dimple Modgil, Zhou Yu",US Utility,4/7/2021,,4/3/2040,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5544284,10/7/2021,3714387,No
4403,19-T-076,Designer Impact Mitigating Architectured Isotropic Materials & Articles,"62/827,987", ,*United States,US,4/2/2019,, ,4/2/2019,19-T-076-001,Small,4/2/2019,1/9/2020,,4/28/2022,Expired Prov - Filed in US,,,78798,"Irmgard Bischofberger, Edwin Chan, Juan de Pablo, Carl Goodrich, Daniel Hexner, Heinrich Jaeger, Andrea Liu, Sidney Nagel, Nidhi Pashine, Daniel Reid, Christopher Soles",Provisional,1/9/2020, ,4/2/2020,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",4208924,,3725894,No
4404,19-T-076,Inverse Design Machine and Making a Designer Impact-Mitigating Architectured Isotropic Structure,"16/837,504", ,*United States,US,4/1/2020,, ,4/1/2020,19-T-076-002,Small,4/2/2019,5/28/2020,No,4/28/2022,Pending,,,19-032US1,"Irmgard Bischofberger, Edwin Chan, Juan de Pablo, Carl Goodrich, Daniel Hexner, Heinrich Jaeger, Andrea Liu, Sidney Nagel, Nidhi Pashine, Daniel Reid, Christopher Soles",US Utility,5/28/2020, ,,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",4598104,,3725894,No
4405,19-T-080,Predicting Returns with Text Data,"62/821,575", ,*United States,US,3/21/2019,, ,3/21/2019,19-T-080-001,Small,3/21/2019,5/20/2019,,4/28/2022,Expired Prov - Filed in US,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0682US.P1,"Bryan Kelly, Dacheng Xiu, Tracy Zheng",Provisional,5/20/2019, ,3/21/2020,"Ramirez, Mario Riojas",Dacheng Xiu,"Smith, Dane",3726795,,3726643,No
4406,19-T-080,Predicting Returns with Text Data,"16/826,000", ,*United States,US,3/20/2020,,US-2020-0302540-A1,3/20/2020,19-T-080-002,Small,3/21/2019,3/22/2020,No,6/3/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0682US,"Bryan Kelly, Dacheng Xiu, Tracy Zheng",US Utility,3/22/2020, ,3/20/2040,"Ramirez, Mario Riojas",Dacheng Xiu,"Smith, Dane",4416560,9/24/2020,3726643,No
4407,19-T-086,Nucleic Acid-Derivatized Therapeutics,"63/074,644", ,*United States,US,9/4/2020,, ,9/4/2020,19-T-086-001,Small,9/4/2020,10/14/2021,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1734-PRO,"Lev Becker, Kasturi Chakraborty, Chang Cui, Yamuna Krishnan",Provisional,9/17/2020, ,9/4/2021,"Sun, Han",Lev Becker,"Tennant, Thelma",4902728,,3740368,No
4408,19-T-086,Nucleic Acid-Derivatized Therapeutics,PCT/US21/49306, ,*United States,US,9/7/2021,, ,9/7/2021,19-T-086-002,Small,9/4/2020,9/10/2021,No,6/16/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1734-WO,"Lev Becker, Kasturi Chakraborty, Chang Cui, Yamuna Krishnan",PCT,9/10/2021, ,3/4/2023,"Sun, Han",Lev Becker,"Tennant, Thelma",6150492,,3740368,No
4409,19-T-089,Methods of Preparing Regioregular Conjugated Polymers,"62/938,632", ,*United States,US,11/21/2019,, ,11/21/2019,19-T-089-001,Small,11/21/2019,3/2/2021,,4/28/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",37997-75,"Xunshan Liu, Valerii Sharapov, Luping Yu",Provisional,11/22/2019, ,11/21/2020,"Hwang, Luke",Luping Yu,"Juggernauth, Anne",4125303,,3761286,No
4410,19-T-089,Methods of Preparing Regioregular Conjugated Polymers,PCT/US20/59992, ,*United States,US,11/11/2020,,WO/2021/101768,11/11/2020,19-T-089-002,Small,11/21/2019,4/28/2022,No,6/21/2022,Expired PCT - Filed in US only,Armstrong Teasdale,"Brennan, Patrick",37997-87,"Xunshan Liu, Valerii Sharapov, Luping Yu",PCT,10/19/2020, ,5/21/2022,"Hwang, Luke",Luping Yu,"Juggernauth, Anne",4992781,5/27/2021,3761286,No
4411,19-T-089,Methods of Preparing Regioregular Conjugated Polymers,"17/778,550",,*United States,US,11/11/2020,,,5/20/2022,19-T-089-003,Small,11/21/2019,5/27/2022,No,6/23/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-101,"Xunshan Liu, Valerii Sharapov, Luping Yu",Nationalized PCT,4/28/2022,,,"Hwang, Luke",Luping Yu,"Juggernauth, Anne",7179901,,3761286,
4412,19-T-090,Targeted Nanomedicine in Treating Arteriovenous Fistula (AVF) Failure,"62/910,873", ,*United States,US,10/4/2019,, ,10/4/2019,19-T-090-001,Small,10/4/2019,10/8/2019,,6/16/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1839-PRO,"Yun Fang, Yan-Ting Shiu, Matthew Tirrell",Provisional,10/8/2019, ,10/4/2020,"Peace, Shane",Yun Fang,"Tennant, Thelma",4029078,,3762563,No
4413,19-T-090,Targeted Nanomedicine for Treating Vascular Disorders,PCT/US20/54291,,*United States,US,10/5/2020,,,10/5/2020,19-T-090-002,Small,10/4/2019,6/10/2022,No,6/10/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1839-WO,"Yun Fang, Yan-Ting Shiu, Matthew Tirrell",PCT,9/5/2020,,4/4/2022,"Peace, Shane",Yun Fang,"Tennant, Thelma",4874686,,3762563,No
4414,19-T-090,Targeted Nanomedicine for Treating Vascular Disorders,,,*United States,US,10/5/2020,,,,19-T-090-003,Small,10/4/2019,3/24/2022,No,5/20/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",1839-WO-US,"Yun Fang, Yan-Ting Shiu, Matthew Tirrell",Nationalized PCT,3/24/2022,,10/5/2040,"Peace, Shane",Yun Fang,"Tennant, Thelma",6978779,,3762563,
4415,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,"62/878,574", ,*United States,US,7/25/2019,, ,7/25/2019,19-T-095-001,Small,7/25/2019,,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691US.P1,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Provisional,8/8/2019, ,7/25/2020,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",3902211,,3767359,No
4416,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,PCT/US20/70308, ,*United States,US,7/24/2020,,WO 2021/016640 A1,7/24/2020,19-T-095-002,Small,7/25/2019,1/25/2022,No,5/2/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691WO,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",PCT,7/21/2020, ,1/25/2022,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4741619,1/28/2021,3767359,No
4417,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,"63/185,941", ,*United States,US,5/7/2021,, ,5/7/2021,19-T-095-003,Small,5/7/2021,4/26/2022,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0731US.P1,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Provisional,6/23/2021, ,5/7/2022,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5837446,,3767359,No
4418,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,"17/597,793",,*United States,US,7/24/2020,,,1/24/2022,19-T-095-004,Small,7/25/2019,1/25/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691US,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695468,,3767359,No
4419,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,"3,148,621",,Canada,CA,7/24/2020,,,1/24/2022,19-T-095-005,None,7/25/2019,1/25/2022,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691CA,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695508,,3767359,No
4420,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,20844027.1,,European Patent Office (EPO),EP,7/24/2020,,4003401,1/31/2022,19-T-095-006,None,7/25/2019,2/1/2022,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691EP,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695548,6/1/2022,3767359,No
4421,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,2022-504582,,Japan,JP,7/24/2020,,,1/24/2022,19-T-095-007,None,7/25/2019,1/25/2022,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691JP,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695595,,3767359,No
4422,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,2020316002,,Australia,AU,7/24/2020,,,2/9/2022,19-T-095-008,Small,7/25/2019,2/15/2022,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691AU,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695635,,3767359,No
4423,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,202217005465,,India,IN,7/24/2020,,,2/1/2022,19-T-095-009,Small,7/25/2019,2/8/2022,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691IN,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695683,,3767359,No
4424,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,11 2022 001320 5,,Brazil,BR,7/24/2020,,,1/24/2022,19-T-095-010,None,7/25/2019,1/25/2022,No,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691BR,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695743,,3767359,No
4425,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,202080067433.2,,China,CN,7/24/2020,,CN 114466657 A,3/24/2022,19-T-095-011,Small,7/25/2019,3/30/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691CN,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695783,5/10/2022,3767359,No
4426,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,MX/a/2022/000991,,Mexico,MX,7/24/2020,,,1/26/2022,19-T-095-012,None,7/25/2019,2/1/2022,No,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0691MX,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Nationalized PCT,1/25/2022,,7/24/2040,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6695823,,3767359,No
4427,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,"63/313,087", ,*United States,US,2/23/2022,, ,2/23/2022,19-T-095-013,Small,5/7/2021,2/24/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0731US.P2,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",Provisional,2/24/2022, ,2/23/2023,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6846463,,3767359,No
4428,19-T-095,Compositions and Methods Comprising Protease-Activated Therapeutic Agents,PCT/US22/72121,,*United States,US,5/5/2022,,,5/5/2022,19-T-095-014,Small,5/7/2021,5/5/2022,No,6/23/2022,Pending,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0731WO,"Jeffrey Hubbell, Jun Ishihara, Aslan Mansurov, Juan Mendoza",PCT,4/26/2022,,11/7/2023,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7140042,,3767359,
4429,19-T-096,"Large Lateral Scale Two-Dimensional Materials and Other Thin Films, and Associated Systems and Methods","62/911,563",,*United States,US,10/7/2019,,,10/7/2019,19-T-096-001,Small,10/7/2019,2/18/2021,,6/6/2022,Expired Prov - Filed PCT,"Wolf, Greenfield & Sacks, P.C.",,C1604.70000US00,"Baorui Cheng, Jiwoong Park, Yu Zhong",Provisional,8/13/2019,19-T-096-001,10/7/2020,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",3909584,,3769256,No
4430,19-T-096,"Large Lateral Scale Two-Dimensional Materials and Other Thin Films, and Associated Systems and Methods",PCT/US20/54378,,*United States,US,10/6/2020,,,10/6/2020,19-T-096-002,Small,10/7/2019,3/15/2022,No,6/9/2022,Expired PCT - Filed in US only,"Wolf, Greenfield & Sacks, P.C.","Blackwell, Brandon",C1604.7000WO00,"Baorui Cheng, Jiwoong Park, Yu Zhong",PCT,10/14/2020,19-T-096-002,4/7/2022,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",4980241,,3769256,No
4431,19-T-096,"Large Lateral Scale Two-Dimensional Materials and Other Thin Films, and Associated Systems and Methods","17/767,125",,*United States,US,10/6/2020,,,4/7/2022,19-T-096-003,Small,10/7/2019,4/7/2022,No,6/9/2022,Pending,"Wolf, Greenfield & Sacks, P.C.","Blackwell, Brandon",C1604.7000US01,"Baorui Cheng, Jiwoong Park, Yu Zhong",Nationalized PCT,3/15/2022,19-T-096-003,,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",6932280,,3769256,
4432,19-T-097,Sequential Infiltration Synthesis of Group 13 Oxide Electronic Materials,"16/515,718", ,*United States,US,7/18/2019,, ,7/18/2019,19-T-097-001,Small,7/18/2019,8/29/2019,Yes,4/28/2022,Pending,Foley & Lardner,,051583-0890,"Seth Darling, Alex Martinson, Ruben Waldman",US Utility,8/29/2019, ,7/18/2039,"Hwang, Luke",Alex Martinson,"Juggernauth, Anne",3969524,,3777366,No
4433,19-T-100,Covariant Neural Networks for Learning on Position Data Using Moment Tensors,"62/978,571",,*United States,US,2/19/2020,, ,2/19/2020,19-T-100-001,Small,2/19/2020,3/30/2021,,6/6/2022,Abandoned,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1499-PRO,"Brandon Anderson, Imre (Risi) Mikls Kondor",Provisional,2/26/2020,19-T-100-001,2/19/2021,"Ramirez, Mario Riojas",Imre (Risi) Mikls Kondor,"Smith, Dane",4380896,,3793506,No
4434,19-T-103,Novel Biomarkers and Methods for Diagnosing and Evaluating Lymphoma,"62/901,069",,*United States,US,9/16/2019,,,9/16/2019,19-T-103-001,Small,9/16/2019,10/8/2019,,6/24/2022,Abandoned,"Casimir Jones, S.C.",,UCHI-38026.101,"Brian Chiu, Chuan He",Provisional,10/8/2019,19-T-103-001,9/16/2020,"Hwang, Luke",Brian Chiu,"Tennant, Thelma",4028887,,3848730,No
4435,19-T-105,Heterogeneous Rare-Earth Doped Systems,"62/887,373", ,*United States,US,8/15/2019,, ,8/15/2019,19-T-105-001,Small,8/15/2019,8/29/2019,,4/28/2022,Expired Prov - Filed PCT,Barnes & Thornburg,"Kelsey, Jeffrey",21459-298123,"Christina Wicker, Tian Zhong",Provisional,8/29/2019, ,8/15/2020,"Cox, Ben",Tian Zhong,"Juggernauth, Anne",3969458,,3855513,No
4436,19-T-105,Heterogeneous Rare-Earth Doped Systems,PCT/US20/46454, ,*United States,US,8/14/2020,,WO 2021/030724,8/14/2020,19-T-105-002,Small,8/15/2019,3/9/2022,No,4/28/2022,Expired PCT - Filed in US only,Barnes & Thornburg,"Kelsey, Jeffrey",21459-324000,"Christina Wicker, Tian Zhong",PCT,8/18/2020, ,2/15/2022,"Cox, Ben",Tian Zhong,"Juggernauth, Anne",4838440,2/18/2021,3855513,No
4437,19-T-105,Heterogeneous Rare-Earth Doped Systems,"17/635,088",,*United States,US,8/14/2020,,,2/14/2022,19-T-105-003,Small,8/15/2019,2/15/2022,No,6/16/2022,Pending,Barnes & Thornburg,"Kelsey, Jeffrey",21459-352091,"Christina Wicker, Tian Zhong",Nationalized PCT,1/12/2022,19-T-105-003,8/14/2040,"Cox, Ben",Tian Zhong,"Juggernauth, Anne",6585051,,3855513,No
4438,19-T-106,Lamellar Iron Sulfides with Embedded Cations for Electrical Energy Storage,"62/907,979",,*United States,US,9/30/2019,,,9/30/2019,19-T-106-001,Small,9/30/2019,10/24/2019,,6/13/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/17 PROV,"John Anderson, Noah Horwitz, Jiaze Xie",Provisional,10/24/2019,19-T-106-001,9/30/2020,"Peace, Shane",John Anderson,"Tennant, Thelma",4066700,,3856684,No
4439,19-T-106,Lamellar Iron Sulfides with Embedded Cations for Electrical Energy Storage,PCT/US20/53252,,*United States,US,9/29/2020,,WO 2021/067259,9/29/2020,19-T-106-002,Small,9/30/2019,3/1/2022,No,6/13/2022,Expired PCT - Filed in US only,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/17 PCT,"John Anderson, Noah Horwitz, Jiaze Xie",PCT,9/15/2020,19-T-106-002,3/30/2022,"Peace, Shane",John Anderson,"Tennant, Thelma",4893347,4/8/2021,3856684,No
4440,19-T-106,Lamellar Iron Sulfides with Embedded Cations for Electrical Energy Storage,"17/765,176",,*United States,US,9/29/2020,,,3/30/2022,19-T-106-003,Small,9/30/2019,3/31/2022,No,6/24/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/17 PCT/US,"John Anderson, Noah Horwitz, Jiaze Xie",Nationalized PCT,3/1/2022,19-T-106-003,9/29/2040,"Peace, Shane",John Anderson,"Tennant, Thelma",6873178,,3856684,
4441,19-T-107,Sulfur-Containing Inorganic-Organic Hybrid Materials and Methods for Making the Same,"62/925,310",,*United States,US,10/24/2019,,,10/24/2019,19-T-107-001,Small,10/24/2019,3/3/2021,,6/6/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/16 PROV,"John Anderson, Noah Horwitz, Airi Kawamura, Jiaze Xie",Provisional,11/20/2019,19-T-107-001,10/24/2020,"Peace, Shane",John Anderson,"Tennant, Thelma",4123572,,3857275,No
4442,19-T-107,Sulfur-Containing Inorganic-Organic Hybrid Materials and Methods for Making the Same,PCT/US20/56808,,*United States,US,10/22/2020,,WO 2021/081172,10/22/2020,19-T-107-002,Small,10/24/2019,3/21/2022,No,6/6/2022,Expired PCT - Filed in US only,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/16 PCT,"John Anderson, Noah Horwitz, Airi Kawamura, Jiaze Xie",PCT,9/23/2020,19-T-107-002,4/24/2022,"Peace, Shane",John Anderson,"Tennant, Thelma",4913926,4/29/2021,3857275,No
4443,19-T-107,Sulfur-Containing Inorganic-Organic Hybrid Materials and Methods for Making the Same,"17/771,266",,*United States,US,10/22/2020,,,4/22/2022,19-T-107-003,Small,10/24/2019,5/12/2022,No,6/14/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/16 PCT/US,"John Anderson, Noah Horwitz, Airi Kawamura, Jiaze Xie",Nationalized PCT,3/21/2022,19-T-107-003,10/22/2040,"Peace, Shane",John Anderson,"Tennant, Thelma",6958386,,3857275,
4444,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,"62/900,420", ,*United States,US,9/13/2019,, ,9/13/2019,19-T-112-001,Small,9/13/2019,10/8/2019,,4/28/2022,Expired Prov - Filed PCT,"Oblon, Spivak, McClelland, Maier & Neustadt",,523147US,"Andrew Ferguson, Rama Ranganathan",Provisional,10/8/2019, ,9/13/2020,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",4028943,,3901226,No
4445,19-T-112,Method and Apparatus using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,"63/020,083", ,*United States,US,5/5/2020,, ,5/5/2020,19-T-112-002,Small,9/13/2019,5/6/2020,,4/28/2022,Expired Prov - Filed PCT,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt",530246US,"Andrew Ferguson, Rama Ranganathan",Provisional,5/6/2020, ,5/5/2021,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",4528055,,3901226,No
4446,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,PCT/US20/50466, ,*United States,US,9/11/2020,,WO 2021/050923,9/11/2020,19-T-112-003,Small,9/13/2019,2/18/2022,No,6/3/2022,Expired PCT - Nationalized,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/PC,"Andrew Ferguson, Rama Ranganathan",PCT,9/11/2020, ,3/13/2022,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",4887574,3/18/2021,3901226,No
4447,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,"17/642,582",,*United States,US,9/11/2020,,,3/11/2022,19-T-112-004,Small,9/13/2019,3/31/2022,No,5/2/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/US,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822755,,3901226,No
4448,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,3149211,,Canada,CA,9/11/2020,,,2/23/2022,19-T-112-005,Small,9/13/2019,3/31/2022,No,6/24/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/CA,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822780,,3901226,No
4449,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,20863365.1,,European Patent Office (EPO),EP,9/11/2020,,EP4004200,2/23/2022,19-T-112-006,Small,9/13/2019,3/31/2022,No,6/24/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/EP,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822805,6/1/2022,3901226,No
4450,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,2022-515841,,Japan,JP,9/11/2020,,,3/10/2022,19-T-112-007,Small,9/13/2019,6/3/2022,No,6/6/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/JP,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2022,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822835,,3901226,No
4451,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,2020344624,,Australia,AU,9/11/2020,,,3/11/2022,19-T-112-008,Small,9/13/2019,6/3/2022,No,6/3/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/AU,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822860,,3901226,No
4452,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,202217021705,,India,IN,9/11/2020,,,4/12/2022,19-T-112-009,Small,9/13/2019,6/9/2022,No,6/9/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/IN,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822885,,3901226,No
4453,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,785796,,New Zealand,NZ,9/11/2020,,,3/11/2022,19-T-112-012,Small,9/13/2019,6/3/2022,No,6/3/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/NZ,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822917,,3901226,No
4454,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,BR112022004539-5,,Brazil,BR,9/11/2020,,,3/11/2022,19-T-112-010,Small,9/13/2019,6/3/2022,No,6/24/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/BR,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822959,,3901226,No
4455,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,202080078092.9,,China,CN,9/11/2020,,,5/10/2022,19-T-112-011,Small,9/13/2019,6/3/2022,No,6/6/2022,Pending,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940/CN,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6822984,,3901226,No
4456,19-T-112,Method and Apparatus Using Machine Learning for Evolutionary Data-Driven Design of Proteins and Other Sequence Defined Biomolecules,,,Russia,RU,9/11/2020,,,,19-T-112-013,Small,9/13/2019,4/5/2022,No,6/3/2022,Abandoned,"Marshall, Gerstein & Borun","Phelan, Ryan",33300/55940RU,"Andrew Ferguson, Rama Ranganathan",Nationalized PCT,2/18/2022,,9/11/2040,"Cox, Ben",Rama Ranganathan,"Tennant, Thelma",6823010,,3901226,No
4457,19-T-113,Photoproximity profiling of protein-protein interactions in cells,"62/903,621",,*United States,US,9/20/2019,, ,9/20/2019,19-T-113-001,Small,9/20/2019,10/31/2019,,6/13/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/14 PROV,"David McCutcheon, Raymond Moellering",Provisional,10/31/2019,19-T-113-001,9/20/2020,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4094297,,3901680,No
4458,19-T-113,Photoproximity profiling of protein-protein interactions in cells,PCT/US20/51834,,*United States,US,9/21/2020,,WO 2021/055960,9/21/2020,19-T-113-002,Small,9/20/2019,3/30/2022,No,6/13/2022,Expired PCT - Nationalized,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/14 PCT,"Anthony Carlos, David McCutcheon, Raymond Moellering",PCT,9/25/2020,19-T-113-002,3/20/2022,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4916348,3/25/2021,3901680,No
4459,19-T-113,Photoproximity profiling of protein-protein interactions in cells,"17/762,180",,*United States,US,9/21/2020,,,3/21/2022,19-T-113-003,Small,9/20/2019,3/30/2022,No,6/21/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/14 PCT/US,"Anthony Carlos, David McCutcheon, Raymond Moellering",Nationalized PCT,3/30/2022,19-T-113-003,,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",7004307,,3901680,
4460,19-T-113,Photoproximity profiling of protein-protein interactions in cells,20866338.5,,European Patent Office (EPO),EP,9/21/2020,,,4/20/2022,19-T-113-004,Small,9/20/2019,4/26/2022,No,5/31/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/14 PCT/EP,"Anthony Carlos, David McCutcheon, Raymond Moellering",Nationalized PCT,4/26/2022,,,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",7137416,,3901680,
4461,19-T-113,Photoproximity profiling of protein-protein interactions in cells,,,China,CN,9/21/2020,,,5/19/2022,19-T-113-005,Small,9/20/2019,6/1/2022,No,6/23/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/14 PCT/CN,"Anthony Carlos, David McCutcheon, Raymond Moellering",Nationalized PCT,4/26/2022,,,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",7137446,,3901680,
4462,19-T-115,Combination Therapy for the Treatment of Migraines,"62/897,686", ,*United States,US,9/9/2019,, ,9/9/2019,19-T-115-001,Small,9/9/2019,9/11/2019,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697US.P1,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",Provisional,9/11/2019, ,9/9/2020,"Sun, Han",Richard Kraig,"Tennant, Thelma",3989413,,3908016,No
4463,19-T-115,Combination Therapy for the Treatment of Migraines,"62/946,122", ,*United States,US,12/10/2019,, ,12/10/2019,19-T-115-002,Small,12/10/2019,12/13/2019,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697US.P2,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",Provisional,12/13/2019, ,12/10/2020,"Sun, Han",Richard Kraig,"Tennant, Thelma",4190532,,3908016,No
4464,19-T-115,Combination Therapy for the Treatment of Migraines,PCT/US20/70511, ,*United States,US,9/9/2020,,WO 2021/1051130,9/9/2020,19-T-115-003,Small,9/9/2019,2/21/2022,No,6/16/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697WO,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",PCT,9/10/2020, ,3/9/2022,"Sun, Han",Richard Kraig,"Tennant, Thelma",4882844,3/18/2021,3908016,No
4465,19-T-115,Combination Therapy for the Treatment of Migraines,"16/948,219", ,*United States,US,9/9/2020,,US-2021-0077591-A1,9/9/2020,19-T-115-004,Small,9/9/2019,9/10/2020,No,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697US,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",US Utility,9/10/2020, ,9/9/2039,"Sun, Han",Richard Kraig,"Tennant, Thelma",4882900,3/18/2021,3908016,No
4466,19-T-115,Combination Therapy for the Treatment of Migraines,"3,153,776",,Canada,CA,9/9/2020,,,3/8/2022,19-T-115-005,Small,9/9/2019,3/8/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697CA,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",Nationalized PCT,2/21/2022,,9/9/2040,"Sun, Han",Richard Kraig,"Tennant, Thelma",6827798,,3908016,
4467,19-T-115,Combination Therapy for the Treatment of Migraines,20862880.0,,European Patent Office (EPO),EP,9/9/2020,,4027984,3/1/2022,19-T-115-006,Small,9/9/2019,3/1/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697EP,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",Nationalized PCT,2/21/2022,,9/9/2040,"Sun, Han",Richard Kraig,"Tennant, Thelma",6827843,7/20/2022,3908016,
4468,19-T-115,Combination Therapy for the Treatment of Migraines,2022-515624,,Japan,JP,9/9/2020,,,3/8/2022,19-T-115-007,Small,9/9/2019,3/8/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697JP,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",Nationalized PCT,2/21/2022,,9/9/2040,"Sun, Han",Richard Kraig,"Tennant, Thelma",6827888,,3908016,
4469,19-T-115,Combination Therapy for the Treatment of Migraines,2020346186,,Australia,AU,9/9/2020,,,3/15/2022,19-T-115-008,Small,9/9/2019,3/16/2022,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0697AU,"Richard Kraig, Aya Pusic, Kae Pusic, Martin Sanders, Lisa Won",Nationalized PCT,2/21/2022,,2/9/2040,"Sun, Han",Richard Kraig,"Tennant, Thelma",6827933,,3908016,
4470,19-T-118,Hairpin Oligonucleotides and Uses Thereof,"63/110,605", ,*United States,US,11/6/2020,, ,11/6/2020,19-T-118-001,Small,11/6/2020,3/9/2022,,4/28/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",749457,"Christopher Katanski, Tao Pan, Christopher Watkins",Provisional,5/28/2020, ,11/6/2021,"Dembo, Anna",Tao Pan,"Tennant, Thelma",4597968,,3909995,No
4471,19-T-118,Hairpin Oligonucleotides and Uses Thereof,PCT/US21/58258, ,*United States,US,11/5/2021,, ,11/5/2021,19-T-118-002,Small,11/6/2020,11/12/2021,No,6/21/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757154,"Christopher Katanski, Tao Pan, Christopher Watkins",PCT,11/12/2021, ,5/6/2023,"Dembo, Anna",Tao Pan,"Tennant, Thelma",6391135,,3909995,No
4472,19-T-120,Strongly Lewis Acidic Metal-Organic Frameworks for Continuous Flow Catalysis,"62/889,871", ,*United States,US,8/21/2019,, ,8/21/2019,19-T-120-001,Small,8/21/2019,3/3/2021,,4/28/2022,Expired Prov - Filed in US,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/15 PROV,"Xuanyu Feng, Pengfei Ji, Wenbin Lin",Provisional,8/29/2019, ,8/21/2020,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",3969719,,3910967,No
4473,19-T-120,Strongly Lewis Acidic Metal-Organic Frameworks for Continuous Flow Catalysis,"16/999,818", ,*United States,US,8/21/2020,,US-2021-0053042-A1,8/21/2020,19-T-120-002,Small,8/21/2019,8/26/2020,No,4/28/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/15/2,"Xuanyu Feng, Pengfei Ji, Wenbin Lin",US Utility,6/16/2020, ,8/21/2040,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4636640,2/25/2021,3910967,No
4474,19-T-121,Methods and Systems for Detection of Nucleic Acid Modifications,"62/913,475",,*United States,US,10/10/2019,,,10/10/2019,19-T-121-001,Small,10/10/2019,10/23/2019,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0698US.P1,"Chuan He, Lulu Hu",Provisional,10/23/2019,19-T-121-001,10/10/2020,"Hwang, Luke",Chuan He,"Tennant, Thelma",4053687,,3914086,No
4475,19-T-121,Methods and Systems for Detection of Nucleic Acid Modifications,PCT/US20/70639,,*United States,US,10/9/2020,,WO 2021/072435 A2,10/9/2020,19-T-121-002,Small,10/10/2019,4/21/2022,No,6/21/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0698WO,"Chuan He, Lulu Hu",PCT,10/14/2020,19-T-121-002,4/10/2022,"Hwang, Luke",Chuan He,"Tennant, Thelma",4981851,4/15/2021,3914086,No
4476,19-T-121,Methods and Systems for Detection of Nucleic Acid Modifications,"17/754,622",,*United States,US,10/9/2020,,,4/7/2022,19-T-121-003,Small,10/10/2019,4/7/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0698US,"Chuan He, Lulu Hu",Nationalized PCT,3/30/2022,19-T-121-003,10/9/2040,"Hwang, Luke",Chuan He,"Tennant, Thelma",6993985,,3914086,
4477,19-T-121,Methods and Systems for Detection of Nucleic Acid Modifications,,,China,CN,10/9/2020,,,6/9/2022,19-T-121-004,Small,10/10/2019,6/21/2022,No,6/23/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0698CN,"Chuan He, Lulu Hu",Nationalized PCT,5/12/2022,,,"Hwang, Luke",Chuan He,"Tennant, Thelma",7244015,,3914086,
4478,19-T-122,"Photosensitive, Inorganic Ligand-Capped Inorganic Nanocrystals","62/897,748", ,*United States,US,9/9/2019,, ,9/9/2019,19-T-122-001,Small,9/9/2019,10/24/2019,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0035-PV-3,"Jia-Ahn Pan, Dmitri Talapin, Yuanyuan Wang, Haoqi Wu",Provisional,9/10/2019, ,9/9/2020,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",3987795,,3915773,No
4479,19-T-123,Automated Digital Structure Identification,"62/934,153", ,*United States,US,11/12/2019,, ,11/12/2019,19-T-123-001,Small,11/12/2019,11/21/2019,,4/28/2022,Abandoned,"Bell & Manning, LLC","Kalafut, Christopher",05400-0041-PV,"Daniel Cutright, Tianming Wu",Provisional,11/21/2019, ,11/12/2020,"Cox, Ben",Daniel Cutright,"Smith, Dane",4124182,,3917224,No
4480,19-T-124,Dual Low Vacuum-Ultrahigh Vacuum System for Large-Scale Production of Micro-Channel Plate Photomultipliers,"62/928,598", ,*United States,US,10/31/2019,, ,10/31/2019,19-T-124-001,Small,10/31/2019,11/12/2019,,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Manning, Michelle",05400-0040-PV,"Bernhard Adams, Evan Angelico, Andrey Elagin, Henry Frisch, Eric Spieglan",Provisional,11/12/2019, ,10/31/2020,"Cox, Ben",Henry Frisch,"Tennant, Thelma",4110476,,3970306,No
4481,19-T-124,Dual Low Vacuum-Ultrahigh Vacuum System for Large-Scale Production of Micro-Channel Plate Photomultipliers,"17/082,292",,*United States,US,10/28/2020,,,10/28/2020,19-T-124-002,Small,10/31/2019,10/15/2020,No,6/10/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0040-NP,"Bernhard Adams, Evan Angelico, Andrey Elagin, Henry Frisch, Eric Spieglan",US Utility,10/15/2020,,,"Cox, Ben",Henry Frisch,"Tennant, Thelma",4983335,,3970306,No
4482,19-T-128,METHODS OF PREDICTING RESPONSIVENESS TO IMMUNE-BASED CANCER THERAPIES,"62/875,966", ,*United States,US,7/18/2019,, ,7/18/2019,19-T-128-001,Small,7/18/2019,9/3/2019,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Fleetwood, Margaret",19-1422-PRO,"Priyanka Dutta Gupta, Akash Patnaik",Provisional,9/3/2019,19-T-128-001,7/18/2020,"Sun, Han",Akash Patnaik,"Tennant, Thelma",3971725,,3971091,No
4483,19-T-128,Methods of Predicting Responsiveness to Cancer Therapies,"16/933,885", ,*United States,US,7/20/2020,,US-2021-0017607-A1,7/20/2020,19-T-128-002,Small,7/18/2019,7/21/2020,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Fleetwood, Margaret",19-1422-US,"Priyanka Dutta Gupta, Akash Patnaik",US Utility,7/21/2020,19-T-128-002,7/20/2040,"Sun, Han",Akash Patnaik,"Tennant, Thelma",4740837,1/21/2021,3971091,No
4484,19-T-129,Wearable Word Counter,"15/191,688","10,134,424",*United States,US,6/24/2016,11/20/2018,US 2016/0379671 A1,6/24/2016,19-T-129-001,Small,6/25/2015,,No,6/14/2022,Issued,TechLaw Ventures,"Banta, Travis",VMI-0001.NP,"Jill Desmond, Alvin Lacson, Andy Turk",US Utility,9/10/2019, ,6/24/2036,"Ginsburg, Eric",Alvin Lacson,"Smith, Dane",3988349,12/29/2016,3988220,No
4485,19-T-129,Wearable Word Counter,"16/168,452","10,789,939",*United States,US,10/23/2018,9/29/2020, ,10/23/2018,19-T-129-002,Small,6/25/2015,9/12/2019,No,4/28/2022,Issued,TechLaw Ventures,"Banta, Travis",VMI-0001.CIP1,"Jon Boggiano, Jill Desmond, Alvin Lacson, Jonathan Simon, Andy Turk",Continuation in Part,9/12/2019, ,10/23/2038,"Ginsburg, Eric",Alvin Lacson,"Smith, Dane",3990090,,3988220,No
4486,19-T-129,Wearable Word Counter,"16/168,439","10,959,648",*United States,US,10/23/2018,3/30/2021,US 2019-0117126 A1,10/23/2018,19-T-129-003,Small,6/25/2015,3/11/2021,No,5/27/2022,Issued,TechLaw Ventures,"Banta, Travis",VMI-0001.CIP2,"Chris Boggiano, Jon Boggiano, Nolan Danley, Jill Desmond, Alvin Lacson, Arbind Thakur, Andy Turk",Continuation in Part,11/12/2019, ,10/23/2038,"Ginsburg, Eric",Alvin Lacson,"Smith, Dane",4111394,4/25/2019,3988220,No
4487,19-T-130,Methods and Compositions for Treating Staphyloccocal Infections,"62/900,170", ,*United States,US,9/13/2019,, ,9/13/2019,19-T-130-001,Small,9/13/2019,,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0700US.P1,"Dominique Missiakas, Olaf Schneewind",Provisional,9/16/2019,19-T-130-001,9/13/2020,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",3991610,,3989467,No
4488,19-T-130,Methods and Compositions for Treating Staphyloccocal Infections,"62/992,457", ,*United States,US,3/20/2020,, ,3/20/2020,19-T-130-002,Small,3/20/2020,6/15/2021,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0700US.P2,"Xinhai Chen, Dominique Missiakas, Olaf Schneewind",Provisional,3/30/2020,19-T-130-002,3/20/2021,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",4430996,,3989467,No
4489,19-T-130,Methods and Compositions for Treating Staphyloccocal Infections,PCT/US20/70530, ,*United States,US,9/11/2020,,WO 2021/051136 A1,9/11/2020,19-T-130-003,Small,9/13/2019,3/1/2022,No,6/21/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0700WO,"Xinhai Chen, Dominique Missiakas, Olaf Schneewind",PCT,9/11/2020,19-T-130-003,3/13/2022,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",4886682,3/18/2021,3989467,No
4490,19-T-130,Methods and Compositions for Treating Staphyloccocal Infections,"17/753,692",,*United States,US,9/11/2020,,,3/11/2022,19-T-130-004,Small,9/13/2019,3/11/2022,No,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0700US,"Xinhai Chen, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/1/2022,19-T-130-004,9/11/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6868847,,3989467,
4491,19-T-130,Methods and Compositions for Treating Staphyloccocal Infections,20864007.8,,European Patent Office (EPO),EP,9/11/2020,,4028426,3/22/2022,19-T-130-005,Small,9/13/2019,3/30/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0700EP,"Xinhai Chen, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/1/2022,,9/11/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6868872,7/20/2022,3989467,
4492,19-T-130,Methods and Compositions for Treating Staphyloccocal Infections,202080078967.5,,China,CN,9/11/2020,,,5/12/2022,19-T-130-006,Small,9/13/2019,5/18/2022,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0700CN,"Xinhai Chen, Dominique Missiakas, Olaf Schneewind",Nationalized PCT,3/1/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6868897,,3989467,
4493,19-T-131,"Method of Creating Zero-Burden Digital Biomarkers for Autism, and Exploiting Co-Morbidity Patterns to Drive Early Intervention","62/904,220",,*United States,US,9/23/2019,,,9/23/2019,19-T-131-001,Small,9/23/2019,3/3/2021,,6/6/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",,"Ishanu Chattopadhyay, Yi Huang, Dmytro Onishchenko",Provisional,9/25/2019,19-T-131-001,9/23/2020,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",4005166,,3989812,No
4494,19-T-131,Zero-burden Digital Biomarkers For Autism: Exploiting Co-morbidity Patterns To Drive Early Intervention,"62/937,604",,*United States,US,11/19/2019,,,11/19/2019,19-T-131-002,Small,11/19/2019,3/3/2021,,6/6/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",37997-77,"Ishanu Chattopadhyay, Yi Huang, Dmytro Onishchenko",Provisional,11/21/2019,19-T-131-002,11/19/2020,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",4123744,,3989812,No
4495,19-T-131,"Method of Creating Zero-Burden Digital Biomarkers for Autism, and Exploiting Co-Morbidity Patterns to Drive Early Intervention",PCT/US20/52112,,*United States,US,9/23/2020,,WO 2021/061702,9/23/2020,19-T-131-003,Small,9/23/2019,4/1/2022,No,6/6/2022,Expired PCT - Filed in US only,Armstrong Teasdale,"Block, Zachary",37997-00082,"Ishanu Chattopadhyay, Yi Huang, Dmytro Onishchenko",PCT,8/5/2020,19-T-131-003,3/23/2022,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",4807698,4/1/2021,3989812,No
4496,19-T-131,"Method of Creating Zero-Burden Digital Biomarkers for Autism, and Exploiting Co-Morbidity Patterns to Drive Early Intervention","17/763,089",,*United States,US,9/23/2020,,,3/23/2022,19-T-131-004,Small,9/23/2019,4/5/2022,No,6/15/2022,Pending,Armstrong Teasdale,"Block, Zachary",37997-100,"Ishanu Chattopadhyay, Yi Huang, Dmytro Onishchenko",Nationalized PCT,4/1/2022,19-T-131-004,9/23/2040,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",7020911,,3989812,
4497,19-T-133,Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites,"63/026,415", ,*United States,US,5/18/2020,, ,5/18/2020,19-T-133-001,Small,5/18/2020,6/15/2021,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Harper, David",20-676-PRO,Rima McLeod,Provisional,4/13/2020,19-T-133-001,5/18/2021,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",4466961,,3990494,No
4498,19-T-133,Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites,PCT/US21/33019,,*United States,US,5/18/2021,,WO 2021/236681,5/18/2021,19-T-133-002,Small,5/18/2020,5/19/2021,No,6/23/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Harper, David",20-676-WO,Rima McLeod,PCT,4/27/2021,19-T-133-002,11/19/2023,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",5634639,11/25/2021,3990494,No
4499,19-T-134,Compositions and Methods for Treating and Preventing Post-Cardiopulmonary Resuscitation Injury,"62/902,715", ,*United States,US,9/19/2019,, ,9/19/2019,19-T-134-001,Small,9/19/2019,10/14/2019,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1784-PRO,"Yonghu Fang, Lin Piao, Willard Sharp",Provisional,10/14/2019,19-T-134-001,9/19/2020,"Sun, Han",Willard Sharp,"Tennant, Thelma",4033184,,3993103,No
4500,19-T-134,Compositions and Methods for Treating and Preventing Post-Cardiopulmonary Resuscitation Injury,"17/025,022", ,*United States,US,9/19/2019,,US-2021-0085653-A1,9/18/2020,19-T-134-002,Small,9/19/2019,9/17/2020,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1784-US,"Yonghu Fang, Lin Piao, Willard Sharp",US Utility,9/17/2020,19-T-134-002,9/19/2039,"Sun, Han",Willard Sharp,"Tennant, Thelma",4903594,3/25/2021,3993103,No
4501,19-T-136,Method and System for Assessing Reading Quality,"16/287,951", ,*United States,US,2/27/2019,,2019/0267027,2/27/2019,19-T-136-001,Small,2/27/2018,9/12/2019,No,6/23/2022,Pending,TechLaw Ventures,"Banta, Travis",VMI-0004.NP,"Phil Balliet, Chris Boggiano, Jon Boggiano, Nicola Boyd, Rodrigo Rallo, Jonathan Simon, Alexandra Yorke",US Utility,9/12/2019, ,2/27/2039,"Ramirez, Mario Riojas",Jon Boggiano,"Smith, Dane",3990151,8/29/2019,4022829,No
4502,19-T-136,Method and System for Assessing Reading Quality,"62/636,035", ,*United States,US,2/27/2018,, ,2/27/2018,19-T-136-002,Small,2/27/2018,9/21/2020,,4/28/2022,Expired Prov - Filed in US,TechLaw Ventures,"Banta, Travis",VMI-0004.PO,"Phil Balliet, Chris Boggiano, Jon Boggiano, Nicola Boyd, Rodrigo Rallo, Jonathan Simon, Alexandra Yorke",Provisional,9/21/2020, ,2/27/2019,"Ramirez, Mario Riojas",Jon Boggiano,"Smith, Dane",4909597,,4022829,No
4503,19-T-137,System and Method to Predict Success Based on Analysis of Failure,"62/909,317", ,*United States,US,10/2/2019,, ,10/2/2019,19-T-137-001,Small,10/2/2019,11/12/2019,,4/28/2022,Expired Prov - Filed in US,,,2019-166-01,"James Evans, Dashun Wang, Yang Wang, Yian Yin",Provisional,11/12/2019, ,10/2/2020,"Ramirez, Mario Riojas",James Evans,"Smith, Dane",4110207,,4022855,No
4504,19-T-137,System and Method to Predict Success Based on Analysis of Failure,"17/061,112", ,*United States,US,10/2/2019,, ,10/1/2020,19-T-137-002,Small,10/2/2019,10/1/2020,No,4/28/2022,Pending,,"Kalafut, Christopher",00100-0221-NP,"James Evans, Dashun Wang, Yang Wang, Yian Yin",US Utility,10/1/2020, ,10/1/2040,"Ramirez, Mario Riojas",James Evans,"Smith, Dane",4934480,,4022855,No
4505,19-T-138,Methods and Compositions Comprising Modified FAB Scaffolds and Protein G FAB Binding Domains,"62/914,851",,*United States,US,10/14/2019,,,10/14/2019,19-T-138-001,Small,10/14/2019,10/24/2019,,6/16/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0701US.P1,"Edwin Arauz-Diaz, Elena Davydova, Anthony Kossiakoff, Tomasz (Tomek) Slezak",Provisional,10/24/2019,19-T-138-001,10/14/2020,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",4066624,,4023052,No
4506,19-T-138,Methods and Compositions Comprising Modified FAB Scaffolds and Protein G FAB Binding Domains,PCT/US20/70664,,*United States,US,10/14/2020,,WO 2021/077132 A1,10/14/2020,19-T-138-002,Small,10/14/2019,6/10/2022,No,6/16/2022,Expired PCT - Nationalized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0701WO,"Edwin Arauz-Diaz, Elena Davydova, Anthony Kossiakoff, Tomasz (Tomek) Slezak",PCT,8/6/2020,19-T-138-002,4/14/2022,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",4812992,4/22/2021,4023052,No
4507,19-T-138,Methods and Compositions Comprising Modified FAB Scaffolds and Protein G FAB Binding Domains,"17/754,797",,*United States,US,10/14/2020,,,4/12/2022,19-T-138-003,Small,10/14/2019,4/12/2022,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0701US,"Edwin Arauz-Diaz, Elena Davydova, Anthony Kossiakoff, Tomasz (Tomek) Slezak",Nationalized PCT,3/31/2022,19-T-138-003,,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",7008172,,4023052,
4508,19-T-138,Methods and Compositions Comprising Modified FAB Scaffolds and Protein G FAB Binding Domains,20877293.9,,European Patent Office (EPO),EP,10/14/2020,,,5/9/2022,19-T-138-004,Small,10/14/2019,5/11/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0701EP,"Edwin Arauz-Diaz, Elena Davydova, Anthony Kossiakoff, Tomasz (Tomek) Slezak",Nationalized PCT,3/31/2022,19-T-138-004,10/14/2040,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",7008206,,4023052,
4509,19-T-147,Methods and Systems for Modulating Cellular Activation,"62/915,928", ,*United States,US,10/16/2019,, ,10/16/2019,19-T-147-001,Small,10/16/2019,10/24/2019,,5/2/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1904-PRO,"Menahem Rotenberg, Bozhi Tian",Provisional,10/24/2019,19-T-147-001,10/16/2020,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",4066886,,4035334,No
4510,19-T-147,Methods and Systems for Modulating Cellular Activation,PCT/US20/56106, ,*United States,US,10/16/2020,,WO 2021/076981,10/16/2020,19-T-147-002,Small,10/16/2019,3/8/2022,No,4/28/2022,Expired PCT - Filed in US only,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-1904-WO,"Aleksander Prominski, Menahem Rotenberg, Bozhi Tian",PCT,10/19/2020,19-T-147-002,4/16/2022,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",4992908,4/22/2021,4035334,No
4511,19-T-147,Methods and Systems for Modulating Cellular Activation,"17/768,329",,*United States,US,10/16/2020,,,4/12/2022,19-T-147-003,Small,10/16/2019,4/12/2022,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",19-1904-WO-US,"Aleksander Prominski, Menahem Rotenberg, Bozhi Tian",Nationalized PCT,3/8/2022,,,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",6906391,,4035334,
4512,19-T-149,Systems and Methods for Multiview Super-Resolution Microscopy,"63/001,691", ,*United States,US,3/30/2020,, ,3/30/2020,19-T-149-001,Small,3/30/2020,6/15/2021,,4/28/2022,Expired Prov - Filed PCT,,,E-006-2020-0-US-01,"Xiaofei Han, Patrick La Riviere, Hari Shroff, Yicong Wu",Provisional,1/22/2021, ,3/30/2021,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5295452,,4039286,No
4513,19-T-149,Systems and Methods for Optical Reassignment in Multiview Super-Resolution Microscopy,"63/001,672", ,*United States,US,3/30/2020,, ,3/30/2020,19-T-149-002,Small,3/30/2020,6/15/2021,,4/28/2022,Expired Prov - Filed PCT,,,E-006-2020-1-US-01,"Xiaofei Han, Patrick La Riviere, Hari Shroff, Yicong Wu",Provisional,1/22/2021, ,3/30/2021,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5295481,,4039286,No
4514,19-T-149,Systems and Methods for Multiview Super-Resolution Microscopy,PCT/US21/24512, ,*United States,US,3/30/2020,,WO 2021/202316,3/26/2021,19-T-149-003,Small,3/30/2020,3/30/2021,No,4/28/2022,Pending,,,NIH20312PCT,"Xiaofei Han, Patrick La Riviere, Hari Shroff, Yicong Wu",PCT,3/18/2021, ,9/30/2022,"Cox, Ben",Patrick La Riviere,"Smith, Dane",5495798,10/7/2021,4039286,No
4515,19-T-150,Fluorescent Conjugated Polymers Containing Semi-Ladder Units for Light-Emitting Field-Effect Transistors,"62/936,099", ,*United States,US,11/15/2019,, ,11/15/2019,19-T-150-001,Small,11/15/2019,3/3/2021,,4/28/2022,Expired Prov - Filed in US,Armstrong Teasdale,"Brennan, Patrick",37997-80,"Mohammad Awais, Valerii Sharapov, Luping Yu, Dafei Yuan",Provisional,11/18/2019,19-T-150-001,11/15/2020,"Hwang, Luke",Luping Yu,"Juggernauth, Anne",4118800,,4040135,No
4516,19-T-150,Fluorescent Conjugated Polymers Containing Semi-Ladder Units for Light-Emitting Field-Effect Transistors,"17/097,731", ,*United States,US,11/13/2020,,US-2021-0147747-A1,11/13/2020,19-T-150-002,Small,11/15/2019,10/14/2020,No,4/28/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-85,"Mohammad Awais, Valerii Sharapov, Luping Yu, Dafei Yuan",US Utility,10/14/2020,19-T-150-002,11/13/2040,"Hwang, Luke",Luping Yu,"Juggernauth, Anne",4981284,5/20/2021,4040135,No
4517,19-T-151,Anti-CD73(NT5E) antibodies specific to the tumor microenvironment,,,*United States,US,,,,,19-T-151-001,Small,,2/23/2022,,6/6/2022,Authorized,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0761US.P1,,Provisional,2/23/2022,,,"Dembo, Anna",,"Tennant, Thelma",6842860,,4042088,
4518,19-T-152,Biodegradable Composition and Method of Preparation Thereof,"62/954,772", ,*United States,US,12/30/2019,, ,12/30/2019,19-T-152-001,Small,12/30/2019,2/11/2021,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-2335-PRO,"Yin Fang, Yiliang Lin, Bozhi Tian, Herbert Wang",Provisional,1/9/2020, ,12/30/2020,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",4210676,,4047211,No
4519,19-T-152,Biodegradable Composition and Method of Preparation Thereof,PCT/US20/66097, ,*United States,US,12/18/2020,,WO 2021/138089,12/18/2020,19-T-152-002,Small,12/30/2019,12/28/2020,No,6/17/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",19-2335-WO,"Yin Fang, Yiliang Lin, Bozhi Tian, Herbert Wang",PCT,11/24/2020, ,6/30/2022,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",5120402,7/8/2021,4047211,No
4520,19-T-152,Biodegradable Composition and Method of Preparation Thereof,,,*United States,US,12/18/2020,,,,19-T-152-003,Small,12/30/2019,5/20/2022,No,5/20/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",,"Yin Fang, Yiliang Lin, Bozhi Tian, Herbert Wang",Nationalized PCT,5/16/2022,,,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",7258125,,4047211,
4521,19-T-154,Deep Imitation Learning for Molecular Inverse Problems,"62/930,325", ,*United States,US,11/4/2019,, ,11/4/2019,19-T-154-001,Small,11/4/2019,11/11/2019,,4/28/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",37997-79,Eric Jonas,Provisional,11/11/2019, ,11/4/2020,"Ramirez, Mario Riojas",Eric Jonas,"Smith, Dane",4109576,,4092337,No
4522,19-T-154,Deep Imitation Learning for Molecular Inverse Problems,PCT/US20/58685,,*United States,US,11/3/2020,,WO 2021/091883,11/3/2020,19-T-154-002,Small,11/4/2019,6/10/2022,No,6/15/2022,Expired PCT - Filed in US only,Armstrong Teasdale,"Brennan, Patrick",37997-86,Eric Jonas,PCT,11/3/2020,,5/4/2022,"Ramirez, Mario Riojas",Eric Jonas,"Smith, Dane",5053367,5/14/2021,4092337,No
4523,19-T-154,Deep Imitation Learning for Molecular Inverse Problems,"17/773,647",,*United States,US,11/4/2019,,,5/2/2022,19-T-154-003,Small,11/4/2019,5/2/2022,No,6/15/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-102,Eric Jonas,Nationalized PCT,4/29/2022,,,"Ramirez, Mario Riojas",Eric Jonas,"Smith, Dane",7185920,,4092337,
4524,19-T-155,Annotating Medical Images,"62/364,937", ,*United States,US,7/21/2016,, ,7/21/2016,19-T-155-001,Large,7/21/2016,1/1/2019,Yes,4/28/2022,Expired Prov - Filed PCT,,,2016P00685PRO,"Paul Chang, Gabriel Mankovich, Merlijn Sevenster",Provisional,11/12/2019, ,7/21/2017,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111442,,4111431,No
4525,19-T-155,Annotating Medical Images,PCT/EP17/67972, ,European Patent Office (EPO),EP,7/17/2017,, ,7/17/2017,19-T-155-002,Large,7/21/2016,11/12/2019,No,4/28/2022,Expired PCT - Filed in US only,,,2016P00685WO,"Paul Chang, Gabriel Mankovich, Merlijn Sevenster",PCT,11/12/2019, ,1/17/2019,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111446,,4111431,No
4526,19-T-155,Annotating Medical Images,"16/315,413", ,*United States,US,7/17/2017,,US 2019-0259494 A1,1/4/2019,19-T-155-003,Large,7/21/2016,11/12/2019,No,4/28/2022,Pending,,,2016P00685WOUS,"Paul Chang, Gabriel Mankovich, Merlijn Sevenster",Nationalized PCT,11/12/2019, ,7/17/2037,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111455,8/22/2019,4111431,No
4527,19-T-156,"Device, System, and Method for Determining a Reading Environment by Synthesizing Downstream Needs","62/488,358", ,*United States,US,4/21/2017,, ,4/21/2017,19-T-156-001,Large,4/21/2017,11/12/2019,,4/28/2022,Expired Prov - Filed in US,,,2016P01312PRO,"Paul Chang, Merlijn Sevenster",Provisional,11/12/2019, ,4/21/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111639,,4111473,No
4528,19-T-156,"Device, System, and Method for Determining a Reading Environment by Synthesizing Downstream Needs","15/941,529", ,*United States,US,3/30/2018,,US 2018-0308575 A1,3/30/2018,19-T-156-002,Large,4/21/2017,11/12/2019,No,4/28/2022,Pending,,,2016P01312US01,"Paul Chang, Merlijn Sevenster",US Utility,11/12/2019, ,3/30/2038,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111643,10/25/2018,4111473,No
4529,19-T-157,Facilitated Structured Measurement Management Tool Progress and Compliance Analytics Solution,"62/353,582", ,*United States,US,6/23/2016,, ,6/23/2016,19-T-157-001,Large,6/23/2016,11/12/2019,,4/28/2022,Expired Prov - Filed PCT,,,2016P00307WOUS,"Paul Chang, Merlijn Sevenster",Provisional,11/12/2019, ,6/23/2017,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111928,,4111815,No
4530,19-T-157,Facilitated Structured Measurement Management Tool Progress and Compliance Analytics Solution,PCT/EP17/64331, ,European Patent Office (EPO),EP,6/13/2017,, ,6/13/2017,19-T-157-002,Large,6/23/2016,11/12/2019,No,4/28/2022,Expired PCT - Filed in US only,,,2016P00307WO,"Paul Chang, Merlijn Sevenster",PCT,11/12/2019, ,12/13/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4111993,,4111815,No
4531,19-T-157,Facilitated Structured Measurement Management Tool Progress and Compliance Analytics Solution,"16/312,390", ,*United States,US,6/13/2017,, ,12/21/2018,19-T-157-003,Large,6/23/2016,11/12/2019,No,4/28/2022,Pending,,,2016P00307WOUS,"Paul Chang, Merlijn Sevenster",US Utility,11/12/2019, ,6/13/2037,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112001,,4111815,No
4532,19-T-158,Automated Contextual Determination of ICD Code Relevance for Ranking and Efficient Consumption,"62/319,923", ,*United States,US,4/8/2016,, ,4/8/2016,19-T-158-001,Large,4/8/2016,11/12/2019,,4/28/2022,Expired Prov - Filed PCT,,,2016P00407PRO,"Paul Chang, Merlijn Sevenster, Amir Tahmasebi Maraghoosh",Provisional,11/12/2019, ,4/8/2017,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112076,,4112066,No
4533,19-T-158,Automated Contextual Determination of ICD Code Relevance for Ranking and Efficient Consumption,PCT/IB17/58006, ,EU Intellectual Property Office (EUIPO),EM,4/4/2017,,WO 2017/174591,4/4/2017,19-T-158-002,Large,4/8/2016,11/12/2019,No,4/28/2022,Expired PCT - Filed in US only,,,2016P00407PWO,"Paul Chang, Merlijn Sevenster, Amir Tahmasebi Maraghoosh",PCT,11/12/2019, ,10/4/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112080,10/12/2017,4112066,No
4534,19-T-158,Automated Contextual Determination of ICD Code Relevance for Ranking and Efficient Consumption,"16/087,694", ,*United States,US,4/4/2017,,US 2019-0108175 A1,9/24/2018,19-T-158-003,Large,4/8/2016,11/12/2019,No,4/28/2022,Pending,,,2016P00407PWOUS,"Paul Chang, Merlijn Sevenster, Amir Tahmasebi Maraghoosh",US Utility,11/12/2019, ,10/12/2037,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112089,4/11/2019,4112066,No
4535,19-T-159,Contextual Filtering of Lab Values,"62/313,832", ,*United States,US,3/28/2016,, ,3/28/2016,19-T-159-001,Large,3/28/2016,11/12/2019,,4/28/2022,Expired Prov - Filed PCT,,,2016P00193PRO,"Paul Chang, Merlijn Sevenster",Provisional,11/12/2019, ,3/28/2017,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112110,,4112101,No
4536,19-T-159,Contextual Filtering of Lab Values,PCT/EP17/57234, ,European Patent Office (EPO),EP,3/28/2017,,WO 2017/167704,3/28/2017,19-T-159-002,Large,3/28/2016,11/12/2019,No,4/28/2022,Expired PCT - Filed in US only,,,2016P00193WO,"Paul Chang, Merlijn Sevenster",PCT,11/12/2019, ,9/28/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112144,10/5/2017,4112101,No
4537,19-T-159,Contextual Filtering of Lab Values,"16/084,696", ,*United States,US,3/28/2017,,US 2019-0074084 A1,9/13/2018,19-T-159-003,Large,3/28/2016,11/12/2019,No,4/28/2022,Pending,,,2016P00193WOUS,"Paul Chang, Merlijn Sevenster",US Utility,11/12/2019, ,3/28/2037,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112160,3/7/2019,4112101,No
4538,19-T-160,System and Architecture for Seamless Workflow Integration and Orchestration of Clinical Intelligence,"62/355,417", ,*United States,US,6/28/2016,, ,6/28/2016,19-T-160-001,Large,6/28/2016,11/12/2019,,4/28/2022,Expired Prov - Filed PCT,,,2015P01800PRO,"Paul Chang, Merlijn Sevenster, Aharona Shuali, Amir Tahmasebi Maraghoosh, Robbert Van Ommering, Eliahu Zino",Provisional,11/12/2019, ,6/28/2017,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112229,,4112177,No
4539,19-T-160,System and Architecture for Seamless Workflow Integration and Orchestration of Clinical Intelligence,PCT/IB17/53690, ,International Bureau,IB,6/21/2017,,WO 2018/002776,6/21/2017,19-T-160-002,Large,6/28/2016,11/12/2019,No,4/28/2022,Expired PCT - Filed in US only,,,2015P01800WO,"Paul Chang, Merlijn Sevenster, Aharona Shuali, Amir Tahmasebi Maraghoosh, Robbert Van Ommering, Eliahu Zino",PCT,11/12/2019, ,12/21/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112259,1/4/2018,4112177,No
4540,19-T-160,System and Architecture for Seamless Workflow Integration and Orchestration of Clinical Intelligence,"16/314,132", ,*United States,US,6/21/2017,,US 2019-0252061 A1,12/28/2018,19-T-160-003,Large,6/28/2016,11/12/2019,No,4/28/2022,Pending,,,2015P01800WOU,"Paul Chang, Merlijn Sevenster, Aharona Shuali, Amir Tahmasebi Maraghoosh, Robbert Van Ommering, Eliahu Zino",US Utility,11/12/2019, ,6/21/2037,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112292,8/15/2019,4112177,No
4541,19-T-161,Content-Driven Problem List Ranking in Electronic Medical Records,"62/259,903", ,*United States,US,11/25/2015,, ,11/25/2015,19-T-161-001,Large,11/25/2015,11/12/2019,,4/28/2022,Expired Prov - Filed PCT,,,2015P00986PRO,"Paul Chang, Yuechen Qian, Merlijn Sevenster",Provisional,11/12/2019, ,11/25/2016,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112352,,4112325,No
4542,19-T-161,Content-Driven Problem List Ranking in Electronic Medical Records,PCT/EP16/78851, ,European Patent Office (EPO),EP,11/25/2016,,WO 2017/089564,11/25/2016,19-T-161-002,Large,11/25/2015,11/12/2019,No,4/28/2022,Expired PCT - Filed in US only,,,2015P00986WO,"Paul Chang, Yuechen Qian, Merlijn Sevenster",PCT,11/12/2019, ,5/25/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112368,6/1/2017,4112325,No
4543,19-T-161,Content-Driven Problem List Ranking in Electronic Medical Records,"15/776,822", ,*United States,US,11/25/2016,,US 2018-0330820 A1,5/17/2018,19-T-161-003,Large,11/25/2015,11/12/2019,No,4/28/2022,Pending,,,2015P00986WOUS,"Paul Chang, Yuechen Qian, Merlijn Sevenster",US Utility,11/12/2019, ,11/25/2036,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4112390,11/15/2018,4112325,No
4544,19-T-163,ADAR-Mediated Microrna Editing in Asthma,"63/011,935", ,*United States,US,4/17/2020,, ,4/17/2020,19-T-163-001,Small,4/17/2020,2/18/2021,,4/28/2022,Abandoned,"Casimir Jones, S.C.","Staple, David",UCHI-38302.101,"Kevin Magnaye, Carole Ober, Steven White",Provisional,4/22/2020,19-T-163-001,4/17/2021,"Sun, Han",Carole Ober,"Tennant, Thelma",4481324,,4117217,No
4545,19-T-164,Compositions and Methods for Treating or Preventing Cancer using Deubiquitinase Inhibitors,"62/984,679", ,*United States,US,3/3/2020,, ,3/3/2020,19-T-164-001,Small,3/3/2020,6/15/2021,,6/8/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-38142.101,"Chuan He, Hui-Lung Sun, Huanyu Wang, Jiangbo Wei, Allen Zhu",Provisional,3/18/2020,19-T-164-001,3/3/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",4412759,,4118193,No
4546,19-T-164,Compositions and Methods for Treating or Preventing Cancer Using Deubiquitinase Inhibitors,"63/040,080", ,*United States,US,6/17/2020,, ,6/17/2020,19-T-164-002,Small,3/3/2020,6/15/2021,No,6/8/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-38142.102,"Chuan He, Hui-Lung Sun, Huanyu Wang, Jiangbo Wei, Allen Zhu",Provisional,6/18/2020,19-T-164-002,6/17/2021,"Hwang, Luke",Chuan He,"Tennant, Thelma",4645105,,4118193,No
4547,19-T-164,Compositions and Methods for Treating or Preventing Cancer using Deubiquitinase Inhibitors,PCT/US21/20653, ,*United States,US,3/3/2021,,2021/178525,3/3/2021,19-T-164-003,Small,3/3/2020,3/5/2021,No,6/22/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-38142.601,"Chuan He, Hui-Lung Sun, Huanyu Wang, Jiangbo Wei, Allen Zhu",PCT,3/5/2021,19-T-164-003,9/3/2022,"Hwang, Luke",Chuan He,"Tennant, Thelma",5456884,9/10/2021,4118193,No
4548,19-T-169,Optimally Detuned Parametric Amplication,"62/948,147", ,*United States,US,12/13/2019,, ,12/13/2019,19-T-169-001,Small,12/13/2019,12/19/2019,,4/28/2022,Expired Prov - Filed PCT,Barnes & Thornburg,"McCusker, Kevin",21459-303973,"Aashish Clerk, Alexander McDonald",Provisional,12/19/2019, ,12/13/2020,"Cox, Ben",Aashish Clerk,"Smith, Dane",4195132,,4141578,No
4549,19-T-169,Optimally Detuned Parametric Amplication,PCT/US20/64735,,*United States,US,12/13/2020,,,12/13/2020,19-T-169-002,Small,12/13/2019,6/10/2022,No,6/10/2022,Expired PCT - Filed in US only,Lathrop GPM LLP,"Vock, Curtis",712228,"Aashish Clerk, Alexander McDonald",PCT,11/24/2020,,6/13/2022,"Cox, Ben",Aashish Clerk,"Smith, Dane",5119193,,4141578,No
4550,19-T-169,"Optimally Detuned Parametric Amplification, and Associated Devices","17/756,481",,*United States,US,12/13/2020,,,5/26/2022,19-T-169-003,Small,12/13/2019,5/27/2022,No,6/15/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",730150,"Aashish Clerk, Alexander McDonald",Nationalized PCT,5/12/2022,,,"Cox, Ben",Aashish Clerk,"Smith, Dane",7244823,,4141578,
4551,19-T-171,Avalanche Photodiodes with Adaptive Quenching of Photocurrent,"62/985,095", ,*United States,US,3/4/2020,, ,3/4/2020,19-T-171-001,Small,3/4/2020,3/4/2021,,6/3/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Chen, Gang",7814-415,"Joe Campbell, Supratik Guha, Jiyuan Zheng",Provisional,3/24/2020, ,3/4/2021,"Cox, Ben",Supratik Guha,"Tennant, Thelma",4422203,,4192191,No
4552,19-T-171,Avalanche Photodiodes with Adaptive Quenching of Photocurrent,PCT/US21/20516, ,*United States,US,3/2/2021,, ,3/2/2021,19-T-171-002,Small,3/4/2020,3/4/2021,No,4/28/2022,Pending,Brinks Gilson & Lione,"Chen, Gang",7814-424,"Joe Campbell, Supratik Guha, Jiyuan Zheng",PCT,3/4/2021,19-T-171-002,9/4/2022,"Cox, Ben",Supratik Guha,"Tennant, Thelma",5446567,,4192191,No
4553,20-T-003,Method of Preparation of Silicon Carbide Composition and Use Thereof,"63/011,033", ,*United States,US,4/16/2020,, ,4/16/2020,20-T-003-001,Small,4/16/2020,4/20/2021,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",20-389-PRO,"Vishnu Nair, Bozhi Tian",Provisional,4/28/2020,20-T-003-001,4/16/2021,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",4489386,,4234833,No
4554,20-T-003,Method of Preparation of Silicon Carbide Composition and Use Thereof,PCT/US21/27099, ,*United States,US,4/13/2021,,WO 2021/242425 A3,4/13/2021,20-T-003-002,Small,4/16/2020,4/13/2021,No,5/31/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",20-389-WO,"Vishnu Nair, Aleksander Prominski, Bozhi Tian",PCT,3/26/2021,20-T-003-002,10/16/2022,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",5515647,2/24/2022,4234833,No
4555,20-T-004,Inhibitors of the Artemin Pathway for Treatment of Cancer,"63/055,284", ,*United States,US,7/22/2020,, ,7/22/2020,20-T-004-001,Small,7/22/2020,7/26/2021,,4/28/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-216-PRO,"Yuzhu Hou, Hua Liang, Ralph Weichselbaum",Provisional,7/23/2020,20-T-004-001,7/22/2021,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",4746674,,4236061,No
4556,20-T-004,Inhibitors of the Artemin Pathway for Treatment of Cancer,PCT/US21/42849, ,*United States,US,7/22/2021,,WO 2022/020648,7/22/2021,20-T-004-002,Small,7/22/2020,7/23/2021,No,5/2/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-216-WO,"Yuzhu Hou, Hua Liang, Ralph Weichselbaum",PCT,7/20/2021,20-T-004-002,1/22/2023,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",5921532,3/10/2022,4236061,No
4557,20-T-007,Copper-Graphene Electron Microscopy Grids with Small hole Diameters and high Hole Densities,"62/987,998", ,*United States,US,3/11/2020,, ,3/11/2020,20-T-007-001,Small,3/11/2020,3/18/2020,,4/28/2022,Released to Inventors,"Bell & Manning, LLC","Manning, Michelle",05400-0042-PV,Bharathi Reddy,Provisional,3/18/2020, ,3/11/2021,"Cox, Ben",Bharathi Reddy,"Smith, Dane",4411935,,4236369,No
4558,20-T-009,"Device, System, and Method for Optimizing Image Acquisition Workflows",PCT/EP18/70231, ,European Patent Office (EPO),EP,7/25/2018,,WO 2019/020717 A1,7/25/2018,20-T-009-001,Large,7/25/2017,3/3/2021,No,4/28/2022,Expired - Inactive,,,2017P01774WOUS,"Paul Chang, Nicole Schadewaldt, Merlijn Sevenster, Amir Tahmasebi Maraghoosh",PCT,1/23/2020, ,1/25/2020,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4239517,1/31/2019,4237824,No
4559,20-T-009,"Device, System, and Method for Optimizing Image Acquisition Workflows","62/536,620", ,*United States,US,7/25/2017,, ,7/25/2017,20-T-009-002,Large,7/25/2017,1/23/2020,,4/28/2022,Expired Prov - Filed PCT,,,2017P01774US,"Paul Chang, Nicole Schadewaldt, Merlijn Sevenster, Amir Tahmasebi Maraghoosh",Provisional,1/23/2020, ,7/25/2018,"Ginsburg, Eric",Paul Chang,"Smith, Dane",4239642,,4237824,No
4560,20-T-011,Continuous Analysis Word Counter,"14/872,927","9,548,046",*United States,US,10/1/2015,1/17/2017, ,10/1/2015,20-T-011-001,Small,10/1/2015,1/23/2020,Yes,4/28/2022,Issued,TechLaw Ventures,"Banta, Travis",VMI-0003.NP,"Chris Boggiano, Jon Boggiano, Matthew Chung, Jill Desmond",US Utility,1/23/2020, ,10/1/2035,"Unassigned, Unassigned",Jon Boggiano,"Unassigned, Unassigned",4242267,,4240601,No
4561,20-T-014,Reporting Tool with Integrated Lesion Stager,"61/859,423", ,*United States,US,7/29/2013,, ,7/29/2013,20-T-014-001,Small,7/29/2013,2/5/2020,,4/28/2022,Expired Prov - Filed PCT,,,2012P02101P1,Merlijn Sevenster,Provisional,2/5/2020, ,7/29/2017,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4257192,,4250925,No
4562,20-T-014,Reporting Tool with Integrated Lesion Stager,PCT/IB14/63472, ,International Bureau,IB,7/28/2014,, ,7/28/2014,20-T-014-002,None,7/29/2013,2/5/2020,No,4/28/2022,Expired PCT - Filed in US only,,,2012P02101WO,Merlijn Sevenster,PCT,2/5/2020, ,1/28/2016,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4257200,,4250925,No
4563,20-T-014,Reporting Tool with Integrated Lesion Stager,"14/906,349", ,*United States,US,7/28/2014,, ,1/20/2016,20-T-014-003,Small,7/29/2013,2/5/2020,No,4/28/2022,Pending,,,2012P02101WOUS,Merlijn Sevenster,Nationalized PCT,2/5/2020, ,7/28/2034,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4257218,,4250925,No
4564,20-T-018,Methods and Compositions for Treating Autoimmune and Allergic Disorders,"63/055,227", ,*United States,US,7/22/2020,, ,7/22/2020,20-T-018-001,Small,7/22/2020,6/24/2021,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0710US.P1,"Riyue Bao, Lauren Hesser, Kari Nadeau, Cathryn Nagler",Provisional,7/24/2020,20-T-018-001,7/22/2021,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",4750232,,4257049,No
4565,20-T-018,Methods and Compositions for Treating Autoimmune and Allergic Disorders,"63/108,736", ,*United States,US,11/2/2020,, ,11/2/2020,20-T-018-002,Small,11/2/2020,6/24/2021,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0710US.P2,"Riyue Bao, Lauren Hesser, Kari Nadeau, Cathryn Nagler",Provisional,11/3/2020,20-T-018-002,11/2/2021,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5052804,,4257049,No
4566,20-T-018,Methods and Compositions for Treating Autoimmune and Allergic Disorders,"63/122,833", ,*United States,US,12/8/2020,, ,12/8/2020,20-T-018-003,Small,12/8/2020,6/24/2021,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0710US.P3,"Riyue Bao, Lauren Hesser, Kari Nadeau, Cathryn Nagler",Provisional,3/24/2021,20-T-018-003,12/8/2021,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5509771,,4257049,No
4567,20-T-018,Methods and Compositions for Treating Autoimmune and Allergic Disorders,PCT/US21/70926, ,*United States,US,7/22/2021,,WO 2022/020852 A1,7/22/2021,20-T-018-004,Small,7/22/2020,7/22/2021,No,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0710WO,"Riyue Bao, Lauren Hesser, Kari Nadeau, Cathryn Nagler",PCT,6/22/2021,20-T-018-004,1/22/2023,"Dembo, Anna",Cathryn Nagler,"Tennant, Thelma",5834367,1/27/2022,4257049,No
4568,20-T-019,Covalent Surface Modification of Two Dimensional Metal Carbides,"63/020,885", ,*United States,US,5/6/2020,, ,5/6/2020,20-T-019-001,Small,5/6/2020,6/15/2021,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0044-PV,"Vladislav Kamysbayev, Dmitri Talapin",Provisional,3/27/2020,20-T-019-001,5/6/2021,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",4428778,,4258283,No
4569,20-T-019,Covalent Surface Modification of Two Dimensional Metal Carbides,PCT/US21/30860, ,*United States,US,5/5/2021,,WO 2021/226221,5/5/2021,20-T-019-002,Small,5/6/2020,5/5/2021,No,5/19/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0044-PCT,"Vladislav Kamysbayev, Dmitri Talapin",PCT,5/6/2021,20-T-019-002,11/6/2022,"Hwang, Luke",Dmitri Talapin,"Smith, Dane",5713827,11/11/2021,4258283,No
4570,20-T-021,Trans-acting RNA-based translational activators,"62/983,030",,*United States,US,2/28/2020,, ,2/28/2020,20-T-021-001,Small,2/28/2020,3/1/2021,,5/31/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0708US.P1,"Yang Cao, Bryan Dickinson",Provisional,3/1/2020,20-T-021-001,2/28/2021,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",4388562,,4259396,No
4571,20-T-021,Trans-acting RNA-based translational activators,"62/993,151",,*United States,US,3/23/2020,, ,3/23/2020,20-T-021-002,Small,3/23/2020,3/1/2021,No,5/31/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0708US.P2,"Yang Cao, Bryan Dickinson",Provisional,3/30/2020,20-T-021-002,3/23/2021,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",4431031,,4259396,No
4572,20-T-021,Trans-acting RNA-based translational activators,PCT/US21/70200,,*United States,US,2/26/2021,,WO 2021/074259 A1,2/26/2021,20-T-021-003,Small,2/28/2020,2/28/2021,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0708WO,"Yang Cao, Bryan Dickinson",PCT,2/28/2021,20-T-021-003,8/28/2022,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5424769,9/2/2021,4259396,No
4573,20-T-022,Wearable Microphone Jammer,"63/004,229",,*United States,US,4/2/2020,, ,4/2/2020,20-T-022-001,Small,4/2/2020,6/15/2021,,6/6/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Kalafut, Christopher",05400-0043-PV,"Yuxin Chen, Huiying Li, Pedro Lopes, Shan-Yuan Teng, Ben Zhao, Haitao Zheng",Provisional,4/3/2020,20-T-022-001,4/2/2021,"Ramirez, Mario Riojas",Pedro Lopes,"Smith, Dane",4458475,,4270546,No
4574,20-T-022,Wearable Microphone Jammer,PCT/US21/25116,,*United States,US,3/31/2021,,WO 2021/202686,3/31/2021,20-T-022-002,Small,4/2/2020,4/1/2021,No,6/6/2022,Pending,"Bell & Manning, LLC","Kalafut, Christopher",05400-0043-PCT,"Yuxin Chen, Huiying Li, Pedro Lopes, Shan-Yuan Teng, Ben Zhao, Haitao Zheng",PCT,4/1/2021,20-T-022-002,10/2/2022,"Ramirez, Mario Riojas",Pedro Lopes,"Smith, Dane",5530333,10/7/2021,4270546,No
4575,20-T-023,Composition and Methods for Tumor Imaging and Treatment,"63/022,902", ,*United States,US,5/11/2020,, ,5/11/2020,20-T-023-001,Small,5/11/2020,6/15/2021,,4/28/2022,Expired Prov - Filed in US,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/18,"Jae Won Chang, Raymond Moellering",Provisional,4/2/2020, ,5/11/2021,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4456566,,4385331,No
4576,20-T-023,Composition and Methods for Tumor Imaging and Treatment,"17/317,529", ,*United States,US,5/11/2021,,US-2021-0346525-A1,5/11/2021,20-T-023-002,Small,5/11/2020,7/23/2021,No,6/6/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/18/2,"Jae Won Chang, Raymond Moellering",US Utility,5/13/2021, ,5/11/2041,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",5734445,11/11/2021,4385331,No
4577,20-T-029,"Chemically Tunable, Optically Addressable Molecular-Spin Qubit and Associated Methods","63/008,589",,*United States,US,4/10/2020,, ,4/10/2020,20-T-029-001,Small,4/10/2020,6/15/2021,,6/6/2022,Expired Prov - Filed PCT,Lathrop GPM LLP,"Vock, Curtis",704292,"David Awschalom, Sam Bayliss, Berk Diler Kovos, Majed Fataftah, Danna Freedman, Daniel Laorenza, Peter Mintun",Provisional,4/13/2020,20-T-029-001,4/10/2021,"Cox, Ben",David Awschalom,"Juggernauth, Anne",4467022,,4394905,No
4578,20-T-029,"Chemically Tunable, Optically Addressable Molecular-Spin Qubit and Associated Methods",PCT/US21/26728,,*United States,US,4/9/2021,,,4/9/2021,20-T-029-002,Small,4/10/2020,1/10/2022,No,6/6/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",716303,"David Awschalom, Sam Bayliss, Berk Diler Kovos, Majed Fataftah, Danna Freedman, Daniel Laorenza, Peter Mintun",PCT,3/5/2021,20-T-029-002,10/10/2022,"Cox, Ben",David Awschalom,"Juggernauth, Anne",5457187,,4394905,No
4579,20-T-031,Universal Fast-Flux Control of Low-Frequency Qubits,"62/978,017",,*United States,US,2/18/2020,, ,2/18/2020,20-T-031-001,Small,2/18/2020,3/2/2021,,6/6/2022,Expired Prov - Filed PCT,Lathrop GPM LLP,,700464,"David Schuster, Helin Zhang",Provisional,3/2/2020,20-T-031-001,2/18/2021,"Cox, Ben",David Schuster,"Juggernauth, Anne",4390681,,4396411,No
4580,20-T-031,Universal Fast-Flux Control of Low-Frequency Qubits,PCT/US21/18428,,*United States,US,2/17/2021,,,2/17/2021,20-T-031-002,Small,2/18/2020,2/18/2021,No,6/6/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",714330,"David Schuster, Helin Zhang",PCT,2/4/2021,20-T-031-002,8/18/2022,"Cox, Ben",David Schuster,"Juggernauth, Anne",5350535,,4396411,No
4581,20-T-035,End point-driven classification and representation of narrative documents,"62/488,289", ,*United States,US,4/21/2017,, ,4/21/2017,20-T-035-001,Large,4/21/2017,3/18/2020,,4/28/2022,Expired Prov - Filed PCT,,, ,"Paul Chang, Sandeep Dalal, Merlijn Sevenster, Amir Tahmasebi",Provisional,3/18/2020, ,4/21/2018,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4412714,,4408476,No
4582,20-T-035,End point-driven classification and representation of narrative documents,PCT/EP18/60090, ,European Patent Office (EPO),EP,4/19/2018,, ,4/19/2018,20-T-035-002,Large,4/21/2017,3/18/2020,No,4/28/2022,Expired PCT - Nationalized,,, ,"Paul Chang, Sandeep Dalal, Merlijn Sevenster, Amir Tahmasebi",PCT,3/18/2020, ,10/19/2019,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4412736,,4408476,No
4583,20-T-035,Summarization of Clinical Documents with End Points Thereof,"16/500,825",,*United States,US,4/19/2018,,,10/4/2019,20-T-035-003,Small,4/21/2017,3/21/2022,No,3/21/2022,Prosecution by Other Party,,,2016P01316WOUS,"Paul Chang, Sandeep Dalal, Merlijn Sevenster, Amir Tahmasebi",Nationalized PCT,3/19/2020,,4/19/2038,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4414613,,4408476,No
4584,20-T-036,Interactive self-learning problem list viewing environment,"62/430,577", ,*United States,US,12/6/2016,, ,12/6/2016,20-T-036-001,Large,12/6/2016,3/18/2020,,4/28/2022,Expired Prov - Filed PCT,,, ,"Paul Chang, Thomas Forsberg, Merlijn Sevenster",Provisional,3/18/2020, ,12/6/2017,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4412672,,4408727,No
4585,20-T-036,Interactive self-learning problem list viewing environment,PCT/EP17/81541, ,European Patent Office (EPO),EP,12/5/2017,, ,12/5/2017,20-T-036-002,Large,12/6/2016,3/18/2020,No,4/28/2022,Expired PCT - Filed in US only,,,2016P00907WOUS,"Paul Chang, Thomas Forsberg, Merlijn Sevenster",PCT,3/18/2020, ,12/5/2037,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4412694,,4408727,No
4586,20-T-036,Interactive self-learning problem list viewing environment,"16/463,396", ,*United States,US,12/5/2017,, ,5/23/2019,20-T-036-003,Small,12/6/2016,3/19/2020,No,4/28/2022,Pending,,,2016P00907WOUS,"Paul Chang, Thomas Forsberg, Merlijn Sevenster",US Utility,3/19/2020, ,12/5/2037,"Ginsburg, Eric",Merlijn Sevenster,"Smith, Dane",4414655,,4408727,No
4587,20-T-043,En Masse Patterning of DNA Dumbbells,"62/506,992", ,*United States,US,5/16/2017,, ,5/16/2017,20-T-043-001,Small,5/16/2017,3/30/2020,,4/28/2022,Expired Prov - Filed PCT,,,P170209US01,"Juan de Pablo, Juan Hernandez-Ortiz, Kyubong Jo, Kristy Kounovsky-Shafer, Konstantions Potamousis, David Schwartz",Provisional,3/30/2020, ,5/16/2018,"Hwang, Luke",David Schwartz,"Tennant, Thelma",4433781,,4428140,No
4588,20-T-043,System and Method for En Masse Patterning of Molecule Structures,PCT/US18/32987, ,*United States,US,5/16/2018,, ,5/16/2018,20-T-043-002,Small,5/16/2017,3/30/2020,No,4/28/2022,Expired PCT - Nationalized,,,P170209WO01,"Juan de Pablo, Juan Hernandez-Ortiz, Kyubong Jo, Kristy Kounovsky-Shafer, Konstantions Potamousis, David Schwartz",PCT,3/30/2020, ,11/16/2019,"Hwang, Luke",David Schwartz,"Tennant, Thelma",4433819,,4428140,No
4589,20-T-045,Functionally Graded Organic Thermoelectric Materials and Use Thereof,"63/003,749",,*United States,US,4/1/2020,,,4/1/2020,20-T-045-001,Small,4/1/2020,4/6/2021,,5/31/2022,Expired PCT - Filed in US only,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP008PUS,"Garrett Grocke, William Kent, Tengzhou Ma, Shrayesh Patel",Provisional,4/23/2020,20-T-045-001,4/1/2021,"Hwang, Luke",Shrayesh Patel,"Hwang, Luke",4482611,,4430990,No
4590,20-T-045,Functionally Graded Organic Thermoelectric Materials and Uses Thereof,"17/301,403",,*United States,US,4/1/2021,,US-2021-0313503-A1,4/1/2021,20-T-045-002,None,4/1/2020,4/6/2021,No,5/31/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP008,"Garrett Grocke, William Kent, Tengzhou Ma, Shrayesh Patel",US Utility,4/6/2021,20-T-045-002,4/1/2041,"Hwang, Luke",Shrayesh Patel,"Hwang, Luke",5539861,10/7/2021,4430990,No
4591,20-T-047,Tocilizumab for the Treatment of Viral Infections,"63/003,729", ,*United States,US,4/1/2020,, ,4/1/2020,20-T-047-001,Small,4/1/2020,4/7/2021,,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-38400.101,"Brian Heiss, Mark Ratain, Pankti Reid, Garth Strohbehn",Provisional,4/3/2020, ,4/1/2021,"Sun, Han",Mark Ratain,"Tennant, Thelma",4458201,,4448039,No
4592,20-T-047,Tocilizumab for the Treatment of Viral Infections,"63/018,956", ,*United States,US,5/1/2020,, ,5/1/2020,20-T-047-002,Small,4/1/2020,4/7/2021,No,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-38400.102,"Brian Heiss, Mark Ratain, Pankti Reid, Garth Strohbehn",Provisional,5/5/2020, ,5/1/2021,"Sun, Han",Mark Ratain,"Tennant, Thelma",4526210,,4448039,No
4593,20-T-047,Tocilizumab for the Treatment of Viral Infections,PCT/US21/25444, ,*United States,US,4/1/2021,,WO 2021/202919,4/1/2021,20-T-047-003,Small,4/1/2020,4/7/2021,No,4/28/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-38400.601,"Brian Heiss, Mark Ratain, Pankti Reid, Garth Strohbehn",PCT,4/7/2021, ,10/1/2022,"Sun, Han",Mark Ratain,"Tennant, Thelma",5544955,10/7/2021,4448039,No
4594,20-T-051,Methods and Systems for Protecting Coherence in Qubits,"63/023,579", ,*United States,US,5/12/2020,, ,5/12/2020,20-T-051-001,Small,5/12/2020,6/15/2021,,5/3/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Chen, Gang",7814-418,"David Awschalom, Kevin Miao",Provisional,5/13/2020,20-T-051-001,5/12/2021,"Cox, Ben",David Awschalom,"Juggernauth, Anne",4546214,,4481398,No
4595,20-T-051,Methods and Systems for Protecting Coherence in Qubits,PCT/US21/31569, ,*United States,US,5/10/2021,,WO 2022/015399,5/10/2021,20-T-051-002,Small,5/12/2020,5/11/2021,No,5/19/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000425,"David Awschalom, Kevin Miao",PCT,4/9/2021,20-T-051-002,11/12/2022,"Cox, Ben",David Awschalom,"Juggernauth, Anne",5553840,3/24/2022,4481398,No
4596,20-T-052,Quantum repeaters with concatenated quantum error correction,"63/035,589", ,*United States,US,6/5/2020,, ,6/5/2020,20-T-052-001,Small,6/5/2020,6/15/2021,,4/28/2022,Expired Prov - Filed PCT,Lathrop GPM LLP,"Vock, Curtis",705606,"Liang Jiang, Kyungjoo Noh, Filip Rozpedek",Provisional,6/23/2020, ,6/5/2021,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",4656078,,4483103,No
4597,20-T-052,Quantum repeaters with concatenated quantum error correction,PCT/US21/35940, ,*United States,US,6/4/2021,, ,6/4/2021,20-T-052-002,None,6/5/2020,6/9/2021,No,6/10/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",718646,"Liang Jiang, Kyungjoo Noh, Filip Rozpedek",PCT,5/13/2021, ,12/5/2022,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",5733657,,4483103,No
4598,20-T-055,Method and System for Mask Disinfection,"63/028,713", ,*United States,US,5/22/2020,, ,5/22/2020,20-T-055-001,Small,5/22/2020,6/15/2021,,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Kalafut, Christopher",05400-0045-PV,"Jon Brickman, Talon Chandler, Peter Eng, Naoum Issa, Patrick La Riviere, Michael Proskey",Provisional,5/11/2020, ,5/22/2021,"Ginsburg, Eric",Peter Eng,"Juggernauth, Anne",4539356,,4484720,No
4599,20-T-055,Method and System for Mask Disinfection,"17/326,860", ,*United States,US,5/21/2021,,US-2021-0361798-A1,5/21/2021,20-T-055-002,Small,5/11/2020,5/18/2021,No,4/28/2022,Pending,"Bell & Manning, LLC","Kalafut, Christopher",05400-0045-NP,"Jon Brickman, Talon Chandler, Peter Eng, Naoum Issa, Patrick La Riviere, Michael Proskey, Joanne Stubbs",US Utility,5/18/2021, ,5/22/2040,"Ginsburg, Eric",Peter Eng,"Juggernauth, Anne",5747831,5/21/2021,4484720,No
4600,20-T-056,Systems and Methods for High-Order Stochastic Block Modeling,"63/093,142", ,*United States,US,10/16/2020,, ,10/16/2020,20-T-056-001,Small,10/16/2020,10/11/2021,,4/28/2022,Expired Prov - Filed in US,Lathrop GPM LLP,"Vock, Curtis",707135,"James Evans, Feng Shi",Provisional,6/11/2020, ,10/16/2021,"Ramirez, Mario Riojas",James Evans,"Smith, Dane",4624325,,4486639,No
4601,20-T-056,Systems and Methods for High-Order Modeling of Predictive Hypotheses,"17/451,320", ,*United States,US,10/18/2021,, ,10/18/2021,20-T-056-002,Small,10/16/2020,11/10/2021,No,5/31/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",723281,"James Evans, Feng Shi, Jamshid Sourati",US Utility,10/12/2021, ,10/18/2041,"Ramirez, Mario Riojas",James Evans,"Smith, Dane",6269244,,4486639,No
4602,20-T-058,Surface-Functionalized Molybdenum Disulfide Membrane for Filtration Applications,"63/050,566", ,*United States,US,7/10/2020,, ,7/10/2020,20-T-058-001,Small,7/10/2020,11/1/2021,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0046-PV,"Eli Hoenig, Chong Liu",Provisional,6/18/2020, ,7/10/2021,"Hwang, Luke",Chong Liu,"Tennant, Thelma",4644809,,4524111,No
4603,20-T-058,Surface-Functionalized Molybdenum Disulfide Membrane for Filtration Applications,PCT/US21/40606, ,*United States,US,7/10/2020,,WO 2022/010960,7/7/2021,20-T-058-002,None,6/18/2020,8/26/2021,No,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0046-PCT,"Eli Hoenig, Chong Liu",PCT,7/8/2021, ,1/7/2023,"Hwang, Luke",Chong Liu,"Tennant, Thelma",5882148,1/13/2022,4524111,No
4604,20-T-060,Metal-Organic Frameworks Deliver Small Molecules and Biomacromolecules for Cancer Immunotherapy,"63/028,891",,*United States,US,5/22/2020,, ,5/22/2020,20-T-060-001,Small,5/22/2020,6/15/2021,,5/31/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/19 PRO,"Guangxu Lan, Wenbin Lin, Taokun Luo, Kaiyuan Ni",Provisional,5/26/2020,20-T-060-001,5/22/2021,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4571846,,4532679,No
4605,20-T-060,Metal-Organic Frameworks Deliver Small Molecules and Biomacromolecules for Cancer Immunotherapy,"63/045,499",,*United States,US,7/1/2020,, ,7/1/2020,20-T-060-002,Small,7/1/2020,6/15/2021,No,5/31/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/19/2 PROV,"Guangxu Lan, Wenbin Lin, Taokun Luo, Kaiyuan Ni",Provisional,6/19/2020,20-T-060-002,7/1/2021,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4648109,,4532679,No
4606,20-T-060,Metal-Organic Frameworks Deliver Small Molecules and Biomacromolecules for Cancer Immunotherapy,PCT/US21/33886,,*United States,US,5/24/2021,,WO 2021/237209,5/24/2021,20-T-060-003,Small,5/22/2020,6/9/2021,No,6/10/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/19 PCT,"Guangxu Lan, Wenbin Lin, Taokun Luo, Kaiyuan Ni",PCT,4/28/2021,20-T-060-003,11/22/2022,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",5641309,11/25/2021,4532679,No
4607,20-T-062,Inhibition of Nidoviruses That Encode NSP15,"63/027,198",,*United States,US,5/19/2020,, ,5/19/2020,20-T-062-001,Small,5/19/2020,3/11/2021,,5/31/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",749462,"Robert Jedrzejczak, Andrzej Joachimiak, Youngchang Kim, Natalia Maltseva, Glenn Randall, Jacek Wower",Provisional,5/20/2020,20-T-062-001,3/11/2021,"Peace, Shane",Andrzej Joachimiak,"Onishi, Kenneth",4566187,,4545109,No
4608,20-T-062,Inhibition of Nidoviruses That Encode NSP15,PCT/US21/21913,,*United States,US,3/11/2021,, ,3/11/2021,20-T-062-002,None,5/19/2020,3/11/2021,No,5/31/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",753202,"Robert Jedrzejczak, Andrzej Joachimiak, Youngchang Kim, Natalia Maltseva, Glenn Randall, Jacek Wower",PCT,3/11/2021,20-T-062-002,11/19/2022,"Peace, Shane",Andrzej Joachimiak,"Onishi, Kenneth",5476713,,4545109,No
4609,20-T-063,"Quantification of Proteins, Protein Complexes and mRNA in Single-Cells by Proximity-Sequencing","63/025,094", ,*United States,US,5/14/2020,, ,5/14/2020,20-T-063-001,Small,5/14/2020,4/21/2021,,4/28/2022,Abandoned,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP010PUS,"Hoang Van Phan, Savas Tay, Luke Vistain",Provisional,5/15/2020,20-T-063-001,5/14/2021,"Cox, Ben",Savas Tay,"Tennant, Thelma",4557785,,4547824,No
4610,20-T-065,Materials and Methods of Treating Viral Infection with Amphiphilic Block Copolymers,"63/074,951", ,*United States,US,9/4/2020,, ,9/4/2020,20-T-065-001,Small,9/4/2020,11/1/2021,,4/28/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",750541,"Victoria Bigdelle, Raphael Lee, Michelle Ling, Kyle McCollum, Michelle Nguyen",Provisional,8/21/2020, ,9/4/2021,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",4844832,,4565827,No
4611,20-T-065,Methods and use of amphiphilic multi-block co-polymers to block viral infection,PCT/US21/49266,,*United States,US,9/7/2021,,WO 2022/051713,9/7/2021,20-T-065-002,Small,9/4/2020,9/10/2021,No,6/1/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757361,"Victoria Bigdelle, Raphael Lee, Michelle Ling, Kyle McCollum, Michelle Nguyen",PCT,9/1/2021,,3/9/2024,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",6121014,5/10/2022,4565827,No
4612,20-T-077,Method for Improving Quantum Repeater Rate,"63/068,153",,*United States,US,8/20/2020,, ,8/20/2020,20-T-077-001,Small,8/20/2020,11/1/2021,,6/6/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Chen, Gang",7814-420,"Supratik Guha, Manish Kumar Singh",Provisional,7/23/2020,20-T-077-001,8/20/2021,"Cox, Ben",Supratik Guha,"Tennant, Thelma",4747605,,4625796,No
4613,20-T-077,A Method for Improving Quantum Repeater Rate,PCT/US21/46252,,*United States,US,8/17/2021,, ,8/17/2021,20-T-077-002,Small,8/20/2020,8/19/2021,No,6/6/2022,Pending,Crowell & Moring LLP,,07814.00430,"Supratik Guha, Manish Kumar Singh",PCT,7/27/2021,20-T-077-002,2/20/2023,"Cox, Ben",Supratik Guha,"Tennant, Thelma",5958768,,4625796,No
4614,20-T-082,Targeted Nanomedicine for Treating Lung Disorders,"63/353,464",,*United States,US,6/17/2022,,,6/17/2022,20-T-082-001,Small,6/6/2022,6/17/2022,,6/21/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-0632-US-PRO,Yun Fang,Provisional,6/6/2022,,,"Peace, Shane",Yun Fang,"Tennant, Thelma",7396669,,4649400,
4615,21-T-006,Synthetic DNA Binding Domains and Uses Thereof,"63/117,710",,*United States,US,11/24/2020,, ,11/24/2020,21-T-006-001,Small,11/24/2020,3/3/2022,,6/13/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",750318,"Raymond Moellering, Sean Shangguan, Thomas Speltz",Provisional,8/18/2020,21-T-006-001,11/24/2021,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",4838163,,4723812,No
4616,21-T-006,Synthetic DNA Binding Domains and Uses Thereof,PCT/US21/60808,,*United States,US,11/24/2021,, ,11/24/2021,21-T-006-002,Small,11/24/2020,12/6/2021,No,6/21/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",758265,"Raymond Moellering, Sean Shangguan, Thomas Speltz",PCT,12/6/2021,21-T-006-002,6/6/2024,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",6466497,,4723812,No
4617,21-T-007,Rapid Enumeration of Microorganisms,"63/184,447",,*United States,US,5/5/2021,,,5/5/2021,21-T-007-001,Small,5/5/2021,5/20/2022,,5/20/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",750789,"Mustafa Abasiyanik, Yulder Angarita Marmolejo, Jing Lin, Melikhan Tanyeri",Provisional,2/3/2021,,5/5/2022,"Cox, Ben",Jing Lin,"Muite, Kevin",5346915,,4733449,No
4618,21-T-007,Rapid Enumeration of Microorganisms,PCT/US21/44964, ,*United States,US,8/6/2021,, ,8/6/2021,21-T-007-002,Small,5/5/2021,8/9/2021,No,5/2/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",756705,"Mustafa Abasiyanik, Yulder Angarita Marmolejo, Jing Lin, Melikhan Tanyeri",PCT,8/6/2021, ,11/5/2023,"Cox, Ben",Jing Lin,"Muite, Kevin",5994144,,4733449,No
4619,21-T-008,Nidovirus Inhibitors,"63/061,054",,*United States,US,8/4/2020,,,8/4/2020,21-T-008-001,Small,8/4/2020,7/9/2021,,5/27/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",750094,"Saara-Anne Azizi, Bryan Dickinson, Krysten Jones, Rahul Kathayat, Vladislav Lisnyak, Samantha Maki, Scott Snyder, Cooper Taylor, Yu-An Zhang, Zhiyao Zhou",Provisional,8/13/2020,21-T-008-001,8/4/2021,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",4825149,,4751770,No
4620,21-T-011,Methods and Systems for Genomic Based Prediction of Virus Mutation,"63/198,849",,*United States,US,11/17/2020,, ,11/17/2020,21-T-011-001,Small,11/17/2020,3/9/2022,,6/6/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",37997-84,Ishanu Chattopadhyay,Provisional,11/18/2020,21-T-011-001,11/17/2021,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",5097320,,4774248,No
4621,21-T-011,Methods and Systems for Genomic Based Prediction of Virus Mutation,PCT/US21/59616,,*United States,US,11/17/2021,,WO 2022/108965,11/17/2021,21-T-011-002,Small,11/17/2020,11/16/2021,No,6/24/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-00095,Ishanu Chattopadhyay,PCT,11/16/2021,21-T-011-002,5/17/2023,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",6399748,5/27/2022,4774248,No
4622,21-T-012,Anti-Inflammatory Cytokines and Methods of Use,"63/083,722", ,*United States,US,9/25/2020,, ,9/25/2020,21-T-012-001,Small,9/25/2020,10/12/2021,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0711US.P1,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Elyse Watkins, Eiji Yuba",Provisional,9/5/2020, ,9/25/2021,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",4874364,,4777200,No
4623,21-T-012,Anti-Inflammatory Cytokines and Methods of Use,PCT/US21/71587, ,*United States,US,9/24/2021,,WO 2022/067334 A1,9/24/2021,21-T-012-002,Small,9/25/2020,9/27/2021,No,5/31/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0711WO,"Jeffrey Hubbell, Ako Ishihara, Jun Ishihara, Elyse Watkins, Eiji Yuba",PCT,9/23/2021, ,3/5/2023,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6199092,3/31/2022,4777200,No
4624,21-T-014,Polypeptides for Detecting and treatment of SARS-COV-2,"63/108,614", ,*United States,US,11/2/2020,, ,11/2/2020,21-T-014-001,Small,11/2/2020,3/9/2022,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0712US.P1,"Anthony Kossiakoff, Tomasz (Tomek) Slezak",Provisional,10/2/2020, ,11/2/2021,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",4936421,,4810981,No
4625,21-T-014,Polypeptides for Detection and Treatment of SARS-COV-2,PCT/US21/72152,,*United States,US,11/1/2021,,WO 2022/094622 A1,11/1/2021,21-T-014-002,Small,11/2/2021,11/4/2021,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0712WO,"Anthony Kossiakoff, Tomasz (Tomek) Slezak",PCT,9/9/2021,,5/2/2024,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",6149977,5/5/2022,4810981,No
4626,21-T-015,Modified Serine Protease Proproteins,"63/067,059", ,*United States,US,8/18/2020,, ,8/18/2020,21-T-015-001,Small,8/18/2020,12/6/2021,,4/28/2022,Expired Prov - Filed PCT,,,OPNI-002/00US 332575-2002,"Lev Becker, Marc Nasoff",Provisional,8/22/2020, ,8/18/2021,"Sun, Han",Lev Becker,"Tennant, Thelma",4848064,,4816131,No
4627,21-T-015,Modified Serine Protease Proproteins,PCT/US21/46467, ,*United States,US,8/18/2021,, ,8/18/2021,21-T-015-002,Small,8/18/2020,12/6/2021,No,4/28/2022,Pending,,,OPNI-002/00US 332575-2002,"Lev Becker, Marc Nasoff",PCT,12/6/2021, ,2/18/2023,"Sun, Han",Lev Becker,"Tennant, Thelma",6468249,,4816131,No
4628,21-T-016,Photon-Number Dependent Hamiltonian Engineering for Resonators,"63/144,230",,*United States,US,2/1/2021,, ,2/1/2021,21-T-016-001,Small,2/1/2021,1/12/2022,,6/13/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Chen, Gang",7814-422,"Steven Girvin, Liang Jiang, Jos Lebreuilly, Kyungjoo Noh, Chiao-Hsuan Wang",Provisional,2/3/2021,21-T-016-001,2/1/2022,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",5346316,,4820577,No
4629,21-T-016,Photon-Number Dependent Hamiltonian Engineering for Resonators,PCT/US22/14603,,*United States,US,1/31/2022,,,1/31/2022,21-T-016-002,Small,2/1/2021,2/2/2022,No,6/13/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000443,"Steven Girvin, Liang Jiang, Jos Lebreuilly, Kyungjoo Noh, Chiao-Hsuan Wang",PCT,1/12/2022,21-T-016-002,8/1/2023,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6584510,,4820577,No
4630,21-T-017,Pharmaceuticals for Treating or Preventing Nidoviruses,"63/062,775", ,*United States,US,8/7/2020,, ,8/7/2020,21-T-017-001,Small,8/7/2020,6/10/2021,,4/28/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",750422,"Siquan Chen, Nir Drayman, Glenn Randall, Savas Tay",Provisional,8/23/2020, ,8/7/2021,"Cox, Ben",Savas Tay,"Tennant, Thelma",4848275,,4828875,No
4631,21-T-017,Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses,"63/127,436", ,*United States,US,12/18/2020,, ,12/18/2020,21-T-017-002,Large,12/18/2020,6/10/2021,No,4/28/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",751549,"Siquan Chen, Nir Drayman, Glenn Randall, Savas Tay",Provisional,12/11/2020, ,12/18/2021,"Cox, Ben",Savas Tay,"Tennant, Thelma",5190535,,4828875,No
4632,21-T-017,Pharmaceuticals for Treating or Preventing Nidoviruses,PCT/EP21/59355, ,European Patent Office (EPO),EP,4/9/2021,,WO 2021/205029,4/9/2021,21-T-017-003,None,8/7/2020,4/14/2021,No,6/2/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",750422,"Siquan Chen, Nir Drayman, Glenn Randall, Savas Tay",PCT,4/14/2021, ,10/9/2022,"Cox, Ben",Savas Tay,"Tennant, Thelma",5564350,10/14/2021,4828875,No
4633,21-T-017,Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses,PCT/US21/44971,,*United States,US,8/6/2021,,2022/032113 A1,8/6/2021,21-T-017-004,Small,8/7/2020,8/9/2021,No,6/9/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",756710,"Siquan Chen, Nir Drayman, Glenn Randall, Savas Tay",PCT,8/4/2021,,2/7/2023,"Cox, Ben",Savas Tay,"Tennant, Thelma",5984139,2/10/2022,4828875,No
4634,21-T-018,Nanoparticles Containing Multiple Cleavable Prodrugs for Cancer Therapy,"63/068,800", ,*United States,US,8/21/2020,, ,8/21/2020,21-T-018-001,Small,8/21/2020,9/28/2021,,4/28/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/20 PROV,"Wenbo Han, Xiaomin Jiang, Wenbin Lin",Provisional,8/19/2020,21-T-018-001,8/21/2021,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",4839413,,4835127,No
4635,21-T-018,Nanoparticles Containing Multiple Cleavable Prodrugs for Cancer Therapy,PCT/US21/47176, ,*United States,US,8/23/2021,,WO 2022/040635.,8/23/2021,21-T-018-002,Small,8/21/2020,9/7/2021,No,5/2/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/20 PCT,"Wenbo Han, Xiaomin Jiang, Wenbin Lin",PCT,9/7/2021, ,2/21/2023,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",6139391,2/24/2022,4835127,No
4636,21-T-019,Positron Emission Tomography Systems Based on Ionization-Activated Organic Fluor Molecules,"63/106,665", ,*United States,US,10/28/2020,, ,10/28/2020,21-T-019-001,Small,10/28/2020,11/1/2021,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0047-PV,"Bernhard Adams, Evan Angelico, Kepler Domurat-Sousa, Andrey Elagin, Henry Frisch, Patrick La Riviere, Joao Shida, Eric Spieglan",Provisional,8/18/2020, ,10/28/2021,"Cox, Ben",Henry Frisch,"Tennant, Thelma",4837549,,4835601,No
4637,21-T-019,Positron Emission Tomography Systems Based on Ionization-Activated Organic Fluor Molecules,PCT/US21/56535,,*United States,US,10/26/2021,,WO 2022/093732,10/26/2021,21-T-019-002,Small,10/28/2020,10/26/2021,No,6/9/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0047-PCT,"Bernhard Adams, Evan Angelico, Kepler Domurat-Sousa, Andrey Elagin, Henry Frisch, Patrick La Riviere, Joao Shida, Eric Spieglan",PCT,9/20/2021,,4/28/2023,"Cox, Ben",Henry Frisch,"Tennant, Thelma",6183043,5/5/2022,4835601,No
4638,21-T-027,"Targeted, Intracellular Delivery of Therapeutic Peptides Using Supramolecular Nanomaterials","63/072,286", ,*United States,US,8/31/2020,, ,8/31/2020,21-T-027-001,Small,8/31/2020,11/1/2021,,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-38732.101,"Jeffrey Hubbell, James LaBelle, Mathew Schnorenberg, Matthew Tirrell, Elyse Watkins",Provisional,9/5/2020,21-T-027-001,8/31/2021,"Dembo, Anna",James LaBelle,"Muite, Kevin",4874018,,4860192,No
4639,21-T-027,"Targeted, Intracellular Delivery of Therapeutic Peptides Using Supramolecular Nanomaterials",PCT/US21/48492, ,*United States,US,8/31/2021,, ,8/31/2021,21-T-027-002,Small,8/31/2020,10/28/2021,No,5/2/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-38732.601,"Jeffrey Hubbell, James LaBelle, Mathew Schnorenberg, Matthew Tirrell, Elyse Watkins",PCT,8/6/2021,21-T-027-002,2/28/2023,"Dembo, Anna",James LaBelle,"Muite, Kevin",5994864,,4860192,No
4640,21-T-030,Telomerase Targeting Agents,"63/049,531", ,*United States,US,7/8/2020,, ,7/8/2020,21-T-030-001,Small,7/8/2020,6/15/2021,,4/28/2022,Expired Prov - Filed PCT,,,702581.01796.NU2020-162,"Grant Frost, Stephen Kron, Karl Scheidt",Provisional,9/9/2020, ,7/8/2021,"Sun, Han",Stephen Kron,"Tennant, Thelma",4879053,,4877809,No
4641,21-T-033,Compositions and Methods for Treating Neuroblastoma,"63/109,613", ,*United States,US,11/4/2020,, ,11/4/2020,21-T-033-001,Small,11/4/2020,3/9/2022,,4/28/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-1702-PRO,"Mark Applebaum, Susan Cohn, Lucy Godley, Anastasia Hains",Provisional,10/20/2020, ,11/4/2021,"Dembo, Anna",Lucy Godley,"Muite, Kevin",4994548,,4913496,No
4642,21-T-033,Compositions and Methods for Treating Neuroblastoma,"17/519,398", ,*United States,US,11/4/2021,, ,11/4/2021,21-T-033-002,Small,11/4/2020,11/5/2021,No,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",20-1702-US,"Mark Applebaum, Susan Cohn, Lucy Godley, Anastasia Hains",US Utility,10/27/2021, ,11/4/2041,"Dembo, Anna",Lucy Godley,"Muite, Kevin",6309658,,4913496,No
4643,21-T-034,Microfluidic and MEMS Cell Lysis System and Method,"63/112,984", ,*United States,US,11/12/2020,, ,11/12/2020,21-T-034-001,Small,11/12/2020,1/10/2022,,4/28/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",751152,"Anindita Basu, Supratik Guha, Abhiteja Konda, Pavani Vamsi Krishna Nittala",Provisional,10/23/2020,21-T-034-001,11/12/2021,"Cox, Ben",Anindita Basu,"Juggernauth, Anne",5002001,,4935059,No
4644,21-T-034,Microfluidic and MEMS Cell Lysis System and Method,PCT/US21/58570, ,*United States,US,11/9/2021,, ,11/9/2021,21-T-034-002,Small,11/12/2020,11/10/2021,No,6/1/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757995,"Anindita Basu, Supratik Guha, Abhiteja Konda, Pavani Vamsi Krishna Nittala",PCT,10/22/2021,21-T-034-002,5/12/2023,"Cox, Ben",Anindita Basu,"Juggernauth, Anne",6294310,,4935059,No
4645,21-T-035,Porous and Monolithic Carbon Membranes and Their Use,"63/119,612",,*United States,US,11/30/2020,, ,11/30/2020,21-T-035-001,Small,11/30/2020,12/2/2021,,6/6/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",20-1792-PRO,"Lingyuan Meng, Aleksander Prominski, Bozhi Tian",Provisional,1/14/2021,21-T-035-001,11/30/2021,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",5271133,,4971816,No
4646,21-T-035,Porous and Monolithic Carbon Membranes and Their Use,PCT/US21/61122,,*United States,US,11/30/2021,, ,11/30/2021,21-T-035-002,Small,11/30/2020,12/2/2021,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",20-1792-WO,"Lingyuan Meng, Aleksander Prominski, Bozhi Tian",PCT,11/4/2021,21-T-035-002,5/30/2023,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",6349843,,4971816,No
4647,21-T-038,Compositions and Methods for Treating Oral Cavity Squamous Cell Carcinoma,"63/105,724",,*United States,US,10/26/2020,, ,10/26/2020,21-T-038-001,Small,10/26/2020,12/14/2020,,6/13/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0714US.P1,"Nishant Agrawal, Rifat Hasina, Evgeny Izumchenko",Provisional,10/22/2020,21-T-038-001,10/26/2021,"Sun, Han",Nishant Agrawal,"Smith, Dane",4998979,,4986700,No
4648,21-T-038,Compositions and Methods for Treating Oral Cavity Squamous Cell Carcinoma,"63/123,360",,*United States,US,12/9/2020,,,12/9/2020,21-T-038-002,Small,12/9/2020,12/8/2021,,6/13/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0720US.P1,"Nishant Agrawal, Rifat Hasina, Evgeny Izumchenko",Provisional,12/16/2020,21-T-038-002,12/9/2021,"Sun, Han",Nishant Agrawal,"Smith, Dane",5202704,,4986700,No
4649,21-T-038,Ultra-sensitive detection method for tumor-specific mutations in salivary DNA of oral cavity cancer patients,"63/122,859",,*United States,US,12/8/2020,, ,12/8/2020,21-T-038-003,Small,12/8/2020,1/11/2021,No,6/13/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0719US.P1,"Nishant Agrawal, Ramesh Hariharan, Rifat Hasina, Evgeny Izumchenko",Provisional,1/11/2021,21-T-038-003,12/8/2021,"Sun, Han",Nishant Agrawal,"Smith, Dane",5263556,,4986700,No
4650,21-T-038,Compositions and Methods for Treating Oral Cavity Squamous Cell Carcinoma,PCT/US21/72803,,*United States,US,12/8/2021,,,12/8/2021,21-T-038-004,Small,12/9/2020,12/8/2021,No,6/13/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0720WO,"Nishant Agrawal, Rifat Hasina, Evgeny Izumchenko",PCT,11/24/2021,21-T-038-004,6/9/2023,"Sun, Han",Nishant Agrawal,"Smith, Dane",6431969,,4986700,No
4651,21-T-039,Methods and Systems for Detection and Analysis of Angiotensin Binding Antibodies,"63/123,199", ,*United States,US,12/9/2020,, ,12/9/2020,21-T-039-001,Small,12/9/2020,3/9/2022,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0713US.P1,"Priscilla Briquez, Jeffrey Hubbell, Melody Swartz",Provisional,10/20/2020, ,12/9/2021,"Peace, Shane",Melody Swartz,"Tennant, Thelma",4994741,,4987252,No
4652,21-T-039,Methods and Systems for Detection and Analysis of Angiotensin Binding Antibodies,PCT/US21/72823,,*United States,US,12/9/2021,,WO 2022/126119 A2,12/9/2021,21-T-039-002,Small,12/9/2020,1/6/2022,No,6/23/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0713WO,"Priscilla Briquez, Jeffrey Hubbell, Melody Swartz",PCT,1/6/2022,,6/9/2023,"Peace, Shane",Melody Swartz,"Tennant, Thelma",6554313,6/16/2022,4987252,No
4653,21-T-040,Polypeptides for Detection and Treatment of Coronavirus Infection,"63/121,384", ,*United States,US,12/4/2020,, ,12/4/2020,21-T-040-001,Small,12/4/2020,3/9/2022,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0715US.P1,"Haley Dugan, YOSHIHIRO KAWAOKA, Christopher Stamper, Patrick Wilson",Provisional,12/1/2020,21-T-040-001,12/4/2021,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",5145141,,4996616,No
4654,21-T-040,Polypeptides for Detection and Treatment of Coronavirus Infection,PCT/US21/72723,,*United States,US,12/3/2021,,WO 2022/120375 A1,12/3/2021,21-T-040-002,Small,12/4/2020,12/3/2021,No,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0715WO,"Haley Dugan, Christopher Stamper, Patrick Wilson",PCT,11/29/2021,,6/4/2023,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",6436418,6/9/2022,4996616,No
4655,21-T-041,Systems and Methods for Electronically Removing Lesions from Three-Dimensional Medical Images,"63/145,387", ,*United States,US,2/3/2021,, ,2/3/2021,21-T-041-001,Small,2/3/2021,3/9/2022,,4/28/2022,Expired - Inactive,Lathrop GPM LLP,"Vock, Curtis",713032,"Lindsay Douglas, Maryellen Giger, Deepa Sheth",Provisional,2/4/2021,21-T-041-001,2/3/2022,"Cox, Ben",Maryellen Giger,"Tennant, Thelma",5352968,,5003985,No
4656,21-T-041,Systems and Methods for Electronically Removing Lesions from Three-Dimensional Medical Images,"63/267,446", ,*United States,US,2/2/2022,, ,2/2/2022,21-T-041-002,None,1/18/2022,2/7/2022,No,5/16/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",726364,"Lindsay Douglas, Maryellen Giger, Deepa Sheth",Provisional,1/18/2022,21-T-041-002,2/2/2023,"Cox, Ben",Maryellen Giger,"Tennant, Thelma",6609664,,5003985,No
4657,21-T-042,"Enrichment and/or Separation of Isotopes, Isotopologues, as well as Other Chemical Species via Differential Embedding in a Capture Matrix","63/110,681",,*United States,US,11/6/2020,, ,11/6/2020,21-T-042-001,Small,11/6/2020,11/5/2021,,6/6/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Manning, Michelle",05400-0048-PV,"Kevin Gibson, Steven Sibener",Provisional,11/5/2020,21-T-042-001,11/6/2021,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",5057728,,5004773,No
4658,21-T-042,"Enrichment and Separation of Isotopes, Isotopologues, or other Chemical Species, Via Differential Embedding in a Capture Matrix","17/453,357",,*United States,US,11/3/2021,,US-2022-0143551-A1,11/3/2021,21-T-042-002,Small,11/6/2020,11/4/2021,No,6/15/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0048-NP,"Kevin Gibson, Steven Sibener",US Utility,11/4/2021,21-T-042-002,11/3/2041,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",6349742,5/12/2022,5004773,No
4659,21-T-044,Molecular Subtyping of Colorectal Liver Metastases to Personalize Treatment Approaches,"63/166,155", ,*United States,US,3/25/2021,, ,3/25/2021,21-T-044-001,Small,3/25/2021,2/15/2022,,5/31/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0716US.P1,"Sean Pitroda, Mitchell Posner, Mark Talamonti, Ralph Weichselbaum",Provisional,4/9/2021, ,3/25/2022,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",5553624,,5020084,No
4660,21-T-044,Molecular Subtyping of Colorectal Liver Metastases to Personalize Treatment Approaches,PCT/US2022/021978, ,*United States,US,3/25/2022,, ,3/25/2022,21-T-044-002,Small,3/25/2021,4/11/2022,No,6/1/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0716WO,"Sean Pitroda, Mitchell Posner, Mark Talamonti, Ralph Weichselbaum",PCT,2/15/2022, ,9/25/2023,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",6799049,,5020084,No
4661,21-T-045,Systems and Methods for Identifying Progression of Hypoxic-Ischemic Brain Injury,"63/144,234",,*United States,US,2/1/2021,, ,2/1/2021,21-T-045-001,Small,2/1/2021,1/12/2022,,6/13/2022,Expired Prov - Filed PCT,Lathrop GPM LLP,"Vock, Curtis",713029,"Jordan Fuhrman, Maryellen Giger, Fernando Goldenberg, Ali Mansour",Provisional,12/22/2020,21-T-045-001,2/1/2022,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",5224838,,5023240,No
4662,21-T-045,Systems and Methods for Identifying Progression of Hypoxic-Ischemic Brain Injury,PCT/US22/14765,,*United States,US,2/1/2022,,,,21-T-045-002,Small,2/1/2021,2/2/2022,No,6/16/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",725933,"Jordan Fuhrman, Maryellen Giger, Fernando Goldenberg, Ali Mansour",PCT,1/12/2022,21-T-045-002,8/1/2023,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",6585397,,5023240,No
4663,21-T-047,Methods and Compositions for Targeting of Antigens and Other Polypeptides to First Responder Dendritic Cells,"63/187,797",,*United States,US,5/12/2021,, ,5/12/2021,21-T-047-001,Small,5/12/2021,4/27/2022,,6/17/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0717US.P1,"Peter Deak, Aaron Esser-Kahn, Rachel Steinhardt, Bradley Studnitzer",Provisional,12/14/2020,21-T-047-001,5/12/2022,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5195965,,5058627,No
4664,21-T-047,Methods and Compositions for Targeting of Antigens and Other Polypeptides to First Responder Dendritic Cells,PCT/US22/72297,,*United States,US,5/12/2022,,,5/12/2022,21-T-047-002,Small,5/12/2021,5/16/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0717WO,"Peter Deak, Aaron Esser-Kahn, Rachel Steinhardt, Bradley Studnitzer",PCT,4/27/2022,21-T-047-002,11/12/2023,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",7146079,,5058627,
4665,21-T-050,Blockade of SARS-CoV-2 Infection Using Hydrocarbon Stapled Peptides,"63/129,311", ,*United States,US,12/22/2020,, ,12/22/2020,21-T-050-001,Small,12/22/2020,3/9/2022,,4/28/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",39077.101,"Jeffrey Hubbell, Sicheng Jiang, James LaBelle, Yu Tian, Matthew Tirrell",Provisional,1/4/2021, ,12/22/2021,"Dembo, Anna",James LaBelle,"Muite, Kevin",5236547,,5068797,No
4666,21-T-050,Blockade of SARS-CoV-2 Infection Using Hydrocarbon Stapled Peptides,PCT/US21/64937, ,*United States,US,12/22/2021,, ,12/22/2021,21-T-050-002,Small,12/22/2020,1/9/2022,No,6/22/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39077.601,"Jeffrey Hubbell, Sicheng Jiang, James LaBelle, Yu Tian, Matthew Tirrell",PCT,12/3/2021, ,6/22/2023,"Dembo, Anna",James LaBelle,"Muite, Kevin",6460086,,5068797,No
4667,21-T-051,THE RATIONAL DESIGN OF THREE-DIMENSIONAL AUXETIC METAMATERIALS FROM DISORDERED NETWORKS,"63/004,341", ,*United States,US,4/2/2020,, ,4/2/2020,21-T-051-001,Small,4/2/2020,3/30/2021,,4/28/2022,Abandoned,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP009PUS,"Edwin Chan, Juan de Pablo, Sidney Nagel, Marcos Reyes-Martinez, Meng Shen, Christopher Soles",Provisional,11/12/2020,21-T-051-001,4/2/2021,"Hwang, Luke",Meng Shen,"Tennant, Thelma",5074214,,5069094,No
4668,21-T-054,Estrogen Receptor Alpha Antagonists and Uses Thereof,"63/151,479", ,*United States,US,2/19/2021,, ,2/19/2021,21-T-054-001,Small,2/19/2021,1/19/2022,,6/21/2022,Expired Prov - Filed PCT,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",751513,"Sean Fanning, Geoffrey Greene, David Hosfield",Provisional,2/10/2021, ,2/19/2022,"Sun, Han",Sean Fanning,"Tennant, Thelma",5367857,,5111597,No
4669,21-T-054,Estrogen Receptor Alpha Antagonists and Uses Thereof,PCT/US22/16813, ,*United States,US,2/17/2022,, ,2/17/2022,21-T-054-002,Small,2/19/2021,3/1/2022,No,6/21/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",759395,"Sean Fanning, Geoffrey Greene, David Hosfield",PCT,1/19/2022,21-T-054-002,8/19/2023,"Sun, Han",Sean Fanning,"Tennant, Thelma",6615130,,5111597,No
4670,21-T-055,Nanotraps for the Containment and Clearance of SARS-CoV-2,"63/142,320",,*United States,US,1/27/2021,, ,1/27/2021,21-T-055-001,Small,1/27/2021,1/26/2022,,6/6/2022,Expired Prov - Filed PCT,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/22 PROV,"Min Chen, Jun Huang, Jillian Rosenberg",Provisional,2/2/2021,21-T-055-001,1/27/2022,"Hwang, Luke",Jun Huang,"Tennant, Thelma",5345845,,5116751,No
4671,21-T-055,Functionalized Nanoparticles for the Containment and Clearance of Pathogens,PCT/US22/14163,,*United States,US,1/27/2022,, ,1/27/2022,21-T-055-002,Small,1/27/2021,2/15/2022,No,6/6/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/22 PCT,"Min Chen, Jun Huang, Jillian Rosenberg",PCT,1/26/2022,21-T-055-002,7/27/2023,"Hwang, Luke",Jun Huang,"Tennant, Thelma",6712659,,5116751,No
4672,21-T-058,"Radiotherapy Apparatus and Methods for Treatment and Imaging Using Hybrid MeV-keV, Multi-Energy Data Acquisition for Enhanced Imaging","17/339,319", ,*United States,US,6/4/2021,, ,6/4/2021,21-T-058-001,Large,6/4/2021,3/31/2022,,5/24/2022,Prosecution by Other Party,,,38935.04036,"Julian Bertini, Daniel Gagnon, Patrick La Riviere, Phillip Vargas, Zhicong Yu",US Utility,3/31/2022, ,6/4/2041,"Cox, Ben",Patrick La Riviere,"Smith, Dane",7016853,,5153250,No
4673,21-T-063,Core-Shell Structured Mixed Sodium and Lithium Cobalt Oxides for Electrochemical Lithium Extraction,"63/144,816", ,*United States,US,2/2/2021,, ,2/2/2021,21-T-063-001,Small,2/2/2021,1/26/2022,,4/28/2022,Expired Prov - Filed PCT,"Bell & Manning, LLC","Manning, Michelle",05400-0049-PV,"Grant Hill, Chong Liu",Provisional,2/3/2021, ,2/2/2022,"Hwang, Luke",Chong Liu,"Tennant, Thelma",5349317,,5176033,No
4674,21-T-063,Mixed Sodium and Lithium Period Four Transition Metal Oxides For Electrochemical Lithium Extraction,PCT/US22/14682, ,*United States,US,2/1/2022,, ,2/1/2022,21-T-063-002,Small,2/2/2021,2/1/2022,No,5/31/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0049-PCT,"Grant Hill, Chong Liu",PCT,1/26/2022, ,8/2/2023,"Hwang, Luke",Chong Liu,"Tennant, Thelma",6713933,,5176033,No
4675,21-T-065,System and Method of In-Queue Optimizations for Quantum Cloud Computing,"63/180,369",,*United States,US,4/27/2021,, ,4/27/2021,21-T-065-001,Small,4/27/2021,3/15/2022,,6/16/2022,Expired Prov - Filed PCT,Armstrong Teasdale,"Brennan, Patrick",37997-88,"Frederic Chong, Pranav Gokhale, Gokul Subramanian Ravi, Kaitlin Smith",Provisional,4/27/2021,21-T-065-001,4/27/2022,"Cox, Ben",Frederic Chong,"Smith, Dane",5634718,,5196558,No
4676,21-T-065,System and Method of In-Queue Optimizations for Quantum Cloud Computing,PCT/US22/24618,,*United States,US,4/13/2022,,,4/13/2022,21-T-065-002,Small,4/27/2021,4/13/2022,No,6/16/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-00099,"Frederic Chong, Pranav Gokhale, Gokul Subramanian Ravi, Kaitlin Smith",PCT,3/15/2022,21-T-065-002,10/27/2023,"Cox, Ben",Frederic Chong,"Smith, Dane",6933324,,5196558,No
4677,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,PCT/US20/54047, ,*United States,US,10/2/2020,,WO 2021/067785,10/2/2020,21-T-069-003,Large,10/2/2019,3/22/2022,No,6/23/2022,Prosecution by Other Party,,,004852.11707/150WO1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",PCT,1/6/2021,21-T-069-003,4/2/2022,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",5247850,4/8/2021,5235725,No
4678,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,"62/909,458", ,*United States,US,10/2/2019,, ,10/2/2019,21-T-069-001,Large,10/2/2019,1/6/2021,No,5/6/2022,Expired Prov - Filed PCT,,, ,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Provisional,1/6/2021,21-T-069-001,10/2/2020,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",5247894,,5235725,No
4679,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,"62/909,473", ,*United States,US,10/2/2019,, ,10/2/2019,21-T-069-002,None,10/2/2019,1/6/2021,No,5/6/2022,Expired Prov - Filed PCT,,, ,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Provisional,1/6/2021,21-T-069-002,10/2/2020,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",5247936,,5235725,No
4680,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,522432144,,Saudi Arabia,SA,10/2/2020,,,4/1/2022,21-T-069-004,Large,10/2/2019,3/22/2022,No,6/23/2022,Prosecution by Other Party,,,004852.12099/150SA1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6968760,,5235725,
4681,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,,,Qatar,QA,10/2/2020,,,3/31/2022,21-T-069-005,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6968817,,5235725,
4682,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,"17/765,434",,*United States,US,10/2/2020,,,3/28/2022,21-T-069-006,Large,10/2/2019,3/22/2022,No,4/7/2022,Prosecution by Other Party,,,004852.12103/150US2,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6968872,,5235725,
4683,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,"3,155,424",,Canada,CA,10/2/2020,,,3/21/2022,21-T-069-007,Large,10/2/2019,3/22/2022,No,6/21/2022,Prosecution by Other Party,,,004852.12078/150CA1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6968927,,5235725,
4684,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,20800380.6,,European Patent Office (EPO),EP,10/2/2020,,,4/13/2022,21-T-069-008,Large,10/2/2019,3/22/2022,No,5/26/2022,Prosecution by Other Party,,,004852.12084/150EP1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6968982,,5235725,
4685,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,2022-520611,,Japan,JP,10/2/2020,,,4/1/2022,21-T-069-009,Large,10/2/2019,3/22/2022,No,5/24/2022,Prosecution by Other Party,,,004852.12089/150JP1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969037,,5235725,
4686,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,2020358862,,Australia,AU,10/2/2020,,,3/21/2022,21-T-069-010,Large,10/2/2019,3/22/2022,No,4/8/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969092,,5235725,
4687,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,202217025228,,India,IN,10/2/2020,,,4/29/2022,21-T-069-011,Large,10/2/2019,3/22/2022,No,6/15/2022,Prosecution by Other Party,,,004852.12088/150IN1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969149,,5235725,
4688,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,BR112022005615-0,,Brazil,BR,10/2/2020,,,3/24/2022,21-T-069-012,Large,10/2/2019,3/22/2022,No,6/9/2022,Prosecution by Other Party,,,004852.12077/150BR1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969204,,5235725,
4689,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,2022/03774,,South Africa,ZA,10/2/2020,,,4/1/2022,21-T-069-013,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12105/150ZA1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969260,,5235725,
4690,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,202080082318.2,,China,CN,10/2/2020,,,5/26/2022,21-T-069-014,Large,10/2/2019,3/22/2022,No,6/24/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969315,,5235725,
4691,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,291821,,Israel,IL,10/2/2020,,,3/30/2022,21-T-069-015,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12087/150IL1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969370,,5235725,
4692,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,10-2022-7014713,,"Korea, Republic of",KR,10/2/2020,,,4/29/2022,21-T-069-016,Large,10/2/2019,3/22/2022,No,5/24/2022,Prosecution by Other Party,,,004852.12090/150KR1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969425,,5235725,
4693,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,786280,,New Zealand,NZ,10/2/2020,,,3/17/2022,21-T-069-017,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12095/150NZ1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969480,,5235725,
4694,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,,,Hong Kong,HK,10/2/2020,,,,21-T-069-018,Large,10/2/2019,3/22/2022,No,3/24/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969535,,5235725,
4695,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,2022-823,,Chile,CL,10/2/2020,,,4/1/2022,21-T-069-019,Large,10/2/2019,3/22/2022,No,4/8/2022,Prosecution by Other Party,,,004852.12079/150CL1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969590,,5235725,
4696,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,MX/a/2022/004061,,Mexico,MX,10/2/2020,,,4/1/2022,21-T-069-020,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12092/150MX1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969645,,5235725,
4697,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,11202202673X,,Singapore,SG,10/2/2020,,,3/16/2022,21-T-069-021,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12100/150SG1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969700,,5235725,
4698,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,1-2022-02716,,Vietnam,VN,10/2/2020,,,4/28/2022,21-T-069-022,Large,10/2/2019,3/22/2022,No,5/24/2022,Prosecution by Other Party,,,004852.12104/150VN1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969755,,5235725,
4699,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,NC2022/0004541,,Colombia,CO,10/2/2020,,,4/8/2022,21-T-069-023,Large,10/2/2019,3/22/2022,No,5/12/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969810,4/29/2022,5235725,
4700,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,395/2022,,Egypt,EG,10/2/2020,,,3/31/2022,21-T-069-024,Large,10/2/2019,3/22/2022,No,5/24/2022,Prosecution by Other Party,,,004852.12083/150EG1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969865,,5235725,
4701,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,1-2022-550667,,Philippines,PH,10/2/2020,,,3/17/2022,21-T-069-025,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12097/150PH1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969920,,5235725,
4702,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,P00202204967,,Indonesia,ID,10/2/2020,,,4/25/2022,21-T-069-026,Large,10/2/2019,3/22/2022,No,6/3/2022,Prosecution by Other Party,,,004852.12086/150ID1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6969975,,5235725,
4703,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,,,Ukraine,UA,10/2/2020,,,4/29/2022,21-T-069-027,Small,10/2/2019,3/22/2022,No,6/2/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970030,,5235725,
4704,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,F/P/2022/243,,Nigeria,NG,10/2/2020,,,3/31/2022,21-T-069-028,Large,10/2/2019,3/22/2022,No,6/17/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970085,,5235725,
4705,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,20220104,,Bahrain,BH,10/2/2020,,,3/30/2022,21-T-069-029,Large,10/2/2019,3/22/2022,No,4/8/2022,Prosecution by Other Party,,,004852.12076/150BH1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970140,,5235725,
4706,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,202291048,,Eurasian Patent Organization(EAPO),EA,10/2/2020,,,4/29/2022,21-T-069-030,Large,10/2/2019,3/22/2022,No,5/24/2022,Prosecution by Other Party,,,,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970195,,5235725,
4707,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,KW/P/2022/000351,,Kuwait,KW,10/2/2020,,,3/31/2022,21-T-069-031,Large,10/2/2019,3/22/2022,No,5/18/2022,Prosecution by Other Party,,,004852.12091/150KW1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970250,,5235725,
4708,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,PI2022001733,,Malaysia,MY,10/2/2020,,,3/10/2022,21-T-069-032,Large,10/2/2019,3/22/2022,No,5/5/2022,Prosecution by Other Party,,,004852.12093/150MY1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970305,,5235725,
4709,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,OM/P/2022/00156,,Oman,OM,10/2/2020,,,3/31/2022,21-T-069-033,Large,10/2/2019,3/22/2022,No,5/18/2022,Prosecution by Other Party,,,004852.12096/150OM1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970360,,5235725,
4710,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,2201001976,,Thailand,TH,10/2/2020,,,3/31/2022,21-T-069-034,Large,10/2/2019,3/22/2022,No,5/18/2022,Prosecution by Other Party,,,004852.12101/150TH1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970415,,5235725,
4711,21-T-069,STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE,P6000582/22,,United Arab Emirates,AE,10/2/2020,,,4/1/2022,21-T-069-035,Large,10/2/2019,3/22/2022,No,6/23/2022,Prosecution by Other Party,,,004852.12074/150AE1,"Xinhai Chen, Jeffrey Fernandez, Hwan Kim, Dominique Missiakas, Jan Poolman, Olaf Schneewind, Miaomiao Shi, Yan Sun",Nationalized PCT,3/22/2022,,10/2/2040,"Peace, Shane",Dominique Missiakas,"Ginsburg, Eric",6970470,,5235725,
4712,21-T-075,Methods of Treating or Preventing Premature Ovarian Insufficiency (POI) or Polycystic Ovary Syndrome (PCOS) Using Exosomes or Mesenchymal Stem Cells (MSCs),"63/218,793", ,*United States,US,7/6/2021,, ,7/6/2021,21-T-075-001,Small,7/6/2021,7/9/2021,,5/31/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",754967,"Ayman Al-Hendy, Hang-Soo Park",Provisional,7/8/2021, ,7/6/2022,"Peace, Shane",Ayman Al-Hendy,"Tennant, Thelma",5879882,,5270318,No
4713,21-T-075,Methods of Treating or Preventing Premature Ovarian Insufficiency (POI) or Polycystic Ovary Syndrome (PCOS) Using Exosomes or Mesenchymal Stem Cells (MSCs),"63/236,658", ,*United States,US,8/24/2021,, ,8/24/2021,21-T-075-002,Small,7/6/2021,8/27/2021,No,4/28/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",755102,"Ayman Al-Hendy, Hang-Soo Park",Provisional,8/26/2021, ,8/24/2022,"Peace, Shane",Ayman Al-Hendy,"Tennant, Thelma",6086770,,5270318,No
4714,21-T-075,Methods of Treating or Preventing Premature Ovarian Insufficiency or Polycystic Ovary Syndrome Using Exosomes or Mesenchymal Stem Cells,"63/306,763", ,*United States,US,2/4/2022,, ,2/4/2022,21-T-075-003,Small,7/6/2021,2/4/2022,,5/31/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",757905,"Ayman Al-Hendy, Hang-Soo Park",Provisional,9/29/2021, ,2/4/2023,"Peace, Shane",Ayman Al-Hendy,"Tennant, Thelma",6222759,,5270318,No
4715,21-T-077,Continuous Monitoring with Nano-Diamond Hydrogel in Microneedles,"63/203,747", ,*United States,US,7/29/2021,, ,7/29/2021,21-T-077-001,Small,7/29/2021,8/2/2021,,4/28/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP011P/UCHI 21-T-077,"Xiaoyang Wu, Jian Zhang",Provisional,5/26/2021,21-T-077-001,7/29/2022,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",5762393,,5272065,No
4716,21-T-079,Multi-Function Catheter and Methods for Diagnosis and/or Treatment of Venous thromboembolic Disease,"63/221,805", ,*United States,US,7/14/2021,, ,7/14/2021,21-T-079-001,Small,7/14/2021,7/19/2021,,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0728US.P1,"Osmanuddin Ahmed, Jonathan Paul",Provisional,5/28/2021, ,7/14/2022,"Cox, Ben",Jonathan Paul,"Cox, Ben",5770890,,5283505,No
4717,21-T-079,Multi-Function Catheter and Methods for Diagnosis and/or Treatment of Venous thromboembolic Disease,,,*United States,US,7/14/2021,,,,21-T-079-002,Small,7/14/2021,5/24/2022,No,6/22/2022,Authorized,Norton Rose Fulbright US LLP,"Robinson, Eagle",,"Osmanuddin Ahmed, Jonathan Paul",PCT,5/20/2022,,1/14/2024,"Cox, Ben",Jonathan Paul,"Cox, Ben",7276483,,5283505,
4718,21-T-080,"Compositions, Methods, and Kits for Isolation and Culture of Human Cord Blood Derived Hematopoietic Stem and Progenitor Cells","63/135,891", ,*United States,US,1/11/2021,, ,1/11/2021,21-T-080-001,Small,1/11/2021,3/24/2022,,6/8/2022,Expired - Inactive,Bryan Cave,"Fitzpatrick, Ethan",1065334.000163,"Chuan He, Linheng Li, Xinjian Mao, Fang Tao",Provisional,2/5/2021, ,1/11/2022,"Hwang, Luke",Linheng Li,"Tennant, Thelma",5355546,,5285583,No
4719,21-T-081,Small molecule immunopotentiator conjugates of NFKB activators as adjuvants with enhanced efficacy and reduced toxicity,"63/278,011", ,*United States,US,11/10/2021,, ,11/10/2021,21-T-081-001,Small,11/10/2021,11/12/2021,,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0724US.P1,"Aaron Esser-Kahn, Flora Kimani, Saikat Manna, Brittany Moser",Provisional,3/30/2021,21-T-081-001,11/10/2022,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5525297,,5286045,No
4720,21-T-082,ENGINEERING FAST BIAS-PRESERVING GATES ON STABILIZED CAT QUBITS,"63/138,185", ,*United States,US,1/15/2021,, ,1/15/2021,21-T-082-001,Small,1/15/2021,1/12/2022,,4/28/2022,Expired Prov - Filed PCT,Brinks Gilson & Lione,"Chen, Gang",7814-423,"Liang Jiang, Qian Xu",Provisional,1/21/2021,21-T-082-001,1/15/2022,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",5287965,,5286683,No
4721,21-T-082,ENGINEERING FAST BIAS-PRESERVING GATES ON STABILIZED CAT QUBITS,PCT/US22/12490, ,*United States,US,1/14/2022,, ,1/14/2022,21-T-082-002,Small,1/15/2021,1/18/2022,No,6/13/2022,Pending,Brinks Gilson & Lione,"Chen, Gang",507814.5000442,"Liang Jiang, Qian Xu",PCT,1/12/2022,21-T-082-002,7/15/2023,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6584238,,5286683,No
4722,21-T-088,Methods and Composition Using Patient-Derived Autologous Neoantigens for Treating Cancer,"63/246,633", ,*United States,US,9/21/2021,, ,9/21/2021,21-T-088-001,Small,9/21/2021,9/22/2021,,6/9/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0723US.P1,"Vasiliki Anastasopoulou, Michael Bishop, Matthias Leisegang, Hans Schreiber, Karin Schreiber, Amittha Wickrema, Steven Wolf",Provisional,3/24/2021,21-T-088-001,9/21/2022,"Sun, Han",Michael Bishop,"Tennant, Thelma",5509380,,5383939,No
4723,21-T-091,Methods and Compositions for Treating Fibrosis,"63/196,594",,*United States,US,6/3/2021,,,6/3/2021,21-T-091-001,Small,6/3/2021,6/10/2022,,6/24/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0730US.P1,"Jeffrey Hubbell, Michael White",Provisional,6/9/2021,,6/3/2022,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5811004,,5393696,No
4724,21-T-091,Methods and Compositions for Treating Fibrosis,PCT/US22/72720,,*United States,US,6/2/2022,,,6/2/2022,21-T-091-002,Small,6/3/2021,6/3/2022,No,6/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0730WO,"Jeffrey Hubbell, Michael White",PCT,5/12/2022,,12/3/2023,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7244789,,5393696,
4725,21-T-092,Characterization and Treatment of Asthma,"63/210,343",,*United States,US,6/14/2021,,,6/14/2021,21-T-092-001,Small,6/14/2021,6/23/2022,,6/23/2022,Expired Prov - Filed PCT,"Casimir Jones, S.C.","Staple, David",UCHI-39441.101,"Selene Clay, Carole Ober, Nathan Schoettler",Provisional,6/10/2021,21-T-092-001,6/14/2022,"Sun, Han",Carole Ober,"Tennant, Thelma",5813296,,5401465,No
4726,21-T-092,Characterization and Treatment of Asthma,PCT/US22/33442,,*United States,US,6/14/2022,,,6/14/2022,21-T-092-002,Small,6/14/2021,6/16/2022,No,6/16/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39441.601,"Selene Clay, Carole Ober, Nathan Schoettler",PCT,5/12/2022,,12/14/2023,"Sun, Han",Carole Ober,"Tennant, Thelma",7245480,,5401465,
4727,21-T-093,Spectral Correlation Analysis of Layered Evolutionary Signals (SCALES),"63/161,786",,*United States,US,3/16/2021,,,3/16/2021,21-T-093-001,Small,3/16/2021,5/20/2022,,5/20/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0722US.P1,"Arjun Raman, Mark Zaydman",Provisional,3/16/2021,,3/16/2022,"Ramirez, Mario Riojas",Arjun Raman,"Tennant, Thelma",5487753,,5403317,No
4728,21-T-093,Spectral Correlation Analysis of Layered Evolutionary Signals (SCALES),"63/165,006", ,*United States,US,3/23/2021,, ,3/23/2021,21-T-093-002,Small,3/16/2021,3/17/2022,No,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0722US.P2,"Arjun Raman, Mark Zaydman",Provisional,3/26/2021, ,3/23/2022,"Ramirez, Mario Riojas",Arjun Raman,"Tennant, Thelma",5514949,,5403317,No
4729,21-T-093,Spectral Correlation Analysis of Layered Evolutionary Signals,PCT/US22/71184, ,*United States,US,3/16/2022,, ,3/16/2022,21-T-093-003,Small,3/16/2021,3/17/2022,No,6/1/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0722WO,"Arjun Raman, Mark Zaydman",PCT,3/17/2022, ,9/16/2023,"Ramirez, Mario Riojas",Arjun Raman,"Tennant, Thelma",6941536,,5403317,No
4730,21-T-095,1888 & Design,"75/579,078",2389210,*United States,US,10/28/1998,9/26/2000, ,10/28/1998,21-T-095-001,None,,10/28/2021,No,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092318-9090-002,,Trademark,2/26/2021, ,,"Ramirez, Mario Riojas",,"Tennant, Thelma",5421784,,5421694,No
4731,21-T-095,Marine Biological Laboratory,"75/578,855",2396925,*United States,US,10/28/1998,10/24/2000, ,10/28/1998,21-T-095-002,None,,10/28/2021,No,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092318-9087-002,,Trademark,2/26/2021, ,,"Ramirez, Mario Riojas",,"Tennant, Thelma",5421789,,5421694,No
4732,21-T-095,Marine Biological Laboratory,"75/432,390",2220545,*United States,US,2/11/1998,1/26/1999, ,2/11/1998,21-T-095-003,None,,10/28/2021,No,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092318-9087-003,,Trademark,2/26/2021, ,,"Ramirez, Mario Riojas",,"Tennant, Thelma",5421797,,5421694,No
4733,21-T-095,Marine Biological Laboratory Woods Hole 1888 & Design,"75/370,471",2622531,*United States,US,10/8/1997,9/24/2002, ,10/8/1997,21-T-095-004,None,,10/28/2021,No,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092318-9089-002,,Trademark,2/26/2021, ,,"Ramirez, Mario Riojas",,"Tennant, Thelma",5421805,,5421694,No
4734,21-T-095,MBL,"75/584,245",2387012,*United States,US,11/6/1998,9/19/2000, ,11/6/1998,21-T-095-005,None,,10/28/2021,No,4/28/2022,Registered (TM),Michael Best & Friedrich LLP,"Brown, Jeffrey",092318-9088-002,,Trademark,2/26/2021, ,,"Ramirez, Mario Riojas",,"Tennant, Thelma",5421813,,5421694,No
4735,21-T-097,Compositions and Methods Related to Modification and Detection of Pseudouridine and 5-Hydroxymethyl-Cytosine,"63/180,304", ,*United States,US,4/27/2021,, ,4/27/2021,21-T-097-001,Small,4/27/2021,4/27/2022,,6/8/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0726US.P1,"Qing Dai, Chuan He",Provisional,4/5/2021,21-T-097-001,4/27/2022,"Hwang, Luke",Chuan He,"Tennant, Thelma",5536515,,5439335,No
4736,21-T-097,Compositions and Methods Related to Modification and Detection of Pseudouridine and 5-Hydroxymethyl-Cytosine,PCT/US22/71947,,*United States,US,4/27/2022,,,4/27/2022,21-T-097-002,Small,4/27/2021,4/27/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0726WO,"Qing Dai, Chuan He, Chang Ye, Li-Sheng Zhang",PCT,4/27/2022,,10/27/2023,"Hwang, Luke",Chuan He,"Tennant, Thelma",7149231,,5439335,
4737,21-T-098,Methods and Compositions for Treating Amyloid Beta-Related Disorders,"63/177,175", ,*United States,US,4/20/2021,, ,4/20/2021,21-T-098-001,Small,4/20/2021,4/14/2022,,5/31/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0727US.P1,Xiaoyang Wu,Provisional,4/30/2021,21-T-098,4/20/2022,"Hwang, Luke",Xiaoyang Wu,"Tennant, Thelma",5646458,,5465488,No
4738,21-T-100,Strain-Insensitive Soft Pressure Sensor and Method of Measuring Pressure,"63/193,819", ,*United States,US,5/27/2021,, ,5/27/2021,21-T-100-001,Small,5/27/2021,3/21/2022,,6/17/2022,Expired Prov - Filed PCT,Crowell & Moring LLP,"Rittner, Mindy",7814-426,"Yang Li, Qi Su, Sihong Wang",Provisional,4/12/2021,21-T-100-001,5/27/2022,"Cox, Ben",Sihong Wang,"Cox, Ben",5555349,,5469304,No
4739,21-T-100,Strain-Insensitive Soft Pressure Sensor and Method of Measuring Pressure,PCT/US22/28316,,*United States,US,5/9/2022,,,5/9/2022,21-T-100-002,Small,5/27/2021,5/12/2022,No,6/15/2022,Pending,Crowell & Moring LLP,"Rittner, Mindy",507814.5000447,"Yang Li, Qi Su, Sihong Wang",PCT,3/21/2022,21-T-100-002,11/27/2023,"Cox, Ben",Sihong Wang,"Cox, Ben",6961409,,5469304,
4740,21-T-103,Inter-Frequency Parametric Coupling and Energy Transfer of Mechanical Motion,"63/284,420", ,*United States,US,11/30/2021,, ,11/30/2021,21-T-103-001,Small,11/30/2021,12/1/2021,,4/28/2022,Pending,Brinks Gilson & Lione,"Chen, Gang",507814.5000433,Andrew Cleland,Provisional,8/20/2021,21-T-103-001,11/30/2022,"Cox, Ben",Andrew Cleland,"Smith, Dane",6068658,,5471279,No
4741,21-T-104,Differential interference microscope using nanostructured birefringent prisms,"63/306,523",,*United States,US,2/4/2022,,,2/4/2022,21-T-104-001,Small,2/4/2022,5/27/2022,,5/27/2022,Prosecution by Other Party,,,20064,"Peter Kazansky, Michael Shribak",Provisional,5/27/2022,,2/4/2023,"Cox, Ben",Michael Shribak,"Cox, Ben",7336486,,5476799,
4742,21-T-105,Array of Asthma- and Allergy-Associated Differentially-Methylated Sites,"63/342,463",,*United States,US,5/16/2022,,,5/16/2022,21-T-105-001,Small,5/16/2022,5/19/2022,,6/21/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39941.101,"Britney Helling, Andreanne Morin, Carole Ober",Provisional,5/16/2022,,5/16/2023,"Sun, Han",Carole Ober,"Tennant, Thelma",7257646,,5477657,
4743,21-T-109,Methods for Assessing Specificity of Crispr-Mediated Genome Editing,"63/172,942", ,*United States,US,4/9/2021,, ,4/9/2021,21-T-109-001,Small,4/9/2021,4/11/2022,,6/8/2022,Prosecution by Other Party,,,S21-085,"William Greenleaf, Chuan He, Georgi Marinov, Tong Wu",Provisional,4/29/2021, ,4/9/2022,"Hwang, Luke",Chuan He,"Tennant, Thelma",5643037,,5520653,No
4744,21-T-109,Methods for Assessing Specificity of Crispr-Mediated Genome Editing,PCT/US22/23136,,*United States,US,4/1/2022,,,4/1/2022,21-T-109-002,Small,4/9/2021,5/2/2022,No,6/8/2022,Prosecution by Other Party,,,STAN-1837WO,"William Greenleaf, Chuan He, Georgi Marinov, Tong Wu",PCT,5/2/2022,,10/9/2023,"Hwang, Luke",Chuan He,"Tennant, Thelma",7201371,,5520653,
4745,21-T-110,Controlled Photon Fock State Generation Using Arbitrarily Weak Photonic Nonlinearities,"63/312,461", ,*United States,US,2/22/2022,, ,2/22/2022,21-T-110-001,Small,2/22/2022,2/23/2022,,5/31/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000428,"Aashish Clerk, Andrew Lingenfelter",Provisional,7/23/2021,21-T-110-001,2/22/2023,"Cox, Ben",Aashish Clerk,"Smith, Dane",5944455,,5520841,No
4746,21-T-113,Methods for Treating COVID and Chronic Fatigue Syndrome,"63/183,963",,*United States,US,5/4/2021,,,5/4/2021,21-T-113-001,Small,5/4/2021,5/20/2022,,5/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0729US.P1,"Mark Ratain, Anthony Reder",Provisional,4/21/2021,,5/4/2022,"Sun, Han",Mark Ratain,"Tennant, Thelma",5618586,,5616184,No
4747,21-T-113,Methods for Treating COVID and Chronic Fatigue Syndrome,"63/338,682",,*United States,US,5/5/2022,,,5/5/2022,21-T-113-002,Small,4/27/2022,5/11/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0776US.P1,"Mark Ratain, Anthony Reder",Provisional,4/27/2022,,5/5/2023,"Sun, Han",Mark Ratain,"Tennant, Thelma",7149256,,5616184,
4748,21-T-114,Claudin Inhibitors and Methods of Use Thereof,"63/285,837", ,*United States,US,12/3/2021,, ,12/3/2021,21-T-114-001,Small,12/3/2021,12/3/2021,,4/28/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",754968,"Fatemeh Khalili-Araghi, Le Shen, Christopher Weber",Provisional,7/8/2021, ,12/3/2022,"Peace, Shane",Christopher Weber,"Tennant, Thelma",5879896,,5616254,No
4749,21-T-114,Claudin Inhibitors and Methods of Use Thereof,"63/285,853", ,*United States,US,12/3/2021,, ,12/3/2021,21-T-114-002,Small,12/3/2021,12/3/2021,No,5/31/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",758171,"Fatemeh Khalili-Araghi, Le Shen, Christopher Weber",Provisional,12/3/2021, ,12/3/2022,"Peace, Shane",Christopher Weber,"Tennant, Thelma",6463240,,5616254,No
4750,21-T-115,Isotopologue or Isotope Enrichment via Preferential Condensation of Isotopologues or Isotopes Under Non-Equilibrium Gas-Surface Collision Conditions,"63/182,204", ,*United States,US,4/30/2021,, ,4/30/2021,21-T-115-001,Small,4/30/2021,4/27/2022,,4/28/2022,Expired Prov - Filed in US,"Bell & Manning, LLC","Manning, Michelle",05400-0050-PV,"Michelle Brann, Stephen Hansknecht, Steven Sibener",Provisional,4/30/2021,21-T-115-001,4/30/2022,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",5645875,,5616719,No
4751,21-T-115,Isotopologue or Isotope Enrichment via Preferential Condensation of Isotopologues or Isotopes Under Non-Equilibrium Gas-Surface Collision Conditions,"17/728,453",,*United States,US,4/25/2022,,,4/25/2022,21-T-115-002,Small,4/30/2021,4/27/2022,No,6/15/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0050-NP,"Michelle Brann, Stephen Hansknecht, Steven Sibener",US Utility,4/27/2022,,,"Hwang, Luke",Steven Sibener,"Juggernauth, Anne",7148077,,5616719,
4752,21-T-117,Survivin Targeting Polypeptides for Detection and Treatment of Cancer,"63/253,018", ,*United States,US,10/6/2021,, ,10/6/2021,21-T-117-001,Small,10/6/2021,10/13/2021,,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0743US.P1,"Anthony Kossiakoff, Somnath Mukherjee, Annika Saaf, Marcin Ura",Provisional,8/3/2021, ,10/6/2022,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",5981544,,5623344,No
4753,21-T-118,Machine Learning-Based Histopathological Recurrence Prediction Models for HPV+ Head/Neck Squamous Cell Carcinoma,"63/179,091",,*United States,US,4/23/2021,,,4/23/2021,21-T-118-001,Small,4/23/2021,4/26/2022,,6/23/2022,Expired Prov - Filed PCT,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-0538-US-PRO,"Devraj Basu, Robert Brody, James Dolezal, Jalal Jalaly, Alexander Pearson",Provisional,4/23/2021,21-T-118-001,4/23/2022,"Ramirez, Mario Riojas",Alexander Pearson,"Smith, Dane",5626041,,5623387,No
4754,21-T-118,Machine Learning-Based Histopathological Recurrence Prediction Models for HPV+ Head/Neck Squamous Cell Carcinoma,PCT/US22/25699,,*United States,US,4/21/2022,,,4/21/2022,21-T-118-002,Small,4/23/2021,4/29/2022,No,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Borella, Mike",21-0538-WO,"Devraj Basu, Robert Brody, James Dolezal, Jalal Jalaly, Alexander Pearson",PCT,4/26/2022,21-T-118-002,10/23/2023,"Ramirez, Mario Riojas",Alexander Pearson,"Smith, Dane",7134380,,5623387,
4755,21-T-119,Methods and Compositions for Treating Airway Inflammation,"63/287,256", ,*United States,US,12/8/2021,, ,12/8/2021,21-T-119-001,Small,12/8/2021,1/16/2022,,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0740US.P1,"Robert Hamanaka, Gokhan Mutlu, Parker Woods",Provisional,7/23/2021,21-T-119-001,12/8/2022,"Hwang, Luke",Gokhan Mutlu,"Tennant, Thelma",5944520,,5644628,No
4756,21-T-120,Systems and Methods for Modulating RNA,"63/337,481",,*United States,US,5/2/2022,,,5/2/2022,21-T-120-001,Small,,5/3/2022,,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0734US.P1,"Bryan Dickinson, Krysten Jones, Riley Sinnott",Provisional,8/3/2021,,5/2/2023,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",5980432,,5644907,No
4757,21-T-123,RNA splicing as a predictor of anti-tumor immunity and immunotherapy response in cancer,,,*United States,US,,,,,21-T-123-001,Small,,7/26/2021,,6/23/2022,Authorized,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0739US.P1,"Sean Pitroda, Ralph Weichselbaum",Provisional,7/26/2021,,,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",5949938,,5711633,No
4758,21-T-126,Methods and Compositions Comprising Actin Binding Proteins,"63/253,420", ,*United States,US,10/7/2021,, ,10/7/2021,21-T-126-001,Small,10/7/2021,10/11/2021,,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0736US.P1,"Alexander French, Kourtney Kroll, Ronald Rock, Tobin Sosnick",Provisional,7/20/2021,21-T-126-001,10/7/2022,"Peace, Shane",Kourtney Kroll,"Muite, Kevin",5923086,,5725711,No
4759,21-T-127,Biocompatible Soft Pressure Sensor and Method of Monitoring Pressure Subcutaneously,"63/193,999", ,*United States,US,5/27/2021,, ,5/27/2021,21-T-127-001,Small,5/27/2021,4/29/2022,,4/29/2022,Expired - Inactive,Brinks Gilson & Lione,"Rittner, Mindy",7814-427,"Sliman Bensmaia, Stacy Lindau, Sihong Wang",Provisional,5/27/2021, ,5/27/2022,"Cox, Ben",Sihong Wang,"Cox, Ben",5768148,,5734294,No
4760,21-T-127,Biocompatible Soft Pressure Sensor and Method of Monitoring Pressure Subcutaneously,"63/339,623",,*United States,US,5/9/2022,,,5/9/2022,21-T-127-002,Small,4/29/2022,5/24/2022,No,6/17/2022,Pending,Crowell & Moring LLP,"Rittner, Mindy",507814.5000448,"Sliman Bensmaia, Stacy Lindau, Sihong Wang",Provisional,4/29/2022,,5/9/2023,"Cox, Ben",Sihong Wang,"Cox, Ben",7185593,,5734294,
4761,21-T-129,Instant Polarized Light Microscope,"63/306,604", ,*United States,US,2/4/2022,, ,2/4/2022,21-T-129-001,Small,2/4/2022,2/4/2022,,5/31/2022,Pending,"Bell & Manning, LLC","Kalafut, Christopher",05400-0052-PV,"Peter Kazansky, Michael Shribak",Provisional,11/19/2021,21-T-129-001,2/4/2023,"Cox, Ben",Michael Shribak,"Juggernauth, Anne",6420395,,5751982,No
4762,21-T-131,Methods for Detecting and Treating Cerebral Cavernous Malformation,"63/326,488",,*United States,US,4/1/2022,,,4/1/2022,21-T-131-001,Small,,4/4/2022,,6/16/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0732US.P1,"Issam Awad, Romuald Girard",Provisional,6/22/2021,21-T-131-001,4/1/2023,"Dembo, Anna",Issam Awad,"Smith, Dane",5833367,,5759386,No
4763,21-T-133,Fast Multi-Dimensional Search Based on Variance Aware Quantization,"63/188,332",,*United States,US,5/13/2021,,,5/13/2021,21-T-133-001,Small,5/13/2021,5/20/2022,,5/20/2022,Expired Prov - Filed in US,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Borella, Mike",21-0629-US-PRO,"Ikraduya Edian, Aaron Elmore, Michael Franklin, Chunwei Liu, John (Ioannis) Paparrizos",Provisional,5/28/2021,,5/13/2022,"Ramirez, Mario Riojas",John (Ioannis) Paparrizos,"Smith, Dane",5770992,,5770309,No
4764,21-T-133,Fast Multi-Dimensional Search Based on Variance-Aware Quantization,"17/742,928",,*United States,US,5/12/2022,,,5/12/2022,21-T-133-002,Small,5/13/2021,5/16/2022,No,6/21/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Borella, Mike",21-0629-US,"Ikraduya Edian, Aaron Elmore, Michael Franklin, Chunwei Liu, John (Ioannis) Paparrizos",US Utility,4/29/2022,,5/12/2042,"Ramirez, Mario Riojas",John (Ioannis) Paparrizos,"Smith, Dane",7186482,,5770309,
4765,21-T-136,Methods and Compositions for Treating Disorders with Oral Systemically Bioavailable Butyrate Conjugates,"63/176,749", ,*United States,US,4/19/2021,, ,4/19/2021,21-T-136-001,Small,4/19/2021,4/14/2022,,4/28/2022,Expired Prov - Filed PCT,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0721US.P1,"Shijie Cao, Jeffrey Hubbell, Michal Raczy, Elyse Watkins",Provisional,6/29/2021, ,4/19/2022,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",5846857,,5791530,No
4766,21-T-136,Methods and Compositions for Treating Disorders with Oral Systemically Bioavailable Butyrate Conjugates,PCT/US22/71775,,*United States,US,4/18/2022,,,4/18/2022,21-T-136-002,Small,4/19/2021,4/26/2022,No,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0721WO,"Shijie Cao, Jeffrey Hubbell, Michal Raczy, Elyse Watkins",PCT,4/14/2022,,10/19/2023,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7078390,,5791530,No
4767,21-T-139,Method For Engineering Doped Thin-Film Structure and Device,"63/281,194", ,*United States,US,11/19/2021,, ,11/19/2021,21-T-139-001,Small,11/19/2021,11/20/2021,,6/7/2022,Pending,Brinks Gilson & Lione,"Chen, Gang",507814.5000434,"Supratik Guha, Manish Kumar Singh",Provisional,9/20/2021,21-T-139-001,11/19/2022,"Cox, Ben",Supratik Guha,"Juggernauth, Anne",6183223,,5819336,No
4768,21-T-140,"Novel plasma metabolites with mechanistic and clinical links in a neurovascular disease, cavernous angioma",,,*United States,US,,,,,21-T-140-001,Small,,7/30/2021,,6/3/2022,Authorized,Norton Rose Fulbright US LLP,"Shishima, Gina",,Issam Awad,Provisional,7/30/2021,,,"Dembo, Anna",Issam Awad,"Smith, Dane",5969069,,5819486,No
4769,21-T-143,One-Step Method for Producing Adenoviral Vectors,"63/232,326", ,*United States,US,8/12/2021,, ,8/12/2021,21-T-143-001,Small,8/12/2021,8/19/2021,,6/24/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39710.101,Tong-Chuan He,Provisional,7/30/2021, ,8/12/2022,"Sun, Han",Tong-Chuan He,"Muite, Kevin",5967064,,5835782,No
4770,21-T-143,One-Step Method for Producing Adenoviral Vectors,,,*United States,US,,,,,21-T-143-002,None,8/12/2021,6/24/2022,No,6/24/2022,,"Casimir Jones, S.C.","Staple, David",,Tong-Chuan He,US Utility,6/24/2022,,,"Sun, Han",Tong-Chuan He,"Muite, Kevin",7494020,,5835782,
4771,22-T-001,Growth Hormone Receptor Targeting Polypeptides,"63/311,805", ,*United States,US,2/18/2022,, ,2/18/2022,22-T-001-001,Small,2/18/2022,2/21/2022,,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0763US.P1,"Edwin Arauz-Diaz, Anthony Kossiakoff, Maria Lecka, Tomasz (Tomek) Slezak",Provisional,8/18/2021, ,2/18/2023,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",6050958,,5856285,No
4772,22-T-001,Growth Hormone Receptor Targeting Polypeptides,"63/296,595", ,*United States,US,1/5/2022,, ,1/5/2022,22-T-001-002,Small,1/5/2022,2/24/2022,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0748US.P1,"Edwin Arauz-Diaz, Anthony Kossiakoff, Maria Lecka, Tomasz (Tomek) Slezak",Provisional,2/24/2022, ,1/5/2023,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",6845764,,5856285,No
4773,22-T-002,A method to detect queuine modification in RNA by high throughput sequencing,"63/338,160",,*United States,US,5/4/2022,,,5/4/2022,22-T-002-001,Small,,5/4/2022,,6/21/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",756590,"Christopher Katanski, Samuel Miller, Tao Pan, Christopher Watkins",Provisional,8/11/2021,,5/4/2023,"Dembo, Anna",Tao Pan,"Tennant, Thelma",6011989,,5856417,
4774,22-T-003,Compositions and Methods for Inducing Immune Tolerance,"63/277,579", ,*United States,US,11/9/2021,, ,11/9/2021,22-T-003-001,Small,11/9/2021,11/12/2021,,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0744US.P1,"Peter Deak, Aaron Esser-Kahn",Provisional,8/3/2021,22-T-003-001,11/9/2022,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",5981175,,5864574,No
4775,22-T-004,Optically Controllable Mesoscopic Magnetism in Semiconductors,"63/231,817", ,*United States,US,8/11/2021,, ,8/11/2021,22-T-004-001,None,8/11/2021,4/28/2022,,4/28/2022,,Brinks Gilson & Lione,"Chen, Gang",07814.00429,"Kai Hao, Alexander (Alex) High, Robert Shreiner",Provisional,8/12/2021, ,8/11/2022,"Ramirez, Mario Riojas",Alexander (Alex) High,"Juggernauth, Anne",6016102,,5864804,No
4776,22-T-006,Synthesis and applications of porosity-based silicon heterojunctions,"63/282,955", ,*United States,US,11/24/2021,, ,11/24/2021,22-T-006-001,Small,11/24/2021,11/24/2021,,5/31/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Miao, Emily",21-1090-US-PRO,"Aleksander Prominski, Bozhi Tian",Provisional,8/19/2021,22-T-006-001,11/24/2022,"Cox, Ben",Bozhi Tian,"Juggernauth, Anne",6066532,,5866022,No
4777,22-T-007,Electrically-promoted polymerization and crosslinking reactions using piezoelectric nanoparticles,,,*United States,US,,,,,22-T-007-001,Small,3/14/2022,3/14/2022,,3/22/2022,Authorized,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",,"Jorge Luis Ayarza-Leon, Aaron Esser-Kahn, Jun Wang, Zhao Wang",Provisional,3/14/2022,,,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",6928562,,5878378,
4778,22-T-008,Methods and Compositions for PKC-Delta Inhibition and Cancer Immunotherapy,"63/276,953",,*United States,US,11/8/2021,, ,11/8/2021,22-T-008-001,Small,11/8/2021,11/10/2021,,5/26/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0745US.P1,"Kyle Cron, Thomas Gajewski",Provisional,9/27/2021,22-T-008-001,11/8/2022,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",6205906,,5882318,No
4779,22-T-009,Universal Hairpin Primer System for Quantification of MicroRNA,"63/250,438", ,*United States,US,9/30/2021,, ,9/30/2021,22-T-009-001,Small,9/30/2021,10/14/2021,,6/16/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39811.101,Tong-Chuan He,Provisional,8/19/2021, ,9/30/2022,"Sun, Han",Tong-Chuan He,"Tennant, Thelma",6066609,,5887230,No
4780,22-T-010,Biocompatible Surface Functionalization Architecture for a Diamond Quantum Sensor,"63/203,315", ,*United States,US,7/16/2021,, ,7/16/2021,22-T-010-001,Small,7/16/2021,7/19/2021,,6/24/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP012PUS,"Peter Maurer, Mouzhe Xie",Provisional,7/19/2021,22-T-010-001,7/16/2022,"Cox, Ben",Peter Maurer,"Juggernauth, Anne",5920039,,5903573,No
4781,22-T-012,Extremely Anisotropic Van Der Waals Thermal Conductors,"63/231,445",,*United States,US,8/10/2021,,,8/10/2021,22-T-012-001,Small,8/10/2021,8/11/2021,,6/21/2022,Pending,"Wolf, Greenfield & Sacks, P.C.","Blackwell, Brandon","C1604,70001US00","Shi En Kim, Fauzia Mujid, Jiwoong Park, Joonki Suh",Provisional,8/11/2021,,8/10/2022,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",6013348,,5919450,No
4782,22-T-012,Anisotropic Thermal Conductors,"63/233,477",,*United States,US,8/16/2021,,,8/16/2021,22-T-012-002,Small,8/10/2021,8/19/2021,No,6/21/2022,Pending,"Wolf, Greenfield & Sacks, P.C.","Blackwell, Brandon","C1604,70001US01","Shi En Kim, Fauzia Mujid, Jiwoong Park, Joonki Suh",Provisional,8/19/2021,,8/16/2022,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",6060067,,5919450,No
4783,22-T-014,Compositions and Methods for DNA Binding and Transcriptional Regulation,"63/282,647", ,*United States,US,11/23/2021,, ,11/23/2021,22-T-014-001,Small,11/23/2021,11/29/2021,,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0754US.P1,"Shannon Elf, Raymond Moellering, Long Nguyen, Zeyu Qiao, Marsha Rosner",Provisional,10/12/2021,22-T-014-001,11/23/2022,"Hwang, Luke",Raymond Moellering,"Tennant, Thelma",6267913,,5925692,No
4784,22-T-015,Molecular Reorientation of Liquid Crystals Using Acoustic Waves and Fluid Flow in Confinement,"63/366,062",,*United States,US,6/8/2022,,,6/8/2022,22-T-015-001,Small,,6/15/2022,,6/15/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP015PUS,"Juan de Pablo, Tadej Emersic, Gustavo Vasquez Montoya",Provisional,11/22/2021,,6/8/2023,"Hwang, Luke",Juan de Pablo,"Juggernauth, Anne",6421977,,5950749,
4785,22-T-017,Immunotherapeutic Methods for Treating Cancer,"63/255,841", ,*United States,US,10/14/2021,, ,10/14/2021,22-T-017-001,Small,10/14/2021,10/15/2021,,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0738US.P1,"Priscilla Briquez, Zoe Goldberger, Sylvie Hauert, Jeffrey Hubbell",Provisional,8/9/2021, ,10/14/2022,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6004977,,5951034,No
4786,22-T-019,Quantum Data Center,"63/235,275", ,*United States,US,8/20/2021,, ,8/20/2021,22-T-019-001,Small,8/20/2021,8/23/2021,,6/17/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",721381,"Connor Hann, Liang Jiang, Junyu Liu",Provisional,8/16/2021, ,8/20/2022,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6029253,,5951293,No
4787,22-T-020,Practical Architectures and Algorithms for Quantum Source Coding,"63/235,265", ,*United States,US,8/20/2021,, ,8/20/2021,22-T-020-001,Small,8/20/2021,8/20/2021,,6/21/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",721392,"Senrui Chen, Isaac Chuang, Connor Hann, Liang Jiang",Provisional,8/16/2021, ,8/20/2022,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6029097,,5951470,No
4788,22-T-021,Quantum coherent devices using a thin film on Si/SOI platform,"63/329,656", ,*United States,US,4/11/2022,, ,4/11/2022,22-T-021-001,Small,,4/11/2022,,6/16/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000435,"Alan Dibos, Supratik Guha, Manish Kumar Singh",Provisional,11/20/2021, ,4/11/2023,"Cox, Ben",Supratik Guha,"Juggernauth, Anne",6421057,,5981654,No
4789,22-T-023,"Bioactive Compounds Containing 2,3-Dihydro-1H-inden--ol Moiety","63/249,550", ,*United States,US,9/28/2021,, ,9/28/2021,22-T-023-001,Small,9/28/2021,9/29/2021,,4/28/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-1266-US-PRO,"Guangbin Dong, Renhe Li",Provisional,9/29/2021,22-T-023-001,9/28/2022,"Hwang, Luke",Guangbin Dong,"Muite, Kevin",6221961,,6009469,No
4790,22-T-027,Copolymers for the Delivery of Short-Chain Fatty Acids,"63/275,260", ,*United States,US,11/3/2021,, ,11/3/2021,22-T-027-001,Small,11/3/2021,11/18/2021,,5/24/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39935.101,"Mohamed Bashir, Shijie Cao, Jeffrey Hubbell, Cathryn Nagler, Ruyi Wang, D. Scott Wilson",Provisional,10/14/2021, ,11/3/2022,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",6274118,,6010575,No
4791,22-T-029,Pre-Seeding Lithium in One-Dimensional Olivine Hosts for Li Extraction,"63/235,987", ,*United States,US,8/23/2021,, ,8/23/2021,22-T-029-001,Small,8/23/2021,8/23/2021,,5/24/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0051-PV,"Chong Liu, Gangbin Yan",Provisional,8/23/2021, ,8/23/2022,"Hwang, Luke",Chong Liu,"Tennant, Thelma",6072070,,6018864,No
4792,22-T-035,Borealin Targeting Polypeptides for Detection and Treatment of Cancer,"63/252,883", ,*United States,US,10/6/2021,, ,10/6/2021,22-T-035-001,Small,10/6/2021,10/11/2021,No,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0746US.P1,"Anthony Kossiakoff, Somnath Mukherjee, Annika Saaf, Marcin Ura",Provisional,8/3/2021, ,10/6/2022,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",5981592,,6070590,No
4793,22-T-036,Incenp Targeting Polypeptides for Detection and Treatment of Cancer,"63/252,928", ,*United States,US,10/6/2021,, ,10/6/2021,22-T-036-001,Small,10/6/2021,10/15/2021,No,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0747US.P1,"Anthony Kossiakoff, Somnath Mukherjee, Annika Saaf, Marcin Ura",Provisional,8/3/2021, ,10/6/2022,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",5981616,,6070596,No
4794,22-T-037,Noble Gas Solid-State Single Electron Qubit Platform,"17/672,389", ,*United States,US,2/15/2022,, ,2/15/2022,22-T-037-001,Small,1/25/2022,2/25/2022,,4/28/2022,Prosecution by Other Party,"Marshall, Gerstein & Borun",,ANL-IN-21-093,"Dafei Jin, Gerwin Koolstra, David Schuster, Ge Yang, Xianjing Zhou",US Utility,1/25/2022,22-T-037-001,2/15/2042,"Cox, Ben",David Schuster,"Juggernauth, Anne",6698501,,6086789,No
4795,22-T-038,Polypeptides and Methods for Modifying Nucleic Acids,"63/240,525", ,*United States,US,9/3/2021,, ,9/3/2021,22-T-038-001,Small,9/3/2021,9/9/2021,,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0737US.P1,"Weixin Tang, Yulan Xiao",Provisional,9/9/2021, ,9/3/2022,"Hwang, Luke",Weixin Tang,"Tennant, Thelma",6148056,,6090882,No
4796,22-T-040,Trans-Vaccenic Acid (TVA) and Derivatives Thereof in T Cell-Based Cancer Therapies,"63/325,456", ,*United States,US,3/30/2022,, ,3/30/2022,22-T-040-001,Small,,4/7/2022,,5/2/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-39942.101,Jing Chen,Provisional,11/23/2021, ,3/30/2023,"Sun, Han",Jing Chen,"Tennant, Thelma",6428415,,6144351,No
4797,22-T-042,System and Method of In-Queue Optimizations for Quantum Cloud Computing,"63/252,371", ,*United States,US,10/5/2021,, ,10/5/2021,22-T-042-001,Small,10/5/2021,10/14/2021,,4/28/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-94,"Frederic Chong, Pranav Gokhale, Gokul Subramanian Ravi, Kaitlin Smith",Provisional,9/15/2021,22-T-042-001,10/5/2022,"Cox, Ben",Frederic Chong,"Smith, Dane",6168444,,6162896,No
4798,22-T-042,System and Method of In-Queue Optimizations for Quantum Cloud Computing,"63/306,196", ,*United States,US,2/3/2022,, ,2/3/2022,22-T-042-002,None,10/5/2021,3/11/2022,No,5/31/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-93,"Frederic Chong, Pranav Gokhale, Gokul Subramanian Ravi, Kaitlin Smith",Provisional,2/1/2022,22-T-042-002,2/3/2023,"Cox, Ben",Frederic Chong,"Smith, Dane",6745241,,6162896,No
4799,22-T-044,Classifying Medical States of Cells Using Cell Transcriptional Profiling,"63/275,379", ,*United States,US,11/3/2021,, ,11/3/2021,22-T-044-001,Small,11/3/2021,11/12/2021,,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0753US.P1,Arjun Raman,Provisional,10/26/2021, ,11/3/2022,"Ramirez, Mario Riojas",Arjun Raman,"Onishi, Kenneth",6306842,,6181096,No
4800,22-T-045,Selective Backpropagation Through Time,"63/262,704", ,*United States,US,10/19/2021,, ,10/19/2021,22-T-045-001,Small,10/19/2021,11/9/2021,,4/28/2022,Pending,,,22008 PROV (CSP),"Andrea Giovannucci, Matthew Kaufman, Chethan Pandarinath, Andrew Selder, Feng Zhu",Provisional,11/9/2021, ,10/19/2022,"Peace, Shane",Matthew Kaufman,"Juggernauth, Anne",6367719,,6189773,No
4801,22-T-048,Stretchable Light-Emitting Polymers,"63/320,465", ,*United States,US,3/16/2022,, ,3/16/2022,22-T-048-001,Small,,3/17/2022,,6/2/2022,Pending,Crowell & Moring LLP,"Sussman, Adam",507814.5000438,"Juan de Pablo, Wei Liu, Sihong Wang, Cheng Zhang",Provisional,12/7/2021, ,3/16/2023,"Cox, Ben",Sihong Wang,"Juggernauth, Anne",6474232,,6246972,No
4802,22-T-052,Uses of Inhibitors of YTH Domain Family Proteins in the Management of Cognitive or Developmental Disorders,"63/255,039", ,*United States,US,10/13/2021,, ,10/13/2021,22-T-052-001,Small,10/13/2021,10/18/2021,,4/28/2022,Pending,,,22012 PROV,"Chuan He, Peng Jin, Zhongyu Zou",Provisional,10/18/2021, ,10/13/2022,"Hwang, Luke",Chuan He,"Tennant, Thelma",6281395,,6252385,No
4803,22-T-053,Oncolytic Viruses for Delivery of Therapeutic Polypeptides,"63/229,661",,*United States,US,8/5/2021,,,8/5/2021,22-T-053-001,Small,8/5/2021,5/9/2022,,6/9/2022,Prosecution by Other Party,,,OPNI-003/00US 332575-2004,"Lev Becker, Peter Haberz, Court Turner",Provisional,10/12/2021,,8/5/2022,"Sun, Han",Lev Becker,"Tennant, Thelma",6269091,,6252438,No
4804,22-T-053,Oncolytic Viruses for Delivery of Therapeutic Polypeptides,,,*United States,US,,,,,22-T-053-002,Small,5/9/2022,5/9/2022,No,5/20/2022,,,,,"Lev Becker, Peter Haberz, Court Turner",Provisional,5/9/2022,,,"Sun, Han",Lev Becker,"Tennant, Thelma",7232096,,6252438,
4805,22-T-054,Mechanically Adaptive Materials,"63/268,256",,*United States,US,2/18/2022,,,,22-T-054-001,Small,2/18/2022,2/23/2022,,5/26/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP014PUS,"Jorge Luis Ayarza-Leon, Aaron Esser-Kahn, Jun Wang, Zhao Wang",Provisional,10/12/2021,22-T-054-001,2/18/2023,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",6268418,,6252487,
4806,22-T-056,Improving Metrology by Neural Networks,"63/294,018", ,*United States,US,12/27/2021,, ,12/27/2021,22-T-056-001,Small,12/27/2021,1/16/2022,,4/28/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000439,"Tao Hong, Liang Jiang, Changhun Oh, Seyed Alireza Seif Tabrizi",Provisional,12/8/2021, ,12/27/2022,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6483279,,6276522,No
4807,22-T-058,Inhibition of SARS-CoV-2 infection by cannabidiol (CBD) and related cannabinoids,,,*United States,US,,,,,22-T-058-001,Small,3/22/2022,3/22/2022,,5/2/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-1338-US-PRO,Marsha Rosner,Provisional,3/22/2022,,,"Sun, Han",Marsha Rosner,"Tennant, Thelma",6966257,,6276900,
4808,22-T-061,Multi-Layer Stacks of 2D Materials and/or Other Layers and Related Systems and Methods,"63/284,541",,*United States,US,11/30/2021,, ,11/30/2021,22-T-061-001,Small,11/30/2021,12/1/2021,,6/2/2022,Pending,"Wolf, Greenfield & Sacks, P.C.","Blackwell, Brandon",C1604.70002US00,"Andrew Mannix, Jiwoong Park, Andrew Ye",Provisional,11/22/2021,22-T-061-001,11/30/2022,"Hwang, Luke",Jiwoong Park,"Juggernauth, Anne",6422064,,6298462,No
4809,22-T-062,Antibodies Specific to Different Conformational States of the Nonclassical Class 1 MHC Protein HLA-F,"63/312,631", ,*United States,US,2/22/2022,, ,2/22/2022,22-T-062-001,Small,2/22/2022,2/25/2022,,5/2/2022,Pending,"Casimir Jones, S.C.","Hullinger, Rikki",UCHI-40023.101,Erin Adams,Provisional,11/4/2021, ,2/22/2023,"Sun, Han",Erin Adams,"Tennant, Thelma",6350895,,6298594,No
4810,22-T-064,Skin-Like Stretchable Neuromorphic Devices for On-Body Processing of Health Data with Artificial Intelligence,"63/282,859", ,*United States,US,11/24/2021,, ,11/24/2021,22-T-064-001,Small,11/24/2021,11/29/2021,,4/28/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000436,"Shilei Dai, Yahao Dai, Sihong Wang",Provisional,11/20/2021,22-T-064-001,11/24/2022,"Cox, Ben",Sihong Wang,"Juggernauth, Anne",6421165,,6302125,No
4811,22-T-064,Stretchable neuromorphic devices for on-body processing of health data with artificial intelligence,,,*United States,US,,,,,22-T-064-002,Small,11/24/2021,11/23/2021,No,6/23/2022,Authorized,Crowell & Moring LLP,"Chen, Gang",507814.5000437,"Shilei Dai, Yahao Dai, Sihong Wang",Provisional,11/23/2021,,,"Cox, Ben",Sihong Wang,"Juggernauth, Anne",6427646,,6302125,
4812,22-T-067,Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy,"63/134,907", ,*United States,US,1/7/2021,, ,1/7/2021,22-T-067-001,Large,1/7/2021,3/4/2022,,4/28/2022,Prosecution by Other Party,Polsinelli Shughart PC,,E-237-2020-0-US-01,"Xiaofei Han, Patrick La Riviere, Hari Shroff, Yicong Wu",Provisional,11/8/2021, ,1/7/2022,"Cox, Ben",Patrick La Riviere,"Smith, Dane",6365169,,6337688,No
4813,22-T-067,Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy,PCT/US22/11484, ,*United States,US,1/6/2022,, ,1/6/2022,22-T-067-002,Large,1/7/2021,3/4/2022,No,4/28/2022,Prosecution by Other Party,Polsinelli Shughart PC,,E-237-2020-0-US-01,"Xiaofei Han, Patrick La Riviere, Hari Shroff, Yicong Wu",PCT,1/18/2022, ,7/7/2023,"Cox, Ben",Patrick La Riviere,"Smith, Dane",6606520,,6337688,No
4814,22-T-069,Materials and Methods for Large-Scale Spatial Transcriptomics,"63/309,795", ,*United States,US,2/14/2022,, ,2/14/2022,22-T-069-001,Small,2/14/2022,2/15/2022,,5/2/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-40132.101,Nicolas Chevrier,Provisional,12/1/2021, ,2/14/2023,"Sun, Han",Nicolas Chevrier,"Tennant, Thelma",6454239,,6339102,No
4815,22-T-070,Polypeptides for Detection and Treatment of Coronavirus Infection,"63/264,173", ,*United States,US,11/16/2021,, ,11/16/2021,22-T-070-001,Small,11/16/2021,11/18/2021,,4/28/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0752US.P1,"Siriruk Changrob, Haley Dugan, Christopher Stamper, Patrick Wilson",Provisional,11/11/2021, ,11/16/2022,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",6384631,,6339189,No
4816,22-T-071,Vanadyl Sulfate Compositions and Methods of Use Therefor For the Treatment and Prevention of Aging-Related Diseases and Cancer,"63/343,859",,*United States,US,5/19/2022,,,5/19/2022,22-T-071-001,Small,5/11/2022,5/26/2022,,6/17/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-40145.101,Jing Chen,Provisional,5/11/2022,,5/19/2023,"Sun, Han",Jing Chen,"Tennant, Thelma",7240234,,6352386,
4817,22-T-072,Methods and Compositions for Rapid Detection and Analysis of RNA and DNA Cytosine Methylation,"63/297,165", ,*United States,US,1/6/2022,, ,1/6/2022,22-T-072-001,Small,1/6/2022,1/24/2022,,6/8/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0756US.P1,"Qing Dai, Chuan He, Iryna Irkliyenko",Provisional,1/24/2022,22-T-072-001,1/6/2023,"Hwang, Luke",Chuan He,"Tennant, Thelma",6691013,,6352678,No
4818,22-T-073,"Optical Cavity with One or More Intracavity Lenses, and Associated Methods","63/362,242", ,*United States,US,3/31/2022,, ,3/31/2022,22-T-073-001,Small,,4/1/2022,,5/31/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",725934,"David Schuster, Jonathan Simon",Provisional,1/12/2022, ,3/31/2023,"Cox, Ben",David Schuster,"Juggernauth, Anne",6585968,,6365516,No
4819,22-T-074,Low-Dose Tocilizumab for the Treatment or Prevention of Sickle Cell Crisis,"63/286,804", ,*United States,US,12/7/2021,, ,12/7/2021,22-T-074-001,Small,12/7/2021,1/9/2022,,6/8/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-40144.101,Mark Ratain,Provisional,12/2/2021, ,12/7/2022,"Sun, Han",Mark Ratain,"Tennant, Thelma",6458033,,6366684,No
4820,22-T-075,Neoantigens in Cancer,PCT/US20/31357, ,*United States,US,5/4/2020,,WO2020/227233,5/4/2020,22-T-075-005,Small,5/3/2019,2/24/2022,No,4/28/2022,Expired PCT - Filed in US only,,,Y8652-99002,"Tzintzuni Garcia, Randy Sweis",PCT,11/9/2021, ,11/3/2021,"Sun, Han",Randy Sweis,"Tennant, Thelma",6368435,,6366739,No
4821,22-T-075,Neoantigens in Cancer,"62/842,800", ,*United States,US,5/3/2019,, ,5/3/2019,22-T-075-001,Small,5/3/2019,11/9/2021,No,4/28/2022,Expired Prov - Filed PCT,,, ,"Tzintzuni Garcia, Randy Sweis",Provisional,11/9/2021, ,5/3/2020,"Sun, Han",Randy Sweis,"Tennant, Thelma",6368601,,6366739,No
4822,22-T-075,Neoantigens in Cancer,"62/880,965", ,*United States,US,7/31/2019,, ,7/31/2019,22-T-075-002,Small,5/3/2019,11/9/2021,No,4/28/2022,Expired Prov - Filed PCT,,, ,"Tzintzuni Garcia, Randy Sweis",Provisional,11/9/2021, ,7/31/2020,"Sun, Han",Randy Sweis,"Tennant, Thelma",6368636,,6366739,No
4823,22-T-075,Neoantigens in Cancer,"62/932,651", ,*United States,US,11/8/2019,, ,11/8/2019,22-T-075-003,None,5/3/2019,11/9/2021,No,4/28/2022,Expired Prov - Filed PCT,,, ,"Tzintzuni Garcia, Randy Sweis",Provisional,11/9/2021, ,11/8/2020,"Sun, Han",Randy Sweis,"Tennant, Thelma",6368662,,6366739,No
4824,22-T-075,Neoantigens in Cancer,"62/932,654", ,*United States,US,11/8/2019,, ,11/8/2019,22-T-075-004,None,5/3/2019,11/9/2021,No,4/28/2022,Expired Prov - Filed PCT,,, ,"Tzintzuni Garcia, Randy Sweis",Provisional,11/9/2021, ,11/8/2020,"Sun, Han",Randy Sweis,"Tennant, Thelma",6368688,,6366739,No
4825,22-T-075,Neoantigens in Cancer,"17/517,118",,*United States,US,5/4/2020,,,11/2/2021,22-T-075-006,None,5/3/2019,3/7/2022,No,3/17/2022,Prosecution by Other Party,,,Y8652-01002,"Tzintzuni Garcia, Randy Sweis",Continuation in Part,2/24/2022,,5/4/2040,"Sun, Han",Randy Sweis,"Tennant, Thelma",6846410,,6366739,
4826,22-T-076,Quantum Spin Amplifier and Associated Methods,"63/264,617", ,*United States,US,11/29/2021,, ,11/29/2021,22-T-076-001,Small,11/29/2021,12/7/2021,,5/31/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",724465,"Aashish Clerk, Peter Groszkowski, Martin Koppenhoefer",Provisional,11/18/2021,22-T-076-001,11/29/2022,"Cox, Ben",Aashish Clerk,"Juggernauth, Anne",6411081,,6396600,No
4827,22-T-077,Aberrant Expression of N6-Methyladenosine Regulators in Uterine Fibroids,"63/256,847",,*United States,US,10/18/2021,,,10/18/2021,22-T-077-001,Small,10/18/2021,11/18/2021,,6/13/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",758016,"Ayman Al-Hendy, Qiwei Yang",Provisional,11/18/2021,22-T-077-001,10/18/2022,"Peace, Shane",Qiwei Yang,"Tennant, Thelma",6415596,,6396819,No
4828,22-T-080,Embryoid Bodies for Genomic Studies of Functionally Diverse Cell Types,"63/291,045", ,*United States,US,12/17/2021,, ,12/17/2021,22-T-080-001,Small,12/17/2021,1/9/2022,,6/24/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",758658,"Yoav Gilad, Katherine Rhodes",Provisional,1/9/2022,22-T-080-001,12/17/2022,"Ramirez, Mario Riojas",Yoav Gilad,"Smith, Dane",6559743,,6402207,No
4829,22-T-080,Embryoid Bodies for Genomic Studies of Functionally Diverse Cell Types,,,*United States,US,,,,,22-T-080-002,Small,12/17/2021,6/24/2022,No,6/24/2022,Authorized,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",763533,"Yoav Gilad, Katherine Rhodes",US Utility,6/17/2022,,,"Ramirez, Mario Riojas",Yoav Gilad,"Smith, Dane",7463546,,6402207,
4830,22-T-081,Rapid learning with high localized synaptic plasticity,"63/335,684",,*United States,US,4/27/2022,,,4/27/2022,22-T-081-001,Small,,5/12/2022,,6/8/2022,Pending,"Marshall, Gerstein & Borun","Tilton, Noah",27373/57650P,"David Freedman, Nicolas Masse, Matthew Rosen",Provisional,1/25/2022,,4/27/2023,"Ramirez, Mario Riojas",David Freedman,"Ginsburg, Eric",6704212,,6402935,
4831,22-T-083,Remote Floating-Gate Field-effect Transistor,"63/303,714", ,*United States,US,1/27/2022,, ,1/27/2022,22-T-083-001,Small,1/27/2022,1/28/2022,,6/6/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",758623,"Junhong Chen, Hyun-June Jang",Provisional,1/14/2022, ,1/27/2023,"Hwang, Luke",Junhong Chen,"Juggernauth, Anne",6599358,,6409809,No
4832,22-T-084,Systems and Methods for Three-Dimensional Structured Illumination Microscopy with Isotropic Spatial Resolution,"63/275,736", ,*United States,US,11/4/2021,, ,11/4/2021,22-T-084-001,Large,11/4/2021,3/4/2022,,4/28/2022,Prosecution by Other Party,Polsinelli Shughart PC,,E-168-2021-0-US-01,"Patrick La Riviere, Xuesong LI, Hari Shroff, Yicong Wu",Provisional,11/18/2021, ,11/4/2022,"Cox, Ben",Patrick La Riviere,"Smith, Dane",6415064,,6409919,No
4833,22-T-084,Systems and Methods for Three-Dimensional Structured Illumination Microscopy with Isotropic Spatial Resolution Using Computational Means,"63/297,162", ,*United States,US,1/6/2022,, ,1/6/2022,22-T-084-002,Large,11/4/2021,3/4/2022,No,4/28/2022,Prosecution by Other Party,Polsinelli Shughart PC,,E-168-2021-1-US-01,"Patrick La Riviere, Xuesong LI, Hari Shroff, Yicong Wu",Provisional,3/4/2022, ,1/6/2023,"Cox, Ben",Patrick La Riviere,"Smith, Dane",6891524,,6409919,No
4834,22-T-086,Automated RCT Intervention-Communication System (ARCTICS),,,*United States,US,,,,,22-T-086-001,None,,1/12/2022,,5/2/2022,,Michael Best & Friedrich LLP,"Brown, Jeffrey",,,Trademark,1/12/2022,,,"Sun, Han",,"Tennant, Thelma",6587906,,6439632,
4835,22-T-087,Near IR Luminescence and Optically Addressable Quantum Sensing and Magnetic Imaging with Radicaloid Tetrathiafulvalene Tetrathiolates,"63/364,865",,*United States,US,5/17/2022,,,5/17/2022,22-T-087-001,Small,,5/19/2022,,6/21/2022,Pending,Weaver Austin Villeneuve & Sampson LLP,"Bergin, Denise",UCHIP016PUS,"John Anderson, Lauren McNamara",Provisional,3/22/2022,,5/17/2023,"Peace, Shane",John Anderson,"Juggernauth, Anne",6963243,,6439775,
4836,22-T-088,Inhibition of BRD Proteins Suppresses the Phenotype of Uterine Fibroids,"63/256,855", ,*United States,US,10/18/2021,, ,10/18/2021,22-T-088-001,Small,10/18/2021,11/18/2021,,5/31/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",758017,"Ayman Al-Hendy, Qiwei Yang",Provisional,11/18/2021, ,10/18/2022,"Peace, Shane",Qiwei Yang,"Tennant, Thelma",6415511,,6453740,No
4837,22-T-091,Data-driven protein design using normalizing flows and latent-conditioned dilated causal convolutions,"63/314,898", ,*United States,US,2/28/2022,, ,2/28/2022,22-T-091-001,Small,2/28/2022,3/1/2022,,5/24/2022,Pending,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt",542006US,"Andrew Ferguson, Niksa Praljak",Provisional,3/1/2022,22-T-091-001,2/28/2023,"Ramirez, Mario Riojas",Andrew Ferguson,"Smith, Dane",6869944,,6454012,No
4838,22-T-091,Data-driven protein design using normalizing flows and latent-conditioned dilated causal convolutions,,,*United States,US,,,,,22-T-091-002,Small,2/28/2022,5/20/2022,No,6/22/2022,Authorized,"Oblon, Spivak, McClelland, Maier & Neustadt","Berger, Kurt",,"Andrew Ferguson, Niksa Praljak",Provisional,5/3/2022,,,"Ramirez, Mario Riojas",Andrew Ferguson,"Smith, Dane",7206492,,6454012,
4839,22-T-092,Targeting the BRCA1 Pseudogene (BRCA1P1) to Inhibit Cancer Progression and Increase Therapy Responses,,,*United States,US,,,,,22-T-092-001,Small,6/9/2022,6/9/2022,,6/17/2022,Authorized,"Casimir Jones, S.C.","Staple, David",,"Yoo Jane Han, Olufunmilayo Olopade",Provisional,6/9/2022,,,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",7423188,,6460179,
4840,22-T-093,Bionic Breast Trademark,97247140,,*United States,US,1/31/2022,,,,22-T-093-001,Small,,2/1/2022,,5/2/2022,Pending,Michael Best & Friedrich LLP,"Brown, Jeffrey",,,Trademark,2/1/2022,,,"Sun, Han",,"Tennant, Thelma",6741676,,6491961,
4841,22-T-094,Methods and Compositions for Activating Translation,"63/314,177", ,*United States,US,2/25/2022,, ,2/25/2022,22-T-094-001,Small,2/25/2022,3/2/2022,,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0758US.P1,"Mark Berney, Yang Cao, Bryan Dickinson",Provisional,2/3/2022,22-T-094-001,2/25/2023,"Hwang, Luke",Bryan Dickinson,"Tennant, Thelma",6761230,,6477217,No
4842,22-T-095,Mechanism and Methods for Quantifying the Tactile Acuity of the Human Breast,"63/280,807", ,*United States,US,11/18/2021,, ,11/18/2021,22-T-095-001,Small,11/18/2021,12/21/2021,,5/31/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-1528-US-PRO,"Sliman Bensmaia, Stacy Lindau",Provisional,12/21/2021,22-T-095-001,11/18/2022,"Sun, Han",Stacy Lindau,"Tennant, Thelma",6517384,,6485725,No
4843,22-T-096,SOX2 is a Biomarker That Predicts Therapeutic Efficacy of Nuclear Hormone Receptor Signaling Inhibitors (NHRSI) and Indicates the Use of WEE1 Inhibitors to Overcome SOX2-Mediated NHRSI Resistance in Prostate Cancer,,,*United States,US,,,,,22-T-096-001,Small,6/1/2022,6/2/2022,,6/22/2022,,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-1686-US-PRO,"Russell Szmulewitz, Donald Vander Griend, Anthony Williams",Provisional,6/1/2022,,,"Sun, Han",Russell Szmulewitz,"Tennant, Thelma",7367974,,6507415,
4844,22-T-099,Methods for Detecting or Treating Influenza Infections,"63/292,804",,*United States,US,12/22/2021,, ,12/22/2021,22-T-099-001,Small,12/22/2021,1/9/2022,,6/14/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0759US.P1,"Jenna Guthmiller, Patrick Wilson",Provisional,1/9/2022,22-T-099-001,12/22/2022,"Dembo, Anna",Patrick Wilson,"Tennant, Thelma",6560423,,6519469,No
4845,22-T-100,Lithium Ion Batteries Including Co-Intercalation-Free Ether Solvents,"63/327,924",,*United States,US,4/6/2022,,,4/6/2022,22-T-100-001,Small,,6/23/2022,,6/23/2022,Pending,Crowell & Moring LLP,"Sussman, Adam",507814.5000440,"Chibueze Amanchukwu, Peiyuan Ma",Provisional,1/14/2022,,4/6/2023,"Hwang, Luke",Chibueze Amanchukwu,"Juggernauth, Anne",6599838,,6549675,
4846,22-T-102,Methods and Systems for Molecular Subtyping of Cancer Metastases,"63/343,836",,*United States,US,5/19/2022,,,5/19/2022,22-T-102-001,Small,,5/26/2022,,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0762US.P1,"Sean Pitroda, Ralph Weichselbaum",Provisional,2/15/2022,,5/19/2023,"Dembo, Anna",Sean Pitroda,"Tennant, Thelma",6799988,,6551726,
4847,22-T-103,Efficient Algorithm of Molecular Vibronic Spectra,"63/300,320", ,*United States,US,1/18/2022,, ,1/18/2022,22-T-103-001,Small,1/18/2022,1/20/2022,,4/28/2022,Pending,Crowell & Moring LLP,"Chen, Gang",507814.5000444,"William Fefferman, Liang Jiang, Youngrong Lim, Changhun Oh",Provisional,1/20/2022,22-T-103-001,1/18/2023,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6618109,,6580716,No
4848,22-T-103,Efficient Algorithm of Molecular Vibronic Spectra,,,*United States,US,,,,,22-T-103-002,Small,1/18/2022,1/24/2022,No,6/21/2022,Authorized,Crowell & Moring LLP,"Chen, Gang",507814.5000444,"Liang Jiang, Youngrong Lim, Changhun Oh",Provisional,1/20/2022,,,"Ramirez, Mario Riojas",Liang Jiang,"Juggernauth, Anne",6619147,,6580716,
4849,22-T-104,Methods to Rescue Light Sensitivity in Retinas After Photoreceptor Degeneration,"63/218,092", ,*United States,US,7/2/2021,, ,7/2/2021,22-T-104-001,Small,7/2/2021,3/22/2022,,6/22/2022,Prosecution by Other Party,,,UNIA 21.15 PROV,"Francisco Bezanilla, Joao Carvalho-de-Souza",Provisional,1/24/2022, ,7/2/2022,"Cox, Ben",Francisco Bezanilla,"Juggernauth, Anne",6694887,,6583300,No
4850,22-T-104,Methods to Rescue Light Sensitivity in Retinas After Photoreceptor Degeneration,,,*United States,US,,,,,22-T-104-002,Small,7/2/2021,6/17/2022,No,6/23/2022,Prosecution by Other Party,,,UNIA 21.15 NP,"Francisco Bezanilla, Joao Carvalho-de-Souza",US Utility,6/17/2022,,,"Cox, Ben",Francisco Bezanilla,"Juggernauth, Anne",7464949,,6583300,
4851,22-T-106,Granulobot: a modular and morphable robotic platform,,,*United States,US,,,,,22-T-106-001,Small,6/9/2022,,,6/9/2022,,,,,"Heinrich Jaeger, Baudouin Saintyves",Provisional,6/9/2022,,,"Hwang, Luke",Heinrich Jaeger,"Juggernauth, Anne",7428999,,6591875,
4852,22-T-107,Nucleic Acid-Derivatized Therapeutics,"63/277,987", ,*United States,US,11/10/2021,, ,11/10/2021,22-T-107-001,Small,11/10/2021,1/10/2022,No,5/11/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",21-1328-US-PRO,"Lev Becker, Kasturi Chakraborty, Chang Cui, Yamuna Krishnan",Provisional,1/10/2022, ,11/10/2022,"Sun, Han",Lev Becker,"Tennant, Thelma",6570969,,6592333,No
4853,22-T-108,Fiber-integrated bi-directional microwave-optical transducer based on rare-earth-ion doped thin films,,,*United States,US,,,,,22-T-108-001,Small,3/14/2022,3/14/2022,,5/31/2022,Authorized,Foley Hoag LLP,,UCT-00160,Tian Zhong,Provisional,3/14/2022,,,"Cox, Ben",Tian Zhong,"Juggernauth, Anne",6929591,,6640577,
4854,22-T-110,Porcine pancreatic elastase Fc fusion protein,"63/299,201", ,*United States,US,1/13/2022,, ,1/13/2022,22-T-110-001,Small,1/13/2022,,,5/26/2022,Pending,,, ,"Lev Becker, Ramesh Bhatt, Sonia Feau, Ingrid Joseph, Christopher Twitty",Provisional,1/26/2022, ,1/13/2023,"Sun, Han",Lev Becker,"Tennant, Thelma",6712371,,6699388,No
4855,22-T-111,Engineered tRNA and Methods of Use,"63/354,364",,*United States,US,6/22/2022,,,6/22/2022,22-T-111-001,Small,4/27/2022,6/23/2022,,6/23/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0781US.P1,"Christopher Katanski, Tao Pan",Provisional,4/27/2022,,6/22/2023,"Dembo, Anna",Tao Pan,"Tennant, Thelma",7146165,,6720948,
4856,22-T-115,A clinical isolated avirulent strain protects against wildtype  virulent Clostridioides difficile infection,"63/347,268",,*United States,US,5/31/2022,,,5/31/2022,22-T-115-001,Small,5/31/2022,5/31/2022,,6/22/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0771US.P1,"Qiwen Dong, Eric Pamer",Provisional,5/31/2022,,5/31/2023,"Dembo, Anna",Eric Pamer,"Onishi, Kenneth",7343597,,6747439,
4857,22-T-118,Methods to predict clinical outcomes in patients with hypothyroidism,,,*United States,US,,,,,22-T-118-001,Small,4/8/2022,4/8/2022,,6/15/2022,Authorized,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",22-0530-US-PRO,"Antonio Bianco, Matthew Ettleson",Provisional,4/8/2022,,,"Peace, Shane",Antonio Bianco,"Tennant, Thelma",7049819,,6763307,
4858,22-T-121,Optically Addressable Molecular-Spin Qubit Diluted in a Host Matrix,"63/269,186", ,*United States,US,3/11/2022,, ,3/11/2022,22-T-121-001,Small,,3/14/2022,,5/31/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",727706,"David Awschalom, Sam Bayliss, Pratiti Deb, Danna Freedman, Giulia Galli, Daniel Laorenza, Mykyta Onizhuk",Provisional,3/2/2022, ,3/11/2023,"Cox, Ben",David Awschalom,"Juggernauth, Anne",6876943,,6808402,No
4859,22-T-122,Methods for the Controlled Synthesis of Layered Lithium and Sodium Transition Metal Oxides Using Electrochemically Assisted Ion-Exchange,"63/315,698", ,*United States,US,3/2/2022,, ,3/2/2022,22-T-122-001,Small,3/2/2022,3/2/2022,,4/28/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0053-PV,"Yu Han, Chong Liu",Provisional,3/2/2022, ,3/2/2023,"Hwang, Luke",Chong Liu,"Juggernauth, Anne",6874610,,6809351,No
4860,22-T-123,TMW Center NorthStar,,,*United States,US,,,,,22-T-123-001,Small,3/30/2022,3/30/2022,,3/30/2022,Authorized,Foley Hoag LLP,"Huestis, Erik",UCT-00260,"Snigdha Gupta, Arnoldo Muller-Molina, Dana Suskind",Provisional,3/30/2022,,,"Ramirez, Mario Riojas",Dana Suskind,"Juggernauth, Anne",6993372,,6809955,
4861,22-T-124,Methods of Differentiating a Malignant Tumor from a Benign Tumor,"63/315,152", ,*United States,US,3/1/2022,, ,3/1/2022,22-T-124-001,Small,3/1/2022,3/2/2022,,5/31/2022,Pending,"Leydig, Voit & Mayer, Ltd.","Spenner, Jonathan",759649,"Ayman Al-Hendy, Hiba Alkelani",Provisional,3/2/2022, ,3/1/2023,"Peace, Shane",Ayman Al-Hendy,"Tennant, Thelma",6874431,,6819235,No
4862,22-T-125,Immune potentiators and PRR agonists to enhance immune response,"63/278,020", ,*United States,US,11/10/2021,, ,11/10/2021,22-T-125-001,Small,11/10/2021,2/21/2022,,5/2/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0755US.P1,Aaron Esser-Kahn,Provisional,2/21/2022, ,11/10/2022,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",6828970,,6825735,No
4863,22-T-133,Decr2 regulates tumor cell ferroptosis and is required for immunotherapy efficacy,,,*United States,US,,,,,22-T-133-001,Small,,,,5/31/2022,,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",,"Thomas Gajewski, Shuyin Li",Provisional,5/9/2022,,,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",7232004,,6883652,
4864,22-T-134,Methods of inducing neoantigens in tumors,,,*United States,US,,,,,22-T-134-001,Small,4/27/2022,,,5/20/2022,,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0773US.P1,"Jeffrey Hubbell, Maria Montiel, Joshua Rosenthal, Lisa Volpatti, John-Michael Williford",Provisional,4/27/2022,,,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7149176,,6914636,
4865,22-T-136,Flux Bias Line for a Three-Dimensional Microwave Cavity,"63/269,312",,*United States,US,3/14/2022,,,3/14/2022,22-T-136-001,Small,3/15/2022,3/14/2022,,6/22/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",727940,"Riju Banerjee, David Schuster",Provisional,3/15/2022,,3/14/2023,"Cox, Ben",David Schuster,"Juggernauth, Anne",6930635,,6926570,No
4866,22-T-137,Inorganic Porous Coatings and Methods of Making the Same,"17/833,841",,*United States,US,6/6/2022,,,6/6/2022,22-T-137-001,None,6/6/2022,6/15/2022,,6/15/2022,Prosecution by Other Party,,,,"Supratik Guha, Cheng Li, Elena Shevchenko, Zhongbo Zhang",US Utility,6/15/2022,,,"Cox, Ben",Supratik Guha,"Juggernauth, Anne",7451275,,6926712,
4867,22-T-138,Optical Cavity Array,"63/364,678",,*United States,US,5/13/2022,,,5/13/2022,22-T-138-001,Small,4/15/2022,5/16/2022,,5/26/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",728227,"David Schuster, Jonathan Simon",Provisional,4/15/2022,,5/13/2023,"Cox, Ben",Jonathan Simon,"Juggernauth, Anne",7086271,,6933609,
4868,22-T-140,The TET/TDG-mediated 5mC sequencing,,,*United States,US,,,,,22-T-140-001,None,5/11/2022,5/11/2022,,6/15/2022,Authorized,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0769US.P1,"Chuan He, Qinzhe Liu, Weixin Tang, Pingluan Wang",Provisional,5/11/2022,,,"Hwang, Luke",Chuan He,"Tennant, Thelma",7239298,,6934043,
4869,22-T-141,Evolved TadA-assisted N6-methyladenosine sequencing (eTAM-seq),,,*United States,US,,,,,22-T-141-001,Small,4/6/2022,5/3/2022,,6/22/2022,Authorized,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0764US.P1,"Mengjie Chen, Chuan He, Shun Liu, Weixin Tang, Yulan Xiao",Provisional,4/6/2022,,,"Hwang, Luke",Weixin Tang,"Tennant, Thelma",7041308,,6934266,
4870,22-T-142,Cancer vaccines with direct adjuvant binding,,,*United States,US,,,,,22-T-142-001,Small,5/4/2022,,,6/15/2022,,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0774US.P1,"Claudia Battistella, Levi Bennish, Jeffrey Hubbell, Anna Slezak",Provisional,5/4/2022,,,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7211031,,6934388,
4871,22-T-146,Polymeric Immunopotentiators and Methods of Use,"63/343,176",,*United States,US,5/18/2022,,,5/18/2022,22-T-146-001,Small,4/1/2022,5/18/2022,,6/21/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0768US.P1,"Aaron Esser-Kahn, Naorem Nihesh",Provisional,4/1/2022,,5/18/2023,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",7021575,,6962292,
4872,22-T-147,Microbiome Metabolite Profile,,,*United States,US,,,,,22-T-147-001,Small,5/12/2022,5/12/2022,,5/31/2022,,"Casimir Jones, S.C.","Staple, David",,"Nick Dylla, Eric Pamer, Matthew Stutz",Provisional,5/12/2022,,,"Dembo, Anna",Eric Pamer,"Onishi, Kenneth",7244814,,6962398,
4873,22-T-153,Chemical screen of modulators for vaccine adjuvants,"63/347,438",,*United States,US,5/31/2022,,,5/31/2022,22-T-153-001,Small,,6/1/2022,,6/23/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0770US.P1,"Aaron Esser-Kahn, Jeremiah Kim, Matthew Rosenberger",Provisional,5/24/2022,22-T-153-001,5/31/2023,"Sun, Han",Aaron Esser-Kahn,"Tennant, Thelma",7309223,,6991168,
4874,22-T-154,VACCINE TO PROTECT AGAINST TOXOPLASMOSIS USING (1) NOVEL PEPTIDE AND (2) TARGETTED TRL7 MANNOSE BRIDGES,,,*United States,US,,,,,22-T-154-001,Small,6/16/2022,,,6/17/2022,,"Casimir Jones, S.C.","Staple, David",40174.101,"Peter Burkhard, Kamal El Bissati, Jeffrey Hubbell, Rima McLeod, Ying Zhou",Provisional,6/16/2022,,,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",7456668,,6991258,
4875,22-T-156,Iterative synthesis strategy to fabricate monodisperse graphene nanoribbons (GNRs),"63/349,811",,*United States,US,6/7/2022,,,6/7/2022,22-T-156-001,Small,6/7/2022,6/9/2022,,6/22/2022,Pending,"Bell & Manning, LLC","Manning, Michelle",05400-0055-PV,"Guangbin Dong, Daniel Pyle, Jiangliang Yin",Provisional,6/9/2022,,6/7/2023,"Hwang, Luke",Guangbin Dong,"Juggernauth, Anne",7426516,,6991402,
4876,22-T-164,REFRACTIVE INDEX MATCHING OF VO2 NANOPARTICLES BY GRADIENT COPOLYMERS FOR TRANSPARENT SMART WINDOW FILMS,,,*United States,US,,,,,22-T-164-001,Small,5/23/2022,5/24/2022,,6/9/2022,Authorized,"Wolf, Greenfield & Sacks, P.C.","Blackwell, Brandon",C1604.70003US00,"Sovan Banerjee, Wei Chen, Matthew Tirrell",Provisional,5/23/2022,,,"Peace, Shane",Matthew Tirrell,"Tennant, Thelma",7291984,,7022372,
4877,22-T-166,All-trans retinoic acid enhances radiotherapy and overcomes immune suppression for cancer therapy,"63/348,745",,*United States,US,6/3/2022,,,6/3/2022,22-T-166-001,Small,5/2/2022,6/3/2022,,6/24/2022,Pending,Jenkins Wilson Taylor & Hunt P.A.,"Taylor, Arles",3072/23 PROV,"Yingying Li, Hua Liang, Wenbin Lin, Ralph Weichselbaum",Provisional,5/2/2022,,6/3/2023,"Hwang, Luke",Wenbin Lin,"Tennant, Thelma",7203760,,7036622,
4878,22-T-174,Prodrug Polymeric Micelles for Use in the Promotion of Gut Health and the Treatment of Immune and/or Inflammatory Conditions and Food Allergy,"63/329,913", ,*United States,US,4/12/2022,, ,4/12/2022,22-T-174-001,Small,4/8/2022,4/13/2022,,5/31/2022,Pending,"Casimir Jones, S.C.","Staple, David",UCHI-40756.101,"Mohamed Bashir, Shijie Cao, Jeffrey Hubbell, Cathryn Nagler",Provisional,4/8/2022, ,4/12/2023,"Peace, Shane",Cathryn Nagler,"Tennant, Thelma",7051127,,7043043,No
4879,22-T-175,Modulation of m6A RNA methylation via YTHDF2 improves radio- and immune-therapy,,,*United States,US,,,,,22-T-175-001,Small,5/20/2022,,,6/21/2022,,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Chuan He, Hua Liang, Liangliang Wang, Ralph Weichselbaum, Linda Zhang",Provisional,5/20/2022,,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",7275655,,7043169,
4880,22-T-182,Targeted Nanomedicine for Treating Arterial Disease,"63/353,468",,*United States,US,6/17/2022,,,6/17/2022,22-T-182-001,Small,5/20/2022,5/24/2022,,6/21/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",22-0857-US-PRO,Yun Fang,Provisional,5/20/2022,,,"Peace, Shane",Yun Fang,"Tennant, Thelma",7277678,,7107151,
4881,22-T-183,Targeted Nanomedicine for Treating Lung Disorders,"63/353,467",,*United States,US,6/17/2022,,,6/17/2022,22-T-183-001,Small,5/20/2022,5/24/2022,,6/21/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",22-0856-US-PRO,Yun Fang,Provisional,5/20/2022,,,"Peace, Shane",Yun Fang,"Tennant, Thelma",7276528,,7107275,
4882,22-T-186,ERROR DETECTION AND REPAIR IN MAGNETIC RESONANCE DIFFUSION MEASUREMENTS,"63/339,096",,*United States,US,5/6/2022,,,5/6/2022,22-T-186-001,Small,5/6/2022,5/16/2022,,6/23/2022,Pending,"Bell & Manning, LLC","Kalafut, Christopher",05400-0054-PV,"Aritrick Chatterjee, Xiaobing Fan, Gregory Karczmar, Milica Medved, Aytekin Oto, Jay Pittman",Provisional,5/16/2022,,5/6/2023,"Cox, Ben",Gregory Karczmar,"Juggernauth, Anne",7253534,,7232061,
4883,22-T-187,Multi-Function Catheter and Methods for Diagnosis and/or Treatment of Venous Thromboembolic Disease,"63/345,169",,*United States,US,5/24/2022,,,5/24/2022,22-T-187-001,Small,5/18/2022,5/24/2022,,5/24/2022,Pending,Norton Rose Fulbright US LLP,"Robinson, Eagle",ARCD.P0728US.P2,"Osmanuddin Ahmed, Tyler Panian, Jonathan Paul",Provisional,5/18/2022,,5/24/2023,"Cox, Ben",Jonathan Paul,"Juggernauth, Anne",7262393,,7233449,
4884,22-T-188,Boosting NISQ-era Quantum Fidelity with Ordered Diverse Ensemble of Resources,,,*United States,US,,,,,22-T-188-001,Small,6/9/2022,6/9/2022,,6/24/2022,Authorized,Armstrong Teasdale,"Brennan, Patrick",37997-103,"Frederic Chong, Gokul Subramanian Ravi",Provisional,6/9/2022,,,"Cox, Ben",Gokul Subramanian Ravi,"Smith, Dane",7423651,,7233452,
4885,22-T-189,COMPOSITIONS AND METHODS FOR TREATING CANCER AND VIRAL INFECTIONS,"63/334,610",,*United States,US,4/25/2022,,,4/25/2022,22-T-189-001,Small,4/25/2022,,,6/13/2022,Pending,Mcdonnell Boehnen Hulbert & Berghoff LLP,"Conour, John",22-0712-US-PRO,"Theint Aung, Jeffrey Hubbell, Aslan Mansurov, Juan Mendoza",Provisional,5/31/2022,,4/25/2023,"Sun, Han",Juan Mendoza,"Tennant, Thelma",7349673,,7269197,
4886,22-T-191,Zero Burden Universal Screening Algorithms for Complex Diseases,"63/353,236",,*United States,US,6/17/2022,,,6/17/2022,22-T-191-001,Small,6/9/2022,6/17/2022,,6/17/2022,Pending,Armstrong Teasdale,"Brennan, Patrick",37997-104,Ishanu Chattopadhyay,Provisional,6/9/2022,,6/17/2023,"Ramirez, Mario Riojas",Ishanu Chattopadhyay,"Smith, Dane",7426329,,7269816,
4887,22-T-192,NTCP Targeting Polypeptides and Methods for Use,"63/347,796",,*United States,US,6/1/2022,,,6/1/2022,22-T-192-001,Small,5/19/2022,6/1/2022,,6/2/2022,Pending,Norton Rose Fulbright US LLP,"Bruner, Kyle",ARCD.P0777US.P1,"Anthony Kossiakoff, Kaspar Locher",Provisional,5/19/2022,,6/1/2023,"Dembo, Anna",Anthony Kossiakoff,"Tennant, Thelma",7273960,,7272302,
4888,22-T-195,Multi-Element Atom Array,"63/365,310",,*United States,US,5/25/2022,,,5/25/2022,22-T-195-001,Small,5/24/2022,5/27/2022,,6/22/2022,Pending,Lathrop GPM LLP,"Vock, Curtis",730188,"Shraddha Anand, Hannes Bernien, Kevin Singh",Provisional,5/24/2022,,5/25/2023,"Cox, Ben",Hannes Bernien,"Juggernauth, Anne",7307907,,7306207,
4889,22-T-196,Developing a universal quantification of expression (UniQE) system for cost-effective TaqMan qPCR analysis of coding and noncoding RNAs through machine learning,,,*United States,US,,,,,22-T-196-001,Small,5/25/2022,6/6/2022,,6/17/2022,Authorized,"Casimir Jones, S.C.","Staple, David",UCHI-39811.102,Tong-Chuan He,Provisional,5/25/2022,,,"Sun, Han",Tong-Chuan He,"Tennant, Thelma",7316641,,7311198,
4890,22-T-200,Antigen tolerance induction through use of Flt3L variants,"63/348,877",,*United States,US,6/3/2022,,,6/3/2022,22-T-200-001,Small,,6/6/2022,,6/10/2022,Pending,Norton Rose Fulbright US LLP,"Stellman, Laurie",ARCD.P0782US.P1,"Aaron Alpar, Jeffrey Hubbell, Rachel Wallace",Provisional,6/3/2022,,6/3/2023,"Peace, Shane",Jeffrey Hubbell,"Tennant, Thelma",7381884,,7378704,
4891,22-T-208,Computational Models to Analyze RNA Velocity,"63/299,752",,*United States,US,1/14/2022,,,1/14/2022,22-T-208-001,Small,6/17/2022,6/17/2022,,6/17/2022,Pending,Norton Rose Fulbright US LLP,"Shishima, Gina",ARCD.P0760US.P1,Samantha Riesenfeld,Provisional,6/17/2022,,1/14/2023,"Ramirez, Mario Riojas",Samantha Riesenfeld,"Juggernauth, Anne",7466035,,7465879,
4892,73-T-001,Radiant Energy Collection,"05/429,161","3,923,381",*United States,US,12/28/1973,12/2/1975, ,12/28/1973,0002-001,None,12/28/1973,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,Roland Winston,US Utility,4/12/2018,0002-001,12/28/1993,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",614261,,581106,Yes
4893,73-T-001,Radiant Energy Collection,"05/613,577","4,003,638",*United States,US,12/28/1973,1/18/1977, ,9/15/1975,0002-002,None,12/28/1973,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,Roland Winston,Continuation in Part,4/12/2018,0002-002,1/18/1994,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",614262,,581106,Yes
4894,75-T-001,Polysaccharide for Enhancement of Cardiac Output,"05/710,699","4,154,822",*United States,US,8/2/1976,5/15/1979, ,8/2/1976,0001-001,None,8/2/1976,,Yes,4/28/2022,Expired - Inactive,,, ,"Jafar Al-Sadir, Anthony Cutilletta, Philip Polimeni, Ralph Weichselbaum",US Utility,4/12/2018,0001-001,5/15/1996,"Dembo, Anna",Philip Polimeni,"Tennant, Thelma",614123,,581109,Yes
4895,77-T-001,Acylated Dopamine Derivatives,"06/295,478", ,*United States,US,8/24/1981,, ,8/24/1981,0006-002,None,3/1/1978,,No,4/28/2022,Abandoned,,, ,"Joseph Cannon, Leon Goldberg, John Long",US Utility,4/12/2018,0006-002,,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",610254,,581110,Yes
4896,77-T-001,Acylated Dopamine Derivatives,"06/379,585", ,*United States,US,8/24/1981,, ,5/19/1982,0006-003,None,3/1/1978,,No,4/28/2022,Abandoned,,, ,"Joseph Cannon, Leon Goldberg, John Long",Continuation in Part,4/12/2018,0006-003,,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",610255,,581110,Yes
4897,77-T-001,Acylated Dopamine Derivatives,"06/496,155", ,*United States,US,8/24/1981,, ,5/19/1983,0006-004,None,3/1/1978,,No,4/28/2022,Abandoned,,, ,"Joseph Cannon, Leon Goldberg, John Long",Continuation in Part,4/12/2018,0006-004,,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",610256,,581110,Yes
4898,77-T-001,Renal Blood with Dopamine,"05/882,353","4,219,568",*United States,US,3/1/1978,8/26/1980, ,3/1/1978,0006-001,None,3/1/1978,,Yes,4/28/2022,Expired - Inactive,,, ,"Joseph Cannon, Leon Goldberg, John Long",US Utility,4/12/2018,0006-001,3/1/1998,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614392,,581110,Yes
4899,77-T-002,Quaternary Derivatives of Noroxymorphone Which Relieve Intestinal Immobility,"05/928,821","4,176,186",*United States,US,7/28/1978,11/27/1979, ,7/28/1978,0006.1-001,None,7/28/1978,,Yes,4/28/2022,Expired - Inactive,,, ,"Leon Goldberg, Herbert Merz, Jonathan Moss, Klaus Stockhaus",US Utility,4/12/2018,0006.1-001,7/28/1998,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",614256,,581111,Yes
4900,78-T-003,Methods and Materials for Detection of Estrophilin,"05/945,000","4,232,001",*United States,US,9/22/1978,11/4/1980, ,9/22/1978,0107-001,None,9/22/1978,,Yes,4/28/2022,Expired - Inactive,,, ,"Eugene DeSombre, Elwood Jensen",US Utility,4/12/2018,0107-001,9/22/1998,"Unassigned, Unassigned",Elwood Jensen,"Unassigned, Unassigned",613118,,581115,Yes
4901,79-T-001,Food Materials for Prevention of Carious Degradation of Teeth,"06/046,314", ,*United States,US,6/7/1979,, ,6/7/1979,0110-001,None,6/7/1979,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Frank Besic,US Utility,4/12/2018,0110-001,,"Unassigned, Unassigned",Frank Besic,"Unassigned, Unassigned",611607,,581116,Yes
4902,79-T-001,Food Materials for Prevention of Carious Degradation of Teeth,"06/533,750","4,515,770",*United States,US,6/7/1979,5/7/1985, ,9/19/1983,0110-003,None,6/7/1979,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Frank Besic,Divisional,4/12/2018,0110-003,9/20/2000,"Unassigned, Unassigned",Frank Besic,"Unassigned, Unassigned",611608,,581116,Yes
4903,79-T-001,Methods and Materials for Prevention of Carious Degradation of Teeth,"06/139,199","4,405,600",*United States,US,6/7/1979,9/20/1983, ,4/11/1980,0110-002,None,6/7/1979,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Frank Besic,Continuation in Part,4/12/2018,0110-002,9/20/2000,"Unassigned, Unassigned",Frank Besic,"Unassigned, Unassigned",613121,,581116,Yes
4904,79-T-006,Sextupole System for the Correction of Spherical Aberration,"06/088,224","4,303,864",*United States,US,10/25/1979,12/1/1981, ,10/25/1979,0116-001,None,10/25/1979,,Yes,4/28/2022,Expired - Inactive,,, ,"Albert Crewe, David Kopf",US Utility,4/12/2018,0116-001,10/25/1999,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",614489,,581121,Yes
4905,79-T-008,Estrophilin Detection,"06/037,631","4,293,536",*United States,US,5/10/1979,10/6/1981, ,5/10/1979,0115-001,None,5/10/1979,,Yes,4/28/2022,Expired - Inactive,,, ,"Verne Hospelhorn, Elwood Jensen",US Utility,4/12/2018,0115-001,5/10/1999,"Unassigned, Unassigned",Elwood Jensen,"Unassigned, Unassigned",611539,,581123,Yes
4906,79-T-010,Energy Transmission,"05/628,383", ,*United States,US,11/3/1975,, ,11/3/1975,0009-001,None,11/3/1975,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Roland Winston,US Utility,4/12/2018,0009-001,,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611526,,581125,Yes
4907,79-T-010,Energy Transmission,"05/641,557","4,240,692",*United States,US,11/3/1975,12/23/1980, ,12/17/1975,0009-002,None,11/3/1975,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,Roland Winston,Continuation in Part,4/12/2018,0009-002,12/23/1997,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611527,,581125,Yes
4908,79-T-011,Compound Parabolic Concentrator with Cavity for Tubular Absorbers,"06/230,137","4,387,961",*United States,US,1/18/1980,6/14/1983, ,1/30/1981,0118-002,None,1/18/1980,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,Roland Winston,Continuation,4/12/2018,0118-002,6/14/2000,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611234,,581126,Yes
4909,79-T-011,Parabolic Concentrator,"06/113,169", ,*United States,US,1/18/1980,, ,1/18/1980,0118-001,None,1/18/1980,,Yes,4/28/2022,Abandoned,,, ,Roland Winston,US Utility,4/12/2018,0118-001,,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613885,,581126,Yes
4910,79-T-013,Stereocontrolled synthesis of .alpha.-multistriatin,"05/803,734","4,108,870",*United States,US,6/6/1977,8/22/1978, ,6/6/1977,0007-001,None,6/6/1977,,Yes,4/28/2022,Expired - Inactive,,, ,"William Elliott, Josef Fried",US Utility,4/12/2018,0007-001,6/6/1997,"Unassigned, Unassigned",Josef Fried,"Unassigned, Unassigned",614633,,581128,Yes
4911,80-T-001,Certain Fluorine Substituted PGI.sub.2 Compounds,"06/195,291","4,324,730",*United States,US,10/10/1979,4/13/1982, ,10/8/1980,0106-003,None,10/10/1979,,Yes,4/28/2022,Expired - Inactive,,, ,Josef Fried,Continuation in Part,4/12/2018,0106-003,10/8/1981,"Unassigned, Unassigned",Josef Fried,"Unassigned, Unassigned",610823,,581131,Yes
4912,80-T-001,Chemical Synthesis,"06/259,740","4,456,768",*United States,US,10/10/1979,6/26/1984, ,5/1/1981,0106-004,None,10/8/1980,,No,4/28/2022,Expired - Inactive,,, ,Josef Fried,Continuation in Part,4/12/2018,0106-004,6/26/2001,"Unassigned, Unassigned",Josef Fried,"Unassigned, Unassigned",610862,,581131,Yes
4913,80-T-001,Florine Substituted PG12 Compounds,"06/083,398", ,*United States,US,10/10/1979,, ,10/10/1979,0106-001,None,10/10/1979,,Yes,4/28/2022,Abandoned,,, ,Josef Fried,US Utility,4/12/2018,0106-001,,"Unassigned, Unassigned",Josef Fried,"Unassigned, Unassigned",611601,,581131,Yes
4914,80-T-001,Florine Substituted PG12 Compounds,"06/108,525", ,*United States,US,10/10/1979,, ,12/31/1979,0106-002,None,10/10/1979,,No,4/28/2022,Abandoned,,, ,Josef Fried,Continuation in Part,4/12/2018,0106-002,,"Unassigned, Unassigned",Josef Fried,"Unassigned, Unassigned",611602,,581131,Yes
4915,80-T-004,Enhancement of Expression of Protein Synthesis in E. Coli,"06/523,904","4,590,159",*United States,US,8/21/1981,5/20/1986, ,8/17/1983,0123-002,None,8/21/1981,,No,4/28/2022,Abandoned,,, ,"Marc Charette, Alvin Markovitz, Joyce Schoemaker, Barbara Zehnbauer",Continuation,4/12/2018,0123-002,5/20/2003,"Unassigned, Unassigned",Alvin Markovitz,"Unassigned, Unassigned",611533,,581134,Yes
4916,80-T-004,Protein Synthesis in E. Coli,"06/259,121", ,*United States,US,8/21/1981,, ,8/21/1981,0123-001,None,8/21/1981,,Yes,4/28/2022,Abandoned,,, ,"Marc Charette, Alvin Markovitz, Joyce Schoemaker, Barbara Zehnbauer",US Utility,4/12/2018,0123-001,,"Unassigned, Unassigned",Alvin Markovitz,"Unassigned, Unassigned",614222,,581134,Yes
4917,80-T-005,Recombinant Materials and Methods,"06/302,497", ,*United States,US,9/16/1981,, ,9/16/1981,0124-001,None,9/16/1981,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",5950,"Leonard Post, Bernard Roizman",US Utility,4/12/2018,0124-001,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614352,,581135,Yes
4918,80-T-005,Recombinant Methods and Materials,"06/690,369","4,769,331",*United States,US,9/16/1981,9/6/1988, ,1/9/1985,0124-002,None,9/16/1981,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,"Leonard Post, Bernard Roizman",Continuation,4/12/2018,0124-002,9/6/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614353,,581135,Yes
4919,80-T-005,Recombinant Methods and Materials,"07/016,510", ,*United States,US,9/16/1981,, ,3/2/1987,0124-003,None,1/9/1985,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Zeller, James", ,"Leonard Post, Bernard Roizman",Divisional,4/12/2018,0124-003,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614354,,581135,Yes
4920,80-T-005,Recombinant Methods and Materials,87/0818, ,South Africa,ZA,9/16/1981,, ,2/4/1987,0124-004,None,1/9/1985,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,"Leonard Post, Bernard Roizman",Nationalized PCT,4/12/2018,0124-004,2/4/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614355,,581135,Yes
4921,80-T-005,Recombinant Methods and Materials,585126,585126,Australia,AU,9/16/1981,, ,2/4/1987,0124-005,None,1/9/1985,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,"Leonard Post, Bernard Roizman",Nationalized PCT,4/12/2018,0124-005,2/4/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614356,,581135,Yes
4922,81-T-003,Corrector for Axial Aberrations in Electron Optic Instruments,"06/349,442","4,414,474",*United States,US,2/17/1982,11/8/1983, ,2/17/1982,0130-001,None,2/17/1982,,Yes,4/28/2022,Abandoned,,, ,Albert Crewe,US Utility,4/12/2018,0130-001,2/17/2002,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",611346,,581140,Yes
4923,81-T-004,Monoclonal Anti-Erythropoietin,"06/417,429","4,558,005",*United States,US,9/13/1982,12/10/1985, ,9/13/1982,0129-001,None,9/13/1982,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Eugene Goldwasser, Clifford Kavinsky, Tania Weiss",US Utility,4/12/2018,0129-001,12/10/2002,"Unassigned, Unassigned",Eugene Goldwasser,"Unassigned, Unassigned",613520,,581141,Yes
4924,81-T-006,Prostaglandin PGF2A Antagonist,"06/361,824", ,*United States,US,3/25/1982,, ,3/25/1982,0132-001,None,3/25/1982,,Yes,4/28/2022,Abandoned,,, ,"Josef Fried, Leon Goldberg, Jai Kohli",US Utility,4/12/2018,0132-001,,"Unassigned, Unassigned",Josef Fried,"Unassigned, Unassigned",614204,,581143,Yes
4925,81-T-007,Method of Antagonizing PGF2,"06/523,026", ,*United States,US,8/15/1983,, ,8/15/1983,0132.1-001,None,8/15/1983,,Yes,4/28/2022,Abandoned,,, ,Leon Goldberg,US Utility,4/12/2018,0132.1-001,,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",612516,,581144,Yes
4926,81-T-012,Method and Apparatus for Detection of Fertility,"06/375,883","4,534,362",*United States,US,5/7/1982,8/13/1985, ,5/7/1982,0137-001,None,5/7/1982,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,"Gebhard Schumacher, Stephen Usala",US Utility,4/12/2018,0137-001,8/13/2002,"Unassigned, Unassigned",Gebhard Schumacher,"Unassigned, Unassigned",612292,,581149,Yes
4927,81-T-013,Volumetric Samplings of Vaginal Secretions,PCT/US83/00680, ,*United States,US,5/6/1983,, ,5/6/1983,0138-001,None,5/7/1982,,No,4/28/2022,Expired - Inactive,,, ,"Gebhard Schumacher, Stephen Usala",PCT,4/12/2018,0138-001,11/7/1984,"Unassigned, Unassigned",Gebhard Schumacher,"Unassigned, Unassigned",615390,,581150,Yes
4928,82-T-001,Sensor Array for Toxic Gas Detection,"06/585,699","4,670,405",*United States,US,3/2/1984,6/2/1987, ,3/2/1984,82-045-001,Small,3/2/1984,,Yes,4/28/2022,Expired - Inactive,,, ,"Melvin Findlay, William Penrose, Joseph Stetter, Solomon Zaromb",US Utility,4/12/2018,82-045-001,6/2/2004,"Unassigned, Unassigned",Joseph Stetter,"Unassigned, Unassigned",614481,,580946,Yes
4929,82-T-003,Peptide Hormones with Calcitonin-Like Activity,"06/509,123","4,514,331",*United States,US,6/29/1983,4/30/1985, ,6/29/1983,0139-001,None,6/29/1983,,Yes,4/28/2022,Expired - Inactive,,, ,"Emil Kaiser, Gregory Moe",US Utility,4/12/2018,0139-001,6/29/2003,"Unassigned, Unassigned",Emil Kaiser,"Unassigned, Unassigned",613912,,581151,Yes
4930,82-T-004,Radioiodine Labeling During Protein Synthesis,"06/021,103","4,260,737",*United States,US,3/16/1979,4/7/1981, ,3/16/1979,0008-001,Small,3/16/1979,,Yes,4/28/2022,Expired - Inactive,,, ,Neal Scherberg,US Utility,4/12/2018,0008-001,3/16/1999,"Unassigned, Unassigned",Neal Scherberg,"Unassigned, Unassigned",614267,,581152,Yes
4931,82-T-004,Radioiodine Labeling During Protein Synthesis,"06/207,516","4,383,033",*United States,US,3/16/1979,5/10/1983, ,11/17/1980,0008-002,Small,3/16/1979,,No,4/28/2022,Expired - Inactive,,, ,Neal Scherberg,Divisional,4/12/2018,0008-002,5/10/2000,"Unassigned, Unassigned",Neal Scherberg,"Unassigned, Unassigned",614268,,581152,Yes
4932,82-T-006,Anti-Bacterial Peptides,"06/461,048", ,*United States,US,1/26/1983,, ,1/26/1983,0141-001,None,1/26/1983,,Yes,4/28/2022,Abandoned,,, ,Michael Johnston,US Utility,4/12/2018,0141-001,,"Unassigned, Unassigned",Michael Johnston,"Unassigned, Unassigned",610366,,581154,Yes
4933,82-T-006,Antibacterial Peptides,"06/684,763", ,*United States,US,1/26/1983,, ,12/21/1984,0141-002,None,1/26/1983,,No,4/28/2022,Abandoned,,, ,Michael Johnston,Continuation in Part,4/12/2018,0141-002,,"Unassigned, Unassigned",Michael Johnston,"Unassigned, Unassigned",610384,,581154,Yes
4934,82-T-009,Ion Beam Microlithography,"06/496,788", ,*United States,US,5/23/1983,, ,5/23/1983,0144-001,None,5/23/1983,,Yes,4/28/2022,Abandoned,,, ,"Paul LaMarche, Riccardo Levi-Setti",US Utility,4/12/2018,0144-001,,"Unassigned, Unassigned",Riccardo Levi-Setti,"Unassigned, Unassigned",612052,,581157,Yes
4935,83-T-001,Electrochemical Methane Sensor,"06/644,467","4,591,414",*United States,US,8/27/1984,5/27/1986, ,8/27/1984,83-033-001,None,8/27/1984,,Yes,4/28/2022,Expired - Inactive,,, ,"Takaaki Otagawa, Joseph Stetter, Solomon Zaromb",US Utility,4/12/2018,83-033-001,8/27/2004,"Unassigned, Unassigned",Joseph Stetter,"Unassigned, Unassigned",611516,,580948,Yes
4936,83-T-008,Multiple Sextupole System for the Correction of Third and Higher Order Aberration,"06/249,782","4,389,571",*United States,US,4/1/1981,6/21/1983, ,4/1/1981,0101-001,None,4/1/1981,,Yes,4/28/2022,Expired - Inactive,,, ,Albert Crewe,US Utility,4/12/2018,0101-001,4/1/2001,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",613567,,581161,Yes
4937,83-T-009,Vaccine against Epstein-Barr Virus,"06/575,352", ,*United States,US,1/30/1984,, ,1/30/1984,0150-001,Small,1/30/1984,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Chris Beisel, Mary Hummel, Elliott Kieff, Jerome Tanner",US Utility,4/12/2018,0150-001,,"Unassigned, Unassigned",Elliott Kieff,"Unassigned, Unassigned",615341,,581162,Yes
4938,83-T-009,Vaccine against Epstein-Barr Virus,"06/633,558","4,707,358",*United States,US,1/30/1984,11/17/1987, ,7/23/1984,0150-002,Small,1/30/1984,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,203,"Chris Beisel, Mary Hummel, Elliott Kieff, Jerome Tanner",Continuation in Part,4/12/2018,0150-002,11/17/2004,"Unassigned, Unassigned",Elliott Kieff,"Unassigned, Unassigned",615342,,581162,Yes
4939,83-T-011,Enhanced Absorption of Dietary Mineral Components,"06/769,533","4,689,228",*United States,US,8/26/1985,8/25/1987, ,8/26/1985,0155-001,None,8/26/1985,,Yes,4/28/2022,Abandoned,,"Hill, Philip", ,Irwin Rosenberg,US Utility,4/12/2018,0155-001,8/26/2005,"Unassigned, Unassigned",Irwin Rosenberg,"Unassigned, Unassigned",611532,,581164,Yes
4940,84-T-002,Cubane Derivatives,"07/112,231", ,*United States,US,5/23/1984,, ,10/21/1987,0157-002,None,5/23/1984,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"Graziano Castaldi, Philip Eaton",Continuation in Part,4/12/2018,0157-002,,"Ginsburg, Eric",Philip Eaton,"Juggernauth, Anne",611352,,581171,Yes
4941,84-T-002,Cubane Derivatives,"07/405,115", ,*United States,US,5/23/1984,, ,9/7/1989,0157-003,None,5/23/1984,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"Graziano Castaldi, Philip Eaton",Continuation in Part,4/12/2018,0157-003,,"Ginsburg, Eric",Philip Eaton,"Juggernauth, Anne",611353,,581171,Yes
4942,84-T-002,Cubane Derivatives,"07/787,768", ,*United States,US,5/23/1984,, ,11/6/1991,0157-004,None,5/23/1984,,No,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"Graziano Castaldi, Philip Eaton",Continuation in Part,4/12/2018,0157-004,,"Ginsburg, Eric",Philip Eaton,"Juggernauth, Anne",611354,,581171,Yes
4943,84-T-002,Cubylmetallics,"06/613,708", ,*United States,US,5/23/1984,, ,5/23/1984,0157-001,None,5/23/1984,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"Graziano Castaldi, Philip Eaton",US Utility,4/12/2018,0157-001,,"Ginsburg, Eric",Philip Eaton,"Juggernauth, Anne",611355,,581171,Yes
4944,84-T-011,Custom Valved Cervical Cap,"06/108,319","4,322,463",*United States,US,12/31/1979,3/30/1982, ,12/31/1979,0011-001,None,12/31/1979,,Yes,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp",US Utility,4/12/2018,0011-001,12/31/1999,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611356,,581180,Yes
4945,84-T-011,Custom Valved Cervical Cap,PCT/US80/01766, ,*United States,US,12/31/1979,, ,12/24/1980,0011-002,None,12/31/1979,,No,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp",PCT,4/12/2018,0011-002,6/30/1982,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611357,,581180,Yes
4946,84-T-011,Custom Valved Cervical Cap,"06/288,393","4,363,318",*United States,US,12/31/1979,12/14/1982, ,7/30/1981,0011-004,None,12/31/1979,,No,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp",Divisional,4/12/2018,0011-004,12/31/1999,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611358,,581180,Yes
4947,84-T-011,Custom Valved Cervical Cap,"06/310,493","4,467,789",*United States,US,12/31/1979,8/28/1984, ,10/13/1981,0011-005,None,12/31/1979,,Yes,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp",Divisional,4/12/2018,0011-005,8/28/2001,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611359,,581180,Yes
4948,84-T-011,Custom Valved Cervical Cap,"06/619,037","4,543,949",*United States,US,12/31/1979,10/1/1985, ,6/11/1984,0011-006,None,12/31/1979,,No,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp",Divisional,4/12/2018,0011-006,10/1/2002,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611360,,581180,Yes
4949,84-T-011,Implement for Making an Impression of the Cervix Uteri,"06/236,772","4,384,572",*United States,US,12/31/1979,5/24/1983, ,2/23/1981,0011-003,None,12/31/1979,,No,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp",Continuation in Part,4/12/2018,0011-003,5/24/2000,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611935,,581180,Yes
4950,84-T-012,Cervical Cap with Foam Lining,"06/122,541","4,320,751",*United States,US,12/19/1980,3/23/1982, ,12/19/1980,0011.1-001,None,12/19/1980,,Yes,4/28/2022,Expired - Inactive,,, ,Marvin Loeb,US Utility,4/12/2018,0011.1-001,12/19/2000,"Unassigned, Unassigned",Marvin Loeb,"Unassigned, Unassigned",610824,,581181,Yes
4951,84-T-013,Custom Valved Cervical Cap with Deformable Margin,"06/163,328","4,369,219",*United States,US,6/26/1980,1/18/1983, ,6/26/1980,0011.2-001,None,6/26/1980,,Yes,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp, Marvin Loeb",US Utility,4/12/2018,0011.2-001,6/26/2000,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611361,,581182,Yes
4952,84-T-013,Custom Valved Cervical Cap with Deformable Margin,"06/424,227","4,450,836",*United States,US,6/26/1980,5/29/1984, ,9/27/1982,0011.2-002,None,6/26/1980,,No,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp, Marvin Loeb",Divisional,4/12/2018,0011.2-002,5/29/2001,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611362,,581182,Yes
4953,84-T-014,Conforming Valved Cervical Cap Assembly and In-Situ Molding Method,"06/207,904","4,401,534",*United States,US,11/18/1980,8/30/1983, ,11/18/1980,0011.3-001,None,11/18/1980,,Yes,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp, Marvin Loeb",US Utility,4/12/2018,0011.3-001,11/18/2000,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611273,,581183,Yes
4954,84-T-014,Conforming Valved Cervical Cap Assembly and In-Situ Molding Method,"06/510,278","4,517,970",*United States,US,11/18/1980,5/21/1985, ,7/1/1983,0011.3-002,None,11/18/1980,,No,4/28/2022,Expired - Inactive,,, ,"Uwe Freese, Robert Goepp, Marvin Loeb",Divisional,4/12/2018,0011.3-002,5/21/2002,"Unassigned, Unassigned",Robert Goepp,"Unassigned, Unassigned",611274,,581183,Yes
4955,85-T-006,Formation of Thin Walled Ceramic Solid Oxide Fuel Cells,"07/174,146","4,883,497",*United States,US,3/28/1988,11/28/1989, ,3/28/1988,85-072-001,Large,3/28/1988,,Yes,4/28/2022,Expired - Inactive,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach","Rechtin, Michael", ,"Donald Busch, Terry Claar, John Picciolo",US Utility,4/12/2018,85-072-001,3/28/2008,"Unassigned, Unassigned",Terry Claar,"Unassigned, Unassigned",611609,,580958,Yes
4956,85-T-012,Amino Acyl Cephalosporin Derivatives,"06/835,280","4,783,443",*United States,US,3/3/1986,11/8/1988, ,3/3/1986,0170-001,None,3/3/1986,,Yes,4/28/2022,Abandoned,,, ,"Michael Johnston, Shahrair Mobashery",US Utility,4/12/2018,0170-001,3/3/2006,"Unassigned, Unassigned",Michael Johnston,"Unassigned, Unassigned",610305,,581189,Yes
4957,85-T-012,Cephalosporin Derivatives,PCT/US87/00399, ,*United States,US,3/3/1986,, ,2/27/1987,0170-002,None,3/3/1986,,No,4/28/2022,Abandoned,,, ,"Michael Johnston, Shahrair Mobashery",PCT,4/12/2018,0170-002,9/3/1988,"Unassigned, Unassigned",Michael Johnston,"Unassigned, Unassigned",610822,,581189,Yes
4958,86-T-001,Method for the Concentration and Separation of Actinides from Biological and Environmental Samples,"06/921,282","4,835,107",*United States,US,10/21/1986,5/30/1989, ,10/21/1986,86-019-001,None,10/21/1986,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Mark Dietz, Phil Horwitz",US Utility,4/12/2018,86-019-001,10/21/2006,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612506,,580959,Yes
4959,86-T-004,Electromagnetic Confinement for Vertical Casting or Containing Molten Metal,"07/259,387","4,982,796",*United States,US,10/18/1988,1/8/1991, ,10/18/1988,86-048-001,Large,10/18/1988,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,, ,"Robert Lari, Walter Praeg, Larry Turner",US Utility,4/12/2018,86-048-001,10/18/2008,"Unassigned, Unassigned",Larry Turner,"Unassigned, Unassigned",611517,,580962,Yes
4960,86-T-005,Sidewall Containment of Liquid Metal with Vertical Alternating Magnetic Fields,"07/207,818", ,*United States,US,6/17/1988,, ,6/17/1988,86-050-001,None,6/17/1988,,Yes,4/28/2022,Abandoned,,, ,"James Battles, John Hull, Robert Lari, Terence Martin, Walter Praeg, Donald Rote, Larry Turner",US Utility,4/12/2018,86-050-001,,"Unassigned, Unassigned",Larry Turner,"Unassigned, Unassigned",614511,,580963,Yes
4961,86-T-005,Sidewall Containment of Liquid Metal with Vertical Alternating Magnetic Fields,"07/408,418","4,974,661",*United States,US,6/17/1988,12/4/1990, ,9/18/1989,86-050-002,Large,6/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"James Battles, John Hull, Robert Lari, Walter Praeg, Donald Rote, Larry Turner",Continuation,4/12/2018,86-050-002,9/18/2009,"Unassigned, Unassigned",Larry Turner,"Unassigned, Unassigned",614512,,580963,Yes
4962,86-T-006,Apparatus for Efficient Sidewall Containment of Molten Metal with Horizontal Alternating Magnetic Fields Utilizing a Ferromagnetic Dam,"08/381,717","5,601,140",*United States,US,6/7/1990,2/11/1997, ,1/31/1995,86-063-021,Large,11/17/1988,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Continuation in Part,4/12/2018,86-063-021,11/17/2008,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",610535,,580964,Yes
4963,86-T-006,Apparatus for Efficient Sidewall Containment of Molten Metal with Horizontal Alternating Magnetic Fields Utilizing a Ferromagnetic Dam,"2,168,478", ,Canada,CA,6/7/1990,, ,1/30/1996,86-063-022,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-022,1/30/2016,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",610536,,580964,Yes
4964,86-T-006,Apparatus for Efficient Sidewall Containment of Molten Metal with Horizontal Alternating Magnetic Fields Utilizing Low Reluctance Rims,"08/606,583","5,954,118",*United States,US,6/7/1990,9/21/1999, ,2/26/1996,86-063-023,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Continuation in Part,4/12/2018,86-063-023,6/26/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",610537,,580964,Yes
4965,86-T-006,Sdiewell Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8AT,0531286,Austria,AT,6/7/1990,, ,6/7/1990,86-063-010,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-010,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614439,,580964,Yes
4966,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,"07/272,353","4,936,374",*United States,US,11/17/1988,6/26/1990, ,11/17/1988,86-063-001,Large,11/17/1988,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,34636,Walter Praeg,US Utility,4/12/2018,86-063-001,11/17/2008,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614493,,580964,Yes
4967,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,"07/952,519","5,385,201",*United States,US,6/7/1990,1/31/1995, ,7/23/1993,86-063-002,Large,11/17/1988,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,US Utility,4/12/2018,86-063-002,1/31/2012,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614494,,580964,Yes
4968,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,PCT/US90/03243, ,*United States,US,6/7/1990,,WO 91/18696,6/7/1990,86-063-003,Large,11/17/1988,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Walter Praeg,PCT,4/12/2018,86-063-003,5/17/1991,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614495,12/12/1990,580964,Yes
4969,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,58426/90,"655,403",Australia,AU,6/7/1990,5/4/1995, ,6/7/1990,86-063-004,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-004,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614496,,580964,Yes
4970,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,PI9008029-7,PI9008029-7,Brazil,BR,6/7/1990,3/24/1998, ,6/7/1990,86-063-005,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-005,6/7/2015,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614497,,580964,Yes
4971,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8EPO,0531286,European Patent Office (EPO),EP,6/7/1990,8/12/1998,0531286,6/7/1990,86-063-006,Small,11/17/1988,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-006,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614498,3/17/2003,580964,Yes
4972,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,5-64307,2140659,Japan,JP,6/7/1990,4/30/1999, ,6/7/1990,86-063-007,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-007,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614499,,580964,Yes
4973,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,924661,304140,Norway,NO,6/7/1990,11/2/1998, ,6/7/1990,86-063-008,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-008,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614500,,580964,Yes
4974,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,92016326/02,2087248,Russian Federation,RU,6/7/1990,8/20/1997, ,6/7/1990,86-063-009,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-009,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614501,,580964,Yes
4975,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8BE,0531286,Belgium,BE,6/7/1990,8/12/1998, ,6/7/1990,86-063-011,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-011,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614502,,580964,Yes
4976,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8GB,0531286,United Kingdom,GB,6/7/1990,,0531286,6/7/1990,86-063-012,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-012,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614503,3/17/1993,580964,Yes
4977,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8IT,0531286,Italy,IT,6/7/1990,,0531286,6/7/1990,86-063-013,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-013,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614504,3/17/1993,580964,Yes
4978,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8NL,0531286,Netherlands,NL,6/7/1990,,0531286,6/7/1990,86-063-014,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-014,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614505,3/17/1993,580964,Yes
4979,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8DE,0531286,Germany,DE,6/7/1990,,0531286,6/7/1990,86-063-015,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-015,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614506,3/17/1993,580964,Yes
4980,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,90910039.8FR,0531286,France,FR,6/7/1990,,0531286,6/7/1990,86-063-016,Small,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Validated EPO,4/12/2018,86-063-016,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614507,3/17/1993,580964,Yes
4981,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,"2,084,206", ,Canada,CA,6/7/1990,, ,11/30/1992,86-063-018,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-018,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614508,,580964,Yes
4982,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,703117/92,114278,"Korea, Republic of",KR,6/7/1990,4/16/1997, ,12/7/1992,86-063-019,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-019,12/7/2012,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614509,,580964,Yes
4983,86-T-006,Sidewall Containment of Liquid Metal with Horizontal Alternating Magnetic Fields,93002437,24014,Ukraine,UA,6/7/1990,8/31/1998, ,1/26/1993,86-063-020,Large,11/17/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Walter Praeg,Nationalized PCT,4/12/2018,86-063-020,6/7/2010,"Unassigned, Unassigned",Walter Praeg,"Unassigned, Unassigned",614510,,580964,Yes
4984,86-T-010,Expression of Cloned Genes,"07/092,430", ,*United States,US,9/3/1987,, ,9/3/1987,0173-001,None,9/3/1987,,Yes,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,Thomas Terwilliger,US Utility,4/12/2018,0173-001,,"Unassigned, Unassigned",Thomas Terwilliger,"Unassigned, Unassigned",611557,,581192,Yes
4985,86-T-011,Antibody to Human Progesterone Receptor and Diagnostic Materials and Methods,"06/859,135","4,742,000",*United States,US,5/2/1986,5/3/1988, ,5/2/1986,0174-001,Large,5/2/1986,,Yes,4/28/2022,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.","Gagala, Bruce", ,Geoffrey Greene,US Utility,4/12/2018,0174-001,5/2/2006,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",610406,,581193,Yes
4986,86-T-011,Antibody to Human Progesterone Receptor and Diagnostic Materials and Methods,PCT/US87/00970, ,*United States,US,5/2/1986,11/5/1987, ,4/3/1987,0174-002,Large,5/2/1986,,No,4/28/2022,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.","Gagala, Bruce", ,Geoffrey Greene,PCT,4/12/2018,0174-002,11/2/1988,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",610407,,581193,Yes
4987,86-T-012,Contrast Agents for Ultrasonic Imaging,"06/805,975","4,718,433",*United States,US,1/27/1983,1/12/1988, ,12/5/1985,0175-002,Small,1/27/1983,,No,4/28/2022,Expired - Inactive,,, ,"Kunio Doi, Steven Feinstein",Continuation in Part,4/12/2018,0175-002,1/12/2003,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611278,,581194,Yes
4988,86-T-012,Contrast Agents for Ultrasound Imaging,"06/461,664","4,572,203",*United States,US,1/27/1983,2/26/1986, ,1/27/1983,0175-001,Small,1/27/1983,,Yes,4/28/2022,Expired - Inactive,,, ,"Kunio Doi, Steven Feinstein",US Utility,4/12/2018,0175-001,2/26/2003,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611279,,581194,Yes
4989,86-T-014,Mobile Radiography,PCT/US87/03126, ,*United States,US,12/1/1986,, ,11/25/1987,0176-002,None,12/1/1986,,No,4/28/2022,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.",, ,Heber MacMahon,PCT,4/12/2018,0176-002,6/1/1989,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",613423,,581196,Yes
4990,86-T-014,Mobile Radiography Alignment Device,"06/936,192","4,752,948",*United States,US,12/1/1986,6/21/1988, ,12/1/1986,0176-001,Small,12/1/1986,,Yes,4/28/2022,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,Heber MacMahon,US Utility,4/12/2018,0176-001,12/1/2008,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",613424,,581196,Yes
4991,86-T-016,Synthesis of Carboxylic Ring,"07/172,141", ,*United States,US,3/23/1988,, ,3/23/1988,0179-001,None,3/23/1988,,Yes,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,"Kevin Henega, Jeffrey Winkler",US Utility,4/12/2018,0179-001,,"Unassigned, Unassigned",Jeffrey Winkler,"Unassigned, Unassigned",614747,,581198,Yes
4992,87-T-002,"Extracting Metal Ions with Diphosphonic Acid, or Derivative Thereof","07/898,386","5,332,531",*United States,US,11/1/1988,7/26/1994, ,6/10/1992,87-034-005,None,11/1/1988,,Yes,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward",, ,"Ralph Gatrone, Phil Horwitz, Kenneth Nash",Divisional,4/12/2018,87-034-005,7/26/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",611560,,580968,Yes
4993,87-T-002,Membrane Extraction with Thermodynamically Unstable Diphosphonic Acid Derivatives,"08/250,001","5,678,242",*United States,US,11/1/1988,10/14/1997, ,7/7/1994,87-034-006,Small,11/1/1988,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward",, ,"Ralph Gatrone, Phil Horwitz, Kenneth Nash",Divisional,4/12/2018,87-034-006,10/14/2014,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612242,,580968,Yes
4994,87-T-002,Phosphonic Acids and Their Uses in Separation,"07/351,402", ,*United States,US,11/1/1988,, ,5/12/1989,87-034-002,Small,11/1/1988,,Yes,4/28/2022,Abandoned,"Frishauf, Holtz, Goodman & Woodward",, ,"Ralph Gatrone, Phil Horwitz, Kenneth Nash",Continuation in Part,4/12/2018,87-034-002,,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613958,,580968,Yes
4995,87-T-002,Phosphonic Acids and Their Uses in Separation,PCT/US89/04857, ,*United States,US,10/31/1989,,WO 90/05115,10/31/1989,87-034-003,Small,11/1/1988,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Ralph Gatrone, Phil Horwitz, Kenneth Nash",PCT,4/12/2018,87-034-003,5/1/1991,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613959,5/17/1990,580968,Yes
4996,87-T-002,Phosphonic Acids and Their Uses in Separation,502207/1990,3021035,Japan,JP,10/31/1989,1/14/2000, ,10/31/1989,87-034-004,Small,11/1/1988,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Ralph Gatrone, Phil Horwitz, Kenneth Nash",Nationalized PCT,4/12/2018,87-034-004,10/31/2009,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613960,,580968,Yes
4997,87-T-002,Thermally Unstable Complexing Agents and Their Use in the Treatment of Chemical Solutions,"07/265,608", ,*United States,US,11/1/1988,, ,11/1/1988,87-034-001,Small,11/1/1988,,Yes,4/28/2022,Abandoned,"Frishauf, Holtz, Goodman & Woodward",, ,"Ralph Gatrone, Phil Horwitz, Kenneth Nash",US Utility,4/12/2018,87-034-001,,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614910,,580968,Yes
4998,87-T-003,Metal Oxide Superconducting Powder Comprised of Flake-Like Single Crystal Particles,"07/101,821", ,*United States,US,9/28/1987,, ,9/28/1987,87-045-001,Small,9/28/1987,,Yes,4/28/2022,Abandoned,,, ,"D. Capone, J. Dusek, Roger Poeppel",US Utility,4/12/2018,87-045-001,9/28/2007,"Unassigned, Unassigned",Roger Poeppel,"Unassigned, Unassigned",612250,,580969,Yes
4999,87-T-003,Preferential Orientation of Metal Oxide Superconducting Materials,"07/390,930","5,053,385",*United States,US,9/28/1987,10/1/1991, ,8/7/1989,87-045-002,Large,9/28/1987,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"D. Capone, J. Dusek, Roger Poeppel",Continuation,4/12/2018,87-045-002,10/1/2008,"Unassigned, Unassigned",Roger Poeppel,"Unassigned, Unassigned",614135,,580969,Yes
5000,87-T-004,Preferential Orientation of Metal Oxide Superconducting Materials by Mechanical Means,"07/101,818","4,973,575",*United States,US,9/28/1987,11/27/1990, ,9/28/1987,87-045.1-001,Large,9/28/1987,,Yes,4/28/2022,Expired - Inactive,,, ,D. Capone,US Utility,4/12/2018,87-045.1-001,11/27/2007,"Unassigned, Unassigned",D. Capone,"Unassigned, Unassigned",614136,,580970,Yes
5001,87-T-005,Magnetic Preferential Orientation of Metal Oxide Superconducting Materials,"07/101,820","4,942,151",*United States,US,9/28/1987,7/17/1990, ,9/28/1987,87-045.2-001,Large,9/28/1987,,Yes,4/28/2022,Expired - Inactive,,, ,"D. Capone, Bobby Dunlap, Boyd Veal",US Utility,4/12/2018,87-045.2-001,9/28/2007,"Unassigned, Unassigned",D. Capone,"Unassigned, Unassigned",612149,,580971,Yes
5002,87-T-006,Acoustic Plane Wave Preferential Orientation of Metal Oxide Superconducting Materials,"07/101,819","5,045,528",*United States,US,9/28/1987,9/3/1991, ,9/28/1987,87-045.3-001,None,9/28/1987,,Yes,4/28/2022,Expired - Inactive,,, ,"Roger Poeppel, Thomas Tolt",US Utility,4/12/2018,87-045.3-001,11/27/2007,"Unassigned, Unassigned",Roger Poeppel,"Unassigned, Unassigned",610253,,580972,Yes
5003,87-T-007,Metal Oxide Superconducting Powder Comprised of Flake-Like Single Crystal Particles,"07/101,771", ,*United States,US,9/28/1987,, ,9/28/1987,87-045.4-001,None,9/28/1987,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"D. Capone, J. Dusek",US Utility,4/12/2018,87-045.4-001,9/28/2007,"Unassigned, Unassigned",D. Capone,"Unassigned, Unassigned",612251,,580973,Yes
5004,87-T-007,Metal Oxide Superconducting Powder Comprised of Flake-Like Single Crystal Particles,"07/629,089","5,356,869",*United States,US,9/28/1987,10/18/1994, ,12/17/1990,87-045.4-002,Large,9/28/1987,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"D. Capone, J. Dusek",Continuation,4/12/2018,87-045.4-002,10/18/2002,"Unassigned, Unassigned",D. Capone,"Unassigned, Unassigned",612252,,580973,Yes
5005,87-T-008,Sputter Deposition for Multi-Component Thin Films,"07/266,196","4,923,585",*United States,US,11/2/1988,5/8/1990, ,11/2/1988,87-091-001,Small,11/2/1988,,Yes,4/28/2022,Expired - Inactive,,, ,"Orlando Auciello, Alan Krauss",US Utility,4/12/2018,87-091-001,11/2/2008,"Unassigned, Unassigned",Alan Krauss,"Unassigned, Unassigned",614602,,580974,Yes
5006,87-T-009,Molten Salt Electrolyte Battery Cell with Overcharge Tolerance,"07/219,740","4,851,306",*United States,US,7/18/1988,7/25/1989, ,7/18/1988,87-103-001,Large,7/18/1988,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Thomas Kaun, Paul Nelson",US Utility,4/12/2018,87-103-001,7/18/2008,"Unassigned, Unassigned",Thomas Kaun,"Unassigned, Unassigned",613514,,580975,Yes
5007,87-T-010,Chicago Druggist,"07/089,491", ,*United States,US,8/26/1987,, ,8/26/1987,0180-001,None,8/26/1987,,Yes,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,Michael Roizen,US Utility,4/12/2018,0180-001,,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",610879,,581199,Yes
5008,87-T-013,Health Quiz,"07/497,891", ,*United States,US,12/9/1987,, ,3/21/1990,0185-003,Small,12/9/1987,,Yes,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,"Richard Pfisterer, Michael Roizen, Leonid Soren, William Turcotte II",Divisional,4/12/2018,0185-003,3/21/2010,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",611747,,581202,Yes
5009,87-T-013,Health Quiz,"07/711,616", ,*United States,US,12/9/1987,, ,6/6/1991,0185-004,None,12/9/1987,,No,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,"Richard Pfisterer, Michael Roizen, Leonid Soren, William Turcotte II",Continuation in Part,4/12/2018,0185-004,6/6/2011,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",611748,,581202,Yes
5010,87-T-013,Health Quiz,"07/794,295", ,*United States,US,12/9/1987,, ,11/14/1991,0185-005,Small,12/9/1987,,Yes,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,"Richard Pfisterer, Michael Roizen, Leonid Soren, William Turcotte II",Continuation in Part,4/12/2018,0185-005,11/14/2011,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",611749,,581202,Yes
5011,87-T-013,Portable Medical Data Entry Computer,"07/161,662","D312,621",*United States,US,2/29/1988,12/4/1990, ,2/29/1988,0185-002,Small,12/9/1987,,No,4/28/2022,Expired - Inactive,"Laff, Whitesel, Conte & Saret",, ,"Michael Roizen, Leonid Soren",Design Patent,4/12/2018,0185-002,12/4/2007,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",614127,,581202,Yes
5012,87-T-013,Portable Medical Interactive Test Selector Having Plug-In Replaceable Memory,"08/027,920","5,341,291",*United States,US,12/9/1987,8/23/1994, ,3/8/1993,0185-006,None,12/9/1987,,No,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,"Richard Pfisterer, Michael Roizen, William Turcotte II",Continuation in Part,4/12/2018,0185-006,11/14/2011,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",614128,,581202,Yes
5013,87-T-013,Portable System for Choosing Pre-Operative Patient Test,"07/130,934","5,025,374",*United States,US,12/9/1987,6/18/1991, ,12/9/1987,0185-001,Small,12/9/1987,,Yes,4/28/2022,Expired - Inactive,"Laff, Whitesel, Conte & Saret",, ,"Eric Kaplan, Richard Pfisterer, Michael Roizen, Bruce Schreider, William Turcotte II",US Utility,4/12/2018,0185-001,6/18/2008,"Dembo, Anna",Michael Roizen,"Tennant, Thelma",614129,,581202,Yes
5014,87-T-015,Chemiluminescent Compounds,"07/131,113","4,883,898",*United States,US,12/10/1987,11/28/1989, ,12/10/1987,0183-001,None,12/10/1987,,Yes,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,Nien-chu Yang,US Utility,4/12/2018,0183-001,12/10/2007,"Unassigned, Unassigned",Nien-chu Yang,"Unassigned, Unassigned",610863,,581204,Yes
5015,87-T-022,Methods and Compositions for the Preparation and Use of Autocrine Growth Factors,"07/764,689", ,*United States,US,6/24/1987,, ,9/24/1991,0192-002,Large,6/24/1987,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Stephen Gluck, F. Gary Toback, Margaret Walsh-Reitz",Continuation in Part,4/12/2018,0192-002,,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",612903,,581211,Yes
5016,87-T-022,Methods and Compositions for the Preparation and Use of Autocrine Growth Factors,"08/126,103","5,476,922",*United States,US,6/24/1987,12/19/1995, ,9/22/1993,0192-003,Small,6/24/1987,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Kassel, Mark", ,"Stephen Gluck, F. Gary Toback, Margaret Walsh-Reitz",Continuation,4/12/2018,0192-003,12/19/2012,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",612904,,581211,Yes
5017,87-T-022,Production of Autocrine Growth Factors,"07/066,059","5,135,856",*United States,US,6/24/1987,8/4/1992, ,6/24/1987,0192-001,Small,6/24/1987,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Kassel, Mark", ,"Stephen Gluck, F. Gary Toback, Margaret Walsh-Reitz",US Utility,4/12/2018,0192-001,8/4/2009,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614175,,581211,Yes
5018,87-T-022,Regeneration of Kidney Tissue and Use of Autocrine Growth Factors,"08/573,182","5,821,218",*United States,US,6/24/1987,10/13/1998,8,12/15/1995,0192-004,Large,6/24/1987,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Stephen Gluck, F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0192-004,6/24/2007,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614372,,581211,Yes
5019,87-T-024,Method and System for Localization of Inter-Rib Spaces and Automated Lung Texture Analysis in Digital Chest Radiographs,"07/081,143","4,851,984",*United States,US,8/3/1987,7/25/1989, ,8/3/1987,0205-001,Large,8/3/1987,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Shigehiko Katsuragawa",US Utility,4/12/2018,0205-001,8/3/2007,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612369,,581213,Yes
5020,87-T-024,Method and System for Localization of Inter-Rib Spaces and Automated Lung Texture Analysis in Digital Chest Radiographs,P3826287.8,3826287,Germany,DE,8/3/1987,5/7/1997, ,7/30/1988,0205-002,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa",Validated EPO,4/12/2018,0205-002,7/30/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612370,,581213,Yes
5021,87-T-024,Method and System for Localization of Inter-Rib Spaces and Automated Lung Texture Analysis in Digital Chest Radiographs,P63-192171,01-125675,Japan,JP,8/3/1987,8/5/1989, ,8/2/1988,0205-003,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa","Foreign, Non-PCT",4/12/2018,0205-003,8/2/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612371,,581213,Yes
5022,87-T-024,Method and System for Localization of Inter-Rib Spaces and Automated Lung Texture Analysis in Digital Chest Radiographs,P01-115973,P2851057,Japan,JP,8/3/1987,11/13/1998, ,5/11/1989,0205-004,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa","Foreign, Non-PCT",4/12/2018,0205-004,11/5/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612372,,581213,Yes
5023,87-T-025,Method and System for Removing Scatter and Veiling Glate and Other Artifacts in Digital Radiography,JP1989000115972,02250186,Japan,JP,8/3/1987,, ,5/11/1989,0206-001,Large,8/3/1987,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Yuichiro Kume","Foreign, Non-PCT",4/12/2018,0206-001,5/11/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612373,,581214,Yes
5024,87-T-025,Method and System for Removing Scatter and Veiling Glate and Other Artifacts in Digital Radiography,"07/081,001","4,841,555",*United States,US,8/3/1987,6/20/1989, ,8/3/1987,0206-002,Large,8/3/1987,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Yuichiro Kume",US Utility,4/12/2018,0206-002,8/3/2007,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612374,,581214,Yes
5025,87-T-025,Method and System for Removing Scatter and Veiling Glate and Other Artifacts in Digital Radiography,P3826288.6,3826288,Germany,DE,8/3/1987,8/12/1993, ,7/30/1988,0206-003,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Yuichiro Kume",Validated EPO,4/12/2018,0206-003,7/30/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612375,,581214,Yes
5026,87-T-025,Method and System for Removing Scatter and Veiling Glate and Other Artifacts in Digital Radiography,JP1988000192172,01125679,Japan,JP,8/3/1987,, ,8/2/1988,0206-004,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Yuichiro Kume","Foreign, Non-PCT",4/12/2018,0206-004,8/2/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612376,,581214,Yes
5027,87-T-026,Method and System for Enhancement and Detection of Abnormal Anatomic Regions in a Digital Image,"07/068,221","4,907,156",*United States,US,6/30/1987,3/6/1990, ,6/30/1987,0207-001,Large,6/30/1987,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Heang-Ping Chan, Kunio Doi, Maryellen Giger",US Utility,4/12/2018,0207-001,6/30/2007,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612363,,581215,Yes
5028,87-T-026,Method and System for Enhancement and Detection of Abnormal Anatomic Regions in a Digital Image,P3826285.1,3826285,Germany,DE,6/30/1987,2/16/1995, ,7/30/1988,0207-002,Large,6/30/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Heang-Ping Chan, Kunio Doi, Maryellen Giger",Validated EPO,4/12/2018,0207-002,7/30/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612364,,581215,Yes
5029,87-T-026,Method and System for Enhancement and Detection of Abnormal Anatomic Regions in a Digital Image,P63-305133,2638631,Japan,JP,6/30/1987,4/25/1997, ,12/1/1988,0207-003,Large,6/30/1987,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Heang-Ping Chan, Kunio Doi, Maryellen Giger","Foreign, Non-PCT",4/12/2018,0207-003,12/1/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612365,,581215,Yes
5030,87-T-030,Immunoassay for Lipoprotein(A),"07/162,000","4,945,040",*United States,US,2/29/1988,7/31/1990, ,2/29/1988,0198-001,Large,2/29/1988,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,"Gunther Fless, Angelo Scanu",US Utility,4/12/2018,0198-001,2/29/2008,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",611929,,581219,Yes
5031,87-T-031,Magnetic Resonance Analysis of Substances in Samples that Include Dissipative Material.,"06/755,666","4,714,886",*United States,US,7/16/1985,12/22/1987, ,7/16/1985,0191-001,Small,7/16/1985,,Yes,4/28/2022,Expired - Inactive,,, ,"James Bowman, Howard Halpern, Beverly Teicher",US Utility,4/12/2018,0191-001,7/16/2005,"Cox, Ben",Howard Halpern,"Butler, Brittany",612150,,581220,Yes
5032,87-T-032,Magnetic/Electronic Spin Resonance,PCT/US86/01497, ,*United States,US,8/3/1988,, ,7/14/1989,0191.1-002,Small,8/3/1988,,No,4/28/2022,Expired - Inactive,,, ,"James Bowman, Howard Halpern, Beverly Teicher",PCT,4/12/2018,0191.1-002,2/3/1991,"Cox, Ben",Howard Halpern,"Butler, Brittany",612151,,581221,Yes
5033,87-T-032,Selective isotopic labeling of spin labels for electron spin resonance spectroscopy,"07/227,793","5,431,901",*United States,US,8/3/1988,7/11/1995, ,8/3/1988,0191.1-001,Small,8/3/1988,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Napoli, James", ,"James Bowman, Howard Halpern, Beverly Teicher",US Utility,4/12/2018,0191.1-001,7/11/2012,"Cox, Ben",Howard Halpern,"Butler, Brittany",614443,,581221,Yes
5034,87-T-035,High flux Solar Energy Transformation,"07/164,069", ,*United States,US,3/4/1988,, ,3/4/1988,0224-001,Small,3/4/1988,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Borun, Michael", ,"Philip Gleckman, Joseph O'Gallagher, Roland Winston",US Utility,4/12/2018,0224-001,,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611804,,581224,Yes
5035,87-T-035,High Flux Solar Energy Transformation,PCT/US89/00878, ,*United States,US,3/4/1988,, ,3/3/1989,0224-002,Small,3/4/1988,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,"Philip Gleckman, Joseph O'Gallagher, Roland Winston",PCT,4/12/2018,0224-002,9/4/2000,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611805,,581224,Yes
5036,87-T-035,High Flux Solar Energy Transformation,ABND-27566/8443, ,European Patent Office (EPO),EP,3/4/1988,, ,3/3/1989,0224-003,Small,3/4/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Philip Gleckman, Joseph O'Gallagher, Roland Winston",Nationalized PCT,4/12/2018,0224-003,3/3/2009,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611806,,581224,Yes
5037,87-T-035,High Flux Solar Energy Transformation,"1,330,512","1,330,512",Canada,CA,3/4/1988,7/5/1994, ,3/4/1989,0224-004,Small,3/4/1988,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Hirsch, Martin", ,"Philip Gleckman, Joseph O'Gallagher, Roland Winston",Nationalized PCT,4/12/2018,0224-004,7/5/2011,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611807,,581224,Yes
5038,87-T-035,High Flux Solar Energy Transformation,"07/423,616","5,005,958",*United States,US,3/4/1988,4/9/1991, ,10/16/1989,0224-005,Small,3/4/1988,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,"Philip Gleckman, Joseph O'Gallagher, Roland Winston",Continuation,4/12/2018,0224-005,4/9/2008,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611808,,581224,Yes
5039,87-T-037,Nonimaging Radiant Energy Device,"07/348,056","5,243,459",*United States,US,5/5/1989,9/7/1993, ,5/5/1989,0200-002,Small,5/5/1989,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,"Xiaohui Ning, Roland Winston",US Utility,4/12/2018,0200-002,9/7/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613693,,581226,Yes
5040,87-T-037,Nonimaging Radiant Energy Device,PCT/US90/02427, ,*United States,US,5/1/1990,, ,5/1/1990,0200-003,Small,5/5/1989,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,"Xiaohui Ning, Roland Winston",PCT,4/12/2018,0200-003,11/5/1991,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613694,,581226,Yes
5041,87-T-037,Nonimaging Radiant Energy Device,90908362.8DE,69024954.3,Germany,DE,5/1/1990,1/17/1996, ,5/1/1990,0200-004,Small,5/5/1989,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Xiaohui Ning, Roland Winston",Validated EPO,4/12/2018,0200-004,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613695,,581226,Yes
5042,87-T-037,Nonimaging Radiant Energy Device,90908362.8FR,471781,France,FR,5/1/1990,1/17/1995, ,5/1/1990,0200-005,Small,5/5/1989,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Xiaohui Ning, Roland Winston",Validated EPO,4/12/2018,0200-005,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613696,,581226,Yes
5043,87-T-037,Nonimaging Radiant Energy Device,90908362.8GB,471781,United Kingdom,GB,5/1/1990,1/17/1996, ,5/1/1990,0200-006,Small,5/5/1989,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Hirsch, Martin", ,"Xiaohui Ning, Roland Winston",Validated EPO,4/12/2018,0200-006,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613697,,581226,Yes
5044,87-T-037,Nonimaging Radiant Energy Device,90908362.8IT,471781,Italy,IT,5/1/1990,1/17/1996, ,5/1/1990,0200-007,Small,5/5/1989,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Hirsch, Martin", ,"Xiaohui Ning, Roland Winston",Validated EPO,4/12/2018,0200-007,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613698,,581226,Yes
5045,87-T-037,Nonimaging Radiant Energy Device,90908362.8NL,471781,Netherlands,NL,5/1/1990,1/17/1996, ,5/1/1990,0200-008,Small,5/5/1989,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Hirsch, Martin", ,"Xiaohui Ning, Roland Winston",Validated EPO,4/12/2018,0200-008,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613699,,581226,Yes
5046,87-T-037,Nonimaging Radiant Energy Device,HEI 2-508157,3328274,Japan,JP,5/1/1990,2/21/2003, ,5/1/1990,0200-009,Small,5/5/1989,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Hirsch, Martin", ,"Xiaohui Ning, Roland Winston",Nationalized PCT,4/12/2018,0200-009,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613700,,581226,Yes
5047,87-T-037,Nonimaging Radiant Energy Device,2000-402092,3400987,Japan,JP,5/1/1990,2/21/2003, ,5/1/1990,0200-010,Small,5/5/1989,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Hirsch, Martin", ,"Xiaohui Ning, Roland Winston",Divisional,4/12/2018,0200-010,5/1/2010,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613701,,581226,Yes
5048,87-T-037,Nonimaging Radiant Energy Device,"08/115,220","5,557,478",*United States,US,5/5/1989,9/17/1996, ,9/1/1993,0200-011,Small,5/5/1989,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,"Xiaohui Ning, Roland Winston",Divisional,4/12/2018,0200-011,9/17/2013,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613702,,581226,Yes
5049,87-T-037,Nonimaging Radiant Energy Device,"08/471,730","5,610,768",*United States,US,5/5/1989,3/11/1997, ,6/6/1995,0200-012,Small,5/5/1989,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Borun, Michael", ,Roland Winston,Divisional,4/12/2018,0200-012,3/11/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613703,,581226,Yes
5050,87-T-038,Method for Hidden Line and Surface Removal in a Three Dimensional Display,"07/189,320", ,*United States,US,5/2/1988,, ,5/2/1988,0208-001,None,5/2/1988,,Yes,4/28/2022,Abandoned,,, ,Ketan Mulmuley,US Utility,4/12/2018,0208-001,,"Unassigned, Unassigned",Ketan Mulmuley,"Unassigned, Unassigned",612459,,581227,Yes
5051,87-T-038,Method for Hidden Line and Surface Removal in a Three Dimensional Display,"07/730,036","5,086,496",*United States,US,5/2/1988,2/4/1992, ,7/12/1991,0208-002,None,5/2/1988,,No,4/28/2022,Expired - Inactive,,, ,Ketan Mulmuley,Continuation,4/12/2018,0208-002,2/4/2009,"Unassigned, Unassigned",Ketan Mulmuley,"Unassigned, Unassigned",612460,,581227,Yes
5052,87-T-039,Method and System for Automated Classification of Distinction Between Normal Lungs and Abnormal Lungs With Interstitial Disease in Digital Chest Radiographs,"07/126,847","4,839,807",*United States,US,8/3/1987,6/13/1989, ,11/27/1987,0203-001,Large,8/3/1987,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa",Continuation in Part,4/12/2018,0203-001,11/27/2007,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612323,,581228,Yes
5053,87-T-039,Method and System for Automated Classification of Distinction Between Normal Lungs and Abnormal Lungs With Interstitial Disease in Digital Chest Radiographs,P3840257.2DE,P3840257.2,Germany,DE,8/3/1987,7/24/1997, ,11/25/1988,0203-002,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa",Validated EPO,4/12/2018,0203-002,11/25/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612324,11/25/2008,581228,Yes
5054,87-T-039,Method and System for Localization of Inter-Rib Spaces and Automated Lung Texture Analysis in Digital Chest Radiographs,63-330724,1742029,Japan,JP,8/3/1987,3/15/1993, ,12/27/1988,0203-003,Large,8/3/1987,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa","Foreign, Non-PCT",4/12/2018,0203-003,12/27/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612368,,581228,Yes
5055,87-T-040,Method for Determination of 3-D Structure in Biplane Angiography,"07/126,266","4,875,165",*United States,US,11/27/1987,10/17/1989, ,11/27/1987,0204-001,Large,11/27/1987,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Laura Fencil, Charles Metz",US Utility,4/12/2018,0204-001,11/27/2007,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612442,,581229,Yes
5056,87-T-041,DNA Binding Protein Including Androgen Receptor,"07/176,107", ,*United States,US,3/30/1988,, ,3/30/1988,0209-001,Small,3/30/1988,,Yes,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",US Utility,4/12/2018,0209-001,,"Dembo, Anna",Chawnshang Chang,"Tennant, Thelma",611463,,581230,Yes
5057,87-T-041,DNA Binding Protein Including Androgen Receptor,89905265.8EPO, ,European Patent Office (EPO),EP,3/30/1988,, ,3/24/1989,0209-006,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Nationalized PCT,4/12/2018,0209-006,3/24/2009,"Dembo, Anna",Chawnshang Chang,"Tennant, Thelma",611464,,581230,Yes
5058,87-T-041,DNA Binding Protein Including Androgen Receptor,504989/98, ,Japan,JP,3/30/1988,, ,3/24/1989,0209-007,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao","Foreign, Non-PCT",4/12/2018,0209-007,3/24/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611465,,581230,Yes
5059,87-T-041,DNA Binding Protein Including Androgen Receptor,PCT/US90/06015, ,*United States,US,3/30/1988,,WO 91/07423,10/19/1990,0209-011,Small,3/30/1988,,No,4/28/2022,Expired - Inactive,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",PCT,4/12/2018,0209-011,5/17/1992,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611466,5/30/1991,581230,Yes
5060,87-T-041,DNA Binding Protein Including Androgen Receptor,"08/470,150", ,*United States,US,3/30/1988,, ,6/6/1995,0209-013,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Continuation,4/12/2018,0209-013,,"Dembo, Anna",Chawnshang Chang,"Tennant, Thelma",611467,,581230,Yes
5061,87-T-041,DNA Binding Proteins Including Androgen Receptor,"07/253,807", ,*United States,US,3/30/1988,, ,10/5/1988,0209-002,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Continuation in Part,4/12/2018,0209-002,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611468,,581230,Yes
5062,87-T-041,DNA Binding Proteins Including Androgen Receptor,"07/312,763", ,*United States,US,3/30/1988,, ,2/21/1989,0209-003,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Continuation in Part,4/12/2018,0209-003,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611469,,581230,Yes
5063,87-T-041,DNA Binding Proteins Including Androgen Receptor,PCT/US89/01238, ,*United States,US,3/30/1988,,WO 89/09223,3/24/1989,0209-004,Small,3/30/1988,,No,4/28/2022,Expired - Inactive,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",PCT,4/12/2018,0209-004,9/30/2000,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611470,10/5/1989,581230,Yes
5064,87-T-041,DNA Binding Proteins Including Androgen Receptor,90917597.8EPO,505387,European Patent Office (EPO),EP,3/30/1988,, ,3/24/1989,0209-005,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Nationalized PCT,4/12/2018,0209-005,3/24/2009,"Dembo, Anna",Chawnshang Chang,"Tennant, Thelma",611471,,581230,Yes
5065,87-T-041,DNA Binding Proteins Including Androgen Receptor,"595,031","1,341,305",Canada,CA,3/30/1988,10/16/2001,CA1341305A1,3/29/1989,0209-008,Large,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Nationalized PCT,4/12/2018,0209-008,10/16/2018,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611472,10/16/2001,581230,Yes
5066,87-T-041,DNA Binding Proteins Including Androgen Receptor,"07/438,775", ,*United States,US,3/30/1988,, ,11/17/1989,0209-009,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao",Continuation in Part,4/12/2018,0209-009,11/17/1990,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611473,,581230,Yes
5067,87-T-041,DNA Binding Proteins Including Androgen Receptor,500413/91, ,Japan,JP,3/30/1988,, ,10/19/1990,0209-010,Small,3/30/1988,,No,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Chawnshang Chang, Shutsung Liao","Foreign, Non-PCT",4/12/2018,0209-010,10/19/2010,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611474,,581230,Yes
5068,87-T-041,DNA Binding Proteins Including Androgen Receptor,"08/149,691","5,614,620",*United States,US,3/30/1988,3/25/1997, ,11/8/1993,0209-012,Small,3/30/1988,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Chawnshang Chang, Shutsung Liao",Continuation,4/12/2018,0209-012,3/25/2014,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",611475,,581230,Yes
5069,87-T-042,HIV Related Antigens and Antibodies,"07/135,337", ,*United States,US,12/21/1987,, ,12/21/1987,0202-001,None,12/21/1987,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Clifford Gurney, Shung-Tai Ho",US Utility,4/12/2018,0202-001,,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611831,,581231,Yes
5070,87-T-042,HIV Related Antigens and Antibodies,"07/235,011", ,*United States,US,12/21/1987,, ,8/22/1988,0202-002,None,12/21/1987,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Clifford Gurney, Shung-Tai Ho",Continuation in Part,4/12/2018,0202-002,,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611832,,581231,Yes
5071,87-T-042,HIV Related Antigens and Antibodies,"07/237,979", ,*United States,US,12/21/1987,, ,8/29/1988,0202-003,None,12/21/1987,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,8681,"Clifford Gurney, Shung-Tai Ho",Continuation in Part,4/12/2018,0202-003,,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611833,,581231,Yes
5072,87-T-042,HIV Related Antigens and Antibodies,PCT/US88/04552, ,*United States,US,12/21/1987,, ,12/20/1988,0202-004,None,12/21/1987,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Clifford Gurney, Shung-Tai Ho",PCT,4/12/2018,0202-004,12/20/2008,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611834,,581231,Yes
5073,87-T-042,HIV Related Antigens and Antibodies,PCT/US88/04553, ,*United States,US,12/21/1987,, ,12/20/1988,0202-005,None,12/21/1987,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Clifford Gurney, Shung-Tai Ho",PCT,4/12/2018,0202-005,6/21/1990,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611835,,581231,Yes
5074,87-T-042,HIV Related Antigens and Antibodies,"07/499,469", ,*United States,US,12/21/1987,, ,12/11/1989,0202-006,None,12/21/1987,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Clifford Gurney, Shung-Tai Ho",Continuation in Part,4/12/2018,0202-006,,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611836,,581231,Yes
5075,87-T-042,HIV Related Antigens and Antibodies,"07/499,488","5,039,618",*United States,US,12/21/1987,8/13/1991, ,12/11/1989,0202-007,None,12/21/1987,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",, ,"Clifford Gurney, Shung-Tai Ho",Continuation in Part,4/12/2018,0202-007,8/29/2008,"Unassigned, Unassigned",Clifford Gurney,"Unassigned, Unassigned",611837,,581231,Yes
5076,88-T-001,Method of Bonding Metals to Ceramics,"07/286,238","5,010,053",*United States,US,12/19/1988,4/23/1991, ,12/19/1988,88-060-001,Small,12/19/1988,,Yes,4/28/2022,Abandoned,Foley & Lardner,, ,Victor Maroni,US Utility,4/12/2018,88-060-001,12/19/2008,"Unassigned, Unassigned",Victor Maroni,"Unassigned, Unassigned",612517,,580976,Yes
5077,88-T-001,Method of Bonding Metals to Ceramics,"07/566,780","5,079,223",*United States,US,12/19/1988,1/7/1992, ,8/14/1990,88-060-002,Small,12/19/1988,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,Victor Maroni,Divisional,4/12/2018,88-060-002,1/7/2009,"Unassigned, Unassigned",Victor Maroni,"Unassigned, Unassigned",612518,,580976,Yes
5078,88-T-002,High Temperature Crystalline Superconductors from Crystallized Glasses (As Issued),"07/276,379","5,157,014",*United States,US,11/23/1988,10/20/1992, ,11/23/1988,88-066-001,None,11/23/1988,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,Donglu Shi,US Utility,4/12/2018,88-066-001,10/20/2009,"Unassigned, Unassigned",Donglu Shi,"Unassigned, Unassigned",611814,,580977,Yes
5079,88-T-006,SlLIM,"07/172,107", ,*United States,US,3/23/1988,, ,3/23/1988,0233-001,None,3/23/1988,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Shekleton, Gerald", ,"Xiaoping Hu, Paul Lauterbur, David Levin, Thomas Spraggins",US Utility,4/12/2018,0233-001,,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",614560,,581235,Yes
5080,88-T-007,Cloning and Expression of Early Growth Regulatory Protein Genes,"07/249,584","5,206,152",*United States,US,4/8/1988,4/27/1993, ,9/26/1988,0216-003,Small,4/8/1988,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Vikas Sukhatme,Continuation in Part,4/12/2018,0216-003,4/27/2010,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",610896,,581236,Yes
5081,88-T-007,Methods and Materials Relating to DNA Binding Proteins,"07/179,587", ,*United States,US,4/8/1988,, ,4/8/1988,0216-002,None,4/8/1988,,Yes,6/8/2022,Abandoned,"Marshall, Gerstein & Borun",, ,Vikas Sukhatme,US Utility,4/12/2018,0216-002,,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613122,,581236,Yes
5082,88-T-007,Methods and Materials Relating to DNA Binding Proteins,PCT/US89/01473, ,*United States,US,4/8/1988,, ,4/7/1989,0216-004,None,4/8/1988,,No,6/8/2022,Abandoned,,, ,Vikas Sukhatme,PCT,4/12/2018,0216-004,7/29/1994,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613123,,581236,Yes
5083,88-T-007,Methods and Materials Relating to the Functional Domains of DNA Binding,94911543.0EPO, ,European Patent Office (EPO),EP,4/8/1988,,WO9423030,3/10/1994,0216-001,None,4/8/1988,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Andrea Gashier, Vikas Sukhatme, Sowmya Swaminathan",Nationalized PCT,4/12/2018,0216-001,,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613127,10/13/1994,581236,Yes
5084,88-T-007,Methods and Materials Relating to the Functional Domains of DNA Binding Proteins,89904936.5EPO, ,European Patent Office (EPO),EP,4/8/1988,, ,4/7/1989,0216-005,None,4/8/1988,,No,6/8/2022,Abandoned,,, ,"Andrea Gashier, Vikas Sukhatme, Sowmya Swaminathan",Nationalized PCT,4/12/2018,0216-005,4/7/2009,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613128,,581236,Yes
5085,88-T-007,Methods and Materials Relating to the Functional Domains of DNA Binding Proteins,"08/040,548","5,763,209",*United States,US,4/8/1988,6/9/1998, ,3/31/1993,0216-006,None,4/8/1988,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Vikas Sukhatme,Continuation in Part,4/12/2018,0216-006,6/9/2015,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613129,,581236,Yes
5086,88-T-007,Methods and Materials Relating to the Functional Domains of DNA Binding Proteins,PCT/US94/02611, ,*United States,US,4/8/1988,,WO/94/23030,3/10/1994,0216-007,None,4/8/1988,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Vikas Sukhatme,PCT,4/12/2018,0216-007,7/29/1994,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613130,,581236,Yes
5087,88-T-007,Methods and Materials Relating to the Functional Domains of DNA Binding Proteins,"08/466,588","5,866,325",*United States,US,4/8/1988,2/2/1999, ,6/6/1995,0216-008,None,4/8/1988,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Vikas Sukhatme,Divisional,4/12/2018,0216-008,2/2/2016,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613131,,581236,Yes
5088,88-T-007,Methods and Materials Relating to the Functional Domains of DNA Binding Proteins,"08/466,344","5,773,583",*United States,US,4/8/1988,6/30/1998, ,6/6/1995,0216-009,None,4/8/1988,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Vikas Sukhatme,Divisional,4/12/2018,0216-009,6/30/2015,"Unassigned, Unassigned",Vikas Sukhatme,"Unassigned, Unassigned",613132,,581236,Yes
5089,88-T-009,Means to Correlate Images from Scans Taken at Different Times Including Means to Determine the Minimum Distances Between a Patient Anatomical Contour and a Correlating Surface,"07/198,043","4,977,505",*United States,US,5/24/1988,12/11/1990, ,5/24/1988,0212-001,Small,5/24/1988,,Yes,4/28/2022,Abandoned,,, ,"George Chen, Charles Pelizzari",US Utility,4/12/2018,0212-001,5/24/2008,"Ginsburg, Eric",Charles Pelizzari,"Juggernauth, Anne",612230,,581238,Yes
5090,88-T-011,Electron microscope with an asymmetrical Immersion Lens,"07/401,629","5,079,428",*United States,US,8/31/1989,1/7/1992, ,8/31/1989,0220-001,None,8/31/1989,,Yes,4/28/2022,Abandoned,,, ,"Paul Da Lin, Zhifeng Shao",US Utility,4/12/2018,0220-001,8/31/2009,"Unassigned, Unassigned",Zhifeng Shao,"Unassigned, Unassigned",611523,,581240,Yes
5091,88-T-015,Optical Image Processing Method and System to Perform Unsharp Masking Images Detected by an I.I./TV System,DE1989003913758.9, ,Germany,DE,4/22/1988,, ,4/22/1988,0217-001,Large,4/22/1988,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Heang-Ping Chan, Kunio Doi, Michitaka Honda, Kenichi Komatsu, Kwok Lam","Foreign, Non-PCT",4/12/2018,0217-001,4/21/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613828,,581244,Yes
5092,88-T-015,Optical Image Processing Method and System to Perform Unsharp Masking Images Detected by an I.I./TV System,JP1989000101513, ,Japan,JP,4/22/1988,, ,4/22/1988,0217-002,Large,4/22/1988,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Heang-Ping Chan, Kunio Doi, Michitaka Honda, Kenichi Komatsu, Kwok Lam","Foreign, Non-PCT",4/12/2018,0217-002,4/20/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613829,,581244,Yes
5093,88-T-015,Optical Image Processing Method and System to Perform Unsharp Masking on Images Detected by an I.I./TV System,"07/184,791","4,918,534",*United States,US,4/22/1988,4/17/1990, ,4/22/1988,0217-003,Large,4/22/1988,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Heang-Ping Chan, Kunio Doi, Michitaka Honda, Kenichi Komatsu, Kwok Lam",US Utility,4/12/2018,0217-003,4/22/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613830,,581244,Yes
5094,88-T-019,Floating Bearing Prosthetic Knee,"07/613,331", ,*United States,US,11/14/1990,, ,11/14/1990,0228-001,Large,11/14/1990,,Yes,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",US Utility,4/12/2018,0228-001,,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611598,,581248,Yes
5095,88-T-019,Floating Bearing Prosthetic Knee,PCT/US91/08520, ,*United States,US,11/14/1991,,WO 92/08424,11/14/1991,0228-003,Large,11/14/1990,,No,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",PCT,4/12/2018,0228-003,5/14/1993,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611599,5/29/1992,581248,Yes
5096,88-T-019,Floating Bearing Prosthetic Knee,"07/976,803","5,387,240",*United States,US,11/14/1990,2/7/1995, ,11/16/1992,0228-010,Large,11/14/1990,,No,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Continuation in Part,4/12/2018,0228-010,2/7/2012,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611600,,581248,Yes
5097,88-T-019,Improved Floating Bearing Prosthetic Knee,92901122.9GB,0510178,United Kingdom,GB,11/14/1991,2/25/1998,0510178,11/14/1991,0228-002,Large,11/14/1990,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Validated EPO,4/12/2018,0228-002,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611938,10/28/1992,581248,Yes
5098,88-T-019,Improved Floating Bearing Prosthetic Knee,92901122.9EPO,0510178,European Patent Office (EPO),EP,11/14/1991,2/25/1998, ,11/14/1991,0228-004,Large,11/14/1990,,No,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Nationalized PCT,4/12/2018,0228-004,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611939,,581248,Yes
5099,88-T-019,Improved Floating Bearing Prosthetic Knee,92901122.9FR,0510178,France,FR,11/14/1991,2/25/1998,0510178,11/14/1991,0228-005,Large,11/14/1990,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Validated EPO,4/12/2018,0228-005,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611940,10/28/1992,581248,Yes
5100,88-T-019,Improved Floating Bearing Prosthetic Knee,92901122.9DE,0510178,Germany,DE,11/14/1991,2/25/1998,0510178,11/14/1991,0228-006,Large,11/14/1990,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Validated EPO,4/12/2018,0228-006,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611941,10/28/1992,581248,Yes
5101,88-T-019,Improved Floating Bearing Prosthetic Knee,92901122.9ES,0510178,Spain,ES,11/14/1991,2/25/1998,0510178,11/14/1991,0228-007,Large,11/14/1990,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Validated EPO,4/12/2018,0228-007,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611942,10/28/1992,581248,Yes
5102,88-T-019,Improved Floating Bearing Prosthetic Knee,92901122.9IT,0510178,Italy,IT,11/14/1991,2/25/1998,0510178,11/14/1991,0228-008,Large,11/14/1990,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Validated EPO,4/12/2018,0228-008,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611943,10/28/1992,581248,Yes
5103,88-T-019,Improved Floating Bearing Prosthetic Knee,"2,078,228","2,078,228",Canada,CA,11/14/1991,4/11/2000, ,11/14/1991,0228-009,Large,11/14/1990,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Nationalized PCT,4/12/2018,0228-009,11/14/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",611944,,581248,Yes
5104,88-T-019,Stabilized Prosthetic Knee,"08/383,871","5,658,342",*United States,US,11/14/1990,8/19/1997, ,2/6/1995,0228-011,Large,11/14/1990,,Yes,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Continuation in Part,4/12/2018,0228-011,2/7/2012,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614606,,581248,Yes
5105,88-T-019,Stabilized Prosthetic Knee,PCT/US96/01725, ,*United States,US,2/5/1996,,WO 96/24311,2/5/1996,0228-012,Large,2/6/1995,,No,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",PCT,4/12/2018,0228-012,8/6/1997,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614607,8/15/1996,581248,Yes
5106,88-T-019,Stabilized Prosthetic Knee,49753/96,710550,Australia,AU,2/5/1996,1/20/2000, ,2/5/1996,0228-013,Large,2/6/1995,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Nationalized PCT,4/12/2018,0228-013,2/5/2016,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614608,,581248,Yes
5107,88-T-019,Stabilized Prosthetic Knee,"2,187,033","2,187,033",Canada,CA,2/5/1996,2/1/2005, ,2/5/1996,0228-014,Large,2/6/1995,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Nationalized PCT,4/12/2018,0228-014,2/5/2016,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614609,,581248,Yes
5108,88-T-019,Stablized Prosthetic Knee,96906341.1EPO, ,European Patent Office (EPO),EP,2/5/1996,,EP 0 756 476 A1,2/5/1996,0228-015,Large,2/6/1995,,No,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",Nationalized PCT,4/12/2018,0228-015,2/5/2016,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614615,2/5/1996,581248,Yes
5109,88-T-020,Prosthetic Knee with Adjusted Center of Internal/External Rotation,"08/912,506","6,039,764",*United States,US,8/18/1997,3/21/2000, ,8/18/1997,0228.1-001,Large,8/18/1997,,Yes,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Lawrence Pottenger",US Utility,4/12/2018,0228.1-001,8/18/2017,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614205,,581249,Yes
5110,88-T-021,Rotating/Sliding Constrained Prosthetic Knee,"07/590,255", ,*United States,US,9/28/1990,, ,9/28/1990,0264-001,Large,9/28/1990,,Yes,4/28/2022,Abandoned,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Henry Finn",US Utility,4/12/2018,0264-001,,"Ramirez, Mario Riojas",Henry Finn,"Juggernauth, Anne",614414,,581250,Yes
5111,88-T-021,Rotating/Sliding Contrained Prosthetic Knee,"07/987,106","5,370,701",*United States,US,12/7/1992,12/6/1994, ,12/7/1992,0264-002,Large,9/28/1990,,No,4/28/2022,Expired - Inactive,"Harness, Dickey & Pierce PLC","Foss, Steve", ,"Louis Draganich, Henry Finn",Continuation,4/12/2018,0264-002,12/6/2011,"Ramirez, Mario Riojas",Louis Draganich,"Juggernauth, Anne",614415,,581250,Yes
5112,88-T-024,3-D View of Brain Surface,PCT/US89/01165, ,*United States,US,3/21/1989,, ,3/21/1989,0232-001,None,3/21/1989,,No,4/28/2022,Abandoned,,, ,David Levin,PCT,4/12/2018,0232-001,8/17/1991,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",610187,,581253,Yes
5113,88-T-024,Method and Apparatus for Providing 3-D Images of the Brain Surface,"07/600,397", ,*United States,US,10/19/1990,, ,10/19/1990,0232-002,None,10/19/1990,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Cohen, Eric", ,David Levin,US Utility,4/12/2018,0232-002,,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",612296,,581253,Yes
5114,88-T-026,Method for Reducing Emesis & Nausea Induced by the Administration of an Emesis Causing Agent,76319/91,"654,275",Australia,AU,4/30/1991,2/21/1995, ,,0231-022,Small,10/19/1990,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale","Dillard, David", ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-022,4/30/2011,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",612496,,581255,Yes
5115,88-T-026,Method for Reducing Emesis and Nausea Induced by the Administration of an Emesis Causing Agent,"07/540,884","5,102,887",*United States,US,6/15/1990,4/7/1992, ,,0231-021,Small,2/17/1989,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Continuation,4/12/2018,0231-021,4/7/2009,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",612497,,581255,Yes
5116,88-T-026,Method for Reducing Emesis and Nausea Induced by the Administration of an Emesis-Causing Agent (As Amended),"07/312,117", ,*United States,US,2/17/1989,, ,,0231-020,Small,2/17/1989,,Yes,8/4/2020,Abandoned,,, ,Leon Goldberg,US Utility,4/12/2018,0231-020,,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",612498,,581255,Yes
5117,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0AT,0306575,Austria,AT,9/10/1987,7/29/1992, ,,0231-002,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-002,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614238,,581255,Yes
5118,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0BE,0306575,Belgium,BE,9/10/1987,7/29/1992, ,,0231-003,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-003,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614239,,581255,Yes
5119,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0ES,0306575,Spain,ES,9/10/1987,7/29/1992, ,,0231-004,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-004,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614240,,581255,Yes
5120,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0SE,0306575,Sweden,SE,9/10/1987,7/29/1992, ,,0231-005,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-005,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614241,,581255,Yes
5121,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0CH,0306575,Switzerland,CH,9/10/1987,7/29/1992, ,,0231-006,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-006,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614242,,581255,Yes
5122,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0LU,0306575,Luxembourg,LU,9/10/1987,7/29/1992, ,,0231-007,Small,9/10/1987,,No,8/4/2020,Abandoned,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-007,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614243,,581255,Yes
5123,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0GB,0306575,United Kingdom,GB,9/10/1987,7/29/1992, ,,0231-008,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-008,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614244,,581255,Yes
5124,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0FR,0306575,France,FR,9/10/1987,7/29/1992, ,,0231-009,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-009,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614245,,581255,Yes
5125,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0DE,P37808192,Germany,DE,9/10/1987,7/29/1992, ,,0231-010,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-010,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614246,,581255,Yes
5126,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0GR,920402167,Greece,GR,9/10/1987,7/29/1992, ,,0231-011,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-011,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614247,,581255,Yes
5127,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0NL,0306575,Netherlands,NL,9/10/1987,7/29/1992, ,,0231-012,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-012,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614248,,581255,Yes
5128,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0IT,0306575,Italy,IT,9/10/1987,7/29/1992, ,,0231-013,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Validated EPO,4/12/2018,0231-013,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614249,,581255,Yes
5129,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87307999.0EPO,0306575,European Patent Office (EPO),EP,9/10/1987,7/29/1992, ,,0231-014,Small,9/10/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Nationalized PCT,4/12/2018,0231-014,9/10/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614250,,581255,Yes
5130,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,"548,964","1,315,689",Canada,CA,10/9/1987,4/6/1993,CA1315689A1,,0231-015,Small,9/3/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale","Dillard, David", ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-015,4/6/2010,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614251,4/6/1993,581255,Yes
5131,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,222911,222911,New Zealand,NZ,12/14/1987,11/27/1990,NZ222911A,,0231-016,Small,9/3/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale","Dillard, David", ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-016,12/14/2003,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614252,11/27/1990,581255,Yes
5132,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,76107953,35279,"Taiwan, Province of China",TW,12/24/1987,3/24/1990, ,,0231-017,Small,12/24/1987,,Yes,8/4/2020,Abandoned,"Christie, Parker & Hale",, ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-017,12/24/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614253,,581255,Yes
5133,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,62-330356,2625457,Japan,JP,12/28/1987,4/11/1997, ,,0231-018,Small,9/3/1987,,No,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-018,12/28/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614254,,581255,Yes
5134,88-T-026,Quarternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,6933/87,167340,Denmark,DK,12/30/1987,10/18/1993, ,,0231-019,Small,9/3/1987,,No,8/4/2020,Abandoned,"Christie, Parker & Hale",, ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-019,12/30/2007,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614255,,581255,Yes
5135,88-T-026,Quaternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,"07/092,470","4,861,781",*United States,US,9/3/1987,8/29/1989, ,,0231-001,Small,3/7/1986,,Yes,8/4/2020,Expired - Inactive,"Christie, Parker & Hale",, ,Leon Goldberg,Continuation in Part,4/12/2018,0231-001,8/29/2006,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614258,,581255,Yes
5136,88-T-026,Quaternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,87-15208, ,"Korea, Republic of",KR,12/29/1987,, ,,0231-023,Small,3/7/1986,,No,8/4/2020,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-023,,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614259,,581255,Yes
5137,88-T-026,Quaternary Derivatives of Noroxymorphone which Relieve Nausea and Emesis,36178,22582,Philippines,PH,12/7/1987,10/17/1988, ,,0231-024,Small,3/7/1986,,No,8/4/2020,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,Leon Goldberg,"Foreign, Non-PCT",4/12/2018,0231-024,10/17/2005,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614260,,581255,Yes
5138,88-T-033,Anti - Androgen Compounds,"1,338,667","1,338,667",Canada,CA,9/29/1989,10/22/1996,,,0263-003,Large,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki","Foreign, Non-PCT",4/12/2018,0263-003,10/22/2013,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610335,,581262,Yes
5139,88-T-033,Anti-Adrogen Compounds,0547/91,173840,Denmark,DK,10/2/1989,, ,,0263-006,Small,9/30/1988,,No,5/21/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Ronald Harvey, Shutsung Liao, John Pataki","Foreign, Non-PCT",4/12/2018,0263-006,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610338,,581262,Yes
5140,88-T-033,Anti-Adrogen Compounds,89310063.6EPO,363128,European Patent Office (EPO),EP,10/2/1989,9/1/1993, ,,0263-007,Small,9/30/1988,,No,5/21/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Ronald Harvey, Shutsung Liao, John Pataki",Nationalized PCT,4/12/2018,0263-007,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610339,,581262,Yes
5141,88-T-033,Anti-Androgen Compound,PCT/US89/04312, ,*United States,US,10/2/1989,,WO 90/03979,10/2/1989,0263-004,Small,9/30/1988,,No,4/28/2022,Expired - Inactive,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,"Ronald Harvey, Shutsung Liao, John Pataki",PCT,4/12/2018,0263-004,3/30/1991,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610340,4/19/1990,581262,Yes
5142,88-T-033,Anti-Androgen Compounds,"07/252,375",,*United States,US,9/30/1988,,,,0263-001,Small,9/30/1988,,Yes,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",US Utility,4/12/2018,0263-001,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610341,,581262,Yes
5143,88-T-033,Anti-androgen Compounds,"07/413,249","5,208,263",*United States,US,9/27/1989,5/4/1993,,,0263-002,Small,9/30/1988,,Yes,4/12/2018,Expired - Inactive,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Continuation in Part,4/12/2018,0263-002,5/4/2010,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610342,,581262,Yes
5144,88-T-033,Anti-Androgen Compounds,43498/89,"621,947",Australia,AU,10/2/1989,8/31/1992,,,0263-005,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Nationalized PCT,4/12/2018,0263-005,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610343,,581262,Yes
5145,88-T-033,Anti-Androgen Compounds,89310063.6AT,363128,Austria,AT,10/2/1989,9/1/1993,,,0263-008,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-008,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610345,,581262,Yes
5146,88-T-033,Anti-Androgen Compounds,89310063.6BE,363128,Belgium,BE,10/2/1989,9/1/1993,,,0263-009,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-009,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610347,,581262,Yes
5147,88-T-033,Anti-Androgen Compounds,89310063.6FR,363128,France,FR,10/2/1989,9/1/1993,,,0263-010,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-010,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610348,,581262,Yes
5148,88-T-033,Anti-Androgen Compounds,89310063.6GB,363128,United Kingdom,GB,10/2/1989,9/1/1993,,,0263-011,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-011,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610349,,581262,Yes
5149,88-T-033,Anti-Androgen Compounds,89310063.6GR,363128,Greece,GR,10/2/1989,9/1/1993,,,0263-012,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-012,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610351,,581262,Yes
5150,88-T-033,Anti-Androgen Compounds,89310063.6IT,363128,Italy,IT,10/2/1989,9/1/1993,,,0263-013,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-013,10/2/2009,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610353,,581262,Yes
5151,88-T-033,Anti-Androgen Compounds,89310063.6LU,363128,Luxembourg,LU,10/2/1989,9/1/1993,,,0263-014,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-014,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610355,,581262,Yes
5152,88-T-033,Anti-Androgen Compounds,89310063.6NL,363128,Netherlands,NL,10/2/1989,9/1/1993,,,0263-015,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-015,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610356,,581262,Yes
5153,88-T-033,Anti-Androgen Compounds,89310063.6ES,363128,Spain,ES,10/2/1989,9/1/1993,,,0263-016,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-016,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610358,,581262,Yes
5154,88-T-033,Anti-Androgen Compounds,89310063.6CH,363128,Switzerland,CH,10/2/1989,9/1/1993,,,0263-017,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-017,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610360,,581262,Yes
5155,88-T-033,Anti-Androgen Compounds,89310063.6DE,68908829,Germany,DE,10/2/1989,9/1/1993,,,0263-018,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-018,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610361,,581262,Yes
5156,88-T-033,Anti-Androgen Compounds,510698/89,2959785,Japan,JP,10/2/1989,7/30/1999,,,0263-019,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Nationalized PCT,4/12/2018,0263-019,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610362,,581262,Yes
5157,88-T-033,Anti-Androgen Compounds,89310063.6SE,363128,Sweden,SE,10/2/1989,9/1/1993,,,0263-020,Small,9/30/1988,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Validated EPO,4/12/2018,0263-020,10/2/2009,"Dembo, Anna",Ronald Harvey,"Tennant, Thelma",610364,,581262,Yes
5158,88-T-033,Anti-Androgen Compounds,"08/056,523","5,480,913",*United States,US,5/3/1993,1/2/1996,,,0263-021,Small,9/27/1989,,No,4/12/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Ronald Harvey, Shutsung Liao, John Pataki",Divisional,4/12/2018,0263-021,1/2/2013,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610365,,581262,Yes
5159,88-T-034,Method and System for Automated Computerized Analysis of Sizes of Hearts and Lungs in Digital Chest Radiographs,"07/275,720","5,072,384",*United States,US,11/23/1988,12/10/1991,,,0240-001,Large,11/23/1988,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",,,"Kunio Doi, Nobuyuk Nakamori",US Utility,4/12/2018,0240-001,12/10/2008,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612325,,581263,Yes
5160,88-T-034,Method and System for Automated Computerized Analysis of Sizes of Hearts and Lungs in Digital Chest Radiographs,P3938699.6,,Germany,DE,11/18/1989,,,,0240-002,Large,11/23/1988,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",,,"Kunio Doi, Nobuyuk Nakamori",Validated EPO,4/12/2018,0240-002,11/18/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612326,5/31/1990,581263,Yes
5161,88-T-034,Method and System for Automated Computerized Analysis of Sizes of Hearts and Lungs in Digital Chest Radiographs,P01-304542,2796381,Japan,JP,11/22/1989,6/26/1998,,,0240-003,Large,11/23/1988,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Nobuyuk Nakamori","Foreign, Non-PCT",4/12/2018,0240-003,11/22/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612327,,581263,Yes
5162,89-T-001,Binder Enhanced Refuse Derived Fuel,"07/368,184", ,*United States,US,6/19/1989,, ,6/19/1989,89-017-001,Small,6/19/1989,,Yes,4/28/2022,Abandoned,,, ,"Kenneth Daugherty, Oscar Ohlsson, Barney Venables",US Utility,4/12/2018,89-017-001,,"Unassigned, Unassigned",Oscar Ohlsson,"Unassigned, Unassigned",610713,,580978,Yes
5163,89-T-001,Binder Enhanced Refuse Derived Fuel,"08/110,397", ,*United States,US,6/19/1989,, ,8/23/1993,89-017-002,Small,6/19/1989,,Yes,4/28/2022,Abandoned,,, ,"Kenneth Daugherty, Oscar Ohlsson, Barney Venables",Continuation,4/12/2018,89-017-002,,"Unassigned, Unassigned",Oscar Ohlsson,"Unassigned, Unassigned",610714,,580978,Yes
5164,89-T-001,Binder Enhanced Refuse Derived Fuel,"08/420,570","5,562,743",*United States,US,6/19/1989,10/8/1996, ,4/12/1995,89-017-003,Small,8/23/1993,,No,4/28/2022,Abandoned,,, ,"Kenneth Daugherty, Oscar Ohlsson, Barney Venables",Divisional,4/12/2018,89-017-003,10/8/2013,"Unassigned, Unassigned",Oscar Ohlsson,"Unassigned, Unassigned",610715,,580978,Yes
5165,89-T-002,High Temperature Superconductor Current Leads,"07/641,822","5,426,094",*United States,US,1/16/1991,6/20/1995, ,1/16/1991,89-031-001,Small,1/16/1991,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"John Hull, Roger Poeppel",US Utility,4/12/2018,89-031-001,6/20/2012,"Unassigned, Unassigned",Roger Poeppel,"Unassigned, Unassigned",611815,,580979,Yes
5166,89-T-003,Phosphonic Acid Based Ion Exchange Resins,"07/811,098","5,281,631",*United States,US,12/20/1991,1/25/1994, ,12/20/1991,89-051-001,Small,12/20/1991,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",US Utility,4/12/2018,89-051-001,12/20/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613947,,580980,Yes
5167,89-T-003,Phosphonic Acid Based Ion Exchange Resins,"2,126,222","2,126,222",Canada,CA,12/18/1992,1/28/2003, ,12/18/1992,89-051-002,Small,12/20/1991,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz","Foreign, Non-PCT",4/12/2018,89-051-002,12/18/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613948,,580980,Yes
5168,89-T-003,Phosphonic Acid Based Ion Exchange Resins,93901924.6EPO,EP 0 618 843 B1,European Patent Office (EPO),EP,12/18/1992,3/13/2002,EP 0 618 843 A1,12/18/1992,89-051-003,Small,12/20/1991,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Nationalized PCT,4/12/2018,89-051-003,12/18/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613949,10/12/1994,580980,Yes
5169,89-T-003,Phosphonic Acid Based Ion Exchange Resins,5-511836,3345008,Japan,JP,12/18/1992,8/30/2002, ,12/18/1992,89-051-004,Small,12/20/1991,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz","Foreign, Non-PCT",4/12/2018,89-051-004,12/18/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613950,,580980,Yes
5170,89-T-003,Phosphonic Acid Based Ion Exchange Resins,PCT/US92/11105, ,*United States,US,12/18/1992,,WO 93/12882,12/18/1992,89-051-005,Small,12/20/1991,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",PCT,4/12/2018,89-051-005,7/25/1996,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613951,7/8/1993,580980,Yes
5171,89-T-003,Phosphonic Acid Based Ion Exchange Resins,93901924.6GB,EP 0 618 843 B1,United Kingdom,GB,12/18/1992,3/13/2002,EP 0 618 843 A1,12/18/1992,89-051-006,Small,12/20/1991,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Validated EPO,4/12/2018,89-051-006,12/18/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613952,10/12/1994,580980,Yes
5172,89-T-003,Phosphonic Acid Based Ion Exchange Resins,93901924.6FR,EP 0 618 843 B1,France,FR,12/18/1992,3/13/2002,EP 0 618 843 A1,12/18/1992,89-051-007,Small,12/20/1991,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Validated EPO,4/12/2018,89-051-007,12/18/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613953,10/12/1994,580980,Yes
5173,89-T-003,Phosphonic Acid Based Ion Exchange Resins,93901924.6DE,EP 0 618 843 B1,Germany,DE,12/18/1992,3/13/2002,EP 0 618 843 A1,12/18/1992,89-051-008,Small,12/20/1991,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Validated EPO,4/12/2018,89-051-008,12/18/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613954,10/12/1994,580980,Yes
5174,89-T-003,Phosphonic Acid Based Ion Exchange Resins,"08/184,609","5,449,462",*United States,US,12/18/1992,9/12/1995, ,1/21/1994,89-051-010,Small,12/20/1991,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Continuation,4/12/2018,89-051-010,9/12/2012,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613955,,580980,Yes
5175,89-T-003,Phosphonic Acid Based Ion Exchange Resins,"08/428,329","5,539,003",*United States,US,12/18/1992,7/23/1996, ,4/25/1995,89-051-011,Small,12/20/1991,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Continuation,4/12/2018,89-051-011,7/23/2013,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613956,,580980,Yes
5176,89-T-003,Phosphonic Acid Based Ion Exchange Resins (As Issued),"08/184,872", ,*United States,US,12/18/1992,, ,1/21/1994,89-051-009,Small,12/20/1991,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Ralph Gatrone, Phil Horwitz",Divisional,4/12/2018,89-051-009,,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613957,,580980,Yes
5177,89-T-004,Humidity-Resistant Ambient-Temperature Solid-Electrolyte Amperometric Sensing Apparatus,"07/648,649","5,322,611",*United States,US,1/31/1991,6/21/1994, ,1/31/1991,89-074-001,Small,1/31/1991,,Yes,4/28/2022,Abandoned,,"Zaromb, Solomon", ,Solomon Zaromb,US Utility,4/12/2018,89-074-001,6/21/2011,"Unassigned, Unassigned",Solomon Zaromb,"Unassigned, Unassigned",611865,,580981,Yes
5178,89-T-005,Method of Making Nanocrystalline Alpha Alumina,"07/446,585","5,128,081",*United States,US,12/5/1989,7/7/1992, ,12/5/1989,89-080-001,None,12/5/1989,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Jeffrey Eastman, Horst Hahn, Richard Siegel",US Utility,4/12/2018,89-080-001,12/5/2009,"Unassigned, Unassigned",Jeffrey Eastman,"Unassigned, Unassigned",612527,,580982,Yes
5179,89-T-005,Nanocrystalline Ceramic Materials,"07/622,244", ,*United States,US,12/4/1990,, ,12/4/1990,89-080-002,None,12/4/1990,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"Jeffrey Eastman, Horst Hahn, William Nieman, Richard Siegel, Julia Weertman",US Utility,4/12/2018,89-080-002,,"Unassigned, Unassigned",Jeffrey Eastman,"Unassigned, Unassigned",613623,,580982,Yes
5180,89-T-005,Nanocrystalline Ceramic Materials,"08/086,387","5,320,800",*United States,US,12/4/1990,6/14/1994, ,6/30/1993,89-080-003,None,12/4/1990,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Jeffrey Eastman, William Nieman, Richard Siegel, Julia Weertman",Continuation in Part,4/12/2018,89-080-003,6/14/2011,"Unassigned, Unassigned",Richard Siegel,"Unassigned, Unassigned",613624,,580982,Yes
5181,89-T-008,Formulations for Iron Oxides Dissolution,92016380/26,2096499,Russian Federation,RU,12/4/1990,11/20/1997, ,4/26/1991,89-089-001,None,12/4/1990,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Renato Chiarizia, Phil Horwitz",Nationalized PCT,4/12/2018,89-089-001,4/26/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",611610,,580985,Yes
5182,89-T-008,Formulations for Iron Oxides Dissolution,"07/516,436","5,078,894",*United States,US,4/30/1990,1/7/1992, ,4/30/1990,89-089-003,None,4/30/1990,,Yes,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward",, ,"Renato Chiarizia, Phil Horwitz",US Utility,4/12/2018,89-089-003,4/30/2010,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",611611,,580985,Yes
5183,89-T-008,METHOD OF DISSOLVING METAL OXIDES WITH DI- OR POLYPHOSPHONIC ACID AND A REDUCTANT,"08/111,782", ,*United States,US,4/30/1990,4/30/1990, ,8/25/1993,89-089-009,Small,4/30/1990,,No,4/28/2022,Abandoned,"Frishauf, Holtz, Goodman & Woodward",, ,"Renato Chiarizia, Phil Horwitz",Continuation,4/12/2018,89-089-009,4/30/2010,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612521,,580985,Yes
5184,89-T-008,Method of Dissolving Metal Oxides with di- or Polyphosphonic Acid and a Redundant,"08/480,049","5,587,142",*United States,US,4/30/1990,12/24/1996, ,6/6/1995,89-089-010,Small,4/30/1990,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward",, ,"Renato Chiarizia, Phil Horwitz",Continuation,4/12/2018,89-089-010,12/24/2013,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612522,,580985,Yes
5185,89-T-008,New Formulations for Iron Oxide Dissolution,"2,081,767","2,081,767",Canada,CA,4/30/1990,6/5/2001, ,4/26/1991,89-089-004,Large,4/30/1990,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Renato Chiarizia, Phil Horwitz",Nationalized PCT,4/12/2018,89-089-004,4/26/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613655,,580985,Yes
5186,89-T-008,New Formulations for Iron Oxide Dissolution,"07/766,841", ,*United States,US,4/30/1990,4/30/1990, ,9/27/1991,89-089-007,Small,4/30/1990,,Yes,4/28/2022,Abandoned,"Frishauf, Holtz, Goodman & Woodward",, ,"Renato Chiarizia, Phil Horwitz",Divisional,4/12/2018,89-089-007,4/30/2010,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613656,,580985,Yes
5187,89-T-008,New Formulations for Iron Oxides Dissolution,509827/91,3014448,Japan,JP,4/30/1990,12/17/1999, ,4/26/1991,89-089-006,Small,4/30/1990,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Renato Chiarizia, Phil Horwitz",Nationalized PCT,4/12/2018,89-089-006,4/26/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613657,,580985,Yes
5188,89-T-008,Phosphonic Acids and their Uses in Separation,91909854.1GB,0527908,United Kingdom,GB,4/30/1990,8/19/1998, ,4/26/1991,89-089-005,Small,4/30/1990,,No,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Renato Chiarizia, Phil Horwitz",Validated EPO,4/12/2018,89-089-005,4/26/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613961,,580985,Yes
5189,89-T-008,Phosphonic Acids and their Uses in Separation,"2,001,976","2,001,976",Canada,CA,11/1/1989,4/18/2000,"2,001,976",11/1/1989,89-089-008,Large,11/1/1989,,Yes,4/28/2022,Expired - Inactive,"Frishauf, Holtz, Goodman & Woodward","Chick, Marshall", ,"Renato Chiarizia, Phil Horwitz","Foreign, Non-PCT",4/12/2018,89-089-008,11/1/2009,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",613962,5/1/1990,580985,Yes
5190,89-T-012,Nucleic Acid Encoding Sodium Channel Protein,"07/310,330",,*United States,US,2/13/1989,,,,0265-001,Small,2/13/1989,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun",,,Richard Rogart,US Utility,4/12/2018,0265-001,,"Unassigned, Unassigned",Richard Rogart,"Unassigned, Unassigned",613737,,581266,Yes
5191,89-T-012,Nucleic Acid Encoding Sodium Channel Protein,PCT/US90/00768, ,*United States,US,2/9/1990,, ,2/9/1990,0265-002,Small,2/13/1989,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",, ,Richard Rogart,PCT,4/12/2018,0265-002,8/3/1991,"Unassigned, Unassigned",Richard Rogart,"Unassigned, Unassigned",613738,,581266,Yes
5192,89-T-012,Nucleic Acid Encoding Sodium Channel Protein,"07/768,107","5,380,836",*United States,US,9/30/1991,1/10/1995,,,0265-003,Small,2/13/1989,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun",,,Richard Rogart,Continuation,4/12/2018,0265-003,2/13/2009,"Unassigned, Unassigned",Richard Rogart,"Unassigned, Unassigned",613739,,581266,Yes
5193,89-T-013,Protective Tube Laser Endoscopy,"07/534,758","5,308,317",*United States,US,6/7/1990,5/3/1994, ,6/7/1990,0242-001,Small,6/7/1990,,Yes,4/28/2022,Abandoned,"Laff, Whitesel, Conte & Saret",, ,"Mark Ferguson, Lev Melinyshyn, David Schucart",US Utility,4/12/2018,0242-001,5/3/2011,"Unassigned, Unassigned",Mark Ferguson,"Unassigned, Unassigned",614206,,581267,Yes
5194,89-T-017,Human Thyroid  Hormone Receptor DNA,"07/830,766","5,438,126",*United States,US,2/3/1992,8/1/1995,,,0254-002,Small,9/11/1989,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,,,"Leslie DeGroot, Akira Nakai",Continuation,4/12/2018,0254-002,8/1/2012,"Unassigned, Unassigned",Leslie DeGroot,"Unassigned, Unassigned",611862,,581271,Yes
5195,89-T-017,Human Thyroid Hormone Receptor,"07/405,342",,*United States,US,9/11/1989,,,,0254-001,None,9/11/1989,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,,,Leslie DeGroot,US Utility,4/12/2018,0254-001,,"Unassigned, Unassigned",Leslie DeGroot,"Unassigned, Unassigned",611863,,581271,Yes
5196,89-T-017,Human Thyroid Hormone Receptor,"08/407,909","5,712,372",*United States,US,3/21/1995,1/27/1998,,,0254-003,Large,9/11/1989,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Leslie DeGroot, Akira Nakai",Divisional,4/12/2018,0254-003,1/27/2015,"Unassigned, Unassigned",Leslie DeGroot,"Unassigned, Unassigned",611864,,581271,Yes
5197,89-T-020,Expert System for Online Surveillance of Nuclear Reactor Coolant Pumps,"07/827,776","5,223,207",*United States,US,1/29/1992,6/29/1993, ,1/29/1992,89-043-001,Small,1/29/1992,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Ralph Singer",US Utility,4/12/2018,89-043-001,6/29/2010,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",611553,,581274,Yes
5198,89-T-021,Enterotoxin/Polypeptide,"2,071,478",,Canada,CA,4/24/1992,,,,0255-011,Large,10/27/1989,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Nationalized PCT,4/12/2018,0255-011,9/12/2002,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",611534,,581275,Yes
5199,89-T-021,METHODS AND COMPOSITIONS EMPLOYING ANTIBODIES TO T-CELL EPITOPES INCLUDING CD3 FOR IMMUNE POTENTIATION,"07/429,729",,*United States,US,10/27/1989,,,,0255-002,Small,10/27/1989,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,US Utility,4/12/2018,0255-002,,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",612648,,581275,Yes
5200,89-T-021,Methods for Immunopotentiation,"07/524,304",,*United States,US,5/16/1990,,,,0255-003,Small,10/27/1989,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Continuation in Part,4/12/2018,0255-003,,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613199,,581275,Yes
5201,89-T-021,Methods for Immunopotentiation,PCT/US90/916853, ,*United States,US,10/26/1990,, ,10/26/1990,0255-004,Small,10/27/1989,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Jeffrey Bluestone,PCT,4/12/2018,0255-004,4/27/1992,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613200,,581275,Yes
5202,89-T-021,Methods for Immunopotentiation,90916853.6EPO,497883,European Patent Office (EPO),EP,4/23/1992,7/15/1998, ,,0255-005,Small,10/27/1989,,No,5/21/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Jeffrey Bluestone,Nationalized PCT,4/12/2018,0255-005,4/23/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613201,,581275,Yes
5203,89-T-021,Methods for Immunopotentiation,90916853.6,497883,China,CN,4/23/1992,7/15/1998,,,0255-006,Small,10/27/1989,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Nationalized PCT,4/12/2018,0255-006,4/23/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613202,,581275,Yes
5204,89-T-021,Methods for Immunopotentiation,90916853.6DE,69032484.7,Germany,DE,4/23/1992,7/15/1998,,,0255-007,Small,10/27/1989,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Validated EPO,4/12/2018,0255-007,4/23/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613203,,581275,Yes
5205,89-T-021,Methods for Immunopotentiation,90916853.6FR,497883,France,FR,4/23/1992,7/15/1998,,,0255-008,Small,10/27/1989,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Validated EPO,4/12/2018,0255-008,4/23/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613204,,581275,Yes
5206,89-T-021,Methods for Immunopotentiation,90916853.6GB,497883,United Kingdom,GB,4/23/1992,7/15/1998,,,0255-009,Small,10/27/1989,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Validated EPO,4/12/2018,0255-009,4/23/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613205,,581275,Yes
5207,89-T-021,Methods for Immunopotentiation,90916853.6IT,497883,Italy,IT,4/23/1992,7/15/1998,,,0255-010,Small,10/27/1989,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Validated EPO,4/12/2018,0255-010,4/23/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613206,,581275,Yes
5208,89-T-021,Methods for Immunopotentiation,515665/90,2546544,Japan,JP,4/27/1992,8/8/1996,,,0255-012,Small,10/27/1989,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,"Foreign, Non-PCT",4/12/2018,0255-012,4/27/2012,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613207,,581275,Yes
5209,89-T-021,Methods for Immunopotentiation,"07/990,553",,*United States,US,12/14/1992,,,,0255-013,Small,10/27/1989,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Continuation,4/12/2018,0255-013,,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613208,,581275,Yes
5210,89-T-021,Methods of Promoting Immunopotentiation and Preparing Antibodies with Anti-CD3 Antibodies,"08/458,462","6,143,297",*United States,US,6/2/1995,11/7/2000,,,0255-018,Small,10/27/1989,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Divisional,4/12/2018,0255-018,10/27/2009,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613339,,581275,Yes
5211,89-T-021,Methods of stimulating or enhancing the immune system with anti-CD3 antibodies,"08/286,805","6,113,901",*United States,US,8/5/1994,9/5/2000,,,0255-014,Small,10/27/1989,,Yes,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Continuation,4/12/2018,0255-014,9/5/2017,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613347,,581275,Yes
5212,89-T-021,Promoting Immunopotentiation,"08/458,122",,*United States,US,6/2/1995,,,,0255-015,Small,8/5/1994,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Divisional,4/12/2018,0255-015,6/2/2015,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",614200,,581275,Yes
5213,89-T-021,Promoting Immunopotentiation,PCT/US90/06177, ,*United States,US,6/2/1995,12/28/1998, ,6/2/1995,0255-016,None,10/27/1989,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Jeffrey Bluestone,PCT,4/12/2018,0255-016,6/2/2015,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",614201,,581275,Yes
5214,89-T-021,Promoting Immunopotentiation,"08/459,486","6,406,696",*United States,US,6/2/1995,6/18/2002,,,0255-017,Small,8/5/1994,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,Jeffrey Bluestone,Continuation,4/12/2018,0255-017,9/5/2017,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",614202,,581275,Yes
5215,89-T-023,Site Specific Recombination,"07/431,430", ,*United States,US,11/3/1989,, ,11/3/1989,0249-001,None,11/3/1989,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Kent Golic, Susan Lindquist, Edward Petersen",US Utility,4/12/2018,0249-001,,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614522,,581277,Yes
5216,89-T-025,Automated Method and System for the Detection and Classification of Abnormal Lesions and Parenchymal Distortions in Digital Medical Images,"07/383,097","5,133,020",*United States,US,7/21/1989,7/21/1992,,,0251-001,Large,7/21/1989,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Charles Metz, Fang-Fang Yin",US Utility,4/12/2018,0251-001,7/21/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610629,,581279,Yes
5217,89-T-025,Automated Method and System for the Detection and Classification of Abnormal Lesions and Parenchymal Distortions in Digital Medical Images,P02-190921,3001232,Japan,JP,7/20/1990,11/12/1999, ,,0251-002,Large,7/21/1989,,No,8/4/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger, Charles Metz, Fang-Fang Yin","Foreign, Non-PCT",4/12/2018,0251-002,7/20/2010,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610630,,581279,Yes
5218,89-T-037,Method and System for Determination of Instantaneous and Average Blood Flow Rates from Digital Angiograms,"07/428,059","5,150,292",*United States,US,10/27/1989,9/22/1992,,,0267-001,Large,10/27/1989,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Kenneth Hoffmann",US Utility,4/12/2018,0267-001,10/27/2009,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612351,,581291,Yes
5219,89-T-037,Method and System for Determination of Instantaneous and Average Blood Flow Rates from Digital Angiograms,P02-287410,2989878,Japan,JP,10/26/1990,12/13/1999,03-184531,,0267-002,Large,10/27/1989,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy",,"Kunio Doi, Kenneth Hoffmann","Foreign, Non-PCT",4/12/2018,0267-002,10/26/2010,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612352,8/12/1991,581291,Yes
5220,89-T-039,Amylin Precursors,"07/441,108", ,*United States,US,11/24/1989,, ,11/24/1989,0305-001,None,11/24/1989,,Yes,6/8/2022,Abandoned,,, ,"Graeme Bell, Tokio Sanke, Donald Steiner",US Utility,4/12/2018,0305-001,,"Butler, Brittany",Graeme Bell,"Butler, Brittany",610308,,581293,Yes
5221,90-T-002,Electromagnetic Induction Pump for Pumping Liquid Metals and Other Conductive Liquids,"07/778,456","5,209,646",*United States,US,10/16/1991,5/11/1993, ,10/16/1991,90-006-001,Small,10/16/1991,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,Robert Smither,US Utility,4/12/2018,90-006-001,10/16/2011,"Unassigned, Unassigned",Robert Smither,"Unassigned, Unassigned",611518,,580988,Yes
5222,90-T-003,High Temperature Superconductor Fault Current Limiter,"07/923,712", ,*United States,US,7/31/1992,, ,7/31/1992,90-027-001,Small,7/31/1992,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach","Rechtin, Michael", ,John Hull,US Utility,4/12/2018,90-027-001,,"Unassigned, Unassigned",John Hull,"Unassigned, Unassigned",611816,,580989,Yes
5223,90-T-003,High Temperature Superconductor Fault Current Limiter,"08/292,410","5,600,522",*United States,US,7/31/1992,2/4/1997, ,8/18/1994,90-027-002,Large,7/31/1992,,No,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,John Hull,Continuation,4/12/2018,90-027-002,2/4/2014,"Unassigned, Unassigned",John Hull,"Unassigned, Unassigned",611817,,580989,Yes
5224,90-T-004,Methods and Materials Relating to IMPDH and GMP Production,"08/006,655", ,*United States,US,1/21/1993,, ,1/21/1993,90-066-001,None,1/21/1993,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Frank Collart, Eliezer Huberman",US Utility,4/12/2018,90-066-001,1/21/2013,"Ginsburg, Eric",Frank Collart,"Muite, Kevin",613126,,580990,Yes
5225,90-T-012,Method for Treatment of Amyotrophic Lateral Sclerosis Comprising Administration of DMP,"07/560,084","5,229,394",*United States,US,7/30/1990,7/20/1993,,,0297-001,Small,7/30/1990,,Yes,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,Edgar Salazar-Grueso,US Utility,4/12/2018,0297-001,7/30/2010,"Unassigned, Unassigned",Edgar Salazar-Grueso,"Unassigned, Unassigned",612512,,581303,Yes
5226,90-T-012,Method for Treatment of Amyotrophic Lateral Sclerosis Comprising Administration of DMP,PCT/US90/06073, ,*United States,US,7/30/1990,, ,7/30/1990,0297-002,Small,7/30/1990,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Raymond Roos, Edgar Salazar-Grueso",PCT,4/12/2018,0297-002,1/30/1993,"Unassigned, Unassigned",Edgar Salazar-Grueso,"Unassigned, Unassigned",612513,,581303,Yes
5227,90-T-014,METHODS AND COMPOSITIONS FOR THE OMGP GENE AND PROTEIN,"07/551,267",,*United States,US,7/12/1990,,,,0323-001,Small,7/12/1990,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Cooperman, John",,Kari Stefansson,US Utility,4/12/2018,0323-001,,"Unassigned, Unassigned",Kari Stefansson,"Unassigned, Unassigned",612880,,581305,Yes
5228,90-T-014,Nucleic Acid Sequences Encoding OMGP,"08/183,588","5,532,351",*United States,US,1/21/1994,7/2/1996,,,0323-002,Small,7/12/1990,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Kari Stefansson,Continuation,4/12/2018,0323-002,7/2/2013,"Unassigned, Unassigned",Kari Stefansson,"Unassigned, Unassigned",613741,,581305,Yes
5229,90-T-021,Direct Magnesiation,"07/405,561",,*United States,US,9/11/1989,,,,0277-001,None,9/11/1989,,Yes,4/12/2018,Abandoned,,,,"Philip Eaton, Chih-Hung Lee, Yusheng Xiong",US Utility,4/12/2018,0277-001,,"Ginsburg, Eric",Philip Eaton,"Juggernauth, Anne",611459,,581312,Yes
5230,90-T-021,Direct Magnesiation,"07/747,396",,*United States,US,8/16/1991,,,,0277-002,None,9/11/1989,,No,4/12/2018,Abandoned,,,,"Philip Eaton, Chih-Hung Lee, Yusheng Xiong",Continuation in Part,4/12/2018,0277-002,,"Ginsburg, Eric",Philip Eaton,"Juggernauth, Anne",611460,,581312,Yes
5231,90-T-025,Control of Wound Scar Production,"07/387,604",,*United States,US,7/31/1989,,,,0354-001,Small,7/31/1989,,Yes,4/12/2018,Abandoned,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",US Utility,4/12/2018,0354-001,,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611321,,581316,Yes
5232,90-T-025,Control of Wound Scar Production,511636/90,3149180,Japan,JP,7/31/1990,1/19/2001,,,0354-002,Small,7/31/1989,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee","Foreign, Non-PCT",4/12/2018,0354-002,7/31/2010,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611322,,581316,Yes
5233,90-T-025,Control of Wound Scar Production,"07/629,080","5,132,119",*United States,US,12/17/1990,7/21/1992,,,0354-003,Small,7/31/1989,,Yes,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Continuation,4/12/2018,0354-003,7/21/2009,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611323,,581316,Yes
5234,90-T-025,Control of Wound Scar Production,"07/916,412",,*United States,US,7/20/1992,,,,0354-005,Small,12/17/1990,,Yes,4/12/2018,Abandoned,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Continuation in Part,4/12/2018,0354-005,7/20/2012,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611324,,581316,Yes
5235,90-T-025,Control of Wound Scar Production,90912115.4EPO,"0,485,470",European Patent Office (EPO),EP,7/20/1993,3/16/1994, ,,0354-007,Small,7/31/1989,,No,5/21/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice", ,"Louis Cohen, Thomas Krizek, Raphael Lee",Nationalized PCT,4/12/2018,0354-007,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611325,,581316,Yes
5236,90-T-025,Control of Wound Scar Production,90912115.4FR,0485470,France,FR,7/20/1993,3/16/1994,,,0354-008,Small,7/31/1989,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Validated EPO,4/12/2018,0354-008,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611326,,581316,Yes
5237,90-T-025,Control of Wound Scar Production,90912115.4DE,P69007486.7-08,Germany,DE,7/20/1993,3/16/1994,,,0354-009,Small,7/31/1989,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Validated EPO,4/12/2018,0354-009,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611327,,581316,Yes
5238,90-T-025,Control of Wound Scar Production,90912115.4GB,0485470,United Kingdom,GB,7/20/1993,3/16/1994,,,0354-010,Small,7/31/1989,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Validated EPO,4/12/2018,0354-010,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611328,,581316,Yes
5239,90-T-025,Control of Wound Scar Production,"08/190,239","5,569,678",*United States,US,2/1/1994,10/29/1996,,,0354-012,Small,7/31/1989,10/29/2013,No,2/20/2019,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Continuation,4/12/2018,0354-012,10/29/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611329,,581316,Yes
5240,90-T-025,Control of Wound Scar Production,"08/740,242","5,902,609",*United States,US,10/25/1996,5/11/1999,,,0354-013,Small,7/31/1989,6/6/2011,No,2/20/2019,Abandoned,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Continuation,4/12/2018,0354-013,10/25/2016,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611330,,581316,Yes
5241,90-T-025,Control of Wound Scar Production,93918261.4GB,0651637,United Kingdom,GB,7/20/1993,10/4/2006,EP 0 651 637 A1,,0354-014,Small,7/20/1992,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Validated EPO,4/12/2018,0354-014,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611331,5/10/1995,581316,Yes
5242,90-T-025,Control of Wound Scar Production,93918261.4FR,0651637,France,FR,7/20/1993,10/4/2006,EP 0 651 637 A1,,0354-015,Small,7/20/1992,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Validated EPO,4/12/2018,0354-015,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611332,5/10/1995,581316,Yes
5243,90-T-025,Control of Wound Scar Production,93918261.4IT,0651637,Italy,IT,7/20/1993,10/4/2006,EP 0 651 637 A1,,0354-016,Small,7/20/1992,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee",Validated EPO,4/12/2018,0354-016,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611333,5/10/1995,581316,Yes
5244,90-T-025,Control of Wound Scar Production with Calcium Antagonists Alone or in a Combination with a Steroid,PCT/US93/06804, ,*United States,US,7/20/1993,,WO 94/02130,7/20/1993,0354-006,Small,7/20/1992,,No,4/28/2022,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice", ,Raphael Lee,PCT,4/12/2018,0354-006,1/20/1995,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611334,2/3/1994,581316,Yes
5245,90-T-025,Control of Wound Scar Production with Calcium Antagonists Alone or in a Combination with a Steroid,93918261.4EPO,0651637,European Patent Office (EPO),EP,7/20/1993,10/4/2006,EP 0 651 637 A1,,0354-017,Small,7/20/1992,,No,5/21/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice", ,Raphael Lee,Nationalized PCT,4/12/2018,0354-017,7/20/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611335,5/10/1995,581316,Yes
5246,90-T-025,Use of Calcium Antagonists for Treating Scars,"2,059,558","2,059,558",Canada,CA,1/27/1992,11/12/2002,,,0354-004,Small,7/31/1989,,No,4/12/2018,Expired - Inactive,"Hamilton, Brook, Smith & Reynolds P.C.","Carroll, Alice",,"Louis Cohen, Thomas Krizek, Raphael Lee","Foreign, Non-PCT",4/12/2018,0354-004,1/27/2012,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",615160,,581316,Yes
5247,90-T-030,Method and System for Automatic Detection of Ribs and Pneumothorax in Digital Chest Radiographs,"07/617,080",,*United States,US,11/21/1990,,,,0322-001,None,11/21/1990,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigeru Sanada",US Utility,4/12/2018,0322-001,,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612331,,581321,Yes
5248,90-T-030,Method and System for Automatic Detection of Ribs and Pneumothorax in Digital Chest Radiographs,P03-331602,3134009,Japan,JP,11/21/1991,11/24/2000,,,0322-002,Large,11/21/1990,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigeru Sanada","Foreign, Non-PCT",4/12/2018,0322-002,11/21/2011,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612332,,581321,Yes
5249,90-T-030,Method and System for Automatic Detection of Ribs and Pneumothorax in Digital Chest Radiographs,"08/174,175","5,668,888",*United States,US,12/29/1993,9/16/1997,,,0322-003,Large,11/21/1990,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigeru Sanada",Continuation,4/12/2018,0322-003,9/16/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612333,,581321,Yes
5250,90-T-031,Control of Gene Expression by Ionizing Radiation,"07/633,626",,*United States,US,12/20/1990,,,,0328-001,Small,12/20/1990,,Yes,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",US Utility,4/12/2018,0328-001,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611281,,581322,Yes
5251,90-T-031,Control of Gene Expression by Ionizing Radiation,PCT/US91/09651, ,*United States,US,12/19/1991,,WO 92/11033,12/19/1991,0328-002,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",PCT,4/12/2018,0328-002,6/20/1993,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611282,7/9/1992,581322,Yes
5252,90-T-031,Control of Gene Expression by Ionizing Radiation,91702/91,657111,Australia,AU,12/19/1991,6/20/1995,,,0328-003,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-003,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611283,,581322,Yes
5253,90-T-031,Control of Gene Expression by Ionizing Radiation,"2,098,849","2,098,849",Canada,CA,12/19/1991,7/10/2007,,,0328-004,Large,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-004,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611284,,581322,Yes
5254,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2EPO,0563278,European Patent Office (EPO),EP,12/19/1991,3/8/2000,EP 0 563 278 A1,,0328-005,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-005,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611285,10/6/1993,581322,Yes
5255,90-T-031,Control of Gene Expression by Ionizing Radiation,503403/92,3337214,Japan,JP,12/19/1991,8/9/2002,,,0328-006,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-006,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611286,,581322,Yes
5256,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2AT,0563278,Austria,AT,12/19/1991,3/8/2000,,,0328-007,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-007,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611287,,581322,Yes
5257,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2BE,0563278,Belgium,BE,12/19/1991,3/8/2000,,,0328-008,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-008,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611288,,581322,Yes
5258,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2CH,0563278,Switzerland,CH,12/19/1991,3/8/2000,,,0328-009,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-009,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611289,,581322,Yes
5259,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2DE,0563278,Germany,DE,12/19/1991,3/8/2000,,,0328-010,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-010,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611290,,581322,Yes
5260,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2DK,0563278,Denmark,DK,12/19/1991,3/8/2000,,,0328-011,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-011,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611291,,581322,Yes
5261,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2ES,0563278,Spain,ES,12/19/1991,3/8/2000,,,0328-012,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-012,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611292,,581322,Yes
5262,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2FR,0563278,France,FR,12/19/1991,3/8/2000,,,0328-013,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-013,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611293,,581322,Yes
5263,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2GB,0563278,United Kingdom,GB,12/19/1991,3/8/2000,,,0328-014,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-014,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611294,,581322,Yes
5264,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2IT,0563278,Italy,IT,12/19/1991,3/8/2000,,,0328-015,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-015,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611295,,581322,Yes
5265,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2NL,0563278,Netherlands,NL,12/19/1991,3/8/2000,,,0328-017,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-017,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611296,,581322,Yes
5266,90-T-031,Control of Gene Expression by Ionizing Radiation,92903431.2SE,0563278,Sweden,SE,12/19/1991,3/8/2000,,,0328-018,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-018,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611297,,581322,Yes
5267,90-T-031,Control of Gene Expression by Ionizing Radiation,"08/035,897",,*United States,US,3/18/1993,,,,0328-020,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation,4/12/2018,0328-020,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611298,,581322,Yes
5268,90-T-031,Control of Gene Expression by Ionizing Radiation,"08/212,308","5,612,318",*United States,US,3/14/1994,3/18/1997,,,0328-042,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation,4/12/2018,0328-042,3/18/2014,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611299,,581322,Yes
5269,90-T-031,Control of Gene Expression by Ionizing Radiation,"08/486,338","5,817,636",*United States,US,6/7/1995,10/6/1998,,,0328-044,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation,4/12/2018,0328-044,10/6/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611300,,581322,Yes
5270,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,PCT/US93/08432, ,*United States,US,9/8/1993,,WO 94/06916,9/8/1993,0328-021,None,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",PCT,4/12/2018,0328-021,3/11/1995,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611644,3/31/1994,581322,Yes
5271,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,48509/93,686112,Australia,AU,9/8/1993,5/21/1998,,,0328-022,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-022,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611645,,581322,Yes
5272,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,"2,144,406","2,144,406",Canada,CA,9/8/1993,1/6/2009,,,0328-023,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-023,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611646,,581322,Yes
5273,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2EPO,662137,European Patent Office (EPO),EP,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-024,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-024,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611647,12/7/1995,581322,Yes
5274,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,508137/94,,Japan,JP,9/8/1993,,501448,,0328-025,Small,9/11/1992,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0328-025,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611648,2/20/1996,581322,Yes
5275,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2AT,E 295 889,Austria,AT,9/8/1993,5/18/2005,,,0328-026,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-026,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611649,6/26/2006,581322,Yes
5276,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2BE,662137,Belgium,BE,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-027,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-027,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611650,12/7/1995,581322,Yes
5277,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2CH,662137,Switzerland,CH,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-028,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-028,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611651,12/7/1995,581322,Yes
5278,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2DE,69333815.6,Germany,DE,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-029,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-029,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611652,12/7/1995,581322,Yes
5279,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2DK,662137,Denmark,DK,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-030,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-030,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611653,12/7/1995,581322,Yes
5280,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2ES,662137,Spain,ES,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-031,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-031,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611654,12/7/1995,581322,Yes
5281,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2FR,662137,France,FR,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-032,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-032,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611655,12/7/1995,581322,Yes
5282,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2GB,662137,United Kingdom,GB,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-033,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-033,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611656,12/7/1995,581322,Yes
5283,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,3054313,20050402281,Greece,GR,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-034,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-034,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611657,12/7/1995,581322,Yes
5284,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2IE,662137,Ireland,IE,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-035,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-035,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611658,12/7/1995,581322,Yes
5285,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2IT,662137,Italy,IT,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-036,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-036,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611659,12/7/1995,581322,Yes
5286,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2LU,662137,Luxembourg,LU,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-037,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-037,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611660,12/7/1995,581322,Yes
5287,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2MC,662137,Monaco,MC,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-038,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-038,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611661,12/7/1995,581322,Yes
5288,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2NL,662137,Netherlands,NL,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-039,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-039,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611662,12/7/1995,581322,Yes
5289,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2PT,662137,Portugal,PT,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-040,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-040,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611663,12/7/1995,581322,Yes
5290,90-T-031,Gene Transcription and Ioninzing Radiation - Methods and Compositions,93921410.2SE,662137,Sweden,SE,9/8/1993,5/18/2005,EP 0 662 137 A1,,0328-041,Small,9/11/1992,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-041,9/8/2013,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611664,12/7/1995,581322,Yes
5291,90-T-031,Gene Transcription and Ionizing Radiation: Methods and Compositions,"07/943,812","6,605,712",*United States,US,9/11/1992,8/12/2003, ,,0328-019,Small,12/20/1990,8/12/2003,Yes,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC",,,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation in Part,4/12/2018,0328-019,8/12/2020,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611665,,581322,Yes
5292,90-T-031,Gene Transcription and Ionizing Radiation: Methods and Compositions,"08/474,445","5,770,581",*United States,US,6/7/1995,6/23/1998,,,0328-043,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Divisional,4/12/2018,0328-043,6/23/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611666,,581322,Yes
5293,90-T-031,Gene Transcription and Ionizing Radiation: Methods and Compositions,"09/102,997","6,156,736",*United States,US,6/22/1998,12/5/2000,,,0328-045,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation,4/12/2018,0328-045,12/20/2010,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611667,,581322,Yes
5294,90-T-031,Gene Transcription and Ionizing Radiation: Methods and Compositions,"11/257,553",,*United States,US,10/25/2005,,US-2006-0058258A1,,0328-047,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Divisional,4/12/2018,0328-047,12/20/2010,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611668,3/16/2006,581322,Yes
5295,90-T-031,Gene Transcription and Ionizing Radiation:Methods and Compositions,"09/730,630","7,041,653",*United States,US,12/5/2000,5/9/2006,US-2001-006954-A1,,0328-046,Small,12/20/1990,,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation,4/12/2018,0328-046,12/20/2010,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611669,7/5/2001,581322,Yes
5296,90-T-031,Liechtenstein,92903431.2LI,0563278,Lichtenstein,LI,12/19/1991,3/8/2000,,,0328-016,Small,12/20/1990,,No,6/8/2022,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Validated EPO,4/12/2018,0328-016,12/19/2011,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612076,,581322,Yes
5297,90-T-034,Removable Vascular Filter,"07/318,957",,*United States,US,3/6/1989,,,,0327-001,None,3/6/1989,,Yes,4/12/2018,Abandoned,,,,Bruce Gewertz,US Utility,4/12/2018,0327-001,,"Bakalyar, Heather",Bruce Gewertz,"Unassigned, Unassigned",614390,,581325,Yes
5298,90-T-034,Removable Vascular Filter,"07/512,029","4,969,891",*United States,US,4/13/1990,11/13/1990,,,0327-002,None,3/6/1989,,No,4/12/2018,Expired - Inactive,,,,Bruce Gewertz,Continuation,4/12/2018,0327-002,3/6/2009,"Bakalyar, Heather",Bruce Gewertz,"Unassigned, Unassigned",614391,,581325,Yes
5299,90-T-040,Method and System for Differential Diagnosis Based on Clinical and Radiological Information Using Artificial Neural Networks,"07/573,800",,*United States,US,8/28/1990,,,,0330-001,Large,8/28/1990,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,Kunio Doi,US Utility,4/12/2018,0330-001,,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612355,,581331,Yes
5300,90-T-040,Method and System for Differential Diagnosis Based on Clinical and Radiological Information Using Artificial Neural Networks,"08/053,345","5,463,548",*United States,US,4/28/1993,10/31/1995,,,0330-002,Large,8/28/1990,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Naoki Asada, Kunio Doi",Continuation,4/12/2018,0330-002,10/31/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612356,,581331,Yes
5301,90-T-040,Method and System for Differential Diagnosis Based on Clinical and Radiological Information Using Artificial Neural Networks,"08/422,172","5,622,171",*United States,US,4/14/1995,4/22/1997,,,0330-003,Large,8/28/1990,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Naoki Asada, Kunio Doi",Continuation,4/12/2018,0330-003,4/22/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612357,,581331,Yes
5302,90-T-040,Method and System for Differential Diagnosis Based on Clinical and Radiological Information Using Artificial Neural Networks,217518/91,3231810,Japan,JP,8/28/1991,9/14/2001,,,0330-004,Small,8/28/1990,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,Kunio Doi,"Foreign, Non-PCT",4/12/2018,0330-004,9/14/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612358,,581331,Yes
5303,91-T-001,Method of Detection of Human Moncytic and Granulocytic Leukemia Cells,"07/847,924", ,*United States,US,3/6/1992,, ,3/6/1992,91-003-001,None,3/6/1992,,Yes,4/28/2022,Abandoned,,, ,"Eliezer Huberman, Shin-Ichi Murao",US Utility,4/12/2018,91-003-001,,"Unassigned, Unassigned",Shin-Ichi Murao,"Unassigned, Unassigned",612520,,580991,Yes
5304,91-T-002,Centrifugal Pyrocontactor,"07/927,028","5,254,076",*United States,US,8/6/1992,10/19/1993, ,8/6/1992,91-007-001,Small,8/6/1992,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Lorac Chow, Ralph Leonard",US Utility,4/12/2018,91-007-001,8/6/2012,"Unassigned, Unassigned",Lorac Chow,"Unassigned, Unassigned",610821,,580992,Yes
5305,91-T-003,Transition Metal Sulfide Loaded Catalyst,"07/877,308","5,306,683",*United States,US,5/1/1992,4/26/1994, ,5/1/1992,91-079-001,Small,5/1/1992,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach","Rechtin, Michael", ,"Lennox Iton, Theodore Krause, Victor Maroni, James Pasterczyk, Markus Winterer",US Utility,4/12/2018,91-079-001,5/1/2012,"Unassigned, Unassigned",Victor Maroni,"Unassigned, Unassigned",614937,,580993,Yes
5306,91-T-005,Aqueous Biphasic Extraction Process with Ph and Particle Control,"07/928,790","5,411,149",*United States,US,8/11/1992,5/2/1995, ,8/11/1992,91-105-001,Small,8/11/1992,,Yes,4/28/2022,Released to Inventors,Foley & Lardner,, ,"David Chaiko, R. Mensah-Biney",US Utility,4/12/2018,91-105-001,8/11/2012,"Unassigned, Unassigned",David Chaiko,"Unassigned, Unassigned",610562,,580995,Yes
5307,91-T-005,Aqueous Biphasic Plutonium Oxide Extraction Process with Ph and Particle Control,"08/431,733","5,625,862",*United States,US,8/11/1992,4/29/1997, ,5/1/1995,91-105-002,None,8/11/1992,,No,4/28/2022,Released to Inventors,Foley & Lardner,"Rechtin, Michael", ,"David Chaiko, R. Mensah-Biney",Divisional,4/12/2018,91-105-002,4/29/2014,"Unassigned, Unassigned",David Chaiko,"Unassigned, Unassigned",610563,,580995,Yes
5308,91-T-007,Chromosome-specific Staining to Detect Genetic Rearrangements,"09/765,291","8,415,464",*United States,US,1/22/2001,4/9/2013,,,0331-005,Small,6/12/1990,4/9/2013,No,5/14/2019,Expired - Inactive,Barnes & Thornburg,,,"Joe Gray, Daniel Pinkel, Douglas Tkachuk, Carol Westbrook",Divisional,4/12/2018,0331-005,10/18/2016,"Dembo, Anna",Carol Westbrook,"Tennant, Thelma",610890,,581332,Yes
5309,91-T-007,Cosmid C-Hu-ABL (Chromosomal Aberrations),"08/466,781",,*United States,US,6/6/1995,,,,0331-002,Small,10/28/1991,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Rasheed, Nabeela",,Carol Westbrook,Continuation,4/12/2018,0331-002,,"Dembo, Anna",Carol Westbrook,"Tennant, Thelma",611347,,581332,Yes
5310,91-T-007,Methods and Compositions for the Detection of Chromosomal Aberrations,"07/784,222","6,025,126",*United States,US,10/28/1991,2/15/2000,,,0331-001,Small,10/28/1991,3/12/2012,Yes,2/19/2019,Abandoned,Barnes & Thornburg,"Martin, Alice",,Carol Westbrook,US Utility,4/12/2018,0331-001,2/15/2017,"Dembo, Anna",Carol Westbrook,"Tennant, Thelma",612863,,581332,Yes
5311,91-T-007,Methods and Compositions for the Detection of Chromosomal Aberrations,"09/502,954","6,576,421",*United States,US,2/11/2000,6/10/2003,,,0331-003,Small,10/28/1991,6/10/2003,No,7/14/2020,Expired - Inactive,Barnes & Thornburg,"Martin, Alice",,Carol Westbrook,Continuation,4/12/2018,0331-003,6/10/2020,"Dembo, Anna",Carol Westbrook,"Tennant, Thelma",612864,,581332,Yes
5312,91-T-007,Methods and compositions for the detection of chromosomal aberrations,"10/236,880",,*United States,US,9/6/2002,,US-2003-0099987-A1,,0331-004,Small,10/28/1991,,No,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Carol Westbrook,Continuation,4/12/2018,0331-004,10/28/2011,"Dembo, Anna",Carol Westbrook,"Tennant, Thelma",612865,5/29/2003,581332,Yes
5313,91-T-011,Herpes Protease,92108420.8MC,514830,Monaco,MC,5/19/1992,,,,0335-013,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-013,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611756,,581336,Yes
5314,91-T-011,Methods and Compositions for Preparation and Use of a Herpes Protease,00922271.0FI,104427,Finland,FI,5/19/1992,1/31/2000,,,0335-014,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-014,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612833,,581336,Yes
5315,91-T-011,Methods and Compositions for Preparation and Use of a Herpes Protease,DUP 00922271.0FI,104427,Finland,FI,5/19/1992,1/31/2000,,,0335-027,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-027,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612834,,581336,Yes
5316,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,"07/705,814",,*United States,US,5/24/1991,,,,0335-001,Large,5/24/1991,,Yes,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",US Utility,4/12/2018,0335-001,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612881,,581336,Yes
5317,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,"07/832,855","5,478,727",*United States,US,2/7/1992,12/26/1995,,,0335-002,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Continuation in Part,4/12/2018,0335-002,12/26/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612882,,581336,Yes
5318,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,242739,242739,New Zealand,NZ,5/14/1992,12/22/1994,NZ242739A,,0335-003,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-003,5/14/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612883,12/22/1994,581336,Yes
5319,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8EPO,514830,European Patent Office (EPO),EP,5/19/1992,, ,,0335-004,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Fenyong Lui, Bernard Roizman",Nationalized PCT,4/12/2018,0335-004,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612884,,581336,Yes
5320,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8AT,514830,Austria,AT,5/19/1992,5/3/2000,,,0335-005,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-005,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612885,,581336,Yes
5321,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8BE,514830,Belgium,BE,5/19/1992,5/3/2000,,,0335-006,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-006,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612886,,581336,Yes
5322,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8CH,514830,Switzerland,CH,5/19/1992,5/3/2000,,,0335-007,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-007,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612887,,581336,Yes
5323,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8DE,69230984.5,Germany,DE,5/19/1992,5/3/2000,,,0335-008,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-008,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612888,,581336,Yes
5324,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8ES,92108420.8,Spain,ES,5/19/1992,5/19/2001,,,0335-009,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-009,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612889,,581336,Yes
5325,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8FR,514830,France,FR,5/19/1992,5/19/2001,,,0335-010,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-010,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612890,,581336,Yes
5326,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8GB,514830,United Kingdom,GB,5/19/1992,3/25/1999,,,0335-011,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-011,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612891,,581336,Yes
5327,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8IT,514830,Italy,IT,5/19/1992,5/19/2001,,,0335-012,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-012,5/19/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612892,,581336,Yes
5328,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,1992/3689,1992/3689,South Africa,ZA,5/21/1992,1/27/1993,,,0335-015,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-015,5/21/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612893,,581336,Yes
5329,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,922029.0,303645,Norway,NO,5/22/1992,8/10/1998, ,,0335-016,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-016,5/22/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612894,,581336,Yes
5330,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,"2,069,460","2,069,460",Canada,CA,5/22/1992,12/31/2002,,,0335-017,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-017,5/22/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612895,11/25/1992,581336,Yes
5331,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,P9201723,101975,Israel,IL,5/22/1992,11/17/1998,,,0335-018,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-018,5/22/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612896,,581336,Yes
5332,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,92108420.8HU,2166622,Hungary,HU,5/22/1992,6/28/1994,,,0335-019,Large,5/24/1991,,No,1/25/2020,Abandoned,Norton Rose Fulbright US LLP,,,"Fenyong Lui, Bernard Roizman",Validated EPO,4/12/2018,0335-019,5/22/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612897,,581336,Yes
5333,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,17112/92,"666,305",Australia,AU,5/22/1992,6/25/1996,,,0335-020,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Nationalized PCT,4/12/2018,0335-020,5/22/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612898,,581336,Yes
5334,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,928766.0,245318,"Korea, Republic of",KR,5/23/1992,11/29/1999,,,0335-021,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-021,5/23/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612899,,581336,Yes
5335,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,175901/92,3355202,Japan,JP,5/25/1992,9/27/2002,,,0335-022,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-022,5/25/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612900,,581336,Yes
5336,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,1992/1656,083278,Ireland,IE,7/1/1992,12/30/2003, ,,0335-023,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Fenyong Lui, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0335-023,7/1/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612901,,581336,Yes
5337,91-T-011,Methods and Compositions for the Preparation and Use of a Herpes Protease,"08/176,320","6,410,704",*United States,US,1/3/1994,6/25/2002,,,0335-024,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Continuation,4/12/2018,0335-024,6/25/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612902,,581336,Yes
5338,91-T-011,Preparation and Use of a Herpes Protease,"08/447,804",,*United States,US,5/23/1995,,,,0335-025,Large,5/24/1991,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Fenyong Lui, Bernard Roizman",Divisional,4/12/2018,0335-025,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614137,,581336,Yes
5339,91-T-012,Feature Guided Method and Apparatus for Obtaining an Image of an Object,"07/927,352","5,390,258",*United States,US,8/7/1992,2/14/1995,,,0336-001,Small,8/7/1992,,Yes,4/12/2018,Expired - Inactive,Welsh & Katz,"Gamson, Edward",,David Levin,US Utility,4/12/2018,0336-001,8/7/2012,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",611575,,581337,Yes
5340,91-T-012,Feature Guided Method and Apparatus for Obtaining an Image of an Object,"08/286,571","5,546,472",*United States,US,8/5/1994,8/13/1996,,,0336-002,Small,8/7/1992,,No,4/12/2018,Abandoned,Welsh & Katz,"Cohen, Eric",,David Levin,Continuation in Part,4/12/2018,0336-002,8/13/2013,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",611576,,581337,Yes
5341,91-T-013,Tissue Specific Cancers,"07/644,237", ,*United States,US,1/22/1991,, ,1/22/1991,0355-001,Small,1/22/1991,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Robert Hammer, Laimonis Laimins",US Utility,4/12/2018,0355-001,1/22/2011,"Unassigned, Unassigned",Laimonis Laimins,"Unassigned, Unassigned",614919,,581338,Yes
5342,91-T-016,Use of .beta.-adrenergic Agonists to Treat Patients with Demyelinating or Autoimmune Diseases,"07/913,673","5,264,459",*United States,US,7/13/1992,11/23/1993, ,7/13/1992,0339-001,Small,7/13/1992,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"Barry Arnason, Ewa Chelmicka-Schorr, Louis Cohen, Anthony Reder",US Utility,4/12/2018,0339-001,7/13/2012,"Unassigned, Unassigned",Ewa Chelmicka-Schorr,"Unassigned, Unassigned",615151,,581341,Yes
5343,91-T-019,Methods & Compositions of Genetic Stress Response Systems,CA92/04719,,Canada,CA,6/3/1992,,,,0275-004,Large,6/3/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",Nationalized PCT,4/12/2018,0275-004,,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612599,,581344,Yes
5344,91-T-019,Methods & Compositions of Genetic Stress Response Systems,Unknown-AECD-024-JP,,Japan,JP,6/3/1992,,,,0275-005,Small,6/3/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,,,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez","Foreign, Non-PCT",4/12/2018,0275-005,,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612600,,581344,Yes
5345,91-T-019,Methods & Compositions of Genetic Stress Response Systems,92913901.2DE,692 28 116.9,Germany,DE,6/3/1992,1/7/1999,0587788,,0275-006,Small,6/3/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",Validated EPO,4/12/2018,0275-006,6/3/2012,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612601,3/23/1994,581344,Yes
5346,91-T-019,Methods & Compositions of Genetic Stress Response Systems,92913901.2GB,0587788,United Kingdom,GB,6/3/1992,1/7/1999,0587788,,0275-007,Small,6/3/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",Validated EPO,4/12/2018,0275-007,6/3/2012,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",612602,3/23/1994,581344,Yes
5347,91-T-019,Methods and Compositions of Genetic Stress Response Systems,"07/710,187",,*United States,US,6/3/1991,,,,0275-001,Small,6/3/1991,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",US Utility,4/12/2018,0275-001,,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613001,,581344,Yes
5348,91-T-019,Methods and Compositions of Genetic Stress Response Systems,PCT/US92/04719, ,*United States,US,6/3/1992,,WO 92/21747,6/3/1992,0275-002,Small,6/3/1991,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",PCT,4/12/2018,0275-002,12/3/1993,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613002,12/10/1992,581344,Yes
5349,91-T-019,Methods and Compositions of Genetic Stress Response Systems,92913901.2EPO,EP 0 587 788,European Patent Office (EPO),EP,6/3/1992,1/7/1999,EP 0 587 788 B1,,0275-003,Small,6/3/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",Nationalized PCT,4/12/2018,0275-003,6/3/2012,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613003,3/23/1994,581344,Yes
5350,91-T-019,Methods and Compositions of Genetic Stress Response Systems,"08/249,380","5,827,685",*United States,US,5/25/1994,10/27/1998,,,0275-009,Small,6/3/1991,11/29/2006,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Susan Lindquist,Continuation,4/12/2018,0275-009,10/27/2015,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613004,,581344,Yes
5351,91-T-019,Mutations in Heat Shock Therapy,92913901.2FR,0587788,France,FR,6/3/1992,1/7/1999,0587788,,0275-008,Small,6/3/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Kathy Borkovich, Susan Lindquist, Dawn Parsell, Yolanda Sanchez",Validated EPO,4/12/2018,0275-008,6/3/2012,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613578,3/23/1994,581344,Yes
5352,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,"07/835,271","5,470,568",*United States,US,2/13/1992,11/28/1995,,,0345-001,Small,2/13/1992,,Yes,10/11/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,US Utility,4/12/2018,0345-001,11/28/2012,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612989,,581346,Yes
5353,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0CH,0683669,Switzerland,CH,2/12/1993,9/4/2002,,,0345-002,Small,2/13/1992,,No,1/20/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-002,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612990,,581346,Yes
5354,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0IE,0683669,Ireland,IE,2/12/1993,9/4/2002,,,0345-003,Small,2/13/1992,,No,10/11/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-003,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612991,,581346,Yes
5355,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0GB,0683669,United Kingdom,GB,2/12/1993,9/4/2002,,,0345-004,Small,2/13/1992,,No,10/11/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-004,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612992,,581346,Yes
5356,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0EPO,0683669,European Patent Office (EPO),EP,2/12/1993,9/4/2002,EP 0 683 669 A1,,0345-007,Small,2/13/1992,,No,10/11/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,Raphael Lee,Nationalized PCT,4/12/2018,0345-007,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612993,11/29/1995,581346,Yes
5357,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0FR,0683669,France,FR,2/12/1993,9/4/2002,,,0345-008,Small,2/13/1992,,No,1/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-008,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612994,,581346,Yes
5358,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0DE,69332275.6,Germany,DE,2/12/1993,9/4/2002,,,0345-009,Small,2/13/1992,,No,1/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-009,2/13/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612995,4/17/2003,581346,Yes
5359,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,PCT/US93/01327, ,*United States,US,2/12/1993,,WO 93/15745,2/12/1993,0345-010,Small,2/13/1992,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,Raphael Lee,PCT,4/12/2018,0345-010,8/13/1994,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612996,8/19/1993,581346,Yes
5360,91-T-021,Methods and Compositions of a Polymer (Poloxamer) for Cell Repair,93905944.0IT,0683669,Italy,IT,2/12/1993,9/4/2002,,,0345-011,Small,2/13/1992,,No,1/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-011,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612997,,581346,Yes
5361,91-T-021,Methods and compositions of a polymer (poloxamer) for cell repair.,93905944.0DK,0683669,Denmark,DK,2/12/1993,9/4/2002,,,0345-005,Small,2/13/1992,,No,10/11/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-005,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612998,,581346,Yes
5362,91-T-021,Methods and compositions of a polymer (poloxamer) for cell repair.,93905944.0NL,0683669,Netherlands,NL,2/12/1993,9/4/2002,,,0345-006,Small,2/13/1992,,No,10/11/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,Validated EPO,4/12/2018,0345-006,2/12/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612999,,581346,Yes
5363,91-T-026,Radiohalogenation,"07/178,250",,*United States,US,4/6/1988,,,,0351-001,Small,4/6/1988,,Yes,4/12/2018,Abandoned,,,,"Eugene DeSombre, Arnold Friedman, Ronnie Mease, Robert Seevers",US Utility,4/12/2018,0351-001,,"Unassigned, Unassigned",Eugene DeSombre,"Unassigned, Unassigned",614266,,581351,Yes
5364,91-T-026,"Triphenylethylene Radiohalogenated Compounds, Their Use in Therapy or Diagnosis of Cancer and Process for Their Preparation","08/398,483",,*United States,US,3/3/1995,,,,0351-004,Small,4/6/1988,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Eugene DeSombre, Ronnie Mease",US Utility,4/12/2018,0351-004,,"Unassigned, Unassigned",Ronnie Mease,"Unassigned, Unassigned",615116,,581351,Yes
5365,91-T-026,"Triphenylethylene Radiohalogenated Compounds, Their Use in Therapy or Diagnosis of Cancer, and Process for Their Preparation","07/617,452",,*United States,US,11/21/1990,,,,0351-002,Small,4/6/1988,,No,4/12/2018,Abandoned,,,,"Eugene DeSombre, Arnold Friedman, Ronnie Mease, Robert Seevers",Continuation in Part,4/12/2018,0351-002,,"Unassigned, Unassigned",Eugene DeSombre,"Unassigned, Unassigned",615117,,581351,Yes
5366,91-T-026,"Triphenylethylene Radiohalogenated Compounds, Their Use in Therapy or Diagnosis of Cancer, and Process for Their Preparation","07/961,225",,*United States,US,10/15/1992,,,,0351-003,Small,4/6/1988,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Eugene DeSombre, Ronnie Mease, Robert Seevers",Continuation in Part,4/12/2018,0351-003,,"Unassigned, Unassigned",Eugene DeSombre,"Unassigned, Unassigned",615118,,581351,Yes
5367,91-T-027,Methods and Compositions for Preparing Protein Processing Enzymes,"07/484,074",,*United States,US,2/23/1990,,,,0342-001,Small,2/23/1990,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,,,"Steven Smeekens, Donald Steiner",US Utility,4/12/2018,0342-001,,"Unassigned, Unassigned",Donald Steiner,"Unassigned, Unassigned",612835,,581352,Yes
5368,91-T-027,Methods and Compositions for Preparing Protein Processing Enzymes,"07/640,486",,*United States,US,1/14/1991,,,,0342-002,Small,2/23/1990,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Steven Smeekens, Donald Steiner",Continuation in Part,4/12/2018,0342-002,1/14/2011,"Unassigned, Unassigned",Donald Steiner,"Unassigned, Unassigned",612836,,581352,Yes
5369,91-T-027,Methods and Compositions for Preparing Protein Processing Enzymes,"08/098,756","5,541,062",*United States,US,7/28/1993,7/30/1996,,,0342-003,Small,2/23/1990,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Steven Smeekens, Donald Steiner",Continuation,4/12/2018,0342-003,7/30/2013,"Unassigned, Unassigned",Donald Steiner,"Unassigned, Unassigned",612837,,581352,Yes
5370,91-T-027,Methods and Compositions for Preparing Protein Processing Enzymes,"09/082,749",,*United States,US,5/21/1998,,,,0342-004,Small,1/14/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,,,"Steven Smeekens, Donald Steiner",Divisional,4/12/2018,0342-004,1/14/2011,"Unassigned, Unassigned",Donald Steiner,"Unassigned, Unassigned",612838,,581352,Yes
5371,91-T-031,Clonal Hybrid Motor Neuron Cells,"07/770,044", ,*United States,US,10/2/1991,7/20/1993, ,10/2/1991,0357-001,None,10/2/1991,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Edgar Salazar-Grueso,US Utility,4/12/2018,0357-001,10/2/2011,"Unassigned, Unassigned",Edgar Salazar-Grueso,"Unassigned, Unassigned",610895,,581356,Yes
5372,91-T-032,Optical Grid Alignment System for Portable Radiography and Portable Radiography Apparatus Incorporating Same,"07/801,189","5,241,578",*United States,US,12/2/1991,8/31/1993, ,12/2/1991,0358-001,None,12/2/1991,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Heber MacMahon,US Utility,4/12/2018,0358-001,12/2/2011,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",613827,,581357,Yes
5373,91-T-033,High Quality Film Image Connection Duplication Method and System.,2003-56062, ,Japan,JP,10/30/1992,,2004-048655,,0356-003,Large,10/31/1991,,No,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kunio Doi, Hitoshi Yoshimura",Divisional,4/12/2018,0356-003,10/30/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611811,2/12/2004,581358,Yes
5374,91-T-033,High Quality Film Image Correction and Duplication Method and System,"07/786,008","5,224,177",*United States,US,10/31/1991,6/29/1993, ,,0356-001,Large,10/31/1991,,Yes,8/4/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Hitoshi Yoshimura",US Utility,4/12/2018,0356-001,10/31/2011,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611812,,581358,Yes
5375,91-T-033,High Quality Film Image Correction and Duplication Method and system,314379/92, ,Japan,JP,10/30/1992,, ,,0356-002,Large,10/31/1991,,No,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Hitoshi Yoshimura","Foreign, Non-PCT",4/12/2018,0356-002,10/30/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611813,,581358,Yes
5376,91-T-036,"Method and System for Analysis of False Positives Produced by an Automated Scheme for the Detection of Lung Nodules in Digital Chest Radiographs
Copy of Written Opinion/Copy of amendment",64676/93,3417595,Japan,JP,3/1/1993,2/22/1994,,,0361-002,Small,2/28/1992,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Akiko Kano, Tsuneo Matumoto","Foreign, Non-PCT",4/12/2018,0361-002,3/1/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612321,,581361,Yes
5377,91-T-036,Method and System for Analysis of False Positives Produced by an Automated Scheme for the Detection of Lung Nodules in Digital Chest Radiographs,"07/843,715","5,289,374",*United States,US,2/28/1992,2/22/1994,,,0361-001,Large,2/28/1992,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Akiko Kano, Tsuneo Matumoto",US Utility,4/12/2018,0361-001,2/28/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612322,,581361,Yes
5378,91-T-038,Methods and Compositions for Amplification and Detection of Nucleic Acid Sequences,"06/585,850","4,481,049",*United States,US,9/19/1986,11/6/1984,,,0363-001,Small,9/19/1986,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Bernard Roizman, Richard Whitley",US Utility,4/12/2018,0363-001,9/19/2006,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612650,,581363,Yes
5379,91-T-038,Methods and Compositions for Amplification and Detection of Nucleic Acid Sequences,"07/960,253",,*United States,US,10/13/1992,,,,0363-002,Small,9/19/1986,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Bernard Roizman, Richard Whitley",Continuation,4/12/2018,0363-002,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612651,,581363,Yes
5380,91-T-039,Fourier Transform Infrared Spectrometer,"08/055,696","5,416,325",*United States,US,4/29/1993,5/16/1995, ,4/29/1993,0364-001,Small,4/29/1993,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Joseph Buontempo, Stuart Rice, Winston Roland, Roland Winston",US Utility,4/12/2018,0364-001,4/29/2013,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611617,,581364,Yes
5381,91-T-047,Sequences for Promoting Epidermal Cell-Specific Transcription,"07/791,664", ,*United States,US,11/12/1991,, ,,0306-001,None,11/12/1991,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Elaine Fuchs,US Utility,4/12/2018,0306-001,,"Sun, Han",Elaine Fuchs,"Tennant, Thelma",614487,,581372,Yes
5382,91-T-047,Sequences for Promoting Epidermal Cell-specific Transcription,"07/875,790","6,183,984",*United States,US,4/29/1992,2/6/2001, ,,0306-002,None,11/12/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Elaine Fuchs,Continuation in Part,4/12/2018,0306-002,2/6/2018,"Sun, Han",Elaine Fuchs,"Tennant, Thelma",614488,,581372,Yes
5383,91-T-048,Mathods and Compositions for Inhibiting 5 Alpha-Reductase Activity,98956358.0EPO, ,European Patent Office (EPO),EP,10/30/1998,, ,,0362-018,Small,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Shutsung Liao",Nationalized PCT,4/12/2018,0362-018,10/30/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612228,,581373,Yes
5384,91-T-048,Method and Compositions for Inhibiting 5 Alpha-Reductase Activity,"08/442,055","5,605,929",*United States,US,5/16/1995,2/25/1997, ,,0362-007,Small,5/27/1992,,Yes,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",Continuation in Part,4/12/2018,0362-007,5/27/2012,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612308,,581373,Yes
5385,91-T-048,Method and Compositions for Regulation of 5 Alpha-Reductase Activity,"09/530,443","6,576,660",*United States,US,10/30/1998,6/10/2003, ,,0362-019,Small,10/31/1997,10/30/2018,No,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Shutsung Liao",Nationalized PCT,4/12/2018,0362-019,10/30/2018,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612309,,581373,Yes
5386,91-T-048,Method and Compositions for Regulation of 5 Alpha-Reductase Activity,"10/132,050","6,696,484",*United States,US,10/30/1998,2/24/2004,US 2003-0105030 A1,4/24/2002,0362-020,Small,10/31/1997,11/29/2018,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Shutsung Liao",Continuation in Part,4/12/2018,0362-020,11/29/2018,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612310,6/5/2003,581373,Yes
5387,91-T-048,Methods and Compositions for 5 Alpha-Reductase Activity,"10/294,331", ,*United States,US,10/30/1998,,US 2003-0144346 A1,11/14/2002,0362-022,None,10/31/1997,3/21/2008,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Continuation,4/12/2018,0362-022,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612649,7/31/2003,581373,Yes
5388,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,"07/889,589", ,*United States,US,5/27/1992,, ,,0362-001,Small,5/27/1992,,Yes,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",US Utility,4/12/2018,0362-001,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612760,,581373,Yes
5389,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,"07/904,443","5,422,371",*United States,US,7/1/1992,6/6/1995, ,,0362-002,Small,5/27/1992,,Yes,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",Continuation in Part,4/12/2018,0362-002,6/6/2012,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612761,,581373,Yes
5390,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,81105407,82421,"Taiwan, Province of China",TW,7/8/1992,3/26/1997, ,,0362-003,Small,5/27/1992,,No,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao","Foreign, Non-PCT",4/12/2018,0362-003,7/8/2012,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612762,,581373,Yes
5391,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,PCT/US93/04090, ,*United States,US,4/30/1993,,WO 94/01100,4/30/1993,0362-004,Small,7/1/1992,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",PCT,4/12/2018,0362-004,1/1/1995,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612763,1/20/1994,581373,Yes
5392,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,93910950.0EPO,652749,European Patent Office (EPO),EP,4/30/1993,, ,,0362-005,Small,7/1/1992,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-005,4/30/2013,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612764,,581373,Yes
5393,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,503286/94, ,Japan,JP,4/30/1993,, ,,0362-006,Small,7/1/1992,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-006,4/30/2013,"Dembo, Anna",Richard Hiipakka,"Tennant, Thelma",612765,,581373,Yes
5394,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,84108888,119051,"Taiwan, Province of China",TW,8/26/1995,12/20/2000, ,,0362-008,Small,5/27/1992,,No,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-008,8/26/2015,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612766,,581373,Yes
5395,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,PCT/US96/07137, ,*United States,US,5/16/1996,,WO 96/37201,5/16/1996,0362-009,Small,5/16/1995,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",PCT,4/12/2018,0362-009,11/16/1997,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612767,11/28/1996,581373,Yes
5396,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,"2,221,236", ,Canada,CA,5/16/1996,, ,,0362-010,Small,7/1/1992,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-010,5/16/2016,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612768,11/28/1996,581373,Yes
5397,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,96195605.4,ZL96195605.4,China,CN,5/16/1996,4/30/2008,119088,,0362-011,Small,5/27/1992,,No,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-011,5/16/2016,"Dembo, Anna",Richard Hiipakka,"Tennant, Thelma",612769,8/19/1998,581373,Yes
5398,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,96916487.0EPO, ,European Patent Office (EPO),EP,5/16/1996,,827401,,0362-012,Small,5/27/1992,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-012,5/16/2016,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612770,3/11/1998,581373,Yes
5399,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,535769/96, ,Japan,JP,5/16/1996,, ,,0362-013,Small,5/27/1992,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-013,5/16/2016,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612771,,581373,Yes
5400,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,2000-518662,4738592,Japan,JP,10/30/1998,5/13/2011,,,0362-016,Small,10/31/1997,10/14/2021,No,1/20/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei",,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-016,5/1/2020,"Dembo, Anna",Richard Hiipakka,"Tennant, Thelma",612772,,581373,Yes
5401,91-T-048,Methods and Compositions for Inhibiting 5 Alpha-Reductase Activity,2000-7004542, ,"Korea, Republic of",KR,10/30/1998,, ,,0362-017,Small,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Nationalized PCT,4/12/2018,0362-017,10/30/2018,"Dembo, Anna",Tehming Liang,"Tennant, Thelma",612773,,581373,Yes
5402,91-T-048,Methods and Compositions for Regulating 5 Alpha-Reductase Activity,"60/063,770", ,*United States,US,10/31/1997,, ,10/31/1997,0362-014,Small,10/31/1997,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Provisional,4/12/2018,0362-014,10/31/1998,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612847,,581373,Yes
5403,91-T-048,Methods and Compositions for Regulating 5 Alpha-Reductase Activity,PCT/US98/23041, ,*United States,US,10/30/1998,,WO 99/22728,10/30/1998,0362-015,Small,10/31/1997,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Shutsung Liao",PCT,4/12/2018,0362-015,4/30/2000,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612848,5/14/1999,581373,Yes
5404,91-T-048,Methods and Compositions for Regulation of 5 Alpha-Reductase Activity,"10/174,934", ,*United States,US,10/30/1998,,US 2003-0153541 A1,6/19/2002,0362-021,None,10/31/1997,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Tehming Liang, Shutsung Liao",Continuation in Part,4/12/2018,0362-021,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612850,8/14/2003,581373,Yes
5405,91-T-048,Methods and Compositions for Regulation of 5 Alpha-Reductase Activity,"2,489,702", ,Canada,CA,6/19/2003,, ,,0362-029,None,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Richard Hiipakka, Shutsung Liao",Nationalized PCT,4/12/2018,0362-029,6/19/2023,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612851,,581373,Yes
5406,91-T-048,Novel Anticholesterol Compositions and Method for Using Same,PCT/US03/19515, ,*United States,US,6/19/2003,, ,6/19/2003,0362-023,None,6/19/2002,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Robert Dudley, Shutsung Liao, Ching Song",PCT,4/12/2018,0362-023,4/30/2000,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613717,,581373,Yes
5407,91-T-048,Novel Anticholesterol Compositions and Method for Using Same,03739234.7EPO, ,European Patent Office (EPO),EP,6/19/2003,, ,,0362-024,None,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Robert Dudley, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0362-024,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613718,,581373,Yes
5408,91-T-048,Novel Anticholesterol Compositions and Method for Using Same,3739234.7, ,Canada,CA,6/19/2003,, ,,0362-025,None,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Robert Dudley, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0362-025,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613719,,581373,Yes
5409,91-T-048,Novel Anticholesterol Compositions and Method for Using Same,03818575, ,China,CN,6/19/2003,, ,,0362-026,None,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Robert Dudley, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0362-026,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613720,,581373,Yes
5410,91-T-048,Novel Anticholesterol Compositions and Method for Using Same,2004-516031, ,Japan,JP,6/19/2003,, ,,0362-027,None,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Robert Dudley, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0362-027,6/19/2023,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613721,,581373,Yes
5411,91-T-048,Novel Anticholesterol Compositions and Method for Using Same,2003245605, ,Australia,AU,6/19/2003,, ,,0362-028,None,10/31/1997,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Westin, Lorelei", ,"Robert Dudley, Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0362-028,6/19/2023,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613722,,581373,Yes
5412,91-T-049,Image Processing Technique for Digital Radiographs,310380/92,5237083,Japan,JP,11/19/1992,9/17/1993,,,0377-001,Small,12/28/1991,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,Heber MacMahon,"Foreign, Non-PCT",4/12/2018,0377-001,11/19/2012,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",611907,,581374,Yes
5413,91-T-049,Method and System for Digital Radiography,"08/173,935","6,466,689",*United States,US,12/28/1993,10/15/2002,,,0377-002,Small,11/22/1991,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,Heber MacMahon,Continuation,4/12/2018,0377-002,10/15/2019,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",612359,,581374,Yes
5414,91-T-049,Method and System for Digital Radiography,"10/223,442",,*United States,US,8/20/2002,,US-2003-002727-A1,,0377-003,Small,11/22/1991,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,Heber MacMahon,Continuation,4/12/2018,0377-003,11/22/2011,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",612360,1/2/2003,581374,Yes
5415,91-T-049,Method and System for Digital Radiography,"07/802,063",,*United States,US,11/22/1991,,,,0377-004,None,11/22/1991,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",,,Heber MacMahon,US Utility,4/12/2018,0377-004,,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",612361,,581374,Yes
5416,91-T-050,EWES,TXu-783-805,TXu-783-805,*United States,US,2/5/1997,2/5/1997, ,,91-077-001,None,,,No,8/4/2020,Registered (Copyright),Foley & Lardner,, ,Kenneth Gross,Copyright Application,4/12/2018,91-077-001,2/5/2017,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",611543,,581375,Yes
5417,91-T-051,Method and System for Automated Selection of Regions of Interest and Detection of Septal Lines in Digital Chest Radiographs,"07/843,721","5,343,390",*United States,US,2/28/1992,8/30/1994,,,0378-001,Large,2/28/1992,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Xuan Chen, Kunio Doi, Shigehiko Katsuragawa",US Utility,4/12/2018,0378-001,2/28/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612329,,581376,Yes
5418,91-T-051,Method and System for Automated Selection of Regions of Interest and Detection of Septal Lines in Digital Chest Radiographs,64763/93,3400008,Japan,JP,3/1/1993,2/21/2003,6237925,,0378-002,Large,2/28/1992,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Xuan Chen, Kunio Doi, Shigehiko Katsuragawa","Foreign, Non-PCT",4/12/2018,0378-002,3/1/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612330,8/30/1994,581376,Yes
5419,91-T-052,Method of Recovering Tomographic Signal Elements in a Projection Profile or Image by Solving Linear Equations,"07/832,863","5,323,007",*United States,US,2/7/1992,6/21/1994, ,2/7/1992,0374-001,None,2/7/1992,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Christensen, Jon", ,"Chin-Tu Chen, Miles Wernick",US Utility,4/12/2018,0374-001,2/7/2012,"Ginsburg, Eric",Chin-Tu Chen,"Juggernauth, Anne",612533,,581377,Yes
5420,91-T-054,Isolated DNA Encoding a Somatostatin Receptor,"07/816,283","5,436,155",*United States,US,12/31/1991,7/25/1995,,,0360-001,Large,12/31/1991,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",US Utility,4/12/2018,0360-001,7/25/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",612055,,581379,Yes
5421,91-T-054,Somatostatin Receptors,34269/93,"661,110",Australia,AU,12/30/1992,10/31/1995,,,0360-002,Large,12/31/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Nationalized PCT,4/12/2018,0360-002,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614578,,581379,Yes
5422,91-T-054,Somatostatin Receptors,"2,127,262","2,127,262",Canada,CA,12/30/1992,4/7/2009,,,0360-003,Large,12/31/1991,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Nationalized PCT,4/12/2018,0360-003,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614579,,581379,Yes
5423,91-T-054,Somatostatin Receptors,511950/93,3657602,Japan,JP,12/30/1992,3/18/2005,,,0360-004,Large,12/31/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Nationalized PCT,4/12/2018,0360-004,1/23/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614580,,581379,Yes
5424,91-T-054,Somatostatin Receptors,93902841.1EPO,EP 0 621 874 B1,European Patent Office (EPO),EP,12/30/1992,4/5/2000, ,,0360-005,Large,12/31/1991,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Nationalized PCT,4/12/2018,0360-005,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614581,,581379,Yes
5425,91-T-054,Somatostatin Receptors,PCT/US92/11327, ,*United States,US,12/30/1992,,WO 93/13130 A1,12/30/1992,0360-006,Large,12/31/1991,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Susumu Seino, Yuichiro Yamada",PCT,4/12/2018,0360-006,6/30/1994,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614582,7/8/1993,581379,Yes
5426,91-T-054,Somatostatin Receptors,93902841.1FR,EP 0 621 874 B1,France,FR,12/30/1992,4/5/2000,,,0360-007,Large,12/31/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Validated EPO,4/12/2018,0360-007,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614583,,581379,Yes
5427,91-T-054,Somatostatin Receptors,93902841.1DE,EP 0 621 874 B1,Germany,DE,12/30/1992,4/5/2000,,,0360-008,Large,12/31/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Validated EPO,4/12/2018,0360-008,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614584,,581379,Yes
5428,91-T-054,Somatostatin Receptors,93902841.1CH,EP 0 621 874 B1,Switzerland,CH,12/30/1992,4/5/2000,,,0360-009,Large,12/31/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Validated EPO,4/12/2018,0360-009,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614585,,581379,Yes
5429,91-T-054,Somatostatin Receptors,93902841.1GB,EP 0 621 874 B1,United Kingdom,GB,12/30/1992,4/5/2000,,,0360-010,Large,12/31/1991,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Validated EPO,4/12/2018,0360-010,12/30/2012,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614586,,581379,Yes
5430,91-T-054,Somatostatin Receptors,"08/417,103","5,723,299",*United States,US,4/5/1995,3/3/1998,,,0360-011,Large,12/31/1991,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Susumu Seino, Yuichiro Yamada",Divisional,4/12/2018,0360-011,3/3/2015,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614587,,581379,Yes
5431,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"08/127,420", ,*United States,US,9/27/1993,, ,9/27/1993,92-004-001,Small,9/27/1993,,Yes,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,US Utility,4/12/2018,92-004-001,,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612706,,580997,Yes
5432,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"08/303,058", ,*United States,US,9/27/1993,, ,9/8/1994,92-004-002,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Continuation,4/12/2018,92-004-002,,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612707,,580997,Yes
5433,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,PCT/US94/10945, ,*United States,US,9/27/1994,,WO 95/09248,9/27/1994,92-004-003,Small,9/27/1993,,No,4/28/2022,Expired - Inactive,"McAndrews, Held & Malloy, Ltd.","Rasheed, Nabeela", ,Rade Drmanac,PCT,4/12/2018,92-004-003,3/27/1996,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612708,4/6/1995,580997,Yes
5434,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,80727/94,"694,146",Australia,AU,9/27/1994,11/5/1998, ,9/27/1994,92-004-004,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-004,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612709,,580997,Yes
5435,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,PI9407712-6, ,Brazil,BR,9/27/1994,, ,9/27/1994,92-004-005,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-005,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612710,,580997,Yes
5436,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,960604, ,Belarus,BY,9/27/1994,, ,9/27/1994,92-004-006,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-006,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612712,,580997,Yes
5437,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"2,172,722","2,172,722",Canada,CA,9/27/1994,4/24/2007, ,9/27/1994,92-004-007,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-007,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612713,,580997,Yes
5438,92-T-001,Methods and compositions for efficient nucleic acid sequencing,94194301.1,ZL94194301.1,China,CN,9/27/1994,11/26/2003,1136330,9/27/1994,92-004-008,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-008,11/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612714,11/19/1996,580997,Yes
5439,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,PV905-96, ,Czech Republic,CZ,9/27/1994,, ,9/27/1994,92-004-009,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,"Foreign, Non-PCT",4/12/2018,92-004-009,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612715,,580997,Yes
5440,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,94931775.4EPO,0723598,European Patent Office (EPO),EP,9/27/1994,1/14/2004,WO 1995/009248,9/27/1994,92-004-010,Small,9/27/1993,,No,4/28/2022,Expired - Inactive,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-010,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612716,4/6/1995,580997,Yes
5441,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,19961283, ,Finland,FI,9/27/1994,, ,9/27/1994,92-004-011,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-011,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612717,,580997,Yes
5442,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,P9600759,218597,Hungary,HU,9/27/1994,10/30/2000, ,9/27/1994,92-004-012,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-012,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612718,,580997,Yes
5443,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,510426/95, ,Japan,JP,9/27/1994,, ,9/27/1994,92-004-013,None,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,"Foreign, Non-PCT",4/12/2018,92-004-013,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612719,,580997,Yes
5444,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,701592/96,346953,"Korea, Republic of",KR,9/27/1994,7/19/2002, ,9/27/1994,92-004-014,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-014,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612720,,580997,Yes
5445,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,19961165, ,Norway,NO,9/27/1994,, ,9/27/1994,92-004-015,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-015,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612721,,580997,Yes
5446,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,275194,275194,New Zealand,NZ,9/27/1994,1/16/1998, ,9/27/1994,92-004-016,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-016,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612722,,580997,Yes
5447,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,P-313735,180521,Poland,PL,9/27/1994,8/30/2000, ,9/27/1994,92-004-017,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,"Foreign, Non-PCT",4/12/2018,92-004-017,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612723,,580997,Yes
5448,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,96108267,2143004,Russian Federation,RU,9/27/1994,12/20/1999, ,9/27/1994,92-004-018,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-018,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612724,,580997,Yes
5449,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,PV395-96, ,Slovakia,SK,9/27/1994,, ,9/27/1994,92-004-019,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-019,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612725,,580997,Yes
5450,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,96041632,48119,Ukraine,UA,9/27/1994,8/15/2002, ,9/27/1994,92-004-020,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-020,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612727,,580997,Yes
5451,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,04000534.0EPO, ,European Patent Office (EPO),EP,9/27/1994,,EP 1 408 122 A2,9/27/1994,92-004-022,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-022,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612728,4/14/2004,580997,Yes
5452,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,94931775.4DE,69433487.1,Germany,DE,9/27/1994,1/14/2004, ,9/27/1994,92-004-023,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-023,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612729,,580997,Yes
5453,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,94931775.4IT,0723598,Italy,IT,9/27/1994,1/14/2004, ,9/27/1994,92-004-026,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-026,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612730,,580997,Yes
5454,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,94931775.4FR,0723598,France,FR,9/27/1994,1/14/2004, ,9/27/1994,92-004-037,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-037,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612731,,580997,Yes
5455,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,94931775.4GB,0723598,United Kingdom,GB,9/27/1994,1/14/2004, ,9/27/1994,92-004-038,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-038,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612732,,580997,Yes
5456,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"08/619,649", ,*United States,US,9/27/1993,, ,3/27/1996,92-004-039,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Continuation,4/12/2018,92-004-039,9/27/2013,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612733,,580997,Yes
5457,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"09/272,232","6,401,267",*United States,US,9/27/1993,6/11/2002, ,3/18/1999,92-004-040,Small,9/27/1993,,No,4/28/2022,Expired - Inactive,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Continuation,4/12/2018,92-004-040,9/27/2013,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612734,,580997,Yes
5458,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"10/068,301","7,070,927",*United States,US,9/27/1993,7/4/2006,US-2002-197621-A1,2/5/2002,92-004-041,Small,9/27/1993,,No,4/28/2022,Expired - Inactive,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Continuation,4/12/2018,92-004-041,9/27/2013,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612735,12/26/2002,580997,Yes
5459,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,"11/929,038", ,*United States,US,9/27/1993,,US-2008-01-08074-A1,10/30/2007,92-004-042,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Continuation,4/12/2018,92-004-042,9/27/2013,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612736,5/8/2008,580997,Yes
5460,92-T-001,Methods and Compositions for Efficient Nucleic Acid Sequencing,08001215.6EPO, ,European Patent Office (EPO),EP,9/27/1994,, ,9/27/1994,92-004-043,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Divisional,4/12/2018,92-004-043,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612737,,580997,Yes
5461,92-T-001,Methods and Compositions for Efficient Nucleid Acid Sequencing,94931775.4NL,0723598,Netherlands,NL,9/27/1994,1/14/2004, ,9/27/1994,92-004-029,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-029,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612738,,580997,Yes
5462,92-T-001,Methods and Compositions for Efficient Nucleid Acid Sequencing,94931775.4SE,0723598,Sweden,SE,9/27/1994,1/14/2004, ,9/27/1994,92-004-031,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Validated EPO,4/12/2018,92-004-031,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",612739,,580997,Yes
5463,92-T-001,Methods and Compostions for Efficient Nucleic Acid Sequencing,5-1945/96,844,Vietnam,VN,9/27/1994,3/18/1999, ,9/27/1994,92-004-021,Small,9/27/1993,,No,4/28/2022,Abandoned,"McAndrews, Held & Malloy, Ltd.",, ,Rade Drmanac,Nationalized PCT,4/12/2018,92-004-021,9/27/2014,"Ramirez, Mario Riojas",Rade Drmanac,"Tennant, Thelma",613099,,580997,Yes
5464,92-T-002,Cooling for a Rotating Anode X-Ray Tube,"08/212,180","5,737,387",*United States,US,3/11/1994,4/7/1998, ,3/11/1994,92-030-001,Small,3/11/1994,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,Robert Smither,US Utility,4/12/2018,92-030-001,4/7/2015,"Unassigned, Unassigned",Robert Smither,"Unassigned, Unassigned",611344,,580998,Yes
5465,92-T-005,Aberration Free Lens System for Electron Microscope,"07/899,433","5,336,891",*United States,US,6/16/1992,8/9/1994, ,6/16/1992,0381-001,Small,6/16/1992,,Yes,4/28/2022,Abandoned,Foley & Lardner,"Rechtin, Michael", ,Albert Crewe,US Utility,4/12/2018,0381-001,6/16/2012,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",610244,,581381,Yes
5466,92-T-007,Herpes Simplex Virus ORF P,"08/438,415",,*United States,US,5/10/1995,,,,0383-001,Small,5/10/1995,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Joany Chou, Bernard Roizman",US Utility,4/12/2018,0383-001,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611793,,581383,Yes
5467,92-T-007,"Method of screening candidate protective, potentiating, or inhibiting substances","08/483,533","6,172,047",*United States,US,6/7/1995,1/9/2001,,,0383-002,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bernard Roizman",Divisional,4/12/2018,0383-002,1/9/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612536,,581383,Yes
5468,92-T-007,Method of Treating Tumorigenic Disease,"09/283,471","6,340,673",*United States,US,4/1/1999,1/22/2002,,,0383-020,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32742A,"Joany Chou, Bernard Roizman",Continuation,4/12/2018,0383-020,3/31/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612554,,581383,Yes
5469,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death,PCT/US96/14125, ,*United States,US,8/29/1996,,WO 97/09617,8/29/1996,0383-004,Large,9/6/1995,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",32908-PC,"Joany Chou, Bernard Roizman",PCT,4/12/2018,0383-004,3/6/1998,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614422,3/13/1997,581383,Yes
5470,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death,"2,230,988","5,028,970",Canada,CA,8/29/1996,3/16/1999,,,0383-005,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-CA,"Joany Chou, Bernard Roizman",Nationalized PCT,4/12/2018,0383-005,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614423,,581383,Yes
5471,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death,96929881.9EPO,EP 0 874 986 B1,European Patent Office (EPO),EP,8/29/1996,11/7/2001,EP 0 874 986 A1,,0383-006,Large,9/6/1995,,No,5/21/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",32908-EP,"Joany Chou, Bernard Roizman",Nationalized PCT,4/12/2018,0383-006,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614424,11/4/1998,581383,Yes
5472,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death,9-511336,,Japan,JP,8/29/1996,,,,0383-007,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-JP,"Joany Chou, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0383-007,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614425,,581383,Yes
5473,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death,96929881.9DE,69616829.4,Germany,DE,8/29/1996,11/7/2001,,,0383-008,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-DE,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-008,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614426,,581383,Yes
5474,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9BE,0874986,Belgium,BE,8/29/1996,11/7/2001,,,0383-010,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-BE,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-010,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614427,,581383,Yes
5475,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9CH,0874986,Switzerland,CH,8/29/1996,11/7/2001,,,0383-011,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-CH,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-011,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614428,,581383,Yes
5476,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9IE,0874986,Ireland,IE,8/29/1996,11/7/2001,,,0383-012,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-IE,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-012,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614429,,581383,Yes
5477,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9NL,0874986,Netherlands,NL,8/29/1996,11/7/2001,,,0383-013,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-NL,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-013,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614430,,581383,Yes
5478,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9SE,0874986,Sweden,SE,8/29/1996,11/7/2001,,,0383-014,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-SE,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-014,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614431,,581383,Yes
5479,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9GB,0874986,United Kingdom,GB,8/29/1996,11/7/2001,,,0383-016,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-GB,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-016,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614432,,581383,Yes
5480,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9LU,0874986,Luxembourg,LU,8/29/1996,11/7/2001,,,0383-018,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-LU,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-018,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614433,,581383,Yes
5481,92-T-007,Screening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9ES,0874986,Spain,ES,8/29/1996,11/7/2001,,,0383-019,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-ES,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-019,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614434,,581383,Yes
5482,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death (Apoptosis),"08/524,344","5,834,216",*United States,US,9/6/1995,11/10/1998,,,0383-003,Large,9/6/1995,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908,"Joany Chou, Bernard Roizman",US Utility,4/12/2018,0383-003,9/6/2015,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614435,,581383,Yes
5483,92-T-007,Screening Methods for the Identification of Inducers and Inhibitors of Programmed Cell Death (Apoptosis),96929881.9AT,0874986,Austria,AT,8/29/1996,11/7/2001,,,0383-009,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-AT,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-009,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614436,,581383,Yes
5484,92-T-007,Screening methods for the identification of inducers and inhibitors of programmer cell death,96929881.9IT,0874986,Italy,IT,8/29/1996,11/7/2001,,,0383-017,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-IT,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-017,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614437,,581383,Yes
5485,92-T-007,Sreening methods for the identification of inducers and inhibitors of programmed cell death,96929881.9FR,0874986,France,FR,8/29/1996,11/7/2001,,,0383-015,Large,9/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32908-FR,"Joany Chou, Bernard Roizman",Validated EPO,4/12/2018,0383-015,8/29/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614603,,581383,Yes
5486,92-T-008,Materials and Methods for Treating Neurodegenerative Diseases and for Screening for Candidate Apoptosis Inhibitors and Inducers,"08/526,765",,*United States,US,9/10/1995,,,,0383.1-020,Small,3/31/1992,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32686,"Joany Chou, Bin He, Bernard Roizman",US Utility,4/12/2018,0383.1-020,3/31/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612226,,581384,Yes
5487,92-T-008,Materials and Methods for Treating Neurodegenerative Diseases and for Screening for Candidate Apoptosis Inhibitors and Inducers,PCT/US96/14147, ,*United States,US,8/29/1996,,WO 97/10349,8/29/1996,0383.1-021,Small,9/10/1995,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",32686-PC,"Joany Chou, Bin He, Bernard Roizman",PCT,4/12/2018,0383.1-021,3/10/1998,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612227,3/20/1997,581384,Yes
5488,92-T-008,"Method of Screening Candidate Proactive, Potentiating, or Inhibiting Substances","08/419,853",,*United States,US,4/11/1995,,,,0383.1-018,Small,3/31/1992,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bin He, Bernard Roizman",Divisional,4/12/2018,0383.1-018,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612535,,581384,Yes
5489,92-T-008,"Methods and Composition for Gene, Tumore, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Apoptosis)",37818/93,"682,463",Australia,AU,2/26/1993,1/29/1998,,,0383.1-006,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bin He, Bernard Roizman",Nationalized PCT,4/12/2018,0383.1-006,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612625,,581384,Yes
5490,92-T-008,"Methods and Compositions for Gene Therapy, Tumor Therapy, Viral Infection Therapy and Prevention of Programmed Cell Death (APOPTOSIS)","07/861,233",,*United States,US,3/31/1992,,,,0383.1-001,Small,3/31/1992,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bin He, Bernard Roizman",US Utility,4/12/2018,0383.1-001,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612740,,581384,Yes
5491,92-T-008,"Methods and Compositions for Gene, Tumor and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4AT,EP 0 675 961 B1,Austria,AT,2/26/1993,11/27/2002,,,0383.1-007,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-AT,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-007,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612741,,581384,Yes
5492,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programed Cell Death",PCT/US93/01801, ,*United States,US,2/26/1993,,WO 9 319 591,2/26/1993,0383.1-002,Small,3/31/1992,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,"Joany Chou, Bin He, Bernard Roizman",PCT,4/12/2018,0383.1-002,9/30/1994,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612742,10/14/1993,581384,Yes
5493,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programed Cell Death","2,132,976","2,132,976",Canada,CA,2/26/1993,12/30/2003,,,0383.1-003,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-CA,"Joany Chou, Bin He, Bernard Roizman",Nationalized PCT,4/12/2018,0383.1-003,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612743,,581384,Yes
5494,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programed Cell Death",5-517439,3974167,Japan,JP,2/26/1993,6/22/2007,JP 3974167 B2,,0383.1-005,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bin He, Bernard Roizman",Nationalized PCT,4/12/2018,0383.1-005,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612744,9/12/2007,581384,Yes
5495,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programed Cell Death",2006-179944,,Japan,JP,2/26/1993,,,,0383.1-016,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bin He, Bernard Roizman",Divisional,4/12/2018,0383.1-016,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612745,,581384,Yes
5496,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programed Cell Death",93907093.4EPO,EP 0 675 961 B1,European Patent Office (EPO),EP,2/26/1993,11/27/2002, ,,0383.1-022,Small,3/31/1992,,No,5/21/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-EP,"Joany Chou, Bin He, Bernard Roizman",Nationalized PCT,4/12/2018,0383.1-022,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612746,,581384,Yes
5497,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell",93907093.4IT,EP 0 675 961 B1,Italy,IT,2/26/1993,11/27/2002,,,0383.1-012,Large,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-IT,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-012,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612747,,581384,Yes
5498,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4DK,EP 0 675 961 B1,Denmark,DK,2/26/1993,11/27/2002,,,0383.1-008,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-DK,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-008,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612748,,581384,Yes
5499,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4ES,EP 0 675 961 B1,Spain,ES,2/26/1993,11/27/2002,,,0383.1-009,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-ES,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-009,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612749,,581384,Yes
5500,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4GB,EP 0 675 961 B1,United Kingdom,GB,2/26/1993,11/27/2002,,,0383.1-011,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-GB,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-011,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612750,,581384,Yes
5501,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4SE,EP 0 675 961 B1,Sweden,SE,2/26/1993,11/27/2002,,,0383.1-014,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-SE,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-014,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612751,,581384,Yes
5502,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4DE,EP 0 675 961 B1,Germany,DE,2/26/1993,11/27/2002,,,0383.1-015,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-DE,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-015,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612752,,581384,Yes
5503,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4BE,EP 0 675 961 B1,Belgium,BE,2/26/1993,11/27/2002,,,0383.1-017,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-BE,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-017,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612753,,581384,Yes
5504,92-T-008,"Methods and Compositions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Apoptosis)",93907093.4NL,EP 0 675 961 B1,Netherlands,NL,2/26/1993,11/27/2002,,,0383.1-013,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-NL,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-013,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612754,,581384,Yes
5505,92-T-008,"Methods and Compostions for Gene, Tumor, and Viral Infection Therapy, and Prevention of Programmed Cell Death (Adoptosis)",93907093.4FR,EP 0 675 961 B1,France,FR,2/26/1993,11/27/2002,,,0383.1-010,Small,3/31/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31746-FR,"Joany Chou, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.1-010,2/26/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613100,,581384,Yes
5506,92-T-008,Treating Central Nervous System Degenerative Disease,"08/483,532",,*United States,US,6/7/1995,,,,0383.1-019,Small,4/11/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Joany Chou, Bin He, Bernard Roizman",Divisional,4/12/2018,0383.1-019,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614942,,581384,Yes
5507,92-T-009,Inducers and Inhibitors of Programmed Cell Death,"60/036,997", ,*United States,US,1/31/1997,, ,1/31/1997,0383.2-001,Small,1/31/1997,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",33727,"Kenneth Gross, Bin He, Bernard Roizman",Provisional,4/12/2018,0383.2-001,1/31/1998,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612002,,581385,Yes
5508,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,"08/795,470","5,795,713",*United States,US,2/4/1997,8/18/1998,,,0383.2-002,Small,1/31/1997,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742,"Bin He, Bernard Roizman",US Utility,4/12/2018,0383.2-002,1/31/2017,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613188,,581385,Yes
5509,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,PCT/US98/01808, ,*United States,US,1/30/1998,,WO 98/33933,1/30/1998,0383.2-003,Small,2/4/1997,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",33742-PC,"Kenneth Gross, Bin He, Bernard Roizman",PCT,4/12/2018,0383.2-003,8/4/1999,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613189,8/6/1998,581385,Yes
5510,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6EPO,EP 1 019 524 B1,European Patent Office (EPO),EP,1/30/1998,9/29/2004, ,,0383.2-004,Small,2/4/1997,,No,5/21/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-EP,"Kenneth Gross, Bin He, Bernard Roizman",Nationalized PCT,4/12/2018,0383.2-004,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613190,,581385,Yes
5511,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,"2,279,486","2,279,486",Canada,CA,1/30/1998,12/23/2003,,,0383.2-005,Large,1/31/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-CA,"Kenneth Gross, Bin He, Bernard Roizman",Nationalized PCT,4/12/2018,0383.2-005,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613191,,581385,Yes
5512,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,10-533101,,Japan,JP,1/30/1998,,,,0383.2-006,Small,1/31/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-JP,"Kenneth Gross, Bin He, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0383.2-006,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613192,,581385,Yes
5513,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6FI,1019524,Finland,FI,1/30/1998,9/29/2004,,,0383.2-007,Small,2/4/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-FI,"Kenneth Gross, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.2-007,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613193,,581385,Yes
5514,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6AT,E 278 033,Austria,AT,1/30/1998,3/29/2004,,,0383.2-008,Small,2/4/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-AT,"Kenneth Gross, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.2-008,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613194,,581385,Yes
5515,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6BE,1019524,Belgium,BE,1/30/1998,9/29/2004,,,0383.2-009,Small,2/4/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-BE,"Kenneth Gross, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.2-009,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613195,,581385,Yes
5516,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6DK,1019524,Denmark,DK,1/30/1998,9/29/2004,,,0383.2-010,Small,2/4/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-DK,"Kenneth Gross, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.2-010,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613196,,581385,Yes
5517,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6FR,1019524,France,FR,1/30/1998,9/29/2004,,,0383.2-011,Small,2/4/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-FR,"Kenneth Gross, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.2-011,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613197,,581385,Yes
5518,92-T-009,Methods for Identifying Inducers and Inhibitors of Programmed Cell Death,98903847.6DE,69826698.6,Germany,DE,1/30/1998,9/29/2004,,,0383.2-012,None,2/4/1997,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33742-DE,"Kenneth Gross, Bin He, Bernard Roizman",Validated EPO,4/12/2018,0383.2-012,1/30/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613198,,581385,Yes
5519,92-T-012,Hydrated Polymer for Improving Scar Size and Appearance,"08/465,404",,*United States,US,6/5/1995,,,,0386-003,Small,2/9/1993,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,,,Raphael Lee,Continuation in Part,4/12/2018,0386-003,,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",611873,,581388,Yes
5520,92-T-012,Method for Improvement of Scar Size and Appearance,"08/015,216","5,552,162",*United States,US,2/9/1993,9/3/1996,,,0386-001,Small,2/9/1993,,Yes,12/19/2019,Expired - Inactive,Norton Rose Fulbright US LLP,,,Raphael Lee,US Utility,4/12/2018,0386-001,9/3/2013,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612464,,581388,Yes
5521,92-T-012,Method for the Improvement of Scar Size and Appearance,PCT/US94/01377, ,*United States,US,2/7/1994,8/18/1994, ,2/7/1994,0386-002,Small,2/9/1993,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,Raphael Lee,PCT,4/12/2018,0386-002,8/9/1995,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612507,,581388,Yes
5522,92-T-017,Breakpoints in Leukemic Cell Translocations,"07/991,244",,*United States,US,12/16/1992,,,,0399-002,Small,6/17/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Kitchell, Barbara",,"Manuel Diaz, Janet Rowley",Continuation in Part,4/12/2018,0399-002,,"Unassigned, Unassigned",Janet Rowley,"Unassigned, Unassigned",610749,,581393,Yes
5523,92-T-017,Compositions and Methods for  Detecting Gene Rearrangements and Translocations,"08/465,713","6,121,419",*United States,US,6/6/1995,9/19/2000,,,0399-005,Small,6/17/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Manuel Diaz, Janet Rowley",Divisional,4/12/2018,0399-005,9/19/2017,"Unassigned, Unassigned",Janet Rowley,"Unassigned, Unassigned",610977,,581393,Yes
5524,92-T-017,Compositions and Methods of Use for Detecting Gene Rearrangements & Translocations,PCT/US93/05857, ,*United States,US,6/17/1993,,WO93/25713,6/17/1993,0399-004,Small,6/17/1992,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Manuel Diaz, Janet Rowley",PCT,4/12/2018,0399-004,12/17/1994,"Unassigned, Unassigned",Janet Rowley,"Unassigned, Unassigned",611035,,581393,Yes
5525,92-T-017,Compositions and Methods of Use for Detecting Gene Rearrangements and Translocations,"08/080,255","5,487,970",*United States,US,6/17/1993,1/30/1996,,,0399-003,Small,6/17/1992,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Manuel Diaz, Janet Rowley",Continuation in Part,4/12/2018,0399-003,1/30/2013,"Unassigned, Unassigned",Janet Rowley,"Unassigned, Unassigned",611036,,581393,Yes
5526,92-T-017,Methods of Determining Breakpoints in Leukemic Cell Translocation,"07/900,689",,*United States,US,6/17/1992,,,,0399-001,Small,6/17/1992,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Kitchell, Barbara",,"Manuel Diaz, Janet Rowley",US Utility,4/12/2018,0399-001,,"Unassigned, Unassigned",Janet Rowley,"Unassigned, Unassigned",613316,,581393,Yes
5527,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0EPO,0 646 161,European Patent Office (EPO),EP,6/16/1993,5/9/2007,EP0646161A1,,92-025-003,Small,6/16/1992,,No,1/20/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-007,Ali Erdemir,Nationalized PCT,4/12/2018,92-025-003,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611945,5/4/1995,581394,Yes
5528,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,"2,138,275","2,138,275",Canada,CA,6/16/1993,12/14/1999,,,92-025-004,Large,6/16/1992,,No,1/20/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-003,Ali Erdemir,Nationalized PCT,4/12/2018,92-025-004,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611946,12/23/1993,581394,Yes
5529,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,98115714.6,1014371,Hong Kong,HK,12/24/1998,9/14/2007,1014371,,92-025-006,Large,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-012,"Cuma Bindal, Ali Erdemir",Validated EPO,4/12/2018,92-025-006,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611947,9/24/1999,581394,Yes
5530,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0AT,0361967,Austria,AT,6/16/1993,5/9/2007,,,92-025-007,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-001,Ali Erdemir,Validated EPO,4/12/2018,92-025-007,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611948,,581394,Yes
5531,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0BE,646161,Belgium,BE,6/16/1993,5/9/2007,,,92-025-008,Small,6/16/1992,,No,1/20/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-002,Ali Erdemir,Validated EPO,4/12/2018,92-025-008,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611949,,581394,Yes
5532,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0CH,0 646 161,Switzerland,CH,6/16/1993,5/9/2007,,,92-025-009,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-004,Ali Erdemir,Validated EPO,4/12/2018,92-025-009,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611950,,581394,Yes
5533,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0LI,0 646 161,Lichtenstein,LI,6/16/1993,5/9/2007,,,92-025-010,Small,6/16/1992,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-015,Ali Erdemir,Validated EPO,4/12/2018,92-025-010,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611951,,581394,Yes
5534,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0DE,69334137,Germany,DE,6/16/1993,5/9/2007,,,92-025-011,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-005,Ali Erdemir,Validated EPO,4/12/2018,92-025-011,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611952,,581394,Yes
5535,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0DK,646161,Denmark,DK,6/16/1993,5/9/2007,,,92-025-012,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-006,Ali Erdemir,Validated EPO,4/12/2018,92-025-012,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611953,,581394,Yes
5536,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0ES,2286816,Spain,ES,6/16/1993,5/9/2007,,,92-025-013,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-008,Ali Erdemir,Validated EPO,4/12/2018,92-025-013,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611954,,581394,Yes
5537,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0FR,0 646 161,France,FR,6/16/1993,5/9/2007,,,92-025-014,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-009,Ali Erdemir,Validated EPO,4/12/2018,92-025-014,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611955,,581394,Yes
5538,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0GB,646161,United Kingdom,GB,6/16/1993,5/9/2007,,,92-025-015,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-010,Ali Erdemir,Validated EPO,4/12/2018,92-025-015,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611956,,581394,Yes
5539,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0GR,646161,Greece,GR,6/16/1993,5/9/2007,,,92-025-016,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-011,Ali Erdemir,Validated EPO,4/12/2018,92-025-016,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611957,,581394,Yes
5540,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0IE,646161,Ireland,IE,6/16/1993,5/9/2007,,,92-025-017,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-013,Ali Erdemir,Validated EPO,4/12/2018,92-025-017,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611958,,581394,Yes
5541,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0IT,646161,Italy,IT,6/16/1993,5/9/2007,,,92-025-018,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-014,Ali Erdemir,Validated EPO,4/12/2018,92-025-018,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611959,,581394,Yes
5542,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0LU,646161,Luxembourg,LU,6/16/1993,5/9/2007,,,92-025-019,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-016,Ali Erdemir,Validated EPO,4/12/2018,92-025-019,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611960,,581394,Yes
5543,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0MC,0 646 161,Monaco,MC,6/16/1993,5/9/2007,,,92-025-020,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-017,Ali Erdemir,Validated EPO,4/12/2018,92-025-020,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611961,,581394,Yes
5544,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0NL,646161,Netherlands,NL,6/16/1993,5/9/2007,,,92-025-021,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-018,Ali Erdemir,Validated EPO,4/12/2018,92-025-021,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611962,,581394,Yes
5545,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0PT,646161,Portugal,PT,6/16/1993,5/9/2007,,,92-025-022,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-019,Ali Erdemir,Validated EPO,4/12/2018,92-025-022,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611963,,581394,Yes
5546,92-T-018,Improved Lubrication from Mixture of Boric Acid with Oils and Greases,93916570.0SE,646161,Sweden,SE,6/16/1993,5/9/2007,,,92-025-023,Small,6/16/1992,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-020,Ali Erdemir,Validated EPO,4/12/2018,92-025-023,6/16/2013,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611964,,581394,Yes
5547,92-T-018,Lubrication from Mixture of Boric Acid with Oils and Greases,"07/899,665",,*United States,US,6/16/1992,,,,92-025-001,Small,6/16/1992,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-021,Ali Erdemir,US Utility,4/12/2018,92-025-001,,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612134,,581394,Yes
5548,92-T-018,Lubrication from Mixture of Boric Acid with Oils and Greases,PCT/US93/05772, ,*United States,US,6/16/1993,,WO 9 325 642 A1,6/16/1993,92-025-002,Small,6/16/1992,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-023,Ali Erdemir,PCT,4/12/2018,92-025-002,12/16/1994,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612135,12/23/1993,581394,Yes
5549,92-T-018,Lubrication from Mixture of Boric Acid with Oils and Greases,"08/255,231","5,431,830",*United States,US,6/7/1994,7/11/1995,,,92-025-005,Small,6/16/1992,,No,4/12/2018,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9009-022,Ali Erdemir,Continuation,4/12/2018,92-025-005,6/16/2012,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612136,,581394,Yes
5550,92-T-019,Improved Lubrication with Boric Acid Additives,PCT/US96/09586, ,*United States,US,6/7/1996,,WO 96/40847 A3,6/7/1996,92-025.1-002,Small,6/7/1995,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9010-006,"Ali Erdemir, Roger Poeppel",PCT,4/12/2018,92-025.1-002,12/7/1997,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611965,12/19/1996,581395,Yes
5551,92-T-019,Improved Lubrication with Boric Acid Additives,96923237.0EPO, ,European Patent Office (EPO),EP,6/7/1996,,EP 0 865 478 A4,,92-025.1-003,Small,6/7/1995,,No,5/21/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9010-002,"Ali Erdemir, Roger Poeppel",Nationalized PCT,4/12/2018,92-025.1-003,6/7/2015,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611966,5/4/2000,581395,Yes
5552,92-T-019,Improved Lubrication with Boric Acid Additives,501873/97,,Japan,JP,6/7/1996,,11-507676,,92-025.1-004,Large,6/7/1995,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9010-003,"Ali Erdemir, Roger Poeppel",Nationalized PCT,4/12/2018,92-025.1-004,6/7/2015,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611967,6/7/1999,581395,Yes
5553,92-T-019,Improved Lubrication with Boric Acid Additives,"2,223,330","2,223,330",Canada,CA,6/7/1996,3/11/2003,"2,223,330",,92-025.1-005,Large,6/7/1995,,No,1/20/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9010-001,"Ali Erdemir, Roger Poeppel",Nationalized PCT,4/12/2018,92-025.1-005,6/7/2016,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",611968,12/19/1996,581395,Yes
5554,92-T-019,Lubrication with Boric Acid Additives,"08/481,657",,*United States,US,6/7/1995,,,,92-025.1-001,Small,6/16/1992,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9010-004,"Ali Erdemir, Roger Poeppel",Continuation in Part,4/12/2018,92-025.1-001,,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612137,,581395,Yes
5555,92-T-019,Lubrication with Boric Acid Additives,"08/720,221","6,025,306",*United States,US,9/26/1996,2/15/2000,,,92-025.1-006,Small,6/16/1992,,No,4/12/2018,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9010-005,Ali Erdemir,Continuation,4/12/2018,92-025.1-006,6/16/2012,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612138,,581395,Yes
5556,92-T-020,Methods and Compositions of a Plymer (Poloxamer) for Repair of Electriacal Injury,"07/884,429",,*United States,US,5/15/1992,,,,0394-001,None,5/15/1992,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Raphael Lee,US Utility,4/12/2018,0394-001,5/15/1993,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",612988,,581396,Yes
5557,92-T-020,Methods and Compositions of a Polymer (Poloxamer) for Repair of Electrical Injury,"08/461,255","5,605,687",*United States,US,6/5/1995,2/25/1997,,,0394-002,None,5/15/1992,2/25/2014,No,12/19/2019,Expired - Inactive,Norton Rose Fulbright US LLP,,,Raphael Lee,Continuation in Part,4/12/2018,0394-002,2/25/2014,"Hwang, Luke",Raphael Lee,"Tennant, Thelma",613000,,581396,Yes
5558,92-T-022,Phenolic Acid Sulfate Esters for Prevention of Marine Biofouling,"07/989,274","5,384,176",*United States,US,12/11/1992,1/24/1995,,,0391-001,Small,12/11/1992,,Yes,4/12/2018,Expired - Inactive,Foley & Lardner,"Rechtin, Michael",,"Randall Alberte, Phillip Crews, James Todd, Richard Zimmerman",US Utility,4/12/2018,0391-001,12/11/2012,"Unassigned, Unassigned",Randall Alberte,"Unassigned, Unassigned",613939,,581398,Yes
5559,92-T-022,Phenolic Acid Sulfate Esters for Prevention of Marine Biofouling,6-514493,3606526,Japan,JP,12/10/1993,10/15/2004,08-509693,,0391-002,Small,12/11/1992,,Yes,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Randall Alberte, Phillip Crews, James Todd, Richard Zimmerman","Foreign, Non-PCT",4/12/2018,0391-002,12/10/2013,"Unassigned, Unassigned",Randall Alberte,"Unassigned, Unassigned",613940,10/15/1996,581398,Yes
5560,92-T-022,Phenolic Acid Sulfate Esters for Prevention of Marine Biofouling,94903643.8EPO, ,European Patent Office (EPO),EP,12/10/1993,, ,,0391-003,Small,12/11/1992,,No,5/21/2018,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Randall Alberte, Phillip Crews, James Todd, Richard Zimmerman",Nationalized PCT,4/12/2018,0391-003,12/10/2013,"Unassigned, Unassigned",Randall Alberte,"Unassigned, Unassigned",613941,,581398,Yes
5561,92-T-022,Phenolic Acid Sulfate Esters for Prevention of Marine Biofouling,"08/351,624","5,607,741",*United States,US,12/8/1994,3/4/1997,,,0391-004,Small,12/11/1992,,No,4/12/2018,Expired - Inactive,Foley & Lardner,"Rechtin, Michael",,"Randall Alberte, Phillip Crews, James Todd, Richard Zimmerman",Continuation,4/12/2018,0391-004,3/4/2014,"Unassigned, Unassigned",Randall Alberte,"Unassigned, Unassigned",613942,,581398,Yes
5562,92-T-022,Phenolic Acid Sulfate Esters for Prevention of Marine Biofouling,98116116.8,1014687,Hong Kong,HK,12/28/1998,9/30/1999,1014687,,0391-005,Small,12/10/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Randall Alberte, Phillip Crews, James Todd, Richard Zimmerman",Validated EPO,4/12/2018,0391-005,12/10/2013,"Unassigned, Unassigned",Randall Alberte,"Unassigned, Unassigned",613943,9/30/1999,581398,Yes
5563,92-T-024,Detection of Glucokinase-linked Early-Onset Non-Insulin-Dependent Diabetes Mellitus,"07/872,678","5,541,060",*United States,US,4/22/1992,7/30/1996,,,0392-001,Small,4/22/1992,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Daniel Cohen, Philippe Froguel, Simon Pilkis, Marcus Stoffel, Jun Takeda, Gilberto Velho, Nathalie Vionnet, Kazuki Yasuda, Habib Zouali",US Utility,4/12/2018,0392-001,7/30/2013,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",611393,,581400,Yes
5564,92-T-024,DNA Marker for Non-Insulin Dependent(Type 2) Diabetes Mellitus,PCT/US93/03560, ,*United States,US,4/14/1993,, ,4/14/1993,0392-002,Small,4/22/1992,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Graeme Bell, Louis Cohen, Philippe Froguel, Simon Pilkis, Marcus Stoffel, Jun Takeda, Gilberto Velho, Nathalie Vionnet, Kazuki Yasuda, Habib Zouali",PCT,4/12/2018,0392-002,10/22/1994,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",611486,,581400,Yes
5565,92-T-026,Herpes Simplex Virus as A Vector,"07/455,771",,*United States,US,12/28/1989,,,,0395-022,Large,6/4/1984,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",0002A,Bernard Roizman,Continuation,4/12/2018,0395-022,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611767,,581402,Yes
5566,92-T-026,Herpes Simplex Virus as a Vector,"07/923,015","5,288,641",*United States,US,7/30/1992,2/22/1994,,,0395-023,Large,6/4/1984,,Yes,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002B,Bernard Roizman,Continuation,4/12/2018,0395-023,7/30/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611768,,581402,Yes
5567,92-T-026,Herpes Simplex Virus as A Vector,"08/195,356",,*United States,US,2/10/1994,,,,0395-024,Large,7/30/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",0002C,Bernard Roizman,Continuation,4/12/2018,0395-024,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611769,,581402,Yes
5568,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods","06/616,930", ,*United States,US,6/4/1984,, ,6/4/1984,0395-001,Small,6/4/1984,,Yes,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,0003,Bernard Roizman,US Utility,4/12/2018,0395-001,6/4/1985,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614313,,581402,Yes
5569,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods","06/856,052","4,859,587",*United States,US,4/25/1986,8/22/1989,,,0395-002,Small,6/4/1984,,Yes,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003,Bernard Roizman,Continuation in Part,4/12/2018,0395-002,8/22/2006,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614314,,581402,Yes
5570,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",1987/0818,1987/0818,South Africa,ZA,2/4/1987,12/30/1987,,,0395-003,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-ZA,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395-003,2/4/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614315,,581402,Yes
5571,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods","1,305,081","1,305,081",Canada,CA,2/6/1987,7/14/1992,,,0395-004,Large,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-CA,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395-004,7/14/2009,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614316,,581402,Yes
5572,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",68614/87,"585,126",Australia,AU,2/9/1987,10/20/1989,,,0395-005,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-AU,Bernard Roizman,Nationalized PCT,4/12/2018,0395-005,2/9/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614317,,581402,Yes
5573,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",76100725,,"Taiwan, Province of China",TW,2/13/1987,,,,0395-006,Small,6/4/1984,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",0003-TW,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395-006,2/13/1987,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614318,,581402,Yes
5574,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",6292968,2093182,Japan,JP,4/15/1987,9/18/1996,,,0395-007,Large,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-JP,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395-007,4/15/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614319,,581402,Yes
5575,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5BE,0 243 155 B1,Belgium,BE,4/22/1987,8/4/1993,,,0395-008,Large,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-BE,Bernard Roizman,Validated EPO,4/12/2018,0395-008,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614320,,581402,Yes
5576,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5AT,0 243 155 B1,Austria,AT,4/22/1987,8/4/1993,,,0395-009,Large,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-AT,Bernard Roizman,Validated EPO,4/12/2018,0395-009,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614321,,581402,Yes
5577,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5FR,0 243 155,France,FR,4/22/1987,8/4/1993,,,0395-010,Small,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-FR,Bernard Roizman,Validated EPO,4/12/2018,0395-010,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614322,,581402,Yes
5578,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5DE,P3786824.1,Germany,DE,4/22/1987,8/4/1993,,,0395-011,Small,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-DE,Bernard Roizman,Validated EPO,4/12/2018,0395-011,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614323,,581402,Yes
5579,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5GB,0 243 155,United Kingdom,GB,4/22/1987,8/4/1993,,,0395-012,Small,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-GB,Bernard Roizman,Validated EPO,4/12/2018,0395-012,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614324,,581402,Yes
5580,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5GR,0 243 155,Greece,GR,4/22/1987,8/4/1993,,,0395-013,Small,4/25/1986,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-GR,Bernard Roizman,Validated EPO,4/12/2018,0395-013,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614325,,581402,Yes
5581,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5IT,0 243 155,Italy,IT,4/22/1987,8/4/1993,,,0395-014,Large,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-IT,Bernard Roizman,Validated EPO,4/12/2018,0395-014,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614326,,581402,Yes
5582,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5LU,0 243 155,Luxembourg,LU,4/22/1987,8/4/1993,,,0395-015,Small,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-LU,Bernard Roizman,Validated EPO,4/12/2018,0395-015,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614327,,581402,Yes
5583,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5NL,0 243 155,Netherlands,NL,4/22/1987,8/4/1993,,,0395-016,Large,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-NL,Bernard Roizman,Validated EPO,4/12/2018,0395-016,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614328,,581402,Yes
5584,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5ES,0 243 155,Spain,ES,4/22/1987,8/4/1993,,,0395-017,Large,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-ES,Bernard Roizman,Validated EPO,4/12/2018,0395-017,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614329,,581402,Yes
5585,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5SE,0 243 155,Sweden,SE,4/22/1987,8/4/1993,,,0395-018,Small,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-SE,Bernard Roizman,Validated EPO,4/12/2018,0395-018,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614330,,581402,Yes
5586,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5EPO,0 243 155,European Patent Office (EPO),EP,4/22/1987,8/4/1993,EP 0 243 155 A2,,0395-019,Small,4/25/1986,,No,5/21/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-EP,Bernard Roizman,Nationalized PCT,4/12/2018,0395-019,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614331,10/28/1987,581402,Yes
5587,92-T-026,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87303512.5CH,0 243 155,Switzerland,CH,4/22/1987,8/4/1993,,,0395-020,Small,4/25/1986,,No,1/10/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0003-CH,Bernard Roizman,Validated EPO,4/12/2018,0395-020,4/22/2007,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614332,,581402,Yes
5588,92-T-026,Recombinant Herpes Simplex Viruses. Vaccines & Methods,"07/387,017","5,198,343",*United States,US,7/11/1989,3/30/1993,,,0395-021,Large,4/25/1986,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",9054,Bernard Roizman,Continuation,4/12/2018,0395-021,3/30/2010,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614351,,581402,Yes
5589,92-T-027,Herpes Simplex Virus as A Vector,"482,524","1,282,721",Canada,CA,5/28/1985,4/9/1991,,,0395.1-001,Large,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002-CA,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395.1-001,4/9/2008,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611770,,581403,Yes
5590,92-T-027,Herpes Simplex Virus as A Vector,85303791.0FR,0176170,France,FR,5/30/1985,8/19/1992,,,0395.1-002,Large,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-FR,Bernard Roizman,Validated EPO,4/12/2018,0395.1-002,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611771,,581403,Yes
5591,92-T-027,Herpes Simplex Virus as A Vector,85303791.0DE,P3586520.2,Germany,DE,5/30/1985,8/19/1992,,,0395.1-003,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-DE,Bernard Roizman,Validated EPO,4/12/2018,0395.1-003,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611772,,581403,Yes
5592,92-T-027,Herpes Simplex Virus as A Vector,85303791.0GB,0176170,United Kingdom,GB,5/30/1985,8/19/1992,,,0395.1-004,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-GB,Bernard Roizman,Validated EPO,4/12/2018,0395.1-004,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611773,,581403,Yes
5593,92-T-027,Herpes Simplex Virus as A Vector,85303791.0IT,0176170,Italy,IT,5/30/1985,8/19/1992,,,0395.1-005,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-IT,Bernard Roizman,Validated EPO,4/12/2018,0395.1-005,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611774,,581403,Yes
5594,92-T-027,Herpes Simplex Virus as A Vector,85303791.0LU,0176170,Luxembourg,LU,5/30/1985,8/19/1992,,,0395.1-006,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-LU,Bernard Roizman,Validated EPO,4/12/2018,0395.1-006,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611775,,581403,Yes
5595,92-T-027,Herpes Simplex Virus as A Vector,85303791.0NL,0176170,Netherlands,NL,5/30/1985,8/19/1992,,,0395.1-007,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-NL,Bernard Roizman,Validated EPO,4/12/2018,0395.1-007,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611776,,581403,Yes
5596,92-T-027,Herpes Simplex Virus as A Vector,85303791.0SE,0176170,Sweden,SE,5/30/1985,8/19/1992,,,0395.1-008,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-SE,Bernard Roizman,Validated EPO,4/12/2018,0395.1-008,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611777,,581403,Yes
5597,92-T-027,Herpes Simplex Virus as A Vector,85303791.0CH,0176170,Switzerland,CH,5/30/1985,8/19/1992,,,0395.1-009,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-CH,Bernard Roizman,Validated EPO,4/12/2018,0395.1-009,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611778,,581403,Yes
5598,92-T-027,Herpes Simplex Virus as A Vector,85303791.0EPO,0176170,European Patent Office (EPO),EP,5/30/1985,8/19/1992, ,,0395.1-010,Large,6/4/1984,,No,5/21/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-EP,Bernard Roizman,Nationalized PCT,4/12/2018,0395.1-010,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611779,,581403,Yes
5599,92-T-027,Herpes Simplex Virus as A Vector,85303791.0AT,0176170,Austria,AT,5/30/1985,8/19/1992,,,0395.1-011,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-AT,Bernard Roizman,Validated EPO,4/12/2018,0395.1-011,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611780,,581403,Yes
5600,92-T-027,Herpes Simplex Virus as A Vector,85303791.0BE,0176170,Belgium,BE,5/30/1985,8/19/1992,,,0395.1-012,Large,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-BE,Bernard Roizman,Validated EPO,4/12/2018,0395.1-012,5/30/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611781,,581403,Yes
5601,92-T-027,Herpes Simplex Virus as A Vector,"08/419,831","5,599,691",*United States,US,4/11/1995,2/4/1997,,,0395.1-014,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002D,Bernard Roizman,Continuation,4/12/2018,0395.1-014,2/4/2014,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611782,,581403,Yes
5602,92-T-027,Herpes Simplex Virus as A Vector,60118664,2664892,Japan,JP,5/30/1995,6/20/1997,,,0395.1-015,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002-JP,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395.1-015,5/31/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611783,,581403,Yes
5603,92-T-027,Herpes Simplex Virus as A Vector,"08/791,852","5,846,707",*United States,US,1/31/1997,12/8/1998,,,0395.1-016,Small,6/4/1984,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",0002E,Bernard Roizman,Continuation,4/12/2018,0395.1-016,6/4/2004,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611784,,581403,Yes
5604,92-T-027,Herpes Simplex Virus as A Vector,"09/205,162","6,071,692",*United States,US,12/4/1998,6/6/2000,,,0395.1-017,Large,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Uhl, Jill",0002F,Bernard Roizman,Continuation,4/12/2018,0395.1-017,6/4/2004,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611785,,581403,Yes
5605,92-T-027,Method of Obtaining Desired Protein using Herpes Virus,5-174769,2641688,Japan,JP,5/31/1985,5/2/1997,,,0395.1-013,Small,6/4/1984,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0002A-JP,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0395.1-013,5/31/2005,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612530,,581403,Yes
5606,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus,"320,760","1,204,056",Canada,CA,11/10/1982,5/6/1986,,,0397-002,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman","Foreign, Non-PCT",4/12/2018,0397-002,11/10/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615343,,581405,Yes
5607,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus,82110468.4DE,P3275904.5,Germany,DE,12/11/1982,4/1/1987,,,0397-009,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-009,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615344,,581405,Yes
5608,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus,82110468.4FR,79597,France,FR,12/11/1982,4/1/1987,,,0397-010,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-010,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615345,,581405,Yes
5609,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus,82110468.4CH,79597,Switzerland,CH,12/11/1982,,,,0397-011,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-011,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615346,,581405,Yes
5610,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus  (Types 1 and 2),"06/320,760","4,554,159",*United States,US,11/12/1981,11/19/1985,,,0397-001,Small,11/12/1981,,Yes,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",0001,"Robert Lang, Bernard Roizman",US Utility,4/12/2018,0397-001,11/19/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615347,,581405,Yes
5611,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus  (Types 1 and 2),82110468.4EPO,79597,European Patent Office (EPO),EP,12/11/1982,, ,,0397-003,None,11/12/1981,,No,5/21/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,"Robert Lang, Bernard Roizman",Nationalized PCT,4/12/2018,0397-003,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615348,,581405,Yes
5612,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus  (Types 1 and 2),82110468.4SE,79597,Sweden,SE,12/11/1982,4/1/1987,,,0397-004,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-004,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615349,,581405,Yes
5613,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus  (Types 1 and 2),82110468.4NL,79597,Netherlands,NL,12/11/1982,4/1/1987,,,0397-005,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-005,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615350,,581405,Yes
5614,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus  (Types 1 and 2),82110468.4GB,79597,United Kingdom,GB,12/11/1982,4/1/1987,,,0397-008,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-008,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615351,,581405,Yes
5615,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus (Types 1 and 2),82110468.4IT,79597,Italy,IT,12/11/1982,4/1/1987,,,0397-006,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-006,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615352,,581405,Yes
5616,92-T-029,Vaccine and Method of Immunizing Against Herpes Simplex Virus (Types 1 and 2),82110468.4BE,79597,Belgium,BE,12/11/1982,4/1/1987,,,0397-007,None,11/12/1981,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",,"Robert Lang, Bernard Roizman",Validated EPO,4/12/2018,0397-007,12/11/2002,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615353,,581405,Yes
5617,92-T-030,Recombinant Herpes Simplex Viruses Vaccines and Methods,"07/579,834","5,328,688",*United States,US,9/10/1990,7/12/1994,,,0398-001,Large,9/10/1990,,Yes,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",8235,Bernard Roizman,US Utility,4/12/2018,0398-001,7/12/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614311,,581406,Yes
5618,92-T-030,Recombinant Herpes Simplex Viruses Vaccines and Methods,"08/272,772","6,120,773",*United States,US,7/8/1994,9/19/2000,,,0398-020,Large,9/10/1990,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",31916,Bernard Roizman,Continuation,4/12/2018,0398-020,9/10/2010,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614312,,581406,Yes
5619,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods","2,072,627","2,072,627",Canada,CA,9/10/1991,12/16/2003,,,0398-002,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",8235-CA,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0398-002,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614333,,581406,Yes
5620,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2EPO,05000917,European Patent Office (EPO),EP,9/10/1991,5/2/1997,EP 0 500 917 A1,,0398-003,Large,9/10/1990,,No,5/21/2018,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",D8235-EP,Bernard Roizman,Nationalized PCT,4/12/2018,0398-003,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614334,9/2/1992,581406,Yes
5621,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",516968/91,3334876,Japan,JP,9/10/1991,8/15/2002,,,0398-004,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",8235-JP,Bernard Roizman,"Foreign, Non-PCT",4/12/2018,0398-004,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614335,,581406,Yes
5622,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",PCT/US91/06532, ,*United States,US,9/10/1991,,WO 92/04050,9/10/1991,0398-005,Large,9/10/1990,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",D8235-PC,Bernard Roizman,PCT,4/12/2018,0398-005,3/10/1993,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614336,3/19/1992,581406,Yes
5623,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",87418/91,"658,838",Australia,AU,9/10/1991,9/12/1995,,,0398-006,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-AU,Bernard Roizman,Nationalized PCT,4/12/2018,0398-006,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614337,,581406,Yes
5624,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2AT,0500917,Austria,AT,9/10/1991,5/2/1997,,,0398-007,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-AT,Bernard Roizman,Validated EPO,4/12/2018,0398-007,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614338,,581406,Yes
5625,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2BE,0500917,Belgium,BE,9/10/1991,5/2/1997,,,0398-008,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-BE,Bernard Roizman,Validated EPO,4/12/2018,0398-008,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614339,,581406,Yes
5626,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2DK,0500917,Denmark,DK,9/10/1991,5/2/1997,,,0398-009,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-DK,Bernard Roizman,Validated EPO,4/12/2018,0398-009,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614340,,581406,Yes
5627,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2FR,0500917,France,FR,9/10/1991,5/2/1997,,,0398-010,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-FR,Bernard Roizman,Validated EPO,4/12/2018,0398-010,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614341,,581406,Yes
5628,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2DE,69125925.9,Germany,DE,9/10/1991,5/2/1997,,,0398-011,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-DE,Bernard Roizman,Validated EPO,4/12/2018,0398-011,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614342,,581406,Yes
5629,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2GB,0500917,United Kingdom,GB,9/10/1991,5/2/1997,,,0398-012,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-GB,Bernard Roizman,Validated EPO,4/12/2018,0398-012,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614343,,581406,Yes
5630,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2GR,0500917,Greece,GR,9/10/1991,5/2/1997,,,0398-013,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-GR,Bernard Roizman,Validated EPO,4/12/2018,0398-013,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614344,,581406,Yes
5631,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2LU,0500917,Luxembourg,LU,9/10/1991,5/2/1997,,,0398-014,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-LU,Bernard Roizman,Validated EPO,4/12/2018,0398-014,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614345,,581406,Yes
5632,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2NL,0500917,Netherlands,NL,9/10/1991,5/2/1997,,,0398-015,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-NL,Bernard Roizman,Validated EPO,4/12/2018,0398-015,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614346,,581406,Yes
5633,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2ES,0500917,Spain,ES,9/10/1991,5/2/1997,,,0398-016,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-ES,Bernard Roizman,Validated EPO,4/12/2018,0398-016,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614347,,581406,Yes
5634,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2SE,0500917,Sweden,SE,9/10/1991,5/2/1997,,,0398-017,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-SE,Bernard Roizman,Validated EPO,4/12/2018,0398-017,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614348,,581406,Yes
5635,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2CH,0500917,Switzerland,CH,9/10/1991,5/2/1997,,,0398-018,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-CH,Bernard Roizman,Validated EPO,4/12/2018,0398-018,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614349,,581406,Yes
5636,92-T-030,"Recombinant Herpes Simplex Viruses, Vaccines and Methods",91918320.2IT,0500917,Italy,IT,9/10/1991,5/2/1997,,,0398-019,Large,9/10/1990,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",D8235-IT,Bernard Roizman,Validated EPO,4/12/2018,0398-019,9/10/2011,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614350,,581406,Yes
5637,92-T-032,Acetyl-CoA Carboxylase Compositions and Methods of Use,"08/422,560","5,910,626",*United States,US,4/14/1995,6/8/1999,,,0401-004,Large,10/2/1992,,No,12/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",Continuation in Part,4/12/2018,0401-004,7/23/2013,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",610249,,581408,Yes
5638,92-T-032,Acetyl-COA Carboxylase Compositions and Methods of Use,"2,218,139",,Canada,CA,4/12/1996,,,,0401-011,Large,10/2/1992,,No,12/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Piotr Gornicki, Robert Haselkorn",Nationalized PCT,4/12/2018,0401-011,4/12/2016,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",610250,,581408,Yes
5639,92-T-032,ACETYL-CoA CARBOXYLASE COMPOSITIONS AND METHODS OF USE,PCT/US96/05095, ,*United States,US,4/12/1996,,WO 96/32484,4/12/1996,0401-012,Large,10/2/1992,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Piotr Gornicki, Robert Haselkorn",PCT,4/12/2018,0401-012,4/2/1995,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",610251,10/17/1996,581408,Yes
5640,92-T-032,Acetyl-CoA Carboxylase from Wheat,"08/468,793","6,177,267",*United States,US,6/6/1995,1/23/2001,,,0401-005,Large,10/2/1992,,No,12/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Nakashima, Richard",,"Piotr Gornicki, Robert Haselkorn",Continuation in Part,4/12/2018,0401-005,1/23/2018,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",610252,,581408,Yes
5641,92-T-032,Canola Acetyl-CoA Carboxylase Compositions and Methods of Use,"09/767,479",,*United States,US,1/22/2001,,US-2001-036654-A1,,0401-016,Small,10/2/1992,,No,12/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Hanson, Robert",,"Piotr Gornicki, Robert Haselkorn",Divisional,4/12/2018,0401-016,10/2/2012,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",610782,11/1/2001,581408,Yes
5642,92-T-032,Cyanobacterial and Plant Acetyl CoA Carboxylase,PCT/US93/09340, ,*United States,US,9/30/1993,,WO 94/08016,9/30/1993,0401-003,Large,10/2/1992,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Piotr Gornicki, Robert Haselkorn",PCT,4/12/2018,0401-003,4/2/1995,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611363,4/14/1994,581408,Yes
5643,92-T-032,Cyanobacterial and Plant Acetyl-CoA Carboxylase,"07/956,700","5,539,092",*United States,US,10/2/1992,7/23/1996,,,0401-001,Large,10/2/1992,,Yes,12/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",US Utility,4/12/2018,0401-001,7/23/2013,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611364,,581408,Yes
5644,92-T-032,Cyanobacterial and Plant Acetyl-CoA Carboxylase,93923187.4EPO,663012,European Patent Office (EPO),EP,9/30/1993,,EP 0 663 012  A1,,0401-002,Large,10/2/1992,,No,12/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Piotr Gornicki, Robert Haselkorn",Nationalized PCT,4/12/2018,0401-002,9/30/2013,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611365,7/19/1995,581408,Yes
5645,92-T-032,Cyanobacterial and Plant Acetyl-CoA Carboxylase,"08/485,607","5,792,627",*United States,US,6/7/1995,8/11/1998,,,0401-006,Large,10/2/1992,,No,12/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",Continuation,4/12/2018,0401-006,7/23/2013,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611366,,581408,Yes
5646,92-T-032,Cyanobacterial and Plant Acetyl-CoA Carboxylase,"08/475,879","5,972,644",*United States,US,6/7/1995,10/26/1999,,,0401-007,Large,10/2/1992,,No,12/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,"Piotr Gornicki, Robert Haselkorn",Divisional,4/12/2018,0401-007,10/26/2016,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611367,,581408,Yes
5647,92-T-032,Cyanobacterial and Plant Acetyl-CoA Carboxylase,"08/476,537","5,756,290",*United States,US,6/7/1995,5/26/1998,,,0401-008,Large,10/2/1992,,No,12/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",Divisional,4/12/2018,0401-008,5/26/2015,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611368,,581408,Yes
5648,92-T-032,Cyanobacterial and Plant Acetyl-CoA Carboxylase,"09/433,043","6,399,342",*United States,US,10/25/1999,6/4/2002,,,0401-015,Large,10/2/1992,,No,12/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",Divisional,4/12/2018,0401-015,7/23/2013,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",611369,,581408,Yes
5649,92-T-032,Nucleic Acid Compositions Encoding Acetyl CoA Carboxylase and Uses Therefor,"08/611,546",,*United States,US,3/5/1996,,,,0401-010,Large,10/2/1992,,No,12/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",US Utility,4/12/2018,0401-010,10/2/2012,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",613733,,581408,Yes
5650,92-T-032,Nucleic Acid Compositions Encoding Acetyl CoA Carboxylase and Uses Therefor,96912726.5EPO, ,European Patent Office (EPO),EP,4/12/1996,, ,,0401-013,Large,10/2/1992,,No,12/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Piotr Gornicki, Robert Haselkorn",Nationalized PCT,4/12/2018,0401-013,4/12/2016,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",613734,,581408,Yes
5651,92-T-032,Nucleic Acid Compositions Encoding Acetyl CoA Carboxylase and Uses Therefor,55432/96,723686,Australia,AU,4/12/1996,12/14/2000,723686,,0401-014,Large,10/2/1992,,No,12/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn","Foreign, Non-PCT",4/12/2018,0401-014,4/12/2016,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",613735,8/31/2000,581408,Yes
5652,92-T-032,Nucleic Acid Compositions Encoding Acetyl-CoA Carboxylase and Uses Therefor,"08/611,107","5,801,233",*United States,US,3/5/1996,9/1/1998,,,0401-009,Large,10/2/1992,,No,12/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Piotr Gornicki, Robert Haselkorn",Continuation in Part,4/12/2018,0401-009,10/2/2012,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",613736,,581408,Yes
5653,92-T-033,Nucleic acid segments encoding wheat acetyl-CoA carboxylase,"08/934,386","6,306,636",*United States,US,9/19/1997,10/23/2001, ,9/19/1997,0401.1-001,Large,9/19/1997,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Piotr Gornicki, Robert Haselkorn",US Utility,4/12/2018,0401.1-001,9/19/2017,"Ginsburg, Eric",Robert Haselkorn,"Tennant, Thelma",613740,,581409,Yes
5654,92-T-034,Method of Inducing Antibody Production Against an Infectious Agent in a Host,"08/681,811","5,714,153",*United States,US,7/29/1996,2/3/1998,,,0402-021,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,Bernard Roizman,Continuation,4/12/2018,0402-021,12/23/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612525,,581410,Yes
5655,92-T-034,Synthetic Herpes Simplex Virus Promoters,"07/996,961",,*United States,US,12/23/1992,,,,0402-001,Small,12/23/1992,,Yes,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",32325,Bernard Roizman,US Utility,4/12/2018,0402-001,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614756,,581410,Yes
5656,92-T-034,Synthetic Herpes Simplex Virus Promoters,PCT/US93/12507, ,*United States,US,12/22/1993,,WO 94/14971,12/22/1993,0402-002,Large,12/23/1992,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James", ,Bernard Roizman,PCT,4/12/2018,0402-002,6/23/1995,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614757,7/7/1994,581410,Yes
5657,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4EPO,EP 0 675 962 B1,European Patent Office (EPO),EP,12/22/1993,2/5/2003,WO 94/14971,,0402-003,Small,12/23/1992,,No,5/21/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James", ,Bernard Roizman,Nationalized PCT,4/12/2018,0402-003,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614758,7/7/1994,581410,Yes
5658,92-T-034,Synthetic Herpes Simplex Virus Promoters,072628/95,"181,355","Korea, Republic of",KR,12/22/1993,12/7/1998,,,0402-004,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011,Bernard Roizman,Nationalized PCT,4/12/2018,0402-004,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614759,,581410,Yes
5659,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4SE,EP 0675 962 B1,Sweden,SE,12/22/1993,3/6/2003,WO 94/14971,,0402-005,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-SE,Bernard Roizman,Validated EPO,4/12/2018,0402-005,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614760,7/7/1994,581410,Yes
5660,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4BE,EP 0 675 962 B1,Belgium,BE,12/22/1993,2/5/2003,WO 94/14971,,0402-006,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-BE,Bernard Roizman,Validated EPO,4/12/2018,0402-006,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614761,7/7/1994,581410,Yes
5661,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4CH,EP 0 675 962 B1,Switzerland,CH,12/22/1993,2/5/2003,WO 94/14971,,0402-007,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-CH,Bernard Roizman,Validated EPO,4/12/2018,0402-007,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614762,7/7/1994,581410,Yes
5662,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4DE,69332678.6,Germany,DE,12/22/1993,2/5/2003,WO 94/14971,,0402-008,Small,12/23/1992,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,31011-DE,Bernard Roizman,Validated EPO,4/12/2018,0402-008,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614763,7/7/1994,581410,Yes
5663,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4DK,EP 0 675 962 B1,Denmark,DK,12/22/1993,2/5/2003,WO 94/14971,,0402-009,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-DK,Bernard Roizman,Validated EPO,4/12/2018,0402-009,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614764,7/7/1994,581410,Yes
5664,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4ES,EP 0 675 962 B1,Spain,ES,12/22/1993,2/5/2003,WO 94/14971,,0402-010,Small,12/23/1992,,No,10/3/2020,Abandoned,"Marshall, Gerstein & Borun",,31011-ES,Bernard Roizman,Validated EPO,4/12/2018,0402-010,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614765,7/7/1994,581410,Yes
5665,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4FR,EP 0 675 962 B1,France,FR,12/22/1993,,WO 94/14971,,0402-011,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-FR,Bernard Roizman,Validated EPO,4/12/2018,0402-011,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614766,7/7/1994,581410,Yes
5666,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4GB,EP 0 675 962 B1,United Kingdom,GB,12/22/1993,3/6/2003,WO 94/14971,,0402-012,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-GB,Bernard Roizman,Validated EPO,4/12/2018,0402-012,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614767,7/7/1994,581410,Yes
5667,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4GR,3043850,Greece,GR,12/22/1993,3/6/2003,WO 94/14971,,0402-013,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-GR,Bernard Roizman,Validated EPO,4/12/2018,0402-013,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614768,7/7/1994,581410,Yes
5668,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4IE,EP 0 675 962 B1,Ireland,IE,12/22/1993,3/6/2003,WO 94/14971,,0402-014,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-IE,Bernard Roizman,Validated EPO,4/12/2018,0402-014,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614769,7/7/1994,581410,Yes
5669,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4IT,EP 0 675 962 B1,Italy,IT,12/22/1993,3/6/2003,WO 94/14971,,0402-015,None,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-IT,Bernard Roizman,Validated EPO,4/12/2018,0402-015,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614770,7/7/1994,581410,Yes
5670,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4LU,EP 0 675 962 B1,Luxembourg,LU,12/22/1993,3/6/2003,WO 94/14971,,0402-016,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-LU,Bernard Roizman,Validated EPO,4/12/2018,0402-016,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614771,7/7/1994,581410,Yes
5671,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4MC,EP 0 675 962 B1,Monaco,MC,12/22/1993,3/6/2003,WO 94/14971,,0402-017,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-MC,Bernard Roizman,Validated EPO,4/12/2018,0402-017,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614772,7/7/1994,581410,Yes
5672,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4NL,EP 0 675 962 B1,Netherlands,NL,12/22/1993,3/6/2003,WO 94/14971,,0402-018,None,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-NL,Bernard Roizman,Validated EPO,4/12/2018,0402-018,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614773,7/7/1994,581410,Yes
5673,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4PT,EP 0 675 962 B1,Portugal,PT,12/22/1993,3/6/2003,WO 94/14971,,0402-019,Small,12/23/1992,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",31011-PT,Bernard Roizman,Validated EPO,4/12/2018,0402-019,12/22/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614774,7/7/1994,581410,Yes
5674,92-T-034,Synthetic Herpes Simplex Virus Promoters,"08/332,467","5,641,651",*United States,US,10/31/1994,6/24/1997,,,0402-020,Small,12/23/1992,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",32325,Bernard Roizman,Continuation,4/12/2018,0402-020,6/24/2014,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614775,,581410,Yes
5675,92-T-034,Synthetic Herpes Simplex Virus Promoters,94905494.4AT,232238,Austria,AT,9/10/2003,2/15/2003,,,0402-022,Small,12/23/1992,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Wrona, Thomas",31011-AT,Bernard Roizman,Validated EPO,4/12/2018,0402-022,12/22/2003,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614776,12/23/1992,581410,Yes
5676,92-T-035,Papillomavirus: Biosynthetic Process and Assays,"07/930,648",,*United States,US,8/14/1992,,,,0403-001,None,8/14/1992,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Kitchell, Barbara",,"Laimonis Laimins, Craig Meyers",US Utility,4/12/2018,0403-001,,"Unassigned, Unassigned",Laimonis Laimins,"Unassigned, Unassigned",613880,,581411,Yes
5677,92-T-035,Papillomavirus: Biosynthetic Process and Assays,PCT/US93/07171, ,*United States,US,7/30/1993,3/3/1994, ,7/30/1993,0403-002,None,8/14/1992,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Kitchell, Barbara", ,"Laimonis Laimins, Craig Meyers",PCT,4/12/2018,0403-002,2/14/1995,"Unassigned, Unassigned",Laimonis Laimins,"Unassigned, Unassigned",613881,,581411,Yes
5678,92-T-035,Papillomavirus: Biosynthetic Process and Assays,"08/208,807",,*United States,US,3/10/1994,,,,0403-003,None,8/14/1992,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Kitchell, Barbara",,"Laimonis Laimins, Craig Meyers",Continuation,4/12/2018,0403-003,,"Unassigned, Unassigned",Laimonis Laimins,"Unassigned, Unassigned",613882,,581411,Yes
5679,92-T-035,Papillomavirus: Biosynthetic Process and Assays,"2,142,469",,Canada,CA,2/14/1995,,,,0403-004,None,8/14/1992,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Laimonis Laimins, Craig Meyers",Nationalized PCT,4/12/2018,0403-004,2/14/2015,"Unassigned, Unassigned",Laimonis Laimins,"Unassigned, Unassigned",613883,,581411,Yes
5680,92-T-035,Papillomavirus: Biosynthetic Process and Assays,93918517.9EPO, ,European Patent Office (EPO),EP,3/7/1995,, ,,0403-005,None,8/14/1992,,No,6/8/2022,Abandoned,,, ,"Laimonis Laimins, Craig Meyers",Nationalized PCT,4/12/2018,0403-005,3/7/2015,"Unassigned, Unassigned",Laimonis Laimins,"Unassigned, Unassigned",613884,,581411,Yes
5681,92-T-036,Nonimaging Optical Illumination System (OWNED BY 3M),"07/732,982","5,289,356",*United States,US,7/19/1991,2/22/1994,,,0404-001,Small,7/19/1991,,Yes,2/4/2020,Expired - Inactive,Foley & Lardner,,,"Harald Ries, Roland Winston",Continuation in Part,4/12/2018,0404-001,2/22/2011,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613691,,581412,Yes
5682,92-T-036,Nonimaging Optical Illumination System (OWNED BY 3M),"07/774,666","5,335,152",*United States,US,10/11/1991,8/2/1994,,,0404-002,Small,10/11/1991,,Yes,2/4/2020,Expired - Inactive,Foley & Lardner,,,"Harald Ries, Roland Winston",US Utility,4/12/2018,0404-002,10/11/2011,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613692,,581412,Yes
5683,92-T-037,Expression and Purification of Kringle Domains of Human Apolipoprotein (A) in E. Coli,"08/240,839","6,372,886",*United States,US,5/11/1994,4/16/2002,,,0405-002,Small,6/23/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,,,"Gunther Fless, Angelo Scanu",Divisional,4/12/2018,0405-002,4/16/2019,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",611555,,581413,Yes
5684,92-T-037,Expression and Purification of Kringle Domains of Human Apolipoprotein (A) in E.Coli,"07/902,646",,*United States,US,6/23/1992,,,,0405-001,Small,6/23/1992,,Yes,12/19/2019,Abandoned,Norton Rose Fulbright US LLP,,,"Gunther Fless, Angelo Scanu",US Utility,4/12/2018,0405-001,,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",611556,,581413,Yes
5685,92-T-038,Method for Computer-Aided Detection of Clustered Microcalcifications From Digital Mammograms,"07/915,631","5,537,485",*United States,US,7/21/1992,7/16/1996,,,0406-001,Small,7/21/1992,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Robert ""Bob"" Nishikawa",US Utility,4/12/2018,0406-001,7/16/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612430,,581414,Yes
5686,92-T-038,Method for Computer-Aided Detection of Clustered Microcalcifications From Digital Mammograms,1993-178932,3432863,Japan,JP,7/20/1993,5/23/2003,6154201,,0406-002,Small,7/21/1992,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Robert ""Bob"" Nishikawa","Foreign, Non-PCT",4/12/2018,0406-002,7/20/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612431,7/16/1996,581414,Yes
5687,92-T-045,Sequence Independent Amplification of DNA,"08/096,637","5,731,171",*United States,US,7/23/1993,3/24/1998, ,7/23/1993,0413-001,Small,7/23/1993,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Stefan Bohlander,US Utility,4/12/2018,0413-001,3/24/2015,"Unassigned, Unassigned",Stefan Bohlander,"Unassigned, Unassigned",614486,,581421,Yes
5688,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,"07/931,631","5,334,498",*United States,US,8/18/1992,8/2/1994,,,0414-001,Small,8/18/1992,,Yes,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Frances Purves, Bernard Roizman",US Utility,4/12/2018,0414-001,8/18/2012,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611757,,581422,Yes
5689,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,PCT/US93/07547, ,*United States,US,8/12/1993,,WO94/04920,8/12/1993,0414-002,Small,8/18/1992,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Bernard Roizman, Frances Spector",PCT,4/12/2018,0414-002,2/18/1995,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611758,,581422,Yes
5690,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,"08/245,209",,*United States,US,5/17/1994,,,,0414-003,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",Continuation,4/12/2018,0414-003,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611759,,581422,Yes
5691,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,506378/94,,Japan,JP,2/17/1995,,,,0414-004,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",Nationalized PCT,4/12/2018,0414-004,2/17/2015,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611760,,581422,Yes
5692,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,93919969.1EPO,656113,European Patent Office (EPO),EP,3/14/1995,7/24/1996, ,,0414-005,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Bernard Roizman, Frances Spector",Nationalized PCT,4/12/2018,0414-005,3/14/2015,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611761,,581422,Yes
5693,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,93919969.1CH,656113,Switzerland,CH,3/14/1995,7/24/1996,,,0414-006,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",Validated EPO,4/12/2018,0414-006,8/12/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611762,,581422,Yes
5694,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,93919969.1DE,69303822.5,Germany,DE,3/14/1995,7/24/1996,,,0414-007,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",Validated EPO,4/12/2018,0414-007,8/12/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611763,,581422,Yes
5695,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,93919969.1FR,656113,France,FR,3/14/1995,7/24/1996,,,0414-008,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",Validated EPO,4/12/2018,0414-008,8/12/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611764,,581422,Yes
5696,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,93919969.1GB,656113,United Kingdom,GB,3/14/1995,7/24/1996,,,0414-009,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",Validated EPO,4/12/2018,0414-009,8/12/2013,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611765,,581422,Yes
5697,92-T-046,Herpes Simplex Virus 1 UL13 Gene Product: Methods and Compositions,"09/870,931",,*United States,US,5/30/2001,,US-2002-015944-A1,,0414-010,Small,8/18/1992,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Bernard Roizman, Frances Spector",US Utility,4/12/2018,0414-010,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611766,2/7/2002,581422,Yes
5698,92-T-047,Immunosuppressive Activity and Toxicity of Monoclonal Antibodies,"08/557,050","6,491,916",*United States,US,10/9/1998,12/10/2002,,,0415-005,Small,6/1/1993,,No,12/19/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Maria-Luisa Alegre, Jeffrey Bluestone, Linda Jolliffe, Xin-Wei Xu, Robert Zivin",Continuation in Part,4/12/2018,0415-005,12/10/2019,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",611934,,581423,Yes
5699,92-T-047,Methods and Materials for Modulation of the Immunosuppressive Activity and Toxicity of Monoclonal Antibodies,"08/070,116","5,885,573",*United States,US,6/1/1993,3/23/1999,,,0415-001,Small,6/1/1993,,Yes,12/19/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Jeffrey Bluestone, Linda Jolliffe, Robert Zivin",US Utility,4/12/2018,0415-001,3/23/2016,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613119,,581423,Yes
5700,92-T-047,METHODS AND MATERIALS FOR MODULATION OF THE IMMUNOSUPPRESSIVE ACTIVITY AND TOXICITY OF MONOCLONAL ANTIBODIES,PCT/US94/06198, ,*United States,US,6/1/1994,,WO 94/28027,6/1/1994,0415-004,Small,6/1/1993,,No,4/28/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Jeffrey Bluestone, Linda Jolliffe, Robert Zivin",PCT,4/12/2018,0415-004,12/1/1995,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613120,12/8/1994,581423,Yes
5701,92-T-047,Monoclonal Modulation,"2,163,989",,Canada,CA,6/1/1994,,"2,163,989",,0415-002,Large,6/1/1993,,No,12/19/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Maria-Luisa Alegre, Jeffrey Bluestone, Linda Jolliffe, Xin-Wei Xu, Robert Zivin",Nationalized PCT,4/12/2018,0415-002,1/6/2014,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613526,12/8/1994,581423,Yes
5702,92-T-047,Monoclonal Modulation,7-501069,,Japan,JP,6/1/1994,,,,0415-003,Small,6/1/1993,,No,12/19/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Maria-Luisa Alegre, Jeffrey Bluestone, Linda Jolliffe, Xin-Wei Xu, Robert Zivin",Nationalized PCT,4/12/2018,0415-003,6/1/2014,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",613527,,581423,Yes
5703,92-T-049,Adenovirus Mediated  Gene Transfer to Cardiac and Vascular Smooth Muscle,56093/94,694097,Australia,AU,11/16/1993,11/5/1998,,,0417-004,Large,11/18/1992,,No,2/24/2021,Abandoned,Norton Rose Fulbright US LLP,,,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Nationalized PCT,4/12/2018,0417-004,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610257,,581425,Yes
5704,92-T-049,Adenovirus Mediated Gene Transfer to CArdiac and Vascular Smooth Muscle,"2,149,771",,Canada,CA,11/16/1993,,,,0417-005,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Nationalized PCT,4/12/2018,0417-005,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610258,,581425,Yes
5705,92-T-049,Adenovirus Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,94901544.0EPO,EP 0 668 913 B1,European Patent Office (EPO),EP,11/16/1993,1/30/2002,WO 94/11506,,0417-006,Large,11/18/1992,,No,5/21/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Nationalized PCT,4/12/2018,0417-006,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610259,5/26/1994,581425,Yes
5706,92-T-049,Adenovirus Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,6-512466,,Japan,JP,11/16/1993,,,,0417-007,Large,11/18/1992,,No,1/24/2019,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Nationalized PCT,4/12/2018,0417-007,,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610260,,581425,Yes
5707,92-T-049,Adenovirus-Mediated Gene Transfer,"08/417,459",,*United States,US,4/5/1995,,,,0417-017,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Continuation in Part,4/12/2018,0417-017,,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610261,,581425,Yes
5708,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac & Vascular Smooth Muscle,"07/977,496",,*United States,US,11/18/1992,,,,0417-001,Large,11/18/1992,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",US Utility,4/12/2018,0417-001,,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610262,,581425,Yes
5709,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,PCT/US93/11133, ,*United States,US,11/16/1993,,WO 94/11506,11/16/1993,0417-002,Large,11/18/1992,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",PCT,4/12/2018,0417-002,5/18/1995,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610263,5/26/1994,581425,Yes
5710,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,02022269.1EPO,,European Patent Office (EPO),EP,11/16/1993,,EP 1 321 526 A2,,0417-003,Small,11/18/1992,,No,2/4/2020,Abandoned,Norton Rose Fulbright US LLP,,,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Nationalized PCT,4/12/2018,0417-003,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610264,6/25/2003,581425,Yes
5711,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,2004-167855,,Japan,JP,11/16/1993,,,,0417-008,Small,11/16/1993,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Divisional,4/12/2018,0417-008,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610265,,581425,Yes
5712,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,94901544.0FR,EP 0 668 913 B1,France,FR,11/16/1993,1/30/2002,WO 94/11506,,0417-009,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-009,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610266,5/26/1994,581425,Yes
5713,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,94901544.0IE,EP 0 668 913 B1,Ireland,IE,11/16/1993,1/30/2002,WO 94/11506,,0417-010,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-010,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610267,5/26/1994,581425,Yes
5714,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,94901544.0NL,EP 0 668 913 B1,Netherlands,NL,11/16/1993,1/30/2002,WO 94/11506,,0417-011,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-011,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610268,5/26/1994,581425,Yes
5715,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,94901544.0GB,EP 0 668 913 B1,United Kingdom,GB,11/16/1993,1/30/2002,WO 94/11506,,0417-012,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-012,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610269,5/26/1994,581425,Yes
5716,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,94901544.0DE,EP 0 668 913 B1,Germany,DE,11/16/1993,1/30/2002,WO 94/11506,,0417-014,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-014,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610270,5/26/1994,581425,Yes
5717,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,99109240.4EPO,0957171,European Patent Office (EPO),EP,11/16/1993,,EP 0 957 172 A2,,0417-015,Large,11/18/1992,,No,5/21/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Nationalized PCT,4/12/2018,0417-015,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610271,11/17/1999,581425,Yes
5718,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,2006-71837,,Japan,JP,11/16/1993,,,,0417-016,Small,11/16/1993,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Divisional,4/12/2018,0417-016,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610272,,581425,Yes
5719,92-T-049,Adenovirus-mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,"09/371,683",,*United States,US,8/10/1999,,,,0417-020,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",US Utility,4/12/2018,0417-020,11/18/2012,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610273,,581425,Yes
5720,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,99109240.4DE,,Germany,DE,11/16/1993,,,,0417-021,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-021,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610274,,581425,Yes
5721,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,99109240.4FR,,France,FR,11/16/1993,,,,0417-022,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-022,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610275,,581425,Yes
5722,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,99109240.4GB,,United Kingdom,GB,11/16/1993,,,,0417-023,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-023,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610276,,581425,Yes
5723,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,99109240.4NL,,Netherlands,NL,11/16/1993,,,,0417-024,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-024,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610277,,581425,Yes
5724,92-T-049,Adenovirus-Mediated Gene Transfer to Cardiac and Vascular Smooth Muscle,99109240.4IE,,Ireland,IE,11/16/1993,,,,0417-025,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Validated EPO,4/12/2018,0417-025,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610278,,581425,Yes
5725,92-T-049,Adenovirus-Medicated Gene Transfer to Cardiac and Vascular Smooth Muscle,2002-274149,,Japan,JP,11/16/1993,,JP-23102474-A2,,0417-013,Large,11/18/1992,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden, Sabdeep Tripathy",Divisional,4/12/2018,0417-013,11/16/2013,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610279,4/8/2003,581425,Yes
5726,92-T-049,Adenovirus-Medicated Gene Transfer to Cardiac and Vascular Smooth Muscle,"08/972,831","6,297,220",*United States,US,11/18/1997,10/2/2001,,,0417-018,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden",Continuation in Part,4/12/2018,0417-018,11/18/2012,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610280,,581425,Yes
5727,92-T-049,Adenovirus-Medicated Gene Transfer to Cardiac and Vascular Smooth Muscle,"09/186,968","6,436,907",*United States,US,11/5/1998,8/20/2002,,,0417-019,Large,11/18/1992,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden",US Utility,4/12/2018,0417-019,11/18/2012,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610281,,581425,Yes
5728,92-T-050,Method and System for Determining Geometric Pattern Features of Interstitial Infiltrates in Chest Images,"07/981,526","5,319,549",*United States,US,11/25/1992,6/7/1994,,,0418-001,Small,11/25/1992,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigehiko Katsuragawa",US Utility,4/12/2018,0418-001,11/25/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612353,,581426,Yes
5729,92-T-050,Method and System for Determining Geometric Pattern Features of Interstitial Infiltrates in Chest Images,284883/93,6339476,Japan,JP,11/15/1993,6/7/1994,,,0418-002,Small,11/25/1992,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigehiko Katsuragawa","Foreign, Non-PCT",4/12/2018,0418-002,11/15/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612354,,581426,Yes
5730,92-T-051,Method and System for Detection of Interval Change in Temporally Sequential Chest Images,"07/981,471","5,359,513",*United States,US,11/25/1992,10/25/1994,,,0419-001,Small,11/25/1992,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Akiko Kano",US Utility,4/12/2018,0419-001,11/25/2012,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612347,,581427,Yes
5731,92-T-051,Method and System for Detection of Interval Change in Temporally Sequential Chest Images,284884/93,,Japan,JP,11/15/1993,,,,0419-002,Small,11/25/1992,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Akiko Kano","Foreign, Non-PCT",4/12/2018,0419-002,11/15/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612348,,581427,Yes
5732,92-T-051,Method and System for Detection of Interval Change in Temporally Sequential Chest Images,2005-019694,4130661,Japan,JP,11/15/1993,5/30/2008,,,0419-003,Large,11/25/1992,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy",,"Kunio Doi, Akiko Kano",Divisional,4/12/2018,0419-003,11/15/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612349,,581427,Yes
5733,92-T-054,Apolipopritein B RNA Editing Protein Compositions and Methods,"07/984,926",,*United States,US,12/4/1992,,,,0422-001,Small,12/4/1992,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Nicholas Davidson, BaBie Teng",US Utility,4/12/2018,0422-001,,"Sun, Han",Nicholas Davidson,"Muite, Kevin",610440,,581430,Yes
5734,92-T-054,Apolipoprotein B mRNA Editing Protein,PCT/US94/01422, ,*United States,US,2/8/1994,8/18/1994, ,2/8/1994,0422-005,Small,12/4/1992,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Charles Burant, Nicholas Davidson, BaBie Teng",PCT,4/12/2018,0422-005,6/4/1995,"Sun, Han",Nicholas Davidson,"Muite, Kevin",610441,,581430,Yes
5735,92-T-054,Apolipoprotein B mRNA Editing Protein Compositions and Methods,"08/015,203","5,550,034",*United States,US,2/9/1993,8/27/1996,,,0422-002,Small,12/4/1992,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Charles Burant, Nicholas Davidson, BaBie Teng",Continuation in Part,4/12/2018,0422-002,8/27/2013,"Sun, Han",Nicholas Davidson,"Muite, Kevin",610442,,581430,Yes
5736,92-T-054,Apolipoprotein B MRNA Editing Protein Compositions and Methods,"08/158,682","5,434,058",*United States,US,11/24/1993,7/18/1995,,,0422-003,Small,2/9/1993,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,,,Nicholas Davidson,Continuation in Part,4/12/2018,0422-003,2/9/2013,"Sun, Han",Nicholas Davidson,"Muite, Kevin",610443,,581430,Yes
5737,92-T-054,Apolipoprotein B RNA Editing Protein: Composition & Methods,09408009.7EPO, ,European Patent Office (EPO),EP,2/8/1994,, ,,0422-004,Small,12/4/1992,,No,5/21/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Denise Bonen, Charles Burant, Nicholas Davidson, Federico Giannoni, Christos Hadjaigapiou, BaBie Teng",Nationalized PCT,4/12/2018,0422-004,2/8/2014,"Sun, Han",Nicholas Davidson,"Muite, Kevin",610444,,581430,Yes
5738,92-T-059,Organic Tissue Glue for Closure of Wounds,"08/033,314","5,552,452",*United States,US,3/15/1993,9/3/1996,,,0427-001,Small,3/15/1993,,Yes,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Parker, David",,"John Khadem, Toan Truong",US Utility,4/12/2018,0427-001,9/3/2013,"Unassigned, Unassigned",John Khadem,"Unassigned, Unassigned",613859,,581435,Yes
5739,92-T-059,Organic Tissue Glue for Closure of Wounds,"08/636,463",,*United States,US,4/23/1996,,,,0427-002,Small,3/15/1993,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Parker, David",,"John Khadem, Toan Truong",Divisional,4/12/2018,0427-002,3/15/2013,"Unassigned, Unassigned",John Khadem,"Unassigned, Unassigned",613860,,581435,Yes
5740,93-T-001,Grafted Methylenediphosphonate Ion Exchange Resins,"08/383,798","5,618,851",*United States,US,2/6/1995,4/8/1997, ,2/6/1995,93-053-001,Small,2/6/1995,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Spiro Alexandratos, Ralph Gatrone, Phil Horwitz, Andrzej Trochimcznk",US Utility,4/12/2018,93-053-001,2/6/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",611703,,581000,Yes
5741,93-T-001,Grafted methylenediphosphonate ion exchange resins,"08/829,998","5,712,347",*United States,US,2/6/1995,1/27/1998, ,4/3/1997,93-053-002,Small,2/6/1995,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Spiro Alexandratos, Ralph Gatrone, Phil Horwitz, Andrzej Trochimcznk",Divisional,4/12/2018,93-053-002,2/6/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",611704,,581000,Yes
5742,93-T-002,Process for Recovering Chaotropic Anions from an Aqueous Solution Also Containing Other Ions,"08/478,382","5,888,397",*United States,US,6/7/1995,3/30/1999, ,6/7/1995,93-057-002,Small,6/7/1995,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Andrew Bond, Phil Horwitz, Robin Rogers",US Utility,4/12/2018,93-057-002,6/7/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614164,,581001,Yes
5743,93-T-002,Process for Recovering Pertechnetate Ions from an Aqueous Solution Also Containing Other Ions,"08/477,330","5,603,834",*United States,US,6/7/1995,2/18/1997, ,6/7/1995,93-057-001,Small,6/7/1995,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Andrew Bond, Phil Horwitz, Robin Rogers",US Utility,4/12/2018,93-057-001,6/7/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614165,,581001,Yes
5744,93-T-002,Process for Separating and Recovering an Anionic Dye From an Aqueous Solution,"08/655,251","5,707,525",*United States,US,6/7/1995,1/13/1998, ,6/5/1996,93-057-005,Small,6/7/1995,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Andrew Bond, Phil Horwitz, Robin Rogers",Continuation in Part,4/12/2018,93-057-005,6/7/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614166,,581001,Yes
5745,93-T-002,Recovering Chaotropic Anions from Aqueous Solution,PCT/US96/08461, ,*United States,US,6/3/1996,,WO 96/40396,6/3/1996,93-057-003,Small,6/7/1995,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Andrew Bond, Phil Horwitz, Robin Rogers",PCT,4/12/2018,93-057-003,12/7/1997,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614363,12/19/1996,581001,Yes
5746,93-T-002,Recovering Chaotropic Anions from Aqueous Solution,96917018.2EPO, ,European Patent Office (EPO),EP,6/3/1996,,EP 0 830 189 A1,6/3/1996,93-057-004,Small,6/7/1995,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Andrew Bond, Phil Horwitz, Robin Rogers",Nationalized PCT,4/12/2018,93-057-004,6/7/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614364,3/25/1998,581001,Yes
5747,93-T-002,Separating Anionic Dye From Aqueous Solution,PCT/US96/09003, ,*United States,US,6/6/1996,,WO 96/40397,6/6/1996,93-057-006,Small,6/7/1995,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Andrew Bond, Phil Horwitz, Robin Rogers",PCT,4/12/2018,93-057-006,12/7/1997,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614482,12/19/1996,581001,Yes
5748,93-T-009,Alignment Method for Radiography and Radiography Apparatus Incorporating Same,"08/158,599","5,388,143",*United States,US,11/26/1993,2/7/1995,,,0433-001,None,11/26/1993,,Yes,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,,,Heber MacMahon,US Utility,4/12/2018,0433-001,2/8/1999,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",610295,,581441,Yes
5749,93-T-009,Alignment Method for Radiography and Radiography Apparatus Incorporating Same,PCT/US94/13635, ,*United States,US,11/28/1994,6/1/1995, ,11/28/1994,0433-002,None,11/26/1993,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,Heber MacMahon,PCT,4/12/2018,0433-002,5/26/1996,"Cox, Ben",Heber MacMahon,"Juggernauth, Anne",610296,,581441,Yes
5750,93-T-011,Identification and Characterization of Inhibitors of Protein Farnesyltransferase,"08/000,931","5,578,477",*United States,US,1/5/1993,11/26/1996,,,0435-001,Small,1/5/1993,,Yes,4/12/2018,Abandoned,Barnes & Thornburg,"Bent, Stephen",,Fuyhiko Tamanoi,US Utility,4/12/2018,0435-001,1/5/2013,"Unassigned, Unassigned",Fuyhiko Tamanoi,"Unassigned, Unassigned",611880,,581443,Yes
5751,93-T-011,Identification and Characterization of Inhibitors of Proteins Farnesyltransferase.,"08/724,416",,*United States,US,10/1/1996,,,,0435-002,Large,1/5/1993,,No,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,"Ruben Gomez, Laurie Goodman, Fuyhiko Tamanoi",Divisional,4/12/2018,0435-002,1/29/2012,"Unassigned, Unassigned",Fuyhiko Tamanoi,"Unassigned, Unassigned",611881,,581443,Yes
5752,93-T-013,Methods of Identifying Agonists and Antagonists of Opioid Receptors,"08/455,683","7,235,366",*United States,US,5/31/1995,6/26/2007,,,0437-013,None,8/19/1994,4/5/2021,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Divisional,4/12/2018,0437-013,6/26/2024,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613322,,581445,Yes
5753,93-T-013,Nucleic Acids Encoding Kappa Opioid Receptors,"08/292,694","6,319,686",*United States,US,8/19/1994,11/20/2001,,,0437-012,Small,5/20/1993,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Continuation,4/12/2018,0437-012,11/20/2018,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613743,,581445,Yes
5754,93-T-013,Opioid Receptor: Composition and Method,2004-307483,,Japan,JP,10/21/2004,,JP-25124574-A2,,0437-016,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Divisional,4/12/2018,0437-016,10/21/2024,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613786,5/19/2005,581445,Yes
5755,93-T-013,Opioid Receptors (Including Receptors Obtained from Human Gene Sequences): Compositions and Methods,"08/100,694",,*United States,US,7/30/1993,,,,0437-002,None,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Continuation in Part,4/12/2018,0437-002,7/30/2013,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613787,,581445,Yes
5756,93-T-013,Opioid Receptors Compositions and Methods,"08/066,296",,*United States,US,5/20/1993,,,,0437-001,Small,5/20/1993,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",US Utility,4/12/2018,0437-001,,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613788,,581445,Yes
5757,93-T-013,Opioid Receptors Compositions and Methods,71382/94,678266,Australia,AU,5/20/1994,9/11/1997,,,0437-004,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Graeme Bell, Terry Reisine, Kazuki Yasuda","Foreign, Non-PCT",4/12/2018,0437-004,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613789,,581445,Yes
5758,93-T-013,Opioid Receptors-Compositions and Methods,"08/455,542",,*United States,US,5/31/1995,,,,0437-014,None,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Divisional,4/12/2018,0437-014,,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613790,,581445,Yes
5759,93-T-013,Opioid Receptors: Composition and Methods,"2,163,350",,Canada,CA,5/20/1994,,,,0437-006,Large,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Nationalized PCT,4/12/2018,0437-006,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613791,,581445,Yes
5760,93-T-013,Opioid Receptors: Composition and Methods,7-500850,,Japan,JP,5/20/1994,,,,0437-007,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Nationalized PCT,4/12/2018,0437-007,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613792,,581445,Yes
5761,93-T-013,Opioid Receptors: Compositions and Methods,PCT/US94/05747, ,*United States,US,5/20/1994,,WO 94/28132 A3,5/20/1994,0437-005,None,5/20/1993,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Terry Reisine, Kazuki Yasuda",PCT,4/12/2018,0437-005,11/20/1995,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613793,12/8/1994,581445,Yes
5762,93-T-013,Opioid Receptors: Compositions and Methods,94920679.1EPO,0700438,European Patent Office (EPO),EP,5/20/1994,,EP 0 700 438 A1,,0437-008,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Nationalized PCT,4/12/2018,0437-008,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613794,3/13/1996,581445,Yes
5763,93-T-013,Opioid Receptors: Compositions and Methods,94920679.1DE,69434269.6,Germany,DE,5/20/1994,,EP 0 700 438 A1,,0437-009,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,,,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Validated EPO,4/12/2018,0437-009,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613795,3/13/1996,581445,Yes
5764,93-T-013,Opioid Receptors: Compositions and Methods,94920679.1FR,0700438,France,FR,5/20/1994,,EP 0 700 438 A1,,0437-010,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Validated EPO,4/12/2018,0437-010,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613796,3/13/1996,581445,Yes
5765,93-T-013,Opioid Receptors: Compositions and Methods,94920679.1GB,0700438,United Kingdom,GB,5/20/1994,,EP 0 700 438 A1,,0437-011,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Validated EPO,4/12/2018,0437-011,5/20/2014,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613797,3/13/1996,581445,Yes
5766,93-T-013,Opioid Receptors: Compositions and Methods,"10/277,232",,*United States,US,10/21/2002,,US-2003-211537-A1,,0437-015,Small,5/20/1993,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Continuation,4/12/2018,0437-015,5/20/2013,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",613798,11/13/2003,581445,Yes
5767,93-T-013,Polynucleotides Encoding Kappa Opiod Receptors,"08/147,592","6,096,513",*United States,US,11/5/1993,8/1/2000,,,0437-003,Small,5/20/1993,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Terry Reisine, Kazuki Yasuda",Continuation in Part,4/12/2018,0437-003,8/1/2017,"Ginsburg, Eric",Graeme Bell,"Tennant, Thelma",614109,,581445,Yes
5768,93-T-015,Isolated Nucleic Acid Encoding a Ubiquitous Nuclear Receptor,"08/342,411","5,639,616",*United States,US,11/18/1994,6/17/1997,,,0439-003,Small,11/10/1993,6/17/2014,No,3/5/2019,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Continuation in Part,4/12/2018,0439-003,6/17/2014,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612056,,581447,Yes
5769,93-T-015,Isolated Nucleic Acid Encoding a Ubiquitous Nuclear Receptor,"11/560,340",,*United States,US,11/18/1994,,,,0439-006,Small,11/10/1993,,No,12/13/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Continuation,4/12/2018,0439-006,6/17/2014,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612057,,581447,Yes
5770,93-T-015,"Isolated nucleic acid encoding a ubiquitous nuclear receptor""","10/224,732",,*United States,US,8/20/2002,,,,0439-005,Small,11/10/1993,2/5/2007,No,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Reissue,4/12/2018,0439-005,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612059,,581447,Yes
5771,93-T-015,Isolated Nucleic Acid Encoding a Ubiquitous Nulear Receptor,"10/224,731",,*United States,US,8/20/2002,,,,0439-004,Small,11/10/1993,1/8/2007,No,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Reissue,4/12/2018,0439-004,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",612060,9/15/2005,581447,Yes
5772,93-T-015,Ubiquitous Nuclear Receptor: Compositions and Methods,"08/152,003",,*United States,US,11/10/1993,,,,0439-001,None,11/10/1993,12/16/1994,Yes,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",US Utility,4/12/2018,0439-001,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",615126,,581447,Yes
5773,93-T-015,Ubiquitous Nuclear Receptor: Compositions and Methods,PCT/US94/12883, ,*United States,US,11/8/1994,, ,11/8/1994,0439-002,None,11/10/1993,,No,4/28/2022,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",PCT,4/12/2018,0439-002,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",615127,,581447,Yes
5774,93-T-016,Use of gamma.-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin,"08/485,059","5,840,331",*United States,US,6/7/1995,11/24/1998,,,0440-001,Small,6/7/1995,11/24/2015,Yes,2/20/2019,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Martin Scharf, Eve Van Cauter",US Utility,4/12/2018,0440-001,11/24/2015,"Ginsburg, Eric",Eve Van Cauter,"Muite, Kevin",615192,,581448,Yes
5775,93-T-016,Use of gamma.-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin,PCT/US96/09228, ,*United States,US,6/6/1996,,WO 96/40105,6/6/1996,0440-002,None,6/7/1995,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"Martin Scharf, Eve Van Cauter",PCT,4/12/2018,0440-002,12/7/1997,"Ginsburg, Eric",Eve Van Cauter,"Muite, Kevin",615193,,581448,Yes
5776,93-T-017,Quality Using a Growth Hormone Secreagogue,"60/018,110", ,*United States,US,5/22/1996,, ,5/22/1996,0440.1-001,Small,5/22/1996,,Yes,4/28/2022,Expired - Inactive,Pillsbury Winthrop,"Morduch, Ruth", ,"Georges Copinschi, Eve Van Cauter",Provisional,4/12/2018,0440.1-001,5/22/1997,"Ginsburg, Eric",Eve Van Cauter,"Muite, Kevin",614231,,581449,Yes
5777,93-T-017,Sleep Quality Improvement Using a Growth Hormone Secretagogue,PCT/US97/09188, ,*United States,US,5/22/1997,,WO 97/44042,5/22/1997,0440.1-002,Small,5/22/1996,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Georges Copinschi, Eve Van Cauter",PCT,4/12/2018,0440.1-002,11/22/1998,"Ginsburg, Eric",Eve Van Cauter,"Muite, Kevin",614523,11/27/1997,581449,Yes
5778,93-T-017,Sleep Quality Improvement Using a Growth Hormone Secretagogue,"09/125,562","6,071,926",*United States,US,8/20/1998,6/6/2000,,,0440.1-003,Small,5/22/1996,,No,4/12/2018,Expired - Inactive,Welsh & Katz,"Gamson, Edward",,"Georges Copinschi, Eve Van Cauter",Nationalized PCT,4/12/2018,0440.1-003,5/22/2016,"Ginsburg, Eric",Eve Van Cauter,"Muite, Kevin",614524,,581449,Yes
5779,93-T-017,Sleep Quality Improvement Using a Growth Hormone Secretagogue,"09/492,852","6,313,133",*United States,US,1/27/2000,11/6/2001,,,0440.1-004,Small,5/22/1996,12/2/2013,No,2/20/2019,Abandoned,Welsh & Katz,"Gamson, Edward",,"Georges Copinschi, Eve Van Cauter",Continuation,4/12/2018,0440.1-004,5/22/2017,"Ginsburg, Eric",Eve Van Cauter,"Muite, Kevin",614525,,581449,Yes
5780,93-T-020,Method and System for the Detection of Microcalcifications in Digital Mammograms,"08/060,531","5,491,627",*United States,US,5/13/1993,2/13/1996, ,,0442-001,Small,5/13/1993,,Yes,8/4/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Wei Zhang",US Utility,4/12/2018,0442-001,5/13/2013,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612414,,581452,Yes
5781,93-T-020,Method and System for the Detection of Microcalcifications in Digital Mammograms,97365/94,6343627,Japan,JP,5/11/1994,2/13/1996,,,0442-002,Small,5/13/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Wei Zhang","Foreign, Non-PCT",4/12/2018,0442-002,5/11/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612415,,581452,Yes
5782,93-T-021,Design of Non-imaging Optical Concentrators and Illuminators,99101609.3,,Hong Kong,HK,4/14/1999,,1016696,,0443-011,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-011,4/14/2019,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611377,11/5/1999,581453,Yes
5783,93-T-021,Design of Nonimaging Optical Concentrator,700063/98,393914,"Korea, Republic of",KR,7/3/1996,7/24/2003,GO2B 5/10,,0443-004,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-004,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611378,9/19/2003,581453,Yes
5784,93-T-021,Design of Nonimaging Optical Concentrators,96196814.1,1196125,China,CN,7/3/1996,10/14/1998,CN 1196125A,,0443-003,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-003,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611379,10/14/1998,581453,Yes
5785,93-T-021,Design of Nonimaging Optical Concentrators,96924348.4EPO, ,European Patent Office (EPO),EP,7/3/1996,,871908,,0443-005,Small,7/7/1995,,No,5/21/2018,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-005,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611380,10/21/1998,581453,Yes
5786,93-T-021,Design of Nonimaging Optical Concentrators,505891/97,3682300,Japan,JP,7/3/1996,5/27/2005,11-509011,,0443-006,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-006,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611381,8/3/1999,581453,Yes
5787,93-T-021,Design of Nonimaging Optical Concentrators,PA/A/1996/980207,205267,Mexico,MX,7/3/1996,11/19/2001,,,0443-008,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-008,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611382,,581453,Yes
5788,93-T-021,Design of Nonimaging Optical Concentrators,"2,226,154","2,226,154",Canada,CA,7/3/1996,10/1/2002,,,0443-009,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-009,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611383,1/30/1997,581453,Yes
5789,93-T-021,Design of Nonimaging Optical Concentrators,S19980125,1720,Vietnam,VN,2/6/1998,12/27/2000,,,0443-010,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-010,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611385,,581453,Yes
5790,93-T-021,Design of Nonimaging Optical Concentrators and Illuminators,PCT/US96/11276, ,*United States,US,7/3/1996,,WO 97/03372,7/3/1996,0443-002,Small,7/7/1995,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"David Jenkins, Roland Winston",PCT,4/12/2018,0443-002,1/7/1998,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",611386,1/30/1997,581453,Yes
5791,93-T-021,Nonimaging Optical Concentrators and Illuminators,"08/499,403","5,971,551",*United States,US,7/7/1995,10/26/1999,,,0443-001,Small,7/7/1995,7/7/2015,Yes,2/13/2019,Expired - Inactive,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",US Utility,4/12/2018,0443-001,7/7/2015,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613673,,581453,Yes
5792,93-T-021,Nonimaging Optical Concentrators and Illuminators,64827/96,709997,Australia,AU,7/3/1996,12/23/1999,,,0443-007,Small,7/7/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"David Jenkins, Roland Winston",Nationalized PCT,4/12/2018,0443-007,7/3/2016,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613674,,581453,Yes
5793,93-T-023,B7-2: CTLA4/CD28 COUNTER RECEPTOR,PCT/US94/09252, ,*United States,US,8/16/1994,,WO95/05464,8/17/1994,0445-002,Large,8/16/1993,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Jeffrey Bluestone, Deborah Lenschow",PCT,4/12/2018,0445-002,2/16/2006,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",610671,,581455,Yes
5794,93-T-023,Regulating the Immune Response,"08/696,107", ,*United States,US,8/13/1996,, ,,0445-003,Large,8/16/1993,,No,3/1/2021,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Jeffrey Bluestone,US Utility,4/12/2018,0445-003,8/16/2013,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",614374,,581455,Yes
5795,93-T-023,T-Cell Activation,"08/108,215", ,*United States,US,8/16/1993,, ,,0445-001,Large,8/16/1993,,Yes,3/1/2021,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Jeffrey Bluestone,US Utility,4/12/2018,0445-001,,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",614848,,581455,Yes
5796,93-T-027,Hybrid Neuronal Cell Lines Compositions and Methods,"08/056,844","5,514,552",*United States,US,4/30/1993,5/7/1996,,,0448-001,None,4/30/1993,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,,,"Eva Eves, Marsha Rosner, Bruce Wainer",US Utility,4/12/2018,0448-001,5/7/2013,"Sun, Han",Marsha Rosner,"Tennant, Thelma",611869,,581459,Yes
5797,93-T-027,Hybrid Neuronal Cell Lines Compositions and Methods,PCT/US94/04723, ,*United States,US,4/29/1994,,WO94/25587,4/29/1994,0448-002,None,4/30/1993,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,Marsha Rosner,PCT,4/12/2018,0448-002,10/30/1995,"Sun, Han",Marsha Rosner,"Tennant, Thelma",611870,,581459,Yes
5798,93-T-028,Vertebrate Apoptosis Gene:  Compositions and Methods,94920799.7GB,0706568,United Kingdom,GB,6/22/1994,10/15/2003,0706568,,0449-005,Large,6/22/1993,6/22/2014,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Validated EPO,4/12/2018,0449-005,6/22/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615365,4/17/1996,581460,Yes
5799,93-T-028,Vertebrate Apoptosis Gene:  Compositions and Methods,7-503082,3871339,Japan,JP,6/22/1994,10/27/2006,,,0449-006,Large,6/22/1993,6/22/2014,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Nationalized PCT,4/12/2018,0449-006,6/22/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615366,,581460,Yes
5800,93-T-028,Vertebrate Apoptosis Gene: Composition and Methods,"2,165,969","2,165,969",Canada,CA,6/22/1994,8/10/2010,"2,165,969",,0449-007,Large,6/22/1993,6/22/2014,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Nationalized PCT,4/12/2018,0449-007,6/22/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615367,1/5/1995,581460,Yes
5801,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,"08/081,448","5,646,008",*United States,US,6/22/1993,7/8/1997,,,0449-001,Large,6/22/1993,7/8/2014,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",US Utility,4/12/2018,0449-001,7/8/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615368,,581460,Yes
5802,93-T-028,VERTEBRATE APOPTOSIS GENE: COMPOSITIONS AND METHODS,PCT/US94/07089, ,*United States,US,6/22/1994,,WO 95/00642,6/22/1994,0449-002,Large,6/22/1993,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Lawrence Boise, Gabriel Nunez, Craig Thompson",PCT,4/12/2018,0449-002,12/22/1995,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615369,1/5/1995,581460,Yes
5803,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,94920799.7FR,0706568,France,FR,6/22/1994,10/15/2003,0706568,,0449-003,Large,6/22/1993,6/22/2014,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Validated EPO,4/12/2018,0449-003,6/22/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615370,4/17/1996,581460,Yes
5804,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,94920799.7DE,0706568,Germany,DE,6/22/1994,10/15/2003,0706568,,0449-004,Large,6/22/1993,6/22/2014,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Validated EPO,4/12/2018,0449-004,6/22/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615371,4/17/1996,581460,Yes
5805,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,94920799.7EPO,EP 0 706 568 B1,European Patent Office (EPO),EP,6/22/1994,10/15/2003,EP 0 706 568 A1,,0449-008,Large,6/22/1993,6/22/2014,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Nationalized PCT,4/12/2018,0449-008,6/22/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615372,4/17/1996,581460,Yes
5806,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,"08/461,511","6,303,331",*United States,US,6/5/1995,10/16/2001,,,0449-009,Large,6/22/1993,10/16/2018,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Divisional,4/12/2018,0449-009,10/16/2018,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615373,,581460,Yes
5807,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,"08/470,670","5,834,309",*United States,US,6/6/1995,11/10/1998,,,0449-010,Large,6/22/1993,11/10/2015,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Continuation,4/12/2018,0449-010,11/10/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615374,,581460,Yes
5808,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,"09/271,014","6,395,510",*United States,US,3/17/1999,5/28/2002,,,0449-011,Large,6/22/1993,6/23/2014,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Divisional,4/12/2018,0449-011,5/28/2019,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615375,,581460,Yes
5809,93-T-028,Vertebrate Apoptosis Gene: Compositions and Methods,"09/952,278","6,911,532",*United States,US,9/12/2001,6/28/2005,US-2002-137182-A1,,0449-012,Large,6/22/1993,7/24/2017,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Lawrence Boise, Gabriel Nunez, Craig Thompson",Divisional,4/12/2018,0449-012,5/8/2023,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",615376,9/26/2002,581460,Yes
5810,93-T-031,Automated Detection of Lesions in Computed Tomography,PCT/US95/03640, ,*United States,US,3/30/1995,,WO95/26682,3/30/1995,0452-006,Small,3/31/1994,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",PCT,4/12/2018,0452-006,9/30/1996,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610586,10/12/1995,581463,Yes
5811,93-T-031,Automated Method $ System fir the Detection of Lesions in Medical Computing Tomographic Scans.,95914166.4IT,0760624,Italy,IT,3/30/1995,6/14/2000,0760624,,0452-005,Small,3/31/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Validated EPO,4/12/2018,0452-005,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610588,3/12/1997,581463,Yes
5812,93-T-031,"Automated method $ system for the detection of lesions in medical computing tomographic scans,",95914166.4FR,0760624,France,FR,3/30/2002,6/14/2000,0760624,,0452-011,Small,3/31/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Validated EPO,4/12/2018,0452-011,3/30/2022,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610589,3/12/1997,581463,Yes
5813,93-T-031,Automated Method & System for the Detection of Lesions in Medical Computing Tomographic Scans,95914166.4NL,0760624,Netherlands,NL,3/30/1995,6/14/2000,0760624,,0452-004,Small,3/31/1994,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Validated EPO,4/12/2018,0452-004,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610591,3/12/1997,581463,Yes
5814,93-T-031,Automated Method & System for the Detection of Lesions in Medical Computing Tomographic Scans.,95914166.4GB,0760624,United Kingdom,GB,3/30/1995,6/14/2000,0760624,,0452-003,Small,3/31/1994,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Validated EPO,4/12/2018,0452-003,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610592,3/12/1997,581463,Yes
5815,93-T-031,Automated Method and System for the Detection of Lesions in Medical Computed Tomographic Scans,"08/220,917","5,881,124",*United States,US,3/31/1994,3/9/1999, ,,0452-001,Small,3/31/1994,,Yes,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",US Utility,4/12/2018,0452-001,3/9/2016,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610640,,581463,Yes
5816,93-T-031,Automated Method and System for the Detection of Lesions in Medical Computed Tomographic Scans,69517524.6DE,0760624,Germany,DE,3/30/1995,6/14/2000, ,,0452-002,Small,3/31/1994,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Validated EPO,4/12/2018,0452-002,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610641,,581463,Yes
5817,93-T-031,Automated Method and System for the Detection of Lesions in Medical Computed Tomographic Scans,21270/95,"698,576",Australia,AU,3/30/1995,2/18/1999,,,0452-007,Small,3/31/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0452-007,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610642,3/31/1994,581463,Yes
5818,93-T-031,Automated Method and System for the Detection of Lesions in Medical Computed Tomographic Scans,"2,186,135","2,186,135",Canada,CA,3/30/1995,11/21/2000, ,,0452-008,Large,3/31/1994,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0452-008,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610643,,581463,Yes
5819,93-T-031,Automated Method and System for the Detection of Lesions in Medical Computed Tomographic Scans,95914166.4EPO,0760624,European Patent Office (EPO),EP,3/30/1995,6/14/2000,0760624,,0452-009,Small,3/31/1994,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0452-009,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610644,3/12/1997,581463,Yes
5820,93-T-031,Automated Method and System for the Detection of Lesions in Medical Computed Tomographic Scans,7-525756,3110045,Japan,JP,3/30/1995,9/14/2000, ,,0452-010,Small,3/31/1994,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kyongtae Bae, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0452-010,3/30/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610645,,581463,Yes
5821,93-T-033,Constitute Gene Expression in Conjunction with Ionizing Radiation,PCT/US95/10295, ,*United States,US,8/11/1995,, ,8/11/1995,0454-002,Small,8/11/1994,,No,6/8/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9022-004,"Dennis Hallahan, Ralph Weichselbaum",PCT,4/12/2018,0454-002,2/11/1997,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611275,,581465,Yes
5822,93-T-033,Constitutive Gene Expression in Conjunction with Ionizing Radiation,"08/289,290","7,592,317",*United States,US,8/11/1994,9/22/2009, ,,0454-001,Small,8/11/1994,9/22/2009,Yes,6/8/2022,Issued,"Valauskas Corder, LLC",, ,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",US Utility,4/12/2018,0454-001,9/22/2026,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611276,,581465,Yes
5823,93-T-033,Constitutive Gene Expression in Conjunction with Ionizing Radiation,"12/019,428","7,919,310",*United States,US,1/22/2008,4/5/2011,US-2008-0118471-A1,,0454-003,Small,8/11/1994,4/5/2011,No,6/8/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Dennis Hallahan, Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Continuation,4/12/2018,0454-003,4/17/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611277,5/22/2008,581465,Yes
5824,93-T-039,Human Peroxisome Proliferator Activated Receptor Gamma: Compositions and Methods,"08/134,557","6,200,802",*United States,US,10/8/1993,3/13/2001,,,0461-001,Small,10/8/1993,,Yes,4/12/2018,Released to Inventors,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Bruce Blumberg, Marianne Greene",US Utility,4/12/2018,0461-001,3/13/2018,"Bakalyar, Heather",Marianne Greene,"Tennant, Thelma",611846,,581471,Yes
5825,93-T-039,Human Peroxisome Proliferator Actvated Receptor Gamma: Compositions and Methods,"09/587,549","6,815,168",*United States,US,6/1/2000,11/4/2004,,,0461-002,None,10/8/1993,,No,4/12/2018,Released to Inventors,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin",,"Bruce Blumberg, Geoffrey Greene, Marianne Greene, S. Nimer",Divisional,4/12/2018,0461-002,6/1/2001,"Bakalyar, Heather",Marianne Greene,"Tennant, Thelma",611847,,581471,Yes
5826,93-T-044,Prostaglandin H Synthase Structure,"08/186,390", ,*United States,US,1/20/1994,, ,1/20/1994,0466-001,None,1/20/1994,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Michael Garavito, Patrick Loll, Daniel Picot",US Utility,4/12/2018,0466-001,,"Unassigned, Unassigned",Michael Garavito,"Unassigned, Unassigned",614203,,581476,Yes
5827,93-T-046,Epithelial Cell Gene Expression,"08/182,615", ,*United States,US,1/14/1994,, ,1/14/1994,0468-001,None,1/14/1994,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,Carol Westbrook,US Utility,4/12/2018,0468-001,,"Dembo, Anna",Carol Westbrook,"Tennant, Thelma",611537,,581478,Yes
5828,93-T-050,Second Order Nonlinear Optical Polyimide Polymer with High Temperature Stability,"08/151,072","5,399,664",*United States,US,11/10/1993,3/21/1995, ,11/10/1993,0471-001,None,11/10/1993,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Zhonghua Peng, Luping Yu",US Utility,4/12/2018,0471-001,11/10/2013,"Hwang, Luke",Luping Yu,"Tennant, Thelma",614440,,581482,Yes
5829,93-T-052,Deubiquitinating Enzyme: Compositions and Methods,"08/159,340","5,565,352",*United States,US,11/24/1993,10/15/1996, ,11/24/1993,0474-001,Small,11/24/1993,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Mark Hochstrasser, Feroz Papa",US Utility,4/12/2018,0474-001,11/24/2013,"Unassigned, Unassigned",Mark Hochstrasser,"Unassigned, Unassigned",611396,,581484,Yes
5830,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,"08/158,389", ,*United States,US,11/29/1993,, ,,0475-001,Small,11/29/1993,,Yes,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",US Utility,4/12/2018,0475-001,,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610611,,581485,Yes
5831,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,"08/515,798","5,832,103",*United States,US,11/29/1993,11/3/1998, ,,0475-002,Small,11/29/1993,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",Continuation,4/12/2018,0475-002,11/3/2015,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610612,,581485,Yes
5832,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,PCT/US94/13282, ,*United States,US,11/29/1994,,WO 95/14979,11/29/1994,0475-003,Small,11/29/1993,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",PCT,4/12/2018,0475-003,5/29/1996,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610613,6/1/1995,581485,Yes
5833,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,12570/95,"687,958",Australia,AU,11/29/1994,,,,0475-004,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",Nationalized PCT,4/12/2018,0475-004,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610614,,581485,Yes
5834,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,"2,177,472",,Canada,CA,11/29/1994,,,,0475-005,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",Nationalized PCT,4/12/2018,0475-005,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610615,,581485,Yes
5835,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,95903554.4EPO,EP 0 731 952 B1,European Patent Office (EPO),EP,11/29/1994,5/2/2003,0731952,,0475-006,Small,11/29/1993,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",Nationalized PCT,4/12/2018,0475-006,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610616,9/18/1996,581485,Yes
5836,93-T-053,Automated Method and System for Improved Computerized Detection and Classification of Massess in Mammograms,7-515143,,Japan,JP,11/29/1994,,,,0475-007,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger, Zhimin Huo, Ping Lu",Nationalized PCT,4/12/2018,0475-007,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610617,,581485,Yes
5837,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,AU200679601,,Australia,AU,11/30/1994,,,,0476-001,None,11/30/1993,,No,2/11/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",,,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger","Foreign, Non-PCT",4/12/2018,0476-001,,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610619,,581486,Yes
5838,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,"08/159,136", ,*United States,US,11/30/1993,, ,,0476-002,Small,11/30/1993,,Yes,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger",US Utility,4/12/2018,0476-002,,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610620,,581486,Yes
5839,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,"08/523,210","5,974,165",*United States,US,11/30/1994,10/26/1999, ,,0476-003,Small,11/30/1993,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger",Continuation,4/12/2018,0476-003,10/26/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610621,,581486,Yes
5840,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,PCT/US94/13285, ,*United States,US,11/30/1994,,WO 95/15537,11/30/1994,0476-004,Large,11/30/1993,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger",PCT,4/12/2018,0476-004,5/30/1996,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610622,6/8/1995,581486,Yes
5841,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,"2,177,476",,Canada,CA,11/30/1994,,,,0476-005,Large,11/30/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0476-005,11/30/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610623,,581486,Yes
5842,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,95904081.7EPO, ,European Patent Office (EPO),EP,11/30/1994,,EP 0 731 956 A4,,0476-006,None,11/30/1993,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0476-006,11/30/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610624,4/23/1997,581486,Yes
5843,93-T-054,Automated Method and System for the Alignment and Correlation of Images from Two Different Modalities,7-515647,,Japan,JP,11/30/1994,,,,0476-007,Large,11/30/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Chin-Tu Chen, Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0476-007,11/30/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610625,,581486,Yes
5844,93-T-055,Computerized Radiographic Analysis of Bone,PCT/US94/13280, ,*United States,US,11/29/1994,,WO 95/14431,11/29/1994,0477-002,Small,11/29/1993,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger",PCT,4/12/2018,0477-002,5/29/1996,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611265,6/1/1995,581487,Yes
5845,93-T-055,Method and System for Computerized Radiographic Analysis of Bone,"2,177,478",,Canada,CA,11/29/1994,,,,0477-004,Large,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0477-004,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612336,,581487,Yes
5846,93-T-055,Method and System for Computerized Radiographic Analysis of Bone,95903553.6EPO,0731667,European Patent Office (EPO),EP,11/29/1994,5/7/2003,WO 95/014431,,0477-005,Large,11/29/1993,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0477-005,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612337,1/6/1995,581487,Yes
5847,93-T-055,Method and System for Computerized Radiographic Analysis of Bone,7-515141,,Japan,JP,11/29/1994,,,,0477-007,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0477-007,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612338,,581487,Yes
5848,93-T-055,Method and System for the Computerized Radiographic Analysis of Bone,"08/158,388","5,931,780",*United States,US,11/29/1993,8/3/1999, ,,0477-001,Large,11/29/1993,8/3/2016,Yes,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger",US Utility,4/12/2018,0477-001,8/3/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612406,,581487,Yes
5849,93-T-055,Method and System for the Computerized Radiographic Analysis of Bone,12569/95,"703,194",Australia,AU,11/29/1994,7/1/1999,,,0477-003,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0477-003,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612407,,581487,Yes
5850,93-T-055,Method and System for the Computerized Radiographic Analysis of Bone,"09/298,852","6,205,348",*United States,US,4/26/1999,3/20/2001, ,,0477-008,Small,11/29/1993,4/15/2013,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Maryellen Giger",Divisional,4/12/2018,0477-008,3/20/2013,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612408,,581487,Yes
5851,93-T-055,Method and system for the computerized radiographic analysis of bone.,02020811.2EPO, ,European Patent Office (EPO),EP,11/29/1994,,EP 1 283 492 A1,,0477-006,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Kunio Doi, Maryellen Giger",Nationalized PCT,4/12/2018,0477-006,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612409,2/12/2003,581487,Yes
5852,93-T-056,Automated Method and System for the Detection of Gross Abnormalities and Asymmetries in Chest Images,"08/159,133","5,638,458",*United States,US,11/30/1993,6/10/1997, ,,0478-001,Small,11/30/1993,,Yes,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",US Utility,4/12/2018,0478-001,6/10/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610634,,581488,Yes
5853,93-T-056,Automated Method and System for the Detection of Gross Abnormalities and Asymmetries in Chest Images,PCT/US94/13294, ,*United States,US,11/30/1994,,WO 95/15536,11/30/1994,0478-002,Small,11/30/1993,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",PCT,4/12/2018,0478-002,5/30/1996,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610635,6/8/1995,581488,Yes
5854,93-T-056,Automated Method and System for the Detection of Gross Abnormalities and Asymmetries in Chest Images,12906/95,"685,206",Australia,AU,11/30/1994,4/30/1998,685206,,0478-003,Small,11/30/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0478-003,11/30/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610636,1/15/1998,581488,Yes
5855,93-T-056,Automated Method and System for the Detection of Gross Abnormalities and Asymmetries in Chest Images,"2,177,475",,Canada,CA,11/30/1994,,,,0478-004,Small,11/30/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0478-004,11/30/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610637,,581488,Yes
5856,93-T-056,Automated Method and System for the Detection of Gross Abnormalities and Asymmetries in Chest Images,7-515656,,Japan,JP,11/30/1994,,,,0478-005,Small,11/30/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0478-005,11/30/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610638,,581488,Yes
5857,93-T-056,Automated Method and System for the Detection of Gross Abnormalities and Asymmetries in Chest Images,95904084.1EPO, ,European Patent Office (EPO),EP,9/10/1999,,0731953,,0478-006,Small,11/30/1993,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0478-006,9/10/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610639,9/18/1996,581488,Yes
5858,93-T-057,Automated Method $ System for the Segmentation of Medical Images,95903128.7NL,EP 0 731 959 B1,Netherlands,NL,11/29/1994,2/5/2003,,,0479-012,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Validated EPO,4/12/2018,0479-012,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610590,,581489,Yes
5859,93-T-057,Automated Method & System for the Segmentation of Medical Images,95903128.7FR,EP 0 731 959 B1,France,FR,11/29/1994,2/5/2003,,,0479-007,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Validated EPO,4/12/2018,0479-007,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610593,,581489,Yes
5860,93-T-057,Automated Method & System for the Segmentation of Medical Images,95903128.7DE,69432106.0,Germany,DE,11/29/1994,2/5/2003,WO95/14966,,0479-009,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",Validated EPO,4/12/2018,0479-009,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610594,7/1/1995,581489,Yes
5861,93-T-057,Automated Method and System for the Segmentation of Medical Images,"08/158,320","5,452,367",*United States,US,11/29/1993,9/19/1995, ,,0479-001,Large,11/29/1993,,Yes,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",US Utility,4/12/2018,0479-001,11/29/2013,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610656,,581489,Yes
5862,93-T-057,Automated Method and System for the Segmentation of Medical Images,PCT/US94/13281, ,*United States,US,11/29/1994,,WO 95/14966,11/29/1994,0479-002,Small,11/29/1993,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",PCT,4/12/2018,0479-002,5/29/1996,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610657,6/1/1995,581489,Yes
5863,93-T-057,Automated Method and System for the Segmentation of Medical Images,12103/95,"692,499",Australia,AU,11/29/1994,11/6/1998,,,0479-003,Small,11/29/1993,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0479-003,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610658,,581489,Yes
5864,93-T-057,Automated Method and System for the Segmentation of Medical Images,"2,177,477",,Canada,CA,11/29/1994,,,,0479-004,Large,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0479-004,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610659,,581489,Yes
5865,93-T-057,Automated Method and System for the Segmentation of Medical Images,95903128.7EPO,EP 0 731 959 B1,European Patent Office (EPO),EP,11/29/1994,2/5/2003,WO 95/14966,,0479-005,Small,11/29/1993,,No,5/21/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0479-005,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610660,7/1/1995,581489,Yes
5866,93-T-057,Automated Method and System for the Segmentation of Medical Images,7-515142,,Japan,JP,11/29/1994,,,,0479-006,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0479-006,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610661,,581489,Yes
5867,93-T-057,Automated Method and System for the Segmentation of Medical Images,00111213.5DE,69432995.9,Germany,DE,11/29/1994,7/30/2003,1035508,,0479-008,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",Divisional,4/12/2018,0479-008,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610662,9/13/2000,581489,Yes
5868,93-T-057,Automated Method and System for the Segmentation of Medical Images,00111213.5GB,EP 1 035 508 B1,United Kingdom,GB,11/29/1994,7/30/2003,1035508,,0479-010,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",Divisional,4/12/2018,0479-010,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610663,9/13/2000,581489,Yes
5869,93-T-057,Automated Method and System for the Segmentation of Medical Images,95903128.7GB,EP 0 731 959 B1,United Kingdom,GB,11/29/1994,2/5/2003, ,,0479-011,Small,11/29/1993,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",Validated EPO,4/12/2018,0479-011,11/29/2014,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610664,,581489,Yes
5870,93-T-062,A Neural Network Based System for Equipment Surveillance,PCT/US96/13899, ,*United States,US,8/30/1996,,WO 97/08627,8/30/1996,93-112-002,Small,8/31/1995,,No,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Kenneth Gross, Rick Vilim, Stephan Wegerich",PCT,4/12/2018,93-112-002,2/28/1998,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",610222,3/6/1997,581494,Yes
5871,93-T-062,NEBSESS,TXu-763-422,TXu-763-422,*United States,US,2/5/1997,2/5/1997, ,,93-112-003,None,,,No,8/4/2020,Registered (Copyright),,, ,"Kenneth Gross, Rick Vilim, Stephan Wegerich",Copyright Application,4/12/2018,93-112-003,2/5/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613649,,581494,Yes
5872,93-T-062,Neural Network Based System for Equipment Surveillance,"08/521,892","5,745,382",*United States,US,8/31/1995,4/28/1998, ,,93-112-001,Small,8/31/1995,,Yes,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Rick Vilim, Stephan Wegerich",US Utility,4/12/2018,93-112-001,8/31/2015,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613650,,581494,Yes
5873,93-T-067,DNA Damaging Agents and Tyrosine Kinase Inhibitors or Activators,"08/520,923",,*United States,US,8/30/1995,,,,0488-005,Small,8/19/1994,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Surender Kharbanda, Donald Kufe, Ralph Weichselbaum",Continuation in Part,4/12/2018,0488-005,9/19/2014,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611477,,581499,Yes
5874,93-T-067,DNA Damaging Agents in Combination with Tyrosine Kinase Inhibitors,"08/309,315","6,524,832",*United States,US,8/19/1994,2/25/2003,,,0488-003,Small,2/4/1994,2/25/2003,Yes,11/2/2020,Expired - Inactive,Barnes & Thornburg,"Martin, Alice",,"Donald Kufe, Ralph Weichselbaum",Continuation in Part,4/12/2018,0488-003,2/25/2020,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611478,,581499,Yes
5875,93-T-067,DNA Damaging Agents in Combination with Tyrosine Kinase Inhibitors,PCT/US95/01540, ,*United States,US,2/6/1995,,WO95/20960,2/6/1995,0488-004,Small,8/20/1994,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Donald Kufe, Ralph Weichselbaum",PCT,4/12/2018,0488-004,3/19/1997,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611479,,581499,Yes
5876,93-T-067,DNA Damaging Agents in Combination with Tyrosine Kinase Inhibitors,"10/375,684","7,070,968",*United States,US,2/4/1994,7/4/2006,US-2004-077087-A1,,0488-008,Small,2/4/1994,8/4/2014,No,8/4/2020,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Donald Kufe, Ralph Weichselbaum",Continuation,4/12/2018,0488-008,7/4/2023,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611480,4/22/2004,581499,Yes
5877,93-T-067,DNA Damaging Agents in Combination with Tyrosine Kinase Inhibitors,"11/381,311","7,838,512",*United States,US,8/19/1994,11/23/2010,US2006-0251734-A1,5/2/2006,0488-009,Small,2/4/1994,1/26/2018,No,4/28/2022,In Appeal,Barnes & Thornburg,"Martin, Alice",21459-108522,"Donald Kufe, Ralph Weichselbaum",Continuation,4/12/2018,0488-009,1/24/2029,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611482,11/9/2006,581499,Yes
5878,93-T-067,DNA Damaging Agents in Combination with Tyrosine Kinase Inhibitors,"12/903,706",,*United States,US,10/13/2010,,,,0488-010,Large,8/19/1994,10/1/2012,No,3/4/2019,Abandoned,Barnes & Thornburg,"Martin, Alice",,"Donald Kufe, Ralph Weichselbaum",Divisional,4/12/2018,0488-010,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611483,,581499,Yes
5879,93-T-067,DNA Damaging Agents in Combination with Tyrosine Kinase Inhibitors,"13/533,643", ,*United States,US,6/26/2012,,US-2013-0164811-A1,,0488-011,Large,8/19/1994,11/27/2013,No,8/4/2020,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"Donald Kufe, Ralph Weichselbaum",Continuation,4/12/2018,0488-011,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",611484,6/27/2013,581499,Yes
5880,93-T-067,Ionizing Radiation: Signal Transduction Pathways,"08/192,107",,*United States,US,2/4/1994,,,,0488-001,Small,2/4/1994,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Donald Kufe, Ralph Weichselbaum, Zhi-Min Yuan",US Utility,4/12/2018,0488-001,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612053,,581499,Yes
5881,93-T-067,METHODS AND COMPOSITIONS FOR MODULATION OF GROWTH RESPONSE,PCT/US97/12498, ,*United States,US,7/18/1997,,WO 98/03195,7/18/1997,0488-007,Small,8/20/1994,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Donald Kufe, Ralph Weichselbaum, Zhi-Min Yuan",PCT,4/12/2018,0488-007,3/19/1997,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612812,1/29/1998,581499,Yes
5882,93-T-067,METHODS AND COMPOSITIONS INCLUDING DNA DAMAGING AGENTS AND TYROSINE KINASEINHIBITORS OR ACTIVATORS,PCT/US96/13922, ,*United States,US,8/30/1996,,WO 97/08184,8/30/1996,0488-006,Small,8/20/1994,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Surender Kharbanda, Donald Kufe, Ralph Weichselbaum",PCT,4/12/2018,0488-006,3/19/1997,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612944,3/6/1997,581499,Yes
5883,93-T-068,Phospholipase A2 Inhibitors as Mediators of Gene Expression,"08/248,058","6,486,170",*United States,US,5/24/1994,11/26/2002,,,0488-002,Small,2/4/1994,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9023-001,"Dennis Hallahan, Donald Kufe, Ralph Weichselbaum",Continuation,4/12/2018,0488-002,11/26/2019,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613946,,581500,Yes
5884,93-T-068,Regulation of X-Ray Mediated Gene Expression,"08/278,452","5,641,755",*United States,US,7/20/1994,6/24/1997,,,0490-002,Small,2/4/1994,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9023-002,"Dennis Hallahan, Donald Kufe, Ralph Weichselbaum",Continuation in Part,4/12/2018,0490-002,6/24/2014,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",614388,,581500,Yes
5885,93-T-069,Method for Protection Against Genotoxic Mutagenesis,"07/851,210","5,488,042",*United States,US,3/13/1992,1/30/1996,,,0489-001,Large,3/13/1992,,Yes,10/23/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",,David Grdina,US Utility,4/12/2018,0489-001,1/30/2013,"Cox, Ben",David Grdina,"Tennant, Thelma",612486,,581501,Yes
5886,93-T-069,Method for Protection Against Genotoxic Mutagenesis,"08/121,946","5,567,686",*United States,US,9/13/1993,10/22/1996,,,0489-002,Large,3/13/1992,,Yes,10/23/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",,David Grdina,Continuation in Part,4/12/2018,0489-002,10/22/2013,"Cox, Ben",David Grdina,"Tennant, Thelma",612487,,581501,Yes
5887,93-T-069,Method for Protection Against Genotoxic Mutagenesis,PCT/US94/10315, ,*United States,US,9/12/1994,,WO 95/07700,9/12/1994,0489-003,Large,9/13/1993,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,David Grdina,PCT,4/12/2018,0489-003,3/13/1996,"Cox, Ben",David Grdina,"Tennant, Thelma",612488,3/23/1995,581501,Yes
5888,93-T-069,Method for Protection Against Genotoxic Mutagenesis,7-509309,,Japan,JP,9/12/1994,,JP 9506071,,0489-004,Small,9/13/1993,,No,10/23/2020,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"David Grdina, Donald Kufe, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0489-004,9/12/2014,"Cox, Ben",David Grdina,"Tennant, Thelma",612489,6/17/1997,581501,Yes
5889,93-T-069,Method for Protection against Genotoxic Mutagenesis,04004524.7EPO,,European Patent Office (EPO),EP,9/12/1994,,1 437 139 A2,,0489-006,Large,9/13/1993,,No,10/23/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"David Grdina, Donald Kufe, Ralph Weichselbaum",Divisional,4/12/2018,0489-006,9/12/2014,"Cox, Ben",David Grdina,"Tennant, Thelma",612490,7/14/2004,581501,Yes
5890,93-T-069,Method for Protection Against Genotoxic Mutagenesis,"08/481,885","5,869,338",*United States,US,6/7/1995,2/9/1999,,,0489-007,Large,3/13/1992,,No,10/23/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",,David Grdina,Continuation in Part,4/12/2018,0489-007,2/9/2016,"Cox, Ben",David Grdina,"Tennant, Thelma",612491,,581501,Yes
5891,93-T-069,Method for Protection Against Genotoxic Mutagenesis,"08/735,806","5,891,856",*United States,US,10/21/1996,4/6/1999,,,0489-008,Large,3/13/1992,,No,10/23/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina",,David Grdina,Divisional,4/12/2018,0489-008,3/13/2012,"Cox, Ben",David Grdina,"Tennant, Thelma",612492,,581501,Yes
5892,93-T-069,Method for Protection Against Genotoxic Mutagenisis,94927412.0EPO, ,European Patent Office (EPO),EP,9/12/1994,,EP 0 764 027 A1,,0489-005,Large,3/13/1992,,No,10/23/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Grdina, Donald Kufe, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0489-005,9/12/2014,"Cox, Ben",David Grdina,"Tennant, Thelma",612493,3/26/1997,581501,Yes
5893,94-T-002,Finger Wear Detection for Production Line Battery Tester,"08/653,383","5,689,429",*United States,US,5/24/1996,11/18/1997, ,5/24/1996,94-030-001,None,5/24/1996,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,, ,Eduardo Depiante,US Utility,4/12/2018,94-030-001,5/24/2016,"Ginsburg, Eric",Eduardo Depiante,"Unassigned, Unassigned",611594,,581005,Yes
5894,94-T-006,A Composition and Process for Separating Cesium Ions from an Acidic Aqueous Solution Also Containing Other Ions,"08/789,653","5,888,398",*United States,US,1/27/1997,3/30/1999, ,1/27/1997,94-065-001,None,1/27/1997,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Richard Bartsch, Mark Dietz, Phil Horwitz",US Utility,4/12/2018,94-065-001,1/27/2017,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610202,,581009,Yes
5895,94-T-017,A PROCESS OF INHIBITING NON-NEOPLASTIC PATHOLOGICAL CELL PROLIFERATION,PCT/US95/15191, ,*United States,US,11/13/1995,, ,11/13/1995,0491-002,Large,11/22/1994,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Eliav Barr, Jeffrey Leiden",PCT,4/12/2018,0491-002,5/22/1997,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",610234,,581502,Yes
5896,94-T-017,Delivery of Recombinant Protein,"08/343,621",,*United States,US,11/22/1994,,,,0491-001,Large,11/22/1994,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden",US Utility,4/12/2018,0491-001,11/22/2014,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611376,,581502,Yes
5897,94-T-017,Long Term Expression of Erythropoietin Using a Plasmid DNA Vector,"10/726,258",,*United States,US,12/1/2003,,,,0491-010,Small,8/23/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden",Reissue,4/12/2018,0491-010,8/23/2016,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612123,,581502,Yes
5898,94-T-017,Long Term Expression of Erythropoietin Usinga plasmid DNA Vector,41566/97,737129,Australia,AU,8/22/1997,11/22/2001,,,0491-007,Large,8/23/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden",Nationalized PCT,4/12/2018,0491-007,8/22/2017,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612124,,581502,Yes
5899,94-T-017,Long term expression of gene products,"10/615,518",,*United States,US,7/8/2003,,US-2004-013650-A1,,0491-009,Large,8/23/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,Jeffrey Leiden,Continuation,4/12/2018,0491-009,8/23/2016,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612125,1/22/2004,581502,Yes
5900,94-T-017,Long-term expression of erythropoietin and growth hormone by transforming muscle cells,"09/091,134","6,613,319",*United States,US,6/23/1998,9/2/2003,US-2002-122788-A1,,0491-008,Large,8/23/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,Jeffrey Leiden,Continuation in Part,4/12/2018,0491-008,8/23/2016,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612126,9/5/2002,581502,Yes
5901,94-T-017,Long-Term Expression of Gene Products by Transforming Muscle Cells,"60/024,511", ,*United States,US,8/23/1996,, ,8/23/1996,0491-003,Large,8/23/1996,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Eliav Barr, Jeffrey Leiden",Provisional,4/12/2018,0491-003,8/23/1997,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612127,,581502,Yes
5902,94-T-017,Long-Term Expression of Gene Products by Transforming Muscle Cells,97939491.3EPO, ,European Patent Office (EPO),EP,8/22/1997,,EP 0 874 909 A2,,0491-004,Large,8/23/1996,,No,5/21/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary", ,Jeffrey Leiden,Nationalized PCT,4/12/2018,0491-004,8/22/2017,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612128,4/11/1998,581502,Yes
5903,94-T-017,LONG-TERM EXPRESSION OF GENE PRODUCTS BY TRANSFORMING MUSCLE CELLS,PCT/US97/14764, ,*United States,US,8/22/1997,, ,8/22/1997,0491-005,Large,11/22/1994,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,Jeffrey Leiden,PCT,4/12/2018,0491-005,5/22/1997,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612129,,581502,Yes
5904,94-T-017,Long-Term Expression of Gene Products by Transforming Muscle Cells,"2,269,654",,Canada,CA,8/22/1997,,,,0491-006,Large,8/23/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Eliav Barr, Jeffrey Leiden",Nationalized PCT,4/12/2018,0491-006,8/22/2017,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",612130,,581502,Yes
5905,94-T-018,SMP SYSTEM,TXu-782-052,TXu-782-052,*United States,US,2/5/1997,2/5/1997, ,,93-128-002,None,,,No,8/4/2020,Registered (Copyright),,, ,"Kenneth Gross, William Kubic, Andrew White, Roald Wigeland",Copyright Application,4/12/2018,93-128-002,2/5/2017,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614567,,581503,Yes
5906,94-T-018,Surveillance of Industrial Processes with Correlated Parameters,"08/255,586","5,586,066",*United States,US,6/8/1994,12/17/1996, ,6/8/1994,93-128-001,Small,6/8/1994,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Kenneth Gross, William Kubic, Andrew White, Roald Wigeland",US Utility,4/12/2018,93-128-001,6/8/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614736,,581503,Yes
5907,94-T-019,Surveillance of Industrial Processes with Correlated Parameters,"08/767,462", ,*United States,US,6/8/1994,, ,12/16/1996,93-128B-001,Small,6/8/1994,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Kenneth Gross, William Kubic, Andrew White, Roald Wigeland",Continuation in Part,4/12/2018,93-128B-001,6/8/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614737,,581504,Yes
5908,94-T-021,A Process of Increasing the Level of a Gene Product in Cells of the Central Nervous System,"08/234,971", ,*United States,US,4/28/1994,, ,4/28/1994,0493-001,Small,4/28/1994,,Yes,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.",, ,"Eliav Barr, Ghanashyam Ghadge, Jeffrey Leiden, Raymond Roos",US Utility,4/12/2018,0493-001,,"Butler, Brittany",Raymond Roos,"Butler, Brittany",610233,,581506,Yes
5909,94-T-022,Level of a Gene Product in Cells,Unknown-1197, ,*United States,US,4/28/1994,, ,4/28/1994,0494-001,Small,4/28/1994,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Eliav Barr, Ghanashyam Ghadge, Jeffrey Leiden, Raymond Roos",Continuation,4/12/2018,0494-001,4/28/2014,"Butler, Brittany",Raymond Roos,"Butler, Brittany",612072,,581507,Yes
5910,94-T-023,GENETICALLY ENGINEERED CELLS THAT PRODUCE DOPAMINE,PCT/US95/10291, ,*United States,US,8/11/1995,, ,8/11/1995,0495-002,Small,8/12/1994,,No,4/28/2022,Abandoned,,, ,"Fred Gage, Un Jung Kang",PCT,4/12/2018,0495-002,2/12/1997,"Bakalyar, Heather",Un Jung Kang,"Tennant, Thelma",611679,,581508,Yes
5911,94-T-023,Genetically Engineered Cells That Produce L. Dopa,"08/290,028","6,103,226",*United States,US,8/12/1994,8/15/2000,,,0495-001,Small,8/12/1994,,Yes,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,"Fred Gage, Un Jung Kang",US Utility,4/12/2018,0495-001,8/15/2017,"Bakalyar, Heather",Un Jung Kang,"Tennant, Thelma",611680,,581508,Yes
5912,94-T-024,Production of Kidney Cell Autocrine Growth Factors,"60/077,960", ,*United States,US,3/13/1998,, ,3/13/1998,0199-001,Large,3/13/1998,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"Sreedharan Kartha, F. Gary Toback",Provisional,4/12/2018,0199-001,3/13/1999,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",614180,,581509,Yes
5913,94-T-026,Recombinant Herpes Simplex Virus Useful for Treating Neoplastic Disease,"2,356,937",,Canada,CA,12/31/1998,,,,0498-001,Large,12/31/1998,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",33716-CA,"Bernard Roizman, Richard Whitley",Nationalized PCT,4/12/2018,0498-001,12/31/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614306,,581511,Yes
5914,94-T-026,Recombinant Herpes Simplex Virus Useful for Treating Neoplastic Disease,"09/869,674",,*United States,US,12/31/1998,,,,0498-002,Small,12/31/1998,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33716,"Bernard Roizman, Richard Whitley",US Utility,4/12/2018,0498-002,12/31/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614307,,581511,Yes
5915,94-T-026,Recombinant Herpes Simplex Virus Useful For Treating Neoplastic Disease,PCT/US98/27902, ,*United States,US,12/31/1998,,WO 00/40734,12/31/1998,0498-005,Small,12/31/1998,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",33716-PC,"Bernard Roizman, Richard Whitley",PCT,4/12/2018,0498-005,6/30/2001,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614308,7/13/2000,581511,Yes
5916,94-T-026,Recombinant Herpes Simplex Virus Useful for Treating Neoplastic Disease,"11/546,233","7,744,899",*United States,US,10/11/2006,6/29/2010,US-2007-0031383-A1,,0498-028,Small,12/31/1998,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",33716A,"Bernard Roizman, Richard Whitley",Continuation,4/12/2018,0498-028,7/2/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614309,2/8/2007,581511,Yes
5917,94-T-026,Recombinant Herpes Simplex Virus Useful for Treating Neoplastic Disease (as amended),98966139.2EPO, ,European Patent Office (EPO),EP,12/31/1998,,EP1141338A1,,0498-004,Small,12/31/1998,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",33716-EP,"Bernard Roizman, Richard Whitley",Nationalized PCT,4/12/2018,0498-004,12/31/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614310,10/10/2001,581511,Yes
5918,94-T-026,Treatment of Tumors with Genetically Engineered Hepes Virus,29800/00,772471,Australia,AU,2/4/2000,9/30/2004,,,0498-008,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Williams, Joseph",35035-AU,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Nationalized PCT,4/12/2018,0498-008,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615050,,581511,Yes
5919,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,2000-592428,,Japan,JP,12/31/1998,,2003-535565,,0498-003,Small,12/31/1998,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Cawley, Thomas",33716-JP,"Bernard Roizman, Richard Whitley",Nationalized PCT,4/12/2018,0498-003,12/31/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615051,12/2/2003,581511,Yes
5920,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,"09/244,748",,*United States,US,2/5/1999,,,,0498-006,Small,2/5/1999,,Yes,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Williams, Joseph",35035,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",US Utility,4/12/2018,0498-006,2/5/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615052,,581511,Yes
5921,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,PCT/US00/02814, ,*United States,US,2/4/2000,,WO 00/45853 A3,2/4/2000,0498-007,Small,2/5/1999,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Williams, Joseph",35035-PC,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",PCT,4/12/2018,0498-007,8/5/2001,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615053,8/10/2000,581511,Yes
5922,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,2000-596972,4623832,Japan,JP,2/4/2000,11/12/2010,2002536347,,0498-009,None,12/31/1998,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Williams, Joseph",35035-JP,"Bernard Roizman, Richard Whitley",Nationalized PCT,4/12/2018,0498-009,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615054,,581511,Yes
5923,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,"2,361,892","2,361,892",Canada,CA,2/4/2000,5/25/2010,,,0498-010,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Williams, Joseph",35035-CA,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Nationalized PCT,4/12/2018,0498-010,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615055,,581511,Yes
5924,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8EPO,1150696,European Patent Office (EPO),EP,2/4/2000,5/10/2006,EP1150696A2,,0498-011,Small,2/5/1999,,No,10/11/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-EP,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Nationalized PCT,4/12/2018,0498-011,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615056,11/7/2001,581511,Yes
5925,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1EPO,1695714,European Patent Office (EPO),EP,2/4/2000,7/30/2008,1695714,,0498-012,Small,2/5/1999,,No,10/11/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-EP,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Divisional,4/12/2018,0498-012,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615057,8/30/2006,581511,Yes
5926,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8DE,60027870.0,Germany,DE,2/4/2000,5/10/2006,EP1150696A2,,0498-013,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-DE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-013,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615058,11/7/2001,581511,Yes
5927,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8ES,1150696,Spain,ES,2/4/2000,5/10/2006,EP1150696A2,,0498-014,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-ES,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-014,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615059,11/7/2001,581511,Yes
5928,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8FR,1150696,France,FR,2/4/2000,5/10/2006,EP1150696A2,,0498-015,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-FR,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-015,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615060,11/7/2001,581511,Yes
5929,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8GB,1150696,United Kingdom,GB,2/4/2000,5/10/2006,EP1150696A2,,0498-016,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-GB,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-016,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615061,11/7/2001,581511,Yes
5930,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8IT,1150696,Italy,IT,2/4/2000,5/10/2006,EP1150696A2,,0498-017,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-IT,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-017,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615062,11/7/2001,581511,Yes
5931,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8NL,1150696,Netherlands,NL,2/4/2000,5/10/2006,EP1150696A2,,0498-018,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-NL,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-018,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615063,11/7/2001,581511,Yes
5932,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8AT,1150696,Austria,AT,2/4/2000,5/10/2006,EP1150696A2,,0498-019,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-AT,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-019,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615064,11/7/2001,581511,Yes
5933,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8BE,1150696,Belgium,BE,2/4/2000,5/10/2006,EP1150696A2,,0498-020,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-BE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-020,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615065,11/7/2001,581511,Yes
5934,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8IE,1150696,Ireland,IE,2/4/2000,5/10/2006,EP1150696A2,,0498-021,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-IE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-021,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615066,11/7/2001,581511,Yes
5935,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8CH,1150696,Switzerland,CH,2/4/2000,5/10/2006,EP1150696A2,,0498-022,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-CH,"Yancey Gillespie, Bernard Roizman, Ralph Weichselbaum",Validated EPO,4/12/2018,0498-022,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615067,11/7/2001,581511,Yes
5936,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8MC,1150696,Monaco,MC,2/4/2000,5/10/2006,EP1150696A2,,0498-023,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-MC,"Yancey Gillespie, Bernard Roizman, Ralph Weichselbaum",Validated EPO,4/12/2018,0498-023,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615068,11/7/2001,581511,Yes
5937,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,09908465.8LU,1150696,Luxembourg,LU,2/4/2000,5/10/2006,EP1150696A2,,0498-024,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035-LU,"Yancey Gillespie, Bernard Roizman, Ralph Weichselbaum",Validated EPO,4/12/2018,0498-024,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615069,11/7/2001,581511,Yes
5938,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,"09/629,021",,*United States,US,7/31/2000,,,,0498-025,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Williams, Joseph",36638,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Continuation,4/12/2018,0498-025,2/5/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615070,,581511,Yes
5939,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,"09/964,042",,*United States,US,9/26/2001,,US-2002-019362-A1,,0498-026,Small,2/5/1999,,No,1/10/2022,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",36638A,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Continuation,4/12/2018,0498-026,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615071,2/14/2002,581511,Yes
5940,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,2004203458,2004203458,Australia,AU,7/29/2004,8/30/2007,AU-4203458-AA,,0498-027,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035A-AU,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Divisional,4/12/2018,0498-027,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615072,8/26/2004,581511,Yes
5941,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1AT,1695714,Austria,AT,2/4/2000,7/30/2008,1695714,,0498-029,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-AT,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-029,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615073,8/30/2006,581511,Yes
5942,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1BE,1695714,Belgium,BE,2/4/2000,7/30/2008,1695714,,0498-030,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-BE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-030,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615074,8/30/2006,581511,Yes
5943,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1CH,1695714,Switzerland,CH,2/4/2000,7/30/2008,1695714,,0498-031,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-CH,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-031,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615075,8/30/2006,581511,Yes
5944,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1DE,1695714,Germany,DE,2/4/2000,7/30/2008,1695714,,0498-032,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-DE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-032,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615076,8/30/2006,581511,Yes
5945,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1ES,1695714,Spain,ES,2/4/2000,7/30/2008,1695714,,0498-033,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-ES,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-033,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615077,8/30/2006,581511,Yes
5946,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1FR,1695714,France,FR,2/4/2000,7/30/2008,1695714,,0498-034,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-FR,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-034,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615078,8/30/2006,581511,Yes
5947,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1GB,1695714,United Kingdom,GB,2/4/2000,7/30/2008,1695714,,0498-035,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-GB,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-035,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615079,8/30/2006,581511,Yes
5948,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1IE,1695714,Ireland,IE,2/4/2000,7/30/2008,1695714,,0498-036,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-IE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-036,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615080,8/30/2006,581511,Yes
5949,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1IT,1695714,Italy,IT,2/4/2000,7/30/2008,1695714,,0498-037,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-IT,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-037,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615081,8/30/2006,581511,Yes
5950,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1NL,1695714,Netherlands,NL,2/4/2000,7/30/2008,1695714,,0498-038,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-NL,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-038,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615082,8/30/2006,581511,Yes
5951,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1SE,1695714,Sweden,SE,2/4/2000,7/30/2008,1695714,,0498-039,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-SE,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-039,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615083,8/30/2006,581511,Yes
5952,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,06009428.1DK,1695714,Denmark,DK,2/4/2000,7/30/2008,1695714,,0498-040,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Wrona, Thomas",35035B-DK,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Validated EPO,4/12/2018,0498-040,2/4/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615084,8/30/2006,581511,Yes
5953,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,"12/802,443","8,318,691",*United States,US,6/7/2010,11/27/2012,,,0498-041,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",36638C,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Continuation,4/12/2018,0498-041,6/16/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615085,,581511,Yes
5954,94-T-026,Treatment of Tumors with Genetically Engineered Herpes Virus,"13/656,195","8,772,261",*United States,US,10/19/2012,6/8/2014,US-2013-0039890-A1,,0498-043,Small,2/5/1999,,No,10/11/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",,"Bernard Roizman, Ralph Weichselbaum, Richard Whitley",Continuation,4/12/2018,0498-043,2/5/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615086,2/14/2013,581511,Yes
5955,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,"08/540,343",,*United States,US,10/6/1995,,,,0499-001,Small,10/6/1995,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",US Utility,4/12/2018,0499-001,10/6/2015,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612933,,581514,Yes
5956,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,PCT/US96/16047, ,*United States,US,10/7/1996,,WO 97/12623,10/7/1996,0499-002,Small,10/6/1995,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",PCT,4/12/2018,0499-002,4/6/1998,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612934,4/10/1997,581514,Yes
5957,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,"2,234,060",,Canada,CA,10/7/1996,,,,0499-003,Large,10/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",41545-CA,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0499-003,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612935,,581514,Yes
5958,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,514508/97,,Japan,JP,10/7/1996,,,,0499-004,Small,10/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",41545-JP,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0499-004,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612936,,581514,Yes
5959,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,96934086.8EPO, ,European Patent Office (EPO),EP,10/7/1996,,EP 0 862 445 A1,,0499-005,Small,10/6/1995,,No,5/21/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41545-EP,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0499-005,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612937,9/9/1998,581514,Yes
5960,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,"10/946,365",,*United States,US,9/21/2004,,US 2005-0147591 A1,,0499-006,Small,10/6/1995,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",41545A,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Continuation,4/12/2018,0499-006,10/6/2015,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612938,7/7/2005,581514,Yes
5961,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,96934086.8CH,,Switzerland,CH,7/26/2013,,,,0499-008,Small,10/6/1995,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41545-CH,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Validated EPO,4/12/2018,0499-008,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612939,9/9/1998,581514,Yes
5962,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,96934086.8GB,,United Kingdom,GB,7/26/2013,,,,0499-009,Small,10/6/1995,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41545-GB,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Validated EPO,4/12/2018,0499-009,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612940,9/9/1998,581514,Yes
5963,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,96934086.8FR,,France,FR,7/26/2013,,,,0499-010,Small,10/6/1995,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41545-FR,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Validated EPO,4/12/2018,0499-010,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612941,9/9/1998,581514,Yes
5964,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,96934086.8DE,,Germany,DE,7/26/2013,,,,0499-011,Small,10/6/1995,,No,4/12/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Merkel, William",41545-DE,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Validated EPO,4/12/2018,0499-011,10/7/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612942,9/9/1998,581514,Yes
5965,94-T-029,Methods and Compositions for Viral Enhancement of Cell Killing,"11/863,173",,*United States,US,9/27/2007,,US2008-0014175-A1,,0499-012,Large,10/6/1995,2/21/2017,No,3/7/2019,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",,"Dennis Hallahan, Donald Kufe, Bernard Roizman, Gregory Sibley, Ralph Weichselbaum",Continuation,4/12/2018,0499-012,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612943,1/17/2008,581514,Yes
5966,94-T-031,Computer-Aided Diagnosing Method,103306/95,,Japan,JP,4/27/1995,,7299053,,0503-002,Large,4/29/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida","Foreign, Non-PCT",4/12/2018,0503-002,4/27/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611243,11/14/1995,581516,Yes
5967,94-T-031,Computer-Aided Method for Image Feature Analysis and Diagnosis in Mammography,"08/235,530",,*United States,US,4/29/1994,,,,0503-001,Large,4/29/1994,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida",US Utility,4/12/2018,0503-001,,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611248,,581516,Yes
5968,94-T-031,Computer-Aided Method for Image Feature Analysis and Diagnosis in Mammography,"08/536,149",,*United States,US,9/29/1995,,,,0503-003,Large,4/29/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida",Divisional,4/12/2018,0503-003,4/29/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611249,,581516,Yes
5969,94-T-031,Computer-Aided Method for Image Feature Analysis and Diagnosis in Mammography,"08/536,450","5,598,481",*United States,US,9/29/1995,1/28/1997,,,0503-004,Large,4/29/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida",Divisional,4/12/2018,0503-004,4/29/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611250,,581516,Yes
5970,94-T-031,Computer-Aided Method for Image Feature Analysis and Diagnosis in Mammography,"08/536,253","5,740,268",*United States,US,9/29/1995,4/14/1998,,,0503-005,Large,4/29/1994,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida",Divisional,4/12/2018,0503-005,4/29/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611251,,581516,Yes
5971,94-T-031,Computer-Aided Method for Image Feature Analysis and Diagnosis in Mammography,"08/693,502","5,673,332",*United States,US,8/8/1996,9/30/1997,,,0503-006,Large,4/29/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida",Continuation,4/12/2018,0503-006,4/29/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611252,,581516,Yes
5972,94-T-031,Computer-Aided Method for Image Feature Analysis and Diagnosis in Mammography,"08/536,794","5,666,434",*United States,US,9/29/1996,9/9/1997,,,0503-007,Large,4/29/1994,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takehiro Ema, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida",Divisional,4/12/2018,0503-007,4/29/2014,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611253,,581516,Yes
5973,94-T-035,Oral Use of Methylnaltrexone and Related Compounds to Induce Laxation in Chronic Opioid Users,"10/785,320", ,*United States,US,11/3/1998,,US-2004-167147-A1,2/24/2004,0507-017,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-017,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613857,8/26/2004,581520,Yes
5974,94-T-035,Oral Use of Methylnaltrexone and Related Compounds to Treat Constipation in Chronic Opiod Users,"10/785,668", ,*United States,US,11/3/1998,,US-2004-167148-A1,2/24/2004,0507-016,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-016,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",613858,8/26/2004,581520,Yes
5975,94-T-035,Use of Methylnal Trexone and Related Compounds to Treate Chronic Opioid use Side Effects,"10/357,669", ,*United States,US,11/3/1998,,US-2003-187010-A1,2/4/2003,0507-010,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Morgan D'Apuzzo, Chantal", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-010,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615208,10/2/2003,581520,Yes
5976,94-T-035,Use of Methylnaltrexone and Related Compounds,"08/962,742","5,972,954",*United States,US,11/3/1997,10/26/1999, ,,0507-001,Small,11/3/1997,,Yes,8/4/2020,Expired - Inactive,"Christie, Parker & Hale","Dillard, David", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",US Utility,4/12/2018,0507-001,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615209,,581520,Yes
5977,94-T-035,Use of Methylnaltrexone and Related Compounds,13802/99,758416,Australia,AU,11/3/1998,7/3/2003,WO 99/22737,,0507-002,Small,11/3/1997,,No,8/4/2020,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Morgan D'Apuzzo, Chantal", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Nationalized PCT,4/12/2018,0507-002,11/3/2018,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615210,7/14/1999,581520,Yes
5978,94-T-035,Use of Methylnaltrexone and Related Compounds,"09/120,703","6,274,591",*United States,US,7/22/1998,8/14/2001, ,,0507-003,Small,11/3/1997,,No,8/4/2020,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation in Part,4/12/2018,0507-003,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615211,,581520,Yes
5979,94-T-035,Use of Methylnaltrexone and Related Compounds,PCT/US98/23485, ,*United States,US,11/3/1998,,WO 99/22737,11/3/1998,0507-004,Small,11/3/1997,,No,4/28/2022,Expired - Inactive,"Christie, Parker & Hale","Dillard, David", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",PCT,4/12/2018,0507-004,5/3/2000,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615212,5/14/1999,581520,Yes
5980,94-T-035,Use of Methylnaltrexone and Related Compounds,"2,312,234","2,312,234",Canada,CA,11/3/1998,3/22/2005, ,,0507-005,Small,11/3/1997,,No,8/4/2020,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Nationalized PCT,4/12/2018,0507-005,11/3/2018,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615213,,581520,Yes
5981,94-T-035,Use of Methylnaltrexone and Related Compounds,98957573.3EPO,1047426,European Patent Office (EPO),EP,11/3/1998,, ,,0507-006,Small,11/3/1997,,No,8/4/2020,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Nationalized PCT,4/12/2018,0507-006,11/3/2018,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615214,,581520,Yes
5982,94-T-035,Use of Methylnaltrexone and Related Compounds,"09/862,169","6,608,075",*United States,US,11/3/1998,8/19/2003,US 2002-0028825 A1,5/21/2001,0507-008,Small,11/3/1997,,No,4/28/2022,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Morgan D'Apuzzo, Chantal", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-008,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615215,3/7/2002,581520,Yes
5983,94-T-035,Use of Methylnaltrexone and Related Compounds,"10/278,630", ,*United States,US,11/3/1998,,US-2003-065003-A1,10/23/2002,0507-009,Small,11/3/1997,,Yes,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Divisional,4/12/2018,0507-009,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615216,4/3/2003,581520,Yes
5984,94-T-035,Use of Methylnaltrexone and Related Compounds,2003204844,2003204844,Australia,AU,11/3/1998,9/20/2007, ,,0507-012,None,11/3/1997,,No,8/4/2020,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Divisional,4/12/2018,0507-012,11/3/2018,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615217,,581520,Yes
5985,94-T-035,Use of Methylnaltrexone and Related Compounds,"60/168,480", ,*United States,US,12/1/1999,, ,12/1/1999,0507-019,Large,12/1/1999,,Yes,4/28/2022,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Provisional,4/12/2018,0507-019,12/1/2000,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615218,,581520,Yes
5986,94-T-035,Use of Methylnaltrexone and Related Compounds,"10/962,729", ,*United States,US,11/3/1998,,US 2005-0048117 A1,10/12/2004,0507-023,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-023,10/23/2022,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615219,3/3/2005,581520,Yes
5987,94-T-035,Use of Methylnaltrexone and Related Compounds for Treatment of Gastroinstestinal Dysfunction Induced by Endogenous Opioids,"10/779,129", ,*United States,US,11/3/1998,,US-2004-162308-A1,2/12/2004,0507-015,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-015,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615220,8/19/2004,581520,Yes
5988,94-T-035,Use of Methylnaltrexone and Related Compounds for Treatment of Gastrointestinal Dysfunction Induced by Encogenous Opioids.,"12/333,912", ,*United States,US,11/3/1998,, ,12/12/2008,0507-020,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-020,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615221,,581520,Yes
5989,94-T-035,Use of Methylnaltrexone and Related Compounds to Induce Laxation in Chronic Opioid Users,"10/779,128", ,*United States,US,11/3/1998,,US 2004/0162307 A1,2/12/2004,0507-013,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-013,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615222,8/19/2004,581520,Yes
5990,94-T-035,Use of Methylnaltrexone and Related Compounds to Treat Chronic Opioid Use Side Effects,"09/669,358","6,559,158",*United States,US,11/3/1998,5/6/2003, ,9/26/2000,0507-007,Small,11/3/1997,,No,4/28/2022,Expired - Inactive,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation in Part,4/12/2018,0507-007,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615223,,581520,Yes
5991,94-T-035,Use of Methylnaltrexone and Related Compounds to Treat Chronic Opioid Use Side Effects,"10/358,560", ,*United States,US,11/3/1998,,US-2003-158220-A1,2/4/2003,0507-011,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Morgan D'Apuzzo, Chantal", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-011,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615224,8/21/2003,581520,Yes
5992,94-T-035,Use of Methylnaltrexone and Related Compounds to Treat Constipation in Chronic Opioid Users,"10/778,268", ,*United States,US,11/3/1998,,US 2004-0162306 A1,2/12/2004,0507-014,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-014,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615225,8/19/2004,581520,Yes
5993,94-T-035,Use of Methylnaltrexone and Related Compounds to treat constipation in Chronic Opioid Users,"12/495,324", ,*United States,US,11/3/1998,,US-2010-0087472-A1,6/30/2009,0507-018,Small,11/3/1997,,No,4/28/2022,Abandoned,"Wolf, Greenfield & Sacks, P.C.","Zdravseski, Zoran", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-018,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615226,4/8/2010,581520,Yes
5994,94-T-035,Use of Methylnaltrexone and Related Compounds to treat constipation in Chronic Opioid Users,"13/230,193", ,*United States,US,11/3/1998,, ,9/12/2011,0507-021,Large,11/3/1997,,No,4/28/2022,Abandoned,"McCarter & English, LLP","Gulati, Maneesh", ,"William Drell, Joseph Foss, Jonathan Moss, Michael Roizen, Chun-Su Yuan",Continuation,4/12/2018,0507-021,11/3/2017,"Dembo, Anna",Jonathan Moss,"Tennant, Thelma",615227,,581520,Yes
5995,94-T-038,Domains in an Arabidposis Acyl Carrier Protein Gene Promoter Required for Mximal Tissue-Specific Expression,"60/007,682", ,*United States,US,11/29/1995,, ,11/29/1995,0510-001,Small,11/29/1995,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Gayle Lamppa,Provisional,4/12/2018,0510-001,11/29/1996,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",611487,,581523,Yes
5996,94-T-039,Method of Inducing Gene Expression by Ionizing Radiation,"08/241,863","5,571,797",*United States,US,5/11/1994,11/5/1996,,,0512-001,Small,5/11/1994,,Yes,2/22/2019,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",US Utility,4/12/2018,0512-001,5/11/2014,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612526,,581524,Yes
5997,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,PCT/US95/05959, ,*United States,US,5/11/1995,,WO 95/31559,5/11/1995,0512-002,Small,5/11/1994,,No,4/28/2022,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",PCT,4/12/2018,0512-002,11/11/1996,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613323,11/23/1995,581524,Yes
5998,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,26891/95,"696,210",Australia,AU,5/11/1995,12/17/1998,,,0512-003,Small,5/11/1994,,No,2/22/2019,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0512-003,5/11/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613324,,581524,Yes
5999,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,"2,192,813","2,192,813",Canada,CA,5/11/1995,5/1/2007,,,0512-004,Large,5/11/1994,,No,2/22/2019,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0512-004,5/11/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613325,,581524,Yes
6000,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,95922079.9EPO,0759083,European Patent Office (EPO),EP,5/11/1995,2/28/2007,EP 0 759 083 A1,,0512-005,Large,5/11/1994,,No,2/22/2019,Expired - Inactive,"Valauskas Corder, LLC","Fahrlander, Jill", ,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0512-005,2/28/2007,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613326,2/26/1997,581524,Yes
6001,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,95922079.9DE,DE69535407.8-08,Germany,DE,5/11/1995,,5/6/2009,,0512-006,Small,5/11/1994,,No,2/22/2019,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Validated EPO,4/12/2018,0512-006,5/11/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613327,,581524,Yes
6002,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,95922079.9IT,0759083,Italy,IT,5/11/1995,2/28/2007,,,0512-007,Small,5/11/1994,,No,2/22/2019,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Validated EPO,4/12/2018,0512-007,5/11/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613328,,581524,Yes
6003,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,95922079.9GB,0759083,United Kingdom,GB,5/11/1995,2/28/2007,5/6/2009,,0512-008,Small,5/11/1994,,No,2/22/2019,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Validated EPO,4/12/2018,0512-008,5/11/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613329,,581524,Yes
6004,94-T-039,Methods of Inducing Gene Expression by Ionizing Radiation,95922079.9FR,0759083,France,FR,5/11/1995,2/28/2007,,,0512-009,Small,5/11/1994,,No,2/22/2019,Abandoned,"Valauskas Corder, LLC","Fahrlander, Jill",,"Donald Kufe, Tsuneya Ohno, Ralph Weichselbaum",Validated EPO,4/12/2018,0512-009,5/11/2015,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",613330,,581524,Yes
6005,94-T-043,Methods and Compositions for Detecting and Treating Kidney Diseases Associated with Adhesion of Crystals to Cells,"10/299,043", ,*United States,US,3/28/2000,,US-2003-158115-A1,11/18/2002,0515-004,Small,2/15/1995,,No,4/28/2022,Abandoned,Barnes & Thornburg,"Martin, Alice", ,"John Lieske, F. Gary Toback",Continuation,4/12/2018,0515-004,3/28/2020,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",612674,8/21/2003,581528,Yes
6006,94-T-043,Methods and Compositions for Detecting and Treating Kidney Diseases Associated with Adhesion of Crystals to Kidney Cells,"08/389,005","5,618,917",*United States,US,2/15/1995,4/8/1997,,,0515-001,Small,2/15/1995,,Yes,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,"John Lieske, F. Gary Toback",US Utility,4/12/2018,0515-001,2/15/2015,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",612675,,581528,Yes
6007,94-T-043,Methods and Compositions for Detecting and Treating Kidney Diseases Associated with Adhesion of Crystals to Kidney Cells,"08/837,226","6,043,216",*United States,US,4/10/1997,3/28/2000,,,0515-002,Small,2/15/1995,,No,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,"John Lieske, F. Gary Toback",Divisional,4/12/2018,0515-002,2/15/2015,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",612676,,581528,Yes
6008,94-T-043,Methods and Compositions for Detecting and Treating Kidney Diseases Associated With Adhesion of Crystals to Kidney Cells,"09/537,226","6,482,934",*United States,US,3/28/2000,11/19/2002,,,0515-003,Small,2/15/1995,,Yes,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,"John Lieske, F. Gary Toback",Continuation in Part,4/12/2018,0515-003,2/15/2015,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",612677,,581528,Yes
6009,94-T-044,Campothecin Drug Combinations and Methods with Reduced Side Effects,8-503964, ,Japan,JP,7/5/1995,,10-505579,,0516-004,Large,7/5/1994,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elora Gupta, Mark Ratain",Nationalized PCT,4/12/2018,0516-004,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610765,6/2/2002,581529,Yes
6010,94-T-044,Campothecin Drug Combinations and Methods with Reduced Side Effects,2006-242179, ,Japan,JP,7/5/1995,,10-505579,,0516-010,Large,7/5/1994,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elora Gupta, Mark Ratain",Divisional,4/12/2018,0516-010,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610766,6/2/2002,581529,Yes
6011,94-T-044,Camptothecin Drug Combinations and Medicaments With Reduced Side Effects,95925476.4EPO,EP 0 768 895 B1,European Patent Office (EPO),EP,7/5/1995,7/5/1995,EP 0 768 895 A1,,0516-003,Large,7/5/1994,,No,8/4/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elora Gupta, Mark Ratain",Nationalized PCT,4/12/2018,0516-003,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610767,4/23/1997,581529,Yes
6012,94-T-044,Camptothecin Drug Combinations and Medicaments With Reduced Side Effects,"2,194,277", ,Canada,CA,7/5/1995,, ,,0516-005,Large,7/5/1994,7/5/2011,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elora Gupta, Mark Ratain",Nationalized PCT,4/12/2018,0516-005,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610768,,581529,Yes
6013,94-T-044,Camptothecin Drug Combinations and Medicaments With Reduced Side Effects,95925476.4GB,0768895,United Kingdom,GB,7/5/1995,7/5/1995, ,,0516-006,Large,7/5/1994,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elora Gupta, Mark Ratain",Validated EPO,4/12/2018,0516-006,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610769,,581529,Yes
6014,94-T-044,Camptothecin Drug Combinations and Medicaments With Reduced Side Effects,95925476.4IE,0768895,Ireland,IE,7/5/1995,7/5/1995, ,,0516-007,Large,7/5/1994,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elora Gupta, Mark Ratain",Validated EPO,4/12/2018,0516-007,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610770,,581529,Yes
6015,94-T-044,Camptothecin Drug Combinations and Medicaments With Reduced Side Effects,95925476.4LU,0768895,Luxembourg,LU,7/5/1995,7/5/1995, ,,0516-008,Large,7/5/1994,,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Elora Gupta, Mark Ratain",Validated EPO,4/12/2018,0516-008,7/5/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610771,,581529,Yes
6016,94-T-044,Camptothecin Drug Combinations and Medicaments with Reduced Side Effects,PCT/US95/08394, ,*United States,US,7/5/1995,,WO 96/01127,7/5/1995,0516-009,Large,7/5/1994,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Elora Gupta, Mark Ratain",PCT,4/12/2018,0516-009,1/5/1997,"Sun, Han",Mark Ratain,"Tennant, Thelma",610772,1/18/1996,581529,Yes
6017,94-T-044,Camptothecin Drug Combinations and Methods with Reduced Side Effects,"08/423,641","5,786,344",*United States,US,4/17/1995,7/28/1998, ,,0516-002,Large,7/5/1994,8/23/2010,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elora Gupta, Mark Ratain",Continuation in Part,4/12/2018,0516-002,7/28/2015,"Sun, Han",Mark Ratain,"Tennant, Thelma",610773,,581529,Yes
6018,94-T-044,Irinotecan (CPT-11) Combinations and Methods with reduced Side Effects,"08/271,278", ,*United States,US,7/5/1994,, ,,0516-001,Large,7/5/1994,7/21/1995,Yes,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Elora Gupta, Mark Ratain",US Utility,4/12/2018,0516-001,,"Sun, Han",Mark Ratain,"Tennant, Thelma",612054,,581529,Yes
6019,94-T-045,Telomerase Compositions and Methods,"08/326,781",,*United States,US,10/20/1994,,,,0517-001,Small,10/20/1994,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Daniel Gottschling, Miriam Singer",US Utility,4/12/2018,0517-001,,"Ginsburg, Eric",Daniel Gottschling,"Muite, Kevin",614870,,581530,Yes
6020,94-T-045,Telomerase Compositions and Methods,"09/345,294","6,387,619",*United States,US,6/30/1999,5/14/2002,,,0517-004,Small,10/20/1994,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Daniel Gottschling, Miriam Singer",Divisional,4/12/2018,0517-004,10/20/2014,"Ginsburg, Eric",Daniel Gottschling,"Muite, Kevin",614871,,581530,Yes
6021,94-T-045,Telomerase Screening Methods,"08/938,534","5,916,752",*United States,US,9/26/1997,6/29/1999,,,0517-003,Small,10/20/1994,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Parker, David",,"Daniel Gottschling, Miriam Singer",Divisional,4/12/2018,0517-003,10/20/2014,"Ginsburg, Eric",Daniel Gottschling,"Muite, Kevin",614872,,581530,Yes
6022,94-T-045,Yeast Telomerase Compositions,"08/431,080","5,698,686",*United States,US,4/28/1995,12/16/1997,,,0517-002,Small,10/20/1994,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Parker, David",,"Daniel Gottschling, Miriam Singer",Continuation in Part,4/12/2018,0517-002,10/20/2014,"Ginsburg, Eric",Daniel Gottschling,"Muite, Kevin",615426,,581530,Yes
6023,94-T-046,Method and Apparatus for Segmenting Images using Stochastically Deformable Contours,"08/539,204","5,768,413",*United States,US,10/4/1995,6/16/1998, ,10/4/1995,0518-001,None,10/4/1995,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Cohen, Eric", ,"Robert Grzeszczuk, David Levin",US Utility,4/12/2018,0518-001,10/4/2015,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",612300,,581531,Yes
6024,94-T-047,Method and Device for Liner Wear Analysis,"08/388,698","5,610,966",*United States,US,2/15/1995,3/11/1997, ,2/15/1995,0519-001,Small,2/15/1995,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,"Cohen, Eric", ,"Sunjay Berdia, John Martell",US Utility,4/12/2018,0519-001,2/15/2015,"Cox, Ben",John Martell,"Smith, Dane",612317,,581532,Yes
6025,94-T-052,A Growth Promoting Hexapeptide,"60/030,890", ,*United States,US,11/13/1996,, ,11/13/1996,0523-001,Large,11/13/1996,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",Provisional,4/12/2018,0523-001,11/13/1997,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",610204,,581537,Yes
6026,94-T-052,Growth-Promoting Hexapeptide for Kidney Epithelial Cells,PCT/US97/20886, ,*United States,US,11/20/1997,, ,11/20/1997,0523-003,Large,11/20/1997,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",PCT,4/12/2018,0523-003,5/20/2000,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611721,,581537,Yes
6027,94-T-052,Growth-promoting proteins and peptides for kidney epithelial cells.,"08/863,853",,*United States,US,5/27/1997,,,,0523-002,Small,5/28/1996,,No,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",US Utility,4/12/2018,0523-002,5/28/2016,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611723,,581537,Yes
6028,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,"2,310,677","2,310,677",Canada,CA,5/22/1998,12/4/2007,WO9926974,,0523-004,Small,11/13/1996,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0523-004,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611969,,581537,Yes
6029,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,98924865.3GB,1034187,United Kingdom,GB,5/22/1998,1/7/2004,,,0523-005,Small,11/20/1997,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0523-005,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611970,,581537,Yes
6030,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,98924865.3DE,1034187,Germany,DE,5/22/1998,1/7/2004,,,0523-006,Small,11/13/1996,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Validated EPO,4/12/2018,0523-006,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611971,,581537,Yes
6031,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,PCT/US98/10574, ,*United States,US,5/22/1998,,WO 99/26974,5/22/1998,0523-007,Large,11/20/1997,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,"F. Gary Toback, Margaret Walsh-Reitz",PCT,4/12/2018,0523-007,5/20/2000,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611972,6/3/1999,581537,Yes
6032,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,76935/98,745894,Australia,AU,5/22/1998,7/25/2002,WO 99/26974,,0523-008,Small,11/13/1996,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0523-008,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611973,6/3/1999,581537,Yes
6033,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,2000-522130,3820102,Japan,JP,5/22/1998,6/23/2006,2001-524303,,0523-009,Small,11/20/1997,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Nationalized PCT,4/12/2018,0523-009,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611974,12/4/2001,581537,Yes
6034,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,2006-55617,4686379,Japan,JP,5/22/1998,2/18/2011,,,0523-012,Small,11/20/1997,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0523-012,5/22/2018,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611977,,581537,Yes
6035,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,2006-274512,,Japan,JP,5/22/1998,,,,0523-013,Small,11/20/1997,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0523-013,11/20/2017,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611978,,581537,Yes
6036,94-T-052,In Vitro and In Vivo Growth-Promoting Proteins and Peptides for Kidney Epithelial Cells,2010-47155,,Japan,JP,3/3/2010,,,,0523-014,Small,11/20/1997,,No,1/20/2022,Abandoned,Barnes & Thornburg,"Martin, Alice",,"F. Gary Toback, Margaret Walsh-Reitz",Divisional,4/12/2018,0523-014,11/20/2017,"Dembo, Anna",F. Gary Toback,"Tennant, Thelma",611979,,581537,Yes
6037,94-T-055,Pre-Treatment With Lymphokines Prior to Chemotherapy or Radiotherapy,"08/327,469", ,*United States,US,10/21/1994,, ,10/21/1994,0530-001,Small,10/21/1994,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Lawrence Boise, Craig Thompson",US Utility,4/12/2018,0530-001,10/21/2014,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",614134,,581540,Yes
6038,94-T-056,INDUCTION OF E-SELECTIN FOR TARGETTING THERAPEUTIC AGENTS,PCT/US96/02796, ,*United States,US,2/21/1996,,WO96/25947,2/21/1996,0531-002,None,2/21/1995,,No,4/28/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9024-003,"Dennis Hallahan, Ralph Weichselbaum",PCT,4/12/2018,0531-002,10/5/2016,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",612006,8/29/1996,581541,Yes
6039,94-T-056,Methods and Compositions for Targeting Selectins,"08/392,541","5,962,424",*United States,US,2/21/1995,10/5/1999,,,0531-001,Small,2/21/1995,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9024-001,"Dennis Hallahan, Ralph Weichselbaum",US Utility,4/12/2018,0531-001,10/5/2016,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",612858,,581541,Yes
6040,94-T-056,Methods and Compositions for Targeting Selectins,"08/394,645",,*United States,US,2/22/1996,,,,0531-003,None,2/21/1995,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9024,"Dennis Hallahan, Ralph Weichselbaum",Continuation,4/12/2018,0531-003,2/21/2015,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",612859,,581541,Yes
6041,94-T-056,Methods and Compositions for Targeting Selectins,"09/411,870",,*United States,US,10/4/1999,,,,0531-004,Small,2/21/1995,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9024-002,"Dennis Hallahan, Ralph Weichselbaum",Continuation,4/12/2018,0531-004,2/21/2015,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",612860,,581541,Yes
6042,94-T-057,COMPOSITIONS AND METHODS INVOLVING METHYLADENOSINE PHOSPHORYLASE IN THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERS,"11/087,072","7,192,711",*United States,US,3/22/2005,3/20/2007,US-2005-272069-A1,,0533-003,Small,7/2/1995,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,Olufunmilayo Olopade,Continuation,4/12/2018,0533-003,7/1/2016,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",611033,12/8/2005,581542,Yes
6043,94-T-057,Methylthioadenosine Phosphorylase Compositions and Methods of Use in the Diagnosis and Treatment of Proliferative Disorders,"08/674,311","6,870,037",*United States,US,7/1/1996,3/22/2005,,,0533-002,Small,7/2/1995,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,Olufunmilayo Olopade,Continuation in Part,4/12/2018,0533-002,7/1/2016,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",613376,,581542,Yes
6044,94-T-057,Methylthioadenosine Phosphorylase Compositions and Methods of Use in the Diagnosis and Treatment of Proliferative Disorders,"11/617,217",,*United States,US,12/28/2006,,US-2007-0161025-A1,,0533-004,Small,7/2/1995,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Olufunmilayo Olopade,Continuation,4/12/2018,0533-004,7/2/2016,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",613377,7/12/2007,581542,Yes
6045,94-T-057,Methythioadensine Phosphorylase,"60/000,831", ,*United States,US,7/2/1995,, ,7/2/1995,0533-001,Small,7/2/1995,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Kitchell, Barbara", ,Olufunmilayo Olopade,Provisional,4/12/2018,0533-001,7/2/1996,"Sun, Han",Olufunmilayo Olopade,"Tennant, Thelma",613378,,581542,Yes
6046,94-T-058,FC Receptor Non-Binding Anti-CD3 Monoclonal Antibodies,"09/063,849",,*United States,US,4/21/1998,,,,0534-002,Small,4/21/1997,,No,5/7/2022,Abandoned,Norton Rose Fulbright US LLP,,,"Jeffrey Bluestone, Marcus Clark, Michael Cole, Judith Smith, J. Yun Tso",Continuation in Part,4/12/2018,0534-002,4/21/2017,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",611573,,581543,Yes
6047,94-T-058,FC Receptor Non-Binding Anti-CD3 Monoclonal Antibodies,PCT/US98/08029, ,*United States,US,4/21/1998,,WO 98/47531,4/21/1998,0534-003,Small,4/21/1997,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Jeffrey Bluestone, Marcus Clark, Michael Cole, Judith Smith, J. Yun Tso",PCT,4/12/2018,0534-003,10/21/1999,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",611574,10/29/1998,581543,Yes
6048,94-T-058,Uses of Anti-CD3 MAb,"60/044,084", ,*United States,US,4/21/1997,, ,4/21/1997,0534-001,Small,4/21/1997,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Jeffrey Bluestone, Marcus Clark, Michael Cole, Judith Smith, J. Yun Tso",Provisional,4/12/2018,0534-001,4/21/1998,"Dembo, Anna",Jeffrey Bluestone,"Tennant, Thelma",615331,,581543,Yes
6049,94-T-059,Dopamine D-2 Receptor Antagonist,"08/421,557", ,*United States,US,4/13/1995,, ,4/13/1995,0535-001,None,4/13/1995,,Yes,4/28/2022,Abandoned,,, ,"Malcolm Cooper, Malay Das, Jogeshwar Mukherjee, Nien-chu Yang",US Utility,4/12/2018,0535-001,4/13/2015,"Unassigned, Unassigned",Jogeshwar Mukherjee,"Unassigned, Unassigned",611488,,581544,Yes
6050,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,"08/393,779","5,657,362",*United States,US,2/24/1995,8/12/1997, ,,0542-001,Small,2/24/1995,,Yes,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Ping Lu, Ming Zhang",US Utility,4/12/2018,0542-001,2/24/2015,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610598,,581551,Yes
6051,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,51701/96,"706,993",Australia,AU,2/23/1996,10/14/1999,,,0542-002,Small,2/24/1995,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Maryellen Giger, Ping Lu, Ming Zhang","Foreign, Non-PCT",4/12/2018,0542-002,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610599,,581551,Yes
6052,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,"2,188,394","2,188,394",Canada,CA,2/23/1996,7/20/2010, ,,0542-003,Large,2/24/1995,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Ping Lu, Ming Zhang","Foreign, Non-PCT",4/12/2018,0542-003,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610600,,581551,Yes
6053,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,96908470.6EPO,0757544,European Patent Office (EPO),EP,2/23/1996,12/15/2010,0757544,,0542-004,Small,2/24/1995,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Schlier, Carl", ,"Maryellen Giger, Ping Lu, Ming Zhang",Nationalized PCT,4/12/2018,0542-004,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610601,8/29/1996,581551,Yes
6054,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,8-525749,,Japan,JP,2/23/1996,,,,0542-005,Small,2/24/1995,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy",,"Maryellen Giger, Ping Lu, Ming Zhang",Nationalized PCT,4/12/2018,0542-005,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610602,,581551,Yes
6055,94-T-066,Automated method and system for computerized detection of masses and parenchymal distortions in medical images,2003-059220,,Japan,JP,5/3/2003,,,,0542-007,Small,2/23/1996,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Maryellen Giger, Ping Lu, Ming Zhang",Divisional,4/12/2018,0542-007,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610603,1/29/2004,581551,Yes
6056,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,2006-244130, ,Japan,JP,9/8/2006,, ,,0542-008,None,2/23/1996,,No,2/17/2021,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy", ,"Maryellen Giger, Ping Lu, Ming Zhang",Divisional,4/12/2018,0542-008,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610604,,581551,Yes
6057,94-T-066,Automated method and system for computerized detection of masses and parenchymal distortions in medical images,2007-168509,4634418,Japan,JP,6/27/2007,11/26/2010, ,,0542-009,Large,2/23/1996,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Ping Lu, Ming Zhang",Divisional,4/12/2018,0542-009,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610605,,581551,Yes
6058,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,96908470.6GB,0757544,United Kingdom,GB,2/23/1996,12/15/2010, ,,0542-010,Small,2/24/1995,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Schlier, Carl", ,"Maryellen Giger, Ping Lu, Ming Zhang",Validated EPO,4/12/2018,0542-010,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610606,,581551,Yes
6059,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,96908470.6FR,0757544,France,FR,2/23/1996,, ,,0542-011,Small,2/24/1995,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Schlier, Carl", ,"Maryellen Giger, Ping Lu, Ming Zhang",Validated EPO,4/12/2018,0542-011,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610607,,581551,Yes
6060,94-T-066,Automated Method and System for Computerized Detection of Masses and Parenchymal Distortions in Medical Images,96908470.6DE,0757544,Germany,DE,2/23/1996,12/15/2010, ,,0542-012,Small,2/24/1995,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Schlier, Carl", ,"Maryellen Giger, Ping Lu, Ming Zhang",Validated EPO,4/12/2018,0542-012,2/23/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",610608,,581551,Yes
6061,94-T-066,Computerized Detection of Masses and Parenchymal Distortions,PCT/US96/02065, ,*United States,US,2/23/1996,,WO96/25879,2/23/1996,0542-006,Small,2/24/1995,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Ping Lu, Ming Zhang",PCT,4/12/2018,0542-006,8/24/1997,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611260,8/29/1996,581551,Yes
6062,95-T-001,Liquid Chromatographic Extraction Medium,"08/051,608","5,346,618",*United States,US,4/9/1990,9/13/1994, ,4/23/1993,95-005-008,Small,4/9/1990,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz",Continuation,4/12/2018,95-005-008,12/20/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612085,,581020,Yes
6063,95-T-001,Method for Liquid Chromatographic Extraction of Strontium Acid Solutions,"07/822,710", ,*United States,US,4/9/1990,, ,1/21/1992,95-005-007,Small,4/9/1990,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz",Divisional,4/12/2018,95-005-007,,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612476,,581020,Yes
6064,95-T-001,Method for Liquid Chromatographic Extraction of Strontium from Acid Solutions,"07/507,419","5,110,474",*United States,US,4/9/1990,5/5/1992, ,4/9/1990,95-005-001,Small,4/9/1990,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Mark Dietz, Phil Horwitz",US Utility,4/12/2018,95-005-001,4/9/2010,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612477,,581020,Yes
6065,95-T-001,Method for Liquid Chromatographic Extraction of Strontium from Acid Solutions,91908830.2EPO,0525100,European Patent Office (EPO),EP,4/9/1991,3/19/1997,EPO 0525100 B1,4/9/1991,95-005-002,Small,4/9/1990,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz",Nationalized PCT,4/12/2018,95-005-002,4/9/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612478,,581020,Yes
6066,95-T-001,Method for Liquid Chromatographic Extraction of Strontium from Acid Solutions,3-508601,2620447,Japan,JP,4/9/1991,6/1/1997, ,4/9/1991,95-005-003,Small,4/9/1990,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz","Foreign, Non-PCT",4/12/2018,95-005-003,4/9/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612479,,581020,Yes
6067,95-T-001,Method for Liquid Chromatographic Extraction of Strontium from Acid Solutions,91908830.2DE,0525100,Germany,DE,4/9/1991,3/19/1997,EPO 0525100 B1,4/9/1991,95-005-004,Small,4/9/1990,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz",Validated EPO,4/12/2018,95-005-004,4/9/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612480,,581020,Yes
6068,95-T-001,Method for Liquid Chromatographic Extraction of Strontium from Acid Solutions,91908830.2FR,0525100,France,FR,4/9/1991,3/19/1997,EPO 0525100 B1,4/9/1991,95-005-005,Small,4/9/1990,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz",Validated EPO,4/12/2018,95-005-005,4/9/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612481,,581020,Yes
6069,95-T-001,Method for Liquid Chromatographic Extraction of Strontium from Acid Solutions,91908830.2GB,0525100,United Kingdom,GB,4/9/1991,3/19/1997,EPO 0525100 B1,4/9/1991,95-005-006,Small,4/9/1990,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Mark Dietz, Phil Horwitz",Validated EPO,4/12/2018,95-005-006,4/9/2011,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612482,,581020,Yes
6070,95-T-012,Argument Structure Hierarchy System and Method for Facilitating Analysis and Decision-Making Processes (As Filed),"08/786,397","6,098,062",*United States,US,1/17/1997,8/1/2000, ,1/17/1997,95-149-001,None,1/17/1997,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Rauch, John",00022,T. Janssen,US Utility,4/12/2018,95-149-001,1/17/2017,"Unassigned, Unassigned",T. Janssen,"Unassigned, Unassigned",610564,,581031,Yes
6071,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples,"08/467,402","5,651,883",*United States,US,6/6/1995,7/29/1997, ,,95-032-001,Small,6/6/1995,,Yes,9/16/2020,Expired - Inactive,Welsh & Katz,, ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",US Utility,4/12/2018,95-032-001,6/6/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612499,,581552,Yes
6072,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples,PCT/US96/08355, ,*United States,US,6/3/1996,12/12/1996, ,6/3/1996,95-032-003,Small,6/6/1995,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",PCT,4/12/2018,95-032-003,12/6/1997,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612500,,581552,Yes
6073,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples,"08/853,593","5,851,401",*United States,US,5/9/1997,12/22/1998, ,,95-032-007,Small,6/6/1995,,No,9/16/2020,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",Divisional,4/12/2018,95-032-007,6/6/2015,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612501,,581552,Yes
6074,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples (DIPEX),96916966.3EPO,830190,European Patent Office (EPO),EP,6/3/1996,4/24/2002,WO9639238,,95-032-002,Small,6/6/1995,,No,9/16/2020,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",Nationalized PCT,4/12/2018,95-032-002,6/3/2016,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612502,3/25/1998,581552,Yes
6075,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples (DIPEX),96916966.3GB,830190,United Kingdom,GB,6/3/1996,4/24/2002,WO9639238,,95-032-004,Small,6/6/1995,,No,9/16/2020,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",Validated EPO,4/12/2018,95-032-004,6/3/2016,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612503,3/25/1998,581552,Yes
6076,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples (DIPEX),96916966.3FR,830190,France,FR,6/3/1996,4/24/2002,WO9639238,,95-032-005,Small,6/6/1995,,No,9/16/2020,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",Validated EPO,4/12/2018,95-032-005,6/3/2016,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612504,3/25/1998,581552,Yes
6077,95-T-017,Method for the Chromatographic Separation of Cations from Aqueous Samples (DIPEX),96916966.3DE,830190,Germany,DE,6/3/1996,4/24/2002,WO9639238,,95-032-006,Small,6/6/1995,,No,9/16/2020,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, Phil Horwitz",Validated EPO,4/12/2018,95-032-006,6/3/2016,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",612505,3/25/1998,581552,Yes
6078,95-T-018,Detection of Lesions in Medical Images,8-526892,,Japan,JP,3/4/1996,,,,0541-004,Small,3/3/1995,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0541-004,3/4/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611394,,581553,Yes
6079,95-T-018,Detection of Lesions in Medical Images,49932/96,705713,Australia,AU,4/3/1996,9/2/1999,,,0541-006,Small,3/3/1995,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0541-006,3/4/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",611395,,581553,Yes
6080,95-T-018,Method and System for Detection of Lesions in Medical Images,"08/982,282","6,185,320",*United States,US,12/1/1997,2/6/2001, ,,0541-007,Small,3/3/1995,,No,2/17/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Ulrich Bick, Maryellen Giger",Continuation,4/12/2018,0541-007,3/3/2015,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612350,,581553,Yes
6081,95-T-018,Method and System for the Detection of Lesions in Medical Images,"08/398,307", ,*United States,US,3/3/1995,, ,,0541-001,Small,3/3/1995,,Yes,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",US Utility,4/12/2018,0541-001,,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612410,,581553,Yes
6082,95-T-018,Method and System for the Detection of Lesions in Medical Images,"2,214,101",,Canada,CA,3/4/1996,,,,0541-002,Small,3/3/1995,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0541-002,3/4/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612411,,581553,Yes
6083,95-T-018,Method and System for the Detection of Lesions in Medical Images,96906597.8EPO, ,European Patent Office (EPO),EP,3/4/1996,,EP 0 813 720 A1,,0541-003,Small,3/3/1995,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",Nationalized PCT,4/12/2018,0541-003,3/4/2016,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612412,12/29/1997,581553,Yes
6084,95-T-018,Method and System for the Detection of Lesions in Medical Images,PCT/US96/02439, ,*United States,US,3/4/1996,,WO 96/27846 A1,3/4/1996,0541-005,Small,3/3/1995,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger",PCT,4/12/2018,0541-005,9/3/1997,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612413,9/12/1996,581553,Yes
6085,95-T-019,XRCC3 is Required for an Assembly of RAD51-Complexes In Vivo,"09/404,053",,*United States,US,9/22/1999,,,,0543-002,Small,9/25/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Douglas Bishop, Ralph Weichselbaum",US Utility,4/12/2018,0543-002,9/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615396,,581554,Yes
6086,95-T-019,XRCC3 is Required for Assembly of RAD51-Complexes in Vivo,"60/101,909", ,*United States,US,9/25/1998,, ,9/25/1998,0543-001,Small,9/25/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Michael Beckett, Douglas Bishop, Ralph Weichselbaum",Provisional,4/12/2018,0543-001,9/25/1999,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615397,,581554,Yes
6087,95-T-019,XRCC3 Is Required for Assembly of RAD51-Complexes In Vivo,"09/844,538",,*United States,US,4/26/2001,,US-2001-036929-A1,,0543-003,Small,9/25/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Douglas Bishop, Ralph Weichselbaum",Divisional,4/12/2018,0543-003,9/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615398,11/1/2001,581554,Yes
6088,95-T-020,Isolation of APO(A),"60/006,395", ,*United States,US,11/9/1995,, ,11/9/1995,0544-001,None,11/9/1995,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Celina Edelstein, Angelo Scanu",Provisional,4/12/2018,0544-001,11/9/1996,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",612061,,581555,Yes
6089,95-T-020,Isolation of APO(A),"08/691,795",,*United States,US,8/2/1996,,,,0544-002,None,11/9/1995,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Celina Edelstein, Angelo Scanu",US Utility,4/12/2018,0544-002,8/2/2016,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",612062,,581555,Yes
6090,95-T-020,Isolation of APO(A),PCT/US96/18136, ,*United States,US,11/8/1996,5/15/1997, ,11/8/1996,0544-003,Large,11/9/1995,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Celina Edelstein, Angelo Scanu",PCT,4/12/2018,0544-003,5/8/1999,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",612063,,581555,Yes
6091,95-T-021,Superbinding Phenotypes,"60/148,102", ,*United States,US,5/30/1997,, ,5/30/1997,0544.1-001,None,5/30/1997,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Celina Edelstein, Angelo Scanu",Provisional,4/12/2018,0544.1-001,5/30/1998,"Ginsburg, Eric",Angelo Scanu,"Muite, Kevin",614723,,581556,Yes
6092,95-T-022,Nonimaging Optical Illumination System,"08/054,816","5,586,013",*United States,US,4/28/1993,12/17/1996,,,0545-001,Small,7/19/1991,,Yes,4/12/2018,Expired - Inactive,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Continuation in Part,4/12/2018,0545-001,12/17/2013,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613675,,581557,Yes
6093,95-T-022,Nonimaging Optical Illumination System,"08/745,239","5,816,693",*United States,US,11/8/1996,10/6/1998,,,0545-002,Small,4/28/1993,,No,4/12/2018,Expired - Inactive,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Continuation,4/12/2018,0545-002,4/28/2013,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613676,,581557,Yes
6094,95-T-022,Nonimaging Optical Illumination System,"09/167,373","6,019,485",*United States,US,10/6/1998,2/1/2000,,,0545-003,Small,4/28/1993,2/1/2017,No,2/13/2019,Expired - Inactive,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Continuation,4/12/2018,0545-003,2/1/2017,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613677,,581557,Yes
6095,95-T-022,Nonimaging Optical Illumination System,82105503,66449,"Taiwan, Province of China",TW,4/28/1994,6/1/1994,,,0545-004,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0545-004,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613678,,581557,Yes
6096,95-T-022,Nonimaging Optical Illumination System,"109,457","109,457",Israel,IL,4/28/1994,6/19/1997,,,0545-005,Small,4/28/1993,,No,4/10/2021,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0545-005,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613679,,581557,Yes
6097,95-T-022,Nonimaging Optical Illumination System,PCT/US94/04692, ,*United States,US,4/28/1994,, ,4/28/1994,0545-006,Small,4/28/1993,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Harald Ries, Roland Winston",PCT,4/12/2018,0545-006,10/28/1995,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613680,,581557,Yes
6098,95-T-022,Nonimaging Optical Illumination System,67772/94,"696,712",Australia,AU,4/28/1994,1/7/1999,,,0545-007,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0545-007,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613681,,581557,Yes
6099,95-T-022,Nonimaging Optical Illumination System,"2,161,667",,Canada,CA,4/28/1994,,,,0545-008,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0545-008,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613682,,581557,Yes
6100,95-T-022,Nonimaging Optical Illumination System,94915932.1EPO,0699286,European Patent Office (EPO),EP,4/28/1994,7/24/2002, ,,0545-009,Small,4/28/1993,,No,5/21/2018,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0545-009,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613683,,581557,Yes
6101,95-T-022,Nonimaging Optical Illumination System,6-524541,,Japan,JP,4/28/1994,,,,0545-010,Small,4/28/1993,,No,1/24/2019,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0545-010,,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613684,,581557,Yes
6102,95-T-022,Nonimaging Optical Illumination System,01112816.2EPO,,European Patent Office (EPO),EP,4/28/1994,,EP 1139012 A2,,0545-011,Small,7/19/1991,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Divisional,4/12/2018,0545-011,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613685,10/4/2001,581557,Yes
6103,95-T-022,Nonimaging Optical Illumination System,94915932.1IT,0699286,Italy,IT,4/28/1994,7/24/2002,,,0545-012,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0545-012,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613686,,581557,Yes
6104,95-T-022,Nonimaging Optical Illumination System,94915932.1ES,0699286,Spain,ES,4/28/1994,7/24/2002,,,0545-013,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0545-013,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613687,,581557,Yes
6105,95-T-022,Nonimaging Optical Illumination System,94915932.1DE,69431057.3,Germany,DE,4/28/1994,7/24/2002,,,0545-014,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0545-014,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613688,,581557,Yes
6106,95-T-022,Nonimaging Optical Illumination System,94915932.1NL,0699286,Netherlands,NL,4/28/1994,7/24/2002,,,0545-015,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0545-015,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613689,,581557,Yes
6107,95-T-022,Nonimaging Optical Illumination System,94915932.1GB,0699286,United Kingdom,GB,4/28/1994,7/24/2002,,,0545-016,Small,4/28/1993,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0545-016,4/28/2014,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613690,,581557,Yes
6108,95-T-025,SABLE,TXu-782-699,TXu-782-699,*United States,US,2/3/1997,2/3/1997, ,,94-081-001,None,,,No,8/4/2020,Registered (Copyright),,, ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Copyright Application,4/12/2018,94-081-001,2/3/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614417,,581560,Yes
6109,95-T-025,Self-Tuning System for Industrial Surveillance,"08/900,545","6,131,076",*United States,US,7/25/1997,10/10/2000, ,,94-081-002,Large,7/25/1997,,Yes,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",US Utility,4/12/2018,94-081-002,7/25/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614445,,581560,Yes
6110,95-T-025,Self-Tuning System for Industrial Surveillance,PCT/US98/15280, ,*United States,US,7/23/1998,,WO 99/05685,7/23/1998,94-081-003,Small,7/25/1997,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",PCT,4/12/2018,94-081-003,1/25/2000,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614446,2/4/1999,581560,Yes
6111,95-T-031,A Method of preventing colon cancer with vitamin D3 analogues,"08/418,638","6,040,300",*United States,US,4/7/1995,3/21/2000,,,0553-001,None,4/7/1995,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Marc Bissonnette, Thomas Brasitus, Michael Sitrin",US Utility,4/12/2018,0553-001,3/21/2017,"Unassigned, Unassigned",Thomas Brasitus,"Unassigned, Unassigned",610215,,581566,Yes
6112,95-T-031,A Method of preventing colon cancer with vitamin D3 analogues,PCT/US96/04681, ,*United States,US,4/5/1996,, ,4/5/1996,0553-002,None,4/7/1995,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,, ,"Marc Bissonnette, Thomas Brasitus, Michael Sitrin",PCT,4/12/2018,0553-002,10/7/1997,"Unassigned, Unassigned",Thomas Brasitus,"Unassigned, Unassigned",610216,,581566,Yes
6113,95-T-032,Magnetic Lens Apparatus for a Low-Voltage High-Resolution Electron Microscope,"08/487,926","5,563,415",*United States,US,6/7/1995,10/8/1996,,,0554-001,Small,6/7/1995,,Yes,11/14/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,Albert Crewe,US Utility,4/12/2018,0554-001,6/7/2015,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",612144,,581567,Yes
6114,95-T-032,MAGNETIC LENS APPARATUS FOR USE IN HIGH-RESOLUTION SCANNING ELECTRON MICROSCOPES AND LITHOGRAPHIC PROCESSES,PCT/US96/09906, ,*United States,US,6/7/1996,,WO 96/41362,6/7/1996,0554-002,Small,6/7/1995,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,Albert Crewe,PCT,4/12/2018,0554-002,12/7/1997,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",612145,,581567,Yes
6115,95-T-032,Magnetic Lens Apparatus for Use in High-Resolution Scanning Electron Microscopes and Lithographic Processes,"08/973,706","6,051,839",*United States,US,3/9/1998,4/18/2000,,,0554-003,Small,6/7/1995,,Yes,11/14/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Albert Crewe,US Utility,4/12/2018,0554-003,6/7/2015,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",612146,,581567,Yes
6116,95-T-032,Magnetic Lens Apparatus for Use in High-Resolution Scanning Electron Microscopes and Lithographic Processes,"09/550,945","6,410,923",*United States,US,4/17/2000,6/25/2002,,,0554-004,Small,3/9/1998,,No,11/14/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,Albert Crewe,Continuation,4/12/2018,0554-004,6/7/2015,"Unassigned, Unassigned",Albert Crewe,"Unassigned, Unassigned",612147,,581567,Yes
6117,95-T-039,Computer-Aided Method for Automated Image Feature Analysis and Diagnosis of Digitized Medical Images,96852/96,3326070,Japan,JP,4/18/1996,7/5/2002,,,0561-002,Large,4/25/1995,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",,,"Kunio Doi, Shigehiko Katsuragawa, Junji Morishita, Xin-Wei Xu, Wei Zhang","Foreign, Non-PCT",4/12/2018,0561-002,4/18/2016,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611244,,581574,Yes
6118,95-T-039,Computer-Aided Method for Automated Image Feature Analysis and Diagnosis of Digitized Medical Images,"09/098,504","6,011,862",*United States,US,6/17/1998,1/4/2000,,,0561-003,Large,4/25/1995,,No,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigehiko Katsuragawa, Junji Morishita, Xin-Wei Xu",Divisional,4/12/2018,0561-003,4/25/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611245,,581574,Yes
6119,95-T-039,Computer-Aided Method for Automated Image Feature Analysis and Diagnosis of Medical Images,"08/428,867","5,790,690",*United States,US,4/25/1995,8/4/1998,,,0561-001,Large,4/25/1995,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigehiko Katsuragawa, Junji Morishita, Xin-Wei Xu",US Utility,4/12/2018,0561-001,8/4/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611246,,581574,Yes
6120,95-T-044,Atomic Force Microscope for Biological Specimens,"08/547,521","5,874,668",*United States,US,10/24/1995,2/23/1999, ,10/24/1995,0565-001,Small,10/24/1995,,Yes,5/19/2022,Released to Inventors,Foley & Lardner,, ,"Morton Arnsdorf, Shaohua Xu",US Utility,4/12/2018,0565-001,10/24/2015,"Unassigned, Unassigned",Morton Arnsdorf,"Unassigned, Unassigned",610571,,581579,Yes
6121,95-T-047,Plastid Proteolytic Processing Enzyme That Cleaves Precursor Polypeptides,"60/001,746", ,*United States,US,8/1/1995,, ,8/1/1995,0568-001,Large,8/1/1995,,Yes,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Gayle Lamppa,Provisional,4/12/2018,0568-001,8/1/1996,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614060,,581582,Yes
6122,95-T-047,Plastid Proteolytic Processing Enzyme That Cleaves Precursor Polypeptides,"08/690,062",,*United States,US,7/31/1996,,,,0568-002,Large,7/31/1996,,Yes,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Gayle Lamppa,US Utility,4/12/2018,0568-002,7/31/2016,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614061,,581582,Yes
6123,95-T-047,Plastid Proteolytic Processing Enzyme That Cleaves Precursor Polypeptides,"08/695,177",,*United States,US,8/1/1996,,,,0568-003,Small,8/1/1996,,Yes,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Gayle Lamppa,US Utility,4/12/2018,0568-003,8/1/2016,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614062,,581582,Yes
6124,95-T-047,Plastid Proteolytic Processing Enzyme That Cleaves Precursor Polypeptides,"09/187,049","6,117,666",*United States,US,11/5/1998,9/12/2000,,,0568-004,Small,8/1/1995,,No,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Gayle Lamppa,Divisional,4/12/2018,0568-004,8/1/2015,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614063,,581582,Yes
6125,95-T-052,Neuro-Parity Pattern Recognition System and Method,"09/094,413","6,119,111",*United States,US,6/9/1998,9/12/2000, ,,95-065-001,Small,6/9/1998,,Yes,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer, Roland Van Allstine, Stephan Wegerich, Yong Yue",US Utility,4/12/2018,95-065-001,6/9/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613651,,581587,Yes
6126,95-T-052,Neuro-Parity Pattern Recognition System and Method,PCT/US99/13054, ,*United States,US,6/9/1999,,WO 99/64962,6/9/1999,95-065-002,Small,6/9/1998,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer, Roland Van Allstine, Stephan Wegerich, Yong Yue",PCT,4/12/2018,95-065-002,12/9/2000,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613652,12/16/1999,581587,Yes
6127,95-T-052,Neuro-Parity Pattern Recognition System and Method,"11/231,281", ,*United States,US,9/20/2005,, ,,95-065-004,Small,6/9/1998,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer, Roland Van Allstine, Stephan Wegerich, Yong Yue",Divisional,4/12/2018,95-065-004,9/20/2025,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613653,,581587,Yes
6128,95-T-052,Neuro-Parity Recongnition System and Method,"10/242,488", ,*United States,US,9/12/2002,, ,,95-065-003,Small,6/9/1998,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer, Roland Van Allstine, Stephan Wegerich, Yong Yue",Reissue,4/12/2018,95-065-003,6/9/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613654,,581587,Yes
6129,95-T-055,Wavefront Direction Mapping Catheter System,"08/678,162","5,755,664",*United States,US,7/11/1996,5/26/1998, ,7/11/1996,0575-001,Small,7/11/1996,,Yes,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,Donald Rubenstein,US Utility,4/12/2018,0575-001,7/11/2016,"Ginsburg, Eric",Donald Rubenstein,"Juggernauth, Anne",615392,,581590,Yes
6130,95-T-057,STATMON Program,TXu-784-248,TXu-784-248,*United States,US,2/5/1997,2/5/1997, ,,91-078-001,None,,,No,8/4/2020,Registered (Copyright),,, ,Kenneth Gross,Copyright Application,4/12/2018,91-078-001,2/5/2017,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614630,,581592,Yes
6131,95-T-058,An Expert System for Testing Industrial Processes and Determining Sensor Status,PCT/US96/16092, ,*United States,US,10/8/1996,,WO 97/14105,10/8/1996,91-078B-002,Small,10/10/1995,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer",PCT,4/12/2018,91-078B-002,4/10/1998,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",610318,4/17/1997,581593,Yes
6132,95-T-058,An Expert System for Testing Industrial Processes and Determining Sensor Status,96936263.1EPO,EP 0 855 061 B1,European Patent Office (EPO),EP,10/8/1996,2/18/2004,EP 0 855 061 A1,,91-078B-003,Large,10/10/1995,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer",Nationalized PCT,4/12/2018,91-078B-003,10/8/2016,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",610319,7/29/1998,581593,Yes
6133,95-T-058,An Expert System for Testing Industrial Processes and Determining Sensor Status,73955/96,707304,Australia,AU,10/8/1996,10/21/1999,707304,,91-078B-004,Large,10/10/1995,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Kenneth Gross, Ralph Singer","Foreign, Non-PCT",4/12/2018,91-078B-004,10/8/2016,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",610321,8/7/1999,581593,Yes
6134,95-T-058,An Expert System for Testing Industrial Processes and Determining Sensor Status,"2,234,452",2 234 452,Canada,CA,10/8/1996,2/24/2004, ,,91-078B-005,Small,10/10/1995,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer, Stephan Wegerich","Foreign, Non-PCT",4/12/2018,91-078B-005,10/8/2016,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",610322,4/17/1997,581593,Yes
6135,95-T-058,An Expert System for Testing Industrial Processes and Determining Sensor Status,96936263.1GB,EP 0 855 061 B1,United Kingdom,GB,10/8/1996,2/18/2004,EP 0 855 061 A1,,91-078B-006,Large,10/10/1995,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer",Validated EPO,4/12/2018,91-078B-006,10/8/2016,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",610323,7/29/1998,581593,Yes
6136,95-T-058,An Expert System for Testing Industrial Processes and Determining Sensor Status,96936263.1IE,EP 0 855 061 B1,Ireland,IE,10/8/1996,2/18/2004,EP 0 855 061 A1,,91-078B-007,Large,10/10/1995,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer",Validated EPO,4/12/2018,91-078B-007,10/8/2016,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",610324,7/29/1998,581593,Yes
6137,95-T-058,Expert System for Testing Industrial Processes and Determining Sensor Status,"08/541,602","5,761,090",*United States,US,10/10/1995,6/2/1998, ,,91-078B-001,Small,10/10/1995,10/10/2015,Yes,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Ralph Singer",US Utility,4/12/2018,91-078B-001,10/10/2015,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",611554,,581593,Yes
6138,95-T-059,System for Monitoring an Industrial Process and Determining Sensor Status,"08/631,745","5,629,872",*United States,US,5/27/1994,5/13/1997, ,4/8/1996,91-078C-001,Small,5/27/1993,,No,4/28/2022,Abandoned,Foley & Lardner,, ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Continuation,4/12/2018,91-078C-001,1/29/2012,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614804,,581594,Yes
6139,95-T-060,Method and Apparatus for Three-Dimensional Reconstruction of Coronary Vessels from Angiographic Images,"08/665,836","6,047,080",*United States,US,6/19/1996,4/4/2000,,,0577-001,Small,6/19/1996,,Yes,11/14/2018,Expired - Inactive,Welsh & Katz,"Cohen, Eric",,"John Carroll, Shiuh-Yung (James) Chen, Kenneth Hoffmann, Charles Metz",US Utility,4/12/2018,0577-001,6/19/2016,"Ginsburg, Eric",Kenneth Hoffmann,"Smith, Dane",612301,,581595,Yes
6140,95-T-060,Method and Apparatus for Three-Dimensional Reconstruction of Coronary Vessels from Angiographic Images,PCT/US97/10194, ,*United States,US,6/17/1997,,WO 97/49065,6/17/1997,0577-002,Small,6/19/1996,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Shekleton, Gerald", ,"John Carroll, Shiuh-Yung (James) Chen, Kenneth Hoffmann, Charles Metz",PCT,4/12/2018,0577-002,12/19/1998,"Ginsburg, Eric",Kenneth Hoffmann,"Smith, Dane",612302,12/24/1997,581595,Yes
6141,95-T-060,Method and Apparatus for Three-Dimensional Reconstruction of Coronary Vessels from Angiographic Images,"2,258,730",,Canada,CA,6/17/1997,,,,0577-003,Large,6/19/1996,,No,11/14/2018,Abandoned,Welsh & Katz,"Cohen, Eric",,"John Carroll, Shiuh-Yung (James) Chen, Kenneth Hoffmann, Charles Metz",Nationalized PCT,4/12/2018,0577-003,6/17/2017,"Ginsburg, Eric",Kenneth Hoffmann,"Smith, Dane",612303,,581595,Yes
6142,95-T-060,Method and Apparatus for Three-Dimensional Reconstruction of Coronary Vessels from Angiographic Images,97931141.2EPO,EP 0 978 101 A1,European Patent Office (EPO),EP,6/17/1997,2/9/2000, ,,0577-004,Small,6/19/1996,,No,11/14/2018,Abandoned,Welsh & Katz,"Cohen, Eric", ,"John Carroll, Shiuh-Yung (James) Chen, Kenneth Hoffmann, Charles Metz",Nationalized PCT,4/12/2018,0577-004,6/17/2017,"Ginsburg, Eric",Kenneth Hoffmann,"Smith, Dane",612304,,581595,Yes
6143,95-T-061,Lubricated Boride Surfaces,"08/640,288","5,840,132",*United States,US,4/24/1996,11/24/1998,,,95-123-001,Small,4/24/1996,,Yes,1/20/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9011-002,"Cuma Bindal, Ali Erdemir, G. Fenske",US Utility,4/12/2018,95-123-001,4/24/2016,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612131,,581596,Yes
6144,95-T-061,Lubricated Boride Surfaces,PCT/US97/06567, ,*United States,US,4/24/1997,,WO 97/40205,4/24/1997,95-123-002,Small,4/24/1996,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9011-003,"Cuma Bindal, Ali Erdemir, G. Fenske",PCT,4/12/2018,95-123-002,10/24/1998,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612132,10/30/1997,581596,Yes
6145,95-T-061,Lubricated Boride Surfaces,"2,252,840","2,252,840",Canada,CA,4/24/1997,3/12/2002,,,95-123-003,Small,4/24/1996,,No,1/20/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9011-001,"Cuma Bindal, Ali Erdemir, G. Fenske",Nationalized PCT,4/12/2018,95-123-003,4/24/2017,"Ginsburg, Eric",Ali Erdemir,"Juggernauth, Anne",612133,10/30/1997,581596,Yes
6146,95-T-066,"CAD Method, Computer and Storge Medium for Automated Detection of Lung Nodules in Digital Chest Images","08/562,087","6,141,437",*United States,US,11/22/1995,10/31/2000,,,0582-001,Large,11/22/1995,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Xin-Wei Xu",US Utility,4/12/2018,0582-001,11/22/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610763,,581601,Yes
6147,95-T-066,"CAD Method, Computer and Storge Medium for Automated Detection of Lung Nodules in Digital Chest Images",264162/96, ,Japan,JP,10/4/1996,, ,,0582-002,Large,11/22/1995,,No,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Xin-Wei Xu","Foreign, Non-PCT",4/12/2018,0582-002,10/4/2016,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610764,,581601,Yes
6148,95-T-067,DNA Constructs and Viral Vectors Comprising A Smooth Muscle Promoter,"08/726,807","6,090,618",*United States,US,10/7/1996,7/18/2000,,,0583-004,Large,10/5/1995,,Yes,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",US Utility,4/12/2018,0583-004,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",611476,,581602,Yes
6149,95-T-067,Method for Modulating Smooth Muscle Cell Proliferation,"09/258,367","6,114,311",*United States,US,2/26/1999,9/5/2000,,,0583-012,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Divisional,4/12/2018,0583-012,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",612483,,581602,Yes
6150,95-T-067,Method for Modulating Smooth Muscle Cell Proliferation,"09/546,550","6,284,743",*United States,US,4/10/2000,9/4/2001,,,0583-015,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Continuation,4/12/2018,0583-015,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",612484,,581602,Yes
6151,95-T-067,"Method For Promoting Angiogenesis With a Nucleic Acid Construct Comprising
an SM22.alpha.0 Promoter","09/225,670","6,297,221",*United States,US,1/5/1999,10/2/2001,,,0583-011,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Divisional,4/12/2018,0583-011,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",612485,,581602,Yes
6152,95-T-067,Preventing Smooth Muscle Cell Contraction,"08/727,817",,*United States,US,10/7/1996,,,,0583-003,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",US Utility,4/12/2018,0583-003,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",614140,,581602,Yes
6153,95-T-067,Promoter for Expressing Smooth Muscle Cells,2002-136310,,Japan,JP,8/29/1997,,JP-23009894-A2,,0583-009,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Divisional,4/12/2018,0583-009,8/29/2017,"Hwang, Luke",Julian Solway,"Muite, Kevin",614190,1/14/2003,581602,Yes
6154,95-T-067,Promoter for Smooth Muscle Cell Expression,"09/431,349","6,331,527",*United States,US,11/1/1999,12/18/2001,,,0583-001,Large,10/5/1995,,No,2/4/2020,Abandoned,Norton Rose Fulbright US LLP,,,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",US Utility,4/12/2018,0583-001,12/18/2018,"Hwang, Luke",Julian Solway,"Muite, Kevin",614191,,581602,Yes
6155,95-T-067,Promoter for Smooth Muscle Cell Expression,"60/004,868", ,*United States,US,10/5/1995,, ,10/5/1995,0583-002,Large,10/5/1995,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Provisional,4/12/2018,0583-002,10/5/1996,"Hwang, Luke",Julian Solway,"Muite, Kevin",614192,,581602,Yes
6156,95-T-067,Promoter for Smooth Muscle Cell Expression,PCT/US97/16204, ,*United States,US,8/29/1997,,WO 98/15575,8/29/1997,0583-005,Large,10/5/1995,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Corder, Timothy", ,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",PCT,4/12/2018,0583-005,4/5/1998,"Hwang, Luke",Julian Solway,"Muite, Kevin",614193,4/16/1998,581602,Yes
6157,95-T-067,Promoter for Smooth Muscle Cell Expression,97942457.9EPO, ,European Patent Office (EPO),EP,8/29/1997,,941245,,0583-006,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Nationalized PCT,4/12/2018,0583-006,8/29/2017,"Hwang, Luke",Julian Solway,"Muite, Kevin",614194,9/15/1999,581602,Yes
6158,95-T-067,Promoter for Smooth Muscle Cell Expression,"2,267,067",,Canada,CA,8/29/1997,,,,0583-007,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Nationalized PCT,4/12/2018,0583-007,8/29/2017,"Hwang, Luke",Julian Solway,"Muite, Kevin",614195,4/16/1998,581602,Yes
6159,95-T-067,Promoter for Smooth Muscle Cell Expression,10-517528,3457332,Japan,JP,8/29/1997,8/1/2003,,,0583-008,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Nationalized PCT,4/12/2018,0583-008,8/29/2017,"Hwang, Luke",Julian Solway,"Muite, Kevin",614196,,581602,Yes
6160,95-T-067,Promoter for Smooth Muscle Cell Expression,199744150,738651,Australia,AU,8/29/1997,1/3/2002,,,0583-010,Large,10/5/1995,,No,2/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Nationalized PCT,4/12/2018,0583-010,8/29/2017,"Hwang, Luke",Julian Solway,"Muite, Kevin",614197,9/20/2001,581602,Yes
6161,95-T-067,Promoter for Smooth Muscle Cell Expression,"09/431,414","6,291,211",*United States,US,11/1/1999,9/18/2001,,,0583-014,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Divisional,4/12/2018,0583-014,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",614198,,581602,Yes
6162,95-T-067,Promoter for Smooth Muscle Cell Expression,"09/381,750","7,169,764",*United States,US,1/25/2001,1/30/2007,,,0583-016,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",US Utility,4/12/2018,0583-016,1/25/2021,"Hwang, Luke",Julian Solway,"Muite, Kevin",614199,,581602,Yes
6163,95-T-067,Smooth Muscle Cell Expression,"09/258,569",,*United States,US,2/26/1999,,,,0583-013,Large,10/5/1995,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Blanca Camoretti-Mercado, Michael Parmacek, Julian Solway",Divisional,4/12/2018,0583-013,10/5/2015,"Hwang, Luke",Julian Solway,"Muite, Kevin",614566,,581602,Yes
6164,96-T-020,Process for Separation and Preconcentration of Radium from Water,"08/870,914","5,863,439",*United States,US,6/6/1997,1/26/1999, ,6/6/1997,96-079-001,Small,6/6/1997,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Richard Bartsch, Renato Chiarizia, Mark Dietz, Phil Horwitz",US Utility,4/12/2018,96-079-001,6/6/2017,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614167,,581055,Yes
6165,96-T-020,Process for Separation and Preconcentration of Radium from Water,PCT/US98/11537, ,*United States,US,6/6/1997,,WO 98/55201,6/4/1998,96-079-003,Small,6/6/1997,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Richard Bartsch, Renato Chiarizia, Mark Dietz, Phil Horwitz",PCT,4/12/2018,96-079-003,12/6/1999,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614168,12/10/1998,581055,Yes
6166,96-T-020,Radium Separation Through Complexation and Ion Exchange,98926288.6EPO, ,European Patent Office (EPO),EP,6/6/1997,, ,6/4/1998,96-079-004,Small,6/6/1997,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Richard Bartsch, Renato Chiarizia, Mark Dietz, Phil Horwitz",Nationalized PCT,4/12/2018,96-079-004,6/6/2017,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614269,,581055,Yes
6167,96-T-028,Process and Apparatus for Production of BI-213 Cations,"2,292,621","2,292,621",Canada,CA,6/9/1997,12/10/2002,"2,292,621",6/3/1998,96-079-002,Large,6/9/1997,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, John Hines, Phil Horwitz",Nationalized PCT,4/12/2018,96-079-002,6/3/2017,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614149,12/17/1998,581063,Yes
6168,96-T-028,Process and Apparatus for Production of Bi-213 Cations,PCT/US98/11385, ,*United States,US,6/9/1997,,WO 98/57334,6/3/1998,96-114-004,Small,6/9/1997,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, John Hines, Phil Horwitz",PCT,4/12/2018,96-114-004,12/9/1999,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614150,12/17/1998,581063,Yes
6169,96-T-028,Process and Apparatus for the Production of BI-213 Cations,"08/871,517","5,854,968",*United States,US,6/9/1997,12/29/1998, ,6/9/1997,96-114-001,Small,6/9/1997,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, John Hines, Phil Horwitz",US Utility,4/12/2018,96-114-001,6/9/2017,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614157,,581063,Yes
6170,96-T-028,Process and Apparatus for the Production of Bi-213 Cations,77211/98,743466,Australia,AU,6/9/1997,5/9/2002, ,6/3/1998,96-114-002,Small,6/9/1997,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, John Hines, Phil Horwitz",Nationalized PCT,4/12/2018,96-114-002,6/9/2017,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614158,,581063,Yes
6171,96-T-028,Process and Apparatus for the Production of BI-213 Cations,98925207.7EPO, ,European Patent Office (EPO),EP,6/9/1997,,EP  0 988 634 A4,6/3/1998,96-114-003,Small,6/9/1997,,No,4/28/2022,Abandoned,Welsh & Katz,"Gamson, Edward", ,"Renato Chiarizia, Mark Dietz, John Hines, Phil Horwitz",Nationalized PCT,4/12/2018,96-114-003,6/3/2018,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",614159,11/20/2002,581063,Yes
6172,96-T-045,Identification of Activators and Inhibitors of Sebum Formation,PCT/US97/14757, ,*United States,US,8/21/1997,2/26/1998, ,8/21/1997,0592-002,Small,8/23/1996,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Robert Rosenfield,PCT,4/12/2018,0592-002,2/23/1999,"Ginsburg, Eric",Robert Rosenfield,"Tennant, Thelma",611886,,581611,Yes
6173,96-T-045,Identification of Activators and Inhibitors of Sebum Formation,"08/917,653","6,004,751",*United States,US,8/22/1997,12/21/1999,,,0592-003,Small,8/23/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,Robert Rosenfield,Continuation in Part,4/12/2018,0592-003,8/23/2016,"Ginsburg, Eric",Robert Rosenfield,"Tennant, Thelma",611887,,581611,Yes
6174,96-T-045,Identification of Inhibitors of Sebum Formation,"60/028,618", ,*United States,US,8/23/1996,, ,8/23/1996,0592-001,Small,8/23/1996,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,Robert Rosenfield,Provisional,4/12/2018,0592-001,8/23/1997,"Ginsburg, Eric",Robert Rosenfield,"Tennant, Thelma",611889,,581611,Yes
6175,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4EPO,1384781,European Patent Office (EPO),EP,5/2/1996,,EP 1 384 781 A1,,0595-007,Small,5/4/1995,,No,6/8/2022,Expired - Inactive,Foley Hoag LLP,"Smith, DeAnn", ,"Carl June, Craig Thompson",Nationalized PCT,4/12/2018,0595-007,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613213,1/28/2004,581613,Yes
6176,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4BE,1384781,Belgium,BE,5/2/1996,,EP 1 384 781 A1,,0595-018,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-018,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613214,1/28/2004,581613,Yes
6177,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4DK,1384781,Denmark,DK,5/2/1996,,EP 1 384 781 A1,,0595-019,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-019,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613215,1/28/2004,581613,Yes
6178,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4GR,1384781,Greece,GR,5/2/1996,,EP 1 384 781 A1,,0595-020,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-020,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613216,1/28/2004,581613,Yes
6179,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4IT,1384781,Italy,IT,5/2/1996,,EP 1 384 781 A1,,0595-021,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-021,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613217,1/28/2004,581613,Yes
6180,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4LU,1384781,Luxembourg,LU,5/2/1996,,EP 1 384 781 A1,,0595-022,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-022,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613218,1/28/2004,581613,Yes
6181,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4MC,1384781,Monaco,MC,5/2/1996,,EP 1 384 781 A1,,0595-023,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-023,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613219,1/28/2004,581613,Yes
6182,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4CH,1384781,Switzerland,CH,5/2/1996,,EP 1 384 781 A1,,0595-024,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-024,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613220,1/28/2004,581613,Yes
6183,96-T-047,"Methods for Inhibiting T-Cell Survival, by Inhibiting BCL-XL Protein Level (as amended by EPO)",03014974.4AT,1384781,Austria,AT,5/2/1996,,EP 1 384 781 A1,,0595-025,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-025,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613221,1/28/2004,581613,Yes
6184,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-X L Protein Level,96913912.0EPO,0826043,European Patent Office (EPO),EP,5/2/1996,7/2/2003, ,,0595-005,Small,5/4/1995,,No,6/8/2022,Expired - Inactive,Foley Hoag LLP,"Smith, DeAnn", ,"Carl June, Craig Thompson",Nationalized PCT,4/12/2018,0595-005,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613230,,581613,Yes
6185,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-X L Protein Level,96913912.0FR,0826043,France,FR,5/2/1996,7/2/2003,,,0595-014,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-014,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613231,,581613,Yes
6186,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-X L Protein Level,96913912.0DE,0826043,Germany,DE,5/2/1996,7/2/2003,,,0595-015,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-015,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613232,,581613,Yes
6187,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-X L Protein Level,96913912.0IE,0826043,Ireland,IE,5/2/1996,7/2/2003,,,0595-016,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-016,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613233,,581613,Yes
6188,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-X L Protein Level,96913912.0GB,0826043,United Kingdom,GB,5/2/1996,7/2/2003,,,0595-017,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Validated EPO,4/12/2018,0595-017,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613234,,581613,Yes
6189,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-XL Protein Level,"08/435,518",,*United States,US,5/4/1995,,,,0595-001,Small,5/4/1995,,Yes,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",US Utility,4/12/2018,0595-001,,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613235,2/28/2002,581613,Yes
6190,96-T-047,Methods for Modulating T Cell Survival by Modulating BCL-XL Protein Level,"08/481,739","6,143,291",*United States,US,6/7/1995,11/7/2000,,,0595-002,Small,5/4/1995,,Yes,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Continuation in Part,4/12/2018,0595-002,11/7/2017,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613236,,581613,Yes
6191,96-T-047,Methods for Modulating T Cell Survival By Modulating BCL-XL Protein Level,PCT/US96/06203, ,*United States,US,5/2/1996,,WO 96/034956,5/2/1996,0595-003,Small,5/4/1995,,No,6/8/2022,Expired - Inactive,Foley Hoag LLP,"Smith, DeAnn", ,"Carl June, Craig Thompson",PCT,4/12/2018,0595-003,11/4/1997,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613237,11/7/1996,581613,Yes
6192,96-T-047,Methods for Modulating T Cell Survival By Modulating BCL-XL Protein Level,"2,220,012","2,220,012",Canada,CA,5/2/1996,,,,0595-004,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Nationalized PCT,4/12/2018,0595-004,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613238,,581613,Yes
6193,96-T-047,Methods for Modulating T Cell Survival by Modulating bcl-Xl Protein Level,"09/707,087",,*United States,US,11/6/2000,,,,0595-009,Small,6/7/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Continuation,4/12/2018,0595-009,6/7/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613239,,581613,Yes
6194,96-T-047,Methods for Modulating T Cell Survival By Modulating BCL-XL Protein Level,533512/1996,,Japan,JP,5/2/1996,,,,0595-010,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Nationalized PCT,4/12/2018,0595-010,5/4/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613240,,581613,Yes
6195,96-T-047,Methods for Modulating T Cell Survival By Modulating BCL-XL Protein Level,2007-277882,,Japan,JP,5/2/1996,,,,0595-011,Small,5/4/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Nationalized PCT,4/12/2018,0595-011,5/4/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613241,,581613,Yes
6196,96-T-047,Methods for Modulating T Cell Survival by Modulating bcl-Xl Protein Level,"11/296,725",,*United States,US,12/2/2005,,,,0595-026,Large,6/7/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Continuation,4/12/2018,0595-026,6/7/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613242,,581613,Yes
6197,96-T-047,Methods for Modulating T Cell Survival by Modulating bcl-Xl Protein Level,"12/686,175",,*United States,US,1/12/2010,,,,0595-027,Large,6/7/1995,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Continuation,4/12/2018,0595-027,6/7/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613243,,581613,Yes
6198,96-T-047,Methods for Modulating T Cell Survival by Modulating bcl-XL Protien Level,48630/00,,Australia,AU,7/14/2000,,,,0595-008,Small,5/2/1996,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Divisional,4/12/2018,0595-008,7/14/2020,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613244,,581613,Yes
6199,96-T-047,Methods for Modulating T Cell Survival by Modulating bcl-XL Protien Level,2003254769,2003254769,Australia,AU,7/14/2000,,,,0595-012,Small,5/2/1996,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Divisional,4/12/2018,0595-012,5/4/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613245,,581613,Yes
6200,96-T-047,Methods for Modulating T Cell Survival by Modulating bcl-XL Protien Level,2007202459,,Australia,AU,7/14/2000,,,,0595-013,Small,5/2/1996,,No,6/8/2022,Abandoned,Foley Hoag LLP,"Smith, DeAnn",,"Carl June, Craig Thompson",Divisional,4/12/2018,0595-013,5/4/2015,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613246,,581613,Yes
6201,96-T-047,Methods for Modulationg T Cell Survival by Modulating BCL-XL Protein Level,56734/96,,Australia,AU,5/2/1996,,,,0595-006,Small,5/4/1995,,Yes,6/8/2022,Abandoned,Foley Hoag LLP,"Mandragouras, Amy",,"Carl June, Craig Thompson",Nationalized PCT,4/12/2018,0595-006,5/2/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613247,,581613,Yes
6202,96-T-050,Separation of Small Particles,"60/047,511", ,*United States,US,5/23/1997,, ,5/23/1997,0597-001,Small,5/23/1997,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Dean Astumian, Martin Bier, David Grier",Provisional,4/12/2018,0597-001,5/23/1998,"Unassigned, Unassigned",Martin Bier,"Unassigned, Unassigned",614484,,581616,Yes
6203,96-T-050,Separation of Small Particles,"09/083,571","6,001,266",*United States,US,5/22/1998,12/14/1999,,,0597-002,Small,5/23/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,Martin Bier,US Utility,4/12/2018,0597-002,5/23/2017,"Unassigned, Unassigned",Martin Bier,"Unassigned, Unassigned",614485,,581616,Yes
6204,96-T-052,Methods and Compositions Regarding Radioactive Bismuth 212,"60/024,567", ,*United States,US,8/26/1996,, ,8/26/1996,0599-001,Small,8/26/1996,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,"Gamson, Edward", ,"Paul Harper, John Hines, Jacob Rotmensch, Jenny Whitlock",Provisional,4/12/2018,0599-001,8/26/1997,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",613010,,581618,Yes
6205,96-T-052,Process and Apparatus for the Production of Bi-212 and a Use Thereof,97940622.0EPO, ,European Patent Office (EPO),EP,8/26/1997,,EP 0 979 513 A4,,0599-002,Small,8/26/1996,,No,9/16/2020,Released to Inventors,Welsh & Katz,"Gamson, Edward", ,Jacob Rotmensch,Nationalized PCT,4/12/2018,0599-002,8/26/2017,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",614151,10/4/2002,581618,Yes
6206,96-T-052,Process and Apparatus for the Production of Bi-212 and a use Thereof,PCT/US97/14994, ,*United States,US,8/26/1997,,WO 98/08481,8/26/1997,0599-003,Small,8/26/1996,,No,4/28/2022,Released to Inventors,Welsh & Katz,"Gamson, Edward", ,"Paul Harper, John Hines, Jacob Rotmensch, Jenny Whitlock",PCT,4/12/2018,0599-003,2/26/1999,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",614152,3/5/1998,581618,Yes
6207,96-T-052,Process and Apparatus for the Production of BI-212 and a Use Thereof,"2,261,772","2,261,772",Canada,CA,8/26/1997,12/9/2003,,,0599-004,Small,8/26/1996,,No,9/16/2020,Released to Inventors,Welsh & Katz,"Gamson, Edward",,"Paul Harper, John Hines, Jacob Rotmensch, Jenny Whitlock",Nationalized PCT,4/12/2018,0599-004,8/6/2017,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",614153,,581618,Yes
6208,96-T-052,Process and Apparatus for the Production of Bi-212 and a Use Thereof,42359/97,719602,Australia,AU,8/26/1997,8/24/2000,,,0599-006,Small,8/26/1996,,No,9/16/2020,Released to Inventors,Welsh & Katz,"Gamson, Edward",,"Paul Harper, John Hines, Jacob Rotmensch, Jenny Whitlock",Nationalized PCT,4/12/2018,0599-006,8/26/2017,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",614154,,581618,Yes
6209,96-T-052,Process and Apparatus for the Production of BI-212 and a Use Thereof,"09/230,635","6,126,909",*United States,US,1/28/1999,10/3/2000,,,0599-007,Small,8/26/1996,,No,9/16/2020,Abandoned,Welsh & Katz,"Gamson, Edward",,"Paul Harper, John Hines, Jacob Rotmensch, Jenny Whitlock",Nationalized PCT,4/12/2018,0599-007,8/26/2016,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",614155,,581618,Yes
6210,96-T-052,Process and Apparatus for the Production of Bi-212 and the Use Thereof,10-511832,,Japan,JP,8/26/1997,,,,0599-005,Small,8/26/1996,,No,9/16/2020,Released to Inventors,Welsh & Katz,"Gamson, Edward",,"Paul Harper, John Hines, Jacob Rotmensch, Jenny Whitlock",Nationalized PCT,4/12/2018,0599-005,8/26/2017,"Ginsburg, Eric",Jacob Rotmensch,"Juggernauth, Anne",614156,,581618,Yes
6211,96-T-054,Human and Drosophila Inhibitors of Apoptosis Proteins (IAPS),"10/299,067",,*United States,US,11/18/2002,,,,0601-002,Small,5/31/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Colin Duckett, Craig Thompson",Continuation,4/12/2018,0601-002,11/18/2022,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",611839,,581620,Yes
6212,96-T-054,Human and Drosophila Inhibitors of Apoptosis Proteins (IAPS) - Released to Inventor,"08/657,759","6,511,828",*United States,US,5/31/1996,1/28/2003,,,0601-001,Small,5/31/1996,,Yes,6/8/2022,Released to Inventors,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Colin Duckett, Craig Thompson",US Utility,4/12/2018,0601-001,1/28/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",611840,,581620,Yes
6213,96-T-057,Bacterial Sucrose Synthase Compositions and Methods of Use,"08/684,005","6,682,918",*United States,US,7/19/1996,1/27/2004,,,0604-002,Small,7/19/1996,,Yes,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Christopher Bauer, William Buikema, Robert Haselkorn",US Utility,4/12/2018,0604-002,7/19/2016,"Ginsburg, Eric",Robert Haselkorn,"Butler, Brittany",610685,,581623,Yes
6214,96-T-057,Bacterial Sucrose Synthase Compositions and Methods of Use,PCT/US97/12736, ,*United States,US,7/21/1997,1/29/1998, ,7/21/1997,0604-003,Small,7/19/1996,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Kitchell, Barbara", ,"Christopher Bauer, William Buikema, Robert Haselkorn",PCT,4/12/2018,0604-003,1/19/1999,"Ginsburg, Eric",Robert Haselkorn,"Butler, Brittany",610686,,581623,Yes
6215,96-T-057,Bacterial Sucrose Synthase Compositions and Methods of Use,97934246.6EPO,859832,European Patent Office (EPO),EP,7/21/1997,8/26/1998,WO9803637,,0604-004,Small,7/19/1996,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Christopher Bauer, William Buikema, Robert Haselkorn",Nationalized PCT,4/12/2018,0604-004,7/21/2017,"Ginsburg, Eric",Robert Haselkorn,"Butler, Brittany",610687,8/26/1998,581623,Yes
6216,96-T-057,Bacterial Sucrose Synthase Compositions and Methods of Use,"2,234,068",,Canada,CA,4/6/1998,,,,0604-005,Small,7/19/1996,,No,12/4/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Christopher Bauer, William Buikema, Robert Haselkorn",Nationalized PCT,4/12/2018,0604-005,4/6/2018,"Ginsburg, Eric",Robert Haselkorn,"Butler, Brittany",610688,,581623,Yes
6217,96-T-057,Bacterial Sucrose Synthase Compositions and Methods of Use,37349/97,728968,Australia,AU,4/7/1998,5/10/2001,,,0604-006,Small,7/19/1996,,No,12/4/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Christopher Bauer, William Buikema, Robert Haselkorn","Foreign, Non-PCT",4/12/2018,0604-006,7/21/2017,"Ginsburg, Eric",Robert Haselkorn,"Butler, Brittany",610689,,581623,Yes
6218,96-T-060,Shift-Invariant Artificial Neural Network for Computerized Detection of Clustered Microcalcifications in Mammography,"08/562,188","5,732,697",*United States,US,11/22/1995,3/31/1998,,,0607-001,Large,11/22/1995,,Yes,4/12/2018,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Wei Zhang",US Utility,4/12/2018,0607-001,11/22/2015,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614491,,581626,Yes
6219,96-T-060,Shift-Invariant Artificial Neural Network for Computerized Detection of Clustered Microcalcifications in Mammography,268515/96,,Japan,JP,10/9/1996,,,,0607-002,Large,11/22/1995,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Wei Zhang","Foreign, Non-PCT",4/12/2018,0607-002,10/9/2016,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614492,,581626,Yes
6220,96-T-063,Herpes Simplex Virus ICP4 as an Inhibitor of Apoptosis,"08/690,473","5,876,923",*United States,US,7/26/1996,3/2/1999,,,0610-001,Small,7/26/1996,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",US Utility,4/12/2018,0610-001,7/26/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611786,,581629,Yes
6221,96-T-063,Herpes Simplex Virus ICP4 is an Inhibitor of Apoptosis,PCT/US97/12904, ,*United States,US,7/23/1997,2/5/1998, ,7/23/1997,0610-002,Small,7/26/1996,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Rosario Leopardi, Bernard Roizman",PCT,4/12/2018,0610-002,1/26/1999,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611787,,581629,Yes
6222,96-T-063,Herpes Simplex Virus ICP4 is an Inhibitor of Apoptosis,"2,262,013",,Canada,CA,1/26/1999,,,,0610-003,Large,7/26/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",Nationalized PCT,4/12/2018,0610-003,1/26/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611788,,581629,Yes
6223,96-T-063,Herpes Simplex Virus ICP4 is an Inhibitor of Apoptosis,508947/99,,Japan,JP,1/26/1999,,,,0610-004,Small,7/26/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",Nationalized PCT,4/12/2018,0610-004,1/26/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611789,,581629,Yes
6224,96-T-063,Herpes Simplex Virus ICP4 is an Inhibitor of Apoptosis,97935080.8EPO,917577,European Patent Office (EPO),EP,2/23/1999,5/26/1999, ,,0610-005,Small,7/26/1996,,No,5/21/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Rosario Leopardi, Bernard Roizman",Nationalized PCT,4/12/2018,0610-005,2/23/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611790,,581629,Yes
6225,96-T-063,Herpes Simplex Virus ICP4 is an Inhibitor of Apoptosis,"09/259,821","6,210,926",*United States,US,3/1/1999,4/3/2001,,,0610-006,Small,7/26/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",Divisional,4/12/2018,0610-006,7/26/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611791,,581629,Yes
6226,96-T-063,Herpes Simplex Virus ICP4 is an Inhibitor of Apoptosis,"09/825,288","6,723,511",*United States,US,4/2/2001,4/20/2004,US-2002-192822-A1,,0610-007,Small,7/26/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",Continuation,4/12/2018,0610-007,7/26/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611792,12/19/2002,581629,Yes
6227,96-T-064,Herpes Simplex Virus ORF P is a Repressor of Viral Protein Synthesis,"08/706,308","5,846,948",*United States,US,8/30/1996,12/8/1998,,,0611-001,Small,8/30/1996,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Renato Bruni, Bernard Roizman",US Utility,4/12/2018,0611-001,8/30/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611794,,581630,Yes
6228,96-T-064,Herpes Simplex Virus ORF P is a Repressor of Viral Protein Synthesis,"09/206,676","6,383,738",*United States,US,12/7/1998,5/7/2002,,,0611-004,Small,8/30/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Renato Bruni, Bernard Roizman",Divisional,4/12/2018,0611-004,8/30/2016,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611795,,581630,Yes
6229,96-T-064,USE OF HERPES SIMPLEX VIRUS ORF P PROTEIN IN REPRESSION OF VIRAL PROTEIN SYNTHESIS AND RELATED METHODS,PCT/US97/15149, ,*United States,US,8/28/1997,3/5/1998,WO 98/08953,8/28/1997,0611-002,Small,8/30/1996,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Renato Bruni, Bernard Roizman",PCT,4/12/2018,0611-002,3/30/1999,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615195,3/5/1998,581630,Yes
6230,96-T-064,USE OF HERPES SIMPLEX VIRUS ORF P PROTEIN IN REPRESSION OF VIRAL PROTEIN SYNTHESIS AND RELATED METHODS,"2,265,088",,Canada,CA,8/28/1998,,,,0611-003,Small,8/30/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Renato Bruni, Bernard Roizman",Nationalized PCT,4/12/2018,0611-003,8/28/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615196,,581630,Yes
6231,96-T-064,USE OF HERPES SIMPLEX VIRUS ORF P PROTEIN IN REPRESSION OF VIRAL PROTEIN SYNTHESIS AND RELATED METHODS,511901/99,,Japan,JP,3/1/1999,,,,0611-005,Small,8/30/1996,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Renato Bruni, Bernard Roizman",Nationalized PCT,4/12/2018,0611-005,3/1/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615197,,581630,Yes
6232,96-T-064,USE OF HERPES SIMPLEX VIRUS ORF P PROTEIN IN REPRESSION OF VIRAL PROTEIN SYNTHESIS AND RELATED METHODS,97939626.4EPO,938563,European Patent Office (EPO),EP,3/30/1999,9/1/1999, ,,0611-006,Small,8/30/1996,,No,5/21/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Renato Bruni, Bernard Roizman",Nationalized PCT,4/12/2018,0611-006,3/30/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",615198,,581630,Yes
6233,96-T-065,Methods for the Production of Chicken Monoclonal Antibodies,"08/751,359","6,143,559",*United States,US,11/18/1996,11/7/2000,,,0612-001,Small,11/18/1996,,Yes,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Hash, Stephen",,"Mary Ann Accavitti, Nancy Michael, Craig Thompson",US Utility,4/12/2018,0612-001,11/18/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613262,,581631,Yes
6234,96-T-065,Methods for the Production of Chicken Monoclonal Antibodies,PCT/US97/21077, ,*United States,US,11/18/1997,, ,11/18/1997,0612-003,Small,11/18/1996,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Mary Ann Accavitti, Nancy Michael, Craig Thompson",PCT,4/12/2018,0612-003,5/18/1999,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613263,,581631,Yes
6235,96-T-065,Methods for the Production of Chicken Monoclonial Antibodies,"08/907,146","6,316,600",*United States,US,8/6/1997,11/13/2001,,,0612-002,Small,11/18/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Mary Ann Accavitti, Nancy Michael, Craig Thompson",Continuation,4/12/2018,0612-002,11/18/2016,"Dembo, Anna",Craig Thompson,"Tennant, Thelma",613264,,581631,Yes
6236,96-T-067,Flywheel Energy Storage with Superconductor Magnetic Bearings,"07/736,677","5,214,981",*United States,US,7/26/1991,6/1/1993, ,7/26/1991,91-031-001,Large,7/26/1991,7/26/2011,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"John Hull, Lahmer Lynds Jr., Bernard Weinberger",US Utility,4/12/2018,91-031-001,7/26/2011,"Unassigned, Unassigned",John Hull,"Unassigned, Unassigned",611606,,581633,Yes
6237,96-T-068,Combination of Chimeric TGFA Pseudomonas Toxin and Therapeutic Radiation,"09/153,803", ,*United States,US,9/15/1998,, ,9/15/1998,0614-001,Small,9/15/1998,,Yes,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Donald Kufe, Saraswathy Seetharam, Ralph Weichselbaum",US Utility,4/12/2018,0614-001,9/15/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610930,,581634,Yes
6238,96-T-072,Methods and Compounds for Modulating Nuclear Receptor Activity,"2,324,060",,Canada,CA,3/30/1999,,,,0618-002,Large,3/3/1998,,No,4/12/2018,Abandoned,"Morgan, Lewis & Bockius LLP","Bone, Richard",,"David Agard, Geoffrey Greene, Peter Kushner, Andrew Shiau",Nationalized PCT,4/12/2018,0618-002,3/30/2019,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613105,,581638,Yes
6239,96-T-072,Methods and Compounds for Modulating Nuclear Receptor Activity,PCT/US99/06937, ,*United States,US,3/30/1999,,WO 99/50658 A3,3/30/1999,0618-004,Small,3/30/1998,,No,4/28/2022,Expired - Inactive,Cooley Godward LLP,"Eberle, Shelley", ,"David Agard, Geoffrey Greene, Peter Kushner, Andrew Shiau",PCT,4/12/2018,0618-004,3/30/2000,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613106,,581638,Yes
6240,96-T-072,Methods and Compounds for Modulating Nuclear Receptor Activity,99916206.8EPO, ,European Patent Office (EPO),EP,3/30/1999,, ,,0618-005,Small,3/30/1998,,No,5/21/2018,Abandoned,"Morgan, Lewis & Bockius LLP","Bone, Richard", ,"David Agard, Geoffrey Greene, Peter Kushner, Andrew Shiau",Nationalized PCT,4/12/2018,0618-005,,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613107,,581638,Yes
6241,96-T-072,Methods and Compounds for Modulating Nuclear Receptor Activity,2000-541516,,Japan,JP,9/30/2000,,,,0618-006,Small,3/30/1998,,No,4/12/2018,Abandoned,Fish & Richardson P.C.,"Bone, Richard",,"Lin Cheng, Geoffrey Greene",Nationalized PCT,4/12/2018,0618-006,9/30/2020,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613108,,581638,Yes
6242,96-T-072,Methods and Compounds for Modulating Nuclear Receptor Activity,7010940/2000,,"Korea, Republic of",KR,3/30/2000,,,,0618-007,Small,3/30/1998,,No,4/12/2018,Abandoned,"Morgan, Lewis & Bockius LLP","Bone, Richard",,"David Agard, Geoffrey Greene, Peter Kushner, Andrew Shiau",Nationalized PCT,4/12/2018,0618-007,3/30/2020,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613109,,581638,Yes
6243,96-T-072,Methods and Compounds for Modulating Nuclear Receptor Activity,34571/99,,Australia,AU,3/30/2000,,,,0618-008,Small,3/30/1998,,No,4/12/2018,Abandoned,"Morgan, Lewis & Bockius LLP","Bone, Richard",,"David Agard, Geoffrey Greene, Peter Kushner, Andrew Shiau",Divisional,4/12/2018,0618-008,3/30/2020,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613110,,581638,Yes
6244,96-T-072,Methods and compounds for modulating nuclear receptor activity.,"09/830,693",,*United States,US,3/30/1999,,,,0618-003,Small,3/30/1999,,Yes,4/12/2018,Abandoned,"Morgan, Lewis & Bockius LLP","Bone, Richard",,"Lin Cheng, Geoffrey Greene",US Utility,4/12/2018,0618-003,3/30/2019,"Sun, Han",Geoffrey Greene,"Tennant, Thelma",613111,,581638,Yes
6245,96-T-077,Process of Determining 3D Location of Pacemaker Leads in Heart of A Subject,"08/805,074","5,859,922",*United States,US,2/21/1997,1/12/1999, ,2/21/1997,0620-001,Small,2/21/1997,,Yes,4/28/2022,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Katz, Martin", ,Kenneth Hoffmann,US Utility,4/12/2018,0620-001,2/21/2017,"Ginsburg, Eric",Kenneth Hoffmann,"Smith, Dane",614169,,581643,Yes
6246,96-T-081,Compositions and Methods Comprising Gaba and Glycine Receptors,"60/048,770", ,*United States,US,6/5/1997,, ,6/5/1997,0627-001,Small,6/5/1997,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,Neil Harrison,Provisional,4/12/2018,0627-001,6/5/1998,"Unassigned, Unassigned",Neil Harrison,"Unassigned, Unassigned",610976,,581647,Yes
6247,96-T-083,Industrial Process Surveillance System,"08/666,938","5,764,509",*United States,US,6/19/1996,6/9/1998, ,,94-135-001,Small,6/19/1996,,Yes,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",US Utility,4/12/2018,94-135-001,6/19/2016,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612008,,581649,Yes
6248,96-T-083,Industrial Process Surveillance System,97930046.4GB,0906593,United Kingdom,GB,6/13/1997,7/30/2003,EP 0 906 593 A1,,94-135-003,Small,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Validated EPO,4/12/2018,94-135-003,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612009,4/7/1999,581649,Yes
6249,96-T-083,Industrial Process Surveillance System,97930046.4ES,0906593,Spain,ES,6/13/1997,7/30/2003,EP 0 906 593 A1,,94-135-004,Large,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Validated EPO,4/12/2018,94-135-004,6/19/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612010,4/7/1999,581649,Yes
6250,96-T-083,Industrial Process Surveillance System,97930046.4FR,0906593,France,FR,6/13/1997,7/30/2003,906593,,94-135-005,Small,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Validated EPO,4/12/2018,94-135-005,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612011,4/7/1999,581649,Yes
6251,96-T-083,Industrial Process Surveillance System,97930046.4DE,69723839-3,Germany,DE,6/13/1997,7/30/2003,0906593,,94-135-006,Small,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Validated EPO,4/12/2018,94-135-006,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612012,4/7/1999,581649,Yes
6252,96-T-083,Industrial Process Surveillance System,97930046.4IE,0906593,Ireland,IE,6/13/1997,7/30/2003,906593,,94-135-007,Large,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Validated EPO,4/12/2018,94-135-007,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612013,4/7/1999,581649,Yes
6253,96-T-083,Industrial Process Surveillance System,PCT/US97/10430, ,*United States,US,6/13/1997,,WO 97/49011,6/13/1997,94-135-008,Small,6/19/1996,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",PCT,4/12/2018,94-135-008,12/19/1998,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612014,12/24/1997,581649,Yes
6254,96-T-083,Industrial Process Surveillance System,503223/98,3449560,Japan,JP,6/13/1997,7/11/2003,2000-505221,,94-135-009,Large,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich","Foreign, Non-PCT",4/12/2018,94-135-009,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612015,4/25/2000,581649,Yes
6255,96-T-083,Industrial Process Surveillance System,1998-710448,313067,"Korea, Republic of",KR,6/13/1997,10/16/2001, ,,94-135-010,Large,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich","Foreign, Non-PCT",4/12/2018,94-135-010,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612016,,581649,Yes
6256,96-T-083,Industrial Process Surveillance System,"2,257,881","2,257,881",Canada,CA,6/13/1997,2/10/2004,"2,557,881",,94-135-011,Large,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Nationalized PCT,4/12/2018,94-135-011,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612017,12/24/1997,581649,Yes
6257,96-T-083,Industrial Process Surveillance System,97930046.4EPO,0906593,European Patent Office (EPO),EP,6/13/1997,7/30/2003,906593,,94-135-012,Large,6/19/1996,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Nationalized PCT,4/12/2018,94-135-012,6/13/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612018,4/7/1999,581649,Yes
6258,96-T-083,MSET,TXu-782-700,TXu-782-700,*United States,US,2/3/1997,2/3/1997, ,,94-135-002,None,,,No,8/4/2020,Registered (Copyright),,, ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Copyright Application,4/12/2018,94-135-002,2/3/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613547,,581649,Yes
6259,96-T-084,Industrial Process Surveillance System,"09/028,443","6,181,975",*United States,US,6/13/1997,1/30/2001, ,2/24/1998,94-135B-001,Large,6/19/1996,,No,4/28/2022,Expired - Inactive,Foley & Lardner,, ,"Kenneth Gross, Jack Mott, Ralph Singer, Stephan Wegerich",Continuation,4/12/2018,94-135B-001,6/19/2016,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",612019,,581650,Yes
6260,96-T-086,Diabetes Susceptibility Gene Mody 1,"60/028,056", ,*United States,US,10/2/1996,, ,10/2/1996,0630-002,None,10/2/1996,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Provisional,4/12/2018,0630-002,10/2/1997,"Butler, Brittany",Graeme Bell,"Butler, Brittany",611445,,581652,Yes
6261,96-T-086,Diabetes Susceptibility Gene Mody 3,"60/025,719", ,*United States,US,9/10/1996,, ,9/10/1996,0630-001,Small,9/10/1996,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Provisional,4/12/2018,0630-001,9/10/1997,"Butler, Brittany",Graeme Bell,"Butler, Brittany",611446,,581652,Yes
6262,96-T-086,Diabetes Susceptibility Mody 1,"60/029,679", ,*United States,US,10/30/1996,, ,10/30/1996,0630-003,None,10/30/1996,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Provisional,4/12/2018,0630-003,10/30/1997,"Butler, Brittany",Graeme Bell,"Butler, Brittany",611447,,581652,Yes
6263,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (-g(a)), HNF-1-g(b) AND HNF-4-g(a)",97941508.0EPO,0920534,European Patent Office (EPO),EP,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-006,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Nationalized PCT,4/12/2018,0630-006,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613579,6/9/1999,581652,Yes
6264,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (-g(a)), HNF-1-g(b) AND HNF-4-g(a)","2,265,480","2,265,480",Canada,CA,9/10/1997,6/22/2010,,,0630-015,Large,9/10/1996,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Nationalized PCT,4/12/2018,0630-015,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613580,,581652,Yes
6265,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (-g(a)), HNF-1-g(b) AND HNF-4-g(a)","2,698,393",,Canada,CA,9/10/1997,,,,0630-017,Large,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Divisional,4/12/2018,0630-017,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613581,,581652,Yes
6266,96-T-086,"Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (.alpha.), HNF1.beta. and HNF4.alpha.","08/927,219","6,187,533",*United States,US,9/9/1997,2/13/2001,,,0630-004,Small,9/10/1996,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Kazuya Yamagata",US Utility,4/12/2018,0630-004,9/10/2016,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613582,,581652,Yes
6267,96-T-086,"Mutations in the Diabetes Susceptibility Genes Hepatocyte Nuclear Factor (HNF) 1 Alpha (a), HNF-1B and HNF-4a",PCT/US97/16037, ,*United States,US,9/10/1997,,WO 98/11254,9/10/1997,0630-005,None,9/10/1996,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",PCT,4/12/2018,0630-005,3/10/1999,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613583,3/19/1998,581652,Yes
6268,96-T-086,"Mutations in the Diabetes Susceptibility Genes Hepatocyte Nuclear Factor (HNF) 1 Alpha (A), HNF-1B, and HNF-4A","09/754,106",,*United States,US,1/3/2001,,US-2003-224355-A1,,0630-016,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Continuation,4/12/2018,0630-016,9/10/2016,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613584,12/4/2003,581652,Yes
6269,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0DE,6973498.1-08,Germany,DE,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-007,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-007,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613585,6/9/1999,581652,Yes
6270,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0CH,0920534,Switzerland,CH,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-008,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-008,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613586,6/9/1999,581652,Yes
6271,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0ES,0920534,Spain,ES,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-009,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-009,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613587,6/9/1999,581652,Yes
6272,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0AT,0920534,Austria,AT,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-010,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-010,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613588,6/9/1999,581652,Yes
6273,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0IE,0920534,Ireland,IE,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-011,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-011,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613589,6/9/1999,581652,Yes
6274,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0IT,0920534,Italy,IT,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-012,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-012,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613590,6/9/1999,581652,Yes
6275,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0GB,0920534,United Kingdom,GB,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-013,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-013,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613591,6/9/1999,581652,Yes
6276,96-T-086,"MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA, HNF-1 BETA AND HNF-4 ALPHA",97941508.0FR,0920534,France,FR,9/10/1997,12/28/2005,EP 0 920 534 A1,,0630-014,Small,9/10/1996,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Graeme Bell, Nancy Cox, Stefan Fajans, Hiroto Furuta, Yukio Horikawa, Pamela Kaisaki, Stephan Menzel, Naohisa Oda, Richard Spillman, Kunsan Xiang, Kazuya Yamagata",Validated EPO,4/12/2018,0630-014,9/10/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613592,6/9/1999,581652,Yes
6277,96-T-096,Elimination Competent Mini-Chromosomes,"61/533,377", ,*United States,US,9/12/2011,, ,9/12/2011,0640-064,None,9/12/2011,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30005C,"Gregory Copenhaver, Daphne Preuss",Provisional,4/12/2018,0640-064,9/12/2012,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",611524,,581662,Yes
6278,96-T-096,Methods for Generating or Increasing revenue from Crops,"10/170,944","7,193,128",*United States,US,6/12/2002,6/20/2007,US20030131372,,0640-025,Small,6/3/1997,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30001,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Continuation in Part,4/12/2018,0640-025,6/12/2022,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613179,7/10/2003,581662,Yes
6279,96-T-096,Methods for Generating or Increasing Revenue from Crops,PCT/US03/20380, ,*United States,US,6/27/2003,,WO2005/010187,6/27/2003,0640-029,Small,6/27/2003,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30001-PC,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",PCT,4/12/2018,0640-029,12/27/2005,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613180,2/3/2005,581662,Yes
6280,96-T-096,Methods for Generating or Increasing Revenue from Crops,"2,530,178", ,Canada,CA,6/27/2003,, ,,0640-032,Large,6/27/2003,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30001-CA,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-032,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613181,,581662,Yes
6281,96-T-096,Methods for Generating or Increasing revenue from Crops,"11/701,900",,*United States,US,2/2/2007,, ,,0640-055,Small,6/3/1997,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30001,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-055,6/12/2022,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613182,,581662,Yes
6282,96-T-096,Plant Artificial Chromosome (PLAC) Compositions and Methods,"11/331,942","7,847,151",*United States,US,1/13/2006,12/7/2010, ,,0640-051,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000E,"Gregory Copenhaver, Daphne Preuss",Continuation,4/12/2018,0640-051,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613972,,581662,Yes
6283,96-T-096,Plant Artificial Chromosome (PLAC) Compositions and Methods,"12/912,454", ,*United States,US,10/26/2010,, ,,0640-063,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000F,"Gregory Copenhaver, Daphne Preuss",Continuation,4/12/2018,0640-063,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613973,,581662,Yes
6284,96-T-096,Plant artificial chromosome composicions and methods,"09/553,231","6,900,012",*United States,US,4/19/2000,5/31/2005, ,,0640-068,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon", ,"Gregory Copenhaver, Daphne Preuss",Continuation,4/12/2018,0640-068,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613974,,581662,Yes
6285,96-T-096,Plant Artificial Chromosome Compositions (PLAC) and Methods,PCT/US98/11288, ,*United States,US,6/3/1998,,WO 98/55637,6/3/1998,0640-004,Small,6/3/1997,,No,6/13/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,30000-PC,"Gregory Copenhaver, Daphne Preuss",PCT,4/12/2018,0640-004,12/3/1999,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613975,12/10/1998,581662,Yes
6286,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/048,451", ,*United States,US,6/3/1997,, ,6/3/1997,0640-001,Small,6/3/1997,6/3/1997,Yes,4/28/2022,Expired Prov - Filed PCT,"Marshall, Gerstein & Borun",,30000,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-001,6/3/1998,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613976,,581662,Yes
6287,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/073,741", ,*United States,US,2/5/1998,, ,2/5/1998,0640-002,Small,2/5/1998,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30000A,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-002,2/5/1999,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613977,,581662,Yes
6288,96-T-096,Plant Artificial Chromosome Compositions and Methods,"09/090,051","6,156,953",*United States,US,6/3/1998,12/5/2000, ,,0640-003,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000D-B,"Gregory Copenhaver, Daphne Preuss",US Utility,4/12/2018,0640-003,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613978,,581662,Yes
6289,96-T-096,Plant Artificial Chromosome Compositions and Methods,98923903.3EPO, ,European Patent Office (EPO),EP,6/3/1998,,EP 0 986 648 A1,,0640-005,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000-EP,"Gregory Copenhaver, Daphne Preuss",Nationalized PCT,4/12/2018,0640-005,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613979,3/22/2002,581662,Yes
6290,96-T-096,Plant Artificial Chromosome Compositions and Methods,"2,292,893","2,292,893",Canada,CA,6/3/1998,1/17/2012, ,,0640-006,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000-CA,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-006,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613980,,581662,Yes
6291,96-T-096,Plant Artificial Chromosome Compositions and Methods,76086/98,0746775,Australia,AU,6/3/1998,8/15/2002, ,,0640-007,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",30000-AU,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-007,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613981,5/2/2002,581662,Yes
6292,96-T-096,Plant Artificial Chromosome Compositions and Methods,"10/161,849","7,015,372",*United States,US,8/6/2002,3/21/2006,US 2006-0003449 A1,,0640-027,Small,6/3/1997,,No,7/22/2021,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000D-B,"Gregory Copenhaver, Daphne Preuss",Continuation,4/12/2018,0640-027,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613982,1/5/2006,581662,Yes
6293,96-T-096,Plant Artificial Chromosome Compositions and Methods,07022120.5EPO, ,European Patent Office (EPO),EP,6/3/1998,, ,,0640-054,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30000A-EP,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Divisional,4/12/2018,0640-054,6/3/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613983,3/7/2012,581662,Yes
6294,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/125,219", ,*United States,US,3/18/1999,, ,3/18/1999,0640-008,Small,3/18/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30002,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-008,3/18/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613984,,581662,Yes
6295,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/127,409", ,*United States,US,4/1/1999,, ,4/1/1999,0640-009,Small,4/1/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30004,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-009,4/1/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613985,,581662,Yes
6296,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/134,770", ,*United States,US,5/18/1999,, ,5/18/1999,0640-010,Small,5/18/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30005,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-010,5/18/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613986,,581662,Yes
6297,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/153,584", ,*United States,US,9/13/1999,, ,9/13/1999,0640-011,Small,9/13/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30006,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-011,9/13/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613987,,581662,Yes
6298,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/154,603", ,*United States,US,9/17/1999,, ,9/17/1999,0640-012,Small,9/17/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30007,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-012,9/17/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613988,,581662,Yes
6299,96-T-096,Plant Artificial Chromosome Compositions and Methods,"60/172,493", ,*United States,US,12/16/1999,, ,12/16/1999,0640-013,Small,12/16/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30008,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Provisional,4/12/2018,0640-013,12/16/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613989,,581662,Yes
6300,96-T-096,Plant Artificial Chromosome Compositions and Methods,"11/981,296","8,062,885",*United States,US,10/31/2007,11/22/2011, ,,0640-056,Small,3/17/2000,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30001F,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Continuation,4/12/2018,0640-056,4/6/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613990,,581662,Yes
6301,96-T-096,Plant Artificial Chromosome Compositions and Methods,"11/981,451","7,989,202",*United States,US,10/31/2007,8/2/2011,US-2011-0189774,,0640-057,Small,3/17/2000,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30001E,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Continuation,4/12/2018,0640-057,4/6/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613991,8/4/2011,581662,Yes
6302,96-T-096,Plant centromere compositions,"13/195,157", ,*United States,US,8/1/2011,, ,,0640-024,Small,6/3/1997,,No,5/8/2022,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30001G,"Gregory Copenhaver, Daphne Preuss",Continuation,4/12/2018,0640-024,6/3/2017,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613992,,581662,Yes
6303,96-T-096,Plant Centromere Compositions,2012202836, ,Australia,AU,6/27/2003,, ,5/15/2012,0640-000,Small,3/18/1999,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,30002B-AU,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Divisional,4/12/2018,0640-000,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613993,,581662,Yes
6304,96-T-096,Plant centromere compositions,"10/170,912","7,119,250",*United States,US,3/17/2000,10/10/2006,US-2003-124561-A1,6/12/2002,0640-026,Small,3/18/1999,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30001,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Continuation in Part,4/12/2018,0640-026,6/3/2017,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613994,7/3/2003,581662,Yes
6305,96-T-096,Plant Centromere Compositions,PCT/US03/20381, ,*United States,US,6/27/2003,,WO 05/010142,6/27/2003,0640-028,Small,6/27/2003,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-PC,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",PCT,4/12/2018,0640-028,9/13/2004,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613995,2/3/2005,581662,Yes
6306,96-T-096,Plant Centromere Compositions,"2,532,809", ,Canada,CA,6/27/2003,, ,,0640-030,Large,6/27/2003,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",38306-CA,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-030,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613996,,581662,Yes
6307,96-T-096,Plant Centromere Compositions,03817686.3EPO, ,European Patent Office (EPO),EP,6/27/2003,, ,,0640-031,Small,6/27/2003,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-EP,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-031,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613997,,581662,Yes
6308,96-T-096,Plant Centromere Compositions,2003276839,2003276839,Australia,AU,6/27/2003,3/17/2011, ,,0640-033,Small,6/27/2003,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002-AU,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-033,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613998,,581662,Yes
6309,96-T-096,Plant Centromere Compositions,PI0318377-7, ,Brazil,BR,6/27/2003,, ,,0640-034,Small,6/27/2003,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-BR,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-034,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",613999,,581662,Yes
6310,96-T-096,Plant Centromere Compositions,"11/031,554","7,456,013",*United States,US,1/7/2005,11/25/2008,US-2005-268359-A1,,0640-036,Small,6/3/1997,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30001A,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-036,5/24/2019,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614000,12/1/2005,581662,Yes
6311,96-T-096,Plant centromere compositions,"11/049,537","7,227,057",*United States,US,2/2/2005,6/5/2007,US-2005-241015-A1,,0640-037,Small,6/3/1997,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30001C,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-037,4/30/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614001,10/27/2005,581662,Yes
6312,96-T-096,Plant centromere compositions,"11/049,584","7,235,716",*United States,US,2/2/2005,6/26/2007,US-2005-241016-A1,,0640-038,Small,6/3/1997,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30001B,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-038,4/27/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614002,10/27/2005,581662,Yes
6313,96-T-096,Plant centromere compositions,"11/049,179","7,226,782",*United States,US,2/2/2005,7/5/2007,US-2005-257282-A1,,0640-039,Small,6/3/1997,,No,12/13/2018,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30001D,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-039,7/27/2018,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614003,11/17/2005,581662,Yes
6314,96-T-096,Plant Centromere Compositions,06111268.6,,Hong Kong,HK,6/27/2003,,1089481,,0640-052,Small,6/27/2003,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002-HK,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-052,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614004,12/1/2006,581662,Yes
6315,96-T-096,Plant centromere compositions,"12/508,355",,*United States,US,7/23/2009,,2010-0333235,,0640-065,Small,6/3/1997,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,44857,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-065,4/27/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614005,12/30/2010,581662,Yes
6316,96-T-096,Plant Centromere Compositions,10011419.8EPO,,European Patent Office (EPO),EP,6/27/2003,,EP2357240A1,,0640-066,Small,6/27/2003,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002B-EP,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Divisional,4/12/2018,0640-066,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614006,8/17/2011,581662,Yes
6317,96-T-096,Plant Centromere Compositions,10011458.6EPO, ,European Patent Office (EPO),EP,6/27/2003,,2295586,,0640-060,Small,6/27/2003,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002A-EP,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Divisional,4/12/2018,0640-060,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614007,3/16/2011,581662,Yes
6318,96-T-096,Plant Centromere Compositions,2010241309,AU 2010241309 B2,Australia,AU,6/27/2003,5/31/2012, ,,0640-062,Small,6/27/2003,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002A-AU,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Divisional,4/12/2018,0640-062,6/27/2023,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614008,,581662,Yes
6319,96-T-096,Plant Centromeres,0958/DELNP/2001,231756,India,IN,3/17/2000,9/9/2009, ,,0640-014,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-IN,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-014,3/17/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614009,,581662,Yes
6320,96-T-096,Plant Centromeres,37649/00, ,Australia,AU,3/17/2000,,AU0037649,,0640-015,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-AU,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-015,3/17/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614010,10/4/2000,581662,Yes
6321,96-T-096,Plant Centromeres,"2,362,897", ,Canada,CA,3/17/2000,, ,,0640-016,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-CA,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-016,3/17/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614011,11/10/2005,581662,Yes
6322,96-T-096,Plant Centromeres,2000-605743, ,Japan,JP,3/17/2000,,2004512806T,,0640-017,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-JP,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-017,9/18/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614012,4/30/2004,581662,Yes
6323,96-T-096,Plant Centromeres,PI0009119-7,,Brazil,BR,3/17/2000,, ,,0640-018,Small,3/18/1999,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002-BR,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-018,3/17/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614013,12/26/2001,581662,Yes
6324,96-T-096,Plant Centromeres,00916559.8EPO, ,European Patent Office (EPO),EP,3/17/2000,,EP 1 165 792 A2,,0640-019,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Rin-Laures, Li-Hsien",30002-EP,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Nationalized PCT,4/12/2018,0640-019,10/16/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614014,2/1/2002,581662,Yes
6325,96-T-096,Plant Centromeres,4723/DELNP/2005, ,India,IN,3/17/2000,, ,,0640-021,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002A-IN,"Gregory Copenhaver, Daphne Preuss",Divisional,4/12/2018,0640-021,3/17/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614015,,581662,Yes
6326,96-T-096,Plant Centromeres,2005222525,,Australia,AU,3/17/2000,, ,,0640-023,Small,3/18/1999,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002A-AU,"Gregory Copenhaver, Daphne Preuss",Divisional,4/12/2018,0640-023,10/12/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614016,11/10/2005,581662,Yes
6327,96-T-096,Plant Centromeres,2008207566,2008207566,Australia,AU,3/17/2000,12/20/2012, ,,0640-058,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002B-AU,"Gregory Copenhaver, Daphne Preuss",Divisional,4/12/2018,0640-058,3/17/2020,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614017,,581662,Yes
6328,96-T-096,Plant Centromeres,2011-76545,,Japan,JP,3/17/2000,,2011-125354,,0640-059,Small,3/18/1999,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002A-JP,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Divisional,4/12/2018,0640-059,9/18/2021,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614018,6/30/2011,581662,Yes
6329,96-T-096,PLANT CHROMOSOME COMPOSITIONS AND METHODS,PCT/US00/07392, ,*United States,US,3/17/2000,,WO 00/55325 A3,3/17/2000,0640-020,Small,3/18/1999,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30002-PC,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",PCT,4/12/2018,0640-020,12/3/1999,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614019,9/21/2000,581662,Yes
6330,96-T-096,Plant Chromosome Compositions and Methods,"09/531,120","6,972,197",*United States,US,3/17/2000,12/6/2005, ,,0640-022,Small,3/18/1999,,Yes,4/2/2019,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30002A,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",US Utility,4/12/2018,0640-022,3/18/2019,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614020,,581662,Yes
6331,96-T-096,Plant Chromosome Compositions And Methods,"11/117,187", ,*United States,US,4/28/2005,,US-2005-266560-A1,,0640-050,Small,3/18/1999,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30002B,"Gregory Copenhaver, Kevin Keith, Daphne Preuss",Continuation,4/12/2018,0640-050,3/18/2019,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614021,12/1/2005,581662,Yes
6332,96-T-096,Plants Modified with Mini-Chromosomes,2006/07333,2006/07333,South Africa,ZA,2/23/2005,2/27/2008, ,,0640-041,Small,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30003A-ZA,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Nationalized PCT,4/12/2018,0640-041,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614048,,581662,Yes
6333,96-T-096,Plants Modified with Mini-Chromosomes,"2,557,644",,Canada,CA,2/23/2005,, ,,0640-042,Large,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30002-CA,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Nationalized PCT,4/12/2018,0640-042,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614049,,581662,Yes
6334,96-T-096,Plants Modified with Mini-Chromosomes,PI0507934-9,,Brazil,BR,2/23/2005,,Journal No. 1906,,0640-043,Small,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30003A-BR,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Nationalized PCT,4/12/2018,0640-043,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614050,7/17/2007,581662,Yes
6335,96-T-096,Plants Modified with Mini-Chromosomes,PA/A/2006/009225,293082,Mexico,MX,2/23/2005,12/5/2011, ,,0640-044,Small,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30003A-MX,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Nationalized PCT,4/12/2018,0640-044,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614051,,581662,Yes
6336,96-T-096,Plants Modified with Mini-Chromosomes,2005217648,2005217648,Australia,AU,2/23/2005,12/1/2011, ,,0640-045,Small,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30003A-AU,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Nationalized PCT,4/12/2018,0640-045,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614052,,581662,Yes
6337,96-T-096,Plants Modified with Mini-Chromosomes,5480/DELNP/2006, ,India,IN,2/23/2005,, ,,0640-046,Small,2/23/2004,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30003A-IN,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Nationalized PCT,4/12/2018,0640-046,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614053,,581662,Yes
6338,96-T-096,Plants Modified with Mini-Chromosomes,2011204884,,Australia,AU,2/23/2005,, ,,0640-067,Small,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30003B-AU,"Gregory Copenhaver, Mich Hein, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Gary Rudgers, Helge Zieler",Divisional,4/12/2018,0640-067,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614054,,581662,Yes
6339,96-T-096,Plants Transformed with Mini-Chromosomes,"60/547,256", ,*United States,US,2/23/2004,, ,2/23/2004,0640-035,Small,2/23/2004,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30003,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Provisional,4/12/2018,0640-035,2/23/2005,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614055,,581662,Yes
6340,96-T-096,Plants Transformed with Mini-Chromosomes,PCT/US05/06505,,*United States,US,2/23/2005,, ,,0640-047,Small,2/23/2004,,No,2/4/2020,Expired - Inactive,"Marshall, Gerstein & Borun",,30003A-PC,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",PCT,4/12/2018,0640-047,8/23/2006,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614056,,581662,Yes
6341,96-T-096,Plants Transformed with Mini-Chromosomes,05724115.0EPO, ,European Patent Office (EPO),EP,2/23/2005,,1718754,,0640-048,Small,2/23/2004,,No,12/13/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30003A-EP,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-048,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614057,,581662,Yes
6342,96-T-096,Plants Transformed with Mini-Chromosomes,"10/590,546","8,729,341",*United States,US,2/23/2005,5/20/2014,US-2008-0060093-A1,,0640-053,Small,2/23/2004,,No,5/2/2022,Abandoned,"Marshall, Gerstein & Borun",,30003A,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Nationalized PCT,4/12/2018,0640-053,2/23/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614058,3/6/2008,581662,Yes
6343,96-T-096,Plants Transformed with Mini-Chromosomes,"12/718,794","8,350,120",*United States,US,3/5/2010,1/8/2013,US-2010-0235948-A1,,0640-061,Small,2/23/2004,,No,1/24/2020,Abandoned,"Marshall, Gerstein & Borun",,30003B,"Gregory Copenhaver, Rong Guan (Jim) Jin, Kevin Keith, Jennifer Mach, Daphne Preuss, Helge Zieler",Continuation,4/12/2018,0640-061,5/5/2025,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",614059,9/16/2010,581662,Yes
6344,96-T-097,"4-Substituted-1,2-naphthoquinones and Their Use in the Inhibition of Neoplastic Cell Growth","08/744,631","5,883,270",*United States,US,11/6/1996,3/16/1999,,,0641-001,None,2/20/1996,,No,4/12/2018,Abandoned,,,,"(Mary) Eileen Dolan, Benjamin Frydman, Lawrence Marton, Karen Neder, Donald Witiak",Continuation,4/12/2018,0641-001,2/20/2016,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",610189,,581663,Yes
6345,96-T-097,"4-Substituted-1,2-naphthoquinones and their Use in the Inhibition of Neoplastic Cell Growth","09/172,044","5,977,187",*United States,US,10/14/1998,11/2/1999,,,0641-003,None,2/20/1996,,No,4/12/2018,Abandoned,,,,"(Mary) Eileen Dolan, Benjamin Frydman, Lawrence Marton, Karen Neder, Donald Witiak",Divisional,4/12/2018,0641-003,2/20/2016,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",610190,,581663,Yes
6346,96-T-097,"Novel Ortho-Naphthoquinone Derivatives, Novel Synthesis Therefor, and Their use in the Inhibition of Neoplastic Cell Growth",EP0888326 A2,,European Patent Office (EPO),EP,2/20/1997,,,,0641-002,Small,2/20/1996,,No,4/12/2018,Abandoned,,,,"(Mary) Eileen Dolan, Benjamin Frydman, Andrew Geiser, Lawrence Marton, Karen Neder, Jerry Sun, Donald Witiak",Nationalized PCT,4/12/2018,0641-002,2/20/2017,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613731,,581663,Yes
6347,96-T-099,"Anti-Microbial Agents, Diagnostic Reagents, and Vaccines Based on Unique Apicomplexan Parasite Components","60/132,506", ,*United States,US,5/4/1999,, ,5/4/1999,0643-007,Small,5/4/1999,,Yes,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Provisional,4/12/2018,0643-007,5/4/2000,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610368,,581665,Yes
6348,96-T-099,"Anti-Microbial Agents, Diagnostic Reagents, and Vaccines based on Unique Apicomplexan Parasite Components","09/561,250",,*United States,US,4/27/2000,,,,0643-008,Small,7/19/1996,,No,4/12/2018,Released to Inventors,Barnes & Thornburg,"Martin, Alice",,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",US Utility,4/12/2018,0643-008,7/19/2016,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610369,,581665,Yes
6349,96-T-099,"Anti-Microbial Agents, Diagnostic Regaents, and Vaccines based on Unique Apicomplexan Parasite Components",PCT/US00/11478, ,*United States,US,4/27/2000,, ,4/27/2000,0643-009,Small,7/19/1996,,No,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"David Ferguson, Piotr Gornicki, Robert Haselkorn, Jennifer Johnson, Micheal Kirisitis, Russell Lyons, Douglas Mack, Rima McLeod, Ernest Mui, Craig Roberts, Fionna Roberts, Benjamin Samuel, Ellen Zuther",PCT,4/12/2018,0643-009,1/19/1999,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610370,,581665,Yes
6350,96-T-099,"Anti-Microbial Agents, Diagnostic Regaents, and Vaccines Based on Unique Apicomplexan Parasite Components","2,377,131",,Canada,CA,4/27/2000,,,,0643-010,Small,7/19/1996,,No,4/12/2018,Released to Inventors,Barnes & Thornburg,"Martin, Alice",,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Nationalized PCT,4/12/2018,0643-010,4/27/2020,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610371,,581665,Yes
6351,96-T-099,"Antimicrobial Agents, Diagnostic Reagents and Vaccines Based on Unique Apicomplexan Parasite Metabolic Pathways, Enzymes and Nucleic Acids","60/022,209", ,*United States,US,7/19/1996,, ,7/19/1996,0643-001,Small,7/19/1996,,Yes,4/28/2022,Released to Inventors,Brinks Gilson & Lione,,00003,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Provisional,4/12/2018,0643-001,7/19/1997,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610423,,581665,Yes
6352,96-T-099,"Antimicrobial Agents, Diagnostic Reagents, and Vaccines Based on Unique Apicomplexan Parasite Components",PCT/US97/12497, ,*United States,US,7/18/1997,,WO 98/03661,7/18/1997,0643-005,Small,7/19/1996,,No,4/28/2022,Released to Inventors,Barnes & Thornburg,"Rust, Mark", ,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",PCT,4/12/2018,0643-005,1/19/1999,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610424,1/29/1998,581665,Yes
6353,96-T-099,"Antimicrobial Agents, Diagnostic Reagents, and Vaccines Based on Unique Apicomplexan Parasite Components",97937983.1EPO, ,European Patent Office (EPO),EP,7/18/1997,,918868,,0643-006,Small,7/19/1996,,No,5/21/2018,Released to Inventors,,, ,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Nationalized PCT,4/12/2018,0643-006,7/18/2017,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610425,6/2/1999,581665,Yes
6354,96-T-099,"Antimicrobial Agents, Diagnostic REagents, and Vaccines Based on Unique Apicomplexan Parasite Components","09/631,594","6,737,237",*United States,US,8/3/2000,5/18/2004,,,0643-011,Small,5/4/1999,,No,4/12/2018,Released to Inventors,,,,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Continuation in Part,4/12/2018,0643-011,4/27/2019,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610426,,581665,Yes
6355,96-T-099,"Antimicrobial Agents, Diagnostic Reagents, and Vaccines Based on Unique Apicomplexan Parasite Metabolic Pathways, Enzymes, and Nucleic Acids","08/773,302",,*United States,US,12/23/1996,,,,0643-002,Small,7/19/1996,,No,4/12/2018,Released to Inventors,Brinks Gilson & Lione,,00004,"Jennifer Johnson, Rima McLeod, Craig Roberts, Fionna Roberts",Continuation in Part,4/12/2018,0643-002,7/19/2016,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610427,,581665,Yes
6356,96-T-099,Unique Apicomplexan Parasite Components,"60/040,849", ,*United States,US,3/17/1997,, ,3/17/1997,0643-003,Small,3/17/1997,,No,4/28/2022,Released to Inventors,Brinks Gilson & Lione,,00006,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Provisional,4/12/2018,0643-003,3/17/1998,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615148,,581665,Yes
6357,96-T-099,Unique Apicomplexan Parasite Metabolic Pathways,"60/049,620", ,*United States,US,6/13/1997,, ,6/13/1997,0643-004,Small,6/13/1997,,No,4/28/2022,Released to Inventors,Brinks Gilson & Lione,,00008,"Jennifer Johnson, Rima McLeod, Laurens Mets, Craig Roberts, Fionna Roberts",Provisional,4/12/2018,0643-004,6/13/1998,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",615149,,581665,Yes
6358,96-T-100,Apparatus and Method for Computerized Analysis of Interstitial Infiltrates in Chest Images Using Artificial Neural Networks,"08/758,438","5,873,824",*United States,US,11/29/1996,2/23/1999,,,0644-001,Small,11/29/1996,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",US Utility,4/12/2018,0644-001,11/29/2016,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610445,,581666,Yes
6359,96-T-100,Apparatus and Method for Computerized Analysis of Interstitial Infiltrates in Chest Images Using Artificial Neural Networks,307130/97,,Japan,JP,11/10/1997,,,,0644-002,Small,11/29/1996,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa","Foreign, Non-PCT",4/12/2018,0644-002,11/10/2017,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610446,,581666,Yes
6360,96-T-101,Method and System for Displaying Medical Images,"08/757,611","5,987,345",*United States,US,2/24/1997,11/16/1999,,,0645-001,Small,2/24/1997,,Yes,7/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Roger Engelmann, Kenneth Hoffmann, Heber MacMahon",US Utility,4/12/2018,0645-001,2/24/2017,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612362,,581667,Yes
6361,96-T-101,Method for Displaying Medical Images,312337/97,3993285,Japan,JP,11/13/1997,8/3/2007, ,,0645-002,Small,2/24/1997,,No,8/4/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Roger Engelmann, Kenneth Hoffmann, Heber MacMahon","Foreign, Non-PCT",4/12/2018,0645-002,11/13/2017,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612446,,581667,Yes
6362,96-T-105,Chelerythrine & Combination Therapy,"09/505,252",,*United States,US,2/15/2000,,,,0649-024,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-031,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Continuation,4/12/2018,0649-024,3/25/2017,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610838,,581671,Yes
6363,96-T-105,Chelerythrine and Radiation Combined  Tumor Therapy,98914302.9IE,EP 0 971 710 B1,Ireland,IE,3/25/1998,5/26/2004,,,0649-014,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-016,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-014,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610839,1/19/2000,581671,Yes
6364,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,"08/826,814","6,025,365",*United States,US,3/25/1997,2/15/2000,,,0649-001,Small,3/25/1997,,Yes,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-030,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",US Utility,4/12/2018,0649-001,3/25/2017,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610840,,581671,Yes
6365,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,10-545947,,Japan,JP,3/25/1998,,2001-51552,,0649-005,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-018,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-005,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610841,11/6/2001,581671,Yes
6366,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9PT,EP 0 971 710 B1,Portugal,PT,3/25/1998,5/26/2004,,,0649-010,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-026,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-010,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610843,1/19/2000,581671,Yes
6367,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9ES,2 218 814,Spain,ES,3/25/1998,5/26/2004,,,0649-011,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-011,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-011,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610844,1/19/2000,581671,Yes
6368,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9IT,EP 0 971 710 B1,Italy,IT,3/25/1998,5/26/2004,,,0649-015,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-017,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-015,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610845,1/19/2000,581671,Yes
6369,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9SE,EP 0 971 710 B1,Sweden,SE,3/25/1998,5/26/2004,,,0649-016,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-028,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-016,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610846,1/19/2000,581671,Yes
6370,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9CH,EP 0 971 710 B1,Switzerland,CH,3/25/1998,5/26/2004,,,0649-017,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-006,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-017,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610847,1/19/2000,581671,Yes
6371,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9NL,EP 0 971 710 B1,Netherlands,NL,3/25/1998,5/26/2004,,,0649-018,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-025,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-018,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610848,1/19/2000,581671,Yes
6372,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,98914302.9GB,EP 0 971 710 B1,United Kingdom,GB,3/25/1998,5/26/2004,,,0649-019,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-014,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-019,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610849,1/19/2000,581671,Yes
6373,96-T-105,Chelerythrine and Radiation Combined Tumor Therapy,PCT/US98/05842, ,*United States,US,3/25/1998,,WO 98/42339,3/25/1998,0649-021,Small,3/25/1997,,No,5/1/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-032,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",PCT,4/12/2018,0649-021,9/25/1999,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610850,10/1/1998,581671,Yes
6374,96-T-105,Chelerythrine-Based Therapies for Cancer,"09/637,816","6,426,351",*United States,US,8/11/2000,7/30/2002,,,0649-025,Small,8/11/2000,,Yes,5/1/2022,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9025-004,"Steven Chmura, (Mary) Eileen Dolan, Donald Kufe, Ralph Weichselbaum",US Utility,4/12/2018,0649-025,8/11/2020,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610851,,581671,Yes
6375,96-T-105,Chelerythrine-Based Therapies for Cancer,PCT/US01/25021, ,*United States,US,8/8/2001,,WO 02/13803 A3,8/8/2001,0649-026,Small,8/11/2000,,No,4/28/2022,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9025-005,"Steven Chmura, (Mary) Eileen Dolan, Donald Kufe, Ralph Weichselbaum",PCT,4/12/2018,0649-026,2/11/2003,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610852,2/21/2002,581671,Yes
6376,96-T-105,Chelerythrine-based Therapies for Cancer,01962027.7EPO, ,European Patent Office (EPO),EP,8/8/2001,,EP 1 309 350 A2,,0649-027,Small,8/11/2000,,No,5/21/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9025-003,"Steven Chmura, Donald Kufe, Bernard Roizman, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-027,8/8/2021,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610853,5/14/2003,581671,Yes
6377,96-T-105,Chelerythrine-based therapies for cancer.,"2,418,982",,Canada,CA,8/8/2001,,,,0649-028,Large,8/11/2000,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9025-002,"Steven Chmura, (Mary) Eileen Dolan, Donald Kufe, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-028,8/8/2021,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610854,,581671,Yes
6378,96-T-105,Chelerythrine-based therapies for cancer.,2001283243,,Australia,AU,8/8/2001,,,,0649-029,Small,8/11/2000,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9025-001,"Steven Chmura, (Mary) Eileen Dolan, Donald Kufe, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-029,8/8/2021,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610855,,581671,Yes
6379,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98804824.8,ZL98804824.8,China,CN,3/25/1998,10/27/2004,2001-521552,,0649-002,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-007,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-002,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615161,11/6/2001,581671,Yes
6380,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,"2,284,992",,Canada,CA,3/25/1998,,,,0649-003,Large,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-005,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-003,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615162,,581671,Yes
6381,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9RO,0971710,Romania,RO,3/25/1998,5/26/2004,,,0649-004,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-010,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-004,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615163,1/19/2000,581671,Yes
6382,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9BE,EP 0 971 710 B1,Belgium,BE,3/25/1998,5/26/2004,,,0649-006,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-004,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-006,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615164,1/19/2000,581671,Yes
6383,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9DK,EP 0 971 710 B1,Denmark,DK,3/25/1998,5/26/2004,,,0649-007,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-009,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-007,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615165,1/19/2000,581671,Yes
6384,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9FI,EP 0 971 710 B1,Finland,FI,3/25/1998,5/26/2004,,,0649-008,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-012,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-008,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615166,1/19/2000,581671,Yes
6385,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9FR,EP 0 971 710 B1,France,FR,3/25/1998,5/26/2004,,,0649-009,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-013,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-009,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615167,1/19/2000,581671,Yes
6386,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9DE,DE 698 24 165,Germany,DE,3/25/1998,5/26/2004,,,0649-012,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-008,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-012,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615168,1/19/2000,581671,Yes
6387,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9GR,30050004,Greece,GR,3/25/1998,5/26/2004,,,0649-013,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-015,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-013,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615169,1/19/2000,581671,Yes
6388,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,68693/98,737613,Australia,AU,3/25/1998,12/6/2001,WO 98/42339,,0649-020,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-003,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-020,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615170,10/1/1998,581671,Yes
6389,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9AT,EP 0 971 710 B1,Austria,AT,3/25/1998,5/26/2004,,,0649-022,Small,3/25/1997,,No,4/12/2018,Abandoned,Michael Best & Friedrich LLP,"Fahrlander, Jill",092234-9027-002,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Validated EPO,4/12/2018,0649-022,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615171,,581671,Yes
6390,96-T-105,Use of Chelerythrine and Radiation for Tumor Therapy,98914302.9EPO,EP 0 971 710 B1,European Patent Office (EPO),EP,3/25/1998,5/26/2004, ,,0649-023,Small,3/25/1997,,No,5/21/2018,Expired - Inactive,Michael Best & Friedrich LLP,"Welch, Teresa",092234-9027-010,"Steven Chmura, Donald Kufe, Jose Quintans, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0649-023,3/25/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",615172,1/19/2000,581671,Yes
6391,96-T-106,System for Surveillance of Spectral Signals,"08/970,873","6,240,372",*United States,US,11/14/1997,5/29/2001, ,,96-136-001,Large,11/14/1997,,Yes,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",US Utility,4/12/2018,96-136-001,11/14/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614815,,581672,Yes
6392,96-T-106,System for Surveillance of Spectral Signals,PCT/US98/23166, ,*United States,US,10/30/1998,,WO 99/26073,10/30/1998,96-136-002,Large,11/14/1997,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",PCT,4/12/2018,96-136-002,5/14/2000,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614816,5/27/1999,581672,Yes
6393,96-T-106,System for Surveillance of Spectral Signals,"2,309,271","2,309,271",Canada,CA,10/30/1998,7/11/2006, ,,96-136-003,Large,11/14/1997,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Nationalized PCT,4/12/2018,96-136-003,10/30/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614817,,581672,Yes
6394,96-T-106,System for Surveillance of Spectral Signals,12946/99,745828,Australia,AU,10/30/1998,7/25/2002,WO99/26073,,96-136-004,Large,11/14/1997,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Nationalized PCT,4/12/2018,96-136-004,10/30/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614818,4/11/2002,581672,Yes
6395,96-T-106,System for Surveillance of Spectral Signals,98956419.0EPO, ,European Patent Office (EPO),EP,10/30/1998,, ,,96-136-005,Large,11/14/1997,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Nationalized PCT,4/12/2018,96-136-005,10/30/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614819,8/30/2000,581672,Yes
6396,96-T-106,System for Surveillance of Spectral Signals,7005287/00,387457,"Korea, Republic of",KR,10/30/1998,6/2/2003,,,96-136-006,Large,11/14/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Nationalized PCT,4/12/2018,96-136-006,10/30/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614820,6/18/2003,581672,Yes
6397,96-T-106,System for Surveillance of Spectral Signals,2000-521386,,Japan,JP,10/30/1998,,,,96-136-007,Large,11/14/1997,,No,7/22/2021,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Nationalized PCT,4/12/2018,96-136-007,10/30/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614821,,581672,Yes
6398,96-T-106,System for Surveillance of Spectral Signals,"09/858,786","6,553,334",*United States,US,5/16/2001,4/22/2003,US-2002-004692-A1,,96-136-008,Small,11/14/1997,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Continuation,4/12/2018,96-136-008,11/14/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614822,4/11/2002,581672,Yes
6399,96-T-106,System for Surveillance of Spectral Signals,"10/155,155","6,804,628",*United States,US,5/28/2002,10/12/2004,US-2002-188423-A1,,96-136-009,Small,11/14/1997,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",US Utility,4/12/2018,96-136-009,11/14/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614823,12/14/2002,581672,Yes
6400,96-T-106,System for Surveillance of Spectral Signals,"10/771,168","6,999,899",*United States,US,2/2/2004,2/14/2006,US-2004-162685-A1,,96-136-010,Large,11/14/1997,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Cynthia Criss, Kenneth Gross, Stephan Wegerich, Alan Wilks",Continuation,4/12/2018,96-136-010,11/14/2017,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614824,8/19/2004,581672,Yes
6401,96-T-108,"O.sup.6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O.sup.6 -alkylguanine-DNA alkyltransferase depleting activity","07/616,913","5,352,669",*United States,US,11/21/1990,10/4/1994,,,0651-082,Small,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Continuation in Part,4/12/2018,0651-082,10/4/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613744,,581674,Yes
6402,96-T-108,O.sup.6 -substituted guanine compositions and methods for depleting O.sup.6,"08/255,190","5,691,307",*United States,US,6/7/1994,11/25/1997,,,0651-084,Small,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"Mi-Young Chae, (Mary) Eileen Dolan, Mark McDougall, Robert Moschel, Anthony Pegg",Continuation in Part,4/12/2018,0651-084,11/25/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613745,,581674,Yes
6403,96-T-108,O.sup.6 -substituted guanine compounds and methods for depleting O.sup.6 -alkylguanine-DNA alkyltransferase levels,"07/492,468","5,091,430",*United States,US,3/13/1990,2/25/1992,,,0651-081,Small,3/13/1990,,Yes,4/12/2018,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.",,,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",US Utility,4/12/2018,0651-081,3/13/2010,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613746,,581674,Yes
6404,96-T-108,O.sup.6 -substituted guanine compounds and methods for depleting O.sup.6 -alkylguanine-DNA alkyltransferase levels,"07/805,634","5,358,952",*United States,US,12/12/1991,10/25/1994,,,0651-083,Small,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-083,10/25/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613747,,581674,Yes
6405,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9EPO,EP0523100B1,European Patent Office (EPO),EP,3/13/1991,8/28/1996, ,,0651-004,None,3/13/1990,,No,5/21/2018,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.",, ,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-004,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613748,,581674,Yes
6406,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity","2,078,129","2,078,129",Canada,CA,3/13/1991,5/4/1999,,,0651-005,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-005,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613749,,581674,Yes
6407,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",75821/91,,Australia,AU,3/13/1991,,,,0651-006,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-006,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613750,,581674,Yes
6408,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",507224/91,,Japan,JP,3/13/1991,,,,0651-007,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-007,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613751,,581674,Yes
6409,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9AT,EP0523100B1,Austria,AT,3/13/1991,8/28/1996,,,0651-008,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-008,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613752,,581674,Yes
6410,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9BE,EP0523100B1,Belgium,BE,3/13/1991,8/28/1996,,,0651-010,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-010,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613753,,581674,Yes
6411,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9CH,EP0523100B1,Switzerland,CH,3/13/1991,8/28/1996,,,0651-011,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-011,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613754,,581674,Yes
6412,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9DE,EP0523100B1,Germany,DE,3/13/1991,8/28/1996,,,0651-012,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-012,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613755,,581674,Yes
6413,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9DK,EP0523100B1,Denmark,DK,3/13/1991,8/28/1996,,,0651-013,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-013,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613756,,581674,Yes
6414,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9ES,EP0523100B1,Spain,ES,3/13/1991,8/28/1996,,,0651-014,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-014,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613757,,581674,Yes
6415,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9FR,EP0523100B1,France,FR,3/13/1991,8/28/1996,,,0651-015,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-015,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613758,,581674,Yes
6416,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9GB,EP0523100B1,United Kingdom,GB,3/13/1991,8/28/1996,,,0651-016,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-016,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613759,,581674,Yes
6417,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9GR,3021277,Greece,GR,3/13/1991,8/28/1996,,,0651-017,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-017,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613760,,581674,Yes
6418,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9IT,EP0523100B1,Italy,IT,3/13/1991,8/28/1996,,,0651-018,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-018,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613761,,581674,Yes
6419,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9LU,EP0523100B1,Luxembourg,LU,3/13/1991,8/28/1996,,,0651-019,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-019,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613762,,581674,Yes
6420,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9SE,EP0523100B1,Sweden,SE,3/13/1991,8/28/1996,,,0651-020,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-020,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613763,,581674,Yes
6421,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",PCT/US91/01680, ,*United States,US,3/13/1991,, ,3/13/1991,0651-021,None,3/13/1990,,No,4/28/2022,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.",, ,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",PCT,4/12/2018,0651-021,9/13/1992,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613764,,581674,Yes
6422,96-T-108,"O6-Benzylated Guanine, Guanosine and 2'-Deoxyguanosine Compounds Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity",91906818.9NL,EP0523100B1,Netherlands,NL,3/13/1991,8/28/1996,,,0651-022,None,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-022,3/13/2011,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613765,,581674,Yes
6423,96-T-108,O6-Substituted Guanine Derivatives Possessing O6-Alkylguanine-DNA Alkyltransferase Depleting Activity Use in Enhancing the Therapeutic Effectiveness of Chemotherapeutic Alkylating Agents,"07/875,438",,*United States,US,4/29/1992,,,,0651-023,Large,3/13/1990,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Continuation in Part,4/12/2018,0651-023,3/13/2010,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613766,,581674,Yes
6424,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,"09/023,726","6,060,458",*United States,US,2/13/1998,5/9/2000,,,0651-032,None,2/13/1998,,Yes,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",US Utility,4/12/2018,0651-032,2/13/2018,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613770,,581674,Yes
6425,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,26721/99,742667,Australia,AU,2/12/1999,5/2/2002,,,0651-033,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-033,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613771,,581674,Yes
6426,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5EPO,1054890,European Patent Office (EPO),EP,2/12/1999,10/15/2003, ,,0651-034,Small,2/13/1998,,No,5/21/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-034,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613772,,581674,Yes
6427,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,PCT/US99/02963, ,*United States,US,2/12/1999,, ,2/12/1999,0651-035,Small,2/13/1998,,No,4/28/2022,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",PCT,4/12/2018,0651-035,8/13/2000,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613773,,581674,Yes
6428,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,2000-531461,,Japan,JP,2/12/1999,,,,0651-038,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-038,2/13/2018,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613774,,581674,Yes
6429,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,"2,320,288",,Canada,CA,2/12/1999,10/23/2000,,,0651-040,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-040,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613775,,581674,Yes
6430,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5CH,1054890,Switzerland,CH,2/12/1999,10/15/2003,,,0651-041,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-041,2/13/2018,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613776,,581674,Yes
6431,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5DE,1054890,Germany,DE,2/12/1999,10/15/2003,,,0651-042,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-042,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613777,,581674,Yes
6432,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5ES,1054890,Spain,ES,2/12/1999,10/15/2003,,,0651-043,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-043,2/13/2018,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613778,,581674,Yes
6433,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5FR,1054890,France,FR,2/12/1999,10/15/2003,,,0651-044,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-044,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613779,,581674,Yes
6434,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5GB,1054890,United Kingdom,GB,2/12/1999,10/15/2003,,,0651-045,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-045,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613780,,581674,Yes
6435,96-T-108,Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use,99906925.5IT,1054890,Italy,IT,2/12/1999,10/15/2003,,,0651-046,Small,2/13/1998,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-046,2/12/2019,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613781,,581674,Yes
6436,96-T-108,"Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase","09/590,187","6,303,604",*United States,US,7/31/1995,10/16/2001, ,6/9/2000,0651-037,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-037,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",613936,,581674,Yes
6437,96-T-108,Substituted 06-Benzylguanines and 6(4)-Benzyloxpyrimidines,"2,195,856", ,Canada,CA,7/31/1995,, ,7/31/1995,0651-026,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-026,7/31/2015,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614673,,581674,Yes
6438,96-T-108,Substituted 06-Benzylguanines and 6(4)-Benzyloxypyrimidines,"08/283,953","5,525,606",*United States,US,8/1/1994,6/11/1996, ,8/1/1994,0651-024,Small,8/1/1994,,Yes,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",US Utility,4/12/2018,0651-024,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614674,,581674,Yes
6439,96-T-108,Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines,"08/927,846","5,916,894",*United States,US,7/31/1995,6/29/1999, ,9/11/1997,0651-031,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-031,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614675,,581674,Yes
6440,96-T-108,Substituted benzyloxypyrimidines and their inactivation of O.sup.6 -alkylguanine-DNA alkyltransferase,"08/661,923","5,753,668",*United States,US,7/31/1995,5/19/1998, ,6/11/1996,0651-029,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-029,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614676,,581674,Yes
6441,96-T-108,Substituted O6-Benzyl-8-AZA-Guanines,"09/928,410","6,436,945",*United States,US,7/31/1995,8/20/2002,US 2002-0013299 A1,8/14/2001,0651-039,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.","Kilyk, John", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-039,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614677,1/31/2002,581674,Yes
6442,96-T-108,Substituted O6-Benzylguanines,"09/333,047","6,333,331",*United States,US,7/31/1995,12/25/2001, ,6/15/1999,0651-036,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-036,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614678,,581674,Yes
6443,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzylopyrmidines,32079/95,702711,Australia,AU,7/31/1995,6/17/1999, ,7/31/1995,0651-009,None,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.",, ,"(Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-009,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614679,,581674,Yes
6444,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,506694/96,3981407,Japan,JP,7/31/1995,,,,0651-002,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-002,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614681,,581674,Yes
6445,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9EPO,1142893,European Patent Office (EPO),EP,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-027,Small,8/1/1994,,No,4/12/2018,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-027,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614682,10/10/2001,581674,Yes
6446,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7EPO,775142,European Patent Office (EPO),EP,7/31/1995,10/24/2001, ,,0651-028,Small,8/1/1994,,No,5/21/2018,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-028,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614683,,581674,Yes
6447,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9GB,1142893,United Kingdom,GB,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-047,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-047,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614684,10/10/2001,581674,Yes
6448,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9DE,DE69533900T2,Germany,DE,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-048,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-048,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614685,10/10/2001,581674,Yes
6449,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9FR,1142893,France,FR,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-049,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-049,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614686,10/10/2001,581674,Yes
6450,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9CH,1142893,Switzerland,CH,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-050,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-050,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614687,10/10/2001,581674,Yes
6451,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9IT,1142893,Italy,IT,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-051,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-051,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614688,10/10/2001,581674,Yes
6452,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9ES,1142893,Spain,ES,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-052,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-052,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614689,10/10/2001,581674,Yes
6453,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9AT,1142893,Austria,AT,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-053,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-053,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614690,10/10/2001,581674,Yes
6454,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9BE,1142893,Belgium,BE,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-054,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-054,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614691,10/10/2001,581674,Yes
6455,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9IE,1142893,Ireland,IE,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-055,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-055,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614692,10/10/2001,581674,Yes
6456,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9PT,1142893,Portugal,PT,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-056,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-056,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614693,10/10/2001,581674,Yes
6457,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9DK,1142893,Denmark,DK,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-057,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-057,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614694,10/10/2001,581674,Yes
6458,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9GR,1142893,Greece,GR,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-058,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-058,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614695,10/10/2001,581674,Yes
6459,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9NL,1142893,Netherlands,NL,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-059,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-059,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614696,10/10/2001,581674,Yes
6460,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9LU,1142893,Luxembourg,LU,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-060,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-060,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614697,10/10/2001,581674,Yes
6461,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9MC,1142893,Monaco,MC,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-061,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-061,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614698,10/10/2001,581674,Yes
6462,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,01108585.9SE,1142893,Sweden,SE,7/31/1995,12/29/2004,EP 1 142 893 A1,,0651-062,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-062,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614699,10/10/2001,581674,Yes
6463,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7AT,775142,Austria,AT,7/31/1995,10/24/2001,,,0651-063,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-063,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614700,,581674,Yes
6464,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7CH,775142,Switzerland,CH,7/31/1995,10/24/2001,,,0651-064,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-064,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614701,,581674,Yes
6465,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7DE,775142,Germany,DE,7/31/1995,10/24/2001,,,0651-065,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-065,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614702,,581674,Yes
6466,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7ES,775142,Spain,ES,7/31/1995,10/24/2001,,,0651-066,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-066,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614703,,581674,Yes
6467,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7FR,775142,France,FR,7/31/1995,10/24/2001,,,0651-067,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-067,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614704,,581674,Yes
6468,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7GB,775142,United Kingdom,GB,7/31/1995,10/24/2001,,,0651-068,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-068,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614705,,581674,Yes
6469,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7IT,775142,Italy,IT,7/31/1995,10/24/2001,,,0651-069,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-069,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614706,,581674,Yes
6470,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7SE,775142,Sweden,SE,7/31/1995,10/24/2001,,,0651-070,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-070,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614707,,581674,Yes
6471,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7BE,775142,Belgium,BE,7/31/1995,10/24/2001,,,0651-071,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-071,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614708,,581674,Yes
6472,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7DK,775142,Denmark,DK,7/31/1995,10/24/2001,,,0651-072,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-072,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614709,,581674,Yes
6473,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7GR,775142,Greece,GR,7/31/1995,10/24/2001,,,0651-073,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-073,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614710,,581674,Yes
6474,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7IE,775142,Ireland,IE,7/31/1995,10/24/2001,,,0651-074,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-074,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614711,,581674,Yes
6475,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7LU,775142,Luxembourg,LU,7/31/1995,10/24/2001,,,0651-075,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-075,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614712,,581674,Yes
6476,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7MC,775142,Monaco,MC,7/31/1995,10/24/2001,,,0651-076,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-076,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614713,,581674,Yes
6477,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7NL,775142,Netherlands,NL,7/31/1995,10/24/2001,,,0651-077,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-077,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614714,,581674,Yes
6478,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,95928237.7PT,775142,Portugal,PT,7/31/1995,10/24/2001,,,0651-078,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Validated EPO,4/12/2018,0651-078,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614715,,581674,Yes
6479,96-T-108,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,2006-273447,,Japan,JP,7/31/1995,,,,0651-080,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-080,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614716,,581674,Yes
6480,96-T-108,Substituted O6-Benzylguanines and 7- or 9- substituted 8-aza-06-Benzylguanines,04030121.0EPO,1142893,European Patent Office (EPO),EP,7/31/1995,,,,0651-079,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier",,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-079,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614717,,581674,Yes
6481,96-T-108,"Substitutes O.sup.6 -Benzylguanines, Compositions, and Methods of Using Same",PCT/US95/09702,,*United States,US,7/31/1995,,WO 96/04281,,0651-025,Small,8/1/1994,,No,2/4/2020,Expired - Inactive,"Leydig, Voit & Mayer, Ltd.",,,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",PCT,4/12/2018,0651-025,2/1/1997,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614718,2/15/1996,581674,Yes
6482,96-T-108,"Substitutes O.sup.6 -Benzylguanines, Compositions, and Methods of Using Same","08/849,223","5,958,932",*United States,US,7/31/1995,9/28/1999,,,0651-030,Small,8/1/1994,,No,4/12/2018,Abandoned,"Leydig, Voit & Mayer, Ltd.",,,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Nationalized PCT,4/12/2018,0651-030,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614719,,581674,Yes
6483,96-T-109,Substituted O6-Benzylguanines and 6(4)-Benzyloxypyrimidines,"09/318,238","6,172,070",*United States,US,7/31/1995,1/9/2001, ,5/25/1999,0651-001,Small,8/1/1994,,No,4/28/2022,Abandoned,"Leydig, Voit & Mayer, Ltd.","Pillai, Xavier", ,"Mi-Young Chae, (Mary) Eileen Dolan, Robert Moschel, Anthony Pegg",Divisional,4/12/2018,0651-001,8/1/2014,"Dembo, Anna",(Mary) Eileen Dolan,"Tennant, Thelma",614680,,581675,Yes
6484,97-T-018,Method to Identify Specific Inhibitors of IMP Dehydrogenase,"08/997,758","6,153,398",*United States,US,12/24/1997,11/28/2000, ,12/24/1997,97-053-001,None,12/24/1997,,Yes,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"Frank Collart, Eliezer Huberman",US Utility,4/12/2018,97-053-001,12/24/2017,"Ginsburg, Eric",Frank Collart,"Tennant, Thelma",612558,11/28/2000,581093,Yes
6485,97-T-026,Bifunctional phenyl monophosphonic/sulfonic acid ion exchange resin and process for using the same,"09/221,446","6,232,353",*United States,US,12/28/1998,5/15/2001, ,12/28/1998,97-107-001,Small,7/2/1998,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly",Continuation in Part,4/12/2018,97-107-001,7/2/2018,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610698,,581101,Yes
6486,97-T-026,Bifunctional Phenyl Monophosphonic/Sulfonic Acid Ion Exchange Resin and Process for Using the Same,000621-1999,3471,Peru,PE,7/2/1999,3/31/2004, ,7/2/1999,97-107-004,Small,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly","Foreign, Non-PCT",4/12/2018,97-107-004,7/2/2019,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610700,,581101,Yes
6487,97-T-026,Bifunctional Phenyl Monophosphonic/Sulfonic Acid Ion Exchange Resin and Process for Using the Same,PCT/US99/15018, ,*United States,US,7/2/1999,,WO 00/01458,7/2/1999,97-107-005,Small,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Michael Gula, Phil Horwitz, C. Shelly, Xue Sui",PCT,4/12/2018,97-107-005,1/2/2001,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610701,1/13/2000,581101,Yes
6488,97-T-026,Bifunctional Phenyl Monophosphonic/Sulfonic Acid Ion Exchange Resin and Process for Using the Same,54579/99,758853,Australia,AU,7/2/1998,7/17/2003,WO 00/01458,7/2/1999,97-107-007,Small,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly, Song Xue",Nationalized PCT,4/12/2018,97-107-007,7/2/2019,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610702,1/13/2000,581101,Yes
6489,97-T-026,Bifunctional Phenyl Monophosphonic/Sulfonic Acid Ion Exchange Resin and Process for Using the Same,"09/850,474","6,488,859",*United States,US,7/2/1998,12/3/2002,US-2001-052496-A1,5/7/2001,97-107-008,Small,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Michael Gula, James Harvey, Phil Horwitz, C. Shelly, Xue Sui",Continuation,4/12/2018,97-107-008,12/28/2018,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610703,12/20/2001,581101,Yes
6490,97-T-026,Bifunctional Phenyl Monophosphonic/Sulfonic Acid Ion Exchange Resin and Process for Using the Same,1468-99,1468-99,Chile,CL,7/2/1999,3/31/2004, ,7/2/1999,97-107-009,Small,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly","Foreign, Non-PCT",4/12/2018,97-107-009,7/2/2019,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610705,,581101,Yes
6491,97-T-026,Bifunctional Phenyl Monophosphonic/Sulfonic Acid Ion Exchange Resin and Process for Using the Same ANL Case No. 97-107,"2,336,355","2,336,355",Canada,CA,7/2/1999,9/19/2006,2000/001458,7/2/1999,97-107-003,None,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly, Song Xue",Nationalized PCT,4/12/2018,97-107-003,7/2/2019,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610706,1/13/2000,581101,Yes
6492,97-T-026,Bifunctional Phenyl Monophosphonic/Sulphonic Acid Ion Exchange Resin and Process for Using the Same,99940797.6GB, ,United Kingdom,GB,2/2/1999,2/27/2002, ,2/2/1999,97-107-002,Small,7/2/1998,,No,4/28/2022,Abandoned,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly, Song Xue",Validated EPO,4/12/2018,97-107-002,7/2/2019,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610707,,581101,Yes
6493,97-T-026,Bifunctional Phenyl Monophosphonic/Sulphonic Acid Ion Exchange Resin and Process for Using the Same,2000/7801,2000/7801,South Africa,ZA,7/2/1999,2/27/2002, ,7/2/1999,97-107-006,Small,7/2/1998,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Spiro Alexandratos, Renato Chiarizia, Phil Horwitz, C. Shelly, Song Xue","Foreign, Non-PCT",4/12/2018,97-107-006,7/2/2019,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610708,,581101,Yes
6494,97-T-028,Alkaline Earth Cation Extraction from Acid Solution,"09/695,126","6,511,603",*United States,US,10/24/2000,1/28/2003, ,10/24/2000,97-135-001,Small,10/24/2000,2/18/2022,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Mark Dietz, Phil Horwitz",US Utility,4/12/2018,97-135-001,8/8/2021,"Hwang, Luke",Phil Horwitz,"Unassigned, Unassigned",610301,,581103,Yes
6495,97-T-042,Quaternary Derivatives of Noroxymorphone Which Relieve Nausea and Emesis,"06/837,399","4,719,215",*United States,US,3/7/1986,1/12/1988, ,3/7/1986,0006.2-001,None,3/7/1986,,Yes,4/28/2022,Expired - Inactive,"Christie, Parker & Hale",, ,"Leon Goldberg, Jonathan Moss",US Utility,4/12/2018,0006.2-001,1/11/2003,"Dembo, Anna",Leon Goldberg,"Tennant, Thelma",614257,,581691,Yes
6496,97-T-043,Herpes Simplex Virus U S 3 and ICP4 as Inhibitors of Apoptosis,PCT/US98/07573, ,*United States,US,4/16/1998,10/22/1998,WO 98/46637,4/16/1998,0668-003,Small,4/16/1997,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Rosario Leopardi, Bernard Roizman",PCT,4/12/2018,0668-003,10/16/1999,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611796,10/22/1998,581692,Yes
6497,97-T-043,Herpes Simplex Virus Us3 and ICP4 as Inhibitors of Apoptosis,"08/843,659","6,218,103",*United States,US,4/16/1997,4/17/2001,,,0668-001,Small,4/16/1997,,Yes,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",US Utility,4/12/2018,0668-001,4/16/2017,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611797,,581692,Yes
6498,97-T-043,Herpes Simplex Virus US3 and ICP4 as Inhibitors of Apoptosis,"2,286,859",,Canada,CA,4/16/1998,,,,0668-002,Large,4/16/1997,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",Nationalized PCT,4/12/2018,0668-002,4/16/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611798,,581692,Yes
6499,97-T-043,Herpes Simplex Virus Us3 and ICP4 as Inhibitors of Apoptosis,98918236.5EPO,975784,European Patent Office (EPO),EP,4/16/1998,2/2/2000, ,,0668-004,Small,4/16/1997,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Rosario Leopardi, Bernard Roizman",Nationalized PCT,4/12/2018,0668-004,4/16/2018,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611799,,581692,Yes
6500,97-T-043,Herpes Simplex Virus US3 and ICP4 as Inhibitors of Apoptosis,"09/837,861",,*United States,US,4/17/2001,,,,0668-005,Small,4/16/1997,,No,12/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Rosario Leopardi, Bernard Roizman",US Utility,4/12/2018,0668-005,4/16/2017,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",611800,,581692,Yes
6501,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,"60/048,141", ,*United States,US,5/30/1997,, ,5/30/1997,0669-001,Small,5/30/1997,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Mark Abe, Dennis Hallahan, Subbulakshmi Virudachalam",Provisional,4/12/2018,0669-001,5/30/1998,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613867,,581693,Yes
6502,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,PCT/US98/10913, ,*United States,US,5/29/1998,,WO98/53852,5/29/1998,0669-002,Small,5/30/1997,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Dennis Hallahan, Subbulakshmi Virudachalam",PCT,4/12/2018,0669-002,11/30/1999,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613868,,581693,Yes
6503,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,"2,290,563",,Canada,CA,5/29/1998,,,,0669-003,Small,5/30/1997,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Dennis Hallahan, Subbulakshmi Virudachalam",Nationalized PCT,4/12/2018,0669-003,5/29/2018,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613869,,581693,Yes
6504,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,98937941.7DE,EP 0 986 401 B1,Germany,DE,5/29/1998,2/25/2004,,,0669-004,Small,5/30/1997,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Dennis Hallahan, Subbulakshmi Virudachalam",Validated EPO,4/12/2018,0669-004,5/29/2018,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613870,,581693,Yes
6505,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,98937941.7FR,EP 0 986 401 B1,France,FR,5/29/1998,2/25/2004,,,0669-005,Small,5/30/1997,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Dennis Hallahan, Subbulakshmi Virudachalam",Validated EPO,4/12/2018,0669-005,5/29/2018,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613871,,581693,Yes
6506,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,"09/087,427",,*United States,US,5/29/1998,,,,0669-006,Small,5/30/1997,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Mark Abe, Dennis Hallahan, Subbulakshmi Virudachalam",US Utility,4/12/2018,0669-006,5/30/2017,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613872,,581693,Yes
6507,97-T-044,P-Selectin Translocation to Vascular Epithelial Lumen by Ionizing Radiation,98937941.7EPO,EP 0 986 401 B1,European Patent Office (EPO),EP,5/29/1998,2/25/2004, ,,0669-008,Small,5/30/1997,,No,5/21/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Dennis Hallahan, Subbulakshmi Virudachalam",Nationalized PCT,4/12/2018,0669-008,5/29/2018,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613873,,581693,Yes
6508,97-T-044,P-Selecting Translocation to Vascular Epithelial Lumen by Ionizing Radiation,98937941.7GB,EP 0 986 401 B1,United Kingdom,GB,5/29/1998,2/25/2004,,,0669-007,Small,5/30/1997,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Dennis Hallahan, Subbulakshmi Virudachalam",Validated EPO,4/12/2018,0669-007,5/29/2018,"Unassigned, Unassigned",Dennis Hallahan,"Unassigned, Unassigned",613874,,581693,Yes
6509,97-T-046,Fast Spectroscopic Imaging System,"09/003,250","6,037,772",*United States,US,1/6/1998,3/14/2000, ,1/6/1998,0671-001,Small,1/6/1998,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Cohen, Eric", ,"Gregory Karczmar, David Kovar",US Utility,4/12/2018,0671-001,1/6/2018,"Cox, Ben",Gregory Karczmar,"Smith, Dane",611572,,581695,Yes
6510,97-T-048,"Method, Apparatus, and Storage Medium for Detection of Nodules in Biological Tissue Using Wavelet Snakes to Characterize Features in Radiographic Images","08/900,191","6,078,680",*United States,US,7/25/1997,6/20/2000, ,,0673-001,Small,7/25/1997,7/16/2012,Yes,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Yali Amit, Kunio Doi, Shigehiko Katsuragawa, Hiroyuki Yoshida",US Utility,4/12/2018,0673-001,7/25/2017,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612561,,581697,Yes
6511,97-T-048,Wavelet Snake Technique for Discrimination of Nodules and False Positives in Digital Radiographs,PCT/US98/15278, ,*United States,US,7/24/1998,2/4/1999,WO99/05639,7/24/1998,0673-002,Large,7/25/1997,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Yali Amit, Kunio Doi, Shigehiko Katsuragawa, Hiroyuki Yoshida",PCT,4/12/2018,0673-002,1/25/2000,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",615393,2/4/1999,581697,Yes
6512,97-T-049,Large Magnetoresist in Non-Magnetic Silver Chalcogenides and New Class of Magnetoresistive Compounds,"60/058,704", ,*United States,US,9/12/1997,, ,9/12/1997,0674-001,Small,9/12/1997,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Anke Husmann, David Price, Thomas Rosenbaum, Marie Saboungi, Rong Xu",Provisional,4/12/2018,0674-001,9/12/1998,"Ginsburg, Eric",Thomas Rosenbaum,"Juggernauth, Anne",612071,,581698,Yes
6513,97-T-051,Methods for Improving the Accuracy in Differential Diagnosis in Radiologic Examinations,2000-504441,,Japan,JP,1/25/2000,,2001-511372,,0676-004,Small,7/25/1997,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kazuto Ashizawa, Kunio Doi, Chunsheng Jiang, Robert ""Bob"" Nishikawa",Nationalized PCT,4/12/2018,0676-004,1/25/2020,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613209,8/14/2001,581700,Yes
6514,97-T-051,Methods for Improving the Accuracy in Differential Diagnosis on Radiologic Examinations,"08/900,361","6,058,322",*United States,US,7/25/1997,5/2/2000,,,0676-001,Small,7/25/1997,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kazuto Ashizawa, Kunio Doi, Yulei Jiang, Robert ""Bob"" Nishikawa",US Utility,4/12/2018,0676-001,7/25/2017,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613210,,581700,Yes
6515,97-T-051,Methods for Improving the Accuracy in Differential Diagnosis on Radiologic Examinations,PCT/US98/15154, ,*United States,US,7/24/1998,,WO 99/05503,7/24/1998,0676-002,Small,7/25/1997,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kazuto Ashizawa, Kunio Doi, Yulei Jiang, Robert ""Bob"" Nishikawa",PCT,4/12/2018,0676-002,11/2/2002,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613211,2/4/1999,581700,Yes
6516,97-T-051,Methods for Improving the Accuracy in Differential Diagnosis on Radiologic Examinations,98936974.9EPO, ,European Patent Office (EPO),EP,7/24/1998,,0993269,,0676-003,Small,7/25/1997,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kazuto Ashizawa, Kunio Doi, Yulei Jiang, Robert ""Bob"" Nishikawa",Nationalized PCT,4/12/2018,0676-003,7/24/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",613212,4/19/2000,581700,Yes
6517,97-T-052,Method for Detecting Interval Changes in Radiographs,PCT/US98/15171, ,*United States,US,7/24/1998,,WO 99/05641,7/24/1998,0677-002,Large,7/25/1997,,No,5/1/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",PCT,4/12/2018,0677-002,1/25/2000,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612438,2/4/1999,581701,Yes
6518,97-T-052,Method for Detecting Interval Changes in Radiographs,98936980.6EPO, ,European Patent Office (EPO),EP,7/24/1998,,WO 0998721,,0677-003,Large,7/25/1997,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",Nationalized PCT,4/12/2018,0677-003,7/24/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612439,5/10/2000,581701,Yes
6519,97-T-052,Method for Detecting Interval Changes in Radiographs,2000-504546,"4,718,003",Japan,JP,1/25/2000,4/8/2011,2001-511570,,0677-004,Large,7/25/1997,,No,1/20/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",Nationalized PCT,4/12/2018,0677-004,1/25/2020,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612440,8/14/2001,581701,Yes
6520,97-T-052,Method of Detecting Interval Changes in Chest Radiographs Utilizing Temporal Subtraction Combined with Automated Initial Matching of Blurred Low Resolution Images,"08/900,362","5,982,915",*United States,US,7/25/1997,11/9/1999, ,,0677-001,Large,7/25/1997,7/25/2017,Yes,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",US Utility,4/12/2018,0677-001,7/25/2017,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612519,,581701,Yes
6521,97-T-055,Method and System  for the Segmentation and Classification of Lesions,"09/131,162","6,138,045",*United States,US,8/7/1998,10/24/2000, ,,0680-001,Small,8/7/1998,8/7/2018,Yes,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Maryellen Giger, Matthew Kupinski",US Utility,4/12/2018,0680-001,8/7/2018,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612319,,581704,Yes
6522,97-T-055,Method and System  for the Segmentation and Classifications of Lesions,PCT/US99/16706, ,*United States,US,8/6/1999,,WO 00/10457,8/6/1999,0680-002,Small,8/7/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Matthew Kupinski",PCT,4/12/2018,0680-002,2/7/2001,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612320,3/2/2000,581704,Yes
6523,97-T-055,Method and System for Segmentation and Classification of Lesions,55436/99, ,Australia,AU,8/6/1999,, ,,0680-006,Small,8/7/1998,,No,8/4/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Matthew Kupinski",Nationalized PCT,4/12/2018,0680-006,8/6/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612379,,581704,Yes
6524,97-T-055,Method and System for the Segmentation and Classification of Lesions,"2,339,797", ,Canada,CA,8/6/1999,, ,,0680-003,Large,8/7/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Matthew Kupinski",Nationalized PCT,4/12/2018,0680-003,8/6/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612416,,581704,Yes
6525,97-T-055,Method and System for the Segmentation and Classification ofn Lesions,99941965.8EPO, ,European Patent Office (EPO),EP,8/6/1999,,EP 1 102 562 A1,,0680-004,Small,8/7/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Matthew Kupinski",Nationalized PCT,4/12/2018,0680-004,8/6/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612417,5/30/2001,581704,Yes
6526,97-T-055,Method and System for the Segmentation and Classification ofn Lesions,2000-565785, ,Japan,JP,8/6/1999,,2002-523123,,0680-005,Small,8/7/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Matthew Kupinski",Nationalized PCT,4/12/2018,0680-005,8/6/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612418,7/30/2002,581704,Yes
6527,97-T-056,Method and System for the Automated Analysis of Lesions in Magnetic Resonance Images,PCT/US98/15165, ,*United States,US,7/24/1998,,WO 99/04690,7/24/1998,0683-002,Small,7/25/1997,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",PCT,4/12/2018,0683-002,1/25/2000,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612385,2/4/1999,581705,Yes
6528,97-T-056,"Method, Computer Program Product, and System for the Automated Analysis of Lesions in Magnetic Resonance, Mammogram and Ultrasound Images","08/900,188","6,317,617",*United States,US,7/25/1997,11/13/2001, ,,0683-001,Small,7/25/1997,,Yes,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",US Utility,4/12/2018,0683-001,7/25/2017,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612562,,581705,Yes
6529,97-T-057,Method and System for the Segmentation of Lung Regions in Lateral Chest Radiographs,"08/900,189",,*United States,US,7/25/1997,,,,0684-001,Small,7/25/1997,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Maryellen Giger",US Utility,4/12/2018,0684-001,7/25/2017,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612419,,581706,Yes
6530,97-T-057,Method and System for the Segmentation of Lung Regions in Lateral Chest Radiographs,"09/471,088","6,335,980",*United States,US,12/23/1999,1/1/2002,,,0684-002,Small,7/25/1997,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Maryellen Giger, Heber MacMahon",Continuation,4/12/2018,0684-002,7/25/2017,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612420,,581706,Yes
6531,97-T-057,Method and System for the Segmentation of Lung Regions in Lateral Chest Radiographs,PCT/US98/15351, ,*United States,US,7/24/1998,2/4/1999,WO 99/05640,7/24/1998,0684-003,Small,7/25/1997,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger",PCT,4/12/2018,0684-003,1/25/2000,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612421,2/4/1999,581706,Yes
6532,97-T-057,Method and System for the Segmentation of Lung Regions in lAteral Chest Radiographs,98937064.8EPO, ,European Patent Office (EPO),EP,7/24/1998,,0998719,,0684-004,Small,7/25/1997,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger",Nationalized PCT,4/12/2018,0684-004,7/24/2018,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612422,5/10/2000,581706,Yes
6533,97-T-057,Methods & System for the Segmentation of Lung Regions in Lateral Chest Radiographs,2000-504545,,Japan,JP,1/25/2000,,2001-511374,,0684-005,Small,7/25/1997,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Samuel Armato, Maryellen Giger",Nationalized PCT,4/12/2018,0684-005,1/25/2020,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612603,8/14/2001,581706,Yes
6534,97-T-058,Method and System for the Automated Delineation of Lung Regions and Costophrenic Angles in Chest Radiographs,"09/028,518","6,282,307",*United States,US,2/23/1998,8/28/2001, ,,0685-001,Small,2/23/1998,2/23/2018,Yes,5/7/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",US Utility,4/12/2018,0685-001,2/23/2018,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612388,,581707,Yes
6535,97-T-058,Method and System for the Automated Delineation of Lung Regions and Costophrenic Angles in Chest Radiographs,PCT/US99/03287, ,*United States,US,2/23/1999,,WO 99/42031,2/23/1999,0685-002,Small,2/23/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",PCT,4/12/2018,0685-002,8/23/2000,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612389,8/16/1999,581707,Yes
6536,97-T-058,Method and System for the Automated Delineation of Lung Regions and Costophrenic Angles in Chest Radiographs,2000-532053, ,Japan,JP,2/23/1999,,2002-503861,,0685-003,Small,2/23/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0685-003,2/23/2019,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612390,2/5/2002,581707,Yes
6537,97-T-058,Method and System for the Automated Delineation of Lung Regions and Costophrenic Angles in Chest Radiographs,99908179.7EPO, ,European Patent Office (EPO),EP,2/23/1999,,1056390,,0685-004,Small,2/23/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Nationalized PCT,4/12/2018,0685-004,2/23/2019,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612391,12/6/2000,581707,Yes
6538,97-T-058,Method and System for the Automated Delineation of Lung Regions and Costophrenic Angles in Chest Radiographs,"10/283,044","6,724,925",*United States,US,10/30/2002,4/20/2004,US-2003-053674-A1,,0685-006,Small,2/23/1998,,No,5/7/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Continuation,4/12/2018,0685-006,2/23/2018,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612392,3/20/2003,581707,Yes
6539,97-T-058,Method and System for the Automated Delineation of Lung Regions Regions and Costophrenic Angles in Chest Radiographs,"09/842,860","6,483,934",*United States,US,4/27/2001,11/19/2002,US 2001-0021264 A1,,0685-005,Large,2/23/1998,12/15/2014,No,5/7/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Samuel Armato, Maryellen Giger, Heber MacMahon",Divisional,4/12/2018,0685-005,2/23/2018,"Ginsburg, Eric",Samuel Armato,"Juggernauth, Anne",612393,9/13/2001,581707,Yes
6540,97-T-059,Method and System for the Computerized Assessment of Breast Cancer Risk,"09/092,004","6,282,305",*United States,US,6/5/1998,8/28/2001, ,6/5/1998,0681-001,Large,6/5/1998,6/5/2018,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo",US Utility,4/12/2018,0681-001,6/5/2018,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612401,,581708,Yes
6541,97-T-059,Method and System for the Computerized Assessment of Breast Cancer Risk,PCT/US99/11794, ,*United States,US,6/4/1999,,WO 99/63480,6/4/1999,0681-002,Small,6/5/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo",PCT,4/12/2018,0681-002,12/5/2000,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612402,12/9/1999,581708,Yes
6542,97-T-059,Method and System for the Computerized Assessment of Breast Cancer Risk,2000-552624,,Japan,JP,6/4/1999,,2002-517836,,0681-003,Small,6/5/1998,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Maryellen Giger, Zhimin Huo",Nationalized PCT,4/12/2018,0681-003,6/4/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612403,6/18/2002,581708,Yes
6543,97-T-059,Method and System for the Computerized Assessment of Breast Cancer Risk,99955351.4EPO, ,European Patent Office (EPO),EP,6/4/1999,,1082695,,0681-004,Small,6/5/1998,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo",Nationalized PCT,4/12/2018,0681-004,6/4/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612404,3/14/2001,581708,Yes
6544,97-T-059,Method and System for the Computerized Assessment of Breast Cancer Risk,"2,334,227",,Canada,CA,6/4/1999,,,,0681-005,Small,6/5/1998,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Maryellen Giger, Zhimin Huo",Nationalized PCT,4/12/2018,0681-005,6/4/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612405,,581708,Yes
6545,97-T-060,Method and System for the Automated Analysis of Lesions in Ultrasound Images,"08/900,192","5,984,870",*United States,US,7/25/1997,11/16/1999, ,,0682-001,Small,7/25/1997,7/25/2017,Yes,8/4/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Hania Al-Hallaq, Ulrich Bick, Maryellen Giger, Dulcy Wolverton",US Utility,4/12/2018,0682-001,7/25/2017,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612386,,581709,Yes
6546,97-T-060,Method and System for the Automated Analysis of Lesions in Ultrasound Images,PCT/US98/15166, ,*United States,US,7/24/1998,2/4/1999,WO 99/04680,7/24/1998,0682-002,Large,7/25/1997,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Hania Al-Hallaq, Ulrich Bick, Maryellen Giger, Dulcy Wolverton",PCT,4/12/2018,0682-002,1/25/2000,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612387,2/4/1999,581709,Yes
6547,97-T-064,Methods and Compositions for Modulation of Growth Response,"60/022,124", ,*United States,US,7/18/1996,, ,7/18/1996,0688-001,None,7/18/1996,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Donald Kufe, Ralph Weichselbaum, Chun-Su Yuan",Provisional,4/12/2018,0688-001,7/18/1997,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",612813,,581713,Yes
6548,97-T-066,Light Transmission Device,"09/875,820","6,467,916",*United States,US,8/24/1998,10/22/2002,,,0690-007,Small,7/25/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",US Utility,4/12/2018,0690-007,7/25/2017,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",612079,,581715,Yes
6549,97-T-066,Light-Transmission Device,"09/122,136",,*United States,US,7/24/1998,,,,0690-003,Small,7/25/1997,,Yes,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",US Utility,4/12/2018,0690-003,7/25/2017,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",612080,,581715,Yes
6550,97-T-066,Light-Transmission Device,"09/559,623",,*United States,US,4/27/2000,,,,0690-008,Small,7/24/1998,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Continuation,4/12/2018,0690-008,8/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",612081,,581715,Yes
6551,97-T-066,Nontracking solar concentrators,PA/A/2000/000881,239885,Mexico,MX,7/25/1998,8/30/2006,,,0690-001,Small,7/25/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0690-001,7/25/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613705,,581715,Yes
6552,97-T-066,Nontracking Solar Concentrators,"60/053,764", ,*United States,US,7/25/1997,, ,7/25/1997,0690-002,Small,7/25/1997,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Harald Ries, Roland Winston",Provisional,4/12/2018,0690-002,7/25/1998,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613706,,581715,Yes
6553,97-T-066,Nontracking Solar Concentrators,PCT/US98/15443, ,*United States,US,7/24/1998,,WO 99/05462,7/24/1998,0690-004,Small,7/25/1997,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Harald Ries, Roland Winston",PCT,4/12/2018,0690-004,1/25/2000,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613707,2/4/1999,581715,Yes
6554,97-T-066,Nontracking Solar Concentrators,98936007.8EPO,1007890,European Patent Office (EPO),EP,7/24/1998,9/27/2007, ,,0690-005,Small,7/25/1997,,No,5/21/2018,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0690-005,7/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613708,,581715,Yes
6555,97-T-066,Nontracking solar concentrators,AU199885135B2,745347,Australia,AU,7/24/1998,7/4/2002,,,0690-006,Small,7/25/1997,,No,2/11/2020,Abandoned,Foley & Lardner,,,"Harald Ries, Roland Winston",Nationalized PCT,4/12/2018,0690-006,7/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613709,2/16/1999,581715,Yes
6556,97-T-066,Nontracking Solar Concentrators,98936007.8ES,1007890,Spain,ES,7/24/1998,9/7/2007,,,0690-009,Small,7/25/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0690-009,7/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613710,,581715,Yes
6557,97-T-066,Nontracking Solar Concentrators,98936007.8FR,1007890,France,FR,7/24/1998,9/27/2007,,,0690-010,Small,7/25/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0690-010,7/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613711,,581715,Yes
6558,97-T-066,Nontracking Solar Concentrators,98936007.8GR,3064222,Greece,GR,7/24/1998,1/7/2008,,,0690-011,Small,7/25/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0690-011,7/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613712,,581715,Yes
6559,97-T-066,Nontracking Solar Concentrators,98936007.8IT,1007890,Italy,IT,7/24/1998,9/27/2007,,,0690-012,Small,7/25/1997,,No,4/12/2018,Abandoned,Foley & Lardner,"Rechtin, Michael",,"Harald Ries, Roland Winston",Validated EPO,4/12/2018,0690-012,7/24/2018,"Ginsburg, Eric",Roland Winston,"Juggernauth, Anne",613713,,581715,Yes
6560,97-T-067,Combination of Antigen Pulsed APCS and Interleukin 12 for Tumor and Viral Therapy,199938659,767208,Australia,AU,4/23/1999,2/19/2004,WO 99/53949,,0691-006,Large,4/23/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Francesca Fallarino, Thomas Gajewski",Nationalized PCT,4/12/2018,0691-006,4/23/2019,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610924,10/28/1999,581716,Yes
6561,97-T-067,Combination of Antigen Pulsed APCS and Interleukin 12 for Tumor and Viral Therapy,PA/A/2000/010378,,Mexico,MX,10/23/2000,,,,0691-008,Large,4/23/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Francesca Fallarino, Thomas Gajewski",Nationalized PCT,4/12/2018,0691-008,10/23/2020,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610925,,581716,Yes
6562,97-T-067,Combination of Antigen Pulsed APCS and Interleukin 12 for Tumor and Viral Therapy (Amended),99921452.1EPO, ,European Patent Office (EPO),EP,4/23/1999,, ,,0691-004,Large,4/23/1998,,No,5/21/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Francesca Fallarino, Thomas Gajewski",Nationalized PCT,4/12/2018,0691-004,4/23/2019,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610926,,581716,Yes
6563,97-T-067,Combination of Antigen Pulsed APCS and Interleukin 12 for Tumor and Viral Therapy (Amended),"2,326,406",,Canada,CA,4/23/1999,,,,0691-005,Large,4/23/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Francesca Fallarino, Thomas Gajewski",Nationalized PCT,4/12/2018,0691-005,4/23/2019,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610927,,581716,Yes
6564,97-T-067,Combination of Antigen Pulsed APCS and Interleukin 12 for Tumor and Viral Therapy (Amended),2000-544352,,Japan,JP,10/23/2000,,2002-512202,,0691-007,Large,4/23/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Francesca Fallarino, Thomas Gajewski",Nationalized PCT,4/12/2018,0691-007,10/23/2020,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610928,4/23/2002,581716,Yes
6565,97-T-067,Combination of Antigen Pulsed APCS and Interleukin 12 for Tumor and Viral Therapy (Amended),507829,507829,New Zealand,NZ,10/27/2000,7/5/2004,,,0691-009,Large,4/23/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Francesca Fallarino, Thomas Gajewski",Nationalized PCT,4/12/2018,0691-009,4/23/2019,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",610929,,581716,Yes
6566,97-T-067,Vaccine Adjuvants for Immunotheraphy of Melanoma,2004200444,,Australia,AU,2/6/2004,,AU-4200444-AA,,0691-010,Large,4/23/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Krawzsenek, Michael",,"Francesca Fallarino, Thomas Gajewski",Divisional,4/12/2018,0691-010,2/6/2024,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615337,3/4/2004,581716,Yes
6567,97-T-067,Vaccine Adjuvants for Immunotherapy of Melanoma,"09/064,964","6,080,399",*United States,US,4/23/1998,6/27/2000,,,0691-001,Large,4/23/1998,,Yes,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Francesca Fallarino, Thomas Gajewski",US Utility,4/12/2018,0691-001,4/23/2018,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615338,,581716,Yes
6568,97-T-067,Vaccine Adjuvants for Immunotherapy of Melanoma,"09/168,832","6,716,422",*United States,US,10/8/1998,4/6/2004,,,0691-002,Large,4/23/1998,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Francesca Fallarino, Thomas Gajewski",Continuation in Part,4/12/2018,0691-002,4/23/2018,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615339,,581716,Yes
6569,97-T-067,Vaccine Adjuvants for Immunotherapy of Melanoma,PCT/US99/08889, ,*United States,US,4/23/1999,,WO 99/53949,4/23/1999,0691-003,Large,4/23/1998,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Francesca Fallarino, Thomas Gajewski",PCT,4/12/2018,0691-003,10/23/2000,"Sun, Han",Thomas Gajewski,"Tennant, Thelma",615340,10/28/1999,581716,Yes
6570,97-T-068,Combination of Radiotherapy and Angiostatin,"60/089,218", ,*United States,US,6/15/1998,, ,6/15/1998,0692-001,Small,6/15/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Donald Kufe, Gerald Soff, Ralph Weichselbaum",Provisional,4/12/2018,0692-001,6/15/1999,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610931,,581717,Yes
6571,97-T-068,Combination of Radiotherapy and Angiostatin,"60/125,566", ,*United States,US,3/23/1999,, ,3/23/1999,0692-002,Small,3/23/1999,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Provisional,4/12/2018,0692-002,3/23/2000,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610932,,581717,Yes
6572,97-T-068,Combination of Radiotherapy and Anti-Angiogenic Factors,PCT/US99/13567, ,*United States,US,6/15/1999,,WO 99/65515,6/15/1999,0692-003,Small,6/15/1998,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",PCT,4/12/2018,0692-003,12/15/2000,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610933,12/23/1999,581717,Yes
6573,97-T-068,Combination of Radiotherapy and Anti-Angiogenic Factors,99928705.5EPO, ,European Patent Office (EPO),EP,6/15/1999,,EP 1 087 785 A2,,0692-004,Small,6/15/1998,,No,11/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0692-004,6/15/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610934,4/4/2001,581717,Yes
6574,97-T-068,Combination of Radiotherapy and Anti-Angiogenic Factors,"2,335,038",,Canada,CA,6/15/1999,,"2,335,038",,0692-005,Large,6/15/1998,6/15/2010,No,3/7/2019,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0692-005,,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610935,12/23/1999,581717,Yes
6575,97-T-068,Combination of Radiotherapy and Anti-angiogenic Factors,"09/334,084","6,420,335",*United States,US,6/16/1999,7/16/2002,,,0692-006,Small,6/15/1998,8/16/2010,No,3/7/2019,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",US Utility,4/12/2018,0692-006,6/15/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610936,,581717,Yes
6576,97-T-068,Combination of Radiotherapy and Anti-Angiogenic Factors,2000-554393,,Japan,JP,12/15/2000,,,,0692-007,Small,6/15/1998,,No,11/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0692-007,12/15/2020,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610937,,581717,Yes
6577,97-T-068,Combination of Radiotherapy and Anti-Angiogenic Factors,45707/99,762615,Australia,AU,12/28/2000,10/16/2003,762615,,0692-008,Small,6/15/1998,,No,11/13/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Donald Kufe, Vikas Sukhatme, Ralph Weichselbaum",Nationalized PCT,4/12/2018,0692-008,6/15/2018,"Dembo, Anna",Ralph Weichselbaum,"Tennant, Thelma",610938,7/3/2003,581717,Yes
6578,97-T-069,Methods for Detection of Promoter Polymorphism in a UGT Gene Promoter,"10/277,160", ,*United States,US,10/21/2002,,US-2003-152968-A1,,0693-002,Large,2/17/1999,11/27/2006,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Lalitha Iyer, Mark Ratain",Continuation,4/12/2018,0693-002,2/16/2019,"Sun, Han",Mark Ratain,"Tennant, Thelma",613162,8/14/2003,581718,Yes
6579,97-T-069,Methods for Detection of Promoter Polymorphism in a UGT Gene Promoter,"90/007,601","6,395,481",*United States,US,6/22/2005,6/5/2007, ,,0693-003,Large,2/16/1999,6/5/2007,No,8/4/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"Anna Di Rienzo, Lalitha Iyer, Mark Ratain",US Utility,4/12/2018,0693-003,2/16/2019,"Sun, Han",Mark Ratain,"Tennant, Thelma",613163,,581718,Yes
6580,97-T-069,Methods for Detection of Promoter Polymorphism in UGT Gene Promoter,"12/510,094", ,*United States,US,7/27/2009,,US-2009-0318487-A1,,0693-005,Small,2/17/1999,8/7/2011,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Diana Hall, Lalitha Iyer, Mark Ratain",Continuation,4/12/2018,0693-005,2/1/2022,"Sun, Han",Mark Ratain,"Tennant, Thelma",613164,12/24/2009,581718,Yes
6581,97-T-069,Methods for Detection of Promoter Polymorphism in UGT Gene Promoter,"09/251,274","6,395,481",*United States,US,2/16/1999,5/28/2002,US6395481 B1,,0693-006,Small,2/16/1999,5/28/2002,Yes,8/4/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Diana Hall, Mark Ratain",US Utility,4/12/2018,0693-006,2/16/2019,"Sun, Han",Mark Ratain,"Tennant, Thelma",613165,5/28/2002,581718,No
6582,97-T-069,Methods For Detection Of Promoter Polymorphism In UGT Gene Promotor,"11/561,341", ,*United States,US,11/17/2006,, ,,0693-004,None,2/17/1999,11/13/2009,No,8/4/2020,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Anna Di Rienzo, Diana Hall, Lalitha Iyer, Mark Ratain",Continuation,4/12/2018,0693-004,2/16/2025,"Sun, Han",Mark Ratain,"Tennant, Thelma",613166,,581718,Yes
6583,97-T-069,Methods for Detection of Promotor Polymorphism in a UGT Gene Promoter,"10/061,693","6,472,157",*United States,US,2/1/2002,10/29/2002,US-2002-115097-A1,,0693-001,Large,2/17/1999,10/29/2002,No,8/4/2020,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"Anna Di Rienzo, Lalitha Iyer, Mark Ratain",Continuation,4/12/2018,0693-001,2/16/2019,"Sun, Han",Mark Ratain,"Tennant, Thelma",613167,8/22/2002,581718,Yes
6584,97-T-070,Sampling and Reconstruction of RF signals,"09/490,412","6,567,567",*United States,US,1/24/2000,5/20/2003,,,0694-002,Small,4/15/1998,,No,4/12/2018,Abandoned,Welsh & Katz,"Christensen, Jon",,"David Levin, Scott Nagle",Divisional,4/12/2018,0694-002,4/15/2018,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",614418,,581719,Yes
6585,97-T-070,Sampling and Reconstruction of Signals and Images Including MR Images of Multiple Regions,"09/061,513","6,018,600",*United States,US,4/15/1998,1/25/2000,,,0694-001,Small,4/15/1998,,Yes,4/12/2018,Abandoned,Welsh & Katz,"Cohen, Eric",,"David Levin, Scott Nagle",US Utility,4/12/2018,0694-001,4/5/2018,"Ginsburg, Eric",David Levin,"Juggernauth, Anne",614419,,581719,Yes
6586,97-T-071,Method for Determining an Optimally Weighted Wavelet Transform Based on Supervised Training for Detection of Microcalcifications in Digital Mammograms,"08/979,623","6,075,878",*United States,US,11/28/1997,6/13/2000,,,0695-001,Small,11/28/1997,,Yes,2/3/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt",,,"Kunio Doi, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida, Wei Zhang",US Utility,4/12/2018,0695-001,11/28/2017,"Ginsburg, Eric","Robert ""Bob"" Nishikawa","Juggernauth, Anne",612443,,581720,Yes
6587,97-T-071,Method for Determining Optimally Weighted Wavelet Transform,PCT/US98/24933, ,*United States,US,11/25/1998,,WO 99/28860,11/25/1998,0695-002,Large,11/28/1997,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Robert ""Bob"" Nishikawa, Hiroyuki Yoshida, Wei Zhang",PCT,4/12/2018,0695-002,5/28/2000,"Ginsburg, Eric","Robert ""Bob"" Nishikawa","Juggernauth, Anne",612445,6/10/1999,581720,Yes
6588,97-T-072,MSET 2,TXu-893-068,TXu-893-068,*United States,US,9/26/1999,9/26/1999,,,97-101-014,None,,,No,4/12/2018,Registered (Copyright),,,,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Copyright Application,4/12/2018,97-101-014,9/26/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",613548,,581721,Yes
6589,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,"09/006,713","5,987,399",*United States,US,1/14/1998,11/16/1999, ,,97-101-001,Small,1/14/1998,,Yes,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",US Utility,4/12/2018,97-101-001,1/14/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615132,,581721,Yes
6590,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,PCT/US99/00956, ,*United States,US,1/14/1999,,WO 99/36920,1/14/1999,97-101-002,Large,1/14/1998,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",PCT,4/12/2018,97-101-002,7/14/2000,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615133,7/22/1999,581721,Yes
6591,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3EPO,"EPO 1,055,239",European Patent Office (EPO),EP,1/14/1999,3/22/2006,1055239,,97-101-003,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Nationalized PCT,4/12/2018,97-101-003,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615134,11/29/2000,581721,Yes
6592,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,2000-540543,3495705,Japan,JP,1/14/1999,11/21/2003,2002-509324,,97-101-004,Large,1/14/1998,,No,4/28/2021,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Nationalized PCT,4/12/2018,97-101-004,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615135,3/26/2002,581721,Yes
6593,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3FR,1055239,France,FR,1/14/1999,3/22/2006, ,,97-101-005,None,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-005,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615136,,581721,Yes
6594,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3DE,1055239,Germany,DE,1/14/1999,3/22/2006, ,,97-101-006,None,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-006,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615137,,581721,Yes
6595,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3IT,1055239,Italy,IT,1/14/1999,3/22/2006, ,,97-101-007,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-007,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615138,,581721,Yes
6596,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3ES,1055239,Spain,ES,1/14/1999,3/22/2006, ,,97-101-008,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-008,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615139,,581721,Yes
6597,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3GB,1055239,United Kingdom,GB,1/14/1999,3/22/2006, ,,97-101-009,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-009,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615140,,581721,Yes
6598,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3NL,1055239,Netherlands,NL,1/14/1999,3/22/2006, ,,97-101-011,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-011,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615141,,581721,Yes
6599,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,99903131.3BE,1055239,Belgium,BE,1/14/1999,3/22/2006, ,,97-101-012,None,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Validated EPO,4/12/2018,97-101-012,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615142,,581721,Yes
6600,97-T-072,Ultrasensitive Surveillance of Sensors and Processes,"09/373,326","6,202,038",*United States,US,8/12/1999,3/13/2001, ,,97-101-013,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Continuation,4/12/2018,97-101-013,1/14/2018,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615143,,581721,Yes
6601,97-T-072,"Ultrasensitive Surveillance of Sensors and Processes (""HYPERSPRT"")","2,318,093","2,318,093",Canada,CA,1/14/1999,11/23/2004,"2,318,093",,97-101-010,Large,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Nationalized PCT,4/12/2018,97-101-010,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615144,7/22/1999,581721,Yes
6602,97-T-072,"Ultrasensitive Surveillance of Sensors and Processes (""HYPERSPRT"")",23225/99,748987,Australia,AU,1/14/2000,6/13/2002, ,,97-101-015,Small,1/14/1998,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Nationalized PCT,4/12/2018,97-101-015,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615145,,581721,Yes
6603,97-T-072,Ultrasensitive Surveillance of Sensors and Processes (HYPERSPRT),10-2000-7007764,355970,"Korea, Republic of",KR,7/14/2000,9/26/2002,2001-52142,,97-101-016,Large,1/14/1998,,No,4/28/2021,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Kristin Jarman, Stephan Wegerich",Nationalized PCT,4/12/2018,97-101-016,1/14/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",615146,6/25/2001,581721,Yes
6604,97-T-076,Apparatus for Applying Optical Gradient Forces,"09/017,923","6,055,106",*United States,US,2/3/1998,4/25/2000, ,,0699-001,Small,2/3/1998,2/3/2018,Yes,8/4/2020,Expired - Inactive,Akerman Senterfitt,, ,"Eric Dufresne, David Grier",US Utility,4/12/2018,0699-001,2/3/2018,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610498,,581725,Yes
6605,97-T-076,Apparatus for Applying Optical Gradient Forces,PCT/US99/02369, ,*United States,US,2/3/1999,,WO99/39223,2/3/1999,0699-002,Small,2/3/1998,,No,4/28/2022,Expired - Inactive,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",PCT,4/12/2018,0699-002,8/3/2000,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610499,8/5/1999,581725,Yes
6606,97-T-076,Apparatus for Applying Optical Gradient Forces,99904575.0EPO,1053492,European Patent Office (EPO),EP,2/3/1999,5/17/2006,1053492,,0699-003,Small,2/3/1998,,No,7/11/2018,Expired - Inactive,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0699-003,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610500,11/22/2000,581725,Yes
6607,97-T-076,Apparatus for Applying Optical Gradient Forces,2000-529623,3895545,Japan,JP,2/3/1999,12/22/2006,2002-502043,,0699-004,Small,2/3/1998,,No,8/4/2020,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Nationalized PCT,4/12/2018,0699-004,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610501,1/22/2002,581725,Yes
6608,97-T-076,Apparatus for Applying Optical Gradient Forces,99904575.0FR,1053492,France,FR,2/3/1999,5/17/2006,1053492,,0699-006,Small,2/3/1998,,No,8/4/2020,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-006,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610502,11/22/2000,581725,Yes
6609,97-T-076,Apparatus for Applying Optical Gradient Forces,99904575.0DE,69931346.5,Germany,DE,2/3/1999,5/17/2006,1053492,,0699-007,Small,2/3/1998,,No,8/4/2020,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-007,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610503,11/22/2000,581725,Yes
6610,97-T-076,Apparatus for Applying Optical Gradient Forces,99904575.0IT,1053492,Italy,IT,2/3/1999,5/17/2006,1053492,,0699-008,Small,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-008,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610504,11/22/2000,581725,Yes
6611,97-T-076,Apparatus for Applying Optical Gradient Forces,99904575.0GB,1053492,United Kingdom,GB,2/3/1999,5/17/2006,1053492,,0699-009,Small,2/3/1998,,No,8/4/2020,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-009,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610505,11/22/2000,581725,Yes
6612,97-T-076,Apparatus for Applying Optical Gradient Forces,2006-208531,4897382,Japan,JP,2/3/1999,1/6/2012,2007-30162,,0699-010,Small,2/3/1998,,No,8/4/2020,Abandoned,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0699-010,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610506,2/8/2007,581725,Yes
6613,97-T-076,Apparatus for Applying Optical Gradient Forces,06001156.6EPO,1 666 926,European Patent Office (EPO),EP,2/3/1999,10/17/2012,1666926,,0699-011,Large,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Divisional,4/12/2018,0699-011,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610507,10/17/2012,581725,Yes
6614,97-T-076,Apparatus for Applying Optical Gradient Forces,"10/605,319","7,227,688",*United States,US,9/22/2003,6/5/2007,US-2004-105158-A1,,0699-013,Small,2/3/1998,2/3/2018,No,8/4/2020,Expired - Inactive,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Divisional,4/12/2018,0699-013,6/5/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610508,6/3/2004,581725,Yes
6615,97-T-076,Apparatus for Applying Optical Gradient Forces,06113127.3,HK1092541,Hong Kong,HK,2/3/1999,7/19/2013,,,0699-014,Small,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Divisional,4/12/2018,0699-014,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610509,,581725,Yes
6616,97-T-076,Apparatus for Applying Optical Gradient Forces,06001156.6IT,1666926,Italy,IT,2/3/1999,10/17/2012, ,,0699-015,Large,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-015,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610510,,581725,Yes
6617,97-T-076,Apparatus for Applying Optical Gradient Forces,06001156.6GB,1666926,United Kingdom,GB,2/3/1999,10/17/2012, ,,0699-016,Large,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-016,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610511,,581725,Yes
6618,97-T-076,Apparatus for Applying Optical Gradient Forces,06001156.6DE,69944448.9,Germany,DE,2/3/1999,10/17/2012,1666926,,0699-017,Large,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-017,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610512,,581725,Yes
6619,97-T-076,Apparatus for Applying Optical Gradient Forces,06001156.6FR,1666926,France,FR,2/3/1999,10/17/2012, ,,0699-018,Large,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-018,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610513,,581725,Yes
6620,97-T-076,Apparatus for Applying Opticl Gradient Forces,00103520.2,HK1033855,Hong Kong,HK,2/3/1999,12/22/2006,,,0699-005,Small,2/3/1998,,No,4/12/2018,Abandoned,Akerman Senterfitt,"Edwards, Jean",,"Eric Dufresne, David Grier",Validated EPO,4/12/2018,0699-005,2/3/2019,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",610534,,581725,Yes
6621,97-T-076,Method for Applying Optical Gradient Forces and Moving Material,"09/495,064","6,624,940",*United States,US,1/31/2000,9/23/2003, ,,0699-012,Small,2/3/1998,2/3/2018,No,8/4/2020,Expired - Inactive,Akerman Senterfitt,"Edwards, Jean", ,"Eric Dufresne, David Grier",Continuation,4/12/2018,0699-012,2/3/2018,"Ginsburg, Eric",David Grier,"Juggernauth, Anne",612424,,581725,Yes
6622,97-T-077,A Multisampling Technique for the Automated Detection of Breast Lesions,"08/979,639",,*United States,US,11/28/1997,,,,0700-001,Small,11/28/1997,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Darrin Edwards, Robert ""Bob"" Nishikawa",US Utility,4/12/2018,0700-001,11/28/2017,"Ginsburg, Eric","Robert ""Bob"" Nishikawa","Juggernauth, Anne",610220,,581726,Yes
6623,97-T-077,Method and System for Automated Multi-Sampled Detection of Lesions in Images,PCT/US98/24932, ,*United States,US,11/25/1998,6/10/1999,WO 99/28854,11/25/1998,0700-002,Large,11/28/1997,,No,4/28/2022,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Robert ""Bob"" Nishikawa",PCT,4/12/2018,0700-002,5/28/2000,"Ginsburg, Eric","Robert ""Bob"" Nishikawa","Juggernauth, Anne",612328,6/10/1999,581726,Yes
6624,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,"08/068,713","5,459,675",*United States,US,5/27/1993,10/17/1995, ,,91-77/78-001,Small,1/29/1992,,Yes,8/4/2020,Abandoned,Foley & Lardner,, ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Continuation in Part,4/12/2018,91-77/78-001,4/25/2012,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614805,,581728,Yes
6625,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,94918170.5EPO,EP 0 746 855 B1,European Patent Office (EPO),EP,5/27/1994,6/23/1999, ,,91-77/78-002,Small,5/27/1993,,No,8/4/2020,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Nationalized PCT,4/12/2018,91-77/78-002,5/27/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614806,,581728,Yes
6626,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,PCT/US94/06086, ,*United States,US,5/27/1994,,WO 94/28557,5/27/1994,91-77/78-003,Small,5/27/1993,,No,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Kristin Jarman",PCT,4/12/2018,91-77/78-003,11/27/1995,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614807,12/8/1994,581728,Yes
6627,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,94918170.5GB,EP 0 746 855 B1,United Kingdom,GB,5/27/1994,6/23/1999,0746855,,91-77/78-004,Small,5/27/1993,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Validated EPO,4/12/2018,91-77/78-004,5/27/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614808,6/23/1999,581728,Yes
6628,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,94918170.5FR,EP 0 746 855 B1,France,FR,5/27/1994,6/23/1999, ,,91-77/78-005,Small,5/27/1993,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Validated EPO,4/12/2018,91-77/78-005,5/27/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614809,,581728,Yes
6629,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,94918170.5IT,EP 0 746 855 B1,Italy,IT,5/27/1994,6/23/1999, ,,91-77/78-006,Small,5/27/1993,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Validated EPO,4/12/2018,91-77/78-006,5/27/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614810,,581728,Yes
6630,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,94918170.5DE,EP 0 746 855 B1,Germany,DE,5/27/1994,6/23/1999, ,,91-77/78-007,Small,5/27/1993,,No,8/4/2020,Abandoned,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Validated EPO,4/12/2018,91-77/78-007,5/27/2014,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614811,,581728,Yes
6631,97-T-079,System for Monitoring an Industrial Process and Determining Sensor Status,"08/472,749", ,*United States,US,5/27/1994,, ,6/7/1995,91-77/78-008,Small,5/27/1993,,Yes,4/28/2022,Abandoned,"Reinhart, Boerner, Van Deuren, Norris & Rieselbach",, ,"Kenneth Gross, Keith Humenik, Kristin Jarman",Continuation,4/12/2018,91-77/78-008,,"Ginsburg, Eric",Kenneth Gross,"Smith, Dane",614812,,581728,Yes
6632,97-T-080,Human Nkx Polypeptide-Encoding Nucleic Acids and Transgenic Animals Derived Therefrom,PCT/US98/14765, ,*United States,US,7/16/1998,,WO 99/05258,7/16/1998,0701-002,None,7/25/1997,,No,6/8/2022,Expired - Inactive,"Bozicevic, Field & Francis","Francis, Carol", ,"Graeme Bell, Hiroto Furuta, Michael German, Dennis Hartigan-O'Connor, Roger Pedersen, Donald Rubenstein, Lori Sussel",PCT,4/12/2018,0701-002,1/25/2000,"Butler, Brittany",Graeme Bell,"Butler, Brittany",611844,,581729,Yes
6633,97-T-080,Human Nkx-2.2 Polypeptide-Encoding Nucleotide Sequences,"09/008,892","6,239,258",*United States,US,1/20/1998,5/29/2001,,,0701-001,None,7/25/1997,,No,6/8/2022,Expired - Inactive,"Bozicevic, Field & Francis","Francis, Carol",,"Graeme Bell, Hiroto Furuta, Michael German, Lori Sussel",Continuation in Part,4/12/2018,0701-001,7/25/2017,"Butler, Brittany",Graeme Bell,"Butler, Brittany",611845,,581729,Yes
6634,97-T-081,Methods for Identifying Factors Controlling Amyloid Protein Aggregation,PCT/US98/26113, ,*United States,US,12/9/1998,6/17/1999,WO 99/29891,12/9/1998,0702-004,Small,12/9/1997,,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,"Brennan, Jack", ,Susan Lindquist,PCT,4/12/2018,0702-004,6/9/2000,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613183,6/17/1999,581730,Yes
6635,97-T-081,Methods for Identifying Factors that Control the Folding of Amyloid Proteins of Diverse Origin,"60/069,168", ,*United States,US,12/9/1997,, ,12/9/1997,0702-001,Small,12/9/1997,,Yes,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,"Brennan, Jack", ,Susan Lindquist,Provisional,4/12/2018,0702-001,12/9/1998,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613184,,581730,Yes
6636,97-T-081,Methods for Identifying Factors that Control the Folding of Amyloid Proteins of Diverse Origin,"60/084,824", ,*United States,US,5/8/1998,, ,5/8/1998,0702-002,Small,5/8/1998,,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,Susan Lindquist,Provisional,4/12/2018,0702-002,5/8/1999,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613185,,581730,Yes
6637,97-T-081,Methods for Identifying Factors that Control the Folding of Amyloid Proteins of Diverse Origin,"09/207,649","7,799,535",*United States,US,12/8/1998,9/21/2010, ,,0702-003,Small,12/9/1997,9/21/2010,No,6/8/2022,Expired - Inactive,Fish & Richardson P.C.,, ,Susan Lindquist,Continuation in Part,4/12/2018,0702-003,5/16/2019,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613186,,581730,Yes
6638,97-T-081,Methods for Identifying Factors that Control the Folding of Amyloid Proteins of Diverse Origin,"12/854,608",,*United States,US,8/11/2010,, ,,0702-005,Small,12/9/1997,,No,6/8/2022,Abandoned,Fish & Richardson P.C.,,,Susan Lindquist,Continuation,4/12/2018,0702-005,12/9/2017,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",613187,,581730,Yes
6639,97-T-083,A Method for Protection Against Tumor Metastasis Formation,PCT/US00/06653, ,*United States,US,3/14/2000,,WO 00/56299,3/14/2000,0704-003,Small,3/19/1999,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"David Grdina, Luka Milas",PCT,4/12/2018,0704-003,9/19/2001,"Cox, Ben",David Grdina,"Tennant, Thelma",610212,9/28/2000,581732,Yes
6640,97-T-083,A Method for Protection Against Tumor Metastasis Formation,"11/201,760",,*United States,US,8/11/2005,,,,0704-004,Small,3/19/1999,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"David Grdina, Luka Milas",Continuation,4/12/2018,0704-004,8/11/2025,"Cox, Ben",David Grdina,"Tennant, Thelma",610213,,581732,Yes
6641,97-T-083,Method for Protection Against Tumor Metastasis Formation,"60/125,605", ,*United States,US,3/19/1999,, ,3/19/1999,0704-001,Small,3/19/1999,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Parker, David", ,"David Grdina, Luka Milas",Provisional,4/12/2018,0704-001,3/19/2000,"Cox, Ben",David Grdina,"Tennant, Thelma",612494,,581732,Yes
6642,97-T-083,Method for Protection Against Tumor Metastasis Formation,"09/523,886","6,984,619",*United States,US,3/13/2000,1/10/2006,,,0704-002,Small,3/19/1999,,No,1/23/2019,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"David Grdina, Luka Milas",US Utility,4/12/2018,0704-002,3/19/2019,"Cox, Ben",David Grdina,"Tennant, Thelma",612495,,581732,Yes
6643,98-T-003,Sub-Band,"60/354,626", ,*United States,US,2/6/2002,, ,2/6/2002,98-107-001,Small,2/6/2002,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,Stephan Wegerich,Provisional,4/12/2018,98-107-001,2/6/2003,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614671,,581733,Yes
6644,98-T-003,Subband Domain Signal Validation,"10/360,843","7,085,675",*United States,US,2/6/2003,8/1/2006,US-2003-220767-A1,,98-107-002,Small,2/6/2002,,No,4/28/2021,Issued,Foley & Lardner,"Rechtin, Michael", ,Stephan Wegerich,US Utility,4/12/2018,98-107-002,2/6/2023,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",614672,11/27/2003,581733,Yes
6645,98-T-004,Eukaryotic IMPDH Ploynucleotide and Antibody Compositions,"08/925,230","6,147,194",*United States,US,9/8/1997,11/14/2000,,,81-088-002,Large,8/12/1988,,Yes,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Frank Collart, Eliezer Huberman",Divisional,4/12/2018,81-088-002,8/12/2008,"Sun, Han",Frank Collart,"Tennant, Thelma",611540,,581734,Yes
6646,98-T-004,Methods and materials relating to IMPDH and GMP production,"07/232,302","5,665,583",*United States,US,8/12/1988,9/9/1997,,,81-088-001,Large,8/12/1988,,Yes,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Frank Collart, Eliezer Huberman",US Utility,4/12/2018,81-088-001,9/9/2014,"Sun, Han",Frank Collart,"Tennant, Thelma",613124,9/9/1997,581734,Yes
6647,98-T-004,Methods and materials Relating to IMPDH and GMP Production,"09/712,372","6,479,628",*United States,US,11/13/2000,11/12/2002,,,81-088-003,Large,9/8/1997,,No,4/12/2018,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Frank Collart, Eliezer Huberman",Continuation,4/12/2018,81-088-003,8/12/2008,"Sun, Han",Frank Collart,"Tennant, Thelma",613125,,581734,Yes
6648,98-T-005,Method and System for the Automated Temporal Subtraction of Medical Images,"09/027,468","6,363,163",*United States,US,2/23/1998,3/26/2002,US-2002-0097901-A1,,0705-001,Small,2/23/1998,,Yes,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Xin-Wei Xu",US Utility,4/12/2018,0705-001,2/23/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612394,7/25/2002,581735,Yes
6649,98-T-005,Method and System for the Automated Temporal Subtraction of Medical Images,PCT/US99/03282, ,*United States,US,2/22/1999,,WO 99/42949,2/22/1999,0705-002,Small,2/23/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Xin-Wei Xu",PCT,4/12/2018,0705-002,8/23/2000,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612395,8/26/1999,581735,Yes
6650,98-T-005,Method and System for the Automated Temporal Subtraction of Medical Images,"10/036,541",,*United States,US,1/7/2002,,US-2002-097901-A1,,0705-003,Small,2/23/1998,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Xin-Wei Xu",Continuation,4/12/2018,0705-003,2/23/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612396,7/25/2002,581735,Yes
6651,98-T-006,Analysis of Image Features of Histograms of Edge Gradient for False-Positive Reduction in Lung Nodule Detection in Chest Radiographs,2000-532812,4326695,Japan,JP,2/23/1999,6/19/2009,2002-504727,,0706-004,Small,2/23/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Xin-Wei Xu","Foreign, Non-PCT",4/12/2018,0706-004,2/23/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610330,2/12/2002,581736,Yes
6652,98-T-006,Lung Nodule Detection Using Edge Gradient Histograms,PCT/US99/03288, ,*United States,US,2/23/1999,8/26/1999,WO 99/42950,2/23/1999,0706-002,Small,2/23/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Xin-Wei Xu",PCT,4/12/2018,0706-002,8/23/2000,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612139,8/26/1999,581736,Yes
6653,98-T-006,Lung Nodule Detection Using Edge Gradient Histograms,99909494.9EPO, ,European Patent Office (EPO),EP,2/23/1999,,1082694,,0706-003,Large,2/23/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Xin-Wei Xu",Nationalized PCT,4/12/2018,0706-003,2/23/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612140,3/14/2001,581736,Yes
6654,98-T-006,Method and computer readable medium for automated analysis of chest radiograph images using histograms of edge gradients for false positive reduction in lung nodule detection,"09/027,685","6,088,473",*United States,US,2/23/1998,7/11/2000, ,,0706-001,Small,2/23/1998,2/23/2018,Yes,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Xin-Wei Xu",US Utility,4/12/2018,0706-001,2/23/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612316,,581736,Yes
6655,98-T-007,"Method, System and Computer Readable Medium for Iterative Image Warping Prior to Temporal Subtraction of Chest Radiographs in the Detection of Interval Changes","09/053,798","6,067,373",*United States,US,4/2/1998,5/23/2000, ,,0707-001,Large,4/2/1998,4/2/2018,Yes,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",US Utility,4/12/2018,0707-001,4/2/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612578,,581737,Yes
6656,98-T-007,"Method, System and Computer Readable Medium for Iterative Image Warping Prior to Temporal Subtraction of Chest Radiographs in the Detection of Interval Changes",PCT/US99/04290, ,*United States,US,4/2/1999,10/28/1999,WO 99/54705,4/2/1999,0707-002,Large,4/2/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",PCT,4/12/2018,0707-002,10/2/2000,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612579,12/28/1999,581737,Yes
6657,98-T-007,"Method, System and Computer Readable Medium for Iterative Image Warping Prior to Temporal Subtraction of Chest Radiographs in the Detection of Interval Changes","2,326,776","2,326,776",Canada,CA,4/2/1999,6/17/2008, ,,0707-003,Large,4/2/1998,6/17/2008,No,1/20/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",Nationalized PCT,4/12/2018,0707-003,4/2/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612580,,581737,Yes
6658,98-T-007,"Method, System and Computer Readable Medium for Iterative Image Warping Prior to Temporal Subtraction of Chest Radiographs in the Detection of Interval Changes",2000-545001, ,Japan,JP,4/2/1999,, ,,0707-004,Large,4/2/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",Nationalized PCT,4/12/2018,0707-004,4/2/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612581,,581737,Yes
6659,98-T-007,"Method, System and Computer Readable Medium for Iterative Image Warping Prior to Temporal Subtraction of Chest Radiographs in the Detection of Interval Changes",99917300.8EPO, ,European Patent Office (EPO),EP,4/2/1999,,1295244,,0707-005,Large,4/2/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa",Nationalized PCT,4/12/2018,0707-005,4/2/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612582,3/26/2003,581737,Yes
6660,98-T-008,Methods and Compositions Comprising the Use of Blocked B-Amyloid Peptide,"60/074,658", ,*United States,US,2/13/1998,, ,2/13/1998,0708-001,None,2/13/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Timothy Burkoth, David Lynn, Stephen Meredith",Provisional,4/12/2018,0708-001,2/13/1999,"Butler, Brittany",Stephen Meredith,"Butler, Brittany",612646,,581738,Yes
6661,98-T-008,Methods and Compositions Comprising the Use of Blocked B-Amyloid Peptide,PCT/US99/03231, ,*United States,US,2/12/1999,8/19/1999, ,2/12/1999,0708-003,Small,2/13/1998,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Timothy Burkoth, David Lynn, Stephen Meredith",PCT,4/12/2018,0708-003,8/13/2000,"Butler, Brittany",Stephen Meredith,"Butler, Brittany",612647,,581738,Yes
6662,98-T-008,Use of Blocked B-Amyloid Peptide,"09/249,480",,*United States,US,2/12/1999,,,,0708-002,None,2/13/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Timothy Burkoth, David Lynn, Stephen Meredith",Continuation,4/12/2018,0708-002,2/13/2018,"Butler, Brittany",Stephen Meredith,"Butler, Brittany",615159,,581738,Yes
6663,98-T-009,Recombinant Prion-Like Genes and Proteins & Materials & Methods Comprising Same,"60/138,833", ,*United States,US,6/9/1999,, ,6/9/1999,0709-001,Large,6/9/1999,,Yes,6/8/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,34978,"Liming Li, Susan Lindquist, Jia-Jia Liu, Jiyan Ma, Thomas Scheibel, Neal Sondheimer",Provisional,4/12/2018,0709-001,6/9/2000,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614357,,581739,Yes
6664,98-T-009,Recombinant Prion-like Genes and Proteins and Materials and Methods Comprising Same,00941299.0EPO, ,European Patent Office (EPO),EP,6/9/2000,,EP 1 879 20 A2,,0709-002,Large,6/9/1999,,No,6/8/2022,Abandoned,"Marshall, Gerstein & Borun","Gass, David", ,"Liming Li, Susan Lindquist, Jia-Jia Liu, Jiyan Ma, Thomas Scheibel, Neal Sondheimer",Nationalized PCT,4/12/2018,0709-002,6/9/2019,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614358,3/20/2002,581739,Yes
6665,98-T-009,Recombinant Prion-like Genes and Proteins and Materials and Methods Comprising Same,"09/591,632","7,569,660",*United States,US,6/9/2000,8/4/2009,,,0709-003,Large,6/9/1999,,No,6/8/2022,Abandoned,"Marshall, Gerstein & Borun","Gass, David",34978A,"Liming Li, Susan Lindquist, Jia-Jia Liu, Jiyan Ma, Thomas Scheibel, Neal Sondheimer",US Utility,4/12/2018,0709-003,6/9/2020,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614359,,581739,Yes
6666,98-T-009,Recombinant Prion-like Genes and Proteins and Materials and Methods Comprising Same,PCT/US00/15876, ,*United States,US,6/9/2000,,WO 00/75324 A2,6/9/2000,0709-004,Large,6/9/1999,,No,6/8/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Pazdera, R. Minako",34978A-PC,"Liming Li, Susan Lindquist, Jia-Jia Liu, Jiyan Ma, Thomas Scheibel, Neal Sondheimer",PCT,4/12/2018,0709-004,12/9/2001,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614360,12/14/2000,581739,Yes
6667,98-T-009,Recombinant Prion-like Genes and Proteins and Materials and Methods Comprising Same,"12/534,768",,*United States,US,8/3/2009,,,,0709-006,Large,6/9/1999,,No,6/8/2022,Abandoned,"Marshall, Gerstein & Borun","Gass, David",34978C,"Liming Li, Susan Lindquist, Jia-Jia Liu, Jiyan Ma, Thomas Scheibel, Neal Sondheimer",Continuation,4/12/2018,0709-006,6/9/2019,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614361,,581739,Yes
6668,98-T-009,Recombinant Prion-like Genes and Proteins and Materials and Methods Comprising the Same,"11/004,418",,*United States,US,12/3/2004,,05/0227322,,0709-005,Small,6/9/1999,,No,6/8/2022,Abandoned,"Marshall, Gerstein & Borun","Gass, David",,"Liming Li, Susan Lindquist, Thomas Scheibel, Neal Sondheimer",Divisional,4/12/2018,0709-005,6/9/2019,"Ginsburg, Eric",Susan Lindquist,"Tennant, Thelma",614362,10/13/2005,581739,Yes
6669,98-T-010,Immobilized Diels-Alder Adducts,"09/322,094", ,*United States,US,5/28/1999,, ,5/28/1999,0710-001,Small,5/28/1999,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00029,Milan Mrksich,US Utility,4/12/2018,0710-001,5/28/2019,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",611927,,581740,Yes
6670,98-T-011,Ex Vivo Activated T Cells,"09/189,586",,*United States,US,11/10/1998,,,,0711-004,Small,11/10/1997,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Carl June, David Liebovitz",Continuation,4/12/2018,0711-004,11/10/2017,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",611544,,581741,Yes
6671,98-T-011,Methods  for Treatment of Tumors and Tumor Cells Using Ex,2000-2412,,Norway,NO,5/9/2000,,,,0711-006,Small,11/10/1997,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Carl June, David Liebovitz",Validated EPO,4/12/2018,0711-006,5/9/2020,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",612598,,581741,Yes
6672,98-T-011,Methods for Treatment of Tumors and Tumor Cells Using (Ex Vivo) Activated T Cells,98957775.4EPO, ,European Patent Office (EPO),EP,11/10/1998,8/30/2000,WO9924045,,0711-001,Small,11/10/1997,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Carl June, David Liebovitz",Nationalized PCT,4/12/2018,0711-001,,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",613286,5/20/1999,581741,Yes
6673,98-T-011,Methods for Treatment of Tumors and Tumor Cells Using Ex Vivo Activated Cells,"60/065,031", ,*United States,US,11/10/1997,, ,11/10/1997,0711-002,Small,11/10/1997,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Carl June, David Liebovitz",Provisional,4/12/2018,0711-002,11/10/1998,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",613287,,581741,Yes
6674,98-T-011,Methods for Treatment of Tumors and Tumor Cells Using Ex Vivo Activated T Cells,PCT/US98/23954, ,*United States,US,11/10/1998,,WO 99/24045,11/10/1998,0711-003,Small,11/10/1997,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Carl June, David Liebovitz",PCT,4/12/2018,0711-003,5/10/2000,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",613288,5/20/1999,581741,Yes
6675,98-T-011,Methods for Treatment of Tumors and Tumor Cells Using Ex Vivo Activated T Cells,"2,309,206",,Canada,CA,5/5/2000,,,,0711-005,Large,11/10/1997,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David",,"Carl June, David Liebovitz",Nationalized PCT,4/12/2018,0711-005,5/5/2020,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",613289,,581741,Yes
6676,98-T-011,Methods for Treatment of Tumors and Tumor Cells Using Ex Vivo Actvated T Cells,2000-520136,,Japan,JP,5/10/2000,,,,0711-007,Small,11/10/1997,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Carl June, David Liebovitz",Nationalized PCT,4/12/2018,0711-007,5/10/2020,"Unassigned, Unassigned",David Liebovitz,"Unassigned, Unassigned",613290,,581741,Yes
6677,98-T-013,A New Strategy for  Genome-Wide Gene Analysis: Integrated Procedure for Gene Identification,PCT/US99/22975, ,*United States,US,9/29/1999,,WO 00/18966,9/29/1999,0713-002,Small,9/29/1998,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Scott Fears, Janet Rowley, San Ming Wang",PCT,4/12/2018,0713-002,3/29/2001,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",610225,4/6/2000,581743,Yes
6678,98-T-013,A New Strategy for  Genome-Wide Gene Analysis: Integrated Procedure for Gene Identification,"09/408,583",,*United States,US,9/29/1999,,,,0713-003,Small,9/29/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Scott Fears, Janet Rowley, San Ming Wang",US Utility,4/12/2018,0713-003,9/29/2018,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",610226,,581743,Yes
6679,98-T-013,Genome-Wide Gene Analysis,"60/102,381", ,*United States,US,9/29/1998,, ,9/29/1998,0713-001,Small,9/29/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Scott Fears, Janet Rowley, San Ming Wang",Provisional,4/12/2018,0713-001,9/29/1999,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",611695,,581743,Yes
6680,98-T-014,Bilateral Subtraction Technique for Detection of Subtle Lung Leisons,PCT/US99/24007, ,*United States,US,11/5/1999,,WO 00/28466,11/5/1999,0714-002,Small,11/5/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa, Qiang Li",PCT,4/12/2018,0714-002,5/5/2001,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610709,5/18/2000,581744,Yes
6681,98-T-014,Bilateral Subtraction Technique for Detection of Subtle Lung Lesions,2000-581581,4638042,Japan,JP,11/5/1999,12/3/2010,2002-529996,,0714-003,Small,11/5/1998,,No,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa, Liming Li, Qiang Li",Nationalized PCT,4/12/2018,0714-003,11/5/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",610710,9/10/2002,581744,Yes
6682,98-T-014,"Method, System and Computer Readable Medium for Computerized Processing of Chest Radiographic Images.","60/107,095", ,*United States,US,11/5/1998,, ,11/5/1998,0714-001,Small,11/5/1998,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Liming Li",Provisional,4/12/2018,0714-001,11/5/1999,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612570,,581744,Yes
6683,98-T-014,System for Computerized Processing of Chest Radiographic Images,"09/830,562","7,043,066",*United States,US,11/5/1999,5/9/2006, ,,0714-004,Large,11/5/1998,5/9/2006,No,9/17/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa, Qiang Li",Nationalized PCT,4/12/2018,0714-004,11/5/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614798,,581744,Yes
6684,98-T-014,System for Computerized Processing of Chest Radiographic Images,99960126.3EPO, ,European Patent Office (EPO),EP,11/5/1999,,EP 1 127 330 A1,,0714-005,Small,11/5/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Takayuki Ishida, Shigehiko Katsuragawa, Qiang Li",Nationalized PCT,4/12/2018,0714-005,5/29/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614799,8/29/2001,581744,Yes
6685,98-T-015,Computerized Analysis of Likelihood of Malignancy in Solitary Pulmonary Nodules on Chest Radiographs,"60/108,167", ,*United States,US,11/13/1998,, ,11/13/1998,0715-001,Small,11/13/1998,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Nobuyuk Nakamori, Katsumi Nakamura",Provisional,4/12/2018,0715-001,11/13/1999,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611255,,581745,Yes
6686,98-T-015,System for Detection of Malignancy in Pulmonary Nodles,2000-582958, ,Japan,JP,11/12/1999,,2002-530133,,0715-003,Small,11/13/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Nobuyuk Nakamori, Katsumi Nakamura","Foreign, Non-PCT",4/12/2018,0715-003,11/12/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614800,9/17/2002,581745,Yes
6687,98-T-015,System for Detection of Malignancy in Pulmonary Nodules,PCT/US99/25998, ,*United States,US,11/12/1999,,WO 00/30021 A1,11/12/1999,0715-002,Small,11/13/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Katsumi Nakamura",PCT,4/12/2018,0715-002,5/13/2001,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614801,5/25/2000,581745,Yes
6688,98-T-015,System for detection of malignancy in pulmonary nodules,99958770.2EPO, ,European Patent Office (EPO),EP,5/8/2001,,1129426,,0715-004,Small,11/13/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Nobuyuk Nakamori, Katsumi Nakamura",Nationalized PCT,4/12/2018,0715-004,5/8/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614802,9/5/2001,581745,Yes
6689,98-T-015,System for Detection of Malignancy in Pulmonary Nodules,"09/830,574","6,738,499",*United States,US,7/2/2001,5/18/2004, ,,0715-005,Small,11/13/1998,6/18/2012,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Katsumi Nakamura",Nationalized PCT,4/12/2018,0715-005,7/2/2021,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614803,,581745,Yes
6690,98-T-017,Computerized Detection of Lung Nodules,2000-561584, ,Japan,JP,7/21/1999,,2002-521896,,0716-004,Large,7/24/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Heber MacMahon, Xin-Wei Xu",Nationalized PCT,4/12/2018,0716-004,7/21/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611256,7/16/2002,581747,Yes
6691,98-T-017,Computerized Detection of Lung Nodules Using Energy-Subtracted Soft-Tissue and Conventional Chest Images,99933560.7EPO, ,European Patent Office (EPO),EP,7/21/1999,, ,,0716-003,Large,7/24/1998,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Heber MacMahon, Xin-Wei Xu",Nationalized PCT,4/12/2018,0716-003,7/21/2019,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611257,,581747,Yes
6692,98-T-017,Computerized Detection of Lung Nodules Using Energy-Subtracted Soft-Tissue and Standard Chest Images,"09/121,719","6,240,201",*United States,US,7/24/1998,5/29/2001, ,,0716-001,Small,7/24/1998,6/24/2013,Yes,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Heber MacMahon, Xin-Wei Xu",US Utility,4/12/2018,0716-001,7/24/2018,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611258,,581747,Yes
6693,98-T-017,Computerized Detection of Lung Nodules Using Energy-Subtracted Soft-Tissue and Standard Chest Images,PCT/US99/14159, ,*United States,US,7/21/1999,,WO 00/05678,7/21/1999,0716-002,Large,7/24/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Heber MacMahon, Xin-Wei Xu",PCT,4/12/2018,0716-002,1/24/2001,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611259,2/3/2000,581747,Yes
6694,98-T-019,Efficient and Stable In Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,"09/473,830","7,078,387",*United States,US,12/28/1999,7/18/2006,,,0719-002,Large,12/28/1998,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Jeffrey Leiden, Eric Svensson",Continuation in Part,4/12/2018,0719-002,12/28/2019,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611503,,581749,Yes
6695,98-T-019,Efficient and Stable In Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,"2,356,551",,Canada,CA,12/28/1999,,,,0719-003,Large,12/28/1999,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Jeffrey Leiden, Eric Svensson",Nationalized PCT,4/12/2018,0719-003,12/28/2019,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611504,,581749,Yes
6696,98-T-019,Efficient and Stable In Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,99967703.2EPO, ,European Patent Office (EPO),EP,12/28/1999,,1139751,,0719-004,Large,12/28/1998,,No,5/21/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Jeffrey Leiden, Eric Svensson",Nationalized PCT,4/12/2018,0719-004,12/28/2019,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611505,10/10/2001,581749,Yes
6697,98-T-019,Efficient and Stable In Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,PCT/US99/31093, ,*United States,US,12/28/1999,,WO 00/38518 A1,12/28/1999,0719-005,Large,12/28/1998,,No,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Jeffrey Leiden, Eric Svensson",PCT,4/12/2018,0719-005,6/28/2001,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611506,7/6/2002,581749,Yes
6698,98-T-019,Efficient and Stable In Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,200023942,763049,Australia,AU,12/28/1999,7/10/2003,,,0719-006,Large,12/28/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Jeffrey Leiden, Eric Svensson",Nationalized PCT,4/12/2018,0719-006,12/28/2019,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611507,,581749,Yes
6699,98-T-019,Efficient and Stable In Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,2000-590483,,Japan,JP,12/28/1999,,,,0719-007,Large,12/28/1998,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Jeffrey Leiden, Eric Svensson",Nationalized PCT,4/12/2018,0719-007,12/28/2019,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611508,,581749,Yes
6700,98-T-019,Efficient and Stable in Vivo Gene Transfer to Cardiomyocytes Using Recombinant Adeno-Associated Virus Vectors,"11/449,778",,*United States,US,6/9/2006,,,,0719-008,Large,12/28/1999,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Schofield, Mary",,"Jeffrey Leiden, Eric Svensson",Continuation,4/12/2018,0719-008,6/9/2026,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",611509,,581749,Yes
6701,98-T-019,Stable Gene Transfer to Cardiomyocytes In Vivo,"60/113,923", ,*United States,US,12/28/1998,, ,12/28/1998,0719-001,Large,12/28/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Schofield, Mary", ,"Jeffrey Leiden, Eric Svensson",Provisional,4/12/2018,0719-001,12/28/1999,"Unassigned, Unassigned",Jeffrey Leiden,"Unassigned, Unassigned",614614,,581749,Yes
6702,98-T-022,Vesicular Monoamine Transporter Gene Therapy in Parkinson's Disease,"60/112,502", ,*United States,US,12/16/1998,, ,12/16/1998,0722-001,Small,12/16/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,Un Jung Kang,Provisional,4/12/2018,0722-001,12/16/1999,"Bakalyar, Heather",Un Jung Kang,"Tennant, Thelma",615377,,581752,Yes
6703,98-T-022,Vesicular Monoamine Transporter Gene Therapy in Parkinson's Disease,"09/461,793","6,506,378",*United States,US,12/15/1999,1/14/2003,,,0722-002,Small,12/16/1998,,No,12/13/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Un Jung Kang,US Utility,4/12/2018,0722-002,12/15/2019,"Bakalyar, Heather",Un Jung Kang,"Tennant, Thelma",615378,,581752,Yes
6704,98-T-022,Vesicular Monoamine Transporter Gene Therapy in Parkinson's Disease,"10/285,308","7,115,258",*United States,US,10/31/2002,10/3/2006,US-2003-143702-A1,,0722-003,Small,12/16/1998,,No,12/13/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Un Jung Kang,Continuation,4/12/2018,0722-003,12/16/2019,"Bakalyar, Heather",Un Jung Kang,"Tennant, Thelma",615379,7/31/2003,581752,Yes
6705,98-T-022,Vesicular Monoamine Transporter Gene Therapy in Parkinson's Disease,"11/427,683",,*United States,US,6/29/2006,,US 2009-0036393 A1,,0722-004,Small,12/16/1998,,No,12/13/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Un Jung Kang,Copyright Application,4/12/2018,0722-004,12/16/2019,"Bakalyar, Heather",Un Jung Kang,"Tennant, Thelma",615380,2/5/2009,581752,Yes
6706,98-T-024,Process for Producing Optically Active b-Amino Esters,"60/125,270", ,*United States,US,3/19/1999,, ,3/19/1999,0724-001,Small,3/19/1999,,Yes,4/28/2022,Expired - Inactive,,, ,"William Wulff, Song Xue",Provisional,4/12/2018,0724-001,3/19/2000,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",614160,,581754,Yes
6707,98-T-024,Process for Producing Optically Active b-Amino Esters Using Metal-Chiral Ligand Catalytic Compounds,Unknown-UOP-104147, ,*United States,US,3/19/1999,, ,3/19/1999,0724-002,Small,3/19/1999,,No,4/28/2022,Expired - Inactive,,, ,"William Wulff, Song Xue",Provisional,4/12/2018,0724-002,3/19/2000,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",614161,,581754,Yes
6708,98-T-024,Process for Producing Optically Active B-Amino Esters Using Metal-Chiral Ligand Catalytic Compounds,"09/527,642",,*United States,US,3/17/2000,,,,0724-004,Small,3/19/1999,9/23/2002,Yes,2/13/2020,Abandoned,Brinks Gilson & Lione,,00049,"William Wulff, Song Xue, Su Yu",US Utility,4/12/2018,0724-004,,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",614162,,581754,Yes
6709,98-T-024,Process for Producing Optically Active B-Amino Esters Using Metal-Chiral Ligand Catalytic Compounds,PCT/US00/06411, ,*United States,US,3/17/2000,,WO 2000/056448,3/17/2000,0724-005,None,3/19/1999,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,07814.00050,"William Wulff, Song Xue",PCT,4/12/2018,0724-005,9/19/2001,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",614163,9/28/2000,581754,Yes
6710,98-T-024,Synthesis of Vapol Ligands,PCT/US00/06412, ,*United States,US,3/17/2000,,WO/2000/056691,3/17/2000,0724-003,Small,3/19/1999,,No,4/28/2022,Abandoned,,,07814.00051,"Jon Antilla, William Wulff, Song Xue",PCT,4/12/2018,0724-003,,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",614753,9/28/2000,581754,Yes
6711,98-T-026,Methods and Compositions for the Diagnosis of Fragile X Syndrome,"60/105,892", ,*United States,US,10/27/1998,, ,10/27/1998,0726-001,Small,10/27/1998,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,, ,"Soma Das, David Ledbetter",Provisional,4/12/2018,0726-001,10/27/1999,"Ginsburg, Eric",Soma Das,"Muite, Kevin",612868,,581756,Yes
6712,98-T-026,Methods and Compositions for the Diagnosis of Fragile X Syndrome,"09/429,499","6,143,504",*United States,US,10/27/1999,11/7/2000,,,0726-002,Small,10/27/1998,,No,4/12/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Soma Das, David Ledbetter",US Utility,4/12/2018,0726-002,10/27/2018,"Ginsburg, Eric",David Ledbetter,"Muite, Kevin",612869,,581756,Yes
6713,98-T-033,Multidimensional Interpolation,"09/166,041","6,052,427",*United States,US,10/5/1998,4/18/2000, ,10/5/1998,0733-001,Small,10/5/1998,,Yes,4/28/2022,Abandoned,Welsh & Katz,"Cohen, Eric", ,Xiaochuan Pan,US Utility,4/12/2018,0733-001,10/5/2018,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",613551,,581763,Yes
6714,98-T-034,Fast Reconstruction of Fan-Beam CT and Spect,"09/289,297","6,115,446",*United States,US,4/9/1999,9/5/2000,,,0734-001,Small,4/9/1999,,Yes,12/12/2018,Abandoned,Welsh & Katz,"Christensen, Jon",,Xiaochuan Pan,US Utility,4/12/2018,0734-001,4/9/2019,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",611569,,581764,Yes
6715,98-T-034,Fast Reconstruction of Fan-Beam CT and Spect,PCT/US99/23177, ,*United States,US,10/5/1999,, ,10/5/1999,0734-002,None,4/9/1999,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Christensen, Jon", ,Xiaochuan Pan,PCT,4/12/2018,0734-002,10/9/2001,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",611570,,581764,Yes
6716,98-T-035,Automated Colon Centerline,"60/118,649", ,*United States,US,2/4/1999,, ,2/4/1999,0735-001,Small,2/4/1999,,Yes,4/28/2022,Released to Inventors,Welsh & Katz,"Cohen, Eric", ,"Kunio Doi, Kenneth Hoffmann",Provisional,4/12/2018,0735-001,2/4/2000,"Ginsburg, Eric",Kenneth Hoffmann,"Juggernauth, Anne",610583,,581765,Yes
6717,98-T-036,Automatic Bone Segmentation Technique for CT Angiographic Studies,"60/117,235", ,*United States,US,1/26/1999,, ,1/26/1999,0736-001,Small,1/26/1999,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,"Christensen, Jon", ,"Kunio Doi, Kenneth Hoffmann",Provisional,4/12/2018,0736-001,1/26/2000,"Ginsburg, Eric",Kenneth Hoffmann,"Juggernauth, Anne",610668,,581766,Yes
6718,98-T-037,Method and System for Computerized Analysis of Bond Mass,99968265.1EPO, ,European Patent Office (EPO),EP,3/30/2001,,1105834,,0737-004,Small,8/28/1998,,No,11/13/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Michael Chinander, Maryellen Giger, Chunsheng Jiang",Nationalized PCT,4/12/2018,0737-004,3/30/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612334,6/13/2001,581767,Yes
6719,98-T-037,Method and System for Computerized Analysis of Bone Mass,2000-568049,,Japan,JP,8/27/1999,,2002-523204,,0737-003,Small,8/28/1998,,No,11/13/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Michael Chinander, Maryellen Giger, Chunsheng Jiang",Nationalized PCT,4/12/2018,0737-003,8/27/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612335,7/30/2002,581767,Yes
6720,98-T-037,Method and System for the Computerized Analysis of Bone Mass and Structure,"09/141,535","6,442,287",*United States,US,8/28/1998,8/27/2002,0025063-A1,,0737-001,Small,8/28/1998,,Yes,11/13/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Michael Chinander, Maryellen Giger, Chunsheng Jiang",US Utility,4/12/2018,0737-001,8/28/2018,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612397,2/28/2002,581767,Yes
6721,98-T-037,Method and System for the Computerized Analysis of Bone Mass and Structure,PCT/US99/18825, ,*United States,US,8/27/1999,3/9/2000,WO 00/13133,8/27/1999,0737-002,Small,8/28/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Michael Chinander, Maryellen Giger, Chunsheng Jiang",PCT,4/12/2018,0737-002,2/28/2001,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612398,3/9/2000,581767,Yes
6722,98-T-037,Method and System for the Computerized Analysis of Bone Mass and Structure,"2,342,344",,Canada,CA,5/10/2001,,,,0737-005,Large,8/28/1998,,No,11/13/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Michael Chinander, Maryellen Giger, Chunsheng Jiang",Nationalized PCT,4/12/2018,0737-005,5/10/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612399,,581767,Yes
6723,98-T-037,Method and System for the Computerized Analysis of Bone Mass and Structure,"10/097,727",,*United States,US,3/15/2002,,US-2002-196966-A1,,0737-006,Small,8/28/1998,,No,11/13/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Michael Chinander, Maryellen Giger, Chunsheng Jiang",US Utility,4/12/2018,0737-006,8/28/2018,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612400,12/26/2002,581767,Yes
6724,98-T-041,Genes Encoding the 5H7 Antibody and Methods for Conferring Programmed Cell Death Properties to Cells,"60/119,238", ,*United States,US,2/9/1999,, ,2/9/1999,0741-001,None,2/9/1999,,Yes,4/28/2022,Expired - Inactive,"Rockey, Milnamow & Katz, Ltd.","Mueller, Lisa", ,"Philimore Holman, David Kranz, Sanjay Kulkarni, E. Steve Woodle",Provisional,4/12/2018,0741-001,2/9/2000,"Unassigned, Unassigned",E. Steve Woodle,"Unassigned, Unassigned",611674,,581771,Yes
6725,98-T-041,Genes Encoding the 5H7 Antibody and Methods for Conferring Programmed Cell Death Properties to Cells,"09/500,299",,*United States,US,2/8/2000,,,,0741-002,None,2/9/1999,,No,11/13/2018,Abandoned,"Rockey, Milnamow & Katz, Ltd.","Mueller, Lisa",,"Philimore Holman, David Kranz, Sanjay Kulkarni, E. Steve Woodle",US Utility,4/12/2018,0741-002,2/8/2020,"Unassigned, Unassigned",E. Steve Woodle,"Unassigned, Unassigned",611675,,581771,Yes
6726,98-T-041,Genes Encoding the 5H7 Antibody and Methods for Conferring Programmed Cell Death Properties to Cells,PCT/US00/03234, ,*United States,US,2/8/2000,,WO 00/47713,2/8/2000,0741-003,Small,2/9/1999,,No,4/28/2022,Expired - Inactive,"Rockey, Milnamow & Katz, Ltd.","Mueller, Lisa", ,"Philimore Holman, David Kranz, Sanjay Kulkarni, Jean  Maguire van Seventer, E. Steve Woodle",PCT,4/12/2018,0741-003,8/9/2001,"Unassigned, Unassigned",E. Steve Woodle,"Unassigned, Unassigned",611676,11/22/2001,581771,Yes
6727,98-T-044,Method and System for the Assessment of Tumor Extent In Magnetic Resonance Images,"09/156,413","6,112,112",*United States,US,9/18/1998,8/29/2000, ,,0744-001,Small,9/18/1998,9/18/2018,Yes,8/4/2020,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",US Utility,4/12/2018,0744-001,9/18/2018,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612380,,581774,Yes
6728,98-T-044,Method and System for the Assessment of Tumor Extent In Magnetic Resonance Images,99946877.0EPO, ,European Patent Office (EPO),EP,9/15/1999,,1113752,,0744-003,Small,9/18/1998,,No,5/21/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",Nationalized PCT,4/12/2018,0744-003,9/15/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612381,7/11/2001,581774,Yes
6729,98-T-044,Method and System for the Assessment of Tumor Extent In Magnetic Resonance Images,PCT/US99/20862, ,*United States,US,9/15/1999,,WO 00/16696 A1,9/15/1999,0744-004,Small,9/18/1998,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",PCT,4/12/2018,0744-004,3/18/2001,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612382,3/30/2000,581774,Yes
6730,98-T-044,Method and System for the Assessment to Tumor Extent in Magnetic Resonance Images,2000-573659,,Japan,JP,9/15/1999,,2002-526190,,0744-002,Small,9/18/1998,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Bottomley, Roy",,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",Nationalized PCT,4/12/2018,0744-002,9/15/2019,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612383,8/20/2002,581774,Yes
6731,98-T-044,Method and System for the Assessment to Tumor Extent in Magnetic Resonance Images,"2,343,825",,Canada,CA,5/15/2001,,,,0744-005,Large,9/18/1998,,No,4/12/2018,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Ulrich Bick, Maryellen Giger, Kenneth Gilhuijs",Nationalized PCT,4/12/2018,0744-005,5/15/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612384,,581774,Yes
6732,98-T-045,Chemokines and Neurotoxicity,"60/150,638", ,*United States,US,8/25/1999,, ,8/25/1999,0745-001,Small,8/25/1999,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Trevor Bushnell, Alessandro Fatatis, Olimpia Meucci, Richard Miller, Arthur Simen",Provisional,4/12/2018,0745-001,8/25/2000,"Unassigned, Unassigned",Richard Miller,"Unassigned, Unassigned",610866,,581775,Yes
6733,98-T-045,Method and Compositions for the Regulation of Hippocampal Neuronal Signalling and GP 120 Neurotoxicity,"09/648,638",,*United States,US,8/25/2000,,,,0745-002,Small,8/25/1999,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Trevor Bushnell, Alessandro Fatatis, Olimpia Meucci, Richard Miller, Arthur Simen",US Utility,4/12/2018,0745-002,8/25/2020,"Unassigned, Unassigned",Richard Miller,"Unassigned, Unassigned",612312,,581775,Yes
6734,98-T-047,Dual Sensitivity Mode System for Monitoring Processes & Sensors,"09/256,884","6,107,919",*United States,US,2/24/1999,8/22/2000, ,2/24/1999,98-082-001,Large,2/24/1999,,Yes,4/28/2022,Expired - Inactive,Foley & Lardner,"Rechtin, Michael", ,"Kenneth Gross, Stephan Wegerich, Alan Wilks",US Utility,4/12/2018,98-082-001,2/24/2019,"Ginsburg, Eric",Stephan Wegerich,"Smith, Dane",611497,,581777,Yes
6735,98-T-049,Method and Apparatus for learning the Morphology of a Natural Language,"09/360,822","6,405,161",*United States,US,7/26/1999,6/11/2002, ,7/26/1999,0748-001,Small,7/26/1999,,Yes,4/28/2022,Abandoned,Brinks Gilson & Lione,"Rauch, John",00035,John Goldsmith,US Utility,4/12/2018,0748-001,7/26/2019,"Ginsburg, Eric",John Goldsmith,"Smith, Dane",612295,,581779,Yes
6736,98-T-051,Regulation of Hair Follicle Morphogenesis Based on Beta-Catenin,PCT/US99/27490, ,*United States,US,11/19/1999,6/2/2000, ,11/19/1999,0750-002,None,11/20/1998,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Neil DasGupta, Linda Degenstein, Elaine Fuchs, Uri Gat",PCT,4/12/2018,0750-002,5/20/2001,"Sun, Han",Elaine Fuchs,"Tennant, Thelma",614375,,581781,Yes
6737,98-T-051,Regulation of Hair Follicle Morphogensis,"60/109,284", ,*United States,US,11/20/1998,, ,11/20/1998,0750-001,None,11/20/1998,,Yes,6/8/2022,Expired - Inactive,,, ,"Neil DasGupta, Linda Degenstein, Elaine Fuchs, Uri Gat",Provisional,4/12/2018,0750-001,11/20/1999,"Sun, Han",Elaine Fuchs,"Tennant, Thelma",614376,,581781,Yes
6738,98-T-053,"3,6-Dihydroxy-24-Amidyl Steroid Derivatives","09/560,236","6,645,955",*United States,US,4/28/2000,11/11/2003,,,0751-013,Small,4/30/1999,,No,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",US Utility,4/12/2018,0751-013,4/3/2019,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",610186,,581783,Yes
6739,98-T-053,Methods of Treating Cancers,"60/617,321", ,*United States,US,10/8/2004,, ,10/8/2004,0751-022,Small,10/8/2004,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Provisional,4/12/2018,0751-022,10/8/2005,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613354,,581783,Yes
6740,98-T-053,Methods of Treating Cancers,"11/246,889",,*United States,US,10/7/2005,,US 2007-0032464 A1,,0751-024,Small,10/8/2004,12/19/2009,No,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",US Utility,4/12/2018,0751-024,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",613355,2/8/2007,581783,Yes
6741,98-T-053,Modulators of the Ubiquitos Nuclear Receptor,"60/131,728", ,*United States,US,4/30/1999,, ,4/30/1999,0751-001,Small,4/30/1999,,Yes,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Provisional,4/12/2018,0751-001,4/30/2000,"Dembo, Anna",Ching Song,"Tennant, Thelma",613502,,581783,Yes
6742,98-T-053,Steriod Derivatives,2000-615640,,Japan,JP,4/27/2000,,2002-543216,,0751-012,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-012,4/27/2020,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614634,12/17/2002,581783,Yes
6743,98-T-053,Steriod Derivatives,2001/9793,2001/9793,South Africa,ZA,11/28/2001,5/28/2003,,,0751-018,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-018,11/28/2021,"Dembo, Anna",Ching Song,"Tennant, Thelma",614635,,581783,Yes
6744,98-T-053,Steroid Derivatives,"60/191,864", ,*United States,US,3/24/2000,, ,3/24/2000,0751-002,Small,3/24/2000,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP",, ,"Shutsung Liao, Ching Song",Provisional,4/12/2018,0751-002,3/24/2001,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614636,,581783,Yes
6745,98-T-053,Steroid Derivatives,200106641-4,84460,Singapore,SG,4/27/2000,12/31/2003,,,0751-003,Small,4/30/1999,,No,7/22/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song","Foreign, Non-PCT",4/12/2018,0751-003,4/27/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614637,,581783,Yes
6746,98-T-053,Steroid Derivatives,PI0010197-4,,Brazil,BR,4/27/2000,,,,0751-004,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-004,4/27/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614638,,581783,Yes
6747,98-T-053,Steroid Derivatives,515810,515810,New Zealand,NZ,4/27/2000,5/28/2004,NZ515810A,,0751-005,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-005,4/27/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614639,5/28/2004,581783,Yes
6748,98-T-053,Steroid Derivatives,PCT/US00/11243, ,*United States,US,4/27/2000,,WO 00/66611,4/27/2000,0751-006,Small,4/30/1999,,No,4/28/2022,Expired - Inactive,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",PCT,4/12/2018,0751-006,10/30/2001,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614640,11/9/2000,581783,Yes
6749,98-T-053,Steroid Derivatives,00806958.1,ZL 00806958.1,China,CN,4/27/2000,2/2/2005,CN 1357003A,,0751-007,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-007,4/27/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614641,7/3/2002,581783,Yes
6750,98-T-053,Steroid Derivatives,46672/00,775630,Australia,AU,4/27/2000,8/5/2004,,,0751-008,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-008,4/27/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614642,,581783,Yes
6751,98-T-053,Steroid Derivatives,20015314,,Norway,NO,4/27/2000,,,,0751-009,Small,4/30/1999,,No,9/21/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Validated EPO,4/12/2018,0751-009,4/27/2020,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614643,,581783,Yes
6752,98-T-053,Steroid Derivatives,"2,372,493",,Canada,CA,4/27/2000,,,,0751-010,Large,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-010,4/27/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614644,,581783,Yes
6753,98-T-053,Steroid Derivatives,00928431.6EPO, ,European Patent Office (EPO),EP,4/27/2000,,EP 1 189  922 A2,,0751-011,Small,4/30/1999,,No,5/21/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky", ,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-011,4/27/2020,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614645,3/27/2002,581783,Yes
6754,98-T-053,Steroid Derivatives,89108181,,"Taiwan, Province of China",TW,5/1/2000,,,,0751-014,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song","Foreign, Non-PCT",4/12/2018,0751-014,5/1/2020,"Dembo, Anna",Ching Song,"Tennant, Thelma",614646,,581783,Yes
6755,98-T-053,Steroid Derivatives,01-1336,38598,"Korea, Democratic People's Republic of",KP,10/30/2001,7/4/2003,,,0751-015,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-015,4/26/2015,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614648,,581783,Yes
6756,98-T-053,Steroid Derivatives,PA/A/2001/011070,,Mexico,MX,10/30/2001,,WO 0066611,,0751-016,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-016,10/30/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614649,9/11/2000,581783,Yes
6757,98-T-053,Steroid Derivatives,2001-7013922,,"Korea, Republic of",KR,10/30/2001,,,,0751-017,Small,4/30/1999,,No,9/21/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-017,10/30/2021,"Dembo, Anna",Ching Song,"Tennant, Thelma",614650,,581783,Yes
6758,98-T-053,Steroid Derivatives,WO-00200102635,,Indonesia,ID,11/30/2001,,,,0751-019,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-019,11/30/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614651,,581783,Yes
6759,98-T-053,Steroid Derivatives,2001/01099/DE,,India,IN,11/30/2001,,,,0751-020,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-020,11/30/2021,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614652,,581783,Yes
6760,98-T-053,Steroid Derivatives,"10/705,398",,*United States,US,11/10/2003,,US-2004-152681-A1,,0751-021,Small,4/30/1999,9/28/2007,No,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Continuation,4/12/2018,0751-021,,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614653,8/5/2004,581783,Yes
6761,98-T-053,Steroid Derivatives,"10/962,199",,*United States,US,10/8/2004,,US 2006-0025393 A1,,0751-023,Small,4/30/1999,8/6/2007,No,3/5/2019,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Qing Dai, Shutsung Liao, Ching Song",Continuation in Part,4/12/2018,0751-023,4/30/2019,"Dembo, Anna",Qing Dai,"Tennant, Thelma",614654,2/2/2006,581783,Yes
6762,98-T-053,Steroid Derivatives,146223,,Israel,IL,4/27/2000,,,,0751-025,Small,4/30/1999,,No,4/12/2018,Abandoned,"Cesari and McKenna, LLP","Tsao, Y. Rocky",,"Shutsung Liao, Ching Song",Nationalized PCT,4/12/2018,0751-025,4/27/2020,"Dembo, Anna",Shutsung Liao,"Tennant, Thelma",614655,,581783,Yes
6763,98-T-057,Catalytic Asymmetric Synthesis of Chiral Aziridines,"60/125,608", ,*United States,US,3/19/1999,, ,3/19/1999,0756-001,Small,3/19/1999,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00032,"Jon Antilla, William Wulff",Provisional,4/12/2018,0756-001,3/19/2000,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",610809,,581787,Yes
6764,98-T-057,Catalytic Asymmetric Synthesis of Chiral Aziridines,"09/528,206","6,258,960",*United States,US,3/17/2000,7/10/2001,,,0756-002,Small,3/19/1999,,No,12/4/2018,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00037,"Jon Antilla, William Wulff",US Utility,4/12/2018,0756-002,3/19/2019,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",610810,,581787,Yes
6765,98-T-057,Catalytic Asymmetric Synthesis of Chiral Aziridines,PCT/US00/06978, ,*United States,US,3/17/2000,,WO 00/56708,3/17/2000,0756-003,Small,3/19/1999,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00038,"Jon Antilla, William Wulff",PCT,4/12/2018,0756-003,9/19/2001,"Unassigned, Unassigned",William Wulff,"Unassigned, Unassigned",610811,9/28/2000,581787,Yes
6766,98-T-060,Fourier and Spline-based Reconstruction of Helical CT Images,"09/362,484","6,272,200",*United States,US,7/28/1999,8/7/2001,,,0759-001,Small,7/28/1999,,Yes,4/12/2018,Abandoned,Welsh & Katz,"Christensen, Jon",,"Patrick La Riviere, Xiaochuan Pan",US Utility,4/12/2018,0759-001,7/28/2019,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",611615,,581790,Yes
6767,98-T-060,Fourier and Spline-based Reconstruction of Helical CT Images,PCT/US00/20665, ,*United States,US,7/28/2000,, ,7/28/2000,0759-002,None,7/28/1999,,No,4/28/2022,Abandoned,Welsh & Katz,"Christensen, Jon", ,"Patrick La Riviere, Xiaochuan Pan",PCT,4/12/2018,0759-002,1/28/2002,"Cox, Ben",Xiaochuan Pan,"Smith, Dane",611616,,581790,Yes
6768,99-T-004,Methods for Characterizing Preterm Labor,"09/642,483",,*United States,US,8/18/2000,,,,0764-002,Small,8/19/1999,,No,11/13/2018,Released to Inventors,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Michal Elovitz, Mark Phillippe",US Utility,4/12/2018,0764-002,8/19/2019,"Unassigned, Unassigned",Mark Phillippe,"Unassigned, Unassigned",613158,,581795,Yes
6769,99-T-004,Preterm Labor Marker,"60/149,559", ,*United States,US,8/19/1999,, ,8/19/1999,0764-001,Small,8/19/1999,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Michal Elovitz, Mark Phillippe",Provisional,4/12/2018,0764-001,8/19/2000,"Unassigned, Unassigned",Mark Phillippe,"Unassigned, Unassigned",614139,,581795,Yes
6770,99-T-015,Chemical and Physical Treatments that Stimulate Recombination,"60/139,906", ,*United States,US,6/17/1999,, ,6/17/1999,0774.1-001,Small,6/17/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Sintich, Sharon",30010,"Gregory Copenhaver, Daphne Preuss",Provisional,4/12/2018,0774.1-001,6/17/2000,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",610857,,581806,Yes
6771,99-T-015,Chemical and Physical Treatments that Stimulate Recombination,PCT/US00/06994, ,*United States,US,3/17/2000,,WO 00/54574 A3,3/17/2000,0774.1-002,Small,3/18/1999,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun",,30003-PC,"Gregory Copenhaver, Daphne Preuss",PCT,4/12/2018,0774.1-002,9/18/2001,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",610858,9/21/2000,581806,Yes
6772,99-T-015,Chemical and Physical Treatments that Stimulate Recombination,"09/527,637", ,*United States,US,3/17/2000,, ,,0774.1-003,Small,3/18/1999,,No,7/18/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30009,"Gregory Copenhaver, Daphne Preuss",US Utility,4/12/2018,0774.1-003,3/18/2019,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",610859,,581806,Yes
6773,99-T-015,Chemical and Physical Treatments that Stimulate Recombination,00918037.3EPO, ,European Patent Office (EPO),EP,3/17/2000,, ,,0774.1-004,Small,3/18/1999,,No,7/18/2018,Abandoned,"Marshall, Gerstein & Borun","Sintich, Sharon",30003-EP,"Gregory Copenhaver, Daphne Preuss",Nationalized PCT,4/12/2018,0774.1-004,,"Unassigned, Unassigned",Daphne Preuss,"Unassigned, Unassigned",610860,,581806,Yes
6774,99-T-016,Methods and Compositions Involving Posttranslational Modification of Herpesvirus Proteins,PCT/US00/09215, ,*United States,US,4/7/2000,, ,4/7/2000,0775-002,Small,4/9/1999,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"William Ogle, Bernard Roizman",PCT,4/12/2018,0775-002,10/9/2001,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612969,,581807,Yes
6775,99-T-016,Methods and Compositions involving Posttranslational Modification of Herpesvirus Proteins,"09/544,793",,*United States,US,4/7/2000,,,,0775-003,Small,4/9/1999,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"William Ogle, Bernard Roizman",US Utility,4/12/2018,0775-003,4/9/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",612970,,581807,Yes
6776,99-T-016,Posttranslational Modification of Herpes Virus Proteins,"60/128,500", ,*United States,US,4/9/1999,, ,4/9/1999,0775-001,Small,4/9/1999,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"William Ogle, Bernard Roizman",Provisional,4/12/2018,0775-001,4/9/2000,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",614133,,581807,Yes
6777,99-T-017,Cellular Protein P60,"60/128,501", ,*United States,US,4/9/1999,, ,4/9/1999,0775.1-001,None,4/9/1999,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Renato Bruni, Beatrice Fineschi, William Ogle, Bernard Roizman",Provisional,4/12/2018,0775.1-001,4/9/2000,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",610817,,581808,Yes
6778,99-T-017,Cellular Protein P60 that Interacts with Herpesvirus Regulatory Proteins,"09/545,036",,*United States,US,4/7/2000,,,,0775.1-002,Small,4/9/1999,,Yes,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Renato Bruni, Beatrice Fineschi, William Ogle, Bernard Roizman",US Utility,4/12/2018,0775.1-002,4/9/2019,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",610818,,581808,Yes
6779,99-T-017,Cellular Protein P60 that Interacts with Herpesvirus Regulatory Proteins,PCT/US00/09214, ,*United States,US,4/7/2000,, ,4/7/2000,0775.1-003,None,4/9/1999,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina", ,"William Ogle, Bernard Roizman",PCT,4/12/2018,0775.1-003,10/9/2001,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",610819,,581808,Yes
6780,99-T-017,Cellular Protein P60 that Interacys with Herpesvirus Regulatory Proteins,"09/620,918",,*United States,US,7/21/2000,,,,0775.1-004,None,4/7/2000,,No,4/12/2018,Abandoned,Norton Rose Fulbright US LLP,"Shishima, Gina",,"Renato Bruni, Beatrice Fineschi, William Ogle, Bernard Roizman",Continuation in Part,4/12/2018,0775.1-004,,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",610820,,581808,Yes
6781,99-T-028,"Encapsulating Particles With Coatings That Conform To Size And Shape Of
The Particles","09/575,844","6,558,665",*United States,US,5/18/2000,5/6/2003,,,0786-002,Small,5/18/1999,,No,2/25/2020,Abandoned,Brinks Gilson & Lione,,00039,"Itai Cohen, Milan Mrksich, Sidney Nagel, Horacio Rilo",US Utility,4/12/2018,0786-002,5/18/2019,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",611525,,581819,Yes
6782,99-T-028,Method for Encapsulating Particles,"60/134,612", ,*United States,US,5/18/1999,, ,5/18/1999,0786-001,Small,5/18/1999,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Taylor, Jonathan",00034,"Itai Cohen, Milan Mrksich, Sidney Nagel, Horacio Rilo",Provisional,4/12/2018,0786-001,5/18/2000,"Unassigned, Unassigned",Milan Mrksich,"Unassigned, Unassigned",612448,,581819,Yes
6783,99-T-031,Apicomplexan Chorismate Synthase  Sequences and an Inhibitor of the Shikimate Pathway,"10/268,611", ,*United States,US,10/10/2002,,US 2003-0186352 A1,10/10/2002,0789-001,Small,10/12/2001,,No,4/28/2022,Released to Inventors,Barnes & Thornburg,"Martin, Alice", ,"Piotr Gornicki, Robert Haselkorn, Rima McLeod, Ellen Zuther",US Utility,4/12/2018,0789-001,10/12/2021,"Dembo, Anna",Rima McLeod,"Tennant, Thelma",610439,10/2/2003,581822,Yes
6784,99-T-032,A Novel Calpein-Like Cysteine Protease in Type 2 Diabetes,"60/105,052", ,*United States,US,10/21/1998,, ,10/21/1998,0790-001,Small,10/21/1998,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Eric Boerwinkle, Patrick Concannon, Nancy Cox, Craig Hanis, Manami Hara, C. Harris, Yoshinori Hinokio, Yukio Horikawa, Naoko Iwasaki, Xiangquan Li, Tom Lindner, Hirosata Mashima, Naohisa Oda, Yukie Oda, Kenichi Otani, Kenneth Polonsky, Scamus Sreenan, Yuping Zhou",Provisional,4/12/2018,0790-001,10/21/1999,"Butler, Brittany",Graeme Bell,"Butler, Brittany",610227,,581823,Yes
6785,99-T-032,Methods of Treatment for Type 2 Diabetes,"09/768,877",,*United States,US,1/23/2001,,US-2002-150896-A1,,0790-006,None,10/21/1998,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Eric Boerwinkle, Patrick Concannon, Nancy Cox, Craig Hanis, Manami Hara, C. Harris, Yoshinori Hinokio, Yukio Horikawa, Naoko Iwasaki, Xiangquan Li, Tom Lindner, Hirosata Mashima, Naohisa Oda, Yukie Oda, Kenichi Otani, Kenneth Polonsky, Scamus Sreenan, Yuping Zhou",Divisional,4/12/2018,0790-006,10/21/2018,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613361,10/17/2002,581823,Yes
6786,99-T-032,Methods of Treatment for Type 2 Diabetes,"11/393,643",,*United States,US,3/30/2006,,US-2006-0234276-A1,,0790-007,None,10/21/1998,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Wilson, Mark",,"Graeme Bell, Eric Boerwinkle, Patrick Concannon, Nancy Cox, Craig Hanis, Manami Hara, C. Harris, Yoshinori Hinokio, Yukio Horikawa, Naoko Iwasaki, Xiangquan Li, Tom Lindner, Hirosata Mashima, Naohisa Oda, Yukie Oda, Kenichi Otani, Kenneth Polonsky, Scamus Sreenan, Yuping Zhou",Divisional,4/12/2018,0790-007,10/21/2019,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613362,10/19/2006,581823,Yes
6787,99-T-032,Methods of Treatment of Type 2 Diabetes,PCT/US99/24890, ,*United States,US,10/21/1999,,WO 00/23603A3,10/21/1999,0790-004,Small,10/21/1998,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Eric Boerwinkle, Patrick Concannon, Nancy Cox, Craig Hanis, Manami Hara, Yoshinori Hinokio, Yukio Horikawa, Naoko Iwasaki, Xiangquan Li, Tom Lindner, Hirosata Mashima, Naohisa Oda, Yukie Oda, Kenichi Otani, Kenneth Polonsky, Scamus Sreenan, Yuping Zhou",PCT,4/12/2018,0790-004,4/21/2001,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613363,4/27/2000,581823,Yes
6788,99-T-032,Methods of Treatment of Type 2 Diabetes,99970689.8EPO, ,European Patent Office (EPO),EP,10/21/1999,,EP 1 080 209 A2,,0790-005,Small,10/21/1998,,No,6/8/2022,Abandoned,Norton Rose Fulbright US LLP,"Parker, David", ,"Graeme Bell, Nancy Cox, Craig Hanis, Yukio Horikawa, Naohisa Oda, Kenichi Otani, Kenneth Polonsky, Scamus Sreenan, Yuping Zhou",Nationalized PCT,4/12/2018,0790-005,10/21/2019,"Butler, Brittany",Graeme Bell,"Butler, Brittany",613364,7/3/2001,581823,Yes
6789,99-T-032,Polynucleotides Encoding Calpain 10,"09/422,869","6,235,481",*United States,US,10/21/1999,5/22/2001,,,0790-003,Small,10/21/1998,,No,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve",,"Graeme Bell, Eric Boerwinkle, Patrick Concannon, Nancy Cox, Craig Hanis, Manami Hara, Yoshinori Hinokio, Yukio Horikawa, Naoko Iwasaki, Xiangquan Li, Tom Lindner, Hirosata Mashima, Naohisa Oda, Yukie Oda, Kenneth Polonsky",US Utility,4/12/2018,0790-003,10/21/2018,"Butler, Brittany",Graeme Bell,"Butler, Brittany",614108,,581823,Yes
6790,99-T-032,Treatment of Type 2 Diabetes,"60/134,175", ,*United States,US,5/13/1999,, ,5/13/1999,0790-002,Small,5/13/1999,,Yes,6/8/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Wilson, Mark", ,"Graeme Bell, Eric Boerwinkle, Patrick Concannon, Nancy Cox, Craig Hanis, Manami Hara, C. Harris, Yoshinori Hinokio, Yukio Horikawa, Naoko Iwasaki, Xiangquan Li, Tom Lindner, Hirosata Mashima, Naohisa Oda, Yukie Oda, Kenichi Otani, Kenneth Polonsky, Scamus Sreenan, Yuping Zhou",Provisional,4/12/2018,0790-002,5/13/2000,"Butler, Brittany",Graeme Bell,"Butler, Brittany",615087,,581823,Yes
6791,99-T-034,Method for Inducing Hypothermia,"60/146,753", ,*United States,US,8/2/1999,, ,8/2/1999,0792-001,Small,8/2/1999,,Yes,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00036,"Lance Becker, Tai-Hsin Chien, Kenneth Kasza, Roger Poeppel, Terry Vanden Hoek, Martin Wambsganss",Provisional,4/12/2018,0792-001,8/2/2000,"Cox, Ben",Lance Becker,"Tennant, Thelma",612468,,581825,Yes
6792,99-T-034,Method for inducing Hypothermia,"09/632,195","6,547,811",*United States,US,8/2/2000,4/15/2003,,,0792-003,Small,8/2/1999,10/29/2021,Yes,10/29/2021,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00040,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",US Utility,4/12/2018,0792-003,1/2/2021,"Cox, Ben",Lance Becker,"Tennant, Thelma",612469,,581825,Yes
6793,99-T-034,Method for Inducing Hypothermia,PCT/US00/21185, ,*United States,US,8/2/2000,,WO 01/08593 A2,8/2/2000,0792-004,Small,8/2/1999,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,"Mrksich, Shannon",00041,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",PCT,4/12/2018,0792-004,2/2/2002,"Cox, Ben",Lance Becker,"Tennant, Thelma",612470,2/2/2001,581825,Yes
6794,99-T-034,Method for Inducing Hypothermia,00955344.7EPO, ,European Patent Office (EPO),EP,8/2/2000,, ,,0792-005,Small,8/2/1999,,No,10/30/2018,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00054,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",Nationalized PCT,4/12/2018,0792-005,8/2/2020,"Cox, Ben",Lance Becker,"Tennant, Thelma",612471,,581825,Yes
6795,99-T-034,Method for Inducing Hypothermia,2001-051331,,Japan,JP,8/2/2000,,,,0792-006,Small,8/2/1999,,No,10/30/2018,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00055,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek","Foreign, Non-PCT",4/12/2018,0792-006,8/2/2020,"Cox, Ben",Lance Becker,"Tennant, Thelma",612472,,581825,Yes
6796,99-T-034,Method for Inducing Hypothermia,"10/162,442","6,962,601",*United States,US,6/3/2002,11/8/2005,US-2004-187512-A1,,0792-008,Small,8/2/1999,12/7/2009,Yes,9/10/2021,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",07814.00063,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",Continuation in Part,4/12/2018,0792-008,8/2/2019,"Cox, Ben",Lance Becker,"Tennant, Thelma",612473,9/30/2004,581825,Yes
6797,99-T-034,Method for Inducing Hypothermia,"11/124,958","7,422,601",*United States,US,5/9/2005,9/9/2008,US-2005-203598-A1,,0792-010,None,8/2/1999,1/28/2020,No,9/10/2021,Abandoned,Brinks Gilson & Lione,,07814.00134,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",Continuation,4/12/2018,0792-010,1/2/2021,"Cox, Ben",Lance Becker,"Tennant, Thelma",612474,9/15/2005,581825,Yes
6798,99-T-034,Method for Inducing Hypothermia,"12/183,386", ,*United States,US,7/31/2008,,US-2009-0125087-A1,,0792-011,Small,8/2/2000,10/3/2012,No,8/4/2020,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00234,"Lance Becker, Kenneth Kasza, Terry Vanden Hoek",Continuation,4/12/2018,0792-011,8/2/2020,"Cox, Ben",Lance Becker,"Tennant, Thelma",612475,5/14/2009,581825,Yes
6799,99-T-034,Methods and Apparatus for Producing Phase Change Ice Particulate Saline Slurries,00952378.8EPO, ,European Patent Office (EPO),EP,8/2/2000,, ,,0792-002,Small,8/2/1999,,No,10/30/2018,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00056,"Lance Becker, Kenneth Kasza",Nationalized PCT,4/12/2018,0792-002,8/2/2020,"Cox, Ben",Kenneth Kasza,"Tennant, Thelma",612609,,581825,Yes
6800,99-T-034,Methods and Apparatus for Producing Phase Change Ice Particulate Saline Slurries,2001-513795,,Japan,JP,8/2/2000,,,,0792-007,Small,8/2/1999,,No,10/30/2018,Abandoned,Brinks Gilson & Lione,"Mrksich, Shannon",00057,"Lance Becker, Kenneth Kasza","Foreign, Non-PCT",4/12/2018,0792-007,8/2/2020,"Cox, Ben",Kenneth Kasza,"Tennant, Thelma",612610,,581825,Yes
6801,99-T-034,The Use of Ice Slurries to Transplant Organs,"60/526,619", ,*United States,US,12/2/2003,, ,12/2/2003,0792-009,Small,12/2/2003,,No,4/28/2022,Expired - Inactive,Brinks Gilson & Lione,,00094,Lance Becker,Provisional,4/12/2018,0792-009,12/2/2004,"Cox, Ben",Lance Becker,"Tennant, Thelma",614879,,581825,Yes
6802,99-T-037,Methods and Apparatus for Producing Phase Change Ice Particulate Saline Slurries,"09/586,576","6,413,444",*United States,US,6/2/2000,7/2/2002,,,99-062B-001,Small,8/2/1999,7/2/2002,No,10/21/2020,Expired - Inactive,Joan Pennington,,,Kenneth Kasza,US Utility,4/12/2018,99-062B-001,6/2/2020,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612611,,581828,Yes
6803,99-T-037,Methods and Apparatus for Producing Phase Change Ice Particulate Saline Slurries,PCT/US00/21000, ,*United States,US,8/2/2000,,WO 01/09558 A1,8/2/2000,99-062B-002,Small,8/2/1999,,No,4/28/2022,Expired - Inactive,Fish & Richardson P.C.,"Boivin, Nicolas", ,Kenneth Kasza,PCT,4/12/2018,99-062B-002,2/2/2002,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612612,8/2/2001,581828,Yes
6804,99-T-038,Methods and Apparatus for Producing Phase Change Ice Particulate Perfluorocarbon Slurries,"09/585,770","6,244,052",*United States,US,6/2/2000,6/12/2001,,,99-062C-001,Small,8/2/1999,6/12/2001,No,10/21/2020,Expired - Inactive,Joan Pennington,,,Kenneth Kasza,US Utility,4/12/2018,99-062C-001,6/2/2020,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612607,,581829,Yes
6805,99-T-038,Methods and Apparatus for Producing Phase Change Ice Particulate Perfluorocarbon Slurries,PCT/US00/20998, ,*United States,US,8/2/2001,,WO 01/08464 A2,8/2/2001,99-062C-002,Small,8/2/1999,,No,4/28/2022,Expired - Inactive,Joan Pennington,"Pennington, Joanne", ,Kenneth Kasza,PCT,4/12/2018,99-062C-002,2/2/2002,"Bakalyar, Heather",Kenneth Kasza,"Juggernauth, Anne",612608,2/8/2001,581829,Yes
6806,99-T-040,TEMP SUB,TX-5-329-245,TX-5-329-245,*United States,US,11/8/1999,,,,0796-001,None,7/7/1999,,No,4/12/2018,Registered (Copyright),,,,"Kunio Doi, Roger Engelmann, Takayuki Ishida, Akiko Kano, Shigehiko Katsuragawa, Qiang Li, Xin-Wei Xu, Hitoshi Yoshimura",Copyright Application,4/12/2018,0796-001,11/8/2029,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",614873,,581831,Yes
6807,99-T-041,Production of Cellulase in Plastids of Transgenic Plants,"09/388,788","6,429,359",*United States,US,9/2/1999,8/6/2002,,,0797-001,Small,9/2/1999,,Yes,4/12/2018,Released to Inventors,Barnes & Thornburg,"Martin, Alice",,Gayle Lamppa,US Utility,4/12/2018,0797-001,9/2/2019,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614176,,581832,Yes
6808,99-T-041,Production of Cellulase in Plastids of Transgenic Plants,"60/152,159", ,*United States,US,9/2/1999,, ,9/2/1999,0797-002,Small,9/2/1999,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Gayle Lamppa,Provisional,4/12/2018,0797-002,9/2/2000,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614177,,581832,Yes
6809,99-T-041,Production of Cellulase in Plastids of Transgenic Plants,"09/652,238",,*United States,US,8/31/2000,,,,0797-003,Small,9/2/1999,,No,4/12/2018,Abandoned,Barnes & Thornburg,"Martin, Alice",,Gayle Lamppa,US Utility,4/12/2018,0797-003,9/2/2019,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614178,,581832,Yes
6810,99-T-041,Production of Cellulase in Plastids of Transgenic Plants,PCT/IB00/01214, ,European Patent Office (EPO),EP,8/31/2000,,WO 01/16338 A2,8/31/2000,0797-004,Small,9/2/1999,,No,4/28/2022,Expired - Inactive,Barnes & Thornburg,"Martin, Alice", ,Gayle Lamppa,Nationalized PCT,4/12/2018,0797-004,3/2/2002,"Unassigned, Unassigned",Gayle Lamppa,"Unassigned, Unassigned",614179,3/8/2001,581832,Yes
6811,99-T-045,Improved Contralateral Subtraction Images,"60/160,790", ,*United States,US,10/21/1999,, ,10/21/1999,0802-001,Large,10/21/1999,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Liming Li, Qiang Li",Provisional,4/12/2018,0802-001,10/21/2000,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",611937,,581836,Yes
6812,99-T-045,"Method, System and Computer Readable Medium for Computerized Processing of Contralateral and Temporal Subtraction Images Using Elastic Matching","09/692,218","6,594,378",*United States,US,10/20/2000,7/15/2003,,,0802-002,Large,10/21/1999,6/29/2021,No,6/29/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",US Utility,4/12/2018,0802-002,10/20/2020,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612571,,581836,Yes
6813,99-T-045,"Method, System and Computer Readable Medium for Computerized Processing of Contralateral and Temporal Subtraction Images Using Elastic Matching",PCT/US00/41299, ,*United States,US,10/20/2000,,WO 01 29770,10/20/2000,0802-003,Large,10/21/1999,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Qiang Li",PCT,4/12/2018,0802-003,4/21/2002,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612572,4/26/2001,581836,Yes
6814,99-T-045,"Method, System and Computer Readable Medium for Computerized Processing of Contralateral and Temporal Subtraction Images Using Elastic Matching",2001-532490, ,Japan,JP,10/20/2000,,2003-512112,,0802-004,Large,10/21/1999,,No,10/13/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Liming Li, Qiang Li",Nationalized PCT,4/12/2018,0802-004,10/20/2020,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612573,4/2/2003,581836,Yes
6815,99-T-045,"Method, System and Computer Readable Medium for Computerized Processing of Contralateral and Temporal Subtraction Images Using Elastic Matching.",00984558.7EPO, ,European Patent Office (EPO),EP,10/20/2002,,1222633,,0802-005,Large,10/21/1999,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Kunio Doi, Shigehiko Katsuragawa, Liming Li, Qiang Li",Nationalized PCT,4/12/2018,0802-005,10/20/2022,"Ginsburg, Eric",Kunio Doi,"Juggernauth, Anne",612574,7/17/2002,581836,Yes
6816,99-T-046,Accurate Image Reconstruction for DOI-PET System,"09/693,478","6,528,793",*United States,US,10/20/2000,3/4/2003,,,0803-003,Small,10/22/1999,,No,4/12/2018,Released to Inventors,Welsh & Katz,"Christensen, Jon",,"Chin-Tu Chen, Chien-Min Kao, Xiaochuan Pan",US Utility,4/12/2018,0803-003,10/22/2020,"Ginsburg, Eric",Chin-Tu Chen,"Juggernauth, Anne",610245,,581837,Yes
6817,99-T-046,Accurate Image Reconstruction for DOI-PET Systems,"60/161,150", ,*United States,US,10/22/1999,, ,10/22/1999,0803-001,Small,10/22/1999,,Yes,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Chin-Tu Chen, Yung-Hsi Kao, David Lynn, Xiaochuan Pan",Provisional,4/12/2018,0803-001,10/22/2000,"Ginsburg, Eric",Yung-Hsi Kao,"Juggernauth, Anne",610246,,581837,Yes
6818,99-T-046,Accurate Image Reconstruction for DOI-PET Systems,PCT/US00/41378, ,*United States,US,10/20/2000,,WO 01/43622 A3,10/20/2000,0803-004,Small,10/22/1999,,No,4/28/2022,Expired - Inactive,Welsh & Katz,"Christensen, Jon", ,"Chin-Tu Chen, Chien-Min Kao, Xiaochuan Pan",PCT,4/12/2018,0803-004,4/22/2002,"Ginsburg, Eric",Chin-Tu Chen,"Juggernauth, Anne",610247,6/21/2001,581837,Yes
6819,99-T-046,Accurate Image Reconstruction for DOI-PET Systems,00992979.5EPO, ,European Patent Office (EPO),EP,10/20/2000,,WO0143622,,0803-005,Small,10/22/1999,,No,5/21/2018,Released to Inventors,Welsh & Katz,"Christensen, Jon", ,"Chin-Tu Chen, Chien-Min Kao, Yung-Hsi Kao, Patrick La Riviere, David Lynn, Xiaochuan Pan, Lifeng Yu",Nationalized PCT,4/12/2018,0803-005,10/20/2020,"Ginsburg, Eric",Chin-Tu Chen,"Juggernauth, Anne",610248,6/21/2001,581837,Yes
6820,99-T-046,Multi-Slice Helical CT,Unknown-0164/77373, ,*United States,US,7/28/1999,, ,7/28/1999,0803-002,Small,7/28/1999,,No,4/28/2022,Expired - Inactive,Welsh & Katz,, ,"Chin-Tu Chen, Chien-Min Kao, Yung-Hsi Kao, Patrick La Riviere, David Lynn, Xiaochuan Pan, Lifeng Yu",Provisional,4/12/2018,0803-002,7/28/2000,"Ginsburg, Eric",Chin-Tu Chen,"Juggernauth, Anne",613549,,581837,Yes
6821,99-T-048,Intelligent Seach Software,TXu-1-111-975,TXu-1-111-975,*United States,US,6/11/2003,6/11/2003, ,,0805-007,Small,,,No,9/17/2020,Registered (Copyright),,, ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",Copyright Application,4/12/2018,0805-007,6/11/2023,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612042,,581839,Yes
6822,99-T-048,Intelligent Search Interface for Computer Assisted Interpretation of Medical Images,01908596.8EPO, ,European Patent Office (EPO),EP,2/5/2001,,EP 1252597 A2,,0805-005,Large,2/4/2000,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",Nationalized PCT,4/12/2018,0805-005,2/5/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612043,10/30/2002,581839,Yes
6823,99-T-048,"Method, System and Computer Readable Medium for an Intelligent Search Workstation for Computer Assisted Interpretation of Medical Images","60/180,162", ,*United States,US,2/4/2000,, ,2/4/2000,0805-001,Small,2/4/2000,,Yes,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",Provisional,4/12/2018,0805-001,2/4/2001,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612564,,581839,Yes
6824,99-T-048,"Method, System and Computer Readable Medium for an Intelligent Search Workstation for Computer Assisted Interpretation of Medical Images","60/207,401", ,*United States,US,5/30/2000,, ,5/30/2000,0805-002,Small,5/30/2000,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt",, ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",Provisional,4/12/2018,0805-002,5/30/2001,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612565,,581839,Yes
6825,99-T-048,"Method, System and Computer Readable Medium for an Intelligent Search Workstation for Computer Assisted Interpretation of Medical Images","09/773,636","6,901,156",*United States,US,2/2/2001,5/31/2005,US-2001-043729-A1,,0805-003,Small,2/4/2000,6/29/2021,No,6/29/2021,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard",,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",US Utility,4/12/2018,0805-003,6/17/2022,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612566,11/22/2001,581839,Yes
6826,99-T-048,"Method, System and Computer Readable Medium for an Intelligent Search Workstation for Computer Assisted Interpretation of Medical Images",PCT/US01/00680, ,*United States,US,2/5/2001,,WO 01/057777 A3,2/5/2001,0805-004,Small,2/4/2000,,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",PCT,4/12/2018,0805-004,8/4/2002,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612567,8/9/2001,581839,Yes
6827,99-T-048,"Method, System and Computer Readable Medium for an Intelligent Search Workstation for Computer Assisted Interpretation of Medical Images",2001-556958, ,Japan,JP,2/5/2001,,2003-524492,,0805-006,Small,2/4/2000,,No,9/17/2020,Abandoned,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",Nationalized PCT,4/12/2018,0805-006,2/5/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612568,8/19/2003,581839,Yes
6828,99-T-048,"Method, System and Computer Readable Medium for an Intelligent Search Workstation for Computer Assisted Interpretation of Medical Images","10/793,799","7,184,582",*United States,US,2/5/2001,2/27/2007,US-2004-247166-A1,3/8/2004,0805-008,Large,2/4/2000,6/29/2021,No,4/28/2022,Expired - Inactive,"Oblon, Spivak, McClelland, Maier & Neustadt","Kuesters, Eckhard", ,"Maryellen Giger, Zhimin Huo, Li Lan, Carl Vyborny",Continuation,4/12/2018,0805-008,2/2/2021,"Cox, Ben",Maryellen Giger,"Juggernauth, Anne",612569,12/9/2004,581839,Yes
6829,99-T-049,Method for Generation of Longer cDNA Fragments from SAGE Tags for Gene Identification,"60/173,617", ,*United States,US,12/29/1999,, ,12/29/1999,0806-001,Small,12/29/1999,,Yes,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",39055,"JianJun Chen, Janet Rowley, San Ming Wang",Provisional,4/12/2018,0806-001,12/29/2000,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612452,,581840,Yes
6830,99-T-049,Method for Generation of Longer cDNA Fragments from SAGE Tags for Gene Identification,"60/174,391", ,*United States,US,1/3/2000,, ,1/3/2000,0806-002,Small,1/3/2000,,Yes,5/7/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",39055A,"JianJun Chen, Janet Rowley, San Ming Wang",Provisional,4/12/2018,0806-002,1/3/2001,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612453,,581840,Yes
6831,99-T-049,Method for Generation of Longer cDNA Fragments from SAGE Tags for Gene Identification,PCT/US00/35579, ,*United States,US,12/22/2000,,WO 01/48247 A2,12/22/2000,0806-003,Small,12/29/1999,,No,4/28/2022,Expired - Inactive,"Marshall, Gerstein & Borun","Zeller, James",39055-PC,"JianJun Chen, Janet Rowley, San Ming Wang",PCT,4/12/2018,0806-003,6/29/2002,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612454,7/5/2001,581840,Yes
6832,99-T-049,Method for Generation of Longer cDNA Fragments from Sage Tags for Gene Identification,00990400.4EPO, ,European Patent Office (EPO),EP,12/22/2000,,EP 1 254 257 A2,,0806-004,Small,12/29/1999,,No,5/21/2018,Abandoned,"Marshall, Gerstein & Borun","Merkel, William",39055-EP,"JianJun Chen, Janet Rowley, San Ming Wang",Nationalized PCT,4/12/2018,0806-004,12/22/2020,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612455,7/5/2001,581840,Yes
6833,99-T-049,Method for Generation of Longer cDNA Fragments from SAGE Tags for Gene Identification,"09/748,710","6,916,610",*United States,US,12/22/2000,7/12/2005,US-2003-104369-A1,12/22/2000,0806-005,Small,12/29/1999,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",39055B,"JianJun Chen, Janet Rowley, San Ming Wang",US Utility,4/12/2018,0806-005,12/22/2020,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612456,6/5/2003,581840,Yes
6834,99-T-049,Method for generation of longer cDNA fragments from Sage Tags for Gene Identification,"2,395,920",,Canada,CA,12/22/2000,,,,0806-006,Small,12/29/1999,,No,4/12/2018,Abandoned,"Marshall, Gerstein & Borun","Zeller, James",39055-CA,"JianJun Chen, Janet Rowley, San Ming Wang",Nationalized PCT,4/12/2018,0806-006,12/22/2020,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612457,,581840,Yes
6835,99-T-049,Method for Generation of Longer cDNA Fragments from SAGE Tags for Gene Identification,"11/179,340", ,*United States,US,12/22/2000,, ,7/12/2005,0806-007,Small,12/29/1999,,No,4/28/2022,Abandoned,"Marshall, Gerstein & Borun",,39055C,"JianJun Chen, Janet Rowley, San Ming Wang",Divisional,4/12/2018,0806-007,12/29/2019,"Unassigned, Unassigned",San Ming Wang,"Unassigned, Unassigned",612458,,581840,Yes
6836,99-T-050,Agrobacterium Transformation of Plants,"60/163,763", ,*United States,US,11/5/1999,, ,11/5/1999,0807-001,Small,11/5/1999,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Andrew Binns, Angela Campbell, David Lynn, Jin Zhang",Provisional,4/12/2018,0807-001,11/5/2000,"Unassigned, Unassigned",David Lynn,"Unassigned, Unassigned",610293,,581841,Yes
6837,99-T-050,Improved Compositions and Methods for Agrobacterium Transformation of Plants,"09/735,701", ,*United States,US,12/12/2000,,US 2003-188344-A1,12/12/2000,0807-002,Small,11/5/1999,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Andrew Binns, Angela Campbell, David Lynn, Jin Zhang",US Utility,4/12/2018,0807-002,11/5/2019,"Unassigned, Unassigned",David Lynn,"Unassigned, Unassigned",611936,2/10/2003,581841,Yes
6838,99-T-052,Methods and Compositions of Herpes Simplex Virus UL34 Protein,"60/175,137", ,*United States,US,1/6/2000,, ,1/6/2000,0809-001,None,1/6/2000,,Yes,4/28/2022,Expired - Inactive,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Bernard Roizman, Guo-Jie Ye",Provisional,4/12/2018,0809-001,1/6/2001,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613005,,581843,Yes
6839,99-T-052,Methods and Compositions of Herpes Simplex Virus UL34 Protein,"09/755,598", ,*United States,US,1/5/2001,, ,1/5/2001,0809-002,None,1/6/2000,,No,4/28/2022,Abandoned,Norton Rose Fulbright US LLP,"Highlander, Steve", ,"Bernard Roizman, Richard Vallee, Kevin Vaughn, Guo-Jie Ye",US Utility,4/12/2018,0809-002,1/6/2020,"Dembo, Anna",Bernard Roizman,"Tennant, Thelma",613006,,581843,Yes
6840,TEST,ANL Suspense - use for Incom License Patent Reimbursement,Suspense, ,*United States,US,2/14/2018,, ,2/14/2018,0000-014,None,2/14/2018,9/17/2019,No,5/2/2022,Pending,"UChicago Argonne, LLC",, ,Cole Johnson,Not Provided,9/17/2019, ,,"Unassigned, Unassigned",Cole Johnson,"Neu, Nick",3992411,,4141150,No
6841,TEST01,thelma and cristi test disclosure,123454, ,*United States,US,,, ,1/2/1900,19-T-027-001,Large,2/26/2019,2/27/2019,,4/28/2022,In Interference,Alston & Bird,"Edwards, Jonathan", ,"Cristianne Frazier, Thelma Tennant",Provisional,2/27/2019, ,2/26/2020,"Unassigned, Unassigned",Cristianne Frazier,"Unassigned, Unassigned",3534194,,3534179,No
6842,TEST02,Provisional Application - Anti-Necrosis Plasma  (TEST PATENT RECORD),,,*United States,US,,,,,20-T-049-001,None,,9/30/1900,,4/27/2022,Authorized,Norton Rose Fulbright US LLP,"Shishima, Gina",,Gregory House,Provisional,7/29/2020,,,"Hanna, Kyle",Gregory House,"Hanna, Kyle",4763842,,4464690,No
